Citrus Sinensis ID: 003391

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820---
Protein Sequence
MLIIYCFLFYTIRTATARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSADDPAQDDYVYGIDPSGVPQAVFRKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCEHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKELSESGQDLFVRMAASELDDIERKKPKKKKKVAIVITSVLLVTGVILLGGFVYLWKRRHRKQGKTDGSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNPPESGSSSSKRSLLSTNEITISLIEGR
Secondary Structure (PSIPRED)
cEEEEHHHHHHccccccccccccccccccccEEEccccEEEEEEccccccccEEEEEEEcccccccEEEEccccccccccccEEEEEEcccEEEEEEcccccEEEEEcccccccccEEEEEEcccEEEEccccccccccEEEcccccccccccccEEEEEEccccEEEEEEEccccccccccEEEEEccccccEEEEEEccEEEEEEccccccEEEccccccccccEEEEEEEcccEEEEEEEEccccccEEEEEcccccEEEEEEccccccEEEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccEEEccccccccccEEEEEccccccccccEEEcccccHHHHHHHcccccccccEEccccccccccEEEEcccccccEEccccccEEEEEEcccccccccccccccccEEEEEEEEHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccEEHHHHHHHHHccccccccccccccccEEEEEccccEEEEEEccccccccHHHHHHHHHHHHHccccccccEEccccccccEEEEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHccccccccEEEcccccccccccccccccccccccHHHcccccccccccEEEEEcccccHHHHcccccEEEcccccEEEEEEEEEEcccccccccccccccHHHHHHHHHccccccEEccccccccccHHHHHHHEEEEEEcccccccccccHHHHHHHHccccccccccccEEEccccccccccccccccccccccEEEEEEEcc
Secondary Structure Prediction (SSPRO)
cEEEEEHHEEEHHHcccccccccccccccccEEEccccEEEEEEEcccccccEEEEEEEEcccccEEEEEEccccccccccEEEEEEccccEEEEEEcccccEEEEEcccccccccEEEEEccccEEEEEccccccccEEEEEccccccccccccEccccccccccEEEEEcccccccccccEEEEEccccccEEEEEcccEEEEEccccccEEEccccccccccEEEEEEEEcccEEEEEEEEEcccEEEEEEEccccEEEEEEEEcccccEEEEEEcccccccccccHcccccccEEcccccccccccccccccccHHHHHccccccccEEcccccccccccEEEEccccccccccEEEcccccHHHHHHHHHHcccEEEEEEEEccccccEEEEEEccHHHHHHcccccccEEEEEccHHHHHccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEcHHHHHHHHcccccccccccccccccEccEcccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEEcccccccHEHEccHccccccHHHHHHHHHHHHHHHHHHHHccHccEEcccccHHHEEEcccccEEEccccccEEcccccccccccEEEEEcccccHHHHHHcEEcHHHHHHHHHHHHHHHHccccccccccccccccHHHHHHHHHHccccHHHHcHHHcccccHHHHHHHHHHHHHHHcccccccccHcHEEEEcccccccccccccEEEEEccccccccccccccccEccEEEEEEEccc
Coil and Loop (DISEMBL)
MLIIYCFLFYTIRTAtardtlnlgqsirdgetlvsanesfelgffspgksksryLGIWYKKIGNGTVIWVAnrdaplsdrsgalnissqgNATLVLLNSTngivwssnasrtarNPVAVLLEsgnlvvkdgkdidpdnflwqsfdypshILIAGMKLGVNLVTGLNRFISswksaddpaqddyvygidpsgvpqavfrkgstiryragswnglhwtgmpqlqpnpvytfeyvsneneVFYRFNLikssvpsmmvmnplgdpqrltwmeqtqkwapfvpfsglildqcdnyaLCGAYAVCnmnsnsakceclegfvpkspsewdlldksdgcvrrtqldcehgdgflkresvklpdtrfslvDNKISLLECKelcskncsctayanadvrgggsgcllwfhDLIDMKELSESGQDLFVRMAASElddierkkpkkkkKVAIVITSVLLVTGVILLGGFVYLWKRrhrkqgktdgsskldyndrgnreeemelpiFDWMAIANAtenfsdknklgeggfgpvykgVLIEGQEIAAKRLSkssgqgmeEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEylpnkslndfiFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVlldnemnpkisdfgmarafgidqteantnrvvgtygymppeyaidglfsvksdvfSFGVLVLEIVCgkrnrgfyhadhHHNLLGHAWRLWIEERPVELinkslggsyslSEVLRCIQVGLLcvqqrpedrpnmSSVVLMLsgerslpqpkqpgffternppesgsssskrsllstNEITISLIEGR
Flexible Loop (DISEMBL)
MLIIYCFLFYTIRTATARDTLNLGQSIRDGETLVSAnesfelgffspgksksrYLGIWYKKIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSADDPAQDDYVYGIDPSGVPQAVFRKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLdcehgdgflkresvklpdtrfSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKELSESGQDLFVRMAAselddierkkpkkkkkvaiVITSVLLVTGVILLGGFVYLWKrrhrkqgktdgsskldyndrgnreeEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFgidqteantnrVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGffternppesgsssskrsllstneitisliegr
Low Complexity Region (SEG)
MLIIYCFLFYTIRTATARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSADDPAQDDYVYGIDPSGVPQAVFRKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCEHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKELSESGQDLFVRMAASELDDIERkkpkkkkkVAivitsvllvtgvillggFVYLWKRRHRKQGKTDGSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNPPEsgsssskrsllsTNEITISLIEGR
Disordered region (IsUnstruct)
*LIIYCFLFYTIRTATARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPL*****ALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSADDPAQDDYVYGIDPSGVPQAVFRKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCEHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKEL******LF**********************AIVITSVLLVTGVILLGGFVYLWKR***************************LPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIA**************FENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQ**************************************************************
Disordered Region (DISOPRED)
MLIIYCFLFYTIRTATARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNA******PVAVLLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSADDPAQDDYVYGIDPSGVPQAVFRKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCEHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKELSESGQDLFVRMAASELDDIERKKPKKKKKVAIVITSVLLVTGVILLGGFVYLWKRRH**********************EMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFF*********************EITISLIEGR
Disordered Region (DISEMBL)
MLIIYCFLFYTIRTATARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSADDPAQDDYVYGIDPSGVPQAVFRKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCEHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKELSESGQDLFVRMAASELDDIE*********VAIVITSVLLVTGVILLGGFVYLWKRRH***********LDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTE**************LLSTNEITISLIEGR
Disordered Region (DISPRO)
MLIIYCFLFYTIRTATARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSADDPAQDDYVYGIDPSGVPQAVFRKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCEHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKELSESGQDLFVRMAASELDDIERKKPKKKKKVAIVITSVLLVTGVILLGGFVYLWKRRHRKQGK*****************EMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERN************LLSTNEITISLIEGR
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MLIIYCFLFYTIRTATARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSADDPAQDDYVYGIDPSGVPQAVFRKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCEHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKELSESGQDLFVRMAASELDDIERKKPKKKKKVAIVITSVLLVTGVILLGGFVYLWKRRHRKQGKTDGSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNPPESGSSSSKRSLLSTNEITISLIEGR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	823	2.2.26 [Sep-21-2011]
O81832	783	G-type lectin S-receptor-	yes	no	0.933	0.980	0.532	0.0
O81905	850	Receptor-like serine/thre	no	no	0.967	0.936	0.483	0.0
O81833	815	G-type lectin S-receptor-	no	no	0.931	0.941	0.507	0.0
Q39086	843	Receptor-like serine/thre	no	no	0.946	0.924	0.485	0.0
Q9S972	847	Receptor-like serine/thre	no	no	0.950	0.923	0.475	0.0
Q09092	857	Putative serine/threonine	N/A	no	0.973	0.934	0.461	0.0
Q9ZT07	833	G-type lectin S-receptor-	no	no	0.963	0.951	0.457	0.0
P0DH86	853	G-type lectin S-receptor-	no	no	0.963	0.929	0.467	0.0
Q9LPZ3	845	G-type lectin S-receptor-	no	no	0.962	0.937	0.456	0.0
O81906	849	G-type lectin S-receptor-	no	no	0.957	0.928	0.447	0.0

>sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4

 Score =  856 bits (2212), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 442/830 (53%), Positives = 572/830 (68%), Gaps = 62/830 (7%)

Query: 1   MLIIYCFLFYTIRTATARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYK 60
           +LII   LF TI  A A D L   Q+++DG+T+VS   SFE+GFFSPG S++RYLGIWYK
Sbjct: 9   LLIIS--LFSTILLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWYK 66

Query: 61  KIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASR-----TARN 115
           KI   TV+WVANRD+PL D SG L +S   N +L L N  N I+WSS++S      + RN
Sbjct: 67  KISLQTVVWVANRDSPLYDLSGTLKVSE--NGSLCLFNDRNHIIWSSSSSPSSQKASLRN 124

Query: 116 PVAVLLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSA 175
           P+  +L++GNLVV++  D D D ++WQS DYP  + + GMK G+N VTGLNRF++SW++ 
Sbjct: 125 PIVQILDTGNLVVRNSGD-DQD-YIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAI 182

Query: 176 DDPAQDDYVYGIDPSGVPQAVFRKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEYVSNE 235
           DDP+  +Y   +DP+GVPQ   +K S + +R G WNGL +TGMP L+PNP+Y +EYV  E
Sbjct: 183 DDPSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFTE 242

Query: 236 NEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGA 295
            EV+Y + L   SV + M +NP G  QR TW++  Q W  ++     ++D CD Y LCG+
Sbjct: 243 EEVYYTYKLENPSVLTRMQLNPNGALQRYTWVDNLQSWNFYL---SAMMDSCDQYTLCGS 299

Query: 296 YAVCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCEHG-DGFLKRESVKLP 354
           Y  CN+N + A C CL+GFV K+P  W   D S+GCVRR +LDC  G DGFLK   +KLP
Sbjct: 300 YGSCNINESPA-CRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLP 358

Query: 355 DTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKELSESGQD 414
           DTR S  D  + L ECK++C +NC+C+AY+  D+R GG GC+LWF DLID++E +E+GQD
Sbjct: 359 DTRTSWYDKNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIREYNENGQD 418

Query: 415 LFVRMAASELDDIERKKPKKKKKVAIVITSVLLVTGVILLGGFVYLWKRRHRKQGKTDGS 474
           L+VR+A+SE++ ++R+  +                                         
Sbjct: 419 LYVRLASSEIETLQRESSR----------------------------------------- 437

Query: 475 SKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAK 534
                + R   EE++ELP  D   ++ AT  FS  NKLG+GGFGPVYKG L  GQE+A K
Sbjct: 438 ----VSSRKQEEEDLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVK 493

Query: 535 RLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDV 594
           RLS++S QG+EEF+NE+ LIAKLQHRNLVK++G C   +ERMLIYEY PNKSL+ FIFD 
Sbjct: 494 RLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDK 553

Query: 595 TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 654
            R + LDW KR +II GIARG+LYLH+DSRLRIIHRDLKASNVLLD++MN KISDFG+AR
Sbjct: 554 ERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLAR 613

Query: 655 AFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHAD 714
             G D+TEANT RVVGTYGYM PEY IDG FS+KSDVFSFGVLVLEIV G+RNRGF + +
Sbjct: 614 TLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRNEE 673

Query: 715 HHHNLLGHAWRLWIEERPVELINKSLGGSYS-LSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
           H  NLLGHAWR ++E++  E+I++++  S + +SEVLR I +GLLCVQQ P+DRPNMS V
Sbjct: 674 HKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMSVV 733

Query: 774 VLMLSGERSLPQPKQPGFFTERNPPESGSSSSKRSLLSTNEITISLIEGR 823
           VLMLS E  L  P+QPGFF ERN   S + S    + S N  T+S+I+ R
Sbjct: 734 VLMLSSEMLLLDPRQPGFFNERNLLFSDTVSINLEIPSNNFQTMSVIDPR 783

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1

 Score =  776 bits (2004), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 408/844 (48%), Positives = 557/844 (65%), Gaps = 48/844 (5%)

Query: 10  YTIRTATARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIW 69
           Y+I   T   + +L  +I    T+VS    FELGFF PG     YLGIWYK I   T +W
Sbjct: 25  YSISANTLSASESL--TISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVW 82

Query: 70  VANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASR-TARNP-VAVLLESGNLV 127
           VANRD PLS   G L IS   ++ LV+L+ ++  VWS+N +    R+P VA LL++GN V
Sbjct: 83  VANRDTPLSSSIGTLKIS---DSNLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFV 139

Query: 128 VKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSADDPAQDDYVYGI 187
           ++D K+  PD  LWQSFD+P+  L+  MKLG +  TG NRFI SWKS DDP+  D+ + +
Sbjct: 140 LRDSKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKL 199

Query: 188 DPSGVPQAVFRKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEYVSNENEVFYRFNLIKS 247
           +  G P+       +  YR+G WNG+ ++G+P++QP     F + +++ EV Y F + KS
Sbjct: 200 ETEGFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVTYSFRITKS 259

Query: 248 SVPSMMVMNPLGDPQRLTWMEQTQKWAPF--VPFSGLILDQCDNYALCGAYAVCNMNSNS 305
            V S + ++  G  QR TW+E  Q W  F   P      DQCD Y  CG Y  C+ N+ S
Sbjct: 260 DVYSRLSISSSGLLQRFTWIETAQNWNQFWYAP-----KDQCDEYKECGVYGYCDSNT-S 313

Query: 306 AKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCEHGDGFLKRESVKLPDTRFSLVDNKI 365
             C C++GF P++P  W L D SDGCVR+T L C  GDGF++ + +KLPDT  + VD  I
Sbjct: 314 PVCNCIKGFKPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGI 373

Query: 366 SLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKELSESGQDLFVRMAASELD 425
            + EC++ C ++C+CTA+AN D+RG GSGC+ W  +L D++  ++ GQDL+VR+AA++L+
Sbjct: 374 GVKECEQKCLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYAKGGQDLYVRLAATDLE 433

Query: 426 DIERKKPKKKKKVAIVITSVLLVTGVILLGGFVY-LWKRRHRKQGKTDG--------SSK 476
           D       K+ + A +I S + V+ ++LL   ++ LWKR+ ++    +         S  
Sbjct: 434 D-------KRNRSAKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRD 486

Query: 477 LDYND----------RGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLI 526
           L  N+          R N  +++ELP+ ++  +A AT NFS+ NKLG+GGFG VYKG L+
Sbjct: 487 LLMNEVVISSRRHISRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLL 546

Query: 527 EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKS 586
           +GQE+A KRLSK+S QG +EF+NEV LIA+LQH NLV+L+ CC    E+MLIYEYL N S
Sbjct: 547 DGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLS 606

Query: 587 LNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPK 646
           L+  +FD +R+  L+W  R  II GIARGLLYLHQDSR RIIHRDLKASN+LLD  M PK
Sbjct: 607 LDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPK 666

Query: 647 ISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR 706
           ISDFGMAR FG D+TEANT +VVGTYGYM PEYA+DG+FS+KSDVFSFGVL+LEI+  KR
Sbjct: 667 ISDFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKR 726

Query: 707 NRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSL---SEVLRCIQVGLLCVQQR 763
           N+GFY++D   NLLG  WR W E + +E+I+  +  S S     E+LRCIQ+GLLCVQ+R
Sbjct: 727 NKGFYNSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQER 786

Query: 764 PEDRPNMSSVVLMLSGER-SLPQPKQPGFFTERNPPESGSSSSKR---SLLSTNEITISL 819
            EDRP MS V+LML  E  ++PQPK PG+  ER+  ++ SSSSK+      + N+IT+S+
Sbjct: 787 AEDRPTMSLVILMLGSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSV 846

Query: 820 IEGR 823
           ++ R
Sbjct: 847 LDAR 850

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1

 Score =  761 bits (1966), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 412/812 (50%), Positives = 549/812 (67%), Gaps = 45/812 (5%)

Query: 27  IRDGETLVSANESFELGFFS---PGKSKSRYLGIWYKKIGNGTVIWVANRDAPLSDRSGA 83
           ++DG+TL S ++ F+LGFFS     + + R+LG+WY  +    V+WVANR+ PL   SG 
Sbjct: 34  LKDGDTLSSPDQVFQLGFFSLDQEEQPQHRFLGLWY--MEPFAVVWVANRNNPLYGTSGF 91

Query: 84  LNISSQGNATLVLLNSTNGIVWSSNASRTA-----RNPVAVLLESGNLVVKDGKDIDPDN 138
           LN+SS G+  L L +  +  +WSS++S T       NP+  +  SGNL+  DG++     
Sbjct: 92  LNLSSLGD--LQLFDGEHKALWSSSSSSTKASKTANNPLLKISCSGNLISSDGEEA---- 145

Query: 139 FLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSADDPAQDDYVYGIDPSGVPQAVFR 198
            LWQSFDYP + ++AGMKLG N  T +   +SSWK+  DP+  D+   +D  G+PQ + R
Sbjct: 146 VLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKDPSPGDFTLSLDTRGLPQLILR 205

Query: 199 KG--STIRYRAGSWNGLHWTGMPQL-QPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVM 255
           K   S+  YR GSWNGL +TG P + + N ++ +++ S+  EV Y +   +  + S +V+
Sbjct: 206 KNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYKFTSSAQEVNYSWT-PRHRIVSRLVL 264

Query: 256 NPLGDPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYAVCNMNS-NSAKCECLEGF 314
           N  G   R    +Q Q    ++  +    D+CD Y++CGAYAVC +NS N+  C CL+GF
Sbjct: 265 NNTGKLHRFIQSKQNQ----WILANTAPEDECDYYSICGAYAVCGINSKNTPSCSCLQGF 320

Query: 315 VPKSPSEWDLLDKSDGCVRRTQLDCEHGDGFLKRESVKLPDTRFSLVD--NKISLLECKE 372
            PKS  +W++   + GCV     +CE  D F+K   +KLPDT +S  D  N+++L +CK 
Sbjct: 321 KPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLPDTSWSWYDAKNEMTLEDCKI 380

Query: 373 LCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKELSESGQDLFVRMAASELDDIERKKP 432
            CS NCSCTAYAN D+R GG GCLLWF DL+DM+E S  GQD+++RM  ++++     K 
Sbjct: 381 KCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSSFGQDVYIRMGFAKIE----FKG 436

Query: 433 KKKKKVAIVITSVLLVTGVILLGGFVYLWKRRHRKQGKTDGSSKLDYNDRGNREEEMELP 492
           ++   + +     + V  V++   F     +R+R +             +G  EE+++LP
Sbjct: 437 REVVGMVVGSVVAIAVVLVVVFACFRKKIMKRYRGENFR----------KGIEEEDLDLP 486

Query: 493 IFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVL 552
           IFD   I+ AT++FS  N LG GGFGPVYKG L +GQEIA KRLS +SGQG+EEF+NEV 
Sbjct: 487 IFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEEFKNEVK 546

Query: 553 LIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGI 612
           LIAKLQHRNLV+L+GCC Q +E MLIYEY+PNKSL+ FIFD  RS  LDW KR  II G+
Sbjct: 547 LIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRMNIINGV 606

Query: 613 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTY 672
           ARG+LYLHQDSRLRIIHRDLKA NVLLDN+MNPKISDFG+A++FG DQ+E++TNRVVGTY
Sbjct: 607 ARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRVVGTY 666

Query: 673 GYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP 732
           GYMPPEYAIDG FSVKSDVFSFGVLVLEI+ GK NRGF HADH  NLLGH W++W+E+R 
Sbjct: 667 GYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLGHVWKMWVEDRE 726

Query: 733 VELINKSLGGSYS-LSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGF 791
           +E+  +      S + EVLRCI V LLCVQQ+PEDRP M+SVVLM   + SLP P QPGF
Sbjct: 727 IEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMASVVLMFGSDSSLPHPTQPGF 786

Query: 792 FTERNPPESGSSSSKRSLLSTNEITISLIEGR 823
           FT RN P+  SS S R   S NE++I++++GR
Sbjct: 787 FTNRNVPDISSSLSLR---SQNEVSITMLQGR 815

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1

 Score =  753 bits (1943), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 401/826 (48%), Positives = 553/826 (66%), Gaps = 47/826 (5%)

Query: 26  SIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLSDRSGALN 85
           +I   +T++S ++ FELGFF+P  S   YLGIWYK I   T +WVANRD PLS  +G L 
Sbjct: 37  TISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVANRDNPLSSSNGTLK 96

Query: 86  ISSQGNATLVLLNSTNGIVWSSNASR-TARNPVAV-LLESGNLVVKDGKDIDPDNFLWQS 143
           IS  GN  LV+ + ++  VWS+N +    R+PVA  LL++GN +++D  +      LWQS
Sbjct: 97  IS--GN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRDSNN----RLLWQS 149

Query: 144 FDYPSHILIAGMKLGVNLVTGLNRFISSWKSADDPAQDDYVYGIDPSGVPQAVFRKGSTI 203
           FD+P+  L+A MKLG +  TG NR + SWK+ DDP+  ++   ++ S  P+       +I
Sbjct: 150 FDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFPEFYICSKESI 209

Query: 204 RYRAGSWNGLHWTGMPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQR 263
            YR+G WNG+ ++ +P         + + +++ EV Y + + K+++ S + +N  G  QR
Sbjct: 210 LYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKEEVTYSYRINKTNLYSRLYLNSAGLLQR 269

Query: 264 LTWMEQTQKWAP--FVPFSGLILDQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKSPSE 321
           LTW E TQ W    + P      D CDNY +CG +  C+ NS    C C++GF P +   
Sbjct: 270 LTWFETTQSWKQLWYSP-----KDLCDNYKVCGNFGYCDSNS-LPNCYCIKGFKPVNEQA 323

Query: 322 WDLLDKSDGCVRRTQLDCEHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCT 381
           WDL D S GC+R+T+L C+  DGF + + +KLPDT  ++VD +I L  CKE C ++C+CT
Sbjct: 324 WDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKERCLEDCNCT 383

Query: 382 AYANADVRGGGSGCLLWFHDLIDMKELSESGQDLFVRMAASELDDIERKKPKKKKKVAIV 441
           A+ANAD+R GGSGC++W  +++DM+  ++ GQDL+VR+AA+EL+D +R K +K    +I 
Sbjct: 384 AFANADIRNGGSGCVIWTREILDMRNYAKGGQDLYVRLAAAELED-KRIKNEKIIGSSIG 442

Query: 442 ITSVLLVTGVILLGGFVYLWKRRHRK----------QGKTDGS-------SKLDYNDRGN 484
           ++ +LL++ VI      + WKR+ ++          Q ++  S       S+  Y  +  
Sbjct: 443 VSILLLLSFVIF-----HFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRRGYTSKEK 497

Query: 485 REEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGM 544
           + E +ELP+ +  A+A AT NFS+ NKLG+GGFG VYKG L++G+EIA KRLSK S QG 
Sbjct: 498 KSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGT 557

Query: 545 EEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSK 604
           +EF NEV LIAKLQH NLV+L+GCC  + E+MLIYEYL N SL+  +FD TRS  L+W K
Sbjct: 558 DEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQK 617

Query: 605 RCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 664
           R  II GIARGLLYLHQDSR RIIHRDLKASNVLLD  M PKISDFGMAR FG ++TEAN
Sbjct: 618 RFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEAN 677

Query: 665 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW 724
           T RVVGTYGYM PEYA+DG+FS+KSDVFSFGVL+LEI+ GKRN+GFY+++   NLLG  W
Sbjct: 678 TRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVW 737

Query: 725 RLWIEERPVELIN----KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 780
           R W E   +E+++     SL   +   E+LRCIQ+GLLCVQ+R EDRP MSSV++ML  E
Sbjct: 738 RHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSE 797

Query: 781 RS-LPQPKQPGFFTERNPPESGSSSSKR--SLLSTNEITISLIEGR 823
            + +PQPK+PGF   R+P E+ SSSS +     + N+IT+S+I+ R
Sbjct: 798 TTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843

Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2

 Score =  748 bits (1932), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 393/827 (47%), Positives = 541/827 (65%), Gaps = 45/827 (5%)

Query: 26  SIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLSDRSGALN 85
           +I   +T++S ++ FELGFF+P  S   YLGIWYK I   T +WVANRD PLS  +G L 
Sbjct: 37  TISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVANRDNPLSSSNGTLK 96

Query: 86  ISSQGNATLVLLNSTNGIVWSSNASR-TARNPVAV-LLESGNLVVKDGKDIDPDNFLWQS 143
           IS   +  LV+ + ++  VWS+N +    R+PVA  LL+ GN V++D K+  P  FLWQS
Sbjct: 97  IS---DNNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRDSKNNKPSGFLWQS 153

Query: 144 FDYPSHILIAGMKLGV-NLVTGLNRFISSWKSADDPAQDDYVYGIDPSGVPQAVFRKGST 202
           FD+P+  L++ MK+G  N   G NR + SWK+ DDP+  D+   +  SG P+       +
Sbjct: 154 FDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEFYIYNKES 213

Query: 203 IRYRAGSWNGLHWTGMPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQ 262
           I YR+G W G  ++ +P ++P       +  N  +V Y + + K+++ S++ ++  G  Q
Sbjct: 214 ITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQQVVYSYRVNKTNIYSILSLSSTGLLQ 273

Query: 263 RLTWMEQTQKWAP--FVPFSGLILDQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKSPS 320
           RLTWME  Q W    + P      D CDNY  CG Y  C+ N+ S  C C++GF P +  
Sbjct: 274 RLTWMEAAQSWKQLWYSP-----KDLCDNYKECGNYGYCDANT-SPICNCIKGFEPMN-E 326

Query: 321 EWDLLDKSDGCVRRTQLDCEHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSC 380
           +  L D S GCVR+T+L C+  DGF++ + ++LPDT  + VD  I L EC+E C K C+C
Sbjct: 327 QAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCLKGCNC 386

Query: 381 TAYANADVRGGGSGCLLWFHDLIDMKELSESGQDLFVRMAASELDDIERKKPKKKKKVAI 440
           TA+AN D+R GGSGC++W   L D++  ++ GQDL+VR+AA +L+D +R K KK    +I
Sbjct: 387 TAFANTDIRNGGSGCVIWSGGLFDIRNYAKGGQDLYVRVAAGDLED-KRIKSKKIIGSSI 445

Query: 441 VITSVLLVTGVILLGGFVYLWKRRHRKQGKTDG-----------------SSKLDYNDRG 483
            ++ +LL++ +I      + WKR+ ++                        +   Y  + 
Sbjct: 446 GVSILLLLSFIIF-----HFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYTSKE 500

Query: 484 NREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQG 543
           N+ + +ELP+ +W A+A AT NFS  NKLG+GGFG VYKG+L++G+EIA KRLSK S QG
Sbjct: 501 NKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQG 560

Query: 544 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWS 603
            +EF NEV LIAKLQH NLV+L+GCC  + E+MLIYEYL N SL+  +FD TRS  L+W 
Sbjct: 561 TDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQ 620

Query: 604 KRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 663
           KR  II GIARGLLYLHQDSR RIIHRDLKASNVLLD  M PKISDFGMAR FG ++TEA
Sbjct: 621 KRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEA 680

Query: 664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 723
           NT RVVGTYGYM PEYA+DG+FS+KSDVFSFGVL+LEI+ GKRN+GFY+++   NLLG  
Sbjct: 681 NTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFV 740

Query: 724 WRLWIEERPVELIN----KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 779
           WR W E + +E+++     +L   +   E+LRCIQ+GLLCVQ+R EDRP MSSV++ML  
Sbjct: 741 WRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGS 800

Query: 780 ERS-LPQPKQPGFFTER--NPPESGSSSSKRSLLSTNEITISLIEGR 823
           E + +PQPK+PGF   R     +S SS+ +    + N++T+S+I+ R
Sbjct: 801 ETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2

 Score =  734 bits (1896), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 396/858 (46%), Positives = 550/858 (64%), Gaps = 57/858 (6%)

Query: 1   MLIIYCFLFYTIRTATARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSR-YLGIWY 59
           M++I+  L   I T ++ ++L    +I   +TLVS    FE+GFF   ++ SR YLG+WY
Sbjct: 22  MILIHPALSIYINTLSSTESL----TISSNKTLVSPGSIFEVGFF---RTNSRWYLGMWY 74

Query: 60  KKIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASR-TARNPV- 117
           KK+ + T +WVANRD PLS+  G L IS  GN  LVLL+ +N  VW +N +R   R+PV 
Sbjct: 75  KKVSDRTYVWVANRDNPLSNAIGTLKIS--GN-NLVLLDHSNKPVWWTNLTRGNERSPVV 131

Query: 118 AVLLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSADD 177
           A LL +GN V++D  + D   +LWQSFDYP+  L+  MKLG NL TGLNRF++SW+S+DD
Sbjct: 132 AELLANGNFVMRDSSNNDASEYLWQSFDYPTDTLLPEMKLGYNLKTGLNRFLTSWRSSDD 191

Query: 178 PAQDDYVYGIDPSGVPQAVFRKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEYVSNENE 237
           P+  ++ Y ++   +P+    + +   +R+G WNG+ ++G+P+ Q      + ++ N  E
Sbjct: 192 PSSGNFSYKLETQSLPEFYLSRENFPMHRSGPWNGIRFSGIPEDQKLSYMVYNFIENNEE 251

Query: 238 VFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYA 297
           V Y F +  +S  S + +   G  QRLTW    + W  F  +S  +  QCD Y +CG YA
Sbjct: 252 VAYTFRMTNNSFYSRLTLISEGYFQRLTWYPSIRIWNRF--WSSPVDPQCDTYIMCGPYA 309

Query: 298 VCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCEHGDGFLKRESVKLPDTR 357
            C++N+ S  C C++GF P++  +WD    + GC+RRTQL C  GDGF + + +KLP+T 
Sbjct: 310 YCDVNT-SPVCNCIQGFNPRNIQQWDQRVWAGGCIRRTQLSCS-GDGFTRMKKMKLPETT 367

Query: 358 FSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKELSES---GQD 414
            + VD  I + ECK+ C  +C+CTA+ANAD+R GGSGC++W   L D++  +     GQD
Sbjct: 368 MATVDRSIGVKECKKRCISDCNCTAFANADIRNGGSGCVIWTERLEDIRNYATDAIDGQD 427

Query: 415 LFVRMAASELDDIERKKPKKKKKVAIVITSVLLVTGVILLGGFVYLWKRRHRKQ------ 468
           L+VR+AA+++         KK+  +  I S+ +   V+LL     LWKR+ ++       
Sbjct: 428 LYVRLAAADI--------AKKRNASGKIISLTVGVSVLLLLIMFCLWKRKQKRAKASAIS 479

Query: 469 -GKTDGSSKLDYND---RGNRE-------EEMELPIFDWMAIANATENFSDKNKLGEGGF 517
              T  +  L  N+      RE       EE+ELP+ +   +  ATENFS  NKLG+GGF
Sbjct: 480 IANTQRNQNLPMNEMVLSSKREFSGEYKFEELELPLIEMETVVKATENFSSCNKLGQGGF 539

Query: 518 GPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 577
           G VYKG L++G+EIA KRLSK+S QG +EF NEV LIA+LQH NLV+++GCC + DE+ML
Sbjct: 540 GIVYKGRLLDGKEIAVKRLSKTSVQGTDEFMNEVTLIARLQHINLVQVLGCCIEGDEKML 599

Query: 578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNV 637
           IYEYL N SL+ ++F  TR   L+W++R  I  G+ARGLLYLHQDSR RIIHRDLK SN+
Sbjct: 600 IYEYLENLSLDSYLFGKTRRSKLNWNERFDITNGVARGLLYLHQDSRFRIIHRDLKVSNI 659

Query: 638 LLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVL 697
           LLD  M PKISDFGMAR F  D+TEANT +VVGTYGYM PEYA+ G+FS KSDVFSFGV+
Sbjct: 660 LLDKNMIPKISDFGMARIFERDETEANTMKVVGTYGYMSPEYAMYGIFSEKSDVFSFGVI 719

Query: 698 VLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS-------YSLSEVL 750
           VLEIV GK+NRGFY+ D+ ++LL + W  W E R +E+++  +  S       +   EVL
Sbjct: 720 VLEIVSGKKNRGFYNLDYENDLLSYVWSRWKEGRALEIVDPVIVDSLSSQPSIFQPQEVL 779

Query: 751 RCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS-LPQPKQPGFFTERNPPESGSSSS---- 805
           +CIQ+GLLCVQ+  E RP MSSVV M   E + +PQPK PG+   R+P E   SSS    
Sbjct: 780 KCIQIGLLCVQELAEHRPAMSSVVWMFGSEATEIPQPKPPGYCVRRSPYELDPSSSWQCD 839

Query: 806 KRSLLSTNEITISLIEGR 823
           +    + N+ T S+I+ R
Sbjct: 840 ENESWTVNQYTCSVIDAR 857

Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain.

Brassica oleracea var. acephala (taxid: 3713)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3

 Score =  719 bits (1855), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 378/826 (45%), Positives = 530/826 (64%), Gaps = 33/826 (3%)

Query: 19  DTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLS 78
           DT+   QS+RDGE ++SA + F  GFFS G S+ RY+GIWY +I   T++WVANRD P++
Sbjct: 20  DTIMRRQSLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDHPIN 79

Query: 79  DRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNP--VAVLLESGNLVVKDGKDIDP 136
           D SG +  S++GN ++   ++   ++WS+N S +   P  VA L + GNLV+ D   +  
Sbjct: 80  DTSGMVKFSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLGNLVLFD--PVTG 137

Query: 137 DNFLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSADDPAQDDYVYGIDPSGVPQAV 196
            +F W+SFD+P+   +  M+LG     GL+R ++SWKS  DP   D +  ++  G PQ +
Sbjct: 138 RSF-WESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGFPQLI 196

Query: 197 FRKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMN 256
             KG T  +R GSW G  W+G+P++    ++   +V+NE+EV + + +  +SV +  ++N
Sbjct: 197 LYKGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVITRTMVN 256

Query: 257 PLGDPQRLTWMEQTQKWAPF--VPFSGLILDQCDNYALCGAYAVCNM-NSNSAKCECLEG 313
             G   R TW+ + ++W  F  VP      +QCDNYA CG    C+  +S + +C CL G
Sbjct: 257 ETGTMHRFTWIARDKRWNDFWSVP-----KEQCDNYAHCGPNGYCDSPSSKTFECTCLPG 311

Query: 314 FVPKSPSEWDLLDKSDGCVRRTQLD-CEHGDGFLKRESVKLPDTRFSLVDNKISLLECKE 372
           F PK P  W L D S GC ++ +   C   DGF+K + +K+PDT  + VD  I+L ECK+
Sbjct: 312 FEPKFPRHWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTSDASVDMNITLKECKQ 371

Query: 373 LCSKNCSCTAYANA--DVRGGGSGCLLWFHDLIDMKELSESGQDLFVRMAASELDDIERK 430
            C KNCSC AYA+A  + + G  GCL W   ++D +    SGQD ++R+   EL    R 
Sbjct: 372 RCLKNCSCVAYASAYHESKRGAIGCLKWHGGMLDARTYLNSGQDFYIRVDKEELARWNRN 431

Query: 431 KPKKKKKVAIVITSVLLVTGVILLGGFVYLWKRRHRKQGKTDGSSK------LDYNDRGN 484
               K++V +++ S  L+  V+LL   ++   R  RK  +   SS        D+++   
Sbjct: 432 GLSGKRRVLLILIS--LIAAVMLLTVILFCVVRERRKSNRHRSSSANFAPVPFDFDESFR 489

Query: 485 REEEM----ELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSS 540
            E++     ELP+FD   I  AT NFS +NKLG GGFGPVYKGVL    EIA KRLS++S
Sbjct: 490 FEQDKARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKRLSRNS 549

Query: 541 GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFL 600
           GQGMEEF+NEV LI+KLQHRNLV+++GCC + +E+ML+YEYLPNKSL+ FIF   +   L
Sbjct: 550 GQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEEQRAEL 609

Query: 601 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 660
           DW KR +I+ GIARG+LYLHQDSRLRIIHRDLKASN+LLD+EM PKISDFGMAR FG +Q
Sbjct: 610 DWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARIFGGNQ 669

Query: 661 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL 720
            E  T+RVVGT+GYM PEYA++G FS+KSDV+SFGVL+LEI+ GK+N  F+  +   NL+
Sbjct: 670 MEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSAFH--EESSNLV 727

Query: 721 GHAWRLWIEERPVELINKSLGG-SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 779
           GH W LW      E+I+  +   +Y   EV++CIQ+GLLCVQ+   DR +MSSVV+ML  
Sbjct: 728 GHIWDLWENGEATEIIDNLMDQETYDEREVMKCIQIGLLCVQENASDRVDMSSVVIMLGH 787

Query: 780 ERS-LPQPKQPGFFT-ERNPPESGSSSSKRSLLSTNEITISLIEGR 823
             + LP PK P F +  R   E+G+    ++ +S N++T S I+GR
Sbjct: 788 NATNLPNPKHPAFTSARRRGGENGACLKGQTGISVNDVTFSDIQGR 833

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1

 Score =  702 bits (1813), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 397/849 (46%), Positives = 544/849 (64%), Gaps = 56/849 (6%)

Query: 8   LFYTIRTATARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTV 67
           L  ++ T +A ++L    +I   +T+VS    FELGFF      S YLGIWYKKI   T 
Sbjct: 28  LSISVNTLSATESL----TISSNKTIVSPGGVFELGFFRI-LGDSWYLGIWYKKISQRTY 82

Query: 68  IWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNP-VAVLLESGNL 126
           +WVANRD PLS+  G L IS   NA LV+L++++  VWS+N +   R+  VA LL++GN 
Sbjct: 83  VWVANRDTPLSNPIGILKIS---NANLVILDNSDTHVWSTNLTGAVRSSVVAELLDNGNF 139

Query: 127 VVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSADDPAQDDYVYG 186
           V++  K  + D FLWQSFD+P+  L+  MKLG +   GLNRF++SWKS+ DP+   +++ 
Sbjct: 140 VLRGSKINESDEFLWQSFDFPTDTLLPQMKLGRDHKRGLNRFVTSWKSSFDPSSGSFMFK 199

Query: 187 IDPSGVPQAVFRKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEYVSNENEVFYRFNLIK 246
           ++  G+P+          YR+G W+GL ++G+ ++Q      + +  N  EV Y F +  
Sbjct: 200 LETLGLPEFFGFTSFLEVYRSGPWDGLRFSGILEMQQWDDIIYNFTENREEVAYTFRVTD 259

Query: 247 SSVPSMMVMNPLGDPQRLTWMEQTQKWAP--FVPFSGLILDQCDNYALCGAYAVCNMNSN 304
            +  S + +N +G  +   W    Q+W    F+P      D CD Y +CG YA C+M S 
Sbjct: 260 HNSYSRLTINTVGRLEGFMWEPTQQEWNMFWFMP-----KDTCDLYGICGPYAYCDM-ST 313

Query: 305 SAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCEHGDGFLKRESVKLPDTRFSLVDNK 364
           S  C C++GF P SP +W   D +  C R+TQL C   D F +  ++K+P T  ++VD +
Sbjct: 314 SPTCNCIKGFQPLSPQDWASGDVTGRCRRKTQLTCGE-DRFFRLMNMKIPATTAAIVDKR 372

Query: 365 ISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKELSESGQDLFVRMAASEL 424
           I L EC+E C  +C+CTAYAN+D+R GGSGC++W  +  D++  +  GQDLFVR+AA+E 
Sbjct: 373 IGLKECEEKCKTHCNCTAYANSDIRNGGSGCIIWIGEFRDIRNYAADGQDLFVRLAAAEF 432

Query: 425 DDIERKKPKKKKKVAIVITSVLLVTGVILLGGFVYLWKRRHRKQGKTDGSSKLDYNDR-- 482
              ER+  + K    I+  S++LV   I+       WK++ ++   T  ++ + Y DR  
Sbjct: 433 G--ERRTIRGKIIGLIIGISLMLVLSFIIYC----FWKKKQKRARAT--AAPIGYRDRIQ 484

Query: 483 ------------GNR----EEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLI 526
                       G R    EE++ELP+ ++  +  ATENFSD N LG GGFG VYKG L+
Sbjct: 485 ELIITNGVVMSSGRRLLGEEEDLELPLTEFETVVMATENFSDSNILGRGGFGIVYKGRLL 544

Query: 527 EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKS 586
           +GQEIA KRLS+ S QG  EF+NEV LIA+LQH NLV+L+ CC   DE++LIYEYL N S
Sbjct: 545 DGQEIAVKRLSEMSSQGTNEFKNEVRLIARLQHINLVRLLSCCIYADEKILIYEYLENGS 604

Query: 587 LNDFIFDVTR-SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP 645
           L+  +F+ T+ S  L+W  R  II GIARGLLYLHQDSR +IIHRDLKASNVLLD  M P
Sbjct: 605 LDSHLFETTQSSNKLNWQTRFSIINGIARGLLYLHQDSRFKIIHRDLKASNVLLDKNMTP 664

Query: 646 KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           KISDFGMAR F  D+TEANT +VVGTYGYM PEYA++G+FSVKSDVFSFGVLVLEIV GK
Sbjct: 665 KISDFGMARIFERDETEANTRKVVGTYGYMSPEYAMEGIFSVKSDVFSFGVLVLEIVSGK 724

Query: 706 RNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS------YSLSEVLRCIQVGLLC 759
           RNRGF+++   +NLLG+ W  W E + +E+++  +  S      +   EVLRCIQ+GLLC
Sbjct: 725 RNRGFHNSGQDNNLLGYTWENWKEGKGLEIVDSIIVDSSSSMSLFQPHEVLRCIQIGLLC 784

Query: 760 VQQRPEDRPNMSSVVLMLSGER-SLPQPKQPGFFTERNPPESG--SSSSKR--SLLSTNE 814
           VQ+R EDRP MSSVVLML  E+  +PQPK+PG+   R+  ++   SSS+KR    L+ N+
Sbjct: 785 VQERAEDRPKMSSVVLMLGSEKGEIPQPKRPGYCVGRSSLDTADSSSSTKRDSESLTVNQ 844

Query: 815 ITISLIEGR 823
           IT+S+I  R
Sbjct: 845 ITVSVINAR 853

Female specificity determinant of self-incompatibility.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3

 Score =  699 bits (1803), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 382/836 (45%), Positives = 522/836 (62%), Gaps = 44/836 (5%)

Query: 19  DTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLS 78
           +T+   QS++DG+ + S  + F  GFFS G SK RY+GIWY ++   T++WVANRD P++
Sbjct: 23  NTILRSQSLKDGDVIYSEGKRFAFGFFSLGNSKLRYVGIWYAQVSEQTIVWVANRDHPIN 82

Query: 79  DRSGALNISSQGNATLVLLNSTNGI--VWSSNASRTARNP--VAVLLESGNLVVKD---G 131
           D SG +  S++GN  L +  S NG   +WS++     + P  VA L + GNLV+ D   G
Sbjct: 83  DTSGLIKFSTRGN--LCVYASGNGTEPIWSTDVIDMIQEPALVAKLSDLGNLVLLDPVTG 140

Query: 132 KDIDPDNFLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSADDPAQDDYVYGIDPSG 191
           K        W+SF++P++ L+  MK G    +G++R ++SW+S  DP   +  Y I+  G
Sbjct: 141 KS------FWESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERRG 194

Query: 192 VPQAVFRKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPS 251
            PQ +  KG T+ +R GSW G  W+G+P++    ++   +V+N +EV   + ++ +SV +
Sbjct: 195 FPQMMMYKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVNNPDEVSITYGVLDASVTT 254

Query: 252 MMVMNPLGDPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYAVCNMNSNSA-KCEC 310
            MV+N  G  QR  W  + +KW   + F     D+CD Y  CG    C+  S    +C C
Sbjct: 255 RMVLNETGTLQRFRWNGRDKKW---IGFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSC 311

Query: 311 LEGFVPKSPSEWDLLDKSDGCVR-RTQLDCEHGDGFLKRESVKLPDTRFSLVDNKISLLE 369
           L G+ PK+P +W L D SDGC R +    C   +GF K + VK+P+T    VD  I+L E
Sbjct: 312 LPGYEPKTPRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTSAVNVDMNITLKE 371

Query: 370 CKELCSKNCSCTAYANA--DVRGGGSGCLLWFHDLIDMKELSESGQDLFVRMAASELDDI 427
           C++ C KNCSC AYA+A  + + G  GCL W  +++D +    SGQD ++R+  SEL   
Sbjct: 372 CEQRCLKNCSCVAYASAYHESQDGAKGCLTWHGNMLDTRTYLSSGQDFYLRVDKSELARW 431

Query: 428 ERKKPKKKKKVAIVITSVLLVTGVILLGGFVYLWKRRHRKQGK-------TDGSSKLDYN 480
                  KK++ +++ S++ V  ++L+    YL KRR R Q         +   S  D  
Sbjct: 432 NGNGASGKKRLVLILISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFAPSSFDLE 491

Query: 481 DRGNREE------EMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAK 534
           D    EE        ELP+F+   IA AT NF+ +NKLG GGFGPVYKGVL  G EIA K
Sbjct: 492 DSFILEELEDKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQNGMEIAVK 551

Query: 535 RLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDV 594
           RLSKSSGQGMEEF+NEV LI+KLQHRNLV+++GCC + +E+ML+YEYLPNKSL+ FIF  
Sbjct: 552 RLSKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYFIFHE 611

Query: 595 TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 654
            +   LDW KR  II GI RG+LYLHQDSRLRIIHRDLKASNVLLDNEM PKI+DFG+AR
Sbjct: 612 EQRAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADFGLAR 671

Query: 655 AFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHAD 714
            FG +Q E +TNRVVGTYGYM PEYA+DG FS+KSDV+SFGVL+LEI+ GKRN  FY  +
Sbjct: 672 IFGGNQIEGSTNRVVGTYGYMSPEYAMDGQFSIKSDVYSFGVLILEIITGKRNSAFY--E 729

Query: 715 HHHNLLGHAWRLWIEERPVELINKSLG-GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
              NL+ H W  W     +E+I+K +G  +Y   EV++C+ +GLLCVQ+   DRP+MSSV
Sbjct: 730 ESLNLVKHIWDRWENGEAIEIIDKLMGEETYDEGEVMKCLHIGLLCVQENSSDRPDMSSV 789

Query: 774 VLMLSGER-SLPQPKQPGFFT--ERNPPESGSSS---SKRSLLSTNEITISLIEGR 823
           V ML      LP PK P F     RN    GSS    S  +  + N++T++ ++GR
Sbjct: 790 VFMLGHNAIDLPSPKHPAFTAGRRRNTKTGGSSDNWPSGETSSTINDVTLTDVQGR 845

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1

 Score =  687 bits (1773), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 390/871 (44%), Positives = 534/871 (61%), Gaps = 83/871 (9%)

Query: 2   LIIYCFLFYTIRTATARDTLNLGQSIRDG---ETLVSANESFELGFFSPGKSKSRYLGIW 58
           L +Y FL+    ++ A +T+  G+S+RDG   + LVS  ++FELGFFSPG S  R+LGIW
Sbjct: 13  LFLYFFLY---ESSMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIW 69

Query: 59  YKKIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSN---ASRTARN 115
           Y  I +  V+WVANR  P+SD+SG L IS+ GN  LVLL+  N  VWSSN   ++    N
Sbjct: 70  YGNIEDKAVVWVANRATPISDQSGVLMISNDGN--LVLLDGKNITVWSSNIESSTTNNNN 127

Query: 116 PVAVLLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSA 175
            V  + ++GN V+ +    D D  +W+SF++P+   +  M++ VN  TG N    SW+S 
Sbjct: 128 RVVSIHDTGNFVLSE---TDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSE 184

Query: 176 DDPAQDDYVYGIDPSGVPQAVFRKGSTIR-YRAGSWNGLHWTGMPQLQ--PNPVYTFEYV 232
            DP+  +Y  G+DPSG P+ V  +G+  R +R+G WN   +TG+P +    N +Y F+  
Sbjct: 185 TDPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLS 244

Query: 233 SNENEVFYRFNLIKSSVPSMMVMNPL---GDPQRLTWMEQTQKWAPFVPFSGLILDQCDN 289
           S  +E    +     S PS+++   +   G  + L W E  +KW  F         +CD 
Sbjct: 245 SPPDETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPD---SECDQ 301

Query: 290 YALCGAYAVCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCEHG-----DG 344
           Y  CG + +C+M  ++  C C+ G+   S   W     S GC RRT L CE       D 
Sbjct: 302 YNRCGKFGICDMKGSNGICSCIHGYEQVSVGNW-----SRGCRRRTPLKCERNISVGEDE 356

Query: 345 FLKRESVKLPDTRF---SLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHD 401
           FL  +SVKLPD      +LVD +    +C+E C +NCSC AY+      GG GC++W  D
Sbjct: 357 FLTLKSVKLPDFEIPEHNLVDPE----DCRERCLRNCSCNAYSLV----GGIGCMIWNQD 408

Query: 402 LIDMKELSESGQDLFVRMAASELDDIERKKPKKKKKVAIVITSVLLVTGVILLGGFVYLW 461
           L+D+++    G  L +R+A SE+ +       +K K+A+++    ++ GVIL+G F  L 
Sbjct: 409 LVDLQQFEAGGSSLHIRLADSEVGE------NRKTKIAVIVA---VLVGVILIGIFALLL 459

Query: 462 KRRHRKQ-------GKTDGSS------------------KLDYNDRGNREEEMELPIFDW 496
            R  RK+       GK   +S                   +D    G      ELP+F  
Sbjct: 460 WRFKRKKDVSGAYCGKNTDTSVVVADLTKSKETTSAFSGSVDIMIEGKAVNTSELPVFSL 519

Query: 497 MAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAK 556
            AIA AT +F  +N+LG GGFGPVYKGVL +G+EIA KRLS  SGQG++EF+NE++LIAK
Sbjct: 520 NAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAK 579

Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 616
           LQHRNLV+L+GCC + +E+ML+YEY+PNKSL+ F+FD T+   +DW  R  II GIARGL
Sbjct: 580 LQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGL 639

Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
           LYLH+DSRLRIIHRDLK SNVLLD EMNPKISDFGMAR FG +Q EANT RVVGTYGYM 
Sbjct: 640 LYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMS 699

Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 736
           PEYA++GLFSVKSDV+SFGVL+LEIV GKRN     +  H +L+G+AW L+   R  EL+
Sbjct: 700 PEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSL-RSSEHGSLIGYAWYLYTHGRSEELV 758

Query: 737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML-SGERSLPQPKQPGFF-TE 794
           +  +  + S  E LRCI V +LCVQ    +RPNM+SV+LML S   +L  P+QP F  T 
Sbjct: 759 DPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPRQPTFTSTR 818

Query: 795 RNPPESGSS--SSKRSLLSTNEITISLIEGR 823
           RN  +   +  SS++ ++S+NEIT +++ GR
Sbjct: 819 RNSIDVNFALDSSQQYIVSSNEITSTVVLGR 849

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	823
224122978	831	predicted protein [Populus trichocarpa]	0.979	0.969	0.633	0.0
224122958	812	predicted protein [Populus trichocarpa]	0.979	0.992	0.608	0.0
147799241	818	hypothetical protein VITISV_027305 [Viti	0.984	0.990	0.590	0.0
224115106	755	predicted protein [Populus trichocarpa]	0.913	0.996	0.634	0.0
255587572	822	S-locus-specific glycoprotein S6 precurs	0.968	0.969	0.592	0.0
359493740	2422	PREDICTED: uncharacterized protein LOC10	0.979	0.332	0.571	0.0
224122858	831	predicted protein [Populus trichocarpa]	0.991	0.981	0.571	0.0
224115102	784	predicted protein [Populus trichocarpa]	0.929	0.975	0.600	0.0
255569631	868	S-locus-specific glycoprotein S13 precur	0.986	0.935	0.576	0.0
359493721	804	PREDICTED: G-type lectin S-receptor-like	0.928	0.950	0.569	0.0

>gi|224122978|ref|XP_002330411.1| predicted protein [Populus trichocarpa] gi|222871796|gb|EEF08927.1| predicted protein [Populus trichocarpa]

 Score = 1045 bits (2701), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 517/816 (63%), Positives = 631/816 (77%), Gaps = 10/816 (1%)

Query: 1   MLIIYCFLFYT-IRTATARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWY 59
           +L ++ FL  + IR +T  DTL  GQSIRDG+ LVSA+ SFELGFFSPG SK RYLGIWY
Sbjct: 10  ILFVHTFLLISAIRAST--DTLTPGQSIRDGDLLVSADGSFELGFFSPGISKGRYLGIWY 67

Query: 60  KKIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAV 119
           +KI  GTV+WVANR+ PL+D SGAL ++ QG   L+LLNS+   +WSSNASRTA+NPV  
Sbjct: 68  QKISAGTVVWVANRETPLNDSSGALIVTDQG--ILILLNSSKDAIWSSNASRTAQNPVMK 125

Query: 120 LLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSADDPA 179
           LL+SGNLVVKD  D + +NFLWQSFDYP   L+ GMK G N+VTGL+R++SSWKS++DPA
Sbjct: 126 LLDSGNLVVKDIND-NSENFLWQSFDYPGDTLLPGMKWGRNMVTGLDRYLSSWKSSNDPA 184

Query: 180 QDDYVYGIDPSGVPQAVFRKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEYVSNENEVF 239
           Q ++ + IDP G  Q +  +G  I YR G+WNG  WTG PQL+PN +YT+ ++S   E++
Sbjct: 185 QGEFTFRIDPRGNTQMLLMRGPKILYRTGTWNGYRWTGTPQLEPNMLYTYGFISTATEMY 244

Query: 240 YRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYAVC 299
           Y+F+LI SSV S +VMN  G  QR TW+ +T  WA F   S ++LDQCD+YALCGAY  C
Sbjct: 245 YKFDLINSSVASRIVMNSSGAAQRFTWITRTNSWARF---SAVLLDQCDDYALCGAYGSC 301

Query: 300 NMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCEHGDGFLKRESVKLPDTRFS 359
           N+N     C CLEGF+PKSP +W + + SDGCVRRT+LDC+ GD FL+   VKLPD   S
Sbjct: 302 NVNKQPV-CACLEGFIPKSPKDWSIQEWSDGCVRRTKLDCDKGDRFLQHGGVKLPDMIKS 360

Query: 360 LVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKELSESGQDLFVRM 419
            VD    L ECK+LC KNCSC AYAN+D+RGGGSGCLLWF +LID +EL+  GQDL++R+
Sbjct: 361 WVDTSKGLKECKDLCLKNCSCVAYANSDIRGGGSGCLLWFDELIDTRELTTGGQDLYIRI 420

Query: 420 AASELDDIERKKPKKKKKVAIVITSVLLVTGVILLGGFVYLWKRRHRKQGKTDGSSKLDY 479
           AASEL +IE+ +   KK++ I++ +++ + GV++L   +Y  +++ +KQ     S   +Y
Sbjct: 421 AASELYNIEKNRSSDKKQLGIIVGTIITIVGVLVLAFILYARRKKLKKQANMKTSHLQNY 480

Query: 480 NDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKS 539
            D   R+E+MELP FD   IANAT+NFS +NKLGEGGFG VYKG LIEGQE+A KRLSK+
Sbjct: 481 EDEDQRKEDMELPTFDLSTIANATDNFSSRNKLGEGGFGSVYKGTLIEGQEVAVKRLSKN 540

Query: 540 SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKF 599
           SGQG+ EF+NEV+LIAKLQHRNLVKL+GCC + DER+LIYEY+PNKSL+ FIFD      
Sbjct: 541 SGQGLTEFKNEVILIAKLQHRNLVKLLGCCIEGDERILIYEYMPNKSLDYFIFDKKTRNS 600

Query: 600 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 659
            DW     I+GGIARGLLYLHQDSRLRIIHRDLKA+NVLLDN MNPKISDFG+AR FG D
Sbjct: 601 SDWRIWINIVGGIARGLLYLHQDSRLRIIHRDLKAANVLLDNGMNPKISDFGLARTFGGD 660

Query: 660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL 719
           QTEANTN++VGTYGYM PEYA+DG FSVKSDVFSFGVLVLEIV GK+NRGF H DHHHNL
Sbjct: 661 QTEANTNKIVGTYGYMSPEYAVDGFFSVKSDVFSFGVLVLEIVSGKKNRGFNHPDHHHNL 720

Query: 720 LGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 779
           LGHAWRLW E  P+ELIN+    S +LSE++RCI VGLLCVQ+RPEDRPNMSSV++MLS 
Sbjct: 721 LGHAWRLWNEGMPLELINEPEQDSCTLSEIIRCIHVGLLCVQKRPEDRPNMSSVIVMLSS 780

Query: 780 ERSLPQPKQPGFFTERNPPESGSSSSKRSLLSTNEI 815
             SLPQPKQPGFFTERN PE  SSSS +   STNEI
Sbjct: 781 GISLPQPKQPGFFTERNLPERESSSSNQKSFSTNEI 816

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224122958|ref|XP_002330406.1| predicted protein [Populus trichocarpa] gi|222871791|gb|EEF08922.1| predicted protein [Populus trichocarpa]

 Score = 1017 bits (2630), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 501/824 (60%), Positives = 608/824 (73%), Gaps = 18/824 (2%)

Query: 1   MLIIYCFLFYTIRTATARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYK 60
           ++ +Y   F  ++ ++A D +N  QS+RDGETLVS   SFELGFF+P  S SRYLG+WYK
Sbjct: 6   VIFVYSLFFSILKISSALDAMNTTQSLRDGETLVSTGGSFELGFFTPAGSTSRYLGLWYK 65

Query: 61  KIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVL 120
           K    TV+WVANR  P+S++ G LN++SQG   LVLLN TN IVWSSN S T +NPVA L
Sbjct: 66  K-SPQTVVWVANRGIPISNKFGTLNVTSQG--ILVLLNGTNNIVWSSNTSTTVQNPVAQL 122

Query: 121 LESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSADDPAQ 180
           L+SGNLVV+DG D   DNFLWQSFDYP   L+ GMKLG NLVTGLN F+SSWK  ++PA 
Sbjct: 123 LDSGNLVVRDGNDNKADNFLWQSFDYPCDTLLPGMKLGSNLVTGLNSFLSSWKGKENPAP 182

Query: 181 DDYVYGIDPSGVPQAVFRKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEYVSNENEVFY 240
             +  GID  G PQ + RK + I YR GSWNG ++TG P+L+P+P+YTFE+V N NEV++
Sbjct: 183 GQFTLGIDVQGYPQLILRKETRIMYRVGSWNGQYFTGFPELKPDPIYTFEFVFNRNEVYF 242

Query: 241 RFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYAVCN 300
           +F L  SSV S + + P G  Q  TW  QT  W     F+  ++D+C+NYALCGA A C+
Sbjct: 243 KFELQNSSVFSRLTVTPSGLVQLFTWSHQTNDW---YVFATAVVDRCENYALCGANARCD 299

Query: 301 MNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCEHGDGFLKRESVKLPDTRFSL 360
            NS S  C+CL+GF+ KSP+EW+  + + GC+RRT LDC   DGF     VKLPDT  S 
Sbjct: 300 SNS-SPVCDCLDGFIHKSPTEWNSQNWTGGCIRRTPLDCTDKDGFQSYTGVKLPDTSSSW 358

Query: 361 VDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKELSESGQDLFVRMA 420
            D+  SL+EC+ LC +NCSC AYAN D RG GSGCL WF DLID + L+E GQD+++R+A
Sbjct: 359 YDDSFSLVECEGLCIQNCSCFAYANLDFRGRGSGCLRWFGDLIDTRRLAEGGQDIYIRLA 418

Query: 421 ASELDDIERKKPKKKKKVAIVITSVLLVTGVILLGGFVYLWKRRHRKQGKTDGSSKLDYN 480
           AS+      KK KKK    ++  +V+L + +++LG    + +R+HRK G        ++ 
Sbjct: 419 ASQSGVTGEKKRKKKTHAGVIGGAVILGSSILILGIVFCIRRRKHRKNG--------NFE 470

Query: 481 DRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSS 540
           DR  +EEEMELP+ D   I +AT+NFS   KLGEGGFG VYKG LIEGQEIA KRLSKSS
Sbjct: 471 DR--KEEEMELPMLDLTTIEHATDNFSSSKKLGEGGFGAVYKGELIEGQEIAVKRLSKSS 528

Query: 541 GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFL 600
           GQG+ EF+NEVLLIAKLQHRNLVKL+GCC   DE+MLIYEY+PN+SL+ FIFD TR KFL
Sbjct: 529 GQGLNEFKNEVLLIAKLQHRNLVKLLGCCIHEDEKMLIYEYMPNRSLDSFIFDPTRRKFL 588

Query: 601 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 660
           DWSKR  II GIARGLLYLHQDSRLRIIHRD+KASN+LLDNE+NPKISDFG+AR FG DQ
Sbjct: 589 DWSKRTHIIDGIARGLLYLHQDSRLRIIHRDIKASNILLDNELNPKISDFGLARMFGGDQ 648

Query: 661 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHH-NL 719
           TEANT RVVGTYGYM PEYA+DG FSVKSDVFSFGVLVLEIV GK+NRGF H D++  NL
Sbjct: 649 TEANTKRVVGTYGYMSPEYALDGHFSVKSDVFSFGVLVLEIVSGKKNRGFCHPDYNQKNL 708

Query: 720 LGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 779
           LGHAW LW    P+ELI++    S + SE LRCI V LLCVQQRPEDRPNMSSVVLML  
Sbjct: 709 LGHAWMLWFNGIPLELIDECFADSCTPSEALRCIHVALLCVQQRPEDRPNMSSVVLMLGS 768

Query: 780 ERSLPQPKQPGFFTERNPPESGSSSSKRSLLSTNEITISLIEGR 823
           E  LPQPKQPGFF   NPPE  +SS+K    S NE+T++L++ R
Sbjct: 769 ENPLPQPKQPGFFMGSNPPEKDTSSNKHQSHSANEVTVTLLQAR 812

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147799241|emb|CAN77004.1| hypothetical protein VITISV_027305 [Vitis vinifera]

 Score =  999 bits (2584), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 487/825 (59%), Positives = 631/825 (76%), Gaps = 15/825 (1%)

Query: 1   MLIIYCFLFYTIRTATARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYK 60
           ++ ++ ++   +R +TA D++   Q I+DGET++SA  +FELGF   G SK++YLGIWYK
Sbjct: 7   LVFLFSYVISILRISTAVDSITANQHIKDGETIISAGGNFELGFVHLGTSKNQYLGIWYK 66

Query: 61  KIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVL 120
           K+   TV+WVANR+ P++D SG L ++ QG  +LV+LN +NG++WSSN+SR+ARNP A L
Sbjct: 67  KVTPRTVVWVANRELPVTDSSGXLKVTDQG--SLVILNGSNGLIWSSNSSRSARNPTAQL 124

Query: 121 LESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSADDPAQ 180
           L+SGNLV+K G D DPDNFLWQSFDYP   L+ GMK G N VTGL+R++SSWKS DDP++
Sbjct: 125 LDSGNLVIKSGNDSDPDNFLWQSFDYPGDTLLPGMKHGRNTVTGLDRYLSSWKSNDDPSK 184

Query: 181 DDYVYGIDPSGVPQAVFRKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEYVSNENEVFY 240
            D+ YG+DPSG PQ   R GST+ +R+G WNG+ + G P+L+PNPV+ + +V NE E+++
Sbjct: 185 GDFTYGLDPSGCPQLFLRSGSTVIFRSGPWNGIRFNGFPELRPNPVFNYSFVFNEKEMYF 244

Query: 241 RFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYAVCN 300
            + L+ SSV S +V+NP G+ QRL W+ +T+ W  +   S    D CD+YALCGAY+ CN
Sbjct: 245 TYKLVNSSVLSRLVLNPNGNVQRLIWIGRTKSWNVY---STAYKDDCDSYALCGAYSTCN 301

Query: 301 MNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCEHGDGFLKRESVKLPDTRFSL 360
           ++  S +C C++GFVPK P +WD +D S+GCVR+T LDC+ GDGF K   VKLPDTR S 
Sbjct: 302 IH-RSPRCGCMKGFVPKFPYQWDTMDWSNGCVRKTSLDCQKGDGFAKYSGVKLPDTRNSW 360

Query: 361 VDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKELSESGQDLFVRMA 420
            +  ++L EC  LC +NCSC+AY N+D++GGGSGCLLWF DLID+KE +E+GQD ++RMA
Sbjct: 361 FNESMNLKECASLCFRNCSCSAYTNSDIKGGGSGCLLWFGDLIDIKEFTENGQDFYIRMA 420

Query: 421 ASELDDIERKKPKKKKKVAIVITSVLLVTGVILLGGFV--YLWKRRHRKQGKTDGSSKLD 478
           ASELD I +   ++      VI S + + G+ILL   V  YL K+R +++G T+ ++  +
Sbjct: 421 ASELDAISKVTKRR-----WVIVSTVSIAGMILLSLVVTLYLLKKRLKRKGTTELNN--E 473

Query: 479 YNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSK 538
             +   R+E++ELP+F    I NAT NFS  NKLGEGGFGPVYKG+L +G+EIA KRLSK
Sbjct: 474 GAETNERQEDLELPLFXLDTILNATHNFSRNNKLGEGGFGPVYKGMLQDGKEIAVKRLSK 533

Query: 539 SSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSK 598
            S QG++EF+NEV+ I+KLQHRNLVKL+GCC   +E+MLIYEY+PNKSLN FIFD  +S 
Sbjct: 534 ESNQGLDEFKNEVIYISKLQHRNLVKLLGCCIHGEEKMLIYEYMPNKSLNFFIFDGIQSM 593

Query: 599 FLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 658
            LDW KR  II GIARGLLYLHQDSRLRIIHRDLKA NVLLDNEMNP+ISDFGMAR+FG 
Sbjct: 594 VLDWPKRFVIINGIARGLLYLHQDSRLRIIHRDLKADNVLLDNEMNPRISDFGMARSFGG 653

Query: 659 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHN 718
           ++T A T RVVGTYGYM PEYAIDG++SVKSDVFSFGVL LEI+ GKRNRGF H DH  N
Sbjct: 654 NETIARTKRVVGTYGYMSPEYAIDGVYSVKSDVFSFGVLXLEIISGKRNRGFNHPDHDLN 713

Query: 719 LLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 778
           LLGHAW L++E  P+ELI+ S+G +Y+ SEVLR + VGLLCVQ+ P+DRPNMSSVVLMLS
Sbjct: 714 LLGHAWTLYMEGTPLELIDASVGYTYNQSEVLRALNVGLLCVQRHPDDRPNMSSVVLMLS 773

Query: 779 GERSLPQPKQPGFFTERNPPESGSSSSKRSLLSTNEITISLIEGR 823
            E +LPQPK+PGFFTERN  E+ S   K ++ S NE TI+++EGR
Sbjct: 774 SEGALPQPKEPGFFTERNMLEADSLQCKHAVFSGNEHTITILEGR 818

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224115106|ref|XP_002316941.1| predicted protein [Populus trichocarpa] gi|222860006|gb|EEE97553.1| predicted protein [Populus trichocarpa]

 Score =  983 bits (2541), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 483/761 (63%), Positives = 583/761 (76%), Gaps = 9/761 (1%)

Query: 39  SFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLN 98
           SF LGFFSPG S +RYLGIWY KI  GTV+WVANR+ PL +R G LN++ QG   LVL N
Sbjct: 3   SFGLGFFSPGSSSNRYLGIWYNKITPGTVVWVANREQPLVNRLGVLNVTGQG--VLVLFN 60

Query: 99  STNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLG 158
           STN  VWSSN SRTA+NPV  LL+SGNL VKDG D +PDNFLWQSFDYPS  L+ GMK G
Sbjct: 61  STNYAVWSSNVSRTAQNPVVQLLDSGNLAVKDGNDNNPDNFLWQSFDYPSETLLPGMKWG 120

Query: 159 VNLVTGLNRFISSWKSADDPAQDDYVYGIDPSGVPQAVFRKGSTIRYRAGSWNGLHWTGM 218
            NLVTGL+R+ISSWKSADDPA+ D+ + +DP G  Q +  +G TI YR G WNG  W G+
Sbjct: 121 KNLVTGLDRYISSWKSADDPARGDFTFRLDPRGYNQMLLMRGLTILYRTGIWNGFRWGGV 180

Query: 219 PQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFVP 278
           P+   N VY  ++VS   E +Y F+L+ SSVPS +V+NP   PQRLTW+ QT  W  +  
Sbjct: 181 PETISNTVYGEQFVSTATESYYTFDLLNSSVPSRLVINPSSIPQRLTWITQTNLWGSY-- 238

Query: 279 FSGLILDQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLD 338
            S + +DQCD Y LCGA  +C+ NSN A C CLE F+P++P  W+  D S GCVRRTQL 
Sbjct: 239 -SVVQIDQCDTYTLCGANGICS-NSNGAVCSCLESFIPRTPESWNKQDWSGGCVRRTQLG 296

Query: 339 CEHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLW 398
           C++GDGFL+   VKLPD   S V+  +SL+EC+ +C  NCSC AY N+D+R G SGC LW
Sbjct: 297 CKNGDGFLQITGVKLPDMSDSWVNTSMSLVECRNMCLSNCSCVAYGNSDIRRGASGCYLW 356

Query: 399 FHDLIDMKELSESGQDLFVRMAASELDDIERKKPKKKKKVAIVITSVLLVTGVILLGGFV 458
           F DL D K L   GQDL++RMAASEL   E+K   K+K+  I+I +++    +++LG  +
Sbjct: 357 FDDLWDTKHLPLGGQDLYIRMAASELSIYEKKSSSKRKRRRIIIGTLISAVVLLVLGFML 416

Query: 459 YLWKRRHRKQGKTDGSSKLD-YNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGF 517
           Y+ +RR  +QGK   S ++D   D   R+++MELP FD++ I NAT+ FS  NKLGEGGF
Sbjct: 417 YMRRRRKTRQGKK--SIRIDNLKDESGRKDDMELPAFDFITIKNATDYFSYNNKLGEGGF 474

Query: 518 GPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 577
           G VYKG L +GQEIA KRLSK+SGQG++EF+NEV+LIAKLQHRNLVKL+GCC + DERML
Sbjct: 475 GSVYKGTLTDGQEIAVKRLSKNSGQGLKEFKNEVILIAKLQHRNLVKLLGCCIEGDERML 534

Query: 578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNV 637
           IYEY+PNKSL++FIFD      LDW     IIGGIARGLLYLHQDSRLRIIHRDLKASNV
Sbjct: 535 IYEYMPNKSLDNFIFDKKSRNLLDWQTHMNIIGGIARGLLYLHQDSRLRIIHRDLKASNV 594

Query: 638 LLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVL 697
           LLDN MNPKISDFGMAR FG DQ EANTNR+VGTYGY+ PEYA+DGLFS+KSDVFSFGVL
Sbjct: 595 LLDNSMNPKISDFGMARIFGGDQIEANTNRIVGTYGYISPEYAVDGLFSIKSDVFSFGVL 654

Query: 698 VLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGL 757
           VLEIV GK+NRGFYH DH+HNLLGHAW+LW E RP+EL++ ++  S SLSE+LR IQVGL
Sbjct: 655 VLEIVSGKKNRGFYHPDHNHNLLGHAWKLWNEGRPLELMDITIDDSSSLSEILRHIQVGL 714

Query: 758 LCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNPP 798
           LCVQQRP+DRP+MS+VV+MLS E SLPQPKQPGF+TERN P
Sbjct: 715 LCVQQRPDDRPSMSTVVVMLSSEISLPQPKQPGFYTERNFP 755

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255587572|ref|XP_002534316.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] gi|223525508|gb|EEF28065.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis]

 Score =  982 bits (2539), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 492/831 (59%), Positives = 612/831 (73%), Gaps = 34/831 (4%)

Query: 14  TATARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANR 73
           +A   +TL  GQS++DGETL+SA+ +FELGFFS G S+SRYLGIWYK+I   TV+WV NR
Sbjct: 5   SAAQLETLYPGQSMKDGETLISADGNFELGFFSQGDSRSRYLGIWYKRIPVKTVVWVGNR 64

Query: 74  DAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKD 133
           + P  D  G L ++ QG   ++L NST GI+WSSN+SRTA+NPV  LL+SGNL+VKDG  
Sbjct: 65  EVPSFDNLGVLQVNEQG--VIILQNSTKGIIWSSNSSRTAKNPVLQLLDSGNLIVKDGNG 122

Query: 134 IDPDNFLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSADDPAQDDYVYGIDPSGVP 193
            +PDN +WQSFD+P + L+  MKLG NL  GLNR+++SWKS DDPAQ ++   ID  G P
Sbjct: 123 NNPDNIVWQSFDFPYNTLLPSMKLGWNLDKGLNRYLTSWKSIDDPAQGNFSCLIDLRGFP 182

Query: 194 QAVFRKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMM 253
           Q   +KG  ++ R+G WNGL +TG PQL PNPV+ F +VSN++E++Y + L  +SV S +
Sbjct: 183 QLFMKKGDAVQVRSGPWNGLQFTGSPQLNPNPVFNFSFVSNKHEIYYSYELKNTSVVSRL 242

Query: 254 VMNPLGDPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYAVCNMNSNSAKCECLEG 313
           +++  G  +R  W+++TQ W  F  FS +  DQCD Y LCGAYA CN+NS    C CLEG
Sbjct: 243 IVSEKGALERHNWIDRTQSWTLF--FS-VPTDQCDTYLLCGAYASCNINSYPV-CSCLEG 298

Query: 314 FVPKSPSEWDLLDKSDGCVRRTQLDCEHGDGFLKRESVKLPDTRFSLVDNKISLLECKEL 373
           FVPKSP++W   D SDGCVRRT+L C  GDGF K + +KLPDT  S VD  + L EC+ +
Sbjct: 299 FVPKSPTDWSASDWSDGCVRRTELSCHTGDGFRKLKGMKLPDTSSSWVDMSMDLKECEGM 358

Query: 374 CSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKELSESGQDLFVRMAASELDDIERKKPK 433
           C +NCSC AYAN+D+RG  SGCLLWF  LIDM++ +E GQDL++R+AASEL     K   
Sbjct: 359 CLRNCSCLAYANSDIRG--SGCLLWFDHLIDMRKFTEGGQDLYIRIAASEL----AKGKS 412

Query: 434 KKKKVAIVITSVLLVTGVILLGGFVYLWKRRHRKQGKT-----------------DGSSK 476
             K+VAI+++ +++  G+  LG  +Y  KR+    G+                   G +K
Sbjct: 413 HGKRVAIIVSCLIIGMGMTALGSLLYTRKRKRNILGQAVPLVLLVSSFAIHFYIISGLAK 472

Query: 477 L----DYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIA 532
                +Y D G +E+  EL  FD + I NAT NFS+ NKLGEGGFGPVYKG L++GQEIA
Sbjct: 473 ETYIENYGDNGAKED-TELIAFDLITIRNATGNFSNYNKLGEGGFGPVYKGTLLDGQEIA 531

Query: 533 AKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIF 592
            KRLS++SGQG +EF+NEV+LIA+LQHRNLVKL+GCC   DE+MLIYEY+PNKSL+ FIF
Sbjct: 532 VKRLSETSGQGGKEFKNEVILIARLQHRNLVKLLGCCIHGDEKMLIYEYMPNKSLDSFIF 591

Query: 593 DVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 652
           D  RS  LDW    +IIGGIARGLLYLHQDSRLRIIHRDLKASN+LLD +MNPKISDFG+
Sbjct: 592 DKKRSMLLDWHMCFRIIGGIARGLLYLHQDSRLRIIHRDLKASNILLDCDMNPKISDFGL 651

Query: 653 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYH 712
           AR FG DQ  ANT RVVGTYGYM PEYA+DGLFSVKSDVFSFGVLVLEIV GKRNRGF H
Sbjct: 652 ARTFGKDQNAANTKRVVGTYGYMSPEYAVDGLFSVKSDVFSFGVLVLEIVSGKRNRGFSH 711

Query: 713 ADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSS 772
            DH  NLLGHAWRLW+EER +EL +K     YS+S+VLRCIQVGLLCVQ+ P DRP+MS+
Sbjct: 712 LDHSLNLLGHAWRLWMEERALELFDKFSQDEYSVSQVLRCIQVGLLCVQRLPHDRPDMSA 771

Query: 773 VVLMLSGERSLPQPKQPGFFTERNPPESGSSSSKRSLLSTNEITISLIEGR 823
           VV+ML  E SLPQPKQPGF+TER+P E+ SS+SK  + S NEI+ +LIE R
Sbjct: 772 VVVMLGSESSLPQPKQPGFYTERDPFEADSSTSKERVWSRNEISSTLIEPR 822

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359493740|ref|XP_002280379.2| PREDICTED: uncharacterized protein LOC100262430 [Vitis vinifera]

 Score =  973 bits (2514), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 485/849 (57%), Positives = 616/849 (72%), Gaps = 43/849 (5%)

Query: 7   FLFYTIRTATARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGT 66
            +F  +R + A DTL + Q I DGET+ SA  SFELGFFSP  S++RY+GIWYKK+   T
Sbjct: 9   LVFSILRVSIAVDTLTVNQIITDGETITSAGGSFELGFFSPDSSRNRYVGIWYKKVATRT 68

Query: 67  VIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNL 126
           V+WVANR  PL+  SG L ++ +G  TLV+LN TN  +WSSN+SR A+NP A LL+SGNL
Sbjct: 69  VVWVANRQIPLTASSGILKVTDRG--TLVILNGTNTTIWSSNSSRPAQNPNAQLLDSGNL 126

Query: 127 VVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSADDPAQDDYVYG 186
           V+K+G D D +NFLWQSFDYP + L+ GMK G N VTGL+R++SSWK+ DDP+  ++ Y 
Sbjct: 127 VMKNGNDSDSENFLWQSFDYPCNTLLPGMKFGRNRVTGLDRYLSSWKTTDDPSIGNFTYR 186

Query: 187 IDPSGVPQAVFRKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEYVSNENEVFYRFNLIK 246
           +DP G PQ + R GST+ +R+G WNGL ++G PQL+PN VY++ ++ N+ E +Y F L+ 
Sbjct: 187 LDPGGSPQLLVRNGSTVTFRSGPWNGLRFSGFPQLRPNSVYSYAFIFNDKETYYTFELVN 246

Query: 247 SSVPSMMVMNPLGDPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYAVCNMNSNSA 306
           SSV + +V++P G  QR TW+++T  W   + +S    D CD+YALCG Y +C +N  S 
Sbjct: 247 SSVITRLVLSPEGYAQRFTWIDRTSDW---ILYSSAQTDDCDSYALCGVYGICEIN-RSP 302

Query: 307 KCECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCEHGDGFLKRESVKLPDTRFSLVDNKIS 366
           KCEC++GF PK  S WD+ D SDGCVR T + C+  +GFLK   VKLPDTR S  +  ++
Sbjct: 303 KCECMKGFEPKFQSNWDMADWSDGCVRSTPMVCQKSNGFLKYSGVKLPDTRNSWFNESMN 362

Query: 367 LLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKELSESGQDLFVRMAASEL-- 424
           L EC  LC  NCSCTAY N+D+RGGGSGCLLWF DLID++E +E+GQD ++RMA SEL  
Sbjct: 363 LKECASLCLGNCSCTAYTNSDIRGGGSGCLLWFGDLIDIREYTENGQDFYIRMAKSELGM 422

Query: 425 ----------DDIERKKPK---------------KKKKVAIVITSVLLVTGVILLGGFVY 459
                     + ++    K               K  K   VI S + + G+ILL   + 
Sbjct: 423 SLSVPYLRIINSVQVFNDKYCTCVYAFAMTNSGSKGAKRKWVIVSTVSIVGIILLSLVLT 482

Query: 460 LW---KRRHRKQGKTDGSSKLDYNDRG----NREEEMELPIFDWMAIANATENFSDKNKL 512
           L+   K+R R++G    S    +N +G     REE++ELP+FD   I NAT+NFS+ NKL
Sbjct: 483 LYVLRKKRLRRKGNNLYSK---HNCKGAEINEREEDLELPLFDLDTILNATDNFSNDNKL 539

Query: 513 GEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR 572
           GEGGFGPVYKG+L +G+EIA KRLSK S QG++EF+NEV  I+KLQHRNLVKL+GCC   
Sbjct: 540 GEGGFGPVYKGMLQDGKEIAVKRLSKESRQGLDEFKNEVTHISKLQHRNLVKLLGCCIHG 599

Query: 573 DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDL 632
           +E+MLIYEY+PNKSL+ FIFD  +S  LDW KR  II GIARGLLYLHQDSRLRIIHRDL
Sbjct: 600 EEKMLIYEYMPNKSLDFFIFDGMQSLVLDWPKRFVIINGIARGLLYLHQDSRLRIIHRDL 659

Query: 633 KASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVF 692
           KA NVLLDNEMNP+ISDFGMAR+F  +++EA T RVVGTYGYM PEYAIDG++S+KSDVF
Sbjct: 660 KADNVLLDNEMNPRISDFGMARSFRGNESEARTKRVVGTYGYMSPEYAIDGVYSIKSDVF 719

Query: 693 SFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRC 752
           SFGVLVLEIV GKRNRGF H DH  NLLGHAW L++E +P+ELI+ S+G S + SEVLR 
Sbjct: 720 SFGVLVLEIVTGKRNRGFNHPDHALNLLGHAWTLYMEGKPLELIDASMGDSCNQSEVLRA 779

Query: 753 IQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNPPESGSSSSKRSLLST 812
           + VGLLCVQ+ P+DRP+MSSVVLMLS E +L QPK+PGFFTERN  E  SS+SK ++ S 
Sbjct: 780 LNVGLLCVQRSPDDRPSMSSVVLMLSSESALHQPKEPGFFTERNMLEGSSSASKHAIFSG 839

Query: 813 NEITISLIE 821
           NE TI+LIE
Sbjct: 840 NEHTITLIE 848

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224122858|ref|XP_002330381.1| predicted protein [Populus trichocarpa] gi|222871766|gb|EEF08897.1| predicted protein [Populus trichocarpa]

 Score =  971 bits (2510), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 472/826 (57%), Positives = 615/826 (74%), Gaps = 10/826 (1%)

Query: 1   MLIIYCFLFYTIRTATARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYK 60
           +L +   +F+    +TA +++N  QS+ DG+TLVS+   FELGFFSPG S++RY+GIWYK
Sbjct: 13  ILFLLSIVFFLSIPSTAIESINATQSLEDGDTLVSSEGHFELGFFSPGNSRNRYMGIWYK 72

Query: 61  KIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVL 120
           KI + TV+WVANR+ PL+D SG L     GN  L  +NSTNG +WSSN SR A NPVA L
Sbjct: 73  KISSFTVVWVANRNTPLNDSSGMLKFVDHGN--LAFINSTNGTIWSSNISRAAINPVAQL 130

Query: 121 LESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSADDPAQ 180
           L++GNLVV+   D DP+NFLWQSFDYP    + GMK G++ VTGLNR+++SWKS  DP+ 
Sbjct: 131 LDTGNLVVRAENDNDPENFLWQSFDYPGDSFLPGMKYGISFVTGLNRYLTSWKSPSDPST 190

Query: 181 DDYVYGIDPSGVPQAVFRKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEYVSNENEVFY 240
             Y   +DP+G+PQ    +GS  ++R+G WNGL ++GM  L+PNP+YTFE+V N+ E++Y
Sbjct: 191 GKYTNKLDPNGLPQYFLSQGSVDQFRSGPWNGLRFSGMINLKPNPIYTFEFVFNQEEIYY 250

Query: 241 RFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYAVCN 300
           ++ +  SSV S MV++P G  QR TW+++TQ W  ++  +   +D CD +ALCGA+ VCN
Sbjct: 251 KYQIANSSVLSRMVLSPDGVLQRFTWIDRTQDWTLYLTAN---MDNCDRFALCGAHGVCN 307

Query: 301 MNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCEHGDGFLKRESVKLPDTRFSL 360
           +N NS  C+CL+ F PKS  EW   D S GCVR+  LDC +G+GF+K   +K+PDTR S 
Sbjct: 308 IN-NSPACDCLKEFEPKSLEEWTAADWSQGCVRKAPLDCSNGEGFIKYTGIKVPDTRKSW 366

Query: 361 VDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKELSESGQDLFVRMA 420
            +  I+L EC+E+C KNCSCTAYAN DVR GGSGC+LWF DLID+++ +E+GQD+++R+A
Sbjct: 367 YNKTINLEECEEVCLKNCSCTAYANLDVRDGGSGCVLWFGDLIDIRQYNENGQDIYIRIA 426

Query: 421 ASELDDIERKKPKKKKKVAIVITSVLLVTGVILLGGFVYLWKRRHRKQGKTDGSSKLD-Y 479
           AS +D   + + KK+ ++ IVI   L+   ++ L  F+   ++  ++Q   +G+   +  
Sbjct: 427 ASVIDKPVKSRGKKRVRI-IVIPVSLVAFSLLALCLFLRFLRKNKQQQLTREGNVVTNPE 485

Query: 480 NDRG--NREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLS 537
            DR   +R E++ELP+FD   + +AT  FS  NKLG+GGFGPVYKG+L +GQEIA KRLS
Sbjct: 486 QDRTKESRNEDLELPLFDLATLTDATNCFSINNKLGQGGFGPVYKGILQDGQEIAVKRLS 545

Query: 538 KSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRS 597
           K S QG+ EF NEV+ IAKLQHRNLVKL+GCC + +ERMLIYEY+PNKSL+ FIFD  R+
Sbjct: 546 KRSRQGINEFRNEVVCIAKLQHRNLVKLLGCCIELEERMLIYEYMPNKSLDSFIFDKRRN 605

Query: 598 KFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 657
             LDW+KR  II GIARGLLYLHQDSRLRIIHRDLKASN+LLD EMNPKISDFGMAR+FG
Sbjct: 606 MLLDWTKRFPIINGIARGLLYLHQDSRLRIIHRDLKASNILLDYEMNPKISDFGMARSFG 665

Query: 658 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHH 717
            D+T ANT+R+VGTYGYM PEYAIDGLFSVKSDVFSFGVLVLEIV G++NRGF HA+H  
Sbjct: 666 GDETSANTSRIVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGRKNRGFRHAEHKL 725

Query: 718 NLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 777
           NLLGHAW L  E RP++LI++S+  +  +SEVLR I+V LLCVQ+ PEDRP MS VVLML
Sbjct: 726 NLLGHAWMLHKEGRPLDLIDESIVDTCIISEVLRSIEVALLCVQKSPEDRPKMSIVVLML 785

Query: 778 SGERSLPQPKQPGFFTERNPPESGSSSSKRSLLSTNEITISLIEGR 823
           S +  LPQPK+PGFFTER+     SS+ K  + S NE+T +L+E R
Sbjct: 786 SSDIVLPQPKEPGFFTERDLSNDSSSTIKHEISSVNELTSTLLEAR 831

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224115102|ref|XP_002316940.1| predicted protein [Populus trichocarpa] gi|222860005|gb|EEE97552.1| predicted protein [Populus trichocarpa]

 Score =  971 bits (2509), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 491/817 (60%), Positives = 586/817 (71%), Gaps = 52/817 (6%)

Query: 2   LIIYCFLFYTIRTATARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKK 61
           L +Y FL  TIR + A D ++ GQ I DG+T+VSA ++FELGFFSPG S  RYLGIWYKK
Sbjct: 15  LFVYSFLLSTIRVSNAPDIISPGQFIGDGDTIVSAGQNFELGFFSPGSSTRRYLGIWYKK 74

Query: 62  IGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLL 121
              GTV+WVANR+ P+ D SG L  ++QG  TL+LLN T  +VWSSN +    NPVA LL
Sbjct: 75  FSTGTVVWVANRENPIFDHSGVLYFTNQG--TLLLLNGTKDVVWSSNRTTPKNNPVAQLL 132

Query: 122 ESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSADDPAQD 181
           ESGNLVVKDG D +P++FLWQSFDYP    +  MKLG NLVTGL+  ISSWKS DDPA+ 
Sbjct: 133 ESGNLVVKDGNDSNPESFLWQSFDYPGDTNLPDMKLGRNLVTGLDWSISSWKSLDDPARG 192

Query: 182 DYVYGIDPSGVPQAVFRKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEYVSNENEVFYR 241
           +Y  GIDP G  Q V++KG  I++RAGSWNG+ +TG  +L+PNPVY +E+V N+ EV++ 
Sbjct: 193 EYSLGIDPRGYQQLVYKKGRAIQFRAGSWNGIRFTGATRLRPNPVYRYEFVLNDKEVYFN 252

Query: 242 FNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYAVCNM 301
           F L+ SSV S  V+N  G  +RLTW+ Q  +W  +        DQCD Y+ CG+ A CN+
Sbjct: 253 FELLNSSVASRFVVNASGVVERLTWISQMHRWTRYFAVGE---DQCDAYSFCGSNAKCNI 309

Query: 302 NSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCEHGDGFLKRESVKLPDTRFSLV 361
           +  S  C CL+GF PKS  +W   D S GCVRRT L C  G+GF+K   +KLPDT  S  
Sbjct: 310 D-KSPVCACLDGFEPKSARDWSFQDWSGGCVRRTTLTCNRGEGFVKHTGMKLPDTSSSWY 368

Query: 362 DNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKELSESGQDLFVRMAA 421
           +  ISL EC+ELC K CSC AYAN DVRGGGSGCLLWF DLIDM+E   +GQDL++RMAA
Sbjct: 369 NTSISLKECQELCLKKCSCMAYANTDVRGGGSGCLLWFGDLIDMREFVNTGQDLYIRMAA 428

Query: 422 SELDDIERKKPKKKKKVAIVITSVLLVTGVILLGGFVYLWKRRHRKQGKTDGSSKLDYND 481
           S L                                            GK     ++DY D
Sbjct: 429 SYL--------------------------------------------GKMKNILEMDY-D 443

Query: 482 RGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSG 541
             +R+EE+ELPI D   IA AT NFS   KLGEGGFG VYKG L  GQ+IA KRLS  SG
Sbjct: 444 SHSRKEELELPIIDLSTIAKATGNFSSNKKLGEGGFGLVYKGTLY-GQDIAVKRLSMYSG 502

Query: 542 QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLD 601
           QG+EEF+NEVLLIAKLQHRNLVKL+GCC + DERMLIYEY+PNKSL+ FIFD +RSK LD
Sbjct: 503 QGIEEFKNEVLLIAKLQHRNLVKLLGCCIEGDERMLIYEYMPNKSLDYFIFDQSRSKLLD 562

Query: 602 WSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
           W  R  II GIARGLLYLHQDSRLRIIHRDLKASNVLLD +MNPKISDFGMAR FG +QT
Sbjct: 563 WPTRISIIDGIARGLLYLHQDSRLRIIHRDLKASNVLLDTDMNPKISDFGMARIFGGNQT 622

Query: 662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLG 721
           EANT RVVGTYGYM PEYA++GLFSVKSD+FSFGVLVLEIV G++NRGF+  +HH NL+G
Sbjct: 623 EANTKRVVGTYGYMAPEYAVEGLFSVKSDIFSFGVLVLEIVSGRKNRGFFSHNHHLNLVG 682

Query: 722 HAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 781
           HAW+LW+EER +EL + +LG S++LSE++R I VGLLCVQQ+P+DRPNMS+ VLML GE 
Sbjct: 683 HAWKLWMEERSLELTDNTLGASHALSEIIRYIHVGLLCVQQQPDDRPNMSTAVLMLGGES 742

Query: 782 SLPQPKQPGFFTERNPPESGSSSSKRSLLSTNEITIS 818
           SLPQPKQPGFF ERN P + SSSS     STN IT++
Sbjct: 743 SLPQPKQPGFFLERNVPRTESSSSNYKSTSTNGITMT 779

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255569631|ref|XP_002525781.1| S-locus-specific glycoprotein S13 precursor, putative [Ricinus communis] gi|223534931|gb|EEF36617.1| S-locus-specific glycoprotein S13 precursor, putative [Ricinus communis]

 Score =  964 bits (2492), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 479/831 (57%), Positives = 612/831 (73%), Gaps = 19/831 (2%)

Query: 1   MLIIYC-FLFYTIRTATARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWY 59
           +L+I+C +L  +I T+TA DT+N+ QS+ DGETLVSA ESF+LGFFSPG S++RYLGIWY
Sbjct: 49  ILVIFCSYLLLSITTSTAADTINITQSVTDGETLVSAGESFKLGFFSPGNSRTRYLGIWY 108

Query: 60  KKIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAV 119
            K+   TV+WVANR+ PL D SG L I+      L LLN     +WSSN +  ARNPVA 
Sbjct: 109 NKVSVMTVVWVANRETPLIDSSGVLKITDH--RILALLNHNGSKIWSSNVTMAARNPVAQ 166

Query: 120 LLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSADDPA 179
           LL+SGNL+VKD  D +P+NFLWQSFDYP + L+ GMKLG N+ TGL+R+ISSWK+  DP+
Sbjct: 167 LLDSGNLIVKDEGDDNPENFLWQSFDYPCNTLLPGMKLGRNIATGLDRYISSWKTPSDPS 226

Query: 180 QDDYVYGIDPSGVPQAVFRKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEYVSNENEVF 239
           + ++ YG+DP+G P+ + R+ S  R+RAG WNG  ++G  QL  NP++ +E+V NE E++
Sbjct: 227 RGNFTYGLDPAGYPEMILRENSIERFRAGPWNGRSYSGTSQLNVNPIFKYEFVINETEIY 286

Query: 240 YRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYAVC 299
           Y F L+ SSV S MV+N  G  QR  W E+ +KW  +        D CD YALCGA+A C
Sbjct: 287 YDFQLLNSSVLSRMVINENGILQRFIWAERERKWRLYFTIQ---TDDCDQYALCGAFASC 343

Query: 300 NMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCEHGDGFLKRESVKLPDTRFS 359
           N+ SNS  C CL GFVPK P EWD  D S GCVR+T L+C   DGF K  + KLP+TR S
Sbjct: 344 NIKSNSY-CSCLNGFVPKFPKEWDQADWSGGCVRKTPLNCS-SDGFQKYLAFKLPETRKS 401

Query: 360 LVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKELSESGQDLFVRM 419
             +  ++L +CK +C KNCSCT YAN D+R G SGCLLWF D+ID  EL   GQD+++RM
Sbjct: 402 WFNRSMNLEDCKNMCVKNCSCTVYANLDIREGESGCLLWFSDVIDTTELDGDGQDIYIRM 461

Query: 420 AASEL-----DDIERKKPKKKKKVAIVITSVLLVTGV--ILLGGFVYLWKRRHRKQGKTD 472
           +AS+L     DD + +     KK   +I S LL  G+  + L   +Y+W+++ +K+GK  
Sbjct: 462 SASQLGVAHDDDPKIQSKSNVKKQMRIILSSLLSAGMMSLSLAVILYVWRKKQKKEGKAI 521

Query: 473 GSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIA 532
           G  ++  ND+G +EE ++LP+FD+  IA AT NFSD NKLGEGGFG    G L +GQEIA
Sbjct: 522 GILEISANDKGEKEE-LKLPLFDFGTIACATCNFSDANKLGEGGFG---LGNLKDGQEIA 577

Query: 533 AKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIF 592
            +RLSK+S QG++EF NEVL IAKLQHRNLV+L+GCC Q +E++LIYE++PNKSL+ FIF
Sbjct: 578 VRRLSKNSNQGVDEFMNEVLHIAKLQHRNLVRLLGCCIQSEEKLLIYEFMPNKSLDFFIF 637

Query: 593 DVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 652
           D T+SK LDW KR  II GIARGLLYLHQDSRLRIIHRDLKA N+LLD EMNPKISDFG 
Sbjct: 638 DQTKSKLLDWPKRYHIINGIARGLLYLHQDSRLRIIHRDLKAGNILLDYEMNPKISDFGP 697

Query: 653 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYH 712
           AR F  ++TEA+T++VVGT+GYM PEYAIDGL+S+KSDVFSFGV+VLEIV GKRNRGFYH
Sbjct: 698 ARCFWGNETEASTDKVVGTHGYMSPEYAIDGLYSMKSDVFSFGVIVLEIVSGKRNRGFYH 757

Query: 713 ADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSS 772
            +H  NLLGHAW+L  + R  E+I+ S+  S +LSEVLR + VGLLCVQQ  EDRP+MS+
Sbjct: 758 PEHQLNLLGHAWKLHKDGRSTEMIDGSMINSCNLSEVLRSVHVGLLCVQQSLEDRPSMSA 817

Query: 773 VVLMLSGERSLPQPKQPGFFTERNPPESGSSSSKRSLLSTNEITISLIEGR 823
            V MLSGE +LP+PKQPGFFTER+  E+ SSSS ++  S+N +TI+L + R
Sbjct: 818 AVYMLSGESALPEPKQPGFFTERDCTEANSSSSIKNFNSSNGLTITLPDAR 868

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359493721|ref|XP_002280717.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera]

 Score =  961 bits (2483), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 471/827 (56%), Positives = 607/827 (73%), Gaps = 63/827 (7%)

Query: 1   MLIIYCFLFYTIRTATARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYK 60
           ++ ++ ++   +R +TA D++   Q I+DGET++SA  +FELGF   G SK++YLGIWYK
Sbjct: 37  LVFLFSYVISILRISTAVDSITANQHIKDGETIISAGGNFELGFVHLGTSKNQYLGIWYK 96

Query: 61  KIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVL 120
           K+   TV+WVANR+ P++D SG L ++ QG  +LV+LN +NG++WSSN+SR+ARNP A L
Sbjct: 97  KVTPRTVVWVANRELPVTDSSGVLKVTDQG--SLVILNGSNGLIWSSNSSRSARNPTAQL 154

Query: 121 LESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSADDPAQ 180
           L+SGNLV+K G D DPDNFLWQSFDYP   L+ GMK G N VTGL+R++SSWKS DDP++
Sbjct: 155 LDSGNLVIKSGNDSDPDNFLWQSFDYPGDTLLPGMKHGRNTVTGLDRYLSSWKSNDDPSK 214

Query: 181 DDYVYGIDPSGVPQAVFRKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEYVSNENEVFY 240
            D+ YG+DPSG PQ   R GST+ +R+G WNG+ + G P+L+PNPV+ + +V NE E+++
Sbjct: 215 GDFTYGLDPSGCPQLFLRSGSTVIFRSGPWNGIRFNGFPELRPNPVFNYSFVFNEKEMYF 274

Query: 241 RFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYAVCN 300
            + L+ SSV S +V+NP G+ QRL W+ +T+ W  +   S    D CD+YALCGAY+ CN
Sbjct: 275 TYKLVNSSVLSRLVLNPNGNVQRLIWIGRTKSWNVY---STAYKDDCDSYALCGAYSTCN 331

Query: 301 MNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCEHGDGFLKRESVKLPDTRFSL 360
           ++  S +C C++GFVPK P +WD +D S+GCVR+T LDC+ GDGF+K   VKLPDTR S 
Sbjct: 332 IH-RSPRCGCMKGFVPKFPYQWDTMDWSNGCVRKTSLDCQKGDGFVKCSGVKLPDTRNSW 390

Query: 361 VDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKELSESGQDLFVRMA 420
            +  ++L EC  LC +NCSC+AY N+D++GGGSGCLLWF DLID+KE +E+GQD ++RMA
Sbjct: 391 FNESMNLKECASLCLRNCSCSAYTNSDIKGGGSGCLLWFGDLIDVKEFTENGQDFYIRMA 450

Query: 421 ASELDDIERKKPKKKKKVAIVITSVLLVTGVILLGGFVYLWKRRHRKQGKTDGSSKLDYN 480
                                                                +S+L+ N
Sbjct: 451 -----------------------------------------------------ASELELN 457

Query: 481 DRG----NREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL 536
           + G     R+E++ELP+FD   I NAT NFS  NKLGEGGFGPVYKG+L +G+EIA KRL
Sbjct: 458 NEGAETNERQEDLELPLFDLDTILNATHNFSRNNKLGEGGFGPVYKGMLQDGKEIAVKRL 517

Query: 537 SKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTR 596
           SK S QG++EF+NEV+ I+KLQHRNLVKL+GCC   +E+MLIYEY+PNKSLN FIFD  +
Sbjct: 518 SKESNQGLDEFKNEVIYISKLQHRNLVKLLGCCIHGEEKMLIYEYMPNKSLNFFIFDGIQ 577

Query: 597 SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 656
           S  LDW KR  II GIARGLLYLHQDSRLRIIHRDLKA NVLLDNEMNP+ISDFGMAR+F
Sbjct: 578 SMVLDWPKRFVIINGIARGLLYLHQDSRLRIIHRDLKADNVLLDNEMNPRISDFGMARSF 637

Query: 657 GIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH 716
           G ++T+A T RVVGTYGYM PEYAIDG++SVKSDVFSFGVL+LEI+ GKRNRGF H DH 
Sbjct: 638 GGNETQARTKRVVGTYGYMSPEYAIDGVYSVKSDVFSFGVLLLEIISGKRNRGFNHPDHD 697

Query: 717 HNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 776
            NLLGHAW L++E  P+ELI+ S+G +Y+ SEVLR + VGLLCVQ+ P+DRPNMSSVVLM
Sbjct: 698 LNLLGHAWTLYMERTPLELIDASVGDTYNQSEVLRALNVGLLCVQRHPDDRPNMSSVVLM 757

Query: 777 LSGERSLPQPKQPGFFTERNPPESGSSSSKRSLLSTNEITISLIEGR 823
           LS E +L QPK+PGFFTERN  E+ S   K ++ S NE TI+++EGR
Sbjct: 758 LSSEGALRQPKEPGFFTERNMLEADSLQCKHAVFSGNEHTITILEGR 804

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	823
TAIR|locus:2131684	783	AT4G27290 [Arabidopsis thalian	0.509	0.535	0.508	9.2e-235
TAIR|locus:2131694	815	AT4G27300 [Arabidopsis thalian	0.931	0.941	0.503	2.9e-206
TAIR|locus:2141181	850	RK3 "receptor kinase 3" [Arabi	0.979	0.948	0.467	3.9e-202
TAIR|locus:2018546	843	RK1 "receptor kinase 1" [Arabi	0.946	0.924	0.475	1.6e-198
TAIR|locus:2018506	847	RK2 "receptor kinase 2" [Arabi	0.980	0.952	0.461	1e-196
TAIR|locus:2141176	849	B120 [Arabidopsis thaliana (ta	0.961	0.931	0.440	2.3e-174
TAIR|locus:2200908	842	AT1G61610 [Arabidopsis thalian	0.974	0.952	0.420	6.9e-173
TAIR|locus:2200151	830	SD1-13 "S-domain-1 13" [Arabid	0.974	0.966	0.402	2.2e-162
TAIR|locus:2197704	831	AT1G61390 [Arabidopsis thalian	0.962	0.953	0.396	1.9e-154
UNIPROTKB|O49974	848	KIK1 "Serine/threonine-protein	0.929	0.902	0.410	1.1e-153

TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)]

 Score = 1181 (420.8 bits), Expect = 9.2e-235, Sum P(2) = 9.2e-235
 Identities = 221/435 (50%), Positives = 303/435 (69%)

Query:     1 MLIIYCFLFYTIRTATARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYK 60
             +LII   LF TI  A A D L   Q+++DG+T+VS   SFE+GFFSPG S++RYLGIWYK
Sbjct:     9 LLIIS--LFSTILLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWYK 66

Query:    61 KIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTA-----RN 115
             KI   TV+WVANRD+PL D SG L +S  G+  L L N  N I+WSS++S ++     RN
Sbjct:    67 KISLQTVVWVANRDSPLYDLSGTLKVSENGS--LCLFNDRNHIIWSSSSSPSSQKASLRN 124

Query:   116 PVAVLLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSA 175
             P+  +L++GNLVV++  D D D ++WQS DYP  + + GMK G+N VTGLNRF++SW++ 
Sbjct:   125 PIVQILDTGNLVVRNSGD-DQD-YIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAI 182

Query:   176 DDPAQDDYVYGIDPSGVPQAVFRKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEYVSNE 235
             DDP+  +Y   +DP+GVPQ   +K S + +R G WNGL +TGMP L+PNP+Y +EYV  E
Sbjct:   183 DDPSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFTE 242

Query:   236 NEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGA 295
              EV+Y + L   SV + M +NP G  QR TW++  Q W  ++     ++D CD Y LCG+
Sbjct:   243 EEVYYTYKLENPSVLTRMQLNPNGALQRYTWVDNLQSWNFYL---SAMMDSCDQYTLCGS 299

Query:   296 YAVCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCEHG-DGFLKRESVKLP 354
             Y  CN+N + A C CL+GFV K+P  W   D S+GCVRR +LDC  G DGFLK   +KLP
Sbjct:   300 YGSCNINESPA-CRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLP 358

Query:   355 DTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKELSESGQD 414
             DTR S  D  + L ECK++C +NC+C+AY+  D+R GG GC+LWF DLID++E +E+GQD
Sbjct:   359 DTRTSWYDKNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIREYNENGQD 418

Query:   415 LFVRMAASELDDIER 429
             L+VR+A+SE++ ++R
Sbjct:   419 LYVRLASSEIETLQR 433

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)]

 Score = 1995 (707.3 bits), Expect = 2.9e-206, P = 2.9e-206
 Identities = 409/812 (50%), Positives = 542/812 (66%)

Query:    27 IRDGETLVSANESFELGFFSPGKSKS---RYLGIWYKKIGNGTVIWVANRDAPLSDRSGA 83
             ++DG+TL S ++ F+LGFFS  + +    R+LG+WY +     V+WVANR+ PL   SG 
Sbjct:    34 LKDGDTLSSPDQVFQLGFFSLDQEEQPQHRFLGLWYME--PFAVVWVANRNNPLYGTSGF 91

Query:    84 LNISSQGNATLVLLNSTNGIVWSSN-----ASRTARNPVAVLLESGNLVVKDGKDIDPDN 138
             LN+SS G+  L L +  +  +WSS+     AS+TA NP+  +  SGNL+  DG++     
Sbjct:    92 LNLSSLGD--LQLFDGEHKALWSSSSSSTKASKTANNPLLKISCSGNLISSDGEEA---- 145

Query:   139 FLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSADDPAQDDYVYGIDPSGVPQAVFR 198
              LWQSFDYP + ++AGMKLG N  T +   +SSWK+  DP+  D+   +D  G+PQ + R
Sbjct:   146 VLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKDPSPGDFTLSLDTRGLPQLILR 205

Query:   199 KG--STIRYRAGSWNGLHWTGMPQL-QPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVM 255
             K   S+  YR GSWNGL +TG P + + N ++ +++ S+  EV Y +   +  + S +V+
Sbjct:   206 KNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYKFTSSAQEVNYSWTP-RHRIVSRLVL 264

Query:   256 NPLGDPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYAVCNMNS-NSAKCECLEGF 314
             N  G   R    +Q Q W   +  +    D+CD Y++CGAYAVC +NS N+  C CL+GF
Sbjct:   265 NNTGKLHRFIQSKQNQ-W---ILANTAPEDECDYYSICGAYAVCGINSKNTPSCSCLQGF 320

Query:   315 VPKSPSEWDLLDKSDGCVRRTQLDCEHGDGFLKRESVKLPDTRFSLVD--NKISLLECKE 372
              PKS  +W++   + GCV     +CE  D F+K   +KLPDT +S  D  N+++L +CK 
Sbjct:   321 KPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLPDTSWSWYDAKNEMTLEDCKI 380

Query:   373 LCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKELSESGQDLFVRMAASELDDIERXXX 432
              CS NCSCTAYAN D+R GG GCLLWF DL+DM+E S  GQD+++RM  ++++   R   
Sbjct:   381 KCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSSFGQDVYIRMGFAKIEFKGRE-- 438

Query:   433 XXXXXVAXXXXXXXXXXXXXXXXXFVYLWKRRHRKQGKTDGSSKLDYNDRGNREEEMELP 492
                  V                  F   ++++  K+ + +   K      G  EE+++LP
Sbjct:   439 -----VVGMVVGSVVAIAVVLVVVFA-CFRKKIMKRYRGENFRK------GIEEEDLDLP 486

Query:   493 IFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVL 552
             IFD   I+ AT++FS  N LG GGFGPVYKG L +GQEIA KRLS +SGQG+EEF+NEV 
Sbjct:   487 IFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEEFKNEVK 546

Query:   553 LIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGI 612
             LIAKLQHRNLV+L+GCC Q +E MLIYEY+PNKSL+ FIFD  RS  LDW KR  II G+
Sbjct:   547 LIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRMNIINGV 606

Query:   613 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTY 672
             ARG+LYLHQDSRLRIIHRDLKA NVLLDN+MNPKISDFG+A++FG DQ+E++TNRVVGTY
Sbjct:   607 ARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRVVGTY 666

Query:   673 GYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP 732
             GYMPPEYAIDG FSVKSDVFSFGVLVLEI+ GK NRGF HADH  NLLGH W++W+E+R 
Sbjct:   667 GYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLGHVWKMWVEDRE 726

Query:   733 VELINKS-LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGF 791
             +E+  +  L  +  + EVLRCI V LLCVQQ+PEDRP M+SVVLM   + SLP P QPGF
Sbjct:   727 IEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMASVVLMFGSDSSLPHPTQPGF 786

Query:   792 FTERNPPEXXXXXXXXXXXXTNEITISLIEGR 823
             FT RN P+             NE++I++++GR
Sbjct:   787 FTNRNVPDISSSLSLRSQ---NEVSITMLQGR 815

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1956 (693.6 bits), Expect = 3.9e-202, P = 3.9e-202
 Identities = 397/850 (46%), Positives = 543/850 (63%)

Query:     1 MLIIYCFLFYTIRTATARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYK 60
             +LI++     +  T +A ++L    +I    T+VS    FELGFF PG     YLGIWYK
Sbjct:    18 LLILFPAYSISANTLSASESL----TISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYK 73

Query:    61 KIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASR-TARNP-VA 118
              I   T +WVANRD PLS   G L IS   ++ LV+L+ ++  VWS+N +    R+P VA
Sbjct:    74 AISKRTYVWVANRDTPLSSSIGTLKIS---DSNLVVLDQSDTPVWSTNLTGGDVRSPLVA 130

Query:   119 VLLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSADDP 178
              LL++GN V++D K+  PD  LWQSFD+P+  L+  MKLG +  TG NRFI SWKS DDP
Sbjct:   131 ELLDNGNFVLRDSKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDP 190

Query:   179 AQDDYVYGIDPSGVPQAVFRKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEYVSNENEV 238
             +  D+ + ++  G P+       +  YR+G WNG+ ++G+P++QP     F + +++ EV
Sbjct:   191 SSGDFSFKLETEGFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEV 250

Query:   239 FYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYAV 298
              Y F + KS V S + ++  G  QR TW+E  Q W  F  ++    DQCD Y  CG Y  
Sbjct:   251 TYSFRITKSDVYSRLSISSSGLLQRFTWIETAQNWNQFW-YAPK--DQCDEYKECGVYGY 307

Query:   299 CNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCEHGDGFLKRESVKLPDTRF 358
             C+ N+ S  C C++GF P++P  W L D SDGCVR+T L C  GDGF++ + +KLPDT  
Sbjct:   308 CDSNT-SPVCNCIKGFKPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTT 366

Query:   359 SLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKELSESGQDLFVR 418
             + VD  I + EC++ C ++C+CTA+AN D+RG GSGC+ W  +L D++  ++ GQDL+VR
Sbjct:   367 ASVDRGIGVKECEQKCLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYAKGGQDLYVR 426

Query:   419 MAASELDDIERXXXXXXXXVAXXXXXXXXXXXXXXXXXFVYLWKRRHRKQGKTDG----- 473
             +AA++L+D +R                             +LWKR+ ++    +      
Sbjct:   427 LAATDLED-KRNRSAKIIG-----SSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDH 480

Query:   474 ---SSKLDYND----------RGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPV 520
                S  L  N+          R N  +++ELP+ ++  +A AT NFS+ NKLG+GGFG V
Sbjct:   481 QLRSRDLLMNEVVISSRRHISRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIV 540

Query:   521 YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 580
             YKG L++GQE+A KRLSK+S QG +EF+NEV LIA+LQH NLV+L+ CC    E+MLIYE
Sbjct:   541 YKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYE 600

Query:   581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD 640
             YL N SL+  +FD +R+  L+W  R  II GIARGLLYLHQDSR RIIHRDLKASN+LLD
Sbjct:   601 YLENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLD 660

Query:   641 NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLE 700
               M PKISDFGMAR FG D+TEANT +VVGTYGYM PEYA+DG+FS+KSDVFSFGVL+LE
Sbjct:   661 KYMTPKISDFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLE 720

Query:   701 IVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSL---SEVLRCIQVGL 757
             I+  KRN+GFY++D   NLLG  WR W E + +E+I+  +  S S     E+LRCIQ+GL
Sbjct:   721 IISSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGL 780

Query:   758 LCVQQRPEDRPNMSSVVLMLSGERS-LPQPKQPGFFTERNPPEXXXXXXXXXXXXT---N 813
             LCVQ+R EDRP MS V+LML  E + +PQPK PG+  ER+  +            +   N
Sbjct:   781 LCVQERAEDRPTMSLVILMLGSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVN 840

Query:   814 EITISLIEGR 823
             +IT+S+++ R
Sbjct:   841 QITVSVLDAR 850

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0005773 "vacuole" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1922 (681.6 bits), Expect = 1.6e-198, P = 1.6e-198
 Identities = 391/822 (47%), Positives = 534/822 (64%)

Query:     2 LIIYCFLFYTIRTATARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKK 61
             LI+  FL +++   T   T +L  +I   +T++S ++ FELGFF+P  S   YLGIWYK 
Sbjct:    15 LILILFLAFSVSPNTLSATESL--TISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKI 72

Query:    62 IGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASR-TARNPVAV- 119
             I   T +WVANRD PLS  +G L IS  GN  LV+ + ++  VWS+N +    R+PVA  
Sbjct:    73 IPIRTYVWVANRDNPLSSSNGTLKIS--GN-NLVIFDQSDRPVWSTNITGGDVRSPVAAE 129

Query:   120 LLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSADDPA 179
             LL++GN +++D  +      LWQSFD+P+  L+A MKLG +  TG NR + SWK+ DDP+
Sbjct:   130 LLDNGNFLLRDSNN----RLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPS 185

Query:   180 QDDYVYGIDPSGVPQAVFRKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEYVSNENEVF 239
               ++   ++ S  P+       +I YR+G WNG+ ++ +P         + + +++ EV 
Sbjct:   186 SGEFSTKLETSEFPEFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKEEVT 245

Query:   240 YRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYAVC 299
             Y + + K+++ S + +N  G  QRLTW E TQ W     +S    D CDNY +CG +  C
Sbjct:   246 YSYRINKTNLYSRLYLNSAGLLQRLTWFETTQSWKQLW-YSPK--DLCDNYKVCGNFGYC 302

Query:   300 NMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCEHGDGFLKRESVKLPDTRFS 359
             + NS    C C++GF P +   WDL D S GC+R+T+L C+  DGF + + +KLPDT  +
Sbjct:   303 DSNS-LPNCYCIKGFKPVNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTAT 361

Query:   360 LVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKELSESGQDLFVRM 419
             +VD +I L  CKE C ++C+CTA+ANAD+R GGSGC++W  +++DM+  ++ GQDL+VR+
Sbjct:   362 IVDREIGLKVCKERCLEDCNCTAFANADIRNGGSGCVIWTREILDMRNYAKGGQDLYVRL 421

Query:   420 AASELDDIERXXXXXXXXVAXXXXXXXXXXXXXXXXXFVYLWKRRHRK----------QG 469
             AA+EL+D +R                             + WKR+ ++          Q 
Sbjct:   422 AAAELED-KRIKNEKIIG-----SSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQV 475

Query:   470 KTDGS-------SKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYK 522
             ++  S       S+  Y  +  + E +ELP+ +  A+A AT NFS+ NKLG+GGFG VYK
Sbjct:   476 RSQDSLINDVVVSRRGYTSKEKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYK 535

Query:   523 GVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 582
             G L++G+EIA KRLSK S QG +EF NEV LIAKLQH NLV+L+GCC  + E+MLIYEYL
Sbjct:   536 GRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYL 595

Query:   583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE 642
              N SL+  +FD TRS  L+W KR  II GIARGLLYLHQDSR RIIHRDLKASNVLLD  
Sbjct:   596 ENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKN 655

Query:   643 MNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
             M PKISDFGMAR FG ++TEANT RVVGTYGYM PEYA+DG+FS+KSDVFSFGVL+LEI+
Sbjct:   656 MTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEII 715

Query:   703 CGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK----SLGGSYSLSEVLRCIQVGLL 758
              GKRN+GFY+++   NLLG  WR W E   +E+++     SL   +   E+LRCIQ+GLL
Sbjct:   716 SGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLL 775

Query:   759 CVQQRPEDRPNMSSVVLMLSGERS-LPQPKQPGFFTERNPPE 799
             CVQ+R EDRP MSSV++ML  E + +PQPK+PGF   R+P E
Sbjct:   776 CVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCIGRSPLE 817

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009875 "pollen-pistil interaction" evidence=TAS

GO:0016020 "membrane" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1905 (675.7 bits), Expect = 1.0e-196, P = 1.0e-196
 Identities = 392/850 (46%), Positives = 538/850 (63%)

Query:     1 MLIIYCFLFYTIRTATARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYK 60
             + II  FL +++  +    T +L  +I   +T++S ++ FELGFF+P  S   YLGIWYK
Sbjct:    14 LFIIILFLAFSVYASNFSATESL--TISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYK 71

Query:    61 KIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASR-TARNPVAV 119
              I   T +WVANRD PLS  +G L IS      LV+ + ++  VWS+N +    R+PVA 
Sbjct:    72 IIPIRTYVWVANRDNPLSSSNGTLKISDNN---LVIFDQSDRPVWSTNITGGDVRSPVAA 128

Query:   120 -LLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGV-NLVTGLNRFISSWKSADD 177
              LL+ GN V++D K+  P  FLWQSFD+P+  L++ MK+G  N   G NR + SWK+ DD
Sbjct:   129 ELLDYGNFVLRDSKNNKPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDD 188

Query:   178 PAQDDYVYGIDPSGVPQAVFRKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEYVSNENE 237
             P+  D+   +  SG P+       +I YR+G W G  ++ +P ++P       +  N  +
Sbjct:   189 PSSGDFSTKLRTSGFPEFYIYNKESITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQQ 248

Query:   238 VFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYA 297
             V Y + + K+++ S++ ++  G  QRLTWME  Q W     +S    D CDNY  CG Y 
Sbjct:   249 VVYSYRVNKTNIYSILSLSSTGLLQRLTWMEAAQSWKQLW-YSPK--DLCDNYKECGNYG 305

Query:   298 VCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCEHGDGFLKRESVKLPDTR 357
              C+ N+ S  C C++GF P +  +  L D S GCVR+T+L C+  DGF++ + ++LPDT 
Sbjct:   306 YCDANT-SPICNCIKGFEPMN-EQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTT 363

Query:   358 FSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKELSESGQDLFV 417
              + VD  I L EC+E C K C+CTA+AN D+R GGSGC++W   L D++  ++ GQDL+V
Sbjct:   364 ETSVDKGIGLKECEERCLKGCNCTAFANTDIRNGGSGCVIWSGGLFDIRNYAKGGQDLYV 423

Query:   418 RMAASELDDIERXXXXXXXXVAXXXXXXXXXXXXXXXXXFVYLWKRRHRKQ--------- 468
             R+AA +L+D +R                             + WKR+ ++          
Sbjct:   424 RVAAGDLED-KRIKSKKIIG-----SSIGVSILLLLSFIIFHFWKRKQKRSITIQTPIVD 477

Query:   469 -GKTDGS--SKL-----DYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPV 520
               ++  S  ++L      Y  + N+ + +ELP+ +W A+A AT NFS  NKLG+GGFG V
Sbjct:   478 LVRSQDSLMNELVKASRSYTSKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIV 537

Query:   521 YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 580
             YKG+L++G+EIA KRLSK S QG +EF NEV LIAKLQH NLV+L+GCC  + E+MLIYE
Sbjct:   538 YKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYE 597

Query:   581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD 640
             YL N SL+  +FD TRS  L+W KR  II GIARGLLYLHQDSR RIIHRDLKASNVLLD
Sbjct:   598 YLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLD 657

Query:   641 NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLE 700
               M PKISDFGMAR FG ++TEANT RVVGTYGYM PEYA+DG+FS+KSDVFSFGVL+LE
Sbjct:   658 KNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLE 717

Query:   701 IVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK----SLGGSYSLSEVLRCIQVG 756
             I+ GKRN+GFY+++   NLLG  WR W E + +E+++     +L   +   E+LRCIQ+G
Sbjct:   718 IISGKRNKGFYNSNRDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIG 777

Query:   757 LLCVQQRPEDRPNMSSVVLMLSGERS-LPQPKQPGFFTERNPPEXXXXXXXXXXX--XTN 813
             LLCVQ+R EDRP MSSV++ML  E + +PQPK+PGF   R+  E               N
Sbjct:   778 LLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVN 837

Query:   814 EITISLIEGR 823
             ++T+S+I+ R
Sbjct:   838 QVTLSVIDAR 847

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0034613 "cellular protein localization" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)]

 Score = 1694 (601.4 bits), Expect = 2.3e-174, P = 2.3e-174
 Identities = 382/868 (44%), Positives = 517/868 (59%)

Query:     2 LIIYCFLFYTIRTATARDTLNLGQSIRDG---ETLVSANESFELGFFSPGKSKSRYLGIW 58
             L +Y FL+    ++ A +T+  G+S+RDG   + LVS  ++FELGFFSPG S  R+LGIW
Sbjct:    13 LFLYFFLY---ESSMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIW 69

Query:    59 YKKIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNA-SRTARNP- 116
             Y  I +  V+WVANR  P+SD+SG L IS+ GN  LVLL+  N  VWSSN  S T  N  
Sbjct:    70 YGNIEDKAVVWVANRATPISDQSGVLMISNDGN--LVLLDGKNITVWSSNIESSTTNNNN 127

Query:   117 -VAVLLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSA 175
              V  + ++GN V+ +    D D  +W+SF++P+   +  M++ VN  TG N    SW+S 
Sbjct:   128 RVVSIHDTGNFVLSE---TDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSE 184

Query:   176 DDPAQDDYVYGIDPSGVPQAVFRKGS-TIRYRAGSWNGLHWTGMPQLQ--PNPVYTFEYV 232
              DP+  +Y  G+DPSG P+ V  +G+ T ++R+G WN   +TG+P +    N +Y F+  
Sbjct:   185 TDPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLS 244

Query:   233 SNENEVFYRFNLIKSSVPSMMVMNPL---GDPQRLTWMEQTQKWAPFVPFSGLILDQCDN 289
             S  +E    +     S PS+++   +   G  + L W E  +KW  F         +CD 
Sbjct:   245 SPPDETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPD---SECDQ 301

Query:   290 YALCGAYAVCNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCEHG-----DG 344
             Y  CG + +C+M  ++  C C+ G+   S   W     S GC RRT L CE       D 
Sbjct:   302 YNRCGKFGICDMKGSNGICSCIHGYEQVSVGNW-----SRGCRRRTPLKCERNISVGEDE 356

Query:   345 FLKRESVKLPDTRFSLVD-NKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLI 403
             FL  +SVKLPD  F + + N +   +C+E C +NCSC AY+      GG GC++W  DL+
Sbjct:   357 FLTLKSVKLPD--FEIPEHNLVDPEDCRERCLRNCSCNAYSLV----GGIGCMIWNQDLV 410

Query:   404 DMKELSESGQDLFVRMAASELDDIERXXXXXXXXVAXXXXXXXXXXXXXXXXXFVYLWKR 463
             D+++    G  L +R+A SE+ +  +        V                   + LW+ 
Sbjct:   411 DLQQFEAGGSSLHIRLADSEVGENRKTKIAVIVAVLVGVILIGIFA--------LLLWRF 462

Query:   464 RHRKQ------GK-TDGS--------SK---------LDYNDRGNREEEMELPIFDWMAI 499
             + +K       GK TD S        SK         +D    G      ELP+F   AI
Sbjct:   463 KRKKDVSGAYCGKNTDTSVVVADLTKSKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAI 522

Query:   500 ANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH 559
             A AT +F  +N+LG GGFGPVYKGVL +G+EIA KRLS  SGQG++EF+NE++LIAKLQH
Sbjct:   523 AIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQH 582

Query:   560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
             RNLV+L+GCC + +E+ML+YEY+PNKSL+ F+FD T+   +DW  R  II GIARGLLYL
Sbjct:   583 RNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYL 642

Query:   620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
             H+DSRLRIIHRDLK SNVLLD EMNPKISDFGMAR FG +Q EANT RVVGTYGYM PEY
Sbjct:   643 HRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEY 702

Query:   680 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 739
             A++GLFSVKSDV+SFGVL+LEIV GKRN     +  H +L+G+AW L+   R  EL++  
Sbjct:   703 AMEGLFSVKSDVYSFGVLLLEIVSGKRNTSL-RSSEHGSLIGYAWYLYTHGRSEELVDPK 761

Query:   740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS-LPQPKQPGFF-TERNP 797
             +  + S  E LRCI V +LCVQ    +RPNM+SV+LML  + + L  P+QP F  T RN 
Sbjct:   762 IRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPRQPTFTSTRRNS 821

Query:   798 PEXXXXXXXXXXX--XTNEITISLIEGR 823
              +              +NEIT +++ GR
Sbjct:   822 IDVNFALDSSQQYIVSSNEITSTVVLGR 849

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0006979 "response to oxidative stress" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)]

 Score = 1680 (596.4 bits), Expect = 6.9e-173, P = 6.9e-173
 Identities = 357/849 (42%), Positives = 508/849 (59%)

Query:     2 LIIYCFLFYTIRTATARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKK 61
             L+I+  L   +  +T+ ++     +IR+G++L+S +ESFELGFF+P  S  RY+GIWYK 
Sbjct:    14 LLIFHQLCSNVSCSTS-NSFTRNHTIREGDSLISEDESFELGFFTPKNSTLRYVGIWYKN 72

Query:    62 IGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLL 121
             I   TV+WVANR+ PL D  GAL I+  GN  LV++N  N  +WS+N    + N VAVL 
Sbjct:    73 IEPQTVVWVANREKPLLDHKGALKIADDGN--LVIVNGQNETIWSTNVEPESNNTVAVLF 130

Query:   122 ESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSADDPAQD 181
             ++G+LV+    D D   + W+SF+ P+   + GM++ VN   G NR    WKS  DP+  
Sbjct:   131 KTGDLVLCS--DSDRRKWYWESFNNPTDTFLPGMRVRVNPSLGENRAFIPWKSESDPSPG 188

Query:   182 DYVYGIDPSGVPQAVFRKGSTIRYRAGSWNGLHWTGMPQLQ--PNPVYTFEYVS---NEN 236
              Y  GIDP G  + V  +G   ++R+G WN   +TG+P +    N +Y F+  S    + 
Sbjct:   189 KYSMGIDPVGALEIVIWEGEKRKWRSGPWNSAIFTGIPDMLRFTNYIYGFKLSSPPDRDG 248

Query:   237 EVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKW--APFVPFSGLILDQCDNYALCG 294
              V++ +    SS      + P G  ++  W +  + W    + P +     +C+ Y  CG
Sbjct:   249 SVYFTYVASDSSDFLRFWIRPDGVEEQFRWNKDIRNWNLLQWKPST-----ECEKYNRCG 303

Query:   295 AYAVCNMNS--NSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCEHG------DGFL 346
              Y+VC+ +   +S KC C++GF P    +W+  D S GC RR  L+C         DGF 
Sbjct:   304 NYSVCDDSKEFDSGKCSCIDGFEPVHQDQWNNRDFSGGCQRRVPLNCNQSLVAGQEDGFT 363

Query:   347 KRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMK 406
               + +K+PD    ++ N      CK++C+++CSC AYA       G GC++W  DLIDM+
Sbjct:   364 VLKGIKVPDFGSVVLHNNSET--CKDVCARDCSCKAYALVV----GIGCMIWTRDLIDME 417

Query:   407 ELSESGQDLFVRMAASELDDIERXXXXXXXXVAXXXXXXXXXXXXXXXXXF-----VYLW 461
                  G  + +R+A S+L    +        V                  F      +LW
Sbjct:   418 HFERGGNSINIRLAGSKLGG-GKENSTLWIIVFSVIGAFLLGLCIWILWKFKKSLKAFLW 476

Query:   462 KRRHRKQGKTDGSSKLDYNDR------GNREEEMELPIFDWMAIANATENFSDKNKLGEG 515
             K++      +D     DY+        G++ +  +LPIF + ++A+AT +F+++NKLG+G
Sbjct:   477 KKKDITV--SDIIENRDYSSSPIKVLVGDQVDTPDLPIFSFDSVASATGDFAEENKLGQG 534

Query:   516 GFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDER 575
             GFG VYKG   EG+EIA KRLS  S QG+EEF+NE+LLIAKLQHRNLV+L+GCC + +E+
Sbjct:   535 GFGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEK 594

Query:   576 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKAS 635
             ML+YEY+PNKSL+ F+FD ++   LDW KR ++IGGIARGLLYLH+DSRL+IIHRDLKAS
Sbjct:   595 MLLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKAS 654

Query:   636 NVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFG 695
             N+LLD EMNPKISDFGMAR F   Q  ANT RVVGTYGYM PEYA++G+FS KSDV+SFG
Sbjct:   655 NILLDTEMNPKISDFGMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFG 714

Query:   696 VLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQV 755
             VL+LEIV G++N  F   DH  +L+G+AW LW + +  E+I+  +  +  ++E +RCI V
Sbjct:   715 VLILEIVSGRKNVSFRGTDHG-SLIGYAWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIHV 773

Query:   756 GLLCVQQRPEDRPNMSSVVLMLSGERS-LPQPKQPGFFTERNPPEXXXXXXXXXXXXTNE 814
             G+LC Q     RPNM SV+LML  + S LP P+QP F +  N  +             N+
Sbjct:   774 GMLCTQDSVIHRPNMGSVLLMLESQTSQLPPPRQPTFHSFLNSGDIELNFDGHDVASVND 833

Query:   815 ITISLIEGR 823
             +T + I GR
Sbjct:   834 VTFTTIVGR 842

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 1581 (561.6 bits), Expect = 2.2e-162, P = 2.2e-162
 Identities = 341/847 (40%), Positives = 492/847 (58%)

Query:     1 MLIIYCFLFYTIRTATARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYK 60
             ++++   + +++R   A D +      RD ET+VS + +F  GFFSP  S  RY GIW+ 
Sbjct:     5 LILLLTLICFSLRLCLATDVITFSSEFRDSETVVSNHSTFRFGFFSPVNSTGRYAGIWFN 64

Query:    61 KIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNAS-RTARNPV-A 118
              I   TV+WVAN ++P++D SG ++IS +GN  LV+++    + WS+N     A N   A
Sbjct:    65 NIPVQTVVWVANSNSPINDSSGMVSISKEGN--LVVMDGRGQVHWSTNVLVPVAANTFYA 122

Query:   119 VLLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSADDP 178
              LL +GNLV+  G     D  LW+SF++P +I +  M L  +  TG +  + SWKS  DP
Sbjct:   123 RLLNTGNLVLL-GTTNTGDEILWESFEHPQNIYLPTMSLATDTKTGRSLKLRSWKSPFDP 181

Query:   179 AQDDYVYGIDPSGVPQAVFRKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEY-VSNENE 237
             +   Y  G+ P   P+ V  K   + +R+G WNG ++ G+P +    +  FE  +S++N 
Sbjct:   182 SPGRYSAGLIPLPFPELVVWKDDLLMWRSGPWNGQYFIGLPNMDYR-INLFELTLSSDNR 240

Query:   238 VFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYA 297
                  +   +++    +++  G   +  W    Q+W  ++        +CD YA CG +A
Sbjct:   241 GSVSMSYAGNTLLYHFLLDSEGSVFQRDWNVAIQEWKTWLKVPST---KCDTYATCGQFA 297

Query:   298 VCNMNSNSAK-CECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCEH---------GDGFLK 347
              C  N  S   C C+ GF P+S +EW+  + + GCVR+  L CE           DGF++
Sbjct:   298 SCRFNPGSTPPCMCIRGFKPQSYAEWNNGNWTQGCVRKAPLQCESRDNNDGSRKSDGFVR 357

Query:   348 RESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKE 407
              + +K+P        N+    +C E C KNCSCTAY+  D RG   GCLLW  +L+DM+E
Sbjct:   358 VQKMKVPHNPQRSGANE---QDCPESCLKNCSCTAYS-FD-RG--IGCLLWSGNLMDMQE 410

Query:   408 LSESGQDLFVRMAASELDDIERXXXXXXXXVAXXXXXXXXXXXXXXXXXFVYLWK-RRHR 466
              S +G   ++R+A SE    +R        V                     LWK  +HR
Sbjct:   411 FSGTGVVFYIRLADSEFK--KRTNRSIVITVTLLVGAFLFAGTVVLA-----LWKIAKHR 463

Query:   467 KQGKT-----DGSSKLDYNDRG----NREEEMELPIFDWMAIANATENFSDKNKLGEGGF 517
             ++ +      +    L  ND G    N+ +  ELP+F++  +A AT NFS  NKLG+GGF
Sbjct:   464 EKNRNTRLLNERMEALSSNDVGAILVNQYKLKELPLFEFQVLAVATNNFSITNKLGQGGF 523

Query:   518 GPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML 577
             G VYKG L EG +IA KRLS++SGQG+EEF NEV++I+KLQHRNLV+L+G C + +ERML
Sbjct:   524 GAVYKGRLQEGLDIAVKRLSRTSGQGVEEFVNEVVVISKLQHRNLVRLLGFCIEGEERML 583

Query:   578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNV 637
             +YE++P   L+ ++FD  + + LDW  R  II GI RGL+YLH+DSRL+IIHRDLKASN+
Sbjct:   584 VYEFMPENCLDAYLFDPVKQRLLDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNI 643

Query:   638 LLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVL 697
             LLD  +NPKISDFG+AR F  ++ E +T RVVGTYGYM PEYA+ GLFS KSDVFS GV+
Sbjct:   644 LLDENLNPKISDFGLARIFQGNEDEVSTVRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVI 703

Query:   698 VLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGL 757
             +LEIV G+RN  FY+   + NL  +AW+LW     + L++  +      +E+ RC+ VGL
Sbjct:   704 LLEIVSGRRNSSFYNDGQNPNLSAYAWKLWNTGEDIALVDPVIFEECFENEIRRCVHVGL 763

Query:   758 LCVQQRPEDRPNMSSVVLMLSGERS-LPQPKQPGFFTERNPPEXXXXXXXXXXXXTNEIT 816
             LCVQ    DRP++++V+ MLS E S LP+PKQP F   R   E             N ++
Sbjct:   764 LCVQDHANDRPSVATVIWMLSSENSNLPEPKQPAFIPRRGTSEVESSGQSDPRASINNVS 823

Query:   817 ISLIEGR 823
             ++ I GR
Sbjct:   824 LTKITGR 830

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

GO:0009637 "response to blue light" evidence=RCA

GO:0010155 "regulation of proton transport" evidence=RCA

GO:0016556 "mRNA modification" evidence=RCA

TAIR|locus:2197704 AT1G61390 [Arabidopsis thaliana (taxid:3702)]

 Score = 1506 (535.2 bits), Expect = 1.9e-154, P = 1.9e-154
 Identities = 333/839 (39%), Positives = 479/839 (57%)

Query:     1 MLIIYCFLFYTIRTATARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYK 60
             M+I  C L   I        +N    +  G+TL S +  +ELGFFSP  S+ +Y+GIW+K
Sbjct:    24 MVIFACLLLLIIFPTFGYADINTSSPLSIGQTLSSPDGVYELGFFSPNNSRKQYVGIWFK 83

Query:    61 KIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVL 120
              I    V+WVANRD P++  +  L ISS G+  L+LL+ T  ++WS+  + T+    A L
Sbjct:    84 NIAPQVVVWVANRDKPVTKTAANLTISSNGS--LILLDGTQDVIWSTGEAFTSNKCHAEL 141

Query:   121 LESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSADDPAQ 180
             L++GNLVV D  D+     LW+SF+   + ++    +  ++  G NR ++SW+S  DP+ 
Sbjct:   142 LDTGNLVVID--DVSGKT-LWKSFENLGNTMLPQSSVMYDIPRGKNRVLTSWRSNSDPSP 198

Query:   181 DDYVYGIDPSGVPQAVFRKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEYVSN--ENEV 238
              ++     P   PQ + R+GS+  +R+G W    ++G+P +  + V  F  + +  +   
Sbjct:   199 GEFTLEFTPQVPPQGLIRRGSSPYWRSGPWAKTRFSGIPGIDASYVSPFTVLQDVAKGTA 258

Query:   239 FYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYAV 298
              + ++++++   S + +   G   ++ W +  + W   + F       CD Y  CG + +
Sbjct:   259 SFSYSMLRNYKLSYVTLTSEGK-MKILWNDG-KSWK--LHFEAPT-SSCDLYRACGPFGL 313

Query:   299 CNMNSNSAKCECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCE-------HG---DGFLKR 348
             C + S + KC CL+GFVPKS  EW   + + GCVRRTQL C         G   D F   
Sbjct:   314 C-VRSRNPKCICLKGFVPKSDDEWKKGNWTSGCVRRTQLSCHTNSSTKTQGKETDSFYHM 372

Query:   349 ESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKEL 408
               VK PD  + L    ++  +C + C  NCSCTA+A       G GCL+W  +L+D  + 
Sbjct:   373 TRVKTPDL-YQLA-GFLNAEQCYQDCLGNCSCTAFAYIS----GIGCLVWNRELVDTVQF 426

Query:   409 SESGQDLFVRMAASELDDIERXXXXXXXXVAXXXXXXXXXXXXXXXXXFVYLWKRRHRKQ 468
                G+ L +R+A+SEL    R        V+                     W+ R  KQ
Sbjct:   427 LSDGESLSLRLASSELAGSNRTKIILGTTVSLSIFVILVFAAYKS-------WRYR-TKQ 478

Query:   469 GKTDGSSKLDYNDRGNREEEME----LPIFDWMAIANATENFSDKNKLGEGGFGPVYKGV 524
              + +        D   ++ E +    + +FD   I  AT NFS  NKLG+GGFGPVYKG 
Sbjct:   479 NEPNPMFIHSSQDAWAKDMEPQDVSGVNLFDMHTIRTATNNFSSSNKLGQGGFGPVYKGK 538

Query:   525 LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPN 584
             L++G+EIA KRLS SSGQG +EF NE+ LI+KLQH+NLV+L+GCC + +E++LIYEYL N
Sbjct:   539 LVDGKEIAVKRLSSSSGQGTDEFMNEIRLISKLQHKNLVRLLGCCIKGEEKLLIYEYLVN 598

Query:   585 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN 644
             KSL+ F+FD T    +DW KR  II G+ARGLLYLH+DSRLR+IHRDLK SN+LLD +M 
Sbjct:   599 KSLDVFLFDSTLKFEIDWQKRFNIIQGVARGLLYLHRDSRLRVIHRDLKVSNILLDEKMI 658

Query:   645 PKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
             PKISDFG+AR     Q + NT RVVGT GYM PEYA  G+FS KSD++SFGVL+LEI+ G
Sbjct:   659 PKISDFGLARMSQGTQYQDNTRRVVGTLGYMAPEYAWTGVFSEKSDIYSFGVLLLEIIIG 718

Query:   705 KRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRP 764
             ++   F  ++    LL +AW  W E + V+L++++L  S   +EV RC+Q+GLLCVQ +P
Sbjct:   719 EKISRF--SEEGKTLLAYAWESWCETKGVDLLDQALADSSHPAEVGRCVQIGLLCVQHQP 776

Query:   765 EDRPNMSSVVLMLSGERSLPQPKQPGFFTERNPPEXXXXXXXXXXXXTNEITISLIEGR 823
              DRPN   ++ ML+    LP PKQP F       +             NEIT S+I+GR
Sbjct:   777 ADRPNTLELMSMLTTISELPSPKQPTFTVHSRDDDSTSNDLIT----VNEITQSVIQGR 831

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)]

 Score = 1499 (532.7 bits), Expect = 1.1e-153, P = 1.1e-153
 Identities = 337/820 (41%), Positives = 474/820 (57%)

Query:    40 FELGFFSPG-KSKSR-YLGIWYKKIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLL 97
             FE GFF+P  K  SR YLGIWY  I   TV+WVANR AP +  S +L ++  G+  ++  
Sbjct:    48 FEAGFFAPDPKQPSRQYLGIWYHSISPRTVVWVANRVAPATSASPSLTLTVTGDLRVLDG 107

Query:    98 NSTNG-----IVWSSNASRTA--RNPV-AVLLESGNLVVKDGKDIDPDNFLWQSFDYPSH 149
              + NG     ++WSSN +  A  R    AVL ++G+L V+       D  LW SF +P+ 
Sbjct:   108 TAANGTADAPLLWSSNTTSRAGPRGGYSAVLQDTGSLEVRS-----EDGVLWDSFWHPTD 162

Query:   150 ILIAGMKLGVNLV-TG-LNRFI-SSWKSADDPAQDDYVYGIDPSGVPQA-VFRKGSTIRY 205
              +++GM++ +     G   R + +SW S  DP+   Y  G+DP    QA +++ G+   +
Sbjct:   163 TILSGMRITLQAPGRGPKERMLFTSWASETDPSPGRYALGLDPGNSGQAYIWKDGNVTYW 222

Query:   206 RAGSWNGLHWTGMPQLQPNPVYTFEYVSNENEV---FYRFNLIKSSVPSMMVMNPLGDPQ 262
             R+G WNG+++ G+P     P+Y   +    + V   +Y +    +S+   +V+ P G   
Sbjct:   223 RSGQWNGVNFIGIPW---RPLYRSGFTPAIDPVLGNYYTYTATNTSLQRFVVL-PNGTDI 278

Query:   263 RLTWMEQTQKWAPFVPFSGLILDQCDNYALCGAYAVCNMNSNS-AKCECLEGFVPKSPSE 321
                  + +Q W   V +     ++C+ YA CG  A C  + +  AKC CL+GF PK   +
Sbjct:   279 CYMVRKSSQDWE-LVWYQPS--NECEYYATCGPNAKCTASQDGKAKCTCLKGFHPKLQEQ 335

Query:   322 WDLLDKSDGCVRRTQLDCE---HGDGFLKRESVKLPDTRF--SLVDNKISLLECKELCSK 376
             W+  + S GC+R   L CE    GDGFL   ++K PD  +  S V ++     C+ +C  
Sbjct:   336 WNAGNWSQGCIRSPPLGCETNQSGDGFLPMGNIKWPDFSYWVSTVGDEPG---CRTVCLN 392

Query:   377 NCSCTAYANADVRGGGSGCLLWFHDLIDMKELSESGQDLFVRMAASEL---DDIERXXXX 433
             NCSC AY    V    +GCL W ++LIDM EL      L +++ ASEL     I +    
Sbjct:   393 NCSCGAY----VYTATTGCLAWGNELIDMHELQTGAYTLNLKLPASELRGHHPIWKIATI 448

Query:   434 XXXXVAXXXXXXXXX--XXXXXXXXFVY-LWKRRHRKQGKTDGSSKLD------YNDRGN 484
                 V                     V+  W+ RH        S+ LD      ++D   
Sbjct:   449 ISAIVLFVLAACLLLWWKHGRNIKDAVHGSWRSRHSSTQSQQNSAMLDISQSIRFDDDVE 508

Query:   485 REEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGM 544
               +  EL ++    I  AT NFSD NKLGEGGFGPVY G L  G+E+A KRL ++SGQG+
Sbjct:   509 DGKSHELKVYSLDRIRTATSNFSDSNKLGEGGFGPVYMGTLPGGEEVAVKRLCRNSGQGL 568

Query:   545 EEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSK 604
             EEF+NEV+LIAKLQHRNLV+L+GCC  R+E++L+YEY+PNKSL+ F+F+  + + LDW K
Sbjct:   569 EEFKNEVILIAKLQHRNLVRLLGCCIPREEKILVYEYMPNKSLDAFLFNPEKQRLLDWKK 628

Query:   605 RCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 664
             R  II GIARGLLYLH+DSRLR++HRDLKASN+LLD +M PKISDFGMAR FG DQ + N
Sbjct:   629 RFDIIEGIARGLLYLHRDSRLRVVHRDLKASNILLDADMKPKISDFGMARMFGGDQNQFN 688

Query:   665 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW 724
             TNRVVGT+GYM PEYA++G+FSVKSDV+ FGVL+LEI+ GKR   F+  +   N+ G+AW
Sbjct:   689 TNRVVGTFGYMSPEYAMEGIFSVKSDVYGFGVLILEIITGKRAVSFHCHEDSLNIAGYAW 748

Query:   725 RLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS-L 783
             R W E+   ELI+  +  S S+ +VLRCI + LLCVQ   ++RP++ +V+LMLS + S L
Sbjct:   749 RQWNEDNAAELIDPVIRASCSVRQVLRCIHIALLCVQDHADERPDIPTVILMLSNDSSSL 808

Query:   784 PQPKQPGFFTERNPPEXXXXXXXXXXXXTNEITISLIEGR 823
             P P+ P         E               +T++ + GR
Sbjct:   809 PNPRPPTLMLRGREIESSKSSEKDRSHSIGTVTMTQLHGR 848

GO:0005515 "protein binding" evidence=IPI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
O81832	Y4729_ARATH	2, ., 7, ., 1, 1, ., 1	0.5325	0.9331	0.9808	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	823
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-53
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-52
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	6e-51
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-49
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-46
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-46
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-46
cd00028	116	cd00028, B_lectin, Bulb-type mannose-specific lect	3e-39
pfam01453	109	pfam01453, B_lectin, D-mannose binding lectin	2e-38
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-37
smart00108	114	smart00108, B_lectin, Bulb-type mannose-specific l	2e-36
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-36
pfam00954	110	pfam00954, S_locus_glycop, S-locus glycoprotein fa	6e-33
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-33
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-32
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-31
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-31
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	7e-31
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	8e-31
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-30
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-30
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-29
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-29
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	7e-29
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-28
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-28
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-28
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-28
pfam08276	66	pfam08276, PAN_2, PAN-like domain	1e-27
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-27
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-26
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-26
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-26
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	7e-26
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	9e-26
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-25
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-25
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-25
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-25
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-25
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-24
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-24
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	7e-24
cd01098	84	cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain	7e-24
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	8e-24
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	8e-24
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	9e-24
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	9e-24
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-23
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-23
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-23
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-23
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-22
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-22
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-22
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-22
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-22
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	6e-22
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	6e-22
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	6e-22
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	6e-22
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	8e-22
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-21
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-21
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-21
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-21
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-21
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-21
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-21
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-21
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-21
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-21
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-21
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	8e-21
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-20
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-20
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-20
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-20
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-20
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-20
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-20
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-20
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-20
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-20
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-20
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-20
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-20
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	8e-20
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-19
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-19
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-19
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-19
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-19
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-19
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-19
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-19
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-19
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-19
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-19
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-19
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-19
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-19
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-19
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-19
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	9e-19
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-18
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-18
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-18
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-18
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-18
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-18
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-18
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-18
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-18
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-18
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-18
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-18
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	7e-18
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	9e-18
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-17
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-17
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-17
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-17
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-17
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-17
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-17
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-17
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-17
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-17
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-17
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-17
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-17
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-17
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	6e-17
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	6e-17
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	6e-17
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	7e-17
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	7e-17
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	9e-17
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	9e-17
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-16
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-16
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-16
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-16
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-16
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-16
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-16
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-16
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-16
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-16
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-16
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-16
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-16
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	6e-16
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	7e-16
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-16
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	8e-16
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	8e-16
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	8e-16
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-15
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-15
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-15
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-15
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-15
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-15
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-15
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-15
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-15
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-15
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-15
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	9e-15
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-14
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-14
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-14
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-14
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-14
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-14
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-14
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	8e-14
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	8e-14
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-13
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-13
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-13
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-13
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-13
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-13
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	6e-13
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-13
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	6e-13
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	7e-13
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	8e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-12
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-12
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-12
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-12
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-12
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-12
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-12
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-12
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-12
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-12
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	8e-12
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-11
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-11
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-11
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-11
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-11
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-11
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-11
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-11
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	5e-11
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	8e-11
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-10
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-10
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-10
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-10
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-10
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-10
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-10
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	6e-10
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	6e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	7e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	7e-10
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	7e-10
pfam11883	48	pfam11883, DUF3403, Domain of unknown function (DU	1e-09
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-09
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-09
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-09
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-09
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-09
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-09
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	6e-09
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-09
smart00473	78	smart00473, PAN_AP, divergent subfamily of APPLE d	6e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	8e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-08
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-08
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-08
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-08
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-07
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-07
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	6e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	7e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	5e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	5e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	8e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-05
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-05
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-05
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-05
cd00129	80	cd00129, PAN_APPLE, PAN/APPLE-like domain; present	3e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-05
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	6e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	9e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-04
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	0.001
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.001

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  185 bits (473), Expect = 2e-53
 Identities = 99/297 (33%), Positives = 134/297 (45%), Gaps = 74/297 (24%)

Query: 511 KLGEGGFGPVYKGVLI-----EGQEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVK 564
           KLGEG FG VYKG L      +  E+A K L +  S Q +EEF  E  ++ KL H N+VK
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           L+G CT+ +  M++ EY+P   L D++    R K L  S        IARG+ YL     
Sbjct: 66  LLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE---S 121

Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT---YGYMPPEYAI 681
              IHRDL A N L+   +  KISDFG++R    D  + +  +V G      +M PE   
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKGGKLPIRWMAPESLK 177

Query: 682 DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 741
           +G F+ KSDV+SFGVL+ EI                                     +LG
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIF------------------------------------TLG 201

Query: 742 GSY----SLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVLML 777
                  S +EVL  ++ G                 L C  + PEDRP  S +V +L
Sbjct: 202 EEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  182 bits (464), Expect = 3e-52
 Identities = 93/282 (32%), Positives = 130/282 (46%), Gaps = 41/282 (14%)

Query: 509 KNKLGEGGFGPVYKGVLI-----EGQEIAAKRLSK-SSGQGMEEFENEVLLIAKLQHRNL 562
             KLGEG FG VYKG L      +  E+A K L + +S Q +EEF  E  ++ KL H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
           VKL+G CT+ +   ++ EY+    L  ++        L  S        IARG+ YL   
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE-- 119

Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT---YGYMPPEY 679
                IHRDL A N L+   +  KISDFG++R    D  + +  R  G      +M PE 
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKLPIRWMAPES 174

Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 739
             +G F+ KSDV+SFGVL+ EI       G               + +      E++   
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIF----TLGE--------------QPYPGMSNEEVLEYL 216

Query: 740 LGGSYSLSEVLRC----IQVGLLCVQQRPEDRPNMSSVVLML 777
             G Y L +   C      + L C  + PEDRP  S +V +L
Sbjct: 217 KNG-YRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  178 bits (455), Expect = 6e-51
 Identities = 91/305 (29%), Positives = 127/305 (41%), Gaps = 81/305 (26%)

Query: 510 NKLGEGGFGPVYKGVLIEGQ----EIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVK 564
            KLGEG FG VYKG L        E+A K L +  S +  ++F  E  ++ KL H N+V+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFI------FDVTRSKFLDWSKRCQIIGGIARGLLY 618
           L+G CT+ +   L+ EY+    L D++      F       L           IA+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG----- 673
           L      + +HRDL A N L+  ++  KISDFG++R         +      T G     
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR-----DVYDDDYYRKKTGGKLPIR 172

Query: 674 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV 733
           +M PE   DG+F+ KSDV+SFGVL+ EI                                
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIF------------------------------- 201

Query: 734 ELINKSLGGS----YSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSS 772
                +LG +     S  EVL  ++ G                 L C Q  PEDRP  S 
Sbjct: 202 -----TLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSE 256

Query: 773 VVLML 777
           +V  L
Sbjct: 257 LVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  172 bits (438), Expect = 3e-49
 Identities = 70/194 (36%), Positives = 104/194 (53%), Gaps = 11/194 (5%)

Query: 512 LGEGGFGPVYKGV-LIEGQEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
           LGEGGFG VY       G+++A K + K  S   +EE   E+ ++ KL H N+VKL G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
              +   L+ EY    SL D + +      L   +  +I+  I  GL YLH      IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115

Query: 630 RDLKASNVLLDN-EMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSV 687
           RDLK  N+LLD+     K++DFG+++   +   ++    +VGT  YM PE  +  G +S 
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173

Query: 688 KSDVFSFGVLVLEI 701
           KSD++S GV++ E+
Sbjct: 174 KSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  167 bits (424), Expect = 1e-46
 Identities = 73/200 (36%), Positives = 104/200 (52%), Gaps = 14/200 (7%)

Query: 511 KLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFE---NEVLLIAKLQHRNLVKLI 566
           KLG G FG VYK      G+ +A K L K S +  ++ +    E+ ++ +L H N+V+LI
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRS-EKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 626
                +D   L+ EY     L D++   +R   L   +  +I   I RGL YLH      
Sbjct: 65  DAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---SNG 118

Query: 627 IIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL-F 685
           IIHRDLK  N+LLD     KI+DFG+A+      +   T   VGT  YM PE  + G  +
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLGGNGY 176

Query: 686 SVKSDVFSFGVLVLEIVCGK 705
             K DV+S GV++ E++ GK
Sbjct: 177 GPKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  166 bits (423), Expect = 2e-46
 Identities = 93/297 (31%), Positives = 127/297 (42%), Gaps = 74/297 (24%)

Query: 511 KLGEGGFGPVYKGVLIE-----GQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVK 564
           KLGEG FG VYKG L         ++A K L + +  +  EEF  E  ++ KL H N+V+
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           L+G CTQ +   ++ EY+P   L DF+      + L      Q+   IA+G+ YL     
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE---S 120

Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG---YMPPEYAI 681
              +HRDL A N L+   +  KISDFG++R   I + +    R  G      +M PE   
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRD--IYEDDYYRKR-GGGKLPIKWMAPESLK 177

Query: 682 DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 741
           DG F+ KSDV+SFGVL+ EI                                     +LG
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIF------------------------------------TLG 201

Query: 742 GS----YSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVLML 777
                  S  EVL  ++ G                 L C    PEDRP  S +V  L
Sbjct: 202 EQPYPGMSNEEVLELLEDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  166 bits (422), Expect = 2e-46
 Identities = 71/265 (26%), Positives = 112/265 (42%), Gaps = 24/265 (9%)

Query: 506 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEE-FENEVLLIAKLQHRNLV 563
           +    KLGEG FG VY     + G+ +A K + K   +   E    E+ ++ KL+H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           +L       D+  L+ EY     L D +    +   L   +    +  I   L YLH   
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARFYLRQILSALEYLHS-- 115

Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
              I+HRDLK  N+LLD + + K++DFG+AR     +        VGT  YM PE  +  
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPEVLLGK 171

Query: 684 LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 743
            +    D++S GV++ E++ GK     +  D     L       I +            S
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKP---PFPGDDQLLELFKK----IGKPKPPFPPPEWDIS 224

Query: 744 YSLSEVLRCIQVGLLCVQQRPEDRP 768
               +++R        + + PE R 
Sbjct: 225 PEAKDLIRK------LLVKDPEKRL 243

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin

 Score =  140 bits (355), Expect = 3e-39
 Identities = 58/123 (47%), Positives = 71/123 (57%), Gaps = 8/123 (6%)

Query: 25  QSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLSDRSGAL 84
             +  G+TLVS+   FELGFF        Y  I YK   + TV+WVANRD P S  S  L
Sbjct: 2   NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGS-SRTVVWVANRDNP-SGSSCTL 59

Query: 85  NISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQSF 144
            + S GN  LV+ + +  +VWSSN +R   N V VLL+ GNLV+ D       NFLWQSF
Sbjct: 60  TLQSDGN--LVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSD----GNFLWQSF 113

Query: 145 DYP 147
           DYP
Sbjct: 114 DYP 116

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116

>gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin

 Score =  137 bits (348), Expect = 2e-38
 Identities = 55/116 (47%), Positives = 71/116 (61%), Gaps = 7/116 (6%)

Query: 64  NGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLES 123
           N TV+WVANR  PL+D S  L + S GN  LVL +    +VWSSN S      VAVL + 
Sbjct: 1   NQTVVWVANRLNPLTDSSYTLILQSDGN--LVLYDGNGRVVWSSNTSGKGSGCVAVLQDD 58

Query: 124 GNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSADDPA 179
           GNLV+ D    +    LWQSFD+P+  L+ G K G N+V G +R ++SWKS  DP+
Sbjct: 59  GNLVLYD----NSGKVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109

These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  139 bits (353), Expect = 5e-37
 Identities = 67/209 (32%), Positives = 107/209 (51%), Gaps = 25/209 (11%)

Query: 510 NKLGEGGFGPVYKGVLIE-GQEIAAK--RLSKSSGQGMEEFENEVLLIAKLQHRNLVKLI 566
             LG G FG VY  +  + G+ +A K   LS  S + +E  E E+ +++ LQH N+V+  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 567 GCCTQRDERML-IY-EYLPNKSLNDFI--F-----DVTRSKFLDWSKRCQIIGGIARGLL 617
           G     ++  L I+ EY+   SL+  +  F      V R     +++  QI+     GL 
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRK----YTR--QIL----EGLA 115

Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           YLH      I+HRD+K +N+L+D++   K++DFG A+  G  +T   T  V GT  +M P
Sbjct: 116 YLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172

Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGKR 706
           E      +   +D++S G  V+E+  GK 
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin

 Score =  132 bits (335), Expect = 2e-36
 Identities = 59/122 (48%), Positives = 72/122 (59%), Gaps = 9/122 (7%)

Query: 25  QSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLSDRSGAL 84
            ++  G+TLVS N  FELGFF+       Y  I YK   + TV+WVANRD P+SD S  L
Sbjct: 2   NTLSSGQTLVSGNSLFELGFFTLIMQN-DYNLILYKSS-SRTVVWVANRDNPVSD-SCTL 58

Query: 85  NISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQSF 144
            + S GN  LVL +    +VWSSN +    N V VLL+ GNLV+ D       NFLWQSF
Sbjct: 59  TLQSDGN--LVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYD----SDGNFLWQSF 112

Query: 145 DY 146
           DY
Sbjct: 113 DY 114

Length = 114

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  137 bits (347), Expect = 3e-36
 Identities = 65/205 (31%), Positives = 103/205 (50%), Gaps = 17/205 (8%)

Query: 506 FSDKNKLGEGGFGPVYKG-VLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
           F    K+G+GGFG VYK      G+E+A K +   S +  E+  NE+ ++ K +H N+VK
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL----YLH 620
             G   ++DE  ++ E+    SL D +   T     +       I  + + LL    YLH
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTE-----SQIAYVCKELLKGLEYLH 115

Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
                 IIHRD+KA+N+LL ++   K+ DFG++            N +VGT  +M PE  
Sbjct: 116 S---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVI 169

Query: 681 IDGLFSVKSDVFSFGVLVLEIVCGK 705
               +  K+D++S G+  +E+  GK
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family

 Score =  122 bits (308), Expect = 6e-33
 Identities = 42/116 (36%), Positives = 68/116 (58%), Gaps = 8/116 (6%)

Query: 205 YRAGSWNGLHWTGMPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRL 264
           +R+G WNG+ ++G+P++Q    Y + +  N  EV+Y + +  +S+ S + ++  G  +R 
Sbjct: 1   WRSGPWNGIRFSGIPEMQKLSYYVYNFTENNEEVYYTYRMTNNSIYSRLTLSSEGSLERF 60

Query: 265 TWMEQTQKWAPF--VPFSGLILDQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKS 318
           TW+  +Q W  F   P      DQCD Y  CG Y  C++N  S KC C++GFVPK+
Sbjct: 61  TWIPNSQDWNLFWSAP-----KDQCDVYGRCGPYGYCDVN-TSPKCNCIKGFVPKN 110

In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  128 bits (324), Expect = 6e-33
 Identities = 90/296 (30%), Positives = 138/296 (46%), Gaps = 45/296 (15%)

Query: 510 NKLGEGGFGPVYKGVLI-----EGQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLV 563
            +LGEG FG V            G+++A K L+ S   Q   +FE E+ ++  L H N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 564 KLIGCCTQRDER--MLIYEYLPNKSLNDFI----FDVTRSKFLDWSKRCQIIGGIARGLL 617
           K  G C +   R   LI EYLP+ SL D++      +   + L +S +      I +G+ 
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQ------ICKGMD 123

Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT--EANTNRVVGTYGYM 675
           YL      R IHRDL A N+L+++E   KISDFG+A+    D+             + Y 
Sbjct: 124 YLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY- 179

Query: 676 PPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHN-------LLGHAWRLWI 728
            PE      FS  SDV+SFGV + E+        F + D   +       ++G A    I
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYEL--------FTYGDPSQSPPAEFLRMIGIAQGQMI 231

Query: 729 EERPVELI--NKSLGGSYSL-SEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER 781
             R +EL+   + L    S   EV   ++   LC +  P+DRP+ + ++L++   R
Sbjct: 232 VTRLLELLKEGERLPRPPSCPDEVYDLMK---LCWEAEPQDRPSFADLILIVDRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  125 bits (317), Expect = 3e-32
 Identities = 87/288 (30%), Positives = 119/288 (41%), Gaps = 54/288 (18%)

Query: 510 NKLGEGGFGPVYKGVLIE--GQEI--AAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVK 564
            +LG G FG V KGV +   G+E+  A K L +     G +EF  E  ++A+L H  +V+
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFD---VTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
           LIG C + +  ML+ E  P   L  ++     +  S   + + +      +A G+ YL  
Sbjct: 61  LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLES 113

Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP----- 676
                 +HRDL A NVLL N    KISDFGM+RA G             T G  P     
Sbjct: 114 K---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKWYA 166

Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVC--GKRNRGFYHADHHHNLLGHAWRLWIEERPVE 734
           PE    G FS KSDV+S+GV + E      K       A+                    
Sbjct: 167 PECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE-------------------- 206

Query: 735 LINKSLGGSYSLSEVLRCIQ----VGLLCVQQRPEDRPNMSSVVLMLS 778
            +   L     L     C Q    + L C + RPEDRP  S +     
Sbjct: 207 -VIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFR 253

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  122 bits (309), Expect = 3e-31
 Identities = 81/255 (31%), Positives = 116/255 (45%), Gaps = 37/255 (14%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E+   + KLG G FG V+ G      ++A K L K      E F  E  ++ KL+H  LV
Sbjct: 6   ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLV 64

Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           +L   C++ +   ++ EY+   SL DF+      K L   +   +   IA G+ YL    
Sbjct: 65  QLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLE--- 120

Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----PE 678
               IHRDL A N+L+   +  KI+DFG+AR    D+  A      G     P     PE
Sbjct: 121 SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE----GA--KFPIKWTAPE 174

Query: 679 YAIDGLFSVKSDVFSFGVLVLEIVC-------GKRN--------RGFY------HADHHH 717
            A  G F++KSDV+SFG+L+ EIV        G  N        RG+         +  +
Sbjct: 175 AANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELY 234

Query: 718 NLLGHAWRLWIEERP 732
           +L+   W    EERP
Sbjct: 235 DLMLQCWDKDPEERP 249

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  121 bits (307), Expect = 6e-31
 Identities = 66/206 (32%), Positives = 105/206 (50%), Gaps = 15/206 (7%)

Query: 505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRN 561
           N+   + +G G FG VYKG+ +E G  +A K++S      + ++    E+ L+  L+H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQIIGGIARGLLYL 619
           +VK IG     D   +I EY  N SL   I      KF  + +      +  + +GL YL
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQII-----KKFGPFPESLVAVYVYQVLQGLAYL 115

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H+     +IHRD+KA+N+L   +   K++DFG+A    ++    +   VVGT  +M PE 
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGVVKLADFGVATK--LNDVSKDDASVVGTPYWMAPEV 170

Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCGK 705
                 S  SD++S G  V+E++ G 
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  122 bits (308), Expect = 7e-31
 Identities = 73/211 (34%), Positives = 108/211 (51%), Gaps = 25/211 (11%)

Query: 512 LGEGGFGPVYKGVLI------EGQEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVK 564
           LGEG FG VYKG L           +A K L ++   +  +EF  E  L++ LQH N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIF-------------DVTRSKFLDWSKRCQIIGG 611
           L+G CT+     +++EYL +  L++F+              D T    LD S    I   
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGIDQTEANTNRVVG 670
           IA G+ YL   S    +HRDL A N L+   +  KISDFG++R  +  D     +  ++ 
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 671 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
              +MPPE  + G F+ +SD++SFGV++ EI
Sbjct: 190 VR-WMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  125 bits (313), Expect = 8e-31
 Identities = 86/329 (26%), Positives = 133/329 (40%), Gaps = 25/329 (7%)

Query: 505 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSK---SSGQGMEEFENEVLLIAKLQH-R 560
           ++    KLGEG FG VY       + +A K L+K   S  + +E F  E+ ++A L H  
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VKL           L+ EY+   SL D +  + R   L  S+   I+  I   L YLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 621 QDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEAN----TNRVVGTYGYM 675
                 IIHRD+K  N+LLD +    K+ DFG+A+      + ++     +  VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 676 PPEYAIDGLF---SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP 732
            PE  +       S  SD++S G+ + E++ G             +       +     P
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK--IILELPTP 233

Query: 733 VELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFF 792
                 S      +S+    +   LL     P++R + SS +        L   K     
Sbjct: 234 SLASPLSPSNPELISKAASDLLKKLLAKD--PKNRLSSSSDLSHD----LLAHLKLKESD 287

Query: 793 TERNPPESGSSSSKRSLLSTNEITISLIE 821
                    S+  + SL  + E  IS + 
Sbjct: 288 LSDLLKPDDSAPLRLSLPPSLEALISSLN 316

Length = 384

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  121 bits (305), Expect = 1e-30
 Identities = 82/292 (28%), Positives = 125/292 (42%), Gaps = 63/292 (21%)

Query: 505 NFSDKNKLGEGGFGPVYKGVLIEGQEI-AAKR--LSKSSGQGMEEFENEVLLIAKLQHRN 561
            +    ++G+G FG VY        ++   K   LS  S +  E+  NEV ++ KL H N
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFI---------FDVTRSKFLDWSKRCQIIGGI 612
           ++K      ++ +  ++ EY     L+  I         F     + LDW    Q+    
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPF--PEEQILDWF--VQL---- 112

Query: 613 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTY 672
              L YLH  SR +I+HRD+K  N+ L +    K+ DFG+++        A T  VVGT 
Sbjct: 113 CLALKYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTP 167

Query: 673 GYMPPE------YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL 726
            Y+ PE      Y      + KSD++S G ++ E+   K      H     NLL      
Sbjct: 168 YYLSPELCQNKPY------NYKSDIWSLGCVLYELCTLK------HPFEGENLL------ 209

Query: 727 WIEERPVELINKSLGGSY-----SLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
                  EL  K L G Y       S  LR +   LL  Q+ PE+RP+++ +
Sbjct: 210 -------ELALKILKGQYPPIPSQYSSELRNLVSSLL--QKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  121 bits (305), Expect = 2e-30
 Identities = 72/235 (30%), Positives = 113/235 (48%), Gaps = 41/235 (17%)

Query: 509 KNKLGEGGFGPVYKG---VLIEGQE---IAAKRLSKSSGQGMEE-FENEVLLIAKLQHRN 561
           K +LGEG FG V+ G    L    +   +A K L +++     + FE E  L+   QH N
Sbjct: 10  KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN 69

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFI-----------------FDVTRSKFLDWSK 604
           +VK  G CT+ D  ++++EY+ +  LN F+                  ++T S+ L    
Sbjct: 70  IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL---- 125

Query: 605 RCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 664
             QI   IA G++YL   +    +HRDL   N L+  ++  KI DFGM+R    D    +
Sbjct: 126 --QIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTD 176

Query: 665 TNRVVGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 715
             RV G       +MPPE  +   F+ +SDV+SFGV++ EI    +   +  ++ 
Sbjct: 177 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE 231

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  118 bits (299), Expect = 2e-29
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 19/211 (9%)

Query: 500 ANATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ 558
            +  E + +  K+GEG  G VYK      G+E+A K++ +   Q  E   NE+L++   +
Sbjct: 15  GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCK 73

Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQI---IGGIARG 615
           H N+V         DE  ++ EY+   SL D I      +        QI      + +G
Sbjct: 74  HPNIVDYYDSYLVGDELWVVMEYMDGGSLTDII-TQNFVRM----NEPQIAYVCREVLQG 128

Query: 616 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR--VVGTYG 673
           L YLH      +IHRD+K+ N+LL  + + K++DFG    F    T+  + R  VVGT  
Sbjct: 129 LEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFG----FAAQLTKEKSKRNSVVGTPY 181

Query: 674 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           +M PE      +  K D++S G++ +E+  G
Sbjct: 182 WMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  116 bits (294), Expect = 4e-29
 Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 19/209 (9%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRL-SKSSGQGMEEFENEVLLIAKLQHRN 561
            +      LG+G  G VYK      G+  A K++      +  ++   E+  +   +   
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIAR----GLL 617
           +VK  G   +  E  ++ EY+   SL D +      K     +   ++  IAR    GL 
Sbjct: 61  VVKCYGAFYKEGEISIVLEYMDGGSLADLL-----KKVGKIPE--PVLAYIARQILKGLD 113

Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           YLH      IIHRD+K SN+L++++   KI+DFG+++   ++ T    N  VGT  YM P
Sbjct: 114 YLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISK--VLENTLDQCNTFVGTVTYMSP 169

Query: 678 EYAIDG-LFSVKSDVFSFGVLVLEIVCGK 705
           E  I G  +S  +D++S G+ +LE   GK
Sbjct: 170 E-RIQGESYSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  116 bits (293), Expect = 7e-29
 Identities = 67/207 (32%), Positives = 113/207 (54%), Gaps = 23/207 (11%)

Query: 512 LGEGGFGPVYKGVLI-EGQ----EIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKL 565
           LG G FG VYKGV I EG+     +A K L + +  +  +E  +E  ++A + H ++V+L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 566 IGCC-TQRDERMLIYEYLPNKSLNDFIF---DVTRSK-FLDWSKRCQIIGGIARGLLYLH 620
           +G C + +    LI + +P   L D++    D   S+  L+W  +      IA+G+ YL 
Sbjct: 75  LGICLSSQ--VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLE 126

Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
           +    R++HRDL A NVL+    + KI+DFG+A+   +D+ E +         +M  E  
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183

Query: 681 IDGLFSVKSDVFSFGVLVLEIVC-GKR 706
           +  +++ KSDV+S+GV V E++  G +
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  114 bits (288), Expect = 2e-28
 Identities = 62/199 (31%), Positives = 104/199 (52%), Gaps = 6/199 (3%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E F+ + KLG G FG V++G+      +A K L        ++F+ EV  + +L+H++L+
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65

Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
            L   C+  +   +I E +   SL  F+      + L  +    +   +A G+ YL +  
Sbjct: 66  SLFAVCSVGEPVYIITELMEKGSLLAFLRS-PEGQVLPVASLIDMACQVAEGMAYLEEQ- 123

Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
               IHRDL A N+L+  ++  K++DFG+AR    D   ++  ++   Y +  PE A  G
Sbjct: 124 --NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHG 179

Query: 684 LFSVKSDVFSFGVLVLEIV 702
            FS KSDV+SFG+L+ E+ 
Sbjct: 180 TFSTKSDVWSFGILLYEMF 198

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  114 bits (288), Expect = 2e-28
 Identities = 85/299 (28%), Positives = 130/299 (43%), Gaps = 56/299 (18%)

Query: 502 ATENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRL-SKSSGQGMEEFENEVLLI 554
             ++ +    LG G FG VY+G+           ++A K L    S Q   +F  E L++
Sbjct: 4   PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63

Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRCQIIG 610
           +K  H+N+V+LIG   +R  R ++ E +    L  F+ +      R   L          
Sbjct: 64  SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123

Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGIDQTEANTN 666
            +A+G  YL ++     IHRD+ A N LL  +  P    KI+DFGMAR    D   A+  
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMAR----DIYRASYY 175

Query: 667 RVVGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-------GKRNRGFYHADH 715
           R  G       +MPPE  +DG+F+ K+DV+SFGVL+ EI         G+ N+       
Sbjct: 176 RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM---- 231

Query: 716 HHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 774
               +    RL   + P                     ++   C Q  PEDRPN ++++
Sbjct: 232 --EFVTGGGRL---DPPKGCPG-------------PVYRIMTDCWQHTPEDRPNFATIL 272

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  113 bits (284), Expect = 6e-28
 Identities = 63/197 (31%), Positives = 99/197 (50%), Gaps = 19/197 (9%)

Query: 509 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGC 568
              +G+G FG V  G    GQ++A K L K      + F  E  ++  L+H NLV+L+G 
Sbjct: 11  GATIGKGEFGDVMLGDY-RGQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68

Query: 569 CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG--IARGLLYLHQDSRLR 626
             Q +   ++ EY+   SL D++    R+     +   Q+     +  G+ YL +     
Sbjct: 69  VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVI---TLAQQLGFALDVCEGMEYLEEK---N 122

Query: 627 IIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTY--GYMPPEYAIDGL 684
            +HRDL A NVL+  ++  K+SDFG+A+       EA+  +  G     +  PE   +  
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKK 175

Query: 685 FSVKSDVFSFGVLVLEI 701
           FS KSDV+SFG+L+ EI
Sbjct: 176 FSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  113 bits (286), Expect = 7e-28
 Identities = 65/233 (27%), Positives = 97/233 (41%), Gaps = 45/233 (19%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEF---ENEVLLIAKL 557
           ++F     +GEG F  V      E  +E A K L K     +   ++   E EVL     
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN- 59

Query: 558 QHRNLVKLIGCCTQRDERML--IYEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIG 610
            H  ++KL    T +DE  L  + EY PN  L  +I      D   ++F           
Sbjct: 60  GHPGIIKLY--YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF--------YAA 109

Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV-- 668
            I   L YLH      IIHRDLK  N+LLD +M+ KI+DFG A+    + +  +      
Sbjct: 110 EILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166

Query: 669 ----------------VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
                           VGT  Y+ PE   +      SD+++ G ++ +++ GK
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain

 Score =  105 bits (265), Expect = 1e-27
 Identities = 39/67 (58%), Positives = 50/67 (74%), Gaps = 1/67 (1%)

Query: 339 CEHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLW 398
           C  GDGFL+  ++KLPDT  ++VD  I L EC++ C  NCSCTAYA AD+R GGSGCL+W
Sbjct: 1   CGGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIR-GGSGCLIW 59

Query: 399 FHDLIDM 405
             +L+DM
Sbjct: 60  TGELVDM 66

Length = 66

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  110 bits (278), Expect = 4e-27
 Identities = 64/197 (32%), Positives = 97/197 (49%), Gaps = 12/197 (6%)

Query: 509 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGC 568
             KLG G FG V++G+      +A K L K      ++F  E  ++ KL+H  L++L   
Sbjct: 11  LRKLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69

Query: 569 CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRII 628
           CT  +   ++ E +   SL +++        L   +   +   +A G+ YL   +    I
Sbjct: 70  CTLEEPIYIVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYLEAQN---YI 125

Query: 629 HRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT---YGYMPPEYAIDGLF 685
           HRDL A NVL+      K++DFG+AR    D  EA      G      +  PE A+   F
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRF 181

Query: 686 SVKSDVFSFGVLVLEIV 702
           S+KSDV+SFG+L+ EIV
Sbjct: 182 SIKSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  108 bits (273), Expect = 4e-26
 Identities = 64/215 (29%), Positives = 109/215 (50%), Gaps = 39/215 (18%)

Query: 510 NKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFE----NEVLLIAKLQHRNLVK 564
            ++GEG +G VYK      G+ +A K++   + +  E F      E+ L+ KL+H N+V+
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHPNIVR 62

Query: 565 LIGCCTQRDER--MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC---QIIGGIARGLLYL 619
           L    T + +    +++EY+ +  L   + D    KF +   +C   Q++     GL YL
Sbjct: 63  LKEIVTSKGKGSIYMVFEYMDH-DLTGLL-DSPEVKFTESQIKCYMKQLL----EGLQYL 116

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE- 678
           H +    I+HRD+K SN+L++N+   K++DFG+AR +    +   TNRV+ T  Y PPE 
Sbjct: 117 HSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPEL 172

Query: 679 --------YAIDGLFSVKSDVFSFGVLVLEIVCGK 705
                     +        D++S G ++ E+  GK
Sbjct: 173 LLGATRYGPEV--------DMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  108 bits (270), Expect = 4e-26
 Identities = 83/250 (33%), Positives = 121/250 (48%), Gaps = 42/250 (16%)

Query: 511 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT 570
           KLG G FG V+ G      ++A K L K      E F  E  L+ +LQH  LV+L    T
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71

Query: 571 QRDERMLIYEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 625
           Q +   +I EY+ N SL DF+       +T +K +D + +      IA G+ ++    R 
Sbjct: 72  Q-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQ------IAEGMAFIE---RK 121

Query: 626 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTY--GYMPPEYAIDG 683
             IHRDL+A+N+L+   +  KI+DFG+AR   I+  E  T R    +   +  PE    G
Sbjct: 122 NYIHRDLRAANILVSETLCCKIADFGLARL--IEDNEY-TAREGAKFPIKWTAPEAINYG 178

Query: 684 LFSVKSDVFSFGVLVLEIVC-------GKRN--------RGFYHA------DHHHNLLGH 722
            F++KSDV+SFG+L+ EIV        G  N        RG+         +  + L+  
Sbjct: 179 TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRL 238

Query: 723 AWRLWIEERP 732
            W+   EERP
Sbjct: 239 CWKEKPEERP 248

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  108 bits (272), Expect = 5e-26
 Identities = 67/218 (30%), Positives = 105/218 (48%), Gaps = 40/218 (18%)

Query: 506 FSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFEN--------EVLLIAKL 557
           +    KLGEG +G VYK    +  EI A +  +     ++  E         E+ L+ +L
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR-----LDNEEEGIPSTALREISLLKEL 55

Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKF-LDWSKR--CQIIGGIAR 614
           +H N+VKL+       +  L++EY  +  L  ++ D        +  K    Q++    R
Sbjct: 56  KHPNIVKLLDVIHTERKLYLVFEYC-DMDLKKYL-DKRPGPLSPNLIKSIMYQLL----R 109

Query: 615 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGY 674
           GL Y H     RI+HRDLK  N+L++ +   K++DFG+ARAFGI      T+ VV T  Y
Sbjct: 110 GLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTHEVV-TLWY 164

Query: 675 MPPE-------YAIDGLFSVKSDVFSFGVLVLEIVCGK 705
             PE       Y+     +V  D++S G +  E++ GK
Sbjct: 165 RAPEILLGSKHYST----AV--DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  107 bits (269), Expect = 7e-26
 Identities = 63/203 (31%), Positives = 106/203 (52%), Gaps = 10/203 (4%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL 562
           E F    KLGEG +G VYK +  E GQ +A K +     + ++E   E+ ++ +     +
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYI 60

Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
           VK  G   +  +  ++ EY    S++D +     +K L   +   I+    +GL YLH  
Sbjct: 61  VKYYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLHS- 117

Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID 682
              + IHRD+KA N+LL+ E   K++DFG+  +  +  T A  N V+GT  +M PE   +
Sbjct: 118 --NKKIHRDIKAGNILLNEEGQAKLADFGV--SGQLTDTMAKRNTVIGTPFWMAPEVIQE 173

Query: 683 GLFSVKSDVFSFGVLVLEIVCGK 705
             ++ K+D++S G+  +E+  GK
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  107 bits (269), Expect = 9e-26
 Identities = 70/202 (34%), Positives = 102/202 (50%), Gaps = 21/202 (10%)

Query: 512 LGEGGFGPV----YKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLI 566
           LG+G FG V    Y  +    G+ +A K+L  S+ + + +FE E+ ++  LQH N+VK  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 567 GCCTQRDER--MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           G C     R   L+ EYLP  SL D++    R + LD  K       I +G+ YL     
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQK-HRER-LDHRKLLLYASQICKGMEYL---GS 126

Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----PEY 679
            R +HRDL   N+L+++E   KI DFG+ +    D+        V   G  P     PE 
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEY----YKVREPGESPIFWYAPES 182

Query: 680 AIDGLFSVKSDVFSFGVLVLEI 701
             +  FSV SDV+SFGV++ E+
Sbjct: 183 LTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  105 bits (264), Expect = 2e-25
 Identities = 66/197 (33%), Positives = 96/197 (48%), Gaps = 16/197 (8%)

Query: 511 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGM-EEFENEVLLIAKLQHRNLVKLIGCC 569
           K+G+G FG VYKGVL    E+A K    +    +  +F  E  ++ +  H N+VKLIG C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
            Q+    ++ E +P  SL  F+    +   L   K  Q+    A G+ YL   +    IH
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIH 116

Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----PEYAIDGL 684
           RDL A N L+      KISDFGM+R     + E     V      +P     PE    G 
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR-----EEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171

Query: 685 FSVKSDVFSFGVLVLEI 701
           ++ +SDV+S+G+L+ E 
Sbjct: 172 YTSESDVWSYGILLWET 188

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  106 bits (265), Expect = 2e-25
 Identities = 71/212 (33%), Positives = 105/212 (49%), Gaps = 28/212 (13%)

Query: 512 LGEGGFGPVYKGVLI-------EGQEIAAKRLSK-SSGQGMEEFENEVLLIAKLQHRNLV 563
           LG G FG VY+G              +A K L K ++ Q  +EF  E  L++   H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKF----LDWSKRCQIIGGIARGLLYL 619
           KL+G C   + + +I E +    L  ++ D    +F    L   +   I   +A+G +YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 620 HQDSRLRIIHRDLKASNVLL-----DNEMNPKISDFGMARAFGIDQTEANTNRVVGT--- 671
            Q   +  IHRDL A N L+     D +   KI DFG+AR    D  +++  R  G    
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR----DIYKSDYYRKEGEGLL 175

Query: 672 -YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
              +M PE  +DG F+ +SDV+SFGVL+ EI+
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  105 bits (264), Expect = 3e-25
 Identities = 77/266 (28%), Positives = 126/266 (47%), Gaps = 22/266 (8%)

Query: 509 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGC 568
           K+KLG G +G VY+GV  +     A +  K     +EEF  E  ++ +++H NLV+L+G 
Sbjct: 11  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 569 CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRII 628
           CT+     +I E++   +L D++ +  R + ++      +   I+  + YL + +    I
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 126

Query: 629 HRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 688
           HRDL A N L+      K++DFG++R    D   A+         +  PE      FS+K
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIK 185

Query: 689 SDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLS 747
           SDV++FGVL+ EI   G            + LL   +R+   ERP        G    + 
Sbjct: 186 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRM---ERPE-------GCPPKVY 235

Query: 748 EVLRCIQVGLLCVQQRPEDRPNMSSV 773
           E++R       C Q  P DRP+ + +
Sbjct: 236 ELMRA------CWQWNPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  104 bits (263), Expect = 3e-25
 Identities = 67/215 (31%), Positives = 101/215 (46%), Gaps = 26/215 (12%)

Query: 512 LGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFE---NEVLLIAKLQHRNLVKLIG 567
           LG+G FG V      + G+  A K L K      +E E    E  +++++ H  +VKL  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 568 CCTQRDERM-LIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
              Q +E++ L+ EY P   L      +  F   R++F            I   L YLH 
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF--------YAAEIVLALEYLH- 110

Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
              L II+RDLK  N+LLD + + K++DFG+A+    + +  NT    GT  Y+ PE  +
Sbjct: 111 --SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLL 166

Query: 682 DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH 716
              +    D +S GVL+ E++ GK    FY  D  
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGKPP--FYAEDRK 199

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  105 bits (262), Expect = 4e-25
 Identities = 74/248 (29%), Positives = 119/248 (47%), Gaps = 38/248 (15%)

Query: 511 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT 570
           ++G G FG V+ G  +E +++A K + +      E+F  E  ++ KL H  LV+L G CT
Sbjct: 11  EIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 571 QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC--QIIGGIARGLLYLHQDSRLRII 628
           +R    L++E++ +  L+D++    R++   +S+     +   +  G+ YL   +   +I
Sbjct: 70  ERSPICLVFEFMEHGCLSDYL----RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VI 122

Query: 629 HRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT---YGYMPPEYAIDGLF 685
           HRDL A N L+      K+SDFGM R    DQ  ++T    GT     +  PE      +
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKY 178

Query: 686 SVKSDVFSFGVLVLEI---------------VCGKRNRGF------YHADHHHNLLGHAW 724
           S KSDV+SFGVL+ E+               V    N GF        +   + L+ H W
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCW 238

Query: 725 RLWIEERP 732
           +   E+RP
Sbjct: 239 KERPEDRP 246

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  103 bits (257), Expect = 2e-24
 Identities = 70/197 (35%), Positives = 101/197 (51%), Gaps = 16/197 (8%)

Query: 511 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT 570
           KLG G FG V+ G      ++A K L K     ++ F  E  L+  LQH  LV+L    T
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 571 QRDERMLIYEYLPNKSLNDFIFD-----VTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 625
           + +   +I EY+   SL DF+       V   K +D+S +      IA G+ Y+    R 
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ------IAEGMAYIE---RK 122

Query: 626 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF 685
             IHRDL+A+NVL+   +  KI+DFG+AR    ++  A          +  PE    G F
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSF 181

Query: 686 SVKSDVFSFGVLVLEIV 702
           ++KSDV+SFG+L+ EIV
Sbjct: 182 TIKSDVWSFGILLYEIV 198

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  102 bits (257), Expect = 2e-24
 Identities = 74/282 (26%), Positives = 131/282 (46%), Gaps = 35/282 (12%)

Query: 505 NFSDKNKLGEGGFGPVYKGVL-IEGQEIAAKR--LSKSSGQGMEEFENEVLLIAKLQHRN 561
           +F   NK+G+G FG V+K V   + +  A K+  LSK + +  EE  +E  ++AKL    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLD---WSKRCQIIGGIARGLLY 618
           +++       + +  ++ EY  N  L+  +         +   W    QI+     GL +
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQIL----LGLAH 116

Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           LH     +I+HRD+K+ N+ LD   N KI D G+A+    +   ANT  +VGT  Y+ PE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171

Query: 679 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 738
              D  ++ KSDV++ GV++ E   GK     + A++   L+          + +  +  
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHP---FDANNQGALI---------LKIIRGVFP 219

Query: 739 SLGGSYS--LSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 778
            +   YS  L++++        C+ +    RP+   ++   S
Sbjct: 220 PVSQMYSQQLAQLID------QCLTKDYRQRPDTFQLLRNPS 255

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score =  102 bits (254), Expect = 7e-24
 Identities = 71/226 (31%), Positives = 117/226 (51%), Gaps = 32/226 (14%)

Query: 511 KLGEGGFGPVYKGVLI------EGQEIAAKRLS-KSSGQGMEEFENEVLLIAKLQHRNLV 563
           +LGE  FG VYKG L       + Q +A K L  K+ G   EEF++E ++ ++LQH N+V
Sbjct: 12  ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71

Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIF-------------DVTRSKFLDWSKRCQIIG 610
            L+G  T+     +I+ Y  +  L++F+              D T    L+ +    I+ 
Sbjct: 72  CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131

Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGIDQTEANTNRVV 669
            IA G+ +L   S   ++H+DL   NVL+ +++N KISD G+ R  +  D  +   N ++
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188

Query: 670 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV-------CGKRNR 708
               +M PE  + G FS+ SD++S+GV++ E+        CG  N+
Sbjct: 189 PIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 233

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

 Score = 95.6 bits (238), Expect = 7e-24
 Identities = 41/89 (46%), Positives = 51/89 (57%), Gaps = 8/89 (8%)

Query: 335 TQLDCEHG---DGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGG 391
           T L+C      DGFLK   VKLPD   +     ISL EC+E C  NCSCTAYA  +   G
Sbjct: 1   TPLNCGGDGSTDGFLKLPDVKLPDN--ASAITAISLEECREACLSNCSCTAYAYNN---G 55

Query: 392 GSGCLLWFHDLIDMKELSESGQDLFVRMA 420
             GCLLW   L +++ LS  G  L++R+A
Sbjct: 56  SGGCLLWNGLLNNLRSLSSGGGTLYLRLA 84

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  101 bits (254), Expect = 8e-24
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 39/216 (18%)

Query: 512 LGEGGFGPVYKGVLI------EGQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQHRNLV 563
           LG+G FG VY+G+            +A K +++  S  + +E F NE  ++ +    ++V
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE-FLNEASVMKEFNCHHVV 72

Query: 564 KLIGCCTQRDERMLIYEYL-------------PNKSLNDFIFDVTRSKFLDWSKRCQIIG 610
           +L+G  +     +++ E +             P    N  +   T  KF+  +       
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA------A 126

Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVG 670
            IA G+ YL      + +HRDL A N ++  ++  KI DFGM R    D  E +  R  G
Sbjct: 127 EIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR----DIYETDYYRKGG 179

Query: 671 T----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
                  +M PE   DG+F+ KSDV+SFGV++ E+ 
Sbjct: 180 KGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMA 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  101 bits (253), Expect = 8e-24
 Identities = 65/198 (32%), Positives = 98/198 (49%), Gaps = 14/198 (7%)

Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ 571
           LG G FG V+ G      ++A K + + +    ++F  E  ++ KL H NLV+L G CT+
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 572 RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRD 631
           +    ++ EY+ N  L +++    R   L       +   +   + YL  +     IHRD
Sbjct: 71  QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125

Query: 632 LKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT---YGYMPPEYAIDGLFSVK 688
           L A N L+  +   K+SDFG+AR    DQ  ++     GT     + PPE      FS K
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRFSSK 181

Query: 689 SDVFSFGVLVLEI-VCGK 705
           SDV+SFGVL+ E+   GK
Sbjct: 182 SDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  101 bits (254), Expect = 9e-24
 Identities = 70/219 (31%), Positives = 110/219 (50%), Gaps = 37/219 (16%)

Query: 509 KNKLGEGGFGPVYKGV---LIEGQE---IAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL 562
           K +LGEG FG V+      L+  Q+   +A K L ++S    ++F+ E  L+  LQH+++
Sbjct: 10  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHI 69

Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRS-----KFLDWSK-----------RC 606
           V+  G CT+    ++++EY+ +  LN F+    RS     K L   +             
Sbjct: 70  VRFYGVCTEGRPLLMVFEYMRHGDLNRFL----RSHGPDAKILAGGEDVAPGQLTLGQML 125

Query: 607 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN 666
            I   IA G++YL   + L  +HRDL   N L+   +  KI DFGM+R    D    +  
Sbjct: 126 AIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYY 178

Query: 667 RVVG----TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
           RV G       +MPPE  +   F+ +SD++SFGV++ EI
Sbjct: 179 RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  100 bits (252), Expect = 9e-24
 Identities = 65/198 (32%), Positives = 89/198 (44%), Gaps = 13/198 (6%)

Query: 511 KLGEGGFGPVYKG----VLIEGQEIAAKRLSKSSGQG-MEEFENEVLLIAKLQHRNLVKL 565
           KLG+G FG V +G       +   +A K L        M++F  E  ++  L H NL++L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 625
            G        M++ E  P  SL D +       FL  S  C     IA G+ YL      
Sbjct: 62  YGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFL-ISTLCDYAVQIANGMRYLESK--- 116

Query: 626 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGI--DQTEANTNRVVGTYGYMPPEYAIDG 683
           R IHRDL A N+LL ++   KI DFG+ RA     D      +  V  + +  PE     
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPESLRTR 175

Query: 684 LFSVKSDVFSFGVLVLEI 701
            FS  SDV+ FGV + E+
Sbjct: 176 TFSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score =  101 bits (252), Expect = 2e-23
 Identities = 71/212 (33%), Positives = 106/212 (50%), Gaps = 25/212 (11%)

Query: 511 KLGEGGFGPVYKGVLI-----EGQEIAAKRLSK-SSGQGMEEFENEVLLIAKLQHRNLVK 564
           +LGE  FG +YKG L        Q +A K L   ++ Q   EF+ E  L+A+L H N+V 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIF--------------DVTRSKFLDWSKRCQIIG 610
           L+G  TQ     +++EYL    L++F+               D T    LD      I  
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA-FGIDQTEANTNRVV 669
            IA G+ YL   S    +H+DL A N+L+  +++ KISD G++R  +  D        ++
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 670 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
               +MPPE  + G FS  SD++SFGV++ EI
Sbjct: 189 PIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 2e-23
 Identities = 63/200 (31%), Positives = 105/200 (52%), Gaps = 20/200 (10%)

Query: 512 LGEGGFGPVYKGVL-IEGQE---IAAKRL-SKSSGQGMEEFENEVLLIAKLQHRNLVKLI 566
           +G G FG V +G L + G++   +A K L + SS +   +F  E  ++ +  H N+++L 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 626
           G  T+    M+I EY+ N SL+ F+      KF    +   ++ GIA G+ YL   S + 
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFL-RENDGKF-TVGQLVGMLRGIASGMKYL---SEMN 126

Query: 627 IIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----PEYAI 681
            +HRDL A N+L+++ +  K+SDFG++R     +    T       G +P     PE   
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKG-----GKIPIRWTAPEAIA 181

Query: 682 DGLFSVKSDVFSFGVLVLEI 701
              F+  SDV+SFG+++ E+
Sbjct: 182 YRKFTSASDVWSFGIVMWEV 201

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  100 bits (250), Expect = 2e-23
 Identities = 76/245 (31%), Positives = 116/245 (47%), Gaps = 32/245 (13%)

Query: 511 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT 570
           KLG G FG V+ G      ++A K L K      E F  E  ++ KL+H  LV+L    +
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 571 QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 630
           +     ++ EY+   SL DF+ D    + L       +   +A G+ Y+    R+  IHR
Sbjct: 72  EE-PIYIVTEYMSKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 126

Query: 631 DLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTY--GYMPPEYAIDGLFSVK 688
           DL+++N+L+ + +  KI+DFG+AR   I+  E  T R    +   +  PE A+ G F++K
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARL--IEDNEY-TARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 689 SDVFSFGVLVLEIVC-------GKRNRGFYHADHH--------------HNLLGHAWRLW 727
           SDV+SFG+L+ E+V        G  NR                      H L+   W+  
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKD 243

Query: 728 IEERP 732
            EERP
Sbjct: 244 PEERP 248

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 99.4 bits (247), Expect = 4e-23
 Identities = 73/243 (30%), Positives = 116/243 (47%), Gaps = 28/243 (11%)

Query: 511 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT 570
           KLG+G FG V+ G       +A K L K      E F  E  ++ KL+H  LV+L    +
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 571 QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 630
           + +   ++ EY+   SL DF+      K+L   +   +   IA G+ Y+    R+  +HR
Sbjct: 72  E-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126

Query: 631 DLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSD 690
           DL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G F++KSD
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 185

Query: 691 VFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGHAWRLWIE 729
           V+SFG+L+ E+    R                RG+         +  H+L+   WR   E
Sbjct: 186 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPE 245

Query: 730 ERP 732
           ERP
Sbjct: 246 ERP 248

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 97.7 bits (244), Expect = 2e-22
 Identities = 57/203 (28%), Positives = 103/203 (50%), Gaps = 13/203 (6%)

Query: 506 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKR--LSKSSGQGMEEFENEVLLIAKLQHRNL 562
           F+    +G+G FG VYK +     Q +A K   L ++  + +E+ + E+  +++ +   +
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSPYI 61

Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
            K  G   +  +  +I EY    S      D+ +   LD +    I+  +  GL YLH++
Sbjct: 62  TKYYGSFLKGSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLEYLHEE 117

Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID 682
                IHRD+KA+N+LL  E + K++DFG++       ++ NT   VGT  +M PE    
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQ 172

Query: 683 GLFSVKSDVFSFGVLVLEIVCGK 705
             +  K+D++S G+  +E+  G+
Sbjct: 173 SGYDEKADIWSLGITAIELAKGE 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 97.3 bits (242), Expect = 3e-22
 Identities = 71/209 (33%), Positives = 104/209 (49%), Gaps = 34/209 (16%)

Query: 512 LGEGGFG--------PVYKGVLIEGQEIAAKRLSKSSGQGMEE-FENEVLLIAKLQHRNL 562
           LGEG FG        P   G    G+ +A K L +  GQ     ++ E+ ++  L H N+
Sbjct: 12  LGEGHFGKVSLYCYDPANDGT---GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68

Query: 563 VKLIGCCTQRDER--MLIYEYLPNKSLNDFI--FDVTRSKFLDWSKRCQIIGGIARGLLY 618
           VK  GCC+++  +   LI EY+P  SL D++    +  ++ L ++++      I  G+ Y
Sbjct: 69  VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ------ICEGMAY 122

Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-- 676
           LH       IHRDL A NVLLDN+   KI DFG+A+A      E +    V   G  P  
Sbjct: 123 LHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV----PEGHEYYRVREDGDSPVF 175

Query: 677 ---PEYAIDGLFSVKSDVFSFGVLVLEIV 702
               E   +  FS  SDV+SFGV + E++
Sbjct: 176 WYAVECLKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 97.1 bits (242), Expect = 3e-22
 Identities = 70/227 (30%), Positives = 119/227 (52%), Gaps = 13/227 (5%)

Query: 505 NFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQHRN 561
           +++   K+GEG +G VYKG     GQ +A K++  +S  +G+      E+ L+ +LQH N
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
           +V L     Q     LI+E+L +  L  ++  + + +++D       +  I +G+L+ H 
Sbjct: 61  IVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH- 118

Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
               R++HRDLK  N+L+DN+   K++DFG+ARAFGI      T+ VV T  Y  PE  +
Sbjct: 119 --SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVV-TLWYRAPEVLL 174

Query: 682 DG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW 727
               +S   D++S G +  E+      +  +H D   + L   +R+ 
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMAT---KKPLFHGDSEIDQLFRIFRIL 218

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 96.6 bits (241), Expect = 5e-22
 Identities = 60/223 (26%), Positives = 98/223 (43%), Gaps = 28/223 (12%)

Query: 501 NATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QH 559
           + T  F     +GEG +G VYK    +  ++ A ++        EE + E  ++ K   H
Sbjct: 3   DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNH 62

Query: 560 RNLVKLIGCCTQR------DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQ------ 607
            N+    G   ++      D+  L+ E     S+ D +            KR +      
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV-----KGLRKKGKRLKEEWIAY 117

Query: 608 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 667
           I+    RGL YLH++   ++IHRD+K  N+LL      K+ DFG++    +D T    N 
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQ--LDSTLGRRNT 172

Query: 668 VVGTYGYMPPE-----YAIDGLFSVKSDVFSFGVLVLEIVCGK 705
            +GT  +M PE        D  +  +SDV+S G+  +E+  GK
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 96.8 bits (241), Expect = 5e-22
 Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 31/217 (14%)

Query: 512 LGEGGFGPVYKGV---LIEGQE---IAAKRLSK-SSGQGMEEFENEVLLIAKLQHRNLVK 564
           +G+G FG V++     L+  +    +A K L + +S     +F+ E  L+A+  H N+VK
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDV---TRSKFLDWSKRCQIIGG---------- 611
           L+G C       L++EY+    LN+F+       +      +   +  G           
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 612 ------IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGIDQTEAN 664
                 +A G+ YL   S  + +HRDL   N L+   M  KI+DFG++R  +  D  +A+
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 665 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
            N  +    +MPPE      ++ +SDV+++GV++ EI
Sbjct: 190 ENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 97.1 bits (241), Expect = 6e-22
 Identities = 68/206 (33%), Positives = 120/206 (58%), Gaps = 30/206 (14%)

Query: 512 LGEGGFGPVYKGVLI-EGQEI----AAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKL 565
           LG G FG VYKG+ + EG+ +    A K L++++G +   EF +E L++A + H +LV+L
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
           +G C     + L+ + +P+  L D++ +    +     L+W  +      IA+G++YL +
Sbjct: 75  LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127

Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY-A 680
               R++HRDL A NVL+ +  + KI+DFG+AR    D+ E N +      G MP ++ A
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADG-----GKMPIKWMA 179

Query: 681 IDGL----FSVKSDVFSFGVLVLEIV 702
           ++ +    F+ +SDV+S+GV + E++
Sbjct: 180 LECIHYRKFTHQSDVWSYGVTIWELM 205

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 96.0 bits (239), Expect = 6e-22
 Identities = 76/289 (26%), Positives = 128/289 (44%), Gaps = 47/289 (16%)

Query: 512 LGEGGFGPVYKGVLIEG----QEIAAK--RLSKSSGQGMEEFENEVLLIAKLQHRNLVKL 565
           LGEG FG V +G L +      ++A K  +L   +   +EEF +E   +    H N++KL
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 566 IGCCTQRDER------MLIYEYLPNKSLNDFIFDV---TRSKFLDWSKRCQIIGGIARGL 616
           IG C +          M+I  ++ +  L+ F+         + L      + +  IA G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA-FGID---QTEANTNRVVGTY 672
            YL   S    IHRDL A N +L  +M   ++DFG+++  +  D   Q       V    
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV---- 179

Query: 673 GYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHH---NLLGHAWRLWIE 729
            ++  E   D +++ KSDV++FGV + EI    R +  Y    +H   + L H  RL   
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIA--TRGQTPYPGVENHEIYDYLRHGNRL--- 234

Query: 730 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 778
           ++P + +++     YS             C +  P+DRP  + +  +L 
Sbjct: 235 KQPEDCLDELYDLMYS-------------CWRADPKDRPTFTKLREVLE 270

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 96.1 bits (239), Expect = 6e-22
 Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 20/208 (9%)

Query: 512 LGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQG---------MEEFENEVLLIAKLQHRN 561
           +G G FG VY G+    G+ +A K++   S            ++    E+ L+ +LQH N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
           +V+ +G     D   +  EY+P  S+   +         + +     +  I +GL YLH 
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVRNFVRQILKGLNYLHN 124

Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GIDQTEANTNR--VVGTYGYMPP 677
                IIHRD+K +N+L+DN+   KISDFG+++        T+ N  R  + G+  +M P
Sbjct: 125 RG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E      ++ K+D++S G LV+E++ GK
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 96.7 bits (241), Expect = 6e-22
 Identities = 69/223 (30%), Positives = 104/223 (46%), Gaps = 46/223 (20%)

Query: 512 LGEGGFGPVYKGVLI------EGQEIAAKRLSKSSGQGMEEFENEVL-LIAKL------- 557
           LGEG FG V K   +      E   +A K L        +  E ++  L++++       
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK------DDATEKDLSDLVSEMEMMKMIG 73

Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG------ 611
           +H+N++ L+G CTQ     ++ EY  + +L DF+    R      S              
Sbjct: 74  KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRA-RRPPGEYASPDDPRPPEETLTQK 132

Query: 612 --------IARGLLYLHQDSRLRIIHRDLKASNVLL--DNEMNPKISDFGMARAF-GIDQ 660
                   +ARG+ +L      + IHRDL A NVL+  D+ M  KI+DFG+AR    ID 
Sbjct: 133 DLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVM--KIADFGLARDIHHIDY 187

Query: 661 TEANTN-RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
               TN R+     +M PE   D +++ +SDV+SFGVL+ EI 
Sbjct: 188 YRKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 95.6 bits (238), Expect = 8e-22
 Identities = 66/205 (32%), Positives = 108/205 (52%), Gaps = 24/205 (11%)

Query: 512 LGEGGFGPVYKGV-LIEGQEIAAKRLS-----KSSGQGMEEFENEVLLIAKLQHRNLVKL 565
           LG G FG VY+G+ L +G   A K +S     ++  + +++ E E+ L++KLQH N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 566 IGCCTQRDERML-IY-EYLPNKSLNDFI--FDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
           +G  T+R+E  L I+ E +P  SL   +  +       +    R QI+ G+     YLH 
Sbjct: 68  LG--TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILLGLE----YLHD 120

Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY-A 680
                 +HRD+K +N+L+D     K++DFGMA+        +      G+  +M PE  A
Sbjct: 121 R---NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIA 174

Query: 681 IDGLFSVKSDVFSFGVLVLEIVCGK 705
             G + + +D++S G  VLE+  GK
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 95.3 bits (237), Expect = 1e-21
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 27/208 (12%)

Query: 512 LGEGGFGPVYKGVLIE-GQEIAAKR-----LSKSSGQGMEEFENEVLLIAKLQHRNLVKL 565
           LG+G FG VY    ++ G+E+A K+      S  + + +   E E+ L+  LQH  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFIF-------DVTRSKFLDWSKRCQIIGGIARGLLY 618
            GC    +   +  EY+P  S+ D +         VTR     ++++      I  G+ Y
Sbjct: 70  YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRK----YTRQ------ILEGVEY 119

Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA-RAFGIDQTEANTNRVVGTYGYMPP 677
           LH +    I+HRD+K +N+L D+  N K+ DFG + R   I  +      V GT  +M P
Sbjct: 120 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176

Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E      +  K+DV+S G  V+E++  K
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 95.9 bits (238), Expect = 1e-21
 Identities = 60/221 (27%), Positives = 119/221 (53%), Gaps = 10/221 (4%)

Query: 486 EEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGM 544
           +EE+   +   ++I +  + ++   K+G+G  G V+  + +  GQE+A K+++       
Sbjct: 1   DEEIMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK 60

Query: 545 EEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSK 604
           E   NE+L++ +L++ N+V  +      DE  ++ EYL   SL D + +      +D ++
Sbjct: 61  ELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC----MDEAQ 116

Query: 605 RCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 664
              +     + L +LH +   ++IHRD+K+ NVLL  + + K++DFG       +Q++ +
Sbjct: 117 IAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS 173

Query: 665 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           T  +VGT  +M PE      +  K D++S G++ +E+V G+
Sbjct: 174 T--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 95.6 bits (238), Expect = 1e-21
 Identities = 62/211 (29%), Positives = 104/211 (49%), Gaps = 17/211 (8%)

Query: 504 ENFSDKNKLGEGGFGPVY----KGVLIEGQE--IAAKRLSKSSGQGME-EFENEVLLIAK 556
            N  +   LG G FG V+    KG+  EG E  +  K L K+  + ++ EF  E+ +  K
Sbjct: 5   SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64

Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFI------FDVTRSKFLDWSKRCQIIG 610
           L H+N+V+L+G C + +   +I EY     L  F+       +  +   L   ++  +  
Sbjct: 65  LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124

Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVG 670
            IA G+ +L   S  R +HRDL A N L+ ++   K+S   +++     +     N ++ 
Sbjct: 125 QIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI- 180

Query: 671 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
              ++ PE   +  FS KSDV+SFGVL+ E+
Sbjct: 181 PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 95.5 bits (237), Expect = 1e-21
 Identities = 69/223 (30%), Positives = 109/223 (48%), Gaps = 39/223 (17%)

Query: 505 NFSDKNKLGEGGFGPVYKGV---LIEGQE---IAAKRLSKSSGQGMEEFENEVLLIAKLQ 558
           N   K +LGEG FG V+      L   Q+   +A K L  +S    ++F  E  L+  LQ
Sbjct: 6   NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65

Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFI----------------FDVTRSKFLDW 602
           H ++VK  G C + D  ++++EY+ +  LN F+                 ++T+S+ L  
Sbjct: 66  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125

Query: 603 SKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 662
           +++      IA G++YL   +    +HRDL   N L+   +  KI DFGM+R    D   
Sbjct: 126 AQQ------IAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYS 172

Query: 663 ANTNRVVG----TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
            +  RV G       +MPPE  +   F+ +SDV+S GV++ EI
Sbjct: 173 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEI 215

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 94.0 bits (233), Expect = 2e-21
 Identities = 78/263 (29%), Positives = 130/263 (49%), Gaps = 22/263 (8%)

Query: 511 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT 570
           KLG+G FG V+ G      ++A K L K      E F  E  ++ KL+H  LV L    +
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 571 QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 630
           + +   ++ E++   SL DF+ +    K+L   +   +   IA G+ Y+    R+  IHR
Sbjct: 72  E-EPIYIVTEFMGKGSLLDFLKE-GDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126

Query: 631 DLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSD 690
           DL+A+N+L+ + +  KI+DFG+AR    ++  A          +  PE A+ G F++KSD
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 185

Query: 691 VFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVL 750
           V+SFG+L+ E+V   + R  Y    +  +L    R +    P        G   SL E++
Sbjct: 186 VWSFGILLTELV--TKGRVPYPGMVNREVLEQVERGYRMPCP-------QGCPESLHELM 236

Query: 751 RCIQVGLLCVQQRPEDRPNMSSV 773
           +      LC ++ P++RP    +
Sbjct: 237 K------LCWKKDPDERPTFEYI 253

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 94.1 bits (234), Expect = 3e-21
 Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 19/212 (8%)

Query: 503 TENFSDKNKLGEGGFGPVYKGVLIEGQ-EIAAKRLSKSSGQGMEEFENEVLLIAKLQHRN 561
            +   ++  LG+G +G VY    +  Q  IA K + +   + ++    E+ L + L+HRN
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG----GIARGLL 617
           +V+ +G  ++     +  E +P  SL+  +    RSK+       Q I      I  GL 
Sbjct: 67  IVQYLGSDSENGFFKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIIFYTKQILEGLK 122

Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMA-RAFGIDQTEANTNRVVGTYGYM 675
           YLH     +I+HRD+K  NVL++      KISDFG + R  GI+     T    GT  YM
Sbjct: 123 YLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC---TETFTGTLQYM 176

Query: 676 PPEYAIDGL--FSVKSDVFSFGVLVLEIVCGK 705
            PE    G   +   +D++S G  ++E+  GK
Sbjct: 177 APEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 94.7 bits (236), Expect = 3e-21
 Identities = 63/226 (27%), Positives = 96/226 (42%), Gaps = 43/226 (19%)

Query: 509 KNKLGEGGFGPVY--KGVLIEGQEIAAKRLSKSSGQ----------------GMEEFENE 550
             KLGEG FG V+  +   ++     A   + ++                    E+F  E
Sbjct: 10  VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKE 69

Query: 551 VLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFI--------FDVTRSKFLDW 602
           V ++++L   N+ +L+G CT      +I EY+ N  LN F+             SK L +
Sbjct: 70  VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129

Query: 603 SKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 662
           S    +   IA G+ YL     L  +HRDL   N L+      KI+DFGM+R        
Sbjct: 130 STLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR-------N 179

Query: 663 ANTN-------RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
             ++       R      +M  E  + G F+ KSDV++FGV + EI
Sbjct: 180 LYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 94.7 bits (235), Expect = 3e-21
 Identities = 66/216 (30%), Positives = 100/216 (46%), Gaps = 30/216 (13%)

Query: 509 KNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL 562
           K +LGEG FG V+           +   +A K L   +    ++F+ E  L+  LQH ++
Sbjct: 10  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69

Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIF-------------DVTRSKFLDWSKRCQII 609
           VK  G C   D  ++++EY+ +  LN F+                     L  S+   I 
Sbjct: 70  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129

Query: 610 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV 669
             IA G++YL   +    +HRDL   N L+   +  KI DFGM+R    D    +  RV 
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVG 182

Query: 670 G----TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
           G       +MPPE  +   F+ +SDV+SFGV++ EI
Sbjct: 183 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 93.9 bits (234), Expect = 3e-21
 Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 16/203 (7%)

Query: 510 NKLGEGGFGPVYKGVLIEGQEIAA-KRLSKSSGQGMEEFE-----NEVLLIAKLQHRNLV 563
             +G+G FG V K       +I   K +   +   M E E     +EV ++ +L+H N+V
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN---MTEKEKQQLVSEVNILRELKHPNIV 62

Query: 564 KLIGCCTQRD-ERMLIY-EYLPNKSLNDFIFDVTRS-KFLDWSKRCQIIGGIARGLLYLH 620
           +       R  + + I  EY     L   I    +  K+++     +I+  +   L   H
Sbjct: 63  RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122

Query: 621 --QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
              D    ++HRDLK +N+ LD   N K+ DFG+A+  G D + A T   VGT  YM PE
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMSPE 180

Query: 679 YAIDGLFSVKSDVFSFGVLVLEI 701
                 +  KSD++S G L+ E+
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYEL 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 93.2 bits (231), Expect = 5e-21
 Identities = 77/271 (28%), Positives = 126/271 (46%), Gaps = 48/271 (17%)

Query: 511 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT 570
           KLG G FG V+     +  ++A K + K     +E F  E  ++  LQH  LVKL    T
Sbjct: 13  KLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71

Query: 571 QRDERMLIYEYLPNKSLNDFIFD-----VTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 625
            ++   +I E++   SL DF+           K +D+S +      IA G+ ++ Q +  
Sbjct: 72  -KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQRN-- 122

Query: 626 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTY--GYMPPEYAIDG 683
             IHRDL+A+N+L+   +  KI+DFG+AR   + +    T R    +   +  PE    G
Sbjct: 123 -YIHRDLRAANILVSASLVCKIADFGLAR---VIEDNEYTAREGAKFPIKWTAPEAINFG 178

Query: 684 LFSVKSDVFSFGVLVLEIVCGKRN--RGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 741
            F++KSDV+SFG+L++EIV   R    G  + +                     + ++L 
Sbjct: 179 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---------------------VIRALE 217

Query: 742 GSYSLSEVLRCIQ----VGLLCVQQRPEDRP 768
             Y +     C +    + + C + RPE+RP
Sbjct: 218 RGYRMPRPENCPEELYNIMMRCWKNRPEERP 248

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 93.0 bits (231), Expect = 6e-21
 Identities = 71/269 (26%), Positives = 128/269 (47%), Gaps = 32/269 (11%)

Query: 512 LGEGGFGPVYK------GVLIEGQEIAAKRLSKSSGQG-MEEFENEVLLIAKLQHRNLVK 564
           LG G F   Y+      G L+  +++   R + S  +  +E    E+ L+A+L H ++++
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQI--IGGIARGLLYLHQD 622
           ++G   +     L  E++   S++  +     SK+  + +   I     + RGL YLH++
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLL-----SKYGAFKEAVIINYTEQLLRGLSYLHEN 122

Query: 623 SRLRIIHRDLKASNVLLDNE-MNPKISDFGMARAFGIDQTEAN--TNRVVGTYGYMPPEY 679
              +IIHRD+K +N+L+D+     +I+DFG A       T A     +++GT  +M PE 
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179

Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 739
                +    DV+S G +++E+   K     ++A+ H N L   +++        +    
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKPP---WNAEKHSNHLALIFKIASATTAPSI---- 232

Query: 740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRP 768
                 LS  LR   V L C++ +PEDRP
Sbjct: 233 ---PEHLSPGLR--DVTLRCLELQPEDRP 256

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 92.6 bits (230), Expect = 8e-21
 Identities = 64/196 (32%), Positives = 102/196 (52%), Gaps = 17/196 (8%)

Query: 511 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT 570
           +LG G FG V+ G      ++A K +++ +    E+F  E  ++ KL H  LV+L G CT
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 571 QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR-----CQIIGGIARGLLYLHQDSRL 625
           Q+    ++ E++ N  L +++    R +    SK      CQ    +  G+ YL ++S  
Sbjct: 70  QQKPLYIVTEFMENGCLLNYL----RQRQGKLSKDMLLSMCQ---DVCEGMEYLERNS-- 120

Query: 626 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF 685
             IHRDL A N L+ +    K+SDFGM R + +D    +++       + PPE      +
Sbjct: 121 -FIHRDLAARNCLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKY 178

Query: 686 SVKSDVFSFGVLVLEI 701
           S KSDV+SFGVL+ E+
Sbjct: 179 SSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 93.0 bits (231), Expect = 1e-20
 Identities = 58/210 (27%), Positives = 111/210 (52%), Gaps = 10/210 (4%)

Query: 497 MAIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIA 555
           +++ +  + ++   K+G+G  G VY  + +  GQE+A K+++       E   NE+L++ 
Sbjct: 12  VSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMR 71

Query: 556 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARG 615
           + +H N+V  +      DE  ++ EYL   SL     DV     +D  +   +     + 
Sbjct: 72  ENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQA 127

Query: 616 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYM 675
           L +LH +   ++IHRD+K+ N+LL  + + K++DFG       +Q++ +T  +VGT  +M
Sbjct: 128 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWM 182

Query: 676 PPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
            PE      +  K D++S G++ +E+V G+
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 92.0 bits (228), Expect = 2e-20
 Identities = 78/284 (27%), Positives = 138/284 (48%), Gaps = 50/284 (17%)

Query: 512 LGEGGFGPVYKGVL-IEGQE---IAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLI 566
           +G G FG V++G+L + G++   +A K L    + +  ++F +E  ++ +  H N+++L 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGLLYLHQDS 623
           G  T+    M+I EY+ N +L+ ++    R    ++S   Q++G   GIA G+ YL   S
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYL----RDHDGEFSS-YQLVGMLRGIAAGMKYL---S 124

Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----PE 678
            +  +HRDL A N+L+++ +  K+SDFG++R    D     T     + G +P     PE
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTT----SGGKIPIRWTAPE 180

Query: 679 YAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 737
                 F+  SDV+SFG+++ E++  G+R                 W +   E     + 
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMSFGERPY---------------WDMSNHE-----VM 220

Query: 738 KSLGGSYSLSEVLRC----IQVGLLCVQQRPEDRPNMSSVVLML 777
           K++   + L   + C     Q+ L C QQ    RP    +V +L
Sbjct: 221 KAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 91.5 bits (227), Expect = 2e-20
 Identities = 63/194 (32%), Positives = 102/194 (52%), Gaps = 13/194 (6%)

Query: 511 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT 570
           +LG G FG V  G    GQ   A ++ K      +EF  E  ++ KL H  LV+L G CT
Sbjct: 11  ELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 571 QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 630
           ++    ++ EY+ N  L +++ +  +      S+  ++   +  G+ YL      + IHR
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESK---QFIHR 124

Query: 631 DLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT---YGYMPPEYAIDGLFSV 687
           DL A N L+D++   K+SDFG++R    D+  ++    VG+     + PPE  +   FS 
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKFSS 180

Query: 688 KSDVFSFGVLVLEI 701
           KSDV++FGVL+ E+
Sbjct: 181 KSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 91.9 bits (228), Expect = 2e-20
 Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 31/219 (14%)

Query: 512 LGEGGFGPVYKGVLIEGQ------EIAAKRLSKSSGQG-MEEFENEVLLIAKLQHRNLVK 564
           LGEG FG V K      +       +A K L +++    + +  +E  L+ ++ H +++K
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFI------------FDVTRSKFLDWS--KRCQIIG 610
           L G C+Q    +LI EY    SL  F+             D  R+     +  +R   +G
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 611 G-------IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 663
                   I+RG+ YL   + ++++HRDL A NVL+      KISDFG++R    + +  
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
             ++      +M  E   D +++ +SDV+SFGVL+ EIV
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 223

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 19/205 (9%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAA-KRLSKSSGQGMEEFENEVLLIAKLQHRNL 562
           E++    ++G G +G VYK   I   E+ A K +    G   E  + E+ ++ + +H N+
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62

Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIAR----GLLY 618
           V   G   +RD+  ++ EY    SL D I+ VTR    +       I  + R    GL Y
Sbjct: 63  VAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSE-----LQIAYVCRETLKGLAY 116

Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           LH+      IHRD+K +N+LL  + + K++DFG++    +  T A     +GT  +M PE
Sbjct: 117 LHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQ--LTATIAKRKSFIGTPYWMAPE 171

Query: 679 YA---IDGLFSVKSDVFSFGVLVLE 700
            A     G +  K D+++ G+  +E
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 91.3 bits (227), Expect = 3e-20
 Identities = 75/270 (27%), Positives = 120/270 (44%), Gaps = 25/270 (9%)

Query: 510 NKLGEGGFGPVYKGVLIEGQE-IAAKR--LSKSSGQGMEEFENEVLLIAKLQHRNLVKLI 566
             +G G    VY  + +   E +A KR  L K     ++E   EV  +++  H N+VK  
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS-VDELRKEVQAMSQCNHPNVVKYY 65

Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 626
                 DE  L+  YL   SL D +        LD +    ++  + +GL YLH + +  
Sbjct: 66  TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123

Query: 627 IIHRDLKASNVLLDNEMNPKISDFGMARAF--GIDQTEANTNRVVGTYGYMPPEYAIDGL 684
            IHRD+KA N+LL  + + KI+DFG++ +   G D+T       VGT  +M PE      
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182

Query: 685 -FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 743
            +  K+D++SFG+  +E+  G        A +          L ++  P  L   +    
Sbjct: 183 GYDFKADIWSFGITAIELATG-------AAPYSKYPPMKVLMLTLQNDPPSLETGADYKK 235

Query: 744 YSLS--EVLRCIQVGLLCVQQRPEDRPNMS 771
           YS S  +++       LC+Q+ P  RP   
Sbjct: 236 YSKSFRKMIS------LCLQKDPSKRPTAE 259

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 91.3 bits (226), Expect = 3e-20
 Identities = 60/204 (29%), Positives = 108/204 (52%), Gaps = 11/204 (5%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVLLIAKLQHRN 561
           E F+   ++G+G FG VYKG+    +E+ A ++   + +   +E+ + E+ ++++     
Sbjct: 4   ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
           + +  G   +  +  +I EYL   S      D+ +   L+ +    I+  I +GL YLH 
Sbjct: 64  ITRYYGSYLKGTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHS 119

Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
           +   R IHRD+KA+NVLL  + + K++DFG+A      Q + NT   VGT  +M PE   
Sbjct: 120 E---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIK 174

Query: 682 DGLFSVKSDVFSFGVLVLEIVCGK 705
              +  K+D++S G+  +E+  G+
Sbjct: 175 QSAYDFKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 90.7 bits (225), Expect = 3e-20
 Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 16/206 (7%)

Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLS------KSSGQGMEEFENEVLLIAKLQHRNLV 563
             LG+G +G VY G+  +GQ IA K++        ++ +  E+ + EV L+  L+H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           + +G C   +   +  E++P  S++  +    R   L     C+    I  G+ YLH + 
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSIL---NRFGPLPEPVFCKYTKQILDGVAYLHNNC 122

Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAF---GIDQTEANTNRVV-GTYGYMPPEY 679
              ++HRD+K +NV+L      K+ DFG AR     G+  T +N  + + GT  +M PE 
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179

Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCGK 705
             +  +  KSD++S G  V E+  GK
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 59/199 (29%), Positives = 101/199 (50%), Gaps = 12/199 (6%)

Query: 511 KLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFEN--EVLLIAKLQHRNLVKLIG 567
           K+GEG +G VYK    + G+ +A K++               E+ L+ +L H N++KL+ 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 568 CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI 627
               + +  L++E++ +  L   I D  R + L  S     +  + +GL + H      I
Sbjct: 66  VFRHKGDLYLVFEFM-DTDLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSH---GI 119

Query: 628 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI-DGLFS 686
           +HRDLK  N+L++ E   K++DFG+AR+FG       T+ VV T  Y  PE  + D  +S
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVV-TRWYRAPELLLGDKGYS 177

Query: 687 VKSDVFSFGVLVLEIVCGK 705
              D++S G +  E++  +
Sbjct: 178 TPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 90.8 bits (226), Expect = 4e-20
 Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 24/205 (11%)

Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR----NLVKL 565
            +LG G  G V K +     +I A +  +      E  + ++L    + H+     +V  
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGF 64

Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA----RGLLYLHQ 621
            G      +  +  EY+   SL D I    + +  +     +I+G IA    +GL YLH 
Sbjct: 65  YGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPE-----RILGKIAVAVLKGLTYLH- 117

Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
             + +IIHRD+K SN+L+++    K+ DFG++    ++ + A T   VGT  YM PE  I
Sbjct: 118 -EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL-VN-SLAKTF--VGTSSYMAPE-RI 171

Query: 682 DGL-FSVKSDVFSFGVLVLEIVCGK 705
            G  +SVKSD++S G+ ++E+  G+
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 90.9 bits (225), Expect = 4e-20
 Identities = 60/204 (29%), Positives = 106/204 (51%), Gaps = 11/204 (5%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVLLIAKLQHRN 561
           E F+   K+G+G FG V+KG+    Q++ A ++   + +   +E+ + E+ ++++     
Sbjct: 4   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
           + K  G   +  +  +I EYL   S      D+     LD ++   I+  I +GL YLH 
Sbjct: 64  VTKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHS 119

Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
           + +   IHRD+KA+NVLL      K++DFG+A    +  T+   N  VGT  +M PE   
Sbjct: 120 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQ--LTDTQIKRNTFVGTPFWMAPEVIK 174

Query: 682 DGLFSVKSDVFSFGVLVLEIVCGK 705
              +  K+D++S G+  +E+  G+
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 90.9 bits (226), Expect = 4e-20
 Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 22/212 (10%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKR--LSKSSGQGMEEFENEVLLIAKLQHRN 561
           E   + ++LGEG  G V K  L     I A +   +  +    ++   E+ +    +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 562 LVKLIGCCTQRDERML--IYEYLPNKSLNDFIFDVTRSKFLDWSKRC--QIIGGIA---- 613
           +VK  G         +    EY    SL D I+   + +      R   +++G IA    
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKR----GGRIGEKVLGKIAESVL 115

Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
           +GL YLH     +IIHRD+K SN+LL  +   K+ DFG++         A T    GT  
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL--AGT--FTGTSF 168

Query: 674 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           YM PE      +S+ SDV+S G+ +LE+   +
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 90.6 bits (225), Expect = 5e-20
 Identities = 71/262 (27%), Positives = 108/262 (41%), Gaps = 28/262 (10%)

Query: 512 LGEGGFGPVY------KGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKL 565
           LG+GGFG V        G +   +++  KRL K  G+ M   E ++L   K+  R +V L
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKIL--EKVSSRFIVSL 58

Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 625
                 +D+  L+   +    L   I++V    F   ++       I  GL +LHQ    
Sbjct: 59  AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGF-PEARAIFYAAQIICGLEHLHQ---R 114

Query: 626 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF 685
           RI++RDLK  NVLLD+  N +ISD G+A      +         GT GYM PE     ++
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEVLQGEVY 171

Query: 686 SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYS 745
               D F+ G  + E++ G   R  +       +     +    E  VE           
Sbjct: 172 DFSVDWFALGCTLYEMIAG---RSPFR-QRKEKVEKEELKRRTLEMAVEY-------PDK 220

Query: 746 LSEVLRCIQVGLLCVQQRPEDR 767
            S   + +   LL   + PE R
Sbjct: 221 FSPEAKDLCEALLQ--KDPEKR 240

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 90.4 bits (224), Expect = 8e-20
 Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 28/218 (12%)

Query: 509 KNKLGEGGFGPVY----KGVL---------IEGQE--IAAKRL-SKSSGQGMEEFENEVL 552
           K KLGEG FG V+    +G+           +GQ   +A K L +  +     +F  E+ 
Sbjct: 10  KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK 69

Query: 553 LIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD-VTRSKF--------LDWS 603
           ++++L++ N+++L+G C   D   +I EY+ N  LN F+      S F        +  +
Sbjct: 70  IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129

Query: 604 KRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 663
               +   IA G+ YL   + L  +HRDL   N L+ N    KI+DFGM+R         
Sbjct: 130 NLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYR 186

Query: 664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
              R V    +M  E  + G F+  SDV++FGV + E+
Sbjct: 187 IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 89.8 bits (222), Expect = 1e-19
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 18/205 (8%)

Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCT 570
           +G G +G VYKG  ++  ++AA ++   +G   EE + E+ ++ K   HRN+    G   
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 571 QR------DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           ++      D+  L+ E+    S+ D I + T+   L       I   I RGL +LHQ   
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRGLSHLHQH-- 130

Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI--- 681
            ++IHRD+K  NVLL      K+ DFG++    +D+T    N  +GT  +M PE      
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ--LDRTVGRRNTFIGTPYWMAPEVIACDE 187

Query: 682 --DGLFSVKSDVFSFGVLVLEIVCG 704
             D  +  KSD++S G+  +E+  G
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 89.7 bits (222), Expect = 1e-19
 Identities = 59/204 (28%), Positives = 108/204 (52%), Gaps = 11/204 (5%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVLLIAKLQHRN 561
           E F+   ++G+G FG V+KG+    Q++ A ++   + +   +E+ + E+ ++++     
Sbjct: 4   ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
           + K  G   +  +  +I EYL   S      D+ R+   D  +   ++  I +GL YLH 
Sbjct: 64  VTKYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHS 119

Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
           + +   IHRD+KA+NVLL  + + K++DFG+A      Q + NT   VGT  +M PE   
Sbjct: 120 EKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQ 174

Query: 682 DGLFSVKSDVFSFGVLVLEIVCGK 705
              +  K+D++S G+  +E+  G+
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 89.4 bits (222), Expect = 1e-19
 Identities = 69/266 (25%), Positives = 125/266 (46%), Gaps = 38/266 (14%)

Query: 512 LGEGGFGPVYKGVLIE-GQEIAAKRLS-KSSGQGMEEFENEVLLIAKLQH---RNLVKLI 566
           +G G +G VY+G  +  G+ +A K ++  +    + + + EV L+++L+     N+ K  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL----YLHQD 622
           G   +     +I EY    S+       T  K    +++   I  I R +L    Y+H+ 
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVR------TLMKAGPIAEKY--ISVIIREVLVALKYIHKV 120

Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID 682
               +IHRD+KA+N+L+ N  N K+ DFG+A     + ++ +T   VGT  +M PE   +
Sbjct: 121 G---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVITE 175

Query: 683 G-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 741
           G  +  K+D++S G+ + E+  G       ++D        A  L  + +P  L +   G
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPP----YSDVD---AFRAMMLIPKSKPPRLEDN--G 226

Query: 742 GSYSLSEVLRCIQVGLLCVQQRPEDR 767
            S  L E +        C+ + P++R
Sbjct: 227 YSKLLREFV------AACLDEEPKER 246

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 89.8 bits (222), Expect = 1e-19
 Identities = 59/221 (26%), Positives = 117/221 (52%), Gaps = 10/221 (4%)

Query: 486 EEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGM 544
           +EE+   +   +++ +  + ++   K+G+G  G VY  + I  GQE+A K+++       
Sbjct: 1   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK 60

Query: 545 EEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSK 604
           E   NE+L++ + ++ N+V  +      DE  ++ EYL   SL D + +      +D  +
Sbjct: 61  ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQ 116

Query: 605 RCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 664
              +     + L +LH +   ++IHRD+K+ N+LL  + + K++DFG       +Q++ +
Sbjct: 117 IAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173

Query: 665 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           T  +VGT  +M PE      +  K D++S G++ +E+V G+
Sbjct: 174 T--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 65/193 (33%), Positives = 100/193 (51%), Gaps = 13/193 (6%)

Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGME-EFENEVLLIAKLQHRNLVKLIGCCT 570
           LG+G FG V+KG L +   +A K   +   Q ++ +F +E  ++ +  H N+VKLIG CT
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 571 QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGLLYLHQDSRLRI 627
           QR    ++ E +P     DF+  + + K  D  K  Q++      A G+ YL   +    
Sbjct: 63  QRQPIYIVMELVPG---GDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESKN---C 114

Query: 628 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSV 687
           IHRDL A N L+      KISDFGM+R    D   +++        +  PE    G +S 
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQED-DGIYSSSGLKQIPIKWTAPEALNYGRYSS 173

Query: 688 KSDVFSFGVLVLE 700
           +SDV+S+G+L+ E
Sbjct: 174 ESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 89.7 bits (222), Expect = 2e-19
 Identities = 87/317 (27%), Positives = 142/317 (44%), Gaps = 70/317 (22%)

Query: 492 PIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEG---QEIAAKRLSKSSGQG-MEEF 547
           P+ +W  I      F D   +GEG FG V K  + +     + A KR+ + + +    +F
Sbjct: 2   PVLEWNDI-----KFQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF 54

Query: 548 ENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFI-----------FDVT 595
             E+ ++ KL  H N++ L+G C  R    L  EY P+ +L DF+           F + 
Sbjct: 55  AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 114

Query: 596 RS--KFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 653
            S    L   +       +ARG+ YL Q    + IHRDL A N+L+      KI+DFG++
Sbjct: 115 NSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS 171

Query: 654 RAFGIDQTEANTNRVVGTYGYMPPEY-AIDGL----FSVKSDVFSFGVLVLEIV------ 702
           R   +         V  T G +P  + AI+ L    ++  SDV+S+GVL+ EIV      
Sbjct: 172 RGQEV--------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223

Query: 703 -CGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQ 761
            CG      Y        L   +RL   E+P+   +          EV   ++    C +
Sbjct: 224 YCGMTCAELYEK------LPQGYRL---EKPLNCDD----------EVYDLMR---QCWR 261

Query: 762 QRPEDRPNMSSVVLMLS 778
           ++P +RP+ + +++ L+
Sbjct: 262 EKPYERPSFAQILVSLN 278

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 89.7 bits (222), Expect = 2e-19
 Identities = 84/288 (29%), Positives = 129/288 (44%), Gaps = 38/288 (13%)

Query: 506 FSDKNKLGEGGFGPVYKGVLIEGQEIAA-KRLSKSSGQGMEEFEN---EVLLIAKLQHRN 561
           FSD  ++G G FG VY    +   E+ A K++S S  Q  E++++   EV  + KL+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
            ++  GC  +     L+ EY    S +D +      K L   +   +  G  +GL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLG-SASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHS 133

Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
            +   +IHRD+KA N+LL      K+ DFG A         A  N  VGT  +M PE  +
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 184

Query: 682 ---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 738
              +G +  K DV+S G+  +E+   +R    ++     N +   + +   E P      
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNM----NAMSALYHIAQNESPALQSGH 238

Query: 739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL---MLSGERSL 783
                   SE  R       C+Q+ P+DRP  S V+L    +  ER  
Sbjct: 239 -------WSEYFRNFVDS--CLQKIPQDRPT-SEVLLKHRFVLRERPP 276

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 88.6 bits (219), Expect = 2e-19
 Identities = 67/214 (31%), Positives = 108/214 (50%), Gaps = 21/214 (9%)

Query: 512 LGEGGFGPVYKGVLIE-GQEIAAKRL-----SKSSGQGMEEFENEVLLIAKLQHRNLVKL 565
           LG+G FG VY    ++ G+E+AAK++     S  + + +   E E+ L+  LQH  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 566 IGCCTQRDERML--IYEYLPNKSLNDFIFD---VTRSKFLDWSKRCQIIGGIARGLLYLH 620
            GC   R E+ L    EY+P  S+ D +     +T S    ++++      I  G+ YLH
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQ------ILEGMSYLH 123

Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQTEANTNRVVGTYGYMPPEY 679
            +    I+HRD+K +N+L D+  N K+ DFG ++    I  +      V GT  +M PE 
Sbjct: 124 SN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180

Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHA 713
                +  K+DV+S G  V+E++  K     Y A
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA 214

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 88.7 bits (220), Expect = 2e-19
 Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 39/218 (17%)

Query: 512 LGEGGFGPVYKGVLIE-GQEIAAKRLS---------KSSGQGM-EEFENEVLLIAKLQHR 560
           +G+G +G VY  + +  G+ +A K++           S  + M +   +E+  +  L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIARG 615
           N+V+ +G  T  +   +  EY+P  S+   +     F+    +F       Q++ G+A  
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFT----EQVLEGLA-- 122

Query: 616 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR----AFGIDQTEANTNRVVGT 671
             YLH      I+HRDLKA N+L+D +   KISDFG+++     +  DQ       + G+
Sbjct: 123 --YLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ----NMSMQGS 173

Query: 672 YGYMPPEYAIDGL---FSVKSDVFSFGVLVLEIVCGKR 706
             +M PE  I      +S K D++S G +VLE+  G+R
Sbjct: 174 VFWMAPE-VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 89.3 bits (221), Expect = 3e-19
 Identities = 69/214 (32%), Positives = 113/214 (52%), Gaps = 28/214 (13%)

Query: 512 LGEGGFGPVYK----GVLIEGQE----IAAKRLS-KSSGQGMEEFENEVLLIAKL-QHRN 561
           LGEG FG V +    G+     +    +A K L   ++ + + +  +E+ L+  + +H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFI-----------FDVTRS--KFLDWSKRCQI 608
           ++ L+G CTQ     +I EY    +L +F+           FD+T+   + L +      
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQTEANTNR 667
              +ARG+ YL  +SR R IHRDL A NVL+  +   KI+DFG+AR    ID  +  +N 
Sbjct: 140 AYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
            +    +M PE   D +++ +SDV+SFG+L+ EI
Sbjct: 197 RLPV-KWMAPEALFDRVYTHQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 88.5 bits (220), Expect = 3e-19
 Identities = 63/212 (29%), Positives = 105/212 (49%), Gaps = 37/212 (17%)

Query: 511 KLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFEN-------EVLLIAKLQHRNL 562
           K+GEG +G VYK    + G+ +A K++   +     E E        E+ L+ +L H N+
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLET-----EDEGVPSTAIREISLLKELNHPNI 60

Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC----QIIGG----IAR 614
           V+L+      ++  L++E+L          D+   K++D S        +I      + +
Sbjct: 61  VRLLDVVHSENKLYLVFEFL----------DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQ 110

Query: 615 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGY 674
           G+ Y H     R++HRDLK  N+L+D E   K++DFG+ARAFG+      T+ VV T  Y
Sbjct: 111 GIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGV-PVRTYTHEVV-TLWY 165

Query: 675 MPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGK 705
             PE  +    +S   D++S G +  E+V  +
Sbjct: 166 RAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 87.5 bits (217), Expect = 4e-19
 Identities = 78/293 (26%), Positives = 120/293 (40%), Gaps = 67/293 (22%)

Query: 505 NFSDKNKLGEGGFGPVYK-GVLIEGQEIAAKR--LSKSSGQGMEEFENEVLLIAKLQHRN 561
           +F    KLG+G +G VYK   L + Q  A K   L   S +  E+  NE+ ++A + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 562 LVK-----LIGC--CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLD--------WSKRC 606
           ++      L G   C        + EY P     D    +++ K           W    
Sbjct: 61  IISYKEAFLDGNKLCI-------VMEYAP---FGDLSKAISKRKKKRKLIPEQEIWRIFI 110

Query: 607 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN 666
           Q+     RGL  LH+    +I+HRDLK++N+LL      KI D G+++   + +  A T 
Sbjct: 111 QL----LRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKV--LKKNMAKT- 160

Query: 667 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL 726
             +GT  YM PE      +S KSD++S G L+ E+                      +  
Sbjct: 161 -QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMA--------------------TFAP 199

Query: 727 WIEERPV-ELINKSLGGSY-----SLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
             E R + +L  K   G Y       S+ L         +Q +P+ RPN   +
Sbjct: 200 PFEARSMQDLRYKVQRGKYPPIPPIYSQDL--QNFIRSMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 87.4 bits (217), Expect = 5e-19
 Identities = 80/274 (29%), Positives = 122/274 (44%), Gaps = 41/274 (14%)

Query: 510 NKLGEGGFGPVYKGV-LIEGQEIAAK--RLSKSSGQGMEEFENEVLLIAKLQHRNLVKLI 566
           NK+G G FG VY  V L  G+ +A K  R+  +  + ++E  +E+ ++  L+H NLVK  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 567 GCCTQRDERMLIYEYLPNKSLNDF-----IFD--VTRSKFLDWSKRCQIIGGIARGLLYL 619
           G    R++  +  EY    +L +      I D  V R   L      Q++     GL YL
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTL------QLL----EGLAYL 115

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT--NRVVGTYGYMPP 677
           H      I+HRD+K +N+ LD+    K+ DFG A     + T        + GT  YM P
Sbjct: 116 HSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172

Query: 678 EYAIDGLFSVK---SDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE 734
           E    G        +D++S G +VLE+  GKR       D+   ++ H   +    +P  
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL--DNEFQIMFH---VGAGHKPP- 226

Query: 735 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRP 768
            I  SL  S    E    +     C++  P+ RP
Sbjct: 227 -IPDSLQLS---PEGKDFLD---RCLESDPKKRP 253

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 87.9 bits (218), Expect = 5e-19
 Identities = 65/206 (31%), Positives = 108/206 (52%), Gaps = 13/206 (6%)

Query: 505 NFSDKNKLGEGGFGPVYKGVLIEGQEIAA-KRLSKSSGQGMEEFE-NEVLLIAKLQHRNL 562
           NF    KLGEG +  VYKG      EI A K +   + +G       E+ L+ +L+H N+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
           V+L       ++ ML++EY+ +K L  ++        LD +        + +G+ + H++
Sbjct: 61  VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119

Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT--NRVVGTYGYMPPEYA 680
              R++HRDLK  N+L++     K++DFG+ARAFGI     NT  N VV T  Y  P+  
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFGI---PVNTFSNEVV-TLWYRAPDVL 172

Query: 681 IDG-LFSVKSDVFSFGVLVLEIVCGK 705
           +    +S   D++S G ++ E++ G+
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 87.8 bits (217), Expect = 5e-19
 Identities = 63/201 (31%), Positives = 108/201 (53%), Gaps = 20/201 (9%)

Query: 512 LGEGGFGPVYKGVLIEGQE-----IAAKRLSK-SSGQGMEEFENEVLLIAKLQHRNLVKL 565
           LG G FG VYKG+ I   E     +A K L + +S +  +E  +E  ++A +    + +L
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
           +G C     + L+ + +P   L D++ +    +     L+W  +      IA+G+ YL +
Sbjct: 75  LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127

Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
              +R++HRDL A NVL+ +  + KI+DFG+AR   ID+TE + +       +M  E  +
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184

Query: 682 DGLFSVKSDVFSFGVLVLEIV 702
              F+ +SDV+S+GV V E++
Sbjct: 185 HRRFTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 86.7 bits (215), Expect = 7e-19
 Identities = 72/278 (25%), Positives = 124/278 (44%), Gaps = 43/278 (15%)

Query: 512 LGEGGFGP--VYK----GVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKL 565
           LG+G FG   +Y+      L+  +E+   RLS+       +  NE+++++ LQH N++  
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQHPNIIAY 64

Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC------QIIGGIARGLLYL 619
                  +  ++  EY    +L D I    R K   + +        QI+  ++    Y+
Sbjct: 65  YNHFMDDNTLLIEMEYANGGTLYDKI---VRQKGQLFEEEMVLWYLFQIVSAVS----YI 117

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H+     I+HRD+K  N+ L      K+ DFG+++  G + + A T  VVGT  YM PE 
Sbjct: 118 HKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPEL 172

Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 739
                ++ KSD+++ G ++ E++  KR    + A    N L    ++        +    
Sbjct: 173 CQGVKYNFKSDIWALGCVLYELLTLKRT---FDAT---NPLNLVVKIVQGNYTPVV---- 222

Query: 740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 777
               YS SE+   I +    +QQ PE RP    V+   
Sbjct: 223 --SVYS-SEL---ISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 87.7 bits (217), Expect = 9e-19
 Identities = 66/216 (30%), Positives = 115/216 (53%), Gaps = 21/216 (9%)

Query: 497 MAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEI----AAKRLSK-SSGQGMEEFENE 550
           + I   TE F     LG G FG VYKG+ I EG+++    A K L + +S +  +E  +E
Sbjct: 1   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 59

Query: 551 VLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRC 606
             ++A + + ++ +L+G C     + LI + +P   L D++ +    +     L+W  + 
Sbjct: 60  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ- 117

Query: 607 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN 666
                IA+G+ YL +    R++HRDL A NVL+    + KI+DFG+A+  G D+ E +  
Sbjct: 118 -----IAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE 169

Query: 667 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
                  +M  E  +  +++ +SDV+S+GV V E++
Sbjct: 170 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 86.0 bits (213), Expect = 1e-18
 Identities = 64/205 (31%), Positives = 111/205 (54%), Gaps = 25/205 (12%)

Query: 512 LGEGGFGPVYKGVLI--EGQEI--AAKRLSK-SSGQGMEEFENEVLLIAKLQHRNLVKLI 566
           +G+G FG VY G LI  +GQ+I  A K L++ +  + +E+F  E +++    H N++ L+
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 567 GCCTQRD-ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGLLYLHQD 622
           G C   +   +++  Y+ +  L +FI   T +  +       +IG    +A+G+ YL   
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVK-----DLIGFGLQVAKGMEYLASK 117

Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY-AI 681
              + +HRDL A N +LD     K++DFG+AR     +  +  N    T   +P ++ A+
Sbjct: 118 ---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH---TGAKLPVKWMAL 171

Query: 682 DGL----FSVKSDVFSFGVLVLEIV 702
           + L    F+ KSDV+SFGVL+ E++
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELM 196

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 86.2 bits (213), Expect = 2e-18
 Identities = 68/219 (31%), Positives = 111/219 (50%), Gaps = 27/219 (12%)

Query: 502 ATENFSDKNKLGEGGFGPVY----KGVLIEGQE--IAAKRLSKS-SGQGMEEFENEVLLI 554
           A E  +   +LG+G FG VY    KGV+ +  E  +A K ++++ S +   EF NE  ++
Sbjct: 4   AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63

Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLD--------WSKRC 606
            +    ++V+L+G  +Q    ++I E +    L  ++  + R +  +          K  
Sbjct: 64  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPEMENNPVQAPPSLKKMI 122

Query: 607 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN 666
           Q+ G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R    D  E +  
Sbjct: 123 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYY 175

Query: 667 RVVGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
           R  G       +M PE   DG+F+  SDV+SFGV++ EI
Sbjct: 176 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 86.7 bits (214), Expect = 2e-18
 Identities = 55/221 (24%), Positives = 116/221 (52%), Gaps = 10/221 (4%)

Query: 486 EEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGM 544
           +EE+   +   +++ +  + ++   K+G+G  G VY  + +  GQE+A ++++       
Sbjct: 2   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61

Query: 545 EEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSK 604
           E   NE+L++ + ++ N+V  +      DE  ++ EYL   SL D + +      +D  +
Sbjct: 62  ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQ 117

Query: 605 RCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 664
              +     + L +LH +   ++IHRD+K+ N+LL  + + K++DFG       +Q++  
Sbjct: 118 IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 172

Query: 665 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
            + +VGT  +M PE      +  K D++S G++ +E++ G+
Sbjct: 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 86.2 bits (213), Expect = 2e-18
 Identities = 62/201 (30%), Positives = 102/201 (50%), Gaps = 20/201 (9%)

Query: 512 LGEGGFGPVYKGVLI-EGQEI----AAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKL 565
           LG G FG V+KG+ I EG  I    A K +   SG Q  +E  + +L +  L H  +V+L
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFIF----DVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
           +G C       L+ +  P  SL D +      +   + L+W  +      IA+G+ YL +
Sbjct: 75  LGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLEE 127

Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
               R++HR+L A N+LL ++   +I+DFG+A     D  +   +       +M  E  +
Sbjct: 128 H---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184

Query: 682 DGLFSVKSDVFSFGVLVLEIV 702
            G ++ +SDV+S+GV V E++
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 85.6 bits (212), Expect = 3e-18
 Identities = 56/207 (27%), Positives = 105/207 (50%), Gaps = 13/207 (6%)

Query: 501 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH 559
           N  + +    +LG+G FG VYK    E G   AAK +   S + +E+F  E+ ++++ +H
Sbjct: 2   NPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKH 61

Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
            N+V L       ++  ++ E+    +L+  + ++ R   L   +   +   +   L +L
Sbjct: 62  PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERG--LTEPQIRYVCRQMLEALNFL 119

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H     ++IHRDLKA N+LL  + + K++DFG++ A     T    +  +GT  +M PE 
Sbjct: 120 HSH---KVIHRDLKAGNILLTLDGDVKLADFGVS-AKNKS-TLQKRDTFIGTPYWMAPEV 174

Query: 680 AI-----DGLFSVKSDVFSFGVLVLEI 701
                  D  +  K+D++S G+ ++E+
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 85.8 bits (212), Expect = 3e-18
 Identities = 86/308 (27%), Positives = 141/308 (45%), Gaps = 69/308 (22%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAA--KRLSK-SSGQGMEEFENEVLLIAKL-Q 558
           E+   ++ +GEG FG V + ++  +G ++ A  K L + +S     +F  E+ ++ KL  
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61

Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWS--------------- 603
           H N++ L+G C  R    +  EY P  +L DF+    +S+ L+                 
Sbjct: 62  HPNIINLLGACENRGYLYIAIEYAPYGNLLDFL---RKSRVLETDPAFAKEHGTASTLTS 118

Query: 604 -KRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 662
            +  Q    +A G+ YL   S  + IHRDL A NVL+   +  KI+DFG++R   +    
Sbjct: 119 QQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEV---- 171

Query: 663 ANTNRVVGTYGYMPPEY-AIDGL----FSVKSDVFSFGVLVLEIV-------CGKRNRGF 710
                V  T G +P  + AI+ L    ++ KSDV+SFGVL+ EIV       CG      
Sbjct: 172 ----YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL 227

Query: 711 YHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNM 770
           Y        L   +R+   E+P    ++       + E++R       C + RP +RP  
Sbjct: 228 YEK------LPQGYRM---EKPRNCDDE-------VYELMR------QCWRDRPYERPPF 265

Query: 771 SSVVLMLS 778
           + + + LS
Sbjct: 266 AQISVQLS 273

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 85.3 bits (211), Expect = 4e-18
 Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 28/212 (13%)

Query: 504 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQHR 560
           + +    K+GEG +G VYK    +  + IA K++  +   +G+      E+ L+ ++QH 
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61

Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLD----WSKRCQIIGG----I 612
           N+V+L           L++EYL          D+   K +D    ++K  ++I      I
Sbjct: 62  NIVRLQDVVHSEKRLYLVFEYL----------DLDLKKHMDSSPDFAKNPRLIKTYLYQI 111

Query: 613 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQTEANTNRVVGT 671
            RG+ Y H     R++HRDLK  N+L+D   N  K++DFG+ARAFGI      T+ VV T
Sbjct: 112 LRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEVV-T 166

Query: 672 YGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIV 702
             Y  PE  +    +S   D++S G +  E+V
Sbjct: 167 LWYRAPEILLGSRHYSTPVDIWSVGCIFAEMV 198

Length = 294

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 84.6 bits (209), Expect = 4e-18
 Identities = 61/194 (31%), Positives = 98/194 (50%), Gaps = 19/194 (9%)

Query: 511 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT 570
            +GEG FG V +G    GQ++A K +        + F  E  ++ KL H+NLV+L+G   
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69

Query: 571 QRDERMLIYEYLPNKSLNDFIFDVTRSKFL-DWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
                 ++ E +   +L +F+   TR + L    +  Q    +A G+ YL      +++H
Sbjct: 70  HNG-LYIVMELMSKGNLVNFL--RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVH 123

Query: 630 RDLKASNVLLDNEMNPKISDFGMARA--FGIDQTEANTNRVVGTYGYMPPEYAIDGLFSV 687
           RDL A N+L+  +   K+SDFG+AR    G+D ++           +  PE      FS 
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK-------WTAPEALKHKKFSS 176

Query: 688 KSDVFSFGVLVLEI 701
           KSDV+S+GVL+ E+
Sbjct: 177 KSDVWSYGVLLWEV 190

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 84.9 bits (210), Expect = 4e-18
 Identities = 67/208 (32%), Positives = 95/208 (45%), Gaps = 17/208 (8%)

Query: 512 LGEGGFGPVY------KGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKL 565
           LG+GGFG V        G L   +++  KRL K  G      E  +L  AK+  R +V L
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRIL--AKVHSRFIVSL 58

Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSK-FLDWSKRCQIIGGIARGLLYLHQDSR 624
                 + +  L+   +    L   I++V          + C     I  GL +LHQ   
Sbjct: 59  AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR-- 116

Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 684
            RII+RDLK  NVLLDN+ N +ISD G+A      Q++  T    GT G+M PE      
Sbjct: 117 -RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEE 173

Query: 685 FSVKSDVFSFGVLVLEIVCGK---RNRG 709
           +    D F+ GV + E++  +   R RG
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGPFRARG 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 85.6 bits (212), Expect = 5e-18
 Identities = 68/203 (33%), Positives = 104/203 (51%), Gaps = 19/203 (9%)

Query: 506 FSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFEN---EVLLIAKLQHRN 561
           F+D  ++G G FG VY    +   + +A K++S S  Q  E++++   EV  + +L+H N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
            ++  GC  +     L+ EY    S +D I +V + K L   +   I  G  +GL YLH 
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCLG-SASD-ILEVHK-KPLQEVEIAAICHGALQGLAYLHS 133

Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE--Y 679
             R   IHRD+KA N+LL      K++DFG A         +  N  VGT  +M PE   
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSA------SLVSPANSFVGTPYWMAPEVIL 184

Query: 680 AID-GLFSVKSDVFSFGVLVLEI 701
           A+D G +  K DV+S G+  +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 85.5 bits (211), Expect = 6e-18
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 19/203 (9%)

Query: 506 FSDKNKLGEGGFGPVYKGVLIEGQEIAA-KRLSKSSGQGMEEFEN---EVLLIAKLQHRN 561
           F+D  ++G G FG VY    +   E+ A K++S S  Q  E++++   EV  + +++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
            ++  GC  +     L+ EY    S +D +      K L   +   I  G  +GL YLH 
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLG-SASDLL--EVHKKPLQEVEIAAITHGALQGLAYLHS 143

Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
            +   +IHRD+KA N+LL      K++DFG A         +  N  VGT  +M PE  +
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSA------SIASPANSFVGTPYWMAPEVIL 194

Query: 682 ---DGLFSVKSDVFSFGVLVLEI 701
              +G +  K DV+S G+  +E+
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 84.3 bits (208), Expect = 7e-18
 Identities = 59/205 (28%), Positives = 104/205 (50%), Gaps = 12/205 (5%)

Query: 501 NATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSK-SSGQGMEEFENEVLLIAKLQH 559
           N  E+F    ++G G +G VYK   +   E+AA ++ K   G+     + E++++   +H
Sbjct: 6   NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKH 65

Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
            N+V   G   +RD+  +  E+    SL D I+ VT    L  S+   +     +GL YL
Sbjct: 66  SNIVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGP--LSESQIAYVSRETLQGLYYL 122

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H   +   +HRD+K +N+LL +  + K++DFG++    I  T A     +GT  +M PE 
Sbjct: 123 HSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQ--ITATIAKRKSFIGTPYWMAPEV 177

Query: 680 AI---DGLFSVKSDVFSFGVLVLEI 701
           A     G ++   D+++ G+  +E+
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 84.8 bits (210), Expect = 7e-18
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 22/211 (10%)

Query: 504 ENFSDKNKLGEGGFGPVYKGV---LIEGQ---EIAAKRL-SKSSGQGMEEFENEVLLIAK 556
            N S    LG G FG V +     L +     ++A K L   +     E   +E+ +++ 
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 557 L-QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARG 615
           L  H N+V L+G CT     ++I EY     L +F+    R  FL           +A+G
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRR-KRESFLTLEDLLSFSYQVAKG 153

Query: 616 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYM 675
           + +L   +    IHRDL A NVLL +    KI DFG+AR    D     +N VV     +
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMND-----SNYVVKGNARL 205

Query: 676 P-----PEYAIDGLFSVKSDVFSFGVLVLEI 701
           P     PE   + +++ +SDV+S+G+L+ EI
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 84.1 bits (208), Expect = 9e-18
 Identities = 67/211 (31%), Positives = 104/211 (49%), Gaps = 29/211 (13%)

Query: 505 NFSDKNKLGEGGFGPVYKGV-LIEGQEIAAK--RLSKSSGQGMEEFENEVLLIAKLQHRN 561
           NF    K+GEG +G VYK    + G+ +A K  RL   +         E+ L+ +L H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL--YL 619
           +VKL+      ++  L++E+L ++ L          KF+D       + GI   L+  YL
Sbjct: 61  IVKLLDVIHTENKLYLVFEFL-HQDLK---------KFMD----ASPLSGIPLPLIKSYL 106

Query: 620 HQ-------DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTY 672
            Q           R++HRDLK  N+L++ E   K++DFG+ARAFG+      T+ VV T 
Sbjct: 107 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TL 164

Query: 673 GYMPPEYAIDG-LFSVKSDVFSFGVLVLEIV 702
            Y  PE  +    +S   D++S G +  E+V
Sbjct: 165 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 84.2 bits (208), Expect = 1e-17
 Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 31/220 (14%)

Query: 509 KNKLGEGGFGPVYKGVLIEGQE------------------IAAKRL-SKSSGQGMEEFEN 549
           K KLGEG FG V+     EG E                  +A K L   ++     +F  
Sbjct: 10  KEKLGEGQFGEVHL-CEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68

Query: 550 EVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFI--------FDVTRSKFLD 601
           E+ ++++L+  N+++L+  C   D   +I EY+ N  LN F+         +      + 
Sbjct: 69  EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128

Query: 602 WSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
           +S    +   IA G+ YL   S L  +HRDL   N L+      KI+DFGM+R       
Sbjct: 129 YSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185

Query: 662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
                R V    +M  E  + G F+  SDV++FGV + EI
Sbjct: 186 YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 83.4 bits (207), Expect = 1e-17
 Identities = 63/203 (31%), Positives = 94/203 (46%), Gaps = 23/203 (11%)

Query: 512 LGEGGFGPVYK-GVLIEGQEIAAKRLSKSS--GQGMEEF---ENEVLLIAKLQHRNLVKL 565
           LG GGFG V    V  + +  A K + K      G +E    E E+L   +  H  +VKL
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEIL--EECNHPFIVKL 58

Query: 566 IGCCTQRDER---MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
               T +D++   ML+ EY     L   + D  R  F +++ R   I  +     YLH  
Sbjct: 59  Y--RTFKDKKYIYMLM-EYCLGGELWTILRD--RGLFDEYTARF-YIACVVLAFEYLH-- 110

Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID 682
               II+RDLK  N+LLD+    K+ DFG A+     Q    T    GT  Y+ PE  ++
Sbjct: 111 -NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILN 166

Query: 683 GLFSVKSDVFSFGVLVLEIVCGK 705
             +    D +S G+L+ E++ G+
Sbjct: 167 KGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 84.0 bits (208), Expect = 1e-17
 Identities = 56/206 (27%), Positives = 101/206 (49%), Gaps = 16/206 (7%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL 562
               +  K+GEG  G V        G+++A K++     Q  E   NEV+++   QH N+
Sbjct: 19  SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78

Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
           V++       DE  ++ E+L   +L D    VT ++ ++  +   +   + + L +LH  
Sbjct: 79  VEMYSSYLVGDELWVVMEFLEGGALTDI---VTHTR-MNEEQIATVCLAVLKALSFLHAQ 134

Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR---VVGTYGYMPPEY 679
               +IHRD+K+ ++LL ++   K+SDFG        Q      R   +VGT  +M PE 
Sbjct: 135 ---GVIHRDIKSDSILLTSDGRVKLSDFGFC-----AQVSKEVPRRKSLVGTPYWMAPEV 186

Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCGK 705
                +  + D++S G++V+E+V G+
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 76/286 (26%), Positives = 126/286 (44%), Gaps = 43/286 (15%)

Query: 503 TENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS---KSSGQGMEEFENEVLLIAKLQ 558
             NF  + K+G+G F  VYK + L++G+ +A K++        +  ++   E+ L+ +L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFL-----DWSKRCQIIGGIA 613
           H N++K +    + +E  ++ E      L+  I    + K L      W    Q+     
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL----C 116

Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
             L ++H     RI+HRD+K +NV +      K+ D G+ R F    T A++  +VGT  
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPY 171

Query: 674 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV 733
           YM PE   +  ++ KSD++S G L+ E+   +    FY         G    L+      
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FY---------GDKMNLY------ 214

Query: 734 ELINKSLGGSYS------LSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
            L  K     Y        SE LR   +   C+   PE RP++S V
Sbjct: 215 SLCKKIEKCDYPPLPADHYSEELR--DLVSRCINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 83.1 bits (205), Expect = 1e-17
 Identities = 61/196 (31%), Positives = 102/196 (52%), Gaps = 13/196 (6%)

Query: 511 KLGEGGFGPVYKGVL-IEGQEI--AAKRLSKSSGQGM-EEFENEVLLIAKLQHRNLVKLI 566
           +LG G FG V KGV  +  ++I  A K L   + + + +E   E  ++ +L +  +V++I
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 626
           G C + +  ML+ E      LN F+    +   +  S   +++  ++ G+ YL   +   
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115

Query: 627 IIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTY--GYMPPEYAIDGL 684
            +HRDL A NVLL N+   KISDFG+++A G D +     R  G +   +  PE      
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY-KARSAGKWPLKWYAPECINFRK 174

Query: 685 FSVKSDVFSFGVLVLE 700
           FS +SDV+S+G+ + E
Sbjct: 175 FSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 82.8 bits (204), Expect = 2e-17
 Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 29/210 (13%)

Query: 512 LGEGGFGPVYKGVLIEGQEI---AAK--RLSKSSGQGMEEFENEVLLIAKLQHRNLVKLI 566
           LGEG FG V +G L +   I   A K  +++  +   ME+F +E + + +  H N+++LI
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 567 GCCTQRDER------MLIYEYLPNKSLNDFIFDVTR----SKFLDWSKRCQIIGGIARGL 616
           G C Q  E       ++I  ++ +  L+ F+   +R     ++L      + +  IA G+
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLL-YSRLGDCPQYLPTQMLVKFMTDIASGM 125

Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YL   S    IHRDL A N +L+  MN  ++DFG+++         +  R  G    MP
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI----YNGDYYR-QGRIAKMP 177

Query: 677 PEY-AIDGL----FSVKSDVFSFGVLVLEI 701
            ++ AI+ L    ++ KSDV+SFGV + EI
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 12/200 (6%)

Query: 511 KLGEGGFGPVYKGVLIEGQEIAA-KRLS-KSSGQGMEEFE-NEVLLIAKLQHRNLVKLIG 567
           K+GEG +G V+K    E  EI A KR+      +G+      E+ L+ +L+H+N+V+L  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 568 CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI 627
                 +  L++EY  ++ L  + FD      +D       +  + +GL + H      +
Sbjct: 67  VLHSDKKLTLVFEYC-DQDLKKY-FDSCNGD-IDPEIVKSFMFQLLKGLAFCHSH---NV 120

Query: 628 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG-LFS 686
           +HRDLK  N+L++     K++DFG+ARAFGI      +  VV T  Y PP+      L+S
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGI-PVRCYSAEVV-TLWYRPPDVLFGAKLYS 178

Query: 687 VKSDVFSFGVLVLEIVCGKR 706
              D++S G +  E+    R
Sbjct: 179 TSIDMWSAGCIFAELANAGR 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 82.4 bits (204), Expect = 3e-17
 Identities = 63/213 (29%), Positives = 91/213 (42%), Gaps = 27/213 (12%)

Query: 505 NFSDKNKLGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEEFEN---EVLLIAKLQHR 560
           +F     +G+G FG V      + +++ A K ++K          N   E  ++ +L H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 561 NLVKLIGCCT-QRDERM-LIYEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIA 613
            LV L    + Q +E M L+ + L    L   +     F   + KF         I  I 
Sbjct: 61  FLVNL--WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF--------WICEIV 110

Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
             L YLH      IIHRD+K  N+LLD + +  I+DF +A        +  T    GT G
Sbjct: 111 LALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGTPG 164

Query: 674 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR 706
           YM PE      +SV  D +S GV   E + GKR
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 82.2 bits (203), Expect = 3e-17
 Identities = 57/204 (27%), Positives = 101/204 (49%), Gaps = 21/204 (10%)

Query: 512 LGEGGFGPVY--------KGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           +G G FG V+        K V+I  ++I  ++++K      +   NE  ++  L H N++
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVII--KQIPVEQMTKDERLAAQ---NECQVLKLLSHPNII 62

Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           +      +    M++ EY P  +L ++I     S   + +    I+    + LL LH   
Sbjct: 63  EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDT----ILHFFVQILLALHHVH 118

Query: 624 RLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID 682
              I+HRDLK  N+LLD ++M  KI DFG+++      +++    VVGT  Y+ PE    
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISPELCEG 175

Query: 683 GLFSVKSDVFSFGVLVLEIVCGKR 706
             ++ KSD+++ G ++ E+   KR
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 83.0 bits (206), Expect = 3e-17
 Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 23/202 (11%)

Query: 510 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN-----EVLLIAKLQHRNLV 563
            KLGEG +  VYK    E G+ +A K++     +  ++  N     E+ L+ +L+H N++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
            L+     +    L++E++    L   I D  +S  L  +     +    RGL YLH   
Sbjct: 66  GLLDVFGHKSNINLVFEFMET-DLEKVIKD--KSIVLTPADIKSYMLMTLRGLEYLH--- 119

Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
              I+HRDLK +N+L+ ++   K++DFG+AR+FG       T++VV T  Y  PE     
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSFG-SPNRKMTHQVV-TRWYRAPEL---- 173

Query: 684 LFSVKS-----DVFSFGVLVLE 700
           LF  +      D++S G +  E
Sbjct: 174 LFGARHYGVGVDMWSVGCIFAE 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 82.8 bits (204), Expect = 3e-17
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 28/214 (13%)

Query: 512 LGEGGFGPVYKGVLI--------EGQEIAAKRLS-KSSGQGMEEFENEVLLIAKL-QHRN 561
           LGEG FG V     +        E   +A K L   ++ + + +  +E+ ++  + +H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFI-----------FDVTR--SKFLDWSKRCQI 608
           ++ L+G CTQ     +I EY    +L +++           +D+ R   + + +      
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQTEANTNR 667
              +ARG+ YL   +  + IHRDL A NVL+      KI+DFG+AR    ID  +  TN 
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
            +    +M PE   D +++ +SDV+SFGVL+ EI
Sbjct: 200 RLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 86.1 bits (213), Expect = 4e-17
 Identities = 70/282 (24%), Positives = 124/282 (43%), Gaps = 32/282 (11%)

Query: 430 KKPKKKKKVAIVITSVLLVTGVILLGGFVYLWKRRHRKQGKTDGSSKLDYNDRGNREEEM 489
           K+ +K       IT  L    V+ L  F +++ R             L+     N +   
Sbjct: 620 KRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNN---------LELKRVENEDGTW 670

Query: 490 ELPIFDW-----MAIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQG 543
           EL  FD      + I +   +  ++N +  G  G  YKG  I+ G +   K ++  +   
Sbjct: 671 ELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP 730

Query: 544 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWS 603
                +E+  + KLQH N+VKLIG C       LI+EY+  K+L+    +V R+  L W 
Sbjct: 731 ----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLS----EVLRN--LSWE 780

Query: 604 KRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 663
           +R +I  GIA+ L +LH      ++  +L    +++D +  P +    +      D    
Sbjct: 781 RRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCF 839

Query: 664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
            ++       Y+ PE       + KSD++ FG++++E++ GK
Sbjct: 840 ISS------AYVAPETRETKDITEKSDIYGFGLILIELLTGK 875

Length = 968

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 82.4 bits (203), Expect = 4e-17
 Identities = 60/197 (30%), Positives = 106/197 (53%), Gaps = 13/197 (6%)

Query: 511 KLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
           +LG+G FG VYK    E G   AAK +   S + +E++  E+ ++A   H  +VKL+G  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
               +  ++ E+ P  +++  + ++ R   L   +   I   +   L YLH    ++IIH
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVICRQMLEALQYLHS---MKIIH 133

Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI-----DGL 684
           RDLKA NVLL  + + K++DFG++ A  + +T    +  +GT  +M PE  +     D  
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVS-AKNV-KTLQRRDSFIGTPYWMAPEVVMCETMKDTP 191

Query: 685 FSVKSDVFSFGVLVLEI 701
           +  K+D++S G+ ++E+
Sbjct: 192 YDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 81.5 bits (201), Expect = 5e-17
 Identities = 81/294 (27%), Positives = 131/294 (44%), Gaps = 70/294 (23%)

Query: 512 LGEGGFGPVYKGVL-IEGQE---IAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLI 566
           +G G FG V  G L + G+    +A K L    + +   +F +E  ++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 567 GCCTQRDERMLIYEYLPNKSLNDFI------FDVTRSKFLDWSKRCQIIG---GIARGLL 617
           G  T+    M++ EY+ N SL+ F+      F V            Q++G   GIA G+ 
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVI-----------QLVGMLRGIASGMK 120

Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP- 676
           YL   S +  +HRDL A N+L+++ +  K+SDFG++R    D   A T R     G +P 
Sbjct: 121 YL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIPI 173

Query: 677 ----PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP 732
               PE      F+  SDV+S+G+++ E++                           ERP
Sbjct: 174 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMS------------------------YGERP 209

Query: 733 V-ELIN----KSLGGSYSLSEVLRC----IQVGLLCVQQRPEDRPNMSSVVLML 777
             E+ N    K++   Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 210 YWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 82.0 bits (202), Expect = 6e-17
 Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 19/209 (9%)

Query: 504 ENFSDKNKLGEGGFGPVYKGV------LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKL 557
           E +   +KLGEG +  VYKG       L+  +EI   RL    G        EV L+  L
Sbjct: 6   ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEI---RLEHEEGAPCTAIR-EVSLLKDL 61

Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +H N+V L           L++EYL +K L  ++ D   S  +   K    +  + RGL 
Sbjct: 62  KHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVK--LFLFQLLRGLN 118

Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           Y H   R +++HRDLK  N+L++     K++DFG+ARA  I  T+  +N VV T  Y PP
Sbjct: 119 YCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYSNEVV-TLWYRPP 173

Query: 678 EYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +  +    +S + D++  G +  E+  G+
Sbjct: 174 DILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 82.1 bits (203), Expect = 6e-17
 Identities = 58/210 (27%), Positives = 108/210 (51%), Gaps = 29/210 (13%)

Query: 510 NKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFE----NEVLLIAKLQHRNLVK 564
            ++GEG +G VYK      G+ +A K++   + +  E F      E+ ++ +L HRN+V 
Sbjct: 13  GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHRNIVN 70

Query: 565 LIGCCTQRDERM----------LIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQIIGGI 612
           L    T + + +          L++EY+ +      +  +  S  + +S+      +  +
Sbjct: 71  LKEIVTDKQDALDFKKDKGAFYLVFEYMDHD-----LMGLLESGLVHFSEDHIKSFMKQL 125

Query: 613 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTY 672
             GL Y H+ + L   HRD+K SN+LL+N+   K++DFG+AR +  +++   TN+V+ T 
Sbjct: 126 LEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TL 181

Query: 673 GYMPPEYAI-DGLFSVKSDVFSFGVLVLEI 701
            Y PPE  + +  +    DV+S G ++ E+
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGEL 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 81.5 bits (201), Expect = 6e-17
 Identities = 68/205 (33%), Positives = 110/205 (53%), Gaps = 24/205 (11%)

Query: 512 LGEGGFGPVY------KGVLIEGQEIAAKRLS-KSSGQGMEEFENEVLLIAKLQHRNLVK 564
           LGEG FG V       +G    G+++A K L  +S G  + + + E+ ++  L H N+VK
Sbjct: 12  LGEGHFGKVELCRYDPEGDNT-GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70

Query: 565 LIGCCTQRDER--MLIYEYLPNKSLNDFIFDVTRSK-FLDWSKRCQIIGGIARGLLYLHQ 621
             G CT+       LI E+LP+ SL +++    R+K  ++  ++ +    I +G+ YL  
Sbjct: 71  YKGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYL-- 125

Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ----TEANTNRVVGTYGYMPP 677
            SR + +HRDL A NVL+++E   KI DFG+ +A   D+     + + +  V  Y    P
Sbjct: 126 GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYA---P 181

Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIV 702
           E  I   F + SDV+SFGV + E++
Sbjct: 182 ECLIQSKFYIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 81.6 bits (201), Expect = 7e-17
 Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 20/206 (9%)

Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCT 570
           +G G +G VYKG  ++  ++AA ++   +    EE + E+ ++ K   HRN+    G   
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83

Query: 571 QR------DERMLIYEYLPNKSLNDFIFDVTRSKFL-DWSKRCQIIGGIARGLLYLHQDS 623
           ++      D+  L+ E+    S+ D + +   +    DW     I   I RGL +LH   
Sbjct: 84  KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI--AYICREILRGLAHLHAH- 140

Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI-- 681
             ++IHRD+K  NVLL      K+ DFG++    +D+T    N  +GT  +M PE     
Sbjct: 141 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ--LDRTVGRRNTFIGTPYWMAPEVIACD 196

Query: 682 ---DGLFSVKSDVFSFGVLVLEIVCG 704
              D  +  +SD++S G+  +E+  G
Sbjct: 197 ENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 82.0 bits (202), Expect = 7e-17
 Identities = 64/205 (31%), Positives = 100/205 (48%), Gaps = 19/205 (9%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAA-KRLSKSSGQGMEEFEN---EVLLIAKLQH 559
           E F   +++G G FG VY        E+ A K++S S  Q  E++++   EV  + +L+H
Sbjct: 21  EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKH 80

Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
            N ++  GC  +     L+ EY    S +D +      K L   +   I  G  +GL YL
Sbjct: 81  PNTIEYKGCYLKEHTAWLVMEYCLG-SASDLL--EVHKKPLQEVEIAAITHGALQGLAYL 137

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H  +   +IHRD+KA N+LL      K++DFG A         +  N  VGT  +M PE 
Sbjct: 138 HSHN---MIHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMAPEV 188

Query: 680 AI---DGLFSVKSDVFSFGVLVLEI 701
            +   +G +  K DV+S G+  +E+
Sbjct: 189 ILAMDEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 80.8 bits (199), Expect = 9e-17
 Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 18/208 (8%)

Query: 501 NATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSK-SSGQGMEEFENEVLLIAKLQH 559
           N   ++    ++G G +G VYK   +   E+AA ++ K   G      + E+ ++ + +H
Sbjct: 6   NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKH 65

Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQI---IGGIARGL 616
            N+V   G    R++  +  EY    SL D I+ VT           QI        +GL
Sbjct: 66  CNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGPL-----SELQIAYVCRETLQGL 119

Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YLH   ++   HRD+K +N+LL +  + K++DFG+A    I  T A     +GT  +M 
Sbjct: 120 AYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVAAK--ITATIAKRKSFIGTPYWMA 174

Query: 677 PEYAI---DGLFSVKSDVFSFGVLVLEI 701
           PE A    +G ++   D+++ G+  +E+
Sbjct: 175 PEVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 80.8 bits (199), Expect = 9e-17
 Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 29/218 (13%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRL-----SKSSGQGMEEFENEVLLIAKL 557
            N+     LG G FG VY     + G+E+A K++     S+ + + +   E E+ L+  L
Sbjct: 2   VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61

Query: 558 QHRNLVKLIGCCTQRDERML--IYEYLPNKSLND-------FIFDVTRSKFLDWSKRCQI 608
           +H  +V+  GC    +E+ L    EY+P  S+ D          +VTR     ++++   
Sbjct: 62  RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRR----YTRQ--- 114

Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA-RAFGIDQTEANTNR 667
              I +G+ YLH +    I+HRD+K +N+L D+  N K+ DFG + R   I  +      
Sbjct: 115 ---ILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS 168

Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           V GT  +M PE      +  K+DV+S    V+E++  K
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 82.2 bits (203), Expect = 1e-16
 Identities = 69/224 (30%), Positives = 105/224 (46%), Gaps = 42/224 (18%)

Query: 502 ATENFSD---KNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGME-EFENEVLLIAK 556
           A ++ S+    N++G G  G VYK +    G+  A K +  +    +  +   E+ ++  
Sbjct: 69  AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRD 128

Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLND-------FIFDVTRSKFLDWSKRCQII 609
           + H N+VK         E  ++ E++   SL         F+ DV R          QI+
Sbjct: 129 VNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----------QIL 178

Query: 610 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV 669
            GIA    YLH   R  I+HRD+K SN+L+++  N KI+DFG++R   + QT    N  V
Sbjct: 179 SGIA----YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LAQTMDPCNSSV 229

Query: 670 GTYGYMPPEY--------AIDGLFSVKSDVFSFGVLVLEIVCGK 705
           GT  YM PE         A DG      D++S GV +LE   G+
Sbjct: 230 GTIAYMSPERINTDLNHGAYDGY---AGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 81.6 bits (202), Expect = 1e-16
 Identities = 61/199 (30%), Positives = 90/199 (45%), Gaps = 48/199 (24%)

Query: 511 KLGEGGFGPVYKGVLIE-GQEIAAKR-LSKSSGQGME-EFENEVLLIAKLQHRNLVKLIG 567
           KLGEG FG VYK   I+ G+ +A K+ L  +   G       E+ ++ KL+H N+V LI 
Sbjct: 15  KLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLID 74

Query: 568 CCTQRDERMLIYEYLPN--KSLNDF-------------IFDVTRSKFLDWSKRC---QII 609
                    +  E      +                  + +    K  +   +C   Q++
Sbjct: 75  ---------MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLL 125

Query: 610 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF----------GID 659
            GI     YLH++    I+HRD+KA+N+L+DN+   KI+DFG+AR +          G  
Sbjct: 126 EGIN----YLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178

Query: 660 QTEANTNRVVGTYGYMPPE 678
            T   TN VV T  Y PPE
Sbjct: 179 GTRKYTNLVV-TRWYRPPE 196

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 80.3 bits (198), Expect = 1e-16
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 35/210 (16%)

Query: 512 LGEGGFGPVYKGVL-IEGQE---IAAKRL-SKSSGQGMEEFENEVLLIAKLQHRNLVKLI 566
           +G G FG V +G L + G+    +A K L S  + +   +F +E  ++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 567 GCCTQRDERMLIYEYLPNKSLNDFI------FDVTRSKFLDWSKRCQIIG---GIARGLL 617
           G  T+    M+I E++ N +L+ F+      F V            Q++G   GIA G+ 
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI-----------QLVGMLRGIAAGMK 120

Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP- 676
           YL   S +  +HRDL A N+L+++ +  K+SDFG++R    D ++      +G  G +P 
Sbjct: 121 YL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLG--GKIPI 175

Query: 677 ----PEYAIDGLFSVKSDVFSFGVLVLEIV 702
               PE      F+  SDV+S+G+++ E++
Sbjct: 176 RWTAPEAIAYRKFTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 80.4 bits (198), Expect = 1e-16
 Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 15/200 (7%)

Query: 512 LGEGGFGPV------YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKL 565
           LG+GGFG V        G +   +++  KRL K SG+ M   E E+L   K+    +V L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58

Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 625
                 +    L+   +    L   I++V   + L+  +       I  G+L+LH    +
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVG-ERGLEMERVIHYSAQITCGILHLHS---M 114

Query: 626 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF 685
            I++RD+K  NVLLD++ N ++SD G+  A  +   +  T R  GT GYM PE   +  +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGL--AVELKDGKTITQR-AGTNGYMAPEILKEEPY 171

Query: 686 SVKSDVFSFGVLVLEIVCGK 705
           S   D F+ G  + E+V G+
Sbjct: 172 SYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 80.4 bits (199), Expect = 2e-16
 Identities = 60/209 (28%), Positives = 107/209 (51%), Gaps = 31/209 (14%)

Query: 510 NKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSG-QGMEEFE-NEVLLIAKLQ---HRNLV 563
            ++GEG +G VYK   L  G+ +A K++      +G+      E+ L+ +L+   H N+V
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 564 KLIGCC-TQRDER----MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           +L+  C   R +R     L++E++ ++ L  ++    +      + +  ++  + RG+ +
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLRGVDF 122

Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           LH     RI+HRDLK  N+L+ ++   KI+DFG+AR +  +   A T+ VV T  Y  PE
Sbjct: 123 LHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM--ALTSVVV-TLWYRAPE 176

Query: 679 ------YAIDGLFSVKSDVFSFGVLVLEI 701
                 YA      V  D++S G +  E+
Sbjct: 177 VLLQSSYA----TPV--DMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 80.4 bits (199), Expect = 2e-16
 Identities = 50/174 (28%), Positives = 87/174 (50%), Gaps = 16/174 (9%)

Query: 511 KLGEGGFGPVYKGVLIE-GQEIAAKR--LSKSSGQGMEEFENEVLLIAKLQHRNLVKLIG 567
           ++GEG  G V+K    E G+ +A K+  L +  G    +   E+  +   QH  +VKL+ 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 568 CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC---QIIGGIARGLLYLHQDSR 624
                   +L+ EY+P+  L++ + D  R    +   +     ++ G+A    Y+H    
Sbjct: 67  VFPHGSGFVLVMEYMPS-DLSEVLRDEERP-LPEAQVKSYMRMLLKGVA----YMHA--- 117

Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
             I+HRDLK +N+L+  +   KI+DFG+AR F  ++    +++ V T  Y  PE
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 80.7 bits (199), Expect = 2e-16
 Identities = 67/232 (28%), Positives = 102/232 (43%), Gaps = 45/232 (19%)

Query: 509 KNKLGEGGFGPVYKGVLIEGQE-----------------IAAKRL-SKSSGQGMEEFENE 550
           K KLGEG FG V+   ++  Q+                 +A K L   ++     +F  E
Sbjct: 10  KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKE 69

Query: 551 VLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLD--------- 601
           V ++++L+  N+++L+G C   D   +I EY+ N  LN F+     S  LD         
Sbjct: 70  VKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL----SSHHLDDKEENGNDA 125

Query: 602 -----------WSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDF 650
                      +S    +   IA G+ YL   S L  +HRDL   N L+   +  KI+DF
Sbjct: 126 VPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADF 182

Query: 651 GMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
           GM+R            R V    +M  E  + G F+  SDV++FGV + EI+
Sbjct: 183 GMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 81.1 bits (200), Expect = 2e-16
 Identities = 65/199 (32%), Positives = 98/199 (49%), Gaps = 15/199 (7%)

Query: 512 LGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFE-----NEVLLIAKLQHRNLVKL 565
           LG+G FG V    L E G+  A K L K      ++ E       +L +A+  H  L +L
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 61

Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 625
             CC Q  +R+       N    D +F + +S+  D ++       I   L++LH     
Sbjct: 62  Y-CCFQTPDRLFFVMEFVNGG--DLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG-- 116

Query: 626 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF 685
            II+RDLK  NVLLD+E + K++DFGM +  GI      T+   GT  Y+ PE   + L+
Sbjct: 117 -IIYRDLKLDNVLLDHEGHCKLADFGMCKE-GI-FNGKTTSTFCGTPDYIAPEILQEMLY 173

Query: 686 SVKSDVFSFGVLVLEIVCG 704
               D ++ GVL+ E++CG
Sbjct: 174 GPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 29/210 (13%)

Query: 512 LGEGGFGPVYKGVLIE-GQEIAAKRL-----SKSSGQGMEEFENEVLLIAKLQHRNLVKL 565
           LG+G FG VY     + G+E+A K++     S  + + +   E E+ L+  L H  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 566 IGCCTQRDERML--IYEYLPNKSLND-------FIFDVTRSKFLDWSKRCQIIGGIARGL 616
            GC     ER L    E++P  S+ D          +VTR     ++++      I  G+
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRK----YTRQ------ILEGV 119

Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQTEANTNRVVGTYGYM 675
            YLH +    I+HRD+K +N+L D+  N K+ DFG ++    I  +      V GT  +M
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWM 176

Query: 676 PPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
            PE      +  K+D++S G  V+E++  K
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 74/278 (26%), Positives = 124/278 (44%), Gaps = 31/278 (11%)

Query: 505 NFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS---KSSGQGMEEFENEVLLIAKLQHR 560
           NF  + K+G G F  VY+   L++G  +A K++        +   +   E+ L+ +L H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLD-----WSKRCQIIGGIARG 615
           N++K      + +E  ++ E      L+  I    + K L      W    Q+   +   
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE-- 120

Query: 616 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYM 675
               H  SR R++HRD+K +NV +      K+ D G+ R F    T A++  +VGT  YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173

Query: 676 PPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 735
            PE   +  ++ KSD++S G L+ E+        FY         G    L+   + +E 
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM--AALQSPFY---------GDKMNLYSLCKKIEQ 222

Query: 736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
            +     S   SE LR  Q+  +C+   PE RP+++ V
Sbjct: 223 CDYPPLPSDHYSEELR--QLVNMCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 79.6 bits (196), Expect = 2e-16
 Identities = 57/191 (29%), Positives = 91/191 (47%), Gaps = 13/191 (6%)

Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ 571
           +G+G FG V  G    G ++A K +   +    + F  E  ++ +L+H NLV+L+G   +
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 572 RDERMLIY-EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 630
               + I  EY+   SL D++    RS  L      +    +   + YL  ++    +HR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126

Query: 631 DLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSD 690
           DL A NVL+  +   K+SDFG+ +     Q             +  PE   +  FS KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKFSTKSD 181

Query: 691 VFSFGVLVLEI 701
           V+SFG+L+ EI
Sbjct: 182 VWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 79.7 bits (196), Expect = 3e-16
 Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 15/206 (7%)

Query: 506 FSDKNKLGEGGFGPV------YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH 559
           F     LG+GGFG V        G +   +++  KR+ K  G+ M   E ++L   K+  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQIL--EKVNS 59

Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
           R +V L      +D   L+   +    L   I+ +  + F +  +       I  GL  L
Sbjct: 60  RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGF-EEGRAVFYAAEICCGLEDL 118

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           HQ+   RI++RDLK  N+LLD+  + +ISD G+A      QT       VGT GYM PE 
Sbjct: 119 HQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGYMAPEV 172

Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCGK 705
             +  ++   D ++ G L+ E++ G+
Sbjct: 173 VKNERYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 80.4 bits (198), Expect = 3e-16
 Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 36/218 (16%)

Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVL------LIAKLQ------- 558
           LGEG FG V   V+ E   I   + +K     ++  +++        L+++++       
Sbjct: 20  LGEGCFGQV---VMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK 76

Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWS-KRCQIIG------- 610
           H+N++ L+G CTQ     ++ EY    +L +++    R   +D+S   C++         
Sbjct: 77  HKNIINLLGACTQDGPLYVLVEYASKGNLREYL-RARRPPGMDYSFDTCKLPEEQLTFKD 135

Query: 611 ------GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGIDQTEA 663
                  +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    ID  + 
Sbjct: 136 LVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK 192

Query: 664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
            TN  +    +M PE   D +++ +SDV+SFGVL+ EI
Sbjct: 193 TTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 79.0 bits (194), Expect = 4e-16
 Identities = 83/299 (27%), Positives = 139/299 (46%), Gaps = 69/299 (23%)

Query: 512 LGEGGFGPVYKGVLI-EGQEI-AAKRLSK--SSGQGMEEFENEVLLIAKL-QHRNLVKLI 566
           +GEG FG V K  +  +G  + AA +  K  +S     +F  E+ ++ KL  H N++ L+
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLD--------------WSKR--CQIIG 610
           G C  R    L  EY P+ +L DF+    +S+ L+               S +       
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVG 670
            +ARG+ YL   S+ + IHRDL A N+L+      KI+DFG++R   +         V  
Sbjct: 120 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--------YVKK 168

Query: 671 TYGYMPPEY-AIDGL----FSVKSDVFSFGVLVLEIV-------CGKRNRGFYHADHHHN 718
           T G +P  + AI+ L    ++  SDV+S+GVL+ EIV       CG      Y       
Sbjct: 169 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK----- 223

Query: 719 LLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 777
            L   +RL   E+P+   ++       + +++R       C +++P +RP+ + +++ L
Sbjct: 224 -LPQGYRL---EKPLNCDDE-------VYDLMR------QCWREKPYERPSFAQILVSL 265

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 78.6 bits (194), Expect = 5e-16
 Identities = 59/198 (29%), Positives = 96/198 (48%), Gaps = 12/198 (6%)

Query: 509 KNKLGEGGFGPVYKGVLI--EGQEIA-AKRLSK--SSGQGMEEFENEVLLIAKLQHRNLV 563
              +GEG FG VY+GV +  E ++IA A +  K  +S    E+F  E  ++ +  H ++V
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           KLIG  T+ +   ++ E  P   L  ++        LD +        ++  L YL    
Sbjct: 71  KLIGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES-- 125

Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
             R +HRD+ A NVL+ +    K+ DFG++R    D++    ++      +M PE     
Sbjct: 126 -KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPESINFR 183

Query: 684 LFSVKSDVFSFGVLVLEI 701
            F+  SDV+ FGV + EI
Sbjct: 184 RFTSASDVWMFGVCMWEI 201

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 78.1 bits (192), Expect = 6e-16
 Identities = 60/195 (30%), Positives = 97/195 (49%), Gaps = 13/195 (6%)

Query: 511 KLGEGGFGPVYKGVL-IEGQEIAAKRLSKSSGQGME-EFENEVLLIAKLQHRNLVKLIGC 568
           ++G G FG V+ G L  +   +A K   ++    ++ +F  E  ++ +  H N+V+LIG 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 569 CTQRDERMLIYEYLPNKSLNDFI-FDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI 627
           CTQ+    ++ E +      DF+ F  T    L   +  Q++   A G+ YL        
Sbjct: 62  CTQKQPIYIVMELVQG---GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---C 115

Query: 628 IHRDLKASNVLLDNEMNPKISDFGMAR--AFGIDQTEANTNRVVGTYGYMPPEYAIDGLF 685
           IHRDL A N L+  +   KISDFGM+R    G+  +     ++     +  PE    G +
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI--PVKWTAPEALNYGRY 173

Query: 686 SVKSDVFSFGVLVLE 700
           S +SDV+SFG+L+ E
Sbjct: 174 SSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 78.1 bits (192), Expect = 7e-16
 Identities = 62/200 (31%), Positives = 105/200 (52%), Gaps = 21/200 (10%)

Query: 511 KLGEGGFGPVYKGVL--IEGQEIAAKRLSKSSGQG---MEEFENEVLLIAKLQHRNLVKL 565
           +LG G FG V KG+    + ++  A ++ K+        +E   E  ++ +L +  +V++
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 625
           IG C + +  ML+ E      LN F+    ++K +      +++  ++ G+ YL + +  
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN-- 115

Query: 626 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE-YAIDGL 684
             +HRDL A NVLL  +   KISDFG+++A G D+          T+G  P + YA + +
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK----THGKWPVKWYAPECM 170

Query: 685 ----FSVKSDVFSFGVLVLE 700
               FS KSDV+SFGVL+ E
Sbjct: 171 NYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 78.1 bits (192), Expect = 7e-16
 Identities = 71/278 (25%), Positives = 125/278 (44%), Gaps = 31/278 (11%)

Query: 505 NFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS---KSSGQGMEEFENEVLLIAKLQHR 560
           NF  + K+G G F  VY+   L++ + +A K++        +  ++   E+ L+ +L H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLD-----WSKRCQIIGGIARG 615
           N++K +    + +E  ++ E      L+  I    + K L      W    Q+   +   
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE-- 120

Query: 616 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYM 675
               H  SR R++HRD+K +NV +      K+ D G+ R F    T A++  +VGT  YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173

Query: 676 PPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 735
            PE   +  ++ KSD++S G L+ E+        FY      NL     ++   + P   
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAA--LQSPFY--GDKMNLFSLCQKIEQCDYP--- 226

Query: 736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
               L   +  SE LR  ++  +C+   P+ RP++  V
Sbjct: 227 ---PLPTEH-YSEKLR--ELVSMCIYPDPDQRPDIGYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 78.1 bits (192), Expect = 8e-16
 Identities = 64/204 (31%), Positives = 103/204 (50%), Gaps = 17/204 (8%)

Query: 509 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFE-NEVL-------LIAKLQHR 560
           + +LG+G FG VY  ++ + + +A +RL       + E   NE +       L++KL H 
Sbjct: 5   QQRLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62

Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRS-KFLDWSKRCQIIGGIARGLLYL 619
            +VK      +RD   +I EY   + L+  + ++  + K L  ++ C+    +  G+ Y+
Sbjct: 63  AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           HQ    RI+HRDLKA N+ L N +  KI DFG++R        A T    GT  YM PE 
Sbjct: 123 HQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEA 176

Query: 680 AIDGLFSVKSDVFSFGVLVLEIVC 703
                +  KSD++S G ++ E+ C
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEMCC 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 78.1 bits (192), Expect = 8e-16
 Identities = 71/280 (25%), Positives = 130/280 (46%), Gaps = 38/280 (13%)

Query: 505 NFSDKNKLGEGGFGPVYKGVLIEGQE------IAAKRLSKSSGQGMEEFENEVLLIAKLQ 558
            +    K+GEG FG +Y   L + +       I    L+K   +  E  + EV+L+AK++
Sbjct: 1   RYEIIKKIGEGSFGKIY---LAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMK 57

Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARG 615
           H N+V       +     ++ EY       D +  + R + + +S+  QI+     I+ G
Sbjct: 58  HPNIVTFFASFQENGRLFIVMEYCDG---GDLMKRINRQRGVLFSED-QILSWFVQISLG 113

Query: 616 LLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGY 674
           L ++H     +I+HRD+K+ N+ L  N M  K+ DFG+AR        A T   VGT  Y
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPYY 168

Query: 675 MPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE 734
           + PE   +  ++ K+D++S G ++ E+   K     +  ++ H L+    + +    P+ 
Sbjct: 169 LSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP---FEGNNLHQLVLKICQGYFA--PI- 222

Query: 735 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 774
               S   S  L  ++  +       +  P DRP+++S++
Sbjct: 223 ----SPNFSRDLRSLISQL------FKVSPRDRPSITSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 78.9 bits (194), Expect = 8e-16
 Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 36/218 (16%)

Query: 512 LGEGGFGPVYKGVLIEG-----------QEIAAKRL-SKSSGQGMEEFENEVLLIAKL-Q 558
           LGEG FG V   V+ E             ++A K L S ++ + + +  +E+ ++  + +
Sbjct: 26  LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82

Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG-------- 610
           H+N++ L+G CTQ     +I EY    +L +++    R   +++      +         
Sbjct: 83  HKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYCYNPTQVPEEQLSFKD 141

Query: 611 ------GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQTEA 663
                  +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    ID  + 
Sbjct: 142 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 198

Query: 664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
            TN  +    +M PE   D +++ +SDV+SFGVL+ EI
Sbjct: 199 TTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 78.1 bits (192), Expect = 1e-15
 Identities = 54/196 (27%), Positives = 97/196 (49%), Gaps = 10/196 (5%)

Query: 511 KLGEGGFGPV-YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
           K+GEG  G V        G+++A K +     Q  E   NEV+++   QH+N+V++    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
              +E  ++ E+L   +L D +        L+  +   +   + + L YLH      +IH
Sbjct: 88  LVGEELWVLMEFLQGGALTDIVSQTR----LNEEQIATVCESVLQALCYLHSQG---VIH 140

Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 689
           RD+K+ ++LL  +   K+SDFG       D  +  +  +VGT  +M PE      +  + 
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTEV 198

Query: 690 DVFSFGVLVLEIVCGK 705
           D++S G++V+E+V G+
Sbjct: 199 DIWSLGIMVIEMVDGE 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 30/218 (13%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRL-SKSSGQGMEEFENEVLLIAKLQH-R 560
           E+  D  ++G G FG V K +    G  +A KR+ S    +  +    ++ ++ +     
Sbjct: 4   EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCP 63

Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF---IFDVTRSKFLDWSKRCQIIGGIA---- 613
            +VK  G    R+    I   L + SL+ F   +++V +S   +     +I+G IA    
Sbjct: 64  YIVKFYGA-LFREGDCWICMELMDISLDKFYKYVYEVLKSVIPE-----EILGKIAVATV 117

Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GIDQTEANTNRVVGT 671
           + L YL ++  L+IIHRD+K SN+LLD   N K+ DFG++      I +T     R  G 
Sbjct: 118 KALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKT-----RDAGC 170

Query: 672 YGYMPPE----YAIDGLFSVKSDVFSFGVLVLEIVCGK 705
             YM PE     A DG + V+SDV+S G+ + E+  GK
Sbjct: 171 RPYMAPERIDPSARDG-YDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 77.7 bits (191), Expect = 1e-15
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 27/210 (12%)

Query: 511 KLGEGGFGPVYKGV---LIEGQ---EIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLV 563
           +LG+G FG VY+G    +I+G+    +A K +++S S +   EF NE  ++      ++V
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--------CQIIGGIARG 615
           +L+G  ++    +++ E + +  L  ++  + R +  +   R         Q+   IA G
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSL-RPEAENNPGRPPPTLQEMIQMAAEIADG 131

Query: 616 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT---- 671
           + YL+     + +HRDL A N ++ ++   KI DFGM R    D  E +  R  G     
Sbjct: 132 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 184

Query: 672 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
             +M PE   DG+F+  SD++SFGV++ EI
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 77.6 bits (192), Expect = 2e-15
 Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 32/217 (14%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAA-KRLSKSSGQGMEEF------ENEVLLIAK 556
           + +   N++ EG +G VY+    +  EI A K+L        E F      E  +LL  K
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKE--KEGFPITSLREINILL--K 60

Query: 557 LQHRNLVKL--IGCCTQRDERMLIYEYLPN--KSLNDFIFDVTRSKFLDWSKRC---QII 609
           LQH N+V +  +   +  D+  ++ EY+ +  KSL     +  +  FL    +C   Q++
Sbjct: 61  LQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSL----METMKQPFLQSEVKCLMLQLL 116

Query: 610 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV 669
            G+A    +LH +    I+HRDLK SN+LL+N    KI DFG+AR +G    +  T  VV
Sbjct: 117 SGVA----HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKPYTQLVV 168

Query: 670 GTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGK 705
            T  Y  PE  +    +S   D++S G +  E++  K
Sbjct: 169 -TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 77.7 bits (191), Expect = 2e-15
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 19/209 (9%)

Query: 504 ENFSDKNKLGEGGFGPVYKGV------LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKL 557
           E +    KLGEG +  V+KG       L+  +EI   RL    G        EV L+  L
Sbjct: 6   ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIR-EVSLLKDL 61

Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +H N+V L           L++EYL +K L  ++ D      +        +  I RGL 
Sbjct: 62  KHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDC--GNIMSMHNVKIFLYQILRGLA 118

Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           Y H   R +++HRDLK  N+L++     K++DFG+ARA  +  T+  +N VV T  Y PP
Sbjct: 119 YCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSV-PTKTYSNEVV-TLWYRPP 173

Query: 678 EYAI-DGLFSVKSDVFSFGVLVLEIVCGK 705
           +  +    +S + D++  G +  E+  G+
Sbjct: 174 DVLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 58/210 (27%), Positives = 90/210 (42%), Gaps = 36/210 (17%)

Query: 515 GGFGPVY---KGVLIEGQEIAAKRLSKSSGQGMEEF-----ENEVLLIAKLQHRNLVKLI 566
           G +G V+   K     G   A K + K+      +      E ++L   + Q   +VKL 
Sbjct: 4   GAYGRVFLAKKK--STGDIYAIKVIKKADMIRKNQVDQVLTERDILS--QAQSPYVVKLY 59

Query: 567 GCCTQRDERM-LIYEYLPN---KSLNDFI--FDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
               Q  + + L+ EYLP     SL + +   D   ++          I  I   L YLH
Sbjct: 60  -YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARI--------YIAEIVLALEYLH 110

Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFG------MARAFGIDQTEANTNRVVGTYGY 674
                 IIHRDLK  N+L+D+  + K++DFG      + R   ++  E    R+VGT  Y
Sbjct: 111 S---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167

Query: 675 MPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           + PE  +    S   D +S G ++ E + G
Sbjct: 168 IAPEVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 77.8 bits (192), Expect = 2e-15
 Identities = 58/193 (30%), Positives = 96/193 (49%), Gaps = 41/193 (21%)

Query: 510 NKLGEGGFGPVYKGVLIEGQEIAA-KRLSKSSGQGMEEFE----NEVLLIAKLQHRNLVK 564
            K+G+G FG V+K    + ++I A K++        E F      E+ ++  L+H N+V 
Sbjct: 18  AKIGQGTFGEVFKARHKKTKQIVALKKVLM--ENEKEGFPITALREIKILQLLKHENVVN 75

Query: 565 LIGCCTQ--------RDERMLIYEY--------LPNKSLNDFIFDVTRSKFLDWSKRCQI 608
           LI  C          +    L++E+        L NK++    F ++  K        ++
Sbjct: 76  LIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK---FTLSEIK--------KV 124

Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN---T 665
           +  +  GL Y+H   R +I+HRD+KA+N+L+  +   K++DFG+ARAF + +       T
Sbjct: 125 MKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181

Query: 666 NRVVGTYGYMPPE 678
           NRVV T  Y PPE
Sbjct: 182 NRVV-TLWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 77.0 bits (189), Expect = 3e-15
 Identities = 55/196 (28%), Positives = 99/196 (50%), Gaps = 10/196 (5%)

Query: 511 KLGEGGFGPV-YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
           K+GEG  G V    V   G+ +A K++     Q  E   NEV+++   QH N+V++    
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
              DE  ++ E+L   +L D    VT ++ ++  +   +   + + L  LH      +IH
Sbjct: 87  LVGDELWVVMEFLEGGALTDI---VTHTR-MNEEQIAAVCLAVLKALSVLHAQG---VIH 139

Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 689
           RD+K+ ++LL ++   K+SDFG      + +       +VGT  +M PE      +  + 
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197

Query: 690 DVFSFGVLVLEIVCGK 705
           D++S G++V+E+V G+
Sbjct: 198 DIWSLGIMVIEMVDGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 77.0 bits (189), Expect = 3e-15
 Identities = 54/196 (27%), Positives = 98/196 (50%), Gaps = 10/196 (5%)

Query: 511 KLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
           K+GEG  G V        G+++A K++     Q  E   NEV+++    H N+V +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
              DE  ++ E+L   +L D    VT ++ ++  +   +   + R L YLH      +IH
Sbjct: 89  LVGDELWVVMEFLEGGALTDI---VTHTR-MNEEQIATVCLSVLRALSYLHNQG---VIH 141

Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 689
           RD+K+ ++LL ++   K+SDFG      + +       +VGT  +M PE      +  + 
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQ--VSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199

Query: 690 DVFSFGVLVLEIVCGK 705
           D++S G++V+E++ G+
Sbjct: 200 DIWSLGIMVIEMIDGE 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 76.6 bits (188), Expect = 3e-15
 Identities = 55/197 (27%), Positives = 102/197 (51%), Gaps = 13/197 (6%)

Query: 511 KLGEGGFGPVYKGVLIEGQEIAA-KRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
           +LG+G FG VYK    E   +AA K +   S + +E++  E+ ++A   H N+VKL+   
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
              +   ++ E+    +++  + ++ R   L   +   +       L YLH++   +IIH
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLELERP--LTEPQIRVVCKQTLEALNYLHEN---KIIH 126

Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI-----DGL 684
           RDLKA N+L   + + K++DFG++      +T    +  +GT  +M PE  +     D  
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKN--TRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184

Query: 685 FSVKSDVFSFGVLVLEI 701
           +  K+DV+S G+ ++E+
Sbjct: 185 YDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 75.9 bits (187), Expect = 6e-15
 Identities = 77/311 (24%), Positives = 137/311 (44%), Gaps = 68/311 (21%)

Query: 499 IANATENFSDKNKLGEGGFGPVYKGVLIEG-----QEIAAKRLSKSSGQ-GMEEFENEVL 552
           IA + +  +  + L EG FG ++ G+LI+      +E+  K +   + +  +     E  
Sbjct: 1   IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60

Query: 553 LIAKLQHRNLVKLIGCCTQRDER-MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG 611
           L+  L H+N++ ++  C +  E   ++Y Y+   +L  F+            ++C++   
Sbjct: 61  LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFL------------QQCRLGEA 108

Query: 612 -----------------IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 654
                            IA G+ YLH   +  +IH+D+ A N ++D E+  KI+D  ++R
Sbjct: 109 NNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSR 165

Query: 655 -AFGIDQ--TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFY 711
             F +D      N NR V    +M  E  ++  +S  SDV+SFGVL+ E++         
Sbjct: 166 DLFPMDYHCLGDNENRPV---KWMALESLVNKEYSSASDVWSFGVLLWELMT-------- 214

Query: 712 HADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRC----IQVGLLCVQQRPEDR 767
                   LG     ++E  P E+      G Y L++ + C      V   C    PE+R
Sbjct: 215 --------LGQT--PYVEIDPFEMAAYLKDG-YRLAQPINCPDELFAVMACCWALDPEER 263

Query: 768 PNMSSVVLMLS 778
           P+ S +V  L+
Sbjct: 264 PSFSQLVQCLT 274

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 75.1 bits (185), Expect = 9e-15
 Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 18/208 (8%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEE--FENEVLLIAKLQHR 560
           E + +   +GEG +G V K    E GQ +A K+  +S    M +     E+ ++ +L+H 
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKF---LDWSKRCQIIGGIARGLL 617
           NLV LI    ++    L++E++ +  L+D        K+   LD S+  + +  I RG+ 
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDHTVLDDL------EKYPNGLDESRVRKYLFQILRGIE 114

Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           + H  +   IIHRD+K  N+L+      K+ DFG AR       E  T+  V T  Y  P
Sbjct: 115 FCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTD-YVATRWYRAP 169

Query: 678 EYAI-DGLFSVKSDVFSFGVLVLEIVCG 704
           E  + D  +    D+++ G LV E++ G
Sbjct: 170 ELLVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 74.9 bits (185), Expect = 1e-14
 Identities = 52/148 (35%), Positives = 74/148 (50%), Gaps = 10/148 (6%)

Query: 511 KLGEGGFGPVYKGVLIEGQEIAA-KRLSKSSGQGMEEFEN--EVLLIAKLQ-HRNLVKLI 566
           +LG+G FG VY     E  E+ A K++ K      EE  N  EV  + KL  H N+VKL 
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKF-YSWEECMNLREVKSLRKLNEHPNIVKLK 64

Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 626
               + DE   ++EY+   +L   + D     F +   R  II  I +GL ++H   +  
Sbjct: 65  EVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIR-SIIYQILQGLAHIH---KHG 119

Query: 627 IIHRDLKASNVLLDNEMNPKISDFGMAR 654
             HRDLK  N+L+      KI+DFG+AR
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 68/203 (33%), Positives = 97/203 (47%), Gaps = 21/203 (10%)

Query: 512 LGEGGFGPVYKGVLIEGQEI-AAKRLSKS---SGQGMEEFENE--VLLIAKLQHRNLVKL 565
           LG+G FG V    L    E+ A K L K        +E    E  VL +A  +H  L +L
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFLTQL 61

Query: 566 IGCCTQRDERM-LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
              C Q  +R+  + EY+      D +F + RS   D  +       I  GL +LH+   
Sbjct: 62  H-SCFQTKDRLFFVMEYVNG---GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG- 116

Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI--DQTEANTNRVVGTYGYMPPEYAID 682
             II+RDLK  NVLLD+E + KI+DFGM +  GI    T   T+   GT  Y+ PE    
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKIADFGMCKE-GILGGVT---TSTFCGTPDYIAPEILSY 170

Query: 683 GLFSVKSDVFSFGVLVLEIVCGK 705
             +    D ++ GVL+ E++ G+
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 74.1 bits (182), Expect = 2e-14
 Identities = 75/281 (26%), Positives = 126/281 (44%), Gaps = 34/281 (12%)

Query: 512 LGEGGFGPVYK-------GVLIEGQEI-----AAKRLSKSSGQGMEEFENEVLLIAK-LQ 558
           LG G FG VYK         L+  +EI     A  +  +   + + +  +EV +I + L+
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC-QIIGGIARGLL 617
           H N+V+      + D   ++ + +    L +    +   K     +R   I   +   L 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           YLH++ R  I+HRDL  +N++L  +    I+DFG+A+     Q E+    VVGT  Y  P
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQ---KQPESKLTSVVGTILYSCP 182

Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 737
           E   +  +  K+DV++FG ++ ++        FY      N+L  A +  I E   E + 
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMC--TLQPPFYST----NMLSLATK--IVEAVYEPLP 234

Query: 738 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 778
           +   G YS  +V   I     C+    E RP++  V  M+S
Sbjct: 235 E---GMYS-EDVTDVITS---CLTPDAEARPDIIQVSAMIS 268

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 74.4 bits (183), Expect = 2e-14
 Identities = 41/105 (39%), Positives = 64/105 (60%), Gaps = 10/105 (9%)

Query: 605 RCQIIGGIA----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 660
             +I+G IA     GL YL+  +  RI+HRD+K SN+L+++    K+ DFG++    +  
Sbjct: 101 PVEILGKIAVAVVEGLTYLY--NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGE--LIN 156

Query: 661 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           + A+T   VGT  YM PE    G ++VKSDV+S G+ ++E+  GK
Sbjct: 157 SIADT--FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 74.3 bits (183), Expect = 3e-14
 Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 34/217 (15%)

Query: 505 NFSDKNKLGEGGFGPVYKGVLIEGQEIAA-KRLSKSSGQGMEEFEN--------EVLLIA 555
            F   N++GEG +G VY+       EI A K++       M+   +        E+ L+ 
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVR------MDNERDGIPISSLREITLLL 61

Query: 556 KLQHRNLVKLIGCCT--QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA 613
            L+H N+V+L         D   L+ EY   + L   + ++    F +   +C ++  + 
Sbjct: 62  NLRHPNIVELKEVVVGKHLDSIFLVMEYC-EQDLASLLDNMPTP-FSESQVKC-LMLQLL 118

Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
           RGL YLH++    IIHRDLK SN+LL ++   KI+DFG+AR +G+      T +VV T  
Sbjct: 119 RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM-TPKVV-TLW 173

Query: 674 YMPPEYAIDGLFSVKS-----DVFSFGVLVLEIVCGK 705
           Y  PE     L    +     D+++ G ++ E++  K
Sbjct: 174 YRAPEL----LLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 17/201 (8%)

Query: 512 LGEGGFGPV------YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKL 565
           LG+GGFG V        G +   +++  KR+ K  G+ M    NE  ++ K+  R +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL--NEKRILEKVNSRFVVSL 65

Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 625
                 +D   L+   +    L   I+++    F D  +       +  GL  L ++   
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF-DEQRAIFYAAELCCGLEDLQRE--- 121

Query: 626 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR-VVGTYGYMPPEYAIDGL 684
           RI++RDLK  N+LLD+  + +ISD G+A    +   E  T R  VGT GYM PE   +  
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLA----VQIPEGETVRGRVGTVGYMAPEVINNEK 177

Query: 685 FSVKSDVFSFGVLVLEIVCGK 705
           ++   D +  G L+ E++ G+
Sbjct: 178 YTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 73.3 bits (180), Expect = 4e-14
 Identities = 63/201 (31%), Positives = 97/201 (48%), Gaps = 17/201 (8%)

Query: 512 LGEGGFGPV------YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKL 565
           LG+GGFG V        G +   +++  KR+ K  G+ M    NE  ++ K+  R +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL--NEKQILEKVNSRFVVSL 65

Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG-IARGLLYLHQDSR 624
                 +D   L+   +    L   I+++    F +  +R       I  GL  LH   R
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDE--ERAVFYAAEITCGLEDLH---R 120

Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 684
            RI++RDLK  N+LLD+  + +ISD G+  A  I + E    R VGT GYM PE   +  
Sbjct: 121 ERIVYRDLKPENILLDDYGHIRISDLGL--AVEIPEGETIRGR-VGTVGYMAPEVVKNER 177

Query: 685 FSVKSDVFSFGVLVLEIVCGK 705
           ++   D +  G L+ E++ GK
Sbjct: 178 YTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 73.1 bits (179), Expect = 6e-14
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 15/206 (7%)

Query: 506 FSDKNKLGEGGFGPV------YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH 559
           F     LG+GGFG V        G +   + +  KR+ K  G+ M   E ++L   K+  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQIL--EKVNS 59

Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
           + +V L      +D   L+   +    L   I+++    F +  +       I  GL  L
Sbjct: 60  QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF-EEERALFYAAEILCGLEDL 118

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H+++    ++RDLK  N+LLD+  + +ISD G+  A  I + E+   R VGT GYM PE 
Sbjct: 119 HREN---TVYRDLKPENILLDDYGHIRISDLGL--AVKIPEGESIRGR-VGTVGYMAPEV 172

Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCGK 705
             +  +++  D +  G L+ E++ G+
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 73.5 bits (180), Expect = 6e-14
 Identities = 61/201 (30%), Positives = 93/201 (46%), Gaps = 17/201 (8%)

Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEE------FENEVLLIAKLQHRNLVKL 565
           LG+G FG V+   L    +  A +  K     M++       E  VL +A  +H  L  L
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTHL 61

Query: 566 IGCCTQRDERML-IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
             C  Q  E +  + EYL      D +F +      D  +       I  GL +LH    
Sbjct: 62  Y-CTFQTKENLFFVMEYLNG---GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG- 116

Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 684
             I++RDLK  N+LLD + + KI+DFGM +   +   +A T    GT  Y+ PE  +   
Sbjct: 117 --IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAKTCTFCGTPDYIAPEILLGQK 172

Query: 685 FSVKSDVFSFGVLVLEIVCGK 705
           ++   D +SFGVL+ E++ G+
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 72.9 bits (179), Expect = 8e-14
 Identities = 67/206 (32%), Positives = 96/206 (46%), Gaps = 27/206 (13%)

Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEE------FENEVLLIAKLQHRNLVKL 565
           LG+G FG V    L    E  A +  K      ++       E  VL +A  +H  L  L
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW-EHPFLTHL 61

Query: 566 IGCCTQRDERML-IYEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIARGLLYL 619
             C  Q  E +  + EYL    L   I     FD  R++F       +II G    L +L
Sbjct: 62  F-CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYA----AEIICG----LQFL 112

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H+     II+RDLK  NVLLD + + KI+DFGM +     + +A+T    GT  Y+ PE 
Sbjct: 113 HKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYIAPEI 167

Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCGK 705
                ++   D +SFGVL+ E++ G+
Sbjct: 168 LKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 72.7 bits (179), Expect = 8e-14
 Identities = 53/191 (27%), Positives = 87/191 (45%), Gaps = 35/191 (18%)

Query: 511 KLGEGGFGPVYKGVLIE---GQEIAAKRL--SKSSGQGMEEFE-NEVLLIAKLQHRNLVK 564
            +G G +G VYK        G+E A K+    K    G+ +    E+ L+ +L+H N+V 
Sbjct: 7   CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66

Query: 565 LIGCCTQRDERM--LIYEYLPNKSLNDF--IFDVTRSKFLDWSKRCQIIGGIAR------ 614
           L+    +  ++   L+++Y    + +D   I    R      +KR  I   + +      
Sbjct: 67  LVEVFLEHADKSVYLLFDY----AEHDLWQIIKFHRQ-----AKRVSIPPSMVKSLLWQI 117

Query: 615 --GLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGID-QTEANTNR 667
             G+ YLH +    ++HRDLK +N+L+  E       KI D G+AR F    +  A+ + 
Sbjct: 118 LNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP 174

Query: 668 VVGTYGYMPPE 678
           VV T  Y  PE
Sbjct: 175 VVVTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 72.3 bits (177), Expect = 1e-13
 Identities = 63/220 (28%), Positives = 106/220 (48%), Gaps = 37/220 (16%)

Query: 502 ATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFE--NEVLLIAKLQ 558
           A  ++ +  KLGEG +  VYKG+  I GQ +A K +S  + +G+  F    E  L+  L+
Sbjct: 3   AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLK 61

Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGI------ 612
           H N+V             L+++ +  K    F+F+   +    +    Q  GG+      
Sbjct: 62  HANIV-------------LLHDIIHTKETLTFVFEYMHTDLAQY--MIQHPGGLHPYNVR 106

Query: 613 ------ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN 666
                  RGL Y+H      I+HRDLK  N+L+      K++DFG+ARA  I  ++  ++
Sbjct: 107 LFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSI-PSQTYSS 162

Query: 667 RVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
            VV T  Y PP+  +    +S   D++  G + +E++ G+
Sbjct: 163 EVV-TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 72.3 bits (178), Expect = 2e-13
 Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 51/218 (23%)

Query: 512 LGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN---------EVLLIAKLQHRN 561
           +G G +G V      + G+++A K+LS         F++         E+ L+  + H N
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKRTYRELRLLKHMDHEN 75

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVT-----------RSKFLDWSKRCQI 608
           ++ L+   T            P  SL DF  ++ VT           + + L       +
Sbjct: 76  VIGLLDVFT------------PASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFL 123

Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
           +  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T+      
Sbjct: 124 VYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDEMTGY 175

Query: 669 VGTYGYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCGK 705
           V T  Y  PE  ++ +   ++ D++S G ++ E++ GK
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 71.1 bits (174), Expect = 2e-13
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 22/208 (10%)

Query: 512 LGEGGFGPVYKGVLIE----GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKL 565
           LG+G FG V +  L       Q++A K L     S   +EEF  E   + +  H N++KL
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 566 IGCCTQRDER------MLIYEYLPNKSLNDFIF--DVTRSKF-LDWSKRCQIIGGIARGL 616
           IG   +   +      M+I  ++ +  L+ F+    +    F L      + +  IA G+
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126

Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GIDQTEANTNRVVGTYGY 674
            YL   S    IHRDL A N +L+  M   ++DFG+++    G    +   +++     +
Sbjct: 127 EYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL--PVKW 181

Query: 675 MPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
           +  E   D +++  SDV++FGV + EI+
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIM 209

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 27/213 (12%)

Query: 504 ENFSDKNKLGEGGFGPVYKG-VLIEGQEIAAK--RLSKSSGQGMEEFENEVLLIAKLQHR 560
           E +   +KLGEG +  V+KG   +    +A K  RL    G        EV L+  L+H 
Sbjct: 5   ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHA 63

Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA------- 613
           N+V L           L++EYL          D    ++LD       +  +        
Sbjct: 64  NIVTLHDIIHTERCLTLVFEYL----------DSDLKQYLDNCGNLMSMHNVKIFMFQLL 113

Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
           RGL Y H   + +I+HRDLK  N+L++ +   K++DFG+ARA  +  T+  +N VV T  
Sbjct: 114 RGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSV-PTKTYSNEVV-TLW 168

Query: 674 YMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           Y PP+  +    +S   D++  G ++ E+  G+
Sbjct: 169 YRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 73/272 (26%), Positives = 119/272 (43%), Gaps = 38/272 (13%)

Query: 512 LGEGGFGPVYKGVLIE----GQEIAAK--RLSKSSGQGMEEFENEVLLIAKLQHRNLVKL 565
           +GEG FG   + +L++     Q+ A K  RL KSS   +E+   E +L+AK++H N+V  
Sbjct: 8   VGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAF 63

Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 625
                      ++ EY     L   I    R K        Q    +  G+ ++H+    
Sbjct: 64  KESFEADGHLYIVMEYCDGGDLMQKIKL-QRGKLFPEDTILQWFVQMCLGVQHIHEK--- 119

Query: 626 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF 685
           R++HRD+K+ N+ L      K+ DFG AR        A T   VGT  Y+PPE   +  +
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMPY 177

Query: 686 SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYS 745
           + KSD++S G ++ E+   K           H    ++W+         LI K   GSY 
Sbjct: 178 NNKSDIWSLGCILYELCTLK-----------HPFQANSWK--------NLILKVCQGSYK 218

Query: 746 LSEVLRCIQVGLLCVQ---QRPEDRPNMSSVV 774
                   ++  L  Q   + P  RP+ ++++
Sbjct: 219 PLPSHYSYELRSLIKQMFKRNPRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 71.4 bits (176), Expect = 3e-13
 Identities = 65/244 (26%), Positives = 99/244 (40%), Gaps = 85/244 (34%)

Query: 506 FSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFEN---------EVLLIA 555
           +     +G G +G V   V    G+++A K++S         F++         E+ L+ 
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLR 54

Query: 556 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVT-----------RSK---- 598
            L+H N++ L+             + L   S  DF  ++ VT           +S     
Sbjct: 55  HLRHENIIGLL-------------DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLT 101

Query: 599 ------FLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM 652
                 FL      QI+    RGL YLH      +IHRDLK SN+L+++  + KI DFG+
Sbjct: 102 DDHIQYFL-----YQIL----RGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGL 149

Query: 653 ARAFGIDQTEAN--TNRVVGTYGYMPPE---------YAIDGLFSVKSDVFSFGVLVLEI 701
           AR    D+ E    T  VV T  Y  PE          AI        D++S G +  E+
Sbjct: 150 ARGVDPDEDEKGFLTEYVV-TRWYRAPELLLSSSRYTKAI--------DIWSVGCIFAEL 200

Query: 702 VCGK 705
           +  K
Sbjct: 201 LTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 70.5 bits (173), Expect = 4e-13
 Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 53/218 (24%)

Query: 511 KLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFEN-------EVLLIAKLQHRNL 562
           KLGEG +  VYKG   + GQ +A K +       +E  E        E  L+  L+H N+
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIR------LEHEEGAPFTAIREASLLKDLKHANI 65

Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDW--------SKRC---QIIGG 611
           V L      +    L++EYL          D    +++D         + R    Q++  
Sbjct: 66  VTLHDIIHTKKTLTLVFEYL----------DTDLKQYMDDCGGGLSMHNVRLFLFQLL-- 113

Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 671
             RGL Y HQ    R++HRDLK  N+L+      K++DFG+ARA  +  ++  +N VV T
Sbjct: 114 --RGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSV-PSKTYSNEVV-T 166

Query: 672 YGYMPPEYAIDGL-----FSVKSDVFSFGVLVLEIVCG 704
             Y PP    D L     +S   D++  G +  E+  G
Sbjct: 167 LWYRPP----DVLLGSTEYSTSLDMWGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 70.0 bits (171), Expect = 6e-13
 Identities = 59/223 (26%), Positives = 111/223 (49%), Gaps = 23/223 (10%)

Query: 511 KLGEGGFGPVYKGVLIE--GQEIAAKRLS-KSSGQGME-EFENEVLLIAKLQ---HRNLV 563
           ++GEG +G V+K   ++  G+ +A KR+  ++  +GM      EV ++  L+   H N+V
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 564 KLIGCCT-QRDER----MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           +L   CT  R +R     L++E++ ++ L  ++  V        + +  ++  + RGL +
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK-DMMFQLLRGLDF 125

Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           LH     R++HRDLK  N+L+ +    K++DFG+AR +     +     VV T  Y  PE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPE 179

Query: 679 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLG 721
             +   ++   D++S G +  E+    R +  +      + LG
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMF---RRKPLFRGSSDVDQLG 219

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 70.1 bits (171), Expect = 6e-13
 Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 13/205 (6%)

Query: 504 ENFSDKNKLGEGGFGPVYKG-VLIEGQEIAAK--RLSKSSGQGMEEFENEVLLIAKLQHR 560
           +++    KLGEG +  VYKG   + G+ +A K  RL +  G        E  L+  L+H 
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63

Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+V L      ++   L++EY+ +  L  ++         +  K    +  + RGL Y+H
Sbjct: 64  NIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVK--LFLFQLLRGLSYIH 120

Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
           Q     I+HRDLK  N+L+ +    K++DFG+ARA  +  +   +N VV T  Y PP+  
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVV-TLWYRPPDVL 175

Query: 681 IDGL-FSVKSDVFSFGVLVLEIVCG 704
           +    +S   D++  G + +E++ G
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 70.6 bits (173), Expect = 6e-13
 Identities = 55/242 (22%), Positives = 108/242 (44%), Gaps = 44/242 (18%)

Query: 497 MAIANATENFSDKNK-LGEGGFGPVYKGV-LIEGQEIAAKR--LSKSSGQGMEEFEN--- 549
               + +E +  K   LGEG +G V K    + G+ +A K+  + + S    ++ +    
Sbjct: 1   NMSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGM 60

Query: 550 ---------EVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPN---KSLNDFIFDVTRS 597
                    E+ ++ +++H N++ L+    + D   L+ + + +   K ++  I      
Sbjct: 61  CGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIR----- 115

Query: 598 KFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 657
              +   +C I+  I  GL  LH+      +HRDL  +N+ ++++   KI+DFG+AR +G
Sbjct: 116 -LTESQVKC-ILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYG 170

Query: 658 ID-------------QTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVC 703
                          + E  T++VV T  Y  PE  +    +    D++S G +  E++ 
Sbjct: 171 YPPYSDTLSKDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229

Query: 704 GK 705
           GK
Sbjct: 230 GK 231

Length = 335

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 69.0 bits (169), Expect = 7e-13
 Identities = 58/199 (29%), Positives = 87/199 (43%), Gaps = 21/199 (10%)

Query: 515 GGFGPVY--KGVLIEGQEIAAKRLSKSSGQGMEEFEN----EVLLIAKLQHRNLVKLIGC 568
           G FG VY  K     G   A K L KS      +  N      +++ + +   + KL   
Sbjct: 7   GAFGSVYLAKKRS-TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65

Query: 569 CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRII 628
              +D   L+ EYL        I         DW+   Q I  +  G+  LHQ     II
Sbjct: 66  FQSKDYLYLVMEYLNGGDCASLI-KTLGGLPEDWA--KQYIAEVVLGVEDLHQRG---II 119

Query: 629 HRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 688
           HRD+K  N+L+D   + K++DFG++R    ++      + VGT  Y+ PE  I G+   K
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYLAPE-TILGVGDDK 172

Query: 689 -SDVFSFGVLVLEIVCGKR 706
            SD +S G ++ E + G  
Sbjct: 173 MSDWWSLGCVIFEFLFGYP 191

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 69.4 bits (170), Expect = 8e-13
 Identities = 41/107 (38%), Positives = 61/107 (57%), Gaps = 15/107 (14%)

Query: 608 IIGGIA----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 663
           I+G IA    + L YLH  S+L +IHRD+K SNVL++     K+ DFG++  + +D   A
Sbjct: 104 ILGKIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS-GYLVDSV-A 159

Query: 664 NTNRVVGTYGYMPPEYAIDGL-----FSVKSDVFSFGVLVLEIVCGK 705
            T    G   YM PE  I+       + VKSDV+S G+ ++E+  G+
Sbjct: 160 KTID-AGCKPYMAPE-RINPELNQKGYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 73/280 (26%), Positives = 124/280 (44%), Gaps = 51/280 (18%)

Query: 511 KLGEGGFGPVYKGVLIEGQE------IAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
           K+GEG FG   K +L++ +E      I    +SK S +  EE   EV +++ ++H N+V+
Sbjct: 7   KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63

Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKF-----LDWSKRCQIIGGIARGLLYL 619
                 +     ++ +Y     L   I       F     LDW  +      I   L ++
Sbjct: 64  YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQ------ICLALKHV 117

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H     +I+HRD+K+ N+ L  +   K+ DFG+AR        A T   +GT  Y+ PE 
Sbjct: 118 HDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYYLSPEI 172

Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 739
             +  ++ KSD+++ G ++ E+   K      HA    N+               L+ K 
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLK------HAFEAGNM-------------KNLVLKI 213

Query: 740 LGGSY-----SLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 774
           + GSY       S  LR +   L   ++ P DRP+++S++
Sbjct: 214 IRGSYPPVSSHYSYDLRNLVSQLF--KRNPRDRPSVNSIL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 69.3 bits (169), Expect = 1e-12
 Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 17/219 (7%)

Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKL 557
           ++ + T+ +     +G+G +G VYK    +   +AA ++        EE E E  ++  L
Sbjct: 16  SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSL 75

Query: 558 -QHRNLVKLIGCCTQRDERM-----LIYEYLPNKSLNDFIFDVTR-SKFLDWSKRCQIIG 610
             H N+VK  G   + D+ +     L+ E     S+ + +  +    + LD +    I+ 
Sbjct: 76  PNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135

Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVG 670
           G   GL +LH +   RIIHRD+K +N+LL  E   K+ DFG++      +   NT+  VG
Sbjct: 136 GALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VG 190

Query: 671 TYGYMPPEY-----AIDGLFSVKSDVFSFGVLVLEIVCG 704
           T  +M PE        D  +  + DV+S G+  +E+  G
Sbjct: 191 TPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 68.7 bits (168), Expect = 2e-12
 Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 17/201 (8%)

Query: 512 LGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEEF-----ENEVLLIAKLQHRNLVKL 565
           LG+G FG V    L    E+ A K L K      ++      E  +L +A  +H  L  L
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTAL 61

Query: 566 IGCCTQRDERML-IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
             CC Q  +R+  + EY+      D +F + RS+  D  +       +   L++LH+   
Sbjct: 62  H-CCFQTKDRLFFVMEYVNG---GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG- 116

Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 684
             +I+RDLK  N+LLD E + K++DFGM +  GI      T    GT  Y+ PE   +  
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCKE-GILN-GVTTTTFCGTPDYIAPEILQELE 172

Query: 685 FSVKSDVFSFGVLVLEIVCGK 705
           +    D ++ GVL+ E++ G+
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 67.6 bits (165), Expect = 2e-12
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 24/207 (11%)

Query: 512 LGEGGFGPVYKGVL-IEGQE---IAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLI 566
           LG G FG + +G L +  +    +A   L    S +    F  E L + +  H N+V+L 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIF----DVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
           G  T+ +  M++ EY+ N +L+ F+      +   + +       ++ G+A G+ YL   
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMG------MLPGLASGMKYL--- 123

Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA--NTNRVVGTYGYMPPEYA 680
           S +  +H+ L A  VL+++++  KIS F   +    D++EA   T        +  PE  
Sbjct: 124 SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE---DKSEAIYTTMSGKSPVLWAAPEAI 180

Query: 681 IDGLFSVKSDVFSFGVLVLEIVC-GKR 706
               FS  SDV+SFG+++ E++  G+R
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMSYGER 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 68.8 bits (169), Expect = 2e-12
 Identities = 67/221 (30%), Positives = 106/221 (47%), Gaps = 46/221 (20%)

Query: 509 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFEN---------EVLLIAKL-Q 558
             KLG+G +G V+K +    +E+ A  L K      + F N         E++ + +L  
Sbjct: 12  LQKLGKGAYGIVWKAIDRRTKEVVA--LKKI----FDAFRNATDAQRTFREIMFLQELGD 65

Query: 559 HRNLVKLIGCCTQRDERM----LIYEYLPNKSLNDFIFDVTRSKFL-DWSKRCQIIGGIA 613
           H N+VKL+     + E      L++EY+    L+  I    R+  L D  KR  I+  + 
Sbjct: 66  HPNIVKLLN--VIKAENDKDIYLVFEYM-ETDLHAVI----RANILEDVHKRY-IMYQLL 117

Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV----V 669
           + L Y+H  S   +IHRDLK SN+LL+++   K++DFG+AR+   +  E   N V    V
Sbjct: 118 KALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLS-ELEENPENPVLTDYV 173

Query: 670 GTYGYMPPEYAIDGLFSVKS-----DVFSFGVLVLEIVCGK 705
            T  Y  PE     L          D++S G ++ E++ GK
Sbjct: 174 ATRWYRAPEI----LLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 68.5 bits (167), Expect = 3e-12
 Identities = 68/252 (26%), Positives = 114/252 (45%), Gaps = 41/252 (16%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQHR 560
           E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+  ++H 
Sbjct: 17  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76

Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--------- 607
           N++ L+   T            P +SL +F  ++ VT     D +   +CQ         
Sbjct: 77  NVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 124

Query: 608 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 667
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T+     
Sbjct: 125 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 176

Query: 668 VVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL 726
            V T  Y  PE  ++ + ++   D++S G ++ E++ G   R  +    H + L    RL
Sbjct: 177 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 233

Query: 727 WIEERPVELINK 738
            +     EL+ K
Sbjct: 234 -VGTPGAELLKK 244

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 68.2 bits (167), Expect = 4e-12
 Identities = 60/201 (29%), Positives = 91/201 (45%), Gaps = 21/201 (10%)

Query: 511 KLGEGGFGPVYKGVLIEGQEIAA-KRLSKSSGQGMEEF-----ENEVLLIAKLQHRNLVK 564
           ++G+GG+G V+     +  EI A KR+ KS    + E      E ++L   K     LVK
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK--SEWLVK 65

Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFL-DWSKRCQIIGGIARGLLYLHQDS 623
           L+      +   L  EY+P     DF   +     L +   R  +       +  LH   
Sbjct: 66  LLYAFQDDEYLYLAMEYVPG---GDFRTLLNNLGVLSEDHARFYMAEMFE-AVDALH--- 118

Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
            L  IHRDLK  N L+D   + K++DFG+++      T AN+  VVG+  YM PE     
Sbjct: 119 ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI---VTYANS--VVGSPDYMAPEVLRGK 173

Query: 684 LFSVKSDVFSFGVLVLEIVCG 704
            +    D +S G ++ E +CG
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 67.8 bits (166), Expect = 4e-12
 Identities = 61/208 (29%), Positives = 91/208 (43%), Gaps = 32/208 (15%)

Query: 512 LGEGGFGPV----YKGVLIEGQEIAAKRLSKSSGQGMEEFEN-----EVLLIA-KLQHRN 561
           LG G FG V    YK     G+  A K L K      +E E+      +   A   +H  
Sbjct: 7   LGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSL----NDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           LV L  C    D    + EY     L    +  +F   R+ F      C ++G     L 
Sbjct: 64  LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFY---AACVVLG-----LQ 115

Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGIDQTEANTNRVVGTYGYMP 676
           YLH++   +I++RDLK  N+LLD E   KI+DFG+ +   G       T+   GT  ++ 
Sbjct: 116 YLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR---TSTFCGTPEFLA 169

Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           PE   +  ++   D +  GVL+ E++ G
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 67.7 bits (165), Expect = 5e-12
 Identities = 65/220 (29%), Positives = 94/220 (42%), Gaps = 28/220 (12%)

Query: 512 LGEGGFGPVYKGVLI-EGQEIAAKRLSKS-----SGQGMEEFENEVLLIAKLQHRNLVKL 565
           LG+G FG V    L  +G+  A K L K              E  VL +A  ++  L  L
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALA-WENPFLTHL 61

Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
                 ++    + E+L    L   I     FD+ R+ F      C        GL +LH
Sbjct: 62  YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC--------GLQFLH 113

Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
                 II+RDLK  NV+LD + + KI+DFGM +        A+T    GT  Y+ PE  
Sbjct: 114 SKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST--FCGTPDYIAPEIL 168

Query: 681 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL 720
               ++   D +SFGVL+ E++ G+     +H D    L 
Sbjct: 169 QGLKYTFSVDWWSFGVLLYEMLIGQSP---FHGDDEDELF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 67.2 bits (165), Expect = 5e-12
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 41/210 (19%)

Query: 512 LGEGGFGPVYKGVLIEGQEI-AAKRLSKS----SGQGMEEFENEVLLIAKLQHRNLVKLI 566
           LG G FG V         +  A K LSK+      Q +E   NE  ++  ++H  LV L 
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLVNLY 67

Query: 567 GCCTQRDERML--IYEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIARGLLYL 619
           G  + +D+  L  + EY+P   L   +     F    ++F            +   L YL
Sbjct: 68  G--SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFY--------AAQVVLALEYL 117

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H    L I++RDLK  N+LLD++   KI+DFG A+     + +  T  + GT  Y+ PE 
Sbjct: 118 HS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPEYLAPE- 168

Query: 680 AIDGLFSVK-----SDVFSFGVLVLEIVCG 704
               +   K      D ++ G+L+ E++ G
Sbjct: 169 ----IILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 67.2 bits (164), Expect = 8e-12
 Identities = 53/169 (31%), Positives = 74/169 (43%), Gaps = 21/169 (12%)

Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 671
           +ARG+ +L   SR + IHRDL A N+LL      KI DFG+AR    D            
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 672 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEI--VCGKRNRGFYHADHHHNLLGHAWRLWIE 729
             +M PE   D +++ +SDV+SFGVL+ EI  +      G    +     L    R+   
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAP 298

Query: 730 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 778
           E             Y+  E+     + L C    PEDRP  S +V +L 
Sbjct: 299 E-------------YATPEIY---SIMLDCWHNNPEDRPTFSELVEILG 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 66.2 bits (162), Expect = 1e-11
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 22/203 (10%)

Query: 511 KLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN-------EVLLIAKLQHRNL 562
           K+GEG +G V+K    E GQ +A K+  +S     E+          E+ ++ +L+H NL
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVES-----EDDPVIKKIALREIRMLKQLKHPNL 62

Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
           V LI    ++ +  L++EY  +  LN+        + +      +II    + + + H+ 
Sbjct: 63  VNLIEVFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCHK- 118

Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI- 681
                IHRD+K  N+L+  +   K+ DFG AR   +     +    V T  Y  PE  + 
Sbjct: 119 --HNCIHRDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTDYVATRWYRAPELLVG 174

Query: 682 DGLFSVKSDVFSFGVLVLEIVCG 704
           D  +    DV++ G +  E++ G
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 66.6 bits (162), Expect = 1e-11
 Identities = 64/213 (30%), Positives = 101/213 (47%), Gaps = 24/213 (11%)

Query: 512 LGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFEN---EVLLIAKLQHRNLVK 564
           LG+G FG V   +L+     G+  A K L K      +E  +   E  ++   +H  L  
Sbjct: 3   LGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59

Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG-IARGLLYLHQDS 623
           L      +D    + EY+    L    F ++R +      R +  G  I   L YLH   
Sbjct: 60  LKYSFQTKDRLCFVMEYVNGGEL---FFHLSRERVFS-EDRTRFYGAEIVSALDYLHSG- 114

Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV-VGTYGYMPPEYAID 682
             +I++RDLK  N++LD + + KI+DFG+ +  GI  T+A T +   GT  Y+ PE   D
Sbjct: 115 --KIVYRDLKLENLMLDKDGHIKITDFGLCKE-GI--TDAATMKTFCGTPEYLAPEVLED 169

Query: 683 GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 715
             +    D +  GV++ E++CG+    FY+ DH
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 66.1 bits (161), Expect = 1e-11
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 19/202 (9%)

Query: 511 KLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFEN--EVLLIAKLQ---HRNLVK 564
           ++G G +G VYK      G  +A K +   + +         EV L+ +L+   H N+V+
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 565 LIG-CCTQRDER----MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
           L+  C T R +R     L++E++ ++ L  ++ D      L       ++    RGL +L
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H +    I+HRDLK  N+L+ +    K++DFG+AR   I   +     VV T  Y  PE 
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLAR---IYSCQMALTPVVVTLWYRAPEV 178

Query: 680 AIDGLFSVKSDVFSFGVLVLEI 701
            +   ++   D++S G +  E+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 31/212 (14%)

Query: 512 LGEGGFGPVYKGVLIE---------GQEIAAKR-LSKSSGQGMEEFENEVLLIAKLQHRN 561
           LG+G F  +YKGVL           GQE++    +  S  +    F     L+++L H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
           LVKL G C  RDE +++ EY+    L+ F+     +  L W  +  +   +A  L YL  
Sbjct: 63  LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119

Query: 622 DSRLRIIHRDLKASNVLL----DNEMNP---KISDFGMARAFGIDQTEANTNRVVGTYGY 674
               +++H ++   N+L+     NE      K+SD G+         E    R+     +
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL--SREERVERI----PW 170

Query: 675 MPPEYAIDGLFSVKS--DVFSFGVLVLEIVCG 704
           + PE   +G  S+    D +SFG  +LEI   
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSN 202

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 66.2 bits (162), Expect = 1e-11
 Identities = 55/239 (23%), Positives = 106/239 (44%), Gaps = 39/239 (16%)

Query: 501 NATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFEN---------E 550
           +    + + + +GEG +G V        G ++A K++S         FE+         E
Sbjct: 2   DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISP--------FEHQTFCQRTLRE 53

Query: 551 VLLIAKLQHRNLVKLIGCCTQRD-ERM----LIYEYLPNKSLNDFIFDVTRSKFLDWSKR 605
           + ++ + +H N++ ++        E      ++ E +        ++ + +++ L     
Sbjct: 54  IKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHI 108

Query: 606 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT 665
              +  I RGL Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR    D    +T
Sbjct: 109 QYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHT 163

Query: 666 NRV---VGTYGYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLL 720
             +   V T  Y  PE  ++     K+ D++S G ++ E++  +    F   D+ H L 
Sbjct: 164 GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPL--FPGKDYLHQLN 220

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 65.8 bits (160), Expect = 2e-11
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 22/212 (10%)

Query: 512 LGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFEN---EVLLIAKLQHRNLVK 564
           LG+G FG V   +L+     G+  A K L K      +E  +   E  ++   +H  L  
Sbjct: 3   LGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59

Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG-IARGLLYLHQDS 623
           L       D    + EY     L    F ++R +     +R +  G  I   L YLH   
Sbjct: 60  LKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFT-EERARFYGAEIVSALEYLHSRD 115

Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
              +++RD+K  N++LD + + KI+DFG+ +  GI    A      GT  Y+ PE   D 
Sbjct: 116 ---VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISD-GATMKTFCGTPEYLAPEVLEDN 170

Query: 684 LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 715
            +    D +  GV++ E++CG+    FY+ DH
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 65.4 bits (160), Expect = 2e-11
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 30/206 (14%)

Query: 510 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN--EVLLIAKLQ-HRNLVKL 565
            K+GEG F  V K    + G+  A K + K   + +E+  N  E+  + +L  H N+++L
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63

Query: 566 I--------GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           I        G         L++E L + +L + I    R + L   +    +  + + L 
Sbjct: 64  IEVLFDRKTGRLA------LVFE-LMDMNLYELIKG--RKRPLPEKRVKSYMYQLLKSLD 114

Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           ++H++    I HRD+K  N+L+ ++   K++DFG  R  GI      T   + T  Y  P
Sbjct: 115 HMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYT-EYISTRWYRAP 167

Query: 678 EYAI-DGLFSVKSDVFSFGVLVLEIV 702
           E  + DG +  K D+++ G +  EI+
Sbjct: 168 ECLLTDGYYGPKMDIWAVGCVFFEIL 193

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 74/283 (26%), Positives = 127/283 (44%), Gaps = 58/283 (20%)

Query: 512 LGEGGFGPVYKGVLI----EGQEIAAKRLS--KSSGQGMEEFENEVLLIAKLQHRNLVK- 564
           +G+G +G V    L+    +G++   K+L+   +S +  +  E E  L+++L+H N+V  
Sbjct: 8   VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64

Query: 565 -------------LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG 611
                        ++G C   D    +Y  L  +          + K L  ++  +    
Sbjct: 65  RESWEGEDGLLYIVMGFCEGGD----LYHKLKEQ----------KGKLLPENQVVEWFVQ 110

Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 671
           IA  L YLH+     I+HRDLK  NV L      K+ D G+AR        A+T  ++GT
Sbjct: 111 IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGT 165

Query: 672 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER 731
             YM PE   +  ++ KSDV++ G  V E+   K      HA +  ++    +R+ IE +
Sbjct: 166 PYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK------HAFNAKDMNSLVYRI-IEGK 218

Query: 732 PVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 774
              +       S  L E++      +L   +RPE RP++ S++
Sbjct: 219 LPPMPKDY---SPELGELIA----TMLS--KRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 66.4 bits (162), Expect = 2e-11
 Identities = 55/187 (29%), Positives = 86/187 (45%), Gaps = 33/187 (17%)

Query: 616 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYM 675
           LL +H      +IHRD+K++N+LL +    K+ DFG ++ +    ++       GT  Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 676 PPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 735
            PE      +S K+D+FS GVL+ E++  KR   F   +                   E+
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRP--FDGENME-----------------EV 253

Query: 736 INKSLGGSY-----SLSEVLRCIQVGLLCVQQRPEDRP------NMSSVVLMLSGERSLP 784
           ++K+L G Y     S+S  ++ I   LL     P+ RP      NM    L +SG   + 
Sbjct: 254 MHKTLAGRYDPLPPSISPEMQEIVTALLSSD--PKRRPSSSKLLNMPICKLFISGLLEIV 311

Query: 785 QPKQPGF 791
           Q  QPGF
Sbjct: 312 Q-TQPGF 317

Length = 496

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 65.4 bits (159), Expect = 3e-11
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 25/214 (11%)

Query: 512 LGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEF-----ENEVLLIAKLQHRNL 562
           LG+G FG V   +L++    G+  A K L K      +E      EN VL  ++  H  L
Sbjct: 3   LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR--HPFL 57

Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG-IARGLLYLHQ 621
             L       D    + EY     L    F ++R +      R +  G  I   L YLH 
Sbjct: 58  TALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFS-EDRARFYGAEIVSALDYLHS 113

Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
           +    +++RDLK  N++LD + + KI+DFG+ +  GI +  A      GT  Y+ PE   
Sbjct: 114 EKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE-GI-KDGATMKTFCGTPEYLAPEVLE 169

Query: 682 DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 715
           D  +    D +  GV++ E++CG+    FY+ DH
Sbjct: 170 DNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 201

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 65.1 bits (159), Expect = 3e-11
 Identities = 38/103 (36%), Positives = 64/103 (62%), Gaps = 10/103 (9%)

Query: 607 QIIGGIA----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 662
            I+G I+    RGL YL +  + +I+HRD+K SN+L+++    K+ DFG++    ID + 
Sbjct: 99  NILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-ID-SM 154

Query: 663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           AN+   VGT  YM PE      ++V+SD++S G+ ++E+  G+
Sbjct: 155 ANS--FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 65.2 bits (159), Expect = 3e-11
 Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 30/207 (14%)

Query: 512 LGEGGFGPVYKGVLIE-------GQEIAAKRLSKSSGQGMEEF--ENEVLLIAKLQHRNL 562
           LG+G FG V+   L+        GQ  A K L K++ +  +    + E  ++A++ H  +
Sbjct: 4   LGQGSFGKVF---LVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60

Query: 563 VKLIGCCTQRDERMLIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           VKL        +  LI ++L    L      + +F     KF         +  +A  L 
Sbjct: 61  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY--------LAELALALD 112

Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           +LH    L II+RDLK  N+LLD E + K++DFG+++   ID  E       GT  YM P
Sbjct: 113 HLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDH-EKKAYSFCGTVEYMAP 167

Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           E       +  +D +SFGVL+ E++ G
Sbjct: 168 EVVNRRGHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 64.8 bits (158), Expect = 4e-11
 Identities = 36/94 (38%), Positives = 50/94 (53%), Gaps = 5/94 (5%)

Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 671
           IA GL +LH      II+RDLK  NV+LD E + KI+DFGM +          T    GT
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG--GKTTRTFCGT 164

Query: 672 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
             Y+ PE      +    D ++FGVL+ E++ G+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 64.0 bits (156), Expect = 5e-11
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 25/203 (12%)

Query: 512 LGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFE---NEVLLIAKLQHRNLVKLIG 567
           +G G FG V+     I     A K ++      +++ +   NE  ++ ++ H  +++L  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF- 67

Query: 568 CCTQRDERML--IYEYLPNKSLNDFIFDVTRSKFLDWSKR---CQIIGGIARGLLYLHQD 622
             T+ D+R L  + EY+P   L  F +     +F + +      +I+  +     YLH  
Sbjct: 68  -WTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYASEIVCALE----YLHS- 119

Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID 682
               I++RDLK  N+LLD E + K++DFG A+    D+T      + GT  Y+ PE    
Sbjct: 120 --KEIVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTWT----LCGTPEYLAPEVIQS 172

Query: 683 GLFSVKSDVFSFGVLVLEIVCGK 705
              +   D ++ G+L+ E++ G 
Sbjct: 173 KGHNKAVDWWALGILIYEMLVGY 195

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 64.5 bits (157), Expect = 5e-11
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 16/207 (7%)

Query: 503 TENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQH 559
           T  + D   +G G FG V      + GQ +A K++ K  S+    +    E+ L+  L+H
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
            N++ L        E +     L    L+  +     S+ L+       +  I RGL Y+
Sbjct: 69  ENIISLSDIFISPLEDIYFVTELLGTDLHRLL----TSRPLEKQFIQYFLYQILRGLKYV 124

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H      ++HRDLK SN+L++   + KI DFG+AR     Q    T  V   Y Y  PE 
Sbjct: 125 HSAG---VVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRY-YRAPEI 176

Query: 680 AID-GLFSVKSDVFSFGVLVLEIVCGK 705
            +    + V+ D++S G +  E++ GK
Sbjct: 177 MLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 63.4 bits (154), Expect = 8e-11
 Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 36/209 (17%)

Query: 509 KNKLGEGGFGPVYKGVLIEGQEIAAKRL------SKSSGQGMEEFENEVLLIAKLQHRNL 562
           +  LG G  G VYK   +  + I A ++       +   Q M E E    ++ K     +
Sbjct: 6   QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELE----ILYKCDSPYI 61

Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA----RGLLY 618
           +   G     +   +  E++   SL+ +                 ++G IA    +GL Y
Sbjct: 62  IGFYGAFFVENRISICTEFMDGGSLDVY-----------RKIPEHVLGRIAVAVVKGLTY 110

Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GIDQTEANTNRVVGTYGYMP 676
           L     L+I+HRD+K SN+L++     K+ DFG++      I +T       VGT  YM 
Sbjct: 111 LWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT------YVGTNAYMA 161

Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           PE      + + SDV+S G+  +E+  G+
Sbjct: 162 PERISGEQYGIHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 63.1 bits (154), Expect = 1e-10
 Identities = 57/205 (27%), Positives = 89/205 (43%), Gaps = 25/205 (12%)

Query: 511 KLGEGGFGPVYKG-VLIEGQEIAAKRL--SKSSGQGMEEFENEVLLIAKLQHRNLVKLIG 567
            +GEG +G V K      G+ +A K+   S+      +    EV ++ +L+H N+V L  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 568 CCTQRDERMLIYEYLPN-------KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
              ++    L++EY+          S      D  RS    W    Q++  IA    Y H
Sbjct: 68  AFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRS--YIW----QLLQAIA----YCH 117

Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
                 IIHRD+K  N+L+      K+ DFG ARA         T+ V  T  Y  PE  
Sbjct: 118 ---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPELL 173

Query: 681 I-DGLFSVKSDVFSFGVLVLEIVCG 704
           + D  +    DV++ G ++ E++ G
Sbjct: 174 VGDTNYGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 63.7 bits (155), Expect = 1e-10
 Identities = 39/158 (24%), Positives = 73/158 (46%), Gaps = 19/158 (12%)

Query: 550 EVLLIAKLQHRNLVKLIGCCTQRDERMLIYE-----YLPNKSLNDFIFDVTRSKFLDWSK 604
           E +L+  + H +++++        +  L+        LP+ S + + +   RS+ L   +
Sbjct: 107 EAMLLQNVNHPSVIRM--------KDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQ 158

Query: 605 RCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 664
              I   I  GL YLH     RIIHRD+K  N+ +++     I D G A+ F +      
Sbjct: 159 ALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPV--VAPA 212

Query: 665 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
              + GT     PE      ++ K+D++S G+++ E++
Sbjct: 213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 37/219 (16%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQHR 560
           E + +   +G G +G V         Q++A K+LS+   S         E+ L+  ++H 
Sbjct: 15  ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74

Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--------- 607
           N++ L+   T            P  S+ +F  ++ VT     D +   +CQ         
Sbjct: 75  NVIGLLDVFT------------PATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF 122

Query: 608 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 667
           +I  + RGL Y+H      IIHRDLK SNV ++ +   +I DFG+AR     Q +     
Sbjct: 123 LIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTG 174

Query: 668 VVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
            V T  Y  PE  ++ + ++   D++S G ++ E++ GK
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 20/212 (9%)

Query: 505 NFSDKNKLGEGGFGPVYKGVLIEGQE----IAAKRLSKSS----GQGMEEFENEVLLIAK 556
           NF     LG G +G V+    + G +     A K L K++     +  E    E  ++  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 557 LQHRNLVKLIGCCTQRDERM-LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQI-IGGIAR 614
           ++    +  +    Q D ++ LI +Y+    L  F     R +F +  +  QI  G I  
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGEL--FTHLSQRERFKE--QEVQIYSGEIVL 116

Query: 615 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGY 674
            L +LH   +L II+RD+K  N+LLD+  +  ++DFG+++ F  D+ E       GT  Y
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEY 172

Query: 675 MPPEYAI--DGLFSVKSDVFSFGVLVLEIVCG 704
           M P+     DG      D +S GVL+ E++ G
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 62.8 bits (152), Expect = 2e-10
 Identities = 35/103 (33%), Positives = 62/103 (60%), Gaps = 10/103 (9%)

Query: 607 QIIGGIA----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 662
           +I+G ++    RGL YL +  + +I+HRD+K SN+L+++    K+ DFG++        +
Sbjct: 103 EILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----ID 156

Query: 663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           +  N  VGT  YM PE      +SV+SD++S G+ ++E+  G+
Sbjct: 157 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 69/285 (24%), Positives = 111/285 (38%), Gaps = 33/285 (11%)

Query: 510 NKLGEGGFGPVYKG---VLIEGQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKL 565
           +++G G FG V  G     +    +  K L  S+       F  EV    +L H N+++ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQ--IIGGIARGLLYLHQDS 623
           +G C +    +L+ E+ P   L +++            K     +   +A GLL+LHQ  
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-- 118

Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARA-FGIDQTEANTNRVVGTYGYMPPEYAI- 681
               IH DL   N  L  +++ KI D+G+A   +  D         V    ++ PE    
Sbjct: 119 -ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELVEI 176

Query: 682 --DGLFSVK----SDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL--WIEERPV 733
               L        S+++S GV + E+        F  AD  +  L     L   + E+ +
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWEL--------FTAADQPYPDLSDEQVLKQVVREQDI 228

Query: 734 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 778
           +L    L   YS     R  +V   C    PE RP    V  +L+
Sbjct: 229 KLPKPQLDLKYS----DRWYEVMQFCWLD-PETRPTAEEVHELLT 268

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 56/213 (26%), Positives = 103/213 (48%), Gaps = 32/213 (15%)

Query: 510 NKLGEGGFGPVYK------GVLIEGQEIAAKRLSKSSGQGMEEFE-NEVLLIAKLQHR-- 560
           ++LG+G +G VYK      GV +  +EI   RL       ++E + N++++   + H+  
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEI---RLE------LDESKFNQIIMELDILHKAV 57

Query: 561 --NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
              +V   G         +  EY+   SL+        ++ +      +I   + +GL +
Sbjct: 58  SPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117

Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           L ++    IIHRD+K +NVL++     K+ DFG++    +  + A TN  +G   YM PE
Sbjct: 118 LKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVASLAKTN--IGCQSYMAPE 171

Query: 679 Y------AIDGLFSVKSDVFSFGVLVLEIVCGK 705
                    +  ++V+SDV+S G+ +LE+  G+
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 62.0 bits (150), Expect = 3e-10
 Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 33/228 (14%)

Query: 493 IFDWMAIANATENFSDKNKLGEGGFGPVYKGVL--IEGQEIAAKRLSKSSGQGMEEFENE 550
           IFD  +  + ++ +     +G+G +G V+K VL    G + A K L        EE E E
Sbjct: 9   IFD--SFPDPSDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDID-EEIEAE 64

Query: 551 VLLIAKLQ-HRNLVKLIGCCTQRDER-----MLIYEYLPNKSLNDFIFDVTRSKFLDWSK 604
             ++  L  H N+VK  G   ++D +      L+ E     S+ D +       FL   +
Sbjct: 65  YNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV-----KGFLKRGE 119

Query: 605 RCQ--IIGGIAR----GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 658
           R +  II  I      GL +LH +   + IHRD+K +N+LL  E   K+ DFG++    +
Sbjct: 120 RMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQ--L 174

Query: 659 DQTEANTNRVVGTYGYMPPEY-----AIDGLFSVKSDVFSFGVLVLEI 701
             T    N  VGT  +M PE       +D  +  + DV+S G+  +E+
Sbjct: 175 TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 62.4 bits (151), Expect = 3e-10
 Identities = 35/103 (33%), Positives = 62/103 (60%), Gaps = 10/103 (9%)

Query: 607 QIIGGIA----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 662
           QI+G ++    +GL YL +  + +I+HRD+K SN+L+++    K+ DFG++        +
Sbjct: 103 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----ID 156

Query: 663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           +  N  VGT  YM PE      +SV+SD++S G+ ++E+  G+
Sbjct: 157 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 62.4 bits (151), Expect = 3e-10
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 33/217 (15%)

Query: 504 ENFSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR 560
           + + +   +G G  G V   Y  +L   + +A K+LS+        F+N+    AK  +R
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKRAYR 72

Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRCQI 608
            LV L+ C   ++   L+  + P KSL +F        + D    +     LD  +   +
Sbjct: 73  ELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131

Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
           +  +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   +   T  V
Sbjct: 132 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYV 186

Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           V  Y Y  PE  +   +    D++S G ++ E++ G 
Sbjct: 187 VTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 61.9 bits (150), Expect = 4e-10
 Identities = 37/90 (41%), Positives = 50/90 (55%), Gaps = 3/90 (3%)

Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 671
           +ARG+ +L   SR + IHRDL A N+LL      KI DFG+AR    D            
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 672 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
             +M PE   D +++ +SDV+SFGVL+ EI
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEI 269

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 62.0 bits (150), Expect = 4e-10
 Identities = 36/90 (40%), Positives = 51/90 (56%), Gaps = 3/90 (3%)

Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 671
           +A+G+ +L   SR + IHRDL A N+LL      KI DFG+AR    D            
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 672 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
             +M PE   D +++++SDV+SFGVL+ EI
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI 274

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 61.8 bits (150), Expect = 4e-10
 Identities = 69/268 (25%), Positives = 113/268 (42%), Gaps = 45/268 (16%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE---GQEIAAKRLSKSSGQGMEE---FENEVLLIAKL 557
           ++F  K+ +G G FG V   V+ E   G   A K + KS     E    FE E  +++  
Sbjct: 1   KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58

Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSL------NDFIFDVTRSKFLDWSKRCQIIGG 611
               + +L      +D   L+ EY P   L       +  FD   ++F            
Sbjct: 59  NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY----------- 107

Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 671
           +A  +L +H   ++  +HRD+K  NVL+D   + K++DFG A     ++   N+   VGT
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VNSKLPVGT 166

Query: 672 YGYMPPEY--AIDG----LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHH----NLLG 721
             Y+ PE    ++G     + V+ D +S GV+  E++ G   R  +H         N++ 
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYG---RSPFHEGTSAKTYNNIMN 223

Query: 722 HAWRLWIEERP------VELINKSLGGS 743
               L   E P      ++LI   L G 
Sbjct: 224 FQRFLKFPEDPKVSSDFLDLIQSLLCGQ 251

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 61.3 bits (149), Expect = 4e-10
 Identities = 36/98 (36%), Positives = 52/98 (53%), Gaps = 6/98 (6%)

Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
           I  I   L +LHQ   L II+RD+K  N+LLD+E +  ++DFG+++ F  ++ E      
Sbjct: 111 IAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSF 166

Query: 669 VGTYGYMPPEY--AIDGLFSVKSDVFSFGVLVLEIVCG 704
            GT  YM PE      G      D +S GVL  E++ G
Sbjct: 167 CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 61.2 bits (148), Expect = 6e-10
 Identities = 46/148 (31%), Positives = 74/148 (50%), Gaps = 16/148 (10%)

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTR-SKFLDWSKRCQII---GGIARGLL 617
           L +L  C    D    + EY+   +  D ++ + +  KF    K  Q +     I+ GL 
Sbjct: 63  LTQLHSCFQTVDRLYFVMEYV---NGGDLMYHIQQVGKF----KEPQAVFYAAEISVGLF 115

Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           +LH+     II+RDLK  NV+LD+E + KI+DFGM +   +D     T    GT  Y+ P
Sbjct: 116 FLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT--FCGTPDYIAP 170

Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E      +    D +++GVL+ E++ G+
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 61.0 bits (148), Expect = 6e-10
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 23/214 (10%)

Query: 504 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKR-LSKSSGQGMEEFE-NEVLLIAKLQHR 560
           + +    K+GEG +G VYK      G+ +A K+   +   +G+      E+ L+  L   
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 561 N-LVKLIGCCTQRDERM------LIYEYLPNKSLNDFIFDVTRSKF---LDWSKRCQIIG 610
             +V+L+      +E+       L++EYL +  L  F+ D         L        + 
Sbjct: 61  IYIVRLL-DVEHVEEKNGKPSLYLVFEYL-DSDLKKFM-DSNGRGPGRPLPAKTIKSFMY 117

Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQTEANTNRVV 669
            + +G+ + H   +  ++HRDLK  N+L+D +    KI+D G+ RAF I   ++ T+ +V
Sbjct: 118 QLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI-PVKSYTHEIV 173

Query: 670 GTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIV 702
            T  Y  PE  +    +S   D++S G +  E+ 
Sbjct: 174 -TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 61.4 bits (149), Expect = 7e-10
 Identities = 35/95 (36%), Positives = 54/95 (56%), Gaps = 13/95 (13%)

Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 671
           +A+G+ +L   +    IHRD+ A NVLL +    KI DFG+AR         ++N VV  
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-----DIMNDSNYVVKG 272

Query: 672 YG-----YMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
                  +M PE   D +++V+SDV+S+G+L+ EI
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 60.8 bits (147), Expect = 7e-10
 Identities = 52/197 (26%), Positives = 97/197 (49%), Gaps = 10/197 (5%)

Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFEN---EVLLIAKLQHRNLVKLIGC 568
           +GEG +G V K    E +EI A +  K S +  E  E    E+ ++  L+  N+V+L   
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 569 CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRII 628
             +R +  L++EY+  K++ + + ++      +  K    I  + + + + H++    I+
Sbjct: 69  FRRRGKLYLVFEYV-EKNMLELLEEMPNGVPPE--KVRSYIYQLIKAIHWCHKND---IV 122

Query: 629 HRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 688
           HRD+K  N+L+ +    K+ DFG AR    + + AN    V T  Y  PE  +   +   
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELLLGAPYGKA 181

Query: 689 SDVFSFGVLVLEIVCGK 705
            D++S G ++ E+  G+
Sbjct: 182 VDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 60.9 bits (148), Expect = 7e-10
 Identities = 37/108 (34%), Positives = 60/108 (55%), Gaps = 15/108 (13%)

Query: 607 QIIGGIA----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 662
            I+G +     + L YL +     +IHRD+K SN+LLD   N K+ DFG++    +D ++
Sbjct: 114 DILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGIS-GRLVD-SK 169

Query: 663 ANTNRVVGTYGYMPPEYAID-----GLFSVKSDVFSFGVLVLEIVCGK 705
           A T R  G   YM PE  ID       + +++DV+S G+ ++E+  G+
Sbjct: 170 AKT-RSAGCAAYMAPE-RIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403)

 Score = 54.3 bits (131), Expect = 1e-09
 Identities = 20/43 (46%), Positives = 29/43 (67%), Gaps = 2/43 (4%)

Query: 783 LPQPKQPGFFTERNPPESGSSSSK--RSLLSTNEITISLIEGR 823
           +PQPKQPGF   R+P E+ SSSS       + N++T+S+I+ R
Sbjct: 6   IPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48

This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 60.5 bits (147), Expect = 1e-09
 Identities = 57/211 (27%), Positives = 89/211 (42%), Gaps = 64/211 (30%)

Query: 525 LIEGQEIAAKRLSKSSGQGMEEFEN---------EVLLIAKLQHRNLVKLIGCCTQRDER 575
            + GQ +A K+LS+        F+N         E++L+  + H+N++ L+   T     
Sbjct: 38  TVTGQNVAIKKLSRP-------FQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFT----- 85

Query: 576 MLIYEYLPNKSLNDF--------------------IFDVTRSKFLDWSKRCQIIGGIARG 615
                  P KSL +F                      D  R  +L +   C        G
Sbjct: 86  -------PQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLC--------G 130

Query: 616 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYM 675
           + +LH      IIHRDLK SN+++ ++   KI DFG+AR  G       T  VV  Y Y 
Sbjct: 131 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YR 184

Query: 676 PPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
            PE  I G+ +    D++S G ++ E++ G 
Sbjct: 185 APE-VILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 37/94 (39%), Positives = 52/94 (55%), Gaps = 5/94 (5%)

Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 671
           IA GL +LH      II+RDLK  NV+LD+E + KI+DFGM +    D     T    GT
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGT 164

Query: 672 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
             Y+ PE      +    D ++FGVL+ E++ G+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 61.4 bits (149), Expect = 2e-09
 Identities = 47/192 (24%), Positives = 86/192 (44%), Gaps = 20/192 (10%)

Query: 528 GQEIAAKRLSKSSGQGMEE---FENEVLLIAKLQHRNLVKLIGCCTQRDERML-IYEYLP 583
           G E+A K L   + +   +   F  E  L A+L H N+V L+         +  ++EY+P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 584 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL---D 640
            ++L + +        L   +  +++  +   L   H      I+HRDLK  N+++    
Sbjct: 63  GRTLREVL---AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTG 116

Query: 641 NEMNPKISDFGMARAFGIDQTEAN------TNRVVGTYGYMPPEYAIDGLFSVKSDVFSF 694
              + K+ DFG+         +A+      T  V+GT  Y  PE       +  SD++++
Sbjct: 117 VRPHAKVLDFGIG-TLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175

Query: 695 GVLVLEIVCGKR 706
           G++ LE + G+R
Sbjct: 176 GLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 59.8 bits (145), Expect = 2e-09
 Identities = 61/215 (28%), Positives = 95/215 (44%), Gaps = 28/215 (13%)

Query: 512 LGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEF-----ENEVLLIAKLQHRNL 562
           LG+G FG V   +L+     G+  A K L K      +E      E+ VL     +H  L
Sbjct: 3   LGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVL--QNTRHPFL 57

Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG-IARGLLYLHQ 621
             L       D    + EY     L    F ++R +      R +  G  I   L YLH 
Sbjct: 58  TALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFS-EDRARFYGAEIVSALGYLH- 112

Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV-VGTYGYMPPEYA 680
                +++RDLK  N++LD + + KI+DFG+ +      ++  T +   GT  Y+ PE  
Sbjct: 113 --SCDVVYRDLKLENLMLDKDGHIKITDFGLCKE---GISDGATMKTFCGTPEYLAPEVL 167

Query: 681 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 715
            D  +    D +  GV++ E++CG+    FY+ DH
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 60.1 bits (146), Expect = 2e-09
 Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 5/95 (5%)

Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 671
           I RGL YLH      I+HRD+K  N+L+++    KI DFG+AR    D+++  T  VV  
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168

Query: 672 YGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           Y Y  PE  +    ++   D++S G +  E++  +
Sbjct: 169 Y-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 60.0 bits (145), Expect = 2e-09
 Identities = 34/90 (37%), Positives = 48/90 (53%), Gaps = 3/90 (3%)

Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 671
           +ARG+ +L   +    +HRDL A NVLL      KI DFG+AR    D    +       
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302

Query: 672 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
             +M PE   D L++  SDV+S+G+L+ EI
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEI 332

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 28/210 (13%)

Query: 512 LGEGGFGPVYKGVLIE----GQ----EIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           LG+G F  ++KG+  E    G+    E+  K L KS     E F     ++++L H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
              G C   DE +++ EY+   SL+ ++        ++ S + ++   +A  L +L    
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWALHFLEDKG 120

Query: 624 RLRIIHRDLKASNVLLDNEM-----NP---KISDFGMARAFGIDQTEANTNRVVGTYGYM 675
              + H ++ A NVLL  E      NP   K+SD G++    +   E    R+     ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT--VLPKEILLERI----PWV 171

Query: 676 PPEYAIDGL-FSVKSDVFSFGVLVLEIVCG 704
           PPE   +    S+ +D +SFG  + EI  G
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 59.7 bits (144), Expect = 2e-09
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 37/210 (17%)

Query: 512 LGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT 570
           +G G  G V      + G  +A K+LS+        F+N+    AK  +R LV L+ C  
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRP-------FQNQTH--AKRAYRELV-LLKCVN 78

Query: 571 QRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRCQIIGGIARGLLY 618
            ++   L+  + P KSL +F        + D    +     LD  +   ++  +  G+ +
Sbjct: 79  HKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKH 138

Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTY----GY 674
           LH      IIHRDLK SN+++ ++   KI DFG+AR        A TN ++  Y     Y
Sbjct: 139 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART-------ACTNFMMTPYVVTRYY 188

Query: 675 MPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
             PE  +   +    D++S G ++ E+V G
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 59.2 bits (143), Expect = 3e-09
 Identities = 56/219 (25%), Positives = 100/219 (45%), Gaps = 37/219 (16%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQHR 560
           + + D  ++G G +G V   +    G ++A K+L +   S    +    E+ L+  ++H 
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74

Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKFLDWSK----RCQ- 607
           N++ L+   T            P+ SL+ F               K +   K    R Q 
Sbjct: 75  NVIGLLDVFT------------PDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF 122

Query: 608 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 667
           ++  + +GL Y+H      IIHRDLK  N+ ++ +   KI DFG+AR     QT++    
Sbjct: 123 LVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTG 174

Query: 668 VVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
            V T  Y  PE  ++ + ++   D++S G ++ E++ GK
Sbjct: 175 YVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 58.0 bits (140), Expect = 4e-09
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 9/149 (6%)

Query: 511 KLGEGGFGPVYKGVLIEG---QEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLI 566
           ++G G FG V  G +  G    ++  K L  S+  Q   +F  E      LQH NL++ +
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFL--DWSKRCQIIGGIARGLLYLHQDSR 624
           G CT+    +L+ E+ P   L  ++    +++ +  D +   ++   IA GLL+LH+++ 
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120

Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMA 653
              IH DL   N LL  ++  KI D+G++
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 58.8 bits (143), Expect = 4e-09
 Identities = 55/231 (23%), Positives = 91/231 (39%), Gaps = 51/231 (22%)

Query: 512 LGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEE---FENEVLLIAKLQHRNLVKLIG 567
           +G G FG V+     +  ++ A K L KS      +      E  ++A      +VKL  
Sbjct: 9   IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY- 67

Query: 568 CCTQRDERML--IYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
             + +DE  L  + EY+P   L        +F    ++F            IA  +L L 
Sbjct: 68  -YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFY-----------IAELVLALD 115

Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG----------------------- 657
              +L  IHRD+K  N+L+D + + K++DFG+ +                          
Sbjct: 116 SVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175

Query: 658 ----IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
                 Q     N  VGT  Y+ PE      + ++ D +S GV++ E++ G
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 58.5 bits (142), Expect = 5e-09
 Identities = 59/224 (26%), Positives = 101/224 (45%), Gaps = 34/224 (15%)

Query: 512 LGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN---------EVLLIAKLQHRN 561
           +G G +G V      E  +++A K+++ +       F+N         E+ L+  L H N
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANA-------FDNRIDAKRTLREIKLLRHLDHEN 65

Query: 562 LVKLIGCC--TQRD---ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQ-IIGGIARG 615
           ++ +        R+   +  ++YE L +  L+  I    RS        CQ  +  + RG
Sbjct: 66  VIAIKDIMPPPHREAFNDVYIVYE-LMDTDLHQII----RSSQTLSDDHCQYFLYQLLRG 120

Query: 616 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYM 675
           L Y+H  +   ++HRDLK SN+LL+   + KI DFG+AR    ++ +  T  VV  +   
Sbjct: 121 LKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVVTRWYRA 176

Query: 676 PPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL 719
           P        ++   DV+S G +  E++   R   F   D+ H L
Sbjct: 177 PELLLNCSEYTTAIDVWSVGCIFAELL--GRKPLFPGKDYVHQL 218

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 58.1 bits (140), Expect = 6e-09
 Identities = 45/147 (30%), Positives = 70/147 (47%), Gaps = 8/147 (5%)

Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           H  LV L  C         + EY+      D +F + R + L           I+  L Y
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNG---GDLMFHMQRQRKLPEEHARFYSAEISLALNY 111

Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           LH+     II+RDLK  NVLLD+E + K++D+GM +  G+   +  T+   GT  Y+ PE
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGD-TTSTFCGTPNYIAPE 166

Query: 679 YAIDGLFSVKSDVFSFGVLVLEIVCGK 705
                 +    D ++ GVL+ E++ G+
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 58.6 bits (141), Expect = 6e-09
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 33/214 (15%)

Query: 504 ENFSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR 560
           + + +   +G G  G V   Y  VL   + +A K+LS+        F+N+    AK  +R
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYR 65

Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRCQI 608
            LV L+ C   ++   L+  + P KSL +F        + D    +     LD  +   +
Sbjct: 66  ELV-LMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 124

Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
           +  +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   +   T  V
Sbjct: 125 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYV 179

Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
           V  Y Y  PE  +   +    D++S G ++ E+V
Sbjct: 180 VTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains

 Score = 53.0 bits (127), Expect = 6e-09
 Identities = 25/81 (30%), Positives = 36/81 (44%), Gaps = 6/81 (7%)

Query: 340 EHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSK-NCSCTAYANADVRGGGSGCLLW 398
           +  D F++  + KLP     ++    SL EC   C   NCSC ++       G  GCLLW
Sbjct: 1   KSDDCFVRLPNTKLPGFSRIVISV-ASLEECASKCLNSNCSCRSFTY---NNGTKGCLLW 56

Query: 399 -FHDLIDMKELSESGQDLFVR 418
               L D +     G DL+ +
Sbjct: 57  SESSLGDARLFPSGGVDLYEK 77

Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 57.6 bits (139), Expect = 8e-09
 Identities = 35/94 (37%), Positives = 51/94 (54%), Gaps = 3/94 (3%)

Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 671
           IA  +L L    +  I++RDLK  N+LLD   +  + DFG+++A   D     TN   GT
Sbjct: 102 IAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD--NKTTNTFCGT 159

Query: 672 YGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCG 704
             Y+ PE  +D   ++   D +S GVLV E+ CG
Sbjct: 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 34/94 (36%), Positives = 56/94 (59%), Gaps = 8/94 (8%)

Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 671
           I  GL ++H  +R  +++RDLK +N+LLD   + +ISD G+A  F   +  A+    VGT
Sbjct: 106 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 158

Query: 672 YGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCG 704
           +GYM PE    G+ +   +D FS G ++ +++ G
Sbjct: 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 57.0 bits (138), Expect = 2e-08
 Identities = 36/102 (35%), Positives = 52/102 (50%), Gaps = 15/102 (14%)

Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT--NRVV 669
           + RGL Y+H  +   +IHRDLK SN+L++ +   +I DFGMAR      TE        V
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172

Query: 670 GTYGYMPPEYAIDGLFSV-----KSDVFSFGVLVLEIVCGKR 706
            T  Y  PE     L S+       D++S G +  E++ G+R
Sbjct: 173 ATRWYRAPEL----LLSLPEYTTAIDMWSVGCIFAEML-GRR 209

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 56.8 bits (137), Expect = 2e-08
 Identities = 46/140 (32%), Positives = 72/140 (51%), Gaps = 13/140 (9%)

Query: 569 CTQRDERM-LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI 627
           C Q + R+  + E++      D +F + R + L           I+  L +LH+     I
Sbjct: 64  CFQTESRLFFVIEFVSG---GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG---I 117

Query: 628 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY--AIDGLF 685
           I+RDLK  NVLLD E + K++D+GM +  GI   +  T+   GT  Y+ PE     D  F
Sbjct: 118 IYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDT-TSTFCGTPNYIAPEILRGEDYGF 175

Query: 686 SVKSDVFSFGVLVLEIVCGK 705
           SV  D ++ GVL+ E++ G+
Sbjct: 176 SV--DWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 34/94 (36%), Positives = 55/94 (58%), Gaps = 8/94 (8%)

Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 671
           I  GL ++H  +R  +++RDLK +N+LLD   + +ISD G+A  F   +  A+    VGT
Sbjct: 106 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 158

Query: 672 YGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCG 704
           +GYM PE    G  +   +D FS G ++ +++ G
Sbjct: 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 19/207 (9%)

Query: 511 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFE-NEVLLIAKLQHRNLVKLIGCC 569
           K+G G +G VYK    +G++     L +  G G+      E+ L+ +L+H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 570 TQRDERM--LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY-----LHQD 622
               +R   L+++Y  +   +  I    R+   +  K  Q+  G+ + LLY     +H  
Sbjct: 68  LSHADRKVWLLFDYAEHDLWH--IIKFHRASKAN-KKPVQLPRGMVKSLLYQILDGIHYL 124

Query: 623 SRLRIIHRDLKASNVLLDNEMNP-----KISDFGMARAFGID-QTEANTNRVVGTYGYMP 676
               ++HRDLK +N+L+  E  P     KI+D G AR F    +  A+ + VV T+ Y  
Sbjct: 125 HANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 677 PEYAIDGLFSVKS-DVFSFGVLVLEIV 702
           PE  +      K+ D+++ G +  E++
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 56.4 bits (136), Expect = 3e-08
 Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 36/218 (16%)

Query: 504 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQHR 560
           E ++   ++G G +G V   +    G+++A K+LS+   S    +    E+ L+  +QH 
Sbjct: 15  ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74

Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK---------RCQ-I 608
           N++ L+   T               S ++F   + V      D  K         + Q +
Sbjct: 75  NVIGLLDVFT------------SAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYL 122

Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
           +  +  GL Y+H      IIHRDLK  N+ ++ +   KI DFG+AR       +A     
Sbjct: 123 VYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGY 174

Query: 669 VGTYGYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCGK 705
           V T  Y  PE  ++ +   ++ D++S G ++ E++ GK
Sbjct: 175 VVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 55.9 bits (135), Expect = 3e-08
 Identities = 43/173 (24%), Positives = 76/173 (43%), Gaps = 40/173 (23%)

Query: 506 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
           + D   LG G  G V+  V  +  + +A K++  +  Q ++    E+ +I +L H N+VK
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 565 LIGCCTQRDERMLIYEYLPNKS--LNDFIFDVTR-------SKFLDWSKRCQIIGG---- 611
                        +YE L      L + +  +T         ++++      +  G    
Sbjct: 67  -------------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSE 113

Query: 612 ---------IARGLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMAR 654
                    + RGL Y+H  +   ++HRDLK +NV ++ E +  KI DFG+AR
Sbjct: 114 EHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLAR 163

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 55.8 bits (134), Expect = 4e-08
 Identities = 43/144 (29%), Positives = 68/144 (47%), Gaps = 8/144 (5%)

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
           LV L  C        L+ EY+      D +F + R + L           I   L +LH+
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNG---GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHE 114

Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
                II+RDLK  NVLLD + + K++D+GM +  G+   +  T+   GT  Y+ PE   
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGD-TTSTFCGTPNYIAPEILR 169

Query: 682 DGLFSVKSDVFSFGVLVLEIVCGK 705
              +    D ++ GVL+ E++ G+
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 55.6 bits (134), Expect = 4e-08
 Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 16/201 (7%)

Query: 512 LGEGGFGPVYKGVLIEGQE----IAAKRLSKS----SGQGMEEFENEVLLIAKLQHRNLV 563
           LG+GG+G V++   + G +     A K L K+    + +     + E  ++  ++H  +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
            LI       +  LI EYL    L  F+       F++    C  +  I+  L +LHQ  
Sbjct: 64  DLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFME-DTACFYLSEISLALEHLHQ-- 118

Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
              II+RDLK  N+LLD + + K++DFG+ +    + T  +T    GT  YM PE  +  
Sbjct: 119 -QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT--FCGTIEYMAPEILMRS 175

Query: 684 LFSVKSDVFSFGVLVLEIVCG 704
                 D +S G L+ +++ G
Sbjct: 176 GHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 54.4 bits (131), Expect = 1e-07
 Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 37/215 (17%)

Query: 505 NFSDKNKLGEGGFGPV----YKGVLIEGQEIAAKRLSKSSGQGMEEFEN---EVLLIAKL 557
           +F     LG G FG V    +KG    G+  A K L K     M++ ++   E  ++ +L
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75

Query: 558 QHRNLVKLIGCCTQRDERM-LIYEYLPN-------KSLNDFIFDVTRSKFLDWSKRCQII 609
            H  +V ++ C  Q + R+  + E++         +    F  DV  +KF          
Sbjct: 76  SHPFIVNMM-CSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDV--AKFYH-------- 124

Query: 610 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV 669
             +     YLH      II+RDLK  N+LLDN+ + K++DFG A+     +    T  + 
Sbjct: 125 AELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLC 176

Query: 670 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           GT  Y+ PE           D ++ GVL+ E + G
Sbjct: 177 GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 54.3 bits (130), Expect = 1e-07
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 19/207 (9%)

Query: 511 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFE-NEVLLIAKLQHRNLVKLIGCC 569
           K+G G +G VYK    +G++     L +  G G+      E+ L+ +L+H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 570 TQRDERM--LIYEYLPNKSLNDFIFDVT-----RSKFLDWSKRCQIIGGIARGLLYLHQD 622
               +R   L+++Y  +   +   F        +   L  S    ++  I  G+ YLH +
Sbjct: 68  LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127

Query: 623 SRLRIIHRDLKASNVLLDNEMNP-----KISDFGMARAFGID-QTEANTNRVVGTYGYMP 676
               ++HRDLK +N+L+  E  P     KI+D G AR F    +  A+ + VV T+ Y  
Sbjct: 128 ---WVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 677 PEYAIDGLFSVKS-DVFSFGVLVLEIV 702
           PE  +      K+ D+++ G +  E++
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 54.2 bits (130), Expect = 1e-07
 Identities = 33/96 (34%), Positives = 55/96 (57%), Gaps = 5/96 (5%)

Query: 610 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV 669
           G I   L +LH   +L I++RD+K  N+LLD+E +  ++DFG+++ F + + +  T    
Sbjct: 112 GEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFC 167

Query: 670 GTYGYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCG 704
           GT  YM PE         K+ D +S G+L+ E++ G
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 54.2 bits (130), Expect = 1e-07
 Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 3/90 (3%)

Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 671
           +A G+ +L   +    +HRDL A NVL+      KI DFG+AR    D    +       
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304

Query: 672 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
             +M PE   + L++  SDV+SFG+L+ EI
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 53.8 bits (129), Expect = 2e-07
 Identities = 53/206 (25%), Positives = 86/206 (41%), Gaps = 16/206 (7%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQ--EIAAKRLSKSS---GQGMEEFENEVLLIAKLQ 558
           E+F+    LG G FG V            +A KR  KS     + ++   +E  ++  + 
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89

Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           H   V L G         L+ E++       F+    R+K       C     I     Y
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL---RRNKRFPNDVGCFYAAQIVLIFEY 146

Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           L     L I++RDLK  N+LLD +   K++DFG A+       +  T  + GT  Y+ PE
Sbjct: 147 LQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEYIAPE 198

Query: 679 YAIDGLFSVKSDVFSFGVLVLEIVCG 704
             ++      +D ++ G+ + EI+ G
Sbjct: 199 ILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 53.7 bits (129), Expect = 2e-07
 Identities = 34/95 (35%), Positives = 53/95 (55%), Gaps = 13/95 (13%)

Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 671
           +A+G+ +L   +    IHRDL A N+LL +    KI DFG+AR    D     +N VV  
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRND-----SNYVVKG 274

Query: 672 YG-----YMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
                  +M PE   + +++ +SDV+S+G+L+ EI
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 53.1 bits (127), Expect = 3e-07
 Identities = 43/145 (29%), Positives = 70/145 (48%), Gaps = 20/145 (13%)

Query: 569 CTQRDERML--IYEYLPNKSLNDFI--FDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           C  +D++ L  + EY+P   L + +  +DV       W+K        A  +L L     
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFYT-----AEVVLALDAIHS 160

Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT-EANTNRVVGTYGYMPPEY---- 679
           + +IHRD+K  N+LLD   + K++DFG      +D+T     +  VGT  Y+ PE     
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLADFGT--CMKMDETGMVRCDTAVGTPDYISPEVLKSQ 218

Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCG 704
             DG +  + D +S GV + E++ G
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 52.2 bits (125), Expect = 5e-07
 Identities = 32/113 (28%), Positives = 56/113 (49%), Gaps = 13/113 (11%)

Query: 592 FDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG 651
           FD++R++F             A  L  L    +  +I+RDLK  N+LLD + +  + DFG
Sbjct: 90  FDLSRARFY-----------TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFG 138

Query: 652 MARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           + +   +   +  TN   GT  Y+ PE  +   ++   D ++ GVL+ E++ G
Sbjct: 139 LCK-LNMKDDD-KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 51.7 bits (124), Expect = 6e-07
 Identities = 52/173 (30%), Positives = 79/173 (45%), Gaps = 15/173 (8%)

Query: 512 LGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEF-----ENEVLLIAKLQHRNLVKL 565
           +G+G FG V       +G+  A K L K +    +E      E  VLL   ++H  LV L
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLL-KNVKHPFLVGL 61

Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 625
                  D+   + +Y+    L    F + R +     +       IA  L YLH    L
Sbjct: 62  HYSFQTADKLYFVLDYVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLHS---L 115

Query: 626 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
            II+RDLK  N+LLD++ +  ++DFG+ +  GI +    T+   GT  Y+ PE
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE-GI-EHSKTTSTFCGTPEYLAPE 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 52.4 bits (125), Expect = 7e-07
 Identities = 48/174 (27%), Positives = 84/174 (48%), Gaps = 12/174 (6%)

Query: 533 AKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI---YEYLPNKSLND 589
           AKR+ K+  +   + ENE+L + +L H N++K+           +I   Y++     + D
Sbjct: 197 AKRV-KAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYD 255

Query: 590 FIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISD 649
             FD      L    R  I+  +   + Y+H     ++IHRD+K  N+ L+ +    + D
Sbjct: 256 EAFDWKDRPLL-KQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGD 310

Query: 650 FGMARAFGIDQTEANTNRVVGTYGYMPPE-YAIDGLFSVKSDVFSFGVLVLEIV 702
           FG A  F   + EA     VGT     PE  A DG   + +D++S G+++L+++
Sbjct: 311 FGTAMPFE-KEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDML 362

Length = 501

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 50.9 bits (122), Expect = 1e-06
 Identities = 34/98 (34%), Positives = 51/98 (52%), Gaps = 8/98 (8%)

Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN---TNRV 668
           I  GL Y+H  +   ++HRDLK  N+L++ +   KI DFG+AR F  +  E     T   
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTE-Y 169

Query: 669 VGTYGYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCGK 705
           V T  Y  PE  +      K+ DV+S G ++ E++  K
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 50.8 bits (121), Expect = 2e-06
 Identities = 67/258 (25%), Positives = 119/258 (46%), Gaps = 39/258 (15%)

Query: 466 RKQGKTDGSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDK--NKLGEGGFGPVYKG 523
               K D   +   N+ G  E+E ++   D     N + N S K  N +G G FG VY+ 
Sbjct: 30  MNDKKLDEEERSHNNNAGEDEDEEKMIDND----INRSPNKSYKLGNIIGNGSFGVVYEA 85

Query: 524 VLIEGQE-IAAKRLSKSSGQGMEEFENEVLLIAK-LQHRNLVKLIGC----CTQRDERML 577
           + I+  E +A K++ +       +++N  LLI K L H N++ L       C +++E+ +
Sbjct: 86  ICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140

Query: 578 ----IYEYLPNKSLNDFIFDVTRSK-----FLDWSKRCQIIGGIARGLLYLHQDSRLRII 628
               + E++P ++++ ++    R+      FL      Q+     R L Y+H      I 
Sbjct: 141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQL----CRALAYIHSKF---IC 192

Query: 629 HRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL-FS 686
           HRDLK  N+L+D N    K+ DFG A+     Q   +    + +  Y  PE  +    ++
Sbjct: 193 HRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS---YICSRFYRAPELMLGATNYT 249

Query: 687 VKSDVFSFGVLVLEIVCG 704
              D++S G ++ E++ G
Sbjct: 250 THIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 17/211 (8%)

Query: 512 LGEGGFGPVYKGVL-IEGQEIAAKRLSKSSGQGMEE-----FENEVLLIAKLQHRNLVKL 565
           +G+G FG V      ++G+  A K L K      +E      E  VLL   ++H  LV L
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLL-KNVKHPFLVGL 61

Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 625
                  ++   + +++    L    F + R +     +       IA  L YLH    +
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLHS---I 115

Query: 626 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF 685
            I++RDLK  N+LLD++ +  ++DFG+ +  GI Q++  T    GT  Y+ PE      +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTT-FCGTPEYLAPEVIRKQPY 173

Query: 686 SVKSDVFSFGVLVLEIVCGKRNRGFYHADHH 716
               D +  G ++ E++ G     FY  D  
Sbjct: 174 DNTVDWWCLGAVLYEMLYGLPP--FYCRDVA 202

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 49.8 bits (119), Expect = 3e-06
 Identities = 35/97 (36%), Positives = 47/97 (48%), Gaps = 10/97 (10%)

Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGIDQTEANTNRVVGTY 672
           R L Y+H  +   + HRDLK  N+L + +   KI DFG+AR AF    T       V T 
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 673 GYMPPEYAIDGLFSVKS----DVFSFGVLVLEIVCGK 705
            Y  PE    G F  K     D++S G +  E++ GK
Sbjct: 171 WYRAPELC--GSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 49.8 bits (119), Expect = 3e-06
 Identities = 40/182 (21%), Positives = 63/182 (34%), Gaps = 37/182 (20%)

Query: 540 SGQGMEEFENEVLLIAKLQHRNLVKLIG--------CCTQRDERMLIYEYLPNKS---LN 588
           +  G +    E+ ++  + HR ++ LI         C      +  ++ Y+       L 
Sbjct: 126 AVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLE 185

Query: 589 DFIFDVTRSKFLDWSKRCQIIGGIARGLL----YLHQDSRLRIIHRDLKASNVLLDNEMN 644
             I                    I R LL    YLH      IIHRD+K  N+ LD   N
Sbjct: 186 QAIT-------------------IQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPEN 223

Query: 645 PKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
             + DFG A                GT     PE      +  K+D++S G+++ E+   
Sbjct: 224 AVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVK 283

Query: 705 KR 706
             
Sbjct: 284 NV 285

Length = 392

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 47.0 bits (112), Expect = 5e-06
 Identities = 29/148 (19%), Positives = 55/148 (37%), Gaps = 17/148 (11%)

Query: 507 SDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV--K 564
           S    L  G    VY  +  + ++   K     S +   + E EV ++  L  + L   K
Sbjct: 1   SSIKLLKGGLTNRVYL-LGTKDEDYVLKI--NPSREKGADREREVAILQLLARKGLPVPK 57

Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG-IARGLLYLHQDS 623
           ++          L+ E++  ++L             +     + +   +A+    LHQ  
Sbjct: 58  VLASGESDGWSYLLMEWIEGETL-------DEVSEEEKEDIAEQLAELLAK----LHQLP 106

Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFG 651
            L + H DL   N+L+D+     I D+ 
Sbjct: 107 LLVLCHGDLHPGNILVDDGKILGIIDWE 134

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 49.4 bits (118), Expect = 5e-06
 Identities = 53/212 (25%), Positives = 84/212 (39%), Gaps = 48/212 (22%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKR--LSKSSGQG-MEEFENEVLL------I 554
           ++F    KLGEG FG VYK  L+  Q     +  L K++  G +E + NE +        
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSC 191

Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLND------FIFDVTRSKFLD------- 601
           A   +  L  +     + DE  L++ Y    +L D      F ++V              
Sbjct: 192 ADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKG 249

Query: 602 WSKRCQIIGGIARGLLY----LHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMAR-- 654
             +  +II  I R +L+    LH      I+HRD+K  N++        KI D G A   
Sbjct: 250 LERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAAADL 306

Query: 655 AFGIDQTEANTNRVVGTYGYMPPEYAIDGLFS 686
             GI+              Y+P E+ +D  ++
Sbjct: 307 RVGIN--------------YIPKEFLLDPRYA 324

Length = 566

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 48.5 bits (115), Expect = 8e-06
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 6/99 (6%)

Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 671
           IA  +L +H   +L  +HRD+K  NVLLD   + +++DFG       D T   ++  VGT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGT 166

Query: 672 YGYMPPEY--AID---GLFSVKSDVFSFGVLVLEIVCGK 705
             Y+ PE   A++   G +  + D +S GV + E++ G+
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 48.1 bits (114), Expect = 1e-05
 Identities = 38/159 (23%), Positives = 69/159 (43%), Gaps = 14/159 (8%)

Query: 550 EVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQII 609
           E  ++  + H ++++L G  T      LI   LP    + + +   +         C I+
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNI----AICDIL 185

Query: 610 G---GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN 666
                + R + YLH++   RIIHRD+KA N+ +++  +  + DFG A  F +D       
Sbjct: 186 AIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKYY 241

Query: 667 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
              GT     PE      +    D++S G+++ E+    
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 47.2 bits (113), Expect = 1e-05
 Identities = 40/148 (27%), Positives = 64/148 (43%), Gaps = 13/148 (8%)

Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           + N +KL    T     +LI +Y+ +  L D    + +   L  ++  +II  +   L  
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDL---LKKEGKLSEAEVKKIIRQLVEALND 124

Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           LH   +  IIH D+K  NVL D   +   + D+G+ +  G            GT  Y  P
Sbjct: 125 LH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------GTLDYFSP 175

Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E      + V  D ++ GVL  E++ GK
Sbjct: 176 EKIKGHNYDVSFDWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 48.6 bits (115), Expect = 2e-05
 Identities = 65/247 (26%), Positives = 106/247 (42%), Gaps = 40/247 (16%)

Query: 511 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFEN-----EVLLIAKLQHRNLVKL 565
           K+G G FG V+       QE    +    S +G++E E      EV ++ +L+H+N+V+ 
Sbjct: 20  KIGNGRFGEVFLVKHKRTQEFFCWK--AISYRGLKEREKSQLVIEVNVMRELKHKNIVRY 77

Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL----YLHQ 621
           I     +  + L Y  +      D   ++ +   +        I  I R LL    Y H 
Sbjct: 78  IDRFLNKANQKL-YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHN 136

Query: 622 ----DSRLRIIHRDLKASNVLLD-------------NEMN----PKISDFGMARAFGIDQ 660
                +  R++HRDLK  N+ L              N +N     KI DFG+++  GI  
Sbjct: 137 LKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI-- 194

Query: 661 TEANTNRVVGTYGYMPPEYAIDGLFSV--KSDVFSFGVLVLEIVCGKRNRGFYHADHHHN 718
            E+  +  VGT  Y  PE  +    S   KSD+++ G ++ E+  GK    F+ A++   
Sbjct: 195 -ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP--FHKANNFSQ 251

Query: 719 LLGHAWR 725
           L+    R
Sbjct: 252 LISELKR 258

Length = 1021

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 62/280 (22%), Positives = 115/280 (41%), Gaps = 50/280 (17%)

Query: 511 KLGEGGFGPVYKGVLIEGQEIA---AKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLI 566
           ++G G FG V    +     +A    K L  ++  +   EF  +      LQH N+++ +
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61

Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR-----------CQIIGGIARG 615
           G C +    +L++EY     L  ++      +   W +R           C+    IA G
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYL----SQE--QWHRRNSQLLLLQRMACE----IAAG 111

Query: 616 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA-FGIDQTEANTNRVVGTYGY 674
           + ++H   +   +H DL   N  L +++  K+ D+G+  + +  D  E   ++ V    +
Sbjct: 112 VTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRW 167

Query: 675 MPPEYAI---DGLFSVK----SDVFSFGVLVLEIV-CGKRNRGFYHADHHHNLLGHAWRL 726
           + PE       GL + +    S+V++ GV + E+     +    Y       +L H    
Sbjct: 168 LAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP---YSHLSDREVLNHV--- 221

Query: 727 WIEERPVELINKSLGGSYS--LSEVLRCIQVGLLCVQQRP 764
            I+++ V+L    L   YS    EVL   Q   L  ++R 
Sbjct: 222 -IKDQQVKLFKPQLELPYSERWYEVL---QFCWLSPEKRA 257

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 5/93 (5%)

Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 671
           +A  + YLH    L II+RDLK  N+LLD++ +  ++DFG+ +  G++  E  T+   GT
Sbjct: 105 VASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKE-GVEP-EETTSTFCGT 159

Query: 672 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
             Y+ PE      +    D +  G ++ E++ G
Sbjct: 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 46.7 bits (111), Expect = 3e-05
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 6/99 (6%)

Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 671
           +A  +L +    +L  +HRD+K  NVLLD   + +++DFG       D T   +N  VGT
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQSNVAVGT 166

Query: 672 YGYMPPEY--AID---GLFSVKSDVFSFGVLVLEIVCGK 705
             Y+ PE   A++   G +  + D +S GV + E++ G+
Sbjct: 167 PDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 46.5 bits (110), Expect = 3e-05
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 9/95 (9%)

Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN--TNRVV 669
           IA  L YLH    L I++RDLK  N+LLD++ +  ++DFG+ +    +  E N  T+   
Sbjct: 105 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTSTFC 157

Query: 670 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           GT  Y+ PE      +    D +  G ++ E++ G
Sbjct: 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|238074 cd00129, PAN_APPLE, PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins

 Score = 42.7 bits (100), Expect = 3e-05
 Identities = 21/84 (25%), Positives = 36/84 (42%), Gaps = 13/84 (15%)

Query: 339 CEHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSKN---CSCTAYANADVRGGGSGC 395
           C+     L + ++K+  T+ +  D      EC   C KN    SC A+  A  R     C
Sbjct: 5   CKSAGTTLIKIALKIKTTKANTAD------ECANRCEKNGLPFSCKAFVFAKARK---QC 55

Query: 396 LLW-FHDLIDMKELSESGQDLFVR 418
           L + F+ +  +++    G DL+  
Sbjct: 56  LWFPFNSMSGVRKEFSHGFDLYEN 79

Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. Length = 80

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 47.2 bits (112), Expect = 3e-05
 Identities = 21/46 (45%), Positives = 31/46 (67%), Gaps = 3/46 (6%)

Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 654
           I  +A  L YLH+     IIHRDLK  N+L+ NE + K++DFG+++
Sbjct: 110 ISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 46.5 bits (110), Expect = 4e-05
 Identities = 40/141 (28%), Positives = 65/141 (46%), Gaps = 18/141 (12%)

Query: 572 RDERML--IYEYLPNKSLNDFI--FDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI 627
           +D+R L  + EY+P   L + +  +DV       W++        A  +L L     +  
Sbjct: 113 QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFYT-----AEVVLALDAIHSMGF 163

Query: 628 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY----AIDG 683
           IHRD+K  N+LLD   + K++DFG       +      +  VGT  Y+ PE       DG
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDG 222

Query: 684 LFSVKSDVFSFGVLVLEIVCG 704
            +  + D +S GV + E++ G
Sbjct: 223 YYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 47.1 bits (112), Expect = 4e-05
 Identities = 55/222 (24%), Positives = 93/222 (41%), Gaps = 35/222 (15%)

Query: 511 KLGEGGFGPVYKGV-LIEGQEIAAKRLSKS-SGQGM--EEFENEVLLIAKLQHRNLVKLI 566
            +G+GG G VY     +  + +A K++ +  S   +  + F  E  + A L H  +V + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQ----------IIGGIARGL 616
             C+  D       Y+   +L   +  V + + L  SK             I   I   +
Sbjct: 69  SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESL--SKELAEKTSVGAFLSIFHKICATI 126

Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA--------FGIDQTEANT--- 665
            Y+H  S+  ++HRDLK  N+LL       I D+G A            ID  E N    
Sbjct: 127 EYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183

Query: 666 -----NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
                 ++VGT  YM PE  +    S  +D+++ GV++ +++
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225

Length = 932

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 46.3 bits (110), Expect = 4e-05
 Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 32/217 (14%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEE---FENEVLLIAK 556
           E+F     +G G FG V    L+      Q  A K LSK       +   F  E  ++A 
Sbjct: 43  EDFDVIKVIGRGAFGEVQ---LVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAH 99

Query: 557 LQHRNLVKLIGCCTQRDERML--IYEYLPNKSLNDFI--FDVTRSKFLDWSKRCQIIGGI 612
                +V+L      +D++ L  + EY+P   L + +  +D+       W++        
Sbjct: 100 ANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE----KWARFY-----T 148

Query: 613 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID-QTEANTNRVVGT 671
           A  +L L     +  IHRD+K  N+LLD   + K++DFG       +     +T   VGT
Sbjct: 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT--AVGT 206

Query: 672 YGYMPPEY----AIDGLFSVKSDVFSFGVLVLEIVCG 704
             Y+ PE       DG +  + D +S GV + E++ G
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 45.8 bits (109), Expect = 5e-05
 Identities = 61/245 (24%), Positives = 95/245 (38%), Gaps = 70/245 (28%)

Query: 512 LGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEEFEN------EVLLIAKLQHRNLVK 564
           +G G FG V      +   I A K+L KS    M E E       E  ++A+  +  +VK
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKKLRKSE---MLEKEQVAHVRAERDILAEADNPWVVK 65

Query: 565 LIGCCTQRDER--MLIYEYLPNKSL-------NDFIFDVTRSKFLDWSKRCQIIGGIARG 615
           L    + +DE    LI EYLP   +       + F  + TR  F            IA  
Sbjct: 66  LY--YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETR--FY-----------IAET 110

Query: 616 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG----------IDQTEANT 665
           +L +    +L  IHRD+K  N+LLD + + K+SDFG+               +     + 
Sbjct: 111 ILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170

Query: 666 NR--------------------------VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVL 699
                                        VGT  Y+ PE  +   ++ + D +S GV++ 
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY 230

Query: 700 EIVCG 704
           E++ G
Sbjct: 231 EMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 45.4 bits (108), Expect = 6e-05
 Identities = 35/181 (19%), Positives = 70/181 (38%), Gaps = 34/181 (18%)

Query: 544 MEEF---ENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFL 600
            E+    + E++   +LQH N++  +       E  ++   +   S  D +    ++ F 
Sbjct: 40  KEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL----KTHFP 95

Query: 601 DWSKR---CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 657
           +         I+  +   L Y+H       IHR +KAS++LL  +    +S    + +  
Sbjct: 96  EGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSM- 151

Query: 658 IDQTEANTNRVVGTYGYMPPEYAIDGL--------------FSVKSDVFSFGVLVLEIVC 703
                    RVV    +  P+ ++  L              ++ KSD++S G+   E+  
Sbjct: 152 --IKHGKRQRVV----HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELAN 205

Query: 704 G 704
           G
Sbjct: 206 G 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 45.4 bits (107), Expect = 9e-05
 Identities = 43/182 (23%), Positives = 81/182 (44%), Gaps = 18/182 (9%)

Query: 529 QEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLN 588
           +++ AK +  +  +      +E+  +A   H  +VK        D+ +LI EY     LN
Sbjct: 94  EKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLN 153

Query: 589 DFIFDVTRSK--FLDWSKRCQIIGGIARGLLY------LHQDSRLRIIHRDLKASNVLLD 640
             I    +    F ++            GLL+      L +    +++HRDLK++N+ L 
Sbjct: 154 KQIKQRLKEHLPFQEYEV----------GLLFYQIVLALDEVHSRKMMHRDLKSANIFLM 203

Query: 641 NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLE 700
                K+ DFG ++ +    +    +   GT  Y+ PE      +S K+D++S GV++ E
Sbjct: 204 PTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYE 263

Query: 701 IV 702
           ++
Sbjct: 264 LL 265

Length = 478

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 44.5 bits (105), Expect = 1e-04
 Identities = 65/265 (24%), Positives = 99/265 (37%), Gaps = 85/265 (32%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH 559
           E+F     +G+G FG V    L++    G+  A K L KS     E F+ + L   K + 
Sbjct: 1   EDFHTVKVIGKGAFGEVR---LVQKKDTGKIYAMKTLLKS-----EMFKKDQLAHVKAER 52

Query: 560 RNL--------VKLIGCCTQRDERMLIYEYLPNKSL-------NDFIFDVTRSKFLDWSK 604
             L        V L           LI E+LP   L       + F  DVTR  F     
Sbjct: 53  DVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTR--FY---- 106

Query: 605 RCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-------- 656
                  +A  +L +    +L  IHRD+K  N+L+D   + K+SDFG++  F        
Sbjct: 107 -------MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159

Query: 657 --GIDQTEANTNRV-----------------------------------VGTYGYMPPEY 679
              + Q ++N NR+                                   VGT  Y+ PE 
Sbjct: 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEI 219

Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCG 704
            +   +  + D +S G ++ E + G
Sbjct: 220 FLQQGYGQECDWWSLGAIMFECLIG 244

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 44.0 bits (104), Expect = 2e-04
 Identities = 39/180 (21%), Positives = 77/180 (42%), Gaps = 20/180 (11%)

Query: 534 KRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIG----CCTQRDERMLIYEYLPNKSLND 589
           K+  K     ++  ENE+  + ++   N++K+ G             LI EY     L +
Sbjct: 52  KKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLRE 111

Query: 590 FIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNEMNPKIS 648
            +    + K L +  +  +     +GL  L++  ++    +++L + + L+      KI 
Sbjct: 112 VL---DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNK---PYKNLTSVSFLVTENYKLKII 165

Query: 649 DFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFS---VKSDVFSFGVLVLEIVCGK 705
             G+ +       + N N +V    Y   +   D +FS   +K D++S GV++ EI  GK
Sbjct: 166 CHGLEKILSSPPFK-NVNFMV----YFSYKMLND-IFSEYTIKDDIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 41.6 bits (97), Expect = 0.001
 Identities = 27/87 (31%), Positives = 48/87 (55%), Gaps = 6/87 (6%)

Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY--AI 681
           +L  +HRD+K  N+L+D   + +++DFG       D T   ++  VGT  Y+ PE   A+
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAM 178

Query: 682 D---GLFSVKSDVFSFGVLVLEIVCGK 705
           +   G +  + D +S GV + E++ G+
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 41.6 bits (97), Expect = 0.001
 Identities = 34/126 (26%), Positives = 54/126 (42%), Gaps = 33/126 (26%)

Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA----------------RA 655
           IA  +L +    +L  IHRD+K  N+LLD++ + K+SDFG+                  +
Sbjct: 107 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHS 166

Query: 656 FGIDQTEANTN-----------------RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLV 698
              D T  N N                   VGT  Y+ PE  +   ++   D +S GV++
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226

Query: 699 LEIVCG 704
            E++ G
Sbjct: 227 YEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	823
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.98
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.98
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.98
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.98
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.98
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.98
PHA03210	501	serine/threonine kinase US3; Provisional	99.98
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.98
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.98
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.98
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.98
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.98
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.98
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.98
KOG0586	596	consensus Serine/threonine protein kinase [General	99.98
PHA02882	294	putative serine/threonine kinase; Provisional	99.98
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.98
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.98
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.98
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.98
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.98
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.98
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.98
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.97
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.97
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.97
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.97
PLN00009	294	cyclin-dependent kinase A; Provisional	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.97
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.97
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.97
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.97
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.97
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.96
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.96
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.95
PF01453	114	B_lectin: D-mannose binding lectin; InterPro: IPR0	99.95
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.95
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.95
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.95
PF00954	110	S_locus_glycop: S-locus glycoprotein family; Inter	99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.94
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.93
cd00028	116	B_lectin Bulb-type mannose-specific lectin. The do	99.93
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.93
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.93
KOG1152	772	consensus Signal transduction serine/threonine kin	99.93
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.92
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.91
smart00108	114	B_lectin Bulb-type mannose-specific lectin.	99.91
PLN00181	793	protein SPA1-RELATED; Provisional	99.9
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.9
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.9
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.89
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.88
PRK09188	365	serine/threonine protein kinase; Provisional	99.87
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.86
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.83
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.81
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.81
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.81
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.78
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.78
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.77
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.76
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.75
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.74
PRK12274	218	serine/threonine protein kinase; Provisional	99.73
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.72
PRK10345	210	hypothetical protein; Provisional	99.71
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.7
PF08276	66	PAN_2: PAN-like domain; InterPro: IPR013227 PAN do	99.67
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.66
smart00090	237	RIO RIO-like kinase.	99.65
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.65
PRK14879	211	serine/threonine protein kinase; Provisional	99.65
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.63
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.62
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.62
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.59
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.53
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.52
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.48
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.45
cd00129	80	PAN_APPLE PAN/APPLE-like domain; present in N-term	99.44
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.36
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.36
cd01098	84	PAN_AP_plant Plant PAN/APPLE-like domain; present	99.33
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.19
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.16
KOG1243	690	consensus Protein kinase [General function predict	99.09
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.05
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.03
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.97
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.89
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.84
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.83
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.83
KOG3087	229	consensus Serine/threonine protein kinase [General	98.77
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.69
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.68
COG4248	637	Uncharacterized protein with protein kinase and he	98.58
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.41
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.38
PRK09902	216	hypothetical protein; Provisional	98.34
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.34
smart00473	78	PAN_AP divergent subfamily of APPLE domains. Apple	98.34
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.25
smart00108	114	B_lectin Bulb-type mannose-specific lectin.	98.23
PF11883	48	DUF3403: Domain of unknown function (DUF3403); Int	98.2
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.19
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.12
cd00028	116	B_lectin Bulb-type mannose-specific lectin. The do	98.11
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.94
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.94
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.9
PF01636	239	APH: Phosphotransferase enzyme family This family	97.89
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.88
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.88
PF01453	114	B_lectin: D-mannose binding lectin; InterPro: IPR0	97.88
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.85
PLN02876	822	acyl-CoA dehydrogenase	97.7
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.61
PRK10593	297	hypothetical protein; Provisional	97.54
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.46
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.38
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.34
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.29
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.17
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.1
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.02
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.9
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.68
PRK05231	319	homoserine kinase; Provisional	96.68
cd01100	73	APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d	96.59
PLN02236	344	choline kinase	96.5
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.12
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.07
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.06
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.71
PLN02756	418	S-methyl-5-thioribose kinase	95.59
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.4
COG2334	331	Putative homoserine kinase type II (protein kinase	95.1
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.06
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	95.06

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-53  Score=459.05  Aligned_cols=291  Identities=44%  Similarity=0.743  Sum_probs=257.2

Q ss_pred             ccCccCHHHHHHHhcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEe
Q 003391          490 ELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC  569 (823)
Q Consensus       490 ~~~~~~~~~l~~~~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~  569 (823)
                      ....|++.++..+|++|...+.||+|+||.||+|.+.+++.||||++.....+...+|.+|+.++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            56679999999999999999999999999999999999999999988766543256699999999999999999999999


Q ss_pred             ecCC-ceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceee
Q 003391          570 TQRD-ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKIS  648 (823)
Q Consensus       570 ~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~  648 (823)
                      .+.+ +++||||||++|+|.++|+..... .++|.+|++||.++|+||+|||+.+.++|||||||++|||||+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9999 599999999999999999875444 89999999999999999999999998899999999999999999999999


Q ss_pred             ccccceecCCCccccccccc-cccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHh
Q 003391          649 DFGMARAFGIDQTEANTNRV-VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW  727 (823)
Q Consensus       649 DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  727 (823)
                      |||+|+.....  ....... .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+...+.....+..|++..+
T Consensus       220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            99999764321  1111112 79999999999999999999999999999999999999887665555666888988888


Q ss_pred             hhcCchhhhhhhcC-CCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCCC
Q 003391          728 IEERPVELINKSLG-GSYSL-SEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL  783 (823)
Q Consensus       728 ~~~~~~~~~~~~l~-~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~  783 (823)
                      .+....+++|+.+. ..+.. +++..+.+++.+|++.+|.+||+|.||+++|+.+...
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            88889999999987 55554 6888999999999999999999999999999665443

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-44  Score=388.64  Aligned_cols=255  Identities=31%  Similarity=0.473  Sum_probs=209.4

Q ss_pred             CcCCeeeccCccceEEEEeecCcEEEEEEecCCcccc--HHHHHHHHHHHhccCCCCceeEEEEeecCC-ceEEEEeecC
Q 003391          507 SDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQG--MEEFENEVLLIAKLQHRNLVKLIGCCTQRD-ERMLIYEYLP  583 (823)
Q Consensus       507 ~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV~e~~~  583 (823)
                      ...+.||+|+||+||+|.+.....||+|++.......  .++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||+
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            3345699999999999999554449999997653322  568999999999999999999999999887 7999999999


Q ss_pred             CCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCC-CceeeccccceecCCCccc
Q 003391          584 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DFGla~~~~~~~~~  662 (823)
                      +|+|.++|+.. +...+++..+++++.+||+||.|||+.++  ||||||||+|||++.+. ++||+|||+++......  
T Consensus       124 ~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--  198 (362)
T KOG0192|consen  124 GGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--  198 (362)
T ss_pred             CCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--
Confidence            99999999764 45679999999999999999999999874  99999999999999997 99999999998754321  


Q ss_pred             cccccccccCCccCccccc--cCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhc
Q 003391          663 ANTNRVVGTYGYMPPEYAI--DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL  740 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~--~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l  740 (823)
                      .......||+.|||||++.  ...|+.|+||||||++||||+||+.||.....      ...+.         .++....
T Consensus       199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~---------~v~~~~~  263 (362)
T KOG0192|consen  199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVAS---------AVVVGGL  263 (362)
T ss_pred             ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHH---------HHHhcCC
Confidence            2233368999999999999  56999999999999999999999999864332      11111         1111222


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          741 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      +...+......+..++.+||+.||++||++.+++.+|+.+.
T Consensus       264 Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~  304 (362)
T KOG0192|consen  264 RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM  304 (362)
T ss_pred             CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence            23333345668889999999999999999999999998653

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-43  Score=379.93  Aligned_cols=256  Identities=31%  Similarity=0.475  Sum_probs=213.8

Q ss_pred             CCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCCC
Q 003391          506 FSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNK  585 (823)
Q Consensus       506 ~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (823)
                      +...+.||+|-||.||.|.+.....||+|.+... ....+.|.+|+++|.+|+|+|||+++|+|...+..+||||||++|
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            4446799999999999999987889999999654 455688999999999999999999999999988999999999999


Q ss_pred             CcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccccc
Q 003391          586 SLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT  665 (823)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  665 (823)
                      +|.+||.. ..+..+...+.+.++.|||+||+||+++.   +|||||.++||||+++..+||+|||||+....+.... .
T Consensus       287 sLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~-~  361 (468)
T KOG0197|consen  287 SLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA-S  361 (468)
T ss_pred             cHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceee-c
Confidence            99999965 34566899999999999999999999998   9999999999999999999999999999554333322 2


Q ss_pred             ccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCC
Q 003391          666 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY  744 (823)
Q Consensus       666 ~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~  744 (823)
                      ....-+..|.|||.+....|+.|||||||||+||||+| |+.|++.....                +..+.++.--+-..
T Consensus       362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~----------------ev~~~le~GyRlp~  425 (468)
T KOG0197|consen  362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE----------------EVLELLERGYRLPR  425 (468)
T ss_pred             CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH----------------HHHHHHhccCcCCC
Confidence            22345679999999999999999999999999999999 77775433221                12223333333344


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCCC
Q 003391          745 SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL  783 (823)
Q Consensus       745 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~  783 (823)
                      +..++.++.+||..||+.+|++|||++.+...|+.....
T Consensus       426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  426 PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            555777899999999999999999999999999876543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3e-43  Score=361.10  Aligned_cols=249  Identities=27%  Similarity=0.361  Sum_probs=206.2

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC-ccccHHHHHHHHHHHhccCCCCceeEEEEeecCC-ceEEEEee
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD-ERMLIYEY  581 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV~e~  581 (823)
                      +++..+.||+|..|+|||++|+. ++.+|+|.+... .+...+++.+|++++++.+||+||.++|.|.... ...++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            34456799999999999999976 778999999655 3445678999999999999999999999999988 49999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      |++|||++++...   +.+++...-+|+.+|++||.|||+.-  +||||||||+|||++..|++||+|||.++.+-..  
T Consensus       160 MDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--  232 (364)
T KOG0581|consen  160 MDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--  232 (364)
T ss_pred             cCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence            9999999998533   55899999999999999999999732  4999999999999999999999999999876432  


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                        ..+..+||..|||||.+.+..|+.++||||||+.++|+.+|+-|+........              ...++++.++.
T Consensus       233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~--------------~~~~Ll~~Iv~  296 (364)
T KOG0581|consen  233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL--------------DIFELLCAIVD  296 (364)
T ss_pred             --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC--------------CHHHHHHHHhc
Confidence              44568999999999999999999999999999999999999999765411111              11233333333


Q ss_pred             CC---CCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          742 GS---YSL-SEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       742 ~~---~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      +.   .+. ....++.+++..||++||.+||+++|+++.
T Consensus       297 ~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  297 EPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             CCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            21   112 234578999999999999999999999864

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.7e-43  Score=377.25  Aligned_cols=246  Identities=27%  Similarity=0.399  Sum_probs=212.6

Q ss_pred             cCCCcCCeeeccCccceEEEEe-ecCcEEEEEEecCC---ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVL-IEGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~-~~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ..|...+.||+|||+.+|+++. ..|+.||+|++.+.   .....+...+||++.++|+|||||+++++|++.++.|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5688899999999999999998 56999999999774   3345667899999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      |+|++++|.+++.   +++.+++.+++.+..||+.||.|||+.+   |+|||||..|+||+++.++||+|||||..+..+
T Consensus        98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999883   6778999999999999999999999998   999999999999999999999999999987644


Q ss_pred             ccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                      .  .+....+||+.|+|||++....++..+||||+|||||-|+.|++||+..                   ...+.....
T Consensus       172 ~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-------------------~vkety~~I  230 (592)
T KOG0575|consen  172 G--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK-------------------TVKETYNKI  230 (592)
T ss_pred             c--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc-------------------hHHHHHHHH
Confidence            3  3445589999999999999999999999999999999999999998531                   223333333


Q ss_pred             cCCCCCHH--HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          740 LGGSYSLS--EVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       740 l~~~~~~~--~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ...++..+  ...+..+|+..+|+.+|.+|||+++|+..
T Consensus       231 k~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  231 KLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             HhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            33333332  23466789999999999999999999863

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=6.4e-43  Score=392.48  Aligned_cols=261  Identities=29%  Similarity=0.446  Sum_probs=216.2

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec------CcEEEEEEecCCccc-cHHHHHHHHHHHhccCCCCceeEEEEeecCCce
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSSGQ-GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDER  575 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~------~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~  575 (823)
                      ..+....+.||+|.||.||+|+...      ...||||.++..... ...+|++|++++..++|||||+|+|+|.+++..
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            3455567899999999999999643      457999999887655 788999999999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhccC-------C----CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCC
Q 003391          576 MLIYEYLPNKSLNDFIFDVT-------R----SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN  644 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~  644 (823)
                      +||+|||..|+|.+||....       .    ..+++..+.+.||.|||.||+||-++.   +|||||..+|+||.++..
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence            99999999999999996421       1    123889999999999999999999886   999999999999999999


Q ss_pred             ceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHH
Q 003391          645 PKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHA  723 (823)
Q Consensus       645 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~  723 (823)
                      +||+||||++.....+.........-+.+|||||.++.++||.+||||||||+|||+++ |+.|+.....++.       
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV-------  714 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV-------  714 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH-------
Confidence            99999999998766555444434455789999999999999999999999999999998 7777543332211       


Q ss_pred             HHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCC
Q 003391          724 WRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  782 (823)
Q Consensus       724 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  782 (823)
                               .+.+...---+.+..++.++..||..||+.+|++||+++||-..|+....
T Consensus       715 ---------Ie~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  715 ---------IECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             ---------HHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence                     11111111123455677899999999999999999999999999987543

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=352.06  Aligned_cols=199  Identities=30%  Similarity=0.510  Sum_probs=179.7

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC--ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ..+|...++||.|.|++||+|++.. +.+||||.+.+.  .....+.+..|+.+|+.++|||||++++++..++..+|||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            4578888899999999999999876 889999999776  5566677899999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCC------CCceeeccccc
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE------MNPKISDFGMA  653 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~------~~~kl~DFGla  653 (823)
                      |||++|+|.+||+.   .+.+++..+..+..|||.||++||+++   ||||||||+||||+..      -.+||+|||+|
T Consensus        89 EyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            99999999999953   346899999999999999999999998   9999999999999765      45899999999


Q ss_pred             eecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCC
Q 003391          654 RAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGF  710 (823)
Q Consensus       654 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~  710 (823)
                      +.+..   .......+|++-|||||++..++|+.|+|+||.|+||||+++|+.||+.
T Consensus       163 R~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a  216 (429)
T KOG0595|consen  163 RFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA  216 (429)
T ss_pred             hhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence            98753   3344558999999999999999999999999999999999999999863

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-42  Score=354.71  Aligned_cols=247  Identities=26%  Similarity=0.414  Sum_probs=199.9

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccc-------cHHHHHHHHHHHhccCCCCceeEEEEeecCCc
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQ-------GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE  574 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~-------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~  574 (823)
                      .+.|...+.||+|+||.|-+|.... ++.||||++++....       ......+|+++|++++|||||++.+++.+.+.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            3567778999999999999999765 999999999775211       12235799999999999999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCC---CCceeeccc
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFG  651 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DFG  651 (823)
                      .||||||++||.|.+++-   ..+.+.+..-.-++.|++.|+.|||+.|   |+||||||+|||+..+   ..+||+|||
T Consensus       251 ~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG  324 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG  324 (475)
T ss_pred             eEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence            999999999999999984   4455777778889999999999999999   9999999999999766   679999999


Q ss_pred             cceecCCCccccccccccccCCccCccccccCC---CCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhh
Q 003391          652 MARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL---FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWI  728 (823)
Q Consensus       652 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~  728 (823)
                      +|+..+   ........+||+.|.|||++.+..   +..++|+||+|||||-+++|..||.....+.             
T Consensus       325 lAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-------------  388 (475)
T KOG0615|consen  325 LAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-------------  388 (475)
T ss_pred             hhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-------------
Confidence            999864   334456689999999999997654   3348899999999999999999985322211             


Q ss_pred             hcCchhhhhhhcCCCCCH------HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          729 EERPVELINKSLGGSYSL------SEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       729 ~~~~~~~~~~~l~~~~~~------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                           .+.+....+.+..      +--++.++++.+||+.||++|||+.|+++.
T Consensus       389 -----sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  389 -----SLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             -----cHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence                 1112222222211      123477899999999999999999999753

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.6e-42  Score=334.69  Aligned_cols=254  Identities=25%  Similarity=0.391  Sum_probs=205.1

Q ss_pred             cCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCC--ccccHHHHHHHHHHHhccCCCCceeEEE-EeecCCc-eEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIG-CCTQRDE-RMLI  578 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g-~~~~~~~-~~lV  578 (823)
                      .+|.+.++||+|.||.|||++.. +|..+|.|++.-.  +.+.......|+.+|++|+|||||++++ .+.+..+ ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            45777889999999999999964 5889999998744  3445667889999999999999999998 4555555 8999


Q ss_pred             EeecCCCCcchhhhccC-CCCccCHHHHHHHHHHHHHHHHHHHhcCC-CceEecccCCCcEEEcCCCCceeeccccceec
Q 003391          579 YEYLPNKSLNDFIFDVT-RSKFLDWSKRCQIIGGIARGLLYLHQDSR-LRIIHRDLKASNVLLDNEMNPKISDFGMARAF  656 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  656 (823)
                      |||+..|+|...+...+ +.+.+++..+++++.|++.||..+|+.-+ .-|+||||||.||+|+.+|.+||+|||+++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            99999999999997643 45568999999999999999999999431 23999999999999999999999999999988


Q ss_pred             CCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          657 GIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       657 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      ......  ....+|||.||+||.+.+.+|+.|+||||+||++|||..-+.||...      ++.             ++-
T Consensus       179 ~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~-------------~L~  237 (375)
T KOG0591|consen  179 SSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLL-------------SLC  237 (375)
T ss_pred             cchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHH-------------HHH
Confidence            654333  34589999999999999999999999999999999999999997532      222             222


Q ss_pred             hhhcCCCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003391          737 NKSLGGSYS----LSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS  778 (823)
Q Consensus       737 ~~~l~~~~~----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  778 (823)
                      .++-+++++    .-...++..|+..|+..||+.||+...++.-+.
T Consensus       238 ~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  238 KKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             HHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence            222233332    223457888999999999999998555444443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-41  Score=342.84  Aligned_cols=240  Identities=25%  Similarity=0.344  Sum_probs=202.0

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      ..++|+..++||+|+||.|+.++..+ ++.+|+|++++..   ....+...+|..+|.+++||+||+++-.|++.+.+||
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            35789999999999999999999877 8889999997762   3356678899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      |+||+.||.|..+|.   +...+++..+.-++..|+.||.|||+.+   ||||||||+|||||++|+++|+|||+++..-
T Consensus       103 Vld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~  176 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL  176 (357)
T ss_pred             EEeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence            999999999999994   4556899999999999999999999998   9999999999999999999999999999643


Q ss_pred             CCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhh
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN  737 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  737 (823)
                      .  ....+...+||+.|||||++.+..|+..+|+||+|+++|||++|..||...+                   .....+
T Consensus       177 ~--~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~-------------------~~~~~~  235 (357)
T KOG0598|consen  177 K--DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED-------------------VKKMYD  235 (357)
T ss_pred             c--CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc-------------------HHHHHH
Confidence            2  2234455899999999999999999999999999999999999999975322                   122223


Q ss_pred             hhcCCC-CCHH--HHHHHHHHHHHccccCCCCCC
Q 003391          738 KSLGGS-YSLS--EVLRCIQVGLLCVQQRPEDRP  768 (823)
Q Consensus       738 ~~l~~~-~~~~--~~~~l~~l~~~Cl~~dP~~RP  768 (823)
                      ..+.+. ...+  -..+..+++...++.||++|.
T Consensus       236 ~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  236 KILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             HHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence            333222 1111  123667899999999999996

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=364.61  Aligned_cols=255  Identities=26%  Similarity=0.404  Sum_probs=213.9

Q ss_pred             CCcCCeeeccCccceEEEEeec----CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          506 FSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       506 ~~~~~~LG~G~fg~Vyk~~~~~----~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      ..+.++||.|.||.|++|+++-    ...||||.++... +....+|..|..||.+..||||++|.|+.......++|.|
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE  710 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE  710 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence            3567899999999999999864    3479999997763 4456789999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      ||+||+|+.||+.  +...+++.+...++++||.||.||-+.+   +|||||.++|||++.+..+|++||||++.+..+.
T Consensus       711 yMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~  785 (996)
T KOG0196|consen  711 YMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  785 (996)
T ss_pred             hhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC
Confidence            9999999999964  3455999999999999999999999988   9999999999999999999999999999875443


Q ss_pred             ccccccccc--ccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhh
Q 003391          661 TEANTNRVV--GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN  737 (823)
Q Consensus       661 ~~~~~~~~~--gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  737 (823)
                       ........  -+.+|.|||.+...+++.++||||||+|+||.++ |.+|+-....                .+....++
T Consensus       786 -~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN----------------QdVIkaIe  848 (996)
T KOG0196|consen  786 -EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN----------------QDVIKAIE  848 (996)
T ss_pred             -CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch----------------HHHHHHHH
Confidence             22121122  2468999999999999999999999999999876 8898532211                12223334


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCC
Q 003391          738 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  782 (823)
Q Consensus       738 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  782 (823)
                      ...+-..+++++..+.+||+.|||+|-.+||.+.+++.+|+....
T Consensus       849 ~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr  893 (996)
T KOG0196|consen  849 QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR  893 (996)
T ss_pred             hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence            444456678888999999999999999999999999999987643

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.7e-40  Score=327.68  Aligned_cols=263  Identities=21%  Similarity=0.329  Sum_probs=204.5

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc--ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG--QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      +.|+...++|+|+||+|||+++++ |+.||||++.....  .-.+-..+||++|++++|+|+|.++++|..+...+||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            457778899999999999999987 99999999966533  233446899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |++..-|.+ |..  ....++.+.+.+++.|+++|+.|+|+++   +|||||||+||||+.++.+||+|||+|+.+..  
T Consensus        82 ~~dhTvL~e-Le~--~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--  153 (396)
T KOG0593|consen   82 YCDHTVLHE-LER--YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA--  153 (396)
T ss_pred             ecchHHHHH-HHh--ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC--
Confidence            998755544 322  2334788999999999999999999998   99999999999999999999999999998753  


Q ss_pred             cccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhh--
Q 003391          661 TEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN--  737 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~--  737 (823)
                      ........+.|..|+|||.+.+ ..|+..+|||+.||++.||++|..-|+.....+...++......+.... .+++.  
T Consensus       154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prh-q~iF~~N  232 (396)
T KOG0593|consen  154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRH-QSIFSSN  232 (396)
T ss_pred             CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHH-HHHhccC
Confidence            2333445788999999999987 6899999999999999999999988876655555444433222211110 11110  


Q ss_pred             --------hhcCCCCCHHH-----HHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          738 --------KSLGGSYSLSE-----VLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       738 --------~~l~~~~~~~~-----~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                              +......+.+.     ..-+++++..|++.||.+|++-++++.
T Consensus       233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence                    11111111111     125789999999999999999999874

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-39  Score=374.56  Aligned_cols=261  Identities=31%  Similarity=0.460  Sum_probs=214.2

Q ss_pred             cCCCcCCeeeccCccceEEEEeec--Cc----EEEEEEecCC-ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE--GQ----EIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM  576 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~--~~----~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  576 (823)
                      ++.+..+.||+|.||.||+|...+  +.    .||+|.+.+. +.+...+|.+|..+|++++|||||+++|+|.+....+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            445667899999999999999865  33    4899999776 5667789999999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhccCC----CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccc
Q 003391          577 LIYEYLPNKSLNDFIFDVTR----SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM  652 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl  652 (823)
                      +++|||++|+|..||++.+.    ...++....+.++.+||+|+.|||++.   +|||||.++|+||++...+||+||||
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence            99999999999999976432    345889999999999999999999987   99999999999999999999999999


Q ss_pred             ceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcC
Q 003391          653 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEER  731 (823)
Q Consensus       653 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~  731 (823)
                      |+.+...+.........-+..|||||.++++.|+.|+|||||||+||||+| |..|++..+..+.       ...+.++.
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v-------~~~~~~gg  921 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV-------LLDVLEGG  921 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH-------HHHHHhCC
Confidence            997665555544444445679999999999999999999999999999999 7777653222111       01011111


Q ss_pred             chhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCCC
Q 003391          732 PVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL  783 (823)
Q Consensus       732 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~  783 (823)
                               +-..+.-++..+.+||..||+.+|++||++..+++.+..+...
T Consensus       922 ---------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  922 ---------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             ---------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence                     1223445567888999999999999999999999988766433

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=8.3e-39  Score=351.30  Aligned_cols=262  Identities=26%  Similarity=0.384  Sum_probs=203.7

Q ss_pred             HhcCCCcCCeeeccCccceEEEEee------cCcEEEEEEecCCcc-ccHHHHHHHHHHHhcc-CCCCceeEEEEeecC-
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSSG-QGMEEFENEVLLIAKL-QHRNLVKLIGCCTQR-  572 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~------~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-  572 (823)
                      ..++|.+.++||+|+||.||+|.+.      .++.||+|++..... ...+.+.+|+.++.++ +||||+++++++... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            3467888999999999999999752      246799999865432 3346789999999999 899999999998764 


Q ss_pred             CceEEEEeecCCCCcchhhhccCC--------------------------------------------------------
Q 003391          573 DERMLIYEYLPNKSLNDFIFDVTR--------------------------------------------------------  596 (823)
Q Consensus       573 ~~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------  596 (823)
                      ...++||||+++|+|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            457899999999999999864211                                                        


Q ss_pred             ---CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccccccccccccCC
Q 003391          597 ---SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG  673 (823)
Q Consensus       597 ---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~  673 (823)
                         ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++...............++..
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence               134788899999999999999999987   99999999999999999999999999986543322222233456788


Q ss_pred             ccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHH
Q 003391          674 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRC  752 (823)
Q Consensus       674 y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l  752 (823)
                      |+|||++.+..++.++||||||++||||++ |+.||.......      ...........         ...+......+
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~~---------~~~~~~~~~~l  306 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLKDGTR---------MRAPENATPEI  306 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHhcCCC---------CCCCCCCCHHH
Confidence            999999999999999999999999999997 999976432211      01111111110         01111223467


Q ss_pred             HHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          753 IQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       753 ~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      .+++.+|++.+|++||++.|++++|+.+.
T Consensus       307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         307 YRIMLACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            89999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-39  Score=347.07  Aligned_cols=264  Identities=26%  Similarity=0.395  Sum_probs=208.1

Q ss_pred             HHHHhcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceE
Q 003391          499 IANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM  576 (823)
Q Consensus       499 l~~~~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  576 (823)
                      .+...+.+.....||+|.||+||+|.+.  ..||||++....  .+..+.|++|+..+++-+|.||+-++|+|.+... .
T Consensus       387 WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A  463 (678)
T KOG0193|consen  387 WEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A  463 (678)
T ss_pred             cccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence            3344456677889999999999999984  479999997653  3467789999999999999999999999998777 9


Q ss_pred             EEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceec
Q 003391          577 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  656 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  656 (823)
                      +|+.+|+|-+|+.+|+..+  ..++..+.+.|++||++||.|||.++   |||||||..||+|.+++++||+|||++..-
T Consensus       464 IiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk  538 (678)
T KOG0193|consen  464 IITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVK  538 (678)
T ss_pred             eeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeee
Confidence            9999999999999997533  45888999999999999999999998   999999999999999999999999999764


Q ss_pred             CCCccccccccccccCCccCccccccC---CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCch
Q 003391          657 GIDQTEANTNRVVGTYGYMPPEYAIDG---LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV  733 (823)
Q Consensus       657 ~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  733 (823)
                      ..-..........|...|||||+++.+   +|+..+||||||+|+|||+||..|+.....+.....+...      .-..
T Consensus       539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG------~l~p  612 (678)
T KOG0193|consen  539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRG------YLMP  612 (678)
T ss_pred             eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccc------ccCc
Confidence            332222222334577899999999754   6999999999999999999999997622222111111110      0000


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCC
Q 003391          734 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  782 (823)
Q Consensus       734 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  782 (823)
                      +..      ........++.+|+..||..++++||.+.+|+.+|+.+..
T Consensus       613 d~s------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  613 DLS------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             cch------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            110      1122345578899999999999999999999998887654

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=334.00  Aligned_cols=269  Identities=25%  Similarity=0.398  Sum_probs=202.7

Q ss_pred             CCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhc--cCCCCceeEEEEeecCC----ceEEE
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAK--LQHRNLVKLIGCCTQRD----ERMLI  578 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~~----~~~lV  578 (823)
                      .....+++|+|+||.||||.+ +++.||||++...   ..+.|.+|-.+...  ++|+||++++++-..+.    +++||
T Consensus       211 pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             chhhHHHhhcCccceeehhhc-cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            344567899999999999999 5699999999654   34556666666554  68999999999876665    89999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhc------CCCceEecccCCCcEEEcCCCCceeecccc
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD------SRLRIIHRDLKASNVLLDNEMNPKISDFGM  652 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl  652 (823)
                      +||.++|+|.+||    +...++|....+|+..+++||+|||+.      .+++|+|||||++||||.+|+++.|+|||+
T Consensus       287 t~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  287 TEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             eeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            9999999999999    456799999999999999999999975      356799999999999999999999999999


Q ss_pred             ceecCCCccccccccccccCCccCccccccCC-CC-----ccchhHhHHHHHHHHHhcCCCCCCcCCCCccch-------
Q 003391          653 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL-FS-----VKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL-------  719 (823)
Q Consensus       653 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s-----~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l-------  719 (823)
                      |..+.........-..+||.+|||||++.+.- +.     .+.||||+|.|||||++...-+......+..-.       
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~  442 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN  442 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence            99987665555555689999999999997653 22     369999999999999997755421111111111       


Q ss_pred             ---hHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCCCC
Q 003391          720 ---LGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLP  784 (823)
Q Consensus       720 ---~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~  784 (823)
                         +...+..+..++....+-.....   ...+..+++.+..||..||+.|.|+.=|.+.+..+..+.
T Consensus       443 hPt~e~mq~~VV~kK~RP~~p~~W~~---h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  443 HPTLEEMQELVVRKKQRPKIPDAWRK---HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             CCCHHHHHHHHHhhccCCCChhhhhc---CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence               11111111111111111111111   134557889999999999999999999999988775444

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-39  Score=335.85  Aligned_cols=258  Identities=28%  Similarity=0.400  Sum_probs=203.0

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCC--ceEEEEe
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD--ERMLIYE  580 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~e  580 (823)
                      .++...+.||+|.||.||++...+ |...|||.+........+.+.+|+.+|.+++|||||+.+|......  .+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            346667899999999999999876 8999999987664444677899999999999999999999865554  6899999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcC-CCCceeeccccceecCC-
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-EMNPKISDFGMARAFGI-  658 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DFGla~~~~~-  658 (823)
                      |+++|+|.+++.....  .+++..+..++.||++||+|||+++   ||||||||+||||+. ++.+||+|||+++.... 
T Consensus        97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            9999999999954332  6999999999999999999999998   999999999999999 79999999999987653 


Q ss_pred             CccccccccccccCCccCccccccCC-CCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN  737 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  737 (823)
                      ...........||+.|||||++.++. ...++||||+||++.||+||+.|+...     ..............       
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~-------  239 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGRED-------  239 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccC-------
Confidence            12223344578999999999999643 345999999999999999999996432     00111111111111       


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          738 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       738 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                        ....++.....+..+++..|++.+|++|||++++++..--.
T Consensus       240 --~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~  280 (313)
T KOG0198|consen  240 --SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK  280 (313)
T ss_pred             --CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence              01122222334677899999999999999999999875443

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.9e-39  Score=337.50  Aligned_cols=267  Identities=24%  Similarity=0.355  Sum_probs=204.9

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecC--CceEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR--DERML  577 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l  577 (823)
                      .+.|+..++||+|.||.||||+... |+.||+|++....  +.......+||.+|++|+||||++|.+...+.  ...||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            3557777899999999999999755 8899999997765  44556678999999999999999999999876  68999


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      |+|||++ +|.-++.  ...-.++..++..++.||+.||+|+|+.+   |+|||||..|||||++|.+||+|||||+.+.
T Consensus       196 VFeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence            9999977 7777763  23346899999999999999999999998   9999999999999999999999999999886


Q ss_pred             CCccccccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHH-----HHhhhcC
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW-----RLWIEER  731 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~-----~~~~~~~  731 (823)
                      .......+ ..+-|..|.|||++++. .|+.++|+||.||||.||++|+..+......++.+.+...-     ..|....
T Consensus       270 ~~~~~~~T-~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k  348 (560)
T KOG0600|consen  270 PSGSAPYT-SRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK  348 (560)
T ss_pred             CCCCcccc-cceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence            55544444 35679999999999876 69999999999999999999999876554443333222110     0011000


Q ss_pred             ch--hhhhhhcCCCCCHHH-----HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          732 PV--ELINKSLGGSYSLSE-----VLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       732 ~~--~~~~~~l~~~~~~~~-----~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ..  ..+.+...-.-...|     ....++|+..+|..||.+|.|+.++++.
T Consensus       349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            00  001000000000111     2356788999999999999999999853

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.1e-38  Score=311.65  Aligned_cols=277  Identities=24%  Similarity=0.349  Sum_probs=211.3

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccc--cHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQ--GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      ++|...++||+|.||.||+|++.. |+.||||++......  -.....+||+.|+.++|+||+.++++|...+...||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            457778899999999999999755 999999999765322  23457899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      ||+. +|+..+.+  +...++...+..++.++++||+|||++.   |+||||||.|+|+++++.+||+|||+|+.+..+.
T Consensus        82 fm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             eccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            9976 89988854  4557899999999999999999999998   9999999999999999999999999999987654


Q ss_pred             cccccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCc------h
Q 003391          661 TEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP------V  733 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~------~  733 (823)
                      .....  .+-|..|.|||.+.+. .|+..+||||.|||+.||+-|..-|....+.++.   ....+.+-....      .
T Consensus       156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL---~~If~~LGTP~~~~WP~~~  230 (318)
T KOG0659|consen  156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQL---SKIFRALGTPTPDQWPEMT  230 (318)
T ss_pred             ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHH---HHHHHHcCCCCcccCcccc
Confidence            44333  3779999999999875 5999999999999999999988765543332222   222221111110      0


Q ss_pred             hhhhhhc--------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCCCCCCCCCCCc
Q 003391          734 ELINKSL--------GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFF  792 (823)
Q Consensus       734 ~~~~~~l--------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~p~~p~~~  792 (823)
                      ++.+...        ....-.....+.++++..++..||.+|++++|++++ ......|.|..|.-.
T Consensus       231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~-~yf~~~P~pt~~~~l  296 (318)
T KOG0659|consen  231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH-PYFKSLPLPTPPSKL  296 (318)
T ss_pred             ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc-hhhhcCCCCCChhhC
Confidence            1111100        001112223466899999999999999999999876 233445555544443

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=338.93  Aligned_cols=265  Identities=25%  Similarity=0.332  Sum_probs=214.8

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC---ccccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERM  576 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~  576 (823)
                      ...+|..++.||+|+|++|++|+..+ ++++|||++.+.   .+...+-...|-.+|.+| .||.|++|+-.|++...+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            45678899999999999999999766 899999999765   233445567788889999 8999999999999999999


Q ss_pred             EEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceec
Q 003391          577 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  656 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  656 (823)
                      +|+||+++|+|.++|.   +-..+++...+.++.+|+.||+|||+.|   ||||||||+|||||+|+++||+|||-|+.+
T Consensus       151 FvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             EEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence            9999999999999995   3456999999999999999999999998   999999999999999999999999999988


Q ss_pred             CCCccc---------ccc--ccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHH
Q 003391          657 GIDQTE---------ANT--NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR  725 (823)
Q Consensus       657 ~~~~~~---------~~~--~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~  725 (823)
                      ...+..         ...  ...+||..|.+||++.+...++.+|+|+||||||+|+.|+.||....+            
T Consensus       225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne------------  292 (604)
T KOG0592|consen  225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE------------  292 (604)
T ss_pred             ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH------------
Confidence            543222         111  458999999999999999999999999999999999999999853211            


Q ss_pred             HhhhcCchhhhhhhcC--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh-------ccCCCCCCCCCCCC
Q 003391          726 LWIEERPVELINKSLG--GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML-------SGERSLPQPKQPGF  791 (823)
Q Consensus       726 ~~~~~~~~~~~~~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L-------~~~~~~~~p~~p~~  791 (823)
                             .-++.+++.  -.++..-.+.+.+|+.+.|..||.+|++..++-+..       +.+.....|+.-.|
T Consensus       293 -------yliFqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~~~PP~l~py  360 (604)
T KOG0592|consen  293 -------YLIFQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLWQQTPPKLQPY  360 (604)
T ss_pred             -------HHHHHHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhhhcCCCcccCC
Confidence                   111111111  112222235677899999999999999999988764       34455555554444

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-40  Score=342.76  Aligned_cols=266  Identities=23%  Similarity=0.306  Sum_probs=208.1

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHH--HHHHHHHHhccC-CCCceeEEEEeecCC-ceE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEE--FENEVLLIAKLQ-HRNLVKLIGCCTQRD-ERM  576 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~--~~~Ei~~l~~l~-H~niv~l~g~~~~~~-~~~  576 (823)
                      ..++|...++||.|.||.||+|+... +..||||++++.-.. .++  -.+|+..|++|+ |||||++.+++.+.+ .++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            34678888999999999999999765 889999999765432 333  368999999998 999999999998888 899


Q ss_pred             EEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceec
Q 003391          577 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  656 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  656 (823)
                      +|||||+. +|++.+.+.  ++.+++..+..|+.||++||+|+|.+|   +.||||||+|||+..+..+||+|||+|+..
T Consensus        87 fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   87 FVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             eeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence            99999954 999988653  778999999999999999999999999   999999999999999999999999999987


Q ss_pred             CCCccccccccccccCCccCccccc-cCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCch--
Q 003391          657 GIDQTEANTNRVVGTYGYMPPEYAI-DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV--  733 (823)
Q Consensus       657 ~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~--  733 (823)
                      ....   .....+.|..|+|||++. .+.|+.+.|||++|||++||.+-+.-|+...+.++...+-.+...-.+....  
T Consensus       161 ~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg  237 (538)
T KOG0661|consen  161 RSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG  237 (538)
T ss_pred             ccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence            5432   334578899999999986 5679999999999999999999998887654433322222211110011000  


Q ss_pred             hhhhhhcCCCC------CH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003391          734 ELINKSLGGSY------SL-----SEVLRCIQVGLLCVQQRPEDRPNMSSVVLML  777 (823)
Q Consensus       734 ~~~~~~l~~~~------~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  777 (823)
                      ..+...++-.+      +.     ....++++++.+|+..||.+|||++|++++-
T Consensus       238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence            01111111111      11     1345889999999999999999999999864

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=342.88  Aligned_cols=251  Identities=26%  Similarity=0.388  Sum_probs=207.7

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      ...|....+||+|..|.||.++... ++.||||++........+-+.+|+.+|+..+|+|||+++..+..++++++||||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            3567777899999999999998654 889999999887777777889999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      |++|+|.+.+    ....+++.++..|+.++++||+|||.++   |+|||||.+|||++.++.+||+|||++..+...+.
T Consensus       352 m~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~  424 (550)
T KOG0578|consen  352 MEGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS  424 (550)
T ss_pred             cCCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence            9999999988    3345899999999999999999999998   99999999999999999999999999998755443


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                        .....+||+.|||||++....|++|+||||||++++||+-|+.||=...+.....++      ...+ ..+     + 
T Consensus       425 --KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI------a~ng-~P~-----l-  489 (550)
T KOG0578|consen  425 --KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNG-TPK-----L-  489 (550)
T ss_pred             --ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH------hhcC-CCC-----c-
Confidence              444589999999999999999999999999999999999999996322111111110      0000 000     1 


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          742 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                       ......-..+.++..+||+.|+++||+++|+|+.
T Consensus       490 -k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  490 -KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             -CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence             1111122467889999999999999999999863

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=339.40  Aligned_cols=264  Identities=27%  Similarity=0.415  Sum_probs=211.5

Q ss_pred             cCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCcccc-HHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQG-MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      ....++++||+|-||.|..+....+..||||+++...... ..+|..|+++|.+++|||||+++|+|..++.+++|+|||
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            4556788999999999999999888999999998876554 488999999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  662 (823)
                      ++|+|..||...... .+.-....+|+.||+.||+||.+..   +|||||.++|+|++.++++||+|||+++.+...+..
T Consensus       618 EnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             hcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence            999999999653222 1455667789999999999999987   999999999999999999999999999988766666


Q ss_pred             cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcC--CCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhc
Q 003391          663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK--RNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL  740 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~--~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l  740 (823)
                      ......+-+.+|||||.+.-++++.++|||+||+.+||+++-+  +|++....+.   .+...-. +........+    
T Consensus       694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~-~~~~~~~~~~----  765 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGE-FFRDQGRQVV----  765 (807)
T ss_pred             eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhh-hcCCCCccee----
Confidence            5555667789999999999999999999999999999987744  4543221111   1111111 1111111110    


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          741 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                       ...+.-++..+.+++++||..+-++||+++++...|++.
T Consensus       766 -l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  766 -LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             -ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence             112233455788999999999999999999999998764

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-38  Score=325.53  Aligned_cols=262  Identities=23%  Similarity=0.365  Sum_probs=206.9

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc-ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      .+.|+..+.||.|..++||+|+... +..||||++....- ...+.+.+|+..++.++||||++.+..|..+..+|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            4678888999999999999999754 88999999976532 346889999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      ||.+||+.+.++..-... +++..+..|.+++++||.|||++|   .||||||+.||||+++|.+||+|||.+..+....
T Consensus       105 fMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            999999999997644333 899999999999999999999998   9999999999999999999999999887653322


Q ss_pred             cc--cccccccccCCccCcccccc--CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          661 TE--ANTNRVVGTYGYMPPEYAID--GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       661 ~~--~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      ..  ......+||+.|||||+++.  ..|+.|+||||||+...||.+|..||..+.+-..      .... ..+.+..+.
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv------Ll~t-Lqn~pp~~~  253 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV------LLLT-LQNDPPTLL  253 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH------HHHH-hcCCCCCcc
Confidence            21  12256789999999999754  3589999999999999999999999875543211      0111 112221111


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ...+..+.....-..+.+++..|++.||.+|||++++++
T Consensus       254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            111111111111237788999999999999999999875

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.4e-37  Score=336.19  Aligned_cols=264  Identities=26%  Similarity=0.387  Sum_probs=201.9

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-----------------CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-----------------GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKL  565 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l  565 (823)
                      ++|...++||+|+||.||++.+.+                 +..||+|.+.... .....+|.+|+.++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            567888999999999999998643                 2369999987653 2345678999999999999999999


Q ss_pred             EEEeecCCceEEEEeecCCCCcchhhhccC----------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEe
Q 003391          566 IGCCTQRDERMLIYEYLPNKSLNDFIFDVT----------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH  629 (823)
Q Consensus       566 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH  629 (823)
                      ++++.+.+..++||||+++++|.+++....                ....+++..+.+++.||+.||.|||+.+   |+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence            999999999999999999999999885421                1234788999999999999999999988   999


Q ss_pred             cccCCCcEEEcCCCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcC--CC
Q 003391          630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK--RN  707 (823)
Q Consensus       630 ~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~--~p  707 (823)
                      |||||+|||+++++.+||+|||+++.+.............++..|+|||++....++.++||||||+++|||+++.  .|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            9999999999999999999999998654332222233345678999999999889999999999999999999854  44


Q ss_pred             CCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          708 RGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       708 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                      +.....   ..........+.... ..     .....+......+.+++.+|++.+|++|||+.+|.+.|++
T Consensus       242 ~~~~~~---~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         242 YGELTD---EQVIENAGEFFRDQG-RQ-----VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCcCCH---HHHHHHHHHHhhhcc-cc-----ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            432211   111111111111000 00     0011112234578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-38  Score=345.42  Aligned_cols=262  Identities=30%  Similarity=0.402  Sum_probs=208.6

Q ss_pred             hcCCCcCCeeeccCccceEEEEeecC----cE-EEEEEecC---CccccHHHHHHHHHHHhccCCCCceeEEEEeecCCc
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIEG----QE-IAAKRLSK---SSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE  574 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~~----~~-vavK~l~~---~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~  574 (823)
                      .++....++||+|+||.||+|++...    .. ||+|....   .......+|.+|.+++++++|||||+++|++.....
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP  235 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            34555668999999999999998652    23 89998875   245677889999999999999999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccce
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  654 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  654 (823)
                      .++|||+|+||+|.++|...  .+.++..++..++.++|.||+|||+.+   +|||||.++|+|++.+..+||+||||++
T Consensus       236 l~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~  310 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSR  310 (474)
T ss_pred             cEEEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccccc
Confidence            99999999999999999542  225899999999999999999999998   9999999999999999999999999987


Q ss_pred             ecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCch
Q 003391          655 AFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPV  733 (823)
Q Consensus       655 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  733 (823)
                      .-.  ..........-+..|+|||.+....|+.++|||||||++||+++ |..|+......       .+..        
T Consensus       311 ~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-------~v~~--------  373 (474)
T KOG0194|consen  311 AGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-------EVKA--------  373 (474)
T ss_pred             CCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-------HHHH--------
Confidence            542  11111111234679999999999999999999999999999999 77776433221       0000        


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCCCCCC
Q 003391          734 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQP  786 (823)
Q Consensus       734 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~p  786 (823)
                      .++........+...+.++..++..|++.+|++||+|.++.+.|+.+.....+
T Consensus       374 kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  374 KIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             HHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence            11111112223334556778889999999999999999999999987555444

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-37  Score=338.13  Aligned_cols=246  Identities=23%  Similarity=0.376  Sum_probs=204.2

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC----cc-ccHHHHHHHHHHHhccC-CCCceeEEEEeecCCc
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS----SG-QGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDE  574 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~----~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~  574 (823)
                      ...+|...+.||+|.||.|+.|.+.. +..||+|.+.+.    .. ...+.+.+|+.+++.++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            45688899999999999999998764 799999977653    12 33556778999999998 9999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCC-CCceeeccccc
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMA  653 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DFGla  653 (823)
                      .++||||+.+|+|.+++.+   ...+.+..+.+++.|++.|++|+|+.+   |+||||||+|||++.+ +++||+|||++
T Consensus        95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            9999999999999999954   456888999999999999999999998   9999999999999999 99999999999


Q ss_pred             eecCCCccccccccccccCCccCccccccCC-CC-ccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcC
Q 003391          654 RAFGIDQTEANTNRVVGTYGYMPPEYAIDGL-FS-VKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER  731 (823)
Q Consensus       654 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s-~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  731 (823)
                      ....  .........+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||+...                   
T Consensus       169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~-------------------  227 (370)
T KOG0583|consen  169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN-------------------  227 (370)
T ss_pred             cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc-------------------
Confidence            8763  2233445579999999999999877 75 78999999999999999999986411                   


Q ss_pred             chhhhhhhcCCCCCHHH---HHHHHHHHHHccccCCCCCCCHHHHH
Q 003391          732 PVELINKSLGGSYSLSE---VLRCIQVGLLCVQQRPEDRPNMSSVV  774 (823)
Q Consensus       732 ~~~~~~~~l~~~~~~~~---~~~l~~l~~~Cl~~dP~~RPs~~evl  774 (823)
                      ...+......+.+..+.   -.++..++.+|++.+|.+|+++.+++
T Consensus       228 ~~~l~~ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  228 VPNLYRKIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             HHHHHHHHhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            11111112222222111   34778999999999999999999999

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3e-37  Score=329.93  Aligned_cols=246  Identities=20%  Similarity=0.296  Sum_probs=198.4

Q ss_pred             CCeeeccCccceEEEEeecCcEEEEEEecCCcccc---HHHHHHHHHHHhccCCCCceeEEEEeec----CCceEEEEee
Q 003391          509 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQG---MEEFENEVLLIAKLQHRNLVKLIGCCTQ----RDERMLIYEY  581 (823)
Q Consensus       509 ~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~e~  581 (823)
                      ...||+|++|.||+|.+ +++.||||++.......   .+.|.+|+.++.+++||||++++|++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            35899999999999998 78999999997654333   5678899999999999999999999876    3467899999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhc-CCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      +++|+|.+++..   .+.+++.....++.+++.||.|||+. +   ++||||||+|||+++++.+||+|||+++.+....
T Consensus       104 ~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~  177 (283)
T PHA02988        104 CTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP  177 (283)
T ss_pred             CCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence            999999999853   34688999999999999999999985 5   7899999999999999999999999998653221


Q ss_pred             cccccccccccCCccCcccccc--CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          661 TEANTNRVVGTYGYMPPEYAID--GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                           ....++..|+|||++.+  ..++.++|||||||++|||++|+.||......   .+.    .....        .
T Consensus       178 -----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~~~----~~i~~--------~  237 (283)
T PHA02988        178 -----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---EIY----DLIIN--------K  237 (283)
T ss_pred             -----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---HHH----HHHHh--------c
Confidence                 12467889999999976  68999999999999999999999998633211   111    11110        0


Q ss_pred             hcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       739 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      ......+......+.+++.+||+.||++|||++|+++.|+...
T Consensus       238 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        238 NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             CCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            0111122233457889999999999999999999999998754

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-38  Score=310.06  Aligned_cols=235  Identities=28%  Similarity=0.355  Sum_probs=199.1

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc---ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      .++|...+.||.|+||.|..++.+. |..+|+|++.+..-   ...+...+|..+|+.+.||+++++.+.+.+.+.++||
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            3567888999999999999999876 88899999987643   3345567899999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      |||++||.|..+|+   +...+++..++-++.+|+.||+|||+.+   |++|||||+|||||.+|.+||.|||+|+... 
T Consensus       123 meyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~-  195 (355)
T KOG0616|consen  123 MEYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS-  195 (355)
T ss_pred             EeccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec-
Confidence            99999999999995   4445899999999999999999999998   9999999999999999999999999999753 


Q ss_pred             CccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                          ..+...+||+.|+|||++....+..++|.|+|||++|||+.|..||...                   .+..+.++
T Consensus       196 ----~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~-------------------~~~~iY~K  252 (355)
T KOG0616|consen  196 ----GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD-------------------NPIQIYEK  252 (355)
T ss_pred             ----CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC-------------------ChHHHHHH
Confidence                2355689999999999999999999999999999999999999997432                   22334444


Q ss_pred             hcCCCCCH--HHHHHHHHHHHHccccCCCCC
Q 003391          739 SLGGSYSL--SEVLRCIQVGLLCVQQRPEDR  767 (823)
Q Consensus       739 ~l~~~~~~--~~~~~l~~l~~~Cl~~dP~~R  767 (823)
                      ++.+....  ---.++.+|+...+|.|-.+|
T Consensus       253 I~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  253 ILEGKVKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             HHhCcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence            44443222  122356678888889988888

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.6e-37  Score=343.69  Aligned_cols=260  Identities=26%  Similarity=0.379  Sum_probs=202.8

Q ss_pred             hcCCCcCCeeeccCccceEEEEee------cCcEEEEEEecCCc-cccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCc
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDE  574 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~  574 (823)
                      .++|+..++||+|+||.||+|+..      .+..||+|+++... ....+.+.+|+.++..+ +||||+++++++.+.+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            456888999999999999999742      25689999986543 33456788999999999 89999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCC----------------------------------------------------------
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTR----------------------------------------------------------  596 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~----------------------------------------------------------  596 (823)
                      .++||||+++|+|.+++.....                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999999854211                                                          


Q ss_pred             --------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc
Q 003391          597 --------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       597 --------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  662 (823)
                                    ...+++..+.+++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                          124788999999999999999999987   999999999999999999999999999876433222


Q ss_pred             cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |..||.......  ..    ........         .
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~----~~~~~~~~---------~  335 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KF----YKMIKEGY---------R  335 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HH----HHHHHhCc---------c
Confidence            22222345678999999999999999999999999999998 778864322111  11    11111110         0


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          742 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      ...+.....++.+++.+|++.||++||+++||+++|+..
T Consensus       336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            001111234678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.9e-38  Score=339.21  Aligned_cols=245  Identities=26%  Similarity=0.361  Sum_probs=208.4

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc---ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      .-|+.++.||+|+-|.|..|++.. |+..|||++.+..+   .....+.+||.+|+-+.|||++++++++++..++|||.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            446778899999999999999865 99999999977632   23456789999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+++|.|.+++.   +.+.+.+.++.+++.||+.|+.|+|..+   |+||||||+|+|||...++||+|||||..-.  
T Consensus        92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~--  163 (786)
T KOG0588|consen   92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV--  163 (786)
T ss_pred             EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc--
Confidence            9999999999994   4556899999999999999999999998   9999999999999999999999999998632  


Q ss_pred             ccccccccccccCCccCccccccCCC-CccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                       ........+|.+.|.|||++++.+| +.++||||+|||||.|+||+.||+   .                +....++.+
T Consensus       164 -~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd---D----------------dNir~LLlK  223 (786)
T KOG0588|consen  164 -PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD---D----------------DNIRVLLLK  223 (786)
T ss_pred             -CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC---C----------------ccHHHHHHH
Confidence             2233445799999999999999998 678999999999999999999986   1                222334444


Q ss_pred             hcCCCCCHHH--HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          739 SLGGSYSLSE--VLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       739 ~l~~~~~~~~--~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ...+.+.++.  ..++.+|+.+|+..||++|.|+.||++.
T Consensus       224 V~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  224 VQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             HHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence            4445444332  3477889999999999999999999975

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-38  Score=335.10  Aligned_cols=243  Identities=28%  Similarity=0.413  Sum_probs=201.8

Q ss_pred             CCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCCC
Q 003391          506 FSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNK  585 (823)
Q Consensus       506 ~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (823)
                      ....+-||.|+-|.||+|++ .++.||||+++...       ..+|+-|++|+||||+.|.|+|.....++||||||..|
T Consensus       126 IsELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G  197 (904)
T KOG4721|consen  126 ISELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG  197 (904)
T ss_pred             hhhhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence            34467899999999999998 67899999985432       35788999999999999999999999999999999999


Q ss_pred             CcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccccc
Q 003391          586 SLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT  665 (823)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  665 (823)
                      -|...|.   .+..+.......+..+||.||.|||.+.   |||||||.-||||..+..+||+|||.++.....   ...
T Consensus       198 qL~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STk  268 (904)
T KOG4721|consen  198 QLYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STK  268 (904)
T ss_pred             cHHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhh
Confidence            9999994   4556888899999999999999999997   999999999999999999999999999876422   344


Q ss_pred             ccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCC
Q 003391          666 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYS  745 (823)
Q Consensus       666 ~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~  745 (823)
                      ..++||..|||||++.+.+.++|+||||||||||||+||..|+.-.+..  ..+.             -+=...+.-..+
T Consensus       269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss--AIIw-------------GVGsNsL~LpvP  333 (904)
T KOG4721|consen  269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS--AIIW-------------GVGSNSLHLPVP  333 (904)
T ss_pred             hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh--eeEE-------------eccCCcccccCc
Confidence            5689999999999999999999999999999999999999996422111  0000             000112222334


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          746 LSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       746 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      ..++.-+.-|+..||+..|..||++++++..|+=.
T Consensus       334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            45666777889999999999999999999998743

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3e-37  Score=342.84  Aligned_cols=260  Identities=27%  Similarity=0.421  Sum_probs=203.1

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec------CcEEEEEEecCCc-cccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCc
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSS-GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDE  574 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~  574 (823)
                      .++|...+.||+|+||.||+|+...      +..||+|++.... ....+.+.+|+.+++.+ +|+||+++++++...+.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            4578889999999999999998532      3579999997543 23345688999999999 89999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccC-----------------------------------------------------------
Q 003391          575 RMLIYEYLPNKSLNDFIFDVT-----------------------------------------------------------  595 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~-----------------------------------------------------------  595 (823)
                      .++||||+++|+|.+++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999999885321                                                           


Q ss_pred             --------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccccccc
Q 003391          596 --------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR  667 (823)
Q Consensus       596 --------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  667 (823)
                              ....+++.++++++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++.............
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                    1124788899999999999999999987   99999999999999999999999999986543322222222


Q ss_pred             ccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCH
Q 003391          668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSL  746 (823)
Q Consensus       668 ~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~  746 (823)
                      ..++..|+|||++.+..++.++||||||+++|||++ |+.||.......  ..    .....         .......+.
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~----~~~~~---------~~~~~~~~~  338 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KF----YKMVK---------RGYQMSRPD  338 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HH----HHHHH---------cccCccCCC
Confidence            345678999999999999999999999999999997 999975332111  00    00000         000111111


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          747 SEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       747 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      ....++.+++.+|++.+|++||++.+|+++|+.+
T Consensus       339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1134678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.5e-36  Score=376.76  Aligned_cols=264  Identities=25%  Similarity=0.452  Sum_probs=209.8

Q ss_pred             HHhcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          501 NATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       501 ~~~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      .....+...+.||+|+||.||+|+.. ++..||+|++......    ...|++++++++|||||+++|+|.+.+..++||
T Consensus       687 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~  762 (968)
T PLN00113        687 DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH  762 (968)
T ss_pred             HHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence            33456778889999999999999974 5889999998654322    235688999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+++|+|.+++.      .++|..+.+|+.||++||+|||+.+.++|+||||||+||+++.++..++. ||.+..... 
T Consensus       763 Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-  834 (968)
T PLN00113        763 EYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-  834 (968)
T ss_pred             eCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-
Confidence            9999999999984      27999999999999999999997655679999999999999999888875 665543211 


Q ss_pred             ccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                           .....+++.|+|||++.+..++.++|||||||++|||+||+.|++.... ....+..+.............+++.
T Consensus       835 -----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  908 (968)
T PLN00113        835 -----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPS  908 (968)
T ss_pred             -----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCcc
Confidence                 1123678999999999999999999999999999999999999853222 2233444433332233333445555


Q ss_pred             cCC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCC
Q 003391          740 LGG--SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  782 (823)
Q Consensus       740 l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  782 (823)
                      +..  ..+.++..++.+++.+|++.+|++||+|+||+++|+....
T Consensus       909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            533  2345667789999999999999999999999999997643

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=8.4e-38  Score=332.07  Aligned_cols=245  Identities=25%  Similarity=0.376  Sum_probs=207.8

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      ++|.+.+.||+|.||.||||+.+. .+.||+|.+.+..  +...+.+.+|+++++.++|||||.+++.|+...+.++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            467778899999999999999876 7889999987653  4456678999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |+.+ +|..+|.   ....++++.+..|+.+++.||.|||+..   |.|||+||+|||++..+.+|++|||+|+..... 
T Consensus        82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-  153 (808)
T KOG0597|consen   82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-  153 (808)
T ss_pred             hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-
Confidence            9988 9999984   4556999999999999999999999987   999999999999999999999999999976432 


Q ss_pred             cccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhc
Q 003391          661 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL  740 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l  740 (823)
                       ......+.||+.|||||.+.+++|+..+|+||+||||||+++|+.||-                   .....+++..++
T Consensus       154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~-------------------a~si~~Lv~~I~  213 (808)
T KOG0597|consen  154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY-------------------ARSITQLVKSIL  213 (808)
T ss_pred             -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch-------------------HHHHHHHHHHHh
Confidence             233445789999999999999999999999999999999999999962                   122233333333


Q ss_pred             CCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          741 GGS--YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       741 ~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ...  .+......+..++...+++||.+|.+..+++..
T Consensus       214 ~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  214 KDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             cCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence            322  223344578899999999999999999998764

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-37  Score=335.21  Aligned_cols=241  Identities=25%  Similarity=0.372  Sum_probs=207.1

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC---ccccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERM  576 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~  576 (823)
                      ..++|...++||+|.||.|+++.++. ++.+|||.+++.   ..+..+..+.|-.++... +||.+++++.+++.+++++
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            45789999999999999999999876 788999999886   356677788888888777 5999999999999999999


Q ss_pred             EEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceec
Q 003391          577 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  656 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  656 (823)
                      +||||+.||++..+.    +...+++..+.-++..|+.||.|||+++   ||+||||.+|||||.+|.+||+||||++..
T Consensus       446 fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~  518 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG  518 (694)
T ss_pred             EEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence            999999999965544    4566999999999999999999999998   999999999999999999999999999964


Q ss_pred             CCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          657 GIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       657 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      -  .....+...+||+.|||||++.+..|+..+|.|||||+||||+.|+.||+..+.                   .+++
T Consensus       519 m--~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE-------------------ee~F  577 (694)
T KOG0694|consen  519 M--GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE-------------------EEVF  577 (694)
T ss_pred             C--CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH-------------------HHHH
Confidence            2  133456779999999999999999999999999999999999999999864332                   3455


Q ss_pred             hhhcCCC--CCHHHHHHHHHHHHHccccCCCCCCCH
Q 003391          737 NKSLGGS--YSLSEVLRCIQVGLLCVQQRPEDRPNM  770 (823)
Q Consensus       737 ~~~l~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPs~  770 (823)
                      +.++..+  ++.-...+.+.|+.+++..+|++|.-+
T Consensus       578 dsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  578 DSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            5555443  333445578899999999999999977

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=7.6e-37  Score=326.02  Aligned_cols=271  Identities=23%  Similarity=0.278  Sum_probs=211.3

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      ..++|.....||+|+||.||.++-++ |..+|+|++++..   ....+..+.|-.+|....+|.||+|+..|++.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            45789999999999999999999876 8899999998874   3445667889999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      ||||++||++..+|   .+...|++..+..++.+++.|+..||+.|   +|||||||+|+|||..|++||+||||+.-+.
T Consensus       219 iMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence            99999999999998   45667999999999999999999999998   9999999999999999999999999996431


Q ss_pred             CC---------------------cccc-----c-------------------cccccccCCccCccccccCCCCccchhH
Q 003391          658 ID---------------------QTEA-----N-------------------TNRVVGTYGYMPPEYAIDGLFSVKSDVF  692 (823)
Q Consensus       658 ~~---------------------~~~~-----~-------------------~~~~~gt~~y~aPE~l~~~~~s~ksDVw  692 (823)
                      ..                     ....     .                   ....+|||.|||||++.+..|+..+|.|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            10                     0000     0                   1136799999999999999999999999


Q ss_pred             hHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCC---
Q 003391          693 SFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPN---  769 (823)
Q Consensus       693 S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---  769 (823)
                      |+|||+||||.|.+||....+.+.-.-+......             +......+...+..+||.+|+. ||++|.-   
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~-------------l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G  438 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET-------------LKFPEEVDLSDEAKDLITRLLC-DPENRLGSKG  438 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh-------------ccCCCcCcccHHHHHHHHHHhc-CHHHhcCccc
Confidence            9999999999999998755443321111110000             1111111112467789999999 9999986   


Q ss_pred             HHHHHHH-------hccCCCCCCCCCCCCc
Q 003391          770 MSSVVLM-------LSGERSLPQPKQPGFF  792 (823)
Q Consensus       770 ~~evl~~-------L~~~~~~~~p~~p~~~  792 (823)
                      +.||-++       .+.+.+.+.|=.|...
T Consensus       439 ~~EIK~HPfF~~v~W~~l~~~~apfvP~v~  468 (550)
T KOG0605|consen  439 AEEIKKHPFFKGVDWDHLREMPAPFVPQVN  468 (550)
T ss_pred             HHHHhcCCccccCCcchhhcCCCCCCCCCC
Confidence            4444432       1345555555555544

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.2e-36  Score=330.90  Aligned_cols=259  Identities=26%  Similarity=0.438  Sum_probs=202.6

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-Cc----EEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQ----EIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~----~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      .+|+..+.||+|+||.||+|++.. +.    .||+|++.... ....+++.+|+.+++.++||||++++|+|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            468888999999999999998653 33    38999986543 34456789999999999999999999999764 5789


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      |+||+++|+|.+++...  ...+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence            99999999999998542  335789999999999999999999987   9999999999999999999999999998765


Q ss_pred             CCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      .............+..|+|||.+.+..++.++||||||+++|||++ |+.|++.....   .+    ... ..       
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~----~~~-~~-------  225 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EI----SSI-LE-------  225 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HH----HHH-Hh-------
Confidence            4332222222334678999999999999999999999999999998 99887432110   00    000 00       


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCCCC
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLP  784 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~  784 (823)
                       .......+.....++.+++.+|++.+|++||++.+++..|......+
T Consensus       226 -~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         226 -KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             -CCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence             00000111122346788999999999999999999999998765433

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.9e-36  Score=323.65  Aligned_cols=257  Identities=30%  Similarity=0.476  Sum_probs=205.2

Q ss_pred             cCCCcCCeeeccCccceEEEEeecC------cEEEEEEecCCcc-ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIEG------QEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM  576 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~~------~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  576 (823)
                      ++|+..+.||+|+||.||+|.....      ..+|+|.+..... ....++.+|+.++.+++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            4677889999999999999987542      5799998865432 33457899999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhccCC-------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCC
Q 003391          577 LIYEYLPNKSLNDFIFDVTR-------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM  643 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~  643 (823)
                      ++|||+++++|.+++.....             ...+++..+..++.|+++||.|||+.+   ++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999999864221             145888999999999999999999988   99999999999999999


Q ss_pred             CceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHH
Q 003391          644 NPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGH  722 (823)
Q Consensus       644 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~  722 (823)
                      .+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||......   .+   
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~---  235 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EV---  235 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HH---
Confidence            999999999986543332222333456789999999999999999999999999999998 99887432211   01   


Q ss_pred             HHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          723 AWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       723 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                       ..         .+........+.....++.+|+.+|++.+|.+||+++||++.|+.
T Consensus       236 -~~---------~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         236 -IE---------MIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             -HH---------HHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence             01         111111111222334678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-37  Score=319.14  Aligned_cols=255  Identities=26%  Similarity=0.355  Sum_probs=204.8

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--------------cccHHHHHHHHHHHhccCCCCceeEE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--------------GQGMEEFENEVLLIAKLQHRNLVKLI  566 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--------------~~~~~~~~~Ei~~l~~l~H~niv~l~  566 (823)
                      ..+.|++.+.||+|.||.|-+|+... ++.||||++.+..              ....+...+||.+|++++|||||+|+
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            45778999999999999999999754 8899999986642              11346789999999999999999999


Q ss_pred             EEeecC--CceEEEEeecCCCCcchhhhccCCCCc-cCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCC
Q 003391          567 GCCTQR--DERMLIYEYLPNKSLNDFIFDVTRSKF-LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM  643 (823)
Q Consensus       567 g~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~  643 (823)
                      ++..+.  +..|||+|||..|.+...-    ..+. ++..++++++.+++.||+|||.++   ||||||||.|+||++++
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence            999765  5789999999998876532    3344 899999999999999999999998   99999999999999999


Q ss_pred             CceeeccccceecCCC---ccccccccccccCCccCccccccCC----CCccchhHhHHHHHHHHHhcCCCCCCcCCCCc
Q 003391          644 NPKISDFGMARAFGID---QTEANTNRVVGTYGYMPPEYAIDGL----FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH  716 (823)
Q Consensus       644 ~~kl~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPE~l~~~~----~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~  716 (823)
                      ++||+|||.+..+...   .........+||+.|+|||.+.++.    .+.+.||||+||.||.|+.|+.||-       
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~-------  320 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF-------  320 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc-------
Confidence            9999999999876222   1112233478999999999998743    3668999999999999999999963       


Q ss_pred             cchhHHHHHHhhhcCchhhhhhhcCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCC
Q 003391          717 HNLLGHAWRLWIEERPVELINKSLGGS----YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  782 (823)
Q Consensus       717 ~~l~~~~~~~~~~~~~~~~~~~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  782 (823)
                                  .+...++.+++++..    ...+.-+++.+|+.++|++||++|.+..+|....--...
T Consensus       321 ------------~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  321 ------------DDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             ------------cchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence                        222334444444332    222345678899999999999999999999877654443

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5.4e-37  Score=323.71  Aligned_cols=249  Identities=33%  Similarity=0.505  Sum_probs=192.8

Q ss_pred             CCeeeccCccceEEEEee-----cCcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          509 KNKLGEGGFGPVYKGVLI-----EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       509 ~~~LG~G~fg~Vyk~~~~-----~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      .+.||.|.||.||+|.+.     .+..|+||.+.... ....++|.+|++.+.+++||||++++|++...+..++|+||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            468999999999999987     26789999996543 334788999999999999999999999999888899999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  662 (823)
                      ++|+|.++|... ....+++..+..|+.||++||+|||+.+   ++|+||+++||++++++.+||+|||++.........
T Consensus        84 ~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   84 PGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence            999999999654 2456899999999999999999999987   999999999999999999999999999876333222


Q ss_pred             cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                      ...........|+|||.+.+..++.++||||||+++|||++ |+.|+.....   ..    ......+...         
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~----~~~~~~~~~~---------  223 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EE----IIEKLKQGQR---------  223 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HH----HHHHHHTTEE---------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccc---cc----cccccccccc---------
Confidence            33333456789999999999999999999999999999999 6777532211   00    1111111111         


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003391          742 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML  777 (823)
Q Consensus       742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  777 (823)
                      ...+......+.+++..||..+|++||++.++++.|
T Consensus       224 ~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            111222345678999999999999999999999886

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-36  Score=317.56  Aligned_cols=255  Identities=27%  Similarity=0.411  Sum_probs=205.3

Q ss_pred             hcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      .++|+..+.||+|++|.||+|...+++.||+|.++... ...+++.+|+.++++++||||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            45688889999999999999998778899999986543 34577899999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  662 (823)
                      ++++|.+++.... ...+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||+++........
T Consensus        84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            9999999985432 346899999999999999999999987   999999999999999999999999999876522111


Q ss_pred             cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                       .......+..|+|||.+.+..++.++||||||+++|||++ |+.|+......       .........         ..
T Consensus       160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~---------~~  222 (261)
T cd05068         160 -AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-------EVLQQVDQG---------YR  222 (261)
T ss_pred             -ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcC---------CC
Confidence             1111223458999999999999999999999999999999 88886432110       011111110         00


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          742 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                      ...+......+.+++.+|++.+|++||++.++++.|+.
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            11112233578899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=324.96  Aligned_cols=249  Identities=24%  Similarity=0.415  Sum_probs=206.9

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC-ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      ..|+..++||+|.||.||||.... ++.||+|++... .+..++++++|+.++.+++++||.+.+|.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            456677899999999999999866 788999999755 456678899999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +.+|++.+.|   +....+++..+.-|..+++.||.|||.++   .+|||||+.|||+..++.+||+|||.+-.+.....
T Consensus        93 ~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   93 CGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             hcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            9999999988   34445588888889999999999999998   99999999999999999999999999988754433


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                      ..  ...+||+.|||||++....|+.|+||||||++.+||.+|..|+...++-....++..        ..    -+.+.
T Consensus       167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk--------~~----PP~L~  232 (467)
T KOG0201|consen  167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK--------SA----PPRLD  232 (467)
T ss_pred             cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC--------CC----CCccc
Confidence            33  568999999999999988999999999999999999999999765554222211110        00    11122


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          742 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      +.+    -..+.+++..|++.+|+.||+++++++.
T Consensus       233 ~~~----S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  233 GDF----SPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             ccc----CHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            222    2357789999999999999999998863

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.4e-36  Score=322.06  Aligned_cols=259  Identities=25%  Similarity=0.422  Sum_probs=202.7

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec------CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCc
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE  574 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~  574 (823)
                      ..++|+..+.||+|+||.||+|.+..      +..+|+|++.... .....++.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            45778999999999999999998642      4679999886543 2344568899999999999999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCC-------CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCcee
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTR-------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI  647 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl  647 (823)
                      .++||||+++++|.+++.....       ...+++..+..++.|+++||.|||+.+   ++|+||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            9999999999999999864221       234678899999999999999999987   999999999999999999999


Q ss_pred             eccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHH
Q 003391          648 SDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRL  726 (823)
Q Consensus       648 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~  726 (823)
                      +|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+......       .....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~-------~~~~~  233 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-------QVLRF  233 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHH
Confidence            99999986543322222222345778999999999999999999999999999999 67776432111       11111


Q ss_pred             hhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          727 WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       727 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                      .......         ..+......+.+++.+|++.+|++||++.|++++|+.
T Consensus       234 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         234 VMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            1111100         1111223468899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.4e-36  Score=320.56  Aligned_cols=257  Identities=28%  Similarity=0.446  Sum_probs=210.7

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      +..+|+..++||.|+||.||+|...+++.+++|.+.........++.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            34568888999999999999999988999999999877665677899999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++++|.+++... ....+++..+..++.||+.||.|||+.+   |+|+||||+||++++++.+||+|||++........
T Consensus        84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            9999999999653 2345899999999999999999999988   99999999999999999999999999986643221


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhc
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL  740 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l  740 (823)
                      .  .....++..|+|||.+.+..++.++||||||++++||++ |+.|+.....   ......    ..         ...
T Consensus       160 ~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~----~~---------~~~  221 (261)
T cd05148         160 L--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQ----IT---------AGY  221 (261)
T ss_pred             c--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHH----HH---------hCC
Confidence            1  112345678999999998899999999999999999998 8888753221   111111    01         111


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          741 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      ....+......+.+++.+|++.+|.+|||++++++.|+.+
T Consensus       222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            1112223345788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.5e-36  Score=319.92  Aligned_cols=255  Identities=24%  Similarity=0.345  Sum_probs=201.3

Q ss_pred             cCCCcCCeeeccCccceEEEEee----cCcEEEEEEecCCcc-ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLI----EGQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~----~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      ++|+..+.||+|+||.||+|.+.    .+..||+|.++.... ...+.+.+|+.++.+++||||+++++++..++..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            46788899999999999999864    256899999876532 3345788999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      |||+++|+|.+++...  ...+++..++.++.||+.||+|||+.+   ++||||||+||+++.++.++++|||.+.....
T Consensus        85 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          85 TEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             EEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            9999999999998532  346899999999999999999999987   99999999999999999999999998765322


Q ss_pred             CccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN  737 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  737 (823)
                      ... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......   .+.    ......       
T Consensus       160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~----~~~~~~-------  224 (266)
T cd05064         160 EAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVI----KAVEDG-------  224 (266)
T ss_pred             cch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHH----HHHHCC-------
Confidence            111 11112345678999999999999999999999999999775 99987532211   010    111110       


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          738 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       738 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                        .....+...+..+.+++..||+.+|++||++.++++.|+..
T Consensus       225 --~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         225 --FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             --CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence              00111222345678899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3e-36  Score=336.38  Aligned_cols=261  Identities=25%  Similarity=0.368  Sum_probs=205.0

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec------CcEEEEEEecCCcc-ccHHHHHHHHHHHhccC-CCCceeEEEEeecCCc
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDE  574 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~------~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~  574 (823)
                      .++|.+.++||+|+||.||+|+...      ...||+|++..... ...+.+.+|+.++.++. ||||+++++++.+...
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            4678889999999999999998632      34699999975533 33457899999999996 9999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCC----------------------------------------------------------
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTR----------------------------------------------------------  596 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~----------------------------------------------------------  596 (823)
                      .+|||||+++|+|.++|.....                                                          
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            9999999999999998864210                                                          


Q ss_pred             -----------------------------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcC
Q 003391          597 -----------------------------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN  641 (823)
Q Consensus       597 -----------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~  641 (823)
                                                         ...+++..+..++.||++||+|||+.+   |+|+||||+|||+++
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence                                               124788889999999999999999987   999999999999999


Q ss_pred             CCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchh
Q 003391          642 EMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLL  720 (823)
Q Consensus       642 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~  720 (823)
                      ++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+.....+.  .+ 
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--~~-  349 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--TF-  349 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--HH-
Confidence            99999999999987643322222233456788999999999999999999999999999997 888875322111  00 


Q ss_pred             HHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          721 GHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       721 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                         .......         ............+.+++.+||+.+|++||++.+|+++|+.+.
T Consensus       350 ---~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         350 ---YNKIKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             ---HHHHhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence               0001110         001111223357789999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4.5e-36  Score=315.99  Aligned_cols=252  Identities=27%  Similarity=0.385  Sum_probs=201.0

Q ss_pred             cCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecC
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP  583 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (823)
                      ++|+..+.||+|+||.||++.+.++..+|+|.+... ....+++.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            457778899999999999999888889999988543 3345788999999999999999999999999999999999999


Q ss_pred             CCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccc
Q 003391          584 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA  663 (823)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  663 (823)
                      +|+|.+++...  ...+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.+||+|||+++........ 
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05114          83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-  156 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence            99999988542  235889999999999999999999988   999999999999999999999999999865322211 


Q ss_pred             ccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCC
Q 003391          664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG  742 (823)
Q Consensus       664 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~  742 (823)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.....   ......    ......         .
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~----i~~~~~---------~  220 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEM----ISRGFR---------L  220 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH----HHCCCC---------C
Confidence            1122345668999999998899999999999999999999 8888643221   111111    111100         0


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003391          743 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS  778 (823)
Q Consensus       743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  778 (823)
                      ..+......+.+++.+|++.+|++||++++++++|+
T Consensus       221 ~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         221 YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            001112246789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=4.1e-36  Score=321.66  Aligned_cols=250  Identities=24%  Similarity=0.339  Sum_probs=198.3

Q ss_pred             CCcCCeeeccCccceEEEEee-cCcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          506 FSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       506 ~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      |+..+.||+|+||.||++... +++.||+|++....   ......+.+|+.++.+++|+|++++++++.+.+..++|+||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            667789999999999999975 48899999986542   22344678999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++|+|.+++.... ...+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++....... 
T Consensus        82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          82 MNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             cCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence            99999998875432 335899999999999999999999988   9999999999999999999999999998753221 


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                        ......||..|+|||++.+..++.++|||||||++|||++|+.||.........   ........        ..  .
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~--------~~--~  221 (285)
T cd05631         157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVK--------ED--Q  221 (285)
T ss_pred             --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhh--------cc--c
Confidence              123357899999999999999999999999999999999999998643221110   00000000        00  0


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 003391          742 GSYSLSEVLRCIQVGLLCVQQRPEDRPN-----MSSVVL  775 (823)
Q Consensus       742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  775 (823)
                      ..+.......+.+|+.+||+.||++||+     ++++++
T Consensus       222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            1111122346778999999999999997     777775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.2e-36  Score=321.42  Aligned_cols=257  Identities=29%  Similarity=0.456  Sum_probs=204.8

Q ss_pred             cCCCcCCeeeccCccceEEEEeec------CcEEEEEEecCCccc-cHHHHHHHHHHHhccCCCCceeEEEEeecCCceE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSSGQ-GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM  576 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~------~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  576 (823)
                      ++|...+.||+|+||.||+|+..+      ++.+|+|.+...... ..+.+.+|++++++++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            457778899999999999998743      478999998765444 4578999999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhccC-----------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCc
Q 003391          577 LIYEYLPNKSLNDFIFDVT-----------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP  645 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  645 (823)
                      +||||+++++|.+++....           ....+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence            9999999999999996422           2345789999999999999999999988   9999999999999999999


Q ss_pred             eeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHH
Q 003391          646 KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAW  724 (823)
Q Consensus       646 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~  724 (823)
                      ||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......   ....   
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~~---  235 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVIE---  235 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH---
Confidence            9999999986533222222223445788999999999999999999999999999998 99986432211   1111   


Q ss_pred             HHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          725 RLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       725 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                       ......         ....+......+.+++.+||+.+|++||++.||++.|+.
T Consensus       236 -~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         236 -CITQGR---------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             -HHHcCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence             001110         001111233567899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4.1e-36  Score=317.13  Aligned_cols=255  Identities=28%  Similarity=0.409  Sum_probs=205.2

Q ss_pred             hcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      .++|+..++||+|+||.||+|...+++.+|+|++.... ...+.+.+|+.++++++|+||+++++.+.+.+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            35788889999999999999998888899999886533 34578899999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  662 (823)
                      ++++|.+++... ....+++..+..++.|+++||+|||+.+   ++|+||||+||++++++.++|+|||++.........
T Consensus        84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05072          84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT  159 (261)
T ss_pred             CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence            999999998543 2345889999999999999999999987   999999999999999999999999999876432211


Q ss_pred             cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                       ......++..|+|||.+....++.++||||||+++|||++ |+.||......   ...    .......         .
T Consensus       160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~----~~~~~~~---------~  222 (261)
T cd05072         160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVM----SALQRGY---------R  222 (261)
T ss_pred             -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHH----HHHHcCC---------C
Confidence             1122345678999999998899999999999999999998 88887532111   111    1111110         0


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          742 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                      ..........+.+++.+|++.+|++||++++++++|+.
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         223 MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            01111223467899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.2e-36  Score=329.58  Aligned_cols=265  Identities=22%  Similarity=0.288  Sum_probs=202.7

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      .++|+..+.||+|+||.||+++... +..+|+|.+.... ....+++.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            3678889999999999999999865 7788999886543 2345678999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||+.+  .|+||||||+|||++.++.+||+|||++..+... 
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  157 (331)
T cd06649          84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (331)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence            9999999999853   345889999999999999999999863  3999999999999999999999999999765321 


Q ss_pred             cccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHH----------------
Q 003391          661 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW----------------  724 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~----------------  724 (823)
                         ......|+..|+|||++.+..++.++||||||+++|||++|+.||...+..+.........                
T Consensus       158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (331)
T cd06649         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR  234 (331)
T ss_pred             ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence               2233568999999999999999999999999999999999999985432211000000000                


Q ss_pred             -----------HHhhhcCchhhhhhhcCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          725 -----------RLWIEERPVELINKSLGGS----YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       725 -----------~~~~~~~~~~~~~~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                                 .........+..+......    .......++.+++.+||+.||++|||+.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                       0000000000111111100    011123468899999999999999999999865

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=333.50  Aligned_cols=253  Identities=21%  Similarity=0.291  Sum_probs=202.0

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ++|.+.+.||+|+||.||+|+... ++.||+|++.+..   ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            367888999999999999999875 8899999987542   234567889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..... 
T Consensus        81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            99999999999843   345889999999999999999999998   99999999999999999999999999986432 


Q ss_pred             ccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                          ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+   ...    ......  ..+...
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~----~i~~~~--~~~~~~  220 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE---TWE----NLKYWK--ETLQRP  220 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH---HHH----HHHhcc--ccccCC
Confidence                2334678999999999999999999999999999999999999985432211   100    000000  000000


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       740 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ...........++.+++.+|++.+|.+||++.++++.
T Consensus       221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            0000001123467789999999999999999999976

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.9e-36  Score=329.56  Aligned_cols=245  Identities=22%  Similarity=0.257  Sum_probs=198.4

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ++|...+.||+|+||.||+|+... ++.+|+|++....   ....+.+.+|+.++++++||||+++++.+.+.+..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            568888999999999999999865 7899999986542   234567889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+++++|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            99999999999853   345788899999999999999999998   999999999999999999999999999865322


Q ss_pred             ccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                           .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....       ...........        
T Consensus       172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-------~~~~~~i~~~~--------  231 (329)
T PTZ00263        172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-------FRIYEKILAGR--------  231 (329)
T ss_pred             -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-------HHHHHHHhcCC--------
Confidence                 1235789999999999999999999999999999999999999742211       00111111111        


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 003391          740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPN-----MSSVVLM  776 (823)
Q Consensus       740 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~  776 (823)
                      +  ..+.....++.+++.+||+.||.+||+     +++++..
T Consensus       232 ~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        232 L--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             c--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            0  011111235678999999999999997     6777644

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.5e-36  Score=322.39  Aligned_cols=259  Identities=28%  Similarity=0.432  Sum_probs=207.2

Q ss_pred             cCCCcCCeeeccCccceEEEEee------cCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~------~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      ++|...+.||+|+||.||+|+..      +...+++|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45777889999999999999853      245688898876665566789999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccC-------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCC
Q 003391          578 IYEYLPNKSLNDFIFDVT-------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN  644 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~  644 (823)
                      ||||+++++|.+++....             ....+++..++.++.||+.||+|||+.+   |+||||||+||++++++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            999999999999986422             1234899999999999999999999998   999999999999999999


Q ss_pred             ceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHH
Q 003391          645 PKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHA  723 (823)
Q Consensus       645 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~  723 (823)
                      ++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+.......       .
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~  234 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------V  234 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------H
Confidence            99999999986543322222233456788999999999999999999999999999999 998864322211       1


Q ss_pred             HHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          724 WRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       724 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      ..........         .........+.+++.+|++.+|++||++.+|+++|+.+.
T Consensus       235 ~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~  283 (291)
T cd05094         235 IECITQGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG  283 (291)
T ss_pred             HHHHhCCCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence            1111111110         011122346789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=7.6e-36  Score=316.12  Aligned_cols=256  Identities=26%  Similarity=0.392  Sum_probs=203.9

Q ss_pred             cCCCcCCeeeccCccceEEEEeec----CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~----~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      ++|+..+.||+|+||.||+|++..    ...||+|++.... .....+|.+|+.++++++||||+++++++.+.+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            568889999999999999999753    3578999886543 33456788999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      |||+++++|.+++...  ...+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.++|+|||+++.+..
T Consensus        84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            9999999999998542  236899999999999999999999987   99999999999999999999999999987642


Q ss_pred             CccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN  737 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  737 (823)
                      ...........++..|+|||.+.+..++.++||||||+++|||++ |..|+......       ..........      
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-------~~~~~~~~~~------  225 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-------DVIKAVEDGY------  225 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH-------HHHHHHHcCC------
Confidence            222222222345678999999998999999999999999999998 88886422111       0111111100      


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          738 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       738 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                         ....+......+.+++.+|++.+|++||++.|++++|+.+
T Consensus       226 ---~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         226 ---RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence               0011122345678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=7.9e-36  Score=315.46  Aligned_cols=255  Identities=27%  Similarity=0.410  Sum_probs=203.8

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      .+|...++||+|+||.||+|...+ ++.+|+|++... ....+++.+|+++++.++||||+++++++...+..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            346778899999999999999865 788999988644 344677899999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  662 (823)
                      ++++|.+++... ....+++..++.++.|+++||+|||+.+   ++|+||||+||++++++.+||+|||++.........
T Consensus        85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            999999998542 2345899999999999999999999987   999999999999999999999999999865432211


Q ss_pred             cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                       .......+..|+|||.+.+..++.++||||||+++|||++ |..|++.....       ..+......         ..
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~---------~~  223 (263)
T cd05052         161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYELLEKG---------YR  223 (263)
T ss_pred             -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCC---------CC
Confidence             1112234568999999999999999999999999999998 88886532211       111111111         11


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          742 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      ...+......+.+++.+|++.+|++||++.+++++|+.+
T Consensus       224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            111122235688899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5e-36  Score=321.49  Aligned_cols=260  Identities=28%  Similarity=0.442  Sum_probs=206.8

Q ss_pred             cCCCcCCeeeccCccceEEEEee------cCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~------~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      ++|.+.+.||+|+||.||++...      ++..+|+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            56788899999999999999852      245689998876665666789999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccC----------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCcee
Q 003391          578 IYEYLPNKSLNDFIFDVT----------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI  647 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl  647 (823)
                      ||||+++++|.+++....          +...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence            999999999999985322          2235899999999999999999999988   999999999999999999999


Q ss_pred             eccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHH
Q 003391          648 SDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRL  726 (823)
Q Consensus       648 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~  726 (823)
                      +|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.||.......   .    ...
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~----~~~  234 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---V----IEC  234 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHH
Confidence            99999986543322222223445778999999999999999999999999999998 888864322110   1    111


Q ss_pred             hhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCC
Q 003391          727 WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  782 (823)
Q Consensus       727 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  782 (823)
                      ........         .+......+.+++.+|++.+|.+||++.|+++.|+.+..
T Consensus       235 i~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         235 ITQGRVLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             HHcCCcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            11111000         011123468899999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=9.2e-36  Score=318.54  Aligned_cols=257  Identities=30%  Similarity=0.441  Sum_probs=201.8

Q ss_pred             cCCCcCCeeeccCccceEEEEee-----cCcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLI-----EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~-----~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      ++|+..++||+|+||.||+|+..     .+..+++|.+.... .+...++.+|+.++++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            45677789999999999999852     35789999986533 3344678999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccC--------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCC
Q 003391          578 IYEYLPNKSLNDFIFDVT--------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM  643 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~  643 (823)
                      ||||+++++|.+++....              ....+++.....++.|++.||+|||+.+   ++|+||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            999999999999985321              1234788999999999999999999987   99999999999999999


Q ss_pred             CceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHH
Q 003391          644 NPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGH  722 (823)
Q Consensus       644 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~  722 (823)
                      .+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.....   ....  
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~--  236 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVI--  236 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHH--
Confidence            999999999987643332222333455778999999998889999999999999999998 8888642211   0011  


Q ss_pred             HHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          723 AWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       723 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                        ........         ...+.....++.+++.+|++.+|++||++.+++++|..
T Consensus       237 --~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         237 --EMVRKRQL---------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             --HHHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence              11111000         01111223467889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6e-36  Score=342.78  Aligned_cols=252  Identities=18%  Similarity=0.201  Sum_probs=202.2

Q ss_pred             CCCcCCeeeccCccceEEEEeec--CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE--GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      .|...+.||+|+||.||+|....  ++.||+|++..........+.+|+.+++.++||||+++++++...+..+|||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            47888999999999999998654  5678888776555555567888999999999999999999999999999999999


Q ss_pred             CCCCcchhhhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          583 PNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       583 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      ++|+|.++|.+. ....++++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999988642 33456889999999999999999999987   99999999999999999999999999987643322


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ..+.    ........         
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~---~~~~----~~~~~~~~---------  288 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ---REIM----QQVLYGKY---------  288 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HHHH----HHHHhCCC---------
Confidence            2233446799999999999999999999999999999999999999743211   0010    00000000         


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          742 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ...+......+.+++.+||+.+|++||++.+++.
T Consensus       289 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            0011112246789999999999999999999864

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.7e-36  Score=323.29  Aligned_cols=265  Identities=21%  Similarity=0.251  Sum_probs=199.3

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      ++|.+.+.||+|+||.||++++.. ++.+|+|++....  ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            368888999999999999999865 7889999986542  3345678899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |++++.+..+..   ....+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            999987765432   2345889999999999999999999987   9999999999999999999999999998753222


Q ss_pred             cccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHH--------HHHHhhhcCc
Q 003391          661 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH--------AWRLWIEERP  732 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~--------~~~~~~~~~~  732 (823)
                      . .......+++.|+|||++.+..++.++|||||||++|||++|+.||......+.......        .+..+.....
T Consensus       155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence            1 122335689999999999998999999999999999999999999864322111000000        0000000000


Q ss_pred             -hhhhhhhcCCCCC------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          733 -VELINKSLGGSYS------LSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       733 -~~~~~~~l~~~~~------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                       .....+.......      ......+.+++.+|++.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence             0000000000000      011236889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=4.6e-36  Score=328.83  Aligned_cols=261  Identities=28%  Similarity=0.393  Sum_probs=203.1

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec------CcEEEEEEecCCcc-ccHHHHHHHHHHHhcc-CCCCceeEEEEeecC-C
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSSG-QGMEEFENEVLLIAKL-QHRNLVKLIGCCTQR-D  573 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~------~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~  573 (823)
                      .++|++.+.||+|+||.||+|...+      ++.||+|++..... ...+.+..|+.++.++ +|+||++++++|... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            3578889999999999999997532      46899999865432 2345678899999999 899999999988654 5


Q ss_pred             ceEEEEeecCCCCcchhhhccCC---------------------------------------------------------
Q 003391          574 ERMLIYEYLPNKSLNDFIFDVTR---------------------------------------------------------  596 (823)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------  596 (823)
                      ..++++||+++++|.+++.....                                                         
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            67899999999999998853211                                                         


Q ss_pred             -CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccccccccccccCCcc
Q 003391          597 -SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYM  675 (823)
Q Consensus       597 -~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~  675 (823)
                       ...+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.++|+|||+++.+.............++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence             125899999999999999999999987   9999999999999999999999999998764333222233345677899


Q ss_pred             CccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHH
Q 003391          676 PPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQ  754 (823)
Q Consensus       676 aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~  754 (823)
                      |||++.+..++.++|||||||+||||++ |+.||......+   .   ........         .....+.....++.+
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~---~---~~~~~~~~---------~~~~~~~~~~~~~~~  307 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE---E---FCRRLKEG---------TRMRAPEYATPEIYS  307 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH---H---HHHHHhcc---------CCCCCCccCCHHHHH
Confidence            9999999999999999999999999998 998875322111   0   00000000         011111122346789


Q ss_pred             HHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          755 VGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       755 l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      ++.+|++.+|++||++.|++++|+.+.
T Consensus       308 l~~~cl~~~p~~RPs~~ell~~l~~~~  334 (337)
T cd05054         308 IMLDCWHNNPEDRPTFSELVEILGDLL  334 (337)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-36  Score=325.12  Aligned_cols=245  Identities=21%  Similarity=0.251  Sum_probs=198.5

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ++|...+.||+|+||.||+|+... ++.+|+|++....   ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            367888999999999999999864 8899999986532   234456889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+++++|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            99999999999853   345889999999999999999999998   999999999999999999999999999865321


Q ss_pred             ccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                           .....|++.|+|||++.+..++.++|||||||++|||++|+.||......   ..    ........        
T Consensus       155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~---~~----~~~i~~~~--------  214 (291)
T cd05612         155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF---GI----YEKILAGK--------  214 (291)
T ss_pred             -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HH----HHHHHhCC--------
Confidence                 22356899999999999999999999999999999999999997532110   00    11111110        


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 003391          740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPN-----MSSVVLM  776 (823)
Q Consensus       740 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~  776 (823)
                      .  .++......+.+++.+|++.||.+||+     +.|+++.
T Consensus       215 ~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         215 L--EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             c--CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            0  111111346778999999999999995     8887755

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=5.6e-36  Score=321.11  Aligned_cols=260  Identities=23%  Similarity=0.319  Sum_probs=197.1

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      ++|...++||+|+||.||+|+... ++.||+|++.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            568888999999999999999764 7899999986543 23345678999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++ +|.+++..  ....+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.......
T Consensus        85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            975 89888743  2345788999999999999999999988   99999999999999999999999999986532221


Q ss_pred             ccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchh------
Q 003391          662 EANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE------  734 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~------  734 (823)
                        ......+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||......+.   ........ .....+      
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~-~~~~~~~~~~~~  232 (288)
T cd07871         159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE---LHLIFRLL-GTPTEETWPGIT  232 (288)
T ss_pred             --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHh-CCCChHHhhccc
Confidence              1223567899999999875 5689999999999999999999999854322111   11111100 000000      


Q ss_pred             -------hhhhhcCCCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          735 -------LINKSLGGSYS----LSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       735 -------~~~~~l~~~~~----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                             ...+.......    .....++.+++.+|++.||.+|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                   00000000000    011235778999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.1e-36  Score=328.50  Aligned_cols=241  Identities=23%  Similarity=0.285  Sum_probs=194.1

Q ss_pred             CeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCCC
Q 003391          510 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNK  585 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (823)
                      +.||+|+||.||+++... ++.+|+|++.+..   ......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            479999999999999764 8899999987542   234456788999999999999999999999999999999999999


Q ss_pred             CcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccccc
Q 003391          586 SLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT  665 (823)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  665 (823)
                      +|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~  152 (323)
T cd05571          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATM  152 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcc
Confidence            99998843   446899999999999999999999998   999999999999999999999999999753211  1222


Q ss_pred             ccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCC
Q 003391          666 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYS  745 (823)
Q Consensus       666 ~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~  745 (823)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.   ..+.    ......        .  ..++
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~----~~~~~~--------~--~~~p  215 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLF----ELILME--------E--IRFP  215 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH---HHHH----HHHHcC--------C--CCCC
Confidence            346799999999999999999999999999999999999999742211   0010    000000        0  0111


Q ss_pred             HHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003391          746 LSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVL  775 (823)
Q Consensus       746 ~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  775 (823)
                      .....++.+++.+||+.||++||     ++.++++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            12234677899999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.3e-35  Score=316.65  Aligned_cols=257  Identities=25%  Similarity=0.379  Sum_probs=199.8

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-Cc----EEEEEEecCCcc-ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQ----EIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~----~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      ++|+..+.||+|+||.||+|++.. ++    .+++|++..... ....++..|+..+.+++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            467778899999999999999754 43    477787754432 334677888889999999999999998864 56789


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      ++||+++|+|.+++..  ....+++..+..++.||+.||+|||+.+   ++|+||||+||++++++.+||+|||+++...
T Consensus        86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            9999999999999854  2346899999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      ............++..|+|||.+.+..++.++||||||+++|||++ |+.|+.......   .    ..........   
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~----~~~~~~~~~~---  230 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---V----PDLLEKGERL---  230 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHHCCCcC---
Confidence            3322222334557789999999999999999999999999999998 988875322111   0    0001111100   


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCC
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  782 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  782 (823)
                            ..+......+.+++.+|++.+|++||++.|+++.|.....
T Consensus       231 ------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         231 ------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             ------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence                  0111123466789999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.5e-35  Score=312.18  Aligned_cols=252  Identities=27%  Similarity=0.407  Sum_probs=201.3

Q ss_pred             cCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecC
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP  583 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (823)
                      ++|...+.||+|+||.||+|...++..+|+|.+.... ...+++.+|+.++.+++||||+++++++.+....++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4577788999999999999988777789999886443 345779999999999999999999999999889999999999


Q ss_pred             CCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccc
Q 003391          584 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA  663 (823)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  663 (823)
                      +++|.+++...  ...+++..++.++.||+.||+|||+.+   ++|+||||+||++++++.+||+|||+++........ 
T Consensus        83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05113          83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-  156 (256)
T ss_pred             CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence            99999998542  235899999999999999999999987   999999999999999999999999999865432211 


Q ss_pred             ccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCC
Q 003391          664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG  742 (823)
Q Consensus       664 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~  742 (823)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.......   .    .........         .
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~----~~~~~~~~~---------~  220 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---T----VEKVSQGLR---------L  220 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---H----HHHHhcCCC---------C
Confidence            1112345678999999998889999999999999999998 888875322110   0    011111100         0


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003391          743 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS  778 (823)
Q Consensus       743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  778 (823)
                      .........+.+++.+||+.+|++||++.++++.|+
T Consensus       221 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            011112357789999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.3e-35  Score=311.51  Aligned_cols=248  Identities=27%  Similarity=0.381  Sum_probs=195.3

Q ss_pred             CeeeccCccceEEEEee-cCcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCCCCc
Q 003391          510 NKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSL  587 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  587 (823)
                      +.||+|+||.||+|++. +++.+|+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36999999999999986 48889999876543 33456789999999999999999999999999999999999999999


Q ss_pred             chhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccccccc
Q 003391          588 NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR  667 (823)
Q Consensus       588 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  667 (823)
                      .+++..  ....+++..+..++.|++.||+|||+.+   |+|+||||+||+++.++.+||+|||++..............
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            999853  2345889999999999999999999987   99999999999999999999999999875432111111111


Q ss_pred             ccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCH
Q 003391          668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSL  746 (823)
Q Consensus       668 ~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~  746 (823)
                      ...+..|+|||.+.+..++.++||||||+++|||++ |..|+.......       .         ...+........+.
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~---------~~~~~~~~~~~~~~  219 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------T---------REAIEQGVRLPCPE  219 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------H---------HHHHHcCCCCCCcc
Confidence            223457999999999999999999999999999998 777764221100       0         00111111111122


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003391          747 SEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS  778 (823)
Q Consensus       747 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  778 (823)
                      .....+.+++.+|++.+|++||++.+++++|+
T Consensus       220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            22347788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.3e-35  Score=318.72  Aligned_cols=258  Identities=28%  Similarity=0.412  Sum_probs=202.2

Q ss_pred             CCCcCCeeeccCccceEEEEeec------CcEEEEEEecCCcc-ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~------~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      +|...+.||+|+||.||+|+...      ...+++|.+..... ...+++.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            36678899999999999998642      25688888865533 335678899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccC---------------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCc
Q 003391          578 IYEYLPNKSLNDFIFDVT---------------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASN  636 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~N  636 (823)
                      |+||+++++|.+++....                     ....+++..++.++.|++.||+|||+.+   |+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999999885421                     1235789999999999999999999987   9999999999


Q ss_pred             EEEcCCCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCC
Q 003391          637 VLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADH  715 (823)
Q Consensus       637 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~  715 (823)
                      ||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.|+...... 
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-  236 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-  236 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence            9999999999999999986533322222223345678999999988899999999999999999998 88887432111 


Q ss_pred             ccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          716 HHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       716 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                            ..+....         .............++.+++.+|++.+|++||+++|+++.|+++.
T Consensus       237 ------~~~~~~~---------~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         237 ------RLFNLLK---------TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             ------HHHHHHh---------CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence                  1111111         11111111222347789999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-36  Score=311.57  Aligned_cols=246  Identities=23%  Similarity=0.396  Sum_probs=208.2

Q ss_pred             cCCCcCCeeeccCccceEEEEe-ecCcEEEEEEecCC---ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVL-IEGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~-~~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      .+|++.+.||+|.||.|-+|.. ..|+.||||.+++.   +++..-.+++||++|..|+||||+.++.+|++++...+||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            4677788999999999999986 56999999999775   3455567899999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||..+|.|++|+.+   ...+++.++++++.||+.|+.|+|.+.   ++|||||.+|||||.++++||+|||++-.+...
T Consensus       133 EYaS~GeLYDYiSe---r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  133 EYASGGELYDYISE---RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK  206 (668)
T ss_pred             EecCCccHHHHHHH---hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence            99999999999954   455999999999999999999999987   999999999999999999999999999876432


Q ss_pred             ccccccccccccCCccCccccccCCC-CccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                         .....++|++.|.+||++.+.+| .+.+|-||+||+||-|+.|..||+..+   +..+                +..
T Consensus       207 ---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D---hk~l----------------vrQ  264 (668)
T KOG0611|consen  207 ---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD---HKRL----------------VRQ  264 (668)
T ss_pred             ---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch---HHHH----------------HHH
Confidence               23345899999999999999998 678999999999999999999986432   1112                222


Q ss_pred             hcCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003391          739 SLGGSY-SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML  777 (823)
Q Consensus       739 ~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  777 (823)
                      +-++.+ ..+.+.+..-||.|||..+|++|.|+.+|....
T Consensus       265 Is~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  265 ISRGAYREPETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             hhcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence            222222 223345677899999999999999999999875

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-36  Score=325.99  Aligned_cols=241  Identities=21%  Similarity=0.264  Sum_probs=191.5

Q ss_pred             eeccCccceEEEEeec-CcEEEEEEecCC---ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCCCCc
Q 003391          512 LGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSL  587 (823)
Q Consensus       512 LG~G~fg~Vyk~~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  587 (823)
                      ||+|+||.||+++..+ ++.||+|++.+.   .......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            6999999999999865 788999998653   234456778999999999999999999999999999999999999999


Q ss_pred             chhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccccccc
Q 003391          588 NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR  667 (823)
Q Consensus       588 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  667 (823)
                      .+++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++......  .....
T Consensus        81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~  152 (312)
T cd05585          81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT  152 (312)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence            999853   345899999999999999999999988   9999999999999999999999999997542221  22334


Q ss_pred             ccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHH
Q 003391          668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLS  747 (823)
Q Consensus       668 ~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~  747 (823)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||.....      . .........        ..  .++..
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~-~~~~~~~~~--------~~--~~~~~  215 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------N-EMYRKILQE--------PL--RFPDG  215 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------H-HHHHHHHcC--------CC--CCCCc
Confidence            6789999999999999999999999999999999999999753211      0 001111100        00  11112


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003391          748 EVLRCIQVGLLCVQQRPEDRPNMSSVVLML  777 (823)
Q Consensus       748 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  777 (823)
                      ....+.+++.+||+.||++||++..+.+.|
T Consensus       216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence            224677899999999999998654444443

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-36  Score=339.86  Aligned_cols=262  Identities=25%  Similarity=0.307  Sum_probs=212.6

Q ss_pred             hcCCCcCCeeeccCccceEEEEeecC-cEEEEEEecCCccccHHHHHHHHHHHhccC-CCCceeEEEEe-ec------CC
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIEG-QEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRNLVKLIGCC-TQ------RD  573 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~~-~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~-~~------~~  573 (823)
                      ..++++.+.|.+|||+.||.|....+ .++|+|++...++...+.+++||.+|++|+ |+|||.+++.. ..      .-
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            34567788999999999999998876 999999998888899999999999999996 99999999932 21      23


Q ss_pred             ceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccc
Q 003391          574 ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  653 (823)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  653 (823)
                      +.+|.||||++|+|-+++....+.. |++.++++|+.++++|+++||... ++|||||||-+||||..+++.||||||-|
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccc
Confidence            6789999999999999997655554 999999999999999999999985 68999999999999999999999999999


Q ss_pred             eecCCCcccccc-------ccccccCCccCcccc---ccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHH
Q 003391          654 RAFGIDQTEANT-------NRVVGTYGYMPPEYA---IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA  723 (823)
Q Consensus       654 ~~~~~~~~~~~~-------~~~~gt~~y~aPE~l---~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~  723 (823)
                      ...-........       -...-|+.|+|||.+   .+.++++|+|||+|||+||-|+....||+...           
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg-----------  262 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG-----------  262 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-----------
Confidence            754222211100       013358999999987   57789999999999999999999999986321           


Q ss_pred             HHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCCCCC
Q 003391          724 WRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQ  785 (823)
Q Consensus       724 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~  785 (823)
                              ...++...-.-.........+.+||..||+++|++||++-+|+..+..+...+-
T Consensus       263 --------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~  316 (738)
T KOG1989|consen  263 --------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC  316 (738)
T ss_pred             --------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence                    112222222222234556789999999999999999999999999987654443

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.8e-35  Score=315.39  Aligned_cols=259  Identities=29%  Similarity=0.442  Sum_probs=201.8

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec------CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCc
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE  574 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~  574 (823)
                      ..++|...+.||+|+||.||+|.+.+      +..+++|.+.... ......|.+|+.++++++|+||+++++++.+...
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            34678888999999999999999864      4578888876543 3334578999999999999999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCC----CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCC---Ccee
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTR----SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM---NPKI  647 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~---~~kl  647 (823)
                      .++||||+++++|.+++.....    ...+++..+.+++.||+.||+|||+.+   ++|+||||+||+++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence            9999999999999999864321    235899999999999999999999987   99999999999998764   5899


Q ss_pred             eccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHH
Q 003391          648 SDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRL  726 (823)
Q Consensus       648 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~  726 (823)
                      +|||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||......   .+.    ..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~----~~  233 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVM----EF  233 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHH----HH
Confidence            99999987632222111222334568999999999999999999999999999997 88887532211   111    11


Q ss_pred             hhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          727 WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       727 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                      ...         ......+......+.+++.+|++.+|++||++.+|++.|+.
T Consensus       234 ~~~---------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         234 VTG---------GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             HHc---------CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence            111         01111122233567899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.3e-35  Score=317.58  Aligned_cols=272  Identities=27%  Similarity=0.394  Sum_probs=201.0

Q ss_pred             cCCCcCCeeeccCccceEEEEee-----cCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeec--CCceE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLI-----EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ--RDERM  576 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~-----~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~  576 (823)
                      ++|+..+.||+|+||.||++...     .+..||+|++........+.+.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            46777889999999999999853     377899999977766667789999999999999999999998754  34688


Q ss_pred             EEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceec
Q 003391          577 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  656 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  656 (823)
                      +|+||+++++|.+++...  ...+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.+||+|||++...
T Consensus        84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            999999999999998532  345899999999999999999999988   999999999999999999999999999876


Q ss_pred             CCCcccc-ccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhh
Q 003391          657 GIDQTEA-NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL  735 (823)
Q Consensus       657 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  735 (823)
                      ....... ......++..|+|||.+.+..++.++||||||+++|||++|..+..........................+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL  238 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence            4322111 111122345699999999889999999999999999999987764321100000000000000000000011


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       736 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      +...............+.+++.+|++.+|++||||.||+++|+.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            111111111122234688999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-35  Score=310.98  Aligned_cols=252  Identities=27%  Similarity=0.405  Sum_probs=200.5

Q ss_pred             cCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecC
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP  583 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (823)
                      .+|+..+.||+|+||.||++....+..+|+|.+.... ....++.+|+.++++++||||+++++++...+..++|+||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            3477788999999999999998777789999886443 344678899999999999999999999999999999999999


Q ss_pred             CCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccc
Q 003391          584 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA  663 (823)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  663 (823)
                      +++|.+++...  ...+++..+..++.|+++||+|||+.+   ++|+||||+||++++++.+||+|||+++........ 
T Consensus        83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-  156 (256)
T cd05059          83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-  156 (256)
T ss_pred             CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence            99999998542  236899999999999999999999988   999999999999999999999999999865322111 


Q ss_pred             ccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCC
Q 003391          664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG  742 (823)
Q Consensus       664 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~  742 (823)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+......   ...    ......         ...
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~----~~~~~~---------~~~  220 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVV----ESVSAG---------YRL  220 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHH----HHHHcC---------CcC
Confidence            1111234457999999999999999999999999999999 78887532211   111    111000         011


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003391          743 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS  778 (823)
Q Consensus       743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  778 (823)
                      ..+......+.+++.+|++.+|++||++.|++++|.
T Consensus       221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            111223457889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-35  Score=312.57  Aligned_cols=256  Identities=25%  Similarity=0.380  Sum_probs=200.3

Q ss_pred             CCcCCeeeccCccceEEEEeec----CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCc-----
Q 003391          506 FSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE-----  574 (823)
Q Consensus       506 ~~~~~~LG~G~fg~Vyk~~~~~----~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-----  574 (823)
                      |.+.+.||+|+||.||+|.+..    +..+|+|+++...  ....+++.+|+..++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4567899999999999999754    3679999987542  2345678999999999999999999999866554     


Q ss_pred             -eEEEEeecCCCCcchhhhccC---CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecc
Q 003391          575 -RMLIYEYLPNKSLNDFIFDVT---RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDF  650 (823)
Q Consensus       575 -~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF  650 (823)
                       .++|+||+++++|..++....   ....+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             799999999999999985432   2346899999999999999999999987   999999999999999999999999


Q ss_pred             ccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhh
Q 003391          651 GMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIE  729 (823)
Q Consensus       651 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  729 (823)
                      |+++................+..|+|||.+.+..++.++||||||+++|||++ |..|+.....   ..+..    ....
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~----~~~~  230 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYD----YLRH  230 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHH----HHHc
Confidence            99987643322222222345678999999988899999999999999999999 8788643211   11111    0111


Q ss_pred             cCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          730 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       730 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      ..         ....+.....++.+++.+|++.+|++||++.|+++.|+.+
T Consensus       231 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         231 GN---------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CC---------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            10         0111222345788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.3e-35  Score=314.97  Aligned_cols=257  Identities=27%  Similarity=0.415  Sum_probs=203.2

Q ss_pred             cCCCcCCeeeccCccceEEEEee------cCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~------~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      +++...++||+|+||.||++...      ++..+++|.+........+.+.+|+++++.++|+||+++++++.+....++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            45677889999999999999743      255789998877666667789999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCC------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCc
Q 003391          578 IYEYLPNKSLNDFIFDVTR------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP  645 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  645 (823)
                      ++||+++++|.+++.....            ...+++..+..++.|++.||+|||+.+   ++|+||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            9999999999999864321            135889999999999999999999987   9999999999999999999


Q ss_pred             eeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHH
Q 003391          646 KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAW  724 (823)
Q Consensus       646 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~  724 (823)
                      ||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+   ..    
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~----  234 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE---AI----  234 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH---HH----
Confidence            9999999986543322222223345678999999999999999999999999999998 888864221110   00    


Q ss_pred             HHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          725 RLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       725 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                      .......         ....+......+.+++.+|++.+|.+||++.||++.|+.
T Consensus       235 ~~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         235 ECITQGR---------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HHHHcCc---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            0000000         001111223467899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-36  Score=293.17  Aligned_cols=264  Identities=23%  Similarity=0.278  Sum_probs=208.8

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCC-----ceE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD-----ERM  576 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~  576 (823)
                      .++|++.++||+|||+-||.++.. +++.+|+|++.....+..+..++|++.-++++||||++++++...+.     ..+
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            468999999999999999999844 48899999998887788889999999999999999999999875443     489


Q ss_pred             EEEeecCCCCcchhhhccC-CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccccee
Q 003391          577 LIYEYLPNKSLNDFIFDVT-RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                      |+++|...|+|.+.+...+ ++..+++.+.++|+.+|++||++||+.. ++++||||||.|||+.+++.++|.|||.+..
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~  178 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQ  178 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccc
Confidence            9999999999999997644 3448999999999999999999999986 4799999999999999999999999999875


Q ss_pred             cCCCcccc-------ccccccccCCccCccccc---cCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHH
Q 003391          656 FGIDQTEA-------NTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR  725 (823)
Q Consensus       656 ~~~~~~~~-------~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~  725 (823)
                      ....-...       .-..-..|..|.|||.+.   +...++++|||||||+||+|+.|..||+..-... ..+.     
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G-gSla-----  252 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG-GSLA-----  252 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC-CeEE-----
Confidence            42211100       001234688999999884   4567899999999999999999999986432211 1000     


Q ss_pred             HhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          726 LWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       726 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                             ..+....+.-.-+....+.+.+++.+|+|.||.+||++.+++..++.+
T Consensus       253 -------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  253 -------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             -------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                   011111111111122445788999999999999999999999998765

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=309.26  Aligned_cols=269  Identities=23%  Similarity=0.355  Sum_probs=200.2

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhc--cCCCCceeEEEEeecCC----ce
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAK--LQHRNLVKLIGCCTQRD----ER  575 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~~----~~  575 (823)
                      ..+.....+.||+|.||.||+|.+ .|+.||||++....+   +.+.+|.++.+.  |+|+||+.+++.=..+.    .+
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL  284 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL  284 (513)
T ss_pred             hhheeEEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence            346677888999999999999998 789999999976554   345566666654  69999999998765443    58


Q ss_pred             EEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHh-----cCCCceEecccCCCcEEEcCCCCceeecc
Q 003391          576 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ-----DSRLRIIHRDLKASNVLLDNEMNPKISDF  650 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~ivH~Dlk~~NIll~~~~~~kl~DF  650 (823)
                      +||++|.++|||.|||    +...++....++++..+|.||++||-     +++|.|.|||||+.|||+..++.+.|+|+
T Consensus       285 wLvTdYHe~GSL~DyL----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYL----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             EEeeecccCCcHHHHH----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence            9999999999999999    34668999999999999999999994     47889999999999999999999999999


Q ss_pred             ccceecCCC--ccccccccccccCCccCccccccCC----C-C-ccchhHhHHHHHHHHHhcCCCC--------CCcCCC
Q 003391          651 GMARAFGID--QTEANTNRVVGTYGYMPPEYAIDGL----F-S-VKSDVFSFGVLVLEIVCGKRNR--------GFYHAD  714 (823)
Q Consensus       651 Gla~~~~~~--~~~~~~~~~~gt~~y~aPE~l~~~~----~-s-~ksDVwS~Gvvl~elltG~~p~--------~~~~~~  714 (823)
                      |||......  ......+..+||.+|||||++.+.-    + + ..+||||||+|+||+.....--        ++++..
T Consensus       361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V  440 (513)
T KOG2052|consen  361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV  440 (513)
T ss_pred             eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence            999876443  2334456689999999999985432    1 2 2599999999999998633211        111111


Q ss_pred             CccchhHHHHHHhhhcCchhhhhhhcCC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCC
Q 003391          715 HHHNLLGHAWRLWIEERPVELINKSLGG-SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  782 (823)
Q Consensus       715 ~~~~l~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  782 (823)
                      +.+.-.......+.    .+-+.+.+.. ..+.+.+..+.++|..||..+|.-|.|+-.+-+.|.++..
T Consensus       441 p~DPs~eeMrkVVC----v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  441 PSDPSFEEMRKVVC----VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CCCCCHHHHhccee----ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            11100000000000    0111222221 2345777899999999999999999999999888877653

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.3e-35  Score=319.14  Aligned_cols=261  Identities=26%  Similarity=0.401  Sum_probs=205.5

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec------CcEEEEEEecCCc-cccHHHHHHHHHHHhcc-CCCCceeEEEEeecCC
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSS-GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRD  573 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~  573 (823)
                      ..++|+..+.||+|+||.||++....      ...+|+|.+.... .....++.+|+.++.++ +|+||+++++++...+
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            34568888999999999999998753      3578999887542 23445688999999999 8999999999999999


Q ss_pred             ceEEEEeecCCCCcchhhhcc-------------CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEc
Q 003391          574 ERMLIYEYLPNKSLNDFIFDV-------------TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD  640 (823)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~  640 (823)
                      ..+++|||+++++|.+++...             .....+++..++.++.|++.||.|||+.+   |+|+||||+||+++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence            999999999999999998542             22346899999999999999999999987   99999999999999


Q ss_pred             CCCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccch
Q 003391          641 NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNL  719 (823)
Q Consensus       641 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l  719 (823)
                      +++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+......     
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----  241 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-----  241 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH-----
Confidence            999999999999987643322222222345678999999999999999999999999999998 88886422110     


Q ss_pred             hHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          720 LGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       720 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                        ........         ......+......+.+++.+|++.+|++||||.|+++.|+.+.
T Consensus       242 --~~~~~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         242 --ELFKLLKE---------GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             --HHHHHHHc---------CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence              01111111         1111122233457889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.3e-35  Score=317.33  Aligned_cols=256  Identities=27%  Similarity=0.412  Sum_probs=200.7

Q ss_pred             CCCcCCeeeccCccceEEEEeec------CcEEEEEEecCCccc-cHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSSGQ-GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~------~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      +|...++||+|+||.||+|...+      ++.||+|++...... ..+.+.+|+.++.+++||||+++++++......++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            35667899999999999998643      468999998755433 24568899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhcc-------------CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCC
Q 003391          578 IYEYLPNKSLNDFIFDV-------------TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN  644 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~  644 (823)
                      ++||+++++|.+++...             .....+++..+..++.|++.||.|||+.+   |+||||||.||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence            99999999999998421             11235788899999999999999999987   999999999999999999


Q ss_pred             ceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHH
Q 003391          645 PKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHA  723 (823)
Q Consensus       645 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~  723 (823)
                      +||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..|+......       ..
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------~~  235 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-------DV  235 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-------HH
Confidence            99999999886543322222233456779999999998899999999999999999998 77775422110       01


Q ss_pred             HHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          724 WRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       724 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                      ........         ...........+.+++..|++.+|++||++++|+..|+.
T Consensus       236 ~~~i~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         236 IEMIRNRQ---------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHHcCC---------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            11111110         011122334567899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.6e-35  Score=316.04  Aligned_cols=261  Identities=23%  Similarity=0.364  Sum_probs=206.4

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-----CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeec-CCc
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-----GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ-RDE  574 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-----~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~  574 (823)
                      ..++|...+.||+|+||.||+|.+.+     +..|++|++.... ....+.+.+|+.++++++||||+++++++.. ...
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            34678888999999999999999876     6789999886543 3345678899999999999999999998766 467


Q ss_pred             eEEEEeecCCCCcchhhhccCCC-----CccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeec
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTRS-----KFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISD  649 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D  649 (823)
                      .++++||+++++|.+++......     ..+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence            89999999999999998654322     46899999999999999999999987   99999999999999999999999


Q ss_pred             cccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhh
Q 003391          650 FGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWI  728 (823)
Q Consensus       650 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~  728 (823)
                      ||+++.+.............++..|+|||.+.+..++.++||||||+++||+++ |+.|+......   .+.    ....
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~----~~~~  233 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMA----AYLK  233 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHH----HHHH
Confidence            999986543322222223345678999999998899999999999999999999 99987532211   111    1111


Q ss_pred             hcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          729 EERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       729 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      ..         ...........++.+++.+|++.+|++||++.++++.|+.+.
T Consensus       234 ~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         234 DG---------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             cC---------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            11         000111122346789999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.2e-35  Score=325.73  Aligned_cols=263  Identities=22%  Similarity=0.299  Sum_probs=207.5

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec--CcEEEEEEecCC---ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE--GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~--~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      .++|...+.||+|+||.||+|.+..  +..||+|++...   .....+.+.+|+.++..++||||+++++++.+.+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3568888999999999999998754  358999998653   23345678899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      ||||+++|+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            9999999999999853   345889999999999999999999998   9999999999999999999999999998653


Q ss_pred             CCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhh
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN  737 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  737 (823)
                      ..     .....||+.|+|||++.+..++.++|||||||++|||++|+.||......   ..    .......       
T Consensus       183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~~----~~~i~~~-------  243 (340)
T PTZ00426        183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL---LI----YQKILEG-------  243 (340)
T ss_pred             CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH---HH----HHHHhcC-------
Confidence            21     22357899999999999999999999999999999999999997532111   00    0111111       


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH--hcc-------CCCCCCCCCCCCcc
Q 003391          738 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVLM--LSG-------ERSLPQPKQPGFFT  793 (823)
Q Consensus       738 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~--L~~-------~~~~~~p~~p~~~~  793 (823)
                       ..  .++......+.+++.+|++.+|++|+     +++++++.  +.+       ...++.|..|.+..
T Consensus       244 -~~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~~  310 (340)
T PTZ00426        244 -II--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKN  310 (340)
T ss_pred             -CC--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCC
Confidence             00  01111123567899999999999995     89988775  222       13455666776644

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.5e-35  Score=312.00  Aligned_cols=255  Identities=25%  Similarity=0.417  Sum_probs=196.9

Q ss_pred             CcCCeeeccCccceEEEEeecCc---EEEEEEecCC--ccccHHHHHHHHHHHhccCCCCceeEEEEeecC------Cce
Q 003391          507 SDKNKLGEGGFGPVYKGVLIEGQ---EIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR------DER  575 (823)
Q Consensus       507 ~~~~~LG~G~fg~Vyk~~~~~~~---~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~  575 (823)
                      .+.++||+|+||.||+|+.....   .+|+|.++..  .....+.+..|+.+++.++|+||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            45689999999999999986533   5899987654  234456788999999999999999999987432      246


Q ss_pred             EEEEeecCCCCcchhhhcc---CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccc
Q 003391          576 MLIYEYLPNKSLNDFIFDV---TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM  652 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl  652 (823)
                      ++|+||+++|+|.+++...   .....+++.....++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence            8999999999999987432   12345899999999999999999999987   99999999999999999999999999


Q ss_pred             ceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcC
Q 003391          653 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEER  731 (823)
Q Consensus       653 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~  731 (823)
                      ++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....   ..+    ........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~----~~~~~~~~  231 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEI----YDYLRQGN  231 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHH----HHHHHcCC
Confidence            987643322111222345678999999999999999999999999999999 7788643211   111    11111111


Q ss_pred             chhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          732 PVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       732 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      ..         .........+.+++.+|++.+|++|||+.++++.|+.+
T Consensus       232 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         232 RL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            00         11112234678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.2e-35  Score=323.98  Aligned_cols=241  Identities=23%  Similarity=0.301  Sum_probs=193.1

Q ss_pred             CeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCCC
Q 003391          510 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNK  585 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (823)
                      +.||+|+||.||+++... ++.||+|++....   ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            479999999999999754 8899999987542   234456778999999999999999999999999999999999999


Q ss_pred             CcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccccc
Q 003391          586 SLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT  665 (823)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  665 (823)
                      +|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++......  ...
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~  152 (323)
T cd05595          81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM  152 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence            99888743   346899999999999999999999998   9999999999999999999999999987532211  122


Q ss_pred             ccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCC
Q 003391          666 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYS  745 (823)
Q Consensus       666 ~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~  745 (823)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......   ....    .....        ..  ..+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~~----~~~~~--------~~--~~p  215 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFE----LILME--------EI--RFP  215 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---HHHH----HHhcC--------CC--CCC
Confidence            3357899999999999999999999999999999999999997532211   1110    00000        00  011


Q ss_pred             HHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003391          746 LSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVL  775 (823)
Q Consensus       746 ~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  775 (823)
                      ......+.+++.+|++.||++||     ++.++++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            11234677899999999999998     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.3e-36  Score=300.55  Aligned_cols=267  Identities=22%  Similarity=0.261  Sum_probs=200.1

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcccc--HHHHHHHHHHHhccCCCCceeEEEEeec--CCceE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQG--MEEFENEVLLIAKLQHRNLVKLIGCCTQ--RDERM  576 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~--~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~  576 (823)
                      ..++|...++|++|.||.||+|++.. ++.||+|+++...+..  .-...+||.+|.+.+|||||.+-.+...  -+..+
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy  153 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY  153 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence            45678889999999999999999866 7789999997654321  2245789999999999999999888754  35799


Q ss_pred             EEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceec
Q 003391          577 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  656 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  656 (823)
                      ||||||+. +|...+....  .++...++..+..|+++|++|||...   |+|||||++|+|+.+.|.+||+|||+|+.+
T Consensus       154 ~VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  154 IVMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY  227 (419)
T ss_pred             eeHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence            99999977 8888885433  56888999999999999999999998   999999999999999999999999999988


Q ss_pred             CCCccccccccccccCCccCccccccCC-CCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcC----
Q 003391          657 GIDQTEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER----  731 (823)
Q Consensus       657 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~----  731 (823)
                      +.+.  ......+-|..|.|||++.+.+ |+...|+||+|||+.||++++.-|......++.+.+-.....-.+..    
T Consensus       228 gsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~  305 (419)
T KOG0663|consen  228 GSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY  305 (419)
T ss_pred             cCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence            6542  2234467899999999998764 99999999999999999999988765433322222111100000000    


Q ss_pred             ----------chhhhhhhcCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          732 ----------PVELINKSLGGSYSLS-EVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       732 ----------~~~~~~~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                                ........+...+... .-..-.++....+..||.+|.|+.|.++.
T Consensus       306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence                      0000011111111111 11345678889999999999999998764

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.7e-35  Score=324.10  Aligned_cols=199  Identities=25%  Similarity=0.360  Sum_probs=172.9

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      .++|+..++||+|+||.||++.+.. +..+|+|.+.... ....+++.+|++++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            3678899999999999999999874 7788888876543 2344678999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |+++++|.+++..   ...+++..+..++.+++.||.|||+..  .|+|+||||+|||+++++.+||+|||++..+... 
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-  157 (333)
T cd06650          84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (333)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence            9999999999853   345888999999999999999999853  3999999999999999999999999999754321 


Q ss_pred             cccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCC
Q 003391          661 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGF  710 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~  710 (823)
                         ......++..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence               12235689999999999998999999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.3e-35  Score=324.21  Aligned_cols=242  Identities=23%  Similarity=0.296  Sum_probs=194.5

Q ss_pred             CeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCCC
Q 003391          510 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNK  585 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (823)
                      +.||+|+||.||+++... ++.+|+|++.+..   ......+.+|+.+++.++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            479999999999999764 8899999997542   334567888999999999999999999999999999999999999


Q ss_pred             CcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccccc
Q 003391          586 SLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT  665 (823)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  665 (823)
                      +|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~  152 (328)
T cd05593          81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATM  152 (328)
T ss_pred             CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--cccc
Confidence            99988843   346899999999999999999999988   999999999999999999999999998753221  1122


Q ss_pred             ccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCC
Q 003391          666 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYS  745 (823)
Q Consensus       666 ~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~  745 (823)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......   ...    .......          ...+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~---~~~----~~~~~~~----------~~~p  215 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLF----ELILMED----------IKFP  215 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH---HHH----HHhccCC----------ccCC
Confidence            3457899999999999999999999999999999999999997532111   000    0000000          0111


Q ss_pred             HHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003391          746 LSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVLM  776 (823)
Q Consensus       746 ~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~  776 (823)
                      .....++.+++.+||+.+|++||     ++.|+++.
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            11224677899999999999997     88988764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2e-35  Score=319.51  Aligned_cols=265  Identities=26%  Similarity=0.386  Sum_probs=207.0

Q ss_pred             HhcCCCcCCeeeccCccceEEEEee--------cCcEEEEEEecCCc-cccHHHHHHHHHHHhcc-CCCCceeEEEEeec
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLI--------EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQ  571 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~--------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~  571 (823)
                      ..++|.+.+.||+|+||.||+++..        ++..+|+|.+.... .....++.+|+.++..+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            3467788899999999999999752        24478999886543 34456789999999999 89999999999999


Q ss_pred             CCceEEEEeecCCCCcchhhhccCC-------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEE
Q 003391          572 RDERMLIYEYLPNKSLNDFIFDVTR-------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVL  638 (823)
Q Consensus       572 ~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIl  638 (823)
                      ....++||||+++++|.+++.....             ...+++..+..++.||++||.|||+.+   |+||||||+||+
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence            9999999999999999999864321             235788999999999999999999988   999999999999


Q ss_pred             EcCCCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCcc
Q 003391          639 LDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHH  717 (823)
Q Consensus       639 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~  717 (823)
                      +++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+.....    
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----  245 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----  245 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH----
Confidence            99999999999999987643322222223345678999999999899999999999999999998 6777542211    


Q ss_pred             chhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCCCCC
Q 003391          718 NLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQ  785 (823)
Q Consensus       718 ~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~  785 (823)
                         ...........         ....+......+.+++.+|++.+|++||++.|+++.|+.+..+..
T Consensus       246 ---~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~  301 (304)
T cd05101         246 ---EELFKLLKEGH---------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT  301 (304)
T ss_pred             ---HHHHHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence               11111111110         001112234567889999999999999999999999988765543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.4e-35  Score=340.02  Aligned_cols=256  Identities=21%  Similarity=0.266  Sum_probs=203.1

Q ss_pred             HhcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCC--ccccHHHHHHHHHHHhccCCCCceeEEEEeecCC-----
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD-----  573 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----  573 (823)
                      ..++|.+.+.||+|+||.||+++.. +++.||+|++...  .......+.+|+..+..++|+|++++...+...+     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            3468999999999999999999875 4899999998654  2344567889999999999999999988765432     


Q ss_pred             ---ceEEEEeecCCCCcchhhhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeec
Q 003391          574 ---ERMLIYEYLPNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISD  649 (823)
Q Consensus       574 ---~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D  649 (823)
                         ..++||||+++|+|.+++... .....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEe
Confidence               367999999999999998643 23456899999999999999999999987   99999999999999999999999


Q ss_pred             cccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhh
Q 003391          650 FGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE  729 (823)
Q Consensus       650 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  729 (823)
                      ||+++.+.............||+.|+|||++.+..++.++||||||+++|||++|+.||.....       .........
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-------~~~~~~~~~  259 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-------EEVMHKTLA  259 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHhc
Confidence            9999876443333333456799999999999999999999999999999999999999753211       001111111


Q ss_pred             cCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          730 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       730 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ...         ...+.....++.+++.+||+.+|.+||++.+++..
T Consensus       260 ~~~---------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        260 GRY---------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             CCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            000         01112223467899999999999999999999864

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.3e-35  Score=325.83  Aligned_cols=248  Identities=25%  Similarity=0.347  Sum_probs=192.5

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc-ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      ++|...++||+|+||.||+|++.. ++.||+|++..... ...+.+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            345567899999999999999764 88999999865433 3346789999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++++|.+..       ..++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.+.... 
T Consensus       154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-  222 (353)
T PLN00034        154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-  222 (353)
T ss_pred             CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence            9999987543       3466778899999999999999988   9999999999999999999999999998754221 


Q ss_pred             ccccccccccCCccCcccccc-----CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          662 EANTNRVVGTYGYMPPEYAID-----GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                       .......||..|+|||.+..     ...+.++|||||||++|||++|+.||......+...+..   . ....      
T Consensus       223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~-~~~~------  291 (353)
T PLN00034        223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC---A-ICMS------  291 (353)
T ss_pred             -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH---H-Hhcc------
Confidence             12233578999999998743     234568999999999999999999986322111100000   0 0000      


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                         ...........++.+++.+||+.+|++||++.|+++.
T Consensus       292 ---~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        292 ---QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ---CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               0011111223467899999999999999999999874

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5e-35  Score=316.19  Aligned_cols=263  Identities=23%  Similarity=0.320  Sum_probs=196.6

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCcc-ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      .++|...++||+|+||.||+|+.. +++.+|+|++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            467888999999999999999986 488999999875432 234467889999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |++ ++|.+++..  ....+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++......
T Consensus        84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            996 578777743  2345788999999999999999999998   9999999999999999999999999997643221


Q ss_pred             cccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCch------
Q 003391          661 TEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV------  733 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~------  733 (823)
                        .......+++.|+|||++.+ ..++.++||||+||++|||++|+.||......  .................      
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  233 (303)
T cd07869         158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWPGVH  233 (303)
T ss_pred             --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhccchh
Confidence              12223567899999999865 45889999999999999999999998643211  11111110000000000      


Q ss_pred             --hhhhhh-c--CCCCCHH-------HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          734 --ELINKS-L--GGSYSLS-------EVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       734 --~~~~~~-l--~~~~~~~-------~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                        ....+. .  .......       ....+.+++.+|++.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence              000000 0  0000000       1135678999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.5e-35  Score=327.55  Aligned_cols=259  Identities=17%  Similarity=0.155  Sum_probs=195.1

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      ..+|...++||+|+||.||+++... ++.||+|+..      ...+.+|++++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            4679999999999999999999765 7889999753      23567899999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +. ++|.+++..   ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++..... .
T Consensus       165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-~  236 (391)
T PHA03212        165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-N  236 (391)
T ss_pred             CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccc-c
Confidence            95 688887743   345889999999999999999999987   999999999999999999999999999753221 1


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCc----cchhHHHHHHhhh---c----
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH----HNLLGHAWRLWIE---E----  730 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~----~~l~~~~~~~~~~---~----  730 (823)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.|+-.......    ...+.........   .    
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence            1222346799999999999999999999999999999999999987532211110    0111111110000   0    


Q ss_pred             ---Cchhhhhhh----c-C--CCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          731 ---RPVELINKS----L-G--GSYS----LSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       731 ---~~~~~~~~~----l-~--~~~~----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                         ...+.....    . .  ....    .....++.+++.+||+.||++|||++|+++
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence               000000000    0 0  0000    112347889999999999999999999985

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5.3e-35  Score=309.01  Aligned_cols=253  Identities=26%  Similarity=0.419  Sum_probs=201.7

Q ss_pred             cCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecC
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP  583 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (823)
                      ++|.+.++||+|+||.||+|++.++..+|+|++.... ...+++.+|++++++++||||+++++.+.+ ...++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence            5688899999999999999998777789999986533 345678999999999999999999998754 56799999999


Q ss_pred             CCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccc
Q 003391          584 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA  663 (823)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  663 (823)
                      +++|.+++... ....+++..+..++.|+++||+|||+.+   ++|+||||+||++++++.++|+|||++..+...... 
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-  158 (262)
T cd05071          84 KGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-  158 (262)
T ss_pred             CCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence            99999998542 2345799999999999999999999987   999999999999999999999999999866433221 


Q ss_pred             ccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCC
Q 003391          664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG  742 (823)
Q Consensus       664 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~  742 (823)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......   ..    .......         ...
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~----~~~~~~~---------~~~  222 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EV----LDQVERG---------YRM  222 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HH----HHHHhcC---------CCC
Confidence            1122346678999999988899999999999999999999 77776432111   01    0100000         001


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          743 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                      ....+....+.+++.+|++.+|++||++++++++|+.
T Consensus       223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~  259 (262)
T cd05071         223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  259 (262)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence            1122334578899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.7e-35  Score=310.04  Aligned_cols=260  Identities=21%  Similarity=0.339  Sum_probs=206.2

Q ss_pred             cCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ++|.+.+.||+|+||.||+|+.. +++.+|+|++....   ......+.+|+++++.++||||+++++++.+.+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57888999999999999999976 48899999875432   233456889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccC-CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          580 EYLPNKSLNDFIFDVT-RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      ||+++++|.+++.... ....++...+..++.|+++||.|||+.+   ++|+||||+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999999885432 2345788999999999999999999987   99999999999999999999999999987643


Q ss_pred             CccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                      ...  ......++..|+|||.+.+..++.++|+||||+++|||++|+.|+.....    ...... .......       
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~-~~~~~~~-------  224 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLC-QKIEQCD-------  224 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHH-HHHhcCC-------
Confidence            221  12234678899999999988899999999999999999999999642211    111110 0000000       


Q ss_pred             hcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       739 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                       ............+.+++.+|++.+|++||++.+|++.|++++
T Consensus       225 -~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         225 -YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             -CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence             000111223356889999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-35  Score=316.69  Aligned_cols=264  Identities=25%  Similarity=0.365  Sum_probs=199.8

Q ss_pred             cCCCcCCeeeccCccceEEEEeec---------------CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE---------------GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIG  567 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~---------------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g  567 (823)
                      ++|...++||+|+||.||+++...               ...||+|+++... ......+.+|++++.+++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578888999999999999988643               2358999987643 334557899999999999999999999


Q ss_pred             EeecCCceEEEEeecCCCCcchhhhccC---------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEE
Q 003391          568 CCTQRDERMLIYEYLPNKSLNDFIFDVT---------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVL  638 (823)
Q Consensus       568 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIl  638 (823)
                      ++...+..++||||+++++|.+++....         ....+++..++.++.|++.||+|||+.+   ++|+||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence            9999999999999999999999985421         1124688999999999999999999988   999999999999


Q ss_pred             EcCCCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcC--CCCCCcCCCCc
Q 003391          639 LDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK--RNRGFYHADHH  716 (823)
Q Consensus       639 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~--~p~~~~~~~~~  716 (823)
                      +++++.+||+|||++................++..|+|||.+.+..++.++||||||++++||+++.  .||......  
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~--  239 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE--  239 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH--
Confidence            9999999999999998654332222222334567899999999999999999999999999999854  444322111  


Q ss_pred             cchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          717 HNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       717 ~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                       .........+....      .......+......+.+++.+|++.+|++||+|.+|++.|+.
T Consensus       240 -~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         240 -QVIENTGEFFRNQG------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             -HHHHHHHHhhhhcc------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence             11111100000000      000001111123478899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=5.7e-35  Score=308.29  Aligned_cols=253  Identities=28%  Similarity=0.450  Sum_probs=201.6

Q ss_pred             cCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecC
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP  583 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (823)
                      ++|++.++||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            46788899999999999999988888999999865433 4567999999999999999999999885 456889999999


Q ss_pred             CCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccc
Q 003391          584 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA  663 (823)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  663 (823)
                      +++|.+++... ....+++..+..++.+++.||+|||+.+   |+|+||||+||++++++.++|+|||++..+...... 
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05070          84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence            99999998542 2345799999999999999999999987   999999999999999999999999999875432211 


Q ss_pred             ccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCC
Q 003391          664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG  742 (823)
Q Consensus       664 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~  742 (823)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....   ....    .....         ....
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~----~~~~~---------~~~~  222 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVL----EQVER---------GYRM  222 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHH----HHHHc---------CCCC
Confidence            1112345668999999988899999999999999999999 8888743211   1111    11110         0111


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          743 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                      ..+......+.+++.+|++.+|++|||+.++.+.|++
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1122234568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-35  Score=313.32  Aligned_cols=258  Identities=25%  Similarity=0.403  Sum_probs=204.4

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec------CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCce
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDER  575 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~  575 (823)
                      .++|...+.||+|+||.||+|....      +..+|+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            3567888999999999999998753      3689999986553 23345788999999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhccCC-------CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceee
Q 003391          576 MLIYEYLPNKSLNDFIFDVTR-------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKIS  648 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~  648 (823)
                      ++||||+++++|.+++.....       ...+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            999999999999999864321       234789999999999999999999987   9999999999999999999999


Q ss_pred             ccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHh
Q 003391          649 DFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLW  727 (823)
Q Consensus       649 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~  727 (823)
                      |||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+......   ....    ..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~----~~  234 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---EVLK----FV  234 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH---HHHH----HH
Confidence            9999986543322222233456789999999998899999999999999999998 88886432211   1111    11


Q ss_pred             hhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          728 IEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       728 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                      .....         ...+......+.+++.+|++.+|++|||+.++++.|+.
T Consensus       235 ~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         235 IDGGH---------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             hcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            11100         01112224578899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.9e-36  Score=321.49  Aligned_cols=249  Identities=23%  Similarity=0.315  Sum_probs=210.4

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCc-eEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE-RMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-~~lV~  579 (823)
                      ++|...+++|+|+||.++..+++. ++.+|+|++....  ....+...+|+.++++++|||||.+.+.+.+++. .++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            567788999999999999988765 7789999986553  3344467899999999999999999999999988 99999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      +|++||+|.+.|.+.+ +..+++++++.++.|++.|+.|||+..   |+|||||+.||+++.+..+||+|||+|+.+..+
T Consensus        84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999986543 567899999999999999999999776   999999999999999999999999999988655


Q ss_pred             ccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                      .  .....++||+.||.||++.+.+|..|+|||||||++|||++-+++|...+                   ...++.++
T Consensus       160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~-------------------m~~Li~ki  218 (426)
T KOG0589|consen  160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN-------------------MSELILKI  218 (426)
T ss_pred             h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc-------------------hHHHHHHH
Confidence            4  23445899999999999999999999999999999999999999875322                   22333333


Q ss_pred             cCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003391          740 LGGS---YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML  777 (823)
Q Consensus       740 l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  777 (823)
                      ....   .+.....++..++..|++.+|..||++.+++.+-
T Consensus       219 ~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P  259 (426)
T KOG0589|consen  219 NRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP  259 (426)
T ss_pred             hhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence            3222   2333445788999999999999999999998763

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=4.7e-35  Score=312.42  Aligned_cols=259  Identities=27%  Similarity=0.399  Sum_probs=202.1

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-Cc----EEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQ----EIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~----~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      ++|...++||+|+||.||+|++.. ++    .||+|++.... ....+++.+|+.++..++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence            567788999999999999998643 44    48999886543 3345678899999999999999999999975 45789


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      ++||+++|+|.+++..  ....+++..+..++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        86 ~~~~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          86 VTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEEcCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence            9999999999999854  2345899999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      ............++..|+|||.+.+..++.++||||||+++|||++ |..|+......   .+..    .....      
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~----~~~~~------  227 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPD----LLEKG------  227 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----HHHCC------
Confidence            3322222222345678999999999999999999999999999998 88886432111   0100    00000      


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCCCC
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLP  784 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~  784 (823)
                         ...........++.+++.+|++.||++||++.++++.|+.....+
T Consensus       228 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         228 ---ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             ---CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence               001111123346788999999999999999999999998776554

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.3e-35  Score=314.28  Aligned_cols=261  Identities=24%  Similarity=0.404  Sum_probs=202.9

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec------CcEEEEEEecCCcc-ccHHHHHHHHHHHhccCCCCceeEEEEeecCCc
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE  574 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~------~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~  574 (823)
                      ..++|++.++||+|+||.||+|...+      +..||+|.+..... .....+.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            45788899999999999999997642      45799998865432 233467889999999999999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCC-------CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCcee
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTR-------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI  647 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl  647 (823)
                      .++||||+++|+|.+++.....       ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999964221       234577888999999999999999987   999999999999999999999


Q ss_pred             eccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHH
Q 003391          648 SDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRL  726 (823)
Q Consensus       648 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~  726 (823)
                      +|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+......   ..    ...
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~~----~~~  233 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---QV----LKF  233 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHH
Confidence            99999986533222222222345678999999999999999999999999999998 67776422110   00    000


Q ss_pred             hhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          727 WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       727 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      ......         ...+......+.+++.+|++.+|++||++.++++.|....
T Consensus       234 ~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         234 VMDGGY---------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HHcCCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            000000         0111122357889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.1e-35  Score=321.15  Aligned_cols=265  Identities=20%  Similarity=0.295  Sum_probs=194.8

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecC-----CceE
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR-----DERM  576 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~~  576 (823)
                      +|+..++||+|+||.||+|+... ++.||+|++....  .....++.+|+.++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            47778899999999999999764 8899999986532  23345688999999999999999999988543     2479


Q ss_pred             EEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceec
Q 003391          577 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  656 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  656 (823)
                      +||||+. ++|.+++.   ....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999995 68888874   3345899999999999999999999998   999999999999999999999999999864


Q ss_pred             CCCccc-cccccccccCCccCcccccc--CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhH--------HHHH
Q 003391          657 GIDQTE-ANTNRVVGTYGYMPPEYAID--GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLG--------HAWR  725 (823)
Q Consensus       657 ~~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~--------~~~~  725 (823)
                      ...... .......+|+.|+|||++.+  ..++.++|||||||++|||++|+.||...........+.        ....
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            322111 12234578999999999876  678999999999999999999999985432211100000        0000


Q ss_pred             HhhhcCchhhhhhhcCCC-CCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          726 LWIEERPVELINKSLGGS-YSL-----SEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       726 ~~~~~~~~~~~~~~l~~~-~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      .+......+.+....... ...     .....+.+++.+|++.+|++||+++|+++.
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            000011111111000000 000     112356789999999999999999999864

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.1e-35  Score=314.50  Aligned_cols=268  Identities=28%  Similarity=0.404  Sum_probs=200.9

Q ss_pred             CCcCCeeeccCccceEEEEe-----ecCcEEEEEEecCCcc-ccHHHHHHHHHHHhccCCCCceeEEEEeecC--CceEE
Q 003391          506 FSDKNKLGEGGFGPVYKGVL-----IEGQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQR--DERML  577 (823)
Q Consensus       506 ~~~~~~LG~G~fg~Vyk~~~-----~~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l  577 (823)
                      |...+.||+|+||+||++..     .+++.+|+|.+..... .....+.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            37788999999999988653     2477899999876532 3456788999999999999999999988654  35789


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      ||||+++++|.+++..    ..+++..+..++.|+++||.|||+.+   |+|+||||+||++++++.+||+|||+++...
T Consensus        86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence            9999999999999843    34899999999999999999999987   9999999999999999999999999998664


Q ss_pred             CCcccc-ccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          658 IDQTEA-NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       658 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      ...... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+....... .................+.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELL  237 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhh
Confidence            322211 1112345667999999998899999999999999999999999864322111 00000000000000111111


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      +.......+......+.+++..|++.+|++||++++++++|+.+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            111111122233457889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.8e-35  Score=327.30  Aligned_cols=260  Identities=25%  Similarity=0.369  Sum_probs=202.6

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec------CcEEEEEEecCCcc-ccHHHHHHHHHHHhccC-CCCceeEEEEeecCCc
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDE  574 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~------~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~  574 (823)
                      .++|.+.++||+|+||.||+|++..      +..||+|++..... ...+.+.+|+.++.++. ||||+++++++...+.
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~  115 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP  115 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence            3567778999999999999998632      46899999976533 23457889999999997 9999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccC-----------------------------------------------------------
Q 003391          575 RMLIYEYLPNKSLNDFIFDVT-----------------------------------------------------------  595 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~-----------------------------------------------------------  595 (823)
                      .++|+||+++|+|.++++...                                                           
T Consensus       116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (401)
T cd05107         116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM  195 (401)
T ss_pred             cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence            999999999999999986421                                                           


Q ss_pred             ------------------------------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEE
Q 003391          596 ------------------------------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL  639 (823)
Q Consensus       596 ------------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll  639 (823)
                                                          ....+++..+..++.||+.||+|||+.+   |+||||||+|||+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl  272 (401)
T cd05107         196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI  272 (401)
T ss_pred             hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence                                                1124678888999999999999999987   9999999999999


Q ss_pred             cCCCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccc
Q 003391          640 DNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHN  718 (823)
Q Consensus       640 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~  718 (823)
                      ++++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+......+   
T Consensus       273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~---  349 (401)
T cd05107         273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE---  349 (401)
T ss_pred             eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH---
Confidence            9999999999999986533222122223456788999999998899999999999999999998 888864322110   


Q ss_pred             hhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          719 LLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       719 l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      .   ........         .....+......+.+++..|++.+|.+||+++||++.|+.+
T Consensus       350 ~---~~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         350 Q---FYNAIKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             H---HHHHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            0   00101111         00111112234678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.6e-36  Score=289.27  Aligned_cols=250  Identities=26%  Similarity=0.353  Sum_probs=207.3

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC---ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      +.++|++++.||+|.||.||.|+.+. +-.||+|++.+.   ..+...++.+|+++-..|+||||+++++++.+....||
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            45789999999999999999999866 667899998765   33456789999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      ++||.++|+|...|.+ .+.+.+++.....++.|+|.||.|+|...   |+||||||+|+|++.++.+||+|||-+..-.
T Consensus       100 ilEya~~gel~k~L~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQE-GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP  175 (281)
T ss_pred             EEEecCCchHHHHHHh-cccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence            9999999999999964 34556888999999999999999999987   9999999999999999999999999887532


Q ss_pred             CCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhh
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN  737 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  737 (823)
                          .......+||..|.+||...+..++..+|+|++|++.||++.|..||+-..   +.......            ..
T Consensus       176 ----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~~etYkrI------------~k  236 (281)
T KOG0580|consen  176 ----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---HSETYKRI------------RK  236 (281)
T ss_pred             ----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---hHHHHHHH------------HH
Confidence                334455899999999999999999999999999999999999999986322   11121111            11


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          738 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       738 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ..+  .++..-.....+++..|+..+|.+|.+..|++..
T Consensus       237 ~~~--~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  237 VDL--KFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ccc--cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence            111  1111222367789999999999999999999764

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.9e-36  Score=308.91  Aligned_cols=258  Identities=21%  Similarity=0.292  Sum_probs=195.5

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCC-----ceEEE
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD-----ERMLI  578 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~lV  578 (823)
                      .|...+++|.|.||.||+|++.. ++.||||+.-...+.    -.+|+++|+++.|||||+++-+|....     ...||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            35667899999999999999876 689999998655432    257999999999999999998885432     34689


Q ss_pred             EeecCCCCcchhhhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCC-CCceeeccccceec
Q 003391          579 YEYLPNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMARAF  656 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DFGla~~~  656 (823)
                      ||||+. +|.+++.+. ..+..++...+.-+..||++||+|||+.+   |+||||||.|+|+|.+ +.+||+|||.|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999987 898888642 23445777888889999999999999987   9999999999999977 89999999999987


Q ss_pred             CCCccccccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchh-
Q 003391          657 GIDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE-  734 (823)
Q Consensus       657 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~-  734 (823)
                      ...+..   ....-|..|+|||.+.+. .|+.+.||||.|||+.||+-|+.-|...+..++.   ....+.+-.....+ 
T Consensus       177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL---~eIik~lG~Pt~e~I  250 (364)
T KOG0658|consen  177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQL---VEIIKVLGTPTREDI  250 (364)
T ss_pred             ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHH---HHHHHHhCCCCHHHH
Confidence            544332   235568899999999876 5999999999999999999999988764433322   22222211111111 


Q ss_pred             ---------hhhhhcCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          735 ---------LINKSLGGS-----YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       735 ---------~~~~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                               ...+.+...     .......+.++++.++++.+|.+|.++.|++..
T Consensus       251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence                     111111111     122234578899999999999999999999854

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-37  Score=296.61  Aligned_cols=245  Identities=26%  Similarity=0.393  Sum_probs=199.9

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC--ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      .+.|++.+.||+|.|+.||++.+.. |+.+|+|.+...  .....+++.+|+.+-+.|+|||||++.....+....+||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            4567777899999999999998754 889999887543  3447788999999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCC---CCceeeccccceec
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAF  656 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DFGla~~~  656 (823)
                      |+|+|++|..-|-   ++..+++..+-+.++||+++|.|+|..+   |||||+||+|+||...   --+||+|||+|..+
T Consensus        90 e~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   90 DLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             ecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            9999999876553   3356788888999999999999999998   9999999999999543   45899999999988


Q ss_pred             CCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          657 GIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       657 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      +.   ...-...+||++|||||++...+|+..+|||+.|||||-|+.|+.||...                   ....+.
T Consensus       164 ~~---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~-------------------~~~rly  221 (355)
T KOG0033|consen  164 ND---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE-------------------DQHRLY  221 (355)
T ss_pred             CC---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc-------------------cHHHHH
Confidence            62   22233478999999999999999999999999999999999999997421                   112222


Q ss_pred             hhhcCCCCCHH--H----HHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          737 NKSLGGSYSLS--E----VLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       737 ~~~l~~~~~~~--~----~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      +.++.+.++.+  +    .++..+|+.+||..||.+|.|+.|.+.
T Consensus       222 e~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  222 EQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             HHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            22232222211  1    236678999999999999999998864

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.2e-35  Score=316.71  Aligned_cols=261  Identities=28%  Similarity=0.424  Sum_probs=201.6

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-C--cEEEEEEecCC-ccccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-G--QEIAAKRLSKS-SGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~--~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV  578 (823)
                      ++|+..+.||+|+||.||+|...+ +  ..+++|.++.. .....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            568888999999999999999865 3  24788887643 233456789999999999 799999999999999999999


Q ss_pred             EeecCCCCcchhhhccC-------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCc
Q 003391          579 YEYLPNKSLNDFIFDVT-------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP  645 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  645 (823)
                      +||+++++|.+++....             ....+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999985422             1135889999999999999999999987   9999999999999999999


Q ss_pred             eeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHH
Q 003391          646 KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAW  724 (823)
Q Consensus       646 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~  724 (823)
                      ||+|||++......   ........+..|+|||.+.+..++.++||||||+++|||++ |..||......   .+    .
T Consensus       159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---~~----~  228 (297)
T cd05089         159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---EL----Y  228 (297)
T ss_pred             EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HH----H
Confidence            99999998643211   11111223457999999998899999999999999999997 98887432211   01    1


Q ss_pred             HHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCCCCCC
Q 003391          725 RLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQP  786 (823)
Q Consensus       725 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~p  786 (823)
                      .....         ......+......+.+++.+|++.+|.+||++.++++.|+.+.....+
T Consensus       229 ~~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~  281 (297)
T cd05089         229 EKLPQ---------GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA  281 (297)
T ss_pred             HHHhc---------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence            11110         011111112234678999999999999999999999999877544433

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=6.7e-35  Score=313.89  Aligned_cols=265  Identities=28%  Similarity=0.391  Sum_probs=203.7

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-----------------CcEEEEEEecCCcc-ccHHHHHHHHHHHhccCCCCcee
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-----------------GQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVK  564 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-----------------~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~  564 (823)
                      .++|...++||+|+||.||++...+                 +..+|+|++..... ...+++.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578889999999999999998653                 24589999876532 34567899999999999999999


Q ss_pred             EEEEeecCCceEEEEeecCCCCcchhhhccC--------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCc
Q 003391          565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVT--------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASN  636 (823)
Q Consensus       565 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~N  636 (823)
                      +++++..++..++|+||+++++|.+++....        ....+++..++.++.|++.||+|||+.+   |+|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            9999999999999999999999999986532        1235899999999999999999999987   9999999999


Q ss_pred             EEEcCCCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh--cCCCCCCcCCC
Q 003391          637 VLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC--GKRNRGFYHAD  714 (823)
Q Consensus       637 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt--G~~p~~~~~~~  714 (823)
                      |++++++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++  |..|+..... 
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~-  239 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD-  239 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence            9999999999999999986543332222333456788999999998899999999999999999998  4555432211 


Q ss_pred             CccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          715 HHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       715 ~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                        ..........+........      .........++.+++.+|++.+|++||++.|+++.|+.
T Consensus       240 --~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         240 --QQVIENAGHFFRDDGRQIY------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             --HHHHHHHHhcccccccccc------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence              1111111111100000000      00111223578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-36  Score=320.70  Aligned_cols=254  Identities=27%  Similarity=0.411  Sum_probs=208.5

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      .+....++||.|-||.||.|.++. .-.||||.++. +....++|..|..+|+.++|||+|+|+|+|......|||+|||
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM  345 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM  345 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence            345567899999999999999987 67899999954 4456789999999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  662 (823)
                      .+|+|.+||++..+ ..++-...+.++.||..||+||..+.   +|||||.++|+|+.++..+||+||||++++..+. .
T Consensus       346 ~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT-Y  420 (1157)
T KOG4278|consen  346 CYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT-Y  420 (1157)
T ss_pred             cCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCc-e
Confidence            99999999976544 34667778899999999999999987   9999999999999999999999999999875432 2


Q ss_pred             cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                      .......-++.|.|||-+.-..++.|+|||+|||+||||.| |..|++..+-       ..+         .++++...+
T Consensus       421 TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-------SqV---------Y~LLEkgyR  484 (1157)
T KOG4278|consen  421 TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQV---------YGLLEKGYR  484 (1157)
T ss_pred             ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-------HHH---------HHHHhcccc
Confidence            22222334678999999999999999999999999999998 6666543211       112         233333333


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          742 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                      .+-+..++..+.+||+.||+.+|.+||+++|+-+.||.
T Consensus       485 M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt  522 (1157)
T KOG4278|consen  485 MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET  522 (1157)
T ss_pred             ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence            34445566788999999999999999999998877753

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=7.2e-35  Score=308.92  Aligned_cols=257  Identities=26%  Similarity=0.439  Sum_probs=202.9

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-C---cEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-G---QEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~---~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      .++|+..+.||+|+||.||+|++.. +   ..+++|++.... ....+++..|++++.+++|||++++.+++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            3467788999999999999999864 3   368999886553 3345678999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      ||||+++++|.+++..  ....+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          84 ITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence            9999999999999853  2345899999999999999999999987   9999999999999999999999999998654


Q ss_pred             CCccccc-cccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhh
Q 003391          658 IDQTEAN-TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVEL  735 (823)
Q Consensus       658 ~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  735 (823)
                      ....... ......+..|+|||++....++.++||||||+++|||++ |+.|+......   .+    ......      
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~---~~----~~~i~~------  225 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH---EV----MKAIND------  225 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH---HH----HHHHhc------
Confidence            3221111 111223457999999998889999999999999999998 99997432210   11    111110      


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       736 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                         ........+....+.+++.+|++.+|++||++.+|++.|+++
T Consensus       226 ---~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         226 ---GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ---CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence               011111222345778999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=7.5e-35  Score=306.88  Aligned_cols=246  Identities=28%  Similarity=0.412  Sum_probs=193.8

Q ss_pred             eeeccCccceEEEEee---cCcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCCC
Q 003391          511 KLGEGGFGPVYKGVLI---EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNK  585 (823)
Q Consensus       511 ~LG~G~fg~Vyk~~~~---~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (823)
                      +||+|+||.||+|.+.   .+..+|+|++....  ....+++.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            6899999999999753   36789999886543  234567899999999999999999999885 45678999999999


Q ss_pred             CcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccc-c
Q 003391          586 SLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA-N  664 (823)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~-~  664 (823)
                      +|.+++..   ...+++..+..++.|++.||+|||+.+   |+|+||||.||++++++.+||+|||++.......... .
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            99999843   345889999999999999999999987   9999999999999999999999999998764332211 1


Q ss_pred             cccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCC
Q 003391          665 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS  743 (823)
Q Consensus       665 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~  743 (823)
                      .....++..|+|||.+....++.++||||||+++|||++ |+.||......   ...    ......         ....
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~----~~i~~~---------~~~~  218 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVT----QMIESG---------ERME  218 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHCC---------CCCC
Confidence            112234578999999988889999999999999999998 99887532211   111    111111         1111


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          744 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       744 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                      .+.....++.+++.+|++.+|++||++.+|++.|++
T Consensus       219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            122233567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4.3e-35  Score=314.48  Aligned_cols=261  Identities=23%  Similarity=0.352  Sum_probs=192.5

Q ss_pred             cCCCcCCeeeccCccceEEEEee--cCcEEEEEEecCCc--cccHHHHHHHHHHHhcc---CCCCceeEEEEee-----c
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLI--EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKL---QHRNLVKLIGCCT-----Q  571 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~--~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~-----~  571 (823)
                      ++|...+.||+|+||.||+|+..  +++.||+|++....  ......+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36888899999999999999874  36789999886543  22234566777777665   6999999999985     2


Q ss_pred             CCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccc
Q 003391          572 RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG  651 (823)
Q Consensus       572 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFG  651 (823)
                      ....++||||++ ++|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence            356899999996 5898888543 2345899999999999999999999988   9999999999999999999999999


Q ss_pred             cceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhh--
Q 003391          652 MARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE--  729 (823)
Q Consensus       652 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--  729 (823)
                      +++.....   .......+|+.|+|||.+.+..++.++||||||+++|||++|+.||......+   ...........  
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~  229 (290)
T cd07862         156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPG  229 (290)
T ss_pred             ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCC
Confidence            99865432   22334568999999999999999999999999999999999999986432211   11111110000  


Q ss_pred             --cCchhh--hhhhcC--CCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          730 --ERPVEL--INKSLG--GSYSL-----SEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       730 --~~~~~~--~~~~l~--~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                        ......  ......  .....     .....+.+++.+|++.+|++|||+.|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence              000000  000000  00011     11235678999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=7.7e-35  Score=312.24  Aligned_cols=258  Identities=26%  Similarity=0.420  Sum_probs=202.1

Q ss_pred             hcCCCcCCeeeccCccceEEEEee------cCcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCce
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDER  575 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~  575 (823)
                      .++|+..+.||+|+||.||++...      .+..+|+|++.... .....++.+|+.++++++||||+++++++.++...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            457888899999999999999864      36789999987543 33456789999999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhccC-------------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCc
Q 003391          576 MLIYEYLPNKSLNDFIFDVT-------------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASN  636 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~N  636 (823)
                      ++|+||+++++|.+++....                   ....+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            99999999999999986321                   1124788899999999999999999987   9999999999


Q ss_pred             EEEcCCCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCC
Q 003391          637 VLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADH  715 (823)
Q Consensus       637 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~  715 (823)
                      |++++++.++|+|||++.................+..|+|||.+.+..++.++||||||+++|||++ |..|+...... 
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~-  239 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE-  239 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence            9999999999999999986533322111222334668999999998899999999999999999998 77775321110 


Q ss_pred             ccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          716 HHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       716 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                        ..    .........        . ..+.....++.+++.+|++.+|++||++.|+++.|+.
T Consensus       240 --~~----~~~~~~~~~--------~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 --EV----IYYVRDGNV--------L-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             --HH----HHHHhcCCC--------C-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence              11    111111110        0 1111233578889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.6e-35  Score=317.06  Aligned_cols=259  Identities=27%  Similarity=0.377  Sum_probs=202.2

Q ss_pred             cCCCcCCeeeccCccceEEEEeec--------CcEEEEEEecCCc-cccHHHHHHHHHHHhcc-CCCCceeEEEEeecCC
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE--------GQEIAAKRLSKSS-GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRD  573 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~--------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~  573 (823)
                      ++|.+.+.||+|+||.||+++...        ...+|+|.+.... .....++.+|+.++.++ +||||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            578889999999999999998632        3469999987542 33456788899999999 7999999999999999


Q ss_pred             ceEEEEeecCCCCcchhhhccCC-------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEc
Q 003391          574 ERMLIYEYLPNKSLNDFIFDVTR-------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD  640 (823)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~  640 (823)
                      ..++||||+++++|.+++.....             ...+++..++.++.|++.||+|||+.+   ++|+||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence            99999999999999999964321             235889999999999999999999987   99999999999999


Q ss_pred             CCCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccch
Q 003391          641 NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNL  719 (823)
Q Consensus       641 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l  719 (823)
                      .++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+.....      
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~------  248 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------  248 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH------
Confidence            999999999999976532221111222234568999999999999999999999999999998 7777642211      


Q ss_pred             hHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          720 LGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       720 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                       ..........         .....+.....++.+++.+|++.+|++||+|.+|++.|+.+.
T Consensus       249 -~~~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~  300 (307)
T cd05098         249 -EELFKLLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  300 (307)
T ss_pred             -HHHHHHHHcC---------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence             0111111111         001111222347778999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.2e-34  Score=305.92  Aligned_cols=254  Identities=30%  Similarity=0.428  Sum_probs=202.8

Q ss_pred             hcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      .+.|...++||+|+||.||+|...+++.+|+|.+.... ...+++.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            35678889999999999999998889999999986544 34568899999999999999999999874 45789999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  662 (823)
                      ++++|.+++... ....+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++.........
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          83 ENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence            999999988543 2346899999999999999999999987   999999999999999999999999999865422211


Q ss_pred             cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                       ......++..|+|||.+....++.++||||||+++|||++ |+.||.....   ....    ......         ..
T Consensus       159 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~----~~~~~~---------~~  221 (260)
T cd05067         159 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PEVI----QNLERG---------YR  221 (260)
T ss_pred             -cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HHHH----HHHHcC---------CC
Confidence             1122345678999999998899999999999999999999 9998753221   1111    111111         00


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          742 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                      .........++.+++.+|++.+|++||++++++++|+.
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            11111223468899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.9e-34  Score=305.15  Aligned_cols=259  Identities=23%  Similarity=0.354  Sum_probs=207.4

Q ss_pred             cCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCC---ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ++|+..+.||+|+||.||+|... +++.+|+|.++..   .....+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888999999999999999987 5889999988643   2233567899999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccC-CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          580 EYLPNKSLNDFIFDVT-RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      ||+++++|.+++.... ....+++..+..++.++++||.|||+.+   |+|+||+|+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            9999999999886532 3445899999999999999999999988   99999999999999999999999999986533


Q ss_pred             CccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                      ...  ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.....    .+... .......        
T Consensus       159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~-~~~~~~~--------  223 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSL-CKKIEKC--------  223 (267)
T ss_pred             CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHH-HhhhhcC--------
Confidence            221  12234678899999999988999999999999999999999999643211    11110 0000000        


Q ss_pred             hcCCCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          739 SLGGSYSL-SEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       739 ~l~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                       .....+. .....+.+++.+|++.+|++||++.+|+++|+++.
T Consensus       224 -~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         224 -DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             -CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence             0111111 23346789999999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=8.3e-35  Score=314.23  Aligned_cols=259  Identities=27%  Similarity=0.412  Sum_probs=203.2

Q ss_pred             hcCCCcCCeeeccCccceEEEEee------cCcEEEEEEecCCc-cccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCc
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDE  574 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~  574 (823)
                      .++|...+.||+|+||.||++...      .+..+|+|+++... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            356888999999999999999752      24579999887653 23345789999999999 79999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccce
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  654 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  654 (823)
                      .++||||+++++|.+++... ....+++..+..++.+++.||+|||+.+   |+|+||||+||+++.++.++|+|||+++
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence            99999999999999998542 2334899999999999999999999987   9999999999999999999999999998


Q ss_pred             ecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCch
Q 003391          655 AFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPV  733 (823)
Q Consensus       655 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  733 (823)
                      .+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+......+      .........   
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~------~~~~~~~~~---  260 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS------KFYKLIKEG---  260 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH------HHHHHHHcC---
Confidence            6543322112222345778999999999999999999999999999998 888864322110      000000000   


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          734 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       734 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                            ...........++.+++.+|++.+|++||++.|+++.|+..
T Consensus       261 ------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         261 ------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                  00011111234678999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.5e-34  Score=302.98  Aligned_cols=247  Identities=29%  Similarity=0.378  Sum_probs=196.8

Q ss_pred             CeeeccCccceEEEEeecCcEEEEEEecCCccc-cHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCCCCcc
Q 003391          510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQ-GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLN  588 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~  588 (823)
                      ++||+|+||.||+|.+.+++.+|+|.+...... ....+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            378999999999999888899999998765432 3446889999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccccccccc
Q 003391          589 DFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV  668 (823)
Q Consensus       589 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~  668 (823)
                      +++...  ...+++..+..++.+++.+|.|||+.+   ++|+||||+||++++++.+||+|||++......... .....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~  154 (250)
T cd05085          81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK  154 (250)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence            988532  335789999999999999999999987   999999999999999999999999999754322111 11112


Q ss_pred             cccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHH
Q 003391          669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLS  747 (823)
Q Consensus       669 ~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~  747 (823)
                      .++..|+|||++....++.++||||||+++|||++ |..||......       .........         .....+..
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-------~~~~~~~~~---------~~~~~~~~  218 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-------QAREQVEKG---------YRMSCPQK  218 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-------HHHHHHHcC---------CCCCCCCC
Confidence            34568999999998899999999999999999998 88887432111       000111110         11111222


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003391          748 EVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS  778 (823)
Q Consensus       748 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  778 (823)
                      ....+.+++.+|++.+|++||++.|+++.|.
T Consensus       219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            3457889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.9e-35  Score=319.91  Aligned_cols=241  Identities=24%  Similarity=0.327  Sum_probs=192.3

Q ss_pred             CeeeccCccceEEEEee----cCcEEEEEEecCCc----cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          510 NKLGEGGFGPVYKGVLI----EGQEIAAKRLSKSS----GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~----~~~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      ++||+|+||.||+++..    .++.+|+|.+....    ......+.+|+.+++.++||||+++++.+..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            58999999999999863    47889999986532    23345678899999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++++|.+++..   ...+.+..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  154 (323)
T cd05584          82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-  154 (323)
T ss_pred             CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence            999999998843   345788889999999999999999988   9999999999999999999999999997542221 


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                       .......||+.|+|||++.+..++.++||||||+++|||++|+.||......      . ........        .. 
T Consensus       155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~-~~~~~~~~--------~~-  217 (323)
T cd05584         155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------K-TIDKILKG--------KL-  217 (323)
T ss_pred             -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------H-HHHHHHcC--------CC-
Confidence             1223357899999999999988999999999999999999999997532210      0 00111110        00 


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003391          742 GSYSLSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVL  775 (823)
Q Consensus       742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  775 (823)
                       ..+......+.+++.+|++.+|++||     ++.++++
T Consensus       218 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         218 -NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             -CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence             11111224677999999999999999     7888766

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=6.8e-35  Score=318.77  Aligned_cols=248  Identities=22%  Similarity=0.307  Sum_probs=194.4

Q ss_pred             CeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceEEEEeecCC
Q 003391          510 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEYLPN  584 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (823)
                      +.||+|+||.||++++.. ++.||+|++++..   ....+.+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            479999999999999865 7899999997542   23445678899999988 799999999999999999999999999


Q ss_pred             CCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccccc
Q 003391          585 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN  664 (823)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  664 (823)
                      |+|.+++..   .+.+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~  152 (329)
T cd05588          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDT  152 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCc
Confidence            999988743   346899999999999999999999998   999999999999999999999999998753211  122


Q ss_pred             cccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCc--cchhHHHHHHhhhcCchhhhhhhcCC
Q 003391          665 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH--HNLLGHAWRLWIEERPVELINKSLGG  742 (823)
Q Consensus       665 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~~~~l~~  742 (823)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||+.......  ...............        .  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~--  222 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--------I--  222 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--------C--
Confidence            2346789999999999999999999999999999999999999864332221  111111111111110        0  


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCC------HHHHHH
Q 003391          743 SYSLSEVLRCIQVGLLCVQQRPEDRPN------MSSVVL  775 (823)
Q Consensus       743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs------~~evl~  775 (823)
                      ..+......+.+++.+|++.||.+||+      +.++++
T Consensus       223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            011112246788999999999999997      567764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.2e-34  Score=304.85  Aligned_cols=250  Identities=27%  Similarity=0.352  Sum_probs=202.5

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC--ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      +|...+.||+|++|.||+++... ++.+++|.+...  .....+++.+|++++++++|||++++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            36677899999999999999864 889999988643  334566788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++++|.+++... ....+++..+..++.+++.||.|||+.+   ++|+||||+||++++++.++|+|||+++.+.....
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            9999999998653 2456899999999999999999999987   99999999999999999999999999987643322


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                        ......+++.|+|||++.+..++.++|+||||++++||++|+.|+.....   ...    .......         ..
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~----~~~~~~~---------~~  218 (256)
T cd08529         157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GAL----ILKIIRG---------VF  218 (256)
T ss_pred             --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHH----HHHHHcC---------CC
Confidence              12234678899999999999999999999999999999999999753321   000    0000100         00


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          742 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ..........+.+++.+|++.+|++||++.++++.
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         219 PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            11111233578899999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=9.2e-35  Score=310.36  Aligned_cols=247  Identities=28%  Similarity=0.376  Sum_probs=194.6

Q ss_pred             eeccCccceEEEEeec-CcEEEEEEecCCcc---ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCCCCc
Q 003391          512 LGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSL  587 (823)
Q Consensus       512 LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  587 (823)
                      ||+|+||+||++.... ++.+|+|++.....   ...+.+..|+.++++++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            6999999999999764 78999999865422   2345678899999999999999999999999999999999999999


Q ss_pred             chhhhccC-CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccccccc
Q 003391          588 NDFIFDVT-RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN  666 (823)
Q Consensus       588 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  666 (823)
                      ..++.... ....+++..+..++.||+.||.|||+.+   |+||||||+||++++++.+||+|||++..+.....  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            98875432 3456899999999999999999999987   99999999999999999999999999986543222  223


Q ss_pred             cccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCH
Q 003391          667 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSL  746 (823)
Q Consensus       667 ~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~  746 (823)
                      ...||+.|+|||.+.+..++.++||||||+++|||++|+.||.........   .....        .......  ..+.
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~---~~~~~--------~~~~~~~--~~~~  222 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN---KELKQ--------RILNDSV--TYPD  222 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH---HHHHH--------hhcccCC--CCcc
Confidence            357899999999999999999999999999999999999997543221100   00000        0000000  1112


Q ss_pred             HHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003391          747 SEVLRCIQVGLLCVQQRPEDRP-----NMSSVVLM  776 (823)
Q Consensus       747 ~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~  776 (823)
                      .....+.+++..|++.+|++||     +++++++.
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            2334678899999999999999     67777753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.1e-34  Score=307.67  Aligned_cols=254  Identities=27%  Similarity=0.405  Sum_probs=191.6

Q ss_pred             CeeeccCccceEEEEeec---CcEEEEEEecCCcc-ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCCC
Q 003391          510 NKLGEGGFGPVYKGVLIE---GQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNK  585 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~---~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (823)
                      +.||+|+||.||+|...+   +..+|+|++..... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998654   45789998866543 33457889999999999999999999999999999999999999


Q ss_pred             CcchhhhccC--CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccc
Q 003391          586 SLNDFIFDVT--RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA  663 (823)
Q Consensus       586 sL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  663 (823)
                      +|.+++....  .....++..+..++.|+++||+|||+.+   ++|+||||+||+++.++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999986432  2234677888899999999999999987   9999999999999999999999999997543332222


Q ss_pred             ccccccccCCccCccccccC-------CCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhh
Q 003391          664 NTNRVVGTYGYMPPEYAIDG-------LFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVEL  735 (823)
Q Consensus       664 ~~~~~~gt~~y~aPE~l~~~-------~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  735 (823)
                      ......++..|+|||++.+.       .++.++||||||+++|||++ |+.||......+   .....    ........
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~~~~~~~  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTYT----VREQQLKL  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHH----hhcccCCC
Confidence            22334577889999998642       35789999999999999996 999975432211   11100    00111111


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003391          736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS  778 (823)
Q Consensus       736 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  778 (823)
                      ..+.+    .......+.+++..|+ .+|++|||++||+..|+
T Consensus       231 ~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            11111    1112235677888998 58999999999999886

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=7.1e-35  Score=318.52  Aligned_cols=243  Identities=23%  Similarity=0.312  Sum_probs=190.3

Q ss_pred             CeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceEEEEeecCC
Q 003391          510 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEYLPN  584 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (823)
                      +.||+|+||.||+++... ++.+|+|++.+..   ....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            479999999999999765 7889999987642   23445677888888776 899999999999999999999999999


Q ss_pred             CCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccccc
Q 003391          585 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN  664 (823)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  664 (823)
                      ++|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~  152 (329)
T cd05618          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDT  152 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCc
Confidence            999888743   345899999999999999999999998   999999999999999999999999999753221  112


Q ss_pred             cccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCcc--chhHHHHHHhhhcCchhhhhhhcCC
Q 003391          665 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHH--NLLGHAWRLWIEERPVELINKSLGG  742 (823)
Q Consensus       665 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~--~l~~~~~~~~~~~~~~~~~~~~l~~  742 (823)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||.........  ....+.........          .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~  222 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------I  222 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----------C
Confidence            23467899999999999999999999999999999999999998643221111  11111111111110          0


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCH
Q 003391          743 SYSLSEVLRCIQVGLLCVQQRPEDRPNM  770 (823)
Q Consensus       743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  770 (823)
                      ..+......+.+++.+||+.||++||++
T Consensus       223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         223 RIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            1112223467789999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-34  Score=304.46  Aligned_cols=251  Identities=26%  Similarity=0.383  Sum_probs=203.4

Q ss_pred             hcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      .++|...+.||+|+||.||+|.. .++.||+|++..... ..+++.+|+.++++++|+||+++++++.+....++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            35678889999999999999987 488999999976644 5678999999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  662 (823)
                      ++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++....... 
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence            9999999985432 236899999999999999999999988   99999999999999999999999999986532211 


Q ss_pred             cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                          ....+..|+|||.+....++.++||||||++++||++ |+.|+......   .+    .......         ..
T Consensus       158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~----~~~~~~~---------~~  217 (256)
T cd05039         158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DV----VPHVEKG---------YR  217 (256)
T ss_pred             ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HH----HHHHhcC---------CC
Confidence                2334568999999998899999999999999999997 88886432111   11    1111111         01


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          742 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      ...+......+.+++.+|++.+|++||++.|++++|+.+
T Consensus       218 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         218 MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            111112235778999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.3e-34  Score=314.60  Aligned_cols=240  Identities=26%  Similarity=0.335  Sum_probs=188.8

Q ss_pred             CeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhc-cCCCCceeEEEEeecCCceEEEEeecCC
Q 003391          510 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAK-LQHRNLVKLIGCCTQRDERMLIYEYLPN  584 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (823)
                      +.||+|+||.||+|+..+ ++.||+|.++...   ....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            479999999999999865 7789999987542   2334455667777765 4899999999999999999999999999


Q ss_pred             CCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccccc
Q 003391          585 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN  664 (823)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  664 (823)
                      |+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~  152 (316)
T cd05592          81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence            999998843   345889999999999999999999987   9999999999999999999999999998643222  22


Q ss_pred             cccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCC
Q 003391          665 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY  744 (823)
Q Consensus       665 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~  744 (823)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+    .......          ....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~~----~~~i~~~----------~~~~  215 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---EL----FDSILND----------RPHF  215 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---HH----HHHHHcC----------CCCC
Confidence            33467899999999999999999999999999999999999997532211   01    1111100          0111


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 003391          745 SLSEVLRCIQVGLLCVQQRPEDRPNMS-SVV  774 (823)
Q Consensus       745 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl  774 (823)
                      +.....++.+++.+||+.+|++||++. +++
T Consensus       216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            111224567899999999999999976 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.6e-35  Score=327.62  Aligned_cols=253  Identities=20%  Similarity=0.295  Sum_probs=194.3

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      .|...+.||+|+||+||+|+... ++.+|+|++.+..   ....+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            57778899999999999999765 7899999996542   2345678899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            9999999999853   345888999999999999999999988   9999999999999999999999999986432110


Q ss_pred             c---------------------------------------------ccccccccccCCccCccccccCCCCccchhHhHH
Q 003391          661 T---------------------------------------------EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFG  695 (823)
Q Consensus       661 ~---------------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~G  695 (823)
                      .                                             ........||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            0                                             0001235799999999999999999999999999


Q ss_pred             HHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHH--ccccCCCCCCCHHHH
Q 003391          696 VLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLL--CVQQRPEDRPNMSSV  773 (823)
Q Consensus       696 vvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~--Cl~~dP~~RPs~~ev  773 (823)
                      |++|||++|+.||.......   ..    ......      ...+..........++.+++.+  |+..+|..||++.|+
T Consensus       236 ~il~elltG~~Pf~~~~~~~---~~----~~i~~~------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~  302 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTE---TQ----LKVINW------ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI  302 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHH---HH----HHHHcc------ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence            99999999999985432111   00    000000      0000000000112345566655  666777779999999


Q ss_pred             HHH
Q 003391          774 VLM  776 (823)
Q Consensus       774 l~~  776 (823)
                      +..
T Consensus       303 l~h  305 (381)
T cd05626         303 KAH  305 (381)
T ss_pred             hcC
Confidence            875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.1e-34  Score=303.99  Aligned_cols=253  Identities=28%  Similarity=0.433  Sum_probs=200.5

Q ss_pred             cCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecC
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP  583 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (823)
                      ++|...++||+|++|.||++.+..+..+|+|++.... ...+.+.+|+.++++++|+|++++++++. .+..++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            4577888999999999999998777789999886543 34567899999999999999999999885 456889999999


Q ss_pred             CCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccc
Q 003391          584 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA  663 (823)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  663 (823)
                      +++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++......... 
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05069          84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence            99999998542 2345889999999999999999999987   999999999999999999999999999875432211 


Q ss_pred             ccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCC
Q 003391          664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG  742 (823)
Q Consensus       664 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~  742 (823)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+......   ...    ......         ...
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~----~~~~~~---------~~~  222 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVL----EQVERG---------YRM  222 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcC---------CCC
Confidence            1122345678999999998899999999999999999999 88886432111   111    111110         001


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          743 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                      ..+......+.+++.+|++.+|++||+++++++.|+.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            1112234568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=6e-35  Score=323.70  Aligned_cols=201  Identities=25%  Similarity=0.353  Sum_probs=173.8

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ++|+..+.||+|+||.||+++... ++.+|+|++.+..   ......+.+|+.++.+++||||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            468888999999999999998765 8899999996542   233456788999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            99999999999853   346899999999999999999999988   999999999999999999999999999754321


Q ss_pred             ccc---------------------------------cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCC
Q 003391          660 QTE---------------------------------ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR  706 (823)
Q Consensus       660 ~~~---------------------------------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~  706 (823)
                      ...                                 ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            100                                 00123579999999999999999999999999999999999999


Q ss_pred             CCCC
Q 003391          707 NRGF  710 (823)
Q Consensus       707 p~~~  710 (823)
                      ||..
T Consensus       235 Pf~~  238 (363)
T cd05628         235 PFCS  238 (363)
T ss_pred             CCCC
Confidence            9853

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.7e-35  Score=322.32  Aligned_cols=253  Identities=22%  Similarity=0.279  Sum_probs=198.4

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ++|...+.||+|+||.||+++... ++.+|+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            368888999999999999999764 8899999987542   234566889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+++++|.+++...  ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            999999999998542  246899999999999999999999998   999999999999999999999999999876433


Q ss_pred             ccccccccccccCCccCccccc------cCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCch
Q 003391          660 QTEANTNRVVGTYGYMPPEYAI------DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV  733 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~------~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  733 (823)
                      ... ......||+.|+|||++.      ...++.++||||||+++|||++|+.||.......      . ........  
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~-~~~i~~~~--  225 (330)
T cd05601         156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------T-YNNIMNFQ--  225 (330)
T ss_pred             Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------H-HHHHHcCC--
Confidence            221 222346899999999986      4567899999999999999999999975322110      0 01111000  


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          734 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       734 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                          ..+...........+.+++..|++ +|.+||++.+++..
T Consensus       226 ----~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         226 ----RFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             ----CccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence                000000111122456788889998 99999999999853

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-34  Score=305.16  Aligned_cols=256  Identities=30%  Similarity=0.450  Sum_probs=205.4

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      ..++|.+.++||+|+||.||+|...+++.+|+|.+.... ...+++.+|+.++++++|+|++++++++......++||||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            346788899999999999999998878899999987543 3457899999999999999999999999998999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++++|.+++... ....+++..+..++.+++.||.|||+.+   ++|+||||+||++++++.+||+|||++..+.....
T Consensus        83 ~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          83 MSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             cCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            9999999998542 2345899999999999999999999987   99999999999999999999999999987643211


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhc
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL  740 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l  740 (823)
                       ........+..|+|||.+.+..++.++||||||++++||++ |+.||.....   ......    ....         .
T Consensus       159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~----~~~~---------~  221 (261)
T cd05034         159 -TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVLEQ----VERG---------Y  221 (261)
T ss_pred             -hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HHcC---------C
Confidence             11112234568999999998899999999999999999999 8888743211   111111    0000         0


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          741 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                      ....+.....++.+++.+|++.+|++||+++++++.|+.
T Consensus       222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         222 RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            011111224568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4.9e-35  Score=318.61  Aligned_cols=236  Identities=28%  Similarity=0.408  Sum_probs=189.1

Q ss_pred             CeeeccCccceEEEEeec-CcEEEEEEecCC---ccccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceEEEEeecCC
Q 003391          510 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEYLPN  584 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (823)
                      +.||+|+||.||+|+... ++.||+|++.+.   .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            479999999999999865 789999998654   233456677888888876 699999999999999999999999999


Q ss_pred             CCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccccc
Q 003391          585 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN  664 (823)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  664 (823)
                      |+|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~  152 (320)
T cd05590          81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKT  152 (320)
T ss_pred             chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCc
Confidence            999998843   345889999999999999999999988   999999999999999999999999998754222  112


Q ss_pred             cccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCC
Q 003391          665 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY  744 (823)
Q Consensus       665 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~  744 (823)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||......   .+    ........        .  ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~----~~~i~~~~--------~--~~  215 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---DL----FEAILNDE--------V--VY  215 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HH----HHHHhcCC--------C--CC
Confidence            23457899999999999999999999999999999999999998532211   01    11111110        0  01


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCH
Q 003391          745 SLSEVLRCIQVGLLCVQQRPEDRPNM  770 (823)
Q Consensus       745 ~~~~~~~l~~l~~~Cl~~dP~~RPs~  770 (823)
                      +.....++.+++.+|++.||++||++
T Consensus       216 ~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         216 PTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            11123467889999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-34  Score=304.00  Aligned_cols=250  Identities=33%  Similarity=0.478  Sum_probs=202.7

Q ss_pred             CeeeccCccceEEEEeec----CcEEEEEEecCCcccc-HHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCC
Q 003391          510 NKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQG-MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPN  584 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~----~~~vavK~l~~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (823)
                      +.||+|+||.||+|....    +..+++|.+....... .+++.+|+.++..++|+|++++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            479999999999999865    7789999987664433 67899999999999999999999999999999999999999


Q ss_pred             CCcchhhhccCC------CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          585 KSLNDFIFDVTR------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       585 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      ++|.+++.....      ...+++..+..++.|+++||+|||+.+   ++|+||+|+||++++++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999965422      367899999999999999999999987   99999999999999999999999999987654


Q ss_pred             CccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN  737 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  737 (823)
                      ...........++..|+|||.+....++.++||||+|++++||++ |+.|+......   .+    ........      
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~----~~~~~~~~------  224 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EV----LEYLRKGY------  224 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HH----HHHHHcCC------
Confidence            332223334567889999999988899999999999999999999 58887543111   11    11111100      


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003391          738 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS  778 (823)
Q Consensus       738 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  778 (823)
                         ....+.....++.+++.+|++.+|++||++.|+++.|+
T Consensus       225 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         225 ---RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ---CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence               01111122357889999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=9.1e-35  Score=308.38  Aligned_cols=255  Identities=25%  Similarity=0.392  Sum_probs=199.9

Q ss_pred             CCCcCCeeeccCccceEEEEeec-C---cEEEEEEecCC-ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-G---QEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~---~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      .|...+.||+|+||.||+|++.. +   ..||+|.+... ......+|..|+.++++++||||+++++++.++...++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            46678899999999999999764 2   35999998754 3344568999999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+++++|.+++...  ...+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++......
T Consensus        85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          85 EFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             ecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence            999999999998542  345899999999999999999999987   999999999999999999999999998765332


Q ss_pred             cccccc-cccc--ccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhh
Q 003391          660 QTEANT-NRVV--GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVEL  735 (823)
Q Consensus       660 ~~~~~~-~~~~--gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  735 (823)
                      ...... ....  .+..|+|||.+.+..++.++||||||+++|||++ |..||......   ..    .......     
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~----~~~i~~~-----  227 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DV----INAIEQD-----  227 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HH----HHHHHcC-----
Confidence            211111 1111  2357999999999999999999999999999886 99887432211   00    0000000     


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       736 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                          .......+.+..+.+++..|++.+|.+||++.+++.+|+..
T Consensus       228 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         228 ----YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ----CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                00111122345678999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=6.9e-35  Score=319.35  Aligned_cols=252  Identities=22%  Similarity=0.295  Sum_probs=196.3

Q ss_pred             CCCcCCeeeccCccceEEEEee----cCcEEEEEEecCCc----cccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCce
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLI----EGQEIAAKRLSKSS----GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDER  575 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~----~~~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~  575 (823)
                      +|++.+.||+|+||.||+++..    .++.+|+|++.+..    ....+.+..|+.++..+ +|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4777889999999999998863    47889999986532    23345678899999999 599999999999999999


Q ss_pred             EEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccccee
Q 003391          576 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                      ++||||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            999999999999999853   345889999999999999999999988   99999999999999999999999999986


Q ss_pred             cCCCccccccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchh
Q 003391          656 FGIDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE  734 (823)
Q Consensus       656 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  734 (823)
                      +..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.........   ..........    
T Consensus       155 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~~~~~~~~----  226 (332)
T cd05614         155 FLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ---SEVSRRILKC----  226 (332)
T ss_pred             ccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH---HHHHHHHhcC----
Confidence            532221 122345789999999999865 4789999999999999999999998543221111   1111111110    


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003391          735 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVLM  776 (823)
Q Consensus       735 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~  776 (823)
                            ....+......+.+++.+|++.||++||     +++++++.
T Consensus       227 ------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         227 ------DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence                  0111111224567899999999999999     67777653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.7e-35  Score=318.99  Aligned_cols=242  Identities=24%  Similarity=0.355  Sum_probs=192.4

Q ss_pred             CeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceEEEEeecCC
Q 003391          510 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEYLPN  584 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (823)
                      +.||+|+||.||+|+... ++.+|+|++.+..   ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            469999999999999865 7899999987542   33445677888888866 799999999999999999999999999


Q ss_pred             CCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccccc
Q 003391          585 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN  664 (823)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  664 (823)
                      ++|..++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~  152 (321)
T cd05591          81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT  152 (321)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence            999988843   345889999999999999999999998   9999999999999999999999999997542221  12


Q ss_pred             cccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCC
Q 003391          665 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY  744 (823)
Q Consensus       665 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~  744 (823)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||......   ....    ......        .  ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---~~~~----~i~~~~--------~--~~  215 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---DLFE----SILHDD--------V--LY  215 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---HHHH----HHHcCC--------C--CC
Confidence            23357899999999999999999999999999999999999998533211   1111    011100        0  01


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCC-------CHHHHHHH
Q 003391          745 SLSEVLRCIQVGLLCVQQRPEDRP-------NMSSVVLM  776 (823)
Q Consensus       745 ~~~~~~~l~~l~~~Cl~~dP~~RP-------s~~evl~~  776 (823)
                      +.....++.+++..|++.+|++||       ++.++++.
T Consensus       216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            111124677899999999999999       77888754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.2e-35  Score=288.28  Aligned_cols=249  Identities=24%  Similarity=0.360  Sum_probs=200.6

Q ss_pred             HHHHhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc-----c---cHHHHHHHHHHHhcc-CCCCceeEEEE
Q 003391          499 IANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG-----Q---GMEEFENEVLLIAKL-QHRNLVKLIGC  568 (823)
Q Consensus       499 l~~~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~-----~---~~~~~~~Ei~~l~~l-~H~niv~l~g~  568 (823)
                      -....+.|...+.||.|..++|.++.++. ++++|+|++.....     .   -.+.-..|+.+|+++ .||+|+++.++
T Consensus        12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~   91 (411)
T KOG0599|consen   12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV   91 (411)
T ss_pred             HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence            34445678888999999999999998765 88999999854321     1   133456799999998 69999999999


Q ss_pred             eecCCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceee
Q 003391          569 CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKIS  648 (823)
Q Consensus       569 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~  648 (823)
                      ++.....++|+|.|+.|.|.++|.   ..-.+++....+|..|+.+|++|||...   ||||||||+|||++++.++||+
T Consensus        92 yes~sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~is  165 (411)
T KOG0599|consen   92 YESDAFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKIS  165 (411)
T ss_pred             ccCcchhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEe
Confidence            999999999999999999999994   3345899999999999999999999998   9999999999999999999999


Q ss_pred             ccccceecCCCccccccccccccCCccCcccccc------CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHH
Q 003391          649 DFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID------GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH  722 (823)
Q Consensus       649 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~  722 (823)
                      |||+|+.+...   ......+||++|+|||.+.-      ..|+..+|+|++|||+|-|+.|..||-.            
T Consensus       166 DFGFa~~l~~G---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH------------  230 (411)
T KOG0599|consen  166 DFGFACQLEPG---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH------------  230 (411)
T ss_pred             ccceeeccCCc---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH------------
Confidence            99999987533   34456899999999999852      3488899999999999999999999621            


Q ss_pred             HHHHhhhcCchhhhhhhcCCC--CCHHH----HHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          723 AWRLWIEERPVELINKSLGGS--YSLSE----VLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       723 ~~~~~~~~~~~~~~~~~l~~~--~~~~~----~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                       .++      .-++.-.+.+.  +..++    .....+++.+|+|.||.+|.|++|++.
T Consensus       231 -RkQ------mlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  231 -RKQ------MLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             -HHH------HHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence             111      01111122222  12222    235678999999999999999999985

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.2e-34  Score=307.10  Aligned_cols=255  Identities=22%  Similarity=0.361  Sum_probs=200.4

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      .++|+..+.||+|+||.||+|+.. +++.+|+|++..........+.+|+.++++++||||+++++.+...+..++|+||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            357888999999999999999975 4788999998766555566788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++++|.+++..   ...+++..+..++.|+++||.|||+.+   |+|+||+|+||++++++.++|+|||++..+.... 
T Consensus        88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-  160 (267)
T cd06646          88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI-  160 (267)
T ss_pred             CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc-
Confidence            999999998843   345889999999999999999999987   9999999999999999999999999998653221 


Q ss_pred             ccccccccccCCccCccccc---cCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          662 EANTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                       .......++..|+|||.+.   ...++.++||||||+++|||++|+.|+....+.......       ..   .....+
T Consensus       161 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~-------~~---~~~~~~  229 (267)
T cd06646         161 -AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-------SK---SNFQPP  229 (267)
T ss_pred             -cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee-------ec---CCCCCC
Confidence             1122356888999999884   445788999999999999999999986422211110000       00   000000


Q ss_pred             hcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003391          739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML  777 (823)
Q Consensus       739 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  777 (823)
                      ....  .......+.+++.+|++.+|++||+++++++.|
T Consensus       230 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         230 KLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            0000  111224678999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.5e-34  Score=311.25  Aligned_cols=264  Identities=24%  Similarity=0.365  Sum_probs=200.4

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-----------------CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-----------------GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKL  565 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l  565 (823)
                      ++|+..++||+|+||.||++...+                 ...+|+|++.... .....++.+|+.++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            568889999999999999986421                 3468999987543 3345678999999999999999999


Q ss_pred             EEEeecCCceEEEEeecCCCCcchhhhccCC--------CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcE
Q 003391          566 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTR--------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNV  637 (823)
Q Consensus       566 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NI  637 (823)
                      ++++...+..++||||+++++|.+++.....        ...+++..+..++.|++.||+|||+.+   ++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence            9999999999999999999999999865321        234788899999999999999999998   99999999999


Q ss_pred             EEcCCCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh--cCCCCCCcCCCC
Q 003391          638 LLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC--GKRNRGFYHADH  715 (823)
Q Consensus       638 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt--G~~p~~~~~~~~  715 (823)
                      ++++++.++|+|||+++.+.............++..|+|||......++.++||||||+++|||++  |..|+...... 
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~-  240 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE-  240 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH-
Confidence            999999999999999986543322222222344678999999888899999999999999999998  55665322111 


Q ss_pred             ccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          716 HHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       716 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                        .........+.... ...     ....+......+.+++.+|++.+|++||++.||++.|+.
T Consensus       241 --~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         241 --QVIENTGEFFRDQG-RQV-----YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             --HHHHHHHHHHhhcc-ccc-----cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence              11111100000000 000     000111223577899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=6.6e-35  Score=318.28  Aligned_cols=244  Identities=25%  Similarity=0.353  Sum_probs=191.6

Q ss_pred             CCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHH---hccCCCCceeEEEEeecCCceEEE
Q 003391          506 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLI---AKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       506 ~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l---~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      |++.+.||+|+||.||+|.... ++.||+|++.+..   ....+.+..|+.++   ..++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            4567899999999999999764 8899999997542   23345566676655   566899999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      |||+++++|..++.    ...+++..+..++.||+.||.|||+.+   |+||||||+||++++++.+||+|||+++....
T Consensus        81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            99999999988873    345899999999999999999999988   99999999999999999999999999875322


Q ss_pred             CccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                      .  ........|++.|+|||++.+..++.++|||||||++|||++|+.||......   ...    .......       
T Consensus       154 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~---~~~----~~i~~~~-------  217 (324)
T cd05589         154 F--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE---EVF----DSIVNDE-------  217 (324)
T ss_pred             C--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhCC-------
Confidence            1  12223467899999999999999999999999999999999999997532211   010    0011100       


Q ss_pred             hcCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003391          739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVL  775 (823)
Q Consensus       739 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  775 (823)
                       .  ..+......+.+++.+||+.||.+||     ++.++++
T Consensus       218 -~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         218 -V--RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             -C--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence             0  11111234677899999999999999     4666655

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.7e-34  Score=316.41  Aligned_cols=261  Identities=26%  Similarity=0.385  Sum_probs=203.2

Q ss_pred             cCCCcCCeeeccCccceEEEEeec--------CcEEEEEEecCCc-cccHHHHHHHHHHHhcc-CCCCceeEEEEeecCC
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE--------GQEIAAKRLSKSS-GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRD  573 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~--------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~  573 (823)
                      .+|.+.+.||+|+||.||+++...        ...+|+|.+.... ....+++.+|++++.++ +||||+++++++...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            467888999999999999998532        2368999886543 33456889999999999 8999999999999999


Q ss_pred             ceEEEEeecCCCCcchhhhccC-------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEc
Q 003391          574 ERMLIYEYLPNKSLNDFIFDVT-------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD  640 (823)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~  640 (823)
                      ..++++||+++|+|.+++....             ....+++..+..++.|+++||+|||+.+   |+||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence            9999999999999999986422             1235888999999999999999999987   99999999999999


Q ss_pred             CCCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccch
Q 003391          641 NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNL  719 (823)
Q Consensus       641 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l  719 (823)
                      +++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+.....      
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------  242 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV------  242 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH------
Confidence            999999999999986543221111222334567999999999999999999999999999998 7777643211      


Q ss_pred             hHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCCC
Q 003391          720 LGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL  783 (823)
Q Consensus       720 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~  783 (823)
                       ...........         ...........+.+++.+|++.+|++||++.|+++.|+.+...
T Consensus       243 -~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~  296 (334)
T cd05100         243 -EELFKLLKEGH---------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV  296 (334)
T ss_pred             -HHHHHHHHcCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence             11111111110         0111122234678999999999999999999999999877533

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-35  Score=325.27  Aligned_cols=253  Identities=23%  Similarity=0.326  Sum_probs=201.7

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ++|...+.||+|+||.||+|+... ++.||+|++....   ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            368888999999999999999864 8899999987542   244567889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+++++|.+++...   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999998542   56899999999999999999999987   999999999999999999999999999865433


Q ss_pred             c---------------------------cccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcC
Q 003391          660 Q---------------------------TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYH  712 (823)
Q Consensus       660 ~---------------------------~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~  712 (823)
                      .                           .........||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            2                           0112233578999999999999999999999999999999999999975432


Q ss_pred             CCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 003391          713 ADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPN-MSSVVLM  776 (823)
Q Consensus       713 ~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~  776 (823)
                      ..       ..........      ..+...........+.+++..|++ +|.+||+ +.|+++.
T Consensus       235 ~~-------~~~~~i~~~~------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         235 LQ-------ETYNKIINWK------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HH-------HHHHHHhccC------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            11       0001111000      000000011123467788999998 9999999 9999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.3e-34  Score=314.50  Aligned_cols=260  Identities=27%  Similarity=0.393  Sum_probs=202.1

Q ss_pred             hcCCCcCCeeeccCccceEEEEee--------cCcEEEEEEecCCc-cccHHHHHHHHHHHhcc-CCCCceeEEEEeecC
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI--------EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQR  572 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~--------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~  572 (823)
                      .++|.+.++||+|+||.||+++..        ....+|+|.+.... .....++.+|+.++.++ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            357788899999999999999752        24568899886543 23456788999999999 699999999999998


Q ss_pred             CceEEEEeecCCCCcchhhhccC-------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEE
Q 003391          573 DERMLIYEYLPNKSLNDFIFDVT-------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL  639 (823)
Q Consensus       573 ~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll  639 (823)
                      ...++|+||+++|+|.+++....             ....+++..+.+++.||+.||.|||+.+   ++|+||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence            99999999999999999996532             1245899999999999999999999987   9999999999999


Q ss_pred             cCCCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccc
Q 003391          640 DNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHN  718 (823)
Q Consensus       640 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~  718 (823)
                      ++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+......    
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~----  243 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE----  243 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH----
Confidence            9999999999999986543222111222234567999999999999999999999999999999 78876432111    


Q ss_pred             hhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          719 LLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       719 l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                         ...........         ...+.....++.+++.+|++.+|++||++.|+++.|+...
T Consensus       244 ---~~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         244 ---ELFKLLREGHR---------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             ---HHHHHHHcCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence               11111111100         0111222346778999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.3e-35  Score=320.79  Aligned_cols=242  Identities=23%  Similarity=0.304  Sum_probs=192.9

Q ss_pred             CeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCCC
Q 003391          510 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNK  585 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (823)
                      +.||+|+||.||+++... ++.+|+|++.+..   .....++..|++++..++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            479999999999999754 8899999987542   234456788999999999999999999999999999999999999


Q ss_pred             CcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccccc
Q 003391          586 SLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN  664 (823)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  664 (823)
                      +|..++.   +...+++..+..++.||+.||+|||+ .+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~  152 (325)
T cd05594          81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT  152 (325)
T ss_pred             cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence            9998874   33468999999999999999999997 56   9999999999999999999999999987532211  12


Q ss_pred             cccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCC
Q 003391          665 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY  744 (823)
Q Consensus       665 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~  744 (823)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||......   ....    .....        ..  .+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---~~~~----~i~~~--------~~--~~  215 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFE----LILME--------EI--RF  215 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH---HHHH----HHhcC--------CC--CC
Confidence            23356899999999999999999999999999999999999997532111   0000    00000        00  01


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003391          745 SLSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVLM  776 (823)
Q Consensus       745 ~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~  776 (823)
                      +.....++.+++.+|++.||++|+     ++.++++.
T Consensus       216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            111224677899999999999996     89998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.7e-34  Score=306.66  Aligned_cols=251  Identities=21%  Similarity=0.324  Sum_probs=197.0

Q ss_pred             cCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      ++|...++||+|+||.||+|++. .++.+|+|.+.... .....++.+|+.++.+++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            35677889999999999999875 47889999986542 33446788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++++|..+.       .+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++..+...  
T Consensus        81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--  148 (279)
T cd06619          81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--  148 (279)
T ss_pred             CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence            9999997643       3678888999999999999999988   999999999999999999999999999865322  


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                        ......++..|+|||.+.+..++.++||||||+++|||++|+.||.........................     .+ 
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----~~-  220 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPP-----VL-  220 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCC-----CC-
Confidence              1223578899999999999999999999999999999999999985432222111110111111111000     00 


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          742 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                        .......++.+++.+|++.+|++||++.|+++.
T Consensus       221 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         221 --PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             --CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence              011122367889999999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-34  Score=301.77  Aligned_cols=249  Identities=30%  Similarity=0.391  Sum_probs=197.9

Q ss_pred             CeeeccCccceEEEEeecCcEEEEEEecCCccc-cHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCCCCcc
Q 003391          510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQ-GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLN  588 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~  588 (823)
                      ++||+|+||.||++.+.+++.|++|++...... ..+++.+|++++++++|+||+++++++.+....++|+||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            479999999999999877999999998765443 5568899999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccccccccc
Q 003391          589 DFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV  668 (823)
Q Consensus       589 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~  668 (823)
                      +++...  ...+++..+..++.+++.+|.|||+.+   ++|+||+|+||+++.++.+||+|||++...............
T Consensus        81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            998542  235788999999999999999999987   999999999999999999999999999865322111111122


Q ss_pred             cccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHH
Q 003391          669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLS  747 (823)
Q Consensus       669 ~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~  747 (823)
                      ..+..|+|||.+.+..++.++|+||||+++|||++ |..|+.......   .    .         ..+........+..
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~----~---------~~~~~~~~~~~~~~  219 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---T----R---------ERIESGYRMPAPQL  219 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---H----H---------HHHhcCCCCCCCcc
Confidence            34567999999998899999999999999999999 777764322110   0    0         00111001111222


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          748 EVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       748 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                      ....+.+++.+|++.+|.+||++.|+++.|+.
T Consensus       220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            33578899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-34  Score=309.90  Aligned_cols=252  Identities=25%  Similarity=0.327  Sum_probs=199.0

Q ss_pred             CCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      +|+..++||+|+||.||++... +++.||+|++....   ......+.+|+.++++++||||+++++.+...+..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            3677889999999999999975 48899999986542   2233457789999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |+++++|.+++... ....+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            99999999888543 2345899999999999999999999988   9999999999999999999999999998653221


Q ss_pred             cccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhc
Q 003391          661 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL  740 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l  740 (823)
                         ......|+..|+|||++.+..++.++||||||+++|||++|+.||.......   ........         +.. .
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~---------~~~-~  220 (285)
T cd05605         157 ---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERR---------VKE-D  220 (285)
T ss_pred             ---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHH---------hhh-c
Confidence               1123468999999999999999999999999999999999999986422111   00000000         000 0


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003391          741 GGSYSLSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVLM  776 (823)
Q Consensus       741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~  776 (823)
                      ...........+.+++..|++.||++||     +++++++.
T Consensus       221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         221 QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            0111222334678999999999999999     78888654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-35  Score=325.28  Aligned_cols=253  Identities=21%  Similarity=0.267  Sum_probs=194.5

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ++|...++||+|+||.||+++... ++.||+|++.+..   ....+.+.+|+.++.+++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            468888999999999999998754 8899999986532   234567889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            99999999999853   345888999999999999999999998   999999999999999999999999999643210


Q ss_pred             ccc-----------c----------------------------------ccccccccCCccCccccccCCCCccchhHhH
Q 003391          660 QTE-----------A----------------------------------NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSF  694 (823)
Q Consensus       660 ~~~-----------~----------------------------------~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~  694 (823)
                      ...           .                                  ......||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            000           0                                  0012468999999999999999999999999


Q ss_pred             HHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCC---CCHH
Q 003391          695 GVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDR---PNMS  771 (823)
Q Consensus       695 Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~  771 (823)
                      ||++|||++|+.||......   ....    ......      ..+.-........++.+++.+|++ +|.+|   |++.
T Consensus       235 Gvil~elltG~~Pf~~~~~~---~~~~----~i~~~~------~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~  300 (377)
T cd05629         235 GAIMFECLIGWPPFCSENSH---ETYR----KIINWR------ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAH  300 (377)
T ss_pred             chhhhhhhcCCCCCCCCCHH---HHHH----HHHccC------CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence            99999999999998532211   1111    000000      000000000112356788889997 66664   6999


Q ss_pred             HHHHH
Q 003391          772 SVVLM  776 (823)
Q Consensus       772 evl~~  776 (823)
                      |+++.
T Consensus       301 ~~l~h  305 (377)
T cd05629         301 EIKSH  305 (377)
T ss_pred             HHhcC
Confidence            98876

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-35  Score=325.24  Aligned_cols=253  Identities=22%  Similarity=0.293  Sum_probs=197.1

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ++|+..+.||+|+||.||+++... ++.||||++....   ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            468888999999999999999864 8899999996542   234456788999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            99999999999853   345899999999999999999999998   999999999999999999999999999765321


Q ss_pred             cccc------------------------------------ccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh
Q 003391          660 QTEA------------------------------------NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC  703 (823)
Q Consensus       660 ~~~~------------------------------------~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt  703 (823)
                      ....                                    .....+||+.|+|||++....++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            1100                                    0112468999999999999999999999999999999999


Q ss_pred             cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 003391          704 GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPN---MSSVVLM  776 (823)
Q Consensus       704 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~  776 (823)
                      |+.||......   ..    ........      ..+...........+.+++.+|+. +|.+|++   +.|+++.
T Consensus       235 G~~Pf~~~~~~---~~----~~~i~~~~------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         235 GYPPFCSDNPQ---ET----YRKIINWK------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCCCCCHH---HH----HHHHHcCC------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            99998532211   00    00010000      000000000112356678888886 8999998   8888763

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.3e-34  Score=306.74  Aligned_cols=259  Identities=22%  Similarity=0.332  Sum_probs=204.8

Q ss_pred             cCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ++|...+.||+|+||.||+++.. +++.+++|.+....   .....++.+|+.+++.++||||+++++++.+.+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            46777889999999999999964 58899999886532   233457889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          580 EYLPNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       580 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      ||+++++|.+++... .....+++..+..++.+|++||.|||+.+   ++|+||||+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999988642 23456899999999999999999999988   99999999999999999999999999886533


Q ss_pred             CccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                      ...  ......++..|+|||.+.+..++.++||||||+++|||++|..|+....... ....    ....     ...  
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~----~~~~-----~~~--  224 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLC----KKIE-----QCD--  224 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-HHHh----hhhh-----cCC--
Confidence            221  1223568889999999998899999999999999999999999974321110 0000    0000     000  


Q ss_pred             hcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       739 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                       ............+.+++.+|++.+|++||||.+|+++++..
T Consensus       225 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         225 -YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             -CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence             00001112334678999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.8e-35  Score=299.39  Aligned_cols=264  Identities=25%  Similarity=0.351  Sum_probs=201.0

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccc--cHHHHHHHHHHHhccCCCC-ceeEEEEeecCC------
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQ--GMEEFENEVLLIAKLQHRN-LVKLIGCCTQRD------  573 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~------  573 (823)
                      ..|...++||+|.||+||+|+... |+.||+|++....++  ......+|+.++++++|+| ||++.+++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            445666789999999999999765 889999999766442  4456789999999999999 999999998877      


Q ss_pred             ceEEEEeecCCCCcchhhhccCCC-CccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccc
Q 003391          574 ERMLIYEYLPNKSLNDFIFDVTRS-KFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM  652 (823)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl  652 (823)
                      ..+||+||++. +|..++...... ..++...+..+..||++||+|||+++   |+||||||+||||++++.+||+|||+
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence            78899999955 899988654322 34667889999999999999999998   99999999999999999999999999


Q ss_pred             ceecCCCccccccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcC
Q 003391          653 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER  731 (823)
Q Consensus       653 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  731 (823)
                      |+.+..+...  ....++|..|.|||++.+. .|+...||||+|||+.||++++.-|......   .....+.+.+-...
T Consensus       167 Ara~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~---~ql~~If~~lGtP~  241 (323)
T KOG0594|consen  167 ARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI---DQLFRIFRLLGTPN  241 (323)
T ss_pred             HHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH---HHHHHHHHHcCCCC
Confidence            9976544332  3345789999999999887 7999999999999999999988877654431   11122211111000


Q ss_pred             ----c--hhhhhhh--cCC---CCCHHH-----HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          732 ----P--VELINKS--LGG---SYSLSE-----VLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       732 ----~--~~~~~~~--l~~---~~~~~~-----~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                          +  ..+.+..  ...   ..+...     ..+..+++.+|++.+|.+|.|++.++.+
T Consensus       242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence                0  0000000  000   000000     1367889999999999999999999876

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=9.9e-35  Score=319.38  Aligned_cols=261  Identities=27%  Similarity=0.375  Sum_probs=199.8

Q ss_pred             hcCCCcCCeeeccCccceEEEEe------ecCcEEEEEEecCCc-cccHHHHHHHHHHHhcc-CCCCceeEEEEeecC-C
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVL------IEGQEIAAKRLSKSS-GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQR-D  573 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~------~~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~  573 (823)
                      .++|...++||+|+||.||+|+.      ..++.||||++.... ......+.+|+.++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            35788999999999999999974      236789999997543 23345688999999999 789999999988654 4


Q ss_pred             ceEEEEeecCCCCcchhhhccCC---------------------------------------------------------
Q 003391          574 ERMLIYEYLPNKSLNDFIFDVTR---------------------------------------------------------  596 (823)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------  596 (823)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            67899999999999998853210                                                         


Q ss_pred             -------CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccccccccc
Q 003391          597 -------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV  669 (823)
Q Consensus       597 -------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  669 (823)
                             ...+++..+..++.||++||+|||+.+   |+||||||+||++++++.+||+|||++................
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                   124688889999999999999999987   9999999999999999999999999998653322222222234


Q ss_pred             ccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHHH
Q 003391          670 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSE  748 (823)
Q Consensus       670 gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  748 (823)
                      ++..|+|||.+.+..++.++||||||+++|||++ |..|+.......      ...........         ...+...
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~---------~~~~~~~  307 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTR---------MRAPDYT  307 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH------HHHHHHhccCC---------CCCCCCC
Confidence            5678999999999999999999999999999997 888864322110      00111111100         0001111


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          749 VLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       749 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      ..++.+++..|++.+|++||++.|+++.|+.+.
T Consensus       308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            235789999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2e-34  Score=303.38  Aligned_cols=249  Identities=29%  Similarity=0.409  Sum_probs=198.8

Q ss_pred             CeeeccCccceEEEEeec--C--cEEEEEEecCCcc-ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCC
Q 003391          510 NKLGEGGFGPVYKGVLIE--G--QEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPN  584 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~--~--~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (823)
                      ++||+|++|.||+|.+..  +  ..+|+|.+..... ...+.+.+|+.++++++||||+++++.+.+ ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999999754  2  3689999977665 566789999999999999999999999988 889999999999


Q ss_pred             CCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc-c
Q 003391          585 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE-A  663 (823)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~-~  663 (823)
                      ++|.+++.+... ..+++..+..++.|+++||+|||+.+   ++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999865332 46899999999999999999999987   999999999999999999999999999876432211 1


Q ss_pred             ccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCC
Q 003391          664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG  742 (823)
Q Consensus       664 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~  742 (823)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+......   ......    .. ..       ...
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~----~~-~~-------~~~  220 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QILKKI----DK-EG-------ERL  220 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----Hh-cC-------CcC
Confidence            1223456789999999999999999999999999999999 99987432111   111110    00 00       000


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003391          743 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS  778 (823)
Q Consensus       743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  778 (823)
                      ..+...+..+.+++.+|++.+|++||++.++++.|.
T Consensus       221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            111122357889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-34  Score=304.05  Aligned_cols=252  Identities=25%  Similarity=0.404  Sum_probs=199.9

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc-----ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG-----QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~-----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      ++|...+.||+|++|.||++...+ ++.+|+|.+.....     ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            568889999999999999999754 88999998864421     234568899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      |+||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+|+||+|+||++++++.++|+|||+++...
T Consensus        82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            9999999999998843   345788999999999999999999988   9999999999999999999999999998654


Q ss_pred             CCccccc-cccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          658 IDQTEAN-TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       658 ~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      ....... .....++..|+|||++.+..++.++||||||+++|||++|+.||.....     . ......         .
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~-~~~~~~---------~  220 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA-----M-AAIFKI---------A  220 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch-----H-HHHHHH---------h
Confidence            3211111 1234578899999999999999999999999999999999999642111     0 000000         0


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ........+......+.+++..|++.+|.+||++.|+++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         221 TQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            0001111122223467789999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3e-34  Score=302.40  Aligned_cols=247  Identities=27%  Similarity=0.389  Sum_probs=193.1

Q ss_pred             eeeccCccceEEEEee---cCcEEEEEEecCCcc-ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCCCC
Q 003391          511 KLGEGGFGPVYKGVLI---EGQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKS  586 (823)
Q Consensus       511 ~LG~G~fg~Vyk~~~~---~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  586 (823)
                      .||+|+||.||+|++.   .+..||+|++..... ...+++.+|+.++++++||||+++++++. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999864   245699998866533 33467899999999999999999999885 457899999999999


Q ss_pred             cchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccc-cc
Q 003391          587 LNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA-NT  665 (823)
Q Consensus       587 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~-~~  665 (823)
                      |.+++..  +...+++..+++++.|+++||.|||+.+   ++|+||||+||+++.++.+||+|||++..+....... ..
T Consensus        81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            9999853  2346899999999999999999999987   9999999999999999999999999998653322211 11


Q ss_pred             ccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCC
Q 003391          666 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY  744 (823)
Q Consensus       666 ~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~  744 (823)
                      ....++..|+|||.+....++.++||||||+++|||++ |+.|+......       .........         .....
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~---------~~~~~  219 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-------EVMSFIEQG---------KRLDC  219 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-------HHHHHHHCC---------CCCCC
Confidence            11233578999999988889999999999999999996 99887432111       011111111         11112


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          745 SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       745 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                      +.....++.+++..|++.+|++||++.+|.+.|+.
T Consensus       220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence            22334577889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.9e-34  Score=310.44  Aligned_cols=250  Identities=23%  Similarity=0.381  Sum_probs=201.9

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      ..+|+..+.||+|+||.||+|+.. .++.+++|.+........+.+.+|+.+++.+.|+||+++++.+......++||||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            357888899999999999999865 4889999999776666667889999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++++|.+++.+    ..+++.++..++.|++.||+|||+.+   |+|+||||+||+++.++.+||+|||++........
T Consensus        99 ~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~  171 (296)
T cd06654          99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (296)
T ss_pred             cCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence            999999998842    34789999999999999999999998   99999999999999999999999999876432221


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                        ......+++.|+|||.+.+..++.++|||||||++|||++|+.||.......  .+.    .......      +.+ 
T Consensus       172 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~----~~~~~~~------~~~-  236 (296)
T cd06654         172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALY----LIATNGT------PEL-  236 (296)
T ss_pred             --ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHH----HHhcCCC------CCC-
Confidence              1223468889999999998889999999999999999999999975322111  000    0000000      000 


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          742 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                       ..+......+.+++.+|++.+|++||++.|+++
T Consensus       237 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         237 -QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             -CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence             011122246778999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.4e-34  Score=309.11  Aligned_cols=271  Identities=29%  Similarity=0.416  Sum_probs=204.0

Q ss_pred             cCCCcCCeeeccCccceEEEEee-----cCcEEEEEEecCCccc-cHHHHHHHHHHHhccCCCCceeEEEEeec--CCce
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLI-----EGQEIAAKRLSKSSGQ-GMEEFENEVLLIAKLQHRNLVKLIGCCTQ--RDER  575 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~-----~~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~  575 (823)
                      +.|...+.||+|+||.||++++.     .+..+|+|.+...... ..++|.+|+++++.++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45667789999999999999864     2678999999765443 46789999999999999999999999877  5578


Q ss_pred             EEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccccee
Q 003391          576 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                      ++||||+++++|.+++...  ...+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            9999999999999998542  235899999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCccc-cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchh
Q 003391          656 FGIDQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE  734 (823)
Q Consensus       656 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  734 (823)
                      ....... .......++..|+|||.+.+..++.++||||||++++||++|+.|+......... ...............+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~  237 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-MIGIAQGQMIVTRLLE  237 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc-ccccccccccHHHHHH
Confidence            6422211 1111234456799999999889999999999999999999999886432211100 0000000000000011


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          735 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       735 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      .+........+.....++.+++.+|++.+|++||+|.||+++|+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1111111111222335788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.3e-34  Score=305.02  Aligned_cols=256  Identities=26%  Similarity=0.395  Sum_probs=201.2

Q ss_pred             cCCCcCCeeeccCccceEEEEeec----CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~----~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      ++|+..+.||+|+||.||+|++..    ...+|+|.+.... ....+.+.+|+.++.+++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            467788999999999999998752    3368999886543 23356789999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      |||+++++|.+++...  ...+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++..+..
T Consensus        84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            9999999999998532  345899999999999999999999987   99999999999999999999999999987643


Q ss_pred             Ccccc-ccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          659 DQTEA-NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       659 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      ..... ......++..|+|||.+.+..++.++||||||+++||+++ |+.|+......   ...    ....+.      
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~----~~~~~~------  225 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVI----KAIEEG------  225 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHH----HHHhCC------
Confidence            22211 1111223568999999998899999999999999999886 99886432211   011    111110      


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                         ............+.+++.+|++.+|.+||+|.++++.|+.+
T Consensus       226 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         226 ---YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ---CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence               00011112234678999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-35  Score=299.34  Aligned_cols=268  Identities=22%  Similarity=0.303  Sum_probs=204.1

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC--ccccHHHHHHHHHHHhccCCCCceeEEEEeec-----CC
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ-----RD  573 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-----~~  573 (823)
                      ....|...+.||+|+||.|.+++... ++.||||++...  .....++..+|+.+|+.++|+||+.+.+.+..     -+
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            34556667899999999999999865 899999999743  44566778899999999999999999998855     34


Q ss_pred             ceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccc
Q 003391          574 ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  653 (823)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  653 (823)
                      ..|+|+|+| ..+|...+.   .++.++.....-+..||++||.|+|+.+   |+||||||.|+|++.+..+||+|||+|
T Consensus       100 DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             eeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence            689999999 558888773   3445899999999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCccccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHH--------
Q 003391          654 RAFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW--------  724 (823)
Q Consensus       654 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~--------  724 (823)
                      +...........+..+.|..|.|||++.. ..|+.+.||||.||||.||++|+.-|...+..++..++-...        
T Consensus       173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l  252 (359)
T KOG0660|consen  173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL  252 (359)
T ss_pred             eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence            98754323333456788999999999864 579999999999999999999999987655444333322211        


Q ss_pred             HHhhhcCchhhhhhhc-CCCCCHHH-----HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          725 RLWIEERPVELINKSL-GGSYSLSE-----VLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       725 ~~~~~~~~~~~~~~~l-~~~~~~~~-----~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      .....+.....+.... ....+-..     -...++|..+||..||.+|+|++|+++.
T Consensus       253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            1111111111111100 00111111     1266889999999999999999999864

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=7.2e-35  Score=324.81  Aligned_cols=252  Identities=20%  Similarity=0.279  Sum_probs=193.7

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      +|++.++||+|+||.||+++... ++.+|+|++.+..   ......+.+|+.++.+++||||+++++.+.+.+..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            68888999999999999999765 8899999986532   2334668899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          82 YIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            9999999999843   345788899999999999999999988   9999999999999999999999999985331100


Q ss_pred             c-----------------------------------------ccccccccccCCccCccccccCCCCccchhHhHHHHHH
Q 003391          661 T-----------------------------------------EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVL  699 (823)
Q Consensus       661 ~-----------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~  699 (823)
                      .                                         ........||+.|+|||++.+..++.++|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence            0                                         00112357999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCC---CHHHHHHH
Q 003391          700 EIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRP---NMSSVVLM  776 (823)
Q Consensus       700 elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---s~~evl~~  776 (823)
                      ||++|+.||......+.   .    ....... ..     ............+.+++.+|+ .+|.+|+   ++.|+++.
T Consensus       236 ell~G~~Pf~~~~~~~~---~----~~i~~~~-~~-----~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         236 EMLVGQPPFLADTPAET---Q----LKVINWE-TT-----LHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             ehhhCCCCCCCCCHHHH---H----HHHhccC-cc-----ccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            99999999854322110   0    0000000 00     000000111224456666665 4999999   88888865

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.4e-35  Score=320.86  Aligned_cols=238  Identities=25%  Similarity=0.293  Sum_probs=190.1

Q ss_pred             CeeeccCccceEEEEee----cCcEEEEEEecCCcc--ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecC
Q 003391          510 NKLGEGGFGPVYKGVLI----EGQEIAAKRLSKSSG--QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP  583 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~----~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (823)
                      +.||+|+||.||+++..    .++.+|+|++.....  .....+..|++++.+++||||+++++++.+.+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            57999999999998753    478999999875432  234457789999999999999999999999999999999999


Q ss_pred             CCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccc
Q 003391          584 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA  663 (823)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  663 (823)
                      +++|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++......  .
T Consensus        82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~  153 (318)
T cd05582          82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K  153 (318)
T ss_pred             CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence            9999998843   345899999999999999999999998   9999999999999999999999999998643221  1


Q ss_pred             ccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCC
Q 003391          664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS  743 (823)
Q Consensus       664 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~  743 (823)
                      ......|++.|+|||++.+..++.++||||||+++|||++|+.||......   ...    ......        ..  .
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~----~~i~~~--------~~--~  216 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK---ETM----TMILKA--------KL--G  216 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH---HHH----HHHHcC--------CC--C
Confidence            223457899999999999989999999999999999999999997532210   000    000000        00  1


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 003391          744 YSLSEVLRCIQVGLLCVQQRPEDRPNMSS  772 (823)
Q Consensus       744 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e  772 (823)
                      .+......+.+++.+||+.||++||++.+
T Consensus       217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         217 MPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            11112246778999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.3e-34  Score=312.78  Aligned_cols=255  Identities=27%  Similarity=0.438  Sum_probs=198.1

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-Cc--EEEEEEecCCc-cccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQ--EIAAKRLSKSS-GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~--~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV  578 (823)
                      ++|+..+.||+|+||.||+|.+.+ +.  .+++|++.... .....++.+|+.++.++ +||||+++++++...+..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            567888999999999999999754 43  45777775432 33456788999999999 899999999999999999999


Q ss_pred             EeecCCCCcchhhhccC-------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCc
Q 003391          579 YEYLPNKSLNDFIFDVT-------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP  645 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  645 (823)
                      +||+++++|.+++....             ....+++..++.++.|+++||+|||+.+   ++||||||+|||+++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence            99999999999986432             1235889999999999999999999987   9999999999999999999


Q ss_pred             eeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHH
Q 003391          646 KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAW  724 (823)
Q Consensus       646 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~  724 (823)
                      ||+|||+++....   .........+..|+|||++.+..++.++||||||+++|||+| |..||......   ...    
T Consensus       164 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~----  233 (303)
T cd05088         164 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELY----  233 (303)
T ss_pred             EeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHH----
Confidence            9999999864211   111111234568999999988889999999999999999998 99887432211   010    


Q ss_pred             HHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          725 RLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       725 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      ......         ............+.+++.+|++.+|++||++.+++++|+.+
T Consensus       234 ~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         234 EKLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             HHHhcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            000000         00011111234678899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.9e-34  Score=314.88  Aligned_cols=243  Identities=22%  Similarity=0.298  Sum_probs=192.1

Q ss_pred             CeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceEEEEeecCC
Q 003391          510 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEYLPN  584 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (823)
                      +.||+|+||.||+++... ++.+|+|++.+..   ....+.+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            479999999999999765 7889999997642   23445678899999888 699999999999999999999999999


Q ss_pred             CCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccccc
Q 003391          585 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN  664 (823)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  664 (823)
                      ++|..++..   .+.+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~  152 (327)
T cd05617          81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDT  152 (327)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCc
Confidence            999988743   345899999999999999999999998   999999999999999999999999999753211  112


Q ss_pred             cccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCC
Q 003391          665 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY  744 (823)
Q Consensus       665 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~  744 (823)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......................        .  ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------~--~~  222 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP--------I--RI  222 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC--------C--CC
Confidence            2346789999999999999999999999999999999999999865433322222222221111110        0  01


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCH
Q 003391          745 SLSEVLRCIQVGLLCVQQRPEDRPNM  770 (823)
Q Consensus       745 ~~~~~~~l~~l~~~Cl~~dP~~RPs~  770 (823)
                      +......+.+++.+|++.||++||++
T Consensus       223 p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         223 PRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            11112456789999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.4e-34  Score=321.90  Aligned_cols=261  Identities=20%  Similarity=0.285  Sum_probs=196.0

Q ss_pred             CCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCC-----ceE
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD-----ERM  576 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~  576 (823)
                      +|+..++||+|+||.||++... +++.||+|++....  ....+++.+|+.+++.++||||+++++++....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4677899999999999999975 48899999986542  234567889999999999999999999998776     789


Q ss_pred             EEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceec
Q 003391          577 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  656 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  656 (823)
                      +|+||+. ++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999997 57777763   3446899999999999999999999998   999999999999999999999999999865


Q ss_pred             CCCccccccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCc---
Q 003391          657 GIDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP---  732 (823)
Q Consensus       657 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---  732 (823)
                      ...... ......+++.|+|||++.+. .++.++|||||||++|||++|+.||........   .............   
T Consensus       154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~g~~~~~~~  229 (372)
T cd07853         154 EPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ---LDLITDLLGTPSLEAM  229 (372)
T ss_pred             ccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHcCCCCHHHH
Confidence            432211 22234678899999998874 479999999999999999999999864332111   1111000000000   


Q ss_pred             --------hhhhhhhcCC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          733 --------VELINKSLGG-------SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       733 --------~~~~~~~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                              ..+.......       ........++.+++.+|++.||++|||+.|+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                    0000000000       0011113467899999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.1e-34  Score=316.49  Aligned_cols=241  Identities=27%  Similarity=0.330  Sum_probs=191.2

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCC-CceeEEEEeecCCceEEEE
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHR-NLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~-niv~l~g~~~~~~~~~lV~  579 (823)
                      +|+..+.||+|+||.||+|+..+ ++.||+|++.+..   ....+.+..|+.++..++|+ +|+++.+++.+.+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            46778899999999999999765 6789999987542   33456778899999999764 6888999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            99999999998843   345789999999999999999999987   999999999999999999999999998753221


Q ss_pred             ccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                      .  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+..    ......        
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~----~i~~~~--------  217 (324)
T cd05587         155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQ----SIMEHN--------  217 (324)
T ss_pred             C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHH----HHHcCC--------
Confidence            1  1223457899999999999999999999999999999999999997532211   1111    011000        


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 003391          740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNM  770 (823)
Q Consensus       740 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  770 (823)
                        ...+.....++.+++.+|++.+|.+||+.
T Consensus       218 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         218 --VSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             --CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence              01111122467789999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-34  Score=301.72  Aligned_cols=249  Identities=32%  Similarity=0.469  Sum_probs=195.6

Q ss_pred             CeeeccCccceEEEEeec-C---cEEEEEEecCCcc-ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCC
Q 003391          510 NKLGEGGFGPVYKGVLIE-G---QEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPN  584 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~-~---~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (823)
                      ++||+|+||.||+|+... +   ..+|+|.+..... ...+++.+|+.+++++.||||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            479999999999998644 2   6899999876544 34567899999999999999999999876 4568999999999


Q ss_pred             CCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccccc
Q 003391          585 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN  664 (823)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  664 (823)
                      ++|.+++...   ..+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++.+........
T Consensus        80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            9999999532   36899999999999999999999987   99999999999999999999999999987643322111


Q ss_pred             -cccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCC
Q 003391          665 -TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG  742 (823)
Q Consensus       665 -~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~  742 (823)
                       .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.....   ......    ......         .
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~----~~~~~~---------~  217 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAM----LESGER---------L  217 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHH----HHcCCc---------C
Confidence             111223567999999998999999999999999999998 8998753321   111111    111110         0


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          743 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      .........+.+++.+|++.+|++||++.+++++|++..
T Consensus       218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            111122346789999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.4e-34  Score=309.52  Aligned_cols=263  Identities=25%  Similarity=0.391  Sum_probs=201.3

Q ss_pred             cCCCcCCeeeccCccceEEEEee-----cCcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecC--Cce
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLI-----EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR--DER  575 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~-----~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~  575 (823)
                      +.|...+.||+|+||.||+++..     .+..+|+|.+.... ....+.+.+|+.++++++|||++++.+++.+.  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            34677889999999999999842     37789999987553 33456789999999999999999999998775  568


Q ss_pred             EEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccccee
Q 003391          576 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                      ++||||+++++|.+++...  ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||+++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence            8999999999999998432  235899999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCccc-cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCC--------CccchhHHHHHH
Q 003391          656 FGIDQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHAD--------HHHNLLGHAWRL  726 (823)
Q Consensus       656 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~--------~~~~l~~~~~~~  726 (823)
                      +...... .......++..|+|||.+.+..++.++||||||+++|||++++.|.......        ........... 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  237 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR-  237 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH-
Confidence            6433221 1122345677899999999889999999999999999999987663211000        00000000000 


Q ss_pred             hhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          727 WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       727 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                              .+...............+.+++.+|++.+|++||++.++++.|+.+
T Consensus       238 --------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         238 --------VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             --------HHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence                    0000001111112345788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.3e-34  Score=302.94  Aligned_cols=240  Identities=21%  Similarity=0.322  Sum_probs=188.3

Q ss_pred             CeeeccCccceEEEEeec-------------CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceE
Q 003391          510 NKLGEGGFGPVYKGVLIE-------------GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM  576 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~-------------~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  576 (823)
                      +.||+|+||.||+|++..             ...+++|.+..........+.+|+.++..++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999998532             2258888887665555667889999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCC-------ceeec
Q 003391          577 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN-------PKISD  649 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~-------~kl~D  649 (823)
                      +||||+++++|..++..  +...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.       ++++|
T Consensus        81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            99999999999988743  2345899999999999999999999987   999999999999987664       89999


Q ss_pred             cccceecCCCccccccccccccCCccCccccc-cCCCCccchhHhHHHHHHHHH-hcCCCCCCcCCCCccchhHHHHHHh
Q 003391          650 FGMARAFGIDQTEANTNRVVGTYGYMPPEYAI-DGLFSVKSDVFSFGVLVLEIV-CGKRNRGFYHADHHHNLLGHAWRLW  727 (823)
Q Consensus       650 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~ksDVwS~Gvvl~ell-tG~~p~~~~~~~~~~~l~~~~~~~~  727 (823)
                      ||++......      ....++..|+|||.+. +..++.++||||||+++|||+ +|+.|+......+       . ...
T Consensus       156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~-~~~  221 (262)
T cd05077         156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-------K-ERF  221 (262)
T ss_pred             CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-------H-HHH
Confidence            9998754321      2245778999999887 467899999999999999998 4777753221100       0 000


Q ss_pred             hhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003391          728 IEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS  778 (823)
Q Consensus       728 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  778 (823)
                      ...        ..  ....+...++.+++.+||+.||.+||++.++++.|+
T Consensus       222 ~~~--------~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         222 YEG--------QC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             Hhc--------Cc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            000        00  011112346789999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.4e-34  Score=314.27  Aligned_cols=241  Identities=26%  Similarity=0.359  Sum_probs=190.3

Q ss_pred             CeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhc-cCCCCceeEEEEeecCCceEEEEeecCC
Q 003391          510 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAK-LQHRNLVKLIGCCTQRDERMLIYEYLPN  584 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (823)
                      +.||+|+||.||+|++.. ++.||+|+++...   ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            479999999999999865 7889999987642   2344556778888876 4899999999999999999999999999


Q ss_pred             CCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccccc
Q 003391          585 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN  664 (823)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  664 (823)
                      |+|.+++..   ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  152 (316)
T cd05619          81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence            999998843   345889999999999999999999987   9999999999999999999999999997532211  12


Q ss_pred             cccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCC
Q 003391          665 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY  744 (823)
Q Consensus       665 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~  744 (823)
                      .....||..|+|||++.+..++.++|||||||++|||++|+.||.....   ..+.    .......      .    ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~----~~i~~~~------~----~~  215 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EELF----QSIRMDN------P----CY  215 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHHH----HHHHhCC------C----CC
Confidence            2345789999999999999999999999999999999999999753221   1111    1110000      0    01


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 003391          745 SLSEVLRCIQVGLLCVQQRPEDRPNMS-SVVL  775 (823)
Q Consensus       745 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~  775 (823)
                      +.....++.+++.+|++.+|++||++. ++.+
T Consensus       216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         216 PRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            111223567899999999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.8e-34  Score=303.44  Aligned_cols=257  Identities=23%  Similarity=0.341  Sum_probs=199.2

Q ss_pred             HHhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          501 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       501 ~~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      .+++++.....||+|+||.||+|++.+ +..+++|.+........+.+.+|+.++++++|+||+++++++...+..++|+
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   84 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM   84 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence            355666667799999999999999765 6789999987776666778999999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcC-CCCceeeccccceecCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-EMNPKISDFGMARAFGI  658 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DFGla~~~~~  658 (823)
                      ||+++++|.+++.........++..+..++.||++||+|||+.+   |+|+||||+||+++. ++.++|+|||++.....
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  161 (268)
T cd06624          85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG  161 (268)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence            99999999999864322112277888899999999999999987   999999999999976 67999999999976532


Q ss_pred             CccccccccccccCCccCccccccCC--CCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGL--FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~--~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      ..  .......++..|+|||++....  ++.++||||||+++|||++|+.|+.........     .+..       .  
T Consensus       162 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~-----~~~~-------~--  225 (268)
T cd06624         162 IN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA-----MFKV-------G--  225 (268)
T ss_pred             CC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh-----Hhhh-------h--
Confidence            21  1122245788999999986543  789999999999999999999997532211000     0000       0  


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ........+.....++.+++.+|++.+|.+||++.|+++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         226 MFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             hhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            0000111122233467889999999999999999999863

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.5e-34  Score=305.01  Aligned_cols=254  Identities=24%  Similarity=0.357  Sum_probs=188.0

Q ss_pred             CeeeccCccceEEEEeec---CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCCC
Q 003391          510 NKLGEGGFGPVYKGVLIE---GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNK  585 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~---~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (823)
                      ++||+|+||.||+|...+   ...+++|.+.... ......+.+|+..++.++||||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            369999999999997654   3468888775443 233456889999999999999999999999999999999999999


Q ss_pred             CcchhhhccCC--CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccc
Q 003391          586 SLNDFIFDVTR--SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA  663 (823)
Q Consensus       586 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  663 (823)
                      +|.+++.....  ....++.....++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999865332  233567888999999999999999987   9999999999999999999999999987543222212


Q ss_pred             ccccccccCCccCccccc-------cCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhh
Q 003391          664 NTNRVVGTYGYMPPEYAI-------DGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVEL  735 (823)
Q Consensus       664 ~~~~~~gt~~y~aPE~l~-------~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  735 (823)
                      ......++..|+|||++.       ...++.++||||||+++|||++ |..|+......   ..    ...........+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~----~~~~~~~~~~~~  230 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---QV----LKQVVREQDIKL  230 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH---HH----HHHHhhccCccC
Confidence            223345567899999874       3456889999999999999999 67776422110   01    111111111111


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003391          736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS  778 (823)
Q Consensus       736 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  778 (823)
                      ..+.+    .......+.+++..|+ .+|++||+++||+++|+
T Consensus       231 ~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         231 PKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            11111    1122235566778888 49999999999999984

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.9e-34  Score=323.00  Aligned_cols=262  Identities=18%  Similarity=0.226  Sum_probs=195.6

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      ..+|.+.+.||+|+||.||++.+.. ++.||+|...      ...+.+|++++++++|+|||++++++..++..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            4578889999999999999999876 7889999642      23457899999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +. ++|.+++..  ....+++..++.|+.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.....
T Consensus       242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            95 688888743  2346899999999999999999999998   99999999999999999999999999987643322


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCC-CCcCCCCccchhHHHHHHhhhcCc--h-----
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNR-GFYHADHHHNLLGHAWRLWIEERP--V-----  733 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~-~~~~~~~~~~l~~~~~~~~~~~~~--~-----  733 (823)
                      ........||..|+|||++.+..++.++|||||||+||||++|..++ ................+.......  .     
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~  395 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH  395 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence            22223457999999999999999999999999999999999988654 211111111111111111110000  0     


Q ss_pred             ---hhhh---h----hcCCCCC---H----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          734 ---ELIN---K----SLGGSYS---L----SEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       734 ---~~~~---~----~l~~~~~---~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                         .+..   .    .......   .    .....+.+|+.+||+.||.+|||+.|+++.
T Consensus       396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence               0000   0    0000000   0    011257789999999999999999999864

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.2e-34  Score=305.35  Aligned_cols=251  Identities=31%  Similarity=0.467  Sum_probs=197.1

Q ss_pred             CeeeccCccceEEEEeec-------CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          510 NKLGEGGFGPVYKGVLIE-------GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~-------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      +.||+|+||.||+|+..+       ++.+++|.+.... .....++.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            369999999999998753       2578999876543 24466789999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccC----CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCC-----Cceeecccc
Q 003391          582 LPNKSLNDFIFDVT----RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-----NPKISDFGM  652 (823)
Q Consensus       582 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~-----~~kl~DFGl  652 (823)
                      +++++|.+++....    ....+++..+..++.|++.||+|||+.+   ++|+||||+||+++.+.     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999996432    2235789999999999999999999987   99999999999999877     899999999


Q ss_pred             ceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcC
Q 003391          653 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEER  731 (823)
Q Consensus       653 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~  731 (823)
                      ++...............++..|+|||++.+..++.++||||||+++|||++ |+.|+.....   ......    .... 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~----~~~~-  229 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQH----VTAG-  229 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHH----HhcC-
Confidence            986543322222222345678999999999999999999999999999998 9988753211   011100    0000 


Q ss_pred             chhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          732 PVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       732 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                              ............+.+++.+|++.+|.+||++.+++++|+.
T Consensus       230 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         230 --------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             --------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                    0001112233567899999999999999999999999863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4e-34  Score=301.10  Aligned_cols=249  Identities=24%  Similarity=0.348  Sum_probs=197.4

Q ss_pred             cCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEee-cCCceEEEEeec
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT-QRDERMLIYEYL  582 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~-~~~~~~lV~e~~  582 (823)
                      ++|...+.||+|+||.||++.. .+..+|+|.+....  ..+.+.+|+.++++++|+|++++++++. +.+..++|+||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            4677889999999999999976 47889999886432  3567899999999999999999999764 456789999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  662 (823)
                      ++++|.+++... ....+++..+..++.+++.||+|||+.+   ++|+||||+||++++++.+||+|||+++......  
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            999999998542 2335889999999999999999999987   9999999999999999999999999988643221  


Q ss_pred             cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                         .....+..|+|||++.+..++.++||||||+++|||++ |+.|+.....   ..+.    ......         ..
T Consensus       157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~----~~~~~~---------~~  217 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVV----PRVEKG---------YK  217 (256)
T ss_pred             ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHH----HHHhcC---------CC
Confidence               12334568999999998899999999999999999998 8888642211   0010    101111         01


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          742 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      ..........+.+++.+|++.+|++|||+.++++.|+.+
T Consensus       218 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         218 MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            111122335678899999999999999999999999763

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.1e-34  Score=321.86  Aligned_cols=254  Identities=21%  Similarity=0.252  Sum_probs=198.7

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC---ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      ..++|...++||+|+||.||+++... ++.+|+|++.+.   .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            34678889999999999999999865 889999998653   22334557889999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      ||||+++|+|.+++..    ..++...+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            9999999999998843    34788888899999999999999988   9999999999999999999999999998654


Q ss_pred             CCccccccccccccCCccCccccccC----CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCch
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAIDG----LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV  733 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~~----~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  733 (823)
                      .... .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||......      . .......... 
T Consensus       194 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~-~~~~i~~~~~-  264 (370)
T cd05596         194 ANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------G-TYSKIMDHKN-  264 (370)
T ss_pred             CCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------H-HHHHHHcCCC-
Confidence            3221 122345799999999998653    4789999999999999999999997532210      0 0111111000 


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 003391          734 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPED--RPNMSSVVLM  776 (823)
Q Consensus       734 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~  776 (823)
                           .+...........+.+++..|++.+|.+  ||++.|+++.
T Consensus       265 -----~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         265 -----SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             -----cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence                 0000111112346778999999999988  9999999764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.5e-34  Score=315.43  Aligned_cols=241  Identities=27%  Similarity=0.343  Sum_probs=191.4

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceEEEE
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      +|...+.||+|+||.||+|+... ++.+|+|++.+..   ....+.+..|..++..+ +|++|+++.+++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            46778899999999999999865 6789999987542   23344567788888777 6899999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            99999999988843   345889999999999999999999987   999999999999999999999999999754322


Q ss_pred             ccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                      .  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+...    ....        .
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~----i~~~--------~  217 (323)
T cd05616         155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQS----IMEH--------N  217 (323)
T ss_pred             C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHHHH----HHhC--------C
Confidence            1  1223467899999999999999999999999999999999999998532211   11111    1111        0


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 003391          740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNM  770 (823)
Q Consensus       740 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  770 (823)
                      .  .++.....++.+++.+|++.+|++|++.
T Consensus       218 ~--~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         218 V--AYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             C--CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence            0  1111223467789999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4e-34  Score=300.96  Aligned_cols=252  Identities=28%  Similarity=0.432  Sum_probs=200.0

Q ss_pred             cCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecC
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP  583 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (823)
                      .+|+..+.||+|+||.||++.+.+++.+|+|++.... ....++.+|++++++++|||++++++++......++|+||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            4567788999999999999998778899999886443 345678999999999999999999999999999999999999


Q ss_pred             CCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccc
Q 003391          584 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA  663 (823)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  663 (823)
                      +++|.+++..  ....+++..+..++.+++.||+|||+.+   ++|+||||+||+++.++.++|+|||++......... 
T Consensus        83 ~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-  156 (256)
T cd05112          83 HGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-  156 (256)
T ss_pred             CCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence            9999998853  2235789999999999999999999987   999999999999999999999999999865332211 


Q ss_pred             ccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCC
Q 003391          664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG  742 (823)
Q Consensus       664 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~  742 (823)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+......   .+.    ......         ...
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~----~~~~~~---------~~~  220 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EVV----ETINAG---------FRL  220 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHH----HHHhCC---------CCC
Confidence            1112334678999999998899999999999999999998 88886432110   011    100000         000


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003391          743 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS  778 (823)
Q Consensus       743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  778 (823)
                      ..+......+.+++.+|++.+|++||++.|++++|.
T Consensus       221 ~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         221 YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            001112346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4.4e-34  Score=301.60  Aligned_cols=254  Identities=28%  Similarity=0.419  Sum_probs=202.3

Q ss_pred             hcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      .++|...++||+|+||.||++...++..+|+|.+... ....+.+.+|+.++++++|+|++++.+.+.+ ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            3578888999999999999999877888999988654 2345678999999999999999999999887 7789999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  662 (823)
                      ++++|.+++... ....+++..+..++.+++.||.|||+.+   ++|+||||+||+++.++.+||+|||++..+......
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  158 (260)
T cd05073          83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  158 (260)
T ss_pred             CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence            999999998543 2345789999999999999999999987   999999999999999999999999999865432211


Q ss_pred             cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                       ......++..|+|||.+....++.++|+||||+++|||++ |+.|+.....   ..+.    ........         
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~----~~~~~~~~---------  221 (260)
T cd05073         159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVI----RALERGYR---------  221 (260)
T ss_pred             -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH---HHHH----HHHhCCCC---------
Confidence             1122345678999999998889999999999999999999 8888753211   0111    11111100         


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          742 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                      ..........+.+++.+|++.+|++||++.++.++|+.
T Consensus       222 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         222 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            01111223467899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.2e-34  Score=305.69  Aligned_cols=246  Identities=25%  Similarity=0.330  Sum_probs=191.4

Q ss_pred             eeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCCCCc
Q 003391          512 LGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSL  587 (823)
Q Consensus       512 LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  587 (823)
                      ||+|+||.||+++... ++.+|+|++....   ......+..|++++++++||||+++.+.+.++...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            6999999999999765 8999999986532   12234556799999999999999999999999999999999999999


Q ss_pred             chhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccccccc
Q 003391          588 NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR  667 (823)
Q Consensus       588 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  667 (823)
                      .+++... ....+++..+..++.||+.||+|||+.+   |+||||||+||++++++.++|+|||++.......   ....
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~  153 (277)
T cd05607          81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ  153 (277)
T ss_pred             HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence            9888543 2334889999999999999999999988   9999999999999999999999999998654321   1223


Q ss_pred             ccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHH
Q 003391          668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLS  747 (823)
Q Consensus       668 ~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~  747 (823)
                      ..++..|+|||++.+..++.++|||||||++|||++|+.||.........   ......        ......... ...
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~---~~~~~~--------~~~~~~~~~-~~~  221 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK---EELKRR--------TLEDEVKFE-HQN  221 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH---HHHHHH--------hhccccccc-ccc
Confidence            46889999999999989999999999999999999999997532211100   000000        000000000 001


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          748 EVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       748 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ...++.+++..||+.+|++||+++|+++.
T Consensus       222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~  250 (277)
T cd05607         222 FTEESKDICRLFLAKKPEDRLGSREKNDD  250 (277)
T ss_pred             CCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence            22357899999999999999999877643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.6e-34  Score=310.55  Aligned_cols=260  Identities=27%  Similarity=0.440  Sum_probs=200.4

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-Cc----EEEEEEecCCcc-ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQ----EIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~----~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      ++|+..+.||+|+||.||+|++.. +.    .+|+|.+..... ....++.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            457778899999999999998754 33    478888865432 3344788999999999999999999998754 4679


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      ++||+++|+|.+++..  ....+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          86 VTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence            9999999999999853  2335789999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      ............++..|+|||.+.+..++.++||||||+++|||++ |+.|+......   ..    ........     
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~---~~----~~~~~~~~-----  228 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---EI----PDLLEKGE-----  228 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHHCCC-----
Confidence            3322222223445678999999999999999999999999999997 88886432110   01    01111000     


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCCCCC
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQ  785 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~  785 (823)
                          ...........+.+++..|+..+|++||+++++++.|+.+...+.
T Consensus       229 ----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~  273 (303)
T cd05110         229 ----RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ  273 (303)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence                001111123467889999999999999999999999987644433

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.8e-34  Score=321.47  Aligned_cols=262  Identities=19%  Similarity=0.249  Sum_probs=199.8

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec---CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE---GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~---~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ..+|.+.+.||+|+||.||++...+   +..||+|.+...     +...+|+.++++++||||+++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            3578899999999999999997543   567899987543     24568999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      |++. ++|.+++.   ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.++|+|||+++.+...
T Consensus       166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9996 58888872   3456899999999999999999999998   999999999999999999999999999866443


Q ss_pred             ccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcC-------c
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER-------P  732 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-------~  732 (823)
                      ..........||+.|+|||++....++.++|||||||++|||++|+.||...........+...........       .
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence            333333346799999999999999999999999999999999999999854433222111111111110000       0


Q ss_pred             hhh------hhhhcCCCCCHH-------HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          733 VEL------INKSLGGSYSLS-------EVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       733 ~~~------~~~~l~~~~~~~-------~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ..+      ........+..+       ...++.+++.+|++.+|++||++.|++..
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            000      000011111111       12367789999999999999999999865

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.6e-34  Score=313.14  Aligned_cols=264  Identities=23%  Similarity=0.339  Sum_probs=196.3

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      ++|...++||+|+||.||+|+... ++.+|+|++.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            568888999999999999999764 7789999986543 23345678899999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++ +|.+++...  ...+++..+..++.||++||+|||+.+   |+||||||+||+++.++.+||+|||+++.......
T Consensus        86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            975 888877432  345788999999999999999999988   99999999999999999999999999976533221


Q ss_pred             ccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHH--------HHHHhhhcCc
Q 003391          662 EANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH--------AWRLWIEERP  732 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~--------~~~~~~~~~~  732 (823)
                        ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.......        .|........
T Consensus       160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence              1223467889999998865 4689999999999999999999999864332211111100        0000000000


Q ss_pred             hhhhh-hhcCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          733 VELIN-KSLGGS----YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       733 ~~~~~-~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ....+ +.....    .......++.+++.+|++.||.+|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            00000 000000    00011235678999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.7e-34  Score=314.17  Aligned_cols=242  Identities=27%  Similarity=0.350  Sum_probs=193.2

Q ss_pred             CeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceEEEEeecCC
Q 003391          510 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEYLPN  584 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (823)
                      +.||+|+||.||++++.. ++.+|+|++.+..   ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            479999999999999865 7899999987542   33455677888888887 799999999999999999999999999


Q ss_pred             CCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccccc
Q 003391          585 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN  664 (823)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  664 (823)
                      ++|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+||++++++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~  152 (318)
T cd05570          81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT  152 (318)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence            999988843   345899999999999999999999987   9999999999999999999999999987532211  12


Q ss_pred             cccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCC
Q 003391          665 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY  744 (823)
Q Consensus       665 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~  744 (823)
                      .....|++.|+|||++.+..++.++|||||||++|||++|+.||.....   ...    .......        ..  ..
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~---~~~----~~~i~~~--------~~--~~  215 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE---DEL----FQSILED--------EV--RY  215 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH---HHH----HHHHHcC--------CC--CC
Confidence            2335689999999999999999999999999999999999999753221   111    1111100        00  01


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 003391          745 SLSEVLRCIQVGLLCVQQRPEDRPNM-----SSVVLM  776 (823)
Q Consensus       745 ~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~~  776 (823)
                      +......+.+++.+||+.||++||++     .++++.
T Consensus       216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            11123467889999999999999999     887653

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1e-34  Score=324.24  Aligned_cols=200  Identities=23%  Similarity=0.379  Sum_probs=171.4

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      .|...++||+|+||.||+|+... ++.+|+|++.+..   ......+.+|+.++++++||||+++++.+.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            57788999999999999999765 7889999986542   2344578899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            9999999998843   345788899999999999999999998   9999999999999999999999999985432100


Q ss_pred             c---------------------------------------------ccccccccccCCccCccccccCCCCccchhHhHH
Q 003391          661 T---------------------------------------------EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFG  695 (823)
Q Consensus       661 ~---------------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~G  695 (823)
                      .                                             ........||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence            0                                             0011235689999999999999999999999999


Q ss_pred             HHHHHHHhcCCCCCC
Q 003391          696 VLVLEIVCGKRNRGF  710 (823)
Q Consensus       696 vvl~elltG~~p~~~  710 (823)
                      |+||||++|+.||..
T Consensus       236 vil~elltG~~Pf~~  250 (382)
T cd05625         236 VILYEMLVGQPPFLA  250 (382)
T ss_pred             HHHHHHHhCCCCCCC
Confidence            999999999999853

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.8e-34  Score=313.65  Aligned_cols=240  Identities=25%  Similarity=0.329  Sum_probs=189.5

Q ss_pred             CeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceEEEEeecCC
Q 003391          510 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEYLPN  584 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (823)
                      +.||+|+||.||+|++.. ++.||+|.++...   ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            479999999999999865 7899999987542   23445667788887754 899999999999999999999999999


Q ss_pred             CCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccccc
Q 003391          585 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN  664 (823)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  664 (823)
                      ++|..++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~  152 (316)
T cd05620          81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNR  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCc
Confidence            999998843   345889999999999999999999998   999999999999999999999999998753211  112


Q ss_pred             cccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCC
Q 003391          665 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY  744 (823)
Q Consensus       665 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~  744 (823)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ..+.    .......          ...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~~----~~~~~~~----------~~~  215 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DELF----ESIRVDT----------PHY  215 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHH----HHHHhCC----------CCC
Confidence            2346789999999999999999999999999999999999999853221   1111    1110000          001


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 003391          745 SLSEVLRCIQVGLLCVQQRPEDRPNMS-SVV  774 (823)
Q Consensus       745 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl  774 (823)
                      +.....++.+++.+|++.||++||++. ++.
T Consensus       216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         216 PRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            111223567899999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-35  Score=327.77  Aligned_cols=253  Identities=28%  Similarity=0.410  Sum_probs=209.3

Q ss_pred             CCcCCeeeccCccceEEEEeec-C----cEEEEEEecCC-ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          506 FSDKNKLGEGGFGPVYKGVLIE-G----QEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       506 ~~~~~~LG~G~fg~Vyk~~~~~-~----~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ....++||+|+||+||||.+.- +    -+||+|++... ..+..+++.+|+.+|.++.|||++||+|+|.... ..||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            3446799999999999999743 3    36899988654 5566789999999999999999999999998766 88999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      +||+.|+|.+|++.  .+..+.....+.+..|||+||.|||++.   ++||||.++|||+.....+||.|||+++.+..+
T Consensus       777 q~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            99999999999965  3445788889999999999999999886   999999999999999999999999999998776


Q ss_pred             ccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                      ...-......-.+.|||-|.+....|+.++|||||||.+|||+| |..|+......+.                .++++.
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI----------------~dlle~  915 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI----------------PDLLEK  915 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh----------------hHHHhc
Confidence            66555555566789999999999999999999999999999998 8888543322221                122222


Q ss_pred             hcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       739 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      -.+-+.+.-+..++..++.+||..|+..||+++++...+...
T Consensus       916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~  957 (1177)
T KOG1025|consen  916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM  957 (1177)
T ss_pred             cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence            222233445567889999999999999999999999888654

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-34  Score=303.48  Aligned_cols=250  Identities=28%  Similarity=0.443  Sum_probs=193.6

Q ss_pred             CeeeccCccceEEEEeec-Cc--EEEEEEecCCc-cccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceEEEEeecCC
Q 003391          510 NKLGEGGFGPVYKGVLIE-GQ--EIAAKRLSKSS-GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEYLPN  584 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~-~~--~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (823)
                      +.||+|+||.||+|++.+ +.  .+++|.+.... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999999865 33  46888886533 34456788999999999 899999999999999999999999999


Q ss_pred             CCcchhhhccC-------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccc
Q 003391          585 KSLNDFIFDVT-------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG  651 (823)
Q Consensus       585 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFG  651 (823)
                      ++|.+++....             ....+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999986422             1234789999999999999999999987   9999999999999999999999999


Q ss_pred             cceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhc
Q 003391          652 MARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEE  730 (823)
Q Consensus       652 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~  730 (823)
                      ++.....   .........+..|+|||++....++.++||||||+++|||++ |..||......   ...    ......
T Consensus       158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~----~~~~~~  227 (270)
T cd05047         158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELY----EKLPQG  227 (270)
T ss_pred             Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---HHH----HHHhCC
Confidence            9863211   111111233567999999988899999999999999999997 98887432111   111    111110


Q ss_pred             CchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          731 RPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       731 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                               ............+.+++.+|++.+|.+||++.+++..|+.+.
T Consensus       228 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         228 ---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             ---------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                     000111122346789999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.4e-34  Score=304.73  Aligned_cols=252  Identities=30%  Similarity=0.457  Sum_probs=198.5

Q ss_pred             CCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHH--HHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          506 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGME--EFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       506 ~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~--~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      |+..+.||+|+||+||+++... ++.+|+|++.........  ...+|+.++++++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            4567899999999999999876 568999999776543322  3456999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  662 (823)
                      ++++|.+++.   +...+++..+..++.|+++||.+||+.+   |+|+||||+||++++++.++|+|||.+...  ....
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL--SENN  152 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES--TSTT
T ss_pred             cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc--cccc
Confidence            9999999995   3456899999999999999999999998   999999999999999999999999999864  1222


Q ss_pred             cccccccccCCccCccccc-cCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          663 ANTNRVVGTYGYMPPEYAI-DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~-~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                      .......++..|+|||++. +..++.++||||+|+++++|++|..|+...............       ..... .....
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~-------~~~~~-~~~~~  224 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKI-------LKRPL-PSSSQ  224 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHH-------HHTHH-HHHTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhc-------ccccc-ccccc
Confidence            3334467889999999998 888999999999999999999999997533111111111100       00000 00000


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          742 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      .  .......+.+++..|++.+|++||++.++++
T Consensus       225 ~--~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  225 Q--SREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             S--HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             c--cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0  0001257889999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.6e-34  Score=315.41  Aligned_cols=239  Identities=21%  Similarity=0.261  Sum_probs=187.0

Q ss_pred             CeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHH-HHhccCCCCceeEEEEeecCCceEEEEeecCC
Q 003391          510 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVL-LIAKLQHRNLVKLIGCCTQRDERMLIYEYLPN  584 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (823)
                      +.||+|+||.||+++... ++.+|+|++.+..   .....++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            469999999999999754 8899999986542   233345555654 46778999999999999999999999999999


Q ss_pred             CCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccccc
Q 003391          585 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN  664 (823)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  664 (823)
                      ++|..++.   +...+++..+..++.||++||.|||+.+   |+||||||+|||+++++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~  152 (325)
T cd05604          81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDT  152 (325)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCC
Confidence            99998874   3446899999999999999999999988   999999999999999999999999998753211  122


Q ss_pred             cccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCC
Q 003391          665 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY  744 (823)
Q Consensus       665 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~  744 (823)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+    .......        .+.  .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~----~~~~~~~--------~~~--~  215 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA---EM----YDNILHK--------PLV--L  215 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH---HH----HHHHHcC--------Ccc--C
Confidence            23467899999999999999999999999999999999999997532111   11    1111110        000  1


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 003391          745 SLSEVLRCIQVGLLCVQQRPEDRPNMSSV  773 (823)
Q Consensus       745 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev  773 (823)
                      .......+.+++.+|++.+|.+||++++.
T Consensus       216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~~  244 (325)
T cd05604         216 RPGASLTAWSILEELLEKDRQRRLGAKED  244 (325)
T ss_pred             CCCCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence            11122456789999999999999988643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.4e-34  Score=320.96  Aligned_cols=254  Identities=20%  Similarity=0.249  Sum_probs=196.7

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC---ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      ..++|+..+.||+|+||.||+++... ++.+|+|.+.+.   .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            45789999999999999999999865 788999998643   22334567899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      ||||+++|+|.+++..    ..+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||++..+.
T Consensus       121 v~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         121 VMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            9999999999998843    24788899999999999999999988   9999999999999999999999999998764


Q ss_pred             CCccccccccccccCCccCccccccC----CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCch
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAIDG----LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV  733 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~~----~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  733 (823)
                      .... .......||+.|+|||++.+.    .++.++||||+||++|||++|+.||.....      ... ......... 
T Consensus       194 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~~-~~~i~~~~~-  264 (370)
T cd05621         194 ETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VGT-YSKIMDHKN-  264 (370)
T ss_pred             cCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HHH-HHHHHhCCc-
Confidence            2211 122346799999999998754    378899999999999999999999853221      111 011110000 


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 003391          734 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPED--RPNMSSVVLM  776 (823)
Q Consensus       734 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~  776 (823)
                           .+...........+.+++..|++.+|.+  ||++.|+++.
T Consensus       265 -----~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         265 -----SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             -----ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence                 0000111112235667888899866544  8999999876

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.5e-34  Score=336.51  Aligned_cols=260  Identities=20%  Similarity=0.271  Sum_probs=200.8

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc---ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ++|.+.++||+|+||.||+|+... ++.||+|++.....   ...+++.+|++++.+++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            578889999999999999999765 88999999975432   23457899999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCC--------CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccc
Q 003391          580 EYLPNKSLNDFIFDVTR--------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG  651 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFG  651 (823)
                      ||+++++|.+++.....        ...+++..++.++.||++||+|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            99999999998854211        234567788999999999999999987   9999999999999999999999999


Q ss_pred             cceecCCCcc----------------ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCC
Q 003391          652 MARAFGIDQT----------------EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH  715 (823)
Q Consensus       652 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~  715 (823)
                      +++.......                ........||+.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9987622110                011123569999999999999999999999999999999999999975321110


Q ss_pred             ccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhccC
Q 003391          716 HHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRP-NMSSVVLMLSGE  780 (823)
Q Consensus       716 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~~  780 (823)
                         ...   .    ..   ...+.. .....+....+.+++.+|++.||++|| ++.++++.|+..
T Consensus       239 ---i~~---~----~~---i~~P~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        239 ---ISY---R----DV---ILSPIE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH  290 (932)
T ss_pred             ---hhh---h----hh---ccChhh-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence               000   0    00   000000 000011224577899999999999996 667777766543

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.5e-34  Score=315.26  Aligned_cols=237  Identities=22%  Similarity=0.270  Sum_probs=186.2

Q ss_pred             CeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHH-HHhccCCCCceeEEEEeecCCceEEEEeecCC
Q 003391          510 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVL-LIAKLQHRNLVKLIGCCTQRDERMLIYEYLPN  584 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (823)
                      +.||+|+||.||+|+... ++.||+|++.+..   .....++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            479999999999999864 8899999986542   222344555544 56778999999999999999999999999999


Q ss_pred             CCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccccc
Q 003391          585 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN  664 (823)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  664 (823)
                      |+|.+++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||+++++.+||+|||+++.....  ...
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~  152 (323)
T cd05575          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKT  152 (323)
T ss_pred             CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCc
Confidence            999998843   346889999999999999999999998   999999999999999999999999998753211  122


Q ss_pred             cccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCC
Q 003391          665 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY  744 (823)
Q Consensus       665 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~  744 (823)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ..+    .....        .....  .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~~----~~~i~--------~~~~~--~  215 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT---AEM----YDNIL--------NKPLR--L  215 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH---HHH----HHHHH--------cCCCC--C
Confidence            3345789999999999999999999999999999999999999753211   001    01011        00010  1


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHH
Q 003391          745 SLSEVLRCIQVGLLCVQQRPEDRPNMS  771 (823)
Q Consensus       745 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~  771 (823)
                      .......+.+++.+|++.+|.+||++.
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         216 KPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            111234678899999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.1e-34  Score=309.78  Aligned_cols=264  Identities=22%  Similarity=0.295  Sum_probs=199.1

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      ++|+..++||+|+||.||++.+.. +..+|+|.+.... .....++.+|++++.+++||||+++++++.+.+..++|+||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            368888999999999999999765 6778888876542 23345688999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++++|.+++..   .+.+++..+..++.|+++||.|||+..  +++|+||||+|||+++++.+||+|||++......  
T Consensus        81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  153 (308)
T cd06615          81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  153 (308)
T ss_pred             cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence            999999999853   345889999999999999999999842  3999999999999999999999999998754321  


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhc-----------
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE-----------  730 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-----------  730 (823)
                        ......++..|+|||.+.+..++.++||||||+++|||++|+.|+......................           
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (308)
T cd06615         154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP  231 (308)
T ss_pred             --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence              1233568899999999988889999999999999999999999975332111100000000000000           


Q ss_pred             ------CchhhhhhhcCC---CCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          731 ------RPVELINKSLGG---SYS-LSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       731 ------~~~~~~~~~l~~---~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                            ...+..+.....   ..+ .....++.+++.+|++.+|++||++.++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  000011111100   000 0122368899999999999999999999865

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.3e-34  Score=301.44  Aligned_cols=249  Identities=25%  Similarity=0.417  Sum_probs=198.2

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccc---------cHHHHHHHHHHHhccCCCCceeEEEEeecCCc
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQ---------GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE  574 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~---------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~  574 (823)
                      +|...+.||+|+||.||+|.... ++.+|+|.+......         ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            36677899999999999999754 789999988654322         22568899999999999999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccce
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  654 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  654 (823)
                      .++|+||+++++|.+++..   ...+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||+++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence            9999999999999999843   345788999999999999999999987   9999999999999999999999999998


Q ss_pred             ecCCCccc----cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhc
Q 003391          655 AFGIDQTE----ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE  730 (823)
Q Consensus       655 ~~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  730 (823)
                      ........    .......++..|+|||.+.+..++.++||||||+++|||++|+.||......      ..... ... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~-~~~-  226 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL------QAIFK-IGE-  226 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH------HHHHH-Hhc-
Confidence            76422111    1112345788999999999989999999999999999999999997532110      00000 000 


Q ss_pred             CchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          731 RPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       731 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                              ......+......+.+++.+|++.+|.+||++.|+++
T Consensus       227 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         227 --------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             --------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                    0111122223356788999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.9e-34  Score=304.86  Aligned_cols=253  Identities=27%  Similarity=0.402  Sum_probs=197.1

Q ss_pred             HHhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhcc-CCCCceeEEEEeecC------
Q 003391          501 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQR------  572 (823)
Q Consensus       501 ~~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~------  572 (823)
                      .+.+.|+..+.||+|+||.||+|...+ ++.+|+|++.... ....++..|+.++.++ +|+||+++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            356778888999999999999999765 7789999886543 4456788999999998 799999999998653      


Q ss_pred             CceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccc
Q 003391          573 DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM  652 (823)
Q Consensus       573 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl  652 (823)
                      ...++||||+++++|.+++... ....+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.++|+|||+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence            3578999999999999998542 2345889999999999999999999987   99999999999999999999999999


Q ss_pred             ceecCCCccccccccccccCCccCccccc-----cCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHh
Q 003391          653 ARAFGIDQTEANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW  727 (823)
Q Consensus       653 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  727 (823)
                      +.......  .......|+..|+|||++.     +..++.++|||||||++|||++|+.|+.......     ..  ...
T Consensus       158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-----~~--~~~  228 (272)
T cd06637         158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----AL--FLI  228 (272)
T ss_pred             ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-----HH--HHH
Confidence            98653221  2223356889999999986     3458889999999999999999999974322110     00  000


Q ss_pred             hhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          728 IEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       728 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      .......     .   ........+.+++.+|++.+|.+||++.|+++
T Consensus       229 ~~~~~~~-----~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         229 PRNPAPR-----L---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             hcCCCCC-----C---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            0000000     0   01112246789999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-34  Score=297.77  Aligned_cols=253  Identities=22%  Similarity=0.259  Sum_probs=205.2

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      +.|+..+.||+|.-|+||.+.+.+ +..+|+|++.+..   +....+.+.|-+||+.++||.++.|++.++.++..+|||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            456667899999999999999976 5899999998763   345556788999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC-
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI-  658 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~-  658 (823)
                      |||+||+|...++ .+..+.+++..++-++.+++-||+|||-.|   ||.|||||+||||.++|++-|+||.|+..... 
T Consensus       157 eyCpGGdL~~Lrq-kQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQ-KQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             ecCCCccHHHHHh-hCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            9999999998764 456677999999999999999999999998   99999999999999999999999998754311 


Q ss_pred             --------------------------------C---------------------ccccccccccccCCccCccccccCCC
Q 003391          659 --------------------------------D---------------------QTEANTNRVVGTYGYMPPEYAIDGLF  685 (823)
Q Consensus       659 --------------------------------~---------------------~~~~~~~~~~gt~~y~aPE~l~~~~~  685 (823)
                                                      .                     ......+..+||..|+|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            0                     00122345789999999999999999


Q ss_pred             CccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCC
Q 003391          686 SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPE  765 (823)
Q Consensus       686 s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~  765 (823)
                      +.++|+|+|||+||||+.|..||......+.               ...++...+.-.........+.+||.+.|.+||.
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~T---------------l~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~  377 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKET---------------LRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS  377 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhh---------------HHHHhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence            9999999999999999999999865433211               1112222222112223345788999999999999


Q ss_pred             CCCC----HHHHHH
Q 003391          766 DRPN----MSSVVL  775 (823)
Q Consensus       766 ~RPs----~~evl~  775 (823)
                      +|..    +.||-+
T Consensus       378 kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  378 KRLGSKRGAAEIKR  391 (459)
T ss_pred             hhhccccchHHhhc
Confidence            9998    777765

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-35  Score=311.87  Aligned_cols=254  Identities=26%  Similarity=0.390  Sum_probs=208.6

Q ss_pred             cCCCcCCeeeccCccceEEEEeec---Cc--EEEEEEecCC-ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE---GQ--EIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~---~~--~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      +.....++||.|-||.||+|++.+   |.  .||||..+.+ ..+..+.|..|..+|++++||||++++|.|.+ ...++
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi  467 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI  467 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence            445567799999999999999754   33  4888998774 44567889999999999999999999999986 57899


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      |||.++-|.|.+||..  +...++......++.||+.+|+|||+..   +|||||..+|||+....-+||+|||+++.+.
T Consensus       468 vmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e  542 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLE  542 (974)
T ss_pred             EEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcc
Confidence            9999999999999954  3345888889999999999999999987   9999999999999999999999999999876


Q ss_pred             CCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      .+...... ...-+..|||||.+.-.+++.++|||.|||++||++. |.+||......+                ..-.+
T Consensus       543 d~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD----------------VI~~i  605 (974)
T KOG4257|consen  543 DDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD----------------VIGHI  605 (974)
T ss_pred             ccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc----------------eEEEe
Confidence            54433322 3455779999999999999999999999999999886 889986433322                11122


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      +.--+...+..++..+..|+.+||..+|.+||.+.|+...|+++
T Consensus       606 EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv  649 (974)
T KOG4257|consen  606 ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV  649 (974)
T ss_pred             cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence            22223345566778889999999999999999999998888653

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.4e-34  Score=306.10  Aligned_cols=239  Identities=21%  Similarity=0.286  Sum_probs=186.4

Q ss_pred             eeeccCccceEEEEeec-------------------------CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeE
Q 003391          511 KLGEGGFGPVYKGVLIE-------------------------GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKL  565 (823)
Q Consensus       511 ~LG~G~fg~Vyk~~~~~-------------------------~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l  565 (823)
                      +||+|+||.||+|.+..                         ...|++|++.........+|.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999998531                         13588898876555555678899999999999999999


Q ss_pred             EEEeecCCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCC--
Q 003391          566 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM--  643 (823)
Q Consensus       566 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~--  643 (823)
                      ++++.+....++||||+++++|..++..  ....+++..+..++.||++||+|||+.+   |+||||||+|||++..+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            9999999999999999999999998853  2345889999999999999999999987   99999999999997654  


Q ss_pred             -----CceeeccccceecCCCccccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHH-hcCCCCCCcCCCCc
Q 003391          644 -----NPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIV-CGKRNRGFYHADHH  716 (823)
Q Consensus       644 -----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~ell-tG~~p~~~~~~~~~  716 (823)
                           .+|++|||++......      ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+........
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~  230 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK  230 (274)
T ss_pred             cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence                 3799999988643211      12346788999998875 56899999999999999995 68888653222110


Q ss_pred             cchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003391          717 HNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS  778 (823)
Q Consensus       717 ~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  778 (823)
                         ..             ......  ..+......+.+++.+||+.+|++||++.++++.|+
T Consensus       231 ---~~-------------~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         231 ---ER-------------FYEKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             ---HH-------------HHHhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence               00             000000  011111235788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-34  Score=303.96  Aligned_cols=256  Identities=27%  Similarity=0.419  Sum_probs=201.3

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-Cc----EEEEEEecCCcc-ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQ----EIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~----~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      .+|...+.||+|+||.||+|...+ ++    .+|+|.+..... ....++.+|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            467778899999999999999754 32    588998865543 345678899999999999999999999987 78899


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      |+||+++|+|.+++...  ...+++..+..++.||+.||+|||+.+   ++|+||||+||++++++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence            99999999999998542  334899999999999999999999987   9999999999999999999999999998765


Q ss_pred             CCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      ............++..|+|||.+....++.++|+||||+++|||++ |+.|+......   .+.    ......      
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~----~~~~~~------  227 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIP----DLLEKG------  227 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHH----HHHhCC------
Confidence            3322222222234568999999988899999999999999999998 99987532211   010    001100      


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                         .....+......+.+++.+|+..+|++||++.++++.|+...
T Consensus       228 ---~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~  269 (279)
T cd05057         228 ---ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA  269 (279)
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence               000111112346778999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=5.6e-34  Score=299.76  Aligned_cols=250  Identities=23%  Similarity=0.310  Sum_probs=199.8

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC-ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      +|...++||+|+||.||++.... ++.+|+|.+... .....+.+.+|+.+++.++|+||+++++.+..++..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            46778899999999999999764 889999988643 2334567889999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  662 (823)
                      ++++|.+++... ....+++.....++.|++.||.|||+.+   |+|+||||+||++++++.++|+|||++..+..... 
T Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  155 (255)
T cd08219          81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-  155 (255)
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence            999999988532 3445789999999999999999999987   99999999999999999999999999986543221 


Q ss_pred             cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCC
Q 003391          663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG  742 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~  742 (823)
                       ......+++.|+|||++.+..++.++|+||||+++|+|++|+.||.....   ....    .........         
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~---~~~~----~~~~~~~~~---------  218 (255)
T cd08219         156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW---KNLI----LKVCQGSYK---------  218 (255)
T ss_pred             -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH---HHHH----HHHhcCCCC---------
Confidence             12235688899999999988999999999999999999999999753211   0000    000111000         


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          743 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ..+......+.+++.+||+.+|++||++.+++..
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         219 PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            0111122357789999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.6e-34  Score=325.53  Aligned_cols=260  Identities=20%  Similarity=0.307  Sum_probs=191.3

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecC--------
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR--------  572 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--------  572 (823)
                      ..++|...++||+|+||.||+|+..+ ++.||||++....    ....+|+.+++.++||||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            34679999999999999999999864 7899999885432    2345799999999999999999876432        


Q ss_pred             CceEEEEeecCCCCcchhhhc-cCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCC-Cceeecc
Q 003391          573 DERMLIYEYLPNKSLNDFIFD-VTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-NPKISDF  650 (823)
Q Consensus       573 ~~~~lV~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DF  650 (823)
                      ...++||||+++ +|.+++.. ......+++..+..++.||+.||+|||+.+   |+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence            135689999985 67776643 234456899999999999999999999998   99999999999999665 7999999


Q ss_pred             ccceecCCCccccccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhh
Q 003391          651 GMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE  729 (823)
Q Consensus       651 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  729 (823)
                      |+++.+....   ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+   .+....... .
T Consensus       216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~---~~~~i~~~~-~  288 (440)
T PTZ00036        216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD---QLVRIIQVL-G  288 (440)
T ss_pred             ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHh-C
Confidence            9998654221   12235679999999998764 68999999999999999999999985432211   111111110 0


Q ss_pred             cCchhhhh-----------h-----hcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          730 ERPVELIN-----------K-----SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       730 ~~~~~~~~-----------~-----~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ....+.+.           +     .+...++.....++.+++.+||+.+|.+|||+.|+++.
T Consensus       289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            00000000           0     00000111123468899999999999999999999844

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=6.4e-34  Score=299.19  Aligned_cols=249  Identities=28%  Similarity=0.418  Sum_probs=201.7

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      ++|+..++||+|+||.||+|+..+ ++.+++|.+.....  .+++.+|++++++++||||+++++.+.+....++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            578888999999999999999876 78999999865533  678999999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  662 (823)
                      ++++|.+++..  ....+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++........ 
T Consensus        81 ~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (256)
T cd06612          81 GAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-  154 (256)
T ss_pred             CCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence            99999999843  2356899999999999999999999987   99999999999999999999999999986543221 


Q ss_pred             cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCC
Q 003391          663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG  742 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~  742 (823)
                       ......++..|+|||++.+..++.++||||||+++|||++|+.|+.........       .... ....    ..+  
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-------~~~~-~~~~----~~~--  219 (256)
T cd06612         155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-------FMIP-NKPP----PTL--  219 (256)
T ss_pred             -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-------hhhc-cCCC----CCC--
Confidence             223345788999999999989999999999999999999999997543221100       0000 0000    000  


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          743 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ..+.....++.+++.+|++.+|++||++.|+++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            011112246788999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-33  Score=311.58  Aligned_cols=192  Identities=21%  Similarity=0.305  Sum_probs=164.3

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      ...+|.+.+.||+|+||.||+|+... ++.||+|.....      ....|+.++++++||||+++++++......++|+|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            45679999999999999999999865 678888875332      23568999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      ++. ++|.+++..  ....+++..+..|+.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..... 
T Consensus       138 ~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-  210 (357)
T PHA03209        138 HYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-  210 (357)
T ss_pred             ccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence            995 588888743  3456899999999999999999999998   999999999999999999999999999753211 


Q ss_pred             cccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCC
Q 003391          661 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNR  708 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~  708 (823)
                        .......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus       211 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        211 --PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             --cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence              1222356899999999999999999999999999999999976553

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=7.3e-34  Score=306.13  Aligned_cols=252  Identities=24%  Similarity=0.376  Sum_probs=203.1

Q ss_pred             HhcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      ...+|...+.||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++|||
T Consensus        17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   96 (297)
T cd06656          17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   96 (297)
T ss_pred             hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence            3467888999999999999999974 589999999977665666778999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |+++++|.+++.+    ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        97 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~  169 (297)
T cd06656          97 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (297)
T ss_pred             ccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence            9999999998842    35788999999999999999999987   9999999999999999999999999998653322


Q ss_pred             cccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhc
Q 003391          661 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL  740 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l  740 (823)
                      .  ......+++.|+|||.+.+..++.++||||||+++|||++|+.||............      .....      +..
T Consensus       170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~------~~~~~------~~~  235 (297)
T cd06656         170 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNGT------PEL  235 (297)
T ss_pred             c--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee------ccCCC------CCC
Confidence            1  122346788999999999999999999999999999999999997533221110000      00000      000


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          741 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                        .........+.+++.+|++.+|++||+++++++.
T Consensus       236 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         236 --QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             --CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              0111122456789999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=312.88  Aligned_cols=257  Identities=26%  Similarity=0.426  Sum_probs=206.6

Q ss_pred             eeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCCCCcch
Q 003391          511 KLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLND  589 (823)
Q Consensus       511 ~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~  589 (823)
                      +||+|.||+||.|++.+ ...+|||.+........+-+.+||.+-+.++|.|||+.+|.+.+++..-+.||.++||||.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            79999999999999877 45799999988877777889999999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCcc--CHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEc-CCCCceeeccccceecCCCccccccc
Q 003391          590 FIFDVTRSKFL--DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTN  666 (823)
Q Consensus       590 ~l~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~  666 (823)
                      .|..  +-.++  ++...--+..||++||.|||+..   |||||||-+|||++ -.|.+||+|||.++.+.  .....+.
T Consensus       662 LLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--ginP~TE  734 (1226)
T KOG4279|consen  662 LLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GINPCTE  734 (1226)
T ss_pred             HHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhc--cCCcccc
Confidence            9953  22344  77788889999999999999987   99999999999996 57899999999998763  2344555


Q ss_pred             cccccCCccCccccccCC--CCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCC
Q 003391          667 RVVGTYGYMPPEYAIDGL--FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY  744 (823)
Q Consensus       667 ~~~gt~~y~aPE~l~~~~--~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~  744 (823)
                      ...||.-|||||++-.++  |+.++|||||||.+.||.||++||-.......        ..+      .+=-.......
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------AMF------kVGmyKvHP~i  800 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------AMF------KVGMYKVHPPI  800 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------hhh------hhcceecCCCC
Confidence            678999999999997654  89999999999999999999999843222110        000      00001123344


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhccCCCCCCCCC
Q 003391          745 SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL--MLSGERSLPQPKQ  788 (823)
Q Consensus       745 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~~~~~p~~  788 (823)
                      +.+-..++..++++|+.++|.+||+++++++  .|+.....+.|+.
T Consensus       801 Peelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk~r~~l  846 (1226)
T KOG4279|consen  801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKKPRPKL  846 (1226)
T ss_pred             cHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCCCCCCCC
Confidence            5555678899999999999999999999985  3444333444443

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.8e-34  Score=302.77  Aligned_cols=240  Identities=24%  Similarity=0.390  Sum_probs=188.7

Q ss_pred             CeeeccCccceEEEEeec--------CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          510 NKLGEGGFGPVYKGVLIE--------GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~--------~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      +.||+|+||.||+|....        ...+++|.+........+++.+|+.+++.++|||++++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            369999999999998643        234888887665555567889999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCC--------ceeeccccc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN--------PKISDFGMA  653 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~--------~kl~DFGla  653 (823)
                      +++|+|.+++...  ...+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.        ++++|||++
T Consensus        81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            9999999998542  235889999999999999999999987   999999999999987765        589999988


Q ss_pred             eecCCCccccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcC-CCCCCcCCCCccchhHHHHHHhhhcC
Q 003391          654 RAFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGK-RNRGFYHADHHHNLLGHAWRLWIEER  731 (823)
Q Consensus       654 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~  731 (823)
                      .....      .....++..|+|||++.+ ..++.++||||||+++|||++|. .|+.......        ....... 
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--------~~~~~~~-  220 (258)
T cd05078         156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--------KLQFYED-  220 (258)
T ss_pred             cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--------HHHHHHc-
Confidence            65421      122457889999999986 45799999999999999999995 4432211100        0000000 


Q ss_pred             chhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003391          732 PVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS  778 (823)
Q Consensus       732 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  778 (823)
                               ....+.....++.+++.+|++.+|++||+++++++.|+
T Consensus       221 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 ---------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ---------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                     01112222346789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.7e-34  Score=313.15  Aligned_cols=237  Identities=21%  Similarity=0.276  Sum_probs=185.6

Q ss_pred             CeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHH-HHhccCCCCceeEEEEeecCCceEEEEeecCC
Q 003391          510 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVL-LIAKLQHRNLVKLIGCCTQRDERMLIYEYLPN  584 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (823)
                      ++||+|+||.||+|+... ++.+|+|++.+..   .....++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            479999999999999865 7899999986542   222334555554 57889999999999999999999999999999


Q ss_pred             CCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccccc
Q 003391          585 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN  664 (823)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  664 (823)
                      ++|..++..   ...+++..+..++.||++||.|||+.+   |+||||||+||+++.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~  152 (321)
T cd05603          81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EET  152 (321)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCc
Confidence            999888743   345788889999999999999999987   999999999999999999999999998753221  122


Q ss_pred             cccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCC
Q 003391          665 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY  744 (823)
Q Consensus       665 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~  744 (823)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.   ..+    ......        ..+  ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~----~~~i~~--------~~~--~~  215 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV---SQM----YDNILH--------KPL--QL  215 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH---HHH----HHHHhc--------CCC--CC
Confidence            3345789999999999999999999999999999999999999743211   001    011110        000  11


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHH
Q 003391          745 SLSEVLRCIQVGLLCVQQRPEDRPNMS  771 (823)
Q Consensus       745 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~  771 (823)
                      +......+.+++.+|++.+|.+||++.
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         216 PGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            122334678999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=7.3e-34  Score=303.97  Aligned_cols=263  Identities=26%  Similarity=0.374  Sum_probs=196.8

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      +|+..+.||+|++|.||+|+... ++.||+|++....  ....+.+.+|+.++.+++||||+++++++.++...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            46778899999999999999864 8899999986542  23346788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      ++ ++|.+++........+++..+..++.||++||+|||+.+   |+|+||||+||++++++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            97 688888865444567899999999999999999999987   99999999999999999999999999986543321


Q ss_pred             ccccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHH-------HHhhhcCch
Q 003391          662 EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW-------RLWIEERPV  733 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~-------~~~~~~~~~  733 (823)
                        ......+++.|+|||++.+. .++.++||||||+++|||++|+.||.......  .......       ..+......
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  232 (285)
T cd07861         157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSL  232 (285)
T ss_pred             --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhh
Confidence              11223568899999988654 57899999999999999999999875322111  0000000       000000000


Q ss_pred             hhhhhhcC----CCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          734 ELINKSLG----GSY---SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       734 ~~~~~~l~----~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ........    ...   ......++.+++.+|++.||++|||+.+|++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00000000    000   0011236678999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-34  Score=301.95  Aligned_cols=249  Identities=27%  Similarity=0.421  Sum_probs=201.1

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      ++|...+.||.|++|.||+|+... ++.+|+|.+.... ......+.+|+.+++.++|+|++++++++.+....++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            357778899999999999999764 8899999986543 34456788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++++|.+++..    ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++.+.... 
T Consensus        81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  152 (274)
T cd06609          81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-  152 (274)
T ss_pred             eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence            999999999843    26899999999999999999999987   9999999999999999999999999998764332 


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                       .......++..|+|||.+.+..++.++||||||+++|||++|+.|+...+...   ..    ..........     +.
T Consensus       153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~---~~----~~~~~~~~~~-----~~  219 (274)
T cd06609         153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR---VL----FLIPKNNPPS-----LE  219 (274)
T ss_pred             -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH---HH----HHhhhcCCCC-----Cc
Confidence             12233567889999999999889999999999999999999999975332110   00    0000110100     00


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          742 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ..   .....+.+++.+|++.+|++||+++++++.
T Consensus       220 ~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         220 GN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             cc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            00   023467789999999999999999999873

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-34  Score=311.02  Aligned_cols=251  Identities=24%  Similarity=0.285  Sum_probs=207.9

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccc---cHHHHHHHHHHHhccC-CCCceeEEEEeecCCceE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQ---GMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERM  576 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~  576 (823)
                      ..+.|...+.||+|.||.||+++.+. |+.+|+|.+.+....   ..+.+.+|+.+|+++. |||||.+.+.+++....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            45678888999999999999999887 999999999776443   4468999999999998 999999999999999999


Q ss_pred             EEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCC----CCceeecccc
Q 003391          577 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE----MNPKISDFGM  652 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~----~~~kl~DFGl  652 (823)
                      +|||++.||.|.+.+...    .+++..+..++.|++.++.|||+.+   |+||||||+|+|+...    +.+|++|||+
T Consensus       113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            999999999999999654    2899999999999999999999988   9999999999999643    4799999999


Q ss_pred             ceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCc
Q 003391          653 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP  732 (823)
Q Consensus       653 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  732 (823)
                      +.....   .......+||+.|+|||++....|+.++||||+||++|.|++|..||..........       .......
T Consensus       186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~  255 (382)
T KOG0032|consen  186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF  255 (382)
T ss_pred             ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC
Confidence            998754   344566899999999999999999999999999999999999999986433222110       0000100


Q ss_pred             hhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          733 VELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       733 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                            ......-......+.+++..++..||.+|+|+.++++
T Consensus       256 ------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  256 ------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             ------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence                  1111111122346778999999999999999999998

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.4e-34  Score=305.47  Aligned_cols=247  Identities=26%  Similarity=0.402  Sum_probs=198.3

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      .|+..+.||+|+||.||+|.+.. ++.||+|.+.... ....+.+.+|+.++++++||||+++++++......++|+||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            45566789999999999998754 7789999886543 334567899999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  662 (823)
                      ++++|.+++.    ...+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++..+....  
T Consensus        85 ~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--  155 (277)
T cd06642          85 GGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--  155 (277)
T ss_pred             CCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc--
Confidence            9999999873    245889999999999999999999987   9999999999999999999999999997654321  


Q ss_pred             cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCC
Q 003391          663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG  742 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~  742 (823)
                      .......++..|+|||.+.+..++.++||||||+++|||++|+.|+........   .    ......         ...
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~----~~~~~~---------~~~  219 (277)
T cd06642         156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---L----FLIPKN---------SPP  219 (277)
T ss_pred             hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---H----hhhhcC---------CCC
Confidence            112234678899999999998999999999999999999999998643221110   0    000000         011


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          743 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      .........+.+++.+|++.+|++||+|.++++.
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            1112233567899999999999999999999974

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=7.5e-34  Score=305.86  Aligned_cols=250  Identities=24%  Similarity=0.386  Sum_probs=201.8

Q ss_pred             cCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      .+|+..+.||.|++|.||+|+.. +++.|++|.+........+.+.+|+.+++.++|||++++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            56888899999999999999864 48899999997665556678899999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  662 (823)
                      ++++|.+++.    ...+++.++..++.+++.||+|||+.+   ++|+||||+||+++.++.+||+|||++..+..... 
T Consensus        99 ~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-  170 (296)
T cd06655          99 AGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-  170 (296)
T ss_pred             CCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence            9999999884    235899999999999999999999998   99999999999999999999999999886543221 


Q ss_pred             cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCC
Q 003391          663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG  742 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~  742 (823)
                       ......++..|+|||.+.+..++.++|||||||++|||++|+.||...+....      . .........     .+. 
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~------~-~~~~~~~~~-----~~~-  236 (296)
T cd06655         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------L-YLIATNGTP-----ELQ-  236 (296)
T ss_pred             -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------H-HHHHhcCCc-----ccC-
Confidence             12234688899999999998899999999999999999999999754322110      0 000000000     000 


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          743 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                       ........+.+++.+||+.+|.+||++.+++..
T Consensus       237 -~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         237 -NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             -CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence             111122357789999999999999999999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-35  Score=317.20  Aligned_cols=250  Identities=28%  Similarity=0.399  Sum_probs=203.4

Q ss_pred             CCcCCeeeccCccceEEEEeec--Cc--EEEEEEecCCccc-cHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          506 FSDKNKLGEGGFGPVYKGVLIE--GQ--EIAAKRLSKSSGQ-GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       506 ~~~~~~LG~G~fg~Vyk~~~~~--~~--~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      ....++||+|.||.|++|.+..  |+  .||||.+...... ....|.+|+.+|.+|+|||+++|+|+..+ ...+||+|
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E  190 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE  190 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence            3445799999999999999865  43  5899999776544 77899999999999999999999999987 78899999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      .++.|||.+.|++ .....+-......++.|||.||.||.++.   +|||||..+|+||-....+||+||||.+.+...+
T Consensus       191 LaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  191 LAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             hcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            9999999999987 45566888999999999999999999987   9999999999999999999999999999875443


Q ss_pred             c-ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          661 T-EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       661 ~-~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                      . ........-...|+|||.+....|+.++|||+|||.+|||+| |..|+.....                ....+.+|.
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g----------------~qIL~~iD~  330 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG----------------IQILKNIDA  330 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH----------------HHHHHhccc
Confidence            3 233333445678999999999999999999999999999999 5566432111                001112221


Q ss_pred             hcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       739 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      .-.-.-+..+.+++.+++..||..+|.+|||+..+.+.
T Consensus       331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence            11122344567799999999999999999999999743

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6.7e-34  Score=299.60  Aligned_cols=238  Identities=23%  Similarity=0.407  Sum_probs=188.3

Q ss_pred             CeeeccCccceEEEEeecCc-----------EEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          510 NKLGEGGFGPVYKGVLIEGQ-----------EIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~~~-----------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      +.||+|+||.||+|.+.+..           .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            47999999999999987533           4777876554433 6788999999999999999999999988 778999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCC-------Cceeeccc
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-------NPKISDFG  651 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~-------~~kl~DFG  651 (823)
                      +||+++++|.+++....  ..+++..+..++.||+.||+|||+.+   |+|+||||+||+++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            99999999999985422  26889999999999999999999987   99999999999999887       79999999


Q ss_pred             cceecCCCccccccccccccCCccCccccccC--CCCccchhHhHHHHHHHHHhc-CCCCCCcCCCCccchhHHHHHHhh
Q 003391          652 MARAFGIDQTEANTNRVVGTYGYMPPEYAIDG--LFSVKSDVFSFGVLVLEIVCG-KRNRGFYHADHHHNLLGHAWRLWI  728 (823)
Q Consensus       652 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~ksDVwS~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~  728 (823)
                      ++.....      .....++..|+|||++.+.  .++.++||||||+++|||++| ..|+........   .    ..+.
T Consensus       154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~---~----~~~~  220 (259)
T cd05037         154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK---E----RFYQ  220 (259)
T ss_pred             ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH---H----HHHh
Confidence            9986532      1224566789999999876  789999999999999999995 555533221110   0    0000


Q ss_pred             hcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003391          729 EERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS  778 (823)
Q Consensus       729 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  778 (823)
                      ..           ..........+.+++.+|++.+|.+||++.++++.|+
T Consensus       221 ~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 DQ-----------HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             cC-----------CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            00           0011111257789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.6e-33  Score=297.19  Aligned_cols=254  Identities=20%  Similarity=0.342  Sum_probs=188.0

Q ss_pred             CeeeccCccceEEEEeecCc---EEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCCC
Q 003391          510 NKLGEGGFGPVYKGVLIEGQ---EIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNK  585 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~~~---~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (823)
                      ++||+|+||.||+|...++.   .+++|.+.... ....+.+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            36999999999999865433   45667665443 334568999999999999999999999999999999999999999


Q ss_pred             CcchhhhccC-CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccccc
Q 003391          586 SLNDFIFDVT-RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN  664 (823)
Q Consensus       586 sL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  664 (823)
                      +|.+++.+.. .....++..+..++.||++||+|||+.+   ++|+||||+|||++.++.+||+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            9999996532 2234667778899999999999999987   99999999999999999999999999864322211122


Q ss_pred             cccccccCCccCcccccc-------CCCCccchhHhHHHHHHHHHhc-CCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          665 TNRVVGTYGYMPPEYAID-------GLFSVKSDVFSFGVLVLEIVCG-KRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       665 ~~~~~gt~~y~aPE~l~~-------~~~s~ksDVwS~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      .....++..|+|||++..       ..++.++||||||+++|||+++ ..|+....   .....    .....+....+.
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~---~~~~~----~~~~~~~~~~~~  230 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS---DREVL----NHVIKDQQVKLF  230 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC---HHHHH----HHHHhhcccccC
Confidence            233567889999998753       2457899999999999999975 55653211   11111    111112222222


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS  778 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  778 (823)
                      ++.+...+    ...+.+++..|+ .+|++||++++|++.|.
T Consensus       231 ~~~~~~~~----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         231 KPQLELPY----SERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCccCCCC----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            22222222    235667888899 57999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=8.8e-34  Score=299.44  Aligned_cols=250  Identities=26%  Similarity=0.386  Sum_probs=190.3

Q ss_pred             CeeeccCccceEEEEeec----CcEEEEEEecCC-ccccHHHHHHHHHHHhccCCCCceeEEEEee-cCCceEEEEeecC
Q 003391          510 NKLGEGGFGPVYKGVLIE----GQEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCT-QRDERMLIYEYLP  583 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~----~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~-~~~~~~lV~e~~~  583 (823)
                      +.||+|+||.||+|.+.+    ...+|+|++... .....+.+.+|+.+++.++|||++++++++. .+...++|+||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998643    357999988543 2334567889999999999999999999875 4456889999999


Q ss_pred             CCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc-
Q 003391          584 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE-  662 (823)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~-  662 (823)
                      +++|.+++...  ...+++..+..++.|+++||.|||+.+   ++||||||+|||+++++.+||+|||+++........ 
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            99999998532  234677888999999999999999987   999999999999999999999999999765322111 


Q ss_pred             -cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCC-CCCCcCCCCccchhHHHHHHhhhcCchhhhhhhc
Q 003391          663 -ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR-NRGFYHADHHHNLLGHAWRLWIEERPVELINKSL  740 (823)
Q Consensus       663 -~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~-p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l  740 (823)
                       .......++..|+|||.+.+..++.++||||||+++|||++|.. |+....   ...+..    .......        
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~----~~~~~~~--------  220 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD---SFDITV----YLLQGRR--------  220 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHH----HHhcCCC--------
Confidence             11122345678999999988899999999999999999999654 443211   111111    0111000        


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          741 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                       ...+...+..+.+++..|++.+|++||++.|+++.|+.+
T Consensus       221 -~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         221 -LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             -CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence             000111134678999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.8e-34  Score=313.53  Aligned_cols=240  Identities=21%  Similarity=0.250  Sum_probs=186.2

Q ss_pred             CeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHH-HHHhccCCCCceeEEEEeecCCceEEEEeecCC
Q 003391          510 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEV-LLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPN  584 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei-~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (823)
                      +.||+|+||.||+++... ++.+|+|++.+..   .....++..|. .+++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            479999999999999865 6789999986532   22233444444 456778999999999999999999999999999


Q ss_pred             CCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccccc
Q 003391          585 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN  664 (823)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  664 (823)
                      ++|.+++..   ...+.+..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~  152 (325)
T cd05602          81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGT  152 (325)
T ss_pred             CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCC
Confidence            999998843   345778888899999999999999998   999999999999999999999999999754221  122


Q ss_pred             cccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCC
Q 003391          665 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY  744 (823)
Q Consensus       665 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~  744 (823)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......   ....    ....        ....  .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~----~i~~--------~~~~--~  215 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYD----NILN--------KPLQ--L  215 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH---HHHH----HHHh--------CCcC--C
Confidence            33467999999999999999999999999999999999999997532111   1111    0000        0010  1


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 003391          745 SLSEVLRCIQVGLLCVQQRPEDRPNMSSVV  774 (823)
Q Consensus       745 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl  774 (823)
                      .......+.+++.+|++.+|.+||++.+.+
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         216 KPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            111224677899999999999999987543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=8.8e-34  Score=300.05  Aligned_cols=251  Identities=26%  Similarity=0.408  Sum_probs=198.2

Q ss_pred             CCCcCCeeeccCccceEEEEeecCcEEEEEEecCCc------cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSS------GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      +|...+.||+|+||.||+|...+++.+|+|.+....      ......+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            467788999999999999998788999999886432      12235688999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      +||+++++|.+++..   ...+++..+..++.|++.||+|||+.+   |+|+||+|+||++++++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            999999999999843   235789999999999999999999987   99999999999999999999999999876532


Q ss_pred             Cc----cccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchh
Q 003391          659 DQ----TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE  734 (823)
Q Consensus       659 ~~----~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  734 (823)
                      ..    .........++..|+|||.+.+..++.++||||||+++|||++|+.||.......      ..... ...   .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~-~~~---~  224 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA------AMFYI-GAH---R  224 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH------HHHHh-hhc---c
Confidence            11    1111223568899999999999899999999999999999999999975321110      00000 000   0


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          735 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       735 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                          ............++.+++.+|++.+|++||++.|+++
T Consensus       225 ----~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         225 ----GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             ----CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                0001111222346788999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=8.7e-34  Score=301.03  Aligned_cols=255  Identities=24%  Similarity=0.339  Sum_probs=200.2

Q ss_pred             cCCCcCCeeeccCccceEEEEeecC----cEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIEG----QEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~~----~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      ++|...++||+|+||.||+|.+.+.    ..+++|...... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            4577788999999999999997542    468889886554 4456689999999999999999999999875 557899


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      |||+++++|.+++...  ...+++..+..++.+++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++....
T Consensus        85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence            9999999999998532  335899999999999999999999987   99999999999999999999999999986543


Q ss_pred             CccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN  737 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  737 (823)
                      ..... .....++..|+|||.+....++.++||||||+++|||++ |+.||......   ....    .......     
T Consensus       160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~----~~~~~~~-----  226 (270)
T cd05056         160 ESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIG----RIENGER-----  226 (270)
T ss_pred             cccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHH----HHHcCCc-----
Confidence            32111 112334568999999988889999999999999999996 99997533221   1111    0111000     


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          738 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       738 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                          ..........+.+++.+|+..+|++||++.++++.|+.+.
T Consensus       227 ----~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~  266 (270)
T cd05056         227 ----LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL  266 (270)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                0111122346788999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=6.2e-34  Score=325.98  Aligned_cols=265  Identities=20%  Similarity=0.240  Sum_probs=192.4

Q ss_pred             HHHHHhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCC------CCceeEEEEee
Q 003391          498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH------RNLVKLIGCCT  570 (823)
Q Consensus       498 ~l~~~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H------~niv~l~g~~~  570 (823)
                      ++....++|.+.++||+|+||.||+|.+.. ++.||||+++... ....++..|+.++++++|      .+++++++++.
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            344456889999999999999999999765 7789999986432 233456677777777654      45889999887


Q ss_pred             cC-CceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhc-CCCceEecccCCCcEEEcCCC-----
Q 003391          571 QR-DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEM-----  643 (823)
Q Consensus       571 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NIll~~~~-----  643 (823)
                      .. .+.++|||++ +++|.+++..   ...+++..+..|+.||+.||.|||++ +   ||||||||+|||++.++     
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~  274 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP  274 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence            64 5688999988 7788888843   34689999999999999999999984 6   99999999999998765     


Q ss_pred             -----------CceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcC
Q 003391          644 -----------NPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYH  712 (823)
Q Consensus       644 -----------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~  712 (823)
                                 .+||+|||++....     .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       275 ~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        275 VTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             ccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                       49999999886422     12234679999999999999999999999999999999999999986543


Q ss_pred             CCCccchhHHHHH----Hhhh----cCchhhhhh---------------hcCCCC--CHHHHHHHHHHHHHccccCCCCC
Q 003391          713 ADHHHNLLGHAWR----LWIE----ERPVELINK---------------SLGGSY--SLSEVLRCIQVGLLCVQQRPEDR  767 (823)
Q Consensus       713 ~~~~~~l~~~~~~----~~~~----~~~~~~~~~---------------~l~~~~--~~~~~~~l~~l~~~Cl~~dP~~R  767 (823)
                      ..+....+.....    .+..    ....+++..               ......  ...+...+++|+..||+.||++|
T Consensus       350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R  429 (467)
T PTZ00284        350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR  429 (467)
T ss_pred             hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence            2221111111000    0000    000000000               000000  00112357799999999999999


Q ss_pred             CCHHHHHH
Q 003391          768 PNMSSVVL  775 (823)
Q Consensus       768 Ps~~evl~  775 (823)
                      ||++|+++
T Consensus       430 ~ta~e~L~  437 (467)
T PTZ00284        430 LNARQMTT  437 (467)
T ss_pred             CCHHHHhc
Confidence            99999986

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.7e-33  Score=300.14  Aligned_cols=248  Identities=27%  Similarity=0.397  Sum_probs=200.9

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      ..|+..++||+|+||.||+|+... ++.+|+|.+.... ......+.+|+.++++++||||+++++++.+....++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            356677899999999999999764 7889999886543 34566789999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++++|.+++..    ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++..+.... 
T Consensus        84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06640          84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-  155 (277)
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc-
Confidence            999999998842    35788999999999999999999987   9999999999999999999999999998654322 


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                       .......++..|+|||.+.+..++.++||||||+++|||++|+.|+.........                ..+.....
T Consensus       156 -~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~----------------~~~~~~~~  218 (277)
T cd06640         156 -IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL----------------FLIPKNNP  218 (277)
T ss_pred             -cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh----------------hhhhcCCC
Confidence             1222346788999999999889999999999999999999999997532211100                00000011


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          742 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ..........+.+++.+|++.+|++||++.+++..
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            12223345678899999999999999999999765

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.7e-33  Score=296.21  Aligned_cols=250  Identities=24%  Similarity=0.338  Sum_probs=201.5

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC--ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      +|+..+.||+|+||.||.++... ++.+++|++...  ......++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            47788999999999999988654 888999987654  344556789999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++++|.+++.... ...+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            99999999985432 346899999999999999999999987   99999999999999999999999999987643321


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                        ......+++.|+|||.+.+..++.++||||||+++|||++|+.|+.....   .....    ......        ..
T Consensus       157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~---~~~~~----~~~~~~--------~~  219 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP---LNLVV----KIVQGN--------YT  219 (256)
T ss_pred             --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH---HHHHH----HHHcCC--------CC
Confidence              22335688999999999988899999999999999999999999753211   11110    001000        00


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          742 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                       ........++.+++.+|++.+|++||++.++++.
T Consensus       220 -~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         220 -PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             -CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence             0111223467889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=4.7e-34  Score=311.33  Aligned_cols=240  Identities=27%  Similarity=0.347  Sum_probs=190.2

Q ss_pred             CCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccC-CCCceeEEEEeecCCceEEEEe
Q 003391          506 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       506 ~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      |...+.||+|+||.||+++... ++.||+|++.+..   ....+.+..|..++..+. |++|+++.+++.+.+..++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            6677899999999999999764 8899999987542   234456778888888875 5778889999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++......
T Consensus        82 y~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~  155 (323)
T cd05615          82 YVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG  155 (323)
T ss_pred             CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence            9999999998843   345899999999999999999999988   9999999999999999999999999997542221


Q ss_pred             cccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhc
Q 003391          661 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL  740 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l  740 (823)
                        .......||+.|+|||++.+..++.++||||||+++|||++|+.||.....   .....    .....        ..
T Consensus       156 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~----~i~~~--------~~  218 (323)
T cd05615         156 --VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELFQ----SIMEH--------NV  218 (323)
T ss_pred             --ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHHH----HHHhC--------CC
Confidence              122335689999999999999999999999999999999999999753221   11111    11110        00


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 003391          741 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNM  770 (823)
Q Consensus       741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  770 (823)
                        ..+.....++.+++.+|++.+|.+|++.
T Consensus       219 --~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         219 --SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             --CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence              1111122466789999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=5.4e-34  Score=316.40  Aligned_cols=258  Identities=21%  Similarity=0.236  Sum_probs=198.0

Q ss_pred             HHHHhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC---ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCc
Q 003391          499 IANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE  574 (823)
Q Consensus       499 l~~~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~  574 (823)
                      +....++|...+.||+|+||.||++++.. ++.+|+|.+.+.   .....+.+.+|+.+++.++||||+++++.+.+.+.
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  117 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            34456889999999999999999999875 788999998643   22334557889999999999999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccce
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  654 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  654 (823)
                      .++||||+++|+|.+++..    ..++...+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~  190 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence            9999999999999998843    34788888999999999999999998   9999999999999999999999999998


Q ss_pred             ecCCCccccccccccccCCccCccccccC----CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhc
Q 003391          655 AFGIDQTEANTNRVVGTYGYMPPEYAIDG----LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE  730 (823)
Q Consensus       655 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  730 (823)
                      .+..... .......||+.|+|||++...    .++.++|||||||++|||++|+.||.....      ... .......
T Consensus       191 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~-~~~i~~~  262 (371)
T cd05622         191 KMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGT-YSKIMNH  262 (371)
T ss_pred             EcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHH-HHHHHcC
Confidence            7643221 122346799999999998754    378999999999999999999999853221      111 1111100


Q ss_pred             CchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHh
Q 003391          731 RPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPED--RPNMSSVVLML  777 (823)
Q Consensus       731 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~L  777 (823)
                      ..      .+...........+.+++..|++.++.+  ||++.|+++..
T Consensus       263 ~~------~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         263 KN------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             CC------cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            00      0000011112335678889999854443  78999988853

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.1e-33  Score=305.53  Aligned_cols=198  Identities=25%  Similarity=0.385  Sum_probs=161.1

Q ss_pred             CCeeeccCccceEEEEeec---CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeec--CCceEEEEeecC
Q 003391          509 KNKLGEGGFGPVYKGVLIE---GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ--RDERMLIYEYLP  583 (823)
Q Consensus       509 ~~~LG~G~fg~Vyk~~~~~---~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~~  583 (823)
                      .++||+|+||.||+|+..+   ++.+|+|++....  ....+.+|+.++++++||||+++++++..  ....++|+||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            4689999999999999753   5789999986542  23467889999999999999999998854  456789999986


Q ss_pred             CCCcchhhhcc------CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEE----cCCCCceeeccccc
Q 003391          584 NKSLNDFIFDV------TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNEMNPKISDFGMA  653 (823)
Q Consensus       584 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~DFGla  653 (823)
                      + +|.+++...      .+...+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            5 787776421      12235889999999999999999999998   9999999999999    45678999999999


Q ss_pred             eecCCCcc-ccccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcC
Q 003391          654 RAFGIDQT-EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYH  712 (823)
Q Consensus       654 ~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~  712 (823)
                      +.+..... ........+|+.|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            87643322 1223346789999999998774 58999999999999999999999986443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.3e-33  Score=300.01  Aligned_cols=256  Identities=24%  Similarity=0.360  Sum_probs=197.5

Q ss_pred             CCcCCeeeccCccceEEEEeec----CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCC------
Q 003391          506 FSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD------  573 (823)
Q Consensus       506 ~~~~~~LG~G~fg~Vyk~~~~~----~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------  573 (823)
                      |...+.||+|+||.||+|.+..    ++.+|+|++....  ....+++.+|+.++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            4567899999999999998642    6789999986542  334567889999999999999999999886542      


Q ss_pred             ceEEEEeecCCCCcchhhhccC---CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecc
Q 003391          574 ERMLIYEYLPNKSLNDFIFDVT---RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDF  650 (823)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF  650 (823)
                      ..++++||+++|+|.+++....   ....+++.....++.|++.||+|||+.+   |+|+||||+||++++++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            2478899999999998875321   1224788999999999999999999987   999999999999999999999999


Q ss_pred             ccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhh
Q 003391          651 GMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIE  729 (823)
Q Consensus       651 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  729 (823)
                      |+++...............++..|++||.+....++.++||||||+++|||++ |+.|+.....   ..+...    ...
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~----~~~  230 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNY----LIK  230 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHH----HHc
Confidence            99986643322222223345678999999998899999999999999999999 7787642211   111111    111


Q ss_pred             cCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          730 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       730 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      ...       +  .........+.+++.+|++.+|++||++.|+++.|+++
T Consensus       231 ~~~-------~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         231 GNR-------L--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCc-------C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            100       0  11122335788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.2e-33  Score=300.75  Aligned_cols=256  Identities=26%  Similarity=0.375  Sum_probs=201.2

Q ss_pred             cCCCcCCeeeccCccceEEEEeec------CcEEEEEEecCCccc-cHHHHHHHHHHHhccCCCCceeEEEEeecCCceE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSSGQ-GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM  576 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~------~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  576 (823)
                      ++|...+.||+|+||.||+|+...      .+.+++|.+...... ..+++.+|++++++++|+||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            567888999999999999999642      457899988654433 4567999999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhccCCC------CccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecc
Q 003391          577 LIYEYLPNKSLNDFIFDVTRS------KFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDF  650 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF  650 (823)
                      +||||+++++|.+++......      ..+++..+..++.|++.||+|||+.+   |+|+||||+||+++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999998643321      25899999999999999999999988   999999999999999999999999


Q ss_pred             ccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhh
Q 003391          651 GMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIE  729 (823)
Q Consensus       651 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  729 (823)
                      |++....... ........++..|+|||.+.+..++.++||||||+++|||++ |..||......   ....    ....
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~~~----~~~~  233 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EVLN----RLQA  233 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HHHH----HHHc
Confidence            9987543221 112223456778999999988889999999999999999999 67776422110   0100    0000


Q ss_pred             cCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003391          730 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS  778 (823)
Q Consensus       730 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  778 (823)
                      .        .............+.+++.+|++.+|++||++.|++..|+
T Consensus       234 ~--------~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         234 G--------KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             C--------CcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            0        0001111223357889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=6.3e-34  Score=307.29  Aligned_cols=260  Identities=24%  Similarity=0.339  Sum_probs=196.1

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      ++|...++||+|+||.||+|+... ++.||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            568888999999999999999764 7889999986543 33345678899999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      ++ ++|.+++...  ...+++..+..++.||++||+|||+.+   |+|+||||+||++++++.+||+|||++........
T Consensus        86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            97 5888887542  345789999999999999999999987   99999999999999999999999999976432221


Q ss_pred             ccccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchh----hh
Q 003391          662 EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE----LI  736 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~----~~  736 (823)
                        ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||...+..+   ........+ ......    .+
T Consensus       160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~---~~~~~~~~~-~~~~~~~~~~~~  233 (301)
T cd07873         160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE---QLHFIFRIL-GTPTEETWPGIL  233 (301)
T ss_pred             --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHc-CCCChhhchhhh
Confidence              12224568899999988654 57889999999999999999999986432211   111111000 000000    00


Q ss_pred             h---------hhcCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          737 N---------KSLGGS----YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       737 ~---------~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      .         +.....    ........+.+++.+|++.||.+|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0         000000    00011235678999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.4e-33  Score=302.02  Aligned_cols=250  Identities=26%  Similarity=0.350  Sum_probs=196.8

Q ss_pred             CCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc---ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          506 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       506 ~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      |+..+.||+|+||.||++.... ++.+|+|++.....   .....+.+|+.++++++|+|++++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            5667899999999999999865 78999999865432   2234577899999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.++|+|||++....... 
T Consensus        82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05630          82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-  156 (285)
T ss_pred             cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence            9999999988542 2235889999999999999999999987   9999999999999999999999999997643221 


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                        ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.........    ...........         
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~----~~~~~~~~~~~---------  221 (285)
T cd05630         157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR----EEVERLVKEVQ---------  221 (285)
T ss_pred             --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH----HHHHhhhhhhh---------
Confidence              112346899999999999999999999999999999999999998543211100    00000100000         


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 003391          742 GSYSLSEVLRCIQVGLLCVQQRPEDRPN-----MSSVVL  775 (823)
Q Consensus       742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  775 (823)
                      .........++.+++..|++.||++||+     +.|+++
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            0111112235778999999999999999     778875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.1e-33  Score=302.39  Aligned_cols=250  Identities=23%  Similarity=0.351  Sum_probs=197.3

Q ss_pred             CCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCC
Q 003391          506 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPN  584 (823)
Q Consensus       506 ~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (823)
                      |+..+.||+|+||.||+|.... +..+++|.+........+.+.+|+++++.++|||++++++++...+..++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            5667789999999999999865 678888988766656677889999999999999999999999999999999999999


Q ss_pred             CCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccccc
Q 003391          585 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN  664 (823)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  664 (823)
                      ++|..++..  ....+++..+..++.|+++||.|||+.+   ++|+||||+||+++.++.+||+|||++......  ...
T Consensus        87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~  159 (282)
T cd06643          87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQR  159 (282)
T ss_pred             CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc--ccc
Confidence            999988753  2346899999999999999999999987   999999999999999999999999998764322  122


Q ss_pred             cccccccCCccCccccc-----cCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          665 TNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       665 ~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                      .....++..|+|||++.     +..++.++|||||||++|||++|+.|+......      ..... ..........   
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~-~~~~~~~~~~---  229 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM------RVLLK-IAKSEPPTLA---  229 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH------HHHHH-HhhcCCCCCC---
Confidence            23356889999999984     445788999999999999999999987432210      00000 0001000000   


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       740 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                          .+.....++.+++.+|++.+|.+||++.++++.
T Consensus       230 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         230 ----QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             ----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                011122467889999999999999999998754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.3e-34  Score=303.65  Aligned_cols=260  Identities=23%  Similarity=0.321  Sum_probs=201.5

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      ++|+..+.||+|+||+||++.... ++.+|+|++.... ....+++.+|++++..++||||+++++++.....+++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            467778899999999999999764 7889999876543 34457889999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++++|.+++..   .+.+++..+..++.+++.+|.|||+..  .++|+||+|+||++++++.++|+|||++......  
T Consensus        85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--  157 (284)
T cd06620          85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--  157 (284)
T ss_pred             CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence            999999998743   345899999999999999999999742  3999999999999999999999999998754221  


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                        ......++..|+|||.+.+..++.++|+|||||++|||++|+.||....................    ...+.... 
T Consensus       158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~-  230 (284)
T cd06620         158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL----QQIVQEPP-  230 (284)
T ss_pred             --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHH----HHHhhccC-
Confidence              12235789999999999888999999999999999999999999864332211100000000000    00000000 


Q ss_pred             CCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003391          742 GSYS-LSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML  777 (823)
Q Consensus       742 ~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  777 (823)
                      .... ......+.+++.+|++.+|++||++.|++++.
T Consensus       231 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         231 PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            0111 11334678899999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=5.9e-34  Score=301.73  Aligned_cols=253  Identities=23%  Similarity=0.379  Sum_probs=198.9

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      ++|...++||+|+||.||+|+... ++.+|+|.++.........+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            467778899999999999999764 8889999987665555567889999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  662 (823)
                      ++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++..+...  .
T Consensus        89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~  160 (267)
T cd06645          89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT--I  160 (267)
T ss_pred             CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc--c
Confidence            99999998843   345899999999999999999999998   999999999999999999999999999765322  1


Q ss_pred             cccccccccCCccCccccc---cCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          663 ANTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                      .......|+..|+|||++.   ...++.++|||||||++|||++|+.|+....+...  .    .. .....   ...+.
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~----~~-~~~~~---~~~~~  230 (267)
T cd06645         161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--L----FL-MTKSN---FQPPK  230 (267)
T ss_pred             cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--H----Hh-hhccC---CCCCc
Confidence            1223356889999999874   45688999999999999999999998643221110  0    00 00000   00000


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       740 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      .....  .....+.+++.+|++.+|++||+++++++.
T Consensus       231 ~~~~~--~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         231 LKDKM--KWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             ccccC--CCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            00000  112357789999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=9.9e-34  Score=303.05  Aligned_cols=265  Identities=23%  Similarity=0.298  Sum_probs=198.6

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      ++|+..+.||+|+||.||+|++.. ++.+|+|++....  ....+.+.+|+.++.+++|||++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            467888999999999999999864 8899999886542  2234567899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |+++++|..++.   ....+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            999998887763   2335899999999999999999999987   9999999999999999999999999998764332


Q ss_pred             cccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhh--------cC
Q 003391          661 TEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE--------ER  731 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--------~~  731 (823)
                      .  ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+...........+..        ..
T Consensus       155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07847         155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ  232 (286)
T ss_pred             c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence            1  1223457789999999876 56889999999999999999999998643322111110000000000        00


Q ss_pred             c-hhhhhhhcCCCCCHH-----HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          732 P-VELINKSLGGSYSLS-----EVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       732 ~-~~~~~~~l~~~~~~~-----~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      . .....+......+.+     ....+.+++.+|++.+|++||++.|++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            0 000000000001111     12467899999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.9e-33  Score=298.15  Aligned_cols=255  Identities=23%  Similarity=0.343  Sum_probs=199.3

Q ss_pred             CCCcCCeeeccCccceEEEEeec--CcEEEEEEecCC----------ccccHHHHHHHHHHHhc-cCCCCceeEEEEeec
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE--GQEIAAKRLSKS----------SGQGMEEFENEVLLIAK-LQHRNLVKLIGCCTQ  571 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~--~~~vavK~l~~~----------~~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~  571 (823)
                      +|+..+.||+|+||.||+|++..  ++.+|+|.+...          ......++..|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            46778899999999999999866  678999987532          12234557788888875 799999999999999


Q ss_pred             CCceEEEEeecCCCCcchhhhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecc
Q 003391          572 RDERMLIYEYLPNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDF  650 (823)
Q Consensus       572 ~~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF  650 (823)
                      .+..++||||+++++|.+++... .....+++..++.++.|++.||.|||+..  .++|+||+|+||+++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999999988542 23446899999999999999999999632  3999999999999999999999999


Q ss_pred             ccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhc
Q 003391          651 GMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE  730 (823)
Q Consensus       651 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  730 (823)
                      |++.......   ......++..|+|||.+.+..++.++||||||+++|||++|+.|+......      .. .......
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------~~-~~~~~~~  228 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------SL-ATKIVEA  228 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------HH-HHHHhhc
Confidence            9998754332   233456888999999999988999999999999999999999986422110      00 0000100


Q ss_pred             CchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          731 RPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       731 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                      .        ............+.+++.+|++.+|++||++.|+..+|++
T Consensus       229 ~--------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         229 V--------YEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             c--------CCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence            0        0000011122467889999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.5e-33  Score=301.80  Aligned_cols=250  Identities=25%  Similarity=0.337  Sum_probs=195.7

Q ss_pred             CCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          506 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       506 ~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      |+..+.||+|+||+||++.... ++.+|+|.+....   ......+.+|++++++++|+|++++.+.+..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            5567899999999999999864 8899999986542   22334578899999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++++|.+++.... ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++....... 
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05632          82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-  156 (285)
T ss_pred             ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence            99999998885432 345899999999999999999999988   9999999999999999999999999997643221 


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                        ......|+..|+|||.+.+..++.++|+||||+++|||++|+.||........   ...........          .
T Consensus       157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~~~----------~  221 (285)
T cd05632         157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVLET----------E  221 (285)
T ss_pred             --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhhcc----------c
Confidence              12235689999999999999999999999999999999999999753221110   00000000000          0


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 003391          742 GSYSLSEVLRCIQVGLLCVQQRPEDRPN-----MSSVVL  775 (823)
Q Consensus       742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  775 (823)
                      ..........+.+++..|++.+|++||+     +.+++.
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         222 EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            0111112235678999999999999999     556655

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-34  Score=312.80  Aligned_cols=240  Identities=23%  Similarity=0.279  Sum_probs=183.6

Q ss_pred             eeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhcc---CCCCceeEEEEeecCCceEEEEeecCC
Q 003391          512 LGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKL---QHRNLVKLIGCCTQRDERMLIYEYLPN  584 (823)
Q Consensus       512 LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (823)
                      ||+|+||.||+|+... ++.||+|++.+..   ......+..|..++...   +||||+++++.+.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            6999999999999765 8899999986532   12233455566666655   699999999999999999999999999


Q ss_pred             CCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccccc
Q 003391          585 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN  664 (823)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  664 (823)
                      |+|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~  152 (330)
T cd05586          81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT  152 (330)
T ss_pred             ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence            999988843   345899999999999999999999998   9999999999999999999999999997542221  12


Q ss_pred             cccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCC
Q 003391          665 TNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS  743 (823)
Q Consensus       665 ~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~  743 (823)
                      .....||..|+|||++.+. .++.++|||||||++|||++|+.||......   .+    .........      .+.. 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~---~~----~~~i~~~~~------~~~~-  218 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ---QM----YRNIAFGKV------RFPK-  218 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH---HH----HHHHHcCCC------CCCC-
Confidence            2346789999999998765 4899999999999999999999997432110   00    111110000      0000 


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 003391          744 YSLSEVLRCIQVGLLCVQQRPEDRPN----MSSVVL  775 (823)
Q Consensus       744 ~~~~~~~~l~~l~~~Cl~~dP~~RPs----~~evl~  775 (823)
                        .....++.+++.+||+.+|.+||+    +.++++
T Consensus       219 --~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         219 --NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             --ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence              011235678999999999999994    555554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.8e-33  Score=302.26  Aligned_cols=252  Identities=26%  Similarity=0.379  Sum_probs=199.9

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      +.|++.++||+|+||.||+|+... ++.+++|.+........+.+.+|+.++++++|||++++++.+...+..++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            568888999999999999999865 7899999998776666778999999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  662 (823)
                      ++++|..++.+.  ...+++..+..++.|++.+|.|||+.+   ++|+||||+||+++.++.+||+|||++......  .
T Consensus        92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~  164 (292)
T cd06644          92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--L  164 (292)
T ss_pred             CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc--c
Confidence            999998877432  345899999999999999999999987   999999999999999999999999998754221  1


Q ss_pred             cccccccccCCccCccccc-----cCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhh
Q 003391          663 ANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN  737 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  737 (823)
                      .......++..|+|||.+.     ...++.++|||||||++|||++|+.|+......      .. ............  
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~-~~~~~~~~~~~~--  235 (292)
T cd06644         165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RV-LLKIAKSEPPTL--  235 (292)
T ss_pred             cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HH-HHHHhcCCCccC--
Confidence            1223356788999999984     345788999999999999999999987432210      00 011111100000  


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          738 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       738 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                           ..+.....++.+++.+|++.+|++||++.++++.
T Consensus       236 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         236 -----SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             -----CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                 0111222467789999999999999999999753

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.4e-33  Score=296.53  Aligned_cols=247  Identities=25%  Similarity=0.388  Sum_probs=196.7

Q ss_pred             cCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecC
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP  583 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (823)
                      ++|+..+.||+|+||.||++.. .++.+|+|++....  ..+.+.+|+.++.+++|||++++++++... ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4578889999999999999975 67889999986543  346789999999999999999999998754 5799999999


Q ss_pred             CCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccc
Q 003391          584 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA  663 (823)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  663 (823)
                      +++|.+++.... ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++......    
T Consensus        82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----  153 (254)
T cd05083          82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----  153 (254)
T ss_pred             CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence            999999985432 335789999999999999999999987   999999999999999999999999999764321    


Q ss_pred             ccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCC
Q 003391          664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG  742 (823)
Q Consensus       664 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~  742 (823)
                       ......+..|+|||.+.+..++.++||||||+++|||++ |+.||......+   .    ......         ....
T Consensus       154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~----~~~~~~---------~~~~  216 (254)
T cd05083         154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE---V----KECVEK---------GYRM  216 (254)
T ss_pred             -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH---H----HHHHhC---------CCCC
Confidence             112234568999999998899999999999999999998 888864322110   0    111111         1111


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          743 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                      .........+.+++.+|++.+|++||+++++++.|+.
T Consensus       217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            1112223567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2e-33  Score=311.13  Aligned_cols=260  Identities=22%  Similarity=0.301  Sum_probs=194.8

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC--ccccHHHHHHHHHHHhccCCCCceeEEEEeecCC-----
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD-----  573 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----  573 (823)
                      ..++|...+.||+|+||.||++.... ++.+|+|++...  .......+.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            45789999999999999999999754 889999998654  2334567889999999999999999999986543     


Q ss_pred             -ceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccc
Q 003391          574 -ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM  652 (823)
Q Consensus       574 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl  652 (823)
                       ..++||||+++ +|.+.+.     ..+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence             47999999976 5655552     23788889999999999999999998   99999999999999999999999999


Q ss_pred             ceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHH------
Q 003391          653 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL------  726 (823)
Q Consensus       653 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~------  726 (823)
                      ++.....   .......+|+.|+|||++.+..++.++||||||+++|||++|+.||...+...   ........      
T Consensus       170 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~  243 (359)
T cd07876         170 ARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID---QWNKVIEQLGTPSA  243 (359)
T ss_pred             ccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCcH
Confidence            9754321   12233578999999999999999999999999999999999999986432211   00000000      


Q ss_pred             ------------hhhcCc-------hhhhhhhcCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          727 ------------WIEERP-------VELINKSLGG---SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       727 ------------~~~~~~-------~~~~~~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                                  +.....       .+........   .........+.+++.+|++.||++|||+.|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                        000000       0000000000   0000112367899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.2e-34  Score=317.64  Aligned_cols=201  Identities=24%  Similarity=0.357  Sum_probs=173.3

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ++|+..+.||+|+||.||+++... ++.+|+|++....   ......+.+|+.++.+++||||+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            367888999999999999999865 8899999986532   334567888999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+++|+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            99999999999843   345889999999999999999999998   999999999999999999999999998754221


Q ss_pred             ccc---------------------------------cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCC
Q 003391          660 QTE---------------------------------ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR  706 (823)
Q Consensus       660 ~~~---------------------------------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~  706 (823)
                      ...                                 .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            100                                 01123579999999999999999999999999999999999999


Q ss_pred             CCCC
Q 003391          707 NRGF  710 (823)
Q Consensus       707 p~~~  710 (823)
                      ||..
T Consensus       235 Pf~~  238 (360)
T cd05627         235 PFCS  238 (360)
T ss_pred             CCCC
Confidence            9853

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.5e-33  Score=304.90  Aligned_cols=197  Identities=26%  Similarity=0.392  Sum_probs=160.4

Q ss_pred             CCeeeccCccceEEEEeec---CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeec--CCceEEEEeecC
Q 003391          509 KNKLGEGGFGPVYKGVLIE---GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ--RDERMLIYEYLP  583 (823)
Q Consensus       509 ~~~LG~G~fg~Vyk~~~~~---~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~~  583 (823)
                      .++||+|+||.||+|+..+   +..+|+|.+....  ....+.+|+.++++++||||+++++++..  ....++|+||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            4689999999999999754   4689999886543  23467899999999999999999998854  456789999987


Q ss_pred             CCCcchhhhcc------CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEE----cCCCCceeeccccc
Q 003391          584 NKSLNDFIFDV------TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNEMNPKISDFGMA  653 (823)
Q Consensus       584 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~DFGla  653 (823)
                      + +|.+++...      .....+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 777766421      12235889999999999999999999988   9999999999999    56678999999999


Q ss_pred             eecCCCccc-cccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCc
Q 003391          654 RAFGIDQTE-ANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFY  711 (823)
Q Consensus       654 ~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~  711 (823)
                      +.+...... .......+|..|+|||++.+. .++.++||||||+++|||+||+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            876433221 222345789999999998764 5899999999999999999999998643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-33  Score=296.27  Aligned_cols=253  Identities=24%  Similarity=0.369  Sum_probs=202.5

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      ++|...+.||+|+||.||+|.... ++.+++|.+........+.+.+|++++++++||||+++++++.+....+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            568888999999999999999864 7789999997766666788999999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  662 (823)
                      ++++|.+++...  ...+++..+..++.|++.||+|||+.+   |+|+||+|+||++++++.+||+|||++..+....  
T Consensus        83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--  155 (262)
T cd06613          83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--  155 (262)
T ss_pred             CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh--
Confidence            999999988532  245889999999999999999999987   9999999999999999999999999997653221  


Q ss_pred             cccccccccCCccCccccccC---CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          663 ANTNRVVGTYGYMPPEYAIDG---LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~~~---~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                      .......++..|+|||.+...   .++.++||||||+++|||++|+.|+........      ... ....   ......
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~------~~~-~~~~---~~~~~~  225 (262)
T cd06613         156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA------LFL-ISKS---NFPPPK  225 (262)
T ss_pred             hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-HHhc---cCCCcc
Confidence            112235678899999999776   889999999999999999999999753221110      000 0000   000000


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       740 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      +  ........++.+++.+|++.+|.+||++.+++.
T Consensus       226 ~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         226 L--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             c--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0  111223457889999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3e-33  Score=294.20  Aligned_cols=250  Identities=36%  Similarity=0.512  Sum_probs=198.3

Q ss_pred             CcCCeeeccCccceEEEEeec-----CcEEEEEEecCCccc-cHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          507 SDKNKLGEGGFGPVYKGVLIE-----GQEIAAKRLSKSSGQ-GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       507 ~~~~~LG~G~fg~Vyk~~~~~-----~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      ++.+.||.|+||.||+++..+     +..+|+|++...... ..+.+..|+.++..++|+||+++++++.+.+..+++||
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            456899999999999999865     378999999665433 56789999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |+++++|.+++..... ..+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||+++......
T Consensus        82 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       82 YMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             ccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            9999999999854222 22899999999999999999999997   9999999999999999999999999998765432


Q ss_pred             cccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          661 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                      ..... ...++..|+|||.+.+..++.++||||+|++++||++ |+.|+.....   ..+..    .......       
T Consensus       158 ~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~----~~~~~~~-------  222 (258)
T smart00219      158 YYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLE----YLKKGYR-------  222 (258)
T ss_pred             ccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH----HHhcCCC-------
Confidence            22111 2336789999999988889999999999999999998 6777543111   11111    0011110       


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003391          740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML  777 (823)
Q Consensus       740 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  777 (823)
                        .........++.+++.+|++.+|++|||+.|+++.|
T Consensus       223 --~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 --LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             --CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence              011111334678899999999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.7e-33  Score=294.73  Aligned_cols=250  Identities=24%  Similarity=0.325  Sum_probs=198.7

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecC-CceEEEEe
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR-DERMLIYE  580 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~e  580 (823)
                      +|+..+.||+|++|.||+++... ++.+|+|++....  ....+.+.+|++++++++|+|++++.+.+... ...++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            47788999999999999999765 7889999986542  33456788999999999999999999987644 45789999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |+++++|.+++... ....+++.++..++.+++.|+++||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            99999999998643 2345899999999999999999999998   9999999999999999999999999998764322


Q ss_pred             cccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhc
Q 003391          661 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL  740 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l  740 (823)
                        .......+++.|+|||++.+..++.++||||||++++||++|+.|+...+.      ...... ......        
T Consensus       157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~-~~~~~~--------  219 (257)
T cd08223         157 --DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYR-IIEGKL--------  219 (257)
T ss_pred             --CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHH-HHhcCC--------
Confidence              122335678899999999999999999999999999999999998753211      111000 111100        


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          741 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                       ..........+.+++.+|++.+|++||++.++++.
T Consensus       220 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         220 -PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             -CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence             11112233468899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.9e-33  Score=295.79  Aligned_cols=247  Identities=24%  Similarity=0.355  Sum_probs=199.9

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC--ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      +|+..+.||+|+||.||+++... ++.+|+|++...  .....+++.+|+.++++++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            47788999999999999999754 889999998653  233456789999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            9999999988532 2235789999999999999999999987   99999999999999999999999999986543221


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                        ......+++.|+|||++.+..++.++|+||||++++||++|+.|+.....                   .+.+...+.
T Consensus       157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------------------~~~~~~~~~  215 (256)
T cd08218         157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-------------------KNLVLKIIR  215 (256)
T ss_pred             --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-------------------HHHHHHHhc
Confidence              12234578899999999999999999999999999999999998642111                   011111111


Q ss_pred             CC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          742 GS---YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       742 ~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      +.   .+.....++.+++.+|++.+|++||+|.+|++.
T Consensus       216 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         216 GSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             CCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            11   112223467899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.4e-33  Score=308.67  Aligned_cols=255  Identities=19%  Similarity=0.219  Sum_probs=194.3

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC---ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ++|...+.||+|+||.||+++... ++.+|+|.+.+.   .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            468888999999999999999865 788999998653   2233455788999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+++|+|.+++...  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999999999542  345889999999999999999999988   999999999999999999999999999876433


Q ss_pred             ccccccccccccCCccCcccccc-----CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAID-----GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE  734 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  734 (823)
                      ... ......||+.|+|||++.+     ..++.++||||||++||||++|+.||......      .. ......... .
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~-~~~i~~~~~-~  226 (331)
T cd05624         156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ET-YGKIMNHEE-R  226 (331)
T ss_pred             Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HH-HHHHHcCCC-c
Confidence            221 1223568999999999875     56789999999999999999999997532211      00 011100000 0


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 003391          735 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPED--RPNMSSVVLM  776 (823)
Q Consensus       735 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~  776 (823)
                      .   .+. ........++.+++.+|++.++.+  |++++++++.
T Consensus       227 ~---~~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         227 F---QFP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             c---cCC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            0   000 000112346677888888865544  5688888764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=5.2e-34  Score=305.28  Aligned_cols=261  Identities=26%  Similarity=0.350  Sum_probs=197.5

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc--ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG--QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      ++|+..++||+|+||.||+|.+.+ ++.+|+|++.....  ...+.+.+|+++++.++||||+++++++...+..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            467788999999999999999865 88999998865432  234578899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |+++++|.++...   ...+++..+..++.||++||+|||+.+   ++|+||+|+||++++++.++|+|||++..+....
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            9999999887632   234899999999999999999999987   9999999999999999999999999998754332


Q ss_pred             cccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhh--cCchhh--
Q 003391          661 TEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE--ERPVEL--  735 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--~~~~~~--  735 (823)
                        .......++..|+|||++.+ ..++.++||||||+++|||++|+.|+......+   ...........  ......  
T Consensus       155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07846         155 --EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID---QLYHIIKCLGNLIPRHQEIFQ  229 (286)
T ss_pred             --cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH---HHHHHHHHhCCCchhhHHHhc
Confidence              12223457889999999875 457889999999999999999998875322111   11110000000  000000  


Q ss_pred             ----hhhhcCCCC---------CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          736 ----INKSLGGSY---------SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       736 ----~~~~l~~~~---------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                          .........         .......+.+++.+|++.+|++||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence                000000000         0112346889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=5.4e-34  Score=312.78  Aligned_cols=197  Identities=23%  Similarity=0.344  Sum_probs=169.5

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccC-C-----CCceeEEEEeecCCceEE
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-H-----RNLVKLIGCCTQRDERML  577 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H-----~niv~l~g~~~~~~~~~l  577 (823)
                      +|.+.+.||+|.||.|.||.+.. ++.||||+++. ......+...|+.+|..|+ |     -|+|++++++...++.+|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeecc-ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            78899999999999999999766 88999999954 4445667789999999996 4     389999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCC--Cceeecccccee
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM--NPKISDFGMARA  655 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~--~~kl~DFGla~~  655 (823)
                      |+|.+.. +|+++|...+ -..++...++.++.||+.||.+||+.+   |||+||||+||||.+..  .+||+|||.|+.
T Consensus       266 VfELL~~-NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  266 VFELLST-NLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eehhhhh-hHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence            9999954 9999996533 344899999999999999999999988   99999999999997554  699999999986


Q ss_pred             cCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcC
Q 003391          656 FGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYH  712 (823)
Q Consensus       656 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~  712 (823)
                      ....     ......+..|+|||++.+.+|+.+.||||||||+.||++|..-|....
T Consensus       341 ~~q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n  392 (586)
T KOG0667|consen  341 ESQR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN  392 (586)
T ss_pred             cCCc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence            4211     124667889999999999999999999999999999999987776443

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.7e-33  Score=301.31  Aligned_cols=260  Identities=25%  Similarity=0.346  Sum_probs=199.8

Q ss_pred             HHHHHHhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhcc-CCCCceeEEEEee----
Q 003391          497 MAIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCT----  570 (823)
Q Consensus       497 ~~l~~~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~----  570 (823)
                      ..+..+.++|+..+.||+|+||.||+++... ++.+|+|++.... ....++.+|+.++.++ +||||+++++++.    
T Consensus        11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   89 (286)
T cd06638          11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV   89 (286)
T ss_pred             ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence            3445577899999999999999999999865 7889999875432 2346788999999999 6999999999884    


Q ss_pred             -cCCceEEEEeecCCCCcchhhhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceee
Q 003391          571 -QRDERMLIYEYLPNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKIS  648 (823)
Q Consensus       571 -~~~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~  648 (823)
                       .++..++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+   |+||||||+||++++++.+||+
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~  166 (286)
T cd06638          90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLV  166 (286)
T ss_pred             CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEc
Confidence             345689999999999999987542 23456889999999999999999999987   9999999999999999999999


Q ss_pred             ccccceecCCCccccccccccccCCccCccccc-----cCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHH
Q 003391          649 DFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA  723 (823)
Q Consensus       649 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~  723 (823)
                      |||+++......  .......|++.|+|||++.     +..++.++|||||||++|||++|+.|+.......  .+    
T Consensus       167 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~----  238 (286)
T cd06638         167 DFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--AL----  238 (286)
T ss_pred             cCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HH----
Confidence            999998654322  1223356899999999885     3457889999999999999999999975322110  00    


Q ss_pred             HHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          724 WRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       724 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                       .............       +......+.+++.+|++.+|++||++.|+++.
T Consensus       239 -~~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         239 -FKIPRNPPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             -hhccccCCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence             0000000000000       00112357889999999999999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.5e-33  Score=302.21  Aligned_cols=260  Identities=24%  Similarity=0.327  Sum_probs=190.7

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc--ccHHHHHHHHHHHhcc---CCCCceeEEEEeecC-----C
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG--QGMEEFENEVLLIAKL---QHRNLVKLIGCCTQR-----D  573 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~-----~  573 (823)
                      +|...+.||+|+||.||+|+... ++.+|+|.+.....  .....+.+|+.+++.+   +||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            47778899999999999999865 88999998865422  2234556777777665   799999999988642     4


Q ss_pred             ceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccc
Q 003391          574 ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  653 (823)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  653 (823)
                      ..++|+||+++ +|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+||++++++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            57899999985 888887542 2345899999999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCch
Q 003391          654 RAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV  733 (823)
Q Consensus       654 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  733 (823)
                      +......   ......+|..|+|||++.+..++.++|||||||++|||++|+.||.......   ...............
T Consensus       156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~  229 (288)
T cd07863         156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLIGLPPED  229 (288)
T ss_pred             ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH---HHHHHHHHhCCCChh
Confidence            8653221   1223567899999999999999999999999999999999999875322111   111111100000000


Q ss_pred             h------hhhhhcCC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          734 E------LINKSLGG-------SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       734 ~------~~~~~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      .      ........       ....+....+.+++.+|++.||++|||+.|++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0      00000000       000112236789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.6e-33  Score=308.48  Aligned_cols=255  Identities=18%  Similarity=0.222  Sum_probs=193.1

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC---ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ++|...++||+|+||.||++++.. ++.+|+|++.+.   .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            467888999999999999999865 778999998643   2223445888999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+++|+|.+++.+.  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            999999999999542  345889999999999999999999988   999999999999999999999999999765322


Q ss_pred             ccccccccccccCCccCccccc-----cCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE  734 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  734 (823)
                      .. .......||+.|+|||++.     ...++.++|||||||++|||++|+.||.....      .... ....... ..
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~-~~i~~~~-~~  226 (332)
T cd05623         156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETY-GKIMNHK-ER  226 (332)
T ss_pred             Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHH-HHHhCCC-cc
Confidence            11 1223357899999999986     34688999999999999999999999753211      1111 0011000 00


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 003391          735 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPED--RPNMSSVVLM  776 (823)
Q Consensus       735 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~  776 (823)
                      .   .. .........++.+++.+|+..++.+  ||++.|+++.
T Consensus       227 ~---~~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         227 F---QF-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             c---cC-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            0   00 0000111235667777777554444  7899999876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.9e-33  Score=301.06  Aligned_cols=254  Identities=22%  Similarity=0.350  Sum_probs=198.9

Q ss_pred             cCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCC-ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      ++|+..+.||+|+||.||++... .++.+|+|.+... ......++.+|+.++++++||||+++++.+...+..++|+||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            35778899999999999999986 4889999988654 233456788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++++|..++........+++..+..++.+++.||.|||+..  +|+|+||||+||+++.++.+||+|||++..+...  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  156 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--  156 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence            999999998865333446899999999999999999999742  3999999999999999999999999999765322  


Q ss_pred             ccccccccccCCccCccccccCC------CCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhh
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGL------FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL  735 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~------~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  735 (823)
                        ......++..|+|||.+.+..      ++.++|+|||||++|||++|+.||.....   ...... ........    
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~-~~~~~~~~----  226 (286)
T cd06622         157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY---ANIFAQ-LSAIVDGD----  226 (286)
T ss_pred             --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch---hhHHHH-HHHHhhcC----
Confidence              122345788999999985543      58899999999999999999999753211   111100 00000000    


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       736 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                           ..........++.+++.+|++.+|++||++.+++..
T Consensus       227 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         227 -----PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             -----CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence                 111222234567889999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.7e-33  Score=294.73  Aligned_cols=247  Identities=26%  Similarity=0.415  Sum_probs=198.3

Q ss_pred             CCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCc-----cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS-----GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      +|+..+.||+|+||.||+|... +++.+++|.+....     .+..+.+.+|+.+++.++|+||+++++++.+....++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4667789999999999999987 58899999886543     23456789999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      +||+++++|.+++..   ...+++..+..++.||++||+|||+.+   ++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999999999999843   345889999999999999999999988   99999999999999999999999999986533


Q ss_pred             CccccccccccccCCccCccccccCC-CCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN  737 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  737 (823)
                      ..   ......++..|+|||.+.... ++.++|+||||+++|||++|+.||.....      ....... ....      
T Consensus       155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~-~~~~------  218 (258)
T cd06632         155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKI-GRSK------  218 (258)
T ss_pred             cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHH-Hhcc------
Confidence            22   223356788999999987776 89999999999999999999999753221      0000000 0000      


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          738 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       738 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                        .....+......+.+++.+|++.+|++||++.+++.
T Consensus       219 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         219 --ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             --cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence              001111122346778999999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.6e-33  Score=310.87  Aligned_cols=260  Identities=21%  Similarity=0.280  Sum_probs=195.4

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecC------
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR------  572 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------  572 (823)
                      ..++|...+.||+|+||.||++.... ++.+|||++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            35789999999999999999999754 8889999987542  33456788999999999999999999987543      


Q ss_pred             CceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccc
Q 003391          573 DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM  652 (823)
Q Consensus       573 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl  652 (823)
                      ...++||||+++ +|.+++.     ..+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence            357999999975 6766662     23788899999999999999999987   99999999999999999999999999


Q ss_pred             ceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHH------
Q 003391          653 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL------  726 (823)
Q Consensus       653 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~------  726 (823)
                      ++.....   .......+|..|+|||++.+..++.++|||||||++|||++|+.||...+..+   ........      
T Consensus       173 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~~  246 (364)
T cd07875         173 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID---QWNKVIEQLGTPCP  246 (364)
T ss_pred             ccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCH
Confidence            9865322   12233568999999999999999999999999999999999999986432211   01110000      


Q ss_pred             ------------hhhcCch-------hhhhhhcC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          727 ------------WIEERPV-------ELINKSLG---GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       727 ------------~~~~~~~-------~~~~~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                                  ....++.       ........   ..........+.+++.+|++.||++|||+.|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                        0000000       00000000   00011112367899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4.1e-33  Score=294.88  Aligned_cols=257  Identities=26%  Similarity=0.397  Sum_probs=203.3

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      ++|+..+.||.|+||.||+|.... +..+++|++.... ....+.+.+|+++++.++|+|++++++.+...+..++|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            468888999999999999999754 7789999986543 33567889999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++++|.+++........+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999865433356899999999999999999999988   99999999999999999999999999987644322


Q ss_pred             cc--ccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          662 EA--NTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       662 ~~--~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                      ..  ......++..|+|||.+... .++.++|+||||+++|||++|+.|+.......      ...... .....     
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~-~~~~~-----  225 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTL-QNDPP-----  225 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHh-cCCCC-----
Confidence            21  22335688999999998877 78999999999999999999999975332211      000100 01000     


Q ss_pred             hcCCCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          739 SLGGSYS-LSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       739 ~l~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ....... ......+.+++.+|++.+|++||++.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0100000 122346789999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.6e-33  Score=295.66  Aligned_cols=250  Identities=27%  Similarity=0.429  Sum_probs=191.6

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc-----ccHHHHHHHHHHHhccCCCCceeEEEEeecC--Cce
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG-----QGMEEFENEVLLIAKLQHRNLVKLIGCCTQR--DER  575 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~-----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~  575 (823)
                      .+|...+.||+|+||.||+|.... ++.+++|++.....     ...+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            368888999999999999999765 88999998864321     2345688999999999999999999988653  567


Q ss_pred             EEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccccee
Q 003391          576 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                      ++++||+++++|.+++..   ...+++.....++.|++.||+|||+.+   |+|+||+|+||+++.++.+||+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            899999999999999853   334789999999999999999999887   99999999999999999999999999976


Q ss_pred             cCCCcc-ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchh
Q 003391          656 FGIDQT-EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE  734 (823)
Q Consensus       656 ~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  734 (823)
                      ...... ........++..|+|||.+.+..++.++||||||+++|||++|+.||.....      ......         
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~~~~---------  220 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAAIFK---------  220 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHHHHH---------
Confidence            532211 1112234578899999999998899999999999999999999999753211      000000         


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          735 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       735 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ..........+......+..++ .|+..+|++||+++||++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         221 IATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             HhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            0000001111111122334444 788899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.1e-33  Score=329.66  Aligned_cols=255  Identities=21%  Similarity=0.290  Sum_probs=196.1

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC--ccccHHHHHHHHHHHhccCCCCceeEEEEeecC--CceE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR--DERM  576 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~  576 (823)
                      ..++|.+.++||+|+||.||++++.. +..+|+|.+...  .......+..|+.++.+++|||||++++++...  ...+
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            45689999999999999999999866 667888888654  233456789999999999999999999988543  5689


Q ss_pred             EEEeecCCCCcchhhhccC-CCCccCHHHHHHHHHHHHHHHHHHHhcCC----CceEecccCCCcEEEcCC---------
Q 003391          577 LIYEYLPNKSLNDFIFDVT-RSKFLDWSKRCQIIGGIARGLLYLHQDSR----LRIIHRDLKASNVLLDNE---------  642 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~ivH~Dlk~~NIll~~~---------  642 (823)
                      |||||+++++|.++|.... ....+++..++.|+.||+.||.|||+.+.    ..||||||||+||||+.+         
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            9999999999999986422 23468999999999999999999998542    249999999999999642         


Q ss_pred             --------CCceeeccccceecCCCccccccccccccCCccCcccccc--CCCCccchhHhHHHHHHHHHhcCCCCCCcC
Q 003391          643 --------MNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID--GLFSVKSDVFSFGVLVLEIVCGKRNRGFYH  712 (823)
Q Consensus       643 --------~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwS~Gvvl~elltG~~p~~~~~  712 (823)
                              ..+||+|||++..+....   ......||+.|+|||++.+  ..++.++||||||||||||++|+.||....
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             cccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                    348999999998653321   2233578999999999864  458999999999999999999999985321


Q ss_pred             CCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          713 ADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       713 ~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      .     . ...........       .+   .......++.+|+..||+.+|.+||++.|++.
T Consensus       248 ~-----~-~qli~~lk~~p-------~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        248 N-----F-SQLISELKRGP-------DL---PIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             c-----H-HHHHHHHhcCC-------CC---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            1     1 11111111100       00   00112346789999999999999999999983

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=8.6e-34  Score=313.63  Aligned_cols=260  Identities=23%  Similarity=0.293  Sum_probs=195.2

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecC------
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR------  572 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------  572 (823)
                      ..++|...+.||+|+||.||++.... ++.+|+|++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            45789999999999999999998754 8899999987542  23446778899999999999999999988543      


Q ss_pred             CceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccc
Q 003391          573 DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM  652 (823)
Q Consensus       573 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl  652 (823)
                      ...++||||+++ +|.+.+.     ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence            347999999975 5666552     24788899999999999999999988   99999999999999999999999999


Q ss_pred             ceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHH------
Q 003391          653 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL------  726 (823)
Q Consensus       653 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~------  726 (823)
                      ++.....   .......+|..|+|||++.+..++.++|||||||++|||++|+.||.......   ........      
T Consensus       166 ~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~  239 (355)
T cd07874         166 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID---QWNKVIEQLGTPCP  239 (355)
T ss_pred             cccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCH
Confidence            9864322   12233578999999999999999999999999999999999999985432111   00000000      


Q ss_pred             ------------hhhcCch-------hhhhhhcC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          727 ------------WIEERPV-------ELINKSLG---GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       727 ------------~~~~~~~-------~~~~~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                                  +.+....       ......+.   ..........+.+++.+|++.||++|||+.|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                        0000000       00000000   00011112467899999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-33  Score=307.38  Aligned_cols=200  Identities=25%  Similarity=0.332  Sum_probs=171.4

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC---ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ++|.+.+.||+|+||.||+++... ++.||+|++.+.   .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            468888999999999999999765 889999998653   2234456889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+++|+|.+++..  ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            99999999999853  2345889999999999999999999998   999999999999999999999999999765332


Q ss_pred             ccccccccccccCCccCcccccc-----CCCCccchhHhHHHHHHHHHhcCCCCC
Q 003391          660 QTEANTNRVVGTYGYMPPEYAID-----GLFSVKSDVFSFGVLVLEIVCGKRNRG  709 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwS~Gvvl~elltG~~p~~  709 (823)
                      .. .......||+.|+|||++..     ..++.++|||||||++|||++|+.||.
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~  209 (331)
T cd05597         156 GT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY  209 (331)
T ss_pred             CC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence            21 11223468999999999863     457889999999999999999999975

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-33  Score=302.63  Aligned_cols=253  Identities=22%  Similarity=0.276  Sum_probs=200.3

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccc---cHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQ---GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ++|...+.||+|+||.||++...+ ++.+|+|.+......   ..+.+.+|++++..++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            367888999999999999999876 889999999765322   4567889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+++++|.+++.. .....+++..+..++.|+++||+|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            99999999998853 23456899999999999999999999987   999999999999999999999999998754321


Q ss_pred             ccc---------------------------cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcC
Q 003391          660 QTE---------------------------ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYH  712 (823)
Q Consensus       660 ~~~---------------------------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~  712 (823)
                      ...                           .......|+..|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            110                           11123467889999999999899999999999999999999999975332


Q ss_pred             CCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 003391          713 ADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPN----MSSVVL  775 (823)
Q Consensus       713 ~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs----~~evl~  775 (823)
                      ...  .+             ...................+.+++.+|++.+|++||+    +.|++.
T Consensus       237 ~~~--~~-------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         237 RDE--TF-------------SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             hHH--HH-------------HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            210  00             0011111111111113457889999999999999999    666655

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-33  Score=300.30  Aligned_cols=253  Identities=23%  Similarity=0.370  Sum_probs=200.7

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      .++|.+.+.||+|+||.||++.... +..+|+|.+........+.+..|+.++++++||||+++++.+......++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            4668888999999999999999864 789999998766666667899999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++++|.+++...  ...+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|||++....... 
T Consensus        84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-  157 (280)
T cd06611          84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-  157 (280)
T ss_pred             cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence            9999999988542  345899999999999999999999998   9999999999999999999999999987643221 


Q ss_pred             ccccccccccCCccCccccc-----cCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          662 EANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                       .......++..|+|||.+.     ...++.++||||||+++|||++|+.|+......      ... .........   
T Consensus       158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~-~~~~~~~~~---  226 (280)
T cd06611         158 -QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVL-LKILKSEPP---  226 (280)
T ss_pred             -cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHH-HHHhcCCCC---
Confidence             1222356888999999975     345788999999999999999999997532211      000 001110000   


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                        .+.  .+......+.+++..|++.+|.+||++.++++.
T Consensus       227 --~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         227 --TLD--QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             --CcC--CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence              000  011112367789999999999999999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.2e-33  Score=303.53  Aligned_cols=248  Identities=23%  Similarity=0.340  Sum_probs=197.7

Q ss_pred             CCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCC
Q 003391          506 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPN  584 (823)
Q Consensus       506 ~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (823)
                      |.....||+|+||.||++.... +..+|+|++........+.+.+|+.++++++|+||+++++.+...+..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            3444679999999999999754 889999998766656667789999999999999999999999999999999999999


Q ss_pred             CCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccccc
Q 003391          585 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN  664 (823)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  664 (823)
                      ++|.+++.    ...+++..+..++.||+.||.|||+.+   |+||||||+||++++++.++|+|||++.......  ..
T Consensus       104 ~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~  174 (292)
T cd06658         104 GALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PK  174 (292)
T ss_pred             CcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--cc
Confidence            99999873    234789999999999999999999987   9999999999999999999999999987653222  12


Q ss_pred             cccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCC
Q 003391          665 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY  744 (823)
Q Consensus       665 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~  744 (823)
                      .....++..|+|||.+.+..++.++||||||+++|||++|+.|+.......   ..    .....     .+...+....
T Consensus       175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~----~~~~~-----~~~~~~~~~~  242 (292)
T cd06658         175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---AM----RRIRD-----NLPPRVKDSH  242 (292)
T ss_pred             CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH----HHHHh-----cCCCcccccc
Confidence            233568899999999988899999999999999999999999975321110   00    00000     0111111111


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          745 SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       745 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                        .....+.+++.+|++.+|.+|||+.|+++.
T Consensus       243 --~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         243 --KVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             --ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence              122356788999999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.7e-33  Score=302.91  Aligned_cols=257  Identities=19%  Similarity=0.238  Sum_probs=200.4

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ++|...+.||+|+||.||++.... ++.|++|.+....   ....+.+.+|+.+++.++||||+++++.+...+..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            367888999999999999999865 7889999986553   233457889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+++++|.+++..   ...+++..+..++.++++||.|||+.+   ++|+||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            99999999999843   345899999999999999999999987   999999999999999999999999998742111


Q ss_pred             ccc-------------cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHH
Q 003391          660 QTE-------------ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL  726 (823)
Q Consensus       660 ~~~-------------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  726 (823)
                      ...             .......++..|+|||.+.+..++.++|+||||+++|||++|+.||.....   ..+.    ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~---~~~~----~~  227 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---EELF----GQ  227 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHH----HH
Confidence            000             011124578899999999998999999999999999999999999742211   0111    10


Q ss_pred             hhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          727 WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       727 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      .....   ...+    .........+.+++.+|++.+|++||++.++.++|+..
T Consensus       228 ~~~~~---~~~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~  274 (305)
T cd05609         228 VISDD---IEWP----EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR  274 (305)
T ss_pred             HHhcc---cCCC----CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence            00000   0000    00011234578999999999999999988888887764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4e-33  Score=296.21  Aligned_cols=255  Identities=24%  Similarity=0.399  Sum_probs=196.3

Q ss_pred             CCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCcc----------ccHHHHHHHHHHHhccCCCCceeEEEEeecCC
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG----------QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD  573 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~----------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~  573 (823)
                      +|...+.||+|+||.||+|... +++.+|+|.+.....          ...+.+..|+.++..++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            3667789999999999999875 488999998754211          11346788999999999999999999999999


Q ss_pred             ceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccc
Q 003391          574 ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  653 (823)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  653 (823)
                      ..++|+||+++++|.+++...   ..+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            999999999999999998532   46889999999999999999999987   999999999999999999999999999


Q ss_pred             eecCCCccccccccccccCCccCccccccCC--CCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcC
Q 003391          654 RAFGIDQTEANTNRVVGTYGYMPPEYAIDGL--FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER  731 (823)
Q Consensus       654 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  731 (823)
                      +...............++..|+|||.+....  ++.++||||||+++|||++|..|+.....     . ...... ....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~-~~~~~~-~~~~  228 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-----I-AAMFKL-GNKR  228 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-----H-HHHHHh-hccc
Confidence            8653222222223356788999999987654  88999999999999999999999742111     0 000000 0000


Q ss_pred             chhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          732 PVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       732 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ....    ............+.+++..|++.+|++||++.+|++.
T Consensus       229 ~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         229 SAPP----IPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             cCCc----CCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            0000    0011111223577889999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-32  Score=294.85  Aligned_cols=261  Identities=24%  Similarity=0.313  Sum_probs=200.0

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc-ccHHHHHHHHHHHhccCCCCceeEEEEeecC--CceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQR--DERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~  579 (823)
                      ++|...++||.|++|.||++.+.. ++.+|+|.+..... ....++.+|++++++++||||+++++++.+.  +..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            357778899999999999999865 78899998875433 3456789999999999999999999998654  4689999


Q ss_pred             eecCCCCcchhhhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          580 EYLPNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       580 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      ||+++++|.+++... .....+++..+..++.||++||.|||+.+   ++|+||+|+||++++++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            999999999987542 23445889999999999999999999988   99999999999999999999999999875432


Q ss_pred             CccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                      ..    .....++..|+|||.+.+..++.++||||||+++|||++|+.|+........ ..... .. .........+..
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~-~~-~~~~~~~~~~~~  230 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL-GPIEL-LS-YIVNMPNPELKD  230 (287)
T ss_pred             cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC-ChHHH-HH-HHhcCCchhhcc
Confidence            21    1234578899999999999999999999999999999999999864422111 11110 11 111101111111


Q ss_pred             hcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       739 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ...  ....-...+.+++.+|++.+|++|||+.|+++.
T Consensus       231 ~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         231 EPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             CCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            110  001123467899999999999999999999863

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=6.3e-33  Score=293.58  Aligned_cols=251  Identities=24%  Similarity=0.370  Sum_probs=194.2

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc-----cccHHHHHHHHHHHhccCCCCceeEEEEeecC--Cce
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-----GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR--DER  575 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~  575 (823)
                      ++|+..+.||+|+||.||+|...+ ++.||+|++....     ....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            468888999999999999999765 8899999875332     12345788899999999999999999998764  457


Q ss_pred             EEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccccee
Q 003391          576 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                      ++||||+++++|.+++..   ...+++.....++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++..
T Consensus        82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            899999999999998853   234788889999999999999999988   99999999999999999999999999986


Q ss_pred             cCCCcc-ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchh
Q 003391          656 FGIDQT-EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE  734 (823)
Q Consensus       656 ~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  734 (823)
                      ...... ........++..|+|||.+.+..++.++||||||+++|||++|+.|+.....     . .....         
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~-~~~~~---------  220 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-----M-AAIFK---------  220 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-----H-HHHHH---------
Confidence            532211 1122335688899999999988899999999999999999999999742211     0 00000         


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          735 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       735 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ..........+......+.+++.+|+. +|++||+++|+++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         221 IATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             HhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence            000000111222233466778888885 89999999999853

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=5.3e-33  Score=293.41  Aligned_cols=254  Identities=23%  Similarity=0.335  Sum_probs=199.3

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeec--CCceEEEE
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ--RDERMLIY  579 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~  579 (823)
                      +|...+.||.|+||.||++.... ++.+|+|.+....  ....+++.+|++++++++|||++++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            46778899999999999998754 7889999886542  3345678899999999999999999998754  34678999


Q ss_pred             eecCCCCcchhhhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhcC--CCceEecccCCCcEEEcCCCCceeeccccceec
Q 003391          580 EYLPNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQDS--RLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  656 (823)
Q Consensus       580 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  656 (823)
                      ||+++++|.+++... .....+++..++.++.+|++||.|||..+  ...++|+||+|+||++++++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998653 22456899999999999999999999332  234999999999999999999999999999876


Q ss_pred             CCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          657 GIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       657 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      .....  ......++..|+|||.+.+..++.++|+||||+++++|++|+.|+.....   ..+..    .....      
T Consensus       161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~----~~~~~------  225 (265)
T cd08217         161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLAS----KIKEG------  225 (265)
T ss_pred             cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHHH----HHhcC------
Confidence            43322  12234688999999999998899999999999999999999999754321   11111    11110      


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                         .....+......+.+++.+|++.+|++||++.+|+++
T Consensus       226 ---~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         226 ---KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ---CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence               1111222334578899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=296.54  Aligned_cols=246  Identities=23%  Similarity=0.365  Sum_probs=206.1

Q ss_pred             cCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCcc--ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG--QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      .-|...+.||+|.|..|-.|++- .|..||||++.+...  .....+..|++-|+.++|||||+|+++......+|||+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            45677789999999999999864 599999999987643  345578899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEE-cCCCCceeeccccceecCCC
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL-DNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll-~~~~~~kl~DFGla~~~~~~  659 (823)
                      .-++|+|.+||..  ....+.+....+++.||+.|+.|+|+..   +|||||||+||.+ ..-|-+||.|||++-.+...
T Consensus        98 LGD~GDl~DyImK--He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   98 LGDGGDLFDYIMK--HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             ecCCchHHHHHHh--hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            9999999999954  4455899999999999999999999987   9999999999866 56789999999999776433


Q ss_pred             ccccccccccccCCccCccccccCCCC-ccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFS-VKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s-~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                         ......+|...|.|||++.+..|. +++||||+|||||.|++|+.||+...                   ..+.+.-
T Consensus       173 ---~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN-------------------DSETLTm  230 (864)
T KOG4717|consen  173 ---KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN-------------------DSETLTM  230 (864)
T ss_pred             ---chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc-------------------chhhhhh
Confidence               334457899999999999999884 68999999999999999999975322                   2233333


Q ss_pred             hcCCCCCHH--HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          739 SLGGSYSLS--EVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       739 ~l~~~~~~~--~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ++...+..+  ...++.+||..||+.||.+|.+.+|++..
T Consensus       231 ImDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  231 IMDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             hhcccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence            444444433  34589999999999999999999999753

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.9e-33  Score=298.71  Aligned_cols=262  Identities=26%  Similarity=0.341  Sum_probs=201.2

Q ss_pred             CHHHHHHHhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhcc-CCCCceeEEEEeecC
Q 003391          495 DWMAIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQR  572 (823)
Q Consensus       495 ~~~~l~~~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~  572 (823)
                      ....+..+.++|...+.||+|+||.||++...+ ++.+|+|.+.... ....++.+|+.++.++ +|||++++++++...
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            344555677899999999999999999999854 7889999886542 2346778899999998 899999999998653


Q ss_pred             -----CceEEEEeecCCCCcchhhhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCce
Q 003391          573 -----DERMLIYEYLPNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPK  646 (823)
Q Consensus       573 -----~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k  646 (823)
                           ...++|+||+++++|.+++... .....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+|
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~k  168 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVK  168 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEE
Confidence                 3589999999999999988542 23456899999999999999999999987   99999999999999999999


Q ss_pred             eeccccceecCCCccccccccccccCCccCccccccC-----CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhH
Q 003391          647 ISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG-----LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLG  721 (823)
Q Consensus       647 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~  721 (823)
                      |+|||++........  ......++..|+|||.+...     .++.++|||||||++|||++|+.|+......      .
T Consensus       169 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~------~  240 (291)
T cd06639         169 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV------K  240 (291)
T ss_pred             Eeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH------H
Confidence            999999886532221  12234678899999998543     3688999999999999999999997532111      0


Q ss_pred             HHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          722 HAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       722 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      .... ........+.       ...+....+.+++.+|++.+|++||++.|+++.
T Consensus       241 ~~~~-~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         241 TLFK-IPRNPPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             HHHH-HhcCCCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            0000 0011110000       011223468899999999999999999999864

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=6.7e-33  Score=291.41  Aligned_cols=249  Identities=24%  Similarity=0.342  Sum_probs=198.5

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC--ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      +|...+.||+|+||.||++.... ++.+|+|.+...  .....+.+.+|++++++++|||++++++.+..++..++|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            47778899999999999998754 888999998654  233456789999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCC-CceeeccccceecCCCc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAFGIDQ  660 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DFGla~~~~~~~  660 (823)
                      +++++|.+++... ....+++..+..++.+++++|+|||+.+   ++|+||+|+||+++++. .+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            9999999999542 2345899999999999999999999987   99999999999998654 57999999998764322


Q ss_pred             cccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhc
Q 003391          661 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL  740 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l  740 (823)
                         ......++..|+|||.+.+..++.++||||||+++|||++|+.|+......   ....   .. ....         
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~---~~-~~~~---------  217 (256)
T cd08220         157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---ALVL---KI-MSGT---------  217 (256)
T ss_pred             ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HHHH---HH-HhcC---------
Confidence               122346788999999999888999999999999999999999997532211   1110   00 0000         


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          741 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ...........+.+++..|++.+|++|||+.|+++.
T Consensus       218 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         218 FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            001111223467899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.2e-33  Score=294.50  Aligned_cols=253  Identities=24%  Similarity=0.424  Sum_probs=199.3

Q ss_pred             CCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCcc------ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG------QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      +|+..+.||+|++|.||++... +++.+|+|.+.....      ...+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4777889999999999999864 488999999865431      234678999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCC-Cceeeccccceec
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAF  656 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DFGla~~~  656 (823)
                      |+||+++++|.+++.+   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++ .+||+|||++..+
T Consensus        81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            9999999999999853   346889999999999999999999998   99999999999998776 5999999999876


Q ss_pred             CCCccc--cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchh
Q 003391          657 GIDQTE--ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE  734 (823)
Q Consensus       657 ~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  734 (823)
                      ......  .......++..|+|||.+.+..++.++||||+|++++||++|+.|+.......   .......         
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~---------  222 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN---HLALIFK---------  222 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc---hHHHHHH---------
Confidence            433111  11223567889999999988889999999999999999999999975322111   1111000         


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          735 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       735 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ..........+.....++.+++.+|++.+|++||++.|++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         223 IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             HhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            00000111222223357788999999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=9.3e-33  Score=294.39  Aligned_cols=247  Identities=26%  Similarity=0.405  Sum_probs=198.1

Q ss_pred             CCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      -|+..++||+|+||.||+|... ++..+|+|.+.... ......+.+|+.++.+++||||+++++++.++...++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            4667789999999999999875 47899999886443 334567889999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  662 (823)
                      ++++|.+++.    ...+++..+..++.+++.++.|||+.+   ++|+||+|+||+++.++.++|+|||++..+....  
T Consensus        85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--  155 (277)
T cd06641          85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--  155 (277)
T ss_pred             CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch--
Confidence            9999999883    235889999999999999999999987   9999999999999999999999999998654321  


Q ss_pred             cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCC
Q 003391          663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG  742 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~  742 (823)
                      .......++..|+|||.+.+..++.++|+||||+++|||++|..|+.......   .    ........         ..
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~----~~~~~~~~---------~~  219 (277)
T cd06641         156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK---V----LFLIPKNN---------PP  219 (277)
T ss_pred             hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH---H----HHHHhcCC---------CC
Confidence            11223467889999999998889999999999999999999999974321100   0    00000000         01


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          743 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      .........+.+++.+|++.+|.+||++.++++.
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            1111223467789999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=8.1e-33  Score=298.07  Aligned_cols=261  Identities=23%  Similarity=0.301  Sum_probs=196.6

Q ss_pred             CCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccc-----cHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQ-----GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      +|...+.||+|+||.||+|... +++.||+|++......     ....+..|++++.+++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4677789999999999999976 4889999999765322     334567899999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      |||+ +++|.+++....  ..+++..+..++.||++||.|||+.+   |+|+||+|+||+++.++.++|+|||+++....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 899999985322  36899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CccccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcC------
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER------  731 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------  731 (823)
                      ...  ......++..|+|||.+.+ ..++.++||||||++++||++|..++......   ..............      
T Consensus       155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  229 (298)
T cd07841         155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI---DQLGKIFEALGTPTEENWPG  229 (298)
T ss_pred             CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH---HHHHHHHHHcCCCchhhhhh
Confidence            321  1222356778999998865 46789999999999999999997766432211   11111111000000      


Q ss_pred             ---chhhhhhhcCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          732 ---PVELINKSLGGSYS-----LSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       732 ---~~~~~~~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                         .............+     ......+.+++.+|++.+|++||+++|+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence               00000000001111     1123477899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.5e-33  Score=301.95  Aligned_cols=247  Identities=23%  Similarity=0.334  Sum_probs=197.5

Q ss_pred             CcCCeeeccCccceEEEEee-cCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCCC
Q 003391          507 SDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNK  585 (823)
Q Consensus       507 ~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (823)
                      .....||+|+||.||++... +++.+|+|.+........+.+.+|+.++..++|||++++++++..++..++|+||++++
T Consensus        24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~  103 (297)
T cd06659          24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG  103 (297)
T ss_pred             HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence            33458999999999999975 48899999987655556677899999999999999999999999999999999999999


Q ss_pred             CcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccccc
Q 003391          586 SLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT  665 (823)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  665 (823)
                      +|.+++.    ...+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++..+....  ...
T Consensus       104 ~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~  174 (297)
T cd06659         104 ALTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKR  174 (297)
T ss_pred             CHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--ccc
Confidence            9998773    245889999999999999999999987   9999999999999999999999999987553222  122


Q ss_pred             ccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCC
Q 003391          666 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYS  745 (823)
Q Consensus       666 ~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~  745 (823)
                      ....++..|+|||++.+..++.++||||||+++|||++|+.||.......   ..    ....... ...    ..  ..
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~----~~~~~~~-~~~----~~--~~  240 (297)
T cd06659         175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AM----KRLRDSP-PPK----LK--NA  240 (297)
T ss_pred             cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH----HHHhccC-CCC----cc--cc
Confidence            33568899999999998899999999999999999999999975322111   00    0111100 000    00  00


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          746 LSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       746 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ......+.+++..|++.+|++||++.++++.
T Consensus       241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         241 HKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            1112357789999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.7e-33  Score=305.05  Aligned_cols=258  Identities=23%  Similarity=0.320  Sum_probs=193.6

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecC------
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR------  572 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------  572 (823)
                      ..++|...+.||+|+||.||+|.... ++.||+|++....  ....+.+.+|+.++++++||||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            45789999999999999999999754 7889999986542  22345678899999999999999999987543      


Q ss_pred             CceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccc
Q 003391          573 DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM  652 (823)
Q Consensus       573 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl  652 (823)
                      ...++++|++ +++|.+++.    ...+++..+..++.||++||.|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence            3468999988 778888763    345899999999999999999999998   99999999999999999999999999


Q ss_pred             ceecCCCccccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcC
Q 003391          653 ARAFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER  731 (823)
Q Consensus       653 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  731 (823)
                      ++.....     .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||.......   ........ ....
T Consensus       165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~-~~~~  235 (343)
T cd07878         165 ARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID---QLKRIMEV-VGTP  235 (343)
T ss_pred             ceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHH-hCCC
Confidence            9865321     223568999999999877 568999999999999999999999975322110   11100000 0000


Q ss_pred             chhhhhh--------hcC--CCCCHH--------HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          732 PVELINK--------SLG--GSYSLS--------EVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       732 ~~~~~~~--------~l~--~~~~~~--------~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ..+....        .+.  ......        ....+.+++.+|++.||++|||+.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000000        000  000000        01246789999999999999999999864

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1e-32  Score=295.17  Aligned_cols=262  Identities=21%  Similarity=0.288  Sum_probs=199.1

Q ss_pred             CCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      +|...+.||+|+||.||+|+.. +++.+|+|++....  ....+.+.+|+.++++++|||++++++++......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4677889999999999999975 48899999987654  33456789999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      + +++|.+++....  ..+++..+..++.||++||+|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 999999885432  56899999999999999999999987   99999999999999999999999999987643321


Q ss_pred             ccccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCc--------
Q 003391          662 EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP--------  732 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~--------  732 (823)
                       .......++..|+|||.+.+. .++.++||||+|++++||++|+.++.....   ..........+.....        
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND---IEQLAIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH---HHHHHHHHHHcCCCChHHHhhccC
Confidence             122235688899999998654 468999999999999999999776643211   1111111111100000        


Q ss_pred             ---hhhhhhhcCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          733 ---VELINKSLGGS-----YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       733 ---~~~~~~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                         ...+.......     ...+....+.+++.+|++.+|++||+++++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence               00000000000     001122578899999999999999999999864

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=9.9e-33  Score=291.55  Aligned_cols=252  Identities=27%  Similarity=0.457  Sum_probs=199.4

Q ss_pred             CCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccc--cHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQ--GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      +|...+.||+|+||.||+|+.. +++.+++|.+......  ..+.+.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4777889999999999999975 4889999998766443  667899999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++++|.+++..   ...+++..+..++.++++||+|||+.+   |+|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            999999999853   345789999999999999999999988   99999999999999999999999999987643322


Q ss_pred             ccc--cccccccCCccCccccccCC---CCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          662 EAN--TNRVVGTYGYMPPEYAIDGL---FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       662 ~~~--~~~~~gt~~y~aPE~l~~~~---~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      ...  .....++..|+|||++.+..   ++.++||||||++++||++|+.||...+..     ......... ..     
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-----~~~~~~~~~-~~-----  223 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-----FQIMFHVGA-GH-----  223 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-----HHHHHHHhc-CC-----
Confidence            111  22356788999999998766   889999999999999999999998533210     000000000 00     


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      .+.+..  .......+.+++.+|++.+|.+||++.|++.
T Consensus       224 ~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         224 KPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000  1111345678999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-33  Score=299.88  Aligned_cols=265  Identities=22%  Similarity=0.309  Sum_probs=198.9

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC--ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      +|+..++||+|+||.||+|.+.+ ++.||+|++...  .....+.+.+|++++++++|+||+++++++..++..++|+||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            57888999999999999999875 789999988654  233456789999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      ++++.+..++.   +...+++..+..++.+|+.||.|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        82 ~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          82 VERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA  155 (288)
T ss_pred             CCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence            99877766552   2344899999999999999999999987   99999999999999999999999999987644322


Q ss_pred             ccccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHH--------HHhhhcCc
Q 003391          662 EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW--------RLWIEERP  732 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~--------~~~~~~~~  732 (823)
                       .......++..|+|||++.+. .++.++||||||+++|||++|+.|+......+.........        ..+.....
T Consensus       156 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07833         156 -SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR  234 (288)
T ss_pred             -ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence             122235678899999999888 88999999999999999999998875322111000000000        00000000


Q ss_pred             h---hhhhh----hcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          733 V---ELINK----SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       733 ~---~~~~~----~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      .   +....    .....++.....++.+++.+|++.+|++||+++++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence            0   00000    00000111124578899999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-32  Score=293.98  Aligned_cols=247  Identities=24%  Similarity=0.418  Sum_probs=196.6

Q ss_pred             CCCcCCeeeccCccceEEEEee-cCcEEEEEEecCC-ccccHHHHHHHHHHHhccC---CCCceeEEEEeecCCceEEEE
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS-SGQGMEEFENEVLLIAKLQ---HRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~  579 (823)
                      .|+..+.||+|+||.||+|.+. +++.+|+|.+... .....+++.+|+.++++++   |||++++++++.++...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            4667789999999999999975 4889999998654 3345567889999999986   999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+++++|.+++..    ..+++..+..++.++++||.|||+.+   |+|+||+|+||++++++.++|+|||++..+...
T Consensus        82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            99999999998842    36899999999999999999999988   999999999999999999999999999876433


Q ss_pred             ccccccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                      .  .......|+..|+|||.+.++ .++.++||||||+++|||++|+.|+.........   .    .......     +
T Consensus       155 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~---~----~~~~~~~-----~  220 (277)
T cd06917         155 S--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM---M----LIPKSKP-----P  220 (277)
T ss_pred             c--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh---h----ccccCCC-----C
Confidence            2  122234688899999988754 5789999999999999999999997532211100   0    0000000     0


Q ss_pred             hcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       739 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      .+...   ....++.+++.+|++.+|++||++.|++.
T Consensus       221 ~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         221 RLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            11111   12346788999999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=7.8e-33  Score=297.52  Aligned_cols=251  Identities=24%  Similarity=0.386  Sum_probs=202.0

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      .++|...+.||+|+||.||++... +++.+++|.+........+.+.+|+.++++++|||++++++.+...+..++|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            367888899999999999999865 4788999998765555567789999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++++|.+++..    ..+++..+..++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus        98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            999999998842    34789999999999999999999998   99999999999999999999999999876543222


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                        ......+++.|+|||.+.+..++.++||||||+++|||++|+.||............      .....      +.. 
T Consensus       171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------~~~~~------~~~-  235 (293)
T cd06647         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNGT------PEL-  235 (293)
T ss_pred             --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------hcCCC------CCC-
Confidence              122346888999999998888999999999999999999999998543221110000      00000      000 


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          742 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                       .........+.+++..|++.+|++||++.+++.+
T Consensus       236 -~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         236 -QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             -CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0111123467789999999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=7.2e-33  Score=302.67  Aligned_cols=198  Identities=18%  Similarity=0.245  Sum_probs=163.9

Q ss_pred             CCeeecc--CccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecC
Q 003391          509 KNKLGEG--GFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP  583 (823)
Q Consensus       509 ~~~LG~G--~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (823)
                      .++||+|  +|++||+++... ++.||+|++....  ....+.+.+|+.+++.++||||+++++++..++..++|+||++
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   82 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA   82 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence            4689999  688999998754 8899999986542  2334567889999999999999999999999999999999999


Q ss_pred             CCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc-
Q 003391          584 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE-  662 (823)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~-  662 (823)
                      +++|.+++.... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.++++||+.+......... 
T Consensus        83 ~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          83 YGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            999999985422 234889999999999999999999988   999999999999999999999999876543211110 


Q ss_pred             ----cccccccccCCccCcccccc--CCCCccchhHhHHHHHHHHHhcCCCCCC
Q 003391          663 ----ANTNRVVGTYGYMPPEYAID--GLFSVKSDVFSFGVLVLEIVCGKRNRGF  710 (823)
Q Consensus       663 ----~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwS~Gvvl~elltG~~p~~~  710 (823)
                          .......++..|+|||++.+  ..++.++|||||||++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  212 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  212 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence                01122356778999999976  4689999999999999999999999853

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.2e-32  Score=290.81  Aligned_cols=251  Identities=26%  Similarity=0.349  Sum_probs=204.5

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc-ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      +|...+.||+|++|.||+++... ++.+++|++..... ...+++.+|+..+.+++|+|++++++++...+..++|+||+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            57788999999999999999876 89999999876644 45678999999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      ++++|.+++...   ..+++..+..++.|+++||+|||+ .+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        82 ~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          82 DGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence            999999998532   568999999999999999999999 87   99999999999999999999999999987643222


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                      .  .....++..|+|||.+.+..++.++|+||||+++|||++|+.|+..........+..    .....         ..
T Consensus       156 ~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~----~~~~~---------~~  220 (264)
T cd06623         156 Q--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ----AICDG---------PP  220 (264)
T ss_pred             c--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH----HHhcC---------CC
Confidence            1  123567889999999999999999999999999999999999975443211111111    11100         00


Q ss_pred             CCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          742 GSYSLS-EVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       742 ~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ...+.. ....+.+++.+|++.+|++||++.|+++.
T Consensus       221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            111112 33578899999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=6.6e-33  Score=296.23  Aligned_cols=258  Identities=27%  Similarity=0.402  Sum_probs=198.4

Q ss_pred             HHHHHHHhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhcc-CCCCceeEEEEeec--
Q 003391          496 WMAIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQ--  571 (823)
Q Consensus       496 ~~~l~~~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~--  571 (823)
                      ..++..+.+.|+..+.||+|+||.||+|.+.. ++.+|+|.+.... ....++..|+.++.++ +|+||+++++++..  
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   86 (282)
T cd06636           8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS   86 (282)
T ss_pred             hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence            34444566788999999999999999999855 7889999885543 3346788899999998 79999999999853  


Q ss_pred             ----CCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCcee
Q 003391          572 ----RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI  647 (823)
Q Consensus       572 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl  647 (823)
                          ....+++|||+++++|.+++... ....+++..+..++.||++||.|||+.+   |+|+||+|+||++++++.++|
T Consensus        87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l  162 (282)
T cd06636          87 PPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL  162 (282)
T ss_pred             ccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence                45689999999999999988543 2345788889999999999999999987   999999999999999999999


Q ss_pred             eccccceecCCCccccccccccccCCccCccccc-----cCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHH
Q 003391          648 SDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH  722 (823)
Q Consensus       648 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~  722 (823)
                      +|||++.......  .......++..|+|||.+.     +..++.++||||||+++|||++|+.||........  .   
T Consensus       163 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~--~---  235 (282)
T cd06636         163 VDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA--L---  235 (282)
T ss_pred             eeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh--h---
Confidence            9999987653221  1223356889999999986     34688899999999999999999999743221100  0   


Q ss_pred             HHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          723 AWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       723 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                       .. ......     ..+   ........+.+++.+||+.+|.+||++.|+++
T Consensus       236 -~~-~~~~~~-----~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         236 -FL-IPRNPP-----PKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             -hh-HhhCCC-----CCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence             00 000000     000   01112346889999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=4.6e-33  Score=294.36  Aligned_cols=252  Identities=24%  Similarity=0.354  Sum_probs=200.3

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      +|+..+.||+|+||.||++.+.. ++.+++|++.... ....+++.+|++++++++||||+++++.+......++|+||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            56777899999999999999864 8899999987653 345567899999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      ++++|.+++....  ..+++..+..++.|+++||+|||+ .+   ++|+||||+||++++++.++|+|||.+........
T Consensus        82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence            9999999985432  568889999999999999999999 76   99999999999999999999999999875532211


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                          ....++..|+|||.+.+..++.++||||||+++|||++|+.|+........ ..... .........         
T Consensus       157 ----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~-~~~~~~~~~---------  221 (265)
T cd06605         157 ----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFEL-LQYIVNEPP---------  221 (265)
T ss_pred             ----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHH-HHHHhcCCC---------
Confidence                115678899999999999999999999999999999999999754322111 11111 011111100         


Q ss_pred             CCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          742 GSYSLS-EVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       742 ~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ...... ....+.+++..|+..+|++||++.+++..
T Consensus       222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         222 PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            011111 23467899999999999999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-32  Score=299.23  Aligned_cols=268  Identities=22%  Similarity=0.291  Sum_probs=197.4

Q ss_pred             CCCcCCeeeccCccceEEEEeec---CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecC--CceE
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE---GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR--DERM  576 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~---~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~  576 (823)
                      +|...++||+|+||.||+|....   ++.+|+|.+....   ....+.+.+|+.++.+++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            46778899999999999999864   6899999997743   34456778899999999999999999999888  7899


Q ss_pred             EEEeecCCCCcchhhhccC--CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcC----CCCceeecc
Q 003391          577 LIYEYLPNKSLNDFIFDVT--RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN----EMNPKISDF  650 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~----~~~~kl~DF  650 (823)
                      +||||+++ +|.+++....  ....+++..+..++.||+.||.|||+.+   |+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 6766664322  2236889999999999999999999988   999999999999999    899999999


Q ss_pred             ccceecCCCcc-ccccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccch------hHH
Q 003391          651 GMARAFGIDQT-EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL------LGH  722 (823)
Q Consensus       651 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l------~~~  722 (823)
                      |++..+..... ........++..|+|||.+.+. .++.++||||||++++||++|+.||...........      ...
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99987643322 1222345678899999988764 578999999999999999999999865443321100      000


Q ss_pred             HHHHhhhcC------------chhhhhhhcCCCCC---H--------HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          723 AWRLWIEER------------PVELINKSLGGSYS---L--------SEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       723 ~~~~~~~~~------------~~~~~~~~l~~~~~---~--------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ....+....            .....+.......+   .        ....++.+++.+|++.+|++|||+.|+++.
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            000000000            00000000000011   1        122367899999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-33  Score=297.31  Aligned_cols=262  Identities=25%  Similarity=0.371  Sum_probs=195.2

Q ss_pred             cCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccc-cHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQ-GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      ++|...+.||+|++|.||+|... +++.||+|.+...... ....+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888899999999999999976 4789999998654322 234577899999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++ +|.+++...  ...+++..+..++.|+++||.|||+.+   |+|+||||+||++++++.+||+|||+++.......
T Consensus        85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            985 899887542  236889999999999999999999987   99999999999999999999999999875432211


Q ss_pred             ccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchh---h--
Q 003391          662 EANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE---L--  735 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~---~--  735 (823)
                      .  .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||.....  ........+..........   .  
T Consensus       159 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07844         159 T--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD--VEDQLHKIFRVLGTPTEETWPGVSS  234 (291)
T ss_pred             c--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHhcCCCChhhhhhhhh
Confidence            1  112346789999999875 4589999999999999999999999753221  1111111111100000000   0  


Q ss_pred             ----hh--------hhcCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          736 ----IN--------KSLGGS-YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       736 ----~~--------~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                          ..        ..+... ........+.+++.+|++.+|++||++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                00        000000 01111246778999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.8e-34  Score=307.48  Aligned_cols=245  Identities=24%  Similarity=0.358  Sum_probs=192.6

Q ss_pred             CcCCeeeccCccceEEEEeec-CcEEEEEE--ecCC--ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCc--eEEEE
Q 003391          507 SDKNKLGEGGFGPVYKGVLIE-GQEIAAKR--LSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE--RMLIY  579 (823)
Q Consensus       507 ~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~--l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~--~~lV~  579 (823)
                      +...+||+|.|-+||||.+.. |-+||--.  +.+.  .+...++|..|+.+|+.|+||||++++.+..+...  ..+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            345689999999999999854 66666422  2222  33455889999999999999999999999977655  78899


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCC-CCceeeccccceecCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMARAFGI  658 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DFGla~~~~~  658 (823)
                      |.|..|+|..|+.+   .+.++......+++||++||.|||++. |+|||||||-+||+|+.+ |.+||+|+|||.....
T Consensus       123 EL~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  123 ELFTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             ecccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            99999999999954   445788899999999999999999986 689999999999999754 8999999999997643


Q ss_pred             CccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                      ..    ...+.|||.|||||... ..|.+.+||||||++++||+|+..|+..     . .-...+++.+..+....-+.+
T Consensus       199 s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE-----C-~n~AQIYKKV~SGiKP~sl~k  267 (632)
T KOG0584|consen  199 SH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE-----C-TNPAQIYKKVTSGIKPAALSK  267 (632)
T ss_pred             cc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh-----h-CCHHHHHHHHHcCCCHHHhhc
Confidence            32    23378999999999776 8899999999999999999999999531     1 111223333333333333222


Q ss_pred             hcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       739 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      .-        -.++.++|.+|+.. .++|||+.|++.
T Consensus       268 V~--------dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  268 VK--------DPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             cC--------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            11        12567899999999 899999999986

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.2e-32  Score=293.62  Aligned_cols=264  Identities=25%  Similarity=0.343  Sum_probs=196.1

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc-ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ++++|...+.||+|+||.||+|.... ++.+|+|++..... .....+.+|+.+++.++|+||+++.+++..++..++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            35778889999999999999998754 88999999865432 33446789999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+. ++|.+++..  ....+.+..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||+++.....
T Consensus        83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            9996 677776643  2345788888999999999999999987   999999999999999999999999999764322


Q ss_pred             ccccccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhc--------
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE--------  730 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--------  730 (823)
                      ..  ......++..|+|||++.+. .++.++||||||+++|||++|+.||......  ...+...+..+...        
T Consensus       157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  232 (291)
T cd07870         157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPGV  232 (291)
T ss_pred             CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhhh
Confidence            11  12234568899999998764 5788999999999999999999998643221  11111111110000        


Q ss_pred             -----CchhhhhhhcCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          731 -----RPVELINKSLGGS-----YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       731 -----~~~~~~~~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                           ...+.........     ........+.+++.+|++.+|++|||+.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                 0000000000000     00112346778999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=6.6e-33  Score=296.51  Aligned_cols=261  Identities=24%  Similarity=0.326  Sum_probs=193.7

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      +|+..+.||+|+||.||+|+... |+.+|+|++....  ......+.+|+.++++++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            46778899999999999999864 8899999986542  22345678899999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++ +|.+++..  ....+++..+..++.||++||.|||+.+   |+|+||||+||+++.++.+||+|||+++.+.....
T Consensus        81 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          81 CDQ-DLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence            974 78777643  2345899999999999999999999987   99999999999999999999999999986543221


Q ss_pred             ccccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCc------hh
Q 003391          662 EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP------VE  734 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~------~~  734 (823)
                        ......++..|+|||.+.+. .++.++||||||+++|||++|+.|+....  ..................      .+
T Consensus       155 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         155 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             --CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCC--CHHHHHHHHHHHhCCCChHHhHHhhh
Confidence              12234568899999998765 47899999999999999999998853211  111111111110000000      00


Q ss_pred             hhhh----hcCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          735 LINK----SLGGSYS-----LSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       735 ~~~~----~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ..+.    .......     .....++.+++.+|++.||.+|||++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0000    0000000     011246778999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.4e-32  Score=285.81  Aligned_cols=250  Identities=29%  Similarity=0.440  Sum_probs=202.0

Q ss_pred             CCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecC
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP  583 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (823)
                      +|...+.||+|++|.||++... +++.+++|++........+++.+|+.++++++|+|++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            3667789999999999999986 488999999977665567789999999999999999999999999999999999999


Q ss_pred             CCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccc
Q 003391          584 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA  663 (823)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  663 (823)
                      +++|.+++....  ..+++..+..++.+++++|.|||+.+   ++|+||+|+||++++++.++|+|||.+........  
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            999999885422  46899999999999999999999987   99999999999999999999999999986543321  


Q ss_pred             ccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCC
Q 003391          664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS  743 (823)
Q Consensus       664 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~  743 (823)
                       .....++..|+|||.+.+..++.++||||||++++||++|+.|+.......      .. ..........     +.  
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~-~~~~~~~~~~-----~~--  218 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK------AL-FKIATNGPPG-----LR--  218 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH------HH-HHHHhcCCCC-----cC--
Confidence             234568889999999988889999999999999999999999975332110      00 0000000000     00  


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          744 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       744 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ........+.+++.+|++.+|++|||+.|+++.
T Consensus       219 ~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            001013467889999999999999999999863

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-32  Score=292.85  Aligned_cols=255  Identities=27%  Similarity=0.388  Sum_probs=198.9

Q ss_pred             HHhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhcc-CCCCceeEEEEeecCC-----
Q 003391          501 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRD-----  573 (823)
Q Consensus       501 ~~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~-----  573 (823)
                      .++++|+..+.||+|++|.||+|.... ++.+++|++..... ..+++.+|+.+++++ +|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            356889999999999999999999864 77899998865543 456789999999999 7999999999997644     


Q ss_pred             -ceEEEEeecCCCCcchhhhccC-CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccc
Q 003391          574 -ERMLIYEYLPNKSLNDFIFDVT-RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG  651 (823)
Q Consensus       574 -~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFG  651 (823)
                       ..++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence             4899999999999999886432 2456899999999999999999999987   9999999999999999999999999


Q ss_pred             cceecCCCccccccccccccCCccCcccccc-----CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHH
Q 003391          652 MARAFGIDQTEANTNRVVGTYGYMPPEYAID-----GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL  726 (823)
Q Consensus       652 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  726 (823)
                      ++.......  .......++..|+|||.+..     ..++.++||||||++++||++|+.||......  ..+     ..
T Consensus       159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~-----~~  229 (275)
T cd06608         159 VSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RAL-----FK  229 (275)
T ss_pred             cceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHH-----HH
Confidence            997653221  22233568889999998753     34778999999999999999999997522111  000     00


Q ss_pred             hhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          727 WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       727 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ........     +  ........++.+++.+|++.||++|||+.++++
T Consensus       230 ~~~~~~~~-----~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         230 IPRNPPPT-----L--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hhccCCCC-----C--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            01110000     0  011112346789999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.5e-32  Score=285.77  Aligned_cols=251  Identities=26%  Similarity=0.417  Sum_probs=203.6

Q ss_pred             CCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCcc--ccHHHHHHHHHHHhccCCCCceeEEEEeecC--CceEEEE
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG--QGMEEFENEVLLIAKLQHRNLVKLIGCCTQR--DERMLIY  579 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~  579 (823)
                      +|...+.||+|++|.||+|... +++.+++|++.....  ...+.+.+|+.++++++||||+++++.+.+.  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            3667789999999999999987 488999999866543  4567889999999999999999999999988  8899999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+++++|.+++...   ..+++..+..++.++++||+|||+.+   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            999999999998542   26899999999999999999999987   999999999999999999999999999876544


Q ss_pred             ccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                      ..........++..|+|||.+.+...+.++||||||++++||++|+.|+....     ......+...         ...
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~---------~~~  220 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIG---------SSG  220 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhcc---------ccC
Confidence            32112334568889999999988889999999999999999999999976433     1111111110         000


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       740 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      .....+......+.+++.+|++.+|++||++.|++.
T Consensus       221 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            111122222457889999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=286.13  Aligned_cols=247  Identities=26%  Similarity=0.418  Sum_probs=204.8

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecC
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP  583 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (823)
                      -|.+..+||+|.||.|||+.++. |+.+|+|++..  .....++..|+.++++...|++|+.+|.+.....+++|||||-
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            35667899999999999999876 99999998754  3467889999999999999999999999999999999999999


Q ss_pred             CCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccc
Q 003391          584 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA  663 (823)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  663 (823)
                      -|++.+.++  .+++++++.++..++...++||+|||...   -||||||+.||||+-+|.+||+|||.|..+.  ++-.
T Consensus       112 AGSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLT--DTMA  184 (502)
T KOG0574|consen  112 AGSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLT--DTMA  184 (502)
T ss_pred             CCcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhh--hhHH
Confidence            999999884  46778999999999999999999999876   7999999999999999999999999998763  2334


Q ss_pred             ccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCC
Q 003391          664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS  743 (823)
Q Consensus       664 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~  743 (823)
                      ..+.+.||+.|||||++..-.|..++||||+|+...||.-|+.|+...++-....++        ...        -...
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI--------PT~--------PPPT  248 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI--------PTK--------PPPT  248 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec--------cCC--------CCCC
Confidence            455689999999999999999999999999999999999999996433221111000        000        0111


Q ss_pred             CCHHH--HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          744 YSLSE--VLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       744 ~~~~~--~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      +..+|  ..++-+++..||-..|++|-|+.++++.
T Consensus       249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            11122  2478899999999999999999988764

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.4e-32  Score=293.70  Aligned_cols=250  Identities=23%  Similarity=0.343  Sum_probs=191.6

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc-cccHHHHHHHHHH-HhccCCCCceeEEEEeecCCceEEEEe
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLL-IAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      ++|+..+.||+|+||.||+++... ++.||+|++.... .....++..|+.+ ++.++|||++++++++..++..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            367888999999999999999864 8999999987653 2333455666665 556789999999999999999999999


Q ss_pred             ecCCCCcchhhhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhc-CCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          581 YLPNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       581 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      |++ ++|.+++... .....+++..+..++.||+.||+|||+. +   ++||||||+||+++.++.+||+|||++..+..
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            997 6888887542 2345689999999999999999999986 5   99999999999999999999999999986532


Q ss_pred             CccccccccccccCCccCcccccc----CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAID----GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE  734 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~----~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  734 (823)
                      ..   ......++..|+|||.+.+    ..++.++|+||||+++|||++|+.|+......     ...... ......  
T Consensus       157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~-~~~~~~--  225 (283)
T cd06617         157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQLKQ-VVEEPS--  225 (283)
T ss_pred             cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----HHHHHH-HHhcCC--
Confidence            11   1122457889999998865    45688999999999999999999997422110     011000 011000  


Q ss_pred             hhhhhcCCCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          735 LINKSLGGSYSL-SEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       735 ~~~~~l~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                             ...+. ....++.+++.+|++.+|++||++.++++
T Consensus       226 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         226 -------PQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             -------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   01111 12246788999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-34  Score=304.57  Aligned_cols=245  Identities=30%  Similarity=0.443  Sum_probs=194.6

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcccc---HHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQG---MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ..|...+.||.|+||.||.++... .+.||||+++....+.   ..++..|+..|.+++|||.+.+-|+|......+|||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            456777899999999999999765 6789999998765544   557889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      |||-| |-.|.|.  ...+++.+..+..|..+.+.||+|||+.+   .||||||+.||||++.+.+||+|||.|...   
T Consensus       106 EYClG-SAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~---  176 (948)
T KOG0577|consen  106 EYCLG-SASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIM---  176 (948)
T ss_pred             HHHhc-cHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhc---
Confidence            99954 7777663  24567899999999999999999999998   999999999999999999999999998754   


Q ss_pred             ccccccccccccCCccCccccc---cCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                         ...+.++|||.|||||++.   .+.|+-|+||||+|+...||.-.++|.=  .......++..+     .+..    
T Consensus       177 ---~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF--nMNAMSALYHIA-----QNes----  242 (948)
T KOG0577|consen  177 ---APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF--NMNAMSALYHIA-----QNES----  242 (948)
T ss_pred             ---CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc--CchHHHHHHHHH-----hcCC----
Confidence               2345589999999999985   4679999999999999999998888731  111111110000     0000    


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                       +.+.   ..+=...+++++..||+.-|.+|||..+++.
T Consensus       243 -PtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  243 -PTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             -CCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence             0010   1122347889999999999999999988764

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.7e-32  Score=293.70  Aligned_cols=247  Identities=23%  Similarity=0.348  Sum_probs=197.7

Q ss_pred             CCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCC
Q 003391          506 FSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPN  584 (823)
Q Consensus       506 ~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (823)
                      |...+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            444579999999999999975 4889999998765555566789999999999999999999999999999999999999


Q ss_pred             CCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccccc
Q 003391          585 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN  664 (823)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  664 (823)
                      ++|.+++..    ..+++..+..++.|++.||+|||+.+   |+||||+|+||+++.++.++|+|||++........  .
T Consensus       101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~  171 (285)
T cd06648         101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--R  171 (285)
T ss_pred             CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--c
Confidence            999998843    45889999999999999999999988   99999999999999999999999998875432211  1


Q ss_pred             cccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCC
Q 003391          665 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY  744 (823)
Q Consensus       665 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~  744 (823)
                      .....++..|+|||.+.+..++.++||||||+++|||++|+.|+.....   ....    ........     .....  
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~---~~~~----~~~~~~~~-----~~~~~--  237 (285)
T cd06648         172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP---LQAM----KRIRDNLP-----PKLKN--  237 (285)
T ss_pred             cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH---HHHH----HHHHhcCC-----CCCcc--
Confidence            2234688999999999988899999999999999999999999743211   0010    11111100     00000  


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          745 SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       745 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      .......+.+++.+|++.+|++||++.++++
T Consensus       238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            1112346889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.6e-32  Score=293.37  Aligned_cols=262  Identities=24%  Similarity=0.366  Sum_probs=198.2

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccc-cHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQ-GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      +|+..++||+|++|.||+|+... ++.+|+|++...... ..+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            47778999999999999999864 889999998765432 3466788999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  662 (823)
                      ++ +|.+++........+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++........ 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            85 88888865444456899999999999999999999987   99999999999999999999999999976533211 


Q ss_pred             cccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCc---h-----
Q 003391          663 ANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP---V-----  733 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---~-----  733 (823)
                       ......++..|++||.+.+. .++.++||||||+++|||++|+.|+......+   ..............   .     
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED---QLLKIFRIMGTPTESTWPGISQL  231 (284)
T ss_pred             -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCCCChhhHHHHhcC
Confidence             12234568899999988654 57899999999999999999999975432211   11111110000000   0     


Q ss_pred             hhhhhhcC-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          734 ELINKSLG-------GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       734 ~~~~~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ........       ..........+.+++.+|++.+|.+||++.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00000000       0000112346789999999999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.2e-32  Score=294.81  Aligned_cols=253  Identities=27%  Similarity=0.394  Sum_probs=202.7

Q ss_pred             HhcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      ..+.|...+.||+|++|.||+|.+. +++.+++|++..... ..+.+.+|++++..++|+|++++++.+......++|+|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            5567888889999999999999987 488999999976544 56778999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |+++++|.+++....  ..+++..+..++.+++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            999999999996432  36899999999999999999999987   9999999999999999999999999987553222


Q ss_pred             cccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhc
Q 003391          661 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL  740 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l  740 (823)
                      .  ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.......   ..    ..........     .
T Consensus       171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~---~~----~~~~~~~~~~-----~  236 (286)
T cd06614         171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR---AL----FLITTKGIPP-----L  236 (286)
T ss_pred             h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH---HH----HHHHhcCCCC-----C
Confidence            1  1223457789999999998889999999999999999999999974322110   00    0000000000     0


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          741 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                        .........+.+++.+|++.+|.+||++.++++.
T Consensus       237 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         237 --KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             --cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence              0011123467889999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.5e-32  Score=294.93  Aligned_cols=244  Identities=25%  Similarity=0.292  Sum_probs=197.9

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ++|+..+.||+|+||.||++.... ++.+|+|.+....   ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            367888999999999999999865 8899999986542   234567889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+++++|.+++..   ...+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.+||+|||++......
T Consensus        81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            99999999999843   346889999999999999999999987   999999999999999999999999999865432


Q ss_pred             ccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                           .....+++.|+|||.+.+...+.++||||||+++|||++|+.|+.....       ...........        
T Consensus       155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~--------  214 (290)
T cd05580         155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-------IQIYEKILEGK--------  214 (290)
T ss_pred             -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcCC--------
Confidence                 2335688999999999888899999999999999999999999753221       00011111110        


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003391          740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVL  775 (823)
Q Consensus       740 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  775 (823)
                        ...+......+.+++.+|++.+|.+||     +++|+++
T Consensus       215 --~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         215 --VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             --ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence              011111234677899999999999999     7777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.5e-32  Score=293.66  Aligned_cols=262  Identities=24%  Similarity=0.327  Sum_probs=194.8

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      +|+..+.||.|++|.||+|+... ++.+|+|++....  ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            47778899999999999999764 8899999886543  22345788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +. ++|.+++... ....+++..+..++.|+++||+|||+.+   ++|+||+|+||++++++.+||+|||++..+.....
T Consensus        81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            96 5888887543 2345899999999999999999999987   99999999999999999999999999876543211


Q ss_pred             ccccccccccCCccCccccccCC-CCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCc------hh
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP------VE  734 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~-~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~------~~  734 (823)
                        ......++..|+|||.+.+.. ++.++||||||+++|||+||+.||......  ..+... .........      ..
T Consensus       156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~  230 (284)
T cd07860         156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRI-FRTLGTPDEVVWPGVTS  230 (284)
T ss_pred             --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHH-HHHhCCCChhhhhhhhH
Confidence              122235678999999887654 688999999999999999999997532211  111110 000000000      00


Q ss_pred             h------hhhhcCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          735 L------INKSLGGS---YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       735 ~------~~~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      +      +.......   .......++.+++.+|++.||++||+++|+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence            0      00000000   000112356789999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.5e-32  Score=289.02  Aligned_cols=250  Identities=23%  Similarity=0.344  Sum_probs=198.0

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      +|...+.||+|+||.||+|.... +..+|+|.+....  ....+.+.+|+++++.++|+|++++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            46778899999999999999865 7889999986542  23456788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCC-ceeeccccceecCCCc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN-PKISDFGMARAFGIDQ  660 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~-~kl~DFGla~~~~~~~  660 (823)
                      +++++|.+++... ....+++..+..++.|+++||.|||+.+   ++|+||||+||++++++. +||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            9999999988542 2235799999999999999999999987   999999999999998864 6999999998654322


Q ss_pred             cccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhc
Q 003391          661 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL  740 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l  740 (823)
                      .  ......+++.|+|||++.+..++.++||||||++++||++|+.|+.....      ....... ...        ..
T Consensus       157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~-~~~--------~~  219 (257)
T cd08225         157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKI-CQG--------YF  219 (257)
T ss_pred             c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHH-hcc--------cC
Confidence            1  12224588899999999888899999999999999999999999743211      1111110 000        00


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          741 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      . .........+.+++.+|++.+|++||++.|+++.
T Consensus       220 ~-~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         220 A-PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             C-CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            0 1111223467889999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2e-32  Score=294.54  Aligned_cols=262  Identities=21%  Similarity=0.283  Sum_probs=193.5

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc--ccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCc-----
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG--QGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDE-----  574 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~-----  574 (823)
                      ++|+..+.||+|+||.||+|+... ++.||+|++.....  .....+.+|+.+++++ +||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            468888999999999999999764 88999998765432  2345788899999999 46999999999977665     


Q ss_pred             eEEEEeecCCCCcchhhhccCC--CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcC-CCCceeeccc
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTR--SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-EMNPKISDFG  651 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DFG  651 (823)
                      .++||||+++ +|.+++.....  ...+++..+..++.||++||.|||+.+   |+||||+|+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999986 88888754322  356899999999999999999999987   999999999999998 8899999999


Q ss_pred             cceecCCCccccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhc
Q 003391          652 MARAFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE  730 (823)
Q Consensus       652 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  730 (823)
                      +++.+......  .....+++.|+|||++.+ ..++.++||||||+++|||++|..||.......  .+.. ..... ..
T Consensus       157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~-~~~~~-~~  230 (295)
T cd07837         157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLH-IFKLL-GT  230 (295)
T ss_pred             cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHH-HHHHh-CC
Confidence            99865332111  122356788999998865 457999999999999999999999875422111  1100 00000 00


Q ss_pred             Cchhhh-------hhhcCCC--------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          731 RPVELI-------NKSLGGS--------YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       731 ~~~~~~-------~~~l~~~--------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ......       .......        .......++.+++.+|++.+|.+||++.|++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000000       0000000        00112346788999999999999999999975

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.3e-32  Score=293.86  Aligned_cols=264  Identities=23%  Similarity=0.305  Sum_probs=195.8

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc--ccHHHHHHHHHHHhccCCCCceeEEEEeecC--CceEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG--QGMEEFENEVLLIAKLQHRNLVKLIGCCTQR--DERMLI  578 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV  578 (823)
                      ++|+..+.||+|+||.||+|.... ++.+++|++.....  .....+.+|+.++.+++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            568888999999999999999864 78899999865432  2234567899999999999999999998877  889999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      +||+++ +|.+++...  ...+++..+..++.||++||+|||+.+   ++|+||||+||++++++.+||+|||++..+..
T Consensus        85 ~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            999975 898887432  236899999999999999999999988   99999999999999999999999999987644


Q ss_pred             CccccccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchh--------HHHHHHhhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL--------GHAWRLWIE  729 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~--------~~~~~~~~~  729 (823)
                      ...  ......+++.|+|||.+.+. .++.++|+||||+++|||++|+.||...........+        ...|..+..
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence            321  12234568899999998764 4689999999999999999999997643221100000        000000000


Q ss_pred             ------cCchhhhhhhcCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          730 ------ERPVELINKSLGGSYSLS-EVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       730 ------~~~~~~~~~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                            ..........+...+... ....+.+++..|++.+|++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                  000000000111111111 2345678999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-32  Score=292.48  Aligned_cols=260  Identities=24%  Similarity=0.353  Sum_probs=195.8

Q ss_pred             CCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecC--CceEEEEe
Q 003391          506 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR--DERMLIYE  580 (823)
Q Consensus       506 ~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~e  580 (823)
                      |...++||+|+||.||+|+..+ ++.+|+|++....  ......+.+|+.++++++|+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            4567899999999999999865 7899999997663  33446788999999999999999999999888  88999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |+++ +|.+++...  ...+++..+..++.||++||+|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9975 888887432  246899999999999999999999987   9999999999999999999999999998764432


Q ss_pred             cccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcC--------
Q 003391          661 TEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER--------  731 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--------  731 (823)
                      . .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+.......   .............        
T Consensus       155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07840         155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QLEKIFELCGSPTDENWPGVS  230 (287)
T ss_pred             c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchhhccccc
Confidence            1 11223456788999998765 467999999999999999999999975332211   1111111000000        


Q ss_pred             ---------chhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          732 ---------PVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       732 ---------~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                               ........+.......+...+.+++.+|++.+|.+||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                     00000000000000112447789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=4.6e-32  Score=293.61  Aligned_cols=247  Identities=28%  Similarity=0.401  Sum_probs=193.7

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc---ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      .+.|...+.||+|+||.||+|+... ++.||+|++.....   ...+++.+|+++++.++|||++++.+++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            3568888999999999999999764 88999999865432   2335688999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      +||++ |+|.+++..  ....+++..+..++.|++.||.|||+.+   |+|+||+|+||++++++.++|+|||++.....
T Consensus        94 ~e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          94 MEYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HHhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            99997 577776632  2345899999999999999999999987   99999999999999999999999999875432


Q ss_pred             CccccccccccccCCccCccccc---cCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL  735 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  735 (823)
                      .      ....++..|+|||.+.   ...++.++||||||+++|||++|+.|+......      ..... .......  
T Consensus       168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~------~~~~~-~~~~~~~--  232 (307)
T cd06607         168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYH-IAQNDSP--  232 (307)
T ss_pred             C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH------HHHHH-HhcCCCC--
Confidence            1      2246788999999874   456889999999999999999999986422110      00000 0000000  


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       736 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                            ..........+.+++.+||+.+|++||++.+++..
T Consensus       233 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         233 ------TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             ------CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                  00011223468899999999999999999999865

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=5.1e-32  Score=299.19  Aligned_cols=263  Identities=24%  Similarity=0.322  Sum_probs=195.9

Q ss_pred             HhcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCC--ccccHHHHHHHHHHHhccCCCCceeEEEEeecC------
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR------  572 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------  572 (823)
                      ..++|+..+.||+|+||.||+|+.. .++.+|+|++...  .....+++.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999976 4889999998653  233445678899999999999999999988543      


Q ss_pred             CceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccc
Q 003391          573 DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM  652 (823)
Q Consensus       573 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl  652 (823)
                      ...++||||+.+ +|.+.+..     .++...+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence            357999999964 78877632     2788899999999999999999987   99999999999999999999999999


Q ss_pred             ceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCcc------------chh
Q 003391          653 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHH------------NLL  720 (823)
Q Consensus       653 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~------------~l~  720 (823)
                      ++......   ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.....            .+.
T Consensus       165 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
T cd07850         165 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM  241 (353)
T ss_pred             ceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            98654321   122345788999999999999999999999999999999999998543211000            000


Q ss_pred             ---HHHHHHhhhcCc-------hhhhhhhcCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          721 ---GHAWRLWIEERP-------VELINKSLGG----SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       721 ---~~~~~~~~~~~~-------~~~~~~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                         ......+.....       .+++...+..    .........+.+++.+|++.||++|||+.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence               000000000000       0000000000    0011224467899999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.5e-32  Score=289.52  Aligned_cols=247  Identities=25%  Similarity=0.284  Sum_probs=199.9

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      +|...+.||+|+||.||++.... ++.+|+|.+.+..   ....+.+.+|++++++++||||+++++++.++...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            46778899999999999999864 8899999987543   2456788999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |+++++|.+++..   ...+++..+..++.||++||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            9999999999843   246889999999999999999999987   9999999999999999999999999998654322


Q ss_pred             cccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhc
Q 003391          661 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL  740 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l  740 (823)
                         ......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+..........+    ......          .
T Consensus       155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~----------~  217 (258)
T cd05578         155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI----RAKQET----------A  217 (258)
T ss_pred             ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH----HHHhcc----------c
Confidence               22335678899999999988899999999999999999999999764433211111    000000          0


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCH--HHHH
Q 003391          741 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNM--SSVV  774 (823)
Q Consensus       741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~--~evl  774 (823)
                      ....+......+.+++.+|++.+|.+||++  +|++
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            111122223578899999999999999999  6654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4.5e-32  Score=286.48  Aligned_cols=242  Identities=24%  Similarity=0.329  Sum_probs=193.7

Q ss_pred             eeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCCCCc
Q 003391          512 LGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSL  587 (823)
Q Consensus       512 LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  587 (823)
                      ||.|++|.||+++... ++.+|+|.+.+..   ....+.+.+|+.++++++||||+++++.+.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            6899999999999865 8899999986543   23456789999999999999999999999999999999999999999


Q ss_pred             chhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccccccc
Q 003391          588 NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR  667 (823)
Q Consensus       588 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  667 (823)
                      .+++..   ...+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......   ....
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~  151 (262)
T cd05572          81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT  151 (262)
T ss_pred             HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence            999843   345889999999999999999999987   9999999999999999999999999998764322   2223


Q ss_pred             ccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHH
Q 003391          668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLS  747 (823)
Q Consensus       668 ~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~  747 (823)
                      ..++..|+|||.+.+..++.++|+||||+++|||++|..|+.....+.    ... ..        ...........+..
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~-~~--------~~~~~~~~~~~~~~  218 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEI-YN--------DILKGNGKLEFPNY  218 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHH-HH--------HHhccCCCCCCCcc
Confidence            467889999999988889999999999999999999999975433211    000 00        01100011112222


Q ss_pred             HHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 003391          748 EVLRCIQVGLLCVQQRPEDRPN-----MSSVVL  775 (823)
Q Consensus       748 ~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  775 (823)
                      ...++.+++.+||+.+|++||+     ++|+++
T Consensus       219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            2457889999999999999999     666654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-33  Score=287.64  Aligned_cols=243  Identities=26%  Similarity=0.348  Sum_probs=199.0

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC---ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      +.|+.-++||+||||.||-++... |+.+|.|++.+.   .+++..-..+|-++|.+++.+.||.+--.++.++.++||+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            567788899999999999999766 889999988654   3445566789999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ..|+||+|.-+|.+..+ ..+++..++-++.+|+.||++||...   ||.|||||+|||||+.|+++|+|+|||..+...
T Consensus       265 tlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            99999999999977554 56899999999999999999999987   999999999999999999999999999987543


Q ss_pred             ccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                      +..   ...+||.+|||||++.+..|+...|.||+||+||||+.|+.||........                .+-++.+
T Consensus       341 ~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk----------------~eEvdrr  401 (591)
T KOG0986|consen  341 KPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK----------------REEVDRR  401 (591)
T ss_pred             Ccc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh----------------HHHHHHH
Confidence            322   234899999999999999999999999999999999999999753322111                1111111


Q ss_pred             c---CCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 003391          740 L---GGSYSLSEVLRCIQVGLLCVQQRPEDRPN  769 (823)
Q Consensus       740 l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs  769 (823)
                      .   ...++..-.+++.+|....|+.||++|.-
T Consensus       402 ~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  402 TLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             HhcchhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence            1   11223223345667777889999999873

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-32  Score=301.85  Aligned_cols=262  Identities=20%  Similarity=0.315  Sum_probs=195.1

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecC-----Cce
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR-----DER  575 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~  575 (823)
                      .++|.+.++||+|+||.||+|+... ++.||+|++.... ......+.+|+.++++++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            4688999999999999999998754 8899999986532 33456688899999999999999999987544     357


Q ss_pred             EEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccccee
Q 003391          576 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                      ++|+||+++ +|.+++    ....+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~-~l~~~~----~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELMET-DLYKLI----KTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhccc-CHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence            999999975 777766    3346899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCcccc-ccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCch
Q 003391          656 FGIDQTEA-NTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV  733 (823)
Q Consensus       656 ~~~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  733 (823)
                      ........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+..   ......... ......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~---~~~~~~~~~-~~~~~~  231 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL---HQLNLILGV-LGTPSQ  231 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHH-cCCCCH
Confidence            54322111 1223568899999998755 56899999999999999999999997532211   001110000 000000


Q ss_pred             hhhhhh-----------cC--CCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          734 ELINKS-----------LG--GSYSL-----SEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       734 ~~~~~~-----------l~--~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      +.....           ..  .....     ....++.+++.+|++.+|++||++.|+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000000           00  00010     112467899999999999999999999987

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.98  E-value=4.1e-32  Score=290.20  Aligned_cols=261  Identities=23%  Similarity=0.312  Sum_probs=194.6

Q ss_pred             CCcCCeeeccCccceEEEEee-cCcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          506 FSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       506 ~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      |+..+.||.|++|.||+|... +++.||+|++....  ....+.+.+|+.++++++|||++++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            456789999999999999976 48999999986543  223457889999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  662 (823)
                      + ++|.+++.... ...+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.++|+|||++..+..... 
T Consensus        81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-  154 (283)
T cd07835          81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-  154 (283)
T ss_pred             C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence            5 68999885422 245899999999999999999999987   99999999999999999999999999976533221 


Q ss_pred             cccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcC---------c
Q 003391          663 ANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER---------P  732 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---------~  732 (823)
                       ......++..|+|||++.+. .++.++||||||+++|||++|+.||.......  .+.. .........         .
T Consensus       155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~  230 (283)
T cd07835         155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFR-IFRTLGTPDEDVWPGVTSL  230 (283)
T ss_pred             -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHhCCCChHHhhhhhhc
Confidence             11223568899999988664 57899999999999999999999975432211  0100 000000000         0


Q ss_pred             hhhhhhhcCC------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          733 VELINKSLGG------SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       733 ~~~~~~~l~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      .+........      .........+.+++.+|++.+|++||+++|+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0000000000      0001112467899999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=4.5e-33  Score=296.40  Aligned_cols=253  Identities=25%  Similarity=0.352  Sum_probs=202.0

Q ss_pred             hcCCCcCCeeeccCccceEEEEeecCcEEEEEEecC--CccccHHHHHHHHHHHhccC-CCCceeEEEEeecCCceEEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ...|++.++||.||.+.||++...+.+.+|+|++..  .+.+...-|.+|+..|.+++ |.+||+|++|-..++.+||||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            356888899999999999999988888999998754  35667888999999999995 999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||= ..+|..+|.+... ....| .+..+..|++.++.++|+++   |||.||||.|+|+-. |.+||+|||+|..+..+
T Consensus       440 E~G-d~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD  512 (677)
T ss_pred             ecc-cccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence            986 4589998854322 22334 67788999999999999998   999999999999854 68999999999998877


Q ss_pred             ccccccccccccCCccCccccccCC-----------CCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGL-----------FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWI  728 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~-----------~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~  728 (823)
                      .........+||..||+||.+....           .+.++||||+|||||+|+.|+.||+.+..         .+    
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n---------~~----  579 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN---------QI----  579 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH---------HH----
Confidence            7777777889999999999985432           56789999999999999999999753211         11    


Q ss_pred             hcCchhhhhhhcCCCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          729 EERPVELINKSLGGSYS-LSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       729 ~~~~~~~~~~~l~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                       .+...+.++...-.++ ..+..+++++|..||+.||++||++.|+++.
T Consensus       580 -aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  580 -AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             -HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence             1112233332211111 1222248999999999999999999999864

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.98  E-value=3.5e-32  Score=294.64  Aligned_cols=266  Identities=22%  Similarity=0.353  Sum_probs=193.4

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCC-----
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD-----  573 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----  573 (823)
                      ..++|+..++||+|+||.||+|+... ++.||+|++....  ......+.+|+.++++++||||+++++++...+     
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            34578889999999999999999764 8899999886543  222345678999999999999999999987654     


Q ss_pred             ---ceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecc
Q 003391          574 ---ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDF  650 (823)
Q Consensus       574 ---~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF  650 (823)
                         ..++||||+.+ +|.+++..  ....+++..+..++.||+.||+|||+.+   ++|+||||+||+++.++.+||+||
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence               34999999975 78777743  2335899999999999999999999987   999999999999999999999999


Q ss_pred             ccceecCCCccc--cccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHh
Q 003391          651 GMARAFGIDQTE--ANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW  727 (823)
Q Consensus       651 Gla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  727 (823)
                      |++..+......  .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+...........+.......
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~  243 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI  243 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            999866432211  112234578899999988664 47889999999999999999998875432211111111100000


Q ss_pred             hhc-----Cchhhh-------------hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          728 IEE-----RPVELI-------------NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       728 ~~~-----~~~~~~-------------~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ...     ......             ...+....   +...+.+++.+|++.+|++||+++|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~---~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYV---KDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             ChhhcccccchhhhhhccCCCccchhhHHhccccc---CCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            000     000000             00000000   12356789999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.98  E-value=5.8e-32  Score=288.62  Aligned_cols=242  Identities=24%  Similarity=0.277  Sum_probs=185.6

Q ss_pred             eeeccCccceEEEEeec-CcEEEEEEecCCcc---ccHHHHHHHHHHHh---ccCCCCceeEEEEeecCCceEEEEeecC
Q 003391          511 KLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG---QGMEEFENEVLLIA---KLQHRNLVKLIGCCTQRDERMLIYEYLP  583 (823)
Q Consensus       511 ~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~---~~~~~~~~Ei~~l~---~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (823)
                      .||+|+||.||++...+ ++.+|+|.+.+...   .....+.+|..++.   ..+|||++.+.+.+...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            48999999999999765 78999998865421   22233444544333   3479999999999999999999999999


Q ss_pred             CCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccc
Q 003391          584 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA  663 (823)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  663 (823)
                      +++|.+++..   .+.+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.++|+|||++.......   
T Consensus        81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---  151 (279)
T cd05633          81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (279)
T ss_pred             CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence            9999998843   345899999999999999999999998   9999999999999999999999999997553221   


Q ss_pred             ccccccccCCccCccccc-cCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCC
Q 003391          664 NTNRVVGTYGYMPPEYAI-DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG  742 (823)
Q Consensus       664 ~~~~~~gt~~y~aPE~l~-~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~  742 (823)
                       .....++..|+|||.+. +..++.++||||||++++||++|+.||.........    ......          .....
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~----------~~~~~  216 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMT----------LTVNV  216 (279)
T ss_pred             -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH----HHHHHh----------hcCCc
Confidence             12246899999999986 456899999999999999999999998543221111    000000          00111


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003391          743 SYSLSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVLM  776 (823)
Q Consensus       743 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~  776 (823)
                      ..+.....++.+++..|++.+|++||     +++|+++.
T Consensus       217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            11222234678899999999999999     69999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.98  E-value=1e-31  Score=292.22  Aligned_cols=255  Identities=28%  Similarity=0.395  Sum_probs=197.1

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc---ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      .|...+.||+|+||.||+++... +..+|+|++.....   ....++.+|++++++++|||++++++++.++...++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            36677899999999999999754 78999999865432   234578899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |+++ +|.+.+..  ....+++..+..++.+++.||.|||+.+   |+|+||+|+||+++.++.++|+|||++.....  
T Consensus       106 ~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--  177 (317)
T cd06635         106 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP--  177 (317)
T ss_pred             CCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence            9975 77776643  2345899999999999999999999987   99999999999999999999999999875422  


Q ss_pred             cccccccccccCCccCccccc---cCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhh
Q 003391          661 TEANTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN  737 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  737 (823)
                          .....++..|+|||++.   .+.++.++||||||+++|||++|+.|+......   ....    ......      
T Consensus       178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~----~~~~~~------  240 (317)
T cd06635         178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALY----HIAQNE------  240 (317)
T ss_pred             ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH---HHHH----HHHhcc------
Confidence                22346788999999974   456899999999999999999999986422110   0000    000000      


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCCCCCC
Q 003391          738 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQP  786 (823)
Q Consensus       738 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~p  786 (823)
                        ............+.+++.+|++.+|.+||++.++++.+--....+.+
T Consensus       241 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~  287 (317)
T cd06635         241 --SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPET  287 (317)
T ss_pred             --CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCccc
Confidence              00001112234578899999999999999999999876554444433

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.98  E-value=4.6e-32  Score=284.95  Aligned_cols=249  Identities=26%  Similarity=0.335  Sum_probs=201.2

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      +|+..++||+|+||.||+++... ++.+++|++....  .....++.+|++++++++|+||+++.+++.+....++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            46778899999999999998754 7889999986543  23455778899999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccC-CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          582 LPNKSLNDFIFDVT-RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       582 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      +++++|.+++.+.. ....+++..+..++.+++.||+|||+.+   ++|+||+|+||++++++.+||+|||+++..... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            99999999986522 2356899999999999999999999988   999999999999999999999999999876433 


Q ss_pred             cccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhc
Q 003391          661 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL  740 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l  740 (823)
                         ......++..|+|||.+.+..++.++|+||||+++|||++|+.|+......   .+.    ....         ...
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~----~~~~---------~~~  217 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLR----YKVQ---------RGK  217 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHh---------cCC
Confidence               122245788999999999999999999999999999999999997532211   000    0000         011


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          741 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ..........++.+++.+|++.+|++||++.|+++.
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            111222344578899999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.98  E-value=4.2e-32  Score=312.18  Aligned_cols=268  Identities=21%  Similarity=0.281  Sum_probs=186.9

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec--CcEEEEE------------------EecCCccccHHHHHHHHHHHhccCCCC
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE--GQEIAAK------------------RLSKSSGQGMEEFENEVLLIAKLQHRN  561 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~--~~~vavK------------------~l~~~~~~~~~~~~~Ei~~l~~l~H~n  561 (823)
                      ..++|.+.++||+|+||.||++.+..  +...+.|                  ++. .......++.+|+.++++++|||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence            45789999999999999999987643  1112212                  111 12223456889999999999999


Q ss_pred             ceeEEEEeecCCceEEEEeecCCCCcchhhhccCC--CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEE
Q 003391          562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTR--SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL  639 (823)
Q Consensus       562 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll  639 (823)
                      |+++++++...+..++|+|++. ++|.+++.....  ........+..++.||+.||.|||+.+   |+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence            9999999999999999999985 577777643211  122345667789999999999999988   9999999999999


Q ss_pred             cCCCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCC-CCCcCCCCccc
Q 003391          640 DNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRN-RGFYHADHHHN  718 (823)
Q Consensus       640 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p-~~~~~~~~~~~  718 (823)
                      +.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|..+ +..........
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            9999999999999987643222 122235789999999999999999999999999999999998754 32211111111


Q ss_pred             hhHHHHHHhh---hc---CchhhhhhhcCC-----CCCH-------HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          719 LLGHAWRLWI---EE---RPVELINKSLGG-----SYSL-------SEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       719 l~~~~~~~~~---~~---~~~~~~~~~l~~-----~~~~-------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      +.... ..+.   ++   ....+.+.....     ....       ....++.+++.+||+.||.+|||+.|++..
T Consensus       380 ~~~~~-~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        380 LLKII-DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHH-HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            11110 0000   00   000000000000     0000       011256678899999999999999999864

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.98  E-value=9.9e-32  Score=282.34  Aligned_cols=251  Identities=23%  Similarity=0.325  Sum_probs=203.2

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc--ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG--QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      +|...+.||.|+||.||++.... ++.+++|++.....  ...+++.+|+++++.++|||++++.+.+..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            46778899999999999999864 88999999876533  4566789999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccC-CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          582 LPNKSLNDFIFDVT-RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       582 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      +++++|.+++.... ....+++..+..++.+++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999986532 2467899999999999999999999997   9999999999999999999999999998764432


Q ss_pred             cccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhc
Q 003391          661 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL  740 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l  740 (823)
                        .......+++.|+|||.+.+..++.++||||+|+++++|++|+.|+.....   ..+    ........         
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~---~~~----~~~~~~~~---------  219 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL---LEL----ALKILKGQ---------  219 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH---HHH----HHHHhcCC---------
Confidence              122335688899999999988999999999999999999999999743221   111    11111110         


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          741 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ....+......+.+++.+|++.+|++||++.|+++.
T Consensus       220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            011111233567889999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.98  E-value=6.8e-32  Score=288.22  Aligned_cols=257  Identities=20%  Similarity=0.281  Sum_probs=190.8

Q ss_pred             CCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc-ccHHHHHHHHHHHhccC-CCCceeEEEEeecC--CceEEEEe
Q 003391          506 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQR--DERMLIYE  580 (823)
Q Consensus       506 ~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~lV~e  580 (823)
                      |+..++||+|+||.||+|.... ++.+|+|+++.... .......+|+.++.++. |+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            4567899999999999999754 88999999876432 22234457888898885 99999999999887  88999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |++ ++|.+++...  ...+++..+..++.|++.||+|||+.+   ++|+||+|+||+++. +.+||+|||+++......
T Consensus        81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            997 5888877432  346899999999999999999999987   999999999999999 999999999998764322


Q ss_pred             cccccccccccCCccCccccc-cCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh-
Q 003391          661 TEANTNRVVGTYGYMPPEYAI-DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK-  738 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~-~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~-  738 (823)
                      .   .....++..|+|||.+. +..++.++|||||||++|||++|+.||...+..+   ....... .......+.... 
T Consensus       154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~-~~~~~~~~~~~~~  226 (282)
T cd07831         154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHD-VLGTPDAEVLKKF  226 (282)
T ss_pred             C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHH-HcCCCCHHHHHhh
Confidence            1   12245788999999764 4567899999999999999999999985432211   1111110 000000000000 


Q ss_pred             ----hcCCCC-----------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          739 ----SLGGSY-----------SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       739 ----~l~~~~-----------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                          ......           .......+.+++.+|++.+|++||++.++++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence                000000           01124578899999999999999999999863

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.98  E-value=3.5e-32  Score=287.16  Aligned_cols=247  Identities=24%  Similarity=0.345  Sum_probs=195.9

Q ss_pred             eeccCccceEEEEeec-CcEEEEEEecCCcc---ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCCCCc
Q 003391          512 LGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSL  587 (823)
Q Consensus       512 LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  587 (823)
                      ||+|+||.||+++... ++.+++|.+.....   ...+.+.+|++++++++|||++++++.+..+...++|+||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999875 89999999865533   4556788999999999999999999999999999999999999999


Q ss_pred             chhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc------
Q 003391          588 NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT------  661 (823)
Q Consensus       588 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~------  661 (823)
                      .+++...   ..+++..+..++.||++||+|||+.+   ++|+||+|+||++++++.++|+|||++........      
T Consensus        81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            9998542   36899999999999999999999987   99999999999999999999999999876433211      


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                      ........++..|+|||.+.....+.++||||||++++||++|+.|+......   ...    ......        ...
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~----~~~~~~--------~~~  219 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE---EIF----QNILNG--------KIE  219 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHhcC--------CcC
Confidence            11223356788999999998888999999999999999999999997533211   000    000000        000


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          742 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                      ..........+.+++.+|++.+|++||++.++.+.|+.
T Consensus       220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence            00010013577899999999999999999777777653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=3.1e-33  Score=299.42  Aligned_cols=251  Identities=24%  Similarity=0.387  Sum_probs=200.8

Q ss_pred             CCCcCCeeeccCccceEEEEeecCc-EEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecC
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIEGQ-EIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP  583 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~~~-~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (823)
                      .+.+...||.|+||.||||..++.. ..|.|.+....+...++|.-||++|....||+||+|++.|.-.+.++++.|||.
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            3455668999999999999987644 456788877788888999999999999999999999999999999999999999


Q ss_pred             CCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccc
Q 003391          584 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA  663 (823)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  663 (823)
                      ||-.+..+.+.  ...+++.++.-++.|++.||.|||++.   |||||||+.|||++-+|.++|+|||.+....  ....
T Consensus       113 GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~q  185 (1187)
T KOG0579|consen  113 GGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQ  185 (1187)
T ss_pred             CchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch--hHHh
Confidence            99999988654  346899999999999999999999997   9999999999999999999999999886432  2233


Q ss_pred             ccccccccCCccCcccc-----ccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          664 NTNRVVGTYGYMPPEYA-----IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       664 ~~~~~~gt~~y~aPE~l-----~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                      ....+.||+.|||||++     .+.+|..++||||||+.|.||..+.+|-...      +.++. ........+..++.+
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel------npMRV-llKiaKSePPTLlqP  258 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL------NPMRV-LLKIAKSEPPTLLQP  258 (1187)
T ss_pred             hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc------chHHH-HHHHhhcCCCcccCc
Confidence            44568899999999987     4678999999999999999999999883211      11111 111111222222211


Q ss_pred             hcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       739 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      .       .=...+.++..+||..||..||+++++++.
T Consensus       259 S-------~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  259 S-------HWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             c-------hhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            1       112367789999999999999999998753

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.98  E-value=5.9e-32  Score=290.48  Aligned_cols=244  Identities=23%  Similarity=0.320  Sum_probs=195.1

Q ss_pred             CeeeccCccceEEEEee-cCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCCCCcc
Q 003391          510 NKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLN  588 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~  588 (823)
                      .+||+|+||.||++... +++.+|+|++........+.+.+|+.+++.++|+|++++++.+...+..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            57999999999999885 48899999986655556677899999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccccccccc
Q 003391          589 DFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV  668 (823)
Q Consensus       589 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~  668 (823)
                      +++.    ...+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++........  .....
T Consensus       106 ~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~  176 (292)
T cd06657         106 DIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSL  176 (292)
T ss_pred             HHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--ccccc
Confidence            9773    234789999999999999999999987   99999999999999999999999999876543221  12335


Q ss_pred             cccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHHH
Q 003391          669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSE  748 (823)
Q Consensus       669 ~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  748 (823)
                      .++..|+|||.+.+..++.++|+||||+++|||++|..|+.......   ...    ......     ...+..  ....
T Consensus       177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~---~~~----~~~~~~-----~~~~~~--~~~~  242 (292)
T cd06657         177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMK----MIRDNL-----PPKLKN--LHKV  242 (292)
T ss_pred             ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH----HHHhhC-----CcccCC--cccC
Confidence            67889999999988889999999999999999999999975321110   000    000000     000000  0112


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          749 VLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       749 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ...+.+++.+|++.+|.+||++.++++.
T Consensus       243 ~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         243 SPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             CHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            2356788999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.98  E-value=5.3e-32  Score=293.40  Aligned_cols=262  Identities=25%  Similarity=0.356  Sum_probs=194.1

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc--ccHHHHHHHHHHHhccCCCCceeEEEEeecC--CceEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG--QGMEEFENEVLLIAKLQHRNLVKLIGCCTQR--DERML  577 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l  577 (823)
                      .++|...+.||+|+||.||+|+... ++.||+|++.....  .....+.+|+.++++++|+|++++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            4678889999999999999999865 88999999865432  2233567899999999999999999998755  46899


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      ||||+++ +|.+++...  ...+++..+..++.||++||+|||+.+   ++|+||||+||++++++.+||+|||++....
T Consensus        86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999975 788887532  256899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCccccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhh-
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL-  735 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~-  735 (823)
                      ....  ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......   ......... ....... 
T Consensus       160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~---~~~~~~~~~-~~~~~~~~  233 (309)
T cd07845         160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE---QLDLIIQLL-GTPNESIW  233 (309)
T ss_pred             CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhc-CCCChhhc
Confidence            3321  1122345778999999875 457899999999999999999999975332211   111111100 0000000 


Q ss_pred             --------hhh-hcCCC--CCHH-----HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          736 --------INK-SLGGS--YSLS-----EVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       736 --------~~~-~l~~~--~~~~-----~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                              ... .+...  ....     ....+.+++.+|++.||++|||+.|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                    000 00000  0000     12356789999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.98  E-value=8.8e-32  Score=295.40  Aligned_cols=267  Identities=21%  Similarity=0.323  Sum_probs=196.8

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC--ccccHHHHHHHHHHHhcc-CCCCceeEEEEeecC--Cce
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQR--DER  575 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~--~~~  575 (823)
                      ..++|...+.||+|+||.||+|.... ++.+|+|++...  .......+..|+.++.++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            45678888999999999999999764 788999988653  233445677899999999 999999999998653  468


Q ss_pred             EEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccccee
Q 003391          576 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                      ++||||++ ++|..++..    ..+++..+..++.||+.||+|||+.+   |+|+||||+||++++++.+||+|||++..
T Consensus        85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            99999997 588888732    26889999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCccc---cccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhH--------HH
Q 003391          656 FGIDQTE---ANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLG--------HA  723 (823)
Q Consensus       656 ~~~~~~~---~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~--------~~  723 (823)
                      +......   .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.............        ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED  236 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            6433221   22233568899999998765 457899999999999999999999985432211100000        00


Q ss_pred             HHHhhhcCchhhhhhhcCCC-CCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          724 WRLWIEERPVELINKSLGGS-YSL-----SEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       724 ~~~~~~~~~~~~~~~~l~~~-~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      +..+.......+++...... ...     .....+.+++.+|++.+|++|||+.++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            00000001111111100000 000     123467899999999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.98  E-value=1.6e-32  Score=297.88  Aligned_cols=247  Identities=26%  Similarity=0.366  Sum_probs=206.1

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      ....|.+..+||+|.|+.|..|++.. +.+||+|.+.+..  ......+.+|+++|..++|||||+++.+......+++|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            34678888999999999999999865 8999999998763  33345688999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      |||..+|.+.++|..   ...+....+..++.|+..+++|||+++   |||||||++||||+.+.++||+|||++..+. 
T Consensus       134 ~eya~~ge~~~yl~~---~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-  206 (596)
T KOG0586|consen  134 MEYASGGELFDYLVK---HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD-  206 (596)
T ss_pred             EEeccCchhHHHHHh---cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec-
Confidence            999999999999954   334556888899999999999999998   9999999999999999999999999998875 


Q ss_pred             CccccccccccccCCccCccccccCCC-CccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN  737 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  737 (823)
                        ........+|++.|.|||++.+..| ++++|+||+|++||-|+.|..||+..                   ...++-+
T Consensus       207 --~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~-------------------~lk~Lr~  265 (596)
T KOG0586|consen  207 --YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ-------------------NLKELRP  265 (596)
T ss_pred             --ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc-------------------ccccccc
Confidence              2334455789999999999998876 68999999999999999999998632                   1122222


Q ss_pred             hhcCCCCCHHH--HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          738 KSLGGSYSLSE--VLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       738 ~~l~~~~~~~~--~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ..+.+.+.++.  -.++-+++.+++-.+|.+|++++++.+-
T Consensus       266 rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  266 RVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             hheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence            33333332222  1367789999999999999999998753

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.98  E-value=1.1e-31  Score=288.75  Aligned_cols=260  Identities=19%  Similarity=0.218  Sum_probs=182.1

Q ss_pred             hcCCCcCCeeeccCccceEEEEeecC----cEEEEEEecCCccccH-----------HHHHHHHHHHhccCCCCceeEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIEG----QEIAAKRLSKSSGQGM-----------EEFENEVLLIAKLQHRNLVKLIG  567 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~~----~~vavK~l~~~~~~~~-----------~~~~~Ei~~l~~l~H~niv~l~g  567 (823)
                      .++|.+.++||+|+||.||+|...++    ..+|+|+.........           .....++..+..++|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            36788999999999999999997654    3455554332221110           11223344556678999999999


Q ss_pred             EeecCC----ceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCC
Q 003391          568 CCTQRD----ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM  643 (823)
Q Consensus       568 ~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~  643 (823)
                      ++....    ..++++|++.. ++.+.+..   ....++..+..++.|+++||+|||+.+   |+||||||+|||++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence            775543    23667776643 55555422   223567888999999999999999987   99999999999999999


Q ss_pred             CceeeccccceecCCCcc-----ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccc
Q 003391          644 NPKISDFGMARAFGIDQT-----EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHN  718 (823)
Q Consensus       644 ~~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~  718 (823)
                      .++|+|||+|+.+.....     ........||+.|+|||++.+..++.++|||||||+++||++|+.||......  ..
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~--~~  241 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN--GN  241 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc--hH
Confidence            999999999987642211     11122356999999999999999999999999999999999999998643211  11


Q ss_pred             hhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003391          719 LLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS  778 (823)
Q Consensus       719 l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  778 (823)
                      +.......+..    .+.......   ......+.+++..|++.+|++||++.++++.|+
T Consensus       242 ~~~~~~~~~~~----~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        242 LIHAAKCDFIK----RLHEGKIKI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHHhHHHHHH----Hhhhhhhcc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            11111111110    011111100   111356789999999999999999999998874

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.2e-31  Score=281.34  Aligned_cols=247  Identities=29%  Similarity=0.429  Sum_probs=200.1

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc--ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG--QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      +|+..+.||+|++|.||+++... ++.+++|.+.....  ...+.+.+|++++.+++|||++++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            46778899999999999998764 78999999976643  4567889999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            999999998843   256899999999999999999999987   99999999999999999999999999987643322


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                      .  .....++..|+|||.+.+..++.++|||++|++++||++|+.|+.....     . ...+.. ...         ..
T Consensus       155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~-~~~~~~-~~~---------~~  216 (254)
T cd06627         155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----M-AALFRI-VQD---------DH  216 (254)
T ss_pred             c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----H-HHHHHH-hcc---------CC
Confidence            1  2234678899999999888889999999999999999999998753221     0 000000 000         00


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          742 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ...+......+.+++.+|++.+|++||++.+++.
T Consensus       217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         217 PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            1111122346778999999999999999999974

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.98  E-value=5.7e-32  Score=289.95  Aligned_cols=254  Identities=24%  Similarity=0.347  Sum_probs=192.9

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc-cccHHHHHHHHHHHhccC-CCCceeEEEEeecCCceEEEEee
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      +|...++||+|+||.||+++... ++.+|+|++.... ......+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            45556789999999999999765 7899999987543 234567889999999996 99999999999998999999999


Q ss_pred             cCCCCcchhhhc--cCCCCccCHHHHHHHHHHHHHHHHHHHhc-CCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          582 LPNKSLNDFIFD--VTRSKFLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       582 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      +.. +|.++...  ......+++..+..++.++++||+|||+. +   ++||||||+||+++.++.+||+|||++..+..
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            864 55544321  12235689999999999999999999975 5   99999999999999999999999999976532


Q ss_pred             CccccccccccccCCccCccccccC---CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDG---LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL  735 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~---~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  735 (823)
                      ..   ......++..|+|||.+.+.   .++.++||||||+++|||++|+.||....     ........ ......   
T Consensus       161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~-~~~~~~---  228 (288)
T cd06616         161 SI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQ-VVKGDP---  228 (288)
T ss_pred             CC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhh-hcCCCC---
Confidence            21   11223578899999998766   68999999999999999999999975332     11111100 000000   


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       736 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                        +.+...........+.+++.+|++.+|++||++.+|+..
T Consensus       229 --~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         229 --PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             --CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              111111112234468899999999999999999999864

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.98  E-value=1.2e-31  Score=285.69  Aligned_cols=244  Identities=26%  Similarity=0.341  Sum_probs=190.2

Q ss_pred             eeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCCCCc
Q 003391          512 LGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSL  587 (823)
Q Consensus       512 LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  587 (823)
                      ||+|+||+||++.... ++.+|+|.+....   ......+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            6899999999998654 8899999986542   22344567899999999999999999999999999999999999999


Q ss_pred             chhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccccccc
Q 003391          588 NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR  667 (823)
Q Consensus       588 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  667 (823)
                      .+++..... ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.....   ......
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~  153 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKG  153 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCcccc
Confidence            999864332 35899999999999999999999988   99999999999999999999999999876532   112223


Q ss_pred             ccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHH
Q 003391          668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLS  747 (823)
Q Consensus       668 ~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~  747 (823)
                      ..++..|+|||.+.+..++.++||||||++++||++|+.||...........       .......      .....+..
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~~~------~~~~~~~~  220 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEE-------LKRRTLE------MAVEYPDK  220 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHH-------HHhcccc------ccccCCcc
Confidence            4577899999999888899999999999999999999999754322111000       0000000      00011111


Q ss_pred             HHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003391          748 EVLRCIQVGLLCVQQRPEDRP-----NMSSVVL  775 (823)
Q Consensus       748 ~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  775 (823)
                      ....+.+++.+||+.+|++||     ++.+++.
T Consensus       221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            234678899999999999999     6666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=1.2e-32  Score=274.75  Aligned_cols=252  Identities=22%  Similarity=0.326  Sum_probs=199.1

Q ss_pred             CeeeccCccceEEEEe-ecCcEEEEEEecCCccccHHHHHHHHHHHhccC-CCCceeEEEEeecCCceEEEEeecCCCCc
Q 003391          510 NKLGEGGFGPVYKGVL-IEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLIYEYLPNKSL  587 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL  587 (823)
                      +.||+|+++.|--++. ..+.++|||++.+.......+..+|++++.+.+ |+||++|+++|+++...|||||.|.||+|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            4899999999998885 459999999999887778888999999999985 99999999999999999999999999999


Q ss_pred             chhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCC---ceeeccccceecCCC-----
Q 003391          588 NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN---PKISDFGMARAFGID-----  659 (823)
Q Consensus       588 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~DFGla~~~~~~-----  659 (823)
                      ..+|+   +++.+++.++.++..+|+.||.|||.++   |.||||||+|||..+...   +||+||.+..-+...     
T Consensus       164 LshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp  237 (463)
T KOG0607|consen  164 LSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP  237 (463)
T ss_pred             HHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence            99985   4566899999999999999999999998   999999999999976654   799999988654221     


Q ss_pred             ccccccccccccCCccCccccc-----cCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCcc----chhHHHHHHhhhc
Q 003391          660 QTEANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHH----NLLGHAWRLWIEE  730 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~----~l~~~~~~~~~~~  730 (823)
                      .........+|+..|||||+..     ...|..++|.||+|||||-|++|..||......+..    ......       
T Consensus       238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~C-------  310 (463)
T KOG0607|consen  238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVC-------  310 (463)
T ss_pred             CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHH-------
Confidence            1112223467888999999872     345889999999999999999999999654443221    111111       


Q ss_pred             CchhhhhhhcCCCC--CHHHH----HHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          731 RPVELINKSLGGSY--SLSEV----LRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       731 ~~~~~~~~~l~~~~--~~~~~----~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                       -..+++.+..+.+  +..+.    .+..+++...+..+|.+|.++.+++.
T Consensus       311 -Q~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  311 -QNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             -HHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence             1123344444433  33332    25567888888899999999988876

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.98  E-value=1e-31  Score=289.97  Aligned_cols=265  Identities=23%  Similarity=0.343  Sum_probs=195.6

Q ss_pred             HHhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCC----
Q 003391          501 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD----  573 (823)
Q Consensus       501 ~~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----  573 (823)
                      ...++|++.+.||+|+||.||+|++.. ++.||+|+++...  ......+.+|+++++.++|||++++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            355788999999999999999999865 7899999986543  233456788999999999999999999987654    


Q ss_pred             ------ceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCcee
Q 003391          574 ------ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI  647 (823)
Q Consensus       574 ------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl  647 (823)
                            ..++|+||+++ +|..++..  ....+++..+..++.||+.||+|||+.+   |+|+||||+||++++++.+||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence                  78999999986 67666633  2345899999999999999999999987   999999999999999999999


Q ss_pred             eccccceecCCCccccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHH
Q 003391          648 SDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL  726 (823)
Q Consensus       648 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  726 (823)
                      +|||++..+...... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+......   .........
T Consensus       158 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~---~~~~~~~~~  233 (302)
T cd07864         158 ADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL---AQLELISRL  233 (302)
T ss_pred             CcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHH
Confidence            999999876433221 1122345778999998865 45789999999999999999999887532211   111111111


Q ss_pred             hhhcCch---hh--------hh------hhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          727 WIEERPV---EL--------IN------KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       727 ~~~~~~~---~~--------~~------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      .......   .+        .+      ........ .....+.+++..|++.+|.+||++.+++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             hCCCChhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0000000   00        00      00000000 113467899999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.98  E-value=7.4e-32  Score=287.97  Aligned_cols=260  Identities=23%  Similarity=0.331  Sum_probs=197.2

Q ss_pred             CCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccc--cHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          506 FSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQ--GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       506 ~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      |...+.||+|++|.||++... +++.+++|++......  ....+.+|+.++++++|+||+++++++..+...++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            456689999999999999986 4888999998655332  4567889999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  662 (823)
                      ++ +|.+++...  ...+++..+..++.++++||.|||+.+   |+|+||||+||++++++.++|+|||.+.......  
T Consensus        81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--  152 (283)
T cd05118          81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--  152 (283)
T ss_pred             CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence            75 888877442  246899999999999999999999988   9999999999999999999999999998765433  


Q ss_pred             cccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCc---hhhhh-
Q 003391          663 ANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP---VELIN-  737 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---~~~~~-  737 (823)
                      .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+   ........+.....   ..... 
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID---QLFKIFRTLGTPDPEVWPKFTSL  229 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCchHhcccchhh
Confidence            112224577889999998876 78999999999999999999998875332211   11111111000000   00000 


Q ss_pred             -----hhcC--CC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          738 -----KSLG--GS-----YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       738 -----~~l~--~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                           ....  ..     .......++.+++..|++.+|.+||++.+++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence                 0000  00     011123578899999999999999999999853

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=2.1e-31  Score=281.88  Aligned_cols=250  Identities=25%  Similarity=0.380  Sum_probs=194.7

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC-----ccccHHHHHHHHHHHhccCCCCceeEEEEeecC--Cce
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS-----SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR--DER  575 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~  575 (823)
                      .+|...+.||+|+||.||+|+... ++.+|+|.+...     .......+.+|+.++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            468889999999999999999755 889999987532     223455788999999999999999999998764  457


Q ss_pred             EEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccccee
Q 003391          576 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                      ++|+||+++++|.+++..   ...+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            899999999999998843   334788999999999999999999988   99999999999999999999999999986


Q ss_pred             cCCCcc-ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchh
Q 003391          656 FGIDQT-EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE  734 (823)
Q Consensus       656 ~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  734 (823)
                      ...... ........++..|+|||.+.+..++.++|+||||++++||++|+.||.....     . ....         .
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~-~~~~---------~  220 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA-----M-AAIF---------K  220 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH-----H-HHHH---------H
Confidence            532111 1112235688899999999988899999999999999999999999742110     0 0000         0


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          735 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       735 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ..........+......+.+++..|++ +|.+||++.+++.
T Consensus       221 ~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         221 IATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             HHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            000001111222233467889999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=4.6e-32  Score=297.56  Aligned_cols=262  Identities=22%  Similarity=0.288  Sum_probs=195.7

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC--ccccHHHHHHHHHHHhccCCCCceeEEEEeecC-----Cc
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR-----DE  574 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~  574 (823)
                      .++|...+.||+|+||.||+++... ++.||+|++...  .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            4578889999999999999999754 889999998654  233455678899999999999999999988644     34


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccce
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  654 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  654 (823)
                      .++|+||+. ++|.+++.   ....+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++
T Consensus        84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999996 68888774   3346899999999999999999999987   9999999999999999999999999998


Q ss_pred             ecCCCccccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhh-----
Q 003391          655 AFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWI-----  728 (823)
Q Consensus       655 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~-----  728 (823)
                      ......  .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+...   ..........     
T Consensus       157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~  231 (337)
T cd07858         157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH---QLKLITELLGSPSEE  231 (337)
T ss_pred             ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCChH
Confidence            654321  12223467889999998865 468999999999999999999999985432111   1111110000     


Q ss_pred             ------hcCchhhhhhhcC-CCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          729 ------EERPVELINKSLG-GSY-----SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       729 ------~~~~~~~~~~~l~-~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                            .......+..... ...     ......++.+++.+|++.+|++||+++|+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence                  0000000000000 000     01123467899999999999999999999877

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.97  E-value=1.1e-31  Score=294.09  Aligned_cols=264  Identities=20%  Similarity=0.307  Sum_probs=197.3

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeec----CCce
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ----RDER  575 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~  575 (823)
                      .++|+..+.||+|+||.||+|+... ++.||+|++....  ....+.+.+|+.++++++||||+++.+++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            3678888999999999999999765 8899999987642  2345677889999999999999999988753    3468


Q ss_pred             EEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccccee
Q 003391          576 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                      ++|+||+. ++|.+++.   ....+++..+..++.||++||+|||+.+   |+|+||||+||++++++.+||+|||++..
T Consensus        84 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence            99999996 58888873   3345899999999999999999999987   99999999999999999999999999986


Q ss_pred             cCCCccc--cccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHH------
Q 003391          656 FGIDQTE--ANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL------  726 (823)
Q Consensus       656 ~~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~------  726 (823)
                      .......  .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......   ........      
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~---~~~~~~~~~g~~~~  233 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH---QLKLILSVLGSPSE  233 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH---HHHHHHHHhCCChh
Confidence            5432211  11123578889999999865 458899999999999999999999985322111   11110000      


Q ss_pred             -----hhhcCchhhhhhh-cCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          727 -----WIEERPVELINKS-LGGSYS-----LSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       727 -----~~~~~~~~~~~~~-l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                           .......+..+.. ......     .....++.+++.+|++.+|.+||++++++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                 0000001111100 000111     1123578899999999999999999998874

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.97  E-value=2.7e-32  Score=299.74  Aligned_cols=198  Identities=30%  Similarity=0.432  Sum_probs=173.1

Q ss_pred             CcCCeeeccCccceEEEEeec-CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCC------ceEEE
Q 003391          507 SDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD------ERMLI  578 (823)
Q Consensus       507 ~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~~~lV  578 (823)
                      ...+.||+|+||.||+|+++. |+.||||.+.+.. ....+...+|++++++++|+|||++++.-.+..      ...+|
T Consensus        16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv   95 (732)
T KOG4250|consen   16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV   95 (732)
T ss_pred             eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence            445789999999999999655 9999999997753 334566789999999999999999999876544      57899


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEE--cCCC--Cceeeccccce
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL--DNEM--NPKISDFGMAR  654 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll--~~~~--~~kl~DFGla~  654 (823)
                      ||||.+|||+..|.+..+...+++.+.+.+..+++.||.|||+++   |+||||||.||++  .+++  -.||+|||.|+
T Consensus        96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar  172 (732)
T KOG4250|consen   96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR  172 (732)
T ss_pred             EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence            999999999999988888888999999999999999999999988   9999999999998  3334  36999999999


Q ss_pred             ecCCCccccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCC
Q 003391          655 AFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGF  710 (823)
Q Consensus       655 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~  710 (823)
                      .+..+   ......+||..|++||.... +.|+..+|.|||||++||..||..||..
T Consensus       173 el~d~---s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p  226 (732)
T KOG4250|consen  173 ELDDN---SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP  226 (732)
T ss_pred             cCCCC---CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence            87433   25566899999999999984 8899999999999999999999999854

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.5e-31  Score=282.15  Aligned_cols=245  Identities=24%  Similarity=0.258  Sum_probs=188.5

Q ss_pred             CeeeccCccceEEEEeec-CcEEEEEEecCCcc---ccHHHHHHHHHHH-hccCCCCceeEEEEeecCCceEEEEeecCC
Q 003391          510 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG---QGMEEFENEVLLI-AKLQHRNLVKLIGCCTQRDERMLIYEYLPN  584 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~---~~~~~~~~Ei~~l-~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (823)
                      +.||+|+||.||+|.... ++.+|+|.+.+...   .....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            479999999999999754 88999999865432   2223344554444 445899999999999999999999999999


Q ss_pred             CCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccccc
Q 003391          585 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN  664 (823)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  664 (823)
                      ++|.+++..   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++....      
T Consensus        82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------  149 (260)
T cd05611          82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------  149 (260)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence            999999843   345889999999999999999999987   99999999999999999999999999875432      


Q ss_pred             cccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCC
Q 003391          665 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY  744 (823)
Q Consensus       665 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~  744 (823)
                      .....++..|+|||.+.+..++.++||||||+++|||++|..|+......       ..+........      ......
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~------~~~~~~  216 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-------AVFDNILSRRI------NWPEEV  216 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhccc------CCCCcc
Confidence            22346788999999998888999999999999999999999997532211       01111110000      000011


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          745 SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       745 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                      .......+.+++.+|++.+|++||++.++.+.|+-
T Consensus       217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~  251 (260)
T cd05611         217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH  251 (260)
T ss_pred             cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence            11223567899999999999999988777666553

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.97  E-value=1.6e-31  Score=287.44  Aligned_cols=261  Identities=24%  Similarity=0.304  Sum_probs=192.8

Q ss_pred             cCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      ++|+..+.||+|++|.||+|+.. +++.+|+|++....  ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888899999999999999986 48899999886543  2334678899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcC-CCCceeeccccceecCCC
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-EMNPKISDFGMARAFGID  659 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DFGla~~~~~~  659 (823)
                      |++ ++|.+++... ....+++..+..++.||+.||+|||+.+   ++|+||+|+||+++. ++.+||+|||++......
T Consensus        82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            996 5787777432 2233678888899999999999999987   999999999999985 557999999999765432


Q ss_pred             ccccccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhh--
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI--  736 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~--  736 (823)
                      ..  ......+++.|+|||++.+. .++.++||||||+++|||++|+.||......   .......... ........  
T Consensus       157 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~---~~~~~~~~~~-~~~~~~~~~~  230 (294)
T PLN00009        157 VR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI---DELFKIFRIL-GTPNEETWPG  230 (294)
T ss_pred             cc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHh-CCCChhhccc
Confidence            11  11224568899999988664 5789999999999999999999997532211   1111100000 00000000  


Q ss_pred             ----------hhhcCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          737 ----------NKSLGGS----YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       737 ----------~~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                                .+.....    .......++.+++.+|++.+|++||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence                      0000000    00111235788999999999999999999986

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=312.21  Aligned_cols=261  Identities=29%  Similarity=0.384  Sum_probs=204.1

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec--------CcEEEEEEecCCcc-ccHHHHHHHHHHHhcc-CCCCceeEEEEeec
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE--------GQEIAAKRLSKSSG-QGMEEFENEVLLIAKL-QHRNLVKLIGCCTQ  571 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~--------~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~  571 (823)
                      ..++....+.||+|.||.|++|....        ...||||.++.... ...+.+..|+++|+.+ +|+||+.++|+|.+
T Consensus       294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~  373 (609)
T KOG0200|consen  294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ  373 (609)
T ss_pred             chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence            34445566699999999999998642        34699999876543 4567899999999998 69999999999999


Q ss_pred             CCceEEEEeecCCCCcchhhhccC-------C----C--CccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEE
Q 003391          572 RDERMLIYEYLPNKSLNDFIFDVT-------R----S--KFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVL  638 (823)
Q Consensus       572 ~~~~~lV~e~~~~gsL~~~l~~~~-------~----~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIl  638 (823)
                      ++..++|+||++.|+|.++|+..+       .    .  ..++....+.++.|||.|++||++..   +|||||.++|||
T Consensus       374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVL  450 (609)
T KOG0200|consen  374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVL  450 (609)
T ss_pred             CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEE
Confidence            999999999999999999997644       0    0  23888999999999999999999987   999999999999


Q ss_pred             EcCCCCceeeccccceecCCCcccc-ccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCc
Q 003391          639 LDNEMNPKISDFGMARAFGIDQTEA-NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHH  716 (823)
Q Consensus       639 l~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~  716 (823)
                      +.++..+||+|||+|+......... ......-+..|||||.+....|+.|+|||||||+||||+| |..|++....  .
T Consensus       451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~--~  528 (609)
T KOG0200|consen  451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP--T  528 (609)
T ss_pred             ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc--H
Confidence            9999999999999999754443332 1111113457999999999999999999999999999999 5566532110  0


Q ss_pred             cchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          717 HNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       717 ~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                          ........++         -+...+.-+..++.++|..||+.+|++||+.+++++.|+..
T Consensus       529 ----~~l~~~l~~G---------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  529 ----EELLEFLKEG---------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             ----HHHHHHHhcC---------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence                0111111111         11122333355788999999999999999999999999983

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=3.5e-31  Score=282.46  Aligned_cols=241  Identities=24%  Similarity=0.307  Sum_probs=185.2

Q ss_pred             eeeccCccceEEEEeec-CcEEEEEEecCCcc---ccHHHHHHHHH---HHhccCCCCceeEEEEeecCCceEEEEeecC
Q 003391          511 KLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG---QGMEEFENEVL---LIAKLQHRNLVKLIGCCTQRDERMLIYEYLP  583 (823)
Q Consensus       511 ~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~---~~~~~~~~Ei~---~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (823)
                      .||+|+||.||++.... ++.||+|.+.+...   .....+..|..   .++...||||+++.+++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            48999999999999765 78999999865422   12223344443   3444579999999999999999999999999


Q ss_pred             CCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccc
Q 003391          584 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA  663 (823)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  663 (823)
                      +++|.+++.   +...+++..+..++.|+++||.|||+.+   |+|+||||+||+++.++.+||+|||++..+...    
T Consensus        81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----  150 (278)
T cd05606          81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK----  150 (278)
T ss_pred             CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc----
Confidence            999998884   3456899999999999999999999987   999999999999999999999999999765322    


Q ss_pred             ccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCC
Q 003391          664 NTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG  742 (823)
Q Consensus       664 ~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~  742 (823)
                      ......|+..|+|||.+.++ .++.++||||+|+++|||++|+.||...........    .....          ....
T Consensus       151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~----------~~~~  216 (278)
T cd05606         151 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTL----------TMAV  216 (278)
T ss_pred             CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HHHhh----------ccCC
Confidence            12234689999999998754 689999999999999999999999754322111100    00000          0001


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003391          743 SYSLSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVL  775 (823)
Q Consensus       743 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  775 (823)
                      ..+......+.+++.+|++.+|.+||     ++.++++
T Consensus       217 ~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         217 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            11111234678899999999999999     9999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=2.8e-31  Score=284.70  Aligned_cols=256  Identities=23%  Similarity=0.306  Sum_probs=198.4

Q ss_pred             CCCcCCeeeccCccceEEEEee----cCcEEEEEEecCCc----cccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCce
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLI----EGQEIAAKRLSKSS----GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDER  575 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~----~~~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~  575 (823)
                      +|...+.||+|++|.||+++..    +++.+|+|.+.+..    ....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            3667789999999999999853    36789999886432    23345688999999999 599999999999999999


Q ss_pred             EEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccccee
Q 003391          576 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                      ++||||+++++|.+++..   ...+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            999999999999998843   345889999999999999999999987   99999999999999999999999999986


Q ss_pred             cCCCccccccccccccCCccCccccccCC--CCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCch
Q 003391          656 FGIDQTEANTNRVVGTYGYMPPEYAIDGL--FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV  733 (823)
Q Consensus       656 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  733 (823)
                      +...... ......++..|+|||.+.+..  .+.++||||||+++|||++|..|+.......  .. .......      
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~-~~~~~~~------  224 (288)
T cd05583         155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQ-SEISRRI------  224 (288)
T ss_pred             ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hH-HHHHHHH------
Confidence            5433211 122346788999999987665  7889999999999999999999975322111  00 0100000      


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          734 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       734 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                        ...  ....+......+.+++.+|++.+|++|||+.++.+.|+..
T Consensus       225 --~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         225 --LKS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             --Hcc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence              000  0111111224677899999999999999999998888763

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=2e-31  Score=284.78  Aligned_cols=263  Identities=25%  Similarity=0.305  Sum_probs=193.8

Q ss_pred             CCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc-ccHHHHHHHHHHHhccC-CCCceeEEEEeecCCceEEEEeec
Q 003391          506 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       506 ~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      |.+.+.||+|++|.||+|+..+ ++.+++|++..... .......+|+..+.+++ |+|++++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            4567899999999999999865 78899999865432 22334567999999998 999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  662 (823)
                       +++|.+++.... ...+++..+..++.|++.+|.|||+.+   ++|+||+|+||++++++.++|+|||++.......  
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--  153 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--  153 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC--
Confidence             889998885432 346899999999999999999999987   9999999999999999999999999998653221  


Q ss_pred             cccccccccCCccCccccc-cCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHH-----HHHhhhcC-chhh
Q 003391          663 ANTNRVVGTYGYMPPEYAI-DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA-----WRLWIEER-PVEL  735 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~-~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~-----~~~~~~~~-~~~~  735 (823)
                       ......++..|+|||++. ...++.++|+||||++++||++|+.|+......+........     ...+.+.. ....
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence             122345788999999885 445789999999999999999999887543221110000000     00000000 0000


Q ss_pred             hhhhcCCC--CCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          736 INKSLGGS--YSL-----SEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       736 ~~~~l~~~--~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      +...+...  ...     ....++.+++.+|++.+|++||+++|++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            00000000  000     113578899999999999999999999754

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=2.3e-31  Score=286.52  Aligned_cols=252  Identities=21%  Similarity=0.357  Sum_probs=191.8

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc-cccHHHHHHHHHHHhccC-CCCceeEEEEeecCCceEEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~  579 (823)
                      .++|...+.||+|+||.||+|.+.. ++.+|+|++.... .....++..|+.++.+.. ||||+++++++.++...++||
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            3567888999999999999999876 8899999987543 234455677887777775 999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhc-CCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      ||+++ +|.+++...  ...+++..+..++.||++||+|||+. +   |+|+||+|+||++++++.+||+|||++..+..
T Consensus        94 e~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          94 ELMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             eccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            99854 676665332  23689999999999999999999974 5   99999999999999999999999999976532


Q ss_pred             CccccccccccccCCccCccccccCC----CCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGL----FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE  734 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~----~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  734 (823)
                      ....   ....++..|+|||.+.+..    ++.++||||||+++|||++|+.||......     . .............
T Consensus       168 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~-~~~~~~~~~~~~~  238 (296)
T cd06618         168 SKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----F-EVLTKILQEEPPS  238 (296)
T ss_pred             CCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----H-HHHHHHhcCCCCC
Confidence            2211   2235778999999987554    788999999999999999999997532111     0 0011111111000


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          735 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       735 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                           ..  .......++.+++.+|++.+|.+||++.++++.
T Consensus       239 -----~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         239 -----LP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             -----CC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                 00  011123467899999999999999999999865

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.97  E-value=3.5e-31  Score=287.59  Aligned_cols=261  Identities=19%  Similarity=0.221  Sum_probs=189.6

Q ss_pred             CCeeeccCccceEEEEeecCcEEEEEEecCC--ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCCCC
Q 003391          509 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKS  586 (823)
Q Consensus       509 ~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  586 (823)
                      .+.+|.|+++.||++.. +++.+|+|++...  .....+.+..|+.+++.++|+||+++++++.+.+..+++|||+++++
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            34455556666666554 5899999998754  34456789999999999999999999999999999999999999999


Q ss_pred             cchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc-----
Q 003391          587 LNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT-----  661 (823)
Q Consensus       587 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~-----  661 (823)
                      |.+++.... ...+++..+..++.|+++||+|||+.+   |+|+||||+||+++.++.+||+|||.+........     
T Consensus        86 l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          86 CEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             HHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            999986432 234788999999999999999999987   99999999999999999999999999875532211     


Q ss_pred             ccccccccccCCccCcccccc--CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHh---hhcCchh--
Q 003391          662 EANTNRVVGTYGYMPPEYAID--GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW---IEERPVE--  734 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~---~~~~~~~--  734 (823)
                      ........++..|+|||++..  ..++.++||||||+++|||++|+.||.......  .+........   .......  
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  239 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLY  239 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhh
Confidence            111223456778999999876  358899999999999999999999975322111  1111000000   0000000  


Q ss_pred             ----------hhhhhc----CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          735 ----------LINKSL----GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       735 ----------~~~~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                                ..+...    ..........++.+++.+||+.+|++|||++++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence                      000000    000111122467889999999999999999999864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.97  E-value=1.1e-30  Score=276.90  Aligned_cols=244  Identities=22%  Similarity=0.265  Sum_probs=185.4

Q ss_pred             HhcCCCcCCee--eccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceEE
Q 003391          502 ATENFSDKNKL--GEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       502 ~~~~~~~~~~L--G~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l  577 (823)
                      ..++|...+.+  |+|+||.||++.... +..+|+|.+........     |+.....+ +|||++++++.+...+..++
T Consensus        12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~i   86 (267)
T PHA03390         12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVL   86 (267)
T ss_pred             HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence            34566666665  999999999999754 77888888765422211     22222222 79999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCC-Cceeeccccceec
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAF  656 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DFGla~~~  656 (823)
                      ||||+++++|.+++..   ...+++..+..++.|+++||.|||+.+   ++|+||||+||+++.++ .++|+|||++...
T Consensus        87 v~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~  160 (267)
T PHA03390         87 IMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKII  160 (267)
T ss_pred             EEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence            9999999999999843   237899999999999999999999988   99999999999999998 9999999998765


Q ss_pred             CCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          657 GIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       657 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      ...      ....++..|+|||++.+..++.++||||||+++|||++|+.|+....... ...... ....  .      
T Consensus       161 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~-~~~~--~------  224 (267)
T PHA03390        161 GTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESL-LKRQ--Q------  224 (267)
T ss_pred             CCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHH-HHhh--c------
Confidence            322      12457889999999999899999999999999999999999986322211 001000 0000  0      


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPN-MSSVVL  775 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~  775 (823)
                       ...  .........+.+++.+|++.+|.+||+ ++|+++
T Consensus       225 -~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        225 -KKL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             -ccC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence             000  011122346788999999999999996 688874

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.97  E-value=3.7e-31  Score=289.28  Aligned_cols=261  Identities=22%  Similarity=0.268  Sum_probs=189.9

Q ss_pred             Ceeecc--CccceEEEEee-cCcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCC
Q 003391          510 NKLGEG--GFGPVYKGVLI-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPN  584 (823)
Q Consensus       510 ~~LG~G--~fg~Vyk~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (823)
                      ..||+|  +||+||++++. .++.||+|++....  ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            356666  88999999985 48999999986542  23356788999999999999999999999999999999999999


Q ss_pred             CCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccc-
Q 003391          585 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA-  663 (823)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~-  663 (823)
                      ++|.+++.... ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++++||+.+.......... 
T Consensus        84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            99999886432 234889999999999999999999987   9999999999999999999999998654321111100 


Q ss_pred             ----ccccccccCCccCccccccC--CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHH--------------
Q 003391          664 ----NTNRVVGTYGYMPPEYAIDG--LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA--------------  723 (823)
Q Consensus       664 ----~~~~~~gt~~y~aPE~l~~~--~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------------  723 (823)
                          ......++..|+|||++.+.  .++.++||||||+++|||++|+.||........  .....              
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  237 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTFP  237 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccccc
Confidence                01112345679999999764  478999999999999999999999854321100  00000              


Q ss_pred             --HHHh-------hhcCch---------hhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          724 --WRLW-------IEERPV---------ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       724 --~~~~-------~~~~~~---------~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                        ...+       ......         ......+...........+.+++.+||+.||++|||+.|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence              0000       000000         0000111111122334578899999999999999999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=1e-31  Score=274.65  Aligned_cols=264  Identities=22%  Similarity=0.328  Sum_probs=210.7

Q ss_pred             HHHHHHhcCCCcCCeeeccCccceEEEEeec------CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEe
Q 003391          497 MAIANATENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCC  569 (823)
Q Consensus       497 ~~l~~~~~~~~~~~~LG~G~fg~Vyk~~~~~------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~  569 (823)
                      .++....++++...++-+|.||.||+|.+.+      .+.|-+|.++... +-....+..|.-++..+.|||+..+.+++
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            3455556778888899999999999997654      3456667665443 33456678899999999999999999998


Q ss_pred             ecC-CceEEEEeecCCCCcchhhh-----ccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCC
Q 003391          570 TQR-DERMLIYEYLPNKSLNDFIF-----DVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM  643 (823)
Q Consensus       570 ~~~-~~~~lV~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~  643 (823)
                      .+. ..++.+|.++.-|+|..||.     +......++..+...++.|++.|++|||..+   |||.||.++|++||+..
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence            665 56888999999999999998     4444556788889999999999999999998   99999999999999999


Q ss_pred             CceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHH
Q 003391          644 NPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGH  722 (823)
Q Consensus       644 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~  722 (823)
                      ++||+|=.+++.+-..+.......-..+..||+||.+.+..|+.++|||||||+||||+| |+.|+...++.+....+. 
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk-  512 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK-  512 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh-
Confidence            999999999998755555554554556789999999999999999999999999999998 778864433332211111 


Q ss_pred             HHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          723 AWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       723 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                            ++       .++  ..+..++.++..+|.-||...|++||+.++++.-|.+
T Consensus       513 ------dG-------yRl--aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  513 ------DG-------YRL--AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             ------cc-------cee--cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence                  11       111  1234566688999999999999999999999998864

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=5.9e-31  Score=287.46  Aligned_cols=263  Identities=23%  Similarity=0.321  Sum_probs=195.7

Q ss_pred             HHhcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeec-CCceE
Q 003391          501 NATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ-RDERM  576 (823)
Q Consensus       501 ~~~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~  576 (823)
                      ..+++|+..+.||+|+||.||++... .++.+|+|++.+..  ....+.+.+|+.++.+++||||+++.+++.. ....+
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            46788999999999999999999876 48899999886532  2345678899999999999999999999865 56789


Q ss_pred             EEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceec
Q 003391          577 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  656 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  656 (823)
                      +|+||+ +++|.+++.    ...+++.....++.|+++||.|||+.+   |+|+||+|+||++++++.++|+|||++...
T Consensus        87 lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          87 FVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             EEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            999998 568888773    335788888899999999999999988   999999999999999999999999998754


Q ss_pred             CCCccccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchh--------HHHHHHh
Q 003391          657 GIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL--------GHAWRLW  727 (823)
Q Consensus       657 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~--------~~~~~~~  727 (823)
                      ..     ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||............        .......
T Consensus       159 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (328)
T cd07856         159 DP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI  233 (328)
T ss_pred             CC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            22     1123456889999998866 56899999999999999999999987543221100000        0000000


Q ss_pred             hhcCchhhhhhh-cCCCCCHH-----HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          728 IEERPVELINKS-LGGSYSLS-----EVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       728 ~~~~~~~~~~~~-l~~~~~~~-----~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ......+.+... .....+..     ....+.+++.+|++.+|++||++.+++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            011111111110 00111111     12478899999999999999999999765

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.9e-31  Score=293.22  Aligned_cols=262  Identities=23%  Similarity=0.329  Sum_probs=194.0

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCC------
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD------  573 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------  573 (823)
                      .++|...+.||+|+||.||+|+.. .++.+|+|++....  ......+.+|+.++++++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478888999999999999999975 48899999986542  233456889999999999999999999986543      


Q ss_pred             ceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccc
Q 003391          574 ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  653 (823)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  653 (823)
                      ..++|+||+.. +|..++     ...+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            46899999964 666554     235789999999999999999999987   999999999999999999999999998


Q ss_pred             eecCCCccccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCc
Q 003391          654 RAFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP  732 (823)
Q Consensus       654 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  732 (823)
                      +....     ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......   .......... ....
T Consensus       165 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~---~~~~~~~~~~-~~~~  235 (342)
T cd07879         165 RHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVT-GVPG  235 (342)
T ss_pred             cCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhc-CCCC
Confidence            75422     1223467889999999876 46889999999999999999999998642211   1111111100 0000


Q ss_pred             hhhhhh-----------hcC--CCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHH--hccCCC
Q 003391          733 VELINK-----------SLG--GSYSL-----SEVLRCIQVGLLCVQQRPEDRPNMSSVVLM--LSGERS  782 (823)
Q Consensus       733 ~~~~~~-----------~l~--~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~~  782 (823)
                      .+..+.           ...  .....     .....+.+++.+|++.||++||+++|++..  +++.+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            000000           000  00000     112357899999999999999999999954  665543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.97  E-value=9.1e-31  Score=280.15  Aligned_cols=259  Identities=21%  Similarity=0.329  Sum_probs=191.7

Q ss_pred             CCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccc--cHHHHHHHHHHHhcc---CCCCceeEEEEeecCCc-----
Q 003391          506 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQ--GMEEFENEVLLIAKL---QHRNLVKLIGCCTQRDE-----  574 (823)
Q Consensus       506 ~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~-----  574 (823)
                      |++.+.||+|+||.||+|+... ++.+|+|++......  ....+.+|+.++.++   +|||++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            4567899999999999999875 889999999754322  234566787777665   69999999999988776     


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccce
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  654 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  654 (823)
                      .+++|||+++ +|.+++.... ...+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.+||+|||++.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            8999999975 7888875422 235899999999999999999999987   9999999999999999999999999998


Q ss_pred             ecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCch-
Q 003391          655 AFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV-  733 (823)
Q Consensus       655 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-  733 (823)
                      .+.....   .....++..|+|||.+.+..++.++|+||||+++|||++|+.|+......+   ............... 
T Consensus       156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~  229 (287)
T cd07838         156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD---QLDKIFDVIGLPSEEE  229 (287)
T ss_pred             eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH---HHHHHHHHcCCCChHh
Confidence            7643321   122457889999999999999999999999999999999988875322211   111111100000000 


Q ss_pred             ---------hhhhhhcCCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          734 ---------ELINKSLGGSY---SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       734 ---------~~~~~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                               ...........   ...-...+.+++.+|++.+|++||++.|++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                     00000000000   0112346778999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=4e-31  Score=289.93  Aligned_cols=263  Identities=22%  Similarity=0.273  Sum_probs=193.3

Q ss_pred             cCCC-cCCeeeccCccceEEEEee-cCcEEEEEEecCCcccc--------------HHHHHHHHHHHhccCCCCceeEEE
Q 003391          504 ENFS-DKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQG--------------MEEFENEVLLIAKLQHRNLVKLIG  567 (823)
Q Consensus       504 ~~~~-~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~--------------~~~~~~Ei~~l~~l~H~niv~l~g  567 (823)
                      ++|. ..+.||+|+||.||+|+.. .++.||+|++.......              ...+.+|++++..++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4454 3467999999999999976 48899999986543221              125778999999999999999999


Q ss_pred             EeecCCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCcee
Q 003391          568 CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI  647 (823)
Q Consensus       568 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl  647 (823)
                      ++...+..++||||++ ++|.+++.   ....+++.....++.|++.||+|||+.+   ++|+||+|+||+++.++.++|
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence            9999999999999997 58988874   3345889999999999999999999987   999999999999999999999


Q ss_pred             eccccceecCCCc------------cccccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCC
Q 003391          648 SDFGMARAFGIDQ------------TEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHAD  714 (823)
Q Consensus       648 ~DFGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~  714 (823)
                      +|||++.....+.            .........++..|+|||.+.+. .++.++||||||+++|||++|+.|+......
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~  240 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI  240 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999998664111            01111223467889999998764 4689999999999999999999997543321


Q ss_pred             CccchhHHHHHHhhhcCchhh-----------hhhhcCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          715 HHHNLLGHAWRLWIEERPVEL-----------INKSLGGS---YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       715 ~~~~l~~~~~~~~~~~~~~~~-----------~~~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                         ..................           ........   .......++.+++..|++.+|++||++.|++..
T Consensus       241 ---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        241 ---DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             ---HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence               111111111100000000           00000000   000113467899999999999999999999853

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.97  E-value=5.2e-31  Score=285.45  Aligned_cols=247  Identities=30%  Similarity=0.403  Sum_probs=192.4

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC---ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      +.|+..+.||+|+||.||+|+... ++.+|+|.+...   ......++.+|+++++.++|+|++++.+++......++|+
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            346667899999999999999764 778999988643   2233456788999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+. ++|.+++..  ....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          95 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             EccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            9997 578777643  2345789999999999999999999987   999999999999999999999999998765321


Q ss_pred             ccccccccccccCCccCccccc---cCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                            ....++..|+|||.+.   ...++.++||||||+++|||++|+.|+.......   ...    .......    
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~----~~~~~~~----  231 (308)
T cd06634         169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALY----HIAQNES----  231 (308)
T ss_pred             ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH---HHH----HHhhcCC----
Confidence                  2346788999999975   3567889999999999999999999864321110   000    0000000    


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML  777 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  777 (823)
                          ...........+.+++.+|++.+|++||++.+++...
T Consensus       232 ----~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         232 ----PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             ----CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence                0001112234677899999999999999999999764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=1.7e-31  Score=284.62  Aligned_cols=249  Identities=25%  Similarity=0.343  Sum_probs=200.2

Q ss_pred             cCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCC---ccccHHHHHHHHHHHhccC-CCCceeEEEEeecCCceEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV  578 (823)
                      ++|...+.||+|+||.||+++.. +++.+|+|.+.+.   .....+.+.+|++++++++ ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36788899999999999999986 4889999998653   2233467889999999998 99999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      |||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            999999999999853   336999999999999999999999988   99999999999999999999999999987643


Q ss_pred             Cccc------------------cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchh
Q 003391          659 DQTE------------------ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL  720 (823)
Q Consensus       659 ~~~~------------------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~  720 (823)
                      ....                  .......++..|+|||.+.+..++.++||||||++++||++|+.|+......      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------  228 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY------  228 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH------
Confidence            3211                  2223356788999999999888999999999999999999999997533210      


Q ss_pred             HHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 003391          721 GHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNM----SSVVL  775 (823)
Q Consensus       721 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~----~evl~  775 (823)
                      ... .        ...  ......+......+.+++.+|++.+|++||++    .++++
T Consensus       229 ~~~-~--------~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         229 LTF-Q--------KIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHH-H--------HHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            000 0        000  01111222224567899999999999999999    77764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=8.5e-31  Score=281.19  Aligned_cols=251  Identities=23%  Similarity=0.305  Sum_probs=193.0

Q ss_pred             CCCcCCeeeccCccceEEEEee----cCcEEEEEEecCCc----cccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCce
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLI----EGQEIAAKRLSKSS----GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDER  575 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~----~~~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~  575 (823)
                      +|+..+.||+|+||.||++...    +++.+|+|++....    ....+.+.+|+.++.++ +|+||+++.+.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            3677889999999999999863    57899999986532    22346678999999999 699999999999998999


Q ss_pred             EEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccccee
Q 003391          576 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                      ++|+||+++++|.+++..   ...+++..+..++.|+++||.|||+.+   ++||||+|+|||+++++.+||+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            999999999999999853   345788999999999999999999987   99999999999999999999999999986


Q ss_pred             cCCCccccccccccccCCccCccccccC--CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCch
Q 003391          656 FGIDQTEANTNRVVGTYGYMPPEYAIDG--LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV  733 (823)
Q Consensus       656 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  733 (823)
                      ...... .......++..|+|||.+...  .++.++||||||+++|||++|+.|+......  ....... ......   
T Consensus       155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~-~~~~~~---  227 (290)
T cd05613         155 FHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEIS-RRILKS---  227 (290)
T ss_pred             cccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHH-HHhhcc---
Confidence            543221 122235688899999998753  4688999999999999999999997532111  1110000 000000   


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003391          734 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVL  775 (823)
Q Consensus       734 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  775 (823)
                             ....+......+.+++.+|++.+|++||     ++.+++.
T Consensus       228 -------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         228 -------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             -------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                   0111112234677899999999999997     6666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=1e-30  Score=283.81  Aligned_cols=244  Identities=28%  Similarity=0.426  Sum_probs=189.7

Q ss_pred             CCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc---ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          506 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       506 ~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      |...++||+|+||.||+|+... ++.+++|++.....   .....+.+|+++++.++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            5556789999999999999754 78899999865432   2345678899999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +. ++|.+++..  ....+++..+..++.||+.+|.|||+.+   ++|+||+|+||++++++.+||+|||++....    
T Consensus       103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~----  172 (313)
T cd06633         103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS----  172 (313)
T ss_pred             CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence            96 577777643  2345899999999999999999999988   9999999999999999999999999986421    


Q ss_pred             ccccccccccCCccCccccc---cCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          662 EANTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                        ......++..|+|||++.   ...++.++||||||+++|||++|..|+.....      ......... ......   
T Consensus       173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~-~~~~~~---  240 (313)
T cd06633         173 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQ-NDSPTL---  240 (313)
T ss_pred             --CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHh-cCCCCC---
Confidence              122356888999999984   45688999999999999999999998643211      000000000 000000   


Q ss_pred             hcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       739 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                           ........+.+++.+|++.+|.+||++.+++..
T Consensus       241 -----~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         241 -----QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             -----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 011112357789999999999999999999854

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=4.6e-31  Score=278.43  Aligned_cols=250  Identities=26%  Similarity=0.340  Sum_probs=193.1

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC-----ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS-----SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      +|.+.+.||+|+||.||+++... +..+++|.++..     ......++..|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47778899999999999998754 444555554332     122344577899999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          579 YEYLPNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      +||+++++|.+++... .....+++..+..++.|+++||.|||+.+   ++|+||+|+||++++ +.++|+|||+++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999988642 23456899999999999999999999987   999999999999975 569999999998753


Q ss_pred             CCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhh
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN  737 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  737 (823)
                      ....  ......++..|+|||.+.+..++.++|+||||+++|+|++|..|+....      ..... ......       
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~-~~~~~~-------  220 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVV-LRIVEG-------  220 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHH-HHHHcC-------
Confidence            3221  2223567889999999988889999999999999999999999874211      11110 000000       


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          738 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       738 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                        .....+.....++.+++.+|++.+|++||++.|+++.
T Consensus       221 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         221 --PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             --CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence              0111222334577899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.97  E-value=8.8e-32  Score=309.68  Aligned_cols=252  Identities=27%  Similarity=0.419  Sum_probs=185.8

Q ss_pred             HHhcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeec-------
Q 003391          501 NATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ-------  571 (823)
Q Consensus       501 ~~~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-------  571 (823)
                      +-..+|++.+.||+||||.|||++.+ ||+.+|||+|.... ......+.+|+..+.+|+|||||+++....+       
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            34567888999999999999999965 69999999997653 3345568899999999999999998632100       


Q ss_pred             ----------------------------------------------------------C---------------------
Q 003391          572 ----------------------------------------------------------R---------------------  572 (823)
Q Consensus       572 ----------------------------------------------------------~---------------------  572 (823)
                                                                                +                     
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                      0                     


Q ss_pred             ---------------------------------CceEEEEeecCCCCcchhhhccCCCCcc-CHHHHHHHHHHHHHHHHH
Q 003391          573 ---------------------------------DERMLIYEYLPNKSLNDFIFDVTRSKFL-DWSKRCQIIGGIARGLLY  618 (823)
Q Consensus       573 ---------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l-~~~~~~~i~~~ia~gL~y  618 (823)
                                                       ..+|+=||||+..+|++++.+.   ... .....++++.+|++||+|
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N---~~~~~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN---HFNSQRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc---ccchhhHHHHHHHHHHHHHHHH
Confidence                                             0135667888887777777432   222 456788999999999999


Q ss_pred             HHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC----------C------CccccccccccccCCccCcccccc
Q 003391          619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG----------I------DQTEANTNRVVGTYGYMPPEYAID  682 (823)
Q Consensus       619 LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~----------~------~~~~~~~~~~~gt~~y~aPE~l~~  682 (823)
                      +|+.+   ||||||||.||+|+++..+||+|||+|+...          .      .......+..+||.-|+|||++.+
T Consensus       713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~  789 (1351)
T KOG1035|consen  713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD  789 (1351)
T ss_pred             HHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence            99998   9999999999999999999999999998721          0      011113345789999999999976


Q ss_pred             CC---CCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC--CCCCHHHHHHHHHHHH
Q 003391          683 GL---FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG--GSYSLSEVLRCIQVGL  757 (823)
Q Consensus       683 ~~---~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~--~~~~~~~~~~l~~l~~  757 (823)
                      ..   |+.|+|+||+|+||+||+.-   |+...  +....    ..        .+-+..+.  ..+..++...-.+++.
T Consensus       790 ~~~~~Yn~KiDmYSLGIVlFEM~yP---F~TsM--ERa~i----L~--------~LR~g~iP~~~~f~~~~~~~e~slI~  852 (1351)
T KOG1035|consen  790 TSSNKYNSKIDMYSLGIVLFEMLYP---FGTSM--ERASI----LT--------NLRKGSIPEPADFFDPEHPEEASLIR  852 (1351)
T ss_pred             cccccccchhhhHHHHHHHHHHhcc---CCchH--HHHHH----HH--------hcccCCCCCCcccccccchHHHHHHH
Confidence            55   99999999999999999853   32110  00000    00        01111111  2233445556678999


Q ss_pred             HccccCCCCCCCHHHHHH
Q 003391          758 LCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       758 ~Cl~~dP~~RPs~~evl~  775 (823)
                      ++++.||++|||+.|++.
T Consensus       853 ~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  853 WLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHhcCCCccCCCHHHHhh
Confidence            999999999999999974

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=5.2e-31  Score=289.78  Aligned_cols=262  Identities=21%  Similarity=0.306  Sum_probs=192.7

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecC----------
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR----------  572 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~----------  572 (823)
                      .+|...+.||.|+||.||+|+... ++.||+|++........+.+.+|++++++++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            678889999999999999999765 889999998776666677889999999999999999999776543          


Q ss_pred             ----CceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEc-CCCCcee
Q 003391          573 ----DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKI  647 (823)
Q Consensus       573 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~-~~~~~kl  647 (823)
                          ...++|+||++ ++|.+++.    ...+++..+..++.||++||.|||+.+   |+||||||+||+++ ++..+||
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence                35789999997 58888773    235889999999999999999999988   99999999999997 4567899


Q ss_pred             eccccceecCCCccc-cccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHH
Q 003391          648 SDFGMARAFGIDQTE-ANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR  725 (823)
Q Consensus       648 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~  725 (823)
                      +|||++..+...... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||........   ......
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~---~~~~~~  233 (342)
T cd07854         157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ---MQLILE  233 (342)
T ss_pred             CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHH
Confidence            999999865332111 11122357889999998754 5688899999999999999999999853321110   000000


Q ss_pred             -----------HhhhcCchhhhhhhcCCCCCHH-----HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          726 -----------LWIEERPVELINKSLGGSYSLS-----EVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       726 -----------~~~~~~~~~~~~~~l~~~~~~~-----~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                                 ...................+..     ...++.+++.+|++.+|++||++.|++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence                       0000000000000000001111     12467789999999999999999999853

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.8e-31  Score=292.00  Aligned_cols=262  Identities=22%  Similarity=0.304  Sum_probs=199.3

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCC-----ceE
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD-----ERM  576 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~  576 (823)
                      +|...+.||+|++|.||+|+... ++.+|+|++....  ....+.+.+|+.+++.++|+||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            47778899999999999999865 8899999987654  345567899999999999999999999998775     789


Q ss_pred             EEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceec
Q 003391          577 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  656 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  656 (823)
                      +||||+++ +|.+++..   ...+++..+..++.+|+.||+|||+.+   |+|+||||+||+++.++.++|+|||++...
T Consensus        81 lv~e~~~~-~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELMET-DLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchhh-hHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            99999984 78887742   337899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCcc-ccccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHh-------
Q 003391          657 GIDQT-EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW-------  727 (823)
Q Consensus       657 ~~~~~-~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~-------  727 (823)
                      ..... ........++..|+|||.+.+. .++.++|+||||+++|||++|+.||......+.   ........       
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~  230 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ---LNLIVEVLGTPSEED  230 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHhcCCCChhH
Confidence            44321 0122335678899999999887 789999999999999999999999754332110   00000000       


Q ss_pred             ----hhcCchhhhhhh-cCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          728 ----IEERPVELINKS-LGGSYS-----LSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       728 ----~~~~~~~~~~~~-l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                          ........+... .....+     ......+.+++.+||+.+|++||++.+++..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                000000000000 000000     1123467899999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=9.8e-32  Score=267.45  Aligned_cols=203  Identities=27%  Similarity=0.393  Sum_probs=170.6

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-----CcEEEEEEecCCccc--cHHHHHHHHHHHhccCCCCceeEEEEeec-CCce
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-----GQEIAAKRLSKSSGQ--GMEEFENEVLLIAKLQHRNLVKLIGCCTQ-RDER  575 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-----~~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~  575 (823)
                      ..|+....||+|.||.||||.-.+     ...+|+|+++.....  -.....+|+.+++.++||||+.|..++.+ +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            467788899999999999996543     337899999665321  22356789999999999999999999877 7789


Q ss_pred             EEEEeecCCCCcchhhhc--cCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCC----CCceeec
Q 003391          576 MLIYEYLPNKSLNDFIFD--VTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE----MNPKISD  649 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~----~~~kl~D  649 (823)
                      +|++||.+. +|.+.|+-  ..+.+.++..++..|+.||+.|+.|||+..   |+||||||.|||+..+    |.+||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence            999999977 88887753  334467899999999999999999999997   9999999999999887    8999999


Q ss_pred             cccceecCCCccc-cccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCC
Q 003391          650 FGMARAFGIDQTE-ANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGF  710 (823)
Q Consensus       650 FGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~  710 (823)
                      ||+++.+..+-.. ...+.++-|..|.|||.+.+. .||.+.|||+.|||+.||+|-+.-|..
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence            9999998655332 245567889999999999876 589999999999999999998877653

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.5e-30  Score=284.40  Aligned_cols=262  Identities=21%  Similarity=0.287  Sum_probs=194.3

Q ss_pred             HHHHhcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCC--
Q 003391          499 IANATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD--  573 (823)
Q Consensus       499 l~~~~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--  573 (823)
                      +....++|+..+.||+|+||.||++... ++..||+|++....  ....+.+.+|+.++++++||||+++++++....  
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            3345678999999999999999999865 48899999986532  223456889999999999999999999987553  


Q ss_pred             ----ceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeec
Q 003391          574 ----ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISD  649 (823)
Q Consensus       574 ----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D  649 (823)
                          ..++||||+ +++|.+++.    ...+++..+..++.||++||+|||+.+   |+||||||+||++++++.++|+|
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~d  161 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILD  161 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence                358999998 778888773    345899999999999999999999988   99999999999999999999999


Q ss_pred             cccceecCCCccccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHH------
Q 003391          650 FGMARAFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH------  722 (823)
Q Consensus       650 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~------  722 (823)
                      ||++......     .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.......  .+...      
T Consensus       162 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~--~~~~~~~~~~~  234 (343)
T cd07880         162 FGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD--QLMEIMKVTGT  234 (343)
T ss_pred             cccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCC
Confidence            9999764321     223457889999999876 458899999999999999999999975322110  00000      


Q ss_pred             ----HHHHhhhcCchhhhhhhcCCC------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          723 ----AWRLWIEERPVELINKSLGGS------YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       723 ----~~~~~~~~~~~~~~~~~l~~~------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                          .....................      ........+.+++.+|++.+|++|||+.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         235 PSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             CCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                000000000000000000000      00011235789999999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-32  Score=316.98  Aligned_cols=254  Identities=26%  Similarity=0.370  Sum_probs=200.4

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC--ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      .+-++.....||.|.||.||-|...+ |.-.|+|-+...  .........+|+.++..++|||+|+.+|+-...+..+|.
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence            44566778899999999999999766 777899876543  345566788999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      ||||++|+|.+.+.   .+...++.....+..|++.|++|||+++   ||||||||.||+|+.+|.+|++|||.|..+..
T Consensus      1313 MEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence            99999999999883   3344667777788899999999999998   99999999999999999999999999998754


Q ss_pred             Cc--cccccccccccCCccCccccccCC---CCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCch
Q 003391          659 DQ--TEANTNRVVGTYGYMPPEYAIDGL---FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV  733 (823)
Q Consensus       659 ~~--~~~~~~~~~gt~~y~aPE~l~~~~---~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  733 (823)
                      ..  .....+...||+.|||||++.+..   ...++||||+|||++||+||++|+...+..-  .++.++    -.+.. 
T Consensus      1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~--aIMy~V----~~gh~- 1459 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW--AIMYHV----AAGHK- 1459 (1509)
T ss_pred             chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh--HHHhHH----hccCC-
Confidence            42  112334578999999999997644   5678999999999999999999975433221  000000    00111 


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          734 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       734 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                              +.++..-..+-.+++..|++.||++|-++.|+++.
T Consensus      1460 --------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1460 --------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             --------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                    11222222355688999999999999999888765

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.7e-32  Score=270.09  Aligned_cols=241  Identities=25%  Similarity=0.311  Sum_probs=193.8

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc---ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      .++|...++||+|.||.|-.++-+. ++.+|+|++++..-   .....-..|-++|+..+||.+..+--.++..+++++|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            4678889999999999999998765 88999999987643   3333456788999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      |||..||.|.-+|.   +.+.+++...+-+...|+.||.|||+.+   ||.||||.+|.|||.+|++||+|||+++.-- 
T Consensus       247 MeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-  319 (516)
T KOG0690|consen  247 MEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI-  319 (516)
T ss_pred             EEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc-
Confidence            99999999998883   4566888888899999999999999987   9999999999999999999999999998531 


Q ss_pred             CccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                       .....+...+||+.|+|||++.+..|..++|.|.+|||+|||++|+.||-.  .+. .-+...+            +-.
T Consensus       320 -~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn--~dh-~kLFeLI------------l~e  383 (516)
T KOG0690|consen  320 -KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN--KDH-EKLFELI------------LME  383 (516)
T ss_pred             -cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc--cch-hHHHHHH------------Hhh
Confidence             233455668999999999999999999999999999999999999999742  211 1111110            011


Q ss_pred             hcCCCCCHHHHHHHHHHHHHccccCCCCCC
Q 003391          739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRP  768 (823)
Q Consensus       739 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP  768 (823)
                      .+  .++.....+...|....+..||.+|.
T Consensus       384 d~--kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  384 DL--KFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             hc--cCCccCCHHHHHHHHHHhhcChHhhc
Confidence            11  11111122445677788899999997

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=3.9e-31  Score=291.13  Aligned_cols=263  Identities=24%  Similarity=0.322  Sum_probs=196.0

Q ss_pred             HHHHHHhcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecC-
Q 003391          497 MAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR-  572 (823)
Q Consensus       497 ~~l~~~~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-  572 (823)
                      ..+...+++|...+.||+|+||.||+|... +++.||+|++....  ....+.+.+|+.++.+++||||+++++++... 
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            455667899999999999999999999865 48899999987542  22345678899999999999999999988543 


Q ss_pred             -----CceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCcee
Q 003391          573 -----DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI  647 (823)
Q Consensus       573 -----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl  647 (823)
                           ...+++++++ +++|.+++.    ...+++..+..++.|+++||+|||+.+   |+|+||||+||++++++.+||
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl  161 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI  161 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence                 3467788876 778888763    235899999999999999999999988   999999999999999999999


Q ss_pred             eccccceecCCCccccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHH
Q 003391          648 SDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL  726 (823)
Q Consensus       648 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  726 (823)
                      +|||++.....     ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......   ........
T Consensus       162 ~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~  233 (345)
T cd07877         162 LDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRL  233 (345)
T ss_pred             ecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHH
Confidence            99999875422     1223567889999999876 568899999999999999999999975322111   11110000


Q ss_pred             hhhcCchhhh-----------hhhcC--CCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          727 WIEERPVELI-----------NKSLG--GSYSL-----SEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       727 ~~~~~~~~~~-----------~~~l~--~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      . ........           ...+.  .....     ....++.+++.+|++.+|.+||++.+++..
T Consensus       234 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         234 V-GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             h-CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            0 00000000           00000  00000     112367899999999999999999999865

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=9.2e-31  Score=283.65  Aligned_cols=264  Identities=24%  Similarity=0.305  Sum_probs=191.9

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc--ccHHHHHHHHHHHhccCCCCceeEEEEeecCC------
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG--QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD------  573 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------  573 (823)
                      .++|...++||+|+||.||+|+... ++.+|+|++.....  .....+.+|++++++++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            4788999999999999999999764 78999998865432  22346788999999999999999999875433      


Q ss_pred             --ceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccc
Q 003391          574 --ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG  651 (823)
Q Consensus       574 --~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFG  651 (823)
                        ..++|+||+.+ +|...+..  ....+++..+..++.|+++||.|||+.+   |+|+||||+||++++++.++|+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence              46999999975 66666643  2346899999999999999999999998   9999999999999999999999999


Q ss_pred             cceecCCCcccc---------ccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhH
Q 003391          652 MARAFGIDQTEA---------NTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLG  721 (823)
Q Consensus       652 la~~~~~~~~~~---------~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~  721 (823)
                      ++..........         ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||.......   ...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~---~~~  237 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID---QLH  237 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH---HHH
Confidence            998653322111         11234567889999987654 58899999999999999999999875322211   111


Q ss_pred             HHHHHhhhcCc---------hhhhhhhcC--CCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          722 HAWRLWIEERP---------VELINKSLG--GSYSL-----SEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       722 ~~~~~~~~~~~---------~~~~~~~l~--~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ...........         .........  .....     .....+.+++.+|++.+|++|||+.|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            11110000000         000000000  00000     11146789999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=6.7e-31  Score=280.42  Aligned_cols=259  Identities=26%  Similarity=0.346  Sum_probs=195.9

Q ss_pred             CCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          506 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       506 ~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      |+..+.||+|++|.||+|+... ++.+|+|++....  ....+.+..|+.++++++|+|++++++++.+.+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            4556789999999999999876 8899999987653  334567889999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  662 (823)
                      + ++|.+++....  ..+++..+..++.++++||+|||+.+   |+|+||+|+||++++++.++|+|||++........ 
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  153 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-  153 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence            8 58999985422  45899999999999999999999987   99999999999999999999999999987543221 


Q ss_pred             cccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCch------hh
Q 003391          663 ANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV------EL  735 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~------~~  735 (823)
                       ......++..|+|||.+.+. .++.++||||||++++||++|+.|+.......   ...............      ..
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID---QLFKIFQILGTPTEESWPGVTKL  229 (282)
T ss_pred             -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHHHHhCCCcHHHHHhhccc
Confidence             12223457789999998776 78999999999999999999998875322111   111000000000000      00


Q ss_pred             --hhhhcCC---C-C---CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          736 --INKSLGG---S-Y---SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       736 --~~~~l~~---~-~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                        .+.....   . .   .......+.+++..|++.+|++||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence              0000000   0 0   0011346889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=9.4e-31  Score=286.61  Aligned_cols=261  Identities=21%  Similarity=0.249  Sum_probs=189.6

Q ss_pred             CCCcCCeeeccCccceEEEEeec---CcEEEEEEecCCc--cccHHHHHHHHHHHhcc-CCCCceeEEEEeecC----Cc
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE---GQEIAAKRLSKSS--GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQR----DE  574 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~---~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~----~~  574 (823)
                      +|...+.||+|+||.||+++...   +..+|+|++....  ....+.+.+|+.+++++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            46777899999999999999753   6789999986532  22345678899999999 599999999875432    45


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccce
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  654 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  654 (823)
                      .++++||+. ++|.+++.   ....+++..+..++.||+.||+|||+.+   |+||||||+||++++++.+||+|||+++
T Consensus        81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            678888886 58888874   3456899999999999999999999988   9999999999999999999999999998


Q ss_pred             ecCCCcc--ccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHH------
Q 003391          655 AFGIDQT--EANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR------  725 (823)
Q Consensus       655 ~~~~~~~--~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~------  725 (823)
                      .+.....  ........|+..|+|||.+.+ ..++.++|+||||+++|||++|+.||...+...   .......      
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~  230 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQVLGTPD  230 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHHHHhCCCC
Confidence            6543221  112233578999999998765 568999999999999999999999875432111   1110000      


Q ss_pred             -----HhhhcCchhhhhhh-cCCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          726 -----LWIEERPVELINKS-LGGSYSL-----SEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       726 -----~~~~~~~~~~~~~~-l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                           .+............ .......     .....+.+++.+|++.+|++|||+.|++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                 00000000000000 0000000     11246789999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.4e-30  Score=270.97  Aligned_cols=236  Identities=25%  Similarity=0.334  Sum_probs=190.7

Q ss_pred             eeccCccceEEEEeec-CcEEEEEEecCCcc---ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCCCCc
Q 003391          512 LGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSL  587 (823)
Q Consensus       512 LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  587 (823)
                      ||+|+||.||++...+ ++.+|+|.+.....   ...+.+..|+.++++++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            6899999999999865 88999999876532   2456789999999999999999999999999999999999999999


Q ss_pred             chhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccccccc
Q 003391          588 NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR  667 (823)
Q Consensus       588 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  667 (823)
                      .+++..   ...+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......  .....
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~  152 (250)
T cd05123          81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT  152 (250)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence            999843   235899999999999999999999987   9999999999999999999999999998753321  12234


Q ss_pred             ccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHH
Q 003391          668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLS  747 (823)
Q Consensus       668 ~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~  747 (823)
                      ..++..|+|||.+.+...+.++|+||||+++|||++|+.|+...+.   ....    ..        +....  ...+..
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~----~~--------~~~~~--~~~~~~  215 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIY----EK--------ILKDP--LRFPEF  215 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHH----HH--------HhcCC--CCCCCC
Confidence            5678899999999888899999999999999999999999753221   0000    00        00000  111112


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHH
Q 003391          748 EVLRCIQVGLLCVQQRPEDRPNMSS  772 (823)
Q Consensus       748 ~~~~l~~l~~~Cl~~dP~~RPs~~e  772 (823)
                      ....+.+++.+|++.+|++||++++
T Consensus       216 ~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         216 LSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCHHHHHHHHHHhcCCHhhCCCccc
Confidence            2356788999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.4e-30  Score=286.46  Aligned_cols=258  Identities=23%  Similarity=0.334  Sum_probs=194.5

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCc----
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE----  574 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----  574 (823)
                      ..++|...+.||+|++|.||+|+... ++.+|+|++....  ....+.+.+|+.++++++|||++++.+++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            45788899999999999999999865 7889999886532  2334567789999999999999999988766554    


Q ss_pred             --eEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccc
Q 003391          575 --RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM  652 (823)
Q Consensus       575 --~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl  652 (823)
                        .++|+||+ +++|.+++.    ...+++..+..++.|+++||.|||+.+   |+|+||||+||++++++.++|+|||+
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVK----CQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence              89999998 568988874    245899999999999999999999987   99999999999999999999999999


Q ss_pred             ceecCCCccccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcC
Q 003391          653 ARAFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER  731 (823)
Q Consensus       653 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  731 (823)
                      +......     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......   ..+...... ....
T Consensus       165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~---~~~~~i~~~-~~~~  235 (343)
T cd07851         165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI---DQLKRIMNL-VGTP  235 (343)
T ss_pred             ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHh-cCCC
Confidence            9865322     223467889999999865 36789999999999999999999997532211   001100000 0000


Q ss_pred             chh------------hhhhhcC-CCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          732 PVE------------LINKSLG-GSYSL-----SEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       732 ~~~------------~~~~~l~-~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ...            .+..... .....     .....+.+++.+|++.+|++|||+.||++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            000            0000000 00000     113478899999999999999999999753

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.3e-31  Score=271.87  Aligned_cols=259  Identities=21%  Similarity=0.245  Sum_probs=201.2

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccC-C-C----CceeEEEEeecCCc
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-H-R----NLVKLIGCCTQRDE  574 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H-~----niv~l~g~~~~~~~  574 (823)
                      .+.+|.+..++|+|.||.|-++.+.. +..||+|+++ +.....+..+-|+++++++. + |    -+|++.+++.-.++
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik-~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIK-NVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHH-HHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            36889999999999999999998765 6789999884 44455667788999999993 2 2    37788888999999


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcC-------------
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-------------  641 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~-------------  641 (823)
                      .++|+|.+ |-|+.++|.+ .+-.+++...+..|+.|++++++|||+.+   ++|-||||+|||+.+             
T Consensus       166 iCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             eEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence            99999998 6699999943 33456889999999999999999999987   999999999999832             


Q ss_pred             -------CCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCC
Q 003391          642 -------EMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHAD  714 (823)
Q Consensus       642 -------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~  714 (823)
                             +..+||+|||-|..-.     .....++.|..|.|||++++-.++..+||||+||||.||.+|..-|..-+..
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~-----e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~  315 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDH-----EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL  315 (415)
T ss_pred             ceeccCCCcceEEEecCCcceec-----cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence                   2358999999997632     2225578999999999999999999999999999999999999987654433


Q ss_pred             CccchhHHHHHHhhhcCchhhhhhh----------c---------------C--------CCCCHHHHHHHHHHHHHccc
Q 003391          715 HHHNLLGHAWRLWIEERPVELINKS----------L---------------G--------GSYSLSEVLRCIQVGLLCVQ  761 (823)
Q Consensus       715 ~~~~l~~~~~~~~~~~~~~~~~~~~----------l---------------~--------~~~~~~~~~~l~~l~~~Cl~  761 (823)
                      ++..++..+.    ...+..++...          +               +        ......+..++++|+..+|.
T Consensus       316 EHLaMMerIl----Gp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~  391 (415)
T KOG0671|consen  316 EHLAMMERIL----GPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE  391 (415)
T ss_pred             HHHHHHHHhh----CCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence            3332322221    11111111111          0               0        01233556689999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 003391          762 QRPEDRPNMSSVVL  775 (823)
Q Consensus       762 ~dP~~RPs~~evl~  775 (823)
                      .||.+|+|++|+++
T Consensus       392 fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  392 FDPARRITLREALS  405 (415)
T ss_pred             cCccccccHHHHhc
Confidence            99999999999985

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=4.7e-30  Score=304.31  Aligned_cols=146  Identities=28%  Similarity=0.417  Sum_probs=130.5

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      .++|.+.++||+|+||.||+|.+.. ++.||+|++....   ......+..|+.++..++||||+++++.+......+||
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            3678889999999999999999864 8899999986543   22346788999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccce
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  654 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  654 (823)
                      |||+++++|.+++..   ...+++..++.|+.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999843   345788999999999999999999987   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1e-30  Score=285.39  Aligned_cols=239  Identities=24%  Similarity=0.281  Sum_probs=192.7

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceEEEEe
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      ++.|.....+|.|+|+.|-++.+.. ++..++|++.+...    +..+|+.++... +|||++++.+.+.+..+.++|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            5678888889999999999999765 88999999977632    234567666555 79999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEE-cCCCCceeeccccceecCCC
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL-DNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll-~~~~~~kl~DFGla~~~~~~  659 (823)
                      .+.++-|.+.+..   .+ ....++..|+.+|+.++.|||+++   +|||||||+|||+ ++.++++|+|||.++.....
T Consensus       397 ~l~g~ell~ri~~---~~-~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRS---KP-EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             hccccHHHHHHHh---cc-hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            9999988877632   22 223778889999999999999998   9999999999999 68999999999999876433


Q ss_pred             ccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                           ....+-|..|.|||++....|++++|+||||++||||++|+.||..-..+                  .++....
T Consensus       470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------------------~ei~~~i  526 (612)
T KOG0603|consen  470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------------------IEIHTRI  526 (612)
T ss_pred             -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------------------HHHHHhh
Confidence                 33346788999999999999999999999999999999999997532222                  1222222


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       740 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ..+.++..-.....+|+.+|||.||.+||+|.++..
T Consensus       527 ~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  527 QMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             cCCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            233333333346778999999999999999999864

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.6e-31  Score=300.68  Aligned_cols=273  Identities=22%  Similarity=0.229  Sum_probs=211.7

Q ss_pred             HHHHHhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC---ccccHHHHHHHHHHHhccCCCCceeEEEEeecCC
Q 003391          498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD  573 (823)
Q Consensus       498 ~l~~~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~  573 (823)
                      ++.-..++|.+.++||+|+||.|..++++. ++.+|+|++++.   .+.....|..|-.+|..-+.+-|+++.-.|.+..
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~  148 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER  148 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence            344456889999999999999999999976 778999999873   3455677999999999999999999999999999


Q ss_pred             ceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccc
Q 003391          574 ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  653 (823)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  653 (823)
                      ++|+|||||+||+|-..+..   ...+++..++-++..|+.||.-||+.|   +|||||||+|||||..|++||+|||.+
T Consensus       149 ~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsC  222 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSC  222 (1317)
T ss_pred             ceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhH
Confidence            99999999999999998843   236899999999999999999999998   999999999999999999999999998


Q ss_pred             eecCCCccccccccccccCCccCccccc----c-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhh
Q 003391          654 RAFGIDQTEANTNRVVGTYGYMPPEYAI----D-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWI  728 (823)
Q Consensus       654 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~----~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~  728 (823)
                      ..+..+.. ......+|||.|++||++.    + +.|++.+|.||+||++|||+.|..||-..      .++...     
T Consensus       223 lkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad------slveTY-----  290 (1317)
T KOG0612|consen  223 LKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD------SLVETY-----  290 (1317)
T ss_pred             HhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH------HHHHHH-----
Confidence            77654432 3345579999999999994    3 56999999999999999999999997321      111110     


Q ss_pred             hcCchhhhhh--hcCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHHh-------ccCCCCCCCCCCCCcc
Q 003391          729 EERPVELINK--SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPN---MSSVVLML-------SGERSLPQPKQPGFFT  793 (823)
Q Consensus       729 ~~~~~~~~~~--~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~L-------~~~~~~~~p~~p~~~~  793 (823)
                          ..+++.  .+.-....+-.....+||.+.+. +|+.|..   +.++-..-       +.++....|=.|.+..
T Consensus       291 ----~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevss  362 (1317)
T KOG0612|consen  291 ----GKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSS  362 (1317)
T ss_pred             ----HHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCC
Confidence                011111  11111111223456677777666 6778877   77776543       3456666666776654

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-30  Score=255.39  Aligned_cols=249  Identities=21%  Similarity=0.340  Sum_probs=188.9

Q ss_pred             CcCCeeeccCccceEEEEeec-CcEEEEEEecCCc-cccHHHHHHHHHHHhccC-CCCceeEEEEeecCCceEEEEeecC
Q 003391          507 SDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLIYEYLP  583 (823)
Q Consensus       507 ~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~  583 (823)
                      .....||.|..|.|++++... |..+|||.+.+.. .+..+++...+.++.+-+ .|.||+.+|+|.......+.||.|.
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs  174 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS  174 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence            345679999999999999876 8899999997764 445667778888777765 8999999999999999999999884


Q ss_pred             CCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccc
Q 003391          584 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA  663 (823)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  663 (823)
                      - .++.+|..  -.+++++.-+-++...+++||.||.++.  .|+|||+||+|||+|+.|++||+|||++-.+-...   
T Consensus       175 ~-C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk---  246 (391)
T KOG0983|consen  175 T-CAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---  246 (391)
T ss_pred             H-HHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc---
Confidence            3 45555533  2345788888889999999999999865  59999999999999999999999999997653222   


Q ss_pred             ccccccccCCccCccccc---cCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhc
Q 003391          664 NTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL  740 (823)
Q Consensus       664 ~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l  740 (823)
                      ......|-+.|||||.+.   ...|..++||||||+.|+||.||+.|+..-..+-      ........+.+ ..+....
T Consensus       247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF------e~ltkvln~eP-P~L~~~~  319 (391)
T KOG0983|consen  247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF------EVLTKVLNEEP-PLLPGHM  319 (391)
T ss_pred             ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH------HHHHHHHhcCC-CCCCccc
Confidence            223356888999999985   3468889999999999999999999975422210      01111111111 1111110


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          741 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                            .-...++++...||+.|+.+||...++++.
T Consensus       320 ------gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  320 ------GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             ------CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence                  012467899999999999999999998754

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=6.9e-30  Score=265.75  Aligned_cols=220  Identities=20%  Similarity=0.128  Sum_probs=174.3

Q ss_pred             cCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCCCCcchhhhc
Q 003391          515 GGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD  593 (823)
Q Consensus       515 G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~  593 (823)
                      |.+|.||+++... ++.+|+|++....     .+..|...+....|||++++++++.+.+..++||||+++++|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            8899999999865 7899999996643     234455556666799999999999999999999999999999998853


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccccccccccccCC
Q 003391          594 VTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG  673 (823)
Q Consensus       594 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~  673 (823)
                         ...+++..+..++.|+++||.|||+.+   |+|+||||+||+++.++.++++|||.+......     .....++..
T Consensus        79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~  147 (237)
T cd05576          79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM  147 (237)
T ss_pred             ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence               234899999999999999999999987   999999999999999999999999988654321     122345678


Q ss_pred             ccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHH
Q 003391          674 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCI  753 (823)
Q Consensus       674 y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~  753 (823)
                      |+|||.+....++.++||||+|+++|||++|+.|+.......            .     ....    ...+......+.
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~-----~~~~----~~~~~~~~~~~~  206 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------N-----THTT----LNIPEWVSEEAR  206 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------c-----cccc----cCCcccCCHHHH
Confidence            999999988889999999999999999999997753211000            0     0000    001111224677


Q ss_pred             HHHHHccccCCCCCCCHH
Q 003391          754 QVGLLCVQQRPEDRPNMS  771 (823)
Q Consensus       754 ~l~~~Cl~~dP~~RPs~~  771 (823)
                      +++.+|++.||++||++.
T Consensus       207 ~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         207 SLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHHccCCHHHhcCCC
Confidence            899999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-30  Score=267.22  Aligned_cols=240  Identities=28%  Similarity=0.349  Sum_probs=190.3

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV  578 (823)
                      .+|....+||+|+||.|..|..+. .+.+|||++++..   .+..+--..|-++|... +-|.++++..+++.-+.+++|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            467778899999999999998765 5679999998763   22334445666666665 578899999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      |||+.||+|--++++.   ..+.+..+.-+|..||-||-+||+++   ||.||||.+||+||.+|++||+|||+++.--.
T Consensus       429 MEyvnGGDLMyhiQQ~---GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~  502 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQV---GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF  502 (683)
T ss_pred             EEEecCchhhhHHHHh---cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc
Confidence            9999999999988553   34677888899999999999999998   99999999999999999999999999985322


Q ss_pred             CccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                        ....+...+||+.|+|||++..++|+..+|.|||||+||||+.|+.||+..+.++   +..            .+++.
T Consensus       503 --~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e---lF~------------aI~eh  565 (683)
T KOG0696|consen  503 --DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQ------------AIMEH  565 (683)
T ss_pred             --CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHH------------HHHHc
Confidence              2234556899999999999999999999999999999999999999987554422   111            11111


Q ss_pred             hcCCCCCHHHHHHHHHHHHHccccCCCCCC
Q 003391          739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRP  768 (823)
Q Consensus       739 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP  768 (823)
                      .  ..++.....+...+....+..+|.+|.
T Consensus       566 n--vsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  566 N--VSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             c--CcCcccccHHHHHHHHHHhhcCCcccc
Confidence            1  123333334556677778888998886

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.96  E-value=2e-31  Score=260.19  Aligned_cols=256  Identities=23%  Similarity=0.328  Sum_probs=191.7

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc-ccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceEEEEee
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG-QGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      +.+....||.|.||+|+|-.++. |+.+|||+++.... ...+++..|.+...+- +.||||+++|.+..++..++-||.
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL  144 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL  144 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence            33445689999999999999865 99999999987644 5667888888876654 799999999999999999999999


Q ss_pred             cCCCCcchhhhc--cCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          582 LPNKSLNDFIFD--VTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       582 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      |+- ||+.+...  ..+...+++.-.-+|..-.+.||.||...-  +|||||+||+||||+..|.+||+|||++-.+...
T Consensus       145 Md~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S  221 (361)
T KOG1006|consen  145 MDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS  221 (361)
T ss_pred             Hhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence            954 66554321  223345788888888888999999998865  6999999999999999999999999999765321


Q ss_pred             ccccccccccccCCccCccccc--cCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAI--DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN  737 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~--~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  737 (823)
                         .....-.|-..|||||.+.  +..|..++||||+|+.|+|+.||+-|+...+.     ...+. .++..+.+..+..
T Consensus       222 ---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql-~~Vv~gdpp~l~~  292 (361)
T KOG1006|consen  222 ---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQL-CQVVIGDPPILLF  292 (361)
T ss_pred             ---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHH-HHHHcCCCCeecC
Confidence               1222346778999999985  33588999999999999999999999643222     11111 1112222222111


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          738 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       738 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      .    .........+++++..|+.+|-++||...++.++
T Consensus       293 ~----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  293 D----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             c----ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            1    1112233578899999999999999999998764

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.1e-30  Score=266.78  Aligned_cols=254  Identities=26%  Similarity=0.384  Sum_probs=192.1

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC--ccc-----cHHHHHHHHHHHhccCCCCceeEEEEeec-CCc
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQ-----GMEEFENEVLLIAKLQHRNLVKLIGCCTQ-RDE  574 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~--~~~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~  574 (823)
                      ++|-..++||+|||+.|||+.+.. .+.||+|+-..+  .++     ..+...+|..+-+.|.||.||++++++.- .+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            456667899999999999999755 667777764332  111     23346789999999999999999999864 467


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcC---CCCceeeccc
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFG  651 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~DFG  651 (823)
                      .+-|+||++|-+|+-||   ++.+.+++.+++.|++||+.||.||.+.. ++|||.||||.||||-+   -|.+||.|||
T Consensus       543 FCTVLEYceGNDLDFYL---KQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYL---KQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             ceeeeeecCCCchhHHH---HhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecc
Confidence            88999999999999998   45667999999999999999999999885 68999999999999954   4789999999


Q ss_pred             cceecCCCccc-----cccccccccCCccCccccccC----CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHH
Q 003391          652 MARAFGIDQTE-----ANTNRVVGTYGYMPPEYAIDG----LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH  722 (823)
Q Consensus       652 la~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~----~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~  722 (823)
                      +++.+..+...     ..+....||..|++||.+.-+    +++.|+||||.|||+|+.+.|++||+......  .++.+
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--dILqe  696 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--DILQE  696 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH--HHHhh
Confidence            99988554333     234557899999999998533    47889999999999999999999987433211  11111


Q ss_pred             HHHHhhhcCchhhhhhhcCCCCCH--HHHHHHHHHHHHccccCCCCCCCHHHHH
Q 003391          723 AWRLWIEERPVELINKSLGGSYSL--SEVLRCIQVGLLCVQQRPEDRPNMSSVV  774 (823)
Q Consensus       723 ~~~~~~~~~~~~~~~~~l~~~~~~--~~~~~l~~l~~~Cl~~dP~~RPs~~evl  774 (823)
                             +.   ++. .-.-.++.  ....+...+|.+||+..-++|....++.
T Consensus       697 -------NT---Ilk-AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  697 -------NT---ILK-ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             -------hc---hhc-ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence                   00   000 00001111  1113566789999999999998777664

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.96  E-value=2.5e-30  Score=272.57  Aligned_cols=242  Identities=26%  Similarity=0.351  Sum_probs=188.2

Q ss_pred             CCeeeccCccceEEEEeec-CcEEEEEEecCC--ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCCC
Q 003391          509 KNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNK  585 (823)
Q Consensus       509 ~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  585 (823)
                      .+.||.|-||+||-|++.. |+.||||++.+.  ......++++|+.+|++++||.||.+.-.|+..+..++|||.+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            3689999999999999865 999999999765  3445678999999999999999999999999999999999999664


Q ss_pred             CcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCC---CCceeeccccceecCCCccc
Q 003391          586 SLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DFGla~~~~~~~~~  662 (823)
                      -|+-.| ... ...+++....-++.||+.||.|||.++   |+|+||||+||||.+.   .++||+|||+|+.++.... 
T Consensus       649 MLEMIL-SsE-kgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-  722 (888)
T KOG4236|consen  649 MLEMIL-SSE-KGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-  722 (888)
T ss_pred             HHHHHH-Hhh-cccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence            454444 322 334788888888999999999999998   9999999999999643   5799999999998864322 


Q ss_pred             cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCC
Q 003391          663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG  742 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~  742 (823)
                        ...++||+.|+|||++.++.|...-|+||.|||+|--++|.-||.....  ..+.++.+.          .    +-.
T Consensus       723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAa----------F----MyP  784 (888)
T KOG4236|consen  723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAA----------F----MYP  784 (888)
T ss_pred             --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--hhHHhhccc----------c----ccC
Confidence              2347999999999999999999999999999999999999999752111  111111110          0    001


Q ss_pred             CCCHHHH-HHHHHHHHHccccCCCCCCCHHHHH
Q 003391          743 SYSLSEV-LRCIQVGLLCVQQRPEDRPNMSSVV  774 (823)
Q Consensus       743 ~~~~~~~-~~l~~l~~~Cl~~dP~~RPs~~evl  774 (823)
                      .-+-.+. ...+++|...||..-.+|-+....+
T Consensus       785 p~PW~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  785 PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence            1111221 2556777788888888888776654

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=7.2e-29  Score=286.95  Aligned_cols=259  Identities=20%  Similarity=0.229  Sum_probs=166.9

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-----CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEE------ee
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-----GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGC------CT  570 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-----~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~------~~  570 (823)
                      ..++|...++||+|+||.||+|++.+     +..||+|++......  +....|  .+....+.+++.++..      +.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            46789999999999999999999865     578999988643221  111111  1122222222222211      24


Q ss_pred             cCCceEEEEeecCCCCcchhhhccCC-----------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccC
Q 003391          571 QRDERMLIYEYLPNKSLNDFIFDVTR-----------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLK  633 (823)
Q Consensus       571 ~~~~~~lV~e~~~~gsL~~~l~~~~~-----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk  633 (823)
                      .....++|+||+++++|.+++.....                 ........+..++.||+.||+|||+.+   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            56679999999999999998853211                 001123345679999999999999987   9999999


Q ss_pred             CCcEEEcC-CCCceeeccccceecCCCccccccccccccCCccCccccccC----------------------CCCccch
Q 003391          634 ASNVLLDN-EMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG----------------------LFSVKSD  690 (823)
Q Consensus       634 ~~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----------------------~~s~ksD  690 (823)
                      |+|||+++ ++.+||+|||+|+.+..... .......+++.|+|||.+...                      .+..++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999986 57999999999986543222 222346789999999966322                      2345679


Q ss_pred             hHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhh-cCchhhhhhhcCCCCCH----------HHHHHHHHHHHHc
Q 003391          691 VFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE-ERPVELINKSLGGSYSL----------SEVLRCIQVGLLC  759 (823)
Q Consensus       691 VwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~l~~~~~~----------~~~~~l~~l~~~C  759 (823)
                      ||||||+||||+++..+.+.       .+... ...+.. +................          .......+|+.+|
T Consensus       362 VwSlGviL~el~~~~~~~~~-------~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~m  433 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDS-------NLIQF-NRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSM  433 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCch-------HHHHH-HHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHH
Confidence            99999999999997765321       01000 000000 00000000000000000          0112345899999


Q ss_pred             cccCCCCCCCHHHHHHH
Q 003391          760 VQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       760 l~~dP~~RPs~~evl~~  776 (823)
                      |+.||++|||++|+++.
T Consensus       434 L~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        434 MRFKGRQRISAKAALAH  450 (566)
T ss_pred             ccCCcccCCCHHHHhCC
Confidence            99999999999999863

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.96  E-value=6.3e-30  Score=253.61  Aligned_cols=248  Identities=24%  Similarity=0.291  Sum_probs=192.6

Q ss_pred             HhcCCCcC-CeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhcc-CCCCceeEEEEeec----CCc
Q 003391          502 ATENFSDK-NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQ----RDE  574 (823)
Q Consensus       502 ~~~~~~~~-~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~----~~~  574 (823)
                      .+++|++. ++||-|-.|.|..+.++. ++.+|+|++...     ...++|+++--.. .|||||.+++++.+    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            45666544 579999999999999876 788999988533     3457888876555 69999999999854    356


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcC---CCCceeeccc
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFG  651 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~DFG  651 (823)
                      +++|||.|+||.|...+.+ +....+++.++..|..||..|+.|||+..   |.||||||+|+|...   |..+||+|||
T Consensus       134 LLiVmE~meGGeLfsriq~-~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQD-RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eEeeeecccchHHHHHHHH-cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence            7899999999999998855 34456899999999999999999999988   999999999999964   5578999999


Q ss_pred             cceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcC
Q 003391          652 MARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER  731 (823)
Q Consensus       652 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  731 (823)
                      +|+.-.   ........+-|+.|.|||++...+|...+|+||+||++|-|++|..||--.+.   ..+.           
T Consensus       210 FAK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg---~ais-----------  272 (400)
T KOG0604|consen  210 FAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG---LAIS-----------  272 (400)
T ss_pred             cccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC---ccCC-----------
Confidence            998632   23334456789999999999999999999999999999999999999732211   1110           


Q ss_pred             chhhhhhhcCC--CCCHHH---H-HHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          732 PVELINKSLGG--SYSLSE---V-LRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       732 ~~~~~~~~l~~--~~~~~~---~-~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                       ..+-..+..+  .++.+|   + +...++++..|..+|++|.|+.|++..
T Consensus       273 -pgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  273 -PGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             -hhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence             0111111112  122222   2 356789999999999999999999864

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=8.8e-29  Score=256.85  Aligned_cols=237  Identities=27%  Similarity=0.335  Sum_probs=191.3

Q ss_pred             CccceEEEEeec-CcEEEEEEecCCcccc-HHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCCCCcchhhhc
Q 003391          516 GFGPVYKGVLIE-GQEIAAKRLSKSSGQG-MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD  593 (823)
Q Consensus       516 ~fg~Vyk~~~~~-~~~vavK~l~~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~  593 (823)
                      +||.||+|+..+ ++.+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999999875 8899999997765544 78899999999999999999999999999999999999999999999854


Q ss_pred             cCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccccccccccccCC
Q 003391          594 VTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG  673 (823)
Q Consensus       594 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~  673 (823)
                      ..   .+++..+..++.++++++.|||+.+   ++|+||+|+||++++++.++|+|||.+.......   ......++..
T Consensus        81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  151 (244)
T smart00220       81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE  151 (244)
T ss_pred             cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence            22   2889999999999999999999987   9999999999999999999999999998764332   2334567889


Q ss_pred             ccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHH-HHHHH
Q 003391          674 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLS-EVLRC  752 (823)
Q Consensus       674 y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~-~~~~l  752 (823)
                      |++||.+....++.++|||+||++++||++|..|+....  .....    .......        ......... ...++
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~--~~~~~----~~~~~~~--------~~~~~~~~~~~~~~~  217 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD--QLLEL----FKKIGKP--------KPPFPPPEWKISPEA  217 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--cHHHH----HHHHhcc--------CCCCccccccCCHHH
Confidence            999999998889999999999999999999998864321  11101    0000000        000000000 33578


Q ss_pred             HHHHHHccccCCCCCCCHHHHHH
Q 003391          753 IQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       753 ~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      .+++.+|+..+|++||++.++++
T Consensus       218 ~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      218 KDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHccCCchhccCHHHHhh
Confidence            89999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=2.6e-31  Score=257.11  Aligned_cols=266  Identities=22%  Similarity=0.387  Sum_probs=192.6

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc--ccHHHHHHHHHHHhccCCCCceeEEEEeecC--------C
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG--QGMEEFENEVLLIAKLQHRNLVKLIGCCTQR--------D  573 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--------~  573 (823)
                      .|....+||+|.||.||+|+..+ ++.||+|++-...+  .......+|+.+|..++|+|++.+++.|...        .
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            35556799999999999999876 77889987644322  2344568899999999999999999988543        3


Q ss_pred             ceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccc
Q 003391          574 ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  653 (823)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  653 (823)
                      ..+||+.+++. +|.-.|.+  ....++..++.++..++..||.|+|...   |+|||+|+.|+||+.++.+||+|||++
T Consensus        98 t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence            47999999976 77777743  2235888999999999999999999987   999999999999999999999999999


Q ss_pred             eecCCCccc--cccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHH-----
Q 003391          654 RAFGIDQTE--ANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR-----  725 (823)
Q Consensus       654 ~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~-----  725 (823)
                      +.+......  ......+-|..|++||.+.+. .|+++.|||.-|||+.||+|+.+-+..........+++....     
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke  251 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE  251 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence            876443322  222335669999999999875 589999999999999999999877654333322222222110     


Q ss_pred             HhhhcCchhhhhhh-----cCCCCC--HHHH------HHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          726 LWIEERPVELINKS-----LGGSYS--LSEV------LRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       726 ~~~~~~~~~~~~~~-----l~~~~~--~~~~------~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      .|-+-...++....     ..+.+.  .+.+      .+.++++..++..||.+||.+++++..
T Consensus       252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            01111111111111     011110  0111      156789999999999999999988753

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=1.4e-28  Score=277.41  Aligned_cols=263  Identities=19%  Similarity=0.269  Sum_probs=178.4

Q ss_pred             HhcCCCcCCeeeccCccceEEEEe-----------------ecCcEEEEEEecCCccccHHH--------------HHHH
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVL-----------------IEGQEIAAKRLSKSSGQGMEE--------------FENE  550 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~-----------------~~~~~vavK~l~~~~~~~~~~--------------~~~E  550 (823)
                      ..++|.+.++||+|+||.||+|.+                 ..++.||||++........++              +..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            457899999999999999999974                 235679999986543322223              3447


Q ss_pred             HHHHhccCCCCc-----eeEEEEeec--------CCceEEEEeecCCCCcchhhhccCC---------------------
Q 003391          551 VLLIAKLQHRNL-----VKLIGCCTQ--------RDERMLIYEYLPNKSLNDFIFDVTR---------------------  596 (823)
Q Consensus       551 i~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~---------------------  596 (823)
                      +.++.+++|.++     ++++++|..        .+..+|||||+++++|.++++....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777766554     677787753        3568999999999999998864211                     


Q ss_pred             CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccccccccccccCCccC
Q 003391          597 SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP  676 (823)
Q Consensus       597 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a  676 (823)
                      ...+++..+..++.|++++|.|||+.+   |+||||||+|||++.++.+||+|||++........ .......+++.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence            123567888999999999999999987   99999999999999999999999999976533211 11112234789999


Q ss_pred             ccccccCC--------------------C--CccchhHhHHHHHHHHHhcCC-CCCCcCCCCc-c---chhHHHHHHhhh
Q 003391          677 PEYAIDGL--------------------F--SVKSDVFSFGVLVLEIVCGKR-NRGFYHADHH-H---NLLGHAWRLWIE  729 (823)
Q Consensus       677 PE~l~~~~--------------------~--s~ksDVwS~Gvvl~elltG~~-p~~~~~~~~~-~---~l~~~~~~~~~~  729 (823)
                      ||.+....                    +  ..+.||||+||+++||++|.. |+........ .   ......|+....
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~  458 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG  458 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence            99885432                    1  234799999999999999885 5431110000 0   000011111111


Q ss_pred             cCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCC---CCCCCHHHHHHH
Q 003391          730 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRP---EDRPNMSSVVLM  776 (823)
Q Consensus       730 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPs~~evl~~  776 (823)
                      ..        ..-...........+++.+++..+|   .+|+|++|+++.
T Consensus       459 ~~--------~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        459 QK--------YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             cC--------CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            00        0000011112356778888888765   689999999853

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1e-28  Score=276.32  Aligned_cols=259  Identities=26%  Similarity=0.387  Sum_probs=204.9

Q ss_pred             HHHHHHhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhcc-CCCCceeEEEEeec---
Q 003391          497 MAIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQ---  571 (823)
Q Consensus       497 ~~l~~~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~---  571 (823)
                      ..+...++.|.+.+.||+|.+|.||+++..+ ++..|+|++... .+..++++.|.++++.. .|||++.++|++..   
T Consensus        12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~   90 (953)
T KOG0587|consen   12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP   90 (953)
T ss_pred             hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence            3344456778888999999999999999765 778888887554 44557788999999988 69999999999854   


Q ss_pred             --CCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeec
Q 003391          572 --RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISD  649 (823)
Q Consensus       572 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D  649 (823)
                        ++.++||||||.+||.-|++.... +..+.|..+.-|++.++.||.+||...   ++|||||-.|||++.++.+||.|
T Consensus        91 ~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvD  166 (953)
T KOG0587|consen   91 GNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVD  166 (953)
T ss_pred             CCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEee
Confidence              467999999999999999997655 677999999999999999999999986   99999999999999999999999


Q ss_pred             cccceecCCCccccccccccccCCccCcccccc-----CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHH
Q 003391          650 FGMARAFGIDQTEANTNRVVGTYGYMPPEYAID-----GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW  724 (823)
Q Consensus       650 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~  724 (823)
                      ||.+..+.  .+....+...||+.|||||++..     ..|+.++|+||+|++..||--|..|+...++-....+     
T Consensus       167 FGvSaQld--sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~-----  239 (953)
T KOG0587|consen  167 FGVSAQLD--STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-----  239 (953)
T ss_pred             eeeeeeee--cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc-----
Confidence            99998764  34445556789999999999853     3478899999999999999999999643322110000     


Q ss_pred             HHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          725 RLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       725 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                        ...+.+..+..       +..=..++.+++..|+..|-++||++.++++.
T Consensus       240 --IpRNPPPkLkr-------p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  240 --IPRNPPPKLKR-------PKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             --CCCCCCccccc-------hhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence              00111111111       11223478899999999999999999988753

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=9.7e-29  Score=247.64  Aligned_cols=277  Identities=22%  Similarity=0.305  Sum_probs=207.3

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC---ccccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l  577 (823)
                      .++|...++||+|+|..|..+++.. .+.+|+|++++.   ..+.++=.+.|-.+..+. +||.+|-+..+++....+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            4678889999999999999999876 778899988764   233344455666666665 79999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      |.||+++|+|--++   .++..++++.++-+...|..||.|||+.+   ||.||||.+|||+|..+.+||.|+|+++.--
T Consensus       329 vieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence            99999999997666   45566999999999999999999999998   9999999999999999999999999998632


Q ss_pred             CCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccch-hHHHHHHhhhcCchhhh
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL-LGHAWRLWIEERPVELI  736 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l-~~~~~~~~~~~~~~~~~  736 (823)
                      .  ....++..+||+.|+|||++.+..|...+|.|++||+++||+.|+.||+....+....- -.+....        ++
T Consensus       403 ~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv--------il  472 (593)
T KOG0695|consen  403 G--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV--------IL  472 (593)
T ss_pred             C--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH--------Hh
Confidence            2  23445668999999999999999999999999999999999999999987544332211 1111111        11


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCC------HHHHH----------HHhccCCCCCCCCCCCCcccCCCC
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPN------MSSVV----------LMLSGERSLPQPKQPGFFTERNPP  798 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs------~~evl----------~~L~~~~~~~~p~~p~~~~~~~~~  798 (823)
                      ++.++-  +.........+...-+++||.+|.-      .+++-          ++|++ +.+..|-+|....+....
T Consensus       473 ekqiri--prslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leq-k~v~ppf~p~i~~d~~l~  547 (593)
T KOG0695|consen  473 EKQIRI--PRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQ-KQVLPPFQPQITDDYGLD  547 (593)
T ss_pred             hhcccc--cceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhh-cccCCCCCCccccccCcc
Confidence            111111  1111224456667778888888752      22221          23333 444455577776666554

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.96  E-value=4.3e-29  Score=230.04  Aligned_cols=260  Identities=25%  Similarity=0.361  Sum_probs=191.1

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC--ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      +|...++||+|.||+|+||+..+ ++.||+|+++..  .+.-.....+|+-+++.++|.|||++++....++.+-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            45566799999999999999766 778999988654  333455678999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +.. +|..|...  -...++.+.+..++.|+++||.++|++.   +.||||||+|.||+.+|++|++|||+++.++.+-.
T Consensus        83 cdq-dlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   83 CDQ-DLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             hhH-HHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence            955 67776532  2345888899999999999999999998   99999999999999999999999999998865432


Q ss_pred             ccccccccccCCccCccccccCC-CCccchhHhHHHHHHHHHhcCCC-CCCcCCCCccchhHHHHHHhh---hcC---ch
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRN-RGFYHADHHHNLLGHAWRLWI---EER---PV  733 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~-~s~ksDVwS~Gvvl~elltG~~p-~~~~~~~~~~~l~~~~~~~~~---~~~---~~  733 (823)
                      -  .+..+-|..|.+|.++.+.+ |+...|+||-|||+.||....+| |+..+.++  .+ ..+...+-   ++.   ..
T Consensus       157 c--ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd--ql-krif~~lg~p~ed~wps~t  231 (292)
T KOG0662|consen  157 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QL-KRIFRLLGTPTEDQWPSMT  231 (292)
T ss_pred             e--eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH--HH-HHHHHHhCCCccccCCccc
Confidence            1  22345688999999998765 89999999999999999985555 43332222  11 11111110   100   11


Q ss_pred             hhhhhhcCCCCC----HHHH-----HHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          734 ELINKSLGGSYS----LSEV-----LRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       734 ~~~~~~l~~~~~----~~~~-----~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      .+-+...-..++    ..+.     ..-.++....+.-+|.+|.++++.++
T Consensus       232 ~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  232 KLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             cCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            111211111111    1111     12245666777889999999998875

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.95  E-value=4.8e-29  Score=277.81  Aligned_cols=246  Identities=26%  Similarity=0.382  Sum_probs=186.8

Q ss_pred             CCcCCeeeccCccc-eEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceEEEEeecC
Q 003391          506 FSDKNKLGEGGFGP-VYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEYLP  583 (823)
Q Consensus       506 ~~~~~~LG~G~fg~-Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~  583 (823)
                      |...+.+|.|..|+ ||+|.. ++++||||++-..   ..+-..+|+..|+.- +|||||++++.-.+....|+..|.| 
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence            44556789999986 799998 7899999988432   334568999999987 6999999999999999999999999 


Q ss_pred             CCCcchhhhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcC---C--CCceeeccccceecC
Q 003391          584 NKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---E--MNPKISDFGMARAFG  657 (823)
Q Consensus       584 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~---~--~~~kl~DFGla~~~~  657 (823)
                      ..+|.+++... .......-...+.+..|+++||++||+.+   ||||||||+||||+.   +  .+++|+|||+++.+.
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            55999999542 11111111445678899999999999987   999999999999976   2  579999999999886


Q ss_pred             CCcccc-ccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhc-CCCCCCcCCCCccchhHHHHHHhhhcCchhh
Q 003391          658 IDQTEA-NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG-KRNRGFYHADHHHNLLGHAWRLWIEERPVEL  735 (823)
Q Consensus       658 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  735 (823)
                      .+.... ......||-+|+|||++....-+.++||+|+|||+|+.++| ..||+-.-..+.. ++       ...  ..+
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N-Il-------~~~--~~L  732 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN-IL-------TGN--YTL  732 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh-hh-------cCc--cce
Confidence            654433 34567899999999999999889999999999999999997 7898632111000 00       000  000


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       736 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ..  +  ....++  +..+||.+|+.++|..||++.+|+.
T Consensus       733 ~~--L--~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  733 VH--L--EPLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             ee--e--ccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            00  0  111111  6678999999999999999999974

>PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity

Probab=99.95  E-value=4.3e-29  Score=225.30  Aligned_cols=110  Identities=47%  Similarity=0.802  Sum_probs=82.1

Q ss_pred             CCcEEEeecCCCCCCC--CCCceEEEecCCceEEEecCCCCeEEee-cCCCCC-CcceEEEecCCCEEEecCCCCCCCcc
Q 003391           64 NGTVIWVANRDAPLSD--RSGALNISSQGNATLVLLNSTNGIVWSS-NASRTA-RNPVAVLLESGNLVVKDGKDIDPDNF  139 (823)
Q Consensus        64 ~~~~vW~an~~~p~~~--~~~~l~~~~~g~~~l~l~~~~~~~~w~~-~~~~~~-~~~~~~l~d~gnlvl~~~~~~~~~~~  139 (823)
                      ++|+||+|||+.|+..  ...+|.|+.|||  |+|++..++++|++ ++.+.. ....|+|+|+|||||++..    +++
T Consensus         1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGn--Lvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~----~~~   74 (114)
T PF01453_consen    1 PRTVVWVANRNSPLTSSSGNYTLILQSDGN--LVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSS----GNV   74 (114)
T ss_dssp             ---------TTEEEEECETTEEEEEETTSE--EEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETT----SEE
T ss_pred             CcccccccccccccccccccccceECCCCe--EEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeec----ceE
Confidence            4799999999999954  348899999999  99999999999999 555443 5788999999999999965    889


Q ss_pred             eeeecCCCcccccccCcccceeccCcceeEEEcccCCCCC
Q 003391          140 LWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSADDPA  179 (823)
Q Consensus       140 ~wqSFd~PTDtlLpgq~l~~~~~tg~~~~l~Sw~s~~dps  179 (823)
                      |||||||||||+||||+|+.+..++.+..++||++.+|||
T Consensus        75 lW~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps  114 (114)
T PF01453_consen   75 LWQSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS  114 (114)
T ss_dssp             EEESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred             EEeecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence            9999999999999999999988878777899999999997

Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B ....

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.7e-29  Score=262.51  Aligned_cols=266  Identities=23%  Similarity=0.282  Sum_probs=207.3

Q ss_pred             cCCCcCCeeeccCccceEEEEeecCc-EEEEEEecCC---ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIEGQ-EIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~~~-~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      .++.....||-|+||.|=........ .+|+|.+++.   .....+....|-.+|...+.|.||+++..|.+.+..|++|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            44556678999999999988875533 3788877654   3444566788999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      |-|-||.|+..|.+   +..++.....-++..+++|++|||+++   ||.|||||+|.+|+.+|-+||.|||+|+.+.. 
T Consensus       500 EaClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~-  572 (732)
T KOG0614|consen  500 EACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS-  572 (732)
T ss_pred             HhhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc-
Confidence            99999999999953   445788888889999999999999998   99999999999999999999999999998753 


Q ss_pred             ccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                        ...+...+||+.|.|||++.+.....++|.||+|+++|||++|..||...++-..-+++-.....             
T Consensus       573 --g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~-------------  637 (732)
T KOG0614|consen  573 --GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK-------------  637 (732)
T ss_pred             --CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh-------------
Confidence              34566789999999999999999999999999999999999999998654442221111111000             


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHh-------ccC--CCCCCCCCCCCcc
Q 003391          740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPN-----MSSVVLML-------SGE--RSLPQPKQPGFFT  793 (823)
Q Consensus       740 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L-------~~~--~~~~~p~~p~~~~  793 (823)
                        -.++..-.....+++.+.+..+|.+|.-     +.++-+.-       +++  +.++.|-.|....
T Consensus       638 --i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~  703 (732)
T KOG0614|consen  638 --IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVAN  703 (732)
T ss_pred             --hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCC
Confidence              0112222235678888999999999985     55555432       233  4566665665543

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=1.1e-27  Score=257.62  Aligned_cols=207  Identities=22%  Similarity=0.363  Sum_probs=175.8

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ..|...+.||-|+||.|.++...+ ...+|+|.+++.+   +......+.|-.||..-..+-||+|+-.|.+++.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            457788899999999999998766 5578999987764   334456788999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      +|++||++-.+|.   +...+.+..++-++.++..|+++.|..|   +|||||||+|||||.+|++||.||||+.-+.-.
T Consensus       709 dYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             eccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence            9999999999884   4456888889999999999999999988   999999999999999999999999999755210


Q ss_pred             ---------ccc-------------------------------cccccccccCCccCccccccCCCCccchhHhHHHHHH
Q 003391          660 ---------QTE-------------------------------ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVL  699 (823)
Q Consensus       660 ---------~~~-------------------------------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~  699 (823)
                               ...                               ......+||+.|+|||++....|+..+|.||.|||||
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence                     000                               0012367999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCcCCCCc
Q 003391          700 EIVCGKRNRGFYHADHH  716 (823)
Q Consensus       700 elltG~~p~~~~~~~~~  716 (823)
                      ||+.|+.||-...+.+.
T Consensus       863 em~~g~~pf~~~tp~~t  879 (1034)
T KOG0608|consen  863 EMLVGQPPFLADTPGET  879 (1034)
T ss_pred             HHhhCCCCccCCCCCcc
Confidence            99999999865555443

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.95  E-value=8.6e-28  Score=226.71  Aligned_cols=201  Identities=25%  Similarity=0.364  Sum_probs=165.8

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc-cccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceEEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      .+.......||+|++|.|-+-++.. |+..|+|++.... .+..++...|+.+..+. .+|.+|.++|........++.|
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM  124 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM  124 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence            3445556789999999998888764 8999999997653 44556777888876664 7999999999999999999999


Q ss_pred             eecCCCCcchhhhc-cCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          580 EYLPNKSLNDFIFD-VTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       580 e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      |.|.- ||+.+-.+ ..++..+++.-.-+|+..+++||.|||++-  .+||||+||+|||++.+|++|++|||.+-.+..
T Consensus       125 E~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d  201 (282)
T KOG0984|consen  125 ELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVD  201 (282)
T ss_pred             HHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence            99954 88877654 455677899999999999999999999975  699999999999999999999999999987632


Q ss_pred             CccccccccccccCCccCcccccc----CCCCccchhHhHHHHHHHHHhcCCCCC
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAID----GLFSVKSDVFSFGVLVLEIVCGKRNRG  709 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~----~~~s~ksDVwS~Gvvl~elltG~~p~~  709 (823)
                      .   -..+...|-..|||||.+..    ..|+.|+||||+|+.+.||.+++.|++
T Consensus       202 S---iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~  253 (282)
T KOG0984|consen  202 S---IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE  253 (282)
T ss_pred             h---hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence            2   11112456779999999843    368999999999999999999999964

>PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation

Probab=99.94  E-value=2.6e-27  Score=213.47  Aligned_cols=110  Identities=45%  Similarity=0.971  Sum_probs=105.9

Q ss_pred             eecCCCCCceeeccCCCCCCCceEEEEeecCceEEEEEeecCCCcceeEEEccCCCeeEEEEecccccceeeecccCCCc
Q 003391          205 YRAGSWNGLHWTGMPQLQPNPVYTFEYVSNENEVFYRFNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFVPFSGLIL  284 (823)
Q Consensus       205 ~~sg~w~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~l~~~G~l~~~~w~~~~~~w~~~~~~~~~~~  284 (823)
                      ||+|+|||..|+|+|++..+..+.+.|+.+.++.+++|.+.+.+.++|++||.+|++++|.|.+..+.|..+|   .+|.
T Consensus         1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~---~~p~   77 (110)
T PF00954_consen    1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFW---SAPK   77 (110)
T ss_pred             CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEE---Eecc
Confidence            8999999999999999999999999999999999999999999999999999999999999999999999999   8999


Q ss_pred             ccCCccCCCCCCccccCCCCCCcccccCCCccCC
Q 003391          285 DQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKS  318 (823)
Q Consensus       285 d~Cd~~g~CG~~g~C~~~~~~~~C~C~~Gf~~~~  318 (823)
                      |+||+|+.||+||+|+.+ ..+.|+||+||+|++
T Consensus        78 d~Cd~y~~CG~~g~C~~~-~~~~C~Cl~GF~P~n  110 (110)
T PF00954_consen   78 DQCDVYGFCGPNGICNSN-NSPKCSCLPGFEPKN  110 (110)
T ss_pred             cCCCCccccCCccEeCCC-CCCceECCCCcCCCc
Confidence            999999999999999876 688999999999975

This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=4.4e-26  Score=230.59  Aligned_cols=211  Identities=36%  Similarity=0.573  Sum_probs=183.4

Q ss_pred             eeccCccceEEEEeec-CcEEEEEEecCCccc-cHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCCCCcch
Q 003391          512 LGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQ-GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLND  589 (823)
Q Consensus       512 LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~  589 (823)
                      ||+|.+|.||+++... ++.+++|++...... ..+.+.+|+..++.++|++++++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999865 889999998765432 35678999999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcC-CCCceeeccccceecCCCccccccccc
Q 003391          590 FIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-EMNPKISDFGMARAFGIDQTEANTNRV  668 (823)
Q Consensus       590 ~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~  668 (823)
                      ++....  ..+++..+..++.++++++.+||+.+   ++|+||+|.||+++. ++.++|+|||.+........  .....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI  153 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence            985321  35889999999999999999999997   999999999999999 89999999999987643321  12234


Q ss_pred             cccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHH
Q 003391          669 VGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLS  747 (823)
Q Consensus       669 ~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~  747 (823)
                      .+...|++||.+... .++.+.|+|++|+++++|                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            577899999999877 888999999999999999                                              


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003391          748 EVLRCIQVGLLCVQQRPEDRPNMSSVVLML  777 (823)
Q Consensus       748 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  777 (823)
                        ..+.+++..|++.+|++||++.++++.|
T Consensus       188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 --PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence              3677899999999999999999998653

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.4e-28  Score=240.44  Aligned_cols=264  Identities=20%  Similarity=0.288  Sum_probs=192.0

Q ss_pred             CcCCeeeccCccceEEEEeec-CcEEEEEEecCC--ccccHHHHHHHHHHHhccCCCCceeEEEEeecC-----CceEEE
Q 003391          507 SDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR-----DERMLI  578 (823)
Q Consensus       507 ~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~~lV  578 (823)
                      +..+.||.|+||.||..+++. |+.||+|++...  .-...+.+.+|+++|...+|.|++..++...-.     ++.|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            446789999999999999865 899999998543  233556788999999999999999988876543     256788


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      +|.|.. +|...|.   ....++-..+.-+..||++||+|||+.+   |.||||||.|.|++.+..+||+|||+|+....
T Consensus       136 TELmQS-DLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  136 TELMQS-DLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHHh-hhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence            888854 7777663   3445788888889999999999999998   99999999999999999999999999997655


Q ss_pred             CccccccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHH--------HHHhhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA--------WRLWIE  729 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~  729 (823)
                      ++....+. -+-|..|.|||++++. .|+.+.||||.|||+.||+..+.-|....+.+...++-..        .+.-.+
T Consensus       209 d~~~hMTq-EVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  209 RDRLNMTH-EVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             hhhhhhHH-HHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence            44444433 4568899999999876 5899999999999999999877766544333333222111        111111


Q ss_pred             cCchhhhhhhcCC-CC--------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003391          730 ERPVELINKSLGG-SY--------SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS  778 (823)
Q Consensus       730 ~~~~~~~~~~l~~-~~--------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  778 (823)
                      +....++....+. +.        ....-.+.+.+...++..||.+|.+..+.+..+-
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence            1111111111111 00        0011124456777889999999999999887763

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.93  E-value=2.1e-26  Score=220.36  Aligned_cols=257  Identities=19%  Similarity=0.314  Sum_probs=189.3

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccccHHHHHHHHHHHhccC-CCCceeEEEEeecC--CceEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQR--DERMLI  578 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~lV  578 (823)
                      .++|++.+++|+|.++.|+.|... +.+.++||++++.   ..+.+.+|+.+|+.+. ||||+++++...+.  ..+.||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            467888999999999999999954 4778899988654   3467899999999997 99999999998765  457899


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCC-CCceeeccccceecC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMARAFG  657 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DFGla~~~~  657 (823)
                      +||+++.+.....      ..++-..+..++.++++||.|+|+.|   |+|||+||.|++||.. ..++|+|+|+|..+.
T Consensus       114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence            9999998766543      24677788899999999999999998   9999999999999864 579999999998765


Q ss_pred             CCccccccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHH--------hh
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL--------WI  728 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~--------~~  728 (823)
                      ....   .+..+.+..|.-||.+.+- .|...-|+|||||+|.+|+..+.||=.. .+....++..+.-.        +.
T Consensus       185 p~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG-~dN~DQLVkIakVLGt~el~~Yl~  260 (338)
T KOG0668|consen  185 PGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG-HDNYDQLVKIAKVLGTDELYAYLN  260 (338)
T ss_pred             CCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCC-CCCHHHHHHHHHHhChHHHHHHHH
Confidence            4332   2234566788899998764 5788999999999999999999997322 22222232221100        00


Q ss_pred             ------hcCchhhhhhhcCC---CC----CHHH-HHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          729 ------EERPVELINKSLGG---SY----SLSE-VLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       729 ------~~~~~~~~~~~l~~---~~----~~~~-~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                            +.....++..-.+.   .+    +... ..+.++++...+..|-.+|||++|...
T Consensus       261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence                  00001111110000   00    0000 136778889999999999999999864

>cd00028 B_lectin Bulb-type mannose-specific lectin

Probab=99.93  E-value=1.6e-25  Score=204.15  Aligned_cols=115  Identities=50%  Similarity=0.827  Sum_probs=102.6

Q ss_pred             CcccCCCeEeeCCCeEEEeeecCCCCCCeEEEEEEeecCCCcEEEeecCCCCCCCCCCceEEEecCCceEEEecCCCCeE
Q 003391           25 QSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIV  104 (823)
Q Consensus        25 ~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~giw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~~~l~l~~~~~~~~  104 (823)
                      ++|.+|++|+|++|.|++|||.+......+.+|||.+++ +++||.||++.| ....+.|.|+.||+  |+|+|.+|.++
T Consensus         2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~-~~~~~~l~l~~dGn--Lvl~~~~g~~v   77 (116)
T cd00028           2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNP-SGSSCTLTLQSDGN--LVIYDGSGTVV   77 (116)
T ss_pred             cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCC-CCCCEEEEEecCCC--eEEEcCCCcEE
Confidence            578999999999999999999987655589999999887 899999999998 44578899999999  99999999999


Q ss_pred             EeecCCCCCCcceEEEecCCCEEEecCCCCCCCcceeeecCCC
Q 003391          105 WSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFDYP  147 (823)
Q Consensus       105 w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqSFd~P  147 (823)
                      |+|++.+.....+++|+|+|||||++.+    +++||||||||
T Consensus        78 W~S~~~~~~~~~~~~L~ddGnlvl~~~~----~~~~W~Sf~~P  116 (116)
T cd00028          78 WSSNTTRVNGNYVLVLLDDGNLVLYDSD----GNFLWQSFDYP  116 (116)
T ss_pred             EEecccCCCCceEEEEeCCCCEEEECCC----CCEEEcCCCCC
Confidence            9999875345667899999999999976    78899999999

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses.

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2.9e-25  Score=233.92  Aligned_cols=131  Identities=28%  Similarity=0.375  Sum_probs=110.8

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccC-----C---CCceeEEEEee----
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-----H---RNLVKLIGCCT----  570 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----H---~niv~l~g~~~----  570 (823)
                      .+|.+.++||-|.|++||++.+.. .+.||+|+. +......+....||.+|++++     |   .+||+|++.|.    
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVv-KSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVV-KSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEE-ehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            678889999999999999999866 667888877 455556677889999999983     3   37999999985    


Q ss_pred             cCCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEE
Q 003391          571 QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL  639 (823)
Q Consensus       571 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll  639 (823)
                      .+.+.+||+|++ |.+|..+|... ..+-++...+.+|+.||+.||.|||.++  .|||-||||+|||+
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence            456899999998 77888888543 3445899999999999999999999988  69999999999999

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.93  E-value=8.7e-27  Score=246.10  Aligned_cols=265  Identities=18%  Similarity=0.194  Sum_probs=200.5

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccC------CCCceeEEEEeecCCc
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ------HRNLVKLIGCCTQRDE  574 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~------H~niv~l~g~~~~~~~  574 (823)
                      ...+|.+....|+|-|++|.+|.... ++.||||+|..+.. -.+.=..|+++|++|+      .-|+++++-.|...++
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH  508 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH  508 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence            34678888889999999999999765 88999999966532 3344578999999995      3489999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCC-Cceeeccccc
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMA  653 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DFGla  653 (823)
                      ++||+|-+ ..+|.+.|....+.-.|....+..++.|+.-||..|...+   |+|.||||.|||+++.. .+||||||.|
T Consensus       509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA  584 (752)
T ss_pred             eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence            99999987 5589999987777777899999999999999999999887   99999999999998764 5799999999


Q ss_pred             eecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHH--------
Q 003391          654 RAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR--------  725 (823)
Q Consensus       654 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~--------  725 (823)
                      ......+    ...+.-+..|.|||++.+.+|....|+||.||.||||.||+..|+........-+.-....        
T Consensus       585 ~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR  660 (752)
T KOG0670|consen  585 SFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR  660 (752)
T ss_pred             ccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh
Confidence            7653222    2224456789999999999999999999999999999999998875444332222111100        


Q ss_pred             --HhhhcC----------------------------chhhhhhhcCC--CCC---HHHHHHHHHHHHHccccCCCCCCCH
Q 003391          726 --LWIEER----------------------------PVELINKSLGG--SYS---LSEVLRCIQVGLLCVQQRPEDRPNM  770 (823)
Q Consensus       726 --~~~~~~----------------------------~~~~~~~~l~~--~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~  770 (823)
                        +|.+..                            +..-+...+.+  ..+   ...+..+.+|...|+..||++|.|.
T Consensus       661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~  740 (752)
T KOG0670|consen  661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV  740 (752)
T ss_pred             hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence              000000                            00000111111  122   2234577889999999999999999


Q ss_pred             HHHHH
Q 003391          771 SSVVL  775 (823)
Q Consensus       771 ~evl~  775 (823)
                      .++|.
T Consensus       741 nqAL~  745 (752)
T KOG0670|consen  741 NQALK  745 (752)
T ss_pred             HHHhc
Confidence            99875

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.93  E-value=1.9e-26  Score=246.68  Aligned_cols=195  Identities=27%  Similarity=0.410  Sum_probs=166.5

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--------cccHHHHHHHHHHHhccC---CCCceeEEEEeec
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--------GQGMEEFENEVLLIAKLQ---HRNLVKLIGCCTQ  571 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~  571 (823)
                      ..|+..+.||.|+||.|+.++++. ..+|+||.+.+..        ....-....||++|..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            457888999999999999999976 5678889886642        112223567999999997   9999999999999


Q ss_pred             CCceEEEEeec-CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecc
Q 003391          572 RDERMLIYEYL-PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDF  650 (823)
Q Consensus       572 ~~~~~lV~e~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF  650 (823)
                      .+.++|+||-. ++-+|.++|   ...+.+++.++.-|+.||+.|+++||+++   |||||||-+||.++.+|-+||+||
T Consensus       641 dd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence            99999999976 466788887   34455899999999999999999999998   999999999999999999999999


Q ss_pred             ccceecCCCccccccccccccCCccCccccccCCC-CccchhHhHHHHHHHHHhcCCCC
Q 003391          651 GMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNR  708 (823)
Q Consensus       651 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwS~Gvvl~elltG~~p~  708 (823)
                      |.|....    .......+||..|.|||++.+.+| +..-|||++|++||-++....|+
T Consensus       715 gsaa~~k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  715 GSAAYTK----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             cchhhhc----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            9987643    234456899999999999999887 55689999999999999887774

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=5.1e-25  Score=226.18  Aligned_cols=198  Identities=33%  Similarity=0.463  Sum_probs=171.8

Q ss_pred             CCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccc-cHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecC
Q 003391          506 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQ-GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP  583 (823)
Q Consensus       506 ~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (823)
                      |...+.||.|++|.||++.+.+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4556799999999999999876 889999999776554 67789999999999999999999999999999999999999


Q ss_pred             CCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccc
Q 003391          584 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA  663 (823)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  663 (823)
                      +++|.+++.....  .+++..+..++.+++.++.+||+.+   ++|+||+|.||+++.++.++|+|||.+........ .
T Consensus        81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~  154 (225)
T smart00221       81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-A  154 (225)
T ss_pred             CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-c
Confidence            9999999854221  1789999999999999999999987   99999999999999999999999999987644321 1


Q ss_pred             ccccccccCCccCcccc-ccCCCCccchhHhHHHHHHHHHhcCCCCC
Q 003391          664 NTNRVVGTYGYMPPEYA-IDGLFSVKSDVFSFGVLVLEIVCGKRNRG  709 (823)
Q Consensus       664 ~~~~~~gt~~y~aPE~l-~~~~~s~ksDVwS~Gvvl~elltG~~p~~  709 (823)
                      ......++..|++||.+ ....++.++|||+||++++||++|+.||.
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence            22335677899999998 66778889999999999999999999974

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.92  E-value=1.8e-25  Score=224.75  Aligned_cols=258  Identities=24%  Similarity=0.306  Sum_probs=188.9

Q ss_pred             cCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCC--ccccHHHHHHHHHHHhccCCCCceeEEEEeecC------Cc
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR------DE  574 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~  574 (823)
                      .+|...+.+|.|.- .|..+.+. .++.||+|++...  .....+...+|...+..++|+|+++++.++.-.      .+
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            46666778888876 45554432 3889999988654  345667788999999999999999999998543      35


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccce
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  654 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  654 (823)
                      .++|||+|. .+|...+.     ..++-.....|..|++.|++|||+.+   |+||||||+||++..+..+||.|||+|+
T Consensus        96 ~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   96 VYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence            799999995 48888774     23666788899999999999999998   9999999999999999999999999998


Q ss_pred             ecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchh--------------
Q 003391          655 AFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL--------------  720 (823)
Q Consensus       655 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~--------------  720 (823)
                      .-..   ....+..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|...+.-+.-..+              
T Consensus       167 ~e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q  243 (369)
T KOG0665|consen  167 TEDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ  243 (369)
T ss_pred             ccCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence            6432   23445578899999999999999999999999999999999999876532211110000              


Q ss_pred             -HHHHHHhhhcCchhhh------------hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          721 -GHAWRLWIEERPVELI------------NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       721 -~~~~~~~~~~~~~~~~------------~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                       ....+.+....+....            ...+..+  ......+.+++.+||-.+|++|.++.++++.
T Consensus       244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~--~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGS--KLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             hhHHHHHHhhcChHhhccchhhhCCcccccccccCC--ccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence             0001111111111110            0001111  1112245678899999999999999999875

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.91  E-value=1e-25  Score=245.06  Aligned_cols=252  Identities=24%  Similarity=0.351  Sum_probs=198.3

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      .++|....++|.|.+|.|||+++.. ++..|+|.++........-...|+-+++..+|||||.++|.+...+..++.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            4567888899999999999999865 888999999887777778888999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +.+|+|.+.-+   -..++++.++...++..++||+|||+.+   -+|||||-.|||+++.+.+|++|||.+-.+.  ..
T Consensus        94 cgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqit--at  165 (829)
T KOG0576|consen   94 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQIT--AT  165 (829)
T ss_pred             cCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhh--hh
Confidence            99999999763   3557889999999999999999999998   7999999999999999999999999987653  23


Q ss_pred             ccccccccccCCccCcccc---ccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          662 EANTNRVVGTYGYMPPEYA---IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l---~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                      -.......||+.|||||+.   +.+.|..++|||+.|+...|+---+.|.-..++      . .+... ..   ...+++
T Consensus       166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp------m-r~l~L-mT---kS~~qp  234 (829)
T KOG0576|consen  166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP------M-RALFL-MT---KSGFQP  234 (829)
T ss_pred             hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch------H-HHHHH-hh---ccCCCC
Confidence            3344557899999999987   456799999999999999999766655211100      0 00000 00   011111


Q ss_pred             h-cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          739 S-LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       739 ~-l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      . ++...  .-...+-+++..|+..+|++||++..++.
T Consensus       235 p~lkDk~--kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  235 PTLKDKT--KWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             CcccCCc--cchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            1 11111  11235668899999999999999876553

>smart00108 B_lectin Bulb-type mannose-specific lectin

Probab=99.91  E-value=6.3e-24  Score=193.12  Aligned_cols=113  Identities=52%  Similarity=0.849  Sum_probs=100.5

Q ss_pred             CcccCCCeEeeCCCeEEEeeecCCCCCCeEEEEEEeecCCCcEEEeecCCCCCCCCCCceEEEecCCceEEEecCCCCeE
Q 003391           25 QSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIV  104 (823)
Q Consensus        25 ~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~giw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~~~l~l~~~~~~~~  104 (823)
                      +.|..|++|+|++|.|++|||.+... ..+.+|||++.+ +++||+|||+.|+.. ++.|.|+.||+  |+|++.+|.++
T Consensus         2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~-~~~vW~snt~~~~~~-~~~l~l~~dGn--Lvl~~~~g~~v   76 (114)
T smart00108        2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSS-RTVVWVANRDNPVSD-SCTLTLQSDGN--LVLYDGDGRVV   76 (114)
T ss_pred             cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCC-CcEEEECCCCCCCCC-CEEEEEeCCCC--EEEEeCCCCEE
Confidence            56889999999999999999998654 678999999887 899999999999876 48899999999  99999999999


Q ss_pred             EeecCCCCCCcceEEEecCCCEEEecCCCCCCCcceeeecCC
Q 003391          105 WSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFDY  146 (823)
Q Consensus       105 w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqSFd~  146 (823)
                      |+|+++.+....+++|+|+|||||++..    +++|||||||
T Consensus        77 W~S~t~~~~~~~~~~L~ddGnlvl~~~~----~~~~W~Sf~~  114 (114)
T smart00108       77 WSSNTTGANGNYVLVLLDDGNLVIYDSD----GNFLWQSFDY  114 (114)
T ss_pred             EEecccCCCCceEEEEeCCCCEEEECCC----CCEEeCCCCC
Confidence            9999874445567899999999999976    7799999997

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.90  E-value=1.9e-24  Score=262.74  Aligned_cols=197  Identities=19%  Similarity=0.242  Sum_probs=138.7

Q ss_pred             ccCC-CCceeEEEEe-------ecCCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 003391          556 KLQH-RNLVKLIGCC-------TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI  627 (823)
Q Consensus       556 ~l~H-~niv~l~g~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i  627 (823)
                      .++| +||.++++++       .+....++++|++ +++|.++|..  ....+++.++..++.||++||.|||+.+   |
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---I  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---I  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            3455 5788888877       2234567888987 5599999953  2345899999999999999999999988   9


Q ss_pred             EecccCCCcEEEcC-------------------CCCceeeccccceecCCCcc--------------ccccccccccCCc
Q 003391          628 IHRDLKASNVLLDN-------------------EMNPKISDFGMARAFGIDQT--------------EANTNRVVGTYGY  674 (823)
Q Consensus       628 vH~Dlk~~NIll~~-------------------~~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y  674 (823)
                      +||||||+||||+.                   ++.+||+|||+++.......              ........||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999954                   45567777777754211000              0001124578899


Q ss_pred             cCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHH
Q 003391          675 MPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQ  754 (823)
Q Consensus       675 ~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~  754 (823)
                      ||||++.+..++.++|||||||+||||++|..|+....     .....    ...    ..    + ............+
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~~----~~~----~~----~-~~~~~~~~~~~~~  243 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMSS----LRH----RV----L-PPQILLNWPKEAS  243 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHHH----HHH----hh----c-ChhhhhcCHHHHH
Confidence            99999999999999999999999999999887743110     00000    000    00    0 0001112234567


Q ss_pred             HHHHccccCCCCCCCHHHHHHH
Q 003391          755 VGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       755 l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ++.+||+++|.+||+|.|+++.
T Consensus       244 ~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        244 FCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHHhCCCChhhCcChHHHhhc
Confidence            8889999999999999999763

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.90  E-value=7.8e-24  Score=220.93  Aligned_cols=199  Identities=27%  Similarity=0.443  Sum_probs=165.7

Q ss_pred             HHHhcCCCcCCeeeccCccceEEEEeec----CcEEEEEEecCCccccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCc
Q 003391          500 ANATENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDE  574 (823)
Q Consensus       500 ~~~~~~~~~~~~LG~G~fg~Vyk~~~~~----~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~  574 (823)
                      ....+.|...++||+|.|++||++++..    .+.||+|.+....  ....+.+|+++|..+ -+.||+++.+++...+.
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~  109 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ  109 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence            3345678889999999999999999754    6789999987654  345789999999999 59999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCC-CCceeeccccc
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMA  653 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DFGla  653 (823)
                      ..+|+||++.....+++..      ++...+..+++.+++||+++|..|   ||||||||.|+|.+.. +.-.|.|||+|
T Consensus       110 v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLA  180 (418)
T ss_pred             eEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhH
Confidence            9999999999998888743      668889999999999999999999   9999999999999754 66899999999


Q ss_pred             eecCCCc-------------cc-----------------------------cccccccccCCccCccccccC-CCCccch
Q 003391          654 RAFGIDQ-------------TE-----------------------------ANTNRVVGTYGYMPPEYAIDG-LFSVKSD  690 (823)
Q Consensus       654 ~~~~~~~-------------~~-----------------------------~~~~~~~gt~~y~aPE~l~~~-~~s~ksD  690 (823)
                      ......+             ..                             ...-...||++|.|||++... ..++++|
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence            7221000             00                             001124599999999999765 4789999


Q ss_pred             hHhHHHHHHHHHhcCCCCC
Q 003391          691 VFSFGVLVLEIVCGKRNRG  709 (823)
Q Consensus       691 VwS~Gvvl~elltG~~p~~  709 (823)
                      |||.|||++-+++++.||-
T Consensus       261 iws~GVI~Lslls~~~PFf  279 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFF  279 (418)
T ss_pred             eeeccceeehhhccccccc
Confidence            9999999999999999973

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.90  E-value=3.1e-24  Score=210.52  Aligned_cols=253  Identities=19%  Similarity=0.320  Sum_probs=186.0

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhcc-CCCCceeEEEE-eecCCceEEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGC-CTQRDERMLIY  579 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~-~~~~~~~~lV~  579 (823)
                      .+.|.+.+.||+|.||.+-.+.++. .+.+|+|.+... ....++|.+|...--.| .|.||+.-++. |+..+.+++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            3568888999999999999999976 678888988554 34567899998765556 58999987754 56677888999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEc--CCCCceeeccccceecC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD--NEMNPKISDFGMARAFG  657 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~--~~~~~kl~DFGla~~~~  657 (823)
                      ||++.|+|.+-+..    ..+-+.-..+++.|++.|+.|||++.   +||||||.+||||-  +..++||+|||+.+..+
T Consensus       102 E~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             ccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence            99999999987732    34667778899999999999999998   99999999999993  44589999999987532


Q ss_pred             CCccccccccccccCCccCccccccC-----CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCc
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAIDG-----LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP  732 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  732 (823)
                           ........+..|.+||.....     ...+.+|+|.||++++.++||+.|+...   .......+.|..|.....
T Consensus       175 -----~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka---~~~d~~Y~~~~~w~~rk~  246 (378)
T KOG1345|consen  175 -----TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA---SIMDKPYWEWEQWLKRKN  246 (378)
T ss_pred             -----ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh---hccCchHHHHHHHhcccC
Confidence                 122223456789999987533     2467899999999999999999997632   222233344555555444


Q ss_pred             hhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 003391          733 VELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML  777 (823)
Q Consensus       733 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  777 (823)
                      ..+-  .....++    ..+.++..+-+..+|++|-...++.++-
T Consensus       247 ~~~P--~~F~~fs----~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  247 PALP--KKFNPFS----EKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             ccCc--hhhcccC----HHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            3221  1111222    2455677788889999986655555544

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.89  E-value=9.8e-23  Score=201.53  Aligned_cols=165  Identities=19%  Similarity=0.182  Sum_probs=122.9

Q ss_pred             CCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccccc
Q 003391          585 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN  664 (823)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~  664 (823)
                      |+|.+++..  +...+++..++.++.||++||.|||+.+         ||+|||++.++.+|+  ||+++......    
T Consensus         1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence            688888853  2446999999999999999999999875         999999999999999  99998653221    


Q ss_pred             cccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCC
Q 003391          665 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY  744 (823)
Q Consensus       665 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~  744 (823)
                         ..||+.|||||++.+..++.++|||||||++|||++|+.|+.....  .......    +.......    ......
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~--~~~~~~~----~~~~~~~~----~~~~~~  130 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE--LSAILEI----LLNGMPAD----DPRDRS  130 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch--hcHHHHH----HHHHhccC----Cccccc
Confidence               2578999999999999999999999999999999999999743221  1111111    11000000    000001


Q ss_pred             CHHHH---HHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          745 SLSEV---LRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       745 ~~~~~---~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                      .....   .++.+++.+|++.+|.+||++.|+++.+..
T Consensus       131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750      131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence            11111   258999999999999999999999998754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.88  E-value=3.1e-23  Score=203.13  Aligned_cols=247  Identities=21%  Similarity=0.316  Sum_probs=189.1

Q ss_pred             CCeeeccCccceEEEEeecCcEEEEEEecCC--ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCCCC
Q 003391          509 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKS  586 (823)
Q Consensus       509 ~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  586 (823)
                      ..+|.+...|..|+|++ .|..+++|++...  .....++|..|.-.|+...||||+.++|.|....++.++..||+.||
T Consensus       195 ~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs  273 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS  273 (448)
T ss_pred             hhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence            34788889999999999 5667777877543  23344679999999999999999999999999999999999999999


Q ss_pred             cchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccccccc
Q 003391          587 LNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN  666 (823)
Q Consensus       587 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  666 (823)
                      |+..|++. ..-..+..++.+++.++++|++|||+..+ -|..--|.++.|++|++.+++|+-=. ++.      .....
T Consensus       274 lynvlhe~-t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad-~kf------sfqe~  344 (448)
T KOG0195|consen  274 LYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMAD-TKF------SFQEV  344 (448)
T ss_pred             HHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheeccc-cee------eeecc
Confidence            99999753 34457888999999999999999999873 24455789999999999998885211 111      01111


Q ss_pred             cccccCCccCccccccCCC---CccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCC
Q 003391          667 RVVGTYGYMPPEYAIDGLF---SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS  743 (823)
Q Consensus       667 ~~~gt~~y~aPE~l~~~~~---s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~  743 (823)
                      .....+.||+||.+...+.   -.++|+|||+++||||.|...||....+-+..               ..+.-+-++..
T Consensus       345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---------------mkialeglrv~  409 (448)
T KOG0195|consen  345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---------------MKIALEGLRVH  409 (448)
T ss_pred             ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh---------------hhhhhcccccc
Confidence            2345689999999987664   35799999999999999999998644332211               11112223334


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          744 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       744 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      .+..-...+.+++.-|+..||.+||.+..++-+||..
T Consensus       410 ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  410 IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            4444456788999999999999999999999999864

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=1.1e-21  Score=212.53  Aligned_cols=166  Identities=17%  Similarity=0.175  Sum_probs=129.3

Q ss_pred             HhcCCCcCCeeeccCccceEEEEee--cCcEEEEEEecCCc-----cccHHHHHHHHHHHhccCCCCceeEEEEeecCCc
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLI--EGQEIAAKRLSKSS-----GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE  574 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~--~~~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~  574 (823)
                      ..++|...+.||+|+||+||+|++.  +++.+|||++....     ....+.|.+|++++++++|+|+++.+..   .+.
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~   92 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGK   92 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCC
Confidence            4578999999999999999999875  36778999875331     1234568999999999999999853332   246


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEeccc-CCCcEEEcCCCCceeeccccc
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDL-KASNVLLDNEMNPKISDFGMA  653 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dl-k~~NIll~~~~~~kl~DFGla  653 (823)
                      .+|||||+++++|....    ...      ...++.+++++|.|||+.+   |+|||| ||+|||++.++.+||+|||+|
T Consensus        93 ~~LVmE~~~G~~L~~~~----~~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA  159 (365)
T PRK09188         93 DGLVRGWTEGVPLHLAR----PHG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLA  159 (365)
T ss_pred             cEEEEEccCCCCHHHhC----ccc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccc
Confidence            79999999999996321    111      1467889999999999988   999999 999999999999999999999


Q ss_pred             eecCCCccccc------cccccccCCccCccccccC
Q 003391          654 RAFGIDQTEAN------TNRVVGTYGYMPPEYAIDG  683 (823)
Q Consensus       654 ~~~~~~~~~~~------~~~~~gt~~y~aPE~l~~~  683 (823)
                      +.+........      .....++..|+|||.+...
T Consensus       160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             eecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            98754322211      1246678899999998543

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=9.6e-21  Score=205.82  Aligned_cols=259  Identities=21%  Similarity=0.246  Sum_probs=191.1

Q ss_pred             CCCcCCeeeccCccceEEEEeecC--cEEEEEEecCCccccHHHHHHHHHHHhccCC----CCceeEEEEe-ecCCceEE
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIEG--QEIAAKRLSKSSGQGMEEFENEVLLIAKLQH----RNLVKLIGCC-TQRDERML  577 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~~--~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H----~niv~l~g~~-~~~~~~~l  577 (823)
                      +|.+.++||+|+||.||++.....  ..+|+|............+..|+.++..+.+    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            789999999999999999997664  4788887765533333377888898888863    5888999888 47778899


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCC-----CCceeecccc
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-----MNPKISDFGM  652 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~-----~~~kl~DFGl  652 (823)
                      ||+.+ |.+|.++..... .+.++...+.+|+.|++.+|++||+.|   ++||||||.|+++...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99987 889999764433 567999999999999999999999998   9999999999999754     4699999999


Q ss_pred             ceecC--CCcc----ccc--cccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHH
Q 003391          653 ARAFG--IDQT----EAN--TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW  724 (823)
Q Consensus       653 a~~~~--~~~~----~~~--~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~  724 (823)
                      ++.+.  ....    ...  ....+||..|.+++...+...+.+.|+||++.++.|++.|..|+.............   
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~---  250 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE---  250 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH---
Confidence            99332  1111    111  234569999999999999999999999999999999999999974333221111100   


Q ss_pred             HHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          725 RLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       725 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                          ..........     .....+..+.++...+-..+..++|....+...|.+.
T Consensus       251 ----~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~  297 (322)
T KOG1164|consen  251 ----KDPRKLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV  297 (322)
T ss_pred             ----HHhhhhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence                0000001000     1111223444555555568889999999999888655

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.83  E-value=3.6e-19  Score=192.82  Aligned_cols=262  Identities=29%  Similarity=0.380  Sum_probs=196.6

Q ss_pred             CCcCCeeeccCccceEEEEeecCcEEEEEEecCCccc---cHHHHHHHHHHHhccCCC-CceeEEEEeecCCceEEEEee
Q 003391          506 FSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQ---GMEEFENEVLLIAKLQHR-NLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       506 ~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~H~-niv~l~g~~~~~~~~~lV~e~  581 (823)
                      |...+.||.|+|+.||++...  ..+++|.+......   ....+.+|+.++..+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            556778999999999999986  88899998766443   367899999999999988 799999999777778999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCC-CceeeccccceecCCCc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAFGIDQ  660 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DFGla~~~~~~~  660 (823)
                      +.++++.+++........+.......+..|++.++.|+|+.+   ++||||||+||+++... .++++|||+++.+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999976643211136888999999999999999999998   99999999999999998 79999999998654333


Q ss_pred             ccc----ccccccccCCccCcccccc---CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCch
Q 003391          661 TEA----NTNRVVGTYGYMPPEYAID---GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV  733 (823)
Q Consensus       661 ~~~----~~~~~~gt~~y~aPE~l~~---~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  733 (823)
                      ...    ......++..|+|||.+.+   ...+...|+|++|++++++++|..|+......   ................
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~  233 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP  233 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc
Confidence            221    2455789999999999987   57899999999999999999999995443321   0011111111111100


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          734 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       734 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                       .................+.+++..|+..+|..|.++.+....
T Consensus       234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 -SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             -ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence             000000000001122466788899999999999999987764

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.81  E-value=2e-20  Score=214.19  Aligned_cols=251  Identities=18%  Similarity=0.235  Sum_probs=183.4

Q ss_pred             CCCcCCeeeccCccceEEEEeecCcEEEEEEecCCc-cccHHHHHHHHHHH--hccCCCCceeEEEEeecCCceEEEEee
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSS-GQGMEEFENEVLLI--AKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~-~~~~~~~~~Ei~~l--~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      ++...+.||.+.|=.|.+|++.+|. |+||++-+.. .-..+.|.++++-+  ..++|||.+++.-.-......|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5666789999999999999997777 8899886654 44555665555444  445899999998887777788999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +.+ +|+|.|   ..++++...+..-|+.|++.||.-+|..+   |+|||||.+||||+.-..+.|+||.--+-...++.
T Consensus       103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            965 888887   46677888899999999999999999998   99999999999999999999999987664433322


Q ss_pred             cc-c----cccccccCCccCccccccC----------C-CCccchhHhHHHHHHHHHhc-CCCCCCcCCCCccchhHHHH
Q 003391          662 EA-N----TNRVVGTYGYMPPEYAIDG----------L-FSVKSDVFSFGVLVLEIVCG-KRNRGFYHADHHHNLLGHAW  724 (823)
Q Consensus       662 ~~-~----~~~~~gt~~y~aPE~l~~~----------~-~s~ksDVwS~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~  724 (823)
                      .. .    ......-..|+|||.+-..          . .+++.||||+||++.||++- +.+|...+      +..+. 
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~aYr-  248 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LLAYR-  248 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HHhHh-
Confidence            21 1    1222333489999988431          2 67899999999999999994 66654211      11110 


Q ss_pred             HHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          725 RLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       725 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                       .-.......+++.. ..       ..+..+++.|+|.||++|.++.++++.--|
T Consensus       249 -~~~~~~~e~~Le~I-ed-------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  249 -SGNADDPEQLLEKI-ED-------VSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             -ccCccCHHHHHHhC-cC-------ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence             00001111111111 11       157789999999999999999999887443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.81  E-value=1.5e-20  Score=216.95  Aligned_cols=252  Identities=19%  Similarity=0.256  Sum_probs=185.2

Q ss_pred             CcCCeeeccCccceEEEEeec-CcEEEEEEecC---Cc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          507 SDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK---SS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       507 ~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~---~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ...+.+|.|.+|.|+...... ....+.|....   ..   .+....+..|+.+-..++|||++..+..+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            345789999999877776543 33344443221   11   111122556777777889999988888877777666669


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+++ +|..++.   ....+...++..++.|++.|+.|||+.|   |.|||||++|+++..++.+||+|||.+..+..+
T Consensus       401 E~~~~-Dlf~~~~---~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVM---SNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHh---cccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99999 9999883   2346888899999999999999999998   999999999999999999999999999988666


Q ss_pred             ccc--cccccccccCCccCccccccCCCCc-cchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          660 QTE--ANTNRVVGTYGYMPPEYAIDGLFSV-KSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       660 ~~~--~~~~~~~gt~~y~aPE~l~~~~~s~-ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      ...  ......+|...|+|||.+.+..|.+ ..||||.|+++..|++|+.|+......+......        ....+. 
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~--------~~~~~~-  544 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN--------NYSDQR-  544 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh--------cccccc-
Confidence            554  5566688999999999999998866 5899999999999999999976543332221000        000000 


Q ss_pred             hhhcCCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          737 NKSLGGS--YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       737 ~~~l~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                       ....+.  .....+.+...++.++|+.+|.+|.||.+|++
T Consensus       545 -~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  545 -NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             -ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence             000000  11123346778999999999999999999975

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.81  E-value=3.4e-19  Score=180.04  Aligned_cols=203  Identities=22%  Similarity=0.321  Sum_probs=169.6

Q ss_pred             cCCCcCCeeeccCccceEEEEe-ecCcEEEEEEecCCccccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceEEEEee
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVL-IEGQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      -+|.++++||+|.||.++.|+. .+++.||||.-...+  ..-+++.|....+.| ..+.|...+-|-.++.+-.||+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            4688999999999999999984 468999999654332  335678888888888 478999999888999999999998


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCC-----Cceeeccccceec
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-----NPKISDFGMARAF  656 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~-----~~kl~DFGla~~~  656 (823)
                      + |.||+|++ +. -+..++...++.+|.|++.-++|+|++.   +|.|||||+|+||...+     .+.|+|||||+.+
T Consensus       106 L-GPSLEDLF-D~-CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  106 L-GPSLEDLF-DL-CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             h-CcCHHHHH-HH-hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            8 88999965 32 2345899999999999999999999998   99999999999996543     5899999999988


Q ss_pred             CCCccc-----cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCC
Q 003391          657 GIDQTE-----ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHAD  714 (823)
Q Consensus       657 ~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~  714 (823)
                      ..+.+.     .......||.+||+-...++...+.+.|+-|+|-|+...+-|..|+.....+
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~  242 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD  242 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence            654432     2334578999999999999999999999999999999999999998765443

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.78  E-value=5.2e-19  Score=176.36  Aligned_cols=139  Identities=17%  Similarity=0.147  Sum_probs=108.1

Q ss_pred             CCeeeccCccceEEEEeecCcEEEEEEecCCccc--c-------HHH-----------------HHHHHHHHhccCCCCc
Q 003391          509 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQ--G-------MEE-----------------FENEVLLIAKLQHRNL  562 (823)
Q Consensus       509 ~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~--~-------~~~-----------------~~~Ei~~l~~l~H~ni  562 (823)
                      ...||+|+||.||+|.+.+|+.||+|+++.....  .       ...                 ...|+..+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            3589999999999999888999999999654211  1       112                 2349999999987776


Q ss_pred             eeEEEEeecCCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHH-HhcCCCceEecccCCCcEEEcC
Q 003391          563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL-HQDSRLRIIHRDLKASNVLLDN  641 (823)
Q Consensus       563 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dlk~~NIll~~  641 (823)
                      .....+..  ...+|||||++++++...+.   ....++......++.|++.+|.+| |+.+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence            43332222  23489999999987765432   234588999999999999999999 6777   99999999999998 


Q ss_pred             CCCceeeccccceec
Q 003391          642 EMNPKISDFGMARAF  656 (823)
Q Consensus       642 ~~~~kl~DFGla~~~  656 (823)
                      ++.++|+|||+|...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.78  E-value=2.7e-19  Score=180.34  Aligned_cols=171  Identities=14%  Similarity=0.168  Sum_probs=134.0

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHH---------HHHHHHHHhccCCCCceeEEEEeecC
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEE---------FENEVLLIAKLQHRNLVKLIGCCTQR  572 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~---------~~~Ei~~l~~l~H~niv~l~g~~~~~  572 (823)
                      ...+|...++||.|+||.||.... +++.+|+|.+..........         +.+|+..+.+++|++|..+..++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            357899999999999999999655 67789999997654333222         68999999999999999998886533


Q ss_pred             --------CceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCC
Q 003391          573 --------DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN  644 (823)
Q Consensus       573 --------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~  644 (823)
                              ...+|||||++|.+|.++..       ++.    ....+++.+|..+|+.+   ++||||||.||++++++ 
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence                    35789999999999988631       222    24568999999999998   99999999999999988 


Q ss_pred             ceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHH
Q 003391          645 PKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV  702 (823)
Q Consensus       645 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ell  702 (823)
                      ++|+|||.......+...              ..+++...+..++|+|+||+.+..+.
T Consensus       173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            999999988654211111              11345556778999999999987664

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.77  E-value=1.2e-18  Score=168.72  Aligned_cols=203  Identities=23%  Similarity=0.312  Sum_probs=166.0

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccccHHHHHHHHHHHhccCC-CCceeEEEEeecCCceEEEEe
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH-RNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~e  580 (823)
                      ...|...++||.|+||.+|.|... +|.+||||.-+.....  -++..|..+...++| ..|..+..+..++..-.|||+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            467889999999999999999965 4999999987655433  356778888888875 567777788888899999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCC---CCceeeccccceecC
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFG  657 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DFGla~~~~  657 (823)
                      .+ |.||++.+.-.  .+.++..+++-++-|++.-++|+|..+   +|||||||+|+|..-.   .++.++|||+|+.+.
T Consensus        92 LL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             cc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence            88 88999876322  234788899999999999999999998   9999999999999643   468999999999774


Q ss_pred             CCccc-----cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCC
Q 003391          658 IDQTE-----ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHA  713 (823)
Q Consensus       658 ~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~  713 (823)
                      ...+.     .......||.+|.+--...+...+.+.|+-|+|.+|..+--|..|+.....
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka  226 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA  226 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence            33221     222346799999998888888889999999999999999999999865443

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.76  E-value=5e-18  Score=169.85  Aligned_cols=140  Identities=18%  Similarity=0.197  Sum_probs=110.9

Q ss_pred             CCeeeccCccceEEEEeecCcEEEEEEecCCcccc--------------------------HHHHHHHHHHHhccCCCCc
Q 003391          509 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQG--------------------------MEEFENEVLLIAKLQHRNL  562 (823)
Q Consensus       509 ~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~--------------------------~~~~~~Ei~~l~~l~H~ni  562 (823)
                      ...||+|+||.||+|.+.+|+.||||+++......                          ...+..|+..+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            46899999999999998789999999987653210                          1123578999999999987


Q ss_pred             eeEEEEeecCCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCceEecccCCCcEEEcC
Q 003391          563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDN  641 (823)
Q Consensus       563 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NIll~~  641 (823)
                      .....+...  ..+|||||++++++.....   ....++......++.+++.++.+||+ .+   |+||||||+||+++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence            544443332  3489999999886544321   22346788899999999999999999 77   99999999999999 


Q ss_pred             CCCceeeccccceecC
Q 003391          642 EMNPKISDFGMARAFG  657 (823)
Q Consensus       642 ~~~~kl~DFGla~~~~  657 (823)
                      ++.++|+|||++....
T Consensus       153 ~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCEEEEEcccceecC
Confidence            8899999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.75  E-value=4.2e-18  Score=187.64  Aligned_cols=217  Identities=24%  Similarity=0.341  Sum_probs=162.0

Q ss_pred             HhccCCCCceeEEEEeecCCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccC
Q 003391          554 IAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLK  633 (823)
Q Consensus       554 l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk  633 (823)
                      |+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+..  ....++|.-...++.+|++||+|||...  -..|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence            4578999999999999999999999999999999999965  3445899999999999999999999864  23999999


Q ss_pred             CCcEEEcCCCCceeeccccceecCCCccccccccccccCCccCccccccCC-------CCccchhHhHHHHHHHHHhcCC
Q 003391          634 ASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL-------FSVKSDVFSFGVLVLEIVCGKR  706 (823)
Q Consensus       634 ~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-------~s~ksDVwS~Gvvl~elltG~~  706 (823)
                      +.|+++|....+||+|||+.....................|.|||.+.+..       .+.+.||||||++++|+++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            999999999999999999987653211111111223455799999987642       4678999999999999999999


Q ss_pred             CCCCcCCCCcc-chhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          707 NRGFYHADHHH-NLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       707 p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      ||+........ +++...    .. .....+.+.+....  +...++..++..||..+|++||+++.|-..++...
T Consensus       157 ~~~~~~~~~~~~eii~~~----~~-~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~  225 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRV----KK-GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN  225 (484)
T ss_pred             ccccccccCChHHHHHHH----Hh-cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence            98754333322 222221    11 11111222221111  22236889999999999999999999998887654

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.74  E-value=2e-17  Score=171.76  Aligned_cols=232  Identities=20%  Similarity=0.291  Sum_probs=149.1

Q ss_pred             CCcCCeeeccCccceEEEEeec-CcEEEEEEecCC---ccccHHHHHHHHHHHhccCC----------CCceeEEEEee-
Q 003391          506 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQH----------RNLVKLIGCCT-  570 (823)
Q Consensus       506 ~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H----------~niv~l~g~~~-  570 (823)
                      +...+.||.|+++.||.+++.+ ++++|+|+....   .....+++++|...+..+.+          -.++..++... 
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            4456789999999999999977 899999987543   33456777777766665432          12222222211 


Q ss_pred             --------cC---C-----ceEEEEeecCCCCcchhhh---ccCC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEec
Q 003391          571 --------QR---D-----ERMLIYEYLPNKSLNDFIF---DVTR-SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR  630 (823)
Q Consensus       571 --------~~---~-----~~~lV~e~~~~gsL~~~l~---~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~  630 (823)
                              .+   .     ..+++|+-+ -++|.+++.   ...+ ...+....+..+..|+++.+++||+.+   ++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence                    11   1     236677777 558877753   2222 233445566778899999999999998   9999


Q ss_pred             ccCCCcEEEcCCCCceeeccccceecCCCccccccccccccCCccCcccccc--------CCCCccchhHhHHHHHHHHH
Q 003391          631 DLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID--------GLFSVKSDVFSFGVLVLEIV  702 (823)
Q Consensus       631 Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~s~ksDVwS~Gvvl~ell  702 (823)
                      ||+|+|++++.+|.++|+||+.....+.....     ...+..|.+||....        ..++.+.|.|++|+++|.|+
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            99999999999999999999988754322111     233468999997743        24788999999999999999


Q ss_pred             hcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCC
Q 003391          703 CGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDR  767 (823)
Q Consensus       703 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R  767 (823)
                      +|..|++...+......                    ....+. +-++.+..|+..+|+.+|.+|
T Consensus       245 C~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999875433221111                    111233 445567789999999999988

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.73  E-value=2.4e-17  Score=162.44  Aligned_cols=184  Identities=19%  Similarity=0.142  Sum_probs=138.0

Q ss_pred             CcCCeeeccCccceEEEEeecCcEEEEEEecCCccc----cHHHHHHHHHHHhccC-CCCceeEEEEeecCCceEEEEee
Q 003391          507 SDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQ----GMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       507 ~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~----~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      .....|++|+||+||.+.. .+.+++.+.+......    ....+.+|+++|++++ |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3457899999999997765 6788887777554331    1225789999999995 5889999886    446999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEeccc-CCCcEEEcCCCCceeeccccceecCCCc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDL-KASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dl-k~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      ++|.+|...+.    .      ....++.|++++|.++|+.+   |+|||| ||.|||++.++.++|+|||+|.......
T Consensus        80 I~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         80 LAGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             ecCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            99999865431    0      11357789999999999998   999999 7999999999999999999998654322


Q ss_pred             cc----cc-------cccccccCCccCccccccC-CCC-ccchhHhHHHHHHHHHhcCCCC
Q 003391          661 TE----AN-------TNRVVGTYGYMPPEYAIDG-LFS-VKSDVFSFGVLVLEIVCGKRNR  708 (823)
Q Consensus       661 ~~----~~-------~~~~~gt~~y~aPE~l~~~-~~s-~ksDVwS~Gvvl~elltG~~p~  708 (823)
                      ..    ..       ......++.|++|+...-. ..+ ...+.++-|.-+|.++|++.+.
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence            10    00       1112357788888754322 233 5679999999999999999873

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.72  E-value=7.4e-18  Score=197.84  Aligned_cols=198  Identities=22%  Similarity=0.264  Sum_probs=160.2

Q ss_pred             HHhcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccC---CCCceeEEEEeecCCceEE
Q 003391          501 NATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ---HRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       501 ~~~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~l  577 (823)
                      ...+.|.+.+.||+|+||+||+|...+++.||+|+-+......   |--=.+++.+|+   -+-|+.+..++.-.+.-+|
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l  771 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVL  771 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence            3457788999999999999999999889999999887665432   211222333333   2334444444455667899


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEc-------CCCCceeecc
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD-------NEMNPKISDF  650 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~-------~~~~~kl~DF  650 (823)
                      |+||.+.|+|.+++.   ..+.++|..++.++.|+++.+++||..+   |||+||||+|.||.       ++..++|+||
T Consensus       772 v~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf  845 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDF  845 (974)
T ss_pred             eeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEec
Confidence            999999999999984   6678999999999999999999999998   99999999999994       2345899999


Q ss_pred             ccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCC
Q 003391          651 GMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRN  707 (823)
Q Consensus       651 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p  707 (823)
                      |.+-.+..-.........++|-.+-.+|...+.++++++|.|.++.+++-|+.|+..
T Consensus       846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            999876544444566678899999999999999999999999999999999999853

>PRK10345 hypothetical protein; Provisional

Probab=99.71  E-value=4.7e-17  Score=163.72  Aligned_cols=137  Identities=20%  Similarity=0.282  Sum_probs=107.4

Q ss_pred             CCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhcc-----CCCCceeEEEEeecCC---c-eE
Q 003391          506 FSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKL-----QHRNLVKLIGCCTQRD---E-RM  576 (823)
Q Consensus       506 ~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-----~H~niv~l~g~~~~~~---~-~~  576 (823)
                      +...+.||+|+||.||.  +++....+||++........+++.+|+.++..+     .||||++++|++.++.   . ..
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            34467999999999996  555444579988765555667899999999999     5799999999998764   3 33


Q ss_pred             EEEee--cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHH-HHHHhcCCCceEecccCCCcEEEcC----CCCceeec
Q 003391          577 LIYEY--LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL-LYLHQDSRLRIIHRDLKASNVLLDN----EMNPKISD  649 (823)
Q Consensus       577 lV~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivH~Dlk~~NIll~~----~~~~kl~D  649 (823)
                      +|+||  +++++|.+++.+    ..+++.  ..++.+++.++ +|||+++   |+||||||+|||++.    +..++|+|
T Consensus        82 ~I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EEecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            78999  668999999943    124444  35677888777 9999998   999999999999974    34799999


Q ss_pred             cccc
Q 003391          650 FGMA  653 (823)
Q Consensus       650 FGla  653 (823)
                      |+-+
T Consensus       153 g~G~  156 (210)
T PRK10345        153 NIGE  156 (210)
T ss_pred             CCCC
Confidence            4433

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.70  E-value=7e-18  Score=185.34  Aligned_cols=231  Identities=25%  Similarity=0.287  Sum_probs=174.8

Q ss_pred             eeeccCccceEEEEe----ecCcEEEEEEecCCccc--cHHHHHHHHHHHhccC-CCCceeEEEEeecCCceEEEEeecC
Q 003391          511 KLGEGGFGPVYKGVL----IEGQEIAAKRLSKSSGQ--GMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLIYEYLP  583 (823)
Q Consensus       511 ~LG~G~fg~Vyk~~~----~~~~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~  583 (823)
                      .+|+|.||.|+.++-    ..+.-+|+|.+.+....  .......|..++...+ ||.+|++.-.+..+...+++.+|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            378999999987652    33677888887665221  1114566778888886 9999999999999999999999999


Q ss_pred             CCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccc
Q 003391          584 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA  663 (823)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  663 (823)
                      +|.|...+.   +...++......+...++-+++++|+.+   |+|||+|++||+++.+|.+++.|||+++..-...   
T Consensus        81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---  151 (612)
T KOG0603|consen   81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---  151 (612)
T ss_pred             cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh---
Confidence            999988773   3444667777778888999999999998   9999999999999999999999999998653221   


Q ss_pred             ccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCC-
Q 003391          664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG-  742 (823)
Q Consensus       664 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~-  742 (823)
                         ..+||..|||||++.  .....+|.||||++++||+||..||..                       +++...+.. 
T Consensus       152 ---~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----------------------~~~~~Il~~~  203 (612)
T KOG0603|consen  152 ---IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----------------------DTMKRILKAE  203 (612)
T ss_pred             ---hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----------------------HHHHHHhhhc
Confidence               128999999999988  667889999999999999999999753                       111112211 


Q ss_pred             -CCCHHHHHHHHHHHHHccccCCCCCCCH--HHHHHHhc
Q 003391          743 -SYSLSEVLRCIQVGLLCVQQRPEDRPNM--SSVVLMLS  778 (823)
Q Consensus       743 -~~~~~~~~~l~~l~~~Cl~~dP~~RPs~--~evl~~L~  778 (823)
                       ..+.+......+++..++..+|..|.-.  ..+.++++
T Consensus       204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~  242 (612)
T KOG0603|consen  204 LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ  242 (612)
T ss_pred             cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence             1222233455667777777788887754  45555543

>PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions []

Probab=99.67  E-value=3.8e-17  Score=131.83  Aligned_cols=66  Identities=55%  Similarity=1.141  Sum_probs=59.4

Q ss_pred             ccCCCceEEecccCCCCCcccccccccCHHHHHHHhhhcCCcceeecccccCCCcceeeeeeccccc
Q 003391          339 CEHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDM  405 (823)
Q Consensus       339 C~~~~~f~~~~~v~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~g~~c~~w~~~l~~~  405 (823)
                      |+.+|+|+++++|++|++....++.++++++|++.||+||||+||+|.++. ++++|.+|+++|+|+
T Consensus         1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~   66 (66)
T PF08276_consen    1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL   66 (66)
T ss_pred             CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence            556789999999999999887777789999999999999999999998766 668999999999885

These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.66  E-value=3.9e-17  Score=176.22  Aligned_cols=124  Identities=27%  Similarity=0.442  Sum_probs=109.6

Q ss_pred             ceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccc
Q 003391          574 ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  653 (823)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  653 (823)
                      .+++.|++++..+|.+||.........++.....++.|++.|+.|   ++   .+|+|+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            478999999999999999766666778899999999999999999   55   999999999999999999999999999


Q ss_pred             eecCCCc----cccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh
Q 003391          654 RAFGIDQ----TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC  703 (823)
Q Consensus       654 ~~~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt  703 (823)
                      .......    ........+||..||+||.+.+..|+.|+|||++|+||+||+.
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            8764333    2234456789999999999999999999999999999999997

>smart00090 RIO RIO-like kinase

Probab=99.65  E-value=7.8e-16  Score=158.81  Aligned_cols=143  Identities=17%  Similarity=0.154  Sum_probs=111.5

Q ss_pred             cCCCcCCeeeccCccceEEEE--eecCcEEEEEEecCCccc------------------------cHHHHHHHHHHHhcc
Q 003391          504 ENFSDKNKLGEGGFGPVYKGV--LIEGQEIAAKRLSKSSGQ------------------------GMEEFENEVLLIAKL  557 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~--~~~~~~vavK~l~~~~~~------------------------~~~~~~~Ei~~l~~l  557 (823)
                      ..|.+.+.||+|+||.||+|+  ..+|+.||+|++......                        ....+..|+..+.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            347788999999999999998  457999999998654210                        012356899999999


Q ss_pred             CC--CCceeEEEEeecCCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCC
Q 003391          558 QH--RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKAS  635 (823)
Q Consensus       558 ~H--~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~  635 (823)
                      .+  ..+.++++.    ...++||||+++.+|.....   ....+.......++.||+.++.+||+.+  .|+|+||||+
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~  178 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEY  178 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChh
Confidence            75  334455543    23589999999988876542   2233556667899999999999999986  4999999999


Q ss_pred             cEEEcCCCCceeeccccceec
Q 003391          636 NVLLDNEMNPKISDFGMARAF  656 (823)
Q Consensus       636 NIll~~~~~~kl~DFGla~~~  656 (823)
                      ||+++ ++.++|+|||++...
T Consensus       179 NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhcc
Confidence            99999 889999999998754

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.65  E-value=4.3e-16  Score=161.03  Aligned_cols=198  Identities=20%  Similarity=0.246  Sum_probs=135.8

Q ss_pred             CCCCceeEEEEeec---------------------------CCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHH
Q 003391          558 QHRNLVKLIGCCTQ---------------------------RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG  610 (823)
Q Consensus       558 ~H~niv~l~g~~~~---------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  610 (823)
                      +|||||++.++|.+                           ....|+||.-++. +|++++..    ...+.....-|+.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~----~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT----RHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc----CCCchHHHHHHHH
Confidence            69999998877643                           1236788887754 88888842    2356667778899


Q ss_pred             HHHHHHHHHHhcCCCceEecccCCCcEEEc--CC--CCceeeccccceecCCC----ccccccccccccCCccCcccccc
Q 003391          611 GIARGLLYLHQDSRLRIIHRDLKASNVLLD--NE--MNPKISDFGMARAFGID----QTEANTNRVVGTYGYMPPEYAID  682 (823)
Q Consensus       611 ~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~--~~--~~~kl~DFGla~~~~~~----~~~~~~~~~~gt~~y~aPE~l~~  682 (823)
                      |+++|+.|||.++   |.|||+|++||||.  +|  ..+.|+|||++-.-...    ......-...|...-||||+...
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            9999999999998   99999999999993  33  35799999987532110    01111112456778999999854


Q ss_pred             CC------CCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHH
Q 003391          683 GL------FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVG  756 (823)
Q Consensus       683 ~~------~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~  756 (823)
                      .+      --.|+|.|+.|.+.||+++...||-.  ..+.. +.         .+   ...+......+...+..+.+++
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~--rGem~-L~---------~r---~Yqe~qLPalp~~vpp~~rqlV  490 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK--RGEML-LD---------TR---TYQESQLPALPSRVPPVARQLV  490 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccc--cchhe-ec---------hh---hhhhhhCCCCcccCChHHHHHH
Confidence            33      12589999999999999999999732  11110 00         00   0111111222333445778999


Q ss_pred             HHccccCCCCCCCHHHHHHHhc
Q 003391          757 LLCVQQRPEDRPNMSSVVLMLS  778 (823)
Q Consensus       757 ~~Cl~~dP~~RPs~~evl~~L~  778 (823)
                      ...++.||++||+..-....|+
T Consensus       491 ~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  491 FDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHhcCCccccCCccHHHhHHH
Confidence            9999999999999887777765

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.65  E-value=9.4e-16  Score=156.36  Aligned_cols=134  Identities=21%  Similarity=0.283  Sum_probs=113.0

Q ss_pred             CeeeccCccceEEEEeecCcEEEEEEecCCccc--------cHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQ--------GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~--------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      +.||+|++|.||+|.. .+..+++|+.......        ....+.+|+.++..++|+++.....++......++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 6778999976543211        123577899999999999988877777777888999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccccee
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                      +++++|.+++...      .+ .+..++.+++.+|.+||+.+   ++|+|++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999988431      12 78899999999999999998   99999999999999 78999999998864

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.63  E-value=2.1e-15  Score=152.09  Aligned_cols=141  Identities=19%  Similarity=0.209  Sum_probs=110.6

Q ss_pred             HHhcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccc----------------------cHHHHHHHHHHHhccC
Q 003391          501 NATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQ----------------------GMEEFENEVLLIAKLQ  558 (823)
Q Consensus       501 ~~~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~----------------------~~~~~~~Ei~~l~~l~  558 (823)
                      .....|...+.||+|+||.||++...+++.+|||++......                      ....+..|+.++.++.
T Consensus        12 ~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~   91 (198)
T cd05144          12 KRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY   91 (198)
T ss_pred             HcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence            333447778899999999999999888999999987543210                      1123577899999998


Q ss_pred             CC--CceeEEEEeecCCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCc
Q 003391          559 HR--NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASN  636 (823)
Q Consensus       559 H~--niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~N  636 (823)
                      |+  .+...++.    ...++||||+++++|.....         ......++.++++++.++|+.+   |+|+||||+|
T Consensus        92 ~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~N  155 (198)
T cd05144          92 EEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLSEFN  155 (198)
T ss_pred             HcCCCCCceeec----CCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCCccc
Confidence            77  44445442    34589999999999877541         0234578899999999999987   9999999999


Q ss_pred             EEEcCCCCceeeccccceecC
Q 003391          637 VLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       637 Ill~~~~~~kl~DFGla~~~~  657 (823)
                      |++++++.++|+|||++..+.
T Consensus       156 ill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         156 ILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             EEEcCCCcEEEEECCccccCC
Confidence            999999999999999997553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.62  E-value=1.2e-15  Score=177.13  Aligned_cols=140  Identities=19%  Similarity=0.310  Sum_probs=113.7

Q ss_pred             HHHhcCCCcCCeeeccCccceEEEEeecCcEEEEEE-ecCCcc-------ccHHHHHHHHHHHhccCCCCceeEEEEeec
Q 003391          500 ANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKR-LSKSSG-------QGMEEFENEVLLIAKLQHRNLVKLIGCCTQ  571 (823)
Q Consensus       500 ~~~~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~-l~~~~~-------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~  571 (823)
                      ......|...+.||+|+||.||+|.+.... +++|+ +.+...       ...+.+.+|++++.+++|++++....++..
T Consensus       329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~  407 (535)
T PRK09605        329 EEVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD  407 (535)
T ss_pred             cccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence            334455567889999999999999875544 44443 322111       123568899999999999999988888877


Q ss_pred             CCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccc
Q 003391          572 RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG  651 (823)
Q Consensus       572 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFG  651 (823)
                      ....++||||+++++|.+++.           ....++.+++++|.+||+.+   ++||||||+|||+ +++.++|+|||
T Consensus       408 ~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFG  472 (535)
T PRK09605        408 PEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFG  472 (535)
T ss_pred             CCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCc
Confidence            778899999999999999873           45678999999999999998   9999999999999 67899999999


Q ss_pred             ccee
Q 003391          652 MARA  655 (823)
Q Consensus       652 la~~  655 (823)
                      +++.
T Consensus       473 la~~  476 (535)
T PRK09605        473 LGKY  476 (535)
T ss_pred             cccc
Confidence            9975

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.62  E-value=1.8e-15  Score=152.85  Aligned_cols=130  Identities=23%  Similarity=0.344  Sum_probs=105.9

Q ss_pred             eeeccCccceEEEEeecCcEEEEEEecCCcc--------ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          511 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSG--------QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       511 ~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~--------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      .||+|+||.||+|.+ ++..+++|+......        ...+++.+|++++..++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 678899998654321        11356778999999999887665555555667789999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccccee
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                      ++++|.+++...   ..       .++.+++++|.+||+.+   ++|+|++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~---~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEG---ND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhc---HH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999877321   10       78999999999999998   99999999999999 88999999999864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.59  E-value=8.5e-16  Score=176.74  Aligned_cols=217  Identities=20%  Similarity=0.261  Sum_probs=144.2

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      ..+|...+++..|++|.||..+++. .+.+|+ ++.+..--    .++   ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~li----lRn---ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLI----LRN---ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhh-cccccchh----hhc---cccccCCccee------------------
Confidence            3567788899999999999999875 677888 44333210    001   22222333333                  


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC--
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID--  659 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~--  659 (823)
                         |+-...+   +..+.++...        +.+++|||+.+   |+|||+||+|.+|+.=|++|+.|||+++.....  
T Consensus       136 ---gDc~tll---k~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 ---GDCATLL---KNIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             ---chhhhhc---ccCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence               2222223   1222333332        78899999998   999999999999999999999999998864211  


Q ss_pred             -----------ccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhh
Q 003391          660 -----------QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWI  728 (823)
Q Consensus       660 -----------~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~  728 (823)
                                 ........++||+.|+|||++..+.|...+|+|++|+|+||.+-|+.||....++   +++..+..   
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe---elfg~vis---  272 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---ELFGQVIS---  272 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH---HHHhhhhh---
Confidence                       1111223478999999999999999999999999999999999999997543221   12211111   


Q ss_pred             hcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          729 EERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       729 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                              +.....+.+.....+..+++...|+.+|..|--....+++
T Consensus       273 --------d~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~ev  312 (1205)
T KOG0606|consen  273 --------DDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEV  312 (1205)
T ss_pred             --------hhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhh
Confidence                    0001111122233467788889999999999844444443

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.53  E-value=7.9e-14  Score=133.36  Aligned_cols=135  Identities=21%  Similarity=0.216  Sum_probs=115.0

Q ss_pred             cCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCC--CCceeEEEEeecCCceEEEEeecCCC
Q 003391          508 DKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH--RNLVKLIGCCTQRDERMLIYEYLPNK  585 (823)
Q Consensus       508 ~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lV~e~~~~g  585 (823)
                      +.+.||+|.++.||++...+ ..+++|.......  ...+..|+.++..++|  +++++++++....+..++++||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            35689999999999999844 7899998865543  5678999999999976  58999999988888899999999998


Q ss_pred             CcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccccee
Q 003391          586 SLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                      .+..+          +......++.+++++|++||......++|+|++|+||++++.+.+++.|||.+..
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77653          4566778899999999999986545699999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.52  E-value=5.1e-14  Score=140.64  Aligned_cols=136  Identities=20%  Similarity=0.241  Sum_probs=98.1

Q ss_pred             CCeeeccCccceEEEEeecCcEEEEEEecCCccc--cHHH----------------------HHHHHHHHhccCCC--Cc
Q 003391          509 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQ--GMEE----------------------FENEVLLIAKLQHR--NL  562 (823)
Q Consensus       509 ~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~--~~~~----------------------~~~Ei~~l~~l~H~--ni  562 (823)
                      .+.||+|+||.||+|.+.+++.||||++......  ....                      ...|...+.++.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4689999999999999888999999988654221  1111                      13455566665433  34


Q ss_pred             eeEEEEeecCCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCceEecccCCCcEEEcC
Q 003391          563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDN  641 (823)
Q Consensus       563 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NIll~~  641 (823)
                      .+.+++    ...++||||++++.+.........   .. .....++.+++.++.++|. .+   |+|+||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence            444443    246899999999654322111000   11 5677899999999999999 76   99999999999999 


Q ss_pred             CCCceeeccccceec
Q 003391          642 EMNPKISDFGMARAF  656 (823)
Q Consensus       642 ~~~~kl~DFGla~~~  656 (823)
                      ++.++|+|||.+...
T Consensus       150 ~~~~~liDfg~a~~~  164 (187)
T cd05119         150 DGKVYIIDVPQAVEI  164 (187)
T ss_pred             CCcEEEEECcccccc
Confidence            899999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.48  E-value=2.8e-13  Score=140.14  Aligned_cols=135  Identities=20%  Similarity=0.244  Sum_probs=105.0

Q ss_pred             CCeee-ccCccceEEEEeecCcEEEEEEecCCc-------------cccHHHHHHHHHHHhccCCCCc--eeEEEEeecC
Q 003391          509 KNKLG-EGGFGPVYKGVLIEGQEIAAKRLSKSS-------------GQGMEEFENEVLLIAKLQHRNL--VKLIGCCTQR  572 (823)
Q Consensus       509 ~~~LG-~G~fg~Vyk~~~~~~~~vavK~l~~~~-------------~~~~~~~~~Ei~~l~~l~H~ni--v~l~g~~~~~  572 (823)
                      ...|| .|+.|+||+... .+..+++|++....             ......+.+|+.++.+++|+++  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35788 899999999987 47889998875321             1223567889999999998774  7777775433


Q ss_pred             Cc----eEEEEeecCC-CCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCcee
Q 003391          573 DE----RMLIYEYLPN-KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI  647 (823)
Q Consensus       573 ~~----~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl  647 (823)
                      ..    .++|+|++++ .+|.+++.+    ..++..    ...+|+++|.+||+.+   |+|+||||.|||++.++.++|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence            22    3599999997 688888732    224433    3568999999999998   999999999999999999999


Q ss_pred             ecccccee
Q 003391          648 SDFGMARA  655 (823)
Q Consensus       648 ~DFGla~~  655 (823)
                      +|||.+..
T Consensus       184 IDfg~~~~  191 (239)
T PRK01723        184 IDFDRGEL  191 (239)
T ss_pred             EECCCccc
Confidence            99998864

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.45  E-value=1.3e-14  Score=167.92  Aligned_cols=255  Identities=23%  Similarity=0.302  Sum_probs=186.5

Q ss_pred             cCCCcCCeeeccCccceEEEEeec--CcEEEEEEecCCc--cccHHHHHHHHHHHhccC-CCCceeEEEEeecCCceEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE--GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV  578 (823)
                      ..|...+.||+|.|+.|-......  ...+|+|.+....  ....+....|..+-..+. |+|++++++...+.+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            346667789999999998877644  3456666665443  333344455777777776 99999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHH-hcCCCceEecccCCCcEEEcCCC-Cceeeccccceec
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH-QDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAF  656 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DFGla~~~  656 (823)
                      .+|..++++.+.+.. ......+....-.+..|+..++.|+| ..+   +.|+||||+|.+++..+ ..+++|||+|..+
T Consensus       100 ~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             cCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence            999999999887731 11113556667788999999999999 776   99999999999999999 9999999999987


Q ss_pred             CC-Cccccccccccc-cCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCch
Q 003391          657 GI-DQTEANTNRVVG-TYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV  733 (823)
Q Consensus       657 ~~-~~~~~~~~~~~g-t~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  733 (823)
                      .. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|.............      |.+..  
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~------~~~~~--  247 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSS------WKSNK--  247 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccccee------ecccc--
Confidence            66 445555556778 9999999999884 5577899999999999999999997654433311110      11111  


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 003391          734 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV  774 (823)
Q Consensus       734 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl  774 (823)
                      ............    ....++...++..+|+.|.+.+++.
T Consensus       248 ~~~~~~~~~~~~----~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  248 GRFTQLPWNSIS----DQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             cccccCccccCC----hhhhhcccccccCCchhcccccccc
Confidence            000000111111    2445677788889999999888774

>cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins

Probab=99.44  E-value=9.9e-14  Score=115.46  Aligned_cols=71  Identities=24%  Similarity=0.430  Sum_probs=62.1

Q ss_pred             ccCCCceEEecccCCCCCcccccccccCHHHHHHHhhh---cCCcceeecccccCCCcceeeeeecc-cccccccccccc
Q 003391          339 CEHGDGFLKRESVKLPDTRFSLVDNKISLLECKELCSK---NCSCTAYANADVRGGGSGCLLWFHDL-IDMKELSESGQD  414 (823)
Q Consensus       339 C~~~~~f~~~~~v~~p~~~~~~~~~~~s~~~C~~~Cl~---nCsC~a~~~~~~~~~g~~c~~w~~~l-~~~~~~~~~g~~  414 (823)
                      |....+|+++.+|++|++..      ++++||++.|++   ||||+||+|.+.   ++||.+|+++| ++++.....|.+
T Consensus         5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~---~~gC~~W~~~l~~d~~~~~~~g~~   75 (80)
T cd00129           5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA---RKQCLWFPFNSMSGVRKEFSHGFD   75 (80)
T ss_pred             eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC---CCCeEEecCcchhhHHhccCCCce
Confidence            44456899999999999764      789999999999   999999999753   35899999999 999988878999


Q ss_pred             ceee
Q 003391          415 LFVR  418 (823)
Q Consensus       415 lyvr  418 (823)
                      +|+|
T Consensus        76 Ly~r   79 (80)
T cd00129          76 LYEN   79 (80)
T ss_pred             eEeE
Confidence            9997

Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.36  E-value=3.1e-12  Score=143.79  Aligned_cols=141  Identities=21%  Similarity=0.295  Sum_probs=101.3

Q ss_pred             CCeeeccCccceEEEEeecCcEEEEEEecCCccccH----------------------------------------HHHH
Q 003391          509 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGM----------------------------------------EEFE  548 (823)
Q Consensus       509 ~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~----------------------------------------~~~~  548 (823)
                      .+.||.|++|.||+|++.+|+.||||+.++......                                        -+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            368999999999999999999999999876532110                                        0244


Q ss_pred             HHHHHHhcc----CCCCceeEEEEee-cCCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHH-HHHHHHhc
Q 003391          549 NEVLLIAKL----QHRNLVKLIGCCT-QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIAR-GLLYLHQD  622 (823)
Q Consensus       549 ~Ei~~l~~l----~H~niv~l~g~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~  622 (823)
                      +|...+.++    +|.+-+.+-..+. .....+|||||++|++|.++.......  .   .+.+++..+++ .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHhC
Confidence            455555554    2333344433332 245679999999999999876321111  1   23456666666 46788988


Q ss_pred             CCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       623 ~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      +   ++|+|+||.||+++++++++++|||++..+.
T Consensus       277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            7   9999999999999999999999999998764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.36  E-value=3.3e-13  Score=136.93  Aligned_cols=206  Identities=21%  Similarity=0.236  Sum_probs=141.7

Q ss_pred             HHHHHhccCCCCceeEEEEeecC-----CceEEEEeecCCCCcchhhhccC-CCCccCHHHHHHHHHHHHHHHHHHHhcC
Q 003391          550 EVLLIAKLQHRNLVKLIGCCTQR-----DERMLIYEYLPNKSLNDFIFDVT-RSKFLDWSKRCQIIGGIARGLLYLHQDS  623 (823)
Q Consensus       550 Ei~~l~~l~H~niv~l~g~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~  623 (823)
                      -+.-|-++-|.|||++..|..+.     .+..++.|||..|+|..+|++.+ ..+.+......+++.||+.||.|||+..
T Consensus       117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~  196 (458)
T KOG1266|consen  117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence            34455566799999999988654     34789999999999999997633 3456778888899999999999999975


Q ss_pred             CCceEecccCCCcEEEcCCCCceeeccccceecCCC---ccccccccccccCCccCccccccCCCCccchhHhHHHHHHH
Q 003391          624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID---QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLE  700 (823)
Q Consensus       624 ~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~e  700 (823)
                       ++|+|+++..+-|++..++-+||.--. .......   ..........+.++|.+||.-.....+..+|||+||+..+|
T Consensus       197 -PpiihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle  274 (458)
T KOG1266|consen  197 -PPIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE  274 (458)
T ss_pred             -CccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence             789999999999999999988875321 1111100   01111222356789999998777778889999999999999


Q ss_pred             HHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          701 IVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       701 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      |.-+..-..-    ....           ....+.+...+.+..+.    .-..++..|++.+|..||+|++++..
T Consensus       275 mailEiq~tn----seS~-----------~~~ee~ia~~i~~len~----lqr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  275 MAILEIQSTN----SESK-----------VEVEENIANVIIGLENG----LQRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             HHHheeccCC----Ccce-----------eehhhhhhhheeeccCc----cccCcCcccccCCCCCCcchhhhhcC
Confidence            9887643110    0000           00011111111111110    11246778999999999999998643

>cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

Probab=99.33  E-value=1.9e-12  Score=110.90  Aligned_cols=80  Identities=50%  Similarity=0.941  Sum_probs=65.5

Q ss_pred             CCcccCC---CceEEecccCCCCCcccccccccCHHHHHHHhhhcCCcceeecccccCCCcceeeeeecccccccccccc
Q 003391          336 QLDCEHG---DGFLKRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHDLIDMKELSESG  412 (823)
Q Consensus       336 ~l~C~~~---~~f~~~~~v~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~g~~c~~w~~~l~~~~~~~~~g  412 (823)
                      +++|...   ++|++++++++|+..+..  .++++++|++.|++||+|.||+|.+   ++++|.+|...+.+.+.....+
T Consensus         2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~~~~~~   76 (84)
T cd01098           2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSLSSGG   76 (84)
T ss_pred             CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEeecCCC
Confidence            4567544   689999999999886643  7889999999999999999999974   3568999999999877655556


Q ss_pred             ccceeeec
Q 003391          413 QDLFVRMA  420 (823)
Q Consensus       413 ~~lyvrv~  420 (823)
                      ..+|+|++
T Consensus        77 ~~~yiKv~   84 (84)
T cd01098          77 GTLYLRLA   84 (84)
T ss_pred             cEEEEEeC
Confidence            78898874

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.19  E-value=7.9e-11  Score=115.44  Aligned_cols=129  Identities=21%  Similarity=0.148  Sum_probs=96.8

Q ss_pred             CeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCce-eEEEEeecCCceEEEEeecCCCCcc
Q 003391          510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV-KLIGCCTQRDERMLIYEYLPNKSLN  588 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~e~~~~gsL~  588 (823)
                      +.|+.|.++.||+++. .++.+++|....... ....+..|+.++..+.+.+++ +++.+.  ....++||||+++.++.
T Consensus         4 ~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~   79 (170)
T cd05151           4 SPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL   79 (170)
T ss_pred             eecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence            5788999999999986 478899998755432 223567899999988655544 444443  23468999999998876


Q ss_pred             hhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcC--CCceEecccCCCcEEEcCCCCceeeccccce
Q 003391          589 DFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS--RLRIIHRDLKASNVLLDNEMNPKISDFGMAR  654 (823)
Q Consensus       589 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  654 (823)
                      +.-           .....+..+++++|+.||+..  ...++|+|++|.||+++ ++.++++|||.+.
T Consensus        80 ~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          80 TED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            530           011245678999999999876  23469999999999999 6689999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.16  E-value=1.2e-10  Score=132.39  Aligned_cols=144  Identities=15%  Similarity=0.199  Sum_probs=95.8

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcccc----------------------------------H----
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQG----------------------------------M----  544 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~----------------------------------~----  544 (823)
                      ..|+. +.||.|++|.||+|++.+ |+.||||++++.....                                  .    
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45665 789999999999999988 9999999997653110                                  0    


Q ss_pred             --HHHHHHHHHHhcc----CCCCceeEEEEeec-CCceEEEEeecCCCCcchhhhccCCC---CccCHHHHHHHHHHHHH
Q 003391          545 --EEFENEVLLIAKL----QHRNLVKLIGCCTQ-RDERMLIYEYLPNKSLNDFIFDVTRS---KFLDWSKRCQIIGGIAR  614 (823)
Q Consensus       545 --~~~~~Ei~~l~~l----~H~niv~l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~~ia~  614 (823)
                        -+|.+|+..+.++    .+.+.+.+-..+.+ ....+|||||++|+.|.++-.-...+   +.+....+..++.|   
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q---  275 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ---  275 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence              1134455444444    24444555454433 45688999999999998742111111   11222222222333   


Q ss_pred             HHHHHHhcCCCceEecccCCCcEEEcCCC----CceeeccccceecCC
Q 003391          615 GLLYLHQDSRLRIIHRDLKASNVLLDNEM----NPKISDFGMARAFGI  658 (823)
Q Consensus       615 gL~yLH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~DFGla~~~~~  658 (823)
                          ++..+   ++|+|+||.||+++.++    ++++.|||++..+..
T Consensus       276 ----if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        276 ----VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ----HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                33455   99999999999999988    999999999987743

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.09  E-value=9.4e-10  Score=122.90  Aligned_cols=167  Identities=17%  Similarity=0.246  Sum_probs=124.9

Q ss_pred             ecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCCCCcchhhhccCCCCccCHHHH
Q 003391          526 IEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR  605 (823)
Q Consensus       526 ~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~  605 (823)
                      .++.+|.|...+.......+...+-++.|+.++||||++++......+..|||+|-+.  .|..++.+      +.....
T Consensus        35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~v  106 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEEV  106 (690)
T ss_pred             ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHHH
Confidence            3578888888866655445567888999999999999999999999999999999873  35555532      234556


Q ss_pred             HHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccccccccccccCCccCccccccCCC
Q 003391          606 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF  685 (823)
Q Consensus       606 ~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~  685 (823)
                      .-.+.||+.||.|||+.+  .++|++|.-..|++++.|..||++|.++....  +.........--..|..|+.+.... 
T Consensus       107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~--~~~~~~~~~~~~~s~~~P~~~~~s~-  181 (690)
T KOG1243|consen  107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKAS--GFNAPAKSLYLIESFDDPEEIDPSE-  181 (690)
T ss_pred             HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccc--cCCcccccchhhhcccChhhcCccc-
Confidence            667889999999999877  59999999999999999999999999886431  1111111122233566666442221 


Q ss_pred             CccchhHhHHHHHHHHHhcCC
Q 003391          686 SVKSDVFSFGVLVLEIVCGKR  706 (823)
Q Consensus       686 s~ksDVwS~Gvvl~elltG~~  706 (823)
                       -..|.|.||++++|++.|..
T Consensus       182 -~s~D~~~Lg~li~el~ng~~  201 (690)
T KOG1243|consen  182 -WSIDSWGLGCLIEELFNGSL  201 (690)
T ss_pred             -cchhhhhHHHHHHHHhCccc
Confidence             34699999999999999943

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.05  E-value=2.4e-10  Score=126.63  Aligned_cols=249  Identities=20%  Similarity=0.258  Sum_probs=173.8

Q ss_pred             cCCCcCCeeec--cCccceEEEEe--e-cCcEEEEEEecCCcc--ccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCce
Q 003391          504 ENFSDKNKLGE--GGFGPVYKGVL--I-EGQEIAAKRLSKSSG--QGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDER  575 (823)
Q Consensus       504 ~~~~~~~~LG~--G~fg~Vyk~~~--~-~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~  575 (823)
                      ..|...+.+|.  |.+|.||++..  . ++..+|+|+-+....  .....=.+|+....++ .|+|.++.......++..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            34556678999  99999999987  3 377899998543322  3333335677777777 599999988888999999


Q ss_pred             EEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHH----HHHHHHhcCCCceEecccCCCcEEEcCC-CCceeecc
Q 003391          576 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIAR----GLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDF  650 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DF  650 (823)
                      ++-+|++. .+|..+.+.  ....++....+.+..+..+    ||.++|+..   ++|-|+||.||++..+ ...++.||
T Consensus       194 fiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence            99999885 677777643  3344666777778888888    999999987   9999999999999999 88999999


Q ss_pred             ccceecCCCcccccc---ccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHh
Q 003391          651 GMARAFGIDQTEANT---NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW  727 (823)
Q Consensus       651 Gla~~~~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  727 (823)
                      |+...+.........   ....+...|++||.+ ...++.+.|+|++|.+..|-.++.......-.        ..|...
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~--------~~W~~~  338 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN--------SSWSQL  338 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC--------CCcccc
Confidence            999987654322211   122567789999965 56778899999999999999988755321100        001111


Q ss_pred             hhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          728 IEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       728 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ....   +-+....+     -..++...+..+++.+|-.|++.+.+..
T Consensus       339 r~~~---ip~e~~~~-----~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  339 RQGY---IPLEFCEG-----GSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             cccc---CchhhhcC-----cchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            1000   00000100     0113334777889999999998877654

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.03  E-value=2.4e-09  Score=109.75  Aligned_cols=142  Identities=18%  Similarity=0.253  Sum_probs=110.5

Q ss_pred             CeeeccCccceEEEEeecCcEEEEEEecCCcc-ccHHHHHHHHHHHhccCC--CCceeEEEEeecCC---ceEEEEeecC
Q 003391          510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQH--RNLVKLIGCCTQRD---ERMLIYEYLP  583 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~---~~~lV~e~~~  583 (823)
                      +.|+.|..+.||+++..+|+.+++|....... ....++..|+++++.+.+  .++.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            57899999999999986668999998765432 245678999999999965  45677888776643   5689999999


Q ss_pred             CCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 003391          584 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS----------------------------------------  623 (823)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------  623 (823)
                      +.++.+.+..    ..++......++.++++.|..||+..                                        
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9988876521    34677777788888888888888531                                        


Q ss_pred             -------------CCceEecccCCCcEEEcC--CCCceeecccccee
Q 003391          624 -------------RLRIIHRDLKASNVLLDN--EMNPKISDFGMARA  655 (823)
Q Consensus       624 -------------~~~ivH~Dlk~~NIll~~--~~~~kl~DFGla~~  655 (823)
                                   ...++|+|+++.||++++  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         235799999999999998  56689999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.97  E-value=9e-09  Score=101.90  Aligned_cols=136  Identities=12%  Similarity=0.083  Sum_probs=98.2

Q ss_pred             CeeeccCccceEEEEeec-------CcEEEEEEecCCcc----------------------ccHHHHH----HHHHHHhc
Q 003391          510 NKLGEGGFGPVYKGVLIE-------GQEIAAKRLSKSSG----------------------QGMEEFE----NEVLLIAK  556 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~-------~~~vavK~l~~~~~----------------------~~~~~~~----~Ei~~l~~  556 (823)
                      ..||.|--+.||.|...+       +..+|||+.+....                      ...+.+.    +|+..|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            478999999999998653       47899997643210                      0012233    79999999


Q ss_pred             cC--CCCceeEEEEeecCCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHH-HhcCCCceEecccC
Q 003391          557 LQ--HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL-HQDSRLRIIHRDLK  633 (823)
Q Consensus       557 l~--H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dlk  633 (823)
                      +.  ..++.+++++    ..-+|||||+.+..+.....   +...++......+..+++.+|..| |..+   |||+||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs  152 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS  152 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence            84  3567777765    46789999998754432111   112244456677889999999999 7776   9999999


Q ss_pred             CCcEEEcCCCCceeeccccceec
Q 003391          634 ASNVLLDNEMNPKISDFGMARAF  656 (823)
Q Consensus       634 ~~NIll~~~~~~kl~DFGla~~~  656 (823)
                      +.||+++ ++.+.|+|||.+...
T Consensus       153 ~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         153 EYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             HHHEEEE-CCcEEEEECCCceeC
Confidence            9999997 468999999988754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.89  E-value=2.7e-08  Score=107.80  Aligned_cols=168  Identities=23%  Similarity=0.320  Sum_probs=131.7

Q ss_pred             cceEEEEee-cCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeec----CCceEEEEeecCC-CCcchhh
Q 003391          518 GPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ----RDERMLIYEYLPN-KSLNDFI  591 (823)
Q Consensus       518 g~Vyk~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~e~~~~-gsL~~~l  591 (823)
                      .+.||+... +|..+++|+++....+.......-+++++++.|+|+|++..++..    +..+++||+|+++ ++|.+.-
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            468998864 589999999966655555455667889999999999999988863    3468999999986 5777766


Q ss_pred             hccC------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          592 FDVT------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       592 ~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      +...            +....++...+.++.|+..||.++|+.|   +.-+-|.+++|+++.+.+++|+..|....+..+
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            5321            2234678899999999999999999998   788999999999999999999999988766443


Q ss_pred             ccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCC
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRN  707 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p  707 (823)
                      ....                +..   -.+-|.=.||.+++-|.||...
T Consensus       447 ~~~~----------------le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  447 PTEP----------------LES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCcc----------------hhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            3111                111   2356899999999999999765

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.84  E-value=2.3e-09  Score=118.94  Aligned_cols=245  Identities=21%  Similarity=0.203  Sum_probs=169.6

Q ss_pred             hcCCCcCCeeeccCccceEEEEee--cCcEEEEEEecCCccccHHHH--HHHHHHHhcc-CCCCceeEEEEeecCCceEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI--EGQEIAAKRLSKSSGQGMEEF--ENEVLLIAKL-QHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~--~~~~vavK~l~~~~~~~~~~~--~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l  577 (823)
                      ..+|.....||.|.|+.|++....  ++..+++|.+.+.......+.  ..|+.+...+ .|.++++....+......++
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i  343 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI  343 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence            456788889999999999987743  377899998866543333322  3456555555 58888887777776777778


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCC-CCceeeccccceec
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMARAF  656 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DFGla~~~  656 (823)
                      =-||++++++...+   .-...++...++++..|++.++.++|+..   ++|+|+||.||++..+ +..++.|||++..+
T Consensus       344 p~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~  417 (524)
T KOG0601|consen  344 PLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRL  417 (524)
T ss_pred             chhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccccc
Confidence            89999999887765   22234677788899999999999999887   9999999999999886 88899999998643


Q ss_pred             CCCccccccccccccCCcc--CccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchh
Q 003391          657 GIDQTEANTNRVVGTYGYM--PPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE  734 (823)
Q Consensus       657 ~~~~~~~~~~~~~gt~~y~--aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  734 (823)
                      .....     ...+.-+++  +|+......+..+.|++|||.-+.|.+++..-.+-..                  ....
T Consensus       418 ~~~~~-----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~------------------~~~~  474 (524)
T KOG0601|consen  418 AFSSG-----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV------------------QSLT  474 (524)
T ss_pred             ceecc-----cccccccccccchhhccccccccccccccccccccccccCcccCcccc------------------ccee
Confidence            22111     112233444  5666667788999999999999999999874311000                  0000


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003391          735 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS  778 (823)
Q Consensus       735 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  778 (823)
                      +..... ...+..- ..+..+...++..++..||.+.++..+.+
T Consensus       475 i~~~~~-p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  475 IRSGDT-PNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             eecccc-cCCCchH-HhhhhhhhhhcCCccccchhhhhhcccch
Confidence            000000 0011111 34556667788899999999988876554

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.83  E-value=9.1e-10  Score=127.88  Aligned_cols=245  Identities=18%  Similarity=0.216  Sum_probs=164.8

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC---ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      ..+.+.+.+-+-.|.++.++.+.-.. +...++|.....   .....+....+-.++-..+||-+++..--+.......|
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            45667777788889999988765322 323333322111   11112222223233333355666666555566778899


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      +++|+.+++|...|+...   ..+.......+..+.+.++|||...   +.|+|++|.|+|...++..+++|||......
T Consensus       882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg  955 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG  955 (1205)
T ss_pred             hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence            999999999998885432   3555666677788899999999876   8999999999999999999999998433221


Q ss_pred             C-------------------------Cccc----cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCC
Q 003391          658 I-------------------------DQTE----ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNR  708 (823)
Q Consensus       658 ~-------------------------~~~~----~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~  708 (823)
                      .                         +...    .......+|+.|.+||.+.+......+|.|+.|++++|.++|..||
T Consensus       956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen  956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred             cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence            0                         0000    1122357899999999999999999999999999999999999997


Q ss_pred             CCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHH
Q 003391          709 GFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYS-----LSEVLRCIQVGLLCVQQRPEDRPNMS  771 (823)
Q Consensus       709 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~  771 (823)
                      ....+                   ..+++..++...+     .....+..+++...+..+|.+|-.|.
T Consensus      1036 na~tp-------------------q~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETP-------------------QQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCcch-------------------hhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            53322                   2233333332221     12223556777778888888888776

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.83  E-value=2.9e-08  Score=94.78  Aligned_cols=131  Identities=22%  Similarity=0.337  Sum_probs=97.9

Q ss_pred             CeeeccCccceEEEEeecCcEEEEEE-ecCCcc-------ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          510 NKLGEGGFGPVYKGVLIEGQEIAAKR-LSKSSG-------QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~~~~vavK~-l~~~~~-------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      ..+++|+-+.+|.+.+. |..+++|. +.+.-+       -..+.-.+|+.++.+++--.|.-.+=+..+.....++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35788999999998663 44455553 322211       1123456899999998765555555566677888999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccccee
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                      ++|..|.+.+...          ...++..+-+-+.-||..+   |+|+||.++||++.... +.++||||+..
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999888432          2456667777788899998   99999999999998776 99999999974

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.77  E-value=7e-08  Score=91.60  Aligned_cols=143  Identities=22%  Similarity=0.304  Sum_probs=104.4

Q ss_pred             cCCeeeccCccceEEEEeecCcEEEEEE-ecCCc-------cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          508 DKNKLGEGGFGPVYKGVLIEGQEIAAKR-LSKSS-------GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       508 ~~~~LG~G~fg~Vyk~~~~~~~~vavK~-l~~~~-------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ....|-||+-+.|+++.. .|+...||. ..+.-       .-...+..+|++.+.++.--.|.-..-++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            456889999999999987 566666653 33221       123445678999999987555555555666677778999


Q ss_pred             eecCC-CCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCC---Cceeecccccee
Q 003391          580 EYLPN-KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM---NPKISDFGMARA  655 (823)
Q Consensus       580 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~DFGla~~  655 (823)
                      ||+++ .++.+++........ .......++..|-+.+.-||..+   |+|+||..+||+|..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99987 578888865333322 22223677888889999999998   99999999999997654   358999999864

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.69  E-value=2.5e-07  Score=96.94  Aligned_cols=140  Identities=19%  Similarity=0.133  Sum_probs=99.9

Q ss_pred             eeeccCccceEEEEeecCcEEEEEEecCCccc-----------cHHHHHHHHHHHhccC--CCCceeEEEEeec-----C
Q 003391          511 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQ-----------GMEEFENEVLLIAKLQ--HRNLVKLIGCCTQ-----R  572 (823)
Q Consensus       511 ~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~-----------~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~-----~  572 (823)
                      .+-.-....|.+..+ +|+.+.||+.......           ....+.+|...+.++.  .....+++++...     .
T Consensus        29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            444333444667665 6788999977433211           1124778999888884  3344455666543     2


Q ss_pred             CceEEEEeecCCC-CcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcC-------CCC
Q 003391          573 DERMLIYEYLPNK-SLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-------EMN  644 (823)
Q Consensus       573 ~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~-------~~~  644 (823)
                      ...+||+|++++. +|.+++.+.. ....+...+..++.+++..+.-||..+   |+|+|+++.|||++.       +..
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence            3468999999986 8988874322 233456677789999999999999998   999999999999975       468


Q ss_pred             ceeecccccee
Q 003391          645 PKISDFGMARA  655 (823)
Q Consensus       645 ~kl~DFGla~~  655 (823)
                      +.|+||+.+..
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            99999998753

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.68  E-value=1.9e-07  Score=92.25  Aligned_cols=125  Identities=25%  Similarity=0.334  Sum_probs=82.2

Q ss_pred             ceEEEEeecCcEEEEEEecCCc--------------c------------ccHHHHHHHHHHHhccCCC--CceeEEEEee
Q 003391          519 PVYKGVLIEGQEIAAKRLSKSS--------------G------------QGMEEFENEVLLIAKLQHR--NLVKLIGCCT  570 (823)
Q Consensus       519 ~Vyk~~~~~~~~vavK~l~~~~--------------~------------~~~~~~~~Ei~~l~~l~H~--niv~l~g~~~  570 (823)
                      .||.|...++..+|+|..+...              +            ......++|++.|.++..-  ++.+++.+. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            3899999899999999864321              0            0122457899999999755  566776553 


Q ss_pred             cCCceEEEEeecC--CCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHH-HHhcCCCceEecccCCCcEEEcCCCCcee
Q 003391          571 QRDERMLIYEYLP--NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY-LHQDSRLRIIHRDLKASNVLLDNEMNPKI  647 (823)
Q Consensus       571 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~ivH~Dlk~~NIll~~~~~~kl  647 (823)
                         .-.|||||++  +..+.... +..    ++......++.+++..+.. +|..+   |+|+||.+.||+++++ .+.|
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~-~~~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLK-DVD----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHH-HCG----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred             ---CCEEEEEecCCCccchhhHH-hcc----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence               4579999998  54454432 211    1134456677778875555 56776   9999999999999988 9999


Q ss_pred             eccccceec
Q 003391          648 SDFGMARAF  656 (823)
Q Consensus       648 ~DFGla~~~  656 (823)
                      +|||.+...
T Consensus       148 IDf~qav~~  156 (188)
T PF01163_consen  148 IDFGQAVDS  156 (188)
T ss_dssp             --GTTEEET
T ss_pred             EecCcceec
Confidence            999988754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.58  E-value=9e-07  Score=93.82  Aligned_cols=263  Identities=16%  Similarity=0.132  Sum_probs=154.9

Q ss_pred             CCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhcc-CCCCceeEEEEe------ecCC-ceEE
Q 003391          506 FSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCC------TQRD-ERML  577 (823)
Q Consensus       506 ~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~------~~~~-~~~l  577 (823)
                      ....+.||+|+-+.+|-.-  .-...+.|+++........+   .+..|.+. .||-+-.-+.+-      .+.+ ...+
T Consensus        13 i~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf   87 (637)
T COG4248          13 IPPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF   87 (637)
T ss_pred             cCCCccccCCccceeeecc--hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence            3456789999999998642  22334567777665433232   23333333 566444322221      1122 2556


Q ss_pred             EEeecCCCC-cchhhhc---cCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccc
Q 003391          578 IYEYLPNKS-LNDFIFD---VTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  653 (823)
Q Consensus       578 V~e~~~~gs-L~~~l~~---~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  653 (823)
                      .|..+++.- +.+++..   ...-...+|.-.++.+..++.+.+.||..|   .+-+|++++|+|+.+++.+.|.|=..-
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccce
Confidence            777776642 2233222   122345789999999999999999999998   889999999999999999999984322


Q ss_pred             eecCCCccccccccccccCCccCccccc-----cCCCCccchhHhHHHHHHHHHhc-CCCCCCcCCC-CccchhHH--HH
Q 003391          654 RAFGIDQTEANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLEIVCG-KRNRGFYHAD-HHHNLLGH--AW  724 (823)
Q Consensus       654 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwS~Gvvl~elltG-~~p~~~~~~~-~~~~l~~~--~~  724 (823)
                      ..   ..........+|...|.+||.-.     +..-+...|-|.+||++++|+.| ++||...... ........  +.
T Consensus       165 qi---~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~  241 (637)
T COG4248         165 QI---NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH  241 (637)
T ss_pred             ee---ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence            21   12222223356888999999754     33456789999999999999987 8898542211 11111110  00


Q ss_pred             HHhhhcCchhhhhhhcCCCCCHHH-HHHHHHHHHHccccC--CCCCCCHHHHHHHhcc
Q 003391          725 RLWIEERPVELINKSLGGSYSLSE-VLRCIQVGLLCVQQR--PEDRPNMSSVVLMLSG  779 (823)
Q Consensus       725 ~~~~~~~~~~~~~~~l~~~~~~~~-~~~l~~l~~~Cl~~d--P~~RPs~~evl~~L~~  779 (823)
                      ..+........-...--.+.+.+- +.++..+..+|+...  +.-|||++-.+..|..
T Consensus       242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a  299 (637)
T COG4248         242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA  299 (637)
T ss_pred             ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence            011100000000000001111111 235556777888753  5689999988877754

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.41  E-value=1.3e-06  Score=99.10  Aligned_cols=145  Identities=18%  Similarity=0.290  Sum_probs=96.0

Q ss_pred             cCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCcccc------------------------------HH--------
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQG------------------------------ME--------  545 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~------------------------------~~--------  545 (823)
                      ..|.. +.|+.++-|.||+|++.+|+.||||+.++.....                              .+        
T Consensus       126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~  204 (517)
T COG0661         126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE  204 (517)
T ss_pred             HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence            34442 6899999999999999999999999987653211                              01        


Q ss_pred             --HHHHHHHHHhcc----CCCCceeEEEEeec-CCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHH-HH
Q 003391          546 --EFENEVLLIAKL----QHRNLVKLIGCCTQ-RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARG-LL  617 (823)
Q Consensus       546 --~~~~Ei~~l~~l----~H~niv~l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g-L~  617 (823)
                        ++..|...+.++    +...-+++-..+.+ .....|+|||++|-.+.+...-..  ...+..   .++..++++ +.
T Consensus       205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k---~ia~~~~~~f~~  279 (517)
T COG0661         205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRK---ELAELLVRAFLR  279 (517)
T ss_pred             HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHH---HHHHHHHHHHHH
Confidence              133344444443    22233334344433 467899999999999998752211  223422   333333333 22


Q ss_pred             HHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       618 yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      .+-..+   ++|+|.+|.||+++.++++.+.|||+...+.
T Consensus       280 q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         280 QLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             HHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence            232344   9999999999999999999999999998764

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.38  E-value=1.9e-06  Score=87.31  Aligned_cols=106  Identities=26%  Similarity=0.333  Sum_probs=84.1

Q ss_pred             HHHHHHHHHHHhccC--CCCceeEEEEeecCC----ceEEEEeecCCC-CcchhhhccCCCCccCHHHHHHHHHHHHHHH
Q 003391          544 MEEFENEVLLIAKLQ--HRNLVKLIGCCTQRD----ERMLIYEYLPNK-SLNDFIFDVTRSKFLDWSKRCQIIGGIARGL  616 (823)
Q Consensus       544 ~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~----~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL  616 (823)
                      ...+.+|...+..+.  .-...+.+++.....    ..+||+|++++. +|.+++.....   ++......++.++++.+
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI  131 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence            346778888888774  445666777765533    358999999984 79988854222   55667788999999999


Q ss_pred             HHHHhcCCCceEecccCCCcEEEcCCC---Cceeecccccee
Q 003391          617 LYLHQDSRLRIIHRDLKASNVLLDNEM---NPKISDFGMARA  655 (823)
Q Consensus       617 ~yLH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~DFGla~~  655 (823)
                      +-||+.+   |+|+|+++.|||++.+.   .+.++||+-++.
T Consensus       132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9999998   99999999999999887   899999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.34  E-value=6.1e-06  Score=81.98  Aligned_cols=139  Identities=16%  Similarity=0.146  Sum_probs=102.6

Q ss_pred             eeccCccceEEEEeecCcEEEEEEecCCc------cccHHHHHHHHHHHhccC--CCCceeEEEEeecC----CceEEEE
Q 003391          512 LGEGGFGPVYKGVLIEGQEIAAKRLSKSS------GQGMEEFENEVLLIAKLQ--HRNLVKLIGCCTQR----DERMLIY  579 (823)
Q Consensus       512 LG~G~fg~Vyk~~~~~~~~vavK~l~~~~------~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~----~~~~lV~  579 (823)
                      -|+||-+.|++-.+ +|+.+-+|+.....      +-....|.+|+..|.++.  ...+.+++......    -...||+
T Consensus        26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            46788888999776 45578999875221      335678999999999984  33355555222221    1358999


Q ss_pred             eecCC-CCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCC--ceeecccccee
Q 003391          580 EYLPN-KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN--PKISDFGMARA  655 (823)
Q Consensus       580 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~--~kl~DFGla~~  655 (823)
                      |-+++ .+|.+++.+.. ....+...+..++.++++.+.-||+.+   +.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            97764 58888874322 224577778899999999999999998   999999999999986667  99999986653

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.34  E-value=3.3e-06  Score=85.74  Aligned_cols=133  Identities=21%  Similarity=0.246  Sum_probs=94.0

Q ss_pred             CcCCeeeccCccceEEEEeecCcEEEEEEecCCc----------------------cccHHHHHHHHHHHhccCCC--Cc
Q 003391          507 SDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSS----------------------GQGMEEFENEVLLIAKLQHR--NL  562 (823)
Q Consensus       507 ~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~----------------------~~~~~~~~~Ei~~l~~l~H~--ni  562 (823)
                      .++.+||-|--+.||.|..++|.++|||.=+...                      .......++|.++|+++.-.  .+
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            4567999999999999999999999999532110                      01233467899999998644  56


Q ss_pred             eeEEEEeecCCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCC
Q 003391          563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE  642 (823)
Q Consensus       563 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~  642 (823)
                      .+.+++    +.-.+||||+++-.|...-        ++....-.|+..|++-+.-+-..|   |||+|+.+-||+++++
T Consensus       174 P~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~d  238 (304)
T COG0478         174 PKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTED  238 (304)
T ss_pred             CCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecC
Confidence            655554    3457999999997766532        122233344444554444444555   9999999999999999


Q ss_pred             CCceeeccccce
Q 003391          643 MNPKISDFGMAR  654 (823)
Q Consensus       643 ~~~kl~DFGla~  654 (823)
                      +.+.++||--+.
T Consensus       239 g~~~vIDwPQ~v  250 (304)
T COG0478         239 GDIVVIDWPQAV  250 (304)
T ss_pred             CCEEEEeCcccc
Confidence            999999996554

>smart00473 PAN_AP divergent subfamily of APPLE domains

Probab=98.34  E-value=7.7e-07  Score=74.65  Aligned_cols=72  Identities=35%  Similarity=0.687  Sum_probs=55.3

Q ss_pred             CceEEecccCCCCCcccccccccCHHHHHHHhhh-cCCcceeecccccCCCcceeeee-eccccccccccccccceee
Q 003391          343 DGFLKRESVKLPDTRFSLVDNKISLLECKELCSK-NCSCTAYANADVRGGGSGCLLWF-HDLIDMKELSESGQDLFVR  418 (823)
Q Consensus       343 ~~f~~~~~v~~p~~~~~~~~~~~s~~~C~~~Cl~-nCsC~a~~~~~~~~~g~~c~~w~-~~l~~~~~~~~~g~~lyvr  418 (823)
                      ..|.+++++.+++..... ....++++|++.|++ +|+|.||+|..   ++.+|.+|. +.+.+.......+.++|.|
T Consensus         4 ~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~~~~~~~~~~y~~   77 (78)
T smart00473        4 DCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDARLFPSGGVDLYEK   77 (78)
T ss_pred             ceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCccccceecccCCceeEEe
Confidence            469999999999665433 456799999999999 99999999975   346899999 7777766444455555554

Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.25  E-value=2.8e-07  Score=103.91  Aligned_cols=153  Identities=18%  Similarity=0.285  Sum_probs=99.9

Q ss_pred             HHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccc-------ccccccccCCccCccccc
Q 003391          609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA-------NTNRVVGTYGYMPPEYAI  681 (823)
Q Consensus       609 ~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~-------~~~~~~gt~~y~aPE~l~  681 (823)
                      +.+++.||.|+|...  ++||++|.|++|.++..+..||+.|+.+.....+....       ...-......|.|||++.
T Consensus       105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            445669999999865  69999999999999999999999999886543311111       011122456899999999


Q ss_pred             cCCCCccchhHhHHHHHHHHHhcCCC-CCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHcc
Q 003391          682 DGLFSVKSDVFSFGVLVLEIVCGKRN-RGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCV  760 (823)
Q Consensus       682 ~~~~s~ksDVwS~Gvvl~elltG~~p-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl  760 (823)
                      ....+.++|+||+|+++|-+..|..+ +.....     ...+.......+        .-...++..-+.++.+=+.+.+
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~-----~~~~~~~~~~~~--------~~~~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGG-----LLSYSFSRNLLN--------AGAFGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCC-----cchhhhhhcccc--------cccccccccCcHHHHHHHHHHh
Confidence            98889999999999999999955544 221111     111111100000        0001112222345556667788


Q ss_pred             ccCCCCCCCHHHHHHH
Q 003391          761 QQRPEDRPNMSSVVLM  776 (823)
Q Consensus       761 ~~dP~~RPs~~evl~~  776 (823)
                      ..++.-||++.++...
T Consensus       250 ~~~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLSI  265 (700)
T ss_pred             cCCcccCcchhhhhcc
Confidence            9999999977766543

>smart00108 B_lectin Bulb-type mannose-specific lectin

Probab=98.23  E-value=4e-06  Score=76.14  Aligned_cols=87  Identities=25%  Similarity=0.391  Sum_probs=61.4

Q ss_pred             eEEEecCCceEEEecCC-CCeEEeecCCCCC-CcceEEEecCCCEEEecCCCCCCCcceeeecCCCcccccccCccccee
Q 003391           84 LNISSQGNATLVLLNST-NGIVWSSNASRTA-RNPVAVLLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVNL  161 (823)
Q Consensus        84 l~~~~~g~~~l~l~~~~-~~~~w~~~~~~~~-~~~~~~l~d~gnlvl~~~~~~~~~~~~wqSFd~PTDtlLpgq~l~~~~  161 (823)
                      +.++.||+  +|+++.. +.++|++++.... ....+.|.++|||||++.+    +.++|+|=.   .            
T Consensus        24 ~~~q~dgn--lV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~----g~~vW~S~t---~------------   82 (114)
T smart00108       24 LIMQNDYN--LILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGD----GRVVWSSNT---T------------   82 (114)
T ss_pred             cCCCCCEE--EEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCC----CCEEEEecc---c------------
Confidence            44567888  9999765 5799999975432 3367889999999999876    677898711   1            


Q ss_pred             ccCcceeEEEcccCCCCCCCccEEeeCCCCCCeEEEEcCceeeeecC
Q 003391          162 VTGLNRFISSWKSADDPAQDDYVYGIDPSGVPQAVFRKGSTIRYRAG  208 (823)
Q Consensus       162 ~tg~~~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~sg  208 (823)
                                      ...|.+.+.++.+|..+++-..+ .+.|.+.
T Consensus        83 ----------------~~~~~~~~~L~ddGnlvl~~~~~-~~~W~Sf  112 (114)
T smart00108       83 ----------------GANGNYVLVLLDDGNLVIYDSDG-NFLWQSF  112 (114)
T ss_pred             ----------------CCCCceEEEEeCCCCEEEECCCC-CEEeCCC
Confidence                            12456788999999887654433 4667653

>PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins

Probab=98.20  E-value=1.5e-06  Score=64.01  Aligned_cols=45  Identities=58%  Similarity=0.901  Sum_probs=39.5

Q ss_pred             cCCCCCCCCCCCCcccCCCCCCCCCCccC--CcccccceeeeeeccC
Q 003391          779 GERSLPQPKQPGFFTERNPPESGSSSSKR--SLLSTNEITISLIEGR  823 (823)
Q Consensus       779 ~~~~~~~p~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  823 (823)
                      +...+|.|++|+|+.++...+..+++.+.  +..|+|+||+|+++||
T Consensus         2 e~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R   48 (48)
T PF11883_consen    2 ETATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR   48 (48)
T ss_pred             CcccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence            35689999999999999988777776655  8999999999999999

; GO: 0004674 protein serine/threonine kinase activity

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.19  E-value=1.9e-05  Score=81.05  Aligned_cols=138  Identities=16%  Similarity=0.166  Sum_probs=86.0

Q ss_pred             CeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCC--CceeEEEEeecCCceEEEEeecCCCC-
Q 003391          510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR--NLVKLIGCCTQRDERMLIYEYLPNKS-  586 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g~~~~~~~~~lV~e~~~~gs-  586 (823)
                      .+||+|..+.||+.   .+..+++|......  ......+|.+++..+..-  .+.+.+++....+...+|||+++|.. 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            57999999999984   35567788876533  345578899999888543  35677888877777889999999963 


Q ss_pred             cchhh---------------------hccCCCCccCHHHHH-HHHH----------HHHH-HHHHHHhc-CCCceEeccc
Q 003391          587 LNDFI---------------------FDVTRSKFLDWSKRC-QIIG----------GIAR-GLLYLHQD-SRLRIIHRDL  632 (823)
Q Consensus       587 L~~~l---------------------~~~~~~~~l~~~~~~-~i~~----------~ia~-gL~yLH~~-~~~~ivH~Dl  632 (823)
                      +...+                     +.... ......... .+..          .+.+ ...+|... ....++|+|+
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~-~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKC-DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC-CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence            21111                     10000 001111100 0100          0111 12222211 2345789999


Q ss_pred             CCCcEEEcCCCCceeeccccce
Q 003391          633 KASNVLLDNEMNPKISDFGMAR  654 (823)
Q Consensus       633 k~~NIll~~~~~~kl~DFGla~  654 (823)
                      .|.||++++++ +.|+||+.+.
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcC
Confidence            99999999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.12  E-value=2.2e-05  Score=88.78  Aligned_cols=139  Identities=16%  Similarity=0.224  Sum_probs=89.9

Q ss_pred             CeeeccCccceEEEEeecCcEEEEEEecCCcccc-------------------------------------HHHHHHHHH
Q 003391          510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQG-------------------------------------MEEFENEVL  552 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~-------------------------------------~~~~~~Ei~  552 (823)
                      +.||.-..|.||+|++++|+.||||+.++..+..                                     +-+|.+|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            6899999999999999999999999987653211                                     112334444


Q ss_pred             HHhc----cCCCC---ceeEEEEeec-CCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHH-HHhcC
Q 003391          553 LIAK----LQHRN---LVKLIGCCTQ-RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY-LHQDS  623 (823)
Q Consensus       553 ~l~~----l~H~n---iv~l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~  623 (823)
                      -..+    +.|-+   =|++-.++.+ ...+.|+||||+|..+.+.-.-.  ...++...   ++..+.++... +-..|
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~--~~gi~~~~---i~~~l~~~~~~qIf~~G  321 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID--KRGISPHD---ILNKLVEAYLEQIFKTG  321 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH--HcCCCHHH---HHHHHHHHHHHHHHhcC
Confidence            3333    23555   1223333332 35789999999999888764321  12244443   33333333211 11223


Q ss_pred             CCceEecccCCCcEEEcC----CCCceeeccccceec
Q 003391          624 RLRIIHRDLKASNVLLDN----EMNPKISDFGMARAF  656 (823)
Q Consensus       624 ~~~ivH~Dlk~~NIll~~----~~~~kl~DFGla~~~  656 (823)
                         ++|+|=+|.||+++.    +..+.+-|||+...+
T Consensus       322 ---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i  355 (538)
T KOG1235|consen  322 ---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI  355 (538)
T ss_pred             ---CccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence               999999999999984    678999999998765

>cd00028 B_lectin Bulb-type mannose-specific lectin

Probab=98.11  E-value=9.3e-06  Score=73.95  Aligned_cols=87  Identities=23%  Similarity=0.358  Sum_probs=61.9

Q ss_pred             eEEEe-cCCceEEEecCC-CCeEEeecCCCC-CCcceEEEecCCCEEEecCCCCCCCcceeeecCCCcccccccCcccce
Q 003391           84 LNISS-QGNATLVLLNST-NGIVWSSNASRT-ARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVN  160 (823)
Q Consensus        84 l~~~~-~g~~~l~l~~~~-~~~~w~~~~~~~-~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqSFd~PTDtlLpgq~l~~~  160 (823)
                      +.++. ||+  ||+++.. +.++|++++... .....+.|.++|||||++.+    +.++|+|=-.              
T Consensus        24 ~~~q~~dgn--lv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~----g~~vW~S~~~--------------   83 (116)
T cd00028          24 LIMQSRDYN--LILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGS----GTVVWSSNTT--------------   83 (116)
T ss_pred             CCCCCCeEE--EEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCC----CcEEEEeccc--------------
Confidence            34555 777  9998754 589999997642 34566889999999999876    6778986421              


Q ss_pred             eccCcceeEEEcccCCCCCCCccEEeeCCCCCCeEEEEcCceeeeecC
Q 003391          161 LVTGLNRFISSWKSADDPAQDDYVYGIDPSGVPQAVFRKGSTIRYRAG  208 (823)
Q Consensus       161 ~~tg~~~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~sg  208 (823)
                                       .+.+.+.+.++.+|...++-.+ ..+.|.+.
T Consensus        84 -----------------~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf  113 (116)
T cd00028          84 -----------------RVNGNYVLVLLDDGNLVLYDSD-GNFLWQSF  113 (116)
T ss_pred             -----------------CCCCceEEEEeCCCCEEEECCC-CCEEEcCC
Confidence                             1245678889999987766444 35567664

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.94  E-value=8e-05  Score=74.37  Aligned_cols=137  Identities=18%  Similarity=0.178  Sum_probs=89.6

Q ss_pred             hcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHH---------HHHHHHHhccC---CCCceeEEEEee
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEF---------ENEVLLIAKLQ---HRNLVKLIGCCT  570 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~---------~~Ei~~l~~l~---H~niv~l~g~~~  570 (823)
                      ..+|...+.+-......|.+-.. +++.+++|..+.......+.|         .+++..+.+++   --..+.++.+..
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            46677777777777777776655 678899998765543322222         23333333332   222233222222


Q ss_pred             -----cCCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCc
Q 003391          571 -----QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP  645 (823)
Q Consensus       571 -----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  645 (823)
                           -....+|+|||++|..|.++..       ++.    .++..+++++.-||+.|   +.|+|.+|.|+++++++ +
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i  173 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-I  173 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-E
Confidence                 2234679999999988877541       121    35566788899999998   99999999999999655 9


Q ss_pred             eeecccccee
Q 003391          646 KISDFGMARA  655 (823)
Q Consensus       646 kl~DFGla~~  655 (823)
                      ++.||+..+.
T Consensus       174 ~iID~~~k~~  183 (229)
T PF06176_consen  174 RIIDTQGKRM  183 (229)
T ss_pred             EEEECccccc
Confidence            9999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.94  E-value=4.1e-05  Score=75.96  Aligned_cols=105  Identities=23%  Similarity=0.261  Sum_probs=83.3

Q ss_pred             HHHHHHHhccCC-CCceeEEEEeecCCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 003391          548 ENEVLLIAKLQH-RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR  626 (823)
Q Consensus       548 ~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  626 (823)
                      .+|..+++.+++ +++.+++|+|-    .++|.||...+++...-....+--..+|..+.+||.++++.+.+|++...-.
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            468888998876 69999999994    4789999988766432101111123689999999999999999999865445


Q ss_pred             eEecccCCCcEEEcCCCCceeeccccceec
Q 003391          627 IIHRDLKASNVLLDNEMNPKISDFGMARAF  656 (823)
Q Consensus       627 ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  656 (823)
                      +..+|++++|+-+++++++|+.|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            888999999999999999999999877543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.90  E-value=0.00011  Score=73.20  Aligned_cols=133  Identities=17%  Similarity=0.262  Sum_probs=93.9

Q ss_pred             cCCeeeccCccceEEEEeecCcEEEEEEecCCc----------------cccHHHHHHHHHHHhccC------CCCceeE
Q 003391          508 DKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSS----------------GQGMEEFENEVLLIAKLQ------HRNLVKL  565 (823)
Q Consensus       508 ~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~----------------~~~~~~~~~Ei~~l~~l~------H~niv~l  565 (823)
                      ....||+|+.-.||.  ++++...+||+.....                ....++..+|+.....+.      +.+|.++
T Consensus         5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            356899999999996  5677888999887665                223456677777666655      8899999


Q ss_pred             EEEeecCCceEEEEeecCC--C----CcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEE
Q 003391          566 IGCCTQRDERMLIYEYLPN--K----SLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL  639 (823)
Q Consensus       566 ~g~~~~~~~~~lV~e~~~~--g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll  639 (823)
                      +|+.+......+|+|.+.+  |    +|.+++    ....++. ...+.+.   +-..||-+..   |+.+||+|.||++
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l----~~~~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv~  151 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYL----KEGGLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIVV  151 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHH----HcCCccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEEE
Confidence            9999999999999998754  2    466666    2333444 3333333   3445666555   9999999999999


Q ss_pred             cCCC----Cceeec-cccc
Q 003391          640 DNEM----NPKISD-FGMA  653 (823)
Q Consensus       640 ~~~~----~~kl~D-FGla  653 (823)
                      ....    .+.|+| ||-.
T Consensus       152 ~~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  152 QRRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             EecCCCceEEEEEeCCCCc
Confidence            5432    577777 5543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.89  E-value=0.00012  Score=75.36  Aligned_cols=143  Identities=20%  Similarity=0.215  Sum_probs=84.7

Q ss_pred             CeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCC--CceeEEEEeec---CCceEEEEeecCC
Q 003391          510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR--NLVKLIGCCTQ---RDERMLIYEYLPN  584 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g~~~~---~~~~~lV~e~~~~  584 (823)
                      +.|+.|..+.||+....+ +.+++|.....  .....+..|..+++.+...  .+.+++.....   ....+++|+++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            578999999999999866 69999987554  4556778898888888422  35666764432   2346899999999


Q ss_pred             CCcch----------------hhh---cc-CCCCccCHHH---------HHHH------------HHHHHH-HHHHHHh-
Q 003391          585 KSLND----------------FIF---DV-TRSKFLDWSK---------RCQI------------IGGIAR-GLLYLHQ-  621 (823)
Q Consensus       585 gsL~~----------------~l~---~~-~~~~~l~~~~---------~~~i------------~~~ia~-gL~yLH~-  621 (823)
                      ..+..                .+.   .. .......+..         ....            ...+.+ .+..+++ 
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            88777                111   11 0111111111         0000            111222 3333332 


Q ss_pred             ---cCCCceEecccCCCcEEEc-CCCCceeecccccee
Q 003391          622 ---DSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARA  655 (823)
Q Consensus       622 ---~~~~~ivH~Dlk~~NIll~-~~~~~kl~DFGla~~  655 (823)
                         .....++|+|+.+.||+++ +++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence               2345699999999999999 556667999987753

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.88  E-value=0.00014  Score=73.45  Aligned_cols=152  Identities=15%  Similarity=0.176  Sum_probs=99.1

Q ss_pred             CHHHHHHHhcCCCcCC---eeeccCccceEEEEeecCcEEEEEEecCCccc-------------------cHHH-----H
Q 003391          495 DWMAIANATENFSDKN---KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQ-------------------GMEE-----F  547 (823)
Q Consensus       495 ~~~~l~~~~~~~~~~~---~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~-------------------~~~~-----~  547 (823)
                      +.+.+....++..+..   .|..|.-..||+|...++..+|+|++......                   ..++     .
T Consensus        36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~  115 (268)
T COG1718          36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA  115 (268)
T ss_pred             HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence            3444444444444444   45567778899999878999999998543211                   1111     2


Q ss_pred             HHHHHHHhccC--CCCceeEEEEeecCCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCC
Q 003391          548 ENEVLLIAKLQ--HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL  625 (823)
Q Consensus       548 ~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~  625 (823)
                      .+|+.-|.++.  +-.+.+.+++..    -.|||||+....+-.-   ..+.-.+.......+..++++.+.-|-...  
T Consensus       116 ~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP---~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a--  186 (268)
T COG1718         116 RKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAP---RLKDVPLELEEAEGLYEDVVEYMRRLYKEA--  186 (268)
T ss_pred             HHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCC---CcccCCcCchhHHHHHHHHHHHHHHHHHhc--
Confidence            35777777662  455666666543    4799999965421110   011112333356777788888888887633  


Q ss_pred             ceEecccCCCcEEEcCCCCceeeccccceec
Q 003391          626 RIIHRDLKASNVLLDNEMNPKISDFGMARAF  656 (823)
Q Consensus       626 ~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  656 (823)
                      .+||+||..=|||+. ++.+.|+|||-|...
T Consensus       187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             CcccccchhhheEEE-CCeEEEEECcccccc
Confidence            499999999999999 889999999988654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.88  E-value=2.2e-06  Score=95.50  Aligned_cols=183  Identities=17%  Similarity=0.126  Sum_probs=131.8

Q ss_pred             cCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCC-ceeEEEEeecCCceEEEEeecCCC-
Q 003391          508 DKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRN-LVKLIGCCTQRDERMLIYEYLPNK-  585 (823)
Q Consensus       508 ~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e~~~~g-  585 (823)
                      ..+.++++.++.++|.+-...+....+.+...     ....-++++|.+++||| .++.++-+..+...+++++++..+ 
T Consensus       246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r  320 (829)
T KOG0576|consen  246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR  320 (829)
T ss_pred             HHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence            34567899999999987655555555555433     45567899999999999 777777777778889999999876 


Q ss_pred             CcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccccc
Q 003391          586 SLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT  665 (823)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  665 (823)
                      +-..-..  .....+...+...+...-.+++++||+..   =+|+|    ||+..+ ...+..||+.+..+....   ..
T Consensus       321 s~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~  387 (829)
T KOG0576|consen  321 SSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KP  387 (829)
T ss_pred             cccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc---cc
Confidence            2211110  00111223333445556678899999864   48888    777665 678999999987764332   33


Q ss_pred             ccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCC
Q 003391          666 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNR  708 (823)
Q Consensus       666 ~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~  708 (823)
                      ....+++.++|||+..+..+..+.|+|+.|+-.-++--|-.|.
T Consensus       388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            4467899999999999999999999999998777777776664

>PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity

Probab=97.88  E-value=9.5e-05  Score=66.87  Aligned_cols=100  Identities=28%  Similarity=0.459  Sum_probs=66.4

Q ss_pred             CeEeeCCCeEEEeeecCCCCCCeEEEEEEeecCCCcEEEee-cCCCCCCCCCCceEEEecCCceEEEecCCCCeEEeecC
Q 003391           31 ETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVA-NRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNA  109 (823)
Q Consensus        31 ~~l~s~~g~f~~gf~~~~~~~~~~~giw~~~~~~~~~vW~a-n~~~p~~~~~~~l~~~~~g~~~l~l~~~~~~~~w~~~~  109 (823)
                      +++.+.+|.+.|-|...|+     |-| |.  ..++++|.. +...... ..+.+.|..|||  |||+|..+.++|+|..
T Consensus        12 ~p~~~~s~~~~L~l~~dGn-----Lvl-~~--~~~~~iWss~~t~~~~~-~~~~~~L~~~GN--lvl~d~~~~~lW~Sf~   80 (114)
T PF01453_consen   12 SPLTSSSGNYTLILQSDGN-----LVL-YD--SNGSVIWSSNNTSGRGN-SGCYLVLQDDGN--LVLYDSSGNVLWQSFD   80 (114)
T ss_dssp             EEEEECETTEEEEEETTSE-----EEE-EE--TTTEEEEE--S-TTSS--SSEEEEEETTSE--EEEEETTSEEEEESTT
T ss_pred             cccccccccccceECCCCe-----EEE-Ec--CCCCEEEEecccCCccc-cCeEEEEeCCCC--EEEEeecceEEEeecC
Confidence            4565655888888877766     222 33  346789999 4333322 467899999999  9999999999999953


Q ss_pred             CCCCCcceEEEec--CCCEEEecCCCCCCCcceeeecCCCc
Q 003391          110 SRTARNPVAVLLE--SGNLVVKDGKDIDPDNFLWQSFDYPS  148 (823)
Q Consensus       110 ~~~~~~~~~~l~d--~gnlvl~~~~~~~~~~~~wqSFd~PT  148 (823)
                        ......+..++  .||++ +...    ..+.|.|=+.|+
T Consensus        81 --~ptdt~L~~q~l~~~~~~-~~~~----~~~sw~s~~dps  114 (114)
T PF01453_consen   81 --YPTDTLLPGQKLGDGNVT-GKND----SLTSWSSNTDPS  114 (114)
T ss_dssp             --SSS-EEEEEET--TSEEE-EEST----SSEEEESS----
T ss_pred             --CCccEEEeccCcccCCCc-cccc----eEEeECCCCCCC
Confidence              33556677777  89999 6543    457888877663

Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.85  E-value=0.00012  Score=76.39  Aligned_cols=140  Identities=16%  Similarity=0.128  Sum_probs=85.0

Q ss_pred             eeeccCc-cceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccC-CCCceeEEEEeecCCceEEEEeecCCCCcc
Q 003391          511 KLGEGGF-GPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLIYEYLPNKSLN  588 (823)
Q Consensus       511 ~LG~G~f-g~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~  588 (823)
                      .|-.|.. ..||+.... +..+++|+.....   ..++..|++++..+. +.-+.+++++....+..++|||+++|.+|.
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            3444555 678998764 4678888775432   345678888888873 455667788777666789999999998876


Q ss_pred             hhhh-------------------ccCC-CCccC-H-HHHHHHHH--------------------HHHHHHHHHHh----c
Q 003391          589 DFIF-------------------DVTR-SKFLD-W-SKRCQIIG--------------------GIARGLLYLHQ----D  622 (823)
Q Consensus       589 ~~l~-------------------~~~~-~~~l~-~-~~~~~i~~--------------------~ia~gL~yLH~----~  622 (823)
                      ....                   .... ..... + ........                    .+...+..|-.    .
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            4321                   0000 00110 0 00000000                    01111222211    1


Q ss_pred             CCCceEecccCCCcEEEcCCCCceeeccccce
Q 003391          623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  654 (823)
Q Consensus       623 ~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  654 (823)
                      ..+.++|+|+.|.||+++++....|+||+.+.
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            23458999999999999998778899998774

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=97.70  E-value=0.00048  Score=84.52  Aligned_cols=80  Identities=20%  Similarity=0.333  Sum_probs=59.0

Q ss_pred             CCeeeccCccceEEEEeecC---cEEEEEEecCCc-cccHHHHHHHHHHHhccC-CCCc--eeEEEEeecC---CceEEE
Q 003391          509 KNKLGEGGFGPVYKGVLIEG---QEIAAKRLSKSS-GQGMEEFENEVLLIAKLQ-HRNL--VKLIGCCTQR---DERMLI  578 (823)
Q Consensus       509 ~~~LG~G~fg~Vyk~~~~~~---~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV  578 (823)
                      .+.|+.|.+..+|+....++   ..+++|+..... ......+.+|+++++.+. |.++  .+++.+|.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46788999999999876553   467788764432 223457889999999985 6654  7888888764   467899


Q ss_pred             EeecCCCCcc
Q 003391          579 YEYLPNKSLN  588 (823)
Q Consensus       579 ~e~~~~gsL~  588 (823)
                      |||+++..+.
T Consensus       123 ME~v~G~~~~  132 (822)
T PLN02876        123 MEYLEGRIFV  132 (822)
T ss_pred             EEecCCcccC
Confidence            9999987543

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.61  E-value=0.00044  Score=71.61  Aligned_cols=74  Identities=12%  Similarity=0.228  Sum_probs=46.7

Q ss_pred             CeeeccCcc-ceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCC---CceeEEEEeecC---CceEEEEeec
Q 003391          510 NKLGEGGFG-PVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR---NLVKLIGCCTQR---DERMLIYEYL  582 (823)
Q Consensus       510 ~~LG~G~fg-~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~---niv~l~g~~~~~---~~~~lV~e~~  582 (823)
                      +.|+.|+.. .||+.    +..+++|..+..  .....+.+|.+++..+...   .+.+.++.....   ...+++|+++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            467777766 48875    245677765432  2345788999999887521   344445444332   2348899999


Q ss_pred             CCCCcch
Q 003391          583 PNKSLND  589 (823)
Q Consensus       583 ~~gsL~~  589 (823)
                      +|.++.+
T Consensus        77 ~G~~l~~   83 (235)
T cd05155          77 EGETATA   83 (235)
T ss_pred             cCCCCCc
Confidence            9988753

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=97.54  E-value=0.0011  Score=71.00  Aligned_cols=79  Identities=15%  Similarity=0.129  Sum_probs=57.7

Q ss_pred             CCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCC---CCceeEEEEeecC---CceEEEE
Q 003391          506 FSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH---RNLVKLIGCCTQR---DERMLIY  579 (823)
Q Consensus       506 ~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H---~niv~l~g~~~~~---~~~~lV~  579 (823)
                      ....+.||.|..+.||+....++ .+++|..+ . ......+..|...++.+..   ..+.++++++...   +..+|||
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~-~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm   92 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDSQG-NPMPLMAR-S-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL   92 (297)
T ss_pred             hheeeecCCccceeEEEEEcCCC-CEEEEEec-c-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence            34456899999999999876555 46666643 2 1123578899999988842   4688888887543   5689999


Q ss_pred             eecCCCCc
Q 003391          580 EYLPNKSL  587 (823)
Q Consensus       580 e~~~~gsL  587 (823)
                      |+++++++
T Consensus        93 E~i~G~~~  100 (297)
T PRK10593         93 ERLRGVSV  100 (297)
T ss_pred             eccCCEec
Confidence            99998876

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.46  E-value=0.00065  Score=64.96  Aligned_cols=130  Identities=21%  Similarity=0.246  Sum_probs=86.7

Q ss_pred             CcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCCCC
Q 003391          507 SDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKS  586 (823)
Q Consensus       507 ~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  586 (823)
                      ...+.|++|.+|.||+|.+ .+..+|+|+-...++  ...+..|+++|..++-.++-+=+-.+..   -.+.|||+.|..
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~---~~i~me~i~G~~   98 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEW-RGGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGE---DFIRMEYIDGRP   98 (201)
T ss_pred             hhhhhhhcccccEEEEeec-cCceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEech---hhhhhhhhcCcc
Confidence            3456899999999999988 456889998765543  4678899999999987666544333322   234599999988


Q ss_pred             cchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCC-CcEEEcCCCCceeecccccee
Q 003391          587 LNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKA-SNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       587 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~-~NIll~~~~~~kl~DFGla~~  655 (823)
                      |.+.-...      +-    +-...+++.---|...|   |-|+.|.- ...+|-++..+.|+||.-|..
T Consensus        99 L~~~~~~~------~r----k~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          99 LGKLEIGG------DR----KHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhhcc------cH----HHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            87754211      11    22333444434444445   88888864 444444455999999998874

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.38  E-value=0.0013  Score=68.13  Aligned_cols=140  Identities=18%  Similarity=0.251  Sum_probs=81.1

Q ss_pred             CeeeccCccceEEEEeec--CcEEEEEEecCCccccHHHHHHHHHHHhccCCCC-ceeEEEEeecCCceEEEEeecCCCC
Q 003391          510 NKLGEGGFGPVYKGVLIE--GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRN-LVKLIGCCTQRDERMLIYEYLPNKS  586 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e~~~~gs  586 (823)
                      +.|..|-...+|+....+  ++.+++|........ .....+|+.++..+.... ..++++...    ..+||||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            467778888999988654  578888876543222 123357888888884333 344444432    248999999987


Q ss_pred             cchh-------h----------hccCCC--------Ccc-CHHHHHHHHH----------------------HHHHHHHH
Q 003391          587 LNDF-------I----------FDVTRS--------KFL-DWSKRCQIIG----------------------GIARGLLY  618 (823)
Q Consensus       587 L~~~-------l----------~~~~~~--------~~l-~~~~~~~i~~----------------------~ia~gL~y  618 (823)
                      +...       +          +.....        ... -+.....+..                      .+.+.+..
T Consensus        79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  158 (235)
T cd05157          79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW  158 (235)
T ss_pred             CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence            6421       1          111110        011 1122111111                      11111111


Q ss_pred             ----HHhc-CCCceEecccCCCcEEEcC-CCCceeeccccce
Q 003391          619 ----LHQD-SRLRIIHRDLKASNVLLDN-EMNPKISDFGMAR  654 (823)
Q Consensus       619 ----LH~~-~~~~ivH~Dlk~~NIll~~-~~~~kl~DFGla~  654 (823)
                          +... .+..++|+|+.+.|||+++ +..+.|+||..|.
T Consensus       159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence                2211 2345999999999999998 5789999998775

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.34  E-value=0.0012  Score=69.34  Aligned_cols=139  Identities=17%  Similarity=0.105  Sum_probs=79.8

Q ss_pred             eeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCc-eeEEEEeecCCceEEEEeecCCCCcch
Q 003391          511 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL-VKLIGCCTQRDERMLIYEYLPNKSLND  589 (823)
Q Consensus       511 ~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~gsL~~  589 (823)
                      .+..|-...+|+.. .+++.+++|........-.-...+|..+++.+....+ .++++...    ..+|+||++|..+..
T Consensus         3 ~~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            35567778899887 3577888887654332211235778888888854333 34444432    368999999977653


Q ss_pred             h-----------------hhccCC-CCccCHHHH-HHHHHH---------HHHHHHHHHhc-----CCCceEecccCCCc
Q 003391          590 F-----------------IFDVTR-SKFLDWSKR-CQIIGG---------IARGLLYLHQD-----SRLRIIHRDLKASN  636 (823)
Q Consensus       590 ~-----------------l~~~~~-~~~l~~~~~-~~i~~~---------ia~gL~yLH~~-----~~~~ivH~Dlk~~N  636 (823)
                      .                 |+.... ...++.... ..+..+         +.+.+..+...     .+..++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 111110 111222111 111111         11112222211     12358999999999


Q ss_pred             EEEcCCCCceeecccccee
Q 003391          637 VLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       637 Ill~~~~~~kl~DFGla~~  655 (823)
                      |++++++ +.|+||+.+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999877 78999998753

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.29  E-value=0.0014  Score=78.84  Aligned_cols=197  Identities=19%  Similarity=0.148  Sum_probs=132.5

Q ss_pred             HHHHHHHHhccCCCCceeEEEEeecCCceE----EEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhc
Q 003391          547 FENEVLLIAKLQHRNLVKLIGCCTQRDERM----LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD  622 (823)
Q Consensus       547 ~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~----lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~  622 (823)
                      ..-|+..+.++.|+|++.++++-.+.....    +..|++..-++...+.   .-..++....+.+..++.+||+|+|+.
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHHHh
Confidence            455777888899999999999886654333    3457777777777663   334577888889999999999999997


Q ss_pred             CCCceEecccCCC---cEEEcCCCCceee--ccccceecCCCccccccccccccCCccCccccccCCCCc--cchhHhHH
Q 003391          623 SRLRIIHRDLKAS---NVLLDNEMNPKIS--DFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSV--KSDVFSFG  695 (823)
Q Consensus       623 ~~~~ivH~Dlk~~---NIll~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~--ksDVwS~G  695 (823)
                      .   ..|.-+..+   +.-.+.++...++  ||+.++.+.......   ....+..+.+||......+..  ..|+|.+|
T Consensus       306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg  379 (1351)
T KOG1035|consen  306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLG  379 (1351)
T ss_pred             c---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHH
Confidence            4   555555444   4445566666666  888887654322211   123445677888776555444  47999999


Q ss_pred             HHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          696 VLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       696 vvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ..+..+..|..+-..                      ...+...+..... .   .+.+....|+..++++|+++.+++.
T Consensus       380 ll~~~~~~~~~i~~~----------------------~~~~~~~l~~~~~-~---~~~d~~~~~~~~~~~~Rl~~~~ll~  433 (1351)
T KOG1035|consen  380 LLLLQLSQGEDISEK----------------------SAVPVSLLDVLST-S---ELLDALPKCLDEDSEERLSALELLT  433 (1351)
T ss_pred             HHHhhhhhcCccccc----------------------ccchhhhhccccc-h---hhhhhhhhhcchhhhhccchhhhhh
Confidence            999999988765211                      0111111111111 1   3456677899999999999999998


Q ss_pred             Hhc
Q 003391          776 MLS  778 (823)
Q Consensus       776 ~L~  778 (823)
                      ..-
T Consensus       434 ~~f  436 (1351)
T KOG1035|consen  434 HPF  436 (1351)
T ss_pred             chh
Confidence            764

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.17  E-value=0.0058  Score=60.55  Aligned_cols=125  Identities=25%  Similarity=0.361  Sum_probs=88.5

Q ss_pred             cCCCcCCeeeccCc-cceEEEEeecCcEEEEEEecC---Ccc------------------ccHHHHHHHHHHHhccC---
Q 003391          504 ENFSDKNKLGEGGF-GPVYKGVLIEGQEIAAKRLSK---SSG------------------QGMEEFENEVLLIAKLQ---  558 (823)
Q Consensus       504 ~~~~~~~~LG~G~f-g~Vyk~~~~~~~~vavK~l~~---~~~------------------~~~~~~~~Ei~~l~~l~---  558 (823)
                      ..++..+.||.|.- |.|||++. +|+.+|+|....   ...                  ....-|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67888899999999 99999987 788999999321   110                  11235788988888874   


Q ss_pred             CCCc--eeEEEEeecC------------------CceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHH
Q 003391          559 HRNL--VKLIGCCTQR------------------DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY  618 (823)
Q Consensus       559 H~ni--v~l~g~~~~~------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~y  618 (823)
                      +.++  |+.+|+..-.                  ..+.+|.||++...                ....+-+.+|.+-|..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------~~~~~~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------PLQIRDIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------ccchhHHHHHHHHHHH
Confidence            4566  8999987322                  11356777665532                1122334567778888


Q ss_pred             HHhcCCCceEecccCCCcEEEcCCCCceeeccccc
Q 003391          619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  653 (823)
Q Consensus       619 LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  653 (823)
                      +|..+   |+-+|+++.|..     .-||+|||.+
T Consensus       180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            99988   999999999975     4589999854

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.10  E-value=0.0074  Score=66.81  Aligned_cols=75  Identities=13%  Similarity=0.181  Sum_probs=54.6

Q ss_pred             CeeeccCccceEEEEeecC-cEEEEEEecCCc-------cccHHHHHHHHHHHhccC---CCCceeEEEEeecCCceEEE
Q 003391          510 NKLGEGGFGPVYKGVLIEG-QEIAAKRLSKSS-------GQGMEEFENEVLLIAKLQ---HRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~~-~~vavK~l~~~~-------~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV  578 (823)
                      +.||.|.+..||++...+| +.++||.-....       ....+++..|.+.|..+.   -.++.+++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            5799999999999998776 489999753211       234567788888888762   2456677766  34567899


Q ss_pred             EeecCCCC
Q 003391          579 YEYLPNKS  586 (823)
Q Consensus       579 ~e~~~~gs  586 (823)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998744

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.02  E-value=0.0045  Score=66.44  Aligned_cols=142  Identities=20%  Similarity=0.178  Sum_probs=85.6

Q ss_pred             CCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCC--CceeEEEE------eecCCceEEEEe
Q 003391          509 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR--NLVKLIGC------CTQRDERMLIYE  580 (823)
Q Consensus       509 ~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g~------~~~~~~~~lV~e  580 (823)
                      .+.|..|....+|+.... +..+++|+...   ...++...|+.++..+.+.  .+.+++..      ....+..++|++
T Consensus        19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            446777777899998764 45788888754   2345667788888877432  34555442      122345689999


Q ss_pred             ecCCCCcch----hh----------hccCC--------CCccCHHHHH----------HHHHHHHHHHHHHHh----cCC
Q 003391          581 YLPNKSLND----FI----------FDVTR--------SKFLDWSKRC----------QIIGGIARGLLYLHQ----DSR  624 (823)
Q Consensus       581 ~~~~gsL~~----~l----------~~~~~--------~~~l~~~~~~----------~i~~~ia~gL~yLH~----~~~  624 (823)
                      |++|..+..    ..          +....        .....|....          .....+...+.++..    ..+
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999987643    01          11000        0112222211          011123344455543    123


Q ss_pred             CceEecccCCCcEEEcCCCCceeeccccce
Q 003391          625 LRIIHRDLKASNVLLDNEMNPKISDFGMAR  654 (823)
Q Consensus       625 ~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  654 (823)
                      ..++|+|+.|.||+++++..+.|.||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            459999999999999998777899998775

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.90  E-value=0.0049  Score=66.41  Aligned_cols=140  Identities=26%  Similarity=0.347  Sum_probs=82.8

Q ss_pred             CeeeccCccceEEEEeec-------CcEEEEEEecCCccccHHHHHHHHHHHhccCCCC-ceeEEEEeecCCceEEEEee
Q 003391          510 NKLGEGGFGPVYKGVLIE-------GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRN-LVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~-------~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e~  581 (823)
                      +.|..|-...+|+....+       ++.+++|...... .......+|.+++..+.... ..++++++..    .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            356666677899988654       4788888865543 23345577888888874322 3345555532    368999


Q ss_pred             cCCCCcchh-----------------hhccCCCC------cc--CHHHHHH--------------------------HHH
Q 003391          582 LPNKSLNDF-----------------IFDVTRSK------FL--DWSKRCQ--------------------------IIG  610 (823)
Q Consensus       582 ~~~gsL~~~-----------------l~~~~~~~------~l--~~~~~~~--------------------------i~~  610 (823)
                      ++|..+...                 ++......      ..  -|.....                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            999877531                 11111110      00  0111100                          111


Q ss_pred             HHHHHHHHHHh------cCCCceEecccCCCcEEEcCC----CCceeeccccce
Q 003391          611 GIARGLLYLHQ------DSRLRIIHRDLKASNVLLDNE----MNPKISDFGMAR  654 (823)
Q Consensus       611 ~ia~gL~yLH~------~~~~~ivH~Dlk~~NIll~~~----~~~kl~DFGla~  654 (823)
                      .+.+-+..|..      ..+..++|+|+.+.||+++++    +.++++||..|.
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            22222334432      234568999999999999985    889999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.68  E-value=0.031  Score=60.35  Aligned_cols=143  Identities=20%  Similarity=0.186  Sum_probs=82.4

Q ss_pred             CCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCC--CCceeEEEEe------ecCCceEEEEe
Q 003391          509 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH--RNLVKLIGCC------TQRDERMLIYE  580 (823)
Q Consensus       509 ~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~------~~~~~~~lV~e  580 (823)
                      .+.++.|....+|+.... +..+++|+.+...  ..++...|++++..|..  -.+.+++...      ...+..++++|
T Consensus        27 i~~~~~G~~n~~y~v~t~-~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTD-VGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeC-CCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            345667777899998754 4467788765432  23455667777776632  2244544422      22345789999


Q ss_pred             ecCCCCcchh--------------hhccCCC---------CccCHHHHHH------------HHHHHHHHHHHHHh----
Q 003391          581 YLPNKSLNDF--------------IFDVTRS---------KFLDWSKRCQ------------IIGGIARGLLYLHQ----  621 (823)
Q Consensus       581 ~~~~gsL~~~--------------l~~~~~~---------~~l~~~~~~~------------i~~~ia~gL~yLH~----  621 (823)
                      |++|..+...              ++.....         ....|.....            ....+.+.++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            9998664311              1110000         0112221110            01123344555543    


Q ss_pred             cCCCceEecccCCCcEEEcCCCCceeeccccce
Q 003391          622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  654 (823)
Q Consensus       622 ~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  654 (823)
                      ..+..++|+|+++.||++++++...|+||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            223469999999999999998777899999774

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=96.68  E-value=0.033  Score=60.47  Aligned_cols=141  Identities=18%  Similarity=0.210  Sum_probs=77.0

Q ss_pred             CeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccC--CCCceeEEEE------eecCCceEEEEee
Q 003391          510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ--HRNLVKLIGC------CTQRDERMLIYEY  581 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~------~~~~~~~~lV~e~  581 (823)
                      +.|..|....+|+....++ .+++|+...   ...+....|+.++..|.  .-.+.+.+..      ....+..++++||
T Consensus        28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~  103 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF  103 (319)
T ss_pred             chhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence            4566777788999876544 688888752   12334445555555552  1223343321      1224567899999


Q ss_pred             cCCCCcch-----------hh---hccCCC--------CccCH-HHHHH-H-----------HHH-HHHHHHHHHhc---
Q 003391          582 LPNKSLND-----------FI---FDVTRS--------KFLDW-SKRCQ-I-----------IGG-IARGLLYLHQD---  622 (823)
Q Consensus       582 ~~~gsL~~-----------~l---~~~~~~--------~~l~~-~~~~~-i-----------~~~-ia~gL~yLH~~---  622 (823)
                      ++|..+..           .|   +...+.        ..+.| ..... +           ..+ +...+..+...   
T Consensus       104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  183 (319)
T PRK05231        104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP  183 (319)
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence            99976431           11   111100        01112 11111 1           111 11222333211   


Q ss_pred             -CCCceEecccCCCcEEEcCCCCceeeccccce
Q 003391          623 -SRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  654 (823)
Q Consensus       623 -~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  654 (823)
                       -+..++|+|+++.||+++++...-|+||+.+.
T Consensus       184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence             23469999999999999977656899999875

>cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins

Probab=96.59  E-value=0.002  Score=53.12  Aligned_cols=51  Identities=20%  Similarity=0.385  Sum_probs=37.1

Q ss_pred             EecccCCCCCcccccccccCHHHHHHHhhhcCCcceeecccccCCCcceeeeeec
Q 003391          347 KRESVKLPDTRFSLVDNKISLLECKELCSKNCSCTAYANADVRGGGSGCLLWFHD  401 (823)
Q Consensus       347 ~~~~v~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~g~~c~~w~~~  401 (823)
                      .++++.++..+.... ...+.++|++.|+.||+|.||.|..   +...|+++...
T Consensus         8 ~~~~~~~~g~d~~~~-~~~s~~~Cq~~C~~~~~C~afT~~~---~~~~C~lk~~~   58 (73)
T cd01100           8 QGSNVDFRGGDLSTV-FASSAEQCQAACTADPGCLAFTYNT---KSKKCFLKSSE   58 (73)
T ss_pred             ccCCCccccCCccee-ecCCHHHHHHHcCCCCCceEEEEEC---CCCeEEcccCC
Confidence            335666666555433 3568999999999999999999963   23578887754

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>PLN02236 choline kinase

Probab=96.50  E-value=0.021  Score=62.69  Aligned_cols=140  Identities=15%  Similarity=0.257  Sum_probs=81.5

Q ss_pred             eeeccCccceEEEEeec-----CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCc-eeEEEEeecCCceEEEEeecCC
Q 003391          511 KLGEGGFGPVYKGVLIE-----GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL-VKLIGCCTQRDERMLIYEYLPN  584 (823)
Q Consensus       511 ~LG~G~fg~Vyk~~~~~-----~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~  584 (823)
                      .|-.|-.-.+|+....+     ++.+++|..........+ -.+|..++..+..-++ .++++.+..+    .|+||+++
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g  117 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA  117 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence            45456677889887533     357888887665443333 3778888888854333 3556665432    58999988


Q ss_pred             CCcchh-----------------hhccC--CCC-ccCHHHHHHHHHH-----------------HHHHHHHH----Hh-c
Q 003391          585 KSLNDF-----------------IFDVT--RSK-FLDWSKRCQIIGG-----------------IARGLLYL----HQ-D  622 (823)
Q Consensus       585 gsL~~~-----------------l~~~~--~~~-~l~~~~~~~i~~~-----------------ia~gL~yL----H~-~  622 (823)
                      .+|...                 ++...  ... +..|.+..++..+                 +...+..|    .. .
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~  197 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD  197 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence            776521                 11111  001 1122322222211                 11112222    22 2


Q ss_pred             CCCceEecccCCCcEEEcC-CCCceeecccccee
Q 003391          623 SRLRIIHRDLKASNVLLDN-EMNPKISDFGMARA  655 (823)
Q Consensus       623 ~~~~ivH~Dlk~~NIll~~-~~~~kl~DFGla~~  655 (823)
                      .+..++|+|+++.||++++ ++.+.++||..+..
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            2346899999999999986 46899999998753

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.12  E-value=0.055  Score=57.88  Aligned_cols=136  Identities=13%  Similarity=0.225  Sum_probs=80.4

Q ss_pred             cceEEEEeecCcEEEEEEecC--CccccHHHHHHHHHHHhccCC--CCceeEEEEeecCC--ceEEEEeecCCCCcchhh
Q 003391          518 GPVYKGVLIEGQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQH--RNLVKLIGCCTQRD--ERMLIYEYLPNKSLNDFI  591 (823)
Q Consensus       518 g~Vyk~~~~~~~~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~--~~~lV~e~~~~gsL~~~l  591 (823)
                      -.+|..... ++++++. ...  ..........+|+.+|+.+.-  .-+.+.++.|.++.  ..+.||+|++|..+.+.+
T Consensus        39 n~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~  116 (321)
T COG3173          39 NDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSAL  116 (321)
T ss_pred             cceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcC
Confidence            344544432 7778887 321  222344556778888887743  34555677777666  679999999985443332


Q ss_pred             hccCCC-----------------------------------CccCHHHHHHHHH--------HHHHHHHHHHhc-----C
Q 003391          592 FDVTRS-----------------------------------KFLDWSKRCQIIG--------GIARGLLYLHQD-----S  623 (823)
Q Consensus       592 ~~~~~~-----------------------------------~~l~~~~~~~i~~--------~ia~gL~yLH~~-----~  623 (823)
                      ......                                   +...|......+.        ....-..+|++.     +
T Consensus       117 ~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~  196 (321)
T COG3173         117 PPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAG  196 (321)
T ss_pred             CcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCC
Confidence            111000                                   0111222221111        112224455443     3


Q ss_pred             CCceEecccCCCcEEEcCCCCceeecccccee
Q 003391          624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       624 ~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                      +..++|+|+++.||+++....+-|.||+++..
T Consensus       197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             CceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            34699999999999999998899999999875

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.07  E-value=0.0061  Score=63.73  Aligned_cols=145  Identities=17%  Similarity=0.209  Sum_probs=95.5

Q ss_pred             cCHHHHHHHhc---CCCcCCeeeccCccceEEEEeecCcEEEEEEecCC---------cc-------------ccHHHHH
Q 003391          494 FDWMAIANATE---NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKS---------SG-------------QGMEEFE  548 (823)
Q Consensus       494 ~~~~~l~~~~~---~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~---------~~-------------~~~~~~~  548 (823)
                      +++..+.....   -+..+++||-|.-+.||.+...+|++.++|.-+..         .+             -+.-...
T Consensus        79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~  158 (465)
T KOG2268|consen   79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT  158 (465)
T ss_pred             chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence            44555444333   35678899999999999999988999998842110         00             0112345


Q ss_pred             HHHHHHhccC-C-CCceeEEEEeecCCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 003391          549 NEVLLIAKLQ-H-RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR  626 (823)
Q Consensus       549 ~Ei~~l~~l~-H-~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  626 (823)
                      +|+..|+.+. | --+.+.+++    +.-++|||++.+-.|...-      ...+..+   +...+..-+.-|...|   
T Consensus       159 kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~------~v~d~~~---ly~~lm~~Iv~la~~G---  222 (465)
T KOG2268|consen  159 KEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVR------HVEDPPT---LYDDLMGLIVRLANHG---  222 (465)
T ss_pred             HHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeee------ecCChHH---HHHHHHHHHHHHHHcC---
Confidence            6888888874 2 223344433    3457899999888776532      1122333   3333333445566666   


Q ss_pred             eEecccCCCcEEEcCCCCceeeccccce
Q 003391          627 IIHRDLKASNVLLDNEMNPKISDFGMAR  654 (823)
Q Consensus       627 ivH~Dlk~~NIll~~~~~~kl~DFGla~  654 (823)
                      +||+|.+--||+++++..++++||--..
T Consensus       223 lIHgDFNEFNimv~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  223 LIHGDFNEFNIMVKDDDKIVVIDFPQMV  250 (465)
T ss_pred             ceecccchheeEEecCCCEEEeechHhh
Confidence            9999999999999999999999997554

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.06  E-value=0.044  Score=58.06  Aligned_cols=31  Identities=23%  Similarity=0.506  Sum_probs=25.8

Q ss_pred             CceEecccCCCcEEEcCCCC-ceeecccccee
Q 003391          625 LRIIHRDLKASNVLLDNEMN-PKISDFGMARA  655 (823)
Q Consensus       625 ~~ivH~Dlk~~NIll~~~~~-~kl~DFGla~~  655 (823)
                      ..++|+|+++.||+++++++ .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            45899999999999997555 46999998854

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.71  E-value=0.082  Score=56.15  Aligned_cols=75  Identities=21%  Similarity=0.279  Sum_probs=48.5

Q ss_pred             CcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhcc---CCCCceeEEEEeecCCceEEEEeecC
Q 003391          507 SDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKL---QHRNLVKLIGCCTQRDERMLIYEYLP  583 (823)
Q Consensus       507 ~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~~~lV~e~~~  583 (823)
                      +..+.++.|....+|+.. .+++.+.||.-.   ......|..|.+-|+.|   .-..+.+++++....+..+||+||++
T Consensus        20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~   95 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE   95 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred             eeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence            345678888889999877 568889999875   23345678888888887   34567788888877777899999998


Q ss_pred             CC
Q 003391          584 NK  585 (823)
Q Consensus       584 ~g  585 (823)
                      .+
T Consensus        96 ~~   97 (288)
T PF03881_consen   96 MG   97 (288)
T ss_dssp             --
T ss_pred             CC
Confidence            77

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.59  E-value=0.14  Score=56.74  Aligned_cols=73  Identities=14%  Similarity=0.092  Sum_probs=50.9

Q ss_pred             CCeeeccCccceEEEEeecCcEEEEEEecCCcc-------ccHHHHHHHHHHHhccC---CCCceeEEEEeecCCceEEE
Q 003391          509 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSG-------QGMEEFENEVLLIAKLQ---HRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       509 ~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~-------~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV  578 (823)
                      .+.||.|....||+... +++.++||+-.....       ....+-..|...|+.+.   ..++.+++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            45789999999999876 456788987642211       23444455666666553   357888888887  456889


Q ss_pred             EeecCC
Q 003391          579 YEYLPN  584 (823)
Q Consensus       579 ~e~~~~  584 (823)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999977

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.40  E-value=0.081  Score=57.71  Aligned_cols=140  Identities=17%  Similarity=0.227  Sum_probs=79.7

Q ss_pred             eeeccCccceEEEEeec----CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCc-eeEEEEeecCCceEEEEeecCCC
Q 003391          511 KLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL-VKLIGCCTQRDERMLIYEYLPNK  585 (823)
Q Consensus       511 ~LG~G~fg~Vyk~~~~~----~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~g  585 (823)
                      .|..|-...+|+....+    +..+++|......... -.-.+|..+++.+..-++ .++++++..+    +|.+|+++.
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~   95 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINAR   95 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCC
Confidence            45556667789887543    2378888776544332 234678888888865444 3556655322    589999887


Q ss_pred             Ccchh-------h----------hccC-C-CC-ccCHHHHHHHHHHH----------------------HHHHHH----H
Q 003391          586 SLNDF-------I----------FDVT-R-SK-FLDWSKRCQIIGGI----------------------ARGLLY----L  619 (823)
Q Consensus       586 sL~~~-------l----------~~~~-~-~~-~l~~~~~~~i~~~i----------------------a~gL~y----L  619 (823)
                      .|..-       +          +... . .. +.-|....++..++                      .+-+..    +
T Consensus        96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~  175 (330)
T PLN02421         96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT  175 (330)
T ss_pred             CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence            66321       1          1111 0 01 11233222222111                      111211    2


Q ss_pred             Hh-cCCCceEecccCCCcEEEcC-CCCceeecccccee
Q 003391          620 HQ-DSRLRIIHRDLKASNVLLDN-EMNPKISDFGMARA  655 (823)
Q Consensus       620 H~-~~~~~ivH~Dlk~~NIll~~-~~~~kl~DFGla~~  655 (823)
                      .. ..+..++|.|+.+.||++++ ++.++++||..|..
T Consensus       176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            11 12235799999999999975 57899999998853

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.10  E-value=0.24  Score=53.68  Aligned_cols=136  Identities=23%  Similarity=0.271  Sum_probs=80.2

Q ss_pred             CccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccC---CCC---ceeEEEE----eecCCceEEEEeecCCC
Q 003391          516 GFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ---HRN---LVKLIGC----CTQRDERMLIYEYLPNK  585 (823)
Q Consensus       516 ~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---H~n---iv~l~g~----~~~~~~~~lV~e~~~~g  585 (823)
                      .-..+|+....+|+. ++|..+..  ....+...|+..+..+.   .+=   +..+-|-    ........-+++|++|.
T Consensus        37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~  113 (331)
T COG2334          37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR  113 (331)
T ss_pred             ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence            456789988877766 77777654  45567778888888773   221   1222121    11123677899999998


Q ss_pred             Ccch-h--------------hhccC------C---CCccCHHH----H---------HHHHHHHHHHHHHHHhc----CC
Q 003391          586 SLND-F--------------IFDVT------R---SKFLDWSK----R---------CQIIGGIARGLLYLHQD----SR  624 (823)
Q Consensus       586 sL~~-~--------------l~~~~------~---~~~l~~~~----~---------~~i~~~ia~gL~yLH~~----~~  624 (823)
                      .+.. .              ++...      +   .....|..    .         .....++...+..+++.    -+
T Consensus       114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp  193 (331)
T COG2334         114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP  193 (331)
T ss_pred             CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence            8873 1              01100      0   01233331    0         01222333444444432    11


Q ss_pred             ---CceEecccCCCcEEEcCCCC-ceeeccccce
Q 003391          625 ---LRIIHRDLKASNVLLDNEMN-PKISDFGMAR  654 (823)
Q Consensus       625 ---~~ivH~Dlk~~NIll~~~~~-~kl~DFGla~  654 (823)
                         ..+||+|+.|.||+++++.. +.+.||+-+.
T Consensus       194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence               23999999999999999885 8999999775

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.06  E-value=0.061  Score=54.52  Aligned_cols=123  Identities=19%  Similarity=0.250  Sum_probs=60.5

Q ss_pred             CcEEEEEEecCCccccHHHHHHHHHHHhccCCCC-ceeEEEEeecCCceEEEEeecCCCCcchh-------h--------
Q 003391          528 GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRN-LVKLIGCCTQRDERMLIYEYLPNKSLNDF-------I--------  591 (823)
Q Consensus       528 ~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e~~~~gsL~~~-------l--------  591 (823)
                      .+.|++++..... ...-....|..+++.+.... -.++++.+.++    +|+||+++..|..-       +        
T Consensus         2 ~~~~~~Ri~g~~t-~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~   76 (211)
T PF01633_consen    2 PEKYLVRIPGEGT-ENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLA   76 (211)
T ss_dssp             TSEEEEEEEESCG-CSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCCc-ccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHH
Confidence            3567777775553 34455678888888885433 35566665432    67799977665321       1        


Q ss_pred             --hc--c--CCCCccCHHHHHHH----------------------HHHHHHHHHHHHh----c-CCCceEecccCCCcEE
Q 003391          592 --FD--V--TRSKFLDWSKRCQI----------------------IGGIARGLLYLHQ----D-SRLRIIHRDLKASNVL  638 (823)
Q Consensus       592 --~~--~--~~~~~l~~~~~~~i----------------------~~~ia~gL~yLH~----~-~~~~ivH~Dlk~~NIl  638 (823)
                        +.  .  ......-|.....+                      ...+.+-+..+.+    . .+..++|.|+.+.||+
T Consensus        77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil  156 (211)
T PF01633_consen   77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL  156 (211)
T ss_dssp             HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred             HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence              10  0  01111112222222                      0111122222221    1 1234889999999999


Q ss_pred             E-cCCCCceeecccccee
Q 003391          639 L-DNEMNPKISDFGMARA  655 (823)
Q Consensus       639 l-~~~~~~kl~DFGla~~  655 (823)
                      + +.++.++++||..|..
T Consensus       157 ~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  157 INNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             ETSSSSCEEE--GTT-EE
T ss_pred             eccCCCeEEEecHHHHhh
Confidence            9 8899999999998864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=95.06  E-value=0.14  Score=55.62  Aligned_cols=73  Identities=14%  Similarity=0.178  Sum_probs=47.8

Q ss_pred             eeeccCccceEEEEeecC-cEEEEEEecC-------CccccHHHHHHHHHHHhccC--CCC-ceeEEEEeecCCceEEEE
Q 003391          511 KLGEGGFGPVYKGVLIEG-QEIAAKRLSK-------SSGQGMEEFENEVLLIAKLQ--HRN-LVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       511 ~LG~G~fg~Vyk~~~~~~-~~vavK~l~~-------~~~~~~~~~~~Ei~~l~~l~--H~n-iv~l~g~~~~~~~~~lV~  579 (823)
                      .||.|....||++...++ +.|+||.-..       ..+-..++...|...|....  -|. +.+++.  .+.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            579999999999998654 5899986422       12344556667777776653  343 333433  3445667999


Q ss_pred             eecCCC
Q 003391          580 EYLPNK  585 (823)
Q Consensus       580 e~~~~g  585 (823)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            999653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	823
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		8e-54
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-52
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-40
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-40
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-40
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-39
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-39
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-38
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-22
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-22
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-22
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-22
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-22
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-22
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-22
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-22
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-22
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-22
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-22
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		5e-22
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-22
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		6e-22
3a4o_X	286	Lyn Kinase Domain Length = 286		6e-22
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-22
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		7e-22
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		8e-22
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		9e-22
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-21
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-21
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-21
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-21
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-21
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-21
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-21
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-21
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-21
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-21
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-21
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-21
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-21
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-21
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-21
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-21
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-21
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-21
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-21
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-21
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-21
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-21
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-21
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		4e-21
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-21
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-21
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		5e-21
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-21
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		7e-21
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-21
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-21
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-20
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-20
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-20
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-20
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-20
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-20
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-20
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-20
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-20
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-20
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-20
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-20
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-20
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-20
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-20
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-20
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-20
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-20
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-20
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-20
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-20
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-20
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-20
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-20
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-20
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-20
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-20
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-20
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-20
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-20
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-20
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		8e-20
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-19
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-19
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-19
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-19
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-19
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-19
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-19
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-19
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-19
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-19
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-18
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-18
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-18
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-18
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-18
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-18
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		7e-18
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		8e-18
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		8e-18
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		9e-18
1fvr_A	327	Tie2 Kinase Domain Length = 327		9e-18
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		9e-18
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-17
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-17
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-17
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-17
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-17
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-17
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-17
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-17
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-17
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-17
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-17
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-17
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-17
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-17
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-17
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-17
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-17
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-17
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-17
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-17
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-17
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-17
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-17
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-17
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-17
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-17
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-17
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-17
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-17
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-17
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-17
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-17
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-17
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-17
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-17
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-17
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-17
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-17
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-17
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-17
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-17
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-17
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-17
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-17
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-17
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-17
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-17
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-17
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-17
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-17
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-17
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-17
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-17
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-17
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-17
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-17
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-17
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-17
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-17
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-17
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-17
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-17
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-17
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-17
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-17
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-17
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-17
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-17
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-17
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-17
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-17
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		5e-17
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-17
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-17
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-17
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		6e-17
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-17
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		6e-17
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-17
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		6e-17
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-17
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		6e-17
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-17
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-17
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-17
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		6e-17
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-17
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		6e-17
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-17
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-17
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		6e-17
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		6e-17
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		6e-17
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		7e-17
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		7e-17
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		7e-17
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		7e-17
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-17
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		7e-17
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		7e-17
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		7e-17
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-17
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		8e-17
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-17
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		8e-17
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		9e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-17
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-16
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-16
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-16
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-16
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-16
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-16
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-16
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-16
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-16
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-16
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-16
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-16
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-16
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-16
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-16
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-16
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-16
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-16
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-16
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-16
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-16
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-16
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-16
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-16
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-16
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-16
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-16
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-16
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-16
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-16
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-16
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-16
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-16
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-16
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-16
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-16
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-16
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-16
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-16
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-16
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-16
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-16
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		6e-16
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-16
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-16
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-16
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-16
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		7e-16
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-16
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-16
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		7e-16
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		7e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-16
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-16
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-16
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		8e-16
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		8e-16
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		8e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		8e-16
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		8e-16
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		8e-16
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		8e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		9e-16
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		9e-16
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		9e-16
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		9e-16
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		9e-16
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-15
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-15
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-15
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-15
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-15
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-15
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-15
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-15
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-15
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-15
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-15
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-15
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-15
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-15
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-15
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-15
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-15
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-15
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-15
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-15
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-15
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-15
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-15
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-15
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-15
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-15
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-15
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-15
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-15
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-15
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-15
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-15
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-15
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-15
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-15
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-15
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-15
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-15
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-15
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-15
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-15
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-15
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-15
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-15
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-15
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-15
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-15
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-15
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-15
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-15
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-15
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-15
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-15
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-15
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-15
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-15
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-15
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-15
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		5e-15
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-15
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-15
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-15
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-15
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		6e-15
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		6e-15
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		6e-15
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		7e-15
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		7e-15
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-15
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		7e-15
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		8e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		8e-15
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		9e-15
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		9e-15
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-14
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-14
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-14
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-14
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-14
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-14
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-14
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-14
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-14
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-14
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-14
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-14
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-14
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-14
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-14
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-14
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-14
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-14
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-14
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-14
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-14
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-14
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-14
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-14
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-14
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		7e-14
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		7e-14
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-14
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		8e-14
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		8e-14
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		8e-14
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		8e-14
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		8e-14
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		8e-14
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-14
4fie_A	423	Full-Length Human Pak4 Length = 423		9e-14
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		9e-14
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		9e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		9e-14
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		9e-14
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		9e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		9e-14
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		9e-14
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-13
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-13
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-13
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-13
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-13
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-13
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-13
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-13
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-13
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-13
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-13
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-13
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-13
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-13
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-13
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-13
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-13
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-13
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-13
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-13
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-13
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-13
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-13
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-13
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-13
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-13
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-13
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-13
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-13
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-13
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-13
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-13
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		8e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		9e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-12
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-12
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-12
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-12
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-12
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-12
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-12
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-12
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-12
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-12
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-12
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-12
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-12
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-12
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-12
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-12
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-12
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-12
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-12
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-12
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-12
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-12
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-12
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-12
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		5e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-12
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-12
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		5e-12
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		6e-12
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		6e-12
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		6e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		6e-12
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		6e-12
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		6e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		7e-12
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		7e-12
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-12
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-12
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-12
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		7e-12
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		7e-12
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		7e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		8e-12
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		8e-12
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		8e-12
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		8e-12
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		8e-12
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		8e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		8e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		8e-12
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		9e-12
3soa_A	444	Full-Length Human Camkii Length = 444		9e-12
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		9e-12
2oza_B	366	Structure Of P38alpha Complex Length = 366		9e-12
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-11
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-11
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-11
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-11
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-11
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-11
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-11
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-11
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-11
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-11
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-11
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-11
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-11
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-11
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-11
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-11
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-11
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-11
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-11
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-11
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-11
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-11
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-11
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-11
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-11
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-11
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-11
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-11
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-11
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-11
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-11
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-11
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-11
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-11
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-11
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-11
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-11
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-11
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-11
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-11
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-11
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-11
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-11
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-11
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-11
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-11
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-11
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-11
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-11
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-11
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-11
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-11
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-11
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-11
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-11
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-11
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-11
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-11
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-11
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-11
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-11
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-11
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-11
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-11
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-11
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-11
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-11
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-11
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-11
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-11
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-11
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-11
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-11
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		6e-11
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		7e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-11
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		7e-11
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		7e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		7e-11
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		8e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		8e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-11
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		8e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		9e-11
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-10
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-10
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-10
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-10
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-10
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-10
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-10
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-10
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-10
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-10
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-10
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-10
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-10
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-10
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-10
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-10
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-10
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		4e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		4e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-10
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-10
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		5e-10
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-10
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		5e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		5e-10
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		6e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		6e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		6e-10
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		6e-10
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		7e-10
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		7e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		7e-10
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		7e-10
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		8e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		8e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		8e-10
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		8e-10
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		9e-10
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-09
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-09
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-09
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-09
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-09
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-09
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-09
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-09
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-09
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-09
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-09
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-09
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-09
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-09
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-09
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-09
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-09
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		4e-09
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		5e-09
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		5e-09
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-09
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		5e-09
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		5e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		6e-09
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		6e-09
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		6e-09
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		6e-09
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-09
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		6e-09
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		6e-09
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		6e-09
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		6e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		7e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-09
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		7e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-09
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		8e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		8e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		8e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		9e-09
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-09
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		9e-09
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		9e-09
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		9e-09
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-08
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-08
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-08
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-08
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-08
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-08
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-08
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-08
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-08
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-08
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-08
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-08
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-08
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-08
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-08
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		4e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		5e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		5e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		5e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-08
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		5e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		5e-08
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		5e-08
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		5e-08
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		5e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		5e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		6e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		6e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		6e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		6e-08
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		7e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		7e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		7e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		7e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		7e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		7e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		7e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		8e-08
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		8e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		9e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-07
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-07
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-07
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		4e-07
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		4e-07
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		4e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		5e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-07
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		6e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		7e-07
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-06
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-06
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		1e-06
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-06
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-06
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		5e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		5e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		6e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		8e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-05
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-05
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-05
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-05
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		6e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		8e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		8e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		8e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		8e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		8e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		8e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  208 bits (530), Expect = 8e-54,   Method: Compositional matrix adjust.
 Identities = 122/296 (41%), Positives = 178/296 (60%), Gaps = 7/296 (2%)
Query: 490 ELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGME-EFE 548
           +L  F    +  A++NFS+KN LG GGFG VYKG L +G  +A KRL +   QG E +F+
Sbjct: 24  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQ 83
Query: 549 NEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKF-LDWSKRCQ 607
            EV +I+   HRNL++L G C    ER+L+Y Y+ N S+   + +   S+  LDW KR +
Sbjct: 84  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 143
Query: 608 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 667
           I  G ARGL YLH     +IIHRD+KA+N+LLD E    + DFG+A+   +D  + +   
Sbjct: 144 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL--MDYKDXHVXX 201
Query: 668 VV-GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW-R 725
            V GT G++ PEY   G  S K+DVF +GV++LE++ G+R        +  +++   W +
Sbjct: 202 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 261
Query: 726 LWIEERPVE-LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 780
             ++E+ +E L++  L G+Y   EV + IQV LLC Q  P +RP MS VV ML G+
Sbjct: 262 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 317

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  204 bits (520), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 120/296 (40%), Positives = 176/296 (59%), Gaps = 7/296 (2%)
Query: 490 ELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGME-EFE 548
           +L  F    +  A++NF +KN LG GGFG VYKG L +G  +A KRL +   QG E +F+
Sbjct: 16  QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQ 75
Query: 549 NEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKF-LDWSKRCQ 607
            EV +I+   HRNL++L G C    ER+L+Y Y+ N S+   + +   S+  LDW KR +
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 608 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 667
           I  G ARGL YLH     +IIHRD+KA+N+LLD E    + DFG+A+   +D  + +   
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL--MDYKDXHVXX 193
Query: 668 VV-GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW-R 725
            V G  G++ PEY   G  S K+DVF +GV++LE++ G+R        +  +++   W +
Sbjct: 194 AVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 726 LWIEERPVE-LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 780
             ++E+ +E L++  L G+Y   EV + IQV LLC Q  P +RP MS VV ML G+
Sbjct: 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  163 bits (412), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 161/298 (54%), Gaps = 25/298 (8%)
Query: 494 FDWMAIANATENFSDK------NKLGEGGFGPVYKGVLIEGQEIAAKRLSK----SSGQG 543
           F +  + N T NF ++      NK+GEGGFG VYKG  +    +A K+L+     ++ + 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 73
Query: 544 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWS 603
            ++F+ E+ ++AK QH NLV+L+G  +  D+  L+Y Y+PN SL D +  +  +  L W 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 604 KRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 663
            RC+I  G A G+ +LH++     IHRD+K++N+LLD     KISDFG+ARA        
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHN----L 719
             +R+VGT  YM PE A+ G  + KSD++SFGV++LEI+      G    D H      L
Sbjct: 191 MXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIIT-----GLPAVDEHREPQLLL 244
Query: 720 LGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 777
                    E+   + I+K +  + S S V     V   C+ ++   RP++  V  +L
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMNDADSTS-VEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  162 bits (410), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 160/298 (53%), Gaps = 25/298 (8%)
Query: 494 FDWMAIANATENFSDK------NKLGEGGFGPVYKGVLIEGQEIAAKRLSK----SSGQG 543
           F +  + N T NF ++      NK+GEGGFG VYKG  +    +A K+L+     ++ + 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 73
Query: 544 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWS 603
            ++F+ E+ ++AK QH NLV+L+G  +  D+  L+Y Y+PN SL D +  +  +  L W 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 604 KRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 663
            RC+I  G A G+ +LH++     IHRD+K++N+LLD     KISDFG+ARA        
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHN----L 719
              R+VGT  YM PE A+ G  + KSD++SFGV++LEI+      G    D H      L
Sbjct: 191 MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIIT-----GLPAVDEHREPQLLL 244
Query: 720 LGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 777
                    E+   + I+K +  + S S V     V   C+ ++   RP++  V  +L
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMNDADSTS-VEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  162 bits (410), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 160/298 (53%), Gaps = 25/298 (8%)
Query: 494 FDWMAIANATENFSDK------NKLGEGGFGPVYKGVLIEGQEIAAKRLSK----SSGQG 543
           F +  + N T NF ++      NK+GEGGFG VYKG  +    +A K+L+     ++ + 
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 67
Query: 544 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWS 603
            ++F+ E+ ++AK QH NLV+L+G  +  D+  L+Y Y+PN SL D +  +  +  L W 
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 127
Query: 604 KRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 663
            RC+I  G A G+ +LH++     IHRD+K++N+LLD     KISDFG+ARA        
Sbjct: 128 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 184
Query: 664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHN----L 719
              R+VGT  YM PE A+ G  + KSD++SFGV++LEI+      G    D H      L
Sbjct: 185 MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIIT-----GLPAVDEHREPQLLL 238
Query: 720 LGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 777
                    E+   + I+K +  + S S V     V   C+ ++   RP++  V  +L
Sbjct: 239 DIKEEIEDEEKTIEDYIDKKMNDADSTS-VEAMYSVASQCLHEKKNKRPDIKKVQQLL 295

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  160 bits (404), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 105/290 (36%), Positives = 161/290 (55%), Gaps = 9/290 (3%)
Query: 487 EEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEE 546
           E   +P+ D   +  AT NF  K  +G G FG VYKGVL +G ++A KR +  S QG+EE
Sbjct: 25  ESYRVPLVD---LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEE 81
Query: 547 FENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKF-LDWSKR 605
           FE E+  ++  +H +LV LIG C +R+E +LIY+Y+ N +L   ++        + W +R
Sbjct: 82  FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQR 141
Query: 606 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT 665
            +I  G ARGL YLH  +   IIHRD+K+ N+LLD    PKI+DFG+++  G +  + + 
Sbjct: 142 LEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK-GTELDQTHL 197
Query: 666 NRVV-GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW 724
             VV GT GY+ PEY I G  + KSDV+SFGV++ E++C +            NL   A 
Sbjct: 198 XXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV 257
Query: 725 RLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 774
                 +  ++++ +L        + +     + C+    EDRP+M  V+
Sbjct: 258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  159 bits (403), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 105/290 (36%), Positives = 161/290 (55%), Gaps = 9/290 (3%)
Query: 487 EEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEE 546
           E   +P+ D   +  AT NF  K  +G G FG VYKGVL +G ++A KR +  S QG+EE
Sbjct: 25  ESYRVPLVD---LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEE 81
Query: 547 FENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKF-LDWSKR 605
           FE E+  ++  +H +LV LIG C +R+E +LIY+Y+ N +L   ++        + W +R
Sbjct: 82  FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQR 141
Query: 606 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT 665
            +I  G ARGL YLH  +   IIHRD+K+ N+LLD    PKI+DFG+++  G +  + + 
Sbjct: 142 LEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK-GTELGQTHL 197
Query: 666 NRVV-GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW 724
             VV GT GY+ PEY I G  + KSDV+SFGV++ E++C +            NL   A 
Sbjct: 198 XXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV 257
Query: 725 RLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 774
                 +  ++++ +L        + +     + C+    EDRP+M  V+
Sbjct: 258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  157 bits (396), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 88/221 (39%), Positives = 131/221 (59%), Gaps = 15/221 (6%)
Query: 494 FDWMAIANATENFSDK------NKLGEGGFGPVYKGVLIEGQEIAAKRLSK----SSGQG 543
           F +  + N T NF ++      NK GEGGFG VYKG  +    +A K+L+     ++ + 
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 64
Query: 544 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWS 603
            ++F+ E+ + AK QH NLV+L+G  +  D+  L+Y Y PN SL D +  +  +  L W 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 604 KRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 663
            RC+I  G A G+ +LH++     IHRD+K++N+LLD     KISDFG+ARA        
Sbjct: 125 XRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
             +R+VGT  Y  PE A+ G  + KSD++SFGV++LEI+ G
Sbjct: 182 XXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITG 221

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/273 (31%), Positives = 133/273 (48%), Gaps = 36/273 (13%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E      +LG G FG V+ G      ++A K L + S    + F  E  L+ +LQH+ LV
Sbjct: 22  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 80
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIARGLLY 618
           +L    TQ +   +I EY+ N SL DF+       +T +K LD      +   IA G+ +
Sbjct: 81  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD------MAAQIAEGMAF 133
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           + + +    IHRDL+A+N+L+ + ++ KI+DFG+AR    ++  A          +  PE
Sbjct: 134 IEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPE 189
Query: 679 YAIDGLFSVKSDVFSFGVLVLEIVCGKR--NRGFYHADHHHNLLGHAWRLWIEERPVELI 736
               G F++KSDV+SFG+L+ EIV   R    G  + +   NL          ER   ++
Sbjct: 190 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----------ERGYRMV 239
Query: 737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPN 769
                    L +++R      LC ++RPEDRP 
Sbjct: 240 RPD-NCPEELYQLMR------LCWKERPEDRPT 265

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 133/274 (48%), Gaps = 36/274 (13%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E      +LG G FG V+ G      ++A K L + S    + F  E  L+ +LQH+ LV
Sbjct: 14  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 72
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIARGLLY 618
           +L    TQ +   +I EY+ N SL DF+       +T +K LD      +   IA G+ +
Sbjct: 73  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD------MAAQIAEGMAF 125
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           + + +    IHRDL+A+N+L+ + ++ KI+DFG+AR    ++  A          +  PE
Sbjct: 126 IEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPE 181
Query: 679 YAIDGLFSVKSDVFSFGVLVLEIVCGKR--NRGFYHADHHHNLLGHAWRLWIEERPVELI 736
               G F++KSDV+SFG+L+ EIV   R    G  + +   NL          ER   ++
Sbjct: 182 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----------ERGYRMV 231
Query: 737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNM 770
                    L +++R      LC ++RPEDRP  
Sbjct: 232 RPD-NCPEELYQLMR------LCWKERPEDRPTF 258

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 133/274 (48%), Gaps = 36/274 (13%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E      +LG G FG V+ G      ++A K L + S    + F  E  L+ +LQH+ LV
Sbjct: 15  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 73
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIARGLLY 618
           +L    TQ +   +I EY+ N SL DF+       +T +K LD      +   IA G+ +
Sbjct: 74  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD------MAAQIAEGMAF 126
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           + + +    IHRDL+A+N+L+ + ++ KI+DFG+AR    ++  A          +  PE
Sbjct: 127 IEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPE 182
Query: 679 YAIDGLFSVKSDVFSFGVLVLEIVCGKR--NRGFYHADHHHNLLGHAWRLWIEERPVELI 736
               G F++KSDV+SFG+L+ EIV   R    G  + +   NL          ER   ++
Sbjct: 183 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----------ERGYRMV 232
Query: 737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNM 770
                    L +++R      LC ++RPEDRP  
Sbjct: 233 RPD-NCPEELYQLMR------LCWKERPEDRPTF 259

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 132/267 (49%), Gaps = 36/267 (13%)
Query: 511 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT 570
           +LG G FG V+ G      ++A K L + S    + F  E  L+ +LQH+ LV+L    T
Sbjct: 28  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 86
Query: 571 QRDERMLIYEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 625
           Q +   +I EY+ N SL DF+       +T +K LD      +   IA G+ ++ + +  
Sbjct: 87  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD------MAAQIAEGMAFIEERN-- 137
Query: 626 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF 685
             IHRDL+A+N+L+ + ++ KI+DFG+AR    ++  A          +  PE    G F
Sbjct: 138 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTF 195
Query: 686 SVKSDVFSFGVLVLEIVCGKR--NRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 743
           ++KSDV+SFG+L+ EIV   R    G  + +   NL          ER   ++       
Sbjct: 196 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----------ERGYRMVRPD-NCP 244
Query: 744 YSLSEVLRCIQVGLLCVQQRPEDRPNM 770
             L +++R      LC ++RPEDRP  
Sbjct: 245 EELYQLMR------LCWKERPEDRPTF 265

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 132/267 (49%), Gaps = 36/267 (13%)
Query: 511 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT 570
           +LG G FG V+ G      ++A K L + S    + F  E  L+ +LQH+ LV+L    T
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 571 QRDERMLIYEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 625
           Q +   +I EY+ N SL DF+       +T +K LD      +   IA G+ ++ + +  
Sbjct: 79  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD------MAAQIAEGMAFIEERN-- 129
Query: 626 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF 685
             IHRDL+A+N+L+ + ++ KI+DFG+AR    ++  A          +  PE    G F
Sbjct: 130 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTF 187
Query: 686 SVKSDVFSFGVLVLEIVCGKR--NRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 743
           ++KSDV+SFG+L+ EIV   R    G  + +   NL          ER   ++       
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----------ERGYRMVRPD-NCP 236
Query: 744 YSLSEVLRCIQVGLLCVQQRPEDRPNM 770
             L +++R      LC ++RPEDRP  
Sbjct: 237 EELYQLMR------LCWKERPEDRPTF 257

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 133/274 (48%), Gaps = 36/274 (13%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E      +LG G FG V+ G      ++A K L + S    + F  E  L+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIARGLLY 618
           +L    TQ +   +I EY+ N SL DF+       +T +K LD      +   IA G+ +
Sbjct: 72  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD------MAAQIAEGMAF 124
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           + + +    IHRDL+A+N+L+ + ++ KI+DFG+AR    ++  A          +  PE
Sbjct: 125 IEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPE 180
Query: 679 YAIDGLFSVKSDVFSFGVLVLEIVCGKR--NRGFYHADHHHNLLGHAWRLWIEERPVELI 736
               G F++KSDV+SFG+L+ EIV   R    G  + +   NL          ER   ++
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----------ERGYRMV 230
Query: 737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNM 770
                    L +++R      LC ++RPEDRP  
Sbjct: 231 RPD-NCPEELYQLMR------LCWKERPEDRPTF 257

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 84/268 (31%), Positives = 132/268 (49%), Gaps = 36/268 (13%)
Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
            +LG G FG V+ G      ++A K L + S    + F  E  L+ +LQH+ LV+L    
Sbjct: 25  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 570 TQRDERMLIYEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           TQ +   +I EY+ N SL DF+       +T +K LD      +   IA G+ ++ + + 
Sbjct: 84  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD------MAAQIAEGMAFIEERN- 135
Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 684
              IHRDL+A+N+L+ + ++ KI+DFG+AR    ++  A          +  PE    G 
Sbjct: 136 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGT 192
Query: 685 FSVKSDVFSFGVLVLEIVCGKR--NRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 742
           F++KSDV+SFG+L+ EIV   R    G  + +   NL          ER   ++      
Sbjct: 193 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----------ERGYRMVRPD-NC 241
Query: 743 SYSLSEVLRCIQVGLLCVQQRPEDRPNM 770
              L +++R      LC ++RPEDRP  
Sbjct: 242 PEELYQLMR------LCWKERPEDRPTF 263

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 132/267 (49%), Gaps = 36/267 (13%)
Query: 511 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT 570
           +LG G FG V+ G      ++A K L + S    + F  E  L+ +LQH+ LV+L    T
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 571 QRDERMLIYEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 625
           Q +   +I EY+ N SL DF+       +T +K LD      +   IA G+ ++ + +  
Sbjct: 85  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD------MAAQIAEGMAFIEERN-- 135
Query: 626 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF 685
             IHRDL+A+N+L+ + ++ KI+DFG+AR    ++  A          +  PE    G F
Sbjct: 136 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTF 193
Query: 686 SVKSDVFSFGVLVLEIVCGKR--NRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 743
           ++KSDV+SFG+L+ EIV   R    G  + +   NL          ER   ++       
Sbjct: 194 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----------ERGYRMVRPD-NCP 242
Query: 744 YSLSEVLRCIQVGLLCVQQRPEDRPNM 770
             L +++R      LC ++RPEDRP  
Sbjct: 243 EELYQLMR------LCWKERPEDRPTF 263

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 132/267 (49%), Gaps = 36/267 (13%)
Query: 511 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT 570
           +LG G FG V+ G      ++A K L + S    + F  E  L+ +LQH+ LV+L    T
Sbjct: 25  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 83
Query: 571 QRDERMLIYEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 625
           Q +   +I EY+ N SL DF+       +T +K LD      +   IA G+ ++ + +  
Sbjct: 84  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD------MAAQIAEGMAFIEERN-- 134
Query: 626 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF 685
             IHRDL+A+N+L+ + ++ KI+DFG+AR    ++  A          +  PE    G F
Sbjct: 135 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTF 192
Query: 686 SVKSDVFSFGVLVLEIVCGKR--NRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 743
           ++KSDV+SFG+L+ EIV   R    G  + +   NL          ER   ++       
Sbjct: 193 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----------ERGYRMVRPD-NCP 241
Query: 744 YSLSEVLRCIQVGLLCVQQRPEDRPNM 770
             L +++R      LC ++RPEDRP  
Sbjct: 242 EELYQLMR------LCWKERPEDRPTF 262

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 133/274 (48%), Gaps = 36/274 (13%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E      +LG G FG V+ G      ++A K L + S    + F  E  L+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIARGLLY 618
           +L    TQ +   +I EY+ N SL DF+       +T +K LD      +   IA G+ +
Sbjct: 72  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD------MAAQIAEGMAF 124
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           + + +    IHRDL+A+N+L+ + ++ KI+DFG+AR    ++  A          +  PE
Sbjct: 125 IEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPE 180
Query: 679 YAIDGLFSVKSDVFSFGVLVLEIVCGKR--NRGFYHADHHHNLLGHAWRLWIEERPVELI 736
               G F++KSDV+SFG+L+ EIV   R    G  + +   NL          ER   ++
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----------ERGYRMV 230
Query: 737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNM 770
                    L +++R      LC ++RPEDRP  
Sbjct: 231 RPD-NCPEELYQLMR------LCWKERPEDRPTF 257

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 132/267 (49%), Gaps = 36/267 (13%)
Query: 511 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT 570
           +LG G FG V+ G      ++A K L + S    + F  E  L+ +LQH+ LV+L    T
Sbjct: 30  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 88
Query: 571 QRDERMLIYEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 625
           Q +   +I EY+ N SL DF+       +T +K LD      +   IA G+ ++ + +  
Sbjct: 89  Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD------MAAQIAEGMAFIEERN-- 139
Query: 626 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF 685
             IHRDL+A+N+L+ + ++ KI+DFG+AR    ++  A          +  PE    G F
Sbjct: 140 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTF 197
Query: 686 SVKSDVFSFGVLVLEIVCGKR--NRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 743
           ++KSDV+SFG+L+ EIV   R    G  + +   NL          ER   ++       
Sbjct: 198 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----------ERGYRMVRPD-NCP 246
Query: 744 YSLSEVLRCIQVGLLCVQQRPEDRPNM 770
             L +++R      LC ++RPEDRP  
Sbjct: 247 EELYQLMR------LCWKERPEDRPTF 267

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  103 bits (256), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 117/244 (47%), Gaps = 28/244 (11%)
Query: 511 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT 570
           KLG+G FG V+ G       +A K L K      E F  E  ++ KL+H  LV+L    +
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 571 QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 630
           + +   ++ EY+   SL DF+   T  K+L   +   +   IA G+ Y+    R+  +HR
Sbjct: 333 E-EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 387
Query: 631 DLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSD 690
           DL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G F++KSD
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSD 446
Query: 691 VFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGHAWRLWIE 729
           V+SFG+L+ E+    R                RG+         +  H+L+   WR   E
Sbjct: 447 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPE 506
Query: 730 ERPV 733
           ERP 
Sbjct: 507 ERPT 510

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  103 bits (256), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 85/273 (31%), Positives = 134/273 (49%), Gaps = 36/273 (13%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E      +LG G FG V+ G      ++A K L + S    + F  E  L+ +LQH+ LV
Sbjct: 8   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 66
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIARGLLY 618
           +L    TQ +   +I EY+ N SL DF+       +T +K LD + +      IA G+ +
Sbjct: 67  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ------IAEGMAF 119
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           + + +    IHRDL+A+N+L+ + ++ KI+DFG+AR    ++  A          +  PE
Sbjct: 120 IEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPE 175
Query: 679 YAIDGLFSVKSDVFSFGVLVLEIVCGKR--NRGFYHADHHHNLLGHAWRLWIEERPVELI 736
               G F++KSDV+SFG+L+ EIV   R    G  + +   NL          ER   ++
Sbjct: 176 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----------ERGYRMV 225
Query: 737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPN 769
                    L +++R      LC ++RPEDRP 
Sbjct: 226 RPD-NCPEELYQLMR------LCWKERPEDRPT 251

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  103 bits (256), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 120/251 (47%), Gaps = 28/251 (11%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E+   + KLG+G FG V+ G       +A K L K      E F  E  ++ KL+H  LV
Sbjct: 8   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 66
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           +L    ++ +   ++ EY+   SL DF+   T  K+L   +   +   IA G+ Y+    
Sbjct: 67  QLYAVVSE-EPIXIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVE--- 121
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
           R+  +HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G
Sbjct: 122 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYG 180
Query: 684 LFSVKSDVFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGH 722
            F++KSDV+SFG+L+ E+    R                RG+         +  H+L+  
Sbjct: 181 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 240
Query: 723 AWRLWIEERPV 733
            WR   EERP 
Sbjct: 241 CWRKEPEERPT 251

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  102 bits (255), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 81/266 (30%), Positives = 123/266 (46%), Gaps = 38/266 (14%)
Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
            +LG G FG V+ G      ++A K L K     ++ F  E  L+  LQH  LV+L    
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 77
Query: 570 TQRDERMLIYEYLPNKSLNDFIFD-----VTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           T+ +   +I EY+   SL DF+       V   K +D+S +      IA G+ Y+    R
Sbjct: 78  TREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ------IAEGMAYIE---R 128
Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 684
              IHRDL+A+NVL+   +  KI+DFG+AR    ++  A          +  PE    G 
Sbjct: 129 KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI-KWTAPEAINFGC 187
Query: 685 FSVKSDVFSFGVLVLEIVC-------GKRNRGFYHA--------------DHHHNLLGHA 723
           F++KSDV+SFG+L+ EIV        G+ N     A              D  ++++   
Sbjct: 188 FTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRVENCPDELYDIMKMC 247
Query: 724 WRLWIEERPV-ELINKSLGGSYSLSE 748
           W+   EERP  + +   L   Y+ +E
Sbjct: 248 WKEKAEERPTFDYLQSVLDDFYTATE 273

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  102 bits (255), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 108/203 (53%), Gaps = 6/203 (2%)
Query: 509 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLI 566
           K K+G G FG V++     G ++A K L +     + + EF  EV ++ +L+H N+V  +
Sbjct: 42  KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 626
           G  TQ     ++ EYL   SL   +      + LD  +R  +   +A+G+ YLH +    
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPP 159
Query: 627 IIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFS 686
           I+HR+LK+ N+L+D +   K+ DFG++R      T  ++    GT  +M PE   D   +
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA--STFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 687 VKSDVFSFGVLVLEIVCGKRNRG 709
            KSDV+SFGV++ E+   ++  G
Sbjct: 218 EKSDVYSFGVILWELATLQQPWG 240

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  102 bits (255), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 120/251 (47%), Gaps = 28/251 (11%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E+   + KLG+G FG V+ G       +A K L K      E F  E  ++ KL+H  LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           +L    ++ +   ++ EY+   SL DF+   T  K+L   +   +   IA G+ Y+    
Sbjct: 243 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVE--- 297
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
           R+  +HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYG 356
Query: 684 LFSVKSDVFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGH 722
            F++KSDV+SFG+L+ E+    R                RG+         +  H+L+  
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 416
Query: 723 AWRLWIEERPV 733
            WR   EERP 
Sbjct: 417 CWRKEPEERPT 427

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  102 bits (254), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 117/244 (47%), Gaps = 28/244 (11%)
Query: 511 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT 570
           KLG+G FG V+ G       +A K L K      E F  E  ++ KL+H  LV+L    +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 571 QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 630
           + +   ++ EY+   SL DF+   T  K+L   +   +   IA G+ Y+    R+  +HR
Sbjct: 250 E-EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 631 DLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSD 690
           DL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G F++KSD
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIKSD 363
Query: 691 VFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGHAWRLWIE 729
           V+SFG+L+ E+    R                RG+         +  H+L+   WR   E
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPE 423
Query: 730 ERPV 733
           ERP 
Sbjct: 424 ERPT 427

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  102 bits (254), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 120/251 (47%), Gaps = 28/251 (11%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E+   + KLG+G FG V+ G       +A K L K      E F  E  ++ KL+H  LV
Sbjct: 11  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 69
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           +L    ++ +   ++ EY+   SL DF+   T  K+L   +   +   IA G+ Y+    
Sbjct: 70  QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVE--- 124
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
           R+  +HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G
Sbjct: 125 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYG 183
Query: 684 LFSVKSDVFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGH 722
            F++KSDV+SFG+L+ E+    R                RG+         +  H+L+  
Sbjct: 184 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 243
Query: 723 AWRLWIEERPV 733
            WR   EERP 
Sbjct: 244 CWRKEPEERPT 254

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/252 (30%), Positives = 123/252 (48%), Gaps = 36/252 (14%)
Query: 489 MELPIFDWMAIANATE----NFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLS- 537
           ME+P+ +    A   E          +LGE  FG VYKG L       + Q +A K L  
Sbjct: 7   MEMPLINQHKQAKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKD 66
Query: 538 KSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIF----- 592
           K+ G   EEF +E +L A+LQH N+V L+G  T+     +I+ Y  +  L++F+      
Sbjct: 67  KAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPH 126
Query: 593 --------DVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN 644
                   D T    L+      ++  IA G+ YL   S   ++H+DL   NVL+ +++N
Sbjct: 127 SDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLN 183
Query: 645 PKISDFGMAR-AFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV- 702
            KISD G+ R  +  D  +   N ++    +M PE  + G FS+ SD++S+GV++ E+  
Sbjct: 184 VKISDLGLFREVYAADYYKLLGNSLLPI-RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242
Query: 703 ------CGKRNR 708
                 CG  N+
Sbjct: 243 YGLQPYCGYSNQ 254

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 105/208 (50%), Gaps = 25/208 (12%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRL----SKSSGQGMEEFENEVLLIAKLQHRNLVKLIG 567
           +G GGFG VY+   I G E+A K       +   Q +E    E  L A L+H N++ L G
Sbjct: 15  IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 568 CCTQRDERMLIYEYLPNKSLNDFIFD--VTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 625
            C +     L+ E+     LN  +    +     ++W+ +      IARG+ YLH ++ +
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQ------IARGMNYLHDEAIV 127
Query: 626 RIIHRDLKASNVLLDNEMNP--------KISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
            IIHRDLK+SN+L+  ++          KI+DFG+AR +             G Y +M P
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW----HRTTKMSAAGAYAWMAP 183
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E     +FS  SDV+S+GVL+ E++ G+
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGE 211

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 120/251 (47%), Gaps = 28/251 (11%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E+   + KLG+G FG V+ G       +A K L K      E F  E  ++ KL+H  LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           +L    ++ +   ++ EY+   SL DF+   T  K+L   +   +   IA G+ Y+    
Sbjct: 243 QLYAVVSE-EPIYIVGEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVE--- 297
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
           R+  +HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYG 356
Query: 684 LFSVKSDVFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGH 722
            F++KSDV+SFG+L+ E+    R                RG+         +  H+L+  
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 416
Query: 723 AWRLWIEERPV 733
            WR   EERP 
Sbjct: 417 CWRKEPEERPT 427

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 106/203 (52%), Gaps = 6/203 (2%)
Query: 509 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLI 566
           K K+G G FG V++     G ++A K L +     + + EF  EV ++ +L+H N+V  +
Sbjct: 42  KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 626
           G  TQ     ++ EYL   SL   +      + LD  +R  +   +A+G+ YLH +    
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPP 159
Query: 627 IIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFS 686
           I+HRDLK+ N+L+D +   K+ DFG++R          +    GT  +M PE   D   +
Sbjct: 160 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA--SXFLXSKXAAGTPEWMAPEVLRDEPSN 217
Query: 687 VKSDVFSFGVLVLEIVCGKRNRG 709
            KSDV+SFGV++ E+   ++  G
Sbjct: 218 EKSDVYSFGVILWELATLQQPWG 240

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  101 bits (252), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/273 (30%), Positives = 134/273 (49%), Gaps = 36/273 (13%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E      +LG G FG V+ G      ++A K L + S    + F  E  L+ +LQH+ LV
Sbjct: 9   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 67
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIARGLLY 618
           +L    TQ +   +I EY+ N SL DF+       +T +K LD + +      IA G+ +
Sbjct: 68  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ------IAEGMAF 120
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           + + +    IHR+L+A+N+L+ + ++ KI+DFG+AR    ++  A          +  PE
Sbjct: 121 IEERN---YIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPE 176
Query: 679 YAIDGLFSVKSDVFSFGVLVLEIVCGKR--NRGFYHADHHHNLLGHAWRLWIEERPVELI 736
               G F++KSDV+SFG+L+ EIV   R    G  + +   NL          ER   ++
Sbjct: 177 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----------ERGYRMV 226
Query: 737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPN 769
                    L +++R      LC ++RPEDRP 
Sbjct: 227 RPD-NCPEELYQLMR------LCWKERPEDRPT 252

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/227 (32%), Positives = 115/227 (50%), Gaps = 32/227 (14%)
Query: 510 NKLGEGGFGPVYKGVLI------EGQEIAAKRLS-KSSGQGMEEFENEVLLIAKLQHRNL 562
            +LGE  FG VYKG L       + Q +A K L  K+ G   EEF +E +L A+LQH N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIF-------------DVTRSKFLDWSKRCQII 609
           V L+G  T+     +I+ Y  +  L++F+              D T    L+      ++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 610 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGIDQTEANTNRV 668
             IA G+ YL   S   ++H+DL   NVL+ +++N KISD G+ R  +  D  +   N +
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV-------CGKRNR 708
           +    +M PE  + G FS+ SD++S+GV++ E+        CG  N+
Sbjct: 192 LPI-RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 237

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 120/251 (47%), Gaps = 28/251 (11%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E+   + KLG+G FG V+ G       +A K L K      E F  E  ++ KL+H  LV
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 73
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           +L    ++ +   ++ EY+   SL DF+   T  K+L   +   +   IA G+ Y+    
Sbjct: 74  QLYAVVSE-EPIYIVTEYMNKGSLLDFLKGET-GKYLRLPQLVDMSAQIASGMAYVE--- 128
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
           R+  +HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G
Sbjct: 129 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYG 187
Query: 684 LFSVKSDVFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGH 722
            F++KSDV+SFG+L+ E+    R                RG+         +  H+L+  
Sbjct: 188 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 247
Query: 723 AWRLWIEERPV 733
            WR   EERP 
Sbjct: 248 CWRKEPEERPT 258

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/204 (35%), Positives = 104/204 (50%), Gaps = 21/204 (10%)
Query: 510 NKLGEGGFGPV----YKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
            +LG+G FG V    Y  +    G+ +A K+L  S+ + + +FE E+ ++  LQH N+VK
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 565 LIGCCTQRDER--MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
             G C     R   LI EYLP  SL D++     ++ +D  K  Q    I +G+ YL   
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QAHAERIDHIKLLQYTSQICKGMEYL--- 133
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----P 677
              R IHRDL   N+L++NE   KI DFG+ +    D+        V   G  P     P
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAP 189
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEI 701
           E   +  FSV SDV+SFGV++ E+
Sbjct: 190 ESLTESKFSVASDVWSFGVVLYEL 213

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 120/251 (47%), Gaps = 28/251 (11%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E+   + KLG+G FG V+ G       +A K L K      E F  E  ++ KL+H  LV
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 73
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           +L    ++ +   ++ EY+   SL DF+   T  K+L   +   +   IA G+ Y+    
Sbjct: 74  QLYAVVSE-EPIYIVTEYMNKGSLLDFLKGET-GKYLRLPQLVDMSAQIASGMAYVE--- 128
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
           R+  +HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G
Sbjct: 129 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKF-PIKWTAPEAALYG 187
Query: 684 LFSVKSDVFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGH 722
            F++KSDV+SFG+L+ E+    R                RG+         +  H+L+  
Sbjct: 188 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 247
Query: 723 AWRLWIEERPV 733
            WR   EERP 
Sbjct: 248 CWRKEPEERPT 258

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 80/266 (30%), Positives = 123/266 (46%), Gaps = 38/266 (14%)
Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
            KLG G FG V+ G      ++A K L K     ++ F  E  L+  LQH  LV+L    
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 76
Query: 570 TQRDERMLIYEYLPNKSLNDFIFD-----VTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           T+ +   +I E++   SL DF+       V   K +D+S +      IA G+ Y+    R
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ------IAEGMAYIE---R 127
Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 684
              IHRDL+A+NVL+   +  KI+DFG+AR    ++  A          +  PE    G 
Sbjct: 128 KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI-KWTAPEAINFGC 186
Query: 685 FSVKSDVFSFGVLVLEIVC-------GKRNRGFYHA--------------DHHHNLLGHA 723
           F++KS+V+SFG+L+ EIV        G+ N     A              D  ++++   
Sbjct: 187 FTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRMENCPDELYDIMKMC 246
Query: 724 WRLWIEERPV-ELINKSLGGSYSLSE 748
           W+   EERP  + +   L   Y+ +E
Sbjct: 247 WKEKAEERPTFDYLQSVLDDFYTATE 272

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 87/276 (31%), Positives = 136/276 (49%), Gaps = 40/276 (14%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E      +LG G  G V+ G      ++A K L + S    + F  E  L+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIARGLLY 618
           +L    TQ +   +I EY+ N SL DF+       +T +K LD + +      IA G+ +
Sbjct: 72  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ------IAEGMAF 124
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTY--GYMP 676
           + + +    IHRDL+A+N+L+ + ++ KI+DFG+AR   I+  E  T R    +   +  
Sbjct: 125 IEERN---YIHRDLRAANILVSDTLSCKIADFGLARL--IEDAEX-TAREGAKFPIKWTA 178
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCGKR--NRGFYHADHHHNLLGHAWRLWIEERPVE 734
           PE    G F++KSDV+SFG+L+ EIV   R    G  + +   NL          ER   
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----------ERGYR 228
Query: 735 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNM 770
           ++         L +++R      LC ++RPEDRP  
Sbjct: 229 MVRPD-NCPEELYQLMR------LCWKERPEDRPTF 257

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/204 (35%), Positives = 103/204 (50%), Gaps = 21/204 (10%)
Query: 510 NKLGEGGFGPV----YKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
            +LG+G FG V    Y  +    G+ +A K+L  S+ + + +FE E+ ++  LQH N+VK
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 565 LIGCCTQRDER--MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
             G C     R   LI EYLP  SL D++      + +D  K  Q    I +G+ YL   
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 133
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----P 677
              R IHRDL   N+L++NE   KI DFG+ +    D+        V   G  P     P
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAP 189
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEI 701
           E   +  FSV SDV+SFGV++ E+
Sbjct: 190 ESLTESKFSVASDVWSFGVVLYEL 213

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/204 (35%), Positives = 103/204 (50%), Gaps = 21/204 (10%)
Query: 510 NKLGEGGFGPV----YKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
            +LG+G FG V    Y  +    G+ +A K+L  S+ + + +FE E+ ++  LQH N+VK
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 565 LIGCCTQRDER--MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
             G C     R   LI EYLP  SL D++      + +D  K  Q    I +G+ YL   
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 161
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----P 677
              R IHRDL   N+L++NE   KI DFG+ +    D+        V   G  P     P
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAP 217
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEI 701
           E   +  FSV SDV+SFGV++ E+
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYEL 241

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/204 (35%), Positives = 103/204 (50%), Gaps = 21/204 (10%)
Query: 510 NKLGEGGFGPV----YKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
            +LG+G FG V    Y  +    G+ +A K+L  S+ + + +FE E+ ++  LQH N+VK
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 565 LIGCCTQRDER--MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
             G C     R   LI EYLP  SL D++      + +D  K  Q    I +G+ YL   
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 128
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----P 677
              R IHRDL   N+L++NE   KI DFG+ +    D+        V   G  P     P
Sbjct: 129 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAP 184
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEI 701
           E   +  FSV SDV+SFGV++ E+
Sbjct: 185 ESLTESKFSVASDVWSFGVVLYEL 208

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/204 (35%), Positives = 103/204 (50%), Gaps = 21/204 (10%)
Query: 510 NKLGEGGFGPV----YKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
            +LG+G FG V    Y  +    G+ +A K+L  S+ + + +FE E+ ++  LQH N+VK
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 565 LIGCCTQRDER--MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
             G C     R   LI EYLP  SL D++      + +D  K  Q    I +G+ YL   
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 135
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----P 677
              R IHRDL   N+L++NE   KI DFG+ +    D+        V   G  P     P
Sbjct: 136 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAP 191
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEI 701
           E   +  FSV SDV+SFGV++ E+
Sbjct: 192 ESLTESKFSVASDVWSFGVVLYEL 215

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/204 (35%), Positives = 103/204 (50%), Gaps = 21/204 (10%)
Query: 510 NKLGEGGFGPV----YKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
            +LG+G FG V    Y  +    G+ +A K+L  S+ + + +FE E+ ++  LQH N+VK
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 565 LIGCCTQRDER--MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
             G C     R   LI EYLP  SL D++      + +D  K  Q    I +G+ YL   
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 129
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----P 677
              R IHRDL   N+L++NE   KI DFG+ +    D+        V   G  P     P
Sbjct: 130 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAP 185
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEI 701
           E   +  FSV SDV+SFGV++ E+
Sbjct: 186 ESLTESKFSVASDVWSFGVVLYEL 209

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score =  100 bits (249), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 72/204 (35%), Positives = 103/204 (50%), Gaps = 21/204 (10%)
Query: 510 NKLGEGGFGPV----YKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
            +LG+G FG V    Y  +    G+ +A K+L  S+ + + +FE E+ ++  LQH N+VK
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 565 LIGCCTQRDER--MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
             G C     R   LI EYLP  SL D++      + +D  K  Q    I +G+ YL   
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 134
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----P 677
              R IHRDL   N+L++NE   KI DFG+ +    D+        V   G  P     P
Sbjct: 135 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAP 190
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEI 701
           E   +  FSV SDV+SFGV++ E+
Sbjct: 191 ESLTESKFSVASDVWSFGVVLYEL 214

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 119/251 (47%), Gaps = 28/251 (11%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E+   + KLG+G FG V+ G       +A K L K      E F  E  ++ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           +L    ++    ++I EY+   SL DF+      K+L   +   +   IA G+ Y+    
Sbjct: 77  QLYAVVSEEPIYIVI-EYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE--- 131
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
           R+  +HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G
Sbjct: 132 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYG 190
Query: 684 LFSVKSDVFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGH 722
            F++KSDV+SFG+L+ E+    R                RG+         +  H+L+  
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 250
Query: 723 AWRLWIEERPV 733
            WR   EERP 
Sbjct: 251 CWRKDPEERPT 261

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score =  100 bits (249), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 72/204 (35%), Positives = 103/204 (50%), Gaps = 21/204 (10%)
Query: 510 NKLGEGGFGPV----YKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
            +LG+G FG V    Y  +    G+ +A K+L  S+ + + +FE E+ ++  LQH N+VK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 565 LIGCCTQRDER--MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
             G C     R   LI EYLP  SL D++      + +D  K  Q    I +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 130
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----P 677
              R IHRDL   N+L++NE   KI DFG+ +    D+        V   G  P     P
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAP 186
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEI 701
           E   +  FSV SDV+SFGV++ E+
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYEL 210

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 72/204 (35%), Positives = 103/204 (50%), Gaps = 21/204 (10%)
Query: 510 NKLGEGGFGPV----YKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
            +LG+G FG V    Y  +    G+ +A K+L  S+ + + +FE E+ ++  LQH N+VK
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 565 LIGCCTQRDER--MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
             G C     R   LI EYLP  SL D++      + +D  K  Q    I +G+ YL   
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 136
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----P 677
              R IHRDL   N+L++NE   KI DFG+ +    D+        V   G  P     P
Sbjct: 137 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAP 192
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEI 701
           E   +  FSV SDV+SFGV++ E+
Sbjct: 193 ESLTESKFSVASDVWSFGVVLYEL 216

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 72/204 (35%), Positives = 103/204 (50%), Gaps = 21/204 (10%)
Query: 510 NKLGEGGFGPV----YKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
            +LG+G FG V    Y  +    G+ +A K+L  S+ + + +FE E+ ++  LQH N+VK
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 565 LIGCCTQRDER--MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
             G C     R   LI EYLP  SL D++      + +D  K  Q    I +G+ YL   
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 137
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----P 677
              R IHRDL   N+L++NE   KI DFG+ +    D+        V   G  P     P
Sbjct: 138 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAP 193
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEI 701
           E   +  FSV SDV+SFGV++ E+
Sbjct: 194 ESLTESKFSVASDVWSFGVVLYEL 217

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 72/204 (35%), Positives = 103/204 (50%), Gaps = 21/204 (10%)
Query: 510 NKLGEGGFGPV----YKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
            +LG+G FG V    Y  +    G+ +A K+L  S+ + + +FE E+ ++  LQH N+VK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 565 LIGCCTQRDER--MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
             G C     R   LI EYLP  SL D++      + +D  K  Q    I +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 130
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----P 677
              R IHRDL   N+L++NE   KI DFG+ +    D+        V   G  P     P
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAP 186
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEI 701
           E   +  FSV SDV+SFGV++ E+
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYEL 210

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 72/203 (35%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 511 KLGEGGFGPV----YKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKL 565
           +LG+G FG V    Y  +    G+ +A K+L  S+ + + +FE E+ ++  LQH N+VK 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 566 IGCCTQRDER--MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
            G C     R   LI EYLP  SL D++      + +D  K  Q    I +G+ YL    
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 149
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----PE 678
             R IHRDL   N+L++NE   KI DFG+ +    D+        V   G  P     PE
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAPE 205
Query: 679 YAIDGLFSVKSDVFSFGVLVLEI 701
              +  FSV SDV+SFGV++ E+
Sbjct: 206 SLTESKFSVASDVWSFGVVLYEL 228

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 72/204 (35%), Positives = 103/204 (50%), Gaps = 21/204 (10%)
Query: 510 NKLGEGGFGPV----YKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
            +LG+G FG V    Y  +    G+ +A K+L  S+ + + +FE E+ ++  LQH N+VK
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 565 LIGCCTQRDER--MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
             G C     R   LI EYLP  SL D++      + +D  K  Q    I +G+ YL   
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 148
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----P 677
              R IHRDL   N+L++NE   KI DFG+ +    D+        V   G  P     P
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAP 204
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEI 701
           E   +  FSV SDV+SFGV++ E+
Sbjct: 205 ESLTESKFSVASDVWSFGVVLYEL 228

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 119/251 (47%), Gaps = 28/251 (11%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E+   + KLG+G FG V+ G       +A K L K      E F  E  ++ KL+H  LV
Sbjct: 7   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 65
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           +L    ++ +   ++ EY+   SL DF+      K+L   +   +   IA G+ Y+    
Sbjct: 66  QLYAVVSE-EPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE--- 120
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
           R+  +HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G
Sbjct: 121 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYG 179
Query: 684 LFSVKSDVFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGH 722
            F++KSDV+SFG+L+ E+    R                RG+         +  H+L+  
Sbjct: 180 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 239
Query: 723 AWRLWIEERPV 733
            WR   EERP 
Sbjct: 240 CWRKDPEERPT 250

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  100 bits (248), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 119/251 (47%), Gaps = 28/251 (11%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E+   + KLG+G FG V+ G       +A K L K      E F  E  ++ KL+H  LV
Sbjct: 9   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 67
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           +L    ++ +   ++ EY+   SL DF+      K+L   +   +   IA G+ Y+    
Sbjct: 68  QLYAVVSE-EPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE--- 122
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
           R+  +HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G
Sbjct: 123 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYG 181
Query: 684 LFSVKSDVFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGH 722
            F++KSDV+SFG+L+ E+    R                RG+         +  H+L+  
Sbjct: 182 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 241
Query: 723 AWRLWIEERPV 733
            WR   EERP 
Sbjct: 242 CWRKDPEERPT 252

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  100 bits (248), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 119/251 (47%), Gaps = 28/251 (11%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E+   + KLG+G FG V+ G       +A K L K      E F  E  ++ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           +L    ++    ++I EY+   SL DF+      K+L   +   +   IA G+ Y+    
Sbjct: 77  QLYAVVSEEPIYIVI-EYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE--- 131
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
           R+  +HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G
Sbjct: 132 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYG 190
Query: 684 LFSVKSDVFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGH 722
            F++KSDV+SFG+L+ E+    R                RG+         +  H+L+  
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 250
Query: 723 AWRLWIEERPV 733
            WR   EERP 
Sbjct: 251 CWRKDPEERPT 261

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 119/251 (47%), Gaps = 28/251 (11%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E+   + KLG+G FG V+ G       +A K L K      E F  E  ++ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           +L    ++ +   ++ EY+   SL DF+      K+L   +   +   IA G+ Y+    
Sbjct: 77  QLYAVVSE-EPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE--- 131
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
           R+  +HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G
Sbjct: 132 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYG 190
Query: 684 LFSVKSDVFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGH 722
            F++KSDV+SFG+L+ E+    R                RG+         +  H+L+  
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 250
Query: 723 AWRLWIEERPV 733
            WR   EERP 
Sbjct: 251 CWRKDPEERPT 261

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 119/251 (47%), Gaps = 28/251 (11%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E+   + KLG+G FG V+ G       +A K L K      E F  E  ++ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           +L    ++ +   ++ EY+   SL DF+      K+L   +   +   IA G+ Y+    
Sbjct: 77  QLYAVVSE-EPIYIVCEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE--- 131
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
           R+  +HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G
Sbjct: 132 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 190
Query: 684 LFSVKSDVFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGH 722
            F++KSDV+SFG+L+ E+    R                RG+         +  H+L+  
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 250
Query: 723 AWRLWIEERPV 733
            WR   EERP 
Sbjct: 251 CWRKDPEERPT 261

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
           + + K+KLG G FG VY+GV  +     A +  K     +EEF  E  ++ +++H NLV+
Sbjct: 12  DITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 71
Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           L+G CT+     +I E++   +L D++ +  R + +       +   I+  + YL + + 
Sbjct: 72  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKKN- 129
Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 684
              IHRDL A N L+      K++DFG++R    D   A+         +  PE      
Sbjct: 130 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYNK 186
Query: 685 FSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 743
           FS+KSDV++FGVL+ EI   G            + LL   +R+   ERP        G  
Sbjct: 187 FSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRM---ERPE-------GCP 236
Query: 744 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
             + E++R       C Q  P DRP+ + +
Sbjct: 237 EKVYELMRA------CWQWNPSDRPSFAEI 260

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 125/267 (46%), Gaps = 29/267 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E+     +LG G FG V+ G      ++A K L K      E F  E  ++ KL+H  LV
Sbjct: 9   ESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTL-KPGTMSPESFLEEAQIMKKLKHDKLV 67
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           +L    ++ +   ++ EY+   SL DF+ D    + L       +   +A G+ Y+    
Sbjct: 68  QLYAVVSE-EPIYIVTEYMNKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIE--- 122
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
           R+  IHRDL+++N+L+ N +  KI+DFG+AR    ++  A          +  PE A+ G
Sbjct: 123 RMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYG 181
Query: 684 LFSVKSDVFSFGVLVLEIVCGKR---------------NRGFYHADHH------HNLLGH 722
            F++KSDV+SFG+L+ E+V   R                RG+            H L+ H
Sbjct: 182 RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMIH 241
Query: 723 AWRLWIEERPV-ELINKSLGGSYSLSE 748
            W+   EERP  E +   L   ++ +E
Sbjct: 242 CWKKDPEERPTFEYLQSFLEDYFTATE 268

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
           + + K+KLG G +G VY+GV  +     A +  K     +EEF  E  ++ +++H NLV+
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 78
Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           L+G CT+     +I E++   +L D++ +  R + ++      +   I+  + YL + + 
Sbjct: 79  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN- 136
Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 684
              IHRDL A N L+      K++DFG++R    D   A+         +  PE      
Sbjct: 137 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYNK 193
Query: 685 FSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 743
           FS+KSDV++FGVL+ EI   G            + LL   +R+   ERP        G  
Sbjct: 194 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPE-------GCP 243
Query: 744 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
             + E++R       C Q  P DRP+ + +
Sbjct: 244 EKVYELMRA------CWQWNPSDRPSFAEI 267

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 119/251 (47%), Gaps = 28/251 (11%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E+   + KLG+G FG V+ G       +A K L K      E F  E  ++ K++H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKIRHEKLV 76
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           +L    ++ +   ++ EY+   SL DF+      K+L   +   +   IA G+ Y+    
Sbjct: 77  QLYAVVSE-EPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE--- 131
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
           R+  +HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G
Sbjct: 132 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYG 190
Query: 684 LFSVKSDVFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGH 722
            F++KSDV+SFG+L+ E+    R                RG+         +  H+L+  
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 250
Query: 723 AWRLWIEERPV 733
            WR   EERP 
Sbjct: 251 CWRKDPEERPT 261

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 118/251 (47%), Gaps = 28/251 (11%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E+   + KLG+G FG V+ G       +A K L K      E F  E  ++ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           +L    ++ +   ++ EY+   SL DF+      K+L   +   +   IA G+ Y+    
Sbjct: 77  QLYAVVSE-EPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE--- 131
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
           R+  +HRDL A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G
Sbjct: 132 RMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 190
Query: 684 LFSVKSDVFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGH 722
            F++KSDV+SFG+L+ E+    R                RG+         +  H+L+  
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 250
Query: 723 AWRLWIEERPV 733
            WR   EERP 
Sbjct: 251 CWRKDPEERPT 261

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/204 (35%), Positives = 103/204 (50%), Gaps = 21/204 (10%)
Query: 510 NKLGEGGFGPV----YKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
            +LG+G FG V    Y  +    G+ +A K+L  S+ + + +FE E+ ++  LQH N+VK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 565 LIGCCTQRDER--MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
             G C     R   LI EYLP  SL D++      + +D  K  Q    I +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 130
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----P 677
              R IHRDL   N+L++NE   KI DFG+ +    D+        V   G  P     P
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFK----VKEPGESPIFWYAP 186
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEI 701
           E   +  FSV SDV+SFGV++ E+
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYEL 210

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
           + + K+KLG G +G VY+GV  +     A +  K     +EEF  E  ++ +++H NLV+
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 78
Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           L+G CT+     +I E++   +L D++ +  R + ++      +   I+  + YL + + 
Sbjct: 79  LLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN- 136
Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 684
              IHRDL A N L+      K++DFG++R    D   A+         +  PE      
Sbjct: 137 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNK 193
Query: 685 FSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 743
           FS+KSDV++FGVL+ EI   G            + LL   +R+   ERP        G  
Sbjct: 194 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPE-------GCP 243
Query: 744 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
             + E++R       C Q  P DRP+ + +
Sbjct: 244 EKVYELMRA------CWQWNPSDRPSFAEI 267

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/244 (29%), Positives = 115/244 (47%), Gaps = 28/244 (11%)
Query: 511 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT 570
           KLG+G FG V+ G       +A K L K      E F  E  ++ KL+H  LV+L    +
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 571 QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 630
           + +   ++ EY+   SL DF+      K+L   +   +   IA G+ Y+    R+  +HR
Sbjct: 251 E-EPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 305
Query: 631 DLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSD 690
           DL+A+N+L+   +  K++DFG+ R    ++  A          +  PE A+ G F++KSD
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIKSD 364
Query: 691 VFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGHAWRLWIE 729
           V+SFG+L+ E+    R                RG+         +  H+L+   WR   E
Sbjct: 365 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPE 424
Query: 730 ERPV 733
           ERP 
Sbjct: 425 ERPT 428

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
           + + K+KLG G +G VY+GV  +     A +  K     +EEF  E  ++ +++H NLV+
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 71
Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           L+G CT+     +I E++   +L D++ +  R + +       +   I+  + YL + + 
Sbjct: 72  LLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKKN- 129
Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 684
              IHRDL A N L+      K++DFG++R    D   A+         +  PE      
Sbjct: 130 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYNK 186
Query: 685 FSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 743
           FS+KSDV++FGVL+ EI   G            + LL   +R+   ERP        G  
Sbjct: 187 FSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRM---ERPE-------GCP 236
Query: 744 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
             + E++R       C Q  P DRP+ + +
Sbjct: 237 EKVYELMRA------CWQWNPSDRPSFAEI 260

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
           + + K+KLG G +G VY+GV  +     A +  K     +EEF  E  ++ +++H NLV+
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 74
Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           L+G CT+     +I E++   +L D++ +  R + ++      +   I+  + YL + + 
Sbjct: 75  LLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN- 132
Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 684
              IHRDL A N L+      K++DFG++R    D   A+         +  PE      
Sbjct: 133 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYNK 189
Query: 685 FSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 743
           FS+KSDV++FGVL+ EI   G            + LL   +R+   ERP        G  
Sbjct: 190 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPE-------GCP 239
Query: 744 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
             + E++R       C Q  P DRP+ + +
Sbjct: 240 EKVYELMRA------CWQWNPSDRPSFAEI 263

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
           + + K+KLG G +G VY+GV  +     A +  K     +EEF  E  ++ +++H NLV+
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 77
Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           L+G CT+     +I E++   +L D++ +  R + ++      +   I+  + YL + + 
Sbjct: 78  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN- 135
Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 684
              IHRDL A N L+      K++DFG++R    D   A+         +  PE      
Sbjct: 136 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNK 192
Query: 685 FSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 743
           FS+KSDV++FGVL+ EI   G            + LL   +R+   ERP        G  
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPE-------GCP 242
Query: 744 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
             + E++R       C Q  P DRP+ + +
Sbjct: 243 EKVYELMRA------CWQWNPSDRPSFAEI 266

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
           + + K+KLG G +G VY+GV  +     A +  K     +EEF  E  ++ +++H NLV+
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 78
Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           L+G CT+     +I E++   +L D++ +  R + ++      +   I+  + YL + + 
Sbjct: 79  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN- 136
Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 684
              IHRDL A N L+      K++DFG++R    D   A+         +  PE      
Sbjct: 137 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNK 193
Query: 685 FSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 743
           FS+KSDV++FGVL+ EI   G            + LL   +R+   ERP        G  
Sbjct: 194 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPE-------GCP 243
Query: 744 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
             + E++R       C Q  P DRP+ + +
Sbjct: 244 EKVYELMRA------CWQWNPSDRPSFAEI 267

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
           + + K+KLG G +G VY+GV  +     A +  K     +EEF  E  ++ +++H NLV+
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 73
Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           L+G CT+     +I E++   +L D++ +  R + ++      +   I+  + YL + + 
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN- 131
Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 684
              IHRDL A N L+      K++DFG++R    D   A+         +  PE      
Sbjct: 132 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNK 188
Query: 685 FSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 743
           FS+KSDV++FGVL+ EI   G            + LL   +R+   ERP        G  
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPE-------GCP 238
Query: 744 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
             + E++R       C Q  P DRP+ + +
Sbjct: 239 EKVYELMRA------CWQWNPSDRPSFAEI 262

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
           + + K+KLG G +G VY+GV  +     A +  K     +EEF  E  ++ +++H NLV+
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 73
Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           L+G CT+     +I E++   +L D++ +  R + ++      +   I+  + YL + + 
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN- 131
Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 684
              IHRDL A N L+      K++DFG++R    D   A+         +  PE      
Sbjct: 132 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNK 188
Query: 685 FSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 743
           FS+KSDV++FGVL+ EI   G            + LL   +R+   ERP        G  
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPE-------GCP 238
Query: 744 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
             + E++R       C Q  P DRP+ + +
Sbjct: 239 EKVYELMRA------CWQWNPSDRPSFAEI 262

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
           + + K+KLG G +G VY+GV  +     A +  K     +EEF  E  ++ +++H NLV+
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 75
Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           L+G CT+     +I E++   +L D++ +  R + ++      +   I+  + YL + + 
Sbjct: 76  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN- 133
Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 684
              IHRDL A N L+      K++DFG++R    D   A+         +  PE      
Sbjct: 134 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNK 190
Query: 685 FSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 743
           FS+KSDV++FGVL+ EI   G            + LL   +R+   ERP        G  
Sbjct: 191 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPE-------GCP 240
Query: 744 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
             + E++R       C Q  P DRP+ + +
Sbjct: 241 EKVYELMRA------CWQWNPSDRPSFAEI 264

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 118/251 (47%), Gaps = 28/251 (11%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E+   + KLG+G FG V+ G       +A K L K      E F  E  ++ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           +L    ++ +   ++ EY+    L DF+      K+L   +   +   IA G+ Y+    
Sbjct: 77  QLYAVVSE-EPIYIVMEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE--- 131
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
           R+  +HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G
Sbjct: 132 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 190
Query: 684 LFSVKSDVFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGH 722
            F++KSDV+SFG+L+ E+    R                RG+         +  H+L+  
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 250
Query: 723 AWRLWIEERPV 733
            WR   EERP 
Sbjct: 251 CWRKDPEERPT 261

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 118/251 (47%), Gaps = 28/251 (11%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E+   + KLG+G FG V+ G       +A K L K      E F  E  ++ KL+H  LV
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           +L    ++ +   ++ EY+    L DF+      K+L   +   +   IA G+ Y+    
Sbjct: 77  QLYAVVSE-EPIYIVTEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE--- 131
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
           R+  +HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G
Sbjct: 132 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 190
Query: 684 LFSVKSDVFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGH 722
            F++KSDV+SFG+L+ E+    R                RG+         +  H+L+  
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 250
Query: 723 AWRLWIEERPV 733
            WR   EERP 
Sbjct: 251 CWRKDPEERPT 261

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
           + + K+KLG G +G VY+GV  +     A +  K     +EEF  E  ++ +++H NLV+
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 78
Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           L+G CT+     +I E++   +L D++ +  R + ++      +   I+  + YL + + 
Sbjct: 79  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN- 136
Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 684
              IHRDL A N L+      K++DFG++R    D   A+         +  PE      
Sbjct: 137 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNK 193
Query: 685 FSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 743
           FS+KSDV++FGVL+ EI   G            + LL   +R+   ERP        G  
Sbjct: 194 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPE-------GCP 243
Query: 744 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
             + E++R       C Q  P DRP+ + +
Sbjct: 244 EKVYELMRA------CWQWNPSDRPSFAEI 267

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
           + + K+KLG G +G VY+GV  +     A +  K     +EEF  E  ++ +++H NLV+
Sbjct: 27  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 86
Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           L+G CT+     +I E++   +L D++ +  R + ++      +   I+  + YL + + 
Sbjct: 87  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN- 144
Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 684
              IHRDL A N L+      K++DFG++R    D   A+         +  PE      
Sbjct: 145 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNK 201
Query: 685 FSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 743
           FS+KSDV++FGVL+ EI   G            + LL   +R+   ERP        G  
Sbjct: 202 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPE-------GCP 251
Query: 744 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
             + E++R       C Q  P DRP+ + +
Sbjct: 252 EKVYELMRA------CWQWNPSDRPSFAEI 275

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
           + + K+KLG G +G VY+GV  +     A +  K     +EEF  E  ++ +++H NLV+
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 75
Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           L+G CT+     +I E++   +L D++ +  R + ++      +   I+  + YL + + 
Sbjct: 76  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN- 133
Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 684
              IHRDL A N L+      K++DFG++R    D   A+         +  PE      
Sbjct: 134 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNK 190
Query: 685 FSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 743
           FS+KSDV++FGVL+ EI   G            + LL   +R+   ERP        G  
Sbjct: 191 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPE-------GCP 240
Query: 744 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
             + E++R       C Q  P DRP+ + +
Sbjct: 241 EKVYELMRA------CWQWNPSDRPSFAEI 264

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
           + + K+KLG G +G VY+GV  +     A +  K     +EEF  E  ++ +++H NLV+
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 73
Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           L+G CT+     +I E++   +L D++ +  R + +       +   I+  + YL + + 
Sbjct: 74  LLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKKN- 131
Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 684
              IHRDL A N L+      K++DFG++R    D   A+         +  PE      
Sbjct: 132 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNK 188
Query: 685 FSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 743
           FS+KSDV++FGVL+ EI   G            + LL   +R+   ERP        G  
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPE-------GCP 238
Query: 744 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
             + E++R       C Q  P DRP+ + +
Sbjct: 239 EKVYELMRA------CWQWNPSDRPSFAEI 262

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
           + + K+KLG G +G VY+GV  +     A +  K     +EEF  E  ++ +++H NLV+
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 78
Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           L+G CT+     +I E++   +L D++ +  R + +       +   I+  + YL + + 
Sbjct: 79  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKKN- 136
Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 684
              IHRDL A N L+      K++DFG++R    D   A+         +  PE      
Sbjct: 137 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNK 193
Query: 685 FSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 743
           FS+KSDV++FGVL+ EI   G            + LL   +R+   ERP        G  
Sbjct: 194 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPE-------GCP 243
Query: 744 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
             + E++R       C Q  P DRP+ + +
Sbjct: 244 EKVYELMRA------CWQWNPSDRPSFAEI 267

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
           + + K+KLG G +G VY+GV  +     A +  K     +EEF  E  ++ +++H NLV+
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 73
Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           L+G CT+     +I E++   +L D++ +  R + +       +   I+  + YL + + 
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKKN- 131
Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 684
              IHRDL A N L+      K++DFG++R    D   A+         +  PE      
Sbjct: 132 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNK 188
Query: 685 FSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 743
           FS+KSDV++FGVL+ EI   G            + LL   +R+   ERP        G  
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPE-------GCP 238
Query: 744 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
             + E++R       C Q  P DRP+ + +
Sbjct: 239 EKVYELMRA------CWQWNPSDRPSFAEI 262

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/204 (34%), Positives = 103/204 (50%), Gaps = 21/204 (10%)
Query: 510 NKLGEGGFGPV----YKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
            +LG+G FG V    Y  +    G+ +A K+L  S+ + + +FE E+ ++  LQH N+VK
Sbjct: 17  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 76
Query: 565 LIGCCTQRDER--MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
             G C     R   LI EYLP  SL D++      + +D  K  Q    I +G+ YL   
Sbjct: 77  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 131
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----P 677
              R IHR+L   N+L++NE   KI DFG+ +    D+        V   G  P     P
Sbjct: 132 GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYK----VKEPGESPIFWYAP 187
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEI 701
           E   +  FSV SDV+SFGV++ E+
Sbjct: 188 ESLTESKFSVASDVWSFGVVLYEL 211

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
           + + K+KLG G +G VY+GV  +     A +  K     +EEF  E  ++ +++H NLV+
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 73
Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           L+G CT+     +I E++   +L D++ +  R + +       +   I+  + YL + + 
Sbjct: 74  LLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKKN- 131
Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 684
              IHRDL A N L+      K++DFG++R    D   A+         +  PE      
Sbjct: 132 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNK 188
Query: 685 FSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 743
           FS+KSDV++FGVL+ EI   G            + LL   +R+   ERP        G  
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPE-------GCP 238
Query: 744 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
             + E++R       C Q  P DRP+ + +
Sbjct: 239 EKVYELMRA------CWQWNPSDRPSFAEI 262

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
           + + K+KLG G +G VY+GV  +     A +  K     +EEF  E  ++ +++H NLV+
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 73
Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           L+G CT+     +I E++   +L D++ +  R + +       +   I+  + YL + + 
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKKN- 131
Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 684
              IHRDL A N L+      K++DFG++R    D   A+         +  PE      
Sbjct: 132 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNK 188
Query: 685 FSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 743
           FS+KSDV++FGVL+ EI   G            + LL   +R+   ERP        G  
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPE-------GCP 238
Query: 744 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
             + E++R       C Q  P DRP+ + +
Sbjct: 239 EKVYELMRA------CWQWNPSDRPSFAEI 262

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
           + + K+KLG G +G VY+GV  +     A +  K     +EEF  E  ++ +++H NLV+
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 71
Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           L+G CT+     +I E++   +L D++ +  R + +       +   I+  + YL + + 
Sbjct: 72  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKKN- 129
Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 684
              IHRDL A N L+      K++DFG++R    D   A+         +  PE      
Sbjct: 130 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPI-KWTAPESLAYNK 186
Query: 685 FSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 743
           FS+KSDV++FGVL+ EI   G            + LL   +R+   ERP        G  
Sbjct: 187 FSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRM---ERPE-------GCP 236
Query: 744 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
             + E++R       C Q  P DRP+ + +
Sbjct: 237 EKVYELMRA------CWQWNPSDRPSFAEI 260

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
           + + K+KLG G +G VY+GV  +     A +  K     +EEF  E  ++ +++H NLV+
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 74
Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           L+G CT+     +I E++   +L D++ +  R + ++      +   I+  + YL + + 
Sbjct: 75  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN- 132
Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 684
              IHRDL A N L+      K++DFG++R    D   A          +  PE      
Sbjct: 133 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI-KWTAPESLAYNK 189
Query: 685 FSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 743
           FS+KSDV++FGVL+ EI   G            + LL   +R+   ERP        G  
Sbjct: 190 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPE-------GCP 239
Query: 744 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
             + E++R       C Q  P DRP+ + +
Sbjct: 240 EKVYELMRA------CWQWNPSDRPSFAEI 263

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 70/203 (34%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 511 KLGEGGFGPV----YKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKL 565
           +LG+G FG V    Y  +    G+ +A K+L  S+ + + +FE E+ ++  LQH N+VK 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 566 IGCCTQRDER--MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
            G C     R   LI E+LP  SL +++      + +D  K  Q    I +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 134
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----PE 678
             R IHRDL   N+L++NE   KI DFG+ +    D+        V   G  P     PE
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK----VKEPGESPIFWYAPE 190
Query: 679 YAIDGLFSVKSDVFSFGVLVLEI 701
              +  FSV SDV+SFGV++ E+
Sbjct: 191 SLTESKFSVASDVWSFGVVLYEL 213

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
           + + K+KLG G +G VY+GV  +     A +  K     +EEF  E  ++ +++H NLV+
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 75
Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           L+G CT+     +I E++   +L D++ +  R + ++      +   I+  + YL + + 
Sbjct: 76  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN- 133
Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 684
              IHRDL A N L+      K++DFG++R    D   A          +  PE      
Sbjct: 134 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI-KWTAPESLAYNK 190
Query: 685 FSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 743
           FS+KSDV++FGVL+ EI   G            + LL   +R+   ERP        G  
Sbjct: 191 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPE-------GCP 240
Query: 744 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
             + E++R       C Q  P DRP+ + +
Sbjct: 241 EKVYELMRA------CWQWNPSDRPSFAEI 264

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 126/268 (47%), Gaps = 22/268 (8%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
           + + K+KLG G +G VY GV  +     A +  K     +EEF  E  ++ +++H NLV+
Sbjct: 33  DITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 92
Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           L+G CT      ++ EY+P  +L D++ +  R + +       +   I+  + YL + + 
Sbjct: 93  LLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREE-VTAVVLLYMATQISSAMEYLEKKN- 150
Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 684
              IHRDL A N L+      K++DFG++R    D   A+         +  PE      
Sbjct: 151 --FIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNT 207
Query: 685 FSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 743
           FS+KSDV++FGVL+ EI   G            ++LL   +R+   E+P        G  
Sbjct: 208 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRM---EQPE-------GCP 257
Query: 744 YSLSEVLRCIQVGLLCVQQRPEDRPNMS 771
             + E++R       C +  P DRP+ +
Sbjct: 258 PKVYELMRA------CWKWSPADRPSFA 279

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 114/201 (56%), Gaps = 20/201 (9%)
Query: 512 LGEGGFGPVYKGVLI-EGQEI----AAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKL 565
           LG G FG VYKG+ + EG+ +    A K L++++G +   EF +E L++A + H +LV+L
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
           +G C     + L+ + +P+  L +++ +    +     L+W  +      IA+G++YL +
Sbjct: 106 LGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 158
Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
               R++HRDL A NVL+ +  + KI+DFG+AR    D+ E N +       +M  E   
Sbjct: 159 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 215
Query: 682 DGLFSVKSDVFSFGVLVLEIV 702
              F+ +SDV+S+GV + E++
Sbjct: 216 YRKFTHQSDVWSYGVTIWELM 236

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 114/201 (56%), Gaps = 20/201 (9%)
Query: 512 LGEGGFGPVYKGVLI-EGQEI----AAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKL 565
           LG G FG VYKG+ + EG+ +    A K L++++G +   EF +E L++A + H +LV+L
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
           +G C     + L+ + +P+  L +++ +    +     L+W  +      IA+G++YL +
Sbjct: 83  LGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 135
Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
               R++HRDL A NVL+ +  + KI+DFG+AR    D+ E N +       +M  E   
Sbjct: 136 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 192
Query: 682 DGLFSVKSDVFSFGVLVLEIV 702
              F+ +SDV+S+GV + E++
Sbjct: 193 YRKFTHQSDVWSYGVTIWELM 213

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 124/267 (46%), Gaps = 29/267 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E+   + KLG G FG V+     +  ++A K + K     +E F  E  ++  LQH  LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           KL    T ++   +I E++   SL DF+     SK     K       IA G+ ++ Q +
Sbjct: 247 KLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSK-QPLPKLIDFSAQIAEGMAFIEQRN 304
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
               IHRDL+A+N+L+   +  KI+DFG+AR    ++  A          +  PE    G
Sbjct: 305 ---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI-KWTAPEAINFG 360
Query: 684 LFSVKSDVFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGH 722
            F++KSDV+SFG+L++EIV   R                RG+         +  +N++  
Sbjct: 361 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMR 420
Query: 723 AWRLWIEERPV-ELINKSLGGSYSLSE 748
            W+   EERP  E I   L   Y+ +E
Sbjct: 421 CWKNRPEERPTFEYIQSVLDDFYTATE 447

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 106/212 (50%), Gaps = 23/212 (10%)
Query: 509 KNKLGEGGFGPVYKGV---LIEGQE---IAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL 562
           K +LGEG FG V+      L+  Q+   +A K L ++S    ++F+ E  L+  LQH+++
Sbjct: 23  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 82
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIF-------------DVTRSKFLDWSKRCQII 609
           V+  G CT+    ++++EY+ +  LN F+              DV     L   +   + 
Sbjct: 83  VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP-LGLGQLLAVA 141
Query: 610 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV 669
             +A G++YL   + L  +HRDL   N L+   +  KI DFGM+R            R +
Sbjct: 142 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 198
Query: 670 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
               +MPPE  +   F+ +SDV+SFGV++ EI
Sbjct: 199 LPIRWMPPESILYRKFTTESDVWSFGVVLWEI 230

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 106/212 (50%), Gaps = 23/212 (10%)
Query: 509 KNKLGEGGFGPVYKGV---LIEGQE---IAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL 562
           K +LGEG FG V+      L+  Q+   +A K L ++S    ++F+ E  L+  LQH+++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIF-------------DVTRSKFLDWSKRCQII 609
           V+  G CT+    ++++EY+ +  LN F+              DV     L   +   + 
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP-LGLGQLLAVA 164
Query: 610 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV 669
             +A G++YL   + L  +HRDL   N L+   +  KI DFGM+R            R +
Sbjct: 165 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221
Query: 670 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
               +MPPE  +   F+ +SDV+SFGV++ EI
Sbjct: 222 LPIRWMPPESILYRKFTTESDVWSFGVVLWEI 253

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 106/212 (50%), Gaps = 23/212 (10%)
Query: 509 KNKLGEGGFGPVYKGV---LIEGQE---IAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL 562
           K +LGEG FG V+      L+  Q+   +A K L ++S    ++F+ E  L+  LQH+++
Sbjct: 17  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 76
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIF-------------DVTRSKFLDWSKRCQII 609
           V+  G CT+    ++++EY+ +  LN F+              DV     L   +   + 
Sbjct: 77  VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP-LGLGQLLAVA 135
Query: 610 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV 669
             +A G++YL   + L  +HRDL   N L+   +  KI DFGM+R            R +
Sbjct: 136 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 192
Query: 670 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
               +MPPE  +   F+ +SDV+SFGV++ EI
Sbjct: 193 LPIRWMPPESILYRKFTTESDVWSFGVVLWEI 224

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 125/266 (46%), Gaps = 22/266 (8%)
Query: 509 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGC 568
           K+KLG G +G VY+GV  +     A +  K     +EEF  E  ++ +++H NLV+L+G 
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 569 CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRII 628
           CT+     +I E++   +L D++ +  R + +       +   I+  + YL + +    I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKKN---FI 340
Query: 629 HRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 688
           HR+L A N L+      K++DFG++R    D   A+         +  PE      FS+K
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 399
Query: 689 SDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLS 747
           SDV++FGVL+ EI   G            + LL   +R+   ERP        G    + 
Sbjct: 400 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPE-------GCPEKVY 449
Query: 748 EVLRCIQVGLLCVQQRPEDRPNMSSV 773
           E++R       C Q  P DRP+ + +
Sbjct: 450 ELMRA------CWQWNPSDRPSFAEI 469

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 109/224 (48%), Gaps = 39/224 (17%)
Query: 504 ENFSDKNKLGEGGFGPVYKGV---LIEGQE---IAAKRLSKSSGQGMEEFENEVLLIAKL 557
            N   K +LGEG FG V+      L   Q+   +A K L  +S    ++F  E  L+  L
Sbjct: 13  HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 72
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFI----------------FDVTRSKFLD 601
           QH ++VK  G C + D  ++++EY+ +  LN F+                 ++T+S+ L 
Sbjct: 73  QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLH 132
Query: 602 WSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
            +++      IA G++YL   +    +HRDL   N L+   +  KI DFGM+R    D  
Sbjct: 133 IAQQ------IAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVY 179
Query: 662 EANTNRVVG----TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
             +  RV G       +MPPE  +   F+ +SDV+S GV++ EI
Sbjct: 180 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEI 223

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 109/203 (53%), Gaps = 10/203 (4%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL 562
           E F    KLGEG +G VYK +  E GQ +A K++   S   ++E   E+ ++ +    ++
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHV 86
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
           VK  G   +  +  ++ EY    S++D I    R+K L   +   I+    +GL YLH  
Sbjct: 87  VKYYGSYFKNTDLWIVMEYCGAGSVSDIIR--LRNKTLTEDEIATILQSTLKGLEYLH-- 142
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID 682
             +R IHRD+KA N+LL+ E + K++DFG+A    +    A  N V+GT  +M PE   +
Sbjct: 143 -FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQ--LTDXMAKRNXVIGTPFWMAPEVIQE 199
Query: 683 GLFSVKSDVFSFGVLVLEIVCGK 705
             ++  +D++S G+  +E+  GK
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGK 222

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 126/266 (47%), Gaps = 22/266 (8%)
Query: 509 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGC 568
           K+KLG G +G VY+GV  +     A +  K     +EEF  E  ++ +++H NLV+L+G 
Sbjct: 264 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 323
Query: 569 CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRII 628
           CT+     +I E++   +L D++ +  R + ++      +   I+  + YL + +    I
Sbjct: 324 CTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 379
Query: 629 HRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 688
           HR+L A N L+      K++DFG++R    D   A+         +  PE      FS+K
Sbjct: 380 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 438
Query: 689 SDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLS 747
           SDV++FGVL+ EI   G            + LL   +R+   ERP        G    + 
Sbjct: 439 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPE-------GCPEKVY 488
Query: 748 EVLRCIQVGLLCVQQRPEDRPNMSSV 773
           E++R       C Q  P DRP+ + +
Sbjct: 489 ELMRA------CWQWNPSDRPSFAEI 508

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 123/270 (45%), Gaps = 45/270 (16%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E+   + KLG G FG V+     +  ++A K + K     +E F  E  ++  LQH  LV
Sbjct: 182 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 240
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           KL    T ++   +I E++   SL DF+     SK     K       IA G+ ++ Q +
Sbjct: 241 KLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSK-QPLPKLIDFSAQIAEGMAFIEQRN 298
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARA---FGIDQTEANTNRVVGTYGYMPPEYA 680
               IHRDL+A+N+L+   +  KI+DFG+AR    F I  T               PE  
Sbjct: 299 ---YIHRDLRAANILVSASLVCKIADFGLARVGAKFPIKWTA--------------PEAI 341
Query: 681 IDGLFSVKSDVFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNL 719
             G F++KSDV+SFG+L++EIV   R                RG+         +  +N+
Sbjct: 342 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNI 401
Query: 720 LGHAWRLWIEERPV-ELINKSLGGSYSLSE 748
           +   W+   EERP  E I   L   Y+ +E
Sbjct: 402 MMRCWKNRPEERPTFEYIQSVLDDFYTATE 431

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 117/251 (46%), Gaps = 28/251 (11%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E+   + KLG G FG V+     +  ++A K + K     +E F  E  ++  LQH  LV
Sbjct: 15  ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 73
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           KL    T ++   +I E++   SL DF+     SK     K       IA G+ ++ Q +
Sbjct: 74  KLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSK-QPLPKLIDFSAQIAEGMAFIEQRN 131
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
               IHRDL+A+N+L+   +  KI+DFG+AR    ++  A          +  PE    G
Sbjct: 132 ---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI-KWTAPEAINFG 187
Query: 684 LFSVKSDVFSFGVLVLEIVCGKR---------------NRGFYH------ADHHHNLLGH 722
            F++KSDV+SFG+L++EIV   R                RG+         +  +N++  
Sbjct: 188 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMR 247
Query: 723 AWRLWIEERPV 733
            W+   EERP 
Sbjct: 248 CWKNRPEERPT 258

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 106/211 (50%), Gaps = 11/211 (5%)
Query: 499 IANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGM-EEFENEVLLI 554
           I    E+F   N LG+G F  VY+   I  G E+A K + K +    GM +  +NEV + 
Sbjct: 6   IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIAR 614
            +L+H ++++L       +   L+ E   N  +N ++ +  R K    ++    +  I  
Sbjct: 66  CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIIT 123
Query: 615 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGY 674
           G+LYLH      I+HRDL  SN+LL   MN KI+DFG+A    +   +  T  + GT  Y
Sbjct: 124 GMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNY 178
Query: 675 MPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           + PE A      ++SDV+S G +   ++ G+
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 114/244 (46%), Gaps = 28/244 (11%)
Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
            ++G G FG V+ G  +   ++A K + +      E+F  E  ++ KL H  LV+L G C
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
            ++    L++E++ +  L+D++   T+           +   +  G+ YL + S   +IH
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAS---VIH 126
Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 689
           RDL A N L+      K+SDFGM R F +D    ++        +  PE      +S KS
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 185
Query: 690 DVFSFGVLVLEIVC-GK---RNR-----------GF------YHADHHHNLLGHAWRLWI 728
           DV+SFGVL+ E+   GK    NR           GF        + H + ++ H W+   
Sbjct: 186 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERP 245
Query: 729 EERP 732
           E+RP
Sbjct: 246 EDRP 249

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCT 570
           +G G +G VYKG  ++  ++AA ++   +G   EE + E+ ++ K   HRN+    G   
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 571 QR------DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           ++      D+  L+ E+    S+ D I + T+   L       I   I RGL +LHQ   
Sbjct: 92  KKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRGLSHLHQH-- 148
Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI--- 681
            ++IHRD+K  NVLL      K+ DFG++    +D+T    N  +GT  +M PE      
Sbjct: 149 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ--LDRTVGRRNTFIGTPYWMAPEVIACDE 205
Query: 682 --DGLFSVKSDVFSFGVLVLEIVCG 704
             D  +  KSD++S G+  +E+  G
Sbjct: 206 NPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 113/244 (46%), Gaps = 28/244 (11%)
Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
            ++G G FG V+ G  +   ++A K + +      E+F  E  ++ KL H  LV+L G C
Sbjct: 16  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
            ++    L++E++ +  L+D++   T+           +   +  G+ YL +     +IH
Sbjct: 75  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 129
Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 689
           RDL A N L+      K+SDFGM R F +D    ++        +  PE      +S KS
Sbjct: 130 RDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 188
Query: 690 DVFSFGVLVLEIVC-GK---RNR-----------GF------YHADHHHNLLGHAWRLWI 728
           DV+SFGVL+ E+   GK    NR           GF        + H + ++ H WR   
Sbjct: 189 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERP 248
Query: 729 EERP 732
           E+RP
Sbjct: 249 EDRP 252

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 509 KNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL 562
           K +LGEG FG V+           +   +A K L   +    ++F+ E  L+  LQH ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKF-------------LDWSKRCQII 609
           VK  G C   D  ++++EY+ +  LN F+                     L  S+   I 
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 610 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV 669
             IA G++YL   +    +HRDL   N L+   +  KI DFGM+R    D    +  RV 
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVG 192
Query: 670 G----TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
           G       +MPPE  +   F+ +SDV+SFGV++ EI
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 228

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 111/209 (53%), Gaps = 11/209 (5%)
Query: 499 IANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVLLIAK 556
           IA+  E F+   ++G+G FG V+KG+    Q++ A ++   + +   +E+ + E+ ++++
Sbjct: 18  IADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQ 77
Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 616
                + K  G   +  +  +I EYL   S      D+ R+   D  +   ++  I +GL
Sbjct: 78  CDSSYVTKYYGSYLKGSKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGL 133
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YLH + +   IHRD+KA+NVLL  + + K++DFG+A      Q + NT   VGT  +M 
Sbjct: 134 DYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMA 188
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           PE      +  K+D++S G+  +E+  G+
Sbjct: 189 PEVIQQSAYDSKADIWSLGITAIELAKGE 217

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 131/281 (46%), Gaps = 43/281 (15%)
Query: 512 LGEGGFGPVYKGVLIEGQ-----EIAAKRLSKSSGQGME-EFENEVLLIAKLQHRNLVKL 565
           +G G FG VYKG+L          +A K L     +    +F  E  ++ +  H N+++L
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGLLYLHQD 622
            G  ++    M+I EY+ N +L+ F+    R K  ++S   Q++G   GIA G+ YL   
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFL----REKDGEFSV-LQLVGMLRGIAAGMKYL--- 163
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG--YMPPEYA 680
           + +  +HRDL A N+L+++ +  K+SDFG++R    D  EA      G     +  PE  
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEATYTTSGGKIPIRWTAPEAI 222
Query: 681 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 740
               F+  SDV+SFG+++ E++     R ++   +H                   + K++
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMT-YGERPYWELSNHE------------------VMKAI 263
Query: 741 GGSYSLSEVLRC----IQVGLLCVQQRPEDRPNMSSVVLML 777
              + L   + C     Q+ + C QQ    RP  + +V +L
Sbjct: 264 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 304

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 113/244 (46%), Gaps = 28/244 (11%)
Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
            ++G G FG V+ G  +   ++A K + +      E+F  E  ++ KL H  LV+L G C
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
            ++    L++E++ +  L+D++   T+           +   +  G+ YL +     +IH
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 124
Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 689
           RDL A N L+      K+SDFGM R F +D    ++        +  PE      +S KS
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
Query: 690 DVFSFGVLVLEIVC-GK---RNR-----------GF------YHADHHHNLLGHAWRLWI 728
           DV+SFGVL+ E+   GK    NR           GF        + H + ++ H W+   
Sbjct: 184 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERP 243
Query: 729 EERP 732
           E+RP
Sbjct: 244 EDRP 247

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 113/244 (46%), Gaps = 28/244 (11%)
Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
            ++G G FG V+ G  +   ++A K + +      E+F  E  ++ KL H  LV+L G C
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
            ++    L++E++ +  L+D++   T+           +   +  G+ YL +     +IH
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 126
Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 689
           RDL A N L+      K+SDFGM R F +D    ++        +  PE      +S KS
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 185
Query: 690 DVFSFGVLVLEIVC-GK---RNR-----------GF------YHADHHHNLLGHAWRLWI 728
           DV+SFGVL+ E+   GK    NR           GF        + H + ++ H W+   
Sbjct: 186 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERP 245
Query: 729 EERP 732
           E+RP
Sbjct: 246 EDRP 249

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 120/212 (56%), Gaps = 25/212 (11%)
Query: 509 KNKLGEGGFGPVYKGVLIEGQEIAAKR---LSKSSGQ-----GMEEFENEVLLIAKLQHR 560
           + ++G+GGFG V+KG L++ + + A +   L  S G+       +EF+ EV +++ L H 
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VKL G     +   ++ E++P   L   + D  ++  + WS + +++  IA G+ Y+ 
Sbjct: 84  NIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYM- 138
Query: 621 QDSRLRIIHRDLKASNVLLD--NEMNP---KISDFGMARAFGIDQTEANTNRVVGTYGYM 675
           Q+    I+HRDL++ N+ L   +E  P   K++DFG+++     Q+  + + ++G + +M
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWM 193
Query: 676 PPEY--AIDGLFSVKSDVFSFGVLVLEIVCGK 705
            PE   A +  ++ K+D +SF +++  I+ G+
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 88/317 (27%), Positives = 144/317 (45%), Gaps = 70/317 (22%)
Query: 492 PIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEG---QEIAAKRLSK-SSGQGMEEF 547
           P+ DW  I      F D   +GEG FG V K  + +     + A KR+ + +S     +F
Sbjct: 20  PVLDWNDI-----KFQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF 72
Query: 548 ENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFI-----------FDVT 595
             E+ ++ KL  H N++ L+G C  R    L  EY P+ +L DF+           F + 
Sbjct: 73  AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 132
Query: 596 RS--KFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 653
            S    L   +       +ARG+ YL Q    + IHRDL A N+L+      KI+DFG++
Sbjct: 133 NSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS 189
Query: 654 RAFGIDQTEANTNRVVGTYGYMPPEY-AIDGL----FSVKSDVFSFGVLVLEIV------ 702
           R   +         V  T G +P  + AI+ L    ++  SDV+S+GVL+ EIV      
Sbjct: 190 RGQEV--------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
Query: 703 -CGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQ 761
            CG      Y        L   +RL   E+P+   ++       + +++R       C +
Sbjct: 242 YCGMTCAELYEK------LPQGYRL---EKPLNCDDE-------VYDLMR------QCWR 279
Query: 762 QRPEDRPNMSSVVLMLS 778
           ++P +RP+ + +++ L+
Sbjct: 280 EKPYERPSFAQILVSLN 296

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 88/317 (27%), Positives = 144/317 (45%), Gaps = 70/317 (22%)
Query: 492 PIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEG---QEIAAKRLSK-SSGQGMEEF 547
           P+ DW  I      F D   +GEG FG V K  + +     + A KR+ + +S     +F
Sbjct: 10  PVLDWNDI-----KFQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF 62
Query: 548 ENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFI-----------FDVT 595
             E+ ++ KL  H N++ L+G C  R    L  EY P+ +L DF+           F + 
Sbjct: 63  AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 122
Query: 596 RS--KFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 653
            S    L   +       +ARG+ YL Q    + IHRDL A N+L+      KI+DFG++
Sbjct: 123 NSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS 179
Query: 654 RAFGIDQTEANTNRVVGTYGYMPPEY-AIDGL----FSVKSDVFSFGVLVLEIV------ 702
           R   +         V  T G +P  + AI+ L    ++  SDV+S+GVL+ EIV      
Sbjct: 180 RGQEV--------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 231
Query: 703 -CGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQ 761
            CG      Y        L   +RL   E+P+   ++       + +++R       C +
Sbjct: 232 YCGMTCAELYEK------LPQGYRL---EKPLNCDDE-------VYDLMR------QCWR 269
Query: 762 QRPEDRPNMSSVVLMLS 778
           ++P +RP+ + +++ L+
Sbjct: 270 EKPYERPSFAQILVSLN 286

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 101/192 (52%), Gaps = 7/192 (3%)
Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
            +LG G FG V  G    GQ   A ++ K      +EF  E  ++  L H  LV+L G C
Sbjct: 30  KELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
           T++    +I EY+ N  L +++ ++ R +F    +  ++   +   + YL      + +H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREM-RHRFQT-QQLLEMCKDVCEAMEYLESK---QFLH 143
Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 689
           RDL A N L++++   K+SDFG++R + +D  E ++        + PPE  +   FS KS
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 690 DVFSFGVLVLEI 701
           D+++FGVL+ EI
Sbjct: 203 DIWAFGVLMWEI 214

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 144/308 (46%), Gaps = 46/308 (14%)
Query: 502 ATENFSDKNKLGEGGFGPVY----KGVLIEGQE--IAAKRLSKSSGQGME-EFENEVLLI 554
           A E  +   +LG+G FG VY    KGV+ +  E  +A K +++++      EF NE  ++
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIF----DVTRSKFL---DWSKRCQ 607
            +    ++V+L+G  +Q    ++I E +    L  ++     ++  +  L     SK  Q
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 608 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 667
           + G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R    D  E +  R
Sbjct: 137 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXETDXXR 189
Query: 668 VVGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 723
             G       +M PE   DG+F+  SDV+SFGV++ EI         Y    +  +L   
Sbjct: 190 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVL--- 244
Query: 724 WRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 783
            R  +E     L++K       L E++R      +C Q  P+ RP+   ++       S+
Sbjct: 245 -RFVMEGG---LLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEII------SSI 288
Query: 784 PQPKQPGF 791
            +  +PGF
Sbjct: 289 KEEMEPGF 296

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 117/221 (52%), Gaps = 10/221 (4%)
Query: 486 EEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGM 544
           +EE+   +   +++ +  + ++   K+G+G  G VY  + +  GQE+A ++++       
Sbjct: 2   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61
Query: 545 EEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSK 604
           E   NE+L++ + ++ N+V  +      DE  ++ EYL   SL D + +      +D  +
Sbjct: 62  ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQ 117
Query: 605 RCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 664
              +     + L +LH +   ++IHRD+K+ N+LL  + + K++DFG       +Q++ +
Sbjct: 118 IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174
Query: 665 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           T  +VGT  +M PE      +  K D++S G++ +E++ G+
Sbjct: 175 T--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 112/244 (45%), Gaps = 28/244 (11%)
Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
            ++G G FG V+ G  +   ++A K + +      E+F  E  ++ KL H  LV+L G C
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
            ++    L+ E++ +  L+D++   T+           +   +  G+ YL +     +IH
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 127
Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 689
           RDL A N L+      K+SDFGM R F +D    ++        +  PE      +S KS
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 186
Query: 690 DVFSFGVLVLEIVC-GK---RNR-----------GF------YHADHHHNLLGHAWRLWI 728
           DV+SFGVL+ E+   GK    NR           GF        + H + ++ H WR   
Sbjct: 187 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERP 246
Query: 729 EERP 732
           E+RP
Sbjct: 247 EDRP 250

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 144/308 (46%), Gaps = 46/308 (14%)
Query: 502 ATENFSDKNKLGEGGFGPVY----KGVLIEGQE--IAAKRLSKSSGQGME-EFENEVLLI 554
           A E  +   +LG+G FG VY    KGV+ +  E  +A K +++++      EF NE  ++
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 67
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIF----DVTRSKFL---DWSKRCQ 607
            +    ++V+L+G  +Q    ++I E +    L  ++     ++  +  L     SK  Q
Sbjct: 68  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 127
Query: 608 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 667
           + G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R    D  E +  R
Sbjct: 128 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXETDXXR 180
Query: 668 VVGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 723
             G       +M PE   DG+F+  SDV+SFGV++ EI         Y    +  +L   
Sbjct: 181 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVL--- 235
Query: 724 WRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 783
            R  +E     L++K       L E++R      +C Q  P+ RP+   ++       S+
Sbjct: 236 -RFVMEGG---LLDKPDNCPDMLLELMR------MCWQYNPKMRPSFLEII------SSI 279
Query: 784 PQPKQPGF 791
            +  +PGF
Sbjct: 280 KEEMEPGF 287

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 106/204 (51%), Gaps = 9/204 (4%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQHRN 561
           E +    K+GEG +G VYK    +G+ +A KR+   +  +G+      E+ L+ +L H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
           +V LI          L++E++  K L   + D  ++   D   +  +   + RG+ + HQ
Sbjct: 81  IVSLIDVIHSERCLTLVFEFM-EKDLKK-VLDENKTGLQDSQIKIYLYQ-LLRGVAHCHQ 137
Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
               RI+HRDLK  N+L++++   K++DFG+ARAFGI    + T+ VV  +   P     
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVVTLWYRAPDVLMG 193
Query: 682 DGLFSVKSDVFSFGVLVLEIVCGK 705
              +S   D++S G +  E++ GK
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/189 (32%), Positives = 98/189 (51%), Gaps = 18/189 (9%)
Query: 515 GGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGC---CTQ 571
           G FG V+K  L+  + +A K       Q  +  E EV  +  ++H N+++ IG     T 
Sbjct: 35  GRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGAEKRGTS 92
Query: 572 RDERM-LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD-------S 623
            D  + LI  +    SL+DF+    ++  + W++ C I   +ARGL YLH+D        
Sbjct: 93  VDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGH 148
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
           +  I HRD+K+ NVLL N +   I+DFG+A  F   ++  +T+  VGT  YM PE  ++G
Sbjct: 149 KPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE-VLEG 207
Query: 684 LFSVKSDVF 692
             + + D F
Sbjct: 208 AINFQRDAF 216

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 106/204 (51%), Gaps = 9/204 (4%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQHRN 561
           E +    K+GEG +G VYK    +G+ +A KR+   +  +G+      E+ L+ +L H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
           +V LI          L++E++  K L   + D  ++   D   +  +   + RG+ + HQ
Sbjct: 81  IVSLIDVIHSERCLTLVFEFM-EKDLKK-VLDENKTGLQDSQIKIYLYQ-LLRGVAHCHQ 137
Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
               RI+HRDLK  N+L++++   K++DFG+ARAFGI    + T+ VV  +   P     
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVVTLWYRAPDVLMG 193
Query: 682 DGLFSVKSDVFSFGVLVLEIVCGK 705
              +S   D++S G +  E++ GK
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 109/215 (50%), Gaps = 11/215 (5%)
Query: 500 ANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVLLIAKL 557
           A+  E F+   K+G+G FG V+KG+    Q++ A ++   + +   +E+ + E+ ++++ 
Sbjct: 18  ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 77
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
               + K  G   +  +  +I EYL   S      D+     LD ++   I+  I +GL 
Sbjct: 78  DSPYVTKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLD 133
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           YLH + +   IHRD+KA+NVLL      K++DFG+A    +  T+   N  VGT  +M P
Sbjct: 134 YLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQ--LTDTQIKRNXFVGTPFWMAP 188
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYH 712
           E      +  K+D++S G+  +E+  G+      H
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 223

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 114/244 (46%), Gaps = 28/244 (11%)
Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
            ++G G FG V+ G  +   ++A K + + S    ++F  E  ++ KL H  LV+L G C
Sbjct: 33  QEIGSGQFGLVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
            ++    L++E++ +  L+D++   T+           +   +  G+ YL +     +IH
Sbjct: 92  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 146
Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 689
           RDL A N L+      K+SDFGM R F +D    ++        +  PE      +S KS
Sbjct: 147 RDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 205
Query: 690 DVFSFGVLVLEIVC-GK---RNR-----------GF------YHADHHHNLLGHAWRLWI 728
           DV+SFGVL+ E+   GK    NR           GF        + H + ++ H W+   
Sbjct: 206 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERP 265
Query: 729 EERP 732
           E+RP
Sbjct: 266 EDRP 269

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 119/212 (56%), Gaps = 25/212 (11%)
Query: 509 KNKLGEGGFGPVYKGVLIEGQEIAAKR---LSKSSGQ-----GMEEFENEVLLIAKLQHR 560
           + ++G+GGFG V+KG L++ + + A +   L  S G+       +EF+ EV +++ L H 
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VKL G     +   ++ E++P   L   + D  ++  + WS + +++  IA G+ Y+ 
Sbjct: 84  NIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYM- 138
Query: 621 QDSRLRIIHRDLKASNVLLD--NEMNP---KISDFGMARAFGIDQTEANTNRVVGTYGYM 675
           Q+    I+HRDL++ N+ L   +E  P   K++DFG ++     Q+  + + ++G + +M
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVHSVSGLLGNFQWM 193
Query: 676 PPEY--AIDGLFSVKSDVFSFGVLVLEIVCGK 705
            PE   A +  ++ K+D +SF +++  I+ G+
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 137/300 (45%), Gaps = 52/300 (17%)
Query: 505 NFSDKNKLGEGGFGPVYK----GVLI--EGQEIAAKRLSKSSGQGME-EFENEVLLIAKL 557
           N      +GEG FG V++    G+L       +A K L + +   M+ +F+ E  L+A+ 
Sbjct: 48  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 107
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDV--------------TRSKF---- 599
            + N+VKL+G C       L++EY+    LN+F+  +              TR++     
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 600 ---LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-A 655
              L  +++  I   +A G+ YL   S  + +HRDL   N L+   M  KI+DFG++R  
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 224
Query: 656 FGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG--KRNRGFYHA 713
           +  D  +A+ N  +    +MPPE      ++ +SDV+++GV++ EI     +   G  H 
Sbjct: 225 YSADYYKADGNDAIPI-RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 283
Query: 714 DHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
           +  + +         E  P+EL N           ++R      LC  + P DRP+  S+
Sbjct: 284 EVIYYVRDGNILACPENCPLELYN-----------LMR------LCWSKLPADRPSFCSI 326

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 512 LGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT 570
           LG+G FG   K    E G+ +  K L +   +    F  EV ++  L+H N++K IG   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 571 QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 630
           +      I EY+   +L   I  +       WS+R      IA G+ YLH    + IIHR
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLHS---MNIIHR 132
Query: 631 DLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR------------VVGTYGYMPPE 678
           DL + N L+    N  ++DFG+AR    ++T+    R            VVG   +M PE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 679 YAIDGLFSVKSDVFSFGVLVLEIV 702
                 +  K DVFSFG+++ EI+
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEII 216

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/204 (34%), Positives = 108/204 (52%), Gaps = 21/204 (10%)
Query: 510 NKLGEGGFGPV----YKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
           ++LG+G FG V    Y  +    G  +A K+L  S      +F+ E+ ++  L    +VK
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 72
Query: 565 LIGCC--TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
             G      R E  L+ EYLP+  L DF+    R++ LD S+       I +G+ YL   
Sbjct: 73  YRGVSYGPGRPELRLVMEYLPSGCLRDFL-QRHRAR-LDASRLLLYSSQICKGMEYL--G 128
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----P 677
           SR R +HRDL A N+L+++E + KI+DFG+A+   +D+       VV   G  P     P
Sbjct: 129 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXX----VVREPGQSPIFWYAP 183
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEI 701
           E   D +FS +SDV+SFGV++ E+
Sbjct: 184 ESLSDNIFSRQSDVWSFGVVLYEL 207

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 86/292 (29%), Positives = 131/292 (44%), Gaps = 46/292 (15%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQ-------EIAAKRLSK-SSGQGMEEFENEVLLIA 555
           +N +    LG G FG VY+G  + G        ++A K L +  S Q   +F  E L+I+
Sbjct: 45  KNITLIRGLGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIIS 103
Query: 556 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDV----TRSKFLDWSKRCQIIGG 611
           KL H+N+V+ IG   Q   R ++ E +    L  F+ +     ++   L       +   
Sbjct: 104 KLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 163
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGIDQTEANTNRV 668
           IA G  YL ++     IHRD+ A N LL         KI DFGMAR    D   A+  R 
Sbjct: 164 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRK 216
Query: 669 VGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGF--YHADHHHNLLGH 722
            G       +MPPE  ++G+F+ K+D +SFGVL+ EI     + G+  Y +  +  +L  
Sbjct: 217 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF----SLGYMPYPSKSNQEVLEF 272
Query: 723 AWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 774
                  + P        G  Y         ++   C Q +PEDRPN + ++
Sbjct: 273 VTSGGRMDPP----KNCPGPVY---------RIMTQCWQHQPEDRPNFAIIL 311

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 110/208 (52%), Gaps = 11/208 (5%)
Query: 500 ANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVLLIAKL 557
            +  E F+  +++G+G FG VYKG+    +E+ A ++   + +   +E+ + E+ ++++ 
Sbjct: 15  VDPEELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC 74
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
               + +  G   +  +  +I EYL   S      D+ +   L+ +    I+  I +GL 
Sbjct: 75  DSPYITRYFGSYLKSTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLD 130
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           YLH +   R IHRD+KA+NVLL  + + K++DFG+A    +  T+   N  VGT  +M P
Sbjct: 131 YLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQ--LTDTQIKRNXFVGTPFWMAP 185
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E      +  K+D++S G+  +E+  G+
Sbjct: 186 EVIKQSAYDFKADIWSLGITAIELAKGE 213

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 11/206 (5%)
Query: 504 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRL---SKSSGQGMEEFENEVLLIAKLQH 559
           E +   +KLG GG   VY     I   ++A K +    +   + ++ FE EV   ++L H
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
           +N+V +I    + D   L+ EY+   +L+++I        L           I  G+ + 
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHA 127
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H    +RI+HRD+K  N+L+D+    KI DFG+A+A   + +   TN V+GT  Y  PE 
Sbjct: 128 HD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQ 183
Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCGK 705
           A        +D++S G+++ E++ G+
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGE 209

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 118/223 (52%), Gaps = 21/223 (9%)
Query: 490 ELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEI----AAKRLSK-SSGQG 543
           E P    + I   TE F     LG G FG VYKG+ I EG+++    A K L + +S + 
Sbjct: 5   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 63
Query: 544 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKF 599
            +E  +E  ++A + + ++ +L+G C     + LI + +P   L D++ +    +     
Sbjct: 64  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL 122
Query: 600 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 659
           L+W  +      IA+G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G +
Sbjct: 123 LNWCVQ------IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 173
Query: 660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
           + E +         +M  E  +  +++ +SDV+S+GV V E++
Sbjct: 174 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 216

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 127/277 (45%), Gaps = 35/277 (12%)
Query: 506 FSDKNKLGEGGFGPVYKGVLIEGQEIAA-KRLSKSSGQGMEEFEN---EVLLIAKLQHRN 561
           FSD  ++G G FG VY    +   E+ A K++S S  Q  E++++   EV  + KL+H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
            ++  GC  +     L+ EY    S +D +      K L   +   +  G  +GL YLH 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLG-SASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
            +   +IHRD+KA N+LL      K+ DFG A         A  N  VGT  +M PE  +
Sbjct: 173 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 223
Query: 682 ---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 738
              +G +  K DV+S G+  +E+   +R    ++     N +   + +   E P      
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNM----NAMSALYHIAQNESPAL---- 273
Query: 739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 775
               S   SE  R       C+Q+ P+DRP  S V+L
Sbjct: 274 ---QSGHWSEYFRNFVDS--CLQKIPQDRPT-SEVLL 304

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 118/223 (52%), Gaps = 21/223 (9%)
Query: 490 ELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEI----AAKRLSK-SSGQG 543
           E P    + I   TE F     LG G FG VYKG+ I EG+++    A K L + +S + 
Sbjct: 6   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 64
Query: 544 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKF 599
            +E  +E  ++A + + ++ +L+G C     + LI + +P   L D++ +    +     
Sbjct: 65  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL 123
Query: 600 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 659
           L+W  +      IA+G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G +
Sbjct: 124 LNWCVQ------IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 174
Query: 660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
           + E +         +M  E  +  +++ +SDV+S+GV V E++
Sbjct: 175 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 217

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 118/223 (52%), Gaps = 21/223 (9%)
Query: 490 ELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEI----AAKRLSK-SSGQG 543
           E P    + I   TE F     LG G FG VYKG+ I EG+++    A K L + +S + 
Sbjct: 8   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 66
Query: 544 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKF 599
            +E  +E  ++A + + ++ +L+G C     + LI + +P   L D++ +    +     
Sbjct: 67  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL 125
Query: 600 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 659
           L+W  +      IA+G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G +
Sbjct: 126 LNWCVQ------IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 176
Query: 660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
           + E +         +M  E  +  +++ +SDV+S+GV V E++
Sbjct: 177 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 219

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 86/292 (29%), Positives = 131/292 (44%), Gaps = 46/292 (15%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQ-------EIAAKRLSK-SSGQGMEEFENEVLLIA 555
           +N +    LG G FG VY+G  + G        ++A K L +  S Q   +F  E L+I+
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIIS 89
Query: 556 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDV----TRSKFLDWSKRCQIIGG 611
           KL H+N+V+ IG   Q   R ++ E +    L  F+ +     ++   L       +   
Sbjct: 90  KLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 149
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGIDQTEANTNRV 668
           IA G  YL ++     IHRD+ A N LL         KI DFGMAR    D   A+  R 
Sbjct: 150 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRK 202
Query: 669 VGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGF--YHADHHHNLLGH 722
            G       +MPPE  ++G+F+ K+D +SFGVL+ EI     + G+  Y +  +  +L  
Sbjct: 203 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF----SLGYMPYPSKSNQEVLEF 258
Query: 723 AWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 774
                  + P        G  Y         ++   C Q +PEDRPN + ++
Sbjct: 259 VTSGGRMDPP----KNCPGPVY---------RIMTQCWQHQPEDRPNFAIIL 297

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 118/223 (52%), Gaps = 21/223 (9%)
Query: 490 ELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEI----AAKRLSK-SSGQG 543
           E P    + I   TE F     LG G FG VYKG+ I EG+++    A K L + +S + 
Sbjct: 3   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 61
Query: 544 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKF 599
            +E  +E  ++A + + ++ +L+G C     + LI + +P   L D++ +    +     
Sbjct: 62  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL 120
Query: 600 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 659
           L+W  +      IA+G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G +
Sbjct: 121 LNWCVQ------IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 171
Query: 660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
           + E +         +M  E  +  +++ +SDV+S+GV V E++
Sbjct: 172 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 214

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 118/223 (52%), Gaps = 21/223 (9%)
Query: 490 ELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEI----AAKRLSK-SSGQG 543
           E P    + I   TE F     LG G FG VYKG+ I EG+++    A K L + +S + 
Sbjct: 4   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 62
Query: 544 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKF 599
            +E  +E  ++A + + ++ +L+G C     + LI + +P   L D++ +    +     
Sbjct: 63  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL 121
Query: 600 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 659
           L+W  +      IA+G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G +
Sbjct: 122 LNWCVQ------IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 172
Query: 660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
           + E +         +M  E  +  +++ +SDV+S+GV V E++
Sbjct: 173 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 215

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/308 (27%), Positives = 143/308 (46%), Gaps = 46/308 (14%)
Query: 502 ATENFSDKNKLGEGGFGPVY----KGVLIEGQE--IAAKRLSKSSGQGME-EFENEVLLI 554
           A E  +   +LG+G FG VY    KGV+ +  E  +A K +++++      EF NE  ++
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLD-------WSKRCQ 607
            +    ++V+L+G  +Q    ++I E +    L  ++  +  +   +        SK  Q
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 608 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 667
           + G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R    D  E +  R
Sbjct: 143 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYR 195
Query: 668 VVGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 723
             G       +M PE   DG+F+  SDV+SFGV++ EI         Y    +  +L   
Sbjct: 196 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVL--- 250
Query: 724 WRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 783
            R  +E     L++K       L E++R      +C Q  P+ RP+   ++       S+
Sbjct: 251 -RFVMEGG---LLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEII------SSI 294
Query: 784 PQPKQPGF 791
            +  +PGF
Sbjct: 295 KEEMEPGF 302

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 118/223 (52%), Gaps = 21/223 (9%)
Query: 490 ELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEI----AAKRLSK-SSGQG 543
           E P    + I   TE F     LG G FG VYKG+ I EG+++    A K L + +S + 
Sbjct: 2   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 544 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKF 599
            +E  +E  ++A + + ++ +L+G C     + LI + +P   L D++ +    +     
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 600 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 659
           L+W  +      IA+G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G +
Sbjct: 120 LNWCVQ------IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
           + E +         +M  E  +  +++ +SDV+S+GV V E++
Sbjct: 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 118/223 (52%), Gaps = 21/223 (9%)
Query: 490 ELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEI----AAKRLSK-SSGQG 543
           E P    + I   TE F     LG G FG VYKG+ I EG+++    A K L + +S + 
Sbjct: 9   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 67
Query: 544 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKF 599
            +E  +E  ++A + + ++ +L+G C     + LI + +P   L D++ +    +     
Sbjct: 68  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL 126
Query: 600 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 659
           L+W  +      IA+G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G +
Sbjct: 127 LNWCVQ------IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 177
Query: 660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
           + E +         +M  E  +  +++ +SDV+S+GV V E++
Sbjct: 178 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 220

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 118/223 (52%), Gaps = 21/223 (9%)
Query: 490 ELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEI----AAKRLSK-SSGQG 543
           E P    + I   TE F     LG G FG VYKG+ I EG+++    A K L + +S + 
Sbjct: 2   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 544 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKF 599
            +E  +E  ++A + + ++ +L+G C     + LI + +P   L D++ +    +     
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 600 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 659
           L+W  +      IA+G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G +
Sbjct: 120 LNWCVQ------IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
           + E +         +M  E  +  +++ +SDV+S+GV V E++
Sbjct: 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 144/308 (46%), Gaps = 46/308 (14%)
Query: 502 ATENFSDKNKLGEGGFGPVY----KGVLIEGQE--IAAKRLSKSSGQGME-EFENEVLLI 554
           A E  +   +LG+G FG VY    KGV+ +  E  +A K +++++      EF NE  ++
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIF----DVTRSKFL---DWSKRCQ 607
            +    ++V+L+G  +Q    ++I E +    L  ++     ++  +  L     SK  Q
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 608 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 667
           + G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R    D  E +  R
Sbjct: 137 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYR 189
Query: 668 VVGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 723
             G       +M PE   DG+F+  SDV+SFGV++ EI         Y    +  +L   
Sbjct: 190 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVL--- 244
Query: 724 WRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 783
            R  +E     L++K       L E++R      +C Q  P+ RP+   ++       S+
Sbjct: 245 -RFVMEGG---LLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEII------SSI 288
Query: 784 PQPKQPGF 791
            +  +PGF
Sbjct: 289 KEEMEPGF 296

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 118/223 (52%), Gaps = 21/223 (9%)
Query: 490 ELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEI----AAKRLSK-SSGQG 543
           E P    + I   TE F     LG G FG VYKG+ I EG+++    A K L + +S + 
Sbjct: 12  EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 70
Query: 544 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKF 599
            +E  +E  ++A + + ++ +L+G C     + LI + +P   L D++ +    +     
Sbjct: 71  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL 129
Query: 600 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 659
           L+W  +      IA+G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G +
Sbjct: 130 LNWCVQ------IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 180
Query: 660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
           + E +         +M  E  +  +++ +SDV+S+GV V E++
Sbjct: 181 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 223

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 144/308 (46%), Gaps = 46/308 (14%)
Query: 502 ATENFSDKNKLGEGGFGPVY----KGVLIEGQE--IAAKRLSKSSGQGME-EFENEVLLI 554
           A E  +   +LG+G FG VY    KGV+ +  E  +A K +++++      EF NE  ++
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIF----DVTRSKFL---DWSKRCQ 607
            +    ++V+L+G  +Q    ++I E +    L  ++     ++  +  L     SK  Q
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 608 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 667
           + G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R    D  E +  R
Sbjct: 136 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYR 188
Query: 668 VVGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 723
             G       +M PE   DG+F+  SDV+SFGV++ EI         Y    +  +L   
Sbjct: 189 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVL--- 243
Query: 724 WRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 783
            R  +E     L++K       L E++R      +C Q  P+ RP+   ++       S+
Sbjct: 244 -RFVMEGG---LLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEII------SSI 287
Query: 784 PQPKQPGF 791
            +  +PGF
Sbjct: 288 KEEMEPGF 295

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 118/223 (52%), Gaps = 21/223 (9%)
Query: 490 ELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEI----AAKRLSK-SSGQG 543
           E P    + I   TE F     LG G FG VYKG+ I EG+++    A K L + +S + 
Sbjct: 5   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 63
Query: 544 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKF 599
            +E  +E  ++A + + ++ +L+G C     + LI + +P   L D++ +    +     
Sbjct: 64  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL 122
Query: 600 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 659
           L+W  +      IA+G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G +
Sbjct: 123 LNWCVQ------IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 173
Query: 660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
           + E +         +M  E  +  +++ +SDV+S+GV V E++
Sbjct: 174 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 216

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 118/223 (52%), Gaps = 21/223 (9%)
Query: 490 ELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEI----AAKRLSK-SSGQG 543
           E P    + I   TE F     LG G FG VYKG+ I EG+++    A K L + +S + 
Sbjct: 5   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 63
Query: 544 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKF 599
            +E  +E  ++A + + ++ +L+G C     + LI + +P   L D++ +    +     
Sbjct: 64  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL 122
Query: 600 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 659
           L+W  +      IA+G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G +
Sbjct: 123 LNWCVQ------IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 173
Query: 660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
           + E +         +M  E  +  +++ +SDV+S+GV V E++
Sbjct: 174 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 216

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 144/308 (46%), Gaps = 46/308 (14%)
Query: 502 ATENFSDKNKLGEGGFGPVY----KGVLIEGQE--IAAKRLSKSSGQGME-EFENEVLLI 554
           A E  +   +LG+G FG VY    KGV+ +  E  +A K +++++      EF NE  ++
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIF----DVTRSKFL---DWSKRCQ 607
            +    ++V+L+G  +Q    ++I E +    L  ++     ++  +  L     SK  Q
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 608 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 667
           + G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R    D  E +  R
Sbjct: 130 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYR 182
Query: 668 VVGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 723
             G       +M PE   DG+F+  SDV+SFGV++ EI         Y    +  +L   
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVL--- 237
Query: 724 WRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 783
            R  +E     L++K       L E++R      +C Q  P+ RP+   ++       S+
Sbjct: 238 -RFVMEGG---LLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEII------SSI 281
Query: 784 PQPKQPGF 791
            +  +PGF
Sbjct: 282 KEEMEPGF 289

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 85/308 (27%), Positives = 143/308 (46%), Gaps = 46/308 (14%)
Query: 502 ATENFSDKNKLGEGGFGPVY----KGVLIEGQE--IAAKRLSKSSGQGME-EFENEVLLI 554
           A E  +   +LG+G FG VY    KGV+ +  E  +A K +++++      EF NE  ++
Sbjct: 13  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 72
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLD-------WSKRCQ 607
            +    ++V+L+G  +Q    ++I E +    L  ++  +  +   +        SK  Q
Sbjct: 73  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 132
Query: 608 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 667
           + G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R    D  E +  R
Sbjct: 133 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYR 185
Query: 668 VVGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 723
             G       +M PE   DG+F+  SDV+SFGV++ EI         Y    +  +L   
Sbjct: 186 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVL--- 240
Query: 724 WRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 783
            R  +E     L++K       L E++R      +C Q  P+ RP+   ++       S+
Sbjct: 241 -RFVMEGG---LLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEII------SSI 284
Query: 784 PQPKQPGF 791
            +  +PGF
Sbjct: 285 KEEMEPGF 292

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 144/308 (46%), Gaps = 46/308 (14%)
Query: 502 ATENFSDKNKLGEGGFGPVY----KGVLIEGQE--IAAKRLSKSSGQGME-EFENEVLLI 554
           A E  +   +LG+G FG VY    KGV+ +  E  +A K +++++      EF NE  ++
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIF----DVTRSKFL---DWSKRCQ 607
            +    ++V+L+G  +Q    ++I E +    L  ++     ++  +  L     SK  Q
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 608 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 667
           + G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R    D  E +  R
Sbjct: 136 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYR 188
Query: 668 VVGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 723
             G       +M PE   DG+F+  SDV+SFGV++ EI         Y    +  +L   
Sbjct: 189 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVL--- 243
Query: 724 WRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 783
            R  +E     L++K       L E++R      +C Q  P+ RP+   ++       S+
Sbjct: 244 -RFVMEGG---LLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEII------SSI 287
Query: 784 PQPKQPGF 791
            +  +PGF
Sbjct: 288 KEEMEPGF 295

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 118/223 (52%), Gaps = 21/223 (9%)
Query: 490 ELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEI----AAKRLSK-SSGQG 543
           E P    + I   TE F     LG G FG VYKG+ I EG+++    A K L + +S + 
Sbjct: 3   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 61
Query: 544 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKF 599
            +E  +E  ++A + + ++ +L+G C     + LI + +P   L D++ +    +     
Sbjct: 62  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYL 120
Query: 600 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 659
           L+W  +      IA+G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G +
Sbjct: 121 LNWCVQ------IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 171
Query: 660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
           + E +         +M  E  +  +++ +SDV+S+GV V E++
Sbjct: 172 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 214

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 118/223 (52%), Gaps = 21/223 (9%)
Query: 490 ELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEI----AAKRLSK-SSGQG 543
           E P    + I   TE F     LG G FG VYKG+ I EG+++    A K L + +S + 
Sbjct: 5   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 63
Query: 544 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKF 599
            +E  +E  ++A + + ++ +L+G C     + LI + +P   L D++ +    +     
Sbjct: 64  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL 122
Query: 600 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 659
           L+W  +      IA+G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G +
Sbjct: 123 LNWCVQ------IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 173
Query: 660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
           + E +         +M  E  +  +++ +SDV+S+GV V E++
Sbjct: 174 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 216

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 144/308 (46%), Gaps = 46/308 (14%)
Query: 502 ATENFSDKNKLGEGGFGPVY----KGVLIEGQE--IAAKRLSKSSGQGME-EFENEVLLI 554
           A E  +   +LG+G FG VY    KGV+ +  E  +A K +++++      EF NE  ++
Sbjct: 14  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 73
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIF----DVTRSKFL---DWSKRCQ 607
            +    ++V+L+G  +Q    ++I E +    L  ++     ++  +  L     SK  Q
Sbjct: 74  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 133
Query: 608 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 667
           + G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R    D  E +  R
Sbjct: 134 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYR 186
Query: 668 VVGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 723
             G       +M PE   DG+F+  SDV+SFGV++ EI         Y    +  +L   
Sbjct: 187 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVL--- 241
Query: 724 WRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 783
            R  +E     L++K       L E++R      +C Q  P+ RP+   ++       S+
Sbjct: 242 -RFVMEGG---LLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEII------SSI 285
Query: 784 PQPKQPGF 791
            +  +PGF
Sbjct: 286 KEEMEPGF 293

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 116/216 (53%), Gaps = 21/216 (9%)
Query: 497 MAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEI----AAKRLSK-SSGQGMEEFENE 550
           + I   TE F     LG G FG VYKG+ I EG+++    A K L + +S +  +E  +E
Sbjct: 3   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61
Query: 551 VLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRC 606
             ++A + + ++ +L+G C     + LI + +P   L D++ +    +     L+W  + 
Sbjct: 62  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ- 119
Query: 607 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN 666
                IA+G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E +  
Sbjct: 120 -----IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 171
Query: 667 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
                  +M  E  +  +++ +SDV+S+GV V E++
Sbjct: 172 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 207

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 118/223 (52%), Gaps = 21/223 (9%)
Query: 490 ELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEI----AAKRLSK-SSGQG 543
           E P    + I   TE F     LG G FG VYKG+ I EG+++    A K L + +S + 
Sbjct: 4   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 62
Query: 544 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKF 599
            +E  +E  ++A + + ++ +L+G C     + LI + +P   L D++ +    +     
Sbjct: 63  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL 121
Query: 600 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 659
           L+W  +      IA+G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G +
Sbjct: 122 LNWCVQ------IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 172
Query: 660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
           + E +         +M  E  +  +++ +SDV+S+GV V E++
Sbjct: 173 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 215

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 86/283 (30%), Positives = 135/283 (47%), Gaps = 36/283 (12%)
Query: 510 NKLGEGGFGPV----YKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
           ++LG+G FG V    Y  +    G  +A K+L  S      +F+ E+ ++  L    +VK
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 75
Query: 565 LIGCC--TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
             G      R    L+ EYLP+  L DF+    R++ LD S+       I +G+ YL   
Sbjct: 76  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRAR-LDASRLLLYSSQICKGMEYL--G 131
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----P 677
           SR R +HRDL A N+L+++E + KI+DFG+A+   +D+       VV   G  P     P
Sbjct: 132 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DYYVVREPGQSPIFWYAP 186
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 737
           E   D +FS +SDV+SFGV++ E+        F + D   +      R+   ER V  ++
Sbjct: 187 ESLSDNIFSRQSDVWSFGVVLYEL--------FTYCDKSCSPSAEFLRMMGSERDVPALS 238
Query: 738 KSLGGSYS---LSEVLRCI----QVGLLCVQQRPEDRPNMSSV 773
           + L        L     C     ++  LC    P+DRP+ S++
Sbjct: 239 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 281

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 87/317 (27%), Positives = 144/317 (45%), Gaps = 70/317 (22%)
Query: 492 PIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEG---QEIAAKRLSK-SSGQGMEEF 547
           P+ DW  I      F D   +GEG FG V K  + +     + A KR+ + +S     +F
Sbjct: 17  PVLDWNDI-----KFQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF 69
Query: 548 ENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFI-----------FDVT 595
             E+ ++ KL  H N++ L+G C  R    L  EY P+ +L DF+           F + 
Sbjct: 70  AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 129
Query: 596 RS--KFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 653
            S    L   +       +ARG+ YL Q    + IHR+L A N+L+      KI+DFG++
Sbjct: 130 NSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLS 186
Query: 654 RAFGIDQTEANTNRVVGTYGYMPPEY-AIDGL----FSVKSDVFSFGVLVLEIV------ 702
           R   +         V  T G +P  + AI+ L    ++  SDV+S+GVL+ EIV      
Sbjct: 187 RGQEV--------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 238
Query: 703 -CGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQ 761
            CG      Y        L   +RL   E+P+   ++       + +++R       C +
Sbjct: 239 YCGMTCAELYEK------LPQGYRL---EKPLNCDDE-------VYDLMR------QCWR 276
Query: 762 QRPEDRPNMSSVVLMLS 778
           ++P +RP+ + +++ L+
Sbjct: 277 EKPYERPSFAQILVSLN 293

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 144/308 (46%), Gaps = 46/308 (14%)
Query: 502 ATENFSDKNKLGEGGFGPVY----KGVLIEGQE--IAAKRLSKSSGQGME-EFENEVLLI 554
           A E  +   +LG+G FG VY    KGV+ +  E  +A K +++++      EF NE  ++
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIF----DVTRSKFL---DWSKRCQ 607
            +    ++V+L+G  +Q    ++I E +    L  ++     ++  +  L     SK  Q
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 142
Query: 608 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 667
           + G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R    D  E +  R
Sbjct: 143 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYR 195
Query: 668 VVGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 723
             G       +M PE   DG+F+  SDV+SFGV++ EI         Y    +  +L   
Sbjct: 196 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVL--- 250
Query: 724 WRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 783
            R  +E     L++K       L E++R      +C Q  P+ RP+   ++       S+
Sbjct: 251 -RFVMEGG---LLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEII------SSI 294
Query: 784 PQPKQPGF 791
            +  +PGF
Sbjct: 295 KEEMEPGF 302

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 118/223 (52%), Gaps = 21/223 (9%)
Query: 490 ELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEI----AAKRLSK-SSGQG 543
           E P    + I   TE F     LG G FG VYKG+ I EG+++    A K L + +S + 
Sbjct: 2   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 544 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKF 599
            +E  +E  ++A + + ++ +L+G C     + LI + +P   L D++ +    +     
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 600 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 659
           L+W  +      IA+G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G +
Sbjct: 120 LNWCVQ------IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
           + E +         +M  E  +  +++ +SDV+S+GV V E++
Sbjct: 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 103/199 (51%), Gaps = 9/199 (4%)
Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
            ++G G FG VYKG       +    ++  + Q ++ F+NEV ++ K +H N++  +G  
Sbjct: 18  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
           T + +  ++ ++    SL   +   + +KF +  K   I    ARG+ YLH  S   IIH
Sbjct: 78  T-KPQLAIVTQWCEGSSLYHHLH-ASETKF-EMKKLIDIARQTARGMDYLHAKS---IIH 131
Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE---YAIDGLFS 686
           RDLK++N+ L  +   KI DFG+A             ++ G+  +M PE         +S
Sbjct: 132 RDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 191
Query: 687 VKSDVFSFGVLVLEIVCGK 705
            +SDV++FG+++ E++ G+
Sbjct: 192 FQSDVYAFGIVLYELMTGQ 210

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 83/277 (29%), Positives = 127/277 (45%), Gaps = 35/277 (12%)
Query: 506 FSDKNKLGEGGFGPVYKGVLIEGQEIAA-KRLSKSSGQGMEEFEN---EVLLIAKLQHRN 561
           FSD  ++G G FG VY    +   E+ A K++S S  Q  E++++   EV  + KL+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
            ++  GC  +     L+ EY    S +D +      K L   +   +  G  +GL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLG-SASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
            +   +IHRD+KA N+LL      K+ DFG A         A  N  VGT  +M PE  +
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 184
Query: 682 ---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 738
              +G +  K DV+S G+  +E+   +R    ++     N +   + +   E P      
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNM----NAMSALYHIAQNESPA----- 233
Query: 739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 775
               S   SE  R       C+Q+ P+DRP  S V+L
Sbjct: 234 --LQSGHWSEYFRNFVDS--CLQKIPQDRPT-SEVLL 265

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 118/223 (52%), Gaps = 21/223 (9%)
Query: 490 ELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEI----AAKRLSK-SSGQG 543
           E P    + I   TE F     LG G FG VYKG+ I EG+++    A K L + +S + 
Sbjct: 2   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 544 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKF 599
            +E  +E  ++A + + ++ +L+G C     + LI + +P   L D++ +    +     
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYL 119
Query: 600 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 659
           L+W  +      IA+G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G +
Sbjct: 120 LNWCVQ------IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
           + E +         +M  E  +  +++ +SDV+S+GV V E++
Sbjct: 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 144/308 (46%), Gaps = 46/308 (14%)
Query: 502 ATENFSDKNKLGEGGFGPVY----KGVLIEGQE--IAAKRLSKSSGQGME-EFENEVLLI 554
           A E  +   +LG+G FG VY    KGV+ +  E  +A K +++++      EF NE  ++
Sbjct: 45  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 104
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIF----DVTRSKFL---DWSKRCQ 607
            +    ++V+L+G  +Q    ++I E +    L  ++     ++  +  L     SK  Q
Sbjct: 105 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 164
Query: 608 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 667
           + G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R    D  E +  R
Sbjct: 165 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYR 217
Query: 668 VVGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 723
             G       +M PE   DG+F+  SDV+SFGV++ EI         Y    +  +L   
Sbjct: 218 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVL--- 272
Query: 724 WRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 783
            R  +E     L++K       L E++R      +C Q  P+ RP+   ++       S+
Sbjct: 273 -RFVMEGG---LLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEII------SSI 316
Query: 784 PQPKQPGF 791
            +  +PGF
Sbjct: 317 KEEMEPGF 324

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 116/228 (50%), Gaps = 14/228 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQ 558
           + ENF    K+GEG +G VYK    + G+ +A K++   +  +G+      E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           H N+VKL+      ++  L++E+L ++ L DF+ D +    +        +  + +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
            H     R++HRDLK  N+L++ E   K++DFG+ARAFG+       + VV T  Y  PE
Sbjct: 119 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 173
Query: 679 YAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 725
             +    +S   D++S G +  E+V     R  +  D   + L   +R
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 218

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 100/192 (52%), Gaps = 7/192 (3%)
Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
            +LG G FG V  G    GQ   A ++ K      +EF  E  ++  L H  LV+L G C
Sbjct: 15  KELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
           T++    +I EY+ N  L +++ ++ R +F    +  ++   +   + YL      + +H
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREM-RHRFQT-QQLLEMCKDVCEAMEYLESK---QFLH 128
Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 689
           RDL A N L++++   K+SDFG++R + +D    ++        + PPE  +   FS KS
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKS 187
Query: 690 DVFSFGVLVLEI 701
           D+++FGVL+ EI
Sbjct: 188 DIWAFGVLMWEI 199

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 116/228 (50%), Gaps = 14/228 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQ 558
           + ENF    K+GEG +G VYK    + G+ +A K++   +  +G+      E+ L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           H N+VKL+      ++  L++E+L ++ L  F+ D +    +        +  + +GL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
            H     R++HRDLK  N+L++ E   K++DFG+ARAFG+      T+ VV T  Y  PE
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPE 174
Query: 679 YAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 725
             +    +S   D++S G +  E+V     R  +  D   + L   +R
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 219

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 118/223 (52%), Gaps = 21/223 (9%)
Query: 490 ELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEI----AAKRLSK-SSGQG 543
           E P    + I   TE F     LG G FG VYKG+ I EG+++    A K L + +S + 
Sbjct: 27  EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 85
Query: 544 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKF 599
            +E  +E  ++A + + ++ +L+G C     + LI + +P   L D++ +    +     
Sbjct: 86  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL 144
Query: 600 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 659
           L+W  +      IA+G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G +
Sbjct: 145 LNWCVQ------IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 195
Query: 660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
           + E +         +M  E  +  +++ +SDV+S+GV V E++
Sbjct: 196 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 238

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 116/221 (52%), Gaps = 10/221 (4%)
Query: 486 EEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGM 544
           +EE+   +   +++ +  + ++   K+G+G  G VY  + +  GQE+A ++++       
Sbjct: 2   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61
Query: 545 EEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSK 604
           E   NE+L++ + ++ N+V  +      DE  ++ EYL   SL D + +      +D  +
Sbjct: 62  ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQ 117
Query: 605 RCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 664
              +     + L +LH +   ++IHRD+K+ N+LL  + + K++DFG       +Q++  
Sbjct: 118 IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 172
Query: 665 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
            + +VGT  +M PE      +  K D++S G++ +E++ G+
Sbjct: 173 RSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 115/226 (50%), Gaps = 14/226 (6%)
Query: 504 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQHR 560
           ENF    K+GEG +G VYK    + G+ +A K++   +  +G+      E+ L+ +L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VKL+      ++  L++E+L ++ L  F+ D +    +        +  + +GL + H
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
                R++HRDLK  N+L++ E   K++DFG+ARAFG+      T+ VV T  Y  PE  
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 182
Query: 681 ID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 725
           +    +S   D++S G +  E+V     R  +  D   + L   +R
Sbjct: 183 LGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 225

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 119/212 (56%), Gaps = 25/212 (11%)
Query: 509 KNKLGEGGFGPVYKGVLIEGQEIAAKR---LSKSSGQG-----MEEFENEVLLIAKLQHR 560
           + ++G+GGFG V+KG L++ + + A +   L  S G+       +EF+ EV +++ L H 
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VKL G     +   ++ E++P   L   + D  ++  + WS + +++  IA G+ Y+ 
Sbjct: 84  NIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYM- 138
Query: 621 QDSRLRIIHRDLKASNVLLD--NEMNP---KISDFGMARAFGIDQTEANTNRVVGTYGYM 675
           Q+    I+HRDL++ N+ L   +E  P   K++DF +++     Q+  + + ++G + +M
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVSGLLGNFQWM 193
Query: 676 PPEY--AIDGLFSVKSDVFSFGVLVLEIVCGK 705
            PE   A +  ++ K+D +SF +++  I+ G+
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 115/226 (50%), Gaps = 14/226 (6%)
Query: 504 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQHR 560
           ENF    K+GEG +G VYK    + G+ +A K++   +  +G+      E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VKL+      ++  L++E+L ++ L  F+ D +    +        +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
                R++HRDLK  N+L++ E   K++DFG+ARAFG+      T+ VV T  Y  PE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 174
Query: 681 ID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 725
           +    +S   D++S G +  E+V     R  +  D   + L   +R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 217

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 115/226 (50%), Gaps = 14/226 (6%)
Query: 504 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQHR 560
           ENF    K+GEG +G VYK    + G+ +A K++   +  +G+      E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VKL+      ++  L++E+L ++ L  F+ D +    +        +  + +GL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
                R++HRDLK  N+L++ E   K++DFG+ARAFG+      T+ VV T  Y  PE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 681 ID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 725
           +    +S   D++S G +  E+V     R  +  D   + L   +R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 218

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 115/226 (50%), Gaps = 14/226 (6%)
Query: 504 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQHR 560
           ENF    K+GEG +G VYK    + G+ +A K++   +  +G+      E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VKL+      ++  L++E+L ++ L  F+ D +    +        +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
                R++HRDLK  N+L++ E   K++DFG+ARAFG+      T+ VV T  Y  PE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 174
Query: 681 ID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 725
           +    +S   D++S G +  E+V     R  +  D   + L   +R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 217

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 504 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQHR 560
           ENF    K+GEG +G VYK    + G+ +A K++   +  +G+      E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VKL+      ++  L++E+L ++ L  F+ D +    +        +  + +GL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
                R++HRDLK  N+L++ E   K++DFG+ARAFG+      T+ VV T  Y  PE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 681 I-DGLFSVKSDVFSFGVLVLEIVCGK 705
           +    +S   D++S G +  E+V  +
Sbjct: 176 LGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 115/226 (50%), Gaps = 14/226 (6%)
Query: 504 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQHR 560
           ENF    K+GEG +G VYK    + G+ +A K++   +  +G+      E+ L+ +L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VKL+      ++  L++E+L ++ L  F+ D +    +        +  + +GL + H
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
                R++HRDLK  N+L++ E   K++DFG+ARAFG+      T+ VV T  Y  PE  
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 182
Query: 681 I-DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 725
           +    +S   D++S G +  E+V     R  +  D   + L   +R
Sbjct: 183 LGXKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 225

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 107/203 (52%), Gaps = 17/203 (8%)
Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
            ++G G FG VYKG       +    ++  + Q ++ F+NEV ++ K +H N++  +G  
Sbjct: 30  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
           T + +  ++ ++    SL   +   + +KF +  K   I    ARG+ YLH  S   IIH
Sbjct: 90  T-KPQLAIVTQWCEGSSLYHHLH-ASETKF-EMKKLIDIARQTARGMDYLHAKS---IIH 143
Query: 630 RDLKASNVLLDNEMNPKISDFGMA----RAFGIDQTEANTNRVVGTYGYMPPE---YAID 682
           RDLK++N+ L  +   KI DFG+A    R  G  Q E    ++ G+  +M PE       
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRMQDS 199
Query: 683 GLFSVKSDVFSFGVLVLEIVCGK 705
             +S +SDV++FG+++ E++ G+
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 104/199 (52%), Gaps = 9/199 (4%)
Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
            ++G G FG VYKG       +    ++  + Q ++ F+NEV ++ K +H N++  +G  
Sbjct: 19  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
           T + +  ++ ++    SL   +  +  +KF +  K   I    A+G+ YLH  S   IIH
Sbjct: 79  T-KPQLAIVTQWCEGSSLYHHL-HIIETKF-EMIKLIDIARQTAQGMDYLHAKS---IIH 132
Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE---YAIDGLFS 686
           RDLK++N+ L  ++  KI DFG+A             ++ G+  +M PE         +S
Sbjct: 133 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 192
Query: 687 VKSDVFSFGVLVLEIVCGK 705
            +SDV++FG+++ E++ G+
Sbjct: 193 FQSDVYAFGIVLYELMTGQ 211

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 504 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQHR 560
           ENF    K+GEG +G VYK    + G+ +A K++   +  +G+      E+ L+ +L H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VKL+      ++  L++E+L ++ L  F+ D +    +        +  + +GL + H
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
                R++HRDLK  N+L++ E   K++DFG+ARAFG+      T+ VV T  Y  PE  
Sbjct: 125 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 179
Query: 681 ID-GLFSVKSDVFSFGVLVLEIVCGK 705
           +    +S   D++S G +  E+V  +
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 104/199 (52%), Gaps = 9/199 (4%)
Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
            ++G G FG VYKG       +    ++  + Q ++ F+NEV ++ K +H N++  +G  
Sbjct: 16  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
           T + +  ++ ++    SL   +  +  +KF +  K   I    A+G+ YLH  S   IIH
Sbjct: 76  T-KPQLAIVTQWCEGSSLYHHL-HIIETKF-EMIKLIDIARQTAQGMDYLHAKS---IIH 129
Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE---YAIDGLFS 686
           RDLK++N+ L  ++  KI DFG+A             ++ G+  +M PE         +S
Sbjct: 130 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 189
Query: 687 VKSDVFSFGVLVLEIVCGK 705
            +SDV++FG+++ E++ G+
Sbjct: 190 FQSDVYAFGIVLYELMTGQ 208

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 115/226 (50%), Gaps = 14/226 (6%)
Query: 504 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQHR 560
           ENF    K+GEG +G VYK    + G+ +A K++   +  +G+      E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VKL+      ++  L++E+L ++ L  F+ D +    +        +  + +GL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
                R++HRDLK  N+L++ E   K++DFG+ARAFG+      T+ VV T  Y  PE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 681 ID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 725
           +    +S   D++S G +  E+V     R  +  D   + L   +R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 218

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 11/214 (5%)
Query: 501 NATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVLLIAKLQ 558
           +  E F+   K+G+G FG V+KG+    Q++ A ++   + +   +E+ + E+ ++++  
Sbjct: 4   DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 63
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
              + K  G   +  +  +I EYL   S      D+     LD ++   I+  I +GL Y
Sbjct: 64  SPYVTKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDY 119
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           LH + +   IHRD+KA+NVLL      K++DFG+A      Q + NT   VGT  +M PE
Sbjct: 120 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPE 174
Query: 679 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYH 712
                 +  K+D++S G+  +E+  G+      H
Sbjct: 175 VIKQSAYDSKADIWSLGITAIELARGEPPHSELH 208

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 104/199 (52%), Gaps = 9/199 (4%)
Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
            ++G G FG VYKG       +    ++  + Q ++ F+NEV ++ K +H N++  +G  
Sbjct: 19  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
           T + +  ++ ++    SL   +  +  +KF +  K   I    A+G+ YLH  S   IIH
Sbjct: 79  T-KPQLAIVTQWCEGSSLYHHL-HIIETKF-EMIKLIDIARQTAQGMDYLHAKS---IIH 132
Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE---YAIDGLFS 686
           RDLK++N+ L  ++  KI DFG+A             ++ G+  +M PE         +S
Sbjct: 133 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 192
Query: 687 VKSDVFSFGVLVLEIVCGK 705
            +SDV++FG+++ E++ G+
Sbjct: 193 FQSDVYAFGIVLYELMTGQ 211

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 108/214 (50%), Gaps = 11/214 (5%)
Query: 501 NATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVLLIAKLQ 558
           +  E F+   K+G+G FG V+KG+    Q++ A ++   + +   +E+ + E+ ++++  
Sbjct: 4   DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 63
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
              + K  G   +  +  +I EYL   S      D+     LD ++   I+  I +GL Y
Sbjct: 64  SPYVTKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDY 119
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           LH + +   IHRD+KA+NVLL      K++DFG+A    +  T+   N  VGT  +M PE
Sbjct: 120 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQ--LTDTQIKRNXFVGTPFWMAPE 174
Query: 679 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYH 712
                 +  K+D++S G+  +E+  G+      H
Sbjct: 175 VIKQSAYDSKADIWSLGITAIELARGEPPHSELH 208

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 130/292 (44%), Gaps = 46/292 (15%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQ-------EIAAKRLSK-SSGQGMEEFENEVLLIA 555
           +N +    LG G FG VY+G  + G        ++A K L +  S Q   +F  E L+I+
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIIS 88
Query: 556 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDV----TRSKFLDWSKRCQIIGG 611
           K  H+N+V+ IG   Q   R ++ E +    L  F+ +     ++   L       +   
Sbjct: 89  KFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGIDQTEANTNRV 668
           IA G  YL ++     IHRD+ A N LL         KI DFGMAR    D   A+  R 
Sbjct: 149 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRK 201
Query: 669 VGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGF--YHADHHHNLLGH 722
            G       +MPPE  ++G+F+ K+D +SFGVL+ EI     + G+  Y +  +  +L  
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF----SLGYMPYPSKSNQEVLEF 257
Query: 723 AWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 774
                  + P        G  Y         ++   C Q +PEDRPN + ++
Sbjct: 258 VTSGGRMDPP----KNCPGPVY---------RIMTQCWQHQPEDRPNFAIIL 296

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 104/199 (52%), Gaps = 9/199 (4%)
Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
            ++G G FG VYKG       +    ++  + Q ++ F+NEV ++ K +H N++  +G  
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
           T + +  ++ ++    SL   +  +  +KF +  K   I    A+G+ YLH  S   IIH
Sbjct: 74  T-KPQLAIVTQWCEGSSLYHHL-HIIETKF-EMIKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE---YAIDGLFS 686
           RDLK++N+ L  ++  KI DFG+A             ++ G+  +M PE         +S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 687 VKSDVFSFGVLVLEIVCGK 705
            +SDV++FG+++ E++ G+
Sbjct: 188 FQSDVYAFGIVLYELMTGQ 206

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 115/228 (50%), Gaps = 14/228 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQ 558
           + ENF    K+GEG +G VYK    + G+ +A K++   +  +G+      E+ L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           H N+VKL+      ++  L++E+L +  L DF+ D +    +        +  + +GL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
            H     R++HRDLK  N+L++ E   K++DFG+ARAFG+       + VV T  Y  PE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 175
Query: 679 YAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 725
             +    +S   D++S G +  E+V     R  +  D   + L   +R
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 220

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 99/192 (51%), Gaps = 7/192 (3%)
Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
            +LG G FG V  G    GQ   A ++ K      +EF  E  ++  L H  LV+L G C
Sbjct: 30  KELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
           T++    +I EY+ N  L +++ ++ R +F    +  ++   +   + YL      + +H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREM-RHRFQT-QQLLEMCKDVCEAMEYLESK---QFLH 143
Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 689
           RDL A N L++++   K+SDFG++R    D+  ++         + PPE  +   FS KS
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFSSKS 202
Query: 690 DVFSFGVLVLEI 701
           D+++FGVL+ EI
Sbjct: 203 DIWAFGVLMWEI 214

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 130/292 (44%), Gaps = 46/292 (15%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQ-------EIAAKRLSK-SSGQGMEEFENEVLLIA 555
           +N +    LG G FG VY+G  + G        ++A K L +  S Q   +F  E L+I+
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIIS 88
Query: 556 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDV----TRSKFLDWSKRCQIIGG 611
           K  H+N+V+ IG   Q   R ++ E +    L  F+ +     ++   L       +   
Sbjct: 89  KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGIDQTEANTNRV 668
           IA G  YL ++     IHRD+ A N LL         KI DFGMAR    D   A+  R 
Sbjct: 149 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRK 201
Query: 669 VGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGF--YHADHHHNLLGH 722
            G       +MPPE  ++G+F+ K+D +SFGVL+ EI     + G+  Y +  +  +L  
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF----SLGYMPYPSKSNQEVLEF 257
Query: 723 AWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 774
                  + P        G  Y         ++   C Q +PEDRPN + ++
Sbjct: 258 VTSGGRMDPP----KNCPGPVY---------RIMTQCWQHQPEDRPNFAIIL 296

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 115/228 (50%), Gaps = 14/228 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQ 558
           + ENF    K+GEG +G VYK    + G+ +A K++   +  +G+      E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           H N+VKL+      ++  L++E+L +  L DF+ D +    +        +  + +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
            H     R++HRDLK  N+L++ E   K++DFG+ARAFG+       + VV T  Y  PE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 176
Query: 679 YAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 725
             +    +S   D++S G +  E+V     R  +  D   + L   +R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 221

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 130/292 (44%), Gaps = 46/292 (15%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQ-------EIAAKRLSK-SSGQGMEEFENEVLLIA 555
           +N +    LG G FG VY+G  + G        ++A K L +  S Q   +F  E L+I+
Sbjct: 45  KNITLIRGLGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIIS 103
Query: 556 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDV----TRSKFLDWSKRCQIIGG 611
           K  H+N+V+ IG   Q   R ++ E +    L  F+ +     ++   L       +   
Sbjct: 104 KFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 163
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGIDQTEANTNRV 668
           IA G  YL ++     IHRD+ A N LL         KI DFGMAR    D   A+  R 
Sbjct: 164 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRK 216
Query: 669 VGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGF--YHADHHHNLLGH 722
            G       +MPPE  ++G+F+ K+D +SFGVL+ EI     + G+  Y +  +  +L  
Sbjct: 217 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF----SLGYMPYPSKSNQEVLEF 272
Query: 723 AWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 774
                  + P        G  Y         ++   C Q +PEDRPN + ++
Sbjct: 273 VTSGGRMDPP----KNCPGPVY---------RIMTQCWQHQPEDRPNFAIIL 311

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 130/292 (44%), Gaps = 46/292 (15%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQ-------EIAAKRLSK-SSGQGMEEFENEVLLIA 555
           +N +    LG G FG VY+G  + G        ++A K L +  S Q   +F  E L+I+
Sbjct: 22  KNITLIRGLGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIIS 80
Query: 556 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDV----TRSKFLDWSKRCQIIGG 611
           K  H+N+V+ IG   Q   R ++ E +    L  F+ +     ++   L       +   
Sbjct: 81  KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 140
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGIDQTEANTNRV 668
           IA G  YL ++     IHRD+ A N LL         KI DFGMAR    D   A+  R 
Sbjct: 141 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRK 193
Query: 669 VGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGF--YHADHHHNLLGH 722
            G       +MPPE  ++G+F+ K+D +SFGVL+ EI     + G+  Y +  +  +L  
Sbjct: 194 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF----SLGYMPYPSKSNQEVLEF 249
Query: 723 AWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 774
                  + P        G  Y         ++   C Q +PEDRPN + ++
Sbjct: 250 VTSGGRMDPP----KNCPGPVY---------RIMTQCWQHQPEDRPNFAIIL 288

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 104/199 (52%), Gaps = 9/199 (4%)
Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
            ++G G FG VYKG       +    ++  + Q ++ F+NEV ++ K +H N++  +G  
Sbjct: 41  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
           T + +  ++ ++    SL   +  +  +KF +  K   I    A+G+ YLH  S   IIH
Sbjct: 101 T-KPQLAIVTQWCEGSSLYHHLH-IIETKF-EMIKLIDIARQTAQGMDYLHAKS---IIH 154
Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE---YAIDGLFS 686
           RDLK++N+ L  ++  KI DFG+A             ++ G+  +M PE         +S
Sbjct: 155 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 214
Query: 687 VKSDVFSFGVLVLEIVCGK 705
            +SDV++FG+++ E++ G+
Sbjct: 215 FQSDVYAFGIVLYELMTGQ 233

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 116/221 (52%), Gaps = 10/221 (4%)
Query: 486 EEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGM 544
           +EE+   +   +++ +  + ++   K+G+G  G VY  + +  GQE+A ++++       
Sbjct: 2   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61
Query: 545 EEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSK 604
           E   NE+L++ + ++ N+V  +      DE  ++ EYL   SL D + +      +D  +
Sbjct: 62  ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQ 117
Query: 605 RCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 664
              +     + L +LH +   ++IHRD+K+ N+LL  + + K++DFG       +Q++ +
Sbjct: 118 IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174
Query: 665 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
              +VGT  +M PE      +  K D++S G++ +E++ G+
Sbjct: 175 X--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 130/292 (44%), Gaps = 46/292 (15%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQ-------EIAAKRLSK-SSGQGMEEFENEVLLIA 555
           +N +    LG G FG VY+G  + G        ++A K L +  S Q   +F  E L+I+
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIIS 89
Query: 556 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDV----TRSKFLDWSKRCQIIGG 611
           K  H+N+V+ IG   Q   R ++ E +    L  F+ +     ++   L       +   
Sbjct: 90  KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 149
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGIDQTEANTNRV 668
           IA G  YL ++     IHRD+ A N LL         KI DFGMAR    D   A+  R 
Sbjct: 150 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRK 202
Query: 669 VGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGF--YHADHHHNLLGH 722
            G       +MPPE  ++G+F+ K+D +SFGVL+ EI     + G+  Y +  +  +L  
Sbjct: 203 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF----SLGYMPYPSKSNQEVLEF 258
Query: 723 AWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 774
                  + P        G  Y         ++   C Q +PEDRPN + ++
Sbjct: 259 VTSGGRMDPP----KNCPGPVY---------RIMTQCWQHQPEDRPNFAIIL 297

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 99/192 (51%), Gaps = 7/192 (3%)
Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
            +LG G FG V  G    GQ   A ++ K      +EF  E  ++  L H  LV+L G C
Sbjct: 14  KELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
           T++    +I EY+ N  L +++ ++ R +F    +  ++   +   + YL      + +H
Sbjct: 73  TKQRPIFIITEYMANGCLLNYLREM-RHRFQT-QQLLEMCKDVCEAMEYLESK---QFLH 127
Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 689
           RDL A N L++++   K+SDFG++R    D+  ++         + PPE  +   FS KS
Sbjct: 128 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFSSKS 186
Query: 690 DVFSFGVLVLEI 701
           D+++FGVL+ EI
Sbjct: 187 DIWAFGVLMWEI 198

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 99/192 (51%), Gaps = 7/192 (3%)
Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
            +LG G FG V  G    GQ   A ++ K      +EF  E  ++  L H  LV+L G C
Sbjct: 15  KELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
           T++    +I EY+ N  L +++ ++ R +F    +  ++   +   + YL      + +H
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREM-RHRFQT-QQLLEMCKDVCEAMEYLESK---QFLH 128
Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 689
           RDL A N L++++   K+SDFG++R    D+  ++         + PPE  +   FS KS
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFSSKS 187
Query: 690 DVFSFGVLVLEI 701
           D+++FGVL+ EI
Sbjct: 188 DIWAFGVLMWEI 199

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 117/223 (52%), Gaps = 21/223 (9%)
Query: 490 ELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEI----AAKRLSK-SSGQG 543
           E P    + I   TE F     LG G FG VYKG+ I EG+++    A K L + +S + 
Sbjct: 4   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 62
Query: 544 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKF 599
            +E  +E  ++A + + ++ +L+G C     + LI + +P   L D++ +    +     
Sbjct: 63  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL 121
Query: 600 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 659
           L+W  +      IA+G+ YL +D RL  +HRDL A NVL+    + KI+DFG A+  G +
Sbjct: 122 LNWCVQ------IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 172
Query: 660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
           + E +         +M  E  +  +++ +SDV+S+GV V E++
Sbjct: 173 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 215

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 107/211 (50%), Gaps = 11/211 (5%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVLLIAKLQHRN 561
           E F+   K+G+G FG V+KG+    Q++ A ++   + +   +E+ + E+ ++++     
Sbjct: 27  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 86
Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
           + K  G   +  +  +I EYL   S      D+     LD ++   I+  I +GL YLH 
Sbjct: 87  VTKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHS 142
Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
           + +   IHRD+KA+NVLL      K++DFG+A      Q + NT   VGT  +M PE   
Sbjct: 143 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIK 197
Query: 682 DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYH 712
              +  K+D++S G+  +E+  G+      H
Sbjct: 198 QSAYDSKADIWSLGITAIELARGEPPHSELH 228

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 104/199 (52%), Gaps = 9/199 (4%)
Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
            ++G G FG VYKG       +    ++  + Q ++ F+NEV ++ K +H N++  +G  
Sbjct: 42  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
           T + +  ++ ++    SL   +  +  +KF +  K   I    A+G+ YLH  S   IIH
Sbjct: 102 T-KPQLAIVTQWCEGSSLYHHLH-IIETKF-EMIKLIDIARQTAQGMDYLHAKS---IIH 155
Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE---YAIDGLFS 686
           RDLK++N+ L  ++  KI DFG+A             ++ G+  +M PE         +S
Sbjct: 156 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 215
Query: 687 VKSDVFSFGVLVLEIVCGK 705
            +SDV++FG+++ E++ G+
Sbjct: 216 FQSDVYAFGIVLYELMTGQ 234

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 115/226 (50%), Gaps = 14/226 (6%)
Query: 504 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQHR 560
           ENF    K+GEG +G VYK    + G+ +A K++   +  +G+      E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VKL+      ++  L++E+L ++ L  F+ D +    +        +  + +GL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLSFCH 120
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
                R++HRDLK  N+L++ E   K++DFG+ARAFG+      T+ VV T  Y  PE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 681 ID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 725
           +    +S   D++S G +  E+V     R  +  D   + L   +R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 218

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 117/223 (52%), Gaps = 21/223 (9%)
Query: 490 ELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEI----AAKRLSK-SSGQG 543
           E P    + I   TE F     LG G FG VYKG+ I EG+++    A K L + +S + 
Sbjct: 4   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 62
Query: 544 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKF 599
            +E  +E  ++A + + ++ +L+G C     + LI + +P   L D++ +    +     
Sbjct: 63  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL 121
Query: 600 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 659
           L+W  +      IA+G+ YL +D RL  +HRDL A NVL+    + KI+DFG A+  G +
Sbjct: 122 LNWCVQ------IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 172
Query: 660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
           + E +         +M  E  +  +++ +SDV+S+GV V E++
Sbjct: 173 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 215

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 116/221 (52%), Gaps = 10/221 (4%)
Query: 486 EEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGM 544
           +EE+   +   +++ +  + ++   K+G+G  G VY  + +  GQE+A ++++       
Sbjct: 3   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 62
Query: 545 EEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSK 604
           E   NE+L++ + ++ N+V  +      DE  ++ EYL   SL D + +      +D  +
Sbjct: 63  ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQ 118
Query: 605 RCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 664
              +     + L +LH +   ++IHRD+K+ N+LL  + + K++DFG       +Q++ +
Sbjct: 119 IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 175
Query: 665 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
              +VGT  +M PE      +  K D++S G++ +E++ G+
Sbjct: 176 X--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 108/203 (53%), Gaps = 17/203 (8%)
Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
            ++G G FG VYKG       +    ++  + Q ++ F+NEV ++ K +H N++  +G  
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
           T + +  ++ ++    SL   +  +  +KF +  K   I    A+G+ YLH  S   IIH
Sbjct: 74  T-KPQLAIVTQWCEGSSLYHHL-HIIETKF-EMIKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 630 RDLKASNVLLDNEMNPKISDFGMA----RAFGIDQTEANTNRVVGTYGYMPPE---YAID 682
           RDLK++N+ L  ++  KI DFG+A    R  G  Q E    ++ G+  +M PE       
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRMQDK 183
Query: 683 GLFSVKSDVFSFGVLVLEIVCGK 705
             +S +SDV++FG+++ E++ G+
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 108/203 (53%), Gaps = 17/203 (8%)
Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
            ++G G FG VYKG       +    ++  + Q ++ F+NEV ++ K +H N++  +G  
Sbjct: 34  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
           T + +  ++ ++    SL   +  +  +KF +  K   I    A+G+ YLH  S   IIH
Sbjct: 94  T-KPQLAIVTQWCEGSSLYHHL-HIIETKF-EMIKLIDIARQTAQGMDYLHAKS---IIH 147
Query: 630 RDLKASNVLLDNEMNPKISDFGMA----RAFGIDQTEANTNRVVGTYGYMPPE---YAID 682
           RDLK++N+ L  ++  KI DFG+A    R  G  Q E    ++ G+  +M PE       
Sbjct: 148 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRMQDK 203
Query: 683 GLFSVKSDVFSFGVLVLEIVCGK 705
             +S +SDV++FG+++ E++ G+
Sbjct: 204 NPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 130/292 (44%), Gaps = 46/292 (15%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQ-------EIAAKRLSK-SSGQGMEEFENEVLLIA 555
           +N +    LG G FG VY+G  + G        ++A K L +  S Q   +F  E L+I+
Sbjct: 37  KNITLIRGLGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIIS 95
Query: 556 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDV----TRSKFLDWSKRCQIIGG 611
           K  H+N+V+ IG   Q   R ++ E +    L  F+ +     ++   L       +   
Sbjct: 96  KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 155
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGIDQTEANTNRV 668
           IA G  YL ++     IHRD+ A N LL         KI DFGMAR    D   A+  R 
Sbjct: 156 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRK 208
Query: 669 VGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGF--YHADHHHNLLGH 722
            G       +MPPE  ++G+F+ K+D +SFGVL+ EI     + G+  Y +  +  +L  
Sbjct: 209 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF----SLGYMPYPSKSNQEVLEF 264
Query: 723 AWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 774
                  + P        G  Y         ++   C Q +PEDRPN + ++
Sbjct: 265 VTSGGRMDPP----KNCPGPVY---------RIMTQCWQHQPEDRPNFAIIL 303

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 130/292 (44%), Gaps = 46/292 (15%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQ-------EIAAKRLSK-SSGQGMEEFENEVLLIA 555
           +N +    LG G FG VY+G  + G        ++A K L +  S Q   +F  E L+I+
Sbjct: 47  KNITLIRGLGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIIS 105
Query: 556 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDV----TRSKFLDWSKRCQIIGG 611
           K  H+N+V+ IG   Q   R ++ E +    L  F+ +     ++   L       +   
Sbjct: 106 KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 165
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGIDQTEANTNRV 668
           IA G  YL ++     IHRD+ A N LL         KI DFGMAR    D   A+  R 
Sbjct: 166 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRK 218
Query: 669 VGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGF--YHADHHHNLLGH 722
            G       +MPPE  ++G+F+ K+D +SFGVL+ EI     + G+  Y +  +  +L  
Sbjct: 219 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF----SLGYMPYPSKSNQEVLEF 274
Query: 723 AWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 774
                  + P        G  Y         ++   C Q +PEDRPN + ++
Sbjct: 275 VTSGGRMDPP----KNCPGPVY---------RIMTQCWQHQPEDRPNFAIIL 313

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 99/192 (51%), Gaps = 7/192 (3%)
Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
            +LG G FG V  G    GQ   A ++ K      +EF  E  ++  L H  LV+L G C
Sbjct: 21  KELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
           T++    +I EY+ N  L +++ ++ R +F    +  ++   +   + YL      + +H
Sbjct: 80  TKQRPIFIITEYMANGCLLNYLREM-RHRFQT-QQLLEMCKDVCEAMEYLESK---QFLH 134
Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 689
           RDL A N L++++   K+SDFG++R    D+  ++         + PPE  +   FS KS
Sbjct: 135 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFSSKS 193
Query: 690 DVFSFGVLVLEI 701
           D+++FGVL+ EI
Sbjct: 194 DIWAFGVLMWEI 205

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 115/216 (53%), Gaps = 21/216 (9%)
Query: 497 MAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEI----AAKRLSK-SSGQGMEEFENE 550
           + I   TE F     LG G FG VYKG+ I EG+++    A K L + +S +  +E  +E
Sbjct: 6   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 64
Query: 551 VLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRC 606
             ++A + + ++ +L+G C     + LI + +P   L D++ +    +     L+W  + 
Sbjct: 65  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ- 122
Query: 607 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN 666
                IA G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G ++ E +  
Sbjct: 123 -----IAEGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 174
Query: 667 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
                  +M  E  +  +++ +SDV+S+GV V E++
Sbjct: 175 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 210

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 99/192 (51%), Gaps = 7/192 (3%)
Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
            +LG G FG V  G    GQ   A ++ K      +EF  E  ++  L H  LV+L G C
Sbjct: 10  KELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
           T++    +I EY+ N  L +++ ++ R +F    +  ++   +   + YL      + +H
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREM-RHRF-QTQQLLEMCKDVCEAMEYLESK---QFLH 123
Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 689
           RDL A N L++++   K+SDFG++R    D+  ++         + PPE  +   FS KS
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFSSKS 182
Query: 690 DVFSFGVLVLEI 701
           D+++FGVL+ EI
Sbjct: 183 DIWAFGVLMWEI 194

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 117/223 (52%), Gaps = 21/223 (9%)
Query: 490 ELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEI----AAKRLSK-SSGQG 543
           E P    + I   TE F     LG G FG VYKG+ I EG+++    A K L + +S + 
Sbjct: 4   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 62
Query: 544 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKF 599
            +E  +E  ++A + + ++ +L+G C     + LI + +P   L D++ +    +     
Sbjct: 63  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL 121
Query: 600 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 659
           L+W  +      IA+G+ YL +D RL  +HRDL A NVL+    + KI+DFG A+  G +
Sbjct: 122 LNWCVQ------IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 172
Query: 660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
           + E +         +M  E  +  +++ +SDV+S+GV V E++
Sbjct: 173 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 215

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 115/216 (53%), Gaps = 21/216 (9%)
Query: 497 MAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEI----AAKRLSK-SSGQGMEEFENE 550
           + I   TE F     LG G FG VYKG+ I EG+++    A K L + +S +  +E  +E
Sbjct: 13  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 71
Query: 551 VLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRC 606
             ++A + + ++ +L+G C     + LI + +P   L D++ +    +     L+W  + 
Sbjct: 72  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ- 129
Query: 607 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN 666
                IA+G+ YL +D RL  +HRDL A NVL+    + KI+DFG A+  G ++ E +  
Sbjct: 130 -----IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 181
Query: 667 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
                  +M  E  +  +++ +SDV+S+GV V E++
Sbjct: 182 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 217

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 112/210 (53%), Gaps = 10/210 (4%)
Query: 497 MAIANATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIA 555
           +++ +  + ++   K+G+G  G VY  + +  GQE+A ++++       E   NE+L++ 
Sbjct: 14  VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 73
Query: 556 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARG 615
           + ++ N+V  +      DE  ++ EYL   SL D + +      +D  +   +     + 
Sbjct: 74  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQA 129
Query: 616 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYM 675
           L +LH +   ++IHR++K+ N+LL  + + K++DFG       +Q++ +T  +VGT  +M
Sbjct: 130 LEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWM 184
Query: 676 PPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
            PE      +  K D++S G++ +E++ G+
Sbjct: 185 APEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 86/283 (30%), Positives = 135/283 (47%), Gaps = 36/283 (12%)
Query: 510 NKLGEGGFGPV----YKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
           ++LG+G FG V    Y  +    G  +A K+L  S      +F+ E+ ++  L    +VK
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 565 LIGCC--TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
             G      R    L+ EYLP+  L DF+    R++ LD S+       I +G+ YL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRAR-LDASRLLLYSSQICKGMEYL--G 144
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----P 677
           SR R +HRDL A N+L+++E + KI+DFG+A+   +D+       VV   G  P     P
Sbjct: 145 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DYYVVREPGQSPIFWYAP 199
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 737
           E   D +FS +SDV+SFGV++ E+        F + D   +      R+   ER V  ++
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYEL--------FTYCDKSCSPSAEFLRMMGCERDVPALS 251
Query: 738 KSLGGSYS---LSEVLRCI----QVGLLCVQQRPEDRPNMSSV 773
           + L        L     C     ++  LC    P+DRP+ S++
Sbjct: 252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 294

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 117/223 (52%), Gaps = 21/223 (9%)
Query: 490 ELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEI----AAKRLSK-SSGQG 543
           E P    + I   TE F     LG G FG VYKG+ I EG+++    A K L + +S + 
Sbjct: 2   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 544 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKF 599
            +E  +E  ++A + + ++ +L+G C     + LI + +P   L D++ +    +     
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 600 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 659
           L+W  +      IA+G+ YL +D RL  +HRDL A NVL+    + KI+DFG A+  G +
Sbjct: 120 LNWCVQ------IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 170
Query: 660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
           + E +         +M  E  +  +++ +SDV+S+GV V E++
Sbjct: 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 108/203 (53%), Gaps = 17/203 (8%)
Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
            ++G G FG VYKG       +    ++  + Q ++ F+NEV ++ K +H N++  +G  
Sbjct: 42  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
           T + +  ++ ++    SL   +  +  +KF +  K   I    A+G+ YLH  S   IIH
Sbjct: 102 T-KPQLAIVTQWCEGSSLYHHLH-IIETKF-EMIKLIDIARQTAQGMDYLHAKS---IIH 155
Query: 630 RDLKASNVLLDNEMNPKISDFGMA----RAFGIDQTEANTNRVVGTYGYMPPE---YAID 682
           RDLK++N+ L  ++  KI DFG+A    R  G  Q E    ++ G+  +M PE       
Sbjct: 156 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRMQDK 211
Query: 683 GLFSVKSDVFSFGVLVLEIVCGK 705
             +S +SDV++FG+++ E++ G+
Sbjct: 212 NPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 117/223 (52%), Gaps = 21/223 (9%)
Query: 490 ELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEI----AAKRLSK-SSGQG 543
           E P    + I   TE F     LG G FG VYKG+ I EG+++    A K L + +S + 
Sbjct: 9   EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 67
Query: 544 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKF 599
            +E  +E  ++A + + ++ +L+G C     + LI + +P   L D++ +    +     
Sbjct: 68  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL 126
Query: 600 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 659
           L+W  +      IA+G+ YL +D RL  +HRDL A NVL+    + KI+DFG A+  G +
Sbjct: 127 LNWCVQ------IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 177
Query: 660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
           + E +         +M  E  +  +++ +SDV+S+GV V E++
Sbjct: 178 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 220

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 129/292 (44%), Gaps = 46/292 (15%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQ-------EIAAKRLSK-SSGQGMEEFENEVLLIA 555
           +N +    LG G FG VY+G  + G        ++A K L +  S Q   +F  E L+I+
Sbjct: 48  KNITLIRGLGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIIS 106
Query: 556 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDV----TRSKFLDWSKRCQIIGG 611
           K  H+N+V+ IG   Q   R ++ E +    L  F+ +     ++   L       +   
Sbjct: 107 KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 166
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGIDQTEANTNRV 668
           IA G  YL ++     IHRD+ A N LL         KI DFGMAR    D   A   R 
Sbjct: 167 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRK 219
Query: 669 VGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGF--YHADHHHNLLGH 722
            G       +MPPE  ++G+F+ K+D +SFGVL+ EI     + G+  Y +  +  +L  
Sbjct: 220 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF----SLGYMPYPSKSNQEVLEF 275
Query: 723 AWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 774
                  + P        G  Y         ++   C Q +PEDRPN + ++
Sbjct: 276 VTSGGRMDPP----KNCPGPVY---------RIMTQCWQHQPEDRPNFAIIL 314

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 143/308 (46%), Gaps = 46/308 (14%)
Query: 502 ATENFSDKNKLGEGGFGPVY----KGVLIEGQE--IAAKRLSKSSGQGME-EFENEVLLI 554
           A E  +   +LG+G FG VY    KGV+ +  E  +A K +++++      EF NE  ++
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIF----DVTRSKFL---DWSKRCQ 607
            +    ++V+L+G  +Q    ++I E +    L  ++     ++  +  L     SK  Q
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 608 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 667
           + G IA G+ YL+ +   + +HRDL A N  +  +   KI DFGM R    D  E +  R
Sbjct: 130 MAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR----DIYETDYYR 182
Query: 668 VVGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 723
             G       +M PE   DG+F+  SDV+SFGV++ EI         Y    +  +L   
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVL--- 237
Query: 724 WRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL 783
            R  +E     L++K       L E++R      +C Q  P+ RP+   ++       S+
Sbjct: 238 -RFVMEGG---LLDKPDNCPDMLLELMR------MCWQYNPKMRPSFLEII------SSI 281
Query: 784 PQPKQPGF 791
            +  +PGF
Sbjct: 282 KEEMEPGF 289

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 129/292 (44%), Gaps = 46/292 (15%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQ-------EIAAKRLSK-SSGQGMEEFENEVLLIA 555
           +N +    LG G FG VY+G  + G        ++A K L +  S Q   +F  E L+I+
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIIS 129
Query: 556 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDV----TRSKFLDWSKRCQIIGG 611
           K  H+N+V+ IG   Q   R ++ E +    L  F+ +     ++   L       +   
Sbjct: 130 KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 189
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGIDQTEANTNRV 668
           IA G  YL ++     IHRD+ A N LL         KI DFGMAR    D   A   R 
Sbjct: 190 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRK 242
Query: 669 VGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGF--YHADHHHNLLGH 722
            G       +MPPE  ++G+F+ K+D +SFGVL+ EI     + G+  Y +  +  +L  
Sbjct: 243 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF----SLGYMPYPSKSNQEVLEF 298
Query: 723 AWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 774
                  + P        G  Y         ++   C Q +PEDRPN + ++
Sbjct: 299 VTSGGRMDPP----KNCPGPVY---------RIMTQCWQHQPEDRPNFAIIL 337

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 130/292 (44%), Gaps = 46/292 (15%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQ-------EIAAKRLSKS-SGQGMEEFENEVLLIA 555
           +N +    LG G FG VY+G  + G        ++A K L +  S Q   +F  E L+I+
Sbjct: 45  KNITLIRGLGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIIS 103
Query: 556 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDV----TRSKFLDWSKRCQIIGG 611
           K  H+N+V+ IG   Q   R ++ E +    L  F+ +     ++   L       +   
Sbjct: 104 KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 163
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGIDQTEANTNRV 668
           IA G  YL ++     IHRD+ A N LL         KI DFGMAR    D   A+  R 
Sbjct: 164 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRK 216
Query: 669 VG----TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGF--YHADHHHNLLGH 722
            G       +MPPE  ++G+F+ K+D +SFGVL+ EI     + G+  Y +  +  +L  
Sbjct: 217 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF----SLGYMPYPSKSNQEVLEF 272
Query: 723 AWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 774
                  + P        G  Y         ++   C Q +PEDRPN + ++
Sbjct: 273 VTSGGRMDPP----KNCPGPVY---------RIMTQCWQHQPEDRPNFAIIL 311

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 107/204 (52%), Gaps = 21/204 (10%)
Query: 510 NKLGEGGFGPV----YKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
           ++LG+G FG V    Y  +    G  +A K+L  S      +F+ E+ ++  L    +VK
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 76
Query: 565 LIGCC--TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
             G      R    L+ EYLP+  L DF+    R++ LD S+       I +G+ YL   
Sbjct: 77  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRAR-LDASRLLLYSSQICKGMEYL--G 132
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----P 677
           SR R +HRDL A N+L+++E + KI+DFG+A+   +D+       VV   G  P     P
Sbjct: 133 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DYYVVREPGQSPIFWYAP 187
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEI 701
           E   D +FS +SDV+SFGV++ E+
Sbjct: 188 ESLSDNIFSRQSDVWSFGVVLYEL 211

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 106/203 (52%), Gaps = 17/203 (8%)
Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
            ++G G FG VYKG       +    ++  + Q ++ F+NEV ++ K +H N++  +G  
Sbjct: 30  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
           T   +  ++ ++    SL   +   + +KF +  K   I    ARG+ YLH  S   IIH
Sbjct: 90  TA-PQLAIVTQWCEGSSLYHHLH-ASETKF-EMKKLIDIARQTARGMDYLHAKS---IIH 143
Query: 630 RDLKASNVLLDNEMNPKISDFGMA----RAFGIDQTEANTNRVVGTYGYMPPE---YAID 682
           RDLK++N+ L  +   KI DFG+A    R  G  Q E    ++ G+  +M PE       
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRMQDS 199
Query: 683 GLFSVKSDVFSFGVLVLEIVCGK 705
             +S +SDV++FG+++ E++ G+
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAK--RLSKSSGQGMEEFENEVLLIAKLQHRN 561
           E +    K+GEG +G VYK     G+  A K  RL K           E+ ++ +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 562 LVKLIGCCTQRDERMLIYEYLPN--KSLNDF----IFDVTRSKFLDWSKRCQIIGGIARG 615
           +VKL      +   +L++E+L    K L D     +  VT   FL      Q++ GIA  
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL-----LQLLNGIA-- 114
Query: 616 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYM 675
             Y H     R++HRDLK  N+L++ E   KI+DFG+ARAFGI      T+ VV  +   
Sbjct: 115 --YCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEVVTLWYRA 168
Query: 676 PPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           P        +S   D++S G +  E+V G
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 101/201 (50%), Gaps = 13/201 (6%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E  +   +LG G FG V  G   +GQ   A ++ K      +EF  E   + KL H  LV
Sbjct: 8   EEITLLKELGSGQFGVVKLGKW-KGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           K  G C++     ++ EY+ N  L +++   +  K L+ S+  ++   +  G+ +L    
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLESH- 123
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT---YGYMPPEYA 680
             + IHRDL A N L+D ++  K+SDFGM R    DQ  ++    VGT     +  PE  
Sbjct: 124 --QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS----VGTKFPVKWSAPEVF 177
Query: 681 IDGLFSVKSDVFSFGVLVLEI 701
               +S KSDV++FG+L+ E+
Sbjct: 178 HYFKYSSKSDVWAFGILMWEV 198

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 130/292 (44%), Gaps = 46/292 (15%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQ-------EIAAKRLSK-SSGQGMEEFENEVLLIA 555
           +N +    LG G FG VY+G  + G        ++A K L +  S Q   +F  E L+I+
Sbjct: 57  KNITLIRGLGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIIS 115
Query: 556 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDV----TRSKFLDWSKRCQIIGG 611
           K  H+N+V+ IG   Q   R ++ E +    L  F+ +     ++   L       +   
Sbjct: 116 KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 175
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGIDQTEANTNRV 668
           IA G  YL ++     IHRD+ A N LL         KI DFGMAR    D   A+  R 
Sbjct: 176 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRK 228
Query: 669 VG----TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGF--YHADHHHNLLGH 722
            G       +MPPE  ++G+F+ K+D +SFGVL+ EI     + G+  Y +  +  +L  
Sbjct: 229 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF----SLGYMPYPSKSNQEVLEF 284
Query: 723 AWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 774
                  + P        G  Y         ++   C Q +PEDRPN + ++
Sbjct: 285 VTSGGRMDPP----KNCPGPVY---------RIMTQCWQHQPEDRPNFAIIL 323

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAK--RLSKSSGQGMEEFENEVLLIAKLQHRN 561
           E +    K+GEG +G VYK     G+  A K  RL K           E+ ++ +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 562 LVKLIGCCTQRDERMLIYEYLPN--KSLNDF----IFDVTRSKFLDWSKRCQIIGGIARG 615
           +VKL      +   +L++E+L    K L D     +  VT   FL      Q++ GIA  
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL-----LQLLNGIA-- 114
Query: 616 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYM 675
             Y H     R++HRDLK  N+L++ E   KI+DFG+ARAFGI      T+ VV  +   
Sbjct: 115 --YCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEVVTLWYRA 168
Query: 676 PPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           P        +S   D++S G +  E+V G
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 103/199 (51%), Gaps = 9/199 (4%)
Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
            ++G G FG VYKG       +    ++  + Q ++ F+NEV ++ K +H N++  +G  
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
           T   +  ++ ++    SL   +  +  +KF +  K   I    A+G+ YLH  S   IIH
Sbjct: 74  TA-PQLAIVTQWCEGSSLYHHL-HIIETKF-EMIKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE---YAIDGLFS 686
           RDLK++N+ L  ++  KI DFG+A             ++ G+  +M PE         +S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 687 VKSDVFSFGVLVLEIVCGK 705
            +SDV++FG+++ E++ G+
Sbjct: 188 FQSDVYAFGIVLYELMTGQ 206

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 117/223 (52%), Gaps = 21/223 (9%)
Query: 490 ELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEI----AAKRLSK-SSGQG 543
           E P    + I   TE F     L  G FG VYKG+ I EG+++    A K L + +S + 
Sbjct: 9   EAPNQALLRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 67
Query: 544 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKF 599
            +E  +E  ++A + + ++ +L+G C     + LI + +P   L D++ +    +     
Sbjct: 68  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL 126
Query: 600 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 659
           L+W  +      IA+G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G +
Sbjct: 127 LNWCVQ------IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 177
Query: 660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
           + E +         +M  E  +  +++ +SDV+S+GV V E++
Sbjct: 178 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 220

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 117/223 (52%), Gaps = 21/223 (9%)
Query: 490 ELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEI----AAKRLSK-SSGQG 543
           E P    + I   TE F     L  G FG VYKG+ I EG+++    A K L + +S + 
Sbjct: 9   EAPNQALLRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 67
Query: 544 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKF 599
            +E  +E  ++A + + ++ +L+G C     + LI + +P   L D++ +    +     
Sbjct: 68  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL 126
Query: 600 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 659
           L+W  +      IA+G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G +
Sbjct: 127 LNWCVQ------IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 177
Query: 660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
           + E +         +M  E  +  +++ +SDV+S+GV V E++
Sbjct: 178 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 220

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 106/201 (52%), Gaps = 20/201 (9%)
Query: 512 LGEGGFGPVYKGVLIEGQE-----IAAKRLSK-SSGQGMEEFENEVLLIAKLQHRNLVKL 565
           LG G FG VYKG+ I   E     +A K L + +S +  +E  +E  ++A +    + +L
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
           +G C     + L+ + +P   L D + +    +     L+W  +      IA+G+ YL  
Sbjct: 85  LGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQ------IAKGMSYLED 137
Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
              +R++HRDL A NVL+ +  + KI+DFG+AR   ID+TE + +       +M  E  +
Sbjct: 138 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 194
Query: 682 DGLFSVKSDVFSFGVLVLEIV 702
              F+ +SDV+S+GV V E++
Sbjct: 195 RRRFTHQSDVWSYGVTVWELM 215

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 504 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQHR 560
           ENF    K+GEG +G VYK    + G+ +A K++   +  +G+      E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VKL+      ++  L++E++ ++ L  F+ D +    +        +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHV-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
                R++HRDLK  N+L++ E   K++DFG+ARAFG+      T+ VV T  Y  PE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 174
Query: 681 ID-GLFSVKSDVFSFGVLVLEIVCGK 705
           +    +S   D++S G +  E+V  +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAK--RLSKSSGQGMEEFENEVLLIAKLQHRN 561
           E +    K+GEG +G VYK     G+  A K  RL K           E+ ++ +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 562 LVKLIGCCTQRDERMLIYEYLPN--KSLNDF----IFDVTRSKFLDWSKRCQIIGGIARG 615
           +VKL      +   +L++E+L    K L D     +  VT   FL      Q++ GIA  
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL-----LQLLNGIA-- 114
Query: 616 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYM 675
             Y H     R++HRDLK  N+L++ E   KI+DFG+ARAFGI      T+ +V  +   
Sbjct: 115 --YCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIVTLWYRA 168
Query: 676 PPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           P        +S   D++S G +  E+V G
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 115/228 (50%), Gaps = 14/228 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQ 558
           + ENF    K+GEG +G VYK    + G+ +A K++   +  +G+      E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           H N+VKL+      ++  L++E+L ++ L  F+ D +    +        +  + +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
            H     R++HRDLK  N+L++ E   K++DFG+ARAFG+       + VV T  Y  PE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 176
Query: 679 YAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 725
             +    +S   D++S G +  E+V     R  +  D   + L   +R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 221

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 115/228 (50%), Gaps = 14/228 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQ 558
           + ENF    K+GEG +G VYK    + G+ +A K++   +  +G+      E+ L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           H N+VKL+      ++  L++E+L ++ L  F+ D +    +        +  + +GL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
            H     R++HRDLK  N+L++ E   K++DFG+ARAFG+       + VV T  Y  PE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 175
Query: 679 YAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 725
             +    +S   D++S G +  E+V     R  +  D   + L   +R
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 220

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 117/223 (52%), Gaps = 21/223 (9%)
Query: 490 ELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEI----AAKRLSK-SSGQG 543
           E P    + I   TE F     LG G FG VYKG+ I EG+++    A   L + +S + 
Sbjct: 36  EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKA 94
Query: 544 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKF 599
            +E  +E  ++A + + ++ +L+G C     + LI + +P   L D++ +    +     
Sbjct: 95  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL 153
Query: 600 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 659
           L+W  +      IA+G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G +
Sbjct: 154 LNWCVQ------IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 204
Query: 660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
           + E +         +M  E  +  +++ +SDV+S+GV V E++
Sbjct: 205 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 247

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 117/223 (52%), Gaps = 21/223 (9%)
Query: 490 ELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEI----AAKRLSK-SSGQG 543
           E P    + I   TE F     L  G FG VYKG+ I EG+++    A K L + +S + 
Sbjct: 2   EAPNQALLRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 544 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKF 599
            +E  +E  ++A + + ++ +L+G C     + LI + +P   L D++ +    +     
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 600 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 659
           L+W  +      IA+G+ YL +D RL  +HRDL A NVL+    + KI+DFG+A+  G +
Sbjct: 120 LNWCVQ------IAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
           + E +         +M  E  +  +++ +SDV+S+GV V E++
Sbjct: 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 115/228 (50%), Gaps = 14/228 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQ 558
           + ENF    K+GEG +G VYK    + G+ +A K++   +  +G+      E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           H N+VKL+      ++  L++E+L ++ L  F+ D +    +        +  + +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
            H     R++HRDLK  N+L++ E   K++DFG+ARAFG+       + VV T  Y  PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 173
Query: 679 YAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 725
             +    +S   D++S G +  E+V     R  +  D   + L   +R
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 218

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 115/228 (50%), Gaps = 14/228 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQ 558
           + ENF    K+GEG +G VYK    + G+ +A K++   +  +G+      E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           H N+VKL+      ++  L++E+L ++ L  F+ D +    +        +  + +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
            H     R++HRDLK  N+L++ E   K++DFG+ARAFG+       + VV T  Y  PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 173
Query: 679 YAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 725
             +    +S   D++S G +  E+V     R  +  D   + L   +R
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 218

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 115/228 (50%), Gaps = 14/228 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQ 558
           + ENF    K+GEG +G VYK    + G+ +A K++   +  +G+      E+ L+ +L 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           H N+VKL+      ++  L++E+L ++ L  F+ D +    +        +  + +GL +
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
            H     R++HRDLK  N+L++ E   K++DFG+ARAFG+       + VV T  Y  PE
Sbjct: 123 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 177
Query: 679 YAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 725
             +    +S   D++S G +  E+V     R  +  D   + L   +R
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 222

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 115/228 (50%), Gaps = 14/228 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQ 558
           + ENF    K+GEG +G VYK    + G+ +A K++   +  +G+      E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           H N+VKL+      ++  L++E+L ++ L  F+ D +    +        +  + +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
            H     R++HRDLK  N+L++ E   K++DFG+ARAFG+       + VV T  Y  PE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 176
Query: 679 YAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 725
             +    +S   D++S G +  E+V     R  +  D   + L   +R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 221

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 115/228 (50%), Gaps = 14/228 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQ 558
           + ENF    K+GEG +G VYK    + G+ +A K++   +  +G+      E+ L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           H N+VKL+      ++  L++E+L ++ L  F+ D +    +        +  + +GL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
            H     R++HRDLK  N+L++ E   K++DFG+ARAFG+       + VV T  Y  PE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 175
Query: 679 YAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 725
             +    +S   D++S G +  E+V     R  +  D   + L   +R
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 220

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 115/228 (50%), Gaps = 14/228 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQ 558
           + ENF    K+GEG +G VYK    + G+ +A K++   +  +G+      E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           H N+VKL+      ++  L++E+L ++ L  F+ D +    +        +  + +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
            H     R++HRDLK  N+L++ E   K++DFG+ARAFG+       + VV T  Y  PE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 176
Query: 679 YAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 725
             +    +S   D++S G +  E+V     R  +  D   + L   +R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 221

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 115/228 (50%), Gaps = 14/228 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQ 558
           + ENF    K+GEG +G VYK    + G+ +A K++   +  +G+      E+ L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           H N+VKL+      ++  L++E+L ++ L  F+ D +    +        +  + +GL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
            H     R++HRDLK  N+L++ E   K++DFG+ARAFG+       + VV T  Y  PE
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 174
Query: 679 YAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 725
             +    +S   D++S G +  E+V     R  +  D   + L   +R
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 219

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 115/228 (50%), Gaps = 14/228 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQ 558
           + ENF    K+GEG +G VYK    + G+ +A K++   +  +G+      E+ L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           H N+VKL+      ++  L++E+L ++ L  F+ D +    +        +  + +GL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
            H     R++HRDLK  N+L++ E   K++DFG+ARAFG+       + VV T  Y  PE
Sbjct: 121 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 175
Query: 679 YAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 725
             +    +S   D++S G +  E+V     R  +  D   + L   +R
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 220

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 115/228 (50%), Gaps = 14/228 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQ 558
           + ENF    K+GEG +G VYK    + G+ +A K++   +  +G+      E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           H N+VKL+      ++  L++E+L ++ L  F+ D +    +        +  + +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
            H     R++HRDLK  N+L++ E   K++DFG+ARAFG+       + VV T  Y  PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 173
Query: 679 YAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 725
             +    +S   D++S G +  E+V     R  +  D   + L   +R
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 218

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 115/228 (50%), Gaps = 14/228 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQ 558
           + ENF    K+GEG +G VYK    + G+ +A K++   +  +G+      E+ L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           H N+VKL+      ++  L++E+L ++ L  F+ D +    +        +  + +GL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
            H     R++HRDLK  N+L++ E   K++DFG+ARAFG+       + VV T  Y  PE
Sbjct: 120 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 174
Query: 679 YAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 725
             +    +S   D++S G +  E+V     R  +  D   + L   +R
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 219

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 115/228 (50%), Gaps = 14/228 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQ 558
           + ENF    K+GEG +G VYK    + G+ +A K++   +  +G+      E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           H N+VKL+      ++  L++E+L ++ L  F+ D +    +        +  + +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
            H     R++HRDLK  N+L++ E   K++DFG+ARAFG+       + VV T  Y  PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 173
Query: 679 YAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 725
             +    +S   D++S G +  E+V     R  +  D   + L   +R
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 218

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 114/226 (50%), Gaps = 14/226 (6%)
Query: 504 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQHR 560
           ENF    K+GEG +G VYK    + G+ +A  ++   +  +G+      E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VKL+      ++  L++E+L ++ L  F+ D +    +        +  + +GL + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
                R++HRDLK  N+L++ E   K++DFG+ARAFG+      T+ VV T  Y  PE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 175
Query: 681 ID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 725
           +    +S   D++S G +  E+V     R  +  D   + L   +R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 218

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 114/226 (50%), Gaps = 14/226 (6%)
Query: 504 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQHR 560
           ENF    K+GEG +G VYK    + G+ +A  ++   +  +G+      E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VKL+      ++  L++E+L ++ L  F+ D +    +        +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
                R++HRDLK  N+L++ E   K++DFG+ARAFG+      T+ VV T  Y  PE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 174
Query: 681 ID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 725
           +    +S   D++S G +  E+V     R  +  D   + L   +R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 217

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 114/226 (50%), Gaps = 14/226 (6%)
Query: 504 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQHR 560
           ENF    K+GEG +G VYK    + G+ +A K++   +  +G+      E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VKL+      ++  L++E+L ++ L  F+ D +    +        +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
                R++HRDLK  N+L++ E   K++DFG+ARAFG+       + VV T  Y  PE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEIL 174
Query: 681 ID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 725
           +    +S   D++S G +  E+V     R  +  D   + L   +R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 217

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 104/203 (51%), Gaps = 17/203 (8%)
Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
            ++G G FG VYKG       +   ++   + +  + F NEV ++ K +H N++  +G  
Sbjct: 42  TRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM 101
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
           T +D   ++ ++    SL   +  V  +KF    +   I    A+G+ YLH  +   IIH
Sbjct: 102 T-KDNLAIVTQWCEGSSLYKHL-HVQETKF-QMFQLIDIARQTAQGMDYLHAKN---IIH 155
Query: 630 RDLKASNVLLDNEMNPKISDFGMA----RAFGIDQTEANTNRVVGTYGYMPPE---YAID 682
           RD+K++N+ L   +  KI DFG+A    R  G  Q E  T  V+    +M PE      +
Sbjct: 156 RDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVL----WMAPEVIRMQDN 211
Query: 683 GLFSVKSDVFSFGVLVLEIVCGK 705
             FS +SDV+S+G+++ E++ G+
Sbjct: 212 NPFSFQSDVYSYGIVLYELMTGE 234

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 114/236 (48%), Gaps = 30/236 (12%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQ 558
           + ENF    K+GEG +G VYK    + G+ +A K++   +  +G+      E+ L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQI--------IG 610
           H N+VKL+      ++  L++E+L           +   KF+D S    I        + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL----------SMDLKKFMDASALTGIPLPLIKSYLF 111
Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVG 670
            + +GL + H     R++HRDLK  N+L++ E   K++DFG+ARAFG+       + VV 
Sbjct: 112 QLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV- 166
Query: 671 TYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 725
           T  Y  PE  +    +S   D++S G +  E+V     R  +  D   + L   +R
Sbjct: 167 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 219

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 114/236 (48%), Gaps = 30/236 (12%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQ 558
           + ENF    K+GEG +G VYK    + G+ +A K++   +  +G+      E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQI--------IG 610
           H N+VKL+      ++  L++E+L           +   KF+D S    I        + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL----------SMDLKKFMDASALTGIPLPLIKSYLF 113
Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVG 670
            + +GL + H     R++HRDLK  N+L++ E   K++DFG+ARAFG+       + VV 
Sbjct: 114 QLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV- 168
Query: 671 TYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 725
           T  Y  PE  +    +S   D++S G +  E+V     R  +  D   + L   +R
Sbjct: 169 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 221

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 114/226 (50%), Gaps = 14/226 (6%)
Query: 504 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQHR 560
           ENF    K+GEG +G VYK    + G+ +A K++   +  +G+      E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VKL+      ++  L++E+L ++ L  F+ D +    +        +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
                R++HRDLK  N+L++ E   K++DFG+ARAFG+       + VV T  Y  PE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEIL 174
Query: 681 ID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 725
           +    +S   D++S G +  E+V     R  +  D   + L   +R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 217

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 84/292 (28%), Positives = 130/292 (44%), Gaps = 46/292 (15%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQ-------EIAAKRLSK-SSGQGMEEFENEVLLIA 555
           +N +    LG G FG VY+G  + G        ++A K L +  S Q   +F  E L+I+
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIIS 89
Query: 556 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDV----TRSKFLDWSKRCQIIGG 611
           K  H+N+V+ IG   Q   R ++ E +    L  F+ +     ++   L       +   
Sbjct: 90  KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 149
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGIDQTEANTNRV 668
           IA G  YL ++     IHRD+ A N LL         KI DFGMA+    D   A+  R 
Sbjct: 150 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ----DIYRASYYRK 202
Query: 669 VGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGF--YHADHHHNLLGH 722
            G       +MPPE  ++G+F+ K+D +SFGVL+ EI     + G+  Y +  +  +L  
Sbjct: 203 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF----SLGYMPYPSKSNQEVLEF 258
Query: 723 AWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 774
                  + P        G  Y         ++   C Q +PEDRPN + ++
Sbjct: 259 VTSGGRMDPP----KNCPGPVY---------RIMTQCWQHQPEDRPNFAIIL 297

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 108/206 (52%), Gaps = 11/206 (5%)
Query: 504 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQHR 560
           ENF    K+GEG +G VYK    + G+ +A K++   +  +G+      E+ L+ +L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VKL+      ++  L++E+L ++ L  F+ D +    +        +  + +GL + H
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
                R++HRDLK  N+L++ E   K++DFG+ARAFG+       + VV T  Y  PE  
Sbjct: 122 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPEIL 176
Query: 681 ID-GLFSVKSDVFSFGVLVLEIVCGK 705
           +    +S   D++S G +  E+V  +
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 131/290 (45%), Gaps = 48/290 (16%)
Query: 505 NFSDKNKLGEGGFGPVYKG--VLIEGQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQH 559
           N S    +G G FG V  G   L   +EI+    +   G   +   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGL 616
            N+++L G  T+    M++ EY+ N SL+ F+      K        Q++G   GIA G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 160
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YL   S +  +HRDL A N+L+++ +  K+SDFG+AR    D   A T R     G +P
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTR----GGKIP 213
Query: 677 -----PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER 731
                PE      F+  SDV+S+G+++ E+                  + +  R + E  
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEV------------------MSYGERPYWEMS 255
Query: 732 PVELINKSLGGSYSLSEVLRC----IQVGLLCVQQRPEDRPNMSSVVLML 777
             ++I K++   Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 256 NQDVI-KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 114/236 (48%), Gaps = 30/236 (12%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAKLQ 558
           + ENF    K+GEG +G VYK    + G+ +A K++   +  +G+      E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQI--------IG 610
           H N+VKL+      ++  L++E++          D    KF+D S    I        + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHV----------DQDLKKFMDASALTGIPLPLIKSYLF 113
Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVG 670
            + +GL + H     R++HRDLK  N+L++ E   K++DFG+ARAFG+       + VV 
Sbjct: 114 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV- 168
Query: 671 TYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 725
           T  Y  PE  +    +S   D++S G +  E+V     R  +  D   + L   +R
Sbjct: 169 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 221

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 125/282 (44%), Gaps = 31/282 (10%)
Query: 501 NATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS---KSSGQGMEEFENEVLLIAK 556
           N   NF  + K+G G F  VY+   L++G  +A K++        +   +   E+ L+ +
Sbjct: 29  NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQ 88
Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLD-----WSKRCQIIGG 611
           L H N++K      + +E  ++ E      L+  I    + K L      W    Q+   
Sbjct: 89  LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 671
           +       H  SR R++HRD+K +NV +      K+ D G+ R F    T A++  +VGT
Sbjct: 149 LE------HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 199
Query: 672 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER 731
             YM PE   +  ++ KSD++S G L+ E+        FY         G    L+   +
Sbjct: 200 PYYMSPERIHENGYNFKSDIWSLGCLLYEM--AALQSPFY---------GDKMNLYSLCK 248
Query: 732 PVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
            +E  +     S   SE LR  Q+  +C+   PE RP+++ V
Sbjct: 249 KIEQCDYPPLPSDHYSEELR--QLVNMCINPDPEKRPDVTYV 288

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 28/214 (13%)
Query: 512 LGEGGFGPVYKGVLI--------EGQEIAAKRLSK-SSGQGMEEFENEVLLIAKL-QHRN 561
           LGEG FG V     +        E   +A K L   ++ + + +  +E+ ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFI-----------FDVTR--SKFLDWSKRCQI 608
           ++ L+G CTQ     +I EY    +L +++           +D+ R   + + +      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQTEANTNR 667
              +ARG+ YL   +  + IHRDL A NVL+      KI+DFG+AR    ID  +  TN 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
            +    +M PE   D +++ +SDV+SFGVL+ EI
Sbjct: 220 RLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 28/214 (13%)
Query: 512 LGEGGFGPVYKGVLI--------EGQEIAAKRLSK-SSGQGMEEFENEVLLIAKL-QHRN 561
           LGEG FG V     +        E   +A K L   ++ + + +  +E+ ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFI-----------FDVTR--SKFLDWSKRCQI 608
           ++ L+G CTQ     +I EY    +L +++           +D+ R   + + +      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQTEANTNR 667
              +ARG+ YL   +  + IHRDL A NVL+      KI+DFG+AR    ID  +  TN 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
            +    +M PE   D +++ +SDV+SFGVL+ EI
Sbjct: 220 RLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 48/290 (16%)
Query: 505 NFSDKNKLGEGGFGPVYKG--VLIEGQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQH 559
           N S    +G G FG V  G   L   +EI+    +   G   +   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGL 616
            N+++L G  T+    M++ EY+ N SL+ F+      K        Q++G   GIA G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 160
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YL   S +  +HRDL A N+L+++ +  K+SDFG++R    D   A T R     G +P
Sbjct: 161 KYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIP 213
Query: 677 -----PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER 731
                PE      F+  SDV+S+G+++ E+                  + +  R + E  
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEV------------------MSYGERPYWEMS 255
Query: 732 PVELINKSLGGSYSLSEVLRC----IQVGLLCVQQRPEDRPNMSSVVLML 777
             ++I K++   Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 256 NQDVI-KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 102/206 (49%), Gaps = 28/206 (13%)
Query: 512 LGEGGFG--------PVYKGVLIEGQEIAAKRLSKSSGQGMEE-FENEVLLIAKLQHRNL 562
           LGEG FG        P   G    G+ +A K L +  G  +   ++ E+ ++  L H ++
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 563 VKLIGCCTQRDER--MLIYEYLPNKSLNDFI--FDVTRSKFLDWSKRCQIIGGIARGLLY 618
           VK  GCC  + E+   L+ EY+P  SL D++    V  ++ L ++++      I  G+ Y
Sbjct: 74  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQ------ICEGMAY 127
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GIDQTEANTNRVVGTYGYMP 676
           LH       IHR L A NVLLDN+   KI DFG+A+A   G +      +     + Y  
Sbjct: 128 LHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA- 183
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIV 702
           PE   +  F   SDV+SFGV + E++
Sbjct: 184 PECLKECKFYYASDVWSFGVTLYELL 209

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 102/206 (49%), Gaps = 28/206 (13%)
Query: 512 LGEGGFG--------PVYKGVLIEGQEIAAKRLSKSSGQGMEE-FENEVLLIAKLQHRNL 562
           LGEG FG        P   G    G+ +A K L +  G  +   ++ E+ ++  L H ++
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 563 VKLIGCCTQRDER--MLIYEYLPNKSLNDFI--FDVTRSKFLDWSKRCQIIGGIARGLLY 618
           VK  GCC  + E+   L+ EY+P  SL D++    V  ++ L ++++      I  G+ Y
Sbjct: 73  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQ------ICEGMAY 126
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GIDQTEANTNRVVGTYGYMP 676
           LH       IHR L A NVLLDN+   KI DFG+A+A   G +      +     + Y  
Sbjct: 127 LHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA- 182
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIV 702
           PE   +  F   SDV+SFGV + E++
Sbjct: 183 PECLKECKFYYASDVWSFGVTLYELL 208

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 102/206 (49%), Gaps = 28/206 (13%)
Query: 512 LGEGGFG--------PVYKGVLIEGQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNL 562
           LGEG FG        P   G    G+ +A K L    G Q    ++ E+ ++  L H ++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 563 VKLIGCCTQRDER--MLIYEYLPNKSLNDFI--FDVTRSKFLDWSKRCQIIGGIARGLLY 618
           +K  GCC  + E+   L+ EY+P  SL D++    +  ++ L ++++      I  G+ Y
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQ------ICEGMAY 132
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GIDQTEANTNRVVGTYGYMP 676
           LH       IHR+L A NVLLDN+   KI DFG+A+A   G +      +     + Y  
Sbjct: 133 LHSQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA- 188
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIV 702
           PE   +  F   SDV+SFGV + E++
Sbjct: 189 PECLKEYKFYYASDVWSFGVTLYELL 214

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 28/214 (13%)
Query: 512 LGEGGFGPVYKGVLI--------EGQEIAAKRLSK-SSGQGMEEFENEVLLIAKL-QHRN 561
           LGEG FG V     +        E   +A K L   ++ + + +  +E+ ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFI-----------FDVTR--SKFLDWSKRCQI 608
           ++ L+G CTQ     +I EY    +L +++           +D+ R   + + +      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQTEANTNR 667
              +ARG+ YL   +  + IHRDL A NVL+      KI+DFG+AR    ID  +  TN 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
            +    +M PE   D +++ +SDV+SFGVL+ EI
Sbjct: 220 RLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 48/290 (16%)
Query: 505 NFSDKNKLGEGGFGPVYKG--VLIEGQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQH 559
           N S    +G G FG V  G   L   +EI+    +   G   +   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGL 616
            N+++L G  T+    M++ EY+ N SL+ F+      K        Q++G   GIA G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 160
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YL   S +  +HRDL A N+L+++ +  K+SDFG++R    D   A T R     G +P
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIP 213
Query: 677 -----PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER 731
                PE      F+  SDV+S+G+++ E+                  + +  R + E  
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEV------------------MSYGERPYWEMS 255
Query: 732 PVELINKSLGGSYSLSEVLRC----IQVGLLCVQQRPEDRPNMSSVVLML 777
             ++I K++   Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 256 NQDVI-KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 48/290 (16%)
Query: 505 NFSDKNKLGEGGFGPVYKG--VLIEGQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQH 559
           N S    +G G FG V  G   L   +EI+    +   G   +   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGL 616
            N+++L G  T+    M++ EY+ N SL+ F+      K        Q++G   GIA G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 160
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YL   S +  +HRDL A N+L+++ +  K+SDFG++R    D   A T R     G +P
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIP 213
Query: 677 -----PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER 731
                PE      F+  SDV+S+G+++ E+                  + +  R + E  
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEV------------------MSYGERPYWEMS 255
Query: 732 PVELINKSLGGSYSLSEVLRC----IQVGLLCVQQRPEDRPNMSSVVLML 777
             ++I K++   Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 256 NQDVI-KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL---SKSSGQGME-EFENEVLLIAKL 557
           A E+F     LG+G FG VY     + + I A ++   ++    G+E +   EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +H N+++L G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +    +  + + GT  Y+PP
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDTLCGTLDYLPP 176
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E     +   K D++S GVL  E + GK
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL---SKSSGQGME-EFENEVLLIAKL 557
           A E+F     LG+G FG VY     + + I A ++   ++    G+E +   EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +H N+++L G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +    +    + GT  Y+PP
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTELCGTLDYLPP 175
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E     +   K D++S GVL  E + GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 48/290 (16%)
Query: 505 NFSDKNKLGEGGFGPVYKG--VLIEGQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQH 559
           N S    +G G FG V  G   L   +EI+    +   G   +   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGL 616
            N+++L G  T+    M++ EY+ N SL+ F+      K        Q++G   GIA G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 160
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YL   S +  +HRDL A N+L+++ +  K+SDFG++R    D   A T R     G +P
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIP 213
Query: 677 -----PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER 731
                PE      F+  SDV+S+G+++ E+                  + +  R + E  
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEV------------------MSYGERPYWEMS 255
Query: 732 PVELINKSLGGSYSLSEVLRC----IQVGLLCVQQRPEDRPNMSSVVLML 777
             ++I K++   Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 256 NQDVI-KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 48/290 (16%)
Query: 505 NFSDKNKLGEGGFGPVYKG--VLIEGQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQH 559
           N S    +G G FG V  G   L   +EI+    +   G   +   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGL 616
            N+++L G  T+    M++ EY+ N SL+ F+      K        Q++G   GIA G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 160
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YL   S +  +HRDL A N+L+++ +  K+SDFG++R    D   A T R     G +P
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIP 213
Query: 677 -----PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER 731
                PE      F+  SDV+S+G+++ E+                  + +  R + E  
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEV------------------MSYGERPYWEMS 255
Query: 732 PVELINKSLGGSYSLSEVLRC----IQVGLLCVQQRPEDRPNMSSVVLML 777
             ++I K++   Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 256 NQDVI-KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 512 LGEGGFGPVYKGVL-IEGQE---IAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLI 566
           +G G  G V  G L + GQ    +A K L    + +   +F +E  ++ +  H N+++L 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 626
           G  T+    M++ EY+ N SL+ F+   T        +   ++ G+  G+ YL   S L 
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---SDLG 171
Query: 627 IIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----PEYAI 681
            +HRDL A NVL+D+ +  K+SDFG++R    D   A T     T G +P     PE   
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTT----TGGKIPIRWTAPEAIA 227
Query: 682 DGLFSVKSDVFSFGVLVLEIVC 703
              FS  SDV+SFGV++ E++ 
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLA 249

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 102/206 (49%), Gaps = 28/206 (13%)
Query: 512 LGEGGFG--------PVYKGVLIEGQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNL 562
           LGEG FG        P   G    G+ +A K L    G Q    ++ E+ ++  L H ++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 563 VKLIGCCTQRDER--MLIYEYLPNKSLNDFI--FDVTRSKFLDWSKRCQIIGGIARGLLY 618
           +K  GCC  + E+   L+ EY+P  SL D++    +  ++ L ++++      I  G+ Y
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQ------ICEGMAY 132
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GIDQTEANTNRVVGTYGYMP 676
           LH       IHR+L A NVLLDN+   KI DFG+A+A   G +      +     + Y  
Sbjct: 133 LHAQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA- 188
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIV 702
           PE   +  F   SDV+SFGV + E++
Sbjct: 189 PECLKEYKFYYASDVWSFGVTLYELL 214

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 48/290 (16%)
Query: 505 NFSDKNKLGEGGFGPVYKG--VLIEGQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQH 559
           N S    +G G FG V  G   L   +EI+    +   G   +   +F  E  ++ +  H
Sbjct: 44  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 103
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGL 616
            N+++L G  T+    M++ EY+ N SL+ F+      K        Q++G   GIA G+
Sbjct: 104 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 158
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YL   S +  +HRDL A N+L+++ +  K+SDFG++R    D   A T R     G +P
Sbjct: 159 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIP 211
Query: 677 -----PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER 731
                PE      F+  SDV+S+G+++ E+                  + +  R + E  
Sbjct: 212 IRWTSPEAIAYRKFTSASDVWSYGIVLWEV------------------MSYGERPYWEMS 253
Query: 732 PVELINKSLGGSYSLSEVLRC----IQVGLLCVQQRPEDRPNMSSVVLML 777
             ++I K++   Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 254 NQDVI-KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 302

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL---SKSSGQGME-EFENEVLLIAKL 557
           A E+F     LG+G FG VY     + + I A ++   ++    G+E +   EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +H N+++L G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +    +    + GT  Y+PP
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 175
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E     +   K D++S GVL  E + GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 28/214 (13%)
Query: 512 LGEGGFGPVYKGVLI--------EGQEIAAKRLSK-SSGQGMEEFENEVLLIAKL-QHRN 561
           LGEG FG V     +        E   +A K L   ++ + + +  +E+ ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFI-----------FDVTR--SKFLDWSKRCQI 608
           ++ L+G CTQ     +I EY    +L +++           +D+ R   + + +      
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQTEANTNR 667
              +ARG+ YL   +  + IHRDL A NVL+      KI+DFG+AR    ID  +  TN 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
            +    +M PE   D +++ +SDV+SFGVL+ EI
Sbjct: 220 RLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 28/214 (13%)
Query: 512 LGEGGFGPVYKGVLI--------EGQEIAAKRLSK-SSGQGMEEFENEVLLIAKL-QHRN 561
           LGEG FG V     +        E   +A K L   ++ + + +  +E+ ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFI-----------FDVTR--SKFLDWSKRCQI 608
           ++ L+G CTQ     +I EY    +L +++           +D+ R   + + +      
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQTEANTNR 667
              +ARG+ YL   +  + IHRDL A NVL+      KI+DFG+AR    ID  +  TN 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
            +    +M PE   D +++ +SDV+SFGVL+ EI
Sbjct: 220 RLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 16/201 (7%)
Query: 512 LGEGGFGPVYKGVLI-----EGQEIAAKRLS-KSSGQGMEEFENEVLLIAKLQHRNLVKL 565
           LGEG FG V            G+++A K L  +S G  + + + E+ ++  L H N+VK 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 566 IGCCTQR--DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
            G CT+   +   LI E+LP+ SL +++        ++  ++ +    I +G+ YL   S
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL--GS 144
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT--NRVVGTYGYMPPEYAI 681
           R + +HRDL A NVL+++E   KI DFG+ +A   D+       +R    + Y  PE  +
Sbjct: 145 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYA-PECLM 202
Query: 682 DGLFSVKSDVFSFGVLVLEIV 702
              F + SDV+SFGV + E++
Sbjct: 203 QSKFYIASDVWSFGVTLHELL 223

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL---SKSSGQGME-EFENEVLLIAKL 557
           A E+F     LG+G FG VY     + + I A ++   ++    G+E +   EV + + L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +H N+++L G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +    +  + + GT  Y+PP
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGTLDYLPP 201
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E     +   K D++S GVL  E + GK
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 48/290 (16%)
Query: 505 NFSDKNKLGEGGFGPVYKG--VLIEGQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQH 559
           N S    +G G FG V  G   L   +EI+    +   G   +   +F  E  ++ +  H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGL 616
            N+++L G  T+    M++ EY+ N SL+ F+      K        Q++G   GIA G+
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 131
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YL   S +  +HRDL A N+L+++ +  K+SDFG++R    D   A T R     G +P
Sbjct: 132 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIP 184
Query: 677 -----PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER 731
                PE      F+  SDV+S+G+++ E+                  + +  R + E  
Sbjct: 185 IRWTSPEAIAYRKFTSASDVWSYGIVLWEV------------------MSYGERPYWEMS 226
Query: 732 PVELINKSLGGSYSLSEVLRC----IQVGLLCVQQRPEDRPNMSSVVLML 777
             ++I K++   Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 227 NQDVI-KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL---SKSSGQGME-EFENEVLLIAKL 557
           A E+F     LG+G FG VY     + + I A ++   ++    G+E +   EV + + L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +H N+++L G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +    +    + GT  Y+PP
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 201
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E     +   K D++S GVL  E + GK
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 130/290 (44%), Gaps = 48/290 (16%)
Query: 505 NFSDKNKLGEGGFGPVYKG--VLIEGQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQH 559
           N S    +G G FG V  G   L   +EI+    +   G   +   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGL 616
            N+++L G  T+    M++ EY+ N SL+ F+      K        Q++G   GIA G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 160
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YL   S +  +HRDL A N+L+++ +  K+SDFG+ R    D   A T R     G +P
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR----GGKIP 213
Query: 677 -----PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER 731
                PE      F+  SDV+S+G+++ E+                  + +  R + E  
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEV------------------MSYGERPYWEMS 255
Query: 732 PVELINKSLGGSYSLSEVLRC----IQVGLLCVQQRPEDRPNMSSVVLML 777
             ++I K++   Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 256 NQDVI-KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 107/219 (48%), Gaps = 28/219 (12%)
Query: 501 NATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFE-NEVLLIAKLQ 558
           +++  F    KLG G +  VYKG+    G  +A K +   S +G       E+ L+ +L+
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFI-----------FDVTRSKFLDWSKRCQ 607
           H N+V+L       ++  L++E++ N  L  ++            ++   K+  W     
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQ---- 116
Query: 608 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 667
               + +GL + H++   +I+HRDLK  N+L++     K+ DFG+ARAFGI     ++  
Sbjct: 117 ----LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEV 169
Query: 668 VVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGK 705
           V  T  Y  P+  +    +S   D++S G ++ E++ GK
Sbjct: 170 V--TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 16/201 (7%)
Query: 512 LGEGGFGPVYKGVLI-----EGQEIAAKRLS-KSSGQGMEEFENEVLLIAKLQHRNLVKL 565
           LGEG FG V            G+++A K L  +S G  + + + E+ ++  L H N+VK 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 566 IGCCTQR--DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
            G CT+   +   LI E+LP+ SL +++        ++  ++ +    I +G+ YL   S
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL--GS 132
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT--NRVVGTYGYMPPEYAI 681
           R + +HRDL A NVL+++E   KI DFG+ +A   D+       +R    + Y  PE  +
Sbjct: 133 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYA-PECLM 190
Query: 682 DGLFSVKSDVFSFGVLVLEIV 702
              F + SDV+SFGV + E++
Sbjct: 191 QSKFYIASDVWSFGVTLHELL 211

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL---SKSSGQGME-EFENEVLLIAKL 557
           A E+F     LG+G FG VY     + + I A ++   ++    G+E +   EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +H N+++L G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +    +    + GT  Y+PP
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E     +   K D++S GVL  E + GK
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 114/205 (55%), Gaps = 25/205 (12%)
Query: 512 LGEGGFGPVYKGVLIE--GQEI--AAKRLSKSSGQG-MEEFENEVLLIAKLQHRNLVKLI 566
           +G G FG VY G L++  G++I  A K L++ +  G + +F  E +++    H N++ L+
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 567 GCCTQRD-ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGLLYLHQD 622
           G C + +   +++  Y+ +  L +FI + T +  +       +IG    +A+G+ YL   
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL--- 148
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY-AI 681
           +  + +HRDL A N +LD +   K++DFG+AR     +  +  N+   T   +P ++ A+
Sbjct: 149 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNK---TGAKLPVKWMAL 205
Query: 682 DGL----FSVKSDVFSFGVLVLEIV 702
           + L    F+ KSDV+SFGVL+ E++
Sbjct: 206 ESLQTQKFTTKSDVWSFGVLLWELM 230

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 125/265 (47%), Gaps = 38/265 (14%)
Query: 529 QEIAAKRLSKSSGQ-GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSL 587
           +++A KR++    Q  M+E   E+  +++  H N+V        +DE  L+ + L   S+
Sbjct: 36  EKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSV 95
Query: 588 NDFIFDVT-----RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE 642
            D I  +      +S  LD S    I+  +  GL YLH++ +   IHRD+KA N+LL  +
Sbjct: 96  LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGED 152
Query: 643 MNPKISDFGMAR--AFGIDQTEANTNRV-VGTYGYMPPEY--AIDGLFSVKSDVFSFGVL 697
            + +I+DFG++   A G D T     +  VGT  +M PE    + G +  K+D++SFG+ 
Sbjct: 153 GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRG-YDFKADIWSFGIT 211
Query: 698 VLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL--------INKSLGGSYSLSEV 749
            +E+  G        A +H         L ++  P  L        + K  G S+     
Sbjct: 212 AIELATGA-------APYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFR---- 260
Query: 750 LRCIQVGLLCVQQRPEDRPNMSSVV 774
               ++  LC+Q+ PE RP  + ++
Sbjct: 261 ----KMISLCLQKDPEKRPTAAELL 281

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 48/290 (16%)
Query: 505 NFSDKNKLGEGGFGPVYKG--VLIEGQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQH 559
           N S    +G G FG V  G   L   +EI+    +   G   +   +F  E  ++ +  H
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 93
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGL 616
            N+++L G  T+    M++ EY+ N SL+ F+      K        Q++G   GIA G+
Sbjct: 94  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 148
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YL   S +  +HRDL A N+L+++ +  K+SDFG++R    D   A T R     G +P
Sbjct: 149 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIP 201
Query: 677 -----PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER 731
                PE      F+  SDV+S+G+++ E+                  + +  R + E  
Sbjct: 202 IRWTSPEAIAYRKFTSASDVWSYGIVLWEV------------------MSYGERPYWEMS 243
Query: 732 PVELINKSLGGSYSLSEVLRC----IQVGLLCVQQRPEDRPNMSSVVLML 777
             ++I K++   Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 244 NQDVI-KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 292

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 115/222 (51%), Gaps = 27/222 (12%)
Query: 497 MAIANATENFSDKNK----LGEGGFGPVYKGVL----IEGQEIAAKRLSKSSGQGMEEFE 548
           M + ++T  FSD+ K    LG+G FG V   +L    I GQE A K +SK   +   + E
Sbjct: 21  MFVQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKE 77
Query: 549 N---EVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR 605
           +   EV L+ +L H N++KL      +    L+ E      L D I  ++R +F +    
Sbjct: 78  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDA- 134
Query: 606 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFGIDQTE 662
            +II  +  G+ Y+H++   +I+HRDLK  N+LL++   + N +I DFG++  F   +  
Sbjct: 135 ARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EAS 188
Query: 663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
                 +GT  Y+ PE  + G +  K DV+S GV++  ++ G
Sbjct: 189 KKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL---SKSSGQGME-EFENEVLLIAKL 557
           A E+F     LG+G FG VY     + + I A ++   ++    G+E +   EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +H N+++L G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +    +  + + GT  Y+PP
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGTLDYLPP 178
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E     +   K D++S GVL  E + GK
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 512 LGEGGFGPVYKGVL-IEGQE---IAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLI 566
           +G G  G V  G L + GQ    +A K L    + +   +F +E  ++ +  H N+++L 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 626
           G  T+    M++ EY+ N SL+ F+   T        +   ++ G+  G+ YL   S L 
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---SDLG 171
Query: 627 IIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----PEYAI 681
            +HRDL A NVL+D+ +  K+SDFG++R    D   A T     T G +P     PE   
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT----TGGKIPIRWTAPEAIA 227
Query: 682 DGLFSVKSDVFSFGVLVLEIVC 703
              FS  SDV+SFGV++ E++ 
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLA 249

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 28/214 (13%)
Query: 512 LGEGGFGPVYKGVLI--------EGQEIAAKRLSK-SSGQGMEEFENEVLLIAKL-QHRN 561
           LGEG FG V     +        E   +A K L   ++ + + +  +E+ ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFI-----------FDVTR--SKFLDWSKRCQI 608
           ++ L+G CTQ     +I EY    +L +++           +D+ R   + + +      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQTEANTNR 667
              +ARG+ YL   +  + IHRDL A NVL+      KI+DFG+AR    ID  +  TN 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
            +    +M PE   D +++ +SDV+SFGVL+ EI
Sbjct: 220 RLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL---SKSSGQGME-EFENEVLLIAKL 557
           A E+F     LG+G FG VY     + + I A ++   ++    G+E +   EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +H N+++L G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +    +    + GT  Y+PP
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E     +   K D++S GVL  E + GK
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL---SKSSGQGME-EFENEVLLIAKL 557
           A E+F     LG+G FG VY     + + I A ++   ++    G+E +   EV + + L
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +H N+++L G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 121
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +    +    + GT  Y+PP
Sbjct: 122 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 174
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E     +   K D++S GVL  E + GK
Sbjct: 175 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL---SKSSGQGME-EFENEVLLIAKL 557
           A E+F     LG+G FG VY     + + I A ++   ++    G+E +   EV + + L
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +H N+++L G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 139
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +    +    + GT  Y+PP
Sbjct: 140 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 192
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E     +   K D++S GVL  E + GK
Sbjct: 193 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL---SKSSGQGME-EFENEVLLIAKL 557
           A E+F     LG+G FG VY     + + I A ++   ++    G+E +   EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +H N+++L G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +    +    + GT  Y+PP
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTXLCGTLDYLPP 175
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E     +   K D++S GVL  E + GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL---SKSSGQGME-EFENEVLLIAKL 557
           A E+F     LG+G FG VY     + + I A ++   ++    G+E +   EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +H N+++L G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +    +    + GT  Y+PP
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 175
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E     +   K D++S GVL  E + GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL---SKSSGQGME-EFENEVLLIAKL 557
           A E+F     LG+G FG VY     + + I A ++   ++    G+E +   EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +H N+++L G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +    +    + GT  Y+PP
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 176
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E     +   K D++S GVL  E + GK
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL---SKSSGQGME-EFENEVLLIAKL 557
           A E+F     LG+G FG VY     + + I A ++   ++    G+E +   EV + + L
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +H N+++L G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 126
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +    +    + GT  Y+PP
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 179
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E     +   K D++S GVL  E + GK
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL---SKSSGQGME-EFENEVLLIAKL 557
           A E+F     LG+G FG VY     + + I A ++   ++    G+E +   EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +H N+++L G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +    +    + GT  Y+PP
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 175
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E     +   K D++S GVL  E + GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL---SKSSGQGME-EFENEVLLIAKL 557
           A E+F     LG+G FG VY     + + I A ++   ++    G+E +   EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +H N+++L G         LI EY P   +   +  +  SKF D  +    I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKL--SKF-DEQRTATYITELANALS 127
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +    +    + GT  Y+PP
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E     +   K D++S GVL  E + GK
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIA----AKRLSKSSGQG--MEEFENEVLLIAKL 557
           N      LG G FG V +      G+E A    A ++ KS+      E   +E+ +++ L
Sbjct: 39  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 98
Query: 558 -QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFI-------FDVTRSKFLDWSKRCQII 609
            QH N+V L+G CT     ++I EY     L +F+        D    + L+        
Sbjct: 99  GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 158
Query: 610 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV 669
             +A+G+ +L   +    IHRD+ A NVLL N    KI DFG+AR    D          
Sbjct: 159 SQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 215
Query: 670 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
               +M PE   D +++V+SDV+S+G+L+ EI
Sbjct: 216 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 247

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL---SKSSGQGME-EFENEVLLIAKL 557
           A E+F     LG+G FG VY     + + I A ++   ++    G+E +   EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +H N+++L G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +    +    + GT  Y+PP
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 180
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E     +   K D++S GVL  E + GK
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL---SKSSGQGME-EFENEVLLIAKL 557
           A E+F     LG+G FG VY     + + I A ++   ++    G+E +   EV + + L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +H N+++L G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +    +    + GT  Y+PP
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 177
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E     +   K D++S GVL  E + GK
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 125/265 (47%), Gaps = 38/265 (14%)
Query: 529 QEIAAKRLSKSSGQ-GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSL 587
           +++A KR++    Q  M+E   E+  +++  H N+V        +DE  L+ + L   S+
Sbjct: 41  EKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSV 100
Query: 588 NDFIFDVT-----RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE 642
            D I  +      +S  LD S    I+  +  GL YLH++ +   IHRD+KA N+LL  +
Sbjct: 101 LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGED 157
Query: 643 MNPKISDFGMAR--AFGIDQTEANTNRV-VGTYGYMPPEY--AIDGLFSVKSDVFSFGVL 697
            + +I+DFG++   A G D T     +  VGT  +M PE    + G +  K+D++SFG+ 
Sbjct: 158 GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRG-YDFKADIWSFGIT 216
Query: 698 VLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL--------INKSLGGSYSLSEV 749
            +E+  G        A +H         L ++  P  L        + K  G S+     
Sbjct: 217 AIELATGA-------APYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFR---- 265
Query: 750 LRCIQVGLLCVQQRPEDRPNMSSVV 774
               ++  LC+Q+ PE RP  + ++
Sbjct: 266 ----KMISLCLQKDPEKRPTAAELL 286

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 115/222 (51%), Gaps = 27/222 (12%)
Query: 497 MAIANATENFSDKNK----LGEGGFGPVYKGVL----IEGQEIAAKRLSKSSGQGMEEFE 548
           M + ++T  FSD+ K    LG+G FG V   +L    I GQE A K +SK   +   + E
Sbjct: 15  MFVQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKE 71
Query: 549 N---EVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR 605
           +   EV L+ +L H N++KL      +    L+ E      L D I  ++R +F +    
Sbjct: 72  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDA- 128
Query: 606 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFGIDQTE 662
            +II  +  G+ Y+H++   +I+HRDLK  N+LL++   + N +I DFG++  F   +  
Sbjct: 129 ARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EAS 182
Query: 663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
                 +GT  Y+ PE  + G +  K DV+S GV++  ++ G
Sbjct: 183 KKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL---SKSSGQGME-EFENEVLLIAKL 557
           A E+F     LG+G FG VY     + + I A ++   ++    G+E +   EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +H N+++L G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +    +    + GT  Y+PP
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E     +   K D++S GVL  E + GK
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 28/214 (13%)
Query: 512 LGEGGFGPVYKGVLI--------EGQEIAAKRLSK-SSGQGMEEFENEVLLIAKL-QHRN 561
           LGEG FG V     +        E   +A K L   ++ + + +  +E+ ++  + +H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFI-----------FDVTR--SKFLDWSKRCQI 608
           ++ L+G CTQ     +I EY    +L +++           +D+ R   + + +      
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQTEANTNR 667
              +ARG+ YL   +  + IHRDL A NVL+      KI+DFG+AR    ID  +  TN 
Sbjct: 150 TYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
            +    +M PE   D +++ +SDV+SFGVL+ EI
Sbjct: 207 RLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 239

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 115/222 (51%), Gaps = 27/222 (12%)
Query: 497 MAIANATENFSDKNK----LGEGGFGPVYKGVL----IEGQEIAAKRLSKSSGQGMEEFE 548
           M + ++T  FSD+ K    LG+G FG V   +L    I GQE A K +SK   +   + E
Sbjct: 38  MFVQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKE 94
Query: 549 N---EVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR 605
           +   EV L+ +L H N++KL      +    L+ E      L D I  ++R +F +    
Sbjct: 95  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDA- 151
Query: 606 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFGIDQTE 662
            +II  +  G+ Y+H++   +I+HRDLK  N+LL++   + N +I DFG++  F   +  
Sbjct: 152 ARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EAS 205
Query: 663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
                 +GT  Y+ PE  + G +  K DV+S GV++  ++ G
Sbjct: 206 KKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIA----AKRLSKSSGQG--MEEFENEVLLIAKL 557
           N      LG G FG V +      G+E A    A ++ KS+      E   +E+ +++ L
Sbjct: 47  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 558 -QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFI-------FDVTRSKFLDWSKRCQII 609
            QH N+V L+G CT     ++I EY     L +F+        D    + L+        
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 166
Query: 610 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV 669
             +A+G+ +L   +    IHRD+ A NVLL N    KI DFG+AR    D          
Sbjct: 167 SQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 223
Query: 670 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
               +M PE   D +++V+SDV+S+G+L+ EI
Sbjct: 224 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 255

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 131/283 (46%), Gaps = 48/283 (16%)
Query: 512 LGEGGFGPVYKGVL-IEGQE---IAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLI 566
           +G G FG V  G L + G+    +A K L    + +   +F +E  ++ +  H N++ L 
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGLLYLHQDS 623
           G  T+    M+I EY+ N SL+ F+      +F       Q++G   GI  G+ YL   S
Sbjct: 97  GVVTKCKPVMIITEYMENGSLDAFLRK-NDGRF----TVIQLVGMLRGIGSGMKYL---S 148
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----PE 678
            +  +HRDL A N+L+++ +  K+SDFGM+R    D   A T R     G +P     PE
Sbjct: 149 DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR----GGKIPIRWTAPE 204
Query: 679 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 738
                 F+  SDV+S+G+++ E+                  + +  R + +    ++I K
Sbjct: 205 AIAYRKFTSASDVWSYGIVMWEV------------------MSYGERPYWDMSNQDVI-K 245
Query: 739 SLGGSYSLSEVLRCI----QVGLLCVQQRPEDRPNMSSVVLML 777
           ++   Y L   + C     Q+ L C Q+   DRP    +V ML
Sbjct: 246 AIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 288

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL---SKSSGQGME-EFENEVLLIAKL 557
           A E+F     LG+G FG VY     + + I A ++   ++    G+E +   EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +H N+++L G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +    +    + GT  Y+PP
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 175
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E     +   K D++S GVL  E + GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL---SKSSGQGME-EFENEVLLIAKL 557
           A E+F     LG+G FG VY     + + I A ++   ++    G+E +   EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +H N+++L G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +    +    + GT  Y+PP
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 178
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E     +   K D++S GVL  E + GK
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 28/214 (13%)
Query: 512 LGEGGFGPVYKGVLI--------EGQEIAAKRLSK-SSGQGMEEFENEVLLIAKL-QHRN 561
           LGEG FG V     +        E   +A K L   ++ + + +  +E+ ++  + +H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFI-----------FDVTR--SKFLDWSKRCQI 608
           ++ L+G CTQ     +I EY    +L +++           +D+ R   + + +      
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQTEANTNR 667
              +ARG+ YL   +  + IHRDL A NVL+      KI+DFG+AR    ID  +  TN 
Sbjct: 155 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
            +    +M PE   D +++ +SDV+SFGVL+ EI
Sbjct: 212 RLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 244

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL---SKSSGQGME-EFENEVLLIAKL 557
           A E+F     LG+G FG VY     + + I A ++   ++    G+E +   EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +H N+++L G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +    +    + GT  Y+PP
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 178
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E     +   K D++S GVL  E + GK
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 28/214 (13%)
Query: 512 LGEGGFGPVYKGVLI--------EGQEIAAKRLSK-SSGQGMEEFENEVLLIAKL-QHRN 561
           LGEG FG V     +        E   +A K L   ++ + + +  +E+ ++  + +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFI-----------FDVTR--SKFLDWSKRCQI 608
           ++ L+G CTQ     +I EY    +L +++           +D+ R   + + +      
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQTEANTNR 667
              +ARG+ YL   +  + IHRDL A NVL+      KI+DFG+AR    ID  +  TN 
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
            +    +M PE   D +++ +SDV+SFGVL+ EI
Sbjct: 266 RLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 298

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL---SKSSGQGME-EFENEVLLIAKL 557
           A E+F     LG+G FG VY     + + I A ++   ++    G+E +   EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +H N+++L G         LI EY P   +   +  +  SKF D  +    I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKL--SKF-DEQRTATYITELANALS 127
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +    +    + GT  Y+PP
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLXGTLDYLPP 180
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E     +   K D++S GVL  E + GK
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 28/214 (13%)
Query: 512 LGEGGFGPVYKGVLI--------EGQEIAAKRLSK-SSGQGMEEFENEVLLIAKL-QHRN 561
           LGEG FG V     +        E   +A K L   ++ + + +  +E+ ++  + +H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFI-----------FDVTR--SKFLDWSKRCQI 608
           ++ L+G CTQ     +I EY    +L +++           +D+ R   + + +      
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQTEANTNR 667
              +ARG+ YL   +  + IHRDL A NVL+      KI+DFG+AR    ID  +  TN 
Sbjct: 152 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
            +    +M PE   D +++ +SDV+SFGVL+ EI
Sbjct: 209 RLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 241

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 115/222 (51%), Gaps = 27/222 (12%)
Query: 497 MAIANATENFSDKNK----LGEGGFGPVYKGVL----IEGQEIAAKRLSKSSGQGMEEFE 548
           M + ++T  FSD+ K    LG+G FG V   +L    I GQE A K +SK   +   + E
Sbjct: 39  MFVQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKE 95
Query: 549 N---EVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR 605
           +   EV L+ +L H N++KL      +    L+ E      L D I  ++R +F +    
Sbjct: 96  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDA- 152
Query: 606 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFGIDQTE 662
            +II  +  G+ Y+H++   +I+HRDLK  N+LL++   + N +I DFG++  F   +  
Sbjct: 153 ARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EAS 206
Query: 663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
                 +GT  Y+ PE  + G +  K DV+S GV++  ++ G
Sbjct: 207 KKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 114/205 (55%), Gaps = 25/205 (12%)
Query: 512 LGEGGFGPVYKGVLIE--GQEI--AAKRLSKSSGQG-MEEFENEVLLIAKLQHRNLVKLI 566
           +G G FG VY G L++  G++I  A K L++ +  G + +F  E +++    H N++ L+
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 567 GCCTQRD-ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGLLYLHQD 622
           G C + +   +++  Y+ +  L +FI + T +  +       +IG    +A+G+ YL   
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL--- 167
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY-AI 681
           +  + +HRDL A N +LD +   K++DFG+AR     +  +  N+   T   +P ++ A+
Sbjct: 168 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK---TGAKLPVKWMAL 224
Query: 682 DGL----FSVKSDVFSFGVLVLEIV 702
           + L    F+ KSDV+SFGVL+ E++
Sbjct: 225 ESLQTQKFTTKSDVWSFGVLLWELM 249

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 114/205 (55%), Gaps = 25/205 (12%)
Query: 512 LGEGGFGPVYKGVLIE--GQEI--AAKRLSKSSGQG-MEEFENEVLLIAKLQHRNLVKLI 566
           +G G FG VY G L++  G++I  A K L++ +  G + +F  E +++    H N++ L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 567 GCCTQRD-ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGLLYLHQD 622
           G C + +   +++  Y+ +  L +FI + T +  +       +IG    +A+G+ YL   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL--- 149
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY-AI 681
           +  + +HRDL A N +LD +   K++DFG+AR     +  +  N+   T   +P ++ A+
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK---TGAKLPVKWMAL 206
Query: 682 DGL----FSVKSDVFSFGVLVLEIV 702
           + L    F+ KSDV+SFGVL+ E++
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 508 DKNKLGEGGFGPVYKGVLIEGQ-EIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLI 566
           D+  LG+G +G VY G  +  Q  IA K + +   +  +    E+ L   L+H+N+V+ +
Sbjct: 26  DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG----GIARGLLYLHQD 622
           G  ++     +  E +P  SL+  +    RSK+       Q IG     I  GL YLH +
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 141
Query: 623 SRLRIIHRDLKASNVLLDNEMNP-KISDFGMA-RAFGIDQTEANTNRVVGTYGYMPPEYA 680
              +I+HRD+K  NVL++      KISDFG + R  GI+     T    GT  YM PE  
Sbjct: 142 ---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC---TETFTGTLQYMAPEII 195
Query: 681 IDGL--FSVKSDVFSFGVLVLEIVCGK 705
             G   +   +D++S G  ++E+  GK
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 114/205 (55%), Gaps = 25/205 (12%)
Query: 512 LGEGGFGPVYKGVLIE--GQEI--AAKRLSKSSGQG-MEEFENEVLLIAKLQHRNLVKLI 566
           +G G FG VY G L++  G++I  A K L++ +  G + +F  E +++    H N++ L+
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 567 GCCTQRD-ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGLLYLHQD 622
           G C + +   +++  Y+ +  L +FI + T +  +       +IG    +A+G+ YL   
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL--- 168
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY-AI 681
           +  + +HRDL A N +LD +   K++DFG+AR     +  +  N+   T   +P ++ A+
Sbjct: 169 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK---TGAKLPVKWMAL 225
Query: 682 DGL----FSVKSDVFSFGVLVLEIV 702
           + L    F+ KSDV+SFGVL+ E++
Sbjct: 226 ESLQTQKFTTKSDVWSFGVLLWELM 250

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 114/205 (55%), Gaps = 25/205 (12%)
Query: 512 LGEGGFGPVYKGVLIE--GQEI--AAKRLSKSSGQG-MEEFENEVLLIAKLQHRNLVKLI 566
           +G G FG VY G L++  G++I  A K L++ +  G + +F  E +++    H N++ L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 567 GCCTQRD-ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGLLYLHQD 622
           G C + +   +++  Y+ +  L +FI + T +  +       +IG    +A+G+ YL   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL--- 149
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY-AI 681
           +  + +HRDL A N +LD +   K++DFG+AR     +  +  N+   T   +P ++ A+
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK---TGAKLPVKWMAL 206
Query: 682 DGL----FSVKSDVFSFGVLVLEIV 702
           + L    F+ KSDV+SFGVL+ E++
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 114/205 (55%), Gaps = 25/205 (12%)
Query: 512 LGEGGFGPVYKGVLIE--GQEI--AAKRLSKSSGQG-MEEFENEVLLIAKLQHRNLVKLI 566
           +G G FG VY G L++  G++I  A K L++ +  G + +F  E +++    H N++ L+
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 567 GCCTQRD-ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGLLYLHQD 622
           G C + +   +++  Y+ +  L +FI + T +  +       +IG    +A+G+ YL   
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL--- 144
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY-AI 681
           +  + +HRDL A N +LD +   K++DFG+AR     +  +  N+   T   +P ++ A+
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK---TGAKLPVKWMAL 201
Query: 682 DGL----FSVKSDVFSFGVLVLEIV 702
           + L    F+ KSDV+SFGVL+ E++
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELM 226

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 107/214 (50%), Gaps = 28/214 (13%)
Query: 512 LGEGGFGPVYKGVLI--------EGQEIAAKRLSK-SSGQGMEEFENEVLLIAKL-QHRN 561
           LGEG FG V     +        E   +A K L   ++ + + +  +E+ ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFI-----------FDVTR--SKFLDWSKRCQI 608
           ++ L+G CTQ     +I EY    +L +++           +D+ R   + + +      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQTEANTNR 667
              +ARG+ YL   +  + IHRDL A NVL+      +I+DFG+AR    ID  +  TN 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
            +    +M PE   D +++ +SDV+SFGVL+ EI
Sbjct: 220 RLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 131/283 (46%), Gaps = 48/283 (16%)
Query: 512 LGEGGFGPVYKGVL-IEGQE---IAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLI 566
           +G G FG V  G L + G+    +A K L    + +   +F +E  ++ +  H N++ L 
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGLLYLHQDS 623
           G  T+    M+I EY+ N SL+ F+      +F       Q++G   GI  G+ YL   S
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDAFLRK-NDGRF----TVIQLVGMLRGIGSGMKYL---S 133
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----PE 678
            +  +HRDL A N+L+++ +  K+SDFGM+R    D   A T R     G +P     PE
Sbjct: 134 DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR----GGKIPIRWTAPE 189
Query: 679 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 738
                 F+  SDV+S+G+++ E+                  + +  R + +    ++I K
Sbjct: 190 AIAYRKFTSASDVWSYGIVMWEV------------------MSYGERPYWDMSNQDVI-K 230
Query: 739 SLGGSYSLSEVLRCI----QVGLLCVQQRPEDRPNMSSVVLML 777
           ++   Y L   + C     Q+ L C Q+   DRP    +V ML
Sbjct: 231 AIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 273

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 114/205 (55%), Gaps = 25/205 (12%)
Query: 512 LGEGGFGPVYKGVLIE--GQEI--AAKRLSKSSGQG-MEEFENEVLLIAKLQHRNLVKLI 566
           +G G FG VY G L++  G++I  A K L++ +  G + +F  E +++    H N++ L+
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 567 GCCTQRD-ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGLLYLHQD 622
           G C + +   +++  Y+ +  L +FI + T +  +       +IG    +A+G+ YL   
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL--- 147
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY-AI 681
           +  + +HRDL A N +LD +   K++DFG+AR     +  +  N+   T   +P ++ A+
Sbjct: 148 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK---TGAKLPVKWMAL 204
Query: 682 DGL----FSVKSDVFSFGVLVLEIV 702
           + L    F+ KSDV+SFGVL+ E++
Sbjct: 205 ESLQTQKFTTKSDVWSFGVLLWELM 229

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 114/205 (55%), Gaps = 25/205 (12%)
Query: 512 LGEGGFGPVYKGVLIE--GQEI--AAKRLSKSSGQG-MEEFENEVLLIAKLQHRNLVKLI 566
           +G G FG VY G L++  G++I  A K L++ +  G + +F  E +++    H N++ L+
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 567 GCCTQRD-ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGLLYLHQD 622
           G C + +   +++  Y+ +  L +FI + T +  +       +IG    +A+G+ YL   
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL--- 141
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY-AI 681
           +  + +HRDL A N +LD +   K++DFG+AR     +  +  N+   T   +P ++ A+
Sbjct: 142 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK---TGAKLPVKWMAL 198
Query: 682 DGL----FSVKSDVFSFGVLVLEIV 702
           + L    F+ KSDV+SFGVL+ E++
Sbjct: 199 ESLQTQKFTTKSDVWSFGVLLWELM 223

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 131/283 (46%), Gaps = 48/283 (16%)
Query: 512 LGEGGFGPVYKGVL-IEGQE---IAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLI 566
           +G G FG V  G L + G+    +A K L    + +   +F +E  ++ +  H N++ L 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGLLYLHQDS 623
           G  T+    M+I EY+ N SL+ F+      +F       Q++G   GI  G+ YL   S
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDAFLRK-NDGRF----TVIQLVGMLRGIGSGMKYL---S 127
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----PE 678
            +  +HRDL A N+L+++ +  K+SDFGM+R    D   A T R     G +P     PE
Sbjct: 128 DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR----GGKIPIRWTAPE 183
Query: 679 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 738
                 F+  SDV+S+G+++ E+                  + +  R + +    ++I K
Sbjct: 184 AIAYRKFTSASDVWSYGIVMWEV------------------MSYGERPYWDMSNQDVI-K 224
Query: 739 SLGGSYSLSEVLRCI----QVGLLCVQQRPEDRPNMSSVVLML 777
           ++   Y L   + C     Q+ L C Q+   DRP    +V ML
Sbjct: 225 AIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 267

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 114/205 (55%), Gaps = 25/205 (12%)
Query: 512 LGEGGFGPVYKGVLIE--GQEI--AAKRLSKSSGQG-MEEFENEVLLIAKLQHRNLVKLI 566
           +G G FG VY G L++  G++I  A K L++ +  G + +F  E +++    H N++ L+
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 567 GCCTQRD-ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGLLYLHQD 622
           G C + +   +++  Y+ +  L +FI + T +  +       +IG    +A+G+ YL   
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL--- 148
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY-AI 681
           +  + +HRDL A N +LD +   K++DFG+AR     +  +  N+   T   +P ++ A+
Sbjct: 149 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK---TGAKLPVKWMAL 205
Query: 682 DGL----FSVKSDVFSFGVLVLEIV 702
           + L    F+ KSDV+SFGVL+ E++
Sbjct: 206 ESLQTQKFTTKSDVWSFGVLLWELM 230

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL---SKSSGQGME-EFENEVLLIAKL 557
           A E+F     LG+G FG VY     + + I A ++   ++    G+E +   EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +H N+++L G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +    +    + GT  Y+PP
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 175
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E     +   K D++S GVL  E + GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 114/205 (55%), Gaps = 25/205 (12%)
Query: 512 LGEGGFGPVYKGVLIE--GQEI--AAKRLSKSSGQG-MEEFENEVLLIAKLQHRNLVKLI 566
           +G G FG VY G L++  G++I  A K L++ +  G + +F  E +++    H N++ L+
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 567 GCCTQRD-ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGLLYLHQD 622
           G C + +   +++  Y+ +  L +FI + T +  +       +IG    +A+G+ YL   
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYL--- 146
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY-AI 681
           +  + +HRDL A N +LD +   K++DFG+AR     +  +  N+   T   +P ++ A+
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK---TGAKLPVKWMAL 203
Query: 682 DGL----FSVKSDVFSFGVLVLEIV 702
           + L    F+ KSDV+SFGVL+ E++
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELM 228

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 508 DKNKLGEGGFGPVYKGVLIEGQ-EIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLI 566
           D+  LG+G +G VY G  +  Q  IA K + +   +  +    E+ L   L+H+N+V+ +
Sbjct: 12  DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 71
Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG----GIARGLLYLHQD 622
           G  ++     +  E +P  SL+  +    RSK+       Q IG     I  GL YLH +
Sbjct: 72  GSFSENGFIKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 127
Query: 623 SRLRIIHRDLKASNVLLDNEMNP-KISDFGMA-RAFGIDQTEANTNRVVGTYGYMPPEYA 680
              +I+HRD+K  NVL++      KISDFG + R  GI+     T    GT  YM PE  
Sbjct: 128 ---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC---TETFTGTLQYMAPEII 181
Query: 681 IDGL--FSVKSDVFSFGVLVLEIVCGK 705
             G   +   +D++S G  ++E+  GK
Sbjct: 182 DKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 115/205 (56%), Gaps = 25/205 (12%)
Query: 512 LGEGGFGPVYKGVLIE--GQEI--AAKRLSKSSGQG-MEEFENEVLLIAKLQHRNLVKLI 566
           +G G FG VY G L++  G++I  A K L++ +  G + +F  E +++    H N++ L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 567 GCCTQRD-ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGLLYLHQD 622
           G C + +   +++  Y+ +  L +FI + T +  +       +IG    +A+G+ +L   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKFL--- 149
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY-AI 681
           +  + +HRDL A N +LD +   K++DFG+AR     + ++  N+   T   +P ++ A+
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK---TGAKLPVKWMAL 206
Query: 682 DGL----FSVKSDVFSFGVLVLEIV 702
           + L    F+ KSDV+SFGVL+ E++
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 115/205 (56%), Gaps = 25/205 (12%)
Query: 512 LGEGGFGPVYKGVLIE--GQEI--AAKRLSKSSGQG-MEEFENEVLLIAKLQHRNLVKLI 566
           +G G FG VY G L++  G++I  A K L++ +  G + +F  E +++    H N++ L+
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 567 GCCTQRD-ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGLLYLHQD 622
           G C + +   +++  Y+ +  L +FI + T +  +       +IG    +A+G+ +L   
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKFL--- 147
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY-AI 681
           +  + +HRDL A N +LD +   K++DFG+AR     + ++  N+   T   +P ++ A+
Sbjct: 148 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK---TGAKLPVKWMAL 204
Query: 682 DGL----FSVKSDVFSFGVLVLEIV 702
           + L    F+ KSDV+SFGVL+ E++
Sbjct: 205 ESLQTQKFTTKSDVWSFGVLLWELM 229

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 115/205 (56%), Gaps = 25/205 (12%)
Query: 512 LGEGGFGPVYKGVLIE--GQEI--AAKRLSKSSGQG-MEEFENEVLLIAKLQHRNLVKLI 566
           +G G FG VY G L++  G++I  A K L++ +  G + +F  E +++    H N++ L+
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 567 GCCTQRD-ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGLLYLHQD 622
           G C + +   +++  Y+ +  L +FI + T +  +       +IG    +A+G+ +L   
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKFL--- 150
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY-AI 681
           +  + +HRDL A N +LD +   K++DFG+AR     + ++  N+   T   +P ++ A+
Sbjct: 151 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK---TGAKLPVKWMAL 207
Query: 682 DGL----FSVKSDVFSFGVLVLEIV 702
           + L    F+ KSDV+SFGVL+ E++
Sbjct: 208 ESLQTQKFTTKSDVWSFGVLLWELM 232

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL---SKSSGQGME-EFENEVLLIAKL 557
           A E+F     LG+G FG VY     + + I A ++   ++    G+E +   EV + + L
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +H N+++L G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 119
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +    +    + GT  Y+PP
Sbjct: 120 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 172
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E     +   K D++S GVL  E + GK
Sbjct: 173 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 115/205 (56%), Gaps = 25/205 (12%)
Query: 512 LGEGGFGPVYKGVLIE--GQEI--AAKRLSKSSGQG-MEEFENEVLLIAKLQHRNLVKLI 566
           +G G FG VY G L++  G++I  A K L++ +  G + +F  E +++    H N++ L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 567 GCCTQRD-ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGLLYLHQD 622
           G C + +   +++  Y+ +  L +FI + T +  +       +IG    +A+G+ +L   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKFL--- 149
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY-AI 681
           +  + +HRDL A N +LD +   K++DFG+AR     + ++  N+   T   +P ++ A+
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK---TGAKLPVKWMAL 206
Query: 682 DGL----FSVKSDVFSFGVLVLEIV 702
           + L    F+ KSDV+SFGVL+ E++
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVL-IEGQEIAAKRLSKSSGQGME-EFENEVLLIAKLQHRN 561
           E+     ++G G FG V+ G L  +   +A K   ++    ++ +F  E  ++ +  H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFI-FDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           +V+LIG CTQ+    ++ E +      DF+ F  T    L      Q++G  A G+ YL 
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQG---GDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR--AFGIDQTEANTNRVVGTYGYMPPE 678
                  IHRDL A N L+  +   KISDFGM+R  A G+        +V     +  PE
Sbjct: 231 SKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQV--PVKWTAPE 285
Query: 679 YAIDGLFSVKSDVFSFGVLVLE 700
               G +S +SDV+SFG+L+ E
Sbjct: 286 ALNYGRYSSESDVWSFGILLWE 307

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 115/205 (56%), Gaps = 25/205 (12%)
Query: 512 LGEGGFGPVYKGVLIE--GQEI--AAKRLSKSSGQG-MEEFENEVLLIAKLQHRNLVKLI 566
           +G G FG VY G L++  G++I  A K L++ +  G + +F  E +++    H N++ L+
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 567 GCCTQRD-ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGLLYLHQD 622
           G C + +   +++  Y+ +  L +FI + T +  +       +IG    +A+G+ +L   
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKFL--- 208
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY-AI 681
           +  + +HRDL A N +LD +   K++DFG+AR     + ++  N+   T   +P ++ A+
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK---TGAKLPVKWMAL 265
Query: 682 DGL----FSVKSDVFSFGVLVLEIV 702
           + L    F+ KSDV+SFGVL+ E++
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELM 290

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL---SKSSGQGME-EFENEVLLIAKL 557
           A E+F     LG+G FG VY     + + I A ++   ++    G+E +   EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +H N+++L G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           Y H     R+IHRD+K  N+LL +    KI+DFG    + +    +    + GT  Y+PP
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E         K D++S GVL  E + GK
Sbjct: 181 EXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 115/205 (56%), Gaps = 25/205 (12%)
Query: 512 LGEGGFGPVYKGVLIE--GQEI--AAKRLSKSSGQG-MEEFENEVLLIAKLQHRNLVKLI 566
           +G G FG VY G L++  G++I  A K L++ +  G + +F  E +++    H N++ L+
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 567 GCCTQRD-ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGLLYLHQD 622
           G C + +   +++  Y+ +  L +FI + T +  +       +IG    +A+G+ +L   
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKFL--- 154
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY-AI 681
           +  + +HRDL A N +LD +   K++DFG+AR     + ++  N+   T   +P ++ A+
Sbjct: 155 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK---TGAKLPVKWMAL 211
Query: 682 DGL----FSVKSDVFSFGVLVLEIV 702
           + L    F+ KSDV+SFGVL+ E++
Sbjct: 212 ESLQTQKFTTKSDVWSFGVLLWELM 236

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 115/205 (56%), Gaps = 25/205 (12%)
Query: 512 LGEGGFGPVYKGVLIE--GQEI--AAKRLSKSSGQG-MEEFENEVLLIAKLQHRNLVKLI 566
           +G G FG VY G L++  G++I  A K L++ +  G + +F  E +++    H N++ L+
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 567 GCCTQRD-ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGLLYLHQD 622
           G C + +   +++  Y+ +  L +FI + T +  +       +IG    +A+G+ +L   
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKFL--- 150
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY-AI 681
           +  + +HRDL A N +LD +   K++DFG+AR     + ++  N+   T   +P ++ A+
Sbjct: 151 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNK---TGAKLPVKWMAL 207
Query: 682 DGL----FSVKSDVFSFGVLVLEIV 702
           + L    F+ KSDV+SFGVL+ E++
Sbjct: 208 ESLQTQKFTTKSDVWSFGVLLWELM 232

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 107/198 (54%), Gaps = 13/198 (6%)
Query: 511 KLGEGGFGPVYKGV--LIEGQ-EIAAKRLSKSSGQG-MEEFENEVLLIAKLQHRNLVKLI 566
           +LG G FG V +GV  + + Q ++A K L + + +   EE   E  ++ +L +  +V+LI
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 626
           G C Q +  ML+ E      L+ F+  V + + +  S   +++  ++ G+ YL + +   
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKN--- 130
Query: 627 IIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTY--GYMPPEYAIDGL 684
            +HRDL A NVLL N    KISDFG+++A G D +   T R  G +   +  PE      
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKWPLKWYAPECINFRK 189
Query: 685 FSVKSDVFSFGVLVLEIV 702
           FS +SDV+S+GV + E +
Sbjct: 190 FSSRSDVWSYGVTMWEAL 207

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 512 LGEGGFG--------PVYKGVLIEGQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNL 562
           LGEG FG        P   G    G+ +A K L   +G Q    ++ E+ ++  L H ++
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 563 VKLIGCCTQRDER--MLIYEYLPNKSLNDFI--FDVTRSKFLDWSKRCQIIGGIARGLLY 618
           +K  GCC         L+ EY+P  SL D++    +  ++ L ++++      I  G+ Y
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQ------ICEGMAY 149
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GIDQTEANTNRVVGTYGYMP 676
           LH       IHRDL A NVLLDN+   KI DFG+A+A   G +      +     + Y  
Sbjct: 150 LHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYA- 205
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIV 702
           PE   +  F   SDV+SFGV + E++
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELL 231

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 505 NFSDKNKLGEGGFGPVYKGV-LIEGQEIA-----AKRLSKSSGQGMEEFENEVLLIAKLQ 558
           N+     LGEG FG V        GQ++A      K L+KS  QG    E E+  +  L+
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLR 71
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           H +++KL      +DE +++ EY  N+ L D+I  V R K  +   R +    I   + Y
Sbjct: 72  HPHIIKLYDVIKSKDEIIMVIEYAGNE-LFDYI--VQRDKMSEQEAR-RFFQQIISAVEY 127
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV-VGTYGYMPP 677
            H   R +I+HRDLK  N+LLD  +N KI+DFG++       T+ N  +   G+  Y  P
Sbjct: 128 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAP 180
Query: 678 EYAIDGLFS-VKSDVFSFGVLVLEIVC 703
           E     L++  + DV+S GV++  ++C
Sbjct: 181 EVISGKLYAGPEVDVWSCGVILYVMLC 207

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 505 NFSDKNKLGEGGFGPVYKGV-LIEGQEIA-----AKRLSKSSGQGMEEFENEVLLIAKLQ 558
           N+     LGEG FG V        GQ++A      K L+KS  QG    E E+  +  L+
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLR 62
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           H +++KL      +DE +++ EY  N+ L D+I  V R K  +   R +    I   + Y
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEYAGNE-LFDYI--VQRDKMSEQEAR-RFFQQIISAVEY 118
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV-VGTYGYMPP 677
            H   R +I+HRDLK  N+LLD  +N KI+DFG++       T+ N  +   G+  Y  P
Sbjct: 119 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAP 171
Query: 678 EYAIDGLFS-VKSDVFSFGVLVLEIVC 703
           E     L++  + DV+S GV++  ++C
Sbjct: 172 EVISGKLYAGPEVDVWSCGVILYVMLC 198

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 505 NFSDKNKLGEGGFGPVYKGV-LIEGQEIA-----AKRLSKSSGQGMEEFENEVLLIAKLQ 558
           N+     LGEG FG V        GQ++A      K L+KS  QG    E E+  +  L+
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLR 72
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           H +++KL      +DE +++ EY  N+ L D+I  V R K  +   R +    I   + Y
Sbjct: 73  HPHIIKLYDVIKSKDEIIMVIEYAGNE-LFDYI--VQRDKMSEQEAR-RFFQQIISAVEY 128
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV-VGTYGYMPP 677
            H   R +I+HRDLK  N+LLD  +N KI+DFG++       T+ N  +   G+  Y  P
Sbjct: 129 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAP 181
Query: 678 EYAIDGLFS-VKSDVFSFGVLVLEIVC 703
           E     L++  + DV+S GV++  ++C
Sbjct: 182 EVISGKLYAGPEVDVWSCGVILYVMLC 208

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 505 NFSDKNKLGEGGFGPVYKGV-LIEGQEIA-----AKRLSKSSGQGMEEFENEVLLIAKLQ 558
           N+     LGEG FG V        GQ++A      K L+KS  QG    E E+  +  L+
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLR 66
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           H +++KL      +DE +++ EY  N+ L D+I  V R K  +   R +    I   + Y
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEYAGNE-LFDYI--VQRDKMSEQEAR-RFFQQIISAVEY 122
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV-VGTYGYMPP 677
            H   R +I+HRDLK  N+LLD  +N KI+DFG++       T+ N  +   G+  Y  P
Sbjct: 123 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAP 175
Query: 678 EYAIDGLFS-VKSDVFSFGVLVLEIVC 703
           E     L++  + DV+S GV++  ++C
Sbjct: 176 EVISGKLYAGPEVDVWSCGVILYVMLC 202

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 109/218 (50%), Gaps = 36/218 (16%)
Query: 512 LGEGGFGPVYKGVLIEG-----------QEIAAKRL-SKSSGQGMEEFENEVLLIAKL-Q 558
           LGEG FG V   VL E             ++A K L S ++ + + +  +E+ ++  + +
Sbjct: 25  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 81
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR------------- 605
           H+N++ L+G CTQ     +I EY    +L +++    R   L++S               
Sbjct: 82  HKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQLSSKD 140
Query: 606 -CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQTEA 663
                  +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    ID  + 
Sbjct: 141 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 197
Query: 664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
            TN  +    +M PE   D +++ +SDV+SFGVL+ EI
Sbjct: 198 TTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 234

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 109/218 (50%), Gaps = 36/218 (16%)
Query: 512 LGEGGFGPVYKGVLIEG-----------QEIAAKRL-SKSSGQGMEEFENEVLLIAKL-Q 558
           LGEG FG V   VL E             ++A K L S ++ + + +  +E+ ++  + +
Sbjct: 29  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 85
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR------------- 605
           H+N++ L+G CTQ     +I EY    +L +++    R   L++S               
Sbjct: 86  HKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQLSSKD 144
Query: 606 -CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQTEA 663
                  +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    ID  + 
Sbjct: 145 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 201
Query: 664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
            TN  +    +M PE   D +++ +SDV+SFGVL+ EI
Sbjct: 202 TTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 238

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVL-IEGQEIAAKRLSKSSGQGME-EFENEVLLIAKLQHRN 561
           E+     ++G G FG V+ G L  +   +A K   ++    ++ +F  E  ++ +  H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFI-FDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           +V+LIG CTQ+    ++ E +      DF+ F  T    L      Q++G  A G+ YL 
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQG---GDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR--AFGIDQTEANTNRVVGTYGYMPPE 678
                  IHRDL A N L+  +   KISDFGM+R  A G+        +V     +  PE
Sbjct: 231 SKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV--PVKWTAPE 285
Query: 679 YAIDGLFSVKSDVFSFGVLVLE 700
               G +S +SDV+SFG+L+ E
Sbjct: 286 ALNYGRYSSESDVWSFGILLWE 307

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 109/218 (50%), Gaps = 36/218 (16%)
Query: 512 LGEGGFGPVYKGVLIEG-----------QEIAAKRL-SKSSGQGMEEFENEVLLIAKL-Q 558
           LGEG FG V   VL E             ++A K L S ++ + + +  +E+ ++  + +
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR------------- 605
           H+N++ L+G CTQ     +I EY    +L +++    R   L++S               
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQLSSKD 151
Query: 606 -CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQTEA 663
                  +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    ID  + 
Sbjct: 152 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
            TN  +    +M PE   D +++ +SDV+SFGVL+ EI
Sbjct: 209 TTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 109/218 (50%), Gaps = 36/218 (16%)
Query: 512 LGEGGFGPVYKGVLIEG-----------QEIAAKRL-SKSSGQGMEEFENEVLLIAKL-Q 558
           LGEG FG V   VL E             ++A K L S ++ + + +  +E+ ++  + +
Sbjct: 28  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 84
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR------------- 605
           H+N++ L+G CTQ     +I EY    +L +++    R   L++S               
Sbjct: 85  HKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQLSSKD 143
Query: 606 -CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQTEA 663
                  +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    ID  + 
Sbjct: 144 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 200
Query: 664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
            TN  +    +M PE   D +++ +SDV+SFGVL+ EI
Sbjct: 201 TTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 237

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL---SKSSGQGME-EFENEVLLIAKL 557
           A E+F     LG+G FG VY     + + I A ++   ++    G+E +   EV + + L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +H N+++L G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           Y H     R+IHRD+K  N+LL +    KI++FG    + +    +    + GT  Y+PP
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPP 177
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E     +   K D++S GVL  E + GK
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 105/197 (53%), Gaps = 13/197 (6%)
Query: 511 KLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
           +LG+G FG VYK    E G   AAK +   S + +E++  E+ ++A   H  +VKL+G  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
               +  ++ E+ P  +++  + ++ R   L   +   +   +   L +LH     RIIH
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLHSK---RIIH 140
Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI-----DGL 684
           RDLKA NVL+  E + +++DFG++ A  + +T    +  +GT  +M PE  +     D  
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVS-AKNL-KTLQKRDSFIGTPYWMAPEVVMCETMKDTP 198
Query: 685 FSVKSDVFSFGVLVLEI 701
           +  K+D++S G+ ++E+
Sbjct: 199 YDYKADIWSLGITLIEM 215

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL---SKSSGQGME-EFENEVLLIAKL 557
           A E+F     LG+G FG VY     + + I A ++   ++    G+E +   EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +H N+++L G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           Y H     R+IHRD+K  N+LL +    KI++FG    + +    +    + GT  Y+PP
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E     +   K D++S GVL  E + GK
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 105/197 (53%), Gaps = 13/197 (6%)
Query: 511 KLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
           +LG+G FG VYK    E G   AAK +   S + +E++  E+ ++A   H  +VKL+G  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
               +  ++ E+ P  +++  + ++ R   L   +   +   +   L +LH     RIIH
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLHSK---RIIH 132
Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI-----DGL 684
           RDLKA NVL+  E + +++DFG++ A  + +T    +  +GT  +M PE  +     D  
Sbjct: 133 RDLKAGNVLMTLEGDIRLADFGVS-AKNL-KTLQKRDSFIGTPYWMAPEVVMCETMKDTP 190
Query: 685 FSVKSDVFSFGVLVLEI 701
           +  K+D++S G+ ++E+
Sbjct: 191 YDYKADIWSLGITLIEM 207

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 28/214 (13%)
Query: 512 LGEGGFGPVYKGVLI--------EGQEIAAKRLSK-SSGQGMEEFENEVLLIAKL-QHRN 561
           LGEG FG V     +        E   +A K L   ++ + + +  +E+ ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFI-----------FDVTR--SKFLDWSKRCQI 608
           ++ L+G CTQ     +I  Y    +L +++           +D+ R   + + +      
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQTEANTNR 667
              +ARG+ YL   +  + IHRDL A NVL+      KI+DFG+AR    ID  +  TN 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
            +    +M PE   D +++ +SDV+SFGVL+ EI
Sbjct: 220 RLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL---SKSSGQGME-EFENEVLLIAKL 557
           A E+F     LG+G FG VY     + + I A ++   ++    G+E +   EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +H N+++L G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           Y H     R+IHRD+K  N+LL +    KI+DFG    +      +    + GT  Y+PP
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSCHAPSSRRTTLSGTLDYLPP 176
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E     +   K D++S GVL  E + GK
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIA----AKRLSKSSGQG--MEEFENEVLLIAKL 557
           N      LG G FG V +      G+E A    A ++ KS+      E   +E+ +++ L
Sbjct: 47  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 558 -QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 616
            QH N+V L+G CT     ++I EY     L +F+    +S+ L+      I    A   
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL--RRKSRVLETDPAFAIANSTASTR 164
Query: 617 LYLHQDSRL----------RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN 666
             LH  S++            IHRD+ A NVLL N    KI DFG+AR    D       
Sbjct: 165 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 667 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
                  +M PE   D +++V+SDV+S+G+L+ EI
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 20/202 (9%)
Query: 512 LGEGGFGPVYKGVLI-EGQEI----AAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKL 565
           LG G FG V+KGV I EG+ I      K +   SG Q  +   + +L I  L H ++V+L
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
           +G C     + L+ +YLP  SL D +      +     L+W  +      IA+G+ YL +
Sbjct: 81  LGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAKGMYYLEE 133
Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
                ++HR+L A NVLL +    +++DFG+A     D  +   +       +M  E   
Sbjct: 134 HG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190
Query: 682 DGLFSVKSDVFSFGVLVLEIVC 703
            G ++ +SDV+S+GV V E++ 
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMT 212

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 109/218 (50%), Gaps = 36/218 (16%)
Query: 512 LGEGGFGPVYKGVLIEG-----------QEIAAKRL-SKSSGQGMEEFENEVLLIAKL-Q 558
           LGEG FG V   VL E             ++A K L S ++ + + +  +E+ ++  + +
Sbjct: 77  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR------------- 605
           H+N++ L+G CTQ     +I EY    +L +++    R   L++S               
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 606 -CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQTEA 663
                  +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    ID  + 
Sbjct: 193 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
            TN  +    +M PE   D +++ +SDV+SFGVL+ EI
Sbjct: 250 TTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 286

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 109/218 (50%), Gaps = 36/218 (16%)
Query: 512 LGEGGFGPVYKGVLIEG-----------QEIAAKRL-SKSSGQGMEEFENEVLLIAKL-Q 558
           LGEG FG V   VL E             ++A K L S ++ + + +  +E+ ++  + +
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWS--------------K 604
           H+N++ L+G CTQ     +I EY    +L +++    R   L++S               
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEFSFNPSHNPEEQLSSKD 151
Query: 605 RCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQTEA 663
                  +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    ID  + 
Sbjct: 152 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKK 208
Query: 664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
            TN  +    +M PE   D +++ +SDV+SFGVL+ EI
Sbjct: 209 TTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 20/202 (9%)
Query: 512 LGEGGFGPVYKGVLI-EGQEI----AAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKL 565
           LG G FG V+KGV I EG+ I      K +   SG Q  +   + +L I  L H ++V+L
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
           +G C     + L+ +YLP  SL D +      +     L+W  +      IA+G+ YL +
Sbjct: 99  LGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAKGMYYLEE 151
Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
                ++HR+L A NVLL +    +++DFG+A     D  +   +       +M  E   
Sbjct: 152 HG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 208
Query: 682 DGLFSVKSDVFSFGVLVLEIVC 703
            G ++ +SDV+S+GV V E++ 
Sbjct: 209 FGKYTHQSDVWSYGVTVWELMT 230

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 128/291 (43%), Gaps = 48/291 (16%)
Query: 512 LGEGGFGPVYKGVL--IEGQE----IAAKRLSK-SSGQGMEEFENEVLLIAKLQHRNLVK 564
           LGEG FG V K     ++G+     +A K L + +S   + +  +E  ++ ++ H +++K
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFI---------------------FDVTRSKFLDWS 603
           L G C+Q    +LI EY    SL  F+                      D    + L   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 604 KRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 663
                   I++G+ YL   + ++++HRDL A N+L+      KISDFG++R    + +  
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGH 722
             ++      +M  E   D +++ +SDV+SFGVL+ EIV  G         +   NLL  
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKT 267
Query: 723 AWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
             R+   ERP               E+ R +   L C +Q P+ RP  + +
Sbjct: 268 GHRM---ERP----------DNCSEEMYRLM---LQCWKQEPDKRPVFADI 302

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 130/290 (44%), Gaps = 48/290 (16%)
Query: 505 NFSDKNKLGEGGFGPVYKG--VLIEGQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQH 559
           N S    +G G FG V  G   L   +EI+    +   G   +   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGL 616
            N+++L G  T+    M++ E + N SL+ F+      K        Q++G   GIA G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 160
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YL   S +  +HRDL A N+L+++ +  K+SDFG++R    D   A T R     G +P
Sbjct: 161 KYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIP 213
Query: 677 -----PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER 731
                PE      F+  SDV+S+G+++ E+                  + +  R + E  
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEV------------------MSYGERPYWEMS 255
Query: 732 PVELINKSLGGSYSLSEVLRC----IQVGLLCVQQRPEDRPNMSSVVLML 777
             ++I K++   Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 256 NQDVI-KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 130/290 (44%), Gaps = 48/290 (16%)
Query: 505 NFSDKNKLGEGGFGPVYKG--VLIEGQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQH 559
           N S    +G G FG V  G   L   +EI+    +   G   +   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGL 616
            N+++L G  T+    M++ E + N SL+ F+      K        Q++G   GIA G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 160
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YL   S +  +HRDL A N+L+++ +  K+SDFG++R    D   A T R     G +P
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIP 213
Query: 677 -----PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER 731
                PE      F+  SDV+S+G+++ E+                  + +  R + E  
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEV------------------MSYGERPYWEMS 255
Query: 732 PVELINKSLGGSYSLSEVLRC----IQVGLLCVQQRPEDRPNMSSVVLML 777
             ++I K++   Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 256 NQDVI-KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 28/214 (13%)
Query: 512 LGEGGFGPVYKGVLI--------EGQEIAAKRLSK-SSGQGMEEFENEVLLIAKL-QHRN 561
           LGEG FG V     +        E   +A K L   ++ + + +  +E+ ++  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFI-----------FDVTR--SKFLDWSKRCQI 608
           ++ L+G CTQ     +I  Y    +L +++           +D+ R   + + +      
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQTEANTNR 667
              +ARG+ YL   +  + IHRDL A NVL+      KI+DFG+AR    ID  +  TN 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
            +    +M PE   D +++ +SDV+SFGVL+ EI
Sbjct: 220 RLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 130/284 (45%), Gaps = 50/284 (17%)
Query: 512 LGEGGFGPVYKGVL-IEGQE---IAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLI 566
           +G G FG V  G L + G+    +A K L    + +   +F  E  ++ +  H N++ L 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGLLYLHQDS 623
           G  T+    M++ EY+ N SL+ F+      K        Q++G   GI+ G+ YL   S
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFL-----KKNDGQFTVIQLVGMLRGISAGMKYL---S 141
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----PE 678
            +  +HRDL A N+L+++ +  K+SDFG++R    D   A T R     G +P     PE
Sbjct: 142 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIPIRWTAPE 197
Query: 679 YAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 737
                 F+  SDV+S+G+++ E+V  G+R                 W +  ++     + 
Sbjct: 198 AIAFRKFTSASDVWSYGIVMWEVVSYGERP---------------YWEMTNQD-----VI 237
Query: 738 KSLGGSYSLSEVLRC----IQVGLLCVQQRPEDRPNMSSVVLML 777
           K++   Y L   + C     Q+ L C Q+    RP    +V ML
Sbjct: 238 KAVEEGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNML 281

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 511 KLGEGGFGPV-YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
           K+GEG  G V        G+++A K +     Q  E   NEV+++   QH N+V++    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
              +E  ++ E+L   +L D +  V     L+  +   +   + + L YLH      +IH
Sbjct: 112 LVGEELWVLMEFLQGGALTDIVSQVR----LNEEQIATVCEAVLQALAYLHAQG---VIH 164
Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 689
           RD+K+ ++LL  +   K+SDFG       D  +     +VGT  +M PE     L++ + 
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKX--LVGTPYWMAPEVISRSLYATEV 222
Query: 690 DVFSFGVLVLEIVCGK 705
           D++S G++V+E+V G+
Sbjct: 223 DIWSLGIMVIEMVDGE 238

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 100/206 (48%), Gaps = 25/206 (12%)
Query: 515 GGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD- 573
           G FG V+K  L+   +  A ++     +   + E E+     ++H NL++ I    +   
Sbjct: 26  GRFGCVWKAQLM--NDFVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGSN 83
Query: 574 ---ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD-------- 622
              E  LI  +    SL D++    +   + W++ C +   ++RGL YLH+D        
Sbjct: 84  LEVELWLITAFHDKGSLTDYL----KGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEG 139
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID 682
            +  I HRD K+ NVLL +++   ++DFG+A  F   +   +T+  VGT  YM PE  ++
Sbjct: 140 HKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPE-VLE 198
Query: 683 GLFSVKSDVF------SFGVLVLEIV 702
           G  + + D F      + G+++ E+V
Sbjct: 199 GAINFQRDAFLRIDMYAMGLVLWELV 224

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 19/209 (9%)
Query: 504 ENFSDKNKLGEGGFGPVYKGV------LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKL 557
           E +   +KLGEG +  VYKG       L+  +EI   RL    G        EV L+  L
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI---RLEHEEGAPCTAI-REVSLLKDL 57
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +H N+V L           L++EYL +K L  ++ D      ++       +  + RGL 
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDC--GNIINMHNVKLFLFQLLRGLA 114
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           Y H   R +++HRDLK  N+L++     K++DFG+ARA  I  T+   N VV T  Y PP
Sbjct: 115 YCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYDNEVV-TLWYRPP 169
Query: 678 EYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +  +    +S + D++  G +  E+  G+
Sbjct: 170 DILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 14/205 (6%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL---SKSSGQGME-EFENEVLLIAKLQH 559
           E+F     LG+G FG VY     + + I A ++   ++    G+E +   EV + + L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
            N+++L G         LI EY P  ++   +  ++R    D  +    I  +A  L Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR---FDEQRTATYITELANALSYC 128
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H     R+IHRD+K  N+LL +    KI+DFG    + +    +  + + GT  Y+PPE 
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRDTLCGTLDYLPPEM 181
Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCG 704
               +   K D++S GVL  E + G
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 128/291 (43%), Gaps = 48/291 (16%)
Query: 512 LGEGGFGPVYKGVL--IEGQE----IAAKRLSK-SSGQGMEEFENEVLLIAKLQHRNLVK 564
           LGEG FG V K     ++G+     +A K L + +S   + +  +E  ++ ++ H +++K
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFI---------------------FDVTRSKFLDWS 603
           L G C+Q    +LI EY    SL  F+                      D    + L   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 604 KRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 663
                   I++G+ YL   + ++++HRDL A N+L+      KISDFG++R    + +  
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGH 722
             ++      +M  E   D +++ +SDV+SFGVL+ EIV  G         +   NLL  
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKT 267
Query: 723 AWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
             R+   ERP               E+ R +   L C +Q P+ RP  + +
Sbjct: 268 GHRM---ERP----------DNCSEEMYRLM---LQCWKQEPDKRPVFADI 302

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 130/290 (44%), Gaps = 48/290 (16%)
Query: 505 NFSDKNKLGEGGFGPVYKG--VLIEGQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQH 559
           N S    +G G FG V  G   L   +EI+    +   G   +   +F  E  ++ +  H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGL 616
            N+++L G  T+    M++ E + N SL+ F+      K        Q++G   GIA G+
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-----RKHDAQFTVIQLVGMLRGIASGM 131
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YL   S +  +HRDL A N+L+++ +  K+SDFG++R    D   A T R     G +P
Sbjct: 132 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR----GGKIP 184
Query: 677 -----PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER 731
                PE      F+  SDV+S+G+++ E+                  + +  R + E  
Sbjct: 185 IRWTSPEAIAYRKFTSASDVWSYGIVLWEV------------------MSYGERPYWEMS 226
Query: 732 PVELINKSLGGSYSLSEVLRC----IQVGLLCVQQRPEDRPNMSSVVLML 777
             ++I K++   Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 227 NQDVI-KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 107/198 (54%), Gaps = 13/198 (6%)
Query: 511 KLGEGGFGPVYKGV--LIEGQ-EIAAKRLSKSSGQG-MEEFENEVLLIAKLQHRNLVKLI 566
           +LG G FG V +GV  + + Q ++A K L + + +   EE   E  ++ +L +  +V+LI
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 626
           G C Q +  ML+ E      L+ F+  V + + +  S   +++  ++ G+ YL + +   
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKN--- 456
Query: 627 IIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTY--GYMPPEYAIDGL 684
            +HR+L A NVLL N    KISDFG+++A G D +   T R  G +   +  PE      
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKWPLKWYAPECINFRK 515
Query: 685 FSVKSDVFSFGVLVLEIV 702
           FS +SDV+S+GV + E +
Sbjct: 516 FSSRSDVWSYGVTMWEAL 533

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL---SKSSGQGME-EFENEVLLIAKL 557
           A E+F     LG+G FG VY       + I A ++   ++    G+E +   EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +H N+++L G         LI EY P   L     ++ +    D  +    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           Y H     ++IHRD+K  N+LL +    KI+DFG    + +    +    + GT  Y+PP
Sbjct: 123 YCHSK---KVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 175
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E     +   K D++S GVL  E + GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL---SKSSGQGME-EFENEVLLIAKLQH 559
           E+F     LG+G FG VY     + + I A ++   ++    G+E +   EV + + L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
            N+++L G         LI EY P  ++   +  ++R    D  +    I  +A  L Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR---FDEQRTATYITELANALSYC 128
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H     R+IHRD+K  N+LL +    KI+DFG    + +    +    + GT  Y+PPE 
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 181
Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCG 704
               +   K D++S GVL  E + G
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 99/217 (45%), Gaps = 24/217 (11%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIA----AKRLSKSSGQG--MEEFENEVLLIAKL 557
           N      LG G FG V +      G+E A    A ++ KS+      E   +E+ +++ L
Sbjct: 47  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 558 -QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFI------------FDVTRSKFLDWSK 604
            QH N+V L+G CT     ++I EY     L +F+            F +  S  L    
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST-LSTRD 165
Query: 605 RCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 664
                  +A+G+ +L   +    IHRD+ A NVLL N    KI DFG+AR    D     
Sbjct: 166 LLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 665 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
                    +M PE   D +++V+SDV+S+G+L+ EI
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKG-VLIEGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQH 559
           E+F     LGEG F  V     L   +E A K L K        +     E  ++++L H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 560 RNLVKLIGCCTQRDERMLI-YEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIA 613
              VKL   C Q DE++     Y  N  L  +I     FD T ++F            I 
Sbjct: 97  PFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--------TAEIV 147
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
             L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  
Sbjct: 148 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 204
Query: 674 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           Y+ PE   +      SD+++ G ++ ++V G
Sbjct: 205 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 108/218 (49%), Gaps = 36/218 (16%)
Query: 512 LGEGGFGPVYKGVLIEG-----------QEIAAKRL-SKSSGQGMEEFENEVLLIAKL-Q 558
           LGEG FG V   VL E             ++A K L S ++ + + +  +E+ ++  + +
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDW--------------SK 604
           H+N++ L+G CTQ     +I EY    +L +++    R   L++                
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYCYNPSHNPEEQLSSKD 151
Query: 605 RCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQTEA 663
                  +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    ID  + 
Sbjct: 152 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
            TN  +    +M PE   D +++ +SDV+SFGVL+ EI
Sbjct: 209 TTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 108/218 (49%), Gaps = 36/218 (16%)
Query: 512 LGEGGFGPVYKGVLIEG-----------QEIAAKRL-SKSSGQGMEEFENEVLLIAKL-Q 558
           LGEG FG V   VL E             ++A K L S ++ + + +  +E+ ++  + +
Sbjct: 21  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDW--------------SK 604
           H+N++ L+G CTQ     +I EY    +L +++    R   L++                
Sbjct: 78  HKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYCYNPSHNPEEQLSSKD 136
Query: 605 RCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQTEA 663
                  +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    ID  + 
Sbjct: 137 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
            TN  +    +M PE   D +++ +SDV+SFGVL+ EI
Sbjct: 194 TTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 230

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 101/210 (48%), Gaps = 25/210 (11%)
Query: 505 NFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRN 561
           N+     +G+G F  V     ++ G+E+A K + K+  +   +++   EV ++  L H N
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDW-SKRCQIIGGIARGLLYLH 620
           +VKL           LI EY     + D++    R K  +  SK  QI+  +     Y H
Sbjct: 73  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ----YCH 128
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
           Q    RI+HRDLKA N+LLD +MN KI+DFG +  F +          + T+   PP YA
Sbjct: 129 QK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-------LDTFCGSPP-YA 177
Query: 681 IDGLFSVKS------DVFSFGVLVLEIVCG 704
              LF  K       DV+S GV++  +V G
Sbjct: 178 APELFQGKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 112/220 (50%), Gaps = 27/220 (12%)
Query: 499 IANATENFSDKNK----LGEGGFGPVYKGVL----IEGQEIAAKRLSKSSGQGMEEFEN- 549
           + ++T  FSD+ K    LG+G FG V   +L    I GQE A K +SK   +   + E+ 
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESL 73
Query: 550 --EVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQ 607
             EV L+ +L H N+ KL      +    L+ E      L D I  ++R +F +     +
Sbjct: 74  LREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDA-AR 130
Query: 608 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFGIDQTEAN 664
           II  +  G+ Y H++   +I+HRDLK  N+LL++   + N +I DFG++  F   +    
Sbjct: 131 IIRQVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKK 184
Query: 665 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
               +GT  Y+ PE  + G +  K DV+S GV++  ++ G
Sbjct: 185 XKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 127/291 (43%), Gaps = 48/291 (16%)
Query: 512 LGEGGFGPVYKGVL--IEGQE----IAAKRLSK-SSGQGMEEFENEVLLIAKLQHRNLVK 564
           LGEG FG V K     ++G+     +A K L + +S   + +  +E  ++ ++ H +++K
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFI---------------------FDVTRSKFLDWS 603
           L G C+Q    +LI EY    SL  F+                      D    + L   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 604 KRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 663
                   I++G+ YL   + + ++HRDL A N+L+      KISDFG++R    + +  
Sbjct: 151 DLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGH 722
             ++      +M  E   D +++ +SDV+SFGVL+ EIV  G         +   NLL  
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKT 267
Query: 723 AWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
             R+   ERP               E+ R +   L C +Q P+ RP  + +
Sbjct: 268 GHRM---ERP----------DNCSEEMYRLM---LQCWKQEPDKRPVFADI 302

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 111/217 (51%), Gaps = 34/217 (15%)
Query: 512 LGEGGFGPVYKGVLIEG-----------QEIAAKRL-SKSSGQGMEEFENEVLLIAKL-Q 558
           LGEG FG V   VL E             ++A K L S ++ + + +  +E+ ++  + +
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFI-----------FDVTRSKFLDWSKRCQ 607
           H+N++ L+G CTQ     +I EY    +L +++           ++ + +     S +  
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 608 IIGG--IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQTEAN 664
           +     +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    ID  +  
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 665 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
           TN  +    +M PE   D +++ +SDV+SFGVL+ EI
Sbjct: 210 TNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 113/255 (44%), Gaps = 26/255 (10%)
Query: 497 MAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEE------FENE 550
           + I    E+F     LG+G FG V+     +  +  A +  K     M++       E  
Sbjct: 11  LQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKR 70
Query: 551 VLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG 610
           VL +A  +H  L  +      ++    + EYL      D ++ +      D S+      
Sbjct: 71  VLSLA-WEHPFLTHMFCTFQTKENLFFVMEYLNG---GDLMYHIQSCHKFDLSRATFYAA 126
Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVG 670
            I  GL +LH      I++RDLK  N+LLD + + KI+DFGM +   +   +A TN   G
Sbjct: 127 EIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDAKTNEFCG 181
Query: 671 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL---- 726
           T  Y+ PE  +   ++   D +SFGVL+ E++ G+     +H      L  H+ R+    
Sbjct: 182 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP---FHGQDEEELF-HSIRMDNPF 237
Query: 727 ---WIEERPVELINK 738
              W+E+   +L+ K
Sbjct: 238 YPRWLEKEAKDLLVK 252

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 102/197 (51%), Gaps = 13/197 (6%)
Query: 511 KLGEGGFGPVYKGVLIEGQEIAA-KRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
           +LG+G FG VYK    E   +AA K +   S + +E++  E+ ++A   H N+VKL+   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
              +   ++ E+    +++  + ++ R   L  S+   +       L YLH +   +IIH
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDN---KIIH 158
Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI-----DGL 684
           RDLKA N+L   + + K++DFG++      +T    +  +GT  +M PE  +     D  
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNT--RTIQRRDSFIGTPYWMAPEVVMCETSKDRP 216
Query: 685 FSVKSDVFSFGVLVLEI 701
           +  K+DV+S G+ ++E+
Sbjct: 217 YDYKADVWSLGITLIEM 233

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/315 (24%), Positives = 132/315 (41%), Gaps = 64/315 (20%)
Query: 505 NFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           +F +   +G GGFG V+K    I+G+    +R+  ++    E+ E EV  +AKL H N+V
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNN----EKAEREVKALAKLDHVNIV 68
Query: 564 KLIGC-------CTQRDERMLIYEYLPNKSLND--------FI-------------FDVT 595
              GC           D+ +   +Y P  S N         FI              +  
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 596 RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 655
           R + LD     ++   I +G+ Y+H     ++IHRDLK SN+ L +    KI DFG+  +
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 656 FGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI--VCGKRNRGFYHA 713
               + +    R  GT  YM PE      +  + D+++ G+++ E+  VC   +  F  +
Sbjct: 186 L---KNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVC---DTAFETS 239
Query: 714 DHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
               +L         +++   L+ K L                     ++PEDRPN S +
Sbjct: 240 KFFTDLRDGIISDIFDKKEKTLLQKLLS--------------------KKPEDRPNTSEI 279
Query: 774 VLMLSGERSLPQPKQ 788
           +  L+  +  P+  +
Sbjct: 280 LRTLTVWKKSPEKNE 294

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 108/211 (51%), Gaps = 27/211 (12%)
Query: 511 KLGEGGFGPVYKGV---LIEGQ---EIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLV 563
           +LG+G FG VY+G    +I+G+    +A K +++S+  +   EF NE  ++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--------CQIIGGIARG 615
           +L+G  ++    +++ E + +  L  ++  + R +  +   R         Q+   IA G
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSL-RPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 616 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT---- 671
           + YL+     + +HRDL A N ++ ++   KI DFGM R    D  E +  R  G     
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKGLLP 195
Query: 672 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
             +M PE   DG+F+  SD++SFGV++ EI 
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEIT 226

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 108/211 (51%), Gaps = 27/211 (12%)
Query: 511 KLGEGGFGPVYKGV---LIEGQ---EIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLV 563
           +LG+G FG VY+G    +I+G+    +A K +++S+  +   EF NE  ++      ++V
Sbjct: 21  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--------CQIIGGIARG 615
           +L+G  ++    +++ E + +  L  ++  + R +  +   R         Q+   IA G
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSL-RPEAENNPGRPPPTLQEMIQMAAEIADG 139
Query: 616 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT---- 671
           + YL+     + +HRDL A N ++ ++   KI DFGM R    D  E +  R  G     
Sbjct: 140 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKGLLP 192
Query: 672 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
             +M PE   DG+F+  SD++SFGV++ EI 
Sbjct: 193 VRWMAPESLKDGVFTTSSDMWSFGVVLWEIT 223

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 10/207 (4%)
Query: 500 ANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ 558
            +  E  ++  K+GEG  G V        G+++A K++     Q  E   NEV+++    
Sbjct: 41  GDPREYLANFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH 100
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           H N+V +       DE  ++ E+L   +L D    VT ++ ++  +   +   + R L Y
Sbjct: 101 HDNVVDMYSSYLVGDELWVVMEFLEGGALTDI---VTHTR-MNEEQIATVCLSVLRALSY 156
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           LH      +IHRD+K+ ++LL ++   K+SDFG      + +       +VGT  +M PE
Sbjct: 157 LHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQ--VSKEVPKRKXLVGTPYWMAPE 211
Query: 679 YAIDGLFSVKSDVFSFGVLVLEIVCGK 705
                 +  + D++S G++V+E++ G+
Sbjct: 212 VISRLPYGTEVDIWSLGIMVIEMIDGE 238

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 505 NFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRN 561
           N+     +G+G F  V     ++ G+E+A K + K+  +   +++   EV ++  L H N
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDW-SKRCQIIGGIARGLLYLH 620
           +VKL           LI EY     + D++    R K  +  SK  QI+  +     Y H
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ----YCH 131
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
           Q    RI+HRDLKA N+LLD +MN KI+DFG +  F +       +   G   Y  PE  
Sbjct: 132 QK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GKLDAFCGAPPYAAPE-- 183
Query: 681 IDGLFSVKS------DVFSFGVLVLEIVCG 704
              LF  K       DV+S GV++  +V G
Sbjct: 184 ---LFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 32/215 (14%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIG---- 567
           +G G +G VYKG L E + +A K  S ++ Q     E  +  +  ++H N+ + I     
Sbjct: 21  IGRGRYGAVYKGSLDE-RPVAVKVFSFANRQNFIN-EKNIYRVPLMEHDNIARFIVGDER 78
Query: 568 -CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD---- 622
                R E +L+ EY PN SL  ++   T     DW   C++   + RGL YLH +    
Sbjct: 79  VTADGRMEYLLVMEYYPNGSLXKYLSLHTS----DWVSSCRLAHSVTRGLAYLHTELPRG 134
Query: 623 --SRLRIIHRDLKASNVLLDNEMNPKISDFGMA------RAFGIDQTEANTNRVVGTYGY 674
              +  I HRDL + NVL+ N+    ISDFG++      R     + +      VGT  Y
Sbjct: 135 DHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRY 194
Query: 675 MPPEYAIDGLFSVKS--------DVFSFGVLVLEI 701
           M PE  ++G  +++         D+++ G++  EI
Sbjct: 195 MAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 108/211 (51%), Gaps = 27/211 (12%)
Query: 511 KLGEGGFGPVYKGV---LIEGQ---EIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLV 563
           +LG+G FG VY+G    +I+G+    +A K +++S+  +   EF NE  ++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--------CQIIGGIARG 615
           +L+G  ++    +++ E + +  L  ++  + R +  +   R         Q+   IA G
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSL-RPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 616 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT---- 671
           + YL+     + +HRDL A N ++ ++   KI DFGM R    D  E +  R  G     
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKGLLP 195
Query: 672 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
             +M PE   DG+F+  SD++SFGV++ EI 
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEIT 226

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 15/207 (7%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEE------FENEVLLIAKL 557
           +NF     LG+G FG V    + E  ++ A ++ K      ++       E  +L +A+ 
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR- 81
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
            H  L +L  CC Q  +R+       N    D +F + +S+  D ++       I   L+
Sbjct: 82  NHPFLTQLF-CCFQTPDRLFFVMEFVNGG--DLMFHIQKSRRFDEARARFYAAEIISALM 138
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           +LH      II+RDLK  NVLLD+E + K++DFGM +  GI      T    GT  Y+ P
Sbjct: 139 FLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE-GICNG-VTTATFCGTPDYIAP 193
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           E   + L+    D ++ GVL+ E++CG
Sbjct: 194 EILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 100/199 (50%), Gaps = 16/199 (8%)
Query: 512 LGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEE--FENEVLLIAKLQHRNLVKLIGC 568
           LG+G FG V K    I  QE A K ++K+S +  +      EV L+ KL H N++KL   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 569 CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRII 628
                   ++ E      L D I  + R +F +     +II  +  G+ Y+H+ +   I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDA-ARIIKQVFSGITYMHKHN---IV 143
Query: 629 HRDLKASNVLLDN---EMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF 685
           HRDLK  N+LL++   + + KI DFG++  F   Q        +GT  Y+ PE  + G +
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIAPE-VLRGTY 199
Query: 686 SVKSDVFSFGVLVLEIVCG 704
             K DV+S GV++  ++ G
Sbjct: 200 DEKCDVWSAGVILYILLSG 218

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 25/210 (11%)
Query: 505 NFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRN 561
           N+  +  +G+G F  V     ++ G+E+A K + K+  +   +++   EV ++  L H N
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDW-SKRCQIIGGIARGLLYLH 620
           +VKL           L+ EY     + D++    R K  +  +K  QI+  +     Y H
Sbjct: 76  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ----YCH 131
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
           Q     I+HRDLKA N+LLD +MN KI+DFG +  F +          + T+   PP YA
Sbjct: 132 QKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNK-------LDTFCGSPP-YA 180
Query: 681 IDGLFSVKS------DVFSFGVLVLEIVCG 704
              LF  K       DV+S GV++  +V G
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 113/255 (44%), Gaps = 26/255 (10%)
Query: 497 MAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEE------FENE 550
           + I    E+F     LG+G FG V+     +  +  A +  K     M++       E  
Sbjct: 10  LQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKR 69
Query: 551 VLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG 610
           VL +A  +H  L  +      ++    + EYL      D ++ +      D S+      
Sbjct: 70  VLSLA-WEHPFLTHMFCTFQTKENLFFVMEYLNG---GDLMYHIQSCHKFDLSRATFYAA 125
Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVG 670
            I  GL +LH      I++RDLK  N+LLD + + KI+DFGM +   +   +A TN   G
Sbjct: 126 EIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDAKTNXFCG 180
Query: 671 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL---- 726
           T  Y+ PE  +   ++   D +SFGVL+ E++ G+     +H      L  H+ R+    
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP---FHGQDEEELF-HSIRMDNPF 236
Query: 727 ---WIEERPVELINK 738
              W+E+   +L+ K
Sbjct: 237 YPRWLEKEAKDLLVK 251

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 100/199 (50%), Gaps = 16/199 (8%)
Query: 512 LGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEE--FENEVLLIAKLQHRNLVKLIGC 568
           LG+G FG V K    I  QE A K ++K+S +  +      EV L+ KL H N++KL   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 569 CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRII 628
                   ++ E      L D I  + R +F +     +II  +  G+ Y+H+ +   I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDA-ARIIKQVFSGITYMHKHN---IV 143
Query: 629 HRDLKASNVLLDN---EMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF 685
           HRDLK  N+LL++   + + KI DFG++  F   Q        +GT  Y+ PE  + G +
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIAPE-VLRGTY 199
Query: 686 SVKSDVFSFGVLVLEIVCG 704
             K DV+S GV++  ++ G
Sbjct: 200 DEKCDVWSAGVILYILLSG 218

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 100/199 (50%), Gaps = 16/199 (8%)
Query: 512 LGEGGFGPVYK-GVLIEGQEIAAKRLSKSSGQGMEE--FENEVLLIAKLQHRNLVKLIGC 568
           LG+G FG V K    I  QE A K ++K+S +  +      EV L+ KL H N++KL   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 569 CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRII 628
                   ++ E      L D I  + R +F +     +II  +  G+ Y+H+ +   I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDA-ARIIKQVFSGITYMHKHN---IV 143
Query: 629 HRDLKASNVLLDN---EMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF 685
           HRDLK  N+LL++   + + KI DFG++  F   Q        +GT  Y+ PE  + G +
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIAPE-VLRGTY 199
Query: 686 SVKSDVFSFGVLVLEIVCG 704
             K DV+S GV++  ++ G
Sbjct: 200 DEKCDVWSAGVILYILLSG 218

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 99/225 (44%), Gaps = 31/225 (13%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIA----AKRLSKSSGQG--MEEFENEVLLIAKL 557
           N      LG G FG V +      G+E A    A ++ KS+      E   +E+ +++ L
Sbjct: 32  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 91
Query: 558 -QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFI--------------------FDVTR 596
            QH N+V L+G CT     ++I EY     L +F+                     D   
Sbjct: 92  GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKED 151
Query: 597 SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 656
            + L+          +A+G+ +L   +    IHRD+ A NVLL N    KI DFG+AR  
Sbjct: 152 GRPLELRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDI 208
Query: 657 GIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
             D              +M PE   D +++V+SDV+S+G+L+ EI
Sbjct: 209 MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 253

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 101/218 (46%), Gaps = 24/218 (11%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIA----AKRLSKSSGQG--MEEFENEVLLIAKL 557
           N      LG G FG V +      G+E A    A ++ KS+      E   +E+ +++ L
Sbjct: 47  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 558 -QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFI-----------FDVTRSKFLDWSKR 605
            QH N+V L+G CT     ++I EY     L +F+           ++ + +     S R
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSR 166
Query: 606 --CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA 663
                   +A+G+ +L   +    IHRD+ A NVLL N    KI DFG+AR    D    
Sbjct: 167 DLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 223
Query: 664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
                     +M PE   D +++V+SDV+S+G+L+ EI
Sbjct: 224 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 261

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVLLIAKLQHR 560
            E++     LGEG +G V   V    +E  A ++   K +    E  + E+ + A L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VK  G   + + + L  EY     L D I         D  +       +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLH 122
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
               + I HRD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 681 IDGLFSVKS-DVFSFGVLVLEIVCGK 705
               F  +  DV+S G+++  ++ G+
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 107/204 (52%), Gaps = 23/204 (11%)
Query: 512 LGEGGFGPVYKGVL-IEGQE---IAAKRL-SKSSGQGMEEFENEVLLIAKLQHRNLVKLI 566
           +G G FG V  G L + G+    +A K L S  + +   +F +E  ++ +  H N++ L 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGLLYLHQDS 623
           G  T+    M+I E++ N SL+ F+      +F       Q++G   GIA G+ YL   +
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFLRQ-NDGQF----TVIQLVGMLRGIAAGMKYL---A 152
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----PE 678
            +  +HRDL A N+L+++ +  K+SDFG++R    D ++      +G  G +P     PE
Sbjct: 153 DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG--GKIPIRWTAPE 210
Query: 679 YAIDGLFSVKSDVFSFGVLVLEIV 702
                 F+  SDV+S+G+++ E++
Sbjct: 211 AIQYRKFTSASDVWSYGIVMWEVM 234

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 106/218 (48%), Gaps = 27/218 (12%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQ-EIAAKRLSKSS---------GQGMEEFE----N 549
           E++    KLG G +G V       G  E A K + KS           + +E+F     N
Sbjct: 36  ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 550 EVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQII 609
           E+ L+  L H N++KL      +    L+ E+     L + I  + R KF D      I+
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI--INRHKF-DECDAANIM 152
Query: 610 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGIDQTEANTN 666
             I  G+ YLH+ +   I+HRD+K  N+LL+N+   +N KI DFG++  F  D    +  
Sbjct: 153 KQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR- 208
Query: 667 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
             +GT  Y+ PE  +   ++ K DV+S GV++  ++CG
Sbjct: 209 --LGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKG-VLIEGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQH 559
           E+F     LGEG F  V     L   +E A K L K        +     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 560 RNLVKLIGCCTQRDERMLI-YEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIA 613
              VKL     Q DE++     Y  N  L  +I     FD T ++F            I 
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFY--------TAEIV 142
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
             L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 199
Query: 674 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           Y+ PE   +   S  SD+++ G ++ ++V G
Sbjct: 200 YVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/303 (24%), Positives = 133/303 (43%), Gaps = 53/303 (17%)
Query: 505 NFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           +F +   +G GGFG V+K    I+G+    KR+  ++    E+ E EV  +AKL H N+V
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIV 67
Query: 564 KLIGC-------------CTQRDERMLIY---EYLPNKSLNDFIFDVTRSKFLDWSKRCQ 607
              GC              + R +   ++   E+    +L  +I +  R + LD     +
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALE 126
Query: 608 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 667
           +   I +G+ Y+H     ++I+RDLK SN+ L +    KI DFG+  +    + +    R
Sbjct: 127 LFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRXR 180
Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI--VCGKRNRGFYHADHHHNLLGHAWR 725
             GT  YM PE      +  + D+++ G+++ E+  VC   +  F  +    +L      
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVC---DTAFETSKFFTDLRDGIIS 237
Query: 726 LWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQ 785
              +++   L+ K L                     ++PEDRPN S ++  L+  +  P+
Sbjct: 238 DIFDKKEKTLLQKLLS--------------------KKPEDRPNTSEILRTLTVWKKSPE 277
Query: 786 PKQ 788
             +
Sbjct: 278 KNE 280

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 511 KLGEGGFGPV-YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
           K+GEG  G V    V   G+ +A K++     Q  E   NEV+++   QH N+V++    
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
              DE  ++ E+L   +L D    VT ++ ++  +   +   + + L  LH      +IH
Sbjct: 91  LVGDELWVVMEFLEGGALTDI---VTHTR-MNEEQIAAVCLAVLQALSVLHAQG---VIH 143
Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 689
           RD+K+ ++LL ++   K+SDFG      + +       +VGT  +M PE      +  + 
Sbjct: 144 RDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 201
Query: 690 DVFSFGVLVLEIVCGK 705
           D++S G++V+E+V G+
Sbjct: 202 DIWSLGIMVIEMVDGE 217

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 108/211 (51%), Gaps = 27/211 (12%)
Query: 511 KLGEGGFGPVYKGV---LIEGQ---EIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLV 563
           +LG+G FG VY+G    +I+G+    +A K +++S+  +   EF NE  ++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--------CQIIGGIARG 615
           +L+G  ++    +++ E + +  L  ++  + R +  +   R         Q+   IA G
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSL-RPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 616 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT---- 671
           + YL+     + +HRDL A N ++ ++   KI DFGM R    D  E +  R  G     
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 195
Query: 672 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
             +M PE   DG+F+  SD++SFGV++ EI 
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEIT 226

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 111/228 (48%), Gaps = 21/228 (9%)
Query: 499 IANATENFSD----KNKLGEGGFGPVYKGV-LIEGQEIAAKRLS--KSSGQGMEEFENEV 551
           + NA+  FSD    K +LG+G F  V + V    G E AAK ++  K S +  ++ E E 
Sbjct: 20  MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79
Query: 552 LLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG 611
            +  KLQH N+V+L     +     L+++ +    L +   D+   +F   +     I  
Sbjct: 80  RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFE---DIVAREFYSEADASHCIQQ 136
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN---PKISDFGMARAFGIDQTEANTNRV 668
           I   + Y H +    I+HR+LK  N+LL ++      K++DFG+  A  ++ +EA  +  
Sbjct: 137 ILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEA-WHGF 190
Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH 716
            GT GY+ PE      +S   D+++ GV++  ++ G     F+  D H
Sbjct: 191 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG--YPPFWDEDQH 236

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 511 KLGEGGFGPV-YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
           K+GEG  G V    V   G+ +A K++     Q  E   NEV+++   QH N+V++    
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
              DE  ++ E+L   +L D    VT ++ ++  +   +   + + L  LH      +IH
Sbjct: 96  LVGDELWVVMEFLEGGALTDI---VTHTR-MNEEQIAAVCLAVLQALSVLHAQG---VIH 148
Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 689
           RD+K+ ++LL ++   K+SDFG      + +       +VGT  +M PE      +  + 
Sbjct: 149 RDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 206
Query: 690 DVFSFGVLVLEIVCGK 705
           D++S G++V+E+V G+
Sbjct: 207 DIWSLGIMVIEMVDGE 222

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 17/209 (8%)
Query: 509 KNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKL- 565
           K +LG GGFG V + +  + G+++A K+  +  S +  E +  E+ ++ KL H N+V   
Sbjct: 20  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 79
Query: 566 -----IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
                +      D  +L  EY     L  ++        L       ++  I+  L YLH
Sbjct: 80  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 139
Query: 621 QDSRLRIIHRDLKASNVLLD---NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           ++   RIIHRDLK  N++L      +  KI D G A+   +DQ E  T   VGT  Y+ P
Sbjct: 140 EN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--LDQGELCTE-FVGTLQYLAP 193
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGKR 706
           E      ++V  D +SFG L  E + G R
Sbjct: 194 ELLEQKKYTVTVDYWSFGTLAFECITGFR 222

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 511 KLGEGGFGPV-YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
           K+GEG  G V    V   G+ +A K++     Q  E   NEV+++   QH N+V++    
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
              DE  ++ E+L   +L D    VT ++ ++  +   +   + + L  LH      +IH
Sbjct: 98  LVGDELWVVMEFLEGGALTDI---VTHTR-MNEEQIAAVCLAVLQALSVLHAQG---VIH 150
Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 689
           RD+K+ ++LL ++   K+SDFG      + +       +VGT  +M PE      +  + 
Sbjct: 151 RDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 208
Query: 690 DVFSFGVLVLEIVCGK 705
           D++S G++V+E+V G+
Sbjct: 209 DIWSLGIMVIEMVDGE 224

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 506 FSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEE-FENEVLLIAKLQHR 560
           F  K  LG G F  V   VL E    G+  A K + K + +G E   ENE+ ++ K++H 
Sbjct: 24  FEFKETLGTGAFSEV---VLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHE 80
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+V L       +   L+ + +    L D I +     F        +I  +   + YLH
Sbjct: 81  NIVALEDIYESPNHLYLVMQLVSGGELFDRIVE---KGFYTEKDASTLIRQVLDAVYYLH 137
Query: 621 QDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
              R+ I+HRDLK  N+L    D E    ISDFG+++  G        +   GT GY+ P
Sbjct: 138 ---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDV---MSTACGTPGYVAP 191
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           E      +S   D +S GV+   ++CG
Sbjct: 192 EVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 511 KLGEGGFGPV-YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
           K+GEG  G V    V   G+ +A K++     Q  E   NEV+++   QH N+V++    
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
              DE  ++ E+L   +L D    VT ++ ++  +   +   + + L  LH      +IH
Sbjct: 87  LVGDELWVVMEFLEGGALTDI---VTHTR-MNEEQIAAVCLAVLQALSVLHAQG---VIH 139
Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 689
           RD+K+ ++LL ++   K+SDFG      + +       +VGT  +M PE      +  + 
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 197
Query: 690 DVFSFGVLVLEIVCGK 705
           D++S G++V+E+V G+
Sbjct: 198 DIWSLGIMVIEMVDGE 213

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 17/209 (8%)
Query: 509 KNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKL- 565
           K +LG GGFG V + +  + G+++A K+  +  S +  E +  E+ ++ KL H N+V   
Sbjct: 19  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 566 -----IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
                +      D  +L  EY     L  ++        L       ++  I+  L YLH
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 621 QDSRLRIIHRDLKASNVLLD---NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           ++   RIIHRDLK  N++L      +  KI D G A+   +DQ E  T   VGT  Y+ P
Sbjct: 139 EN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--LDQGELCTE-FVGTLQYLAP 192
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGKR 706
           E      ++V  D +SFG L  E + G R
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 505 NFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRN 561
           N+     +G+G F  V     ++ G+E+A K + K+  +   +++   EV ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDW-SKRCQIIGGIARGLLYLH 620
           +VKL           L+ EY     + D++    R K  +  +K  QI+  +     Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ----YCH 130
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
           Q     I+HRDLKA N+LLD +MN KI+DFG +  F            + T+   PP YA
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-------LDTFCGSPP-YA 179
Query: 681 IDGLFSVKS------DVFSFGVLVLEIVCG 704
              LF  K       DV+S GV++  +V G
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 110/218 (50%), Gaps = 27/218 (12%)
Query: 504 ENFSDKNKLGEGGFGPVYKGV---LIEGQ---EIAAKRLSKSSG-QGMEEFENEVLLIAK 556
           E  +   +LG+G FG VY+G    +I+G+    +A K +++S+  +   EF NE  ++  
Sbjct: 16  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 75
Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--------CQI 608
               ++V+L+G  ++    +++ E + +  L  ++  + R +  +   R         Q+
Sbjct: 76  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSL-RPEAENNPGRPPPTLQEMIQM 134
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
              IA G+ YL+     + +HRDL A N ++ ++   KI DFGM R    D  E +  R 
Sbjct: 135 AAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRK 187
Query: 669 VGT----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
            G       +M PE   DG+F+  SD++SFGV++ EI 
Sbjct: 188 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT 225

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 101/197 (51%), Gaps = 13/197 (6%)
Query: 511 KLGEGGFGPVYKGVLIEGQEIAA-KRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
           +LG+G FG VYK    E   +AA K +   S + +E++  E+ ++A   H N+VKL+   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
              +   ++ E+    +++  + ++ R   L  S+   +       L YLH +   +IIH
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDN---KIIH 158
Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI-----DGL 684
           RDLKA N+L   + + K++DFG++      +     +  +GT  +M PE  +     D  
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNT--RXIQRRDSFIGTPYWMAPEVVMCETSKDRP 216
Query: 685 FSVKSDVFSFGVLVLEI 701
           +  K+DV+S G+ ++E+
Sbjct: 217 YDYKADVWSLGITLIEM 233

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 107/214 (50%), Gaps = 19/214 (8%)
Query: 504 ENFSDKNKLGEGGFGPVYKGV---LIEGQ---EIAAKRLSKSSG-QGMEEFENEVLLIAK 556
           E  +   +LG+G FG VY+G    +I+G+    +A K +++S+  +   EF NE  ++  
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 76
Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--------CQI 608
               ++V+L+G  ++    +++ E + +  L  ++  + R +  +   R         Q+
Sbjct: 77  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSL-RPEAENNPGRPPPTLQEMIQM 135
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
              IA G+ YL+     + +HRDL A N ++ ++   KI DFGM R            + 
Sbjct: 136 AAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKG 192
Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
           +    +M PE   DG+F+  SD++SFGV++ EI 
Sbjct: 193 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT 226

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 505 NFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRN 561
           N+     +G+G F  V     ++ G+E+A K + K+  +   +++   EV ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDW-SKRCQIIGGIARGLLYLH 620
           +VKL           L+ EY     + D++    R K  +  +K  QI+  +     Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ----YCH 130
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
           Q     I+HRDLKA N+LLD +MN KI+DFG +  F            + T+   PP YA
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-------LDTFCGSPP-YA 179
Query: 681 IDGLFSVKS------DVFSFGVLVLEIVCG 704
              LF  K       DV+S GV++  +V G
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 511 KLGEGGFGPV-YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
           K+GEG  G V    V   G+ +A K++     Q  E   NEV+++   QH N+V++    
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
              DE  ++ E+L   +L D    VT ++ ++  +   +   + + L  LH      +IH
Sbjct: 218 LVGDELWVVMEFLEGGALTDI---VTHTR-MNEEQIAAVCLAVLQALSVLHAQG---VIH 270
Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 689
           RD+K+ ++LL ++   K+SDFG      + +       +VGT  +M PE      +  + 
Sbjct: 271 RDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 328
Query: 690 DVFSFGVLVLEIVCGK 705
           D++S G++V+E+V G+
Sbjct: 329 DIWSLGIMVIEMVDGE 344

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 101/197 (51%), Gaps = 13/197 (6%)
Query: 511 KLGEGGFGPVYKGVLIEGQEIAA-KRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
           +LG+G FG VYK    E   +AA K +   S + +E++  E+ ++A   H N+VKL+   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
              +   ++ E+    +++  + ++ R   L  S+   +       L YLH +   +IIH
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDN---KIIH 158
Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI-----DGL 684
           RDLKA N+L   + + K++DFG++      +     +  +GT  +M PE  +     D  
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNT--RXIQRRDXFIGTPYWMAPEVVMCETSKDRP 216
Query: 685 FSVKSDVFSFGVLVLEI 701
           +  K+DV+S G+ ++E+
Sbjct: 217 YDYKADVWSLGITLIEM 233

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 511 KLGEGGFGPV-YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
           K+GEG  G V    V   G+ +A K++     Q  E   NEV+++   QH N+V++    
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
              DE  ++ E+L   +L D    VT ++ ++  +   +   + + L  LH      +IH
Sbjct: 141 LVGDELWVVMEFLEGGALTDI---VTHTR-MNEEQIAAVCLAVLQALSVLHAQG---VIH 193
Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 689
           RD+K+ ++LL ++   K+SDFG      + +       +VGT  +M PE      +  + 
Sbjct: 194 RDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 251
Query: 690 DVFSFGVLVLEIVCGK 705
           D++S G++V+E+V G+
Sbjct: 252 DIWSLGIMVIEMVDGE 267

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVLLIAKLQHR 560
            E++     LGEG +G V   V    +E  A ++   K +    E  + E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VK  G   + + + L  EY     L D I         D  +       +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLH 121
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
               + I HRD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 681 IDGLFSVKS-DVFSFGVLVLEIVCGK 705
               F  +  DV+S G+++  ++ G+
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 23/202 (11%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ 571
           +G G FG V K      +++A K++   S +  + F  E+  ++++ H N+VKL G C  
Sbjct: 17  VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL- 72
Query: 572 RDERMLIYEYLPNKSLNDFIFDV------TRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 625
            +   L+ EY    SL + +         T +  + W  +C      ++G+ YLH     
Sbjct: 73  -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC------SQGVAYLHSMQPK 125
Query: 626 RIIHRDLKASNVLL-DNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 684
            +IHRDLK  N+LL       KI DFG A      QT    N+  G+  +M PE      
Sbjct: 126 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNK--GSAAWMAPEVFEGSN 180
Query: 685 FSVKSDVFSFGVLVLEIVCGKR 706
           +S K DVFS+G+++ E++  ++
Sbjct: 181 YSEKCDVFSWGIILWEVITRRK 202

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 72/214 (33%), Positives = 107/214 (50%), Gaps = 22/214 (10%)
Query: 500 ANATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS-KSSGQGMEEFE-NEVLLIAK 556
           A + + +    KLGEG +G VYK +  +  + +A KR+  +   +G+      EV L+ +
Sbjct: 30  ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKE 89
Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPN--KSLNDFIFDVTRSKFLDWSKRCQIIGGIAR 614
           LQHRN+++L           LI+EY  N  K   D   DV  S  +  S   Q+I G+  
Sbjct: 90  LQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDV--SMRVIKSFLYQLINGVN- 146
Query: 615 GLLYLHQDSRLRIIHRDLKASNVLL---DNEMNP--KISDFGMARAFGIDQTEANTNRVV 669
              + H  SR R +HRDLK  N+LL   D    P  KI DFG+ARAFGI      T+ ++
Sbjct: 147 ---FCH--SR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-PIRQFTHEII 199
Query: 670 GTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIV 702
            T  Y PPE  +    +S   D++S   +  E++
Sbjct: 200 -TLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVLLIAKLQHR 560
            E++     LGEG +G V   V    +E  A ++   K +    E  + E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VK  G   + + + L  EY     L D I         D  +       +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLH 122
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
               + I HRD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 681 IDGLFSVKS-DVFSFGVLVLEIVCGK 705
               F  +  DV+S G+++  ++ G+
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 23/202 (11%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ 571
           +G G FG V K      +++A K++   S +  + F  E+  ++++ H N+VKL G C  
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL- 71
Query: 572 RDERMLIYEYLPNKSLNDFIFDV------TRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 625
            +   L+ EY    SL + +         T +  + W  +C      ++G+ YLH     
Sbjct: 72  -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC------SQGVAYLHSMQPK 124
Query: 626 RIIHRDLKASNVLL-DNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 684
            +IHRDLK  N+LL       KI DFG A      QT    N+  G+  +M PE      
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNK--GSAAWMAPEVFEGSN 179
Query: 685 FSVKSDVFSFGVLVLEIVCGKR 706
           +S K DVFS+G+++ E++  ++
Sbjct: 180 YSEKCDVFSWGIILWEVITRRK 201

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 9/209 (4%)
Query: 500 ANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVLLIAKL 557
           A   E++     LGEG +G V   V    +E  A ++   K +    E  + E+ +   L
Sbjct: 1   APFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 60
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
            H N+VK  G   + + + L  EY     L D I         D  +       +  G++
Sbjct: 61  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVV 117
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           YLH    + I HRD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ P
Sbjct: 118 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174
Query: 678 EYAIDGLFSVKS-DVFSFGVLVLEIVCGK 705
           E      F  +  DV+S G+++  ++ G+
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 203

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 108/220 (49%), Gaps = 17/220 (7%)
Query: 503 TENFSDKNKLGEGGFGPVYKGVL-IEGQEIAAKRLS--KSSGQGMEEFENEVLLIAKLQH 559
           ++N+  K +LG+G F  V + V    G E AAK ++  K S +  ++ E E  +  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
            N+V+L     +     L+++ +    L +   D+   +F   +     I  I   + Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFE---DIVAREFYSEADASHCIQQILESIAYC 121
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMN---PKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
           H +    I+HR+LK  N+LL ++      K++DFG+  A  ++ +EA  +   GT GY+ 
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEA-WHGFAGTPGYLS 175
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH 716
           PE      +S   D+++ GV++  ++ G     F+  D H
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVG--YPPFWDEDQH 213

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 126/283 (44%), Gaps = 38/283 (13%)
Query: 512 LGEGGFGPVYKGVLIE----GQEIAAK--RLSKSSGQGMEEFENEVLLIAKLQHRNLVKL 565
           LGEG FG V +G L +      ++A K  +L  SS + +EEF +E   +    H N+++L
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 566 IGCCTQRDER-----MLIYEYLPNKSLNDFIFDV---TRSKFLDWSKRCQIIGGIARGLL 617
           +G C +   +     M+I  ++    L+ ++      T  K +      + +  IA G+ 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           YL   S    +HRDL A N +L ++M   ++DFG+++                   ++  
Sbjct: 162 YL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL---LGHAWRLWIEERPVE 734
           E   D +++ KSDV++FGV + EI    R    Y    +H +   L H  RL   ++P +
Sbjct: 219 ESLADRVYTSKSDVWAFGVTMWEI--ATRGMTPYPGVQNHEMYDYLLHGHRL---KQPED 273
Query: 735 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 777
            +++     YS             C +  P DRP  S + L L
Sbjct: 274 CLDELYEIMYS-------------CWRTDPLDRPTFSVLRLQL 303

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 108/220 (49%), Gaps = 17/220 (7%)
Query: 503 TENFSDKNKLGEGGFGPVYKGVL-IEGQEIAAKRLS--KSSGQGMEEFENEVLLIAKLQH 559
           ++N+  K +LG+G F  V + V    G E AAK ++  K S +  ++ E E  +  KLQH
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
            N+V+L     +     L+++ +    L +   D+   +F   +     I  I   + Y 
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFE---DIVAREFYSEADASHCIQQILESIAYC 120
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMN---PKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
           H +    I+HR+LK  N+LL ++      K++DFG+  A  ++ +EA  +   GT GY+ 
Sbjct: 121 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEA-WHGFAGTPGYLS 174
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH 716
           PE      +S   D+++ GV++  ++ G     F+  D H
Sbjct: 175 PEVLKKDPYSKPVDIWACGVILYILLVG--YPPFWDEDQH 212

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKG-VLIEGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQH 559
           E+F     LGEG F  V     L   +E A K L K        +     E  ++++L H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 560 RNLVKLIGCCTQRDERMLI-YEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIA 613
              VKL     Q DE++     Y  N  L  +I     FD T ++F            I 
Sbjct: 70  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--------TAEIV 120
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
             L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  
Sbjct: 121 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 177
Query: 674 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           Y+ PE   +      SD+++ G ++ ++V G
Sbjct: 178 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 16/216 (7%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL---SKSSGQGME-EFENEVLLIAKLQH 559
           ++F     LG+G FG VY     +   I A ++   S+   +G+E +   E+ + A L H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
            N+++L      R    LI EY P   L     ++ +S   D  +   I+  +A  L+Y 
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYK---ELQKSCTFDEQRTATIMEELADALMYC 139
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H     ++IHRD+K  N+LL  +   KI+DFG    + +         + GT  Y+PPE 
Sbjct: 140 HGK---KVIHRDIKPENLLLGLKGELKIADFG----WSVHAPSLRRKTMCGTLDYLPPEM 192
Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 715
               + + K D++  GVL  E++ G  N  F  A H
Sbjct: 193 IEGRMHNEKVDLWCIGVLCYELLVG--NPPFESASH 226

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 108/220 (49%), Gaps = 17/220 (7%)
Query: 503 TENFSDKNKLGEGGFGPVYKGVL-IEGQEIAAKRLS--KSSGQGMEEFENEVLLIAKLQH 559
           ++N+  K +LG+G F  V + V    G E AAK ++  K S +  ++ E E  +  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
            N+V+L     +     L+++ +    L +   D+   +F   +     I  I   + Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFE---DIVAREFYSEADASHCIQQILESIAYC 121
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMN---PKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
           H +    I+HR+LK  N+LL ++      K++DFG+  A  ++ +EA  +   GT GY+ 
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEA-WHGFAGTPGYLS 175
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH 716
           PE      +S   D+++ GV++  ++ G     F+  D H
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVG--YPPFWDEDQH 213

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL--SKSSGQGMEEFENEVLLIAKLQHR 560
            E++     LGEG +G V   V    +E  A ++   K +    E  + E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VK  G   + + + L  EY     L D I         D  +       +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLH 121
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
               + I HRD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 681 IDGLFSVKS-DVFSFGVLVLEIVCGK 705
               F  +  DV+S G+++  ++ G+
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKG-VLIEGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQH 559
           E+F     LGEG F  V     L   +E A K L K        +     E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 560 RNLVKLIGCCTQRDERMLI-YEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIA 613
              VKL     Q DE++     Y  N  L  +I     FD T ++F            I 
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--------TAEIV 140
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
             L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 674 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           Y+ PE   +      SD+++ G ++ ++V G
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKG-VLIEGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQH 559
           E+F     LGEG F  V     L   +E A K L K        +     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 560 RNLVKLIGCCTQRDERMLI-YEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIA 613
              VKL     Q DE++     Y  N  L  +I     FD T ++F            I 
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--------TAEIV 142
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
             L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 674 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           Y+ PE   +      SD+++ G ++ ++V G
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKG-VLIEGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQH 559
           E+F     LGEG F  V     L   +E A K L K        +     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 560 RNLVKLIGCCTQRDERMLI-YEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIA 613
              VKL     Q DE++     Y  N  L  +I     FD T ++F            I 
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--------TAEIV 142
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
             L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 674 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           Y+ PE   +      SD+++ G ++ ++V G
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKG-VLIEGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQH 559
           E+F     LGEG F  V     L   +E A K L K        +     E  ++++L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 560 RNLVKLIGCCTQRDERMLI-YEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIA 613
              VKL     Q DE++     Y  N  L  +I     FD T ++F            I 
Sbjct: 93  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--------TAEIV 143
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
             L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  
Sbjct: 144 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 200
Query: 674 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           Y+ PE   +      SD+++ G ++ ++V G
Sbjct: 201 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKG-VLIEGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQH 559
           E+F     LGEG F  V     L   +E A K L K        +     E  ++++L H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 560 RNLVKLIGCCTQRDERMLI-YEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIA 613
              VKL     Q DE++     Y  N  L  +I     FD T ++F            I 
Sbjct: 69  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--------TAEIV 119
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
             L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  
Sbjct: 120 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 176
Query: 674 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           Y+ PE   +      SD+++ G ++ ++V G
Sbjct: 177 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL--SKSSGQGMEEFENEVLLIAKLQHR 560
            E++     LGEG +G V   V    +E  A ++   K +    E  + E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VK  G   + + + L  EY     L D I         D  +       +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLH 122
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
               + I HRD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 681 IDGLFSVKS-DVFSFGVLVLEIVCGK 705
               F  +  DV+S G+++  ++ G+
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL--SKSSGQGMEEFENEVLLIAKLQHR 560
            E++     LGEG +G V   V    +E  A ++   K +    E  + E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VK  G   + + + L  EY     L D I         D  +       +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLH 122
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
               + I HRD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 681 IDGLFSVKS-DVFSFGVLVLEIVCGK 705
               F  +  DV+S G+++  ++ G+
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL--SKSSGQGMEEFENEVLLIAKLQHR 560
            E++     LGEG +G V   V    +E  A ++   K +    E  + E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VK  G   + + + L  EY     L D I         D  +       +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLH 122
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
               + I HRD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 681 IDGLFSVKS-DVFSFGVLVLEIVCGK 705
               F  +  DV+S G+++  ++ G+
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKG-VLIEGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQH 559
           E+F     LGEG F  V     L   +E A K L K        +     E  ++++L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 560 RNLVKLIGCCTQRDERMLI-YEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIA 613
              VKL     Q DE++     Y  N  L  +I     FD T ++F            I 
Sbjct: 93  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--------TAEIV 143
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
             L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  
Sbjct: 144 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 200
Query: 674 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           Y+ PE   +      SD+++ G ++ ++V G
Sbjct: 201 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKG-VLIEGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQH 559
           E+F     LGEG F  V     L   +E A K L K        +     E  ++++L H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 560 RNLVKLIGCCTQRDERMLI-YEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIA 613
              VKL     Q DE++     Y  N  L  +I     FD T ++F            I 
Sbjct: 95  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--------TAEIV 145
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
             L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  
Sbjct: 146 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 202
Query: 674 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           Y+ PE   +      SD+++ G ++ ++V G
Sbjct: 203 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKG-VLIEGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQH 559
           E+F     LGEG F  V     L   +E A K L K        +     E  ++++L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 560 RNLVKLIGCCTQRDERMLI-YEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIA 613
              VKL     Q DE++     Y  N  L  +I     FD T ++F            I 
Sbjct: 68  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--------TAEIV 118
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
             L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  
Sbjct: 119 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 175
Query: 674 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           Y+ PE   +      SD+++ G ++ ++V G
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKG-VLIEGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQH 559
           E+F     LGEG F  V     L   +E A K L K        +     E  ++++L H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 560 RNLVKLIGCCTQRDERMLI-YEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIA 613
              VKL     Q DE++     Y  N  L  +I     FD T ++F            I 
Sbjct: 67  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--------TAEIV 117
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
             L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  
Sbjct: 118 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 174
Query: 674 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           Y+ PE   +      SD+++ G ++ ++V G
Sbjct: 175 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKG-VLIEGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQH 559
           E+F     LGEG F  V     L   +E A K L K        +     E  ++++L H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 560 RNLVKLIGCCTQRDERMLI-YEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIA 613
              VKL     Q DE++     Y  N  L  +I     FD T ++F            I 
Sbjct: 74  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--------TAEIV 124
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
             L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  
Sbjct: 125 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 181
Query: 674 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           Y+ PE   +      SD+++ G ++ ++V G
Sbjct: 182 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKG-VLIEGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQH 559
           E+F     LGEG F  V     L   +E A K L K        +     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 560 RNLVKLIGCCTQRDERMLI-YEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIA 613
              VKL     Q DE++     Y  N  L  +I     FD T ++F            I 
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--------TAEIV 142
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
             L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 674 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           Y+ PE   +      SD+++ G ++ ++V G
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 505 NFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRN 561
           N+     +G+G F  V     ++ G+E+A K + K+  +   +++   EV ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDW-SKRCQIIGGIARGLLYLH 620
           +VKL           L+ EY     + D++    R K  +  +K  QI+  +     Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ----YCH 130
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
           Q     I+HRDLKA N+LLD +MN KI+DFG +  F         N++    G   P YA
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG------NKLDAFCG--APPYA 179
Query: 681 IDGLFSVKS------DVFSFGVLVLEIVCG 704
              LF  K       DV+S GV++  +V G
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL--SKSSGQGMEEFENEVLLIAKLQHR 560
            E++     LGEG +G V   V    +E  A ++   K +    E  + E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VK  G   + + + L  EY     L D I         D  +       +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLH 121
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
               + I HRD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 681 IDGLFSVKS-DVFSFGVLVLEIVCGK 705
               F  +  DV+S G+++  ++ G+
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKG-VLIEGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQH 559
           E+F     LGEG F  V     L   +E A K L K        +     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 560 RNLVKLIGCCTQRDERMLI-YEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIA 613
              VKL     Q DE++     Y  N  L  +I     FD T ++F            I 
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--------TAEIV 142
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
             L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 674 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           Y+ PE   +      SD+++ G ++ ++V G
Sbjct: 200 YVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKG-VLIEGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQH 559
           E+F     LGEG F  V     L   +E A K L K        +     E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 560 RNLVKLIGCCTQRDERMLI-YEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIA 613
              VKL     Q DE++     Y  N  L  +I     FD T ++F            I 
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--------TAEIV 140
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
             L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQ 197
Query: 674 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           Y+ PE   +      SD+++ G ++ ++V G
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 105/223 (47%), Gaps = 12/223 (5%)
Query: 512 LGEGGFGPVYK-GVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT 570
           LG G FG V+K      G ++AAK +     +  EE +NE+ ++ +L H NL++L     
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 571 QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHR 630
            +++ +L+ EY+    L D I D   S  L        +  I  G+ ++HQ   + I+H 
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIID--ESYNLTELDTILFMKQICEGIRHMHQ---MYILHL 211
Query: 631 DLKASNVLLDNE--MNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 688
           DLK  N+L  N      KI DFG+AR +   +         GT  ++ PE       S  
Sbjct: 212 DLKPENILCVNRDAKQIKIIDFGLARRY---KPREKLKVNFGTPEFLAPEVVNYDFVSFP 268
Query: 689 SDVFSFGVLVLEIVCGKRN-RGFYHADHHHNLLGHAWRLWIEE 730
           +D++S GV+   ++ G     G   A+  +N+L   W L  EE
Sbjct: 269 TDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEE 311

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVLLIAKLQHR 560
            E++     LGEG +G V   V    +E  A ++   K +    E  + E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VK  G   + + + L  EY     L D I         D  +       +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLH 121
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
               + I HRD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 681 IDGLFSVKS-DVFSFGVLVLEIVCGK 705
               F  +  DV+S G+++  ++ G+
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL--SKSSGQGMEEFENEVLLIAKLQHR 560
            E++     LGEG +G V   V    +E  A ++   K +    E  + E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VK  G   + + + L  EY     L D I         D  +       +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLH 121
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
               + I HRD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 681 IDGLFSVKS-DVFSFGVLVLEIVCGK 705
               F  +  DV+S G+++  ++ G+
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVLLIAKLQHR 560
            E++     LGEG +G V   V    +E  A ++   K +    E  + E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VK  G   + + + L  EY     L D I         D  +       +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLH 121
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
               + I HRD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 681 IDGLFSVKS-DVFSFGVLVLEIVCGK 705
               F  +  DV+S G+++  ++ G+
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKG-VLIEGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQH 559
           E+F     LGEG F  V     L   +E A K L K        +     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 560 RNLVKLIGCCTQRDERMLI-YEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIA 613
              VKL     Q DE++     Y  N  L  +I     FD T ++F            I 
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--------TAEIV 142
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
             L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 674 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           Y+ PE   +      SD+++ G ++ ++V G
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVLLIAKLQHR 560
            E++     LGEG +G V   V    +E  A ++   K +    E  + E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VK  G   + + + L  EY     L D I         D  +       +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLH 122
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
               + I HRD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 681 IDGLFSVKS-DVFSFGVLVLEIVCGK 705
               F  +  DV+S G+++  ++ G+
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL--SKSSGQGMEEFENEVLLIAKLQHR 560
            E++     LGEG +G V   V    +E  A ++   K +    E  + E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VK  G   + + + L  EY     L D I         D  +       +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLH 122
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
               + I HRD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 681 IDGLFSVKS-DVFSFGVLVLEIVCGK 705
               F  +  DV+S G+++  ++ G+
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKG-VLIEGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQH 559
           E+F     LGEG F  V     L   +E A K L K        +     E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 560 RNLVKLIGCCTQRDERMLI-YEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIA 613
              VKL     Q DE++     Y  N  L  +I     FD T ++F            I 
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--------TAEIV 140
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
             L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 674 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           Y+ PE   +      SD+++ G ++ ++V G
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVLLIAKLQHR 560
            E++     LGEG +G V   V    +E  A ++   K +    E  + E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VK  G   + + + L  EY     L D I         D  +       +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLH 121
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
               + I HRD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 681 IDGLFSVKS-DVFSFGVLVLEIVCGK 705
               F  +  DV+S G+++  ++ G+
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL--SKSSGQGMEEFENEVLLIAKLQHR 560
            E++     LGEG +G V   V    +E  A ++   K +    E  + E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VK  G   + + + L  EY     L D I         D  +       +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLH 121
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
               + I HRD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 681 IDGLFSVKS-DVFSFGVLVLEIVCGK 705
               F  +  DV+S G+++  ++ G+
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVLLIAKLQHR 560
            E++     LGEG +G V   V    +E  A ++   K +    E  + E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VK  G   + + + L  EY     L D I         D  +       +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLH 121
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
               + I HRD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 681 IDGLFSVKS-DVFSFGVLVLEIVCGK 705
               F  +  DV+S G+++  ++ G+
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL--SKSSGQGMEEFENEVLLIAKLQHR 560
            E++     LGEG +G V   V    +E  A ++   K +    E  + E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VK  G   + + + L  EY     L D I         D  +       +  G++YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLH 122
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
               + I HRD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE  
Sbjct: 123 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 179
Query: 681 IDGLFSVKS-DVFSFGVLVLEIVCGK 705
               F  +  DV+S G+++  ++ G+
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVLLIAKLQHR 560
            E++     LGEG +G V   V    +E  A ++   K +    E  + E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VK  G   + + + L  EY     L D I         D  +       +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLH 121
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
               + I HRD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 681 IDGLFSVKS-DVFSFGVLVLEIVCGK 705
               F  +  DV+S G+++  ++ G+
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 504 ENFSDKNKLGEGGFGP-VYKGVLIEGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQH 559
           E+F     LGEG F   V    L   +E A K L K        +     E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 560 RNLVKLIGCCTQRDERMLI-YEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIA 613
              VKL     Q DE++     Y  N  L  +I     FD T ++F            I 
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--------TAEIV 140
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
             L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 674 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           Y+ PE   +      SD+++ G ++ ++V G
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKG-VLIEGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQH 559
           E+F     LGEG F  V     L   +E A K L K        +     E  ++++L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 560 RNLVKLIGCCTQRDERMLI-YEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIA 613
              VKL     Q DE++     Y  N  L  +I     FD T ++F            I 
Sbjct: 89  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--------TAEIV 139
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
             L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  
Sbjct: 140 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 196
Query: 674 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           Y+ PE   +      SD+++ G ++ ++V G
Sbjct: 197 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 505 NFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRN 561
           N+     +G+G F  V     ++ G+E+A + + K+  +   +++   EV ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDW-SKRCQIIGGIARGLLYLH 620
           +VKL           L+ EY     + D++    R K  +  +K  QI+  +     Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ----YCH 130
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
           Q     I+HRDLKA N+LLD +MN KI+DFG +  F            + T+   PP YA
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-------LDTFCGSPP-YA 179
Query: 681 IDGLFSVKS------DVFSFGVLVLEIVCG 704
              LF  K       DV+S GV++  +V G
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKG-VLIEGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQH 559
           E+F     LGEG F  V     L   +E A K L K        +     E  ++++L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 560 RNLVKLIGCCTQRDERMLI-YEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQIIGGIA 613
              VKL     Q DE++     Y  N  L  +I     FD T ++F            I 
Sbjct: 89  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--------TAEIV 139
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
             L YLH      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  
Sbjct: 140 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 196
Query: 674 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           Y+ PE   +      SD+++ G ++ ++V G
Sbjct: 197 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVLLIAKLQHR 560
            E++     LGEG +G V   V    +E  A ++   K +    E  + E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VK  G   + + + L  EY     L D I         D  +       +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLH 121
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
               + I HRD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 681 IDGLFSVKS-DVFSFGVLVLEIVCGK 705
               F  +  DV+S G+++  ++ G+
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 108/204 (52%), Gaps = 23/204 (11%)
Query: 512 LGEGGFGPVYKGVL-IEGQE---IAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLI 566
           +G G FG V +G L   G++   +A K L    + +   EF +E  ++ + +H N+++L 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGLLYLHQDS 623
           G  T     M++ E++ N +L+ F+  +   +F       Q++G   GIA G+ YL +  
Sbjct: 82  GVVTNSMPVMILTEFMENGALDSFL-RLNDGQF----TVIQLVGMLRGIASGMRYLAE-- 134
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----PE 678
            +  +HRDL A N+L+++ +  K+SDFG++R    + ++      +G  G +P     PE
Sbjct: 135 -MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLG--GKIPIRWTAPE 191
Query: 679 YAIDGLFSVKSDVFSFGVLVLEIV 702
                 F+  SD +S+G+++ E++
Sbjct: 192 AIAFRKFTSASDAWSYGIVMWEVM 215

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 108/204 (52%), Gaps = 23/204 (11%)
Query: 512 LGEGGFGPVYKGVL-IEGQE---IAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLI 566
           +G G FG V +G L   G++   +A K L    + +   EF +E  ++ + +H N+++L 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGLLYLHQDS 623
           G  T     M++ E++ N +L+ F+  +   +F       Q++G   GIA G+ YL +  
Sbjct: 84  GVVTNSMPVMILTEFMENGALDSFL-RLNDGQF----TVIQLVGMLRGIASGMRYLAE-- 136
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----PE 678
            +  +HRDL A N+L+++ +  K+SDFG++R    + ++      +G  G +P     PE
Sbjct: 137 -MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLG--GKIPIRWTAPE 193
Query: 679 YAIDGLFSVKSDVFSFGVLVLEIV 702
                 F+  SD +S+G+++ E++
Sbjct: 194 AIAFRKFTSASDAWSYGIVMWEVM 217

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 108/211 (51%), Gaps = 27/211 (12%)
Query: 511 KLGEGGFGPVYKGV---LIEGQ---EIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLV 563
           +LG+G FG VY+G    +I+G+    +A K +++S+  +   EF NE  ++      ++V
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--------CQIIGGIARG 615
           +L+G  ++    +++ E + +  L  ++  + R +  +   R         Q+   IA G
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSL-RPEAENNPGRPPPTLQEMIQMAAEIADG 143
Query: 616 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT---- 671
           + YL+     + +HR+L A N ++ ++   KI DFGM R    D  E +  R  G     
Sbjct: 144 MAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 196
Query: 672 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
             +M PE   DG+F+  SD++SFGV++ EI 
Sbjct: 197 VRWMAPESLKDGVFTTSSDMWSFGVVLWEIT 227

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 108/211 (51%), Gaps = 27/211 (12%)
Query: 511 KLGEGGFGPVYKGV---LIEGQ---EIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLV 563
           +LG+G FG VY+G    +I+G+    +A K +++S+  +   EF NE  ++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--------CQIIGGIARG 615
           +L+G  ++    +++ E + +  L  ++  + R +  +   R         Q+   IA G
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSL-RPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 616 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT---- 671
           + YL+     + +HR+L A N ++ ++   KI DFGM R    D  E +  R  G     
Sbjct: 143 MAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 195
Query: 672 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
             +M PE   DG+F+  SD++SFGV++ EI 
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEIT 226

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 106/204 (51%), Gaps = 23/204 (11%)
Query: 512 LGEGGFGPVYKGVL-IEGQE---IAAKRL-SKSSGQGMEEFENEVLLIAKLQHRNLVKLI 566
           +G G FG V  G L + G+    +A K L S  + +   +F +E  ++ +  H N++ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGLLYLHQDS 623
           G  T+    M+I E++ N SL+ F+      +F       Q++G   GIA G+ YL   +
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFLRQ-NDGQF----TVIQLVGMLRGIAAGMKYL---A 126
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----PE 678
            +  +HR L A N+L+++ +  K+SDFG++R    D ++      +G  G +P     PE
Sbjct: 127 DMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG--GKIPIRWTAPE 184
Query: 679 YAIDGLFSVKSDVFSFGVLVLEIV 702
                 F+  SDV+S+G+++ E++
Sbjct: 185 AIQYRKFTSASDVWSYGIVMWEVM 208

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 118/275 (42%), Gaps = 44/275 (16%)
Query: 461 WKRRHRKQGK-----TDGSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEG 515
           +K++ R + +       GSS  +Y     RE E +L    W       EN      LG G
Sbjct: 3   YKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLK---W---EFPRENLEFGKVLGSG 56
Query: 516 GFGPVYK----GVLIEGQ--EIAAKRL-SKSSGQGMEEFENEVLLIAKL-QHRNLVKLIG 567
            FG V      G+   G   ++A K L  K+     E   +E+ ++ +L  H N+V L+G
Sbjct: 57  AFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLG 116
Query: 568 CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKF---------------------LDWSKRC 606
            CT      LI+EY     L +++    R KF                     L +    
Sbjct: 117 ACTLSGPIYLIFEYCCYGDLLNYL-RSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLL 175
Query: 607 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN 666
                +A+G+ +L   S    +HRDL A NVL+ +    KI DFG+AR    D       
Sbjct: 176 CFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRG 232
Query: 667 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
                  +M PE   +G++++KSDV+S+G+L+ EI
Sbjct: 233 NARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 505 NFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRN 561
           N+     +G+G F  V     ++ G+E+A + + K+  +   +++   EV ++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDW-SKRCQIIGGIARGLLYLH 620
           +VKL           L+ EY     + D++    R K  +  +K  QI+  +     Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ----YCH 130
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
           Q     I+HRDLKA N+LLD +MN KI+DFG +  F         +   G+     P YA
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN---KLDEFCGS-----PPYA 179
Query: 681 IDGLFSVKS------DVFSFGVLVLEIVCG 704
              LF  K       DV+S GV++  +V G
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 99/200 (49%), Gaps = 14/200 (7%)
Query: 510 NKLGEGGFGPVYKGVL-IEGQEIAAKRLSKSSGQGME---EFENEVLLIAKLQHRNLVKL 565
           + LG G FG V  G   + G ++A K L++   + ++   +   E+  +   +H +++KL
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 625
               +   +  ++ EY+    L D+I    R   LD  +  ++   I  G+ Y H   R 
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICKNGR---LDEKESRRLFQQILSGVDYCH---RH 135
Query: 626 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF 685
            ++HRDLK  NVLLD  MN KI+DFG++      +    +    G+  Y  PE     L+
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXS---CGSPNYAAPEVISGRLY 192
Query: 686 S-VKSDVFSFGVLVLEIVCG 704
           +  + D++S GV++  ++CG
Sbjct: 193 AGPEVDIWSSGVILYALLCG 212

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 108/207 (52%), Gaps = 29/207 (14%)
Query: 512 LGEGGFGPVYKGVLIEGQE----IAAKRLSK-SSGQGMEEFENEVLLIAKLQHRNLVKLI 566
           +G+G FG VY G  I+  +     A K LS+ +  Q +E F  E LL+  L H N++ LI
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 567 GCCTQRDERMLIYEYLPNKSL----NDFIFDVTRSKFLDWSKRCQIIGG--IARGLLYLH 620
           G        ML  E LP+  L    +  +    RS   + + +  I  G  +ARG+ YL 
Sbjct: 89  GI-------MLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA 141
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY- 679
           +    + +HRDL A N +LD     K++DFG+AR   +D+   +  +    +  +P ++ 
Sbjct: 142 EQ---KFVHRDLAARNCMLDESFTVKVADFGLARDI-LDREYYSVQQ--HRHARLPVKWT 195
Query: 680 AIDGL----FSVKSDVFSFGVLVLEIV 702
           A++ L    F+ KSDV+SFGVL+ E++
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELL 222

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 35/202 (17%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ 571
           +G+G FG V  G    G ++A K +   +    + F  E  ++ +L+H NLV+L+G   +
Sbjct: 20  IGKGEFGDVMLGD-YRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 572 RDERM-LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG---------IARGLLYLHQ 621
               + ++ EY+   SL D++    RS          ++GG         +   + YL  
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSRGRS----------VLGGDCLLKFSLDVCEAMEYLEG 126
Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTY--GYMPPEY 679
           ++    +HRDL A NVL+  +   K+SDFG+ +       EA++ +  G     +  PE 
Sbjct: 127 NN---FVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEA 176
Query: 680 AIDGLFSVKSDVFSFGVLVLEI 701
             +  FS KSDV+SFG+L+ EI
Sbjct: 177 LREAAFSTKSDVWSFGILLWEI 198

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 12/207 (5%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAA---KRLSKSSGQGMEEFENEVLLIAKLQHR 560
           + +    K+GEG +G V+K    E  EI A    RL             E+ L+ +L+H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+V+L        +  L++E+  ++ L  + FD      LD       +  + +GL + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFC-DQDLKKY-FDSCNGD-LDPEIVKSFLFQLLKGLGFCH 118
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
             +   ++HRDLK  N+L++     K++DFG+ARAFGI      +  VV T  Y PP+  
Sbjct: 119 SRN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI-PVRCYSAEVV-TLWYRPPDVL 173
Query: 681 IDG-LFSVKSDVFSFGVLVLEIVCGKR 706
               L+S   D++S G +  E+    R
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAAR 200

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 94/206 (45%), Gaps = 9/206 (4%)
Query: 503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVLLIAKLQHR 560
            E++     LGEG  G V   V    +E  A ++   K +    E  + E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VK  G   + + + L  EY     L D I         D  +       +  G++YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---FFHQLMAGVVYLH 121
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
               + I HRD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE  
Sbjct: 122 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 681 IDGLFSVKS-DVFSFGVLVLEIVCGK 705
               F  +  DV+S G+++  ++ G+
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 98/216 (45%), Gaps = 37/216 (17%)
Query: 505 NFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRN 561
           N+     +G+G F  V     ++ G+E+A K + K+  +   +++   EV ++  L H N
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIF-------DVTRSKFLDWSKRCQIIGGIAR 614
           +VKL           L+ EY     + D++           R+KF       QI+  +  
Sbjct: 68  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKF------RQIVSAVQ- 120
Query: 615 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGY 674
              Y HQ     I+HRDLKA N+LLD +MN KI+DFG +  F            + T+  
Sbjct: 121 ---YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-------LDTFCG 167
Query: 675 MPPEYAIDGLFSVKS------DVFSFGVLVLEIVCG 704
            PP YA   LF  K       DV+S GV++  +V G
Sbjct: 168 SPP-YAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 107/228 (46%), Gaps = 39/228 (17%)
Query: 505 NFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH---- 559
           +F +   LG+G FG V K    ++ +  A K++ + + + +    +EV+L+A L H    
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVV 65
Query: 560 ---------RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLD--WSKRCQI 608
                    RN VK +    ++    +  EY  N++L D I     ++  D  W    QI
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQI 125
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA----RAFGIDQTEA- 663
           +  ++    Y+H      IIHRDLK  N+ +D   N KI DFG+A    R+  I + ++ 
Sbjct: 126 LEALS----YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 664 -------NTNRVVGTYGYMPPEYAIDGL--FSVKSDVFSFGVLVLEIV 702
                  N    +GT  Y+  E  +DG   ++ K D++S G++  E++
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 35/202 (17%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ 571
           +G+G FG V  G    G ++A K +   +    + F  E  ++ +L+H NLV+L+G   +
Sbjct: 29  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 572 RDERM-LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG---------IARGLLYLHQ 621
               + ++ EY+   SL D++    RS          ++GG         +   + YL  
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRS----------VLGGDCLLKFSLDVCEAMEYLEG 135
Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT--YGYMPPEY 679
           ++    +HRDL A NVL+  +   K+SDFG+ +       EA++ +  G     +  PE 
Sbjct: 136 NN---FVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEA 185
Query: 680 AIDGLFSVKSDVFSFGVLVLEI 701
             +  FS KSDV+SFG+L+ EI
Sbjct: 186 LREKKFSTKSDVWSFGILLWEI 207

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 35/202 (17%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ 571
           +G+G FG V  G    G ++A K +   +    + F  E  ++ +L+H NLV+L+G   +
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 572 RDERM-LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG---------IARGLLYLHQ 621
               + ++ EY+   SL D++    RS          ++GG         +   + YL  
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRS----------VLGGDCLLKFSLDVCEAMEYLEG 307
Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT--YGYMPPEY 679
           ++    +HRDL A NVL+  +   K+SDFG+ +       EA++ +  G     +  PE 
Sbjct: 308 NN---FVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEA 357
Query: 680 AIDGLFSVKSDVFSFGVLVLEI 701
             +  FS KSDV+SFG+L+ EI
Sbjct: 358 LREKKFSTKSDVWSFGILLWEI 379

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 35/202 (17%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ 571
           +G+G FG V  G    G ++A K +   +    + F  E  ++ +L+H NLV+L+G   +
Sbjct: 14  IGKGEFGDVMLGD-YRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 572 RDERM-LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG---------IARGLLYLHQ 621
               + ++ EY+   SL D++    RS          ++GG         +   + YL  
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRS----------VLGGDCLLKFSLDVCEAMEYLEG 120
Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT--YGYMPPEY 679
           ++    +HRDL A NVL+  +   K+SDFG+ +       EA++ +  G     +  PE 
Sbjct: 121 NN---FVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEA 170
Query: 680 AIDGLFSVKSDVFSFGVLVLEI 701
             +  FS KSDV+SFG+L+ EI
Sbjct: 171 LREKKFSTKSDVWSFGILLWEI 192

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 107/222 (48%), Gaps = 36/222 (16%)
Query: 511 KLGEGGFGPVYKGV-LIEGQEIAAKRLS---KSSGQGMEEFENEVLLIAKLQ-HRNLVKL 565
           KLG+G +G V+K +    G+ +A K++    ++S      F  E++++ +L  H N+V L
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNL 74
Query: 566 IGCCTQRDER--MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           +      ++R   L+++Y+        +  V R+  L+   +  ++  + + + YLH   
Sbjct: 75  LNVLRADNDRDVYLVFDYMETD-----LHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG 129
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-------------------GIDQTEAN 664
              ++HRD+K SN+LL+ E + K++DFG++R+F                     D  +  
Sbjct: 130 ---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 665 TNRVVGTYGYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCGK 705
               V T  Y  PE  +      K  D++S G ++ EI+CGK
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 92/216 (42%), Gaps = 34/216 (15%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVL------LIAKLQHRNLV 563
           LG G FG V +       + A  R    K   +G    E+  L      LI    H N+V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 564 KLIGCCTQRDERMLIY------------------EYLPNKSLNDFIFDVTRSKFLDWSKR 605
            L+G CT+    +++                   E++P K+  D   D     FL     
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKD-----FLTLEHL 150
Query: 606 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT 665
                 +A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+AR    D      
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 666 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
                   +M PE   D +++++SDV+SFGVL+ EI
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 14/212 (6%)
Query: 497 MAIANATENFSDKNKLGEGGFGPVY-KGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIA 555
           M   N  + F     LG G F  V+     + G+  A K + KS        ENE+ ++ 
Sbjct: 2   MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLK 61
Query: 556 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARG 615
           K++H N+V L           L+ + +    L D I +  R  + +      +I  +   
Sbjct: 62  KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILE--RGVYTE-KDASLVIQQVLSA 118
Query: 616 LLYLHQDSRLRIIHRDLKASNVL-LDNEMNPKISDFGMARAFGIDQTEAN--TNRVVGTY 672
           + YLH++    I+HRDLK  N+L L  E N KI    M   FG+ + E N   +   GT 
Sbjct: 119 VKYLHENG---IVHRDLKPENLLYLTPEENSKI----MITDFGLSKMEQNGIMSTACGTP 171
Query: 673 GYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           GY+ PE      +S   D +S GV+   ++CG
Sbjct: 172 GYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 505 NFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRN 561
           N+     +G+G F  V     ++ G+E+A K + K+  +   +++   EV +   L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPN 74
Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDW-SKRCQIIGGIARGLLYLH 620
           +VKL           L+ EY     + D++    R K  +  +K  QI+  +     Y H
Sbjct: 75  IVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQ----YCH 130
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
           Q     I+HRDLKA N+LLD + N KI+DFG +  F         N++    G   P YA
Sbjct: 131 QKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFG------NKLDAFCG--APPYA 179
Query: 681 IDGLFSVKS------DVFSFGVLVLEIVCG 704
              LF  K       DV+S GV++  +V G
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 16/214 (7%)
Query: 499 IANATENFSDKNKLGEGGFGPVYK------GVLIEGQEIAAKRLSKSSGQGMEEFENEVL 552
           + +  E++     +G G +G   K      G ++  +E+    ++++  Q +    +EV 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV---SEVN 57
Query: 553 LIAKLQHRNLVKLIGCCTQRDERML--IYEYLPNKSLNDFIFDVTRSK-FLDWSKRCQII 609
           L+ +L+H N+V+       R    L  + EY     L   I   T+ + +LD     +++
Sbjct: 58  LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 117
Query: 610 GGIARGLLYLHQ--DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 667
             +   L   H+  D    ++HRDLK +NV LD + N K+ DFG+AR    D + A T  
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-- 175
Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
            VGT  YM PE      ++ KSD++S G L+ E+
Sbjct: 176 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 109/215 (50%), Gaps = 20/215 (9%)
Query: 499 IANATENFSDKNKLGEGGFGPVYKGVLIE--GQEIAAKRLSKSSGQ-GME-EFENEVLLI 554
           +  A + +    ++GEG +G V+K   ++  G+ +A KR+   +G+ GM      EV ++
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 555 AKLQ---HRNLVKLIGCCT-QRDER----MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC 606
             L+   H N+V+L   CT  R +R     L++E++ ++ L  ++  V        + + 
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK- 123
Query: 607 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN 666
            ++  + RGL +LH     R++HRDLK  N+L+ +    K++DFG+AR +     +    
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALT 177
Query: 667 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
            VV T  Y  PE  +   ++   D++S G +  E+
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 94/209 (44%), Gaps = 23/209 (11%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVL------LIAKLQHRNLV 563
           LG G FG V +       + A  R    K   +G    E+  L      LI    H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 564 KLIGCCTQRD-ERMLIYE---------YLPNKSLNDFI-FDVTRSKFLDWSKRCQIIGGI 612
            L+G CT+     M+I E         YL +K  N+F+ +      FL           +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR-NEFVPYKDLYKDFLTLEHLIXYSFQV 153
Query: 613 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTY 672
           A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+AR    D             
Sbjct: 154 AKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPL 210
Query: 673 GYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
            +M PE   D +++++SDV+SFGVL+ EI
Sbjct: 211 KWMAPETIFDRVYTIQSDVWSFGVLLWEI 239

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVL------LIAKLQHRNLV 563
           LG G FG V +       + A  R    K   +G    E+  L      LI    H N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 564 KLIGCCTQRD-ERMLIYEYLPNKSL--------NDFIFDVTRSKFLDWSKRCQIIG---G 611
            L+G CT+     M+I E+    +L        N+F+       + D+     +I     
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 671
           +A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+AR    D            
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 672 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
             +M PE   D +++++SDV+SFGVL+ EI
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 14/223 (6%)
Query: 496 WMAIANATEN-FSDKNKLGEGGFGPVYKGVLIEGQEIAA----KRLSKSSGQGMEEFENE 550
           W+      E+ F D   LG GGFG V+   +    ++ A     +      +G +    E
Sbjct: 176 WLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVE 235
Query: 551 VLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTR-SKFLDWSKRCQII 609
             ++AK+  R +V L      + +  L+   +    +   I++V   +      +     
Sbjct: 236 KKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 610 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV 669
             I  GL +LHQ +   II+RDLK  NVLLD++ N +ISD G+A      QT+  T    
Sbjct: 296 AQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYA 350
Query: 670 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK---RNRG 709
           GT G+M PE  +   +    D F+ GV + E++  +   R RG
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 14/223 (6%)
Query: 496 WMAIANATEN-FSDKNKLGEGGFGPVYKGVLIEGQEIAA----KRLSKSSGQGMEEFENE 550
           W+      E+ F D   LG GGFG V+   +    ++ A     +      +G +    E
Sbjct: 176 WLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVE 235
Query: 551 VLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTR-SKFLDWSKRCQII 609
             ++AK+  R +V L      + +  L+   +    +   I++V   +      +     
Sbjct: 236 KKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 610 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV 669
             I  GL +LHQ +   II+RDLK  NVLLD++ N +ISD G+A      QT+  T    
Sbjct: 296 AQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYA 350
Query: 670 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK---RNRG 709
           GT G+M PE  +   +    D F+ GV + E++  +   R RG
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 111/246 (45%), Gaps = 40/246 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E +   + +G G +G V     ++ G +IA K+LS+   S    +    E+ L+
Sbjct: 45  TIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLL 104
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P  SL +F  ++ VT     D +   +CQ   
Sbjct: 105 KHMKHENVIGLLDVFT------------PATSLEEFNDVYLVTHLMGADLNNIVKCQKLT 152
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 153 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 204
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL 720
           +      V T  Y  PE  ++ + +++  D++S G ++ E++ G   R  +    H N L
Sbjct: 205 DDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTG---RTLFPGTDHINQL 261
Query: 721 GHAWRL 726
               RL
Sbjct: 262 QQIMRL 267

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 14/223 (6%)
Query: 496 WMAIANATEN-FSDKNKLGEGGFGPVYKGVLIEGQEIAA----KRLSKSSGQGMEEFENE 550
           W+      E+ F D   LG GGFG V+   +    ++ A     +      +G +    E
Sbjct: 176 WLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVE 235
Query: 551 VLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTR-SKFLDWSKRCQII 609
             ++AK+  R +V L      + +  L+   +    +   I++V   +      +     
Sbjct: 236 KKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 610 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV 669
             I  GL +LHQ +   II+RDLK  NVLLD++ N +ISD G+A      QT+  T    
Sbjct: 296 AQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYA 350
Query: 670 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK---RNRG 709
           GT G+M PE  +   +    D F+ GV + E++  +   R RG
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 14/223 (6%)
Query: 496 WMAIANATEN-FSDKNKLGEGGFGPVYKGVLIEGQEIAA----KRLSKSSGQGMEEFENE 550
           W+      E+ F D   LG GGFG V+   +    ++ A     +      +G +    E
Sbjct: 176 WLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVE 235
Query: 551 VLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTR-SKFLDWSKRCQII 609
             ++AK+  R +V L      + +  L+   +    +   I++V   +      +     
Sbjct: 236 KKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 610 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV 669
             I  GL +LHQ +   II+RDLK  NVLLD++ N +ISD G+A      QT+  T    
Sbjct: 296 AQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYA 350
Query: 670 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK---RNRG 709
           GT G+M PE  +   +    D F+ GV + E++  +   R RG
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/182 (31%), Positives = 97/182 (53%), Gaps = 21/182 (11%)
Query: 511 KLGEGGFGPVYKGVLIE-GQEIAAKR-LSKSSGQGME-EFENEVLLIAKLQHRNLVKLIG 567
           K+G+G FG V+K    + GQ++A K+ L ++  +G       E+ ++  L+H N+V LI 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 568 CCTQRDERM--------LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
            C  +            L++++  +  L   + +V     L   KR  ++  +  GL Y+
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYYI 141
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI---DQTEANTNRVVGTYGYMP 676
           H++   +I+HRD+KA+NVL+  +   K++DFG+ARAF +    Q     NRVV T  Y P
Sbjct: 142 HRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYRP 197
Query: 677 PE 678
           PE
Sbjct: 198 PE 199

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 106/228 (46%), Gaps = 39/228 (17%)
Query: 505 NFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH---- 559
           +F +   LG+G FG V K    ++ +  A K++ + + + +    +EV+L+A L H    
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVV 65
Query: 560 ---------RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLD--WSKRCQI 608
                    RN VK +    ++    +  EY  N +L D I     ++  D  W    QI
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA----RAFGIDQTEA- 663
           +  ++    Y+H      IIHRDLK  N+ +D   N KI DFG+A    R+  I + ++ 
Sbjct: 126 LEALS----YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 664 -------NTNRVVGTYGYMPPEYAIDGL--FSVKSDVFSFGVLVLEIV 702
                  N    +GT  Y+  E  +DG   ++ K D++S G++  E++
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/182 (31%), Positives = 97/182 (53%), Gaps = 21/182 (11%)
Query: 511 KLGEGGFGPVYKGVLIE-GQEIAAKR-LSKSSGQGME-EFENEVLLIAKLQHRNLVKLIG 567
           K+G+G FG V+K    + GQ++A K+ L ++  +G       E+ ++  L+H N+V LI 
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 568 CCTQRDERM--------LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
            C  +            L++++  +  L   + +V     L   KR  ++  +  GL Y+
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYYI 140
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI---DQTEANTNRVVGTYGYMP 676
           H++   +I+HRD+KA+NVL+  +   K++DFG+ARAF +    Q     NRVV T  Y P
Sbjct: 141 HRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYRP 196
Query: 677 PE 678
           PE
Sbjct: 197 PE 198

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 109/215 (50%), Gaps = 20/215 (9%)
Query: 499 IANATENFSDKNKLGEGGFGPVYKGVLIE--GQEIAAKRLSKSSGQ-GME-EFENEVLLI 554
           +  A + +    ++GEG +G V+K   ++  G+ +A KR+   +G+ GM      EV ++
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 555 AKLQ---HRNLVKLIGCCT-QRDER----MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC 606
             L+   H N+V+L   CT  R +R     L++E++ ++ L  ++  V        + + 
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK- 123
Query: 607 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN 666
            ++  + RGL +LH     R++HRDLK  N+L+ +    K++DFG+AR +     +    
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALT 177
Query: 667 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
            VV T  Y  PE  +   ++   D++S G +  E+
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/182 (31%), Positives = 97/182 (53%), Gaps = 21/182 (11%)
Query: 511 KLGEGGFGPVYKGVLIE-GQEIAAKR-LSKSSGQGME-EFENEVLLIAKLQHRNLVKLIG 567
           K+G+G FG V+K    + GQ++A K+ L ++  +G       E+ ++  L+H N+V LI 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 568 CCTQRDERM--------LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
            C  +            L++++  +  L   + +V     L   KR  ++  +  GL Y+
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYYI 141
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI---DQTEANTNRVVGTYGYMP 676
           H++   +I+HRD+KA+NVL+  +   K++DFG+ARAF +    Q     NRVV T  Y P
Sbjct: 142 HRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYRP 197
Query: 677 PE 678
           PE
Sbjct: 198 PE 199

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 109/215 (50%), Gaps = 20/215 (9%)
Query: 499 IANATENFSDKNKLGEGGFGPVYKGVLIE--GQEIAAKRLSKSSGQ-GME-EFENEVLLI 554
           +  A + +    ++GEG +G V+K   ++  G+ +A KR+   +G+ GM      EV ++
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 555 AKLQ---HRNLVKLIGCCT-QRDER----MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC 606
             L+   H N+V+L   CT  R +R     L++E++ ++ L  ++  V        + + 
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK- 123
Query: 607 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN 666
            ++  + RGL +LH     R++HRDLK  N+L+ +    K++DFG+AR +     +    
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALT 177
Query: 667 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
            VV T  Y  PE  +   ++   D++S G +  E+
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/182 (31%), Positives = 97/182 (53%), Gaps = 21/182 (11%)
Query: 511 KLGEGGFGPVYKGVLIE-GQEIAAKR-LSKSSGQGME-EFENEVLLIAKLQHRNLVKLIG 567
           K+G+G FG V+K    + GQ++A K+ L ++  +G       E+ ++  L+H N+V LI 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 568 CCTQRDERM--------LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
            C  +            L++++  +  L   + +V     L   KR  ++  +  GL Y+
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYYI 141
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI---DQTEANTNRVVGTYGYMP 676
           H++   +I+HRD+KA+NVL+  +   K++DFG+ARAF +    Q     NRVV T  Y P
Sbjct: 142 HRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYRP 197
Query: 677 PE 678
           PE
Sbjct: 198 PE 199

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 20/217 (9%)
Query: 496 WMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQE----IAAKRLSKSSGQGME-EFENE 550
           W    +  + +  ++ LG G F  V   +L E +     +A K ++K + +G E   ENE
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKKALEGKEGSMENE 66
Query: 551 VLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG 610
           + ++ K++H N+V L           LI + +    L D I +     F       ++I 
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE---KGFYTERDASRLIF 123
Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVL---LDNEMNPKISDFGMARAFGIDQTEANTNR 667
            +   + YLH    L I+HRDLK  N+L   LD +    ISDFG+++   ++   +  + 
Sbjct: 124 QVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLST 177
Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
             GT GY+ PE      +S   D +S GV+   ++CG
Sbjct: 178 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 20/217 (9%)
Query: 496 WMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQE----IAAKRLSKSSGQGME-EFENE 550
           W    +  + +  ++ LG G F  V   +L E +     +A K ++K + +G E   ENE
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 551 VLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG 610
           + ++ K++H N+V L           LI + +    L D I       F       ++I 
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIF 123
Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVL---LDNEMNPKISDFGMARAFGIDQTEANTNR 667
            +   + YLH    L I+HRDLK  N+L   LD +    ISDFG+++   ++   +  + 
Sbjct: 124 QVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLST 177
Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
             GT GY+ PE      +S   D +S GV+   ++CG
Sbjct: 178 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 12/207 (5%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAA---KRLSKSSGQGMEEFENEVLLIAKLQHR 560
           + +    K+GEG +G V+K    E  EI A    RL             E+ L+ +L+H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+V+L        +  L++E+  ++ L  + FD      LD       +  + +GL + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFC-DQDLKKY-FDSCNGD-LDPEIVKSFLFQLLKGLGFCH 118
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
             +   ++HRDLK  N+L++     K+++FG+ARAFGI      +  VV T  Y PP+  
Sbjct: 119 SRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVV-TLWYRPPDVL 173
Query: 681 IDG-LFSVKSDVFSFGVLVLEIVCGKR 706
               L+S   D++S G +  E+    R
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGR 200

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVL------LIAKLQHRNLV 563
           LG G FG V +       + A  R    K   +G    E+  L      LI    H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 564 KLIGCCTQRD-ERMLIYEYLPNKSLNDFI------FDVTRSKFLDWSKRCQIIG---GIA 613
            L+G CT+     M+I E+    +L+ ++      F   +  + D+     +I     +A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
           +G+ +L   +  + IHRDL A N+LL  +   KI DFG+AR    D              
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 674 YMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
           +M PE   D +++++SDV+SFGVL+ EI
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEI 239

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 20/217 (9%)
Query: 496 WMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQE----IAAKRLSKSSGQGME-EFENE 550
           W    +  + +  ++ LG G F  V   +L E +     +A K ++K + +G E   ENE
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 551 VLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG 610
           + ++ K++H N+V L           LI + +    L D I       F       ++I 
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIF 123
Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVL---LDNEMNPKISDFGMARAFGIDQTEANTNR 667
            +   + YLH    L I+HRDLK  N+L   LD +    ISDFG+++   ++   +  + 
Sbjct: 124 QVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLST 177
Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
             GT GY+ PE      +S   D +S GV+   ++CG
Sbjct: 178 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 20/217 (9%)
Query: 496 WMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQE----IAAKRLSKSSGQGME-EFENE 550
           W    +  + +  ++ LG G F  V   +L E +     +A K ++K + +G E   ENE
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 551 VLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG 610
           + ++ K++H N+V L           LI + +    L D I       F       ++I 
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIF 123
Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVL---LDNEMNPKISDFGMARAFGIDQTEANTNR 667
            +   + YLH    L I+HRDLK  N+L   LD +    ISDFG+++   ++   +  + 
Sbjct: 124 QVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLST 177
Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
             GT GY+ PE      +S   D +S GV+   ++CG
Sbjct: 178 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 21/209 (10%)
Query: 506 FSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQ-GMEEFENEVLLIAKLQHR 560
           F  K KLG G FG V+   L+E    G E   K ++K   Q  ME+ E E+ ++  L H 
Sbjct: 24  FIFKRKLGSGAFGDVH---LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYL 619
           N++K+           ++ E      L + I     R K L      +++  +   L Y 
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 620 HQDSRLRIIHRDLKASNVLLDNE--MNP-KISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
           H      ++H+DLK  N+L  +    +P KI DFG+A  F  D+   N     GT  YM 
Sbjct: 141 HSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNA---AGTALYMA 194
Query: 677 PE-YAIDGLFSVKSDVFSFGVLVLEIVCG 704
           PE +  D  F  K D++S GV++  ++ G
Sbjct: 195 PEVFKRDVTF--KCDIWSAGVVMYFLLTG 221

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 130/284 (45%), Gaps = 50/284 (17%)
Query: 512 LGEGGFGPVYKGVL-IEGQE---IAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLI 566
           +G G FG V  G L + G+    +A K L    + +   +F  E  ++ +  H N+V L 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG---GIARGLLYLHQDS 623
           G  T+    M++ E++ N +L+ F+      K        Q++G   GIA G+ YL   +
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFL-----RKHDGQFTVIQLVGMLRGIAAGMRYL---A 162
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----PE 678
            +  +HRDL A N+L+++ +  K+SDFG++R    D     T     T G +P     PE
Sbjct: 163 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTT----TGGKIPVRWTAPE 218
Query: 679 YAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 737
                 F+  SDV+S+G+++ E++  G+R                 W +  ++     + 
Sbjct: 219 AIQYRKFTSASDVWSYGIVMWEVMSYGERP---------------YWDMSNQD-----VI 258
Query: 738 KSLGGSYSLSEVLRCI----QVGLLCVQQRPEDRPNMSSVVLML 777
           K++   Y L   + C     Q+ L C Q+   +RP    +V +L
Sbjct: 259 KAIEEGYRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGIL 302

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 101/201 (50%), Gaps = 14/201 (6%)
Query: 510 NKLGEGGFGPVYKGV-LIEGQEIAAKRLS--KSSGQGMEEFENEVLLIAKLQHRNLVKLI 566
            +LG+G F  V + V ++ GQE AAK ++  K S +  ++ E E  +   L+H N+V+L 
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 87
Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 626
              ++     LI++ +    L +   D+   ++   +     I  I   +L+ HQ   + 
Sbjct: 88  DSISEEGHHYLIFDLVTGGELFE---DIVAREYYSEADASHCIQQILEAVLHCHQ---MG 141
Query: 627 IIHRDLKASNVLLDNEMN---PKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
           ++HRDLK  N+LL +++     K++DFG+  A  ++  +       GT GY+ PE     
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGL--AIEVEGEQQAWFGFAGTPGYLSPEVLRKD 199
Query: 684 LFSVKSDVFSFGVLVLEIVCG 704
            +    D+++ GV++  ++ G
Sbjct: 200 PYGKPVDLWACGVILYILLVG 220

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 102/221 (46%), Gaps = 10/221 (4%)
Query: 506 FSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGM-EEFENEVLLIAKLQHRNLV 563
           +++ + +GEG +G V      +    +A K++S    Q   +    E+ ++ + +H N++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
            +           +   YL    +   ++ + +++ L     C  +  I RGL Y+H  +
Sbjct: 105 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 164
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN-TNRVVGTYGYMPPEYAID 682
              ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++
Sbjct: 165 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 221
Query: 683 GLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 722
                KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 259

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 16/217 (7%)
Query: 496 WMAIANATEN-FSDKNKLGEGGFGPV------YKGVLIEGQEIAAKRLSKSSGQGMEEFE 548
           W+     T+N F     LG+GGFG V        G +   +++  KR+ K  G+ M    
Sbjct: 175 WLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL-- 232
Query: 549 NEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQI 608
           NE  ++ K+  R +V L      +D   L+   +    L   I+ + ++ F + ++    
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPE-ARAVFY 291
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
              I  GL  LH   R RI++RDLK  N+LLD+  + +ISD G+A      QT       
Sbjct: 292 AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGR 345
Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           VGT GYM PE   +  ++   D ++ G L+ E++ G+
Sbjct: 346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 124/302 (41%), Gaps = 50/302 (16%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ 571
           +G+G FG VY G       I    + + +   ++ F+ EV+   + +H N+V  +G C  
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100
Query: 572 RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRD 631
                +I      ++L   + D      LD +K  QI   I +G+ YLH      I+H+D
Sbjct: 101 PPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKD 155
Query: 632 LKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGY-----------MPPEYA 680
           LK+ NV  DN     I+DFG+    G+ Q     +++    G+           + P+  
Sbjct: 156 LKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214
Query: 681 IDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 739
            D L FS  SDVF+ G +  E+                    HA     + +P E I   
Sbjct: 215 EDKLPFSKHSDVFALGTIWYEL--------------------HAREWPFKTQPAEAIIWQ 254
Query: 740 LGGSY--SLSEVLRCIQVG---LLCVQQRPEDRPNMSSVVLMLSGERSLPQP----KQPG 790
           +G     +LS++    ++    L C     E+RP  + ++ ML     LP+       PG
Sbjct: 255 MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE---KLPKRNRRLSHPG 311
Query: 791 FF 792
            F
Sbjct: 312 HF 313

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 16/217 (7%)
Query: 496 WMAIANATEN-FSDKNKLGEGGFGPV------YKGVLIEGQEIAAKRLSKSSGQGMEEFE 548
           W+     T+N F     LG+GGFG V        G +   +++  KR+ K  G+ M    
Sbjct: 175 WLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL-- 232
Query: 549 NEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQI 608
           NE  ++ K+  R +V L      +D   L+   +    L   I+ + ++ F + ++    
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPE-ARAVFY 291
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
              I  GL  LH   R RI++RDLK  N+LLD+  + +ISD G+A      QT       
Sbjct: 292 AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGR 345
Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           VGT GYM PE   +  ++   D ++ G L+ E++ G+
Sbjct: 346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 103/223 (46%), Gaps = 14/223 (6%)
Query: 506 FSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSKSSGQGM-EEFENEVLLIAKLQHRN 561
           +++ + +GEG +G V   Y  V      +A K++S    Q   +    E+ ++ + +H N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
           ++ +           +   Y+    +   ++ + +++ L     C  +  I RGL Y+H 
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN-TNRVVGTYGYMPPEYA 680
            +   ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  
Sbjct: 143 AN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 681 IDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 722
           ++     KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 239

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 103/223 (46%), Gaps = 14/223 (6%)
Query: 506 FSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSKSSGQGM-EEFENEVLLIAKLQHRN 561
           +++ + +GEG +G V   Y  V      +A K++S    Q   +    E+ ++ + +H N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
           ++ +           +   Y+    +   ++ + +++ L     C  +  I RGL Y+H 
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN-TNRVVGTYGYMPPEYA 680
            +   ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  
Sbjct: 143 AN---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 681 IDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 722
           ++     KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 239

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 103/223 (46%), Gaps = 14/223 (6%)
Query: 506 FSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSKSSGQGM-EEFENEVLLIAKLQHRN 561
           +++ + +GEG +G V   Y  V      +A K++S    Q   +    E+ ++ + +H N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
           ++ +           +   Y+    +   ++ + +++ L     C  +  I RGL Y+H 
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN-TNRVVGTYGYMPPEYA 680
            +   ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  
Sbjct: 143 AN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 681 IDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 722
           ++     KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 200 LNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 239

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 102/214 (47%), Gaps = 16/214 (7%)
Query: 499 IANATENFSDKNKLGEGGFGPVYK------GVLIEGQEIAAKRLSKSSGQGMEEFENEVL 552
           + +  E++     +G G +G   K      G ++  +E+    ++++  Q +    +EV 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV---SEVN 57
Query: 553 LIAKLQHRNLVKLIGCCTQRDERML--IYEYLPNKSLNDFIFDVTRSK-FLDWSKRCQII 609
           L+ +L+H N+V+       R    L  + EY     L   I   T+ + +LD     +++
Sbjct: 58  LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 117
Query: 610 GGIARGLLYLHQ--DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 667
             +   L   H+  D    ++HRDLK +NV LD + N K+ DFG+AR    D + A    
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-- 175
Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
            VGT  YM PE      ++ KSD++S G L+ E+
Sbjct: 176 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 102/221 (46%), Gaps = 10/221 (4%)
Query: 506 FSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGM-EEFENEVLLIAKLQHRNLV 563
           +++ + +GEG +G V      +    +A K++S    Q   +    E+ ++ + +H N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 86
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
            +           +   Y+    +   ++ + +++ L     C  +  I RGL Y+H  +
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 146
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN-TNRVVGTYGYMPPEYAID 682
              ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++
Sbjct: 147 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 683 GLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 722
                KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 241

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 102/221 (46%), Gaps = 10/221 (4%)
Query: 506 FSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGM-EEFENEVLLIAKLQHRNLV 563
           +++ + +GEG +G V      +    +A K++S    Q   +    E+ ++ + +H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
            +           +   Y+    +   ++ + +++ L     C  +  I RGL Y+H  +
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN-TNRVVGTYGYMPPEYAID 682
              ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++
Sbjct: 145 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 683 GLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 722
                KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 239

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 111/277 (40%), Gaps = 38/277 (13%)
Query: 510 NKLGEGGFGPVYKGVLI----EGQEIAAKRLSK---SSGQGMEEFENEVLLIAKLQHRNL 562
            KLG+G FG V +G       +   +A K L     S  + M++F  EV  +  L HRNL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
           ++L G       +M + E  P  SL D +        L    R  +   +A G+ YL   
Sbjct: 84  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 140
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GIDQTEANTNRVVGTYGYMPPEYA 680
              R IHRDL A N+LL      KI DFG+ RA     D      +R V  + +  PE  
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAWCAPESL 196
Query: 681 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 740
               FS  SD + FGV + E                  +  +    WI     ++++K  
Sbjct: 197 KTRTFSHASDTWMFGVTLWE------------------MFTYGQEPWIGLNGSQILHKID 238
Query: 741 GGSYSLSEVLRCIQ----VGLLCVQQRPEDRPNMSSV 773
                L     C Q    V + C   +PEDRP   ++
Sbjct: 239 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 275

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 111/277 (40%), Gaps = 38/277 (13%)
Query: 510 NKLGEGGFGPVYKGVLI----EGQEIAAKRLSK---SSGQGMEEFENEVLLIAKLQHRNL 562
            KLG+G FG V +G       +   +A K L     S  + M++F  EV  +  L HRNL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
           ++L G       +M + E  P  SL D +        L    R  +   +A G+ YL   
Sbjct: 78  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 134
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GIDQTEANTNRVVGTYGYMPPEYA 680
              R IHRDL A N+LL      KI DFG+ RA     D      +R V  + +  PE  
Sbjct: 135 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 190
Query: 681 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 740
               FS  SD + FGV + E                  +  +    WI     ++++K  
Sbjct: 191 KTRTFSHASDTWMFGVTLWE------------------MFTYGQEPWIGLNGSQILHKID 232
Query: 741 GGSYSLSEVLRCIQ----VGLLCVQQRPEDRPNMSSV 773
                L     C Q    V + C   +PEDRP   ++
Sbjct: 233 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 269

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 102/214 (47%), Gaps = 16/214 (7%)
Query: 499 IANATENFSDKNKLGEGGFGPVYK------GVLIEGQEIAAKRLSKSSGQGMEEFENEVL 552
           + +  E++     +G G +G   K      G ++  +E+    ++++  Q +    +EV 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV---SEVN 57
Query: 553 LIAKLQHRNLVKLIGCCTQRDERML--IYEYLPNKSLNDFIFDVTRSK-FLDWSKRCQII 609
           L+ +L+H N+V+       R    L  + EY     L   I   T+ + +LD     +++
Sbjct: 58  LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 117
Query: 610 GGIARGLLYLHQ--DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 667
             +   L   H+  D    ++HRDLK +NV LD + N K+ DFG+AR    D+  A    
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFA--KE 175
Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
            VGT  YM PE      ++ KSD++S G L+ E+
Sbjct: 176 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 12/198 (6%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKSS----GQGMEEFENEVLLIAKLQHRNLVKLIG 567
           LG+GGF   Y+   ++ +E+ A ++   S        E+   E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 568 CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI 627
                D   ++ E    +SL +      R K +   +    +    +G+ YLH +   R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLEL---HKRRKAVTEPEARYFMRQTIQGVQYLHNN---RV 163
Query: 628 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSV 687
           IHRDLK  N+ L+++M+ KI DFG+A     D     T  + GT  Y+ PE       S 
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT--LCGTPNYIAPEVLCKKGHSF 221
Query: 688 KSDVFSFGVLVLEIVCGK 705
           + D++S G ++  ++ GK
Sbjct: 222 EVDIWSLGCILYTLLVGK 239

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 102/221 (46%), Gaps = 10/221 (4%)
Query: 506 FSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGM-EEFENEVLLIAKLQHRNLV 563
           +++ + +GEG +G V      +    +A K++S    Q   +    E+ ++ + +H N++
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 92
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
            +           +   Y+    +   ++ + +++ L     C  +  I RGL Y+H  +
Sbjct: 93  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 152
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN-TNRVVGTYGYMPPEYAID 682
              ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++
Sbjct: 153 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 209
Query: 683 GLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 722
                KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 210 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 247

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 102/221 (46%), Gaps = 10/221 (4%)
Query: 506 FSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGM-EEFENEVLLIAKLQHRNLV 563
           +++ + +GEG +G V      +    +A K++S    Q   +    E+ ++ + +H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
            +           +   Y+    +   ++ + +++ L     C  +  I RGL Y+H  +
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN-TNRVVGTYGYMPPEYAID 682
              ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++
Sbjct: 145 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 683 GLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 722
                KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 239

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 102/221 (46%), Gaps = 10/221 (4%)
Query: 506 FSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGM-EEFENEVLLIAKLQHRNLV 563
           +++ + +GEG +G V      +    +A K++S    Q   +    E+ ++ + +H N++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
            +           +   Y+    +   ++ + +++ L     C  +  I RGL Y+H  +
Sbjct: 105 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 164
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN-TNRVVGTYGYMPPEYAID 682
              ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++
Sbjct: 165 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 221
Query: 683 GLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 722
                KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 259

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 111/277 (40%), Gaps = 38/277 (13%)
Query: 510 NKLGEGGFGPVYKGVLI----EGQEIAAKRLSK---SSGQGMEEFENEVLLIAKLQHRNL 562
            KLG+G FG V +G       +   +A K L     S  + M++F  EV  +  L HRNL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
           ++L G       +M + E  P  SL D +        L    R  +   +A G+ YL   
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GIDQTEANTNRVVGTYGYMPPEYA 680
              R IHRDL A N+LL      KI DFG+ RA     D      +R V  + +  PE  
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAWCAPESL 186
Query: 681 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 740
               FS  SD + FGV + E                  +  +    WI     ++++K  
Sbjct: 187 KTRTFSHASDTWMFGVTLWE------------------MFTYGQEPWIGLNGSQILHKID 228
Query: 741 GGSYSLSEVLRCIQ----VGLLCVQQRPEDRPNMSSV 773
                L     C Q    V + C   +PEDRP   ++
Sbjct: 229 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 265

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 501 NATENFSDKNKLGEGGFGPVYK-----GVLIEGQEIAAKRLSKSSGQGM--EEFENEVLL 553
           N  + +    +LG G F  V K       L    +   KR +KSS +G+  E+ E EV +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 554 IAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA 613
           + ++QH N++ L      + + +LI E +    L DF+      + L   +  + +  I 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQIL 124
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGIDQTEANTNRVV 669
            G+ YLH    L+I H DLK  N++L +   P    KI DFG+A          N   + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IF 178
Query: 670 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           GT  ++ PE        +++D++S GV+   ++ G
Sbjct: 179 GTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 102/221 (46%), Gaps = 10/221 (4%)
Query: 506 FSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGM-EEFENEVLLIAKLQHRNLV 563
           +++ + +GEG +G V      +    +A K++S    Q   +    E+ ++ + +H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
            +           +   Y+    +   ++ + +++ L     C  +  I RGL Y+H  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN-TNRVVGTYGYMPPEYAID 682
              ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++
Sbjct: 149 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 683 GLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 722
                KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 243

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKS-----SGQGMEEFENEVLLIAKLQHRNLVKLI 566
           +GEG FG V++G+ +  +  A     K+     S    E+F  E L + +  H ++VKLI
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 626
           G  T+ +   +I E      L  F+    R   LD +        ++  L YL      R
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 627 IIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFS 686
            +HRD+ A NVL+ +    K+ DFG++R +  D T    ++      +M PE      F+
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTXXKASKGKLPIKWMAPESINFRRFT 190
Query: 687 VKSDVFSFGVLVLEIV 702
             SDV+ FGV + EI+
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 102/221 (46%), Gaps = 10/221 (4%)
Query: 506 FSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFE-NEVLLIAKLQHRNLV 563
           +++ + +GEG +G V      +    +A K++S    Q   +    E+ ++ + +H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENII 88
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
            +           +   Y+    +   ++ + +++ L     C  +  I RGL Y+H  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN-TNRVVGTYGYMPPEYAID 682
              ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++
Sbjct: 149 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 683 GLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 722
                KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 243

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 102/221 (46%), Gaps = 10/221 (4%)
Query: 506 FSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGM-EEFENEVLLIAKLQHRNLV 563
           +++ + +GEG +G V      +    +A K++S    Q   +    E+ ++ + +H N++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
            +           +   Y+    +   ++ + +++ L     C  +  I RGL Y+H  +
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 149
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN-TNRVVGTYGYMPPEYAID 682
              ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++
Sbjct: 150 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 206
Query: 683 GLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 722
                KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 207 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 244

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 102/221 (46%), Gaps = 10/221 (4%)
Query: 506 FSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGM-EEFENEVLLIAKLQHRNLV 563
           +++ + +GEG +G V      +    +A K++S    Q   +    E+ ++ + +H N++
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 90
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
            +           +   Y+    +   ++ + +++ L     C  +  I RGL Y+H  +
Sbjct: 91  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 150
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN-TNRVVGTYGYMPPEYAID 682
              ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++
Sbjct: 151 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 207
Query: 683 GLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 722
                KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 208 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 245

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 102/221 (46%), Gaps = 10/221 (4%)
Query: 506 FSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGM-EEFENEVLLIAKLQHRNLV 563
           +++ + +GEG +G V      +    +A K++S    Q   +    E+ ++ + +H N++
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 81
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
            +           +   Y+    +   ++ + +++ L     C  +  I RGL Y+H  +
Sbjct: 82  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 141
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN-TNRVVGTYGYMPPEYAID 682
              ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++
Sbjct: 142 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 198
Query: 683 GLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 722
                KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 199 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 236

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 102/221 (46%), Gaps = 10/221 (4%)
Query: 506 FSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGM-EEFENEVLLIAKLQHRNLV 563
           +++ + +GEG +G V      +    +A K++S    Q   +    E+ ++ + +H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
            +           +   Y+    +   ++ + +++ L     C  +  I RGL Y+H  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN-TNRVVGTYGYMPPEYAID 682
              ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++
Sbjct: 149 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 683 GLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 722
                KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 243

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 111/277 (40%), Gaps = 38/277 (13%)
Query: 510 NKLGEGGFGPVYKGVLI----EGQEIAAKRLSK---SSGQGMEEFENEVLLIAKLQHRNL 562
            KLG+G FG V +G       +   +A K L     S  + M++F  EV  +  L HRNL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
           ++L G       +M + E  P  SL D +        L    R  +   +A G+ YL   
Sbjct: 84  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 140
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GIDQTEANTNRVVGTYGYMPPEYA 680
              R IHRDL A N+LL      KI DFG+ RA     D      +R V  + +  PE  
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 196
Query: 681 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 740
               FS  SD + FGV + E                  +  +    WI     ++++K  
Sbjct: 197 KTRTFSHASDTWMFGVTLWE------------------MFTYGQEPWIGLNGSQILHKID 238
Query: 741 GGSYSLSEVLRCIQ----VGLLCVQQRPEDRPNMSSV 773
                L     C Q    V + C   +PEDRP   ++
Sbjct: 239 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 275

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 105/228 (46%), Gaps = 26/228 (11%)
Query: 491 LPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENE 550
           LP+     IA   +      ++G+G +G V+ G    G+++A K    ++ +     E E
Sbjct: 27  LPLLVQRTIAKQIQMV---KQIGKGRYGEVWMGKW-RGEKVAVKVFF-TTEEASWFRETE 81
Query: 551 VLLIAKLQHRNLVKLIGCCTQRD----ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC 606
           +     ++H N++  I    +      +  LI +Y  N SL D++    +S  LD     
Sbjct: 82  IYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSML 137
Query: 607 QIIGGIARGLLYLHQD-----SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
           ++      GL +LH +      +  I HRDLK+ N+L+       I+D G+A  F  D  
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN 197
Query: 662 EANT--NRVVGTYGYMPPEYAIDGL------FSVKSDVFSFGVLVLEI 701
           E +   N  VGT  YMPPE   + L        + +D++SFG+++ E+
Sbjct: 198 EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 102/221 (46%), Gaps = 10/221 (4%)
Query: 506 FSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGM-EEFENEVLLIAKLQHRNLV 563
           +++ + +GEG +G V      +    +A K++S    Q   +    E+ ++ + +H N++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
            +           +   Y+    +   ++ + +++ L     C  +  I RGL Y+H  +
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 142
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN-TNRVVGTYGYMPPEYAID 682
              ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++
Sbjct: 143 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 199
Query: 683 GLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 722
                KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 200 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 237

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 111/277 (40%), Gaps = 38/277 (13%)
Query: 510 NKLGEGGFGPVYKGVLI----EGQEIAAKRLSK---SSGQGMEEFENEVLLIAKLQHRNL 562
            KLG+G FG V +G       +   +A K L     S  + M++F  EV  +  L HRNL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
           ++L G       +M + E  P  SL D +        L    R  +   +A G+ YL   
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GIDQTEANTNRVVGTYGYMPPEYA 680
              R IHRDL A N+LL      KI DFG+ RA     D      +R V  + +  PE  
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 186
Query: 681 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 740
               FS  SD + FGV + E                  +  +    WI     ++++K  
Sbjct: 187 KTRTFSHASDTWMFGVTLWE------------------MFTYGQEPWIGLNGSQILHKID 228
Query: 741 GGSYSLSEVLRCIQ----VGLLCVQQRPEDRPNMSSV 773
                L     C Q    V + C   +PEDRP   ++
Sbjct: 229 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 265

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKS-----SGQGMEEFENEVLLIAKLQHRNLVKLI 566
           +GEG FG V++G+ +  +  A     K+     S    E+F  E L + +  H ++VKLI
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 626
           G  T+ +   +I E      L  F+    R   LD +        ++  L YL      R
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 627 IIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFS 686
            +HRD+ A NVL+ +    K+ DFG++R +  D T    ++      +M PE      F+
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 687 VKSDVFSFGVLVLEIV 702
             SDV+ FGV + EI+
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 111/277 (40%), Gaps = 38/277 (13%)
Query: 510 NKLGEGGFGPVYKGVLI----EGQEIAAKRLSK---SSGQGMEEFENEVLLIAKLQHRNL 562
            KLG+G FG V +G       +   +A K L     S  + M++F  EV  +  L HRNL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
           ++L G       +M + E  P  SL D +        L    R  +   +A G+ YL   
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GIDQTEANTNRVVGTYGYMPPEYA 680
              R IHRDL A N+LL      KI DFG+ RA     D      +R V  + +  PE  
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 186
Query: 681 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 740
               FS  SD + FGV + E                  +  +    WI     ++++K  
Sbjct: 187 KTRTFSHASDTWMFGVTLWE------------------MFTYGQEPWIGLNGSQILHKID 228
Query: 741 GGSYSLSEVLRCIQ----VGLLCVQQRPEDRPNMSSV 773
                L     C Q    V + C   +PEDRP   ++
Sbjct: 229 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 265

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 510 NKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGME---EFENEVLLIAKLQHRNLVKL 565
           + LG G FG V  G   + G ++A K L++   + ++   + + E+  +   +H +++KL
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 625
               +   +  ++ EY+    L D+I    R + ++  +  Q    I   + Y H   R 
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ---QILSAVDYCH---RH 130
Query: 626 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF 685
            ++HRDLK  NVLLD  MN KI+DFG++      +   ++    G+  Y  PE     L+
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS---CGSPNYAAPEVISGRLY 187
Query: 686 S-VKSDVFSFGVLVLEIVCG 704
           +  + D++S GV++  ++CG
Sbjct: 188 AGPEVDIWSCGVILYALLCG 207

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 510 NKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGME---EFENEVLLIAKLQHRNLVKL 565
           + LG G FG V  G   + G ++A K L++   + ++   + + E+  +   +H +++KL
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 625
               +   +  ++ EY+    L D+I    R + ++  +  Q    I   + Y H   R 
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ---QILSAVDYCH---RH 130
Query: 626 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF 685
            ++HRDLK  NVLLD  MN KI+DFG++     D     T+   G+  Y  PE     L+
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTS--CGSPNYAAPEVISGRLY 187
Query: 686 S-VKSDVFSFGVLVLEIVCG 704
           +  + D++S GV++  ++CG
Sbjct: 188 AGPEVDIWSCGVILYALLCG 207

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 102/221 (46%), Gaps = 10/221 (4%)
Query: 506 FSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGM-EEFENEVLLIAKLQHRNLV 563
           +++ + +GEG +G V      +    +A K++S    Q   +    E+ ++ + +H N++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
            +           +   Y+    +   ++ + +++ L     C  +  I RGL Y+H  +
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 142
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN-TNRVVGTYGYMPPEYAID 682
              ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++
Sbjct: 143 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 199
Query: 683 GLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 722
                KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 200 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 237

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 94/216 (43%), Gaps = 33/216 (15%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVL------LIAKLQHRNLV 563
           LG G FG V +       + A  R    K   +G    E+  L      LI    H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 564 KLIGCCTQRD-ERMLIYEYLPNKSLNDFIFDVTRSK-----------------FLDWSKR 605
            L+G CT+     M+I E+    +L+ ++    RSK                 FL     
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYL----RSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 606 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT 665
                 +A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+AR    D      
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 666 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
                   +M PE   D +++++SDV+SFGVL+ EI
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/285 (23%), Positives = 126/285 (44%), Gaps = 41/285 (14%)
Query: 501 NATENFSDKNKLGEGGFGPVYKGVLIEGQE------IAAKRLSKSSGQGMEEFENEVLLI 554
            + E +    K+GEG FG   K +L++  E      I    +S+ S +  EE   EV ++
Sbjct: 21  QSMEKYVRLQKIGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVL 77
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQII 609
           A ++H N+V+      +     ++ +Y     L   I           + LDW  +    
Sbjct: 78  ANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ---- 133
Query: 610 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV 669
             I   L ++H     +I+HRD+K+ N+ L  +   ++ DFG+AR   ++ T       +
Sbjct: 134 --ICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACI 186
Query: 670 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 729
           GT  Y+ PE   +  ++ KSD+++ G ++ E+   K      HA    ++     ++   
Sbjct: 187 GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK------HAFEAGSMKNLVLKIISG 240
Query: 730 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 774
             P      SL  SY L  ++  +       ++ P DRP+++S++
Sbjct: 241 SFP----PVSLHYSYDLRSLVSQL------FKRNPRDRPSVNSIL 275

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 111/277 (40%), Gaps = 38/277 (13%)
Query: 510 NKLGEGGFGPVYKGVLI----EGQEIAAKRLSK---SSGQGMEEFENEVLLIAKLQHRNL 562
            KLG+G FG V +G       +   +A K L     S  + M++F  EV  +  L HRNL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
           ++L G       +M + E  P  SL D +        L    R  +   +A G+ YL   
Sbjct: 78  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 134
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GIDQTEANTNRVVGTYGYMPPEYA 680
              R IHRDL A N+LL      KI DFG+ RA     D      +R V  + +  PE  
Sbjct: 135 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 190
Query: 681 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 740
               FS  SD + FGV + E                  +  +    WI     ++++K  
Sbjct: 191 KTRTFSHASDTWMFGVTLWE------------------MFTYGQEPWIGLNGSQILHKID 232
Query: 741 GGSYSLSEVLRCIQ----VGLLCVQQRPEDRPNMSSV 773
                L     C Q    V + C   +PEDRP   ++
Sbjct: 233 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 269

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 103/208 (49%), Gaps = 14/208 (6%)
Query: 503 TENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS--KSSGQGMEEFENEVLLIAKLQH 559
           TE +    +LG+G F  V + V ++ GQE AA  ++  K S +  ++ E E  +   L+H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
            N+V+L    ++     LI++ +    L +   D+   ++   +     I  I   +L+ 
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFE---DIVAREYYSEADASHCIQQILEAVLHC 126
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMN---PKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
           HQ   + ++HR+LK  N+LL +++     K++DFG+  A  ++  +       GT GY+ 
Sbjct: 127 HQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGL--AIEVEGEQQAWFGFAGTPGYLS 181
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           PE      +    D+++ GV++  ++ G
Sbjct: 182 PEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 12  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 72  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 119
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 120 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 171
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 172 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 22  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 82  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 129
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 130 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 181
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 182 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKS-----SGQGMEEFENEVLLIAKLQHRNLVKLI 566
           +GEG FG V++G+ +  +  A     K+     S    E+F  E L + +  H ++VKLI
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 626
           G  T+ +   +I E      L  F+    R   LD +        ++  L YL      R
Sbjct: 106 GVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 159
Query: 627 IIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFS 686
            +HRD+ A NVL+ +    K+ DFG++R +  D T    ++      +M PE      F+
Sbjct: 160 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 218
Query: 687 VKSDVFSFGVLVLEIV 702
             SDV+ FGV + EI+
Sbjct: 219 SASDVWMFGVCMWEIL 234

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKS-----SGQGMEEFENEVLLIAKLQHRNLVKLI 566
           +GEG FG V++G+ +  +  A     K+     S    E+F  E L + +  H ++VKLI
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 626
           G  T+ +   +I E      L  F+    R   LD +        ++  L YL      R
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 627 IIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFS 686
            +HRD+ A NVL+ +    K+ DFG++R +  D T    ++      +M PE      F+
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 687 VKSDVFSFGVLVLEIV 702
             SDV+ FGV + EI+
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 102/221 (46%), Gaps = 10/221 (4%)
Query: 506 FSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGM-EEFENEVLLIAKLQHRNLV 563
           +++ + +GEG +G V      +    +A K++S    Q   +    E+ ++ + +H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
            +           +   Y+    +   ++ + +++ L     C  +  I RGL Y+H  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN-TNRVVGTYGYMPPEYAID 682
              ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++
Sbjct: 149 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLN 205
Query: 683 GLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 722
                KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 243

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKS-----SGQGMEEFENEVLLIAKLQHRNLVKLI 566
           +GEG FG V++G+ +  +  A     K+     S    E+F  E L + +  H ++VKLI
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 626
           G  T+ +   +I E      L  F+    R   LD +        ++  L YL      R
Sbjct: 81  GVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 134
Query: 627 IIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFS 686
            +HRD+ A NVL+ +    K+ DFG++R +  D T    ++      +M PE      F+
Sbjct: 135 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 193
Query: 687 VKSDVFSFGVLVLEIV 702
             SDV+ FGV + EI+
Sbjct: 194 SASDVWMFGVCMWEIL 209

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 102/221 (46%), Gaps = 10/221 (4%)
Query: 506 FSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGM-EEFENEVLLIAKLQHRNLV 563
           +++ + +GEG +G V      +    +A K++S    Q   +    E+ ++ + +H N++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
            +           +   Y+    +   ++ + +++ L     C  +  I RGL Y+H  +
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 149
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN-TNRVVGTYGYMPPEYAID 682
              ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++
Sbjct: 150 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLN 206
Query: 683 GLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 722
                KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 207 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 244

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVL------LIAKLQHRNLV 563
           LG G FG V +       + A  R    K   +G    E+  L      LI    H N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 564 KLIGCCTQRD-ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG----------- 611
            L+G CT+     M+I E+    +L+ ++    R++F+ + +  + +             
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRS-KRNEFVPYKEAPEDLYKDFLTLEHLICY 155
Query: 612 ---IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
              +A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+AR    D         
Sbjct: 156 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 212
Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
                +M PE   D +++++SDV+SFGVL+ EI
Sbjct: 213 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 245

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 103/219 (47%), Gaps = 37/219 (16%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQHR 560
           E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+  ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--------- 607
           N++ L+   T            P +SL +F  ++ VT     D +   +CQ         
Sbjct: 82  NVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 608 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 667
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T+     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 668 VVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
            V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 182 YVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 94/216 (43%), Gaps = 33/216 (15%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVL------LIAKLQHRNLV 563
           LG G FG V +       + A  R    K   +G    E+  L      LI    H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 564 KLIGCCTQRD-ERMLIYEYLPNKSLNDFIFDVTRSK-----------------FLDWSKR 605
            L+G CT+     M+I E+    +L+ ++    RSK                 FL     
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYL----RSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 606 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT 665
                 +A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+AR    D      
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 198
Query: 666 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
                   +M PE   D +++++SDV+SFGVL+ EI
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKS-----SGQGMEEFENEVLLIAKLQHRNLVKLI 566
           +GEG FG V++G+ +  +  A     K+     S    E+F  E L + +  H ++VKLI
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 626
           G  T+ +   +I E      L  F+    R   LD +        ++  L YL      R
Sbjct: 83  GVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 136
Query: 627 IIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFS 686
            +HRD+ A NVL+ +    K+ DFG++R +  D T    ++      +M PE      F+
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 195
Query: 687 VKSDVFSFGVLVLEIV 702
             SDV+ FGV + EI+
Sbjct: 196 SASDVWMFGVCMWEIL 211

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 35  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 94
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 95  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 142
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 143 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 194
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 195 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 501 NATENFSDKNKLGEGGFGPVYK-----GVLIEGQEIAAKRLSKSSGQGM--EEFENEVLL 553
           N  + +    +LG G F  V K       L    +   KR +KSS +G+  E+ E EV +
Sbjct: 7   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 554 IAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA 613
           + ++QH N++ L      + + +LI E +    L DF+      + L   +  + +  I 
Sbjct: 67  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQIL 123
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGIDQTEANTNRVV 669
            G+ YLH    L+I H DLK  N++L +   P    KI DFG+A          N   + 
Sbjct: 124 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IF 177
Query: 670 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           GT  ++ PE        +++D++S GV+   ++ G
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 101/221 (45%), Gaps = 10/221 (4%)
Query: 506 FSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGM-EEFENEVLLIAKLQHRNLV 563
           +++ + +GEG +G V      +    +A K++S    Q   +    E+ ++   +H N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
            +           +   Y+    +   ++ + +++ L     C  +  I RGL Y+H  +
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 146
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN-TNRVVGTYGYMPPEYAID 682
              ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++
Sbjct: 147 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 683 GLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 722
                KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 241

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 19/211 (9%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQ-GME-EFENEVLLIAKLQ 558
           AT  +    ++G G +G VYK      G  +A K +   +G+ G+      EV L+ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 559 ---HRNLVKLIG-CCTQRDER----MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG 610
              H N+V+L+  C T R +R     L++E++ ++ L  ++ D      L       ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVG 670
              RGL +LH +    I+HRDLK  N+L+ +    K++DFG+AR +      A    VV 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAP---VVV 173
Query: 671 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
           T  Y  PE  +   ++   D++S G +  E+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKS-----SGQGMEEFENEVLLIAKLQHRNLVKLI 566
           +GEG FG V++G+ +  +  A     K+     S    E+F  E L + +  H ++VKLI
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 626
           G  T+ +   +I E      L  F+    R   LD +        ++  L YL      R
Sbjct: 80  GVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 133
Query: 627 IIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFS 686
            +HRD+ A NVL+ +    K+ DFG++R +  D T    ++      +M PE      F+
Sbjct: 134 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 192
Query: 687 VKSDVFSFGVLVLEIV 702
             SDV+ FGV + EI+
Sbjct: 193 SASDVWMFGVCMWEIL 208

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 36  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 95
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 96  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 143
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 144 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 195
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 196 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 94/216 (43%), Gaps = 33/216 (15%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVL------LIAKLQHRNLV 563
           LG G FG V +       + A  R    K   +G    E+  L      LI    H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 564 KLIGCCTQRD-ERMLIYEYLPNKSLNDFIFDVTRSK-----------------FLDWSKR 605
            L+G CT+     M+I E+    +L+ ++    RSK                 FL     
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYL----RSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 606 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT 665
                 +A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+AR    D      
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 198
Query: 666 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
                   +M PE   D +++++SDV+SFGVL+ EI
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LSK   S    +    E+ L+
Sbjct: 28  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLL 87
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 88  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 135
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 136 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 187
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 188 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKS-----SGQGMEEFENEVLLIAKLQHRNLVKLI 566
           +GEG FG V++G+ +  +  A     K+     S    E+F  E L + +  H ++VKLI
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 626
           G  T+ +   +I E      L  F+    R   LD +        ++  L YL      R
Sbjct: 75  GVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 128
Query: 627 IIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFS 686
            +HRD+ A NVL+ +    K+ DFG++R +  D T    ++      +M PE      F+
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 187
Query: 687 VKSDVFSFGVLVLEIV 702
             SDV+ FGV + EI+
Sbjct: 188 SASDVWMFGVCMWEIL 203

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 501 NATENFSDKNKLGEGGFGPVYK-----GVLIEGQEIAAKRLSKSSGQGM--EEFENEVLL 553
           N  + +    +LG G F  V K       L    +   KR +KSS +G+  E+ E EV +
Sbjct: 7   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 554 IAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA 613
           + ++QH N++ L      + + +LI E +    L DF+      + L   +  + +  I 
Sbjct: 67  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQIL 123
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGIDQTEANTNRVV 669
            G+ YLH    L+I H DLK  N++L +   P    KI DFG+A          N   + 
Sbjct: 124 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IF 177
Query: 670 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           GT  ++ PE        +++D++S GV+   ++ G
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 501 NATENFSDKNKLGEGGFGPVYK-----GVLIEGQEIAAKRLSKSSGQGM--EEFENEVLL 553
           N  + +    +LG G F  V K       L    +   KR +KSS +G+  E+ E EV +
Sbjct: 8   NVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 554 IAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA 613
           + ++QH N++ L      + + +LI E +    L DF+      + L   +  + +  I 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQIL 124
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGIDQTEANTNRVV 669
            G+ YLH    L+I H DLK  N++L +   P    KI DFG+A          N   + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IF 178
Query: 670 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           GT  ++ PE        +++D++S GV+   ++ G
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 501 NATENFSDKNKLGEGGFGPVYK-----GVLIEGQEIAAKRLSKSSGQGM--EEFENEVLL 553
           N  + +    +LG G F  V K       L    +   KR +KSS +G+  E+ E EV +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 554 IAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA 613
           + ++QH N++ L      + + +LI E +    L DF+      + L   +  + +  I 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQIL 124
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGIDQTEANTNRVV 669
            G+ YLH    L+I H DLK  N++L +   P    KI DFG+A          N   + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IF 178
Query: 670 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           GT  ++ PE        +++D++S GV+   ++ G
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 501 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEE--FENEVLLIAKL 557
            + E + +   +GEG +G V K    + G+ +A K+  +S    M +     E+ L+ +L
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF-IFDVTRSKFLDWSKRCQIIGGIARGL 616
           +H NLV L+  C ++    L++E++ +  L+D  +F       LD+    + +  I  G+
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGI 137
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            + H  +   IIHRD+K  N+L+      K+ DFG AR         +    V T  Y  
Sbjct: 138 GFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE--VATRWYRA 192
Query: 677 PEYAI-DGLFSVKSDVFSFGVLVLEIVCGK 705
           PE  + D  +    DV++ G LV E+  G+
Sbjct: 193 PELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 94/216 (43%), Gaps = 33/216 (15%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVL------LIAKLQHRNLV 563
           LG G FG V +       + A  R    K   +G    E+  L      LI    H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 564 KLIGCCTQRD-ERMLIYEYLPNKSLNDFIFDVTRSK-----------------FLDWSKR 605
            L+G CT+     M+I E+    +L+ ++    RSK                 FL     
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYL----RSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 606 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT 665
                 +A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+AR    D      
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRK 207
Query: 666 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
                   +M PE   D +++++SDV+SFGVL+ EI
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 21  TIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 81  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 128
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 129 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HT 180
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 181 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 12  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 72  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 119
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 120 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 171
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 172 DDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 101/221 (45%), Gaps = 10/221 (4%)
Query: 506 FSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGM-EEFENEVLLIAKLQHRNLV 563
           +++ + +GEG +G V      +    +A K++S    Q   +    E+ ++ + +H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
            +           +   Y+    +   ++ + + + L     C  +  I RGL Y+H  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN-TNRVVGTYGYMPPEYAID 682
              ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++
Sbjct: 149 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 683 GLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 722
                KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 243

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 101/221 (45%), Gaps = 10/221 (4%)
Query: 506 FSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGM-EEFENEVLLIAKLQHRNLV 563
           +++ + +GEG +G V      +    +A K++S    Q   +    E+ ++   +H N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
            +           +   Y+    +   ++ + +++ L     C  +  I RGL Y+H  +
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 146
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN-TNRVVGTYGYMPPEYAID 682
              ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++
Sbjct: 147 ---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 683 GLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 722
                KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 241

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 102/221 (46%), Gaps = 10/221 (4%)
Query: 506 FSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGM-EEFENEVLLIAKLQHRNLV 563
           +++ + +GEG +G V      +    +A +++S    Q   +    E+ ++ + +H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
            +           +   Y+    +   ++ + +++ L     C  +  I RGL Y+H  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN-TNRVVGTYGYMPPEYAID 682
              ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y  PE  ++
Sbjct: 149 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 683 GLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 722
                KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 243

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 501 NATENFSDKNKLGEGGFGPVYK-----GVLIEGQEIAAKRLSKSSGQGM--EEFENEVLL 553
           N  + +    +LG G F  V K       L    +   KR +KSS +G+  E+ E EV +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 554 IAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA 613
           + ++QH N++ L      + + +LI E +    L DF+      + L   +  + +  I 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQIL 124
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGIDQTEANTNRVV 669
            G+ YLH    L+I H DLK  N++L +   P    KI DFG+A          N   + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IF 178
Query: 670 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           GT  ++ PE        +++D++S GV+   ++ G
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 81/165 (49%), Gaps = 13/165 (7%)
Query: 539 SSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLND-----FIFD 593
           S     ++F+NE+ +I  +++   +   G  T  DE  +IYEY+ N S+       F+ D
Sbjct: 82  SIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLD 141
Query: 594 VTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 653
              + F+       II  +     Y+H +    I HRD+K SN+L+D     K+SDFG +
Sbjct: 142 KNYTCFIPIQVIKCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGES 199
Query: 654 RAFGIDQTEANTNRVVGTYGYMPPEYAID--GLFSVKSDVFSFGV 696
             + +D+    +    GTY +MPPE+  +       K D++S G+
Sbjct: 200 E-YMVDKKIKGSR---GTYEFMPPEFFSNESSYNGAKVDIWSLGI 240

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 14/207 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL---SKSSGQGME-EFENEVLLIAKL 557
             ++F     LG+G FG VY     + + I A ++   S+   +G+E +   E+ + + L
Sbjct: 13  TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 72
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +H N++++      R    L+ E+ P   L     ++ +    D  +    +  +A  L 
Sbjct: 73  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYK---ELQKHGRFDEQRSATFMEELADALH 129
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           Y H+    ++IHRD+K  N+L+  +   KI+DFG    + +         + GT  Y+PP
Sbjct: 130 YCHER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPP 182
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           E         K D++  GVL  E + G
Sbjct: 183 EMIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 36  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 95
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 96  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 143
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 144 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 195
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 196 DDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 508 DKNKLGEGGFGPVYKGV--LIEGQEIAAKRLSKSSGQG---MEEFENEVLLIAKLQHRNL 562
           +  +LG G FG V KG   + +  +  A ++ K+        +E   E  ++ +L +  +
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
           V++IG C + +  ML+ E      LN ++    +++ +      +++  ++ G+ YL + 
Sbjct: 75  VRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEES 130
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----P 677
           +    +HRDL A NVLL  +   KISDFG+++A   D+          T+G  P     P
Sbjct: 131 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQ----THGKWPVKWYAP 183
Query: 678 EYAIDGLFSVKSDVFSFGVLVLE 700
           E      FS KSDV+SFGVL+ E
Sbjct: 184 ECINYYKFSSKSDVWSFGVLMWE 206

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + +   +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 26  TIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 85
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 86  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 133
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 134 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 185
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 186 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 501 NATENFSDKNKLGEGGFGPVYK-----GVLIEGQEIAAKRLSKSSGQGM--EEFENEVLL 553
           N  + +    +LG G F  V K       L    +   KR +KSS +G+  E+ E EV +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 554 IAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA 613
           + ++QH N++ L      + + +LI E +    L DF+      + L   +  + +  I 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQIL 124
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGIDQTEANTNRVV 669
            G+ YLH    L+I H DLK  N++L +   P    KI DFG+A          N   + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IF 178
Query: 670 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           GT  ++ PE        +++D++S GV+   ++ G
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 14/207 (6%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL---SKSSGQGME-EFENEVLLIAKL 557
             ++F     LG+G FG VY     + + I A ++   S+   +G+E +   E+ + + L
Sbjct: 12  TIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 71
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +H N++++      R    L+ E+ P   L     ++ +    D  +    +  +A  L 
Sbjct: 72  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYK---ELQKHGRFDEQRSATFMEELADALH 128
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           Y H+    ++IHRD+K  N+L+  +   KI+DFG    + +         + GT  Y+PP
Sbjct: 129 YCHER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPP 181
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           E         K D++  GVL  E + G
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 21  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 81  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 128
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 129 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HT 180
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 181 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 501 NATENFSDKNKLGEGGFGPVYK-----GVLIEGQEIAAKRLSKSSGQGM--EEFENEVLL 553
           N  + +    +LG G F  V K       L    +   KR +KSS +G+  E+ E EV +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 554 IAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA 613
           + ++QH N++ L      + + +LI E +    L DF+      + L   +  + +  I 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQIL 124
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGIDQTEANTNRVV 669
            G+ YLH    L+I H DLK  N++L +   P    KI DFG+A          N   + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IF 178
Query: 670 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           GT  ++ PE        +++D++S GV+   ++ G
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFEN--EVLLIAKLQ 558
           AT  +    ++G G +G VYK      G  +A K +   +G+         EV L+ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 559 ---HRNLVKLIG-CCTQRDER----MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG 610
              H N+V+L+  C T R +R     L++E++ ++ L  ++ D      L       ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVG 670
              RGL +LH +    I+HRDLK  N+L+ +    K++DFG+AR +     +   + VV 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALDPVVV 173
Query: 671 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
           T  Y  PE  +   ++   D++S G +  E+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 100/221 (45%), Gaps = 10/221 (4%)
Query: 506 FSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGM-EEFENEVLLIAKLQHRNLV 563
           ++    +GEG +G V      +    +A K++S    Q   +    E+ ++ + +H N++
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
            +           +   Y+    +   ++ + +S+ L     C  +  I RGL Y+H  +
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSAN 164
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN-TNRVVGTYGYMPPEYAID 682
              ++HRDLK SN+L++   + KI DFG+AR    +          V T  Y  PE  ++
Sbjct: 165 ---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLN 221
Query: 683 GLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 722
                KS D++S G ++ E++    NR  +   H+ + L H
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNH 259

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 501 NATENFSDKNKLGEGGFGPVYK-----GVLIEGQEIAAKRLSKSSGQGM--EEFENEVLL 553
           N  + +    +LG G F  V K       L    +   KR +KSS +G+  E+ E EV +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 554 IAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA 613
           + ++QH N++ L      + + +LI E +    L DF+      + L   +  + +  I 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQIL 124
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGIDQTEANTNRVV 669
            G+ YLH    L+I H DLK  N++L +   P    KI DFG+A          N   + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IF 178
Query: 670 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           GT  ++ PE        +++D++S GV+   ++ G
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 23/206 (11%)
Query: 509 KNKLGEGGFGPVYKGVLIEGQEIAA-----KRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           +  LGEG FG V      + Q+  A     ++L K S   M   E E+  +  L+H +++
Sbjct: 14  RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMR-VEREISYLKLLRHPHII 72
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC--QIIGGIARGLLYLHQ 621
           KL    T   + +++ EY     L D+I +  R    D  +R   QII  I     Y H 
Sbjct: 73  KLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMT-EDEGRRFFQQIICAIE----YCH- 125
Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV-VGTYGYMPPEYA 680
             R +I+HRDLK  N+LLD+ +N KI+DFG++       T+ N  +   G+  Y  PE  
Sbjct: 126 --RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAPEVI 179
Query: 681 IDGLFS-VKSDVFSFGVLVLEIVCGK 705
              L++  + DV+S G+++  ++ G+
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 501 NATENFSDKNKLGEGGFGPVYK-----GVLIEGQEIAAKRLSKSSGQGM--EEFENEVLL 553
           N  + +    +LG G F  V K       L    +   KR +KSS +G+  E+ E EV +
Sbjct: 8   NVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 554 IAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA 613
           + ++QH N++ L      + + +LI E +    L DF+      + L   +  + +  I 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQIL 124
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGIDQTEANTNRVV 669
            G+ YLH    L+I H DLK  N++L +   P    KI DFG+A          N   + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IF 178
Query: 670 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           GT  ++ PE        +++D++S GV+   ++ G
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 94/216 (43%), Gaps = 33/216 (15%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVL------LIAKLQHRNLV 563
           LG G FG V +       + A  R    K   +G    E+  L      LI    H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 564 KLIGCCTQRD-ERMLIYEYLPNKSLNDFIFDVTRSK-----------------FLDWSKR 605
            L+G CT+     M+I E+    +L+ ++    RSK                 FL     
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYL----RSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 606 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT 665
                 +A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+AR    D      
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 666 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
                   +M PE   D +++++SDV+SFGVL+ EI
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 508 DKNKLGEGGFGPVYKGV--LIEGQEIAAKRLSKSSGQG---MEEFENEVLLIAKLQHRNL 562
           +  +LG G FG V KG   + +  +  A ++ K+        +E   E  ++ +L +  +
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
           V++IG C + +  ML+ E      LN ++    +++ +      +++  ++ G+ YL + 
Sbjct: 91  VRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEES 146
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----P 677
           +    +HRDL A NVLL  +   KISDFG+++A   D+          T+G  P     P
Sbjct: 147 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAP 199
Query: 678 EYAIDGLFSVKSDVFSFGVLVLE 700
           E      FS KSDV+SFGVL+ E
Sbjct: 200 ECINYYKFSSKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 508 DKNKLGEGGFGPVYKGV--LIEGQEIAAKRLSKSSGQG---MEEFENEVLLIAKLQHRNL 562
           +  +LG G FG V KG   + +  +  A ++ K+        +E   E  ++ +L +  +
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
           V++IG C + +  ML+ E      LN ++    +++ +      +++  ++ G+ YL + 
Sbjct: 91  VRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEES 146
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----P 677
           +    +HRDL A NVLL  +   KISDFG+++A   D+          T+G  P     P
Sbjct: 147 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAP 199
Query: 678 EYAIDGLFSVKSDVFSFGVLVLE 700
           E      FS KSDV+SFGVL+ E
Sbjct: 200 ECINYYKFSSKSDVWSFGVLMWE 222

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 501 NATENFSDKNKLGEGGFGPVYK-----GVLIEGQEIAAKRLSKSSGQGM--EEFENEVLL 553
           N  + +    +LG G F  V K       L    +   KR +KSS +G+  E+ E EV +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 554 IAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA 613
           + ++QH N++ L      + + +LI E +    L DF+      + L   +  + +  I 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQIL 124
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGIDQTEANTNRVV 669
            G+ YLH    L+I H DLK  N++L +   P    KI DFG+A          N   + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IF 178
Query: 670 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           GT  ++ PE        +++D++S GV+   ++ G
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 27  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 86
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 87  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 134
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 135 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HT 186
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 187 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 501 NATENFSDKNKLGEGGFGPVYK-----GVLIEGQEIAAKRLSKSSGQGM--EEFENEVLL 553
           N  + +    +LG G F  V K       L    +   KR +KSS +G+  E+ E EV +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 554 IAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA 613
           + ++QH N++ L      + + +LI E +    L DF+      + L   +  + +  I 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQIL 124
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGIDQTEANTNRVV 669
            G+ YLH    L+I H DLK  N++L +   P    KI DFG+A          N   + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IF 178
Query: 670 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           GT  ++ PE        +++D++S GV+   ++ G
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 91/196 (46%), Gaps = 12/196 (6%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKS-----SGQGMEEFENEVLLIAKLQHRNLVKLI 566
           +GEG FG V++G+ +  +  A     K+     S    E+F  E L + +  H ++VKLI
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 626
           G  T+ +   +I E      L  F+    R   LD +        ++  L YL      R
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 627 IIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFS 686
            +HRD+ A NVL+      K+ DFG++R +  D T    ++      +M PE      F+
Sbjct: 132 FVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 687 VKSDVFSFGVLVLEIV 702
             SDV+ FGV + EI+
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 91/198 (45%), Gaps = 12/198 (6%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKSS----GQGMEEFENEVLLIAKLQHRNLVKLIG 567
           LG+GGF   ++    + +E+ A ++   S        E+   E+ +   L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 568 CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI 627
                D   ++ E    +SL +      R K L   +    +  I  G  YLH++   R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 138
Query: 628 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSV 687
           IHRDLK  N+ L+ ++  KI DFG+A     D     T  + GT  Y+ PE       S 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 196
Query: 688 KSDVFSFGVLVLEIVCGK 705
           + DV+S G ++  ++ GK
Sbjct: 197 EVDVWSIGCIMYTLLVGK 214

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 91/198 (45%), Gaps = 12/198 (6%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKSS----GQGMEEFENEVLLIAKLQHRNLVKLIG 567
           LG+GGF   ++    + +E+ A ++   S        E+   E+ +   L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 568 CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI 627
                D   ++ E    +SL +      R K L   +    +  I  G  YLH++   R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 138
Query: 628 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSV 687
           IHRDLK  N+ L+ ++  KI DFG+A     D     T  + GT  Y+ PE       S 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 196
Query: 688 KSDVFSFGVLVLEIVCGK 705
           + DV+S G ++  ++ GK
Sbjct: 197 EVDVWSIGCIMYTLLVGK 214

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 508 DKNKLGEGGFGPVYKGV--LIEGQEIAAKRLSKSSGQG---MEEFENEVLLIAKLQHRNL 562
           +  +LG G FG V KG   + +  +  A ++ K+        +E   E  ++ +L +  +
Sbjct: 9   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 68
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
           V++IG C + +  ML+ E      LN ++    +++ +      +++  ++ G+ YL + 
Sbjct: 69  VRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEES 124
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----P 677
           +    +HRDL A NVLL  +   KISDFG+++A   D+          T+G  P     P
Sbjct: 125 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAP 177
Query: 678 EYAIDGLFSVKSDVFSFGVLVLE 700
           E      FS KSDV+SFGVL+ E
Sbjct: 178 ECINYYKFSSKSDVWSFGVLMWE 200

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 21  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 81  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 128
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 129 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 180
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 181 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 15  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 74
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 75  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 122
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 123 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 174
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 175 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 21  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 81  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 128
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 129 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 180
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 181 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 508 DKNKLGEGGFGPVYKGV--LIEGQEIAAKRLSKSSGQG---MEEFENEVLLIAKLQHRNL 562
           +  +LG G FG V KG   + +  +  A ++ K+        +E   E  ++ +L +  +
Sbjct: 29  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 88
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
           V++IG C + +  ML+ E      LN ++    +++ +      +++  ++ G+ YL + 
Sbjct: 89  VRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEES 144
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----P 677
           +    +HRDL A NVLL  +   KISDFG+++A   D+          T+G  P     P
Sbjct: 145 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAP 197
Query: 678 EYAIDGLFSVKSDVFSFGVLVLE 700
           E      FS KSDV+SFGVL+ E
Sbjct: 198 ECINYYKFSSKSDVWSFGVLMWE 220

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 94/216 (43%), Gaps = 33/216 (15%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVL------LIAKLQHRNLV 563
           LG G FG V +       + A  R    K   +G    E+  L      LI    H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 564 KLIGCCTQRD-ERMLIYEYLPNKSLNDFIFDVTRSK-----------------FLDWSKR 605
            L+G CT+     M+I E+    +L+ ++    RSK                 FL     
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYL----RSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 606 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT 665
                 +A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+AR    D      
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 198
Query: 666 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
                   +M PE   D +++++SDV+SFGVL+ EI
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 91/198 (45%), Gaps = 12/198 (6%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKSS----GQGMEEFENEVLLIAKLQHRNLVKLIG 567
           LG+GGF   ++    + +E+ A ++   S        E+   E+ +   L H+++V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 568 CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI 627
                D   ++ E    +SL +      R K L   +    +  I  G  YLH++   R+
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 142
Query: 628 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSV 687
           IHRDLK  N+ L+ ++  KI DFG+A     D     T  + GT  Y+ PE       S 
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 200
Query: 688 KSDVFSFGVLVLEIVCGK 705
           + DV+S G ++  ++ GK
Sbjct: 201 EVDVWSIGCIMYTLLVGK 218

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 13  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 72
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 73  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 120
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 121 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 172
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 173 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 13  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 72
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 73  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 120
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 121 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 172
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 173 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 28  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 87
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 88  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 135
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 136 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 187
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 188 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 39  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 98
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 99  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 146
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 147 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 198
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 199 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 28  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 87
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 88  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 135
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 136 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 187
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 188 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 501 NATENFSDKNKLGEGGFGPVYK-----GVLIEGQEIAAKRLSKSSGQGM--EEFENEVLL 553
           N  + +    +LG G F  V K       L    +   KR +KSS +G+  E+ E EV +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 554 IAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA 613
           + ++QH N++ L      + + +LI E +    L DF+      + L   +  + +  I 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQIL 124
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGIDQTEANTNRVV 669
            G+ YLH    L+I H DLK  N++L +   P    KI DFG+A          N   + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IF 178
Query: 670 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           GT  ++ PE        +++D++S GV+   ++ G
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 83  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 130
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 131 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 182
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 183 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 22  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 82  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 129
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 130 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 181
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 182 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 18  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 78  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 125
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 126 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 177
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 178 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 508 DKNKLGEGGFGPVYKGV--LIEGQEIAAKRLSKSSGQG---MEEFENEVLLIAKLQHRNL 562
           +  +LG G FG V KG   + +  +  A ++ K+        +E   E  ++ +L +  +
Sbjct: 373 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 432
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
           V++IG C + +  ML+ E      LN ++    +++ +      +++  ++ G+ YL + 
Sbjct: 433 VRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEES 488
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----P 677
           +    +HRDL A NVLL  +   KISDFG+++A   D+          T+G  P     P
Sbjct: 489 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAP 541
Query: 678 EYAIDGLFSVKSDVFSFGVLVLE 700
           E      FS KSDV+SFGVL+ E
Sbjct: 542 ECINYYKFSSKSDVWSFGVLMWE 564

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 12  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 72  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 119
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 120 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 171
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 172 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 18  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 78  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 125
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 126 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 177
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 178 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 508 DKNKLGEGGFGPVYKGV--LIEGQEIAAKRLSKSSGQG---MEEFENEVLLIAKLQHRNL 562
           +  +LG G FG V KG   + +  +  A ++ K+        +E   E  ++ +L +  +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
           V++IG C + +  ML+ E      LN ++    +++ +      +++  ++ G+ YL + 
Sbjct: 81  VRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEES 136
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----P 677
           +    +HRDL A NVLL  +   KISDFG+++A   D+          T+G  P     P
Sbjct: 137 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAP 189
Query: 678 EYAIDGLFSVKSDVFSFGVLVLE 700
           E      FS KSDV+SFGVL+ E
Sbjct: 190 ECINYYKFSSKSDVWSFGVLMWE 212

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 501 NATENFSDKNKLGEGGFGPVYK-----GVLIEGQEIAAKRLSKSSGQGM--EEFENEVLL 553
           N  + +    +LG G F  V K       L    +   KR +KSS +G+  E+ E EV +
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 554 IAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA 613
           + ++QH N++ L      + + +LI E +    L DF+      + L   +  + +  I 
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFL---AEKESLTEEEATEFLKQIL 124
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGIDQTEANTNRVV 669
            G+ YLH    L+I H DLK  N++L +   P    KI DFG+A          N   + 
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IF 178
Query: 670 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           GT  ++ PE        +++D++S GV+   ++ G
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 94/216 (43%), Gaps = 33/216 (15%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVL------LIAKLQHRNLV 563
           LG G FG V +       + A  R    K   +G    E+  L      LI    H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 564 KLIGCCTQRD-ERMLIYEYLPNKSLNDFIFDVTRSK-----------------FLDWSKR 605
            L+G CT+     M+I E+    +L+ ++    RSK                 FL     
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYL----RSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 606 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT 665
                 +A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+AR    D      
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 198
Query: 666 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
                   +M PE   D +++++SDV+SFGVL+ EI
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 508 DKNKLGEGGFGPVYKGV--LIEGQEIAAKRLSKSSGQG---MEEFENEVLLIAKLQHRNL 562
           +  +LG G FG V KG   + +  +  A ++ K+        +E   E  ++ +L +  +
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
           V++IG C + +  ML+ E      LN ++    +++ +      +++  ++ G+ YL + 
Sbjct: 75  VRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEES 130
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----P 677
           +    +HRDL A NVLL  +   KISDFG+++A   D+          T+G  P     P
Sbjct: 131 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAP 183
Query: 678 EYAIDGLFSVKSDVFSFGVLVLE 700
           E      FS KSDV+SFGVL+ E
Sbjct: 184 ECINYYKFSSKSDVWSFGVLMWE 206

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 14  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 73
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 74  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 121
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 122 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 173
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 174 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 18  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 78  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 125
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 126 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 177
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 178 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 508 DKNKLGEGGFGPVYKGV--LIEGQEIAAKRLSKSSGQG---MEEFENEVLLIAKLQHRNL 562
           +  +LG G FG V KG   + +  +  A ++ K+        +E   E  ++ +L +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
           V++IG C + +  ML+ E      LN ++    +++ +      +++  ++ G+ YL + 
Sbjct: 71  VRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEES 126
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----P 677
           +    +HRDL A NVLL  +   KISDFG+++A   D+          T+G  P     P
Sbjct: 127 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAP 179
Query: 678 EYAIDGLFSVKSDVFSFGVLVLE 700
           E      FS KSDV+SFGVL+ E
Sbjct: 180 ECINYYKFSSKSDVWSFGVLMWE 202

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 36  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 95
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 96  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 143
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 144 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 195
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 196 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 22  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 82  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 129
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 130 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 181
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 182 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 22  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 82  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 129
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 130 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR-----HT 181
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 182 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 508 DKNKLGEGGFGPVYKGV--LIEGQEIAAKRLSKSSGQG---MEEFENEVLLIAKLQHRNL 562
           +  +LG G FG V KG   + +  +  A ++ K+        +E   E  ++ +L +  +
Sbjct: 374 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 433
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
           V++IG C + +  ML+ E      LN ++    +++ +      +++  ++ G+ YL + 
Sbjct: 434 VRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEES 489
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----P 677
           +    +HRDL A NVLL  +   KISDFG+++A   D+          T+G  P     P
Sbjct: 490 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAP 542
Query: 678 EYAIDGLFSVKSDVFSFGVLVLE 700
           E      FS KSDV+SFGVL+ E
Sbjct: 543 ECINYYKFSSKSDVWSFGVLMWE 565

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 18  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 78  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 125
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 126 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR-----HT 177
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 178 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 35/226 (15%)
Query: 505 NFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH---- 559
           +F +   LG+G FG V K    ++ +  A K++ + + + +    +EV L+A L H    
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLASLNHQYVV 65
Query: 560 ---------RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG 610
                    RN VK      ++    +  EY  N++L D I     ++  D  +  ++  
Sbjct: 66  RYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRD--EYWRLFR 123
Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA----RAFGIDQTEA--- 663
            I   L Y+H      IIHR+LK  N+ +D   N KI DFG+A    R+  I + ++   
Sbjct: 124 QILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 664 -----NTNRVVGTYGYMPPEYAIDGL--FSVKSDVFSFGVLVLEIV 702
                N    +GT  Y+  E  +DG   ++ K D +S G++  E +
Sbjct: 181 PGSSDNLTSAIGTAXYVATE-VLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 35  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 94
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 95  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 142
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 143 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 194
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 195 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 94/216 (43%), Gaps = 33/216 (15%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLS--KSSGQGMEEFENEVL------LIAKLQHRNLV 563
           LG G FG V +       + A  R    K   +G    E+  L      LI    H N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 564 KLIGCCTQRD-ERMLIYEYLPNKSLNDFIFDVTRSK-----------------FLDWSKR 605
            L+G CT+     M+I E+    +L+ ++    RSK                 FL     
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYL----RSKRNEFVPYKVAPEDLYKDFLTLEHL 187
Query: 606 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT 665
                 +A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+AR    D      
Sbjct: 188 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 244
Query: 666 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
                   +M PE   D +++++SDV+SFGVL+ EI
Sbjct: 245 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 280

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKSS----GQGMEEFENEVLLIAKLQHRNLVKLIG 567
           LG+GGF   Y+   ++ +E+ A ++   S        E+   E+ +   L + ++V   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 568 CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI 627
                D   ++ E    +SL +      R K +   +    +    +G+ YLH +   R+
Sbjct: 94  FFEDDDFVYVVLEICRRRSLLEL---HKRRKAVTEPEARYFMRQTIQGVQYLHNN---RV 147
Query: 628 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSV 687
           IHRDLK  N+ L+++M+ KI DFG+A     D        + GT  Y+ PE       S 
Sbjct: 148 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD--LCGTPNYIAPEVLCKKGHSF 205
Query: 688 KSDVFSFGVLVLEIVCGK 705
           + D++S G ++  ++ GK
Sbjct: 206 EVDIWSLGCILYTLLVGK 223

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 27  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 86
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 87  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 134
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 135 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 186
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 187 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 27/218 (12%)
Query: 505 NFSDKNKLGE----GGFGPVYKGV-LIEGQEIAAKRLSKSSGQGME---EFENEVLLIAK 556
           + SD+ +LGE    GG   V+    L + +++A K L     +       F  E    A 
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 68
Query: 557 LQHRNLVKLIGCCTQRDER----MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGI 612
           L H  +V +               ++ EY+   +L D +        +   +  ++I   
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADA 125
Query: 613 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG-----IDQTEANTNR 667
            + L + HQ+    IIHRD+K +N+L+      K+ DFG+ARA       + QT A    
Sbjct: 126 CQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAA---- 178
Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           V+GT  Y+ PE A       +SDV+S G ++ E++ G+
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKSS----GQGMEEFENEVLLIAKLQHRNLVKLIG 567
           LG+GGF   Y+   ++ +E+ A ++   S        E+   E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 568 CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI 627
                D   ++ E    +SL +      R K +   +    +    +G+ YLH +   R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLEL---HKRRKAVTEPEARYFMRQTIQGVQYLHNN---RV 163
Query: 628 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSV 687
           IHRDLK  N+ L+++M+ KI DFG+A     D        + GT  Y+ PE       S 
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKX--LCGTPNYIAPEVLCKKGHSF 221
Query: 688 KSDVFSFGVLVLEIVCGK 705
           + D++S G ++  ++ GK
Sbjct: 222 EVDIWSLGCILYTLLVGK 239

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKSS----GQGMEEFENEVLLIAKLQHRNLVKLIG 567
           LG+GGF   Y+   ++ +E+ A ++   S        E+   E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 568 CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI 627
                D   ++ E    +SL +      R K +   +    +    +G+ YLH +   R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLEL---HKRRKAVTEPEARYFMRQTIQGVQYLHNN---RV 163
Query: 628 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSV 687
           IHRDLK  N+ L+++M+ KI DFG+A     D        + GT  Y+ PE       S 
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD--LCGTPNYIAPEVLCKKGHSF 221
Query: 688 KSDVFSFGVLVLEIVCGK 705
           + D++S G ++  ++ GK
Sbjct: 222 EVDIWSLGCILYTLLVGK 239

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKS-----SGQGMEEFENEVLLIAKLQHRNLVKLI 566
           +GEG FG V++G+ +  +  A     K+     S    E+F  E L + +  H ++VKLI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 626
           G  T+ +   +I E      L  F+    R   LD +        ++  L YL      R
Sbjct: 458 GVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 627 IIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFS 686
            +HRD+ A NVL+ +    K+ DFG++R +  D T    ++      +M PE      F+
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 687 VKSDVFSFGVLVLEIV 702
             SDV+ FGV + EI+
Sbjct: 571 SASDVWMFGVCMWEIL 586

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 503 TENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLS--KSSGQGMEEFENEVLLIAKLQH 559
           T+ +     +G+G F  V + V L  G E AAK ++  K S +  ++ E E  +   L+H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
            N+V+L    ++     L+++ +    L +   D+   ++   +     I  I   +L+ 
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFE---DIVAREYYSEADASHCIQQILEAVLHC 119
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMN---PKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
           HQ   + ++HRDLK  N+LL ++      K++DFG+A     DQ         GT GY+ 
Sbjct: 120 HQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLS 174
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           PE      +    D+++ GV++  ++ G
Sbjct: 175 PEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 39  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 98
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 99  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 146
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 147 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 198
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 199 DDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 27/218 (12%)
Query: 505 NFSDKNKLGE----GGFGPVYKGV-LIEGQEIAAKRLSKSSGQGME---EFENEVLLIAK 556
           + SD+ +LGE    GG   V+    L + +++A K L     +       F  E    A 
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 68
Query: 557 LQHRNLVKLIGCCTQRDER----MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGI 612
           L H  +V +               ++ EY+   +L D +        +   +  ++I   
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADA 125
Query: 613 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG-----IDQTEANTNR 667
            + L + HQ+    IIHRD+K +N+++      K+ DFG+ARA       + QT A    
Sbjct: 126 CQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA---- 178
Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           V+GT  Y+ PE A       +SDV+S G ++ E++ G+
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 83  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 130
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 131 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 182
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
                  V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 183 ADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 83  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 130
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 131 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 182
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
                  V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 183 ADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 27/218 (12%)
Query: 505 NFSDKNKLGE----GGFGPVYKGV-LIEGQEIAAKRLSKSSGQGME---EFENEVLLIAK 556
           + SD+ +LGE    GG   V+    L + +++A K L     +       F  E    A 
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 68
Query: 557 LQHRNLVKLIGCCTQRDER----MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGI 612
           L H  +V +               ++ EY+   +L D +        +   +  ++I   
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADA 125
Query: 613 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG-----IDQTEANTNR 667
            + L + HQ+    IIHRD+K +N+++      K+ DFG+ARA       + QT A    
Sbjct: 126 CQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA---- 178
Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           V+GT  Y+ PE A       +SDV+S G ++ E++ G+
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 83  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 130
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 131 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 182
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
                  V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 183 ADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 102/210 (48%), Gaps = 16/210 (7%)
Query: 500 ANATENFSDKNKLGEGGFGPVYKGVLIEGQEI--AAKRLSKSSGQGMEEFENEVLLIAKL 557
            +  + ++ +N +G G +G V K  + +G  I  AAK++ K   + ++ F+ E+ ++  L
Sbjct: 5   GDINQYYTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL 63
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
            H N+++L        +  L+ E      L +    V   +    S   +I+  +   + 
Sbjct: 64  DHPNIIRLYETFEDNTDIYLVMELCTGGELFE---RVVHKRVFRESDAARIMKDVLSAVA 120
Query: 618 YLHQDSRLRIIHRDLKASNVLL--DNEMNP-KISDFGMARAFGIDQTEANTNRVVGTYGY 674
           Y H   +L + HRDLK  N L   D+  +P K+ DFG+A  F   +        VGT  Y
Sbjct: 121 YCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK---VGTPYY 174
Query: 675 MPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           + P+  ++GL+  + D +S GV++  ++CG
Sbjct: 175 VSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI D+G+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLAR-----HT 175
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 12  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +C    
Sbjct: 72  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCAKLT 119
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 120 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 171
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 172 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 102/210 (48%), Gaps = 16/210 (7%)
Query: 500 ANATENFSDKNKLGEGGFGPVYKGVLIEGQEI--AAKRLSKSSGQGMEEFENEVLLIAKL 557
            +  + ++ +N +G G +G V K  + +G  I  AAK++ K   + ++ F+ E+ ++  L
Sbjct: 22  GDINQYYTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL 80
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
            H N+++L        +  L+ E      L +    V   +    S   +I+  +   + 
Sbjct: 81  DHPNIIRLYETFEDNTDIYLVMELCTGGELFE---RVVHKRVFRESDAARIMKDVLSAVA 137
Query: 618 YLHQDSRLRIIHRDLKASNVLL--DNEMNP-KISDFGMARAFGIDQTEANTNRVVGTYGY 674
           Y H   +L + HRDLK  N L   D+  +P K+ DFG+A  F   +        VGT  Y
Sbjct: 138 YCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK---VGTPYY 191
Query: 675 MPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           + P+  ++GL+  + D +S GV++  ++CG
Sbjct: 192 VSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 91/196 (46%), Gaps = 12/196 (6%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKS-----SGQGMEEFENEVLLIAKLQHRNLVKLI 566
           +GEG FG V++G+ +  +  A     K+     S    E+F  E L + +  H ++VKLI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 626
           G  T+ +   +I E      L  F+    R   LD +        ++  L YL      R
Sbjct: 458 GVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 627 IIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFS 686
            +HRD+ A NVL+      K+ DFG++R +  D T    ++      +M PE      F+
Sbjct: 512 FVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 687 VKSDVFSFGVLVLEIV 702
             SDV+ FGV + EI+
Sbjct: 571 SASDVWMFGVCMWEIL 586

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 19/211 (9%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFEN--EVLLIAKLQ 558
           AT  +    ++G G +G VYK      G  +A K +   +G+         EV L+ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 559 ---HRNLVKLIG-CCTQRDER----MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG 610
              H N+V+L+  C T R +R     L++E++ ++ L  ++ D      L       ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVG 670
              RGL +LH +    I+HRDLK  N+L+ +    K++DFG+AR +     +     VV 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALFPVVV 173
Query: 671 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
           T  Y  PE  +   ++   D++S G +  E+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 97/208 (46%), Gaps = 26/208 (12%)
Query: 511 KLGEGGFGPV----YKGVLIEGQEIAAK-----RLSKSS-GQGMEEFENEVLLIAKLQHR 560
           +LG G F  V     KG    G+E AAK     RLS S  G   EE E EV ++ +++H 
Sbjct: 19  ELGSGQFAIVRKCRQKGT---GKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHP 75
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N++ L      + + +LI E +    L DF+      + L   +  Q +  I  G+ YLH
Sbjct: 76  NIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGVHYLH 132
Query: 621 QDSRLRIIHRDLKASNVLL--DNEMNPKIS--DFGMARAFGIDQTEANTNRVVGTYGYMP 676
                RI H DLK  N++L   N  NP+I   DFG+A          N   + GT  ++ 
Sbjct: 133 SK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFGTPEFVA 186
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           PE        +++D++S GV+   ++ G
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 104/229 (45%), Gaps = 26/229 (11%)
Query: 498 AIANATEN-FSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEF----- 547
           A+A  T N F     LG+G FG V   +L++    G+  A K L K      +E      
Sbjct: 2   AMARVTMNEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT 58
Query: 548 ENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQ 607
           EN VL  ++  H  L  L       D    + EY     L    F ++R +      R +
Sbjct: 59  ENRVLQNSR--HPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFS-EDRAR 112
Query: 608 IIGG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN 666
             G  I   L YLH  S   +++RDLK  N++LD + + KI+DFG+ +  GI +  A   
Sbjct: 113 FYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GI-KDGATMK 168
Query: 667 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 715
              GT  Y+ PE   D  +    D +  GV++ E++CG+    FY+ DH
Sbjct: 169 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 215

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKSS----GQGMEEFENEVLLIAKLQHRNLVKLIG 567
           LG+GGF   ++    + +E+ A ++   S        E+   E+ +   L H+++V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 568 CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI 627
                D   ++ E    +SL +      R K L   +    +  I  G  YLH++   R+
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 160
Query: 628 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSV 687
           IHRDLK  N+ L+ ++  KI DFG+A     D        + GT  Y+ PE       S 
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSF 218
Query: 688 KSDVFSFGVLVLEIVCGK 705
           + DV+S G ++  ++ GK
Sbjct: 219 EVDVWSIGCIMYTLLVGK 236

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 503 TENFSDKNKLGEGGFGPVY--KGVLIEGQEIAAKRLSKSSGQGMEE---FENEVLLIAKL 557
           ++ +    KLG G +G V   K  L  G E A K + KSS           +EV ++ +L
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 78
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
            H N++KL      +    L+ E      L D I  + R KF +      I+  +  G  
Sbjct: 79  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEI--ILRQKFSEVDAAV-IMKQVLSGTT 135
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGIDQTEANTNRVVGTYGY 674
           YLH+ +   I+HRDLK  N+LL+++      KI DFG++  F +          +GT  Y
Sbjct: 136 YLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG---GKMKERLGTAYY 189
Query: 675 MPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           + PE  +   +  K DV+S GV++  ++CG
Sbjct: 190 IAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 97/208 (46%), Gaps = 26/208 (12%)
Query: 511 KLGEGGFGPV----YKGVLIEGQEIAAK-----RLSKSS-GQGMEEFENEVLLIAKLQHR 560
           +LG G F  V     KG    G+E AAK     RLS S  G   EE E EV ++ +++H 
Sbjct: 12  ELGSGQFAIVRKCRQKGT---GKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHP 68
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N++ L      + + +LI E +    L DF+      + L   +  Q +  I  G+ YLH
Sbjct: 69  NIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGVHYLH 125
Query: 621 QDSRLRIIHRDLKASNVLL--DNEMNPKIS--DFGMARAFGIDQTEANTNRVVGTYGYMP 676
                RI H DLK  N++L   N  NP+I   DFG+A          N   + GT  ++ 
Sbjct: 126 SK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFGTPEFVA 179
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           PE        +++D++S GV+   ++ G
Sbjct: 180 PEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKSS----GQGMEEFENEVLLIAKLQHRNLVKLIG 567
           LG+GGF   ++    + +E+ A ++   S        E+   E+ +   L H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 568 CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI 627
                D   ++ E    +SL +      R K L   +    +  I  G  YLH++   R+
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 162
Query: 628 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSV 687
           IHRDLK  N+ L+ ++  KI DFG+A     D        + GT  Y+ PE       S 
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSF 220
Query: 688 KSDVFSFGVLVLEIVCGK 705
           + DV+S G ++  ++ GK
Sbjct: 221 EVDVWSIGCIMYTLLVGK 238

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 503 TENFSDKNKLGEGGFGPVY--KGVLIEGQEIAAKRLSKSSGQGMEE---FENEVLLIAKL 557
           ++ +    KLG G +G V   K  L  G E A K + KSS           +EV ++ +L
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
            H N++KL      +    L+ E      L D I  + R KF +      I+  +  G  
Sbjct: 62  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEI--ILRQKFSEVDAAV-IMKQVLSGTT 118
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGIDQTEANTNRVVGTYGY 674
           YLH+ +   I+HRDLK  N+LL+++      KI DFG++  F +          +GT  Y
Sbjct: 119 YLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG---GKMKERLGTAYY 172
Query: 675 MPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           + PE  +   +  K DV+S GV++  ++CG
Sbjct: 173 IAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKSS----GQGMEEFENEVLLIAKLQHRNLVKLIG 567
           LG+GGF   ++    + +E+ A ++   S        E+   E+ +   L H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 568 CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI 627
                D   ++ E    +SL +      R K L   +    +  I  G  YLH++   R+
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 136
Query: 628 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSV 687
           IHRDLK  N+ L+ ++  KI DFG+A     D        + GT  Y+ PE       S 
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSF 194
Query: 688 KSDVFSFGVLVLEIVCGK 705
           + DV+S G ++  ++ GK
Sbjct: 195 EVDVWSIGCIMYTLLVGK 212

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 27/218 (12%)
Query: 505 NFSDKNKLGE----GGFGPVYKGV-LIEGQEIAAKRLSKSSGQGME---EFENEVLLIAK 556
           + SD+ +LGE    GG   V+    L   +++A K L     +       F  E    A 
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 68
Query: 557 LQHRNLVKLIGCCTQRDER----MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGI 612
           L H  +V +               ++ EY+   +L D +        +   +  ++I   
Sbjct: 69  LNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADA 125
Query: 613 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG-----IDQTEANTNR 667
            + L + HQ+    IIHRD+K +N+++      K+ DFG+ARA       + QT A    
Sbjct: 126 CQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA---- 178
Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           V+GT  Y+ PE A       +SDV+S G ++ E++ G+
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLAR-----HT 175
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 23/207 (11%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGC-CT 570
           +G+G +G V++G L  G+ +A K  S    Q     E E+     L+H N++  I    T
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFR-ETEIYNTVLLRHDNILGFIASDMT 73
Query: 571 QRD---ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD----- 622
            R+   +  LI  Y  + SL DF+   T    L      ++    A GL +LH +     
Sbjct: 74  SRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLA----LRLAVSAACGLAHLHVEIFGTQ 129
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMA--RAFGIDQTEANTNRVVGTYGYMPPEYA 680
            +  I HRD K+ NVL+ + +   I+D G+A   + G D  +   N  VGT  YM PE  
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVL 189
Query: 681 -----IDGLFSVK-SDVFSFGVLVLEI 701
                 D   S K +D+++FG+++ EI
Sbjct: 190 DEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 16/201 (7%)
Query: 512 LGEGGFGPVYKGVLIEGQE----IAAKRLSKS----SGQGMEEFENEVLLIAKLQHRNLV 563
           LG+GG+G V++   + G       A K L K+    + +     + E  ++ +++H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
            LI       +  LI EYL   S  +    + R         C  +  I+  L +LHQ  
Sbjct: 85  DLIYAFQTGGKLYLILEYL---SGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG 141
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
              II+RDLK  N++L+++ + K++DFG+ +    D T  +T    GT  YM PE  +  
Sbjct: 142 ---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYMAPEILMRS 196
Query: 684 LFSVKSDVFSFGVLVLEIVCG 704
             +   D +S G L+ +++ G
Sbjct: 197 GHNRAVDWWSLGALMYDMLTG 217

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 27/222 (12%)
Query: 505 NFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQ-GMEEFENEVLLIAKLQHRNL 562
           +F     LG GGFG V++    ++    A KR+   + +   E+   EV  +AKL+H  +
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDW-SKRC-----------QIIG 610
           V+      +++    +    P   L   +    +    DW + RC            I  
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE-------- 662
            IA  + +LH      ++HRDLK SN+    +   K+ DFG+  A   D+ E        
Sbjct: 126 QIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 663 --ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
             A     VGT  YM PE      +S K D+FS G+++ E++
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 26/208 (12%)
Query: 511 KLGEGGFGPV----YKGVLIEGQEIAAKRLSK----SSGQGM--EEFENEVLLIAKLQHR 560
           +LG G F  V     KG    G+E AAK + K    SS +G+  EE E EV ++ +++H 
Sbjct: 33  ELGSGQFAIVRKCRQKGT---GKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHP 89
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N++ L      + + +LI E +    L DF+      + L   +  Q +  I  G+ YLH
Sbjct: 90  NIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGVHYLH 146
Query: 621 QDSRLRIIHRDLKASNVLL--DNEMNPKIS--DFGMARAFGIDQTEANTNRVVGTYGYMP 676
                RI H DLK  N++L   N  NP+I   DFG+A          N   + GT  ++ 
Sbjct: 147 SK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFGTPEFVA 200
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           PE        +++D++S GV+   ++ G
Sbjct: 201 PEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 28/214 (13%)
Query: 512 LGEGGFGPVYKGV---LIE---GQEIAAKRLSKSSG-QGMEEFENEVLLIAKL-QHRNLV 563
           LG G FG V +     LI+      +A K L  S+     E   +E+ +++ L  H N+V
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG------------ 611
            L+G CT     ++I EY     L +F+    R  F+       I+              
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFL-RRKRDSFICSKTSPAIMEDDELALDLEDLLS 165
Query: 612 ----IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 667
               +A+G+ +L   +    IHRDL A N+LL +    KI DFG+AR    D        
Sbjct: 166 FSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 222
Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
                 +M PE   + +++ +SDV+S+G+ + E+
Sbjct: 223 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 256

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 28/214 (13%)
Query: 512 LGEGGFGPVYKGV---LIE---GQEIAAKRLSKSSG-QGMEEFENEVLLIAKL-QHRNLV 563
           LG G FG V +     LI+      +A K L  S+     E   +E+ +++ L  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG------------ 611
            L+G CT     ++I EY     L +F+    R  F+       I+              
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFL-RRKRDSFICSKTSPAIMEDDELALDLEDLLS 172
Query: 612 ----IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 667
               +A+G+ +L   +    IHRDL A N+LL +    KI DFG+AR    D        
Sbjct: 173 FSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGN 229
Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
                 +M PE   + +++ +SDV+S+G+ + E+
Sbjct: 230 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 263

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 102/225 (45%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSKRCQ----- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +     
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKXQKLT 123
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HT 175
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 28/214 (13%)
Query: 512 LGEGGFGPVYKGV---LIE---GQEIAAKRLSKSSG-QGMEEFENEVLLIAKL-QHRNLV 563
           LG G FG V +     LI+      +A K L  S+     E   +E+ +++ L  H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG------------ 611
            L+G CT     ++I EY     L +F+    R  F+       I+              
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFL-RRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 612 ----IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 667
               +A+G+ +L   +    IHRDL A N+LL +    KI DFG+AR    D        
Sbjct: 150 FSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
                 +M PE   + +++ +SDV+S+G+ + E+
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 28/214 (13%)
Query: 512 LGEGGFGPVYKGV---LIE---GQEIAAKRLSKSSG-QGMEEFENEVLLIAKL-QHRNLV 563
           LG G FG V +     LI+      +A K L  S+     E   +E+ +++ L  H N+V
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG------------ 611
            L+G CT     ++I EY     L +F+    R  F+       I+              
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFL-RRKRDSFICSKTSPAIMEDDELALDLEDLLS 167
Query: 612 ----IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 667
               +A+G+ +L   +    IHRDL A N+LL +    KI DFG+AR    D        
Sbjct: 168 FSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 224
Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
                 +M PE   + +++ +SDV+S+G+ + E+
Sbjct: 225 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 258

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 23/207 (11%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGC-CT 570
           +G+G +G V++G   +G+ +A K  S    +     E E+     L+H N++  I    T
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFIASDMT 102
Query: 571 QRDERM---LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH-----QD 622
            R       LI  Y    SL D++   T    LD     +I+  IA GL +LH       
Sbjct: 103 SRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLHIEIFGTQ 158
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMA--RAFGIDQTEANTNRVVGTYGYMPPEY- 679
            +  I HRDLK+ N+L+       I+D G+A   +   +Q +   N  VGT  YM PE  
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 218
Query: 680 ----AIDGLFSVKS-DVFSFGVLVLEI 701
                +D   S K  D+++FG+++ E+
Sbjct: 219 DETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 16/201 (7%)
Query: 512 LGEGGFGPVYKGVLIEGQE----IAAKRLSKS----SGQGMEEFENEVLLIAKLQHRNLV 563
           LG+GG+G V++   + G       A K L K+    + +     + E  ++ +++H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
            LI       +  LI EYL   S  +    + R         C  +  I+  L +LHQ  
Sbjct: 85  DLIYAFQTGGKLYLILEYL---SGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG 141
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
              II+RDLK  N++L+++ + K++DFG+ +    D T   T+   GT  YM PE  +  
Sbjct: 142 ---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHXFCGTIEYMAPEILMRS 196
Query: 684 LFSVKSDVFSFGVLVLEIVCG 704
             +   D +S G L+ +++ G
Sbjct: 197 GHNRAVDWWSLGALMYDMLTG 217

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 98/214 (45%), Gaps = 25/214 (11%)
Query: 512 LGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEF-----ENEVLLIAKLQHRNL 562
           LG+G FG V   +L++    G+  A K L K      +E      EN VL  ++  H  L
Sbjct: 156 LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR--HPFL 210
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG-IARGLLYLHQ 621
             L       D    + EY     L    F ++R +      R +  G  I   L YLH 
Sbjct: 211 TALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFS-EDRARFYGAEIVSALDYLH- 265
Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
            S   +++RDLK  N++LD + + KI+DFG+ +  GI +  A      GT  Y+ PE   
Sbjct: 266 -SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GI-KDGATMKTFCGTPEYLAPEVLE 322
Query: 682 DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 715
           D  +    D +  GV++ E++CG+    FY+ DH
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 354

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 98/214 (45%), Gaps = 25/214 (11%)
Query: 512 LGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEF-----ENEVLLIAKLQHRNL 562
           LG+G FG V   +L++    G+  A K L K      +E      EN VL  ++  H  L
Sbjct: 159 LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR--HPFL 213
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG-IARGLLYLHQ 621
             L       D    + EY     L    F ++R +      R +  G  I   L YLH 
Sbjct: 214 TALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFS-EDRARFYGAEIVSALDYLH- 268
Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
            S   +++RDLK  N++LD + + KI+DFG+ +  GI +  A      GT  Y+ PE   
Sbjct: 269 -SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GI-KDGATMKTFCGTPEYLAPEVLE 325
Query: 682 DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 715
           D  +    D +  GV++ E++CG+    FY+ DH
Sbjct: 326 DNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 357

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 27/218 (12%)
Query: 505 NFSDKNKLGE----GGFGPVYKGV-LIEGQEIAAKRLSKSSGQGME---EFENEVLLIAK 556
           + SD+ +LGE    GG   V+    L   +++A K L     +       F  E    A 
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 68
Query: 557 LQHRNLVKLIGCCTQRDER----MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGI 612
           L H  +V +               ++ EY+   +L D +        +   +  ++I   
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADA 125
Query: 613 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG-----IDQTEANTNR 667
            + L + HQ+    IIHRD+K +N+++      K+ DFG+ARA       + QT A    
Sbjct: 126 CQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA---- 178
Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           V+GT  Y+ PE A       +SDV+S G ++ E++ G+
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 96/204 (47%), Gaps = 24/204 (11%)
Query: 512 LGEGGFGPVYKGVLI----EGQEIAAKRLSKSSGQGMEEFENEVL--LIAKLQHRNLVKL 565
           LG+G FG V+    +     G   A K L K++ +  +    ++   ++A + H  +VKL
Sbjct: 36  LGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKL 95
Query: 566 IGCCTQRDERMLIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
                   +  LI ++L    L      + +F     KF         +  +A GL +LH
Sbjct: 96  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF--------YLAELALGLDHLH 147
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
               L II+RDLK  N+LLD E + K++DFG+++   ID  E       GT  YM PE  
Sbjct: 148 S---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-AIDH-EKKAYSFCGTVEYMAPEVV 202
Query: 681 IDGLFSVKSDVFSFGVLVLEIVCG 704
                S  +D +S+GVL+ E++ G
Sbjct: 203 NRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGC-CT 570
           +G+G +G V++G   +G+ +A K  S    +     E E+     L+H N++  I    T
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFIASDMT 73
Query: 571 QRD---ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH-----QD 622
            R    +  LI  Y    SL D++   T    LD     +I+  IA GL +LH       
Sbjct: 74  SRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMA--RAFGIDQTEANTNRVVGTYGYMPPEY- 679
            +  I HRDLK+ N+L+       I+D G+A   +   +Q +   N  VGT  YM PE  
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 680 ----AIDGLFSVKS-DVFSFGVLVLEI 701
                +D   S K  D+++FG+++ E+
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 28/214 (13%)
Query: 512 LGEGGFGPVYKGV---LIE---GQEIAAKRLSKSSG-QGMEEFENEVLLIAKL-QHRNLV 563
           LG G FG V +     LI+      +A K L  S+     E   +E+ +++ L  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG------------ 611
            L+G CT     ++I EY     L +F+    R  F+       I+              
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFL-RRKRDSFICSKTSPAIMEDDELALDLEDLLS 172
Query: 612 ----IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 667
               +A+G+ +L   +    IHRDL A N+LL +    KI DFG+AR    D        
Sbjct: 173 FSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 229
Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
                 +M PE   + +++ +SDV+S+G+ + E+
Sbjct: 230 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 263

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGC-CT 570
           +G+G +G V++G   +G+ +A K  S    +     E E+     L+H N++  I    T
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFIASDMT 73
Query: 571 QRD---ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH-----QD 622
            R    +  LI  Y    SL D++   T    LD     +I+  IA GL +LH       
Sbjct: 74  SRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMA--RAFGIDQTEANTNRVVGTYGYMPPEY- 679
            +  I HRDLK+ N+L+       I+D G+A   +   +Q +   N  VGT  YM PE  
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 680 ----AIDGLFSVKS-DVFSFGVLVLEI 701
                +D   S K  D+++FG+++ E+
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 41/213 (19%)
Query: 512 LGEGGFGPV---YKGVLIEGQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQHRNLVKLI 566
           +G G +G V   Y   L   Q++A K+LS+   S         E+ L+  L+H N++ L+
Sbjct: 28  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 567 GCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ---------IIGGIA 613
              T            P  S+ DF  ++ VT     D +   +CQ         ++  + 
Sbjct: 86  DVFT------------PATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLL 133
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
           RGL Y+H      IIHRDLK SNV ++ +   +I DFG+AR     Q +      V T  
Sbjct: 134 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADEEMTGYVATRW 185
Query: 674 YMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           Y  PE  ++ + ++   D++S G ++ E++ GK
Sbjct: 186 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 102/225 (45%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSKRCQ----- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +     
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKXQKLT 123
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HT 175
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 41/213 (19%)
Query: 512 LGEGGFGPV---YKGVLIEGQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQHRNLVKLI 566
           +G G +G V   Y   L   Q++A K+LS+   S         E+ L+  L+H N++ L+
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 567 GCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ---------IIGGIA 613
              T            P  S+ DF  ++ VT     D +   +CQ         ++  + 
Sbjct: 94  DVFT------------PATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLL 141
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
           RGL Y+H      IIHRDLK SNV ++ +   +I DFG+AR     Q +      V T  
Sbjct: 142 RGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRW 193
Query: 674 YMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           Y  PE  ++ + ++   D++S G ++ E++ GK
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI  FG+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLAR-----HT 175
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI D G+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLAR-----HT 175
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 98/214 (45%), Gaps = 25/214 (11%)
Query: 512 LGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEF-----ENEVLLIAKLQHRNL 562
           LG+G FG V   +L++    G+  A K L K      +E      EN VL  ++  H  L
Sbjct: 16  LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR--HPFL 70
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG-IARGLLYLHQ 621
             L       D    + EY     L    F ++R +      R +  G  I   L YLH 
Sbjct: 71  TALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFS-EDRARFYGAEIVSALDYLH- 125
Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
            S   +++RDLK  N++LD + + KI+DFG+ +  GI +  A      GT  Y+ PE   
Sbjct: 126 -SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GI-KDGATMKXFCGTPEYLAPEVLE 182
Query: 682 DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 715
           D  +    D +  GV++ E++CG+    FY+ DH
Sbjct: 183 DNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 214

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 74/165 (44%), Gaps = 21/165 (12%)
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 671
           +ARG+ +L   S  + IHRDL A N+LL      KI DFG+AR    +            
Sbjct: 208 VARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 672 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC--GKRNRGFYHADHHHNLLGHAWRLWIE 729
             +M PE   D ++S KSDV+S+GVL+ EI    G    G    +   + L    R+   
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRLREGMRMRAP 324
Query: 730 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 774
           E             YS  E+    Q+ L C  + P++RP  + +V
Sbjct: 325 E-------------YSTPEI---YQIMLDCWHRDPKERPRFAELV 353

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 98/214 (45%), Gaps = 25/214 (11%)
Query: 512 LGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEF-----ENEVLLIAKLQHRNL 562
           LG+G FG V   +L++    G+  A K L K      +E      EN VL  ++  H  L
Sbjct: 18  LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR--HPFL 72
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG-IARGLLYLHQ 621
             L       D    + EY     L    F ++R +      R +  G  I   L YLH 
Sbjct: 73  TALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFS-EDRARFYGAEIVSALDYLH- 127
Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
            S   +++RDLK  N++LD + + KI+DFG+ +  GI +  A      GT  Y+ PE   
Sbjct: 128 -SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GI-KDGATMKXFCGTPEYLAPEVLE 184
Query: 682 DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 715
           D  +    D +  GV++ E++CG+    FY+ DH
Sbjct: 185 DNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 216

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 107/239 (44%), Gaps = 25/239 (10%)
Query: 502 ATENFSDKNKLGEGGFGPVYK------GVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIA 555
           AT  +    ++G G +G VYK      G  +  + +         G        EV L+ 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 556 KLQ---HRNLVKLIG-CCTQRDER----MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQ 607
           +L+   H N+V+L+  C T R +R     L++E++ ++ L  ++ D      L       
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124
Query: 608 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 667
           ++    RGL +LH +    I+HRDLK  N+L+ +    K++DFG+AR +     +     
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALTP 178
Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL 726
           VV T  Y  PE  +   ++   D++S G +  E+    R +  +  +   + LG  + L
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF---RRKPLFCGNSEADQLGKIFDL 234

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI D G+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLAR-----HT 175
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 27/218 (12%)
Query: 505 NFSDKNKLGE----GGFGPVYKGV-LIEGQEIAAKRLSKSSGQGME---EFENEVLLIAK 556
           + SD+ +LGE    GG   V+    L   +++A K L     +       F  E    A 
Sbjct: 26  HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 85
Query: 557 LQHRNLVKLIGCCTQRDER----MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGI 612
           L H  +V +               ++ EY+   +L D +        +   +  ++I   
Sbjct: 86  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADA 142
Query: 613 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG-----IDQTEANTNR 667
            + L + HQ+    IIHRD+K +N+++      K+ DFG+ARA       + QT A    
Sbjct: 143 CQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA---- 195
Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           V+GT  Y+ PE A       +SDV+S G ++ E++ G+
Sbjct: 196 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 233

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 96/204 (47%), Gaps = 24/204 (11%)
Query: 512 LGEGGFGPVYKGVLIEG----QEIAAKRLSKSSGQGMEEFENEVL--LIAKLQHRNLVKL 565
           LG+G FG V+    I G    Q  A K L K++ +  +    ++   ++ ++ H  +VKL
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 566 IGCCTQRDERMLIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
                   +  LI ++L    L      + +F     KF         +  +A  L +LH
Sbjct: 92  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF--------YLAELALALDHLH 143
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
               L II+RDLK  N+LLD E + K++DFG+++   ID  E       GT  YM PE  
Sbjct: 144 S---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDH-EKKAYSFCGTVEYMAPEVV 198
Query: 681 IDGLFSVKSDVFSFGVLVLEIVCG 704
                +  +D +SFGVL+ E++ G
Sbjct: 199 NRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 15/213 (7%)
Query: 497 MAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSK-----SSGQGMEEFE-NE 550
           + + +  + +   + LGEG F  VYK       +I A +  K      +  G+      E
Sbjct: 3   LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE 62
Query: 551 VLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG 610
           + L+ +L H N++ L+     +    L+++++    L   I D   S  L  S     + 
Sbjct: 63  IKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKD--NSLVLTPSHIKAYML 119
Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVG 670
              +GL YLHQ     I+HRDLK +N+LLD     K++DFG+A++FG     A  ++VV 
Sbjct: 120 MTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYXHQVV- 174
Query: 671 TYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIV 702
           T  Y  PE      ++ V  D+++ G ++ E++
Sbjct: 175 TRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 503 TENFSDKNKLGEGGFGPVY----KGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ 558
           +E +    KLG G +G V     K   +E + I   R +  S     +   EV ++  L 
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVE-RAIKIIRKTSVSTSSNSKLLEEVAVLKLLD 94
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           H N++KL      +    L+ E      L D I  + R KF +      II  +  G+ Y
Sbjct: 95  HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI--IHRMKFNEVDAAV-IIKQVLSGVTY 151
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGIDQTEANTNRVVGTYGYM 675
           LH+ +   I+HRDLK  N+LL+++      KI DFG++  F   + +      +GT  Y+
Sbjct: 152 LHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKMKERLGTAYYI 205
Query: 676 PPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
            PE  +   +  K DV+S GV++  ++ G
Sbjct: 206 APE-VLRKKYDEKCDVWSIGVILFILLAG 233

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 101/227 (44%), Gaps = 23/227 (10%)
Query: 498 AIANATENFSDKNKL-GEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFENEVL 552
           A A  T N  D  KL G+G FG V   +L+     G+  A K L K      +E  + V 
Sbjct: 1   ARAKVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVT 57
Query: 553 ---LIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQII 609
              ++   +H  L  L       D    + EY     L    F ++R +     +R +  
Sbjct: 58  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFT-EERARFY 113
Query: 610 GG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
           G  I   L YLH      +++RD+K  N++LD + + KI+DFG+ +  GI    A     
Sbjct: 114 GAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDG-ATMKTF 168
Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 715
            GT  Y+ PE   D  +    D +  GV++ E++CG+    FY+ DH
Sbjct: 169 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 213

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 13/213 (6%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 555 AKLQHRNLVKLIGCCT-QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA 613
             ++H N++ L+   T  R        YL    +   + ++ +S+ L       +I  I 
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQIL 135
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
           RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+ R      T+      V T  
Sbjct: 136 RGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCR-----HTDDEMTGYVATRW 187
Query: 674 YMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 96/204 (47%), Gaps = 24/204 (11%)
Query: 512 LGEGGFGPVYKGVLIEG----QEIAAKRLSKSSGQGMEEFENEVL--LIAKLQHRNLVKL 565
           LG+G FG V+    I G    Q  A K L K++ +  +    ++   ++ ++ H  +VKL
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 92
Query: 566 IGCCTQRDERMLIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
                   +  LI ++L    L      + +F     KF         +  +A  L +LH
Sbjct: 93  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY--------LAELALALDHLH 144
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
               L II+RDLK  N+LLD E + K++DFG+++   ID  E       GT  YM PE  
Sbjct: 145 S---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDH-EKKAYSFCGTVEYMAPEVV 199
Query: 681 IDGLFSVKSDVFSFGVLVLEIVCG 704
                +  +D +SFGVL+ E++ G
Sbjct: 200 NRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 96/204 (47%), Gaps = 24/204 (11%)
Query: 512 LGEGGFGPVYKGVLIEG----QEIAAKRLSKSSGQGMEEFENEVL--LIAKLQHRNLVKL 565
           LG+G FG V+    I G    Q  A K L K++ +  +    ++   ++ ++ H  +VKL
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 566 IGCCTQRDERMLIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
                   +  LI ++L    L      + +F     KF         +  +A  L +LH
Sbjct: 92  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF--------YLAELALALDHLH 143
Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
               L II+RDLK  N+LLD E + K++DFG+++   ID  E       GT  YM PE  
Sbjct: 144 S---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDH-EKKAYSFCGTVEYMAPEVV 198
Query: 681 IDGLFSVKSDVFSFGVLVLEIVCG 704
                +  +D +SFGVL+ E++ G
Sbjct: 199 NRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSK--SSGQGMEEFENEVLLI 554
            I    E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--IFDVTRSKFLDWSK--RCQ--- 607
             ++H N++ L+   T            P +SL +F  ++ VT     D +   +CQ   
Sbjct: 76  KHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 608 ------IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                 +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI D G+AR      T
Sbjct: 124 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLAR-----HT 175
Query: 662 EANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
           +      V T  Y  PE  ++ + ++   D++S G ++ E++ G+
Sbjct: 176 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 89/167 (53%), Gaps = 14/167 (8%)
Query: 544 MEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF-IFDVTRSKFLDW 602
           +E+   E+ ++ KL H N+VKL+      +E  L   Y+  + +N   + +V   K L  
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL---YMVFELVNQGPVMEVPTLKPLSE 136
Query: 603 SKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQT 661
            +       + +G+ YLH     +IIHRD+K SN+L+  + + KI+DFG++  F G D  
Sbjct: 137 DQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 662 EANTNRVVGTYGYMPPEYAID--GLFSVKS-DVFSFGVLVLEIVCGK 705
            +NT   VGT  +M PE   +   +FS K+ DV++ GV +   V G+
Sbjct: 194 LSNT---VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 512 LGEGGFGPV---YKGVLIEGQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQHRNLVKLI 566
           +G G +G V   Y   L   Q++A K+LS+   S         E+ L+  L+H N++ L+
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 567 GCCTQRDERMLIYE-YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 625
              T         E YL    +   + ++ +S+ L       ++  + RGL Y+H     
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAG-- 151
Query: 626 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL- 684
            IIHRDLK SNV ++ +   +I DFG+AR     Q +      V T  Y  PE  ++ + 
Sbjct: 152 -IIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRWYRAPEIMLNWMH 205
Query: 685 FSVKSDVFSFGVLVLEIVCGK 705
           ++   D++S G ++ E++ GK
Sbjct: 206 YNQTVDIWSVGCIMAELLQGK 226

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 122/284 (42%), Gaps = 31/284 (10%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLI----EGQEIAAKRLSKS-SGQGMEEFENEVLLIAK 556
           A E+      LGEG FG VY+GV      E   +A K   K  +    E+F +E +++  
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 65
Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSK-FLDWSKRCQIIGGIARG 615
           L H ++VKLIG   + +   +I E  P   L  ++    R+K  L           I + 
Sbjct: 66  LDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKA 121
Query: 616 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQTEANTNRVVGTYGY 674
           + YL     +  +HRD+   N+L+ +    K+ DFG++R     D  +A+  R+     +
Sbjct: 122 MAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKW 176
Query: 675 MPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE 734
           M PE      F+  SDV+ F V + EI+   +   F+    + +++G      + E+   
Sbjct: 177 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL--ENKDVIG------VLEKGDR 228
Query: 735 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 778
           L    L      + + RC           P DRP  + +V  LS
Sbjct: 229 LPKPDLCPPVLYTLMTRCWDYD-------PSDRPRFTELVCSLS 265

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 122/284 (42%), Gaps = 31/284 (10%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLI----EGQEIAAKRLSKS-SGQGMEEFENEVLLIAK 556
           A E+      LGEG FG VY+GV      E   +A K   K  +    E+F +E +++  
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 81
Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSK-FLDWSKRCQIIGGIARG 615
           L H ++VKLIG   + +   +I E  P   L  ++    R+K  L           I + 
Sbjct: 82  LDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKA 137
Query: 616 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQTEANTNRVVGTYGY 674
           + YL     +  +HRD+   N+L+ +    K+ DFG++R     D  +A+  R+     +
Sbjct: 138 MAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKW 192
Query: 675 MPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE 734
           M PE      F+  SDV+ F V + EI+   +   F+    + +++G      + E+   
Sbjct: 193 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL--ENKDVIG------VLEKGDR 244
Query: 735 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 778
           L    L      + + RC           P DRP  + +V  LS
Sbjct: 245 LPKPDLCPPVLYTLMTRCWDYD-------PSDRPRFTELVCSLS 281

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 107/235 (45%), Gaps = 20/235 (8%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQ----EIAAKRLSKS--SGQGMEEFENEVLLIAKL 557
           + F+    LG+G FG V +  L +      ++A K L     +   +EEF  E   + + 
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 558 QHRNLVKLIGCCTQRDER------MLIYEYLPNKSLNDFIFD--VTRSKF-LDWSKRCQI 608
            H ++ KL+G   +   +      M+I  ++ +  L+ F+    +  + F L      + 
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
           +  IA G+ YL   S    IHRDL A N +L  +M   ++DFG++R              
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCAS 199
Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRN--RGFYHADHHHNLLG 721
                ++  E   D L++V SDV++FGV + EI+   +    G  +A+ ++ L+G
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 33/217 (15%)
Query: 504 ENFSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR 560
           + + +   +G G  G V   Y  +L   + +A K+LS+        F+N+    AK  +R
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKRAYR 72
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRCQI 608
            LV L+ C   ++   L+  + P KSL +F        + D    +     LD  +   +
Sbjct: 73  ELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
           +  +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       
Sbjct: 132 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMEPE 185
Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           V T  Y  PE  +   +    D++S G ++ E+VC K
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 122/284 (42%), Gaps = 31/284 (10%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLI----EGQEIAAKRLSKS-SGQGMEEFENEVLLIAK 556
           A E+      LGEG FG VY+GV      E   +A K   K  +    E+F +E +++  
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 69
Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSK-FLDWSKRCQIIGGIARG 615
           L H ++VKLIG   + +   +I E  P   L  ++    R+K  L           I + 
Sbjct: 70  LDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKA 125
Query: 616 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF-GIDQTEANTNRVVGTYGY 674
           + YL     +  +HRD+   N+L+ +    K+ DFG++R     D  +A+  R+     +
Sbjct: 126 MAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKW 180
Query: 675 MPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE 734
           M PE      F+  SDV+ F V + EI+   +   F+    + +++G      + E+   
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL--ENKDVIG------VLEKGDR 232
Query: 735 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 778
           L    L      + + RC           P DRP  + +V  LS
Sbjct: 233 LPKPDLCPPVLYTLMTRCWDYD-------PSDRPRFTELVCSLS 269

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 33/217 (15%)
Query: 504 ENFSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR 560
           + + +   +G G  G V   Y  +L   + +A K+LS+        F+N+    AK  +R
Sbjct: 29  KRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKRAYR 77
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRCQI 608
            LV L+ C   ++   L+  + P KSL +F        + D    +     LD  +   +
Sbjct: 78  ELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 136
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
           +  +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       
Sbjct: 137 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPY 190
Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           V T  Y  PE  +   +    D++S G ++ E+VC K
Sbjct: 191 VVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 21/214 (9%)
Query: 503 TENFSD-KNKLGEGGFGPVYK-GVLIEGQEIAAK----RLSKSSGQGM--EEFENEVLLI 554
            E+F D   +LG G F  V K      G E AAK    R S++S +G+  EE E EV ++
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIAR 614
            ++ H N++ L      R + +LI E +    L DF+    + + L   +    I  I  
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILD 126
Query: 615 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGIDQTEANTNRVVG 670
           G+ YLH     +I H DLK  N++L ++  P    K+ DFG+A      +       + G
Sbjct: 127 GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFG 180
Query: 671 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           T  ++ PE        +++D++S GV+   ++ G
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 33/217 (15%)
Query: 504 ENFSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR 560
           + + +   +G G  G V   Y  +L   + +A K+LS+        F+N+    AK  +R
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKRAYR 66
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRCQI 608
            LV L+ C   ++   L+  + P KSL +F        + D    +     LD  +   +
Sbjct: 67  ELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 125
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
           +  +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       
Sbjct: 126 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPY 179
Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           V T  Y  PE  +   +    D++S G ++ E+VC K
Sbjct: 180 VVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 20/213 (9%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEI----AAKRLSKSS----GQGMEEFENEVLLIA 555
           ENF     LG G +G V+    I G +     A K L K++     +  E    E  ++ 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 556 KLQHRNLVKLIGCCTQRDERM-LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQI-IGGIA 613
            ++    +  +    Q + ++ LI +Y+    L  F     R +F +     QI +G I 
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGEL--FTHLSQRERFTE--HEVQIYVGEIV 169
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
             L +LH   +L II+RD+K  N+LLD+  +  ++DFG+++ F  D+TE   +   GT  
Sbjct: 170 LALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIE 225
Query: 674 YMPPEYAI--DGLFSVKSDVFSFGVLVLEIVCG 704
           YM P+     D       D +S GVL+ E++ G
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 512 LGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFENEVL---LIAKLQHRNLVK 564
           LG+G FG V   +L+     G+  A K L K      +E  + V    ++   +H  L  
Sbjct: 13  LGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG-IARGLLYLHQDS 623
           L       D    + EY     L    F ++R +     +R +  G  I   L YLH   
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFT-EERARFYGAEIVSALEYLHSRD 125
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
              +++RD+K  N++LD + + KI+DFG+ +  GI    A      GT  Y+ PE   D 
Sbjct: 126 ---VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDG-ATMKXFCGTPEYLAPEVLEDN 180
Query: 684 LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 715
            +    D +  GV++ E++CG+    FY+ DH
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 210

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 21/214 (9%)
Query: 503 TENFSD-KNKLGEGGFGPVYK-GVLIEGQEIAAK----RLSKSSGQGM--EEFENEVLLI 554
            E+F D   +LG G F  V K      G E AAK    R S++S +G+  EE E EV ++
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIAR 614
            ++ H N++ L      R + +LI E +    L DF+    + + L   +    I  I  
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILD 126
Query: 615 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGIDQTEANTNRVVG 670
           G+ YLH     +I H DLK  N++L ++  P    K+ DFG+A      +       + G
Sbjct: 127 GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFG 180
Query: 671 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           T  ++ PE        +++D++S GV+   ++ G
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 512 LGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFENEVL---LIAKLQHRNLVK 564
           LG+G FG V   +L+     G+  A K L K      +E  + V    ++   +H  L  
Sbjct: 18  LGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 74
Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG-IARGLLYLHQDS 623
           L       D    + EY     L    F ++R +     +R +  G  I   L YLH   
Sbjct: 75  LKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFT-EERARFYGAEIVSALEYLHSRD 130
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
              +++RD+K  N++LD + + KI+DFG+ +  GI    A      GT  Y+ PE   D 
Sbjct: 131 ---VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDG-ATMKXFCGTPEYLAPEVLEDN 185
Query: 684 LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 715
            +    D +  GV++ E++CG+    FY+ DH
Sbjct: 186 DYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 215

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 512 LGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFENEVL---LIAKLQHRNLVK 564
           LG+G FG V   +L+     G+  A K L K      +E  + V    ++   +H  L  
Sbjct: 13  LGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG-IARGLLYLHQDS 623
           L       D    + EY     L    F ++R +     +R +  G  I   L YLH   
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFT-EERARFYGAEIVSALEYLHSRD 125
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
              +++RD+K  N++LD + + KI+DFG+ +  GI    A      GT  Y+ PE   D 
Sbjct: 126 ---VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDG-ATMKXFCGTPEYLAPEVLEDN 180
Query: 684 LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 715
            +    D +  GV++ E++CG+    FY+ DH
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 210

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 21/214 (9%)
Query: 503 TENFSD-KNKLGEGGFGPVYK-GVLIEGQEIAAK----RLSKSSGQGM--EEFENEVLLI 554
            E+F D   +LG G F  V K      G E AAK    R S++S +G+  EE E EV ++
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIAR 614
            ++ H N++ L      R + +LI E +    L DF+    + + L   +    I  I  
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILD 126
Query: 615 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGIDQTEANTNRVVG 670
           G+ YLH     +I H DLK  N++L ++  P    K+ DFG+A      +       + G
Sbjct: 127 GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFG 180
Query: 671 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           T  ++ PE        +++D++S GV+   ++ G
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 21/214 (9%)
Query: 503 TENFSD-KNKLGEGGFGPVYK-GVLIEGQEIAAK----RLSKSSGQGM--EEFENEVLLI 554
            E+F D   +LG G F  V K      G E AAK    R S++S +G+  EE E EV ++
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIAR 614
            ++ H N++ L      R + +LI E +    L DF+    + + L   +    I  I  
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILD 126
Query: 615 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGIDQTEANTNRVVG 670
           G+ YLH     +I H DLK  N++L ++  P    K+ DFG+A      +       + G
Sbjct: 127 GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFG 180
Query: 671 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           T  ++ PE        +++D++S GV+   ++ G
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 512 LGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFENEVL---LIAKLQHRNLVK 564
           LG+G FG V   +L+     G+  A K L K      +E  + V    ++   +H  L  
Sbjct: 13  LGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG-IARGLLYLHQDS 623
           L       D    + EY     L    F ++R +     +R +  G  I   L YLH   
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFT-EERARFYGAEIVSALEYLHSRD 125
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
              +++RD+K  N++LD + + KI+DFG+ +  GI    A      GT  Y+ PE   D 
Sbjct: 126 ---VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDG-ATMKXFCGTPEYLAPEVLEDN 180
Query: 684 LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 715
            +    D +  GV++ E++CG+    FY+ DH
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 210

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 21/214 (9%)
Query: 503 TENFSD-KNKLGEGGFGPVYK-GVLIEGQEIAAK----RLSKSSGQGM--EEFENEVLLI 554
            E+F D   +LG G F  V K      G E AAK    R S++S +G+  EE E EV ++
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIAR 614
            ++ H N++ L      R + +LI E +    L DF+    + + L   +    I  I  
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILD 126
Query: 615 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGIDQTEANTNRVVG 670
           G+ YLH     +I H DLK  N++L ++  P    K+ DFG+A      +       + G
Sbjct: 127 GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFG 180
Query: 671 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           T  ++ PE        +++D++S GV+   ++ G
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 512 LGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFENEVL---LIAKLQHRNLVK 564
           LG+G FG V   +L+     G+  A K L K      +E  + V    ++   +H  L  
Sbjct: 13  LGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG-IARGLLYLHQDS 623
           L       D    + EY     L    F ++R +     +R +  G  I   L YLH   
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFT-EERARFYGAEIVSALEYLHSRD 125
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
              +++RD+K  N++LD + + KI+DFG+ +  GI    A      GT  Y+ PE   D 
Sbjct: 126 ---VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDG-ATMKTFCGTPEYLAPEVLEDN 180
Query: 684 LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 715
            +    D +  GV++ E++CG+    FY+ DH
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 210

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 22/212 (10%)
Query: 512 LGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFENEVL---LIAKLQHRNLVK 564
           LG+G FG V   +L+     G+  A K L K      +E  + V    ++   +H  L  
Sbjct: 13  LGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG-IARGLLYLHQDS 623
           L       D    + EY     L    F ++R +     +R +  G  I   L YLH   
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFT-EERARFYGAEIVSALEYLHSRD 125
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
              +++RD+K  N++LD + + KI+DFG+ +  GI    A      GT  Y+ PE   D 
Sbjct: 126 ---VVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDG-ATMKTFCGTPEYLAPEVLEDN 180
Query: 684 LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 715
            +    D +  GV++ E++CG+    FY+ DH
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 210

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 31/215 (14%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFE---NEVLLI 554
           + ++F     LG G FG V+   LI     G+  A K L K     +++ E   +E L++
Sbjct: 4   SLQDFQILRTLGTGSFGRVH---LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML 60
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTR-----SKFLDWSKRCQII 609
           + + H  ++++ G      +  +I +Y+    L   +    R     +KF          
Sbjct: 61  SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY--------A 112
Query: 610 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV 669
             +   L YLH      II+RDLK  N+LLD   + KI+DFG A+          T  + 
Sbjct: 113 AEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKY-----VPDVTYXLC 164
Query: 670 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           GT  Y+ PE      ++   D +SFG+L+ E++ G
Sbjct: 165 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 504 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQHR 560
           + +     +G G +G V   +    G+++A K+LS+   S    +    E+LL+  +QH 
Sbjct: 24  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83
Query: 561 NLVKLIGCCTQRDERMLIYE-YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
           N++ L+   T        Y+ YL    +   +  +   KF +  K   ++  + +GL Y+
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSE-EKIQYLVYQMLKGLKYI 142
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H      ++HRDLK  N+ ++ +   KI DFG+AR       +A     V T  Y  PE 
Sbjct: 143 HSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEV 194
Query: 680 AIDGL-FSVKSDVFSFGVLVLEIVCGK 705
            +  + ++   D++S G ++ E++ GK
Sbjct: 195 ILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 64/106 (60%), Gaps = 10/106 (9%)
Query: 607 QIIGGIA----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 662
           QI+G ++    +GL YL +  + +I+HRD+K SN+L+++    K+ DFG++    ID+  
Sbjct: 107 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDEM- 162
Query: 663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNR 708
              N  VGT  YM PE      +SV+SD++S G+ ++E+  G+  R
Sbjct: 163 --ANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPR 206

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKS----SGQGMEEFENEVLLIAKLQHRNLVKLIG 567
           LG+G FG V        +E+ A ++ K         +E    E  ++A L     +  + 
Sbjct: 27  LGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLH 86
Query: 568 CCTQRDERM-LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 626
            C Q  +R+  + EY+      D ++ + +       +       I+ GL +LH+     
Sbjct: 87  SCFQTVDRLYFVMEYVNG---GDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRG--- 140
Query: 627 IIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFS 686
           II+RDLK  NV+LD+E + KI+DFGM +   +D     T    GT  Y+ PE      + 
Sbjct: 141 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGV--TTREFCGTPDYIAPEIIAYQPYG 198
Query: 687 VKSDVFSFGVLVLEIVCGK 705
              D +++GVL+ E++ G+
Sbjct: 199 KSVDWWAYGVLLYEMLAGQ 217

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 33/217 (15%)
Query: 504 ENFSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR 560
           + + +   +G G  G V   Y  +L   + +A K+LS+        F+N+    AK  +R
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKRAYR 72
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRCQI 608
            LV L+ C   ++   L+  + P KSL +F        + D    +     LD  +   +
Sbjct: 73  ELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
           +  +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       
Sbjct: 132 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMEPE 185
Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           V T  Y  PE  +   +    D++S G ++ E+VC K
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 21/214 (9%)
Query: 503 TENFSD-KNKLGEGGFGPVYK-GVLIEGQEIAAK----RLSKSSGQGM--EEFENEVLLI 554
            E+F D   +LG G F  V K      G E AAK    R S++S +G+  EE E EV ++
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSIL 69
Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIAR 614
            ++ H N++ L      R + +LI E +    L DF+    + + L   +    I  I  
Sbjct: 70  RQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILD 126
Query: 615 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGIDQTEANTNRVVG 670
           G+ YLH     +I H DLK  N++L ++  P    K+ DFG+A      +       + G
Sbjct: 127 GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFG 180
Query: 671 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           T  ++ PE        +++D++S GV+   ++ G
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 102/218 (46%), Gaps = 15/218 (6%)
Query: 494 FDWMAIANA-TENFSDKNKLGEGGFGPVYKGVL-IEGQEIAAKRLS--KSSGQGMEEFEN 549
           F  MA     T+++    +LG+G F  V + V     QE AAK ++  K S +  ++ E 
Sbjct: 20  FQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLER 79
Query: 550 EVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQII 609
           E  +   L+H N+V+L    ++     L+++ +    L +   D+   ++   +     I
Sbjct: 80  EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFE---DIVAREYYSEADASHCI 136
Query: 610 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN---PKISDFGMARAFGIDQTEANTN 666
             I   + ++HQ     I+HRDLK  N+LL ++      K++DFG+  A  +   +    
Sbjct: 137 HQILESVNHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGL--AIEVQGEQQAWF 191
Query: 667 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
              GT GY+ PE      +    D+++ GV++  ++ G
Sbjct: 192 GFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 37/218 (16%)
Query: 504 ENFSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQ 558
           + + +   +G G  G V   Y  +L   + +A K+LS+   +    +    E++L+  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRC 606
           H+N++ L+   T            P KSL +F        + D   S+     LD  +  
Sbjct: 82  HKNIIGLLNVFT------------PQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS 129
Query: 607 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN 666
            ++  +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T     
Sbjct: 130 YLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMT 183
Query: 667 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
             V T  Y  PE  +   +    D++S GV++ E++ G
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 37/218 (16%)
Query: 504 ENFSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQ 558
           + + +   +G G  G V   Y  +L   + +A K+LS+   +    +    E++L+  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVVAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRC 606
           H+N++ L+   T            P KSL +F        + D   S+     LD  +  
Sbjct: 82  HKNIIGLLNVFT------------PQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS 129
Query: 607 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN 666
            ++  +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T     
Sbjct: 130 YLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMT 183
Query: 667 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
             V T  Y  PE  +   +    D++S GV++ E++ G
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 33/216 (15%)
Query: 504 ENFSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR 560
           + + +   +G G  G V   Y  +L   + +A K+LS+        F+N+    AK  +R
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKRAYR 72
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRCQI 608
            LV L+ C   ++   L+  + P KSL +F        + D   S+     LD  +   +
Sbjct: 73  ELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL 131
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
           +  +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       
Sbjct: 132 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPY 185
Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           V T  Y  PE  +   +    D++S G ++ E++ G
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 62/103 (60%), Gaps = 10/103 (9%)
Query: 607 QIIGGIA----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 662
           QI+G ++    +GL YL +  + +I+HRD+K SN+L+++    K+ DFG++        +
Sbjct: 166 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----ID 219
Query: 663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           +  N  VGT  YM PE      +SV+SD++S G+ ++E+  G+
Sbjct: 220 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 103/220 (46%), Gaps = 16/220 (7%)
Query: 503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLS--KSSGQGMEEFENEVLLIAKLQH 559
           T+ +    +LG+G F  V + + I  GQE AAK ++  K S +  ++ E E  +   L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
            N+V+L    ++     L+++ +    L +   D+   ++   +     I  I   + + 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFE---DIVAREYYSEADASHCIQQILESVNHC 119
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMN---PKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
           H +    I+HRDLK  N+LL ++      K++DFG+A     DQ         GT GY+ 
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLS 174
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH 716
           PE      +    D+++ GV++  ++ G     F+  D H
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVG--YPPFWDEDQH 212

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 33/216 (15%)
Query: 504 ENFSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR 560
           + + +   +G G  G V   Y  +L   + +A K+LS+        F+N+    AK  +R
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKRAYR 72
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRCQI 608
            LV L+ C   ++   L+  + P KSL +F        + D   S+     LD  +   +
Sbjct: 73  ELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL 131
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
           +  +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       
Sbjct: 132 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPY 185
Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           V T  Y  PE  +   +    D++S G ++ E++ G
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 504 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQHR 560
           + +     +G G +G V   +    G+++A K+LS+   S    +    E+LL+  +QH 
Sbjct: 42  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 101
Query: 561 NLVKLIGCCTQRDERMLIYE-YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
           N++ L+   T        Y+ YL    +   +  +   +F +  K   ++  + +GL Y+
Sbjct: 102 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSE-EKIQYLVYQMLKGLKYI 160
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H      ++HRDLK  N+ ++ +   KI DFG+AR       +A     V T  Y  PE 
Sbjct: 161 HSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEV 212
Query: 680 AIDGL-FSVKSDVFSFGVLVLEIVCGK 705
            +  + ++   D++S G ++ E++ GK
Sbjct: 213 ILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 103/220 (46%), Gaps = 16/220 (7%)
Query: 503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLS--KSSGQGMEEFENEVLLIAKLQH 559
           T+ +    +LG+G F  V + + I  GQE AAK ++  K S +  ++ E E  +   L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
            N+V+L    ++     L+++ +    L +   D+   ++   +     I  I   + + 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFE---DIVAREYYSEADASHCIQQILESVNHC 119
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMN---PKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
           H +    I+HRDLK  N+LL ++      K++DFG+A     DQ         GT GY+ 
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLS 174
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH 716
           PE      +    D+++ GV++  ++ G     F+  D H
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVG--YPPFWDEDQH 212

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/114 (33%), Positives = 67/114 (58%), Gaps = 12/114 (10%)
Query: 598 KFLDWSKRC--QIIGGIA----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG 651
           + L  +KR   +I+G ++    RGL YL +  + +I+HRD+K SN+L+++    K+ DFG
Sbjct: 103 QVLKEAKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFG 160
Query: 652 MARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           ++        ++  N  VGT  YM PE      +SV+SD++S G+ ++E+  G+
Sbjct: 161 VSGQL----IDSMANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 62/103 (60%), Gaps = 10/103 (9%)
Query: 607 QIIGGIA----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 662
           QI+G ++    +GL YL +  + +I+HRD+K SN+L+++    K+ DFG++        +
Sbjct: 131 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----ID 184
Query: 663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           +  N  VGT  YM PE      +SV+SD++S G+ ++E+  G+
Sbjct: 185 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 33/217 (15%)
Query: 504 ENFSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR 560
           + + +   +G G  G V   Y  VL   + +A K+LS+        F+N+    AK  +R
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYR 65
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRCQI 608
            LV L+ C   ++   L+  + P K+L +F        + D    +     LD  +   +
Sbjct: 66  ELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYL 124
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
           +  +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       
Sbjct: 125 LYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG---TSFMMTPY 178
Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           V T  Y  PE  +   +    D++S G ++ E+V  K
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 27/212 (12%)
Query: 509 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGC 568
           +  +G+G FG V++G    G+E+A K  S    +     E E+     L+H N++  I  
Sbjct: 9   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAA 66
Query: 569 CTQRD----ERMLIYEYLPNKSLNDFI--FDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
             + +    +  L+ +Y  + SL D++  + VT    +      ++    A GL +LH +
Sbjct: 67  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI------KLALSTASGLAHLHME 120
Query: 623 -----SRLRIIHRDLKASNVLLDNEMNPKISDFGMA--RAFGIDQTEANTNRVVGTYGYM 675
                 +  I HRDLK+ N+L+       I+D G+A       D  +   N  VGT  YM
Sbjct: 121 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 180
Query: 676 PPEYAIDGL----FSV--KSDVFSFGVLVLEI 701
            PE   D +    F    ++D+++ G++  EI
Sbjct: 181 APEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 33/217 (15%)
Query: 504 ENFSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR 560
           + + +   +G G  G V   Y  VL   + +A K+LS+        F+N+    AK  +R
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYR 72
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRCQI 608
            LV L+ C   ++   L+  + P K+L +F        + D    +     LD  +   +
Sbjct: 73  ELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYL 131
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
           +  +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       
Sbjct: 132 LYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG---TSFMMTPY 185
Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           V T  Y  PE  +   +    D++S G ++ E+V  K
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 105/241 (43%), Gaps = 30/241 (12%)
Query: 471 TDGSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQE 530
           T+  SK D N  GNR+  M+L  F+++ +            LG+G FG V         E
Sbjct: 2   TNTVSKFDNN--GNRDR-MKLTDFNFLMV------------LGKGSFGKVMLSERKGTDE 46
Query: 531 IAAKRLSKSSGQGMEEFENEVLLIAKL------QHRNLVKLIGCCTQRDERMLIYEYLPN 584
           + A ++ K     +++ + E  ++ K       +   L +L  C    D    + EY+  
Sbjct: 47  LYAVKILKKDVV-IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG 105
Query: 585 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN 644
             L   I  V R K             IA GL +L       II+RDLK  NV+LD+E +
Sbjct: 106 GDLMYHIQQVGRFK---EPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGH 159
Query: 645 PKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
            KI+DFGM +    D     T    GT  Y+ PE      +    D ++FGVL+ E++ G
Sbjct: 160 IKIADFGMCKENIWDGV--TTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 217
Query: 705 K 705
           +
Sbjct: 218 Q 218

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 62/103 (60%), Gaps = 10/103 (9%)
Query: 607 QIIGGIA----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 662
           QI+G ++    +GL YL +  + +I+HRD+K SN+L+++    K+ DFG++        +
Sbjct: 104 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----ID 157
Query: 663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           +  N  VGT  YM PE      +SV+SD++S G+ ++E+  G+
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 62/103 (60%), Gaps = 10/103 (9%)
Query: 607 QIIGGIA----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 662
           QI+G ++    +GL YL +  + +I+HRD+K SN+L+++    K+ DFG++        +
Sbjct: 123 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----ID 176
Query: 663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           +  N  VGT  YM PE      +SV+SD++S G+ ++E+  G+
Sbjct: 177 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/252 (23%), Positives = 113/252 (44%), Gaps = 30/252 (11%)
Query: 469 GKTDGSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGV---- 524
            +  G+  L +   G    E ELP  DW A     + +  K+ +G G    V + V    
Sbjct: 64  AQPKGTENLYFQSMG---PEDELP--DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRAT 118
Query: 525 ----LIEGQEIAAKRLSKSSGQGMEE-FENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLI 578
                ++  E+ A+RLS    + + E    E  ++ ++  H +++ LI          L+
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178
Query: 579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVL 638
           ++ +    L D++   T    L   +   I+  +   + +LH ++   I+HRDLK  N+L
Sbjct: 179 FDLMRKGELFDYL---TEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENIL 232
Query: 639 LDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY---AIDGL---FSVKSDVF 692
           LD+ M  ++SDFG +      +       + GT GY+ PE    ++D     +  + D++
Sbjct: 233 LDDNMQIRLSDFGFSCHL---EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLW 289
Query: 693 SFGVLVLEIVCG 704
           + GV++  ++ G
Sbjct: 290 ACGVILFTLLAG 301

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 62/103 (60%), Gaps = 10/103 (9%)
Query: 607 QIIGGIA----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 662
           QI+G ++    +GL YL +  + +I+HRD+K SN+L+++    K+ DFG++        +
Sbjct: 104 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----ID 157
Query: 663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           +  N  VGT  YM PE      +SV+SD++S G+ ++E+  G+
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 62/103 (60%), Gaps = 10/103 (9%)
Query: 607 QIIGGIA----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 662
           QI+G ++    +GL YL +  + +I+HRD+K SN+L+++    K+ DFG++        +
Sbjct: 104 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----ID 157
Query: 663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           +  N  VGT  YM PE      +SV+SD++S G+ ++E+  G+
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 27/212 (12%)
Query: 509 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGC 568
           +  +G+G FG V++G    G+E+A K  S    +     E E+     L+H N++  I  
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAA 65
Query: 569 CTQRD----ERMLIYEYLPNKSLNDFI--FDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
             + +    +  L+ +Y  + SL D++  + VT    +      ++    A GL +LH +
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI------KLALSTASGLAHLHME 119
Query: 623 -----SRLRIIHRDLKASNVLLDNEMNPKISDFGMA--RAFGIDQTEANTNRVVGTYGYM 675
                 +  I HRDLK+ N+L+       I+D G+A       D  +   N  VGT  YM
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 676 PPEYAIDGL----FSV--KSDVFSFGVLVLEI 701
            PE   D +    F    ++D+++ G++  EI
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 15/203 (7%)
Query: 506 FSDKNKLGEGGFGPVYKGVLIEGQE-IAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
           F  +++LG G    VY+      Q+  A K L K+  + +   E  VLL  +L H N++K
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLL--RLSHPNIIK 112
Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           L        E  L+ E +    L D I +     +         +  I   + YLH++  
Sbjct: 113 LKEIFETPTEISLVLELVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG- 168
Query: 625 LRIIHRDLKASNVLLDN---EMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
             I+HRDLK  N+L      +   KI+DFG+++   I + +     V GT GY  PE   
Sbjct: 169 --IVHRDLKPENLLYATPAPDAPLKIADFGLSK---IVEHQVLMKTVCGTPGYCAPEILR 223
Query: 682 DGLFSVKSDVFSFGVLVLEIVCG 704
              +  + D++S G++   ++CG
Sbjct: 224 GCAYGPEVDMWSVGIITYILLCG 246

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 62/103 (60%), Gaps = 10/103 (9%)
Query: 607 QIIGGIA----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 662
           QI+G ++    +GL YL +  + +I+HRD+K SN+L+++    K+ DFG++        +
Sbjct: 104 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----ID 157
Query: 663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           +  N  VGT  YM PE      +SV+SD++S G+ ++E+  G+
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 62/103 (60%), Gaps = 10/103 (9%)
Query: 607 QIIGGIA----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 662
           QI+G ++    +GL YL +  + +I+HRD+K SN+L+++    K+ DFG++        +
Sbjct: 104 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----ID 157
Query: 663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           +  N  VGT  YM PE      +SV+SD++S G+ ++E+  G+
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 21/216 (9%)
Query: 502 ATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR 560
             E+  D  ++G G +G V K V    GQ +A KR+  +     E+ + ++L+   +  R
Sbjct: 20  TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD---EKEQKQLLMDLDVVMR 76
Query: 561 N-----LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARG 615
           +     +V+  G   +  +  +  E L + S + F   V     LD     +I+G I   
Sbjct: 77  SSDCPYIVQFYGALFREGDCWICME-LMSTSFDKFYKYVY--SVLDDVIPEEILGKITLA 133
Query: 616 LLYL--HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
            +    H    L+IIHRD+K SN+LLD   N K+ DFG++   G         R  G   
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS---GQLVDSIAKTRDAGCRP 190
Query: 674 YMPPEY----AIDGLFSVKSDVFSFGVLVLEIVCGK 705
           YM PE     A    + V+SDV+S G+ + E+  G+
Sbjct: 191 YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 103/237 (43%), Gaps = 30/237 (12%)
Query: 475 SKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAK 534
           SK D N  GNR+  M+L  F+++ +            LG+G FG V         E+ A 
Sbjct: 327 SKFDNN--GNRDR-MKLTDFNFLMV------------LGKGSFGKVMLSERKGTDELYAV 371
Query: 535 RLSKSSGQGMEEFENEVLLIAKL------QHRNLVKLIGCCTQRDERMLIYEYLPNKSLN 588
           ++ K     +++ + E  ++ K       +   L +L  C    D    + EY+    L 
Sbjct: 372 KILKKDVV-IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLM 430
Query: 589 DFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKIS 648
             I  V R K             IA GL +L       II+RDLK  NV+LD+E + KI+
Sbjct: 431 YHIQQVGRFK---EPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIA 484
Query: 649 DFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           DFGM +    D     T    GT  Y+ PE      +    D ++FGVL+ E++ G+
Sbjct: 485 DFGMCKENIWDGV--TTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 27/213 (12%)
Query: 509 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGC 568
           +  +G+G FG V++G    G+E+A K  S    +     E E+     L+H N++  I  
Sbjct: 14  QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAA 71
Query: 569 CTQRD----ERMLIYEYLPNKSLNDFI--FDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
             + +    +  L+ +Y  + SL D++  + VT    +      ++    A GL +LH +
Sbjct: 72  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI------KLALSTASGLAHLHME 125
Query: 623 -----SRLRIIHRDLKASNVLLDNEMNPKISDFGMA--RAFGIDQTEANTNRVVGTYGYM 675
                 +  I HRDLK+ N+L+       I+D G+A       D  +   N  VGT  YM
Sbjct: 126 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 185
Query: 676 PPEYAIDGL----FSV--KSDVFSFGVLVLEIV 702
            PE   D +    F    ++D+++ G++  EI 
Sbjct: 186 APEVLDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 27/213 (12%)
Query: 509 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGC 568
           +  +G+G FG V++G    G+E+A K  S    +     E E+     L+H N++  I  
Sbjct: 11  QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAA 68
Query: 569 CTQRD----ERMLIYEYLPNKSLNDFI--FDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
             + +    +  L+ +Y  + SL D++  + VT    +      ++    A GL +LH +
Sbjct: 69  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI------KLALSTASGLAHLHME 122
Query: 623 -----SRLRIIHRDLKASNVLLDNEMNPKISDFGMA--RAFGIDQTEANTNRVVGTYGYM 675
                 +  I HRDLK+ N+L+       I+D G+A       D  +   N  VGT  YM
Sbjct: 123 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 182
Query: 676 PPEYAIDGL----FSV--KSDVFSFGVLVLEIV 702
            PE   D +    F    ++D+++ G++  EI 
Sbjct: 183 APEVLDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 27/212 (12%)
Query: 509 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGC 568
           +  +G+G FG V++G    G+E+A K  S    +     E E+     L+H N++  I  
Sbjct: 34  QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAA 91
Query: 569 CTQRD----ERMLIYEYLPNKSLNDFI--FDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
             + +    +  L+ +Y  + SL D++  + VT    +      ++    A GL +LH +
Sbjct: 92  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI------KLALSTASGLAHLHME 145
Query: 623 -----SRLRIIHRDLKASNVLLDNEMNPKISDFGMA--RAFGIDQTEANTNRVVGTYGYM 675
                 +  I HRDLK+ N+L+       I+D G+A       D  +   N  VGT  YM
Sbjct: 146 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 205
Query: 676 PPEYAIDGL----FSV--KSDVFSFGVLVLEI 701
            PE   D +    F    ++D+++ G++  EI
Sbjct: 206 APEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 27/213 (12%)
Query: 509 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGC 568
           +  +G+G FG V++G    G+E+A K  S    +     E E+     L+H N++  I  
Sbjct: 47  QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAA 104
Query: 569 CTQRD----ERMLIYEYLPNKSLNDFI--FDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
             + +    +  L+ +Y  + SL D++  + VT    +      ++    A GL +LH +
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI------KLALSTASGLAHLHME 158
Query: 623 -----SRLRIIHRDLKASNVLLDNEMNPKISDFGMA--RAFGIDQTEANTNRVVGTYGYM 675
                 +  I HRDLK+ N+L+       I+D G+A       D  +   N  VGT  YM
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 676 PPEYAIDGL----FSV--KSDVFSFGVLVLEIV 702
            PE   D +    F    ++D+++ G++  EI 
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 51/90 (56%), Gaps = 3/90 (3%)
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 671
           +A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+AR    D            
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 672 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
             +M PE   D +++++SDV+SFGVL+ EI
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI 288

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 103/224 (45%), Gaps = 41/224 (18%)
Query: 506 FSDKNKLGEGGFGPVYKGVLIEGQEIAAKR---LSKSSGQGMEEFENEVLLIAKLQHRNL 562
           +S   ++G GG   V++ VL E ++I A +   L ++  Q ++ + NE+  + KLQ  + 
Sbjct: 14  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 71
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLD---WSKRCQIIGGIARG---- 615
                     D+ + +Y+Y   +  + +I+ V     +D   W K+ + I    R     
Sbjct: 72  ----------DKIIRLYDY---EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWK 118
Query: 616 --LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
             L  +H   +  I+H DLK +N L+ + M  K+ DFG+A     D T    +  VGT  
Sbjct: 119 NMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVN 177
Query: 674 YMPPEYAIDGLFSVKS------------DVFSFGVLVLEIVCGK 705
           YMPPE AI  + S +             DV+S G ++  +  GK
Sbjct: 178 YMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 220

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 51/90 (56%), Gaps = 3/90 (3%)
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 671
           +A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+AR    D            
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 672 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
             +M PE   D +++++SDV+SFGVL+ EI
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI 293

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 51/90 (56%), Gaps = 3/90 (3%)
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 671
           +A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+AR    D            
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 672 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
             +M PE   D +++++SDV+SFGVL+ EI
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI 286

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 103/224 (45%), Gaps = 41/224 (18%)
Query: 506 FSDKNKLGEGGFGPVYKGVLIEGQEIAAKR---LSKSSGQGMEEFENEVLLIAKLQHRNL 562
           +S   ++G GG   V++ VL E ++I A +   L ++  Q ++ + NE+  + KLQ  + 
Sbjct: 58  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 115
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLD---WSKRCQIIGGIARG---- 615
                     D+ + +Y+Y   +  + +I+ V     +D   W K+ + I    R     
Sbjct: 116 ----------DKIIRLYDY---EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWK 162
Query: 616 --LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
             L  +H   +  I+H DLK +N L+ + M  K+ DFG+A     D T    +  VGT  
Sbjct: 163 NMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVN 221
Query: 674 YMPPEYAIDGLFSVKS------------DVFSFGVLVLEIVCGK 705
           YMPPE AI  + S +             DV+S G ++  +  GK
Sbjct: 222 YMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 104/231 (45%), Gaps = 39/231 (16%)
Query: 506 FSDKNKLGEGGFGPVYKGVL-IEGQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQHRNL 562
           + D   +G G +G V   V    G ++A K+L +   S    +    E+ L+  ++H N+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKFLDWSK----RCQ-II 609
           + L+   T            P+++L+DF               K +   K    R Q ++
Sbjct: 87  IGLLDVFT------------PDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLV 134
Query: 610 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV 669
             + +GL Y+H      IIHRDLK  N+ ++ +   KI DFG+AR     Q ++     V
Sbjct: 135 YQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMXGXV 186
Query: 670 GTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL 719
            T  Y  PE  ++ + ++   D++S G ++ E++ GK    F  +DH   L
Sbjct: 187 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL--FKGSDHLDQL 235

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 51/90 (56%), Gaps = 3/90 (3%)
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 671
           +A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+AR    D            
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 672 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
             +M PE   D +++++SDV+SFGVL+ EI
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI 295

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFE---NEVLLIAKLQH 559
           + F     LG G FG V     +E G   A K L K     ++E E   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
             LVKL           ++ EY P   +   +  + R  F +   R      I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR--FSEPHARF-YAAQIVLTFEYL 157
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H    L +I+RDLK  N+++D +   K++DFG+A+     + +  T  + GT  Y+ PE 
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCG 704
            +   ++   D ++ GVL+ E+  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 103/224 (45%), Gaps = 41/224 (18%)
Query: 506 FSDKNKLGEGGFGPVYKGVLIEGQEIAAKR---LSKSSGQGMEEFENEVLLIAKLQHRNL 562
           +S   ++G GG   V++ VL E ++I A +   L ++  Q ++ + NE+  + KLQ  + 
Sbjct: 30  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 87
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLD---WSKRCQIIGGIARG---- 615
                     D+ + +Y+Y   +  + +I+ V     +D   W K+ + I    R     
Sbjct: 88  ----------DKIIRLYDY---EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWK 134
Query: 616 --LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
             L  +H   +  I+H DLK +N L+ + M  K+ DFG+A     D T    +  VGT  
Sbjct: 135 NMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVN 193
Query: 674 YMPPEYAIDGLFSVKS------------DVFSFGVLVLEIVCGK 705
           YMPPE AI  + S +             DV+S G ++  +  GK
Sbjct: 194 YMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 103/224 (45%), Gaps = 41/224 (18%)
Query: 506 FSDKNKLGEGGFGPVYKGVLIEGQEIAAKR---LSKSSGQGMEEFENEVLLIAKLQHRNL 562
           +S   ++G GG   V++ VL E ++I A +   L ++  Q ++ + NE+  + KLQ  + 
Sbjct: 10  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 67
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLD---WSKRCQIIGGIARG---- 615
                     D+ + +Y+Y   +  + +I+ V     +D   W K+ + I    R     
Sbjct: 68  ----------DKIIRLYDY---EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWK 114
Query: 616 --LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
             L  +H   +  I+H DLK +N L+ + M  K+ DFG+A     D T    +  VGT  
Sbjct: 115 NMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVN 173
Query: 674 YMPPEYAIDGLFSVKS------------DVFSFGVLVLEIVCGK 705
           YMPPE AI  + S +             DV+S G ++  +  GK
Sbjct: 174 YMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 216

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 103/224 (45%), Gaps = 41/224 (18%)
Query: 506 FSDKNKLGEGGFGPVYKGVLIEGQEIAAKR---LSKSSGQGMEEFENEVLLIAKLQHRNL 562
           +S   ++G GG   V++ VL E ++I A +   L ++  Q ++ + NE+  + KLQ  + 
Sbjct: 11  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 68
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLD---WSKRCQIIGGIARG---- 615
                     D+ + +Y+Y   +  + +I+ V     +D   W K+ + I    R     
Sbjct: 69  ----------DKIIRLYDY---EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWK 115
Query: 616 --LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
             L  +H   +  I+H DLK +N L+ + M  K+ DFG+A     D T    +  VGT  
Sbjct: 116 NMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVN 174
Query: 674 YMPPEYAIDGLFSVKS------------DVFSFGVLVLEIVCGK 705
           YMPPE AI  + S +             DV+S G ++  +  GK
Sbjct: 175 YMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 103/224 (45%), Gaps = 41/224 (18%)
Query: 506 FSDKNKLGEGGFGPVYKGVLIEGQEIAAKR---LSKSSGQGMEEFENEVLLIAKLQHRNL 562
           +S   ++G GG   V++ VL E ++I A +   L ++  Q ++ + NE+  + KLQ  + 
Sbjct: 58  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 115
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLD---WSKRCQIIGGIARG---- 615
                     D+ + +Y+Y   +  + +I+ V     +D   W K+ + I    R     
Sbjct: 116 ----------DKIIRLYDY---EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWK 162
Query: 616 --LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
             L  +H   +  I+H DLK +N L+ + M  K+ DFG+A     D T    +  VGT  
Sbjct: 163 NMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVN 221
Query: 674 YMPPEYAIDGLFSVKS------------DVFSFGVLVLEIVCGK 705
           YMPPE AI  + S +             DV+S G ++  +  GK
Sbjct: 222 YMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 109/223 (48%), Gaps = 28/223 (12%)
Query: 512 LGEGGFGPVYKG-VLIEGQEIAAKRLSKSSGQGMEEFEN------EVLLIAKLQ----HR 560
           LG+GGFG V+ G  L +  ++A K + ++   G     +      EV L+ K+     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 561 NLVKLIGCCTQRDERMLIYEY-LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
            +++L+     ++  ML+ E  LP + L D+I +  +    +   RC   G +   + + 
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE--KGPLGEGPSRC-FFGQVVAAIQHC 155
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMN-PKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           H      ++HRD+K  N+L+D      K+ DFG + A   D+   + +   GT  Y PPE
Sbjct: 156 HSRG---VVHRDIKDENILIDLRRGCAKLIDFG-SGALLHDEPYTDFD---GTRVYSPPE 208
Query: 679 YAIDGLF-SVKSDVFSFGVLVLEIVCG----KRNRGFYHADHH 716
           +     + ++ + V+S G+L+ ++VCG    +R++    A+ H
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELH 251

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 33/216 (15%)
Query: 504 ENFSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR 560
           + + +   +G G  G V   Y  +L   + +A K+LS+        F+N+    AK  +R
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKRAYR 72
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRCQI 608
            LV L+ C   ++   L+  + P KSL +F        + D    +     LD  +   +
Sbjct: 73  ELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
           +  +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   +   T  V
Sbjct: 132 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPEV 186
Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           V  Y Y  PE  +   +    D++S G ++ E++ G
Sbjct: 187 VTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 504 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL 562
           +++    +LG G FG V++      G   AAK +        E    E+  ++ L+H  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
           V L       +E ++IYE++    L + + D       D  +  + +  + +GL ++H++
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMHEN 274
Query: 623 SRLRIIHRDLKASNVLL----DNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           +    +H DLK  N++      NE+  K+ DFG+       Q+   T    GT  +  PE
Sbjct: 275 N---YVHLDLKPENIMFTTKRSNEL--KLIDFGLTAHLDPKQSVKVT---TGTAEFAAPE 326
Query: 679 YAIDGLFSVKSDVFSFGVLVLEIVCG 704
            A        +D++S GVL   ++ G
Sbjct: 327 VAEGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 504 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL 562
           +++    +LG G FG V++      G   AAK +        E    E+  ++ L+H  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
           V L       +E ++IYE++    L + + D       D  +  + +  + +GL ++H++
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMHEN 168
Query: 623 SRLRIIHRDLKASNVLL----DNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           +    +H DLK  N++      NE+  K+ DFG+       Q+   T    GT  +  PE
Sbjct: 169 N---YVHLDLKPENIMFTTKRSNEL--KLIDFGLTAHLDPKQSVKVT---TGTAEFAAPE 220
Query: 679 YAIDGLFSVKSDVFSFGVLVLEIVCG 704
            A        +D++S GVL   ++ G
Sbjct: 221 VAEGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 33/217 (15%)
Query: 504 ENFSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR 560
           + + +   +G G  G V   Y  VL   + +A K+LS+        F+N+    AK  +R
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYR 73
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRCQI 608
            LV L+ C   ++   L+  + P K+L +F        + D    +     LD  +   +
Sbjct: 74  ELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 132
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
           +  +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       
Sbjct: 133 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPY 186
Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           V T  Y  PE  +   +    D++S G ++ E+V  K
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 33/214 (15%)
Query: 504 ENFSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR 560
           + + +   +G G  G V   Y  VL   + +A K+LS+        F+N+    AK  +R
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYR 110
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRCQI 608
            LV L+ C   ++   L+  + P K+L +F        + D    +     LD  +   +
Sbjct: 111 ELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 169
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
           +  +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       
Sbjct: 170 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPY 223
Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
           V T  Y  PE  +   +    D++S G ++ E+V
Sbjct: 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 33/216 (15%)
Query: 504 ENFSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR 560
           + + +   +G G  G V   Y  +L   + +A K+LS+        F+N+    AK  +R
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKRAYR 73
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRCQI 608
            LV L+ C   ++   L+  + P KSL +F        + D    +     LD  +   +
Sbjct: 74  ELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 132
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
           +  +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       
Sbjct: 133 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPY 186
Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           V T  Y  PE  +   +    D++S G ++ E++ G
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 33/217 (15%)
Query: 504 ENFSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR 560
           + + +   +G G  G V   Y  VL   + +A K+LS+        F+N+    AK  +R
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYR 72
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRCQI 608
            LV L+ C   ++   L+  + P K+L +F        + D    +     LD  +   +
Sbjct: 73  ELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 131
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
           +  +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       
Sbjct: 132 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPY 185
Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           V T  Y  PE  +   +    D++S G ++ E+V  K
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 33/217 (15%)
Query: 504 ENFSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR 560
           + + +   +G G  G V   Y  VL   + +A K+LS+        F+N+    AK  +R
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYR 72
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRCQI 608
            LV L+ C   ++   L+  + P K+L +F        + D    +     LD  +   +
Sbjct: 73  ELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 131
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
           +  +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       
Sbjct: 132 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPY 185
Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           V T  Y  PE  +   +    D++S G ++ E+V  K
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 33/216 (15%)
Query: 504 ENFSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR 560
           + + +   +G G  G V   Y  +L   + +A K+LS+        F+N+    AK  +R
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKRAYR 72
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRCQI 608
            LV L+ C   ++   L+  + P KSL +F        + D    +     LD  +   +
Sbjct: 73  ELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
           +  +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       
Sbjct: 132 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPY 185
Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           V T  Y  PE  +   +    D++S G ++ E++ G
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 33/217 (15%)
Query: 504 ENFSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR 560
           + + +   +G G  G V   Y  VL   + +A K+LS+        F+N+    AK  +R
Sbjct: 23  KRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYR 71
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRCQI 608
            LV L+ C   ++   L+  + P K+L +F        + D    +     LD  +   +
Sbjct: 72  ELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 130
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
           +  +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       
Sbjct: 131 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPY 184
Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           V T  Y  PE  +   +    D++S G ++ E+V  K
Sbjct: 185 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 33/217 (15%)
Query: 504 ENFSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR 560
           + + +   +G G  G V   Y  VL   + +A K+LS+        F+N+    AK  +R
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYR 66
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRCQI 608
            LV L+ C   ++   L+  + P K+L +F        + D    +     LD  +   +
Sbjct: 67  ELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 125
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
           +  +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       
Sbjct: 126 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPY 179
Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           V T  Y  PE  +   +    D++S G ++ E+V  K
Sbjct: 180 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 33/217 (15%)
Query: 504 ENFSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR 560
           + + +   +G G  G V   Y  VL   + +A K+LS+        F+N+    AK  +R
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYR 66
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRCQI 608
            LV L+ C   ++   L+  + P K+L +F        + D    +     LD  +   +
Sbjct: 67  ELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 125
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
           +  +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       
Sbjct: 126 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPY 179
Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           V T  Y  PE  +   +    D++S G ++ E+V  K
Sbjct: 180 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 33/216 (15%)
Query: 504 ENFSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR 560
           + + +   +G G  G V   Y  +L   + +A K+LS+        F+N+    AK  +R
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKRAYR 72
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRCQI 608
            LV L+ C   ++   L+  + P KSL +F        + D    +     LD  +   +
Sbjct: 73  ELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
           +  +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       
Sbjct: 132 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPY 185
Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           V T  Y  PE  +   +    D++S G ++ E++ G
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 33/217 (15%)
Query: 504 ENFSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR 560
           + + +   +G G  G V   Y  VL   + +A K+LS+        F+N+    AK  +R
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYR 73
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRCQI 608
            LV L+ C   ++   L+  + P K+L +F        + D    +     LD  +   +
Sbjct: 74  ELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 132
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
           +  +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       
Sbjct: 133 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPY 186
Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           V T  Y  PE  +   +    D++S G ++ E+V  K
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 33/217 (15%)
Query: 504 ENFSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR 560
           + + +   +G G  G V   Y  VL   + +A K+LS+        F+N+    AK  +R
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYR 65
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRCQI 608
            LV L+ C   ++   L+  + P K+L +F        + D    +     LD  +   +
Sbjct: 66  ELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 124
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
           +  +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       
Sbjct: 125 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPY 178
Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           V T  Y  PE  +   +    D++S G ++ E+V  K
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 37/218 (16%)
Query: 504 ENFSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQ 558
           + + +   +G G  G V   Y  +L   + +A K+LS+   +    +    E++L+  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRC 606
           H+N++ L+   T            P KSL +F        + D   S+     LD  +  
Sbjct: 82  HKNIIGLLNVFT------------PQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS 129
Query: 607 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN 666
            ++  +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T     
Sbjct: 130 YLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMT 183
Query: 667 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
             V T  Y  PE  +   +    D++S G ++ E++ G
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 33/217 (15%)
Query: 504 ENFSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR 560
           + + +   +G G  G V   Y  VL   + +A K+LS+        F+N+    AK  +R
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYR 110
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRCQI 608
            LV L+ C   ++   L+  + P K+L +F        + D    +     LD  +   +
Sbjct: 111 ELV-LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 169
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
           +  +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       
Sbjct: 170 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPY 223
Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           V T  Y  PE  +   +    D++S G ++ E+V  K
Sbjct: 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFE---NEVLLIAKLQH 559
           + F     LG G FG V     +E G   A K L K     +++ E   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
             LVKL           ++ EY+P   +   +  + R  F +   R      I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYL 157
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+ PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCG 704
            +   ++   D ++ GVL+ E+  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFE---NEVLLIAKLQH 559
           + F     LG G FG V     +E G   A K L K     +++ E   NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
             LVKL           ++ EY+P   +   +  + R  F +   R      I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYL 158
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+ PE 
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCG 704
            +   ++   D ++ GVL+ E+  G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 29/214 (13%)
Query: 504 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL 562
           + +     +G G  G V      + G  +A K+LS+        F+N+    AK  +R L
Sbjct: 24  KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP-------FQNQTH--AKRAYREL 74
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRCQIIG 610
           V L+ C   ++   L+  + P K+L +F        + D    +     LD  +   ++ 
Sbjct: 75  V-LLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLY 133
Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVG 670
            +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR      T       V 
Sbjct: 134 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAC---TNFMMTPYVV 187
Query: 671 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           T  Y  PE  +   ++   D++S G ++ E+V G
Sbjct: 188 TRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFE---NEVLLIAKLQH 559
           + F     LG G FG V     +E G   A K L K     +++ E   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
             LVKL           ++ EY+P   +   +  + R  F +   R      I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYL 157
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+ PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCG 704
            +   ++   D ++ GVL+ E+  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFE---NEVLLIAKLQH 559
           + F     +G G FG V     +E G   A K L K     +++ E   NE  ++  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
             LVKL           ++ EY+P   +   +  + R  F +   R      I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGR--FSEPHARF-YAAQIVLTFEYL 157
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H    L +I+RDLK  N+L+D +   K++DFG A+     + +  T  + GT  Y+ PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCG 704
            +   ++   D ++ GVL+ E+  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFE---NEVLLIAKLQH 559
           + F     +G G FG V     +E G   A K L K     +++ E   NE  ++  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
             LVKL           ++ EY+P   +   +  + R  F +   R      I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGR--FSEPHARF-YAAQIVLTFEYL 157
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H    L +I+RDLK  N+L+D +   K++DFG A+     + +  T  + GT  Y+ PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCG 704
            +   ++   D ++ GVL+ E+  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 37/219 (16%)
Query: 504 ENFSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQ 558
           + + +   +G G  G V   Y  VL   + +A K+LS+   +    +    E++L+  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVN 81
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRC 606
           H+N++ L+   T            P K+L +F        + D    +     LD  +  
Sbjct: 82  HKNIISLLNVFT------------PQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS 129
Query: 607 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN 666
            ++  +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T     
Sbjct: 130 YLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG---TSFMMT 183
Query: 667 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
             V T  Y  PE  +   +    D++S G ++ E+V  K
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 89/205 (43%), Gaps = 15/205 (7%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFE---NEVLLIAKLQH 559
           + F     LG G FG V     +E G   A K L K     +++ E   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
             LVKL           ++ EY P   +   +  + R  F +   R      I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYL 157
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H    L +I+RDLK  N+++D +   K++DFG A+     + +  T  + GT  Y+ PE 
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCG 704
            +   ++   D ++ GVL+ E+  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFE---NEVLLIAKLQH 559
           + F     +G G FG V     +E G   A K L K     +++ E   NE  ++  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
             LVKL           ++ EY+P   +   +  + R  F +   R      I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHARF-YAAQIVLTFEYL 157
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H    L +I+RDLK  N+L+D +   K++DFG A+     + +  T  + GT  Y+ PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCG 704
            +   ++   D ++ GVL+ E+  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFE---NEVLLIAKLQH 559
           + F     LG G FG V     +E G   A K L K     ++E E   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
             LVKL           ++ EY P   +   +  + R  F +   R      I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR--FSEPHARF-YAAQIVLTFEYL 157
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H    L +I+RDLK  N+++D +   +++DFG+A+     + +  T  + GT  Y+ PE 
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCG 704
            +   ++   D ++ GVL+ E+  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 37/218 (16%)
Query: 504 ENFSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQ 558
           + + +   +G G  G V   Y  +L   + +A K+LS+   +    +    E++L+  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVN 81
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRC 606
           H+N++ L+   T            P KSL +F        + D   S+     LD  +  
Sbjct: 82  HKNIIGLLNVFT------------PQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS 129
Query: 607 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN 666
            ++  +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T     
Sbjct: 130 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMT 183
Query: 667 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
             V T  Y  PE  +   +    D++S G ++ E++ G
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 512 LGEGGFGPVYKGVLIEGQEIAAKRLSKSSG-------QGMEEFENEVLLIAKLQHRNLVK 564
           LGEG +G V +  +++ + +  + +             G    + E+ L+ +L+H+N+++
Sbjct: 13  LGEGSYGKVKE--VLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 565 LIGCC--TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR---CQIIGGIARGLLYL 619
           L+      ++ +  ++ EY     + + +  V   +F         CQ+I G    L YL
Sbjct: 71  LVDVLYNEEKQKMYMVMEYC-VCGMQEMLDSVPEKRFPVCQAHGYFCQLIDG----LEYL 125
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H      I+H+D+K  N+LL      KIS  G+A A      +       G+  + PPE 
Sbjct: 126 HSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182
Query: 680 A--IDGLFSVKSDVFSFGVLVLEIVCG 704
           A  +D     K D++S GV +  I  G
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 70/147 (47%), Gaps = 8/147 (5%)
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           H  LV L  C         + EY+      D +F + R + L           I+  L Y
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNG---GDLMFHMQRQRKLPEEHARFYSAEISLALNY 168
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           LH+     II+RDLK  NVLLD+E + K++D+GM +  G+   +  T+   GT  Y+ PE
Sbjct: 169 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDT-TSTFCGTPNYIAPE 223
Query: 679 YAIDGLFSVKSDVFSFGVLVLEIVCGK 705
                 +    D ++ GVL+ E++ G+
Sbjct: 224 ILRGEDYGFSVDWWALGVLMFEMMAGR 250

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 15/203 (7%)
Query: 512 LGEGGFGPVYKGVLIE-GQEIAAK-----RLSKSSGQGMEEFENEVLLIAKLQHRNLVKL 565
           +G+G F  V + +  E GQ+ A K     + + S G   E+ + E  +   L+H ++V+L
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFL-DWSKRCQIIGGIARGLLYLHQDSR 624
           +   +      +++E++    L   I     + F+   +     +  I   L Y H ++ 
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN- 150
Query: 625 LRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
             IIHRD+K  NVLL ++ N    K+ DFG+A   G     A     VGT  +M PE   
Sbjct: 151 --IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGR--VGTPHFMAPEVVK 206
Query: 682 DGLFSVKSDVFSFGVLVLEIVCG 704
              +    DV+  GV++  ++ G
Sbjct: 207 REPYGKPVDVWGCGVILFILLSG 229

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 33/216 (15%)
Query: 504 ENFSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR 560
           + + +   +G G  G V   Y  +L   + +A K+LS+        F+N+    AK  +R
Sbjct: 26  KRYQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRP-------FQNQTH--AKRAYR 74
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRCQI 608
            LV L+ C   ++   L+  + P KSL +F        + D    +     LD  +   +
Sbjct: 75  ELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 133
Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
           +  +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       
Sbjct: 134 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMVPF 187
Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           V T  Y  PE  +   +    D++S G ++ E++ G
Sbjct: 188 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 35/218 (16%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
           +++D   +G G FG VY+  L +  E+ A    K   QG      E+ ++ KL H N+V+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVA---IKKVLQGKAFKNRELQIMRKLDHCNIVR 77
Query: 565 L----IGCCTQRDERM--LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA----- 613
           L         ++DE    L+ +Y+P     + ++ V R     +S+  Q +  I      
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVAR----HYSRAKQTLPVIYVKLYM 128
Query: 614 ----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQTEANTNRV 668
               R L Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + E N + +
Sbjct: 129 YQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVSYI 183
Query: 669 VGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
              Y Y  PE       ++   DV+S G ++ E++ G+
Sbjct: 184 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 35/218 (16%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
           +++D   +G G FG VY+  L +  E+ A    K   QG      E+ ++ KL H N+V+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVA---IKKVLQGKAFKNRELQIMRKLDHCNIVR 77
Query: 565 L----IGCCTQRDERM--LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA----- 613
           L         ++DE    L+ +Y+P     + ++ V R     +S+  Q +  I      
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVAR----HYSRAKQTLPVIYVKLYM 128
Query: 614 ----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQTEANTNRV 668
               R L Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + E N + +
Sbjct: 129 YQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVSYI 183
Query: 669 VGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
              Y Y  PE       ++   DV+S G ++ E++ G+
Sbjct: 184 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFE---NEVLLIAKLQH 559
           + F     LG G FG V     +E G   A K L K     +++ E   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
             LVKL           ++ EY+P   +   +  + R  F +   R      I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHARF-YAAQIVLTFEYL 157
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+ PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCG 704
            +   ++   D ++ GVL+ E+  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFE---NEVLLIAKLQH 559
           + F     LG G FG V     +E G   A K L K     +++ E   NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
             LVKL           ++ EY+P   +   +  + R  F +   R      I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHARF-YAAQIVLTFEYL 158
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+ PE 
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCG 704
            +   ++   D ++ GVL+ E+  G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFE---NEVLLIAKLQH 559
           + F     LG G FG V     +E G   A K L K     +++ E   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
             LVKL           ++ EY+P   +   +  + R  F +   R      I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHARF-YAAQIVLTFEYL 157
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+ PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCG 704
            +   ++   D ++ GVL+ E+  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFE---NEVLLIAKLQH 559
           + F     LG G FG V     +E G   A K L K     +++ E   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
             LVKL           ++ EY+P   +   +  + R  F +   R      I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHARF-YAAQIVLTFEYL 157
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+ PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCG 704
            +   ++   D ++ GVL+ E+  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFE---NEVLLIAKLQH 559
           + F     LG G FG V     +E G   A K L K     +++ E   NE  ++  +  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
             LVKL           ++ EY+P   +   +  + R  F +   R      I     YL
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHARF-YAAQIVLTFEYL 143
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+ PE 
Sbjct: 144 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEYLAPEI 195
Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCG 704
            +   ++   D ++ GVL+ E+  G
Sbjct: 196 ILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 35/218 (16%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
           +++D   +G G FG VY+  L +  E+ A    K   QG      E+ ++ KL H N+V+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVA---IKKVLQGKAFKNRELQIMRKLDHCNIVR 77
Query: 565 L----IGCCTQRDERM--LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA----- 613
           L         ++DE    L+ +Y+P       ++ V R     +S+  Q +  I      
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPAT-----VYRVAR----HYSRAKQTLPVIYVKLYM 128
Query: 614 ----RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQTEANTNRV 668
               R L Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + E N + +
Sbjct: 129 YQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVSXI 183
Query: 669 VGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
              Y Y  PE       ++   DV+S G ++ E++ G+
Sbjct: 184 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 29/204 (14%)
Query: 511 KLGEGGFGPVYKGVLIEGQ------EIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
           ++G G F  VYKG+  E        E+  ++L+KS  Q    F+ E   +  LQH N+V+
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ---RFKEEAEXLKGLQHPNIVR 89
Query: 565 LIGC--CTQRDER--MLIYEYLPNKSLNDFI--FDVTRSKFL-DWSKRCQIIGGIARGLL 617
                  T + ++  +L+ E   + +L  ++  F V + K L  W ++      I +GL 
Sbjct: 90  FYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQ------ILKGLQ 143
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
           +LH  +   IIHRDLK  N+ +       KI D G+A      +  +    V+GT  +  
Sbjct: 144 FLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFXA 198
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLE 700
           PE   +  +    DV++FG   LE
Sbjct: 199 PE-XYEEKYDESVDVYAFGXCXLE 221

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 39/220 (17%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN-EVLLIAKLQHRNL 562
           +++D   +G G FG VY+  L + G+ +A K++ +      + F+N E+ ++ KL H N+
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 109
Query: 563 VKL----IGCCTQRDERM--LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA--- 613
           V+L         ++DE    L+ +Y+P     + ++ V R     +S+  Q +  I    
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVAR----HYSRAKQTLPVIYVKL 160
Query: 614 ------RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQTEANTN 666
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + E N +
Sbjct: 161 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVS 215
Query: 667 RVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
            +   Y Y  PE       ++   DV+S G ++ E++ G+
Sbjct: 216 XICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 106/232 (45%), Gaps = 41/232 (17%)
Query: 494 FDWMAIANAT----ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFE 548
           F  + +A++T    + +     +G G  G V      + G  +A K+LS+        F+
Sbjct: 8   FYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP-------FQ 60
Query: 549 NEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKF- 599
           N+    AK  +R LV L+ C   ++   L+  + P K+L +F        + D    +  
Sbjct: 61  NQTH--AKRAYRELV-LLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI 117
Query: 600 ---LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 656
              LD  +   ++  +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  
Sbjct: 118 HMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART- 173
Query: 657 GIDQTEANTNRVVGTYG----YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
                 A+TN ++  Y     Y  PE  +   +    D++S G ++ E+V G
Sbjct: 174 ------ASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 70/147 (47%), Gaps = 8/147 (5%)
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           H  LV L  C         + EY+      D +F + R + L           I+  L Y
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNG---GDLMFHMQRQRKLPEEHARFYSAEISLALNY 136
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           LH+     II+RDLK  NVLLD+E + K++D+GM +  G+   +  T+   GT  Y+ PE
Sbjct: 137 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDT-TSXFCGTPNYIAPE 191
Query: 679 YAIDGLFSVKSDVFSFGVLVLEIVCGK 705
                 +    D ++ GVL+ E++ G+
Sbjct: 192 ILRGEDYGFSVDWWALGVLMFEMMAGR 218

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 24/219 (10%)
Query: 496 WMAIANAT---ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFE 548
           W + A  T   + F     LG G FG V   +L++    G   A K L K     +++ E
Sbjct: 23  WESPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIE 79
Query: 549 ---NEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR 605
              NE  ++  +    LVKL           ++ EY+P   +   +  + R  F +   R
Sbjct: 80  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FXEPHAR 137
Query: 606 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT 665
                 I     YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T
Sbjct: 138 F-YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 188
Query: 666 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
             + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 189 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFE---NEVLLIAKLQH 559
           + F     LG G FG V     +E G   A K L K     +++ E   NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
             LVKL           ++ EY+P   +   +  + R  F +   R      I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHARF-YAAQIVLTFEYL 158
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+ PE 
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEYLAPEI 210
Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCG 704
            +   ++   D ++ GVL+ E+  G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 117/271 (43%), Gaps = 39/271 (14%)
Query: 499 IANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFEN--EVLLIAK 556
           + N + +F  K+ LGEG +G V         EI A +  +   + +       E+ ++  
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKH 65
Query: 557 LQHRNLVKLIGCCTQRDERMLIYE--YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIAR 614
            +H N++ +     QR +    +   Y+  + +   +  V  ++ L        I    R
Sbjct: 66  FKHENIITIFNI--QRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLR 123
Query: 615 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN-------- 666
            +  LH  +   +IHRDLK SN+L+++  + K+ DFG+AR   ID++ A+ +        
Sbjct: 124 AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPTGQQSG 178
Query: 667 --RVVGTYGYMPPEYAI-DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 723
               V T  Y  PE  +    +S   DV+S G ++ E+    R   F   D+ H LL   
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL--RRPIFPGRDYRHQLL--- 233
Query: 724 WRLWIEERPVELINKSLGGSYSLSEVLRCIQ 754
                      LI   +G  +S ++ LRCI+
Sbjct: 234 -----------LIFGIIGTPHSDND-LRCIE 252

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 70/147 (47%), Gaps = 8/147 (5%)
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           H  LV L  C         + EY+      D +F + R + L           I+  L Y
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNG---GDLMFHMQRQRKLPEEHARFYSAEISLALNY 121
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           LH+     II+RDLK  NVLLD+E + K++D+GM +  G+   +  T+   GT  Y+ PE
Sbjct: 122 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDT-TSXFCGTPNYIAPE 176
Query: 679 YAIDGLFSVKSDVFSFGVLVLEIVCGK 705
                 +    D ++ GVL+ E++ G+
Sbjct: 177 ILRGEDYGFSVDWWALGVLMFEMMAGR 203

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 89/205 (43%), Gaps = 15/205 (7%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFE---NEVLLIAKLQH 559
           + F     LG G FG V     +E G   A K L K     +++ E   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
             LVKL           ++ EY P   +   +  + R  F +   R      I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR--FSEPHARF-YAAQIVLTFEYL 157
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H    L +I+RDLK  N+++D +   K++DFG A+     + +  T  + GT  Y+ PE 
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCG 704
            +   ++   D ++ GVL+ E+  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 117/271 (43%), Gaps = 39/271 (14%)
Query: 499 IANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFEN--EVLLIAK 556
           + N + +F  K+ LGEG +G V         EI A +  +   + +       E+ ++  
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKH 65
Query: 557 LQHRNLVKLIGCCTQRDERMLIYE--YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIAR 614
            +H N++ +     QR +    +   Y+  + +   +  V  ++ L        I    R
Sbjct: 66  FKHENIITIFNI--QRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLR 123
Query: 615 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN-------- 666
            +  LH  +   +IHRDLK SN+L+++  + K+ DFG+AR   ID++ A+ +        
Sbjct: 124 AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPTGQQSG 178
Query: 667 --RVVGTYGYMPPEYAI-DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 723
               V T  Y  PE  +    +S   DV+S G ++ E+    R   F   D+ H LL   
Sbjct: 179 MTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL--RRPIFPGRDYRHQLL--- 233
Query: 724 WRLWIEERPVELINKSLGGSYSLSEVLRCIQ 754
                      LI   +G  +S ++ LRCI+
Sbjct: 234 -----------LIFGIIGTPHSDND-LRCIE 252

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 116/286 (40%), Gaps = 69/286 (24%)
Query: 512 LGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFEN------EVLLIAKLQ--HRNL 562
           LG GGFG VY G+ + +   +A K + K       E  N      EV+L+ K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 563 VKLIGCCTQRDERMLIYEYL-PNKSLNDFIF-------DVTRSKF---LDWSKRCQIIGG 611
           ++L+    + D  +LI E   P + L DFI        ++ RS F   L+  + C   G 
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG- 163
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVG 670
                          ++HRD+K  N+L+D N    K+ DFG   A   D    + +   G
Sbjct: 164 ---------------VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---G 204
Query: 671 TYGYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 729
           T  Y PPE+     +  +S  V+S G+L+ ++VCG                         
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG------------------------- 239
Query: 730 ERPVELINKSLGGSYSLSEVL--RCIQVGLLCVQQRPEDRPNMSSV 773
           + P E   + +GG     + +   C  +   C+  RP DRP    +
Sbjct: 240 DIPFEHDEEIIGGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEI 285

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 116/286 (40%), Gaps = 69/286 (24%)
Query: 512 LGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFEN------EVLLIAKLQ--HRNL 562
           LG GGFG VY G+ + +   +A K + K       E  N      EV+L+ K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 563 VKLIGCCTQRDERMLIYEYL-PNKSLNDFIF-------DVTRSKF---LDWSKRCQIIGG 611
           ++L+    + D  +LI E   P + L DFI        ++ RS F   L+  + C   G 
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG- 162
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVG 670
                          ++HRD+K  N+L+D N    K+ DFG   A   D    + +   G
Sbjct: 163 ---------------VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---G 203
Query: 671 TYGYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 729
           T  Y PPE+     +  +S  V+S G+L+ ++VCG                         
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG------------------------- 238
Query: 730 ERPVELINKSLGGSYSLSEVL--RCIQVGLLCVQQRPEDRPNMSSV 773
           + P E   + +GG     + +   C  +   C+  RP DRP    +
Sbjct: 239 DIPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 284

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 70/147 (47%), Gaps = 8/147 (5%)
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           H  LV L  C         + EY+      D +F + R + L           I+  L Y
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNG---GDLMFHMQRQRKLPEEHARFYSAEISLALNY 125
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           LH+     II+RDLK  NVLLD+E + K++D+GM +  G+   +  T+   GT  Y+ PE
Sbjct: 126 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDT-TSXFCGTPNYIAPE 180
Query: 679 YAIDGLFSVKSDVFSFGVLVLEIVCGK 705
                 +    D ++ GVL+ E++ G+
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMAGR 207

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 39/220 (17%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN-EVLLIAKLQHRNL 562
           +++D   +G G FG VY+  L + G+ +A K++ +      + F+N E+ ++ KL H N+
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 154
Query: 563 VKL----IGCCTQRDERM--LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA--- 613
           V+L         ++DE    L+ +Y+P     + ++ V R     +S+  Q +  I    
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVAR----HYSRAKQTLPVIYVKL 205
Query: 614 ------RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQTEANTN 666
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + E N +
Sbjct: 206 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVS 260
Query: 667 RVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
            +   Y Y  PE       ++   DV+S G ++ E++ G+
Sbjct: 261 YICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 117/271 (43%), Gaps = 39/271 (14%)
Query: 499 IANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFEN--EVLLIAK 556
           + N + +F  K+ LGEG +G V         EI A +  +   + +       E+ ++  
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKH 65
Query: 557 LQHRNLVKLIGCCTQRDERMLIYE--YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIAR 614
            +H N++ +     QR +    +   Y+  + +   +  V  ++ L        I    R
Sbjct: 66  FKHENIITIFNI--QRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLR 123
Query: 615 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN-------- 666
            +  LH  +   +IHRDLK SN+L+++  + K+ DFG+AR   ID++ A+ +        
Sbjct: 124 AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPTGQQSG 178
Query: 667 --RVVGTYGYMPPEYAI-DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 723
               V T  Y  PE  +    +S   DV+S G ++ E+    R   F   D+ H LL   
Sbjct: 179 MTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL--RRPIFPGRDYRHQLL--- 233
Query: 724 WRLWIEERPVELINKSLGGSYSLSEVLRCIQ 754
                      LI   +G  +S ++ LRCI+
Sbjct: 234 -----------LIFGIIGTPHSDND-LRCIE 252

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 118/284 (41%), Gaps = 65/284 (22%)
Query: 512 LGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFEN------EVLLIAKLQ--HRNL 562
           LG GGFG VY G+ + +   +A K + K       E  N      EV+L+ K+      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 563 VKLIGCCTQRDERMLIYEYL-PNKSLNDFIF-------DVTRSKF---LDWSKRCQIIGG 611
           ++L+    + D  +LI E + P + L DFI        ++ RS F   L+  + C   G 
Sbjct: 76  IRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG- 134
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVG 670
                          ++HRD+K  N+L+D N    K+ DFG   A   D    + +   G
Sbjct: 135 ---------------VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---G 175
Query: 671 TYGYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 729
           T  Y PPE+     +  +S  V+S G+L+ ++VCG  +  F H +               
Sbjct: 176 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE--------------- 218
Query: 730 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
               E+I   +     +S    C  +   C+  RP DRP    +
Sbjct: 219 ----EIIRGQVFFRQRVSS--ECQHLIRWCLALRPSDRPTFEEI 256

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 116/286 (40%), Gaps = 69/286 (24%)
Query: 512 LGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFEN------EVLLIAKLQ--HRNL 562
           LG GGFG VY G+ + +   +A K + K       E  N      EV+L+ K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 563 VKLIGCCTQRDERMLIYEYL-PNKSLNDFIF-------DVTRSKF---LDWSKRCQIIGG 611
           ++L+    + D  +LI E   P + L DFI        ++ RS F   L+  + C   G 
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG- 162
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVG 670
                          ++HRD+K  N+L+D N    K+ DFG   A   D    + +   G
Sbjct: 163 ---------------VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---G 203
Query: 671 TYGYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 729
           T  Y PPE+     +  +S  V+S G+L+ ++VCG                         
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG------------------------- 238
Query: 730 ERPVELINKSLGGSYSLSEVL--RCIQVGLLCVQQRPEDRPNMSSV 773
           + P E   + +GG     + +   C  +   C+  RP DRP    +
Sbjct: 239 DIPFEHDEEIIGGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEI 284

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFE---NEVLLIAK 556
           + F     LG G FG V   +L++    G   A K L K     +++ E   NE  ++  
Sbjct: 41  DQFERIKTLGTGSFGRV---MLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 616
           +    LVKL           ++ EY+P   +   +  + R  F +   R      I    
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHARF-YAAQIVLTF 154
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+ 
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           PE  +   ++   D ++ GVL+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 41/224 (18%)
Query: 506 FSDKNKLGEGGFGPVYKGVLIEGQEIAAKR---LSKSSGQGMEEFENEVLLIAKLQHRNL 562
           +S   ++G GG   V++ VL E ++I A +   L ++  Q ++ + NE+  + KLQ  + 
Sbjct: 58  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 115
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLD---WSKRCQIIGGIARG---- 615
                     D+ + +Y+Y   +  + +I+ V     +D   W K+ + I    R     
Sbjct: 116 ----------DKIIRLYDY---EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWK 162
Query: 616 --LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
             L  +H   +  I+H DLK +N L+ + M  K+ DFG+A     D T    +  VG   
Sbjct: 163 NMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVN 221
Query: 674 YMPPEYAIDGLFSVKS------------DVFSFGVLVLEIVCGK 705
           YMPPE AI  + S +             DV+S G ++  +  GK
Sbjct: 222 YMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 39/220 (17%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN-EVLLIAKLQHRNL 562
           +++D   +G G FG VY+  L + G+ +A K++ +      + F+N E+ ++ KL H N+
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 113
Query: 563 VKL----IGCCTQRDERM--LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA--- 613
           V+L         ++DE    L+ +Y+P     + ++ V R     +S+  Q +  I    
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVAR----HYSRAKQTLPVIYVKL 164
Query: 614 ------RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQTEANTN 666
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + E N +
Sbjct: 165 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVS 219
Query: 667 RVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
            +   Y Y  PE       ++   DV+S G ++ E++ G+
Sbjct: 220 YICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 39/220 (17%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN-EVLLIAKLQHRNL 562
           +++D   +G G FG VY+  L + G+ +A K++ +      + F+N E+ ++ KL H N+
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 111
Query: 563 VKL----IGCCTQRDERM--LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA--- 613
           V+L         ++DE    L+ +Y+P     + ++ V R     +S+  Q +  I    
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVAR----HYSRAKQTLPVIYVKL 162
Query: 614 ------RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQTEANTN 666
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + E N +
Sbjct: 163 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVS 217
Query: 667 RVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
            +   Y Y  PE       ++   DV+S G ++ E++ G+
Sbjct: 218 YICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 116/286 (40%), Gaps = 69/286 (24%)
Query: 512 LGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFEN------EVLLIAKLQ--HRNL 562
           LG GGFG VY G+ + +   +A K + K       E  N      EV+L+ K+      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 563 VKLIGCCTQRDERMLIYEYL-PNKSLNDFIF-------DVTRSKF---LDWSKRCQIIGG 611
           ++L+    + D  +LI E   P + L DFI        ++ RS F   L+  + C   G 
Sbjct: 72  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG- 130
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVG 670
                          ++HRD+K  N+L+D N    K+ DFG   A   D    + +   G
Sbjct: 131 ---------------VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---G 171
Query: 671 TYGYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 729
           T  Y PPE+     +  +S  V+S G+L+ ++VCG                         
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG------------------------- 206
Query: 730 ERPVELINKSLGGSYSLSEVL--RCIQVGLLCVQQRPEDRPNMSSV 773
           + P E   + +GG     + +   C  +   C+  RP DRP    +
Sbjct: 207 DIPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 252

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFE---NEVLLIAK 556
           + F     LG G FG V   +L++    G   A K L K     +++ E   NE  ++  
Sbjct: 41  DQFERIKTLGTGSFGRV---MLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 616
           +    LVKL           ++ EY+P   +   +  + R  F +   R      I    
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHARF-YAAQIVLTF 154
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+ 
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           PE  +   ++   D ++ GVL+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 39/220 (17%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN-EVLLIAKLQHRNL 562
           +++D   +G G FG VY+  L + G+ +A K++ +      + F+N E+ ++ KL H N+
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 109
Query: 563 VKL----IGCCTQRDERM--LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA--- 613
           V+L         ++DE    L+ +Y+P     + ++ V R     +S+  Q +  I    
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVAR----HYSRAKQTLPVIYVKL 160
Query: 614 ------RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQTEANTN 666
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + E N +
Sbjct: 161 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVS 215
Query: 667 RVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
            +   Y Y  PE       ++   DV+S G ++ E++ G+
Sbjct: 216 YICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 116/286 (40%), Gaps = 69/286 (24%)
Query: 512 LGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFEN------EVLLIAKLQ--HRNL 562
           LG GGFG VY G+ + +   +A K + K       E  N      EV+L+ K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 563 VKLIGCCTQRDERMLIYEYL-PNKSLNDFIF-------DVTRSKF---LDWSKRCQIIGG 611
           ++L+    + D  +LI E   P + L DFI        ++ RS F   L+  + C   G 
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG- 162
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVG 670
                          ++HRD+K  N+L+D N    K+ DFG   A   D    + +   G
Sbjct: 163 ---------------VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---G 203
Query: 671 TYGYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 729
           T  Y PPE+     +  +S  V+S G+L+ ++VCG                         
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG------------------------- 238
Query: 730 ERPVELINKSLGGSYSLSEVL--RCIQVGLLCVQQRPEDRPNMSSV 773
           + P E   + +GG     + +   C  +   C+  RP DRP    +
Sbjct: 239 DIPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 284

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 116/286 (40%), Gaps = 69/286 (24%)
Query: 512 LGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFEN------EVLLIAKLQ--HRNL 562
           LG GGFG VY G+ + +   +A K + K       E  N      EV+L+ K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 563 VKLIGCCTQRDERMLIYEYL-PNKSLNDFIF-------DVTRSKF---LDWSKRCQIIGG 611
           ++L+    + D  +LI E   P + L DFI        ++ RS F   L+  + C   G 
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG- 163
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVG 670
                          ++HRD+K  N+L+D N    K+ DFG   A   D    + +   G
Sbjct: 164 ---------------VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---G 204
Query: 671 TYGYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 729
           T  Y PPE+     +  +S  V+S G+L+ ++VCG                         
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG------------------------- 239
Query: 730 ERPVELINKSLGGSYSLSEVL--RCIQVGLLCVQQRPEDRPNMSSV 773
           + P E   + +GG     + +   C  +   C+  RP DRP    +
Sbjct: 240 DIPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 285

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 116/286 (40%), Gaps = 69/286 (24%)
Query: 512 LGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFEN------EVLLIAKLQ--HRNL 562
           LG GGFG VY G+ + +   +A K + K       E  N      EV+L+ K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 563 VKLIGCCTQRDERMLIYEYL-PNKSLNDFIF-------DVTRSKF---LDWSKRCQIIGG 611
           ++L+    + D  +LI E   P + L DFI        ++ RS F   L+  + C   G 
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG- 163
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVG 670
                          ++HRD+K  N+L+D N    K+ DFG   A   D    + +   G
Sbjct: 164 ---------------VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---G 204
Query: 671 TYGYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 729
           T  Y PPE+     +  +S  V+S G+L+ ++VCG                         
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG------------------------- 239
Query: 730 ERPVELINKSLGGSYSLSEVL--RCIQVGLLCVQQRPEDRPNMSSV 773
           + P E   + +GG     + +   C  +   C+  RP DRP    +
Sbjct: 240 DIPFEHDEEIIGGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEI 285

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 41/224 (18%)
Query: 506 FSDKNKLGEGGFGPVYKGVLIEGQEIAAKR---LSKSSGQGMEEFENEVLLIAKLQHRNL 562
           +S   ++G GG   V++ VL E ++I A +   L ++  Q ++ + NE+  + KLQ  + 
Sbjct: 30  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 87
Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLD---WSKRCQIIGGIARG---- 615
                     D+ + +Y+Y   +  + +I+ V     +D   W K+ + I    R     
Sbjct: 88  ----------DKIIRLYDY---EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWK 134
Query: 616 --LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
             L  +H   +  I+H DLK +N L+ + M  K+ DFG+A     D      +  VGT  
Sbjct: 135 NMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXVVKDSQVGTVN 193
Query: 674 YMPPEYAIDGLFSVKS------------DVFSFGVLVLEIVCGK 705
           YMPPE AI  + S +             DV+S G ++  +  GK
Sbjct: 194 YMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 39/220 (17%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN-EVLLIAKLQHRNL 562
           +++D   +G G FG VY+  L + G+ +A K++ +      + F+N E+ ++ KL H N+
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 103
Query: 563 VKL----IGCCTQRDERM--LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA--- 613
           V+L         ++DE    L+ +Y+P     + ++ V R     +S+  Q +  I    
Sbjct: 104 VRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVAR----HYSRAKQTLPVIYVKL 154
Query: 614 ------RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQTEANTN 666
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + E N +
Sbjct: 155 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVS 209
Query: 667 RVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
            +   Y Y  PE       ++   DV+S G ++ E++ G+
Sbjct: 210 YICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 509 KNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRNLVKLI 566
           ++ LGEG    V   + LI  QE A K + K  G        EV ++ + Q HRN+++LI
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 626
               + D   L++E +   S+   I        L+ S    ++  +A  L +LH      
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDFLHNKG--- 131
Query: 627 IIHRDLKASNVLLD--NEMNP-KISDFGMARAFGI--DQTEANTNRVV---GTYGYMPPE 678
           I HRDLK  N+L +  N+++P KI DFG+     +  D +  +T  ++   G+  YM PE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 679 YA-----IDGLFSVKSDVFSFGVLVLEIVCG 704
                     ++  + D++S GV++  ++ G
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 39/220 (17%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN-EVLLIAKLQHRNL 562
           +++D   +G G FG VY+  L + G+ +A K++ +      + F+N E+ ++ KL H N+
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 87
Query: 563 VKL----IGCCTQRDERM--LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA--- 613
           V+L         ++DE    L+ +Y+P     + ++ V R     +S+  Q +  I    
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARH----YSRAKQTLPVIYVKL 138
Query: 614 ------RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQTEANTN 666
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + E N +
Sbjct: 139 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVS 193
Query: 667 RVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
            +   Y Y  PE       ++   DV+S G ++ E++ G+
Sbjct: 194 XICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 504 ENFSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQ 558
           + + +   +G G  G V   Y  VL   + +A K+LS+   +    +    E++L+  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVN 81
Query: 559 HRNLVKLIGCCT-QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           H+N++ L+   T Q+        YL  + ++  +  V + + LD  +   ++  +  G+ 
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME-LDHERMSYLLYQMLCGIK 140
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T       V T  Y  P
Sbjct: 141 HLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG---TSFMMTPYVVTRYYRAP 194
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E  +   +    D++S G ++ E+V  K
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 116/286 (40%), Gaps = 69/286 (24%)
Query: 512 LGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFEN------EVLLIAKLQ--HRNL 562
           LG GGFG VY G+ + +   +A K + K       E  N      EV+L+ K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 563 VKLIGCCTQRDERMLIYEYL-PNKSLNDFIF-------DVTRSKF---LDWSKRCQIIGG 611
           ++L+    + D  +LI E   P + L DFI        ++ RS F   L+  + C   G 
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG- 163
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVG 670
                          ++HRD+K  N+L+D N    K+ DFG   A   D    + +   G
Sbjct: 164 ---------------VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---G 204
Query: 671 TYGYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 729
           T  Y PPE+     +  +S  V+S G+L+ ++VCG                         
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG------------------------- 239
Query: 730 ERPVELINKSLGGSYSLSEVL--RCIQVGLLCVQQRPEDRPNMSSV 773
           + P E   + +GG     + +   C  +   C+  RP DRP    +
Sbjct: 240 DIPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 285

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFE---NEVLLIAK 556
           + F     LG G FG V   +L++    G   A K L K     +++ E   NE  ++  
Sbjct: 41  DQFERIKTLGTGSFGRV---MLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 616
           +    LVKL           ++ EY+P   +   +  + R  F +   R      I    
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHARF-YAAQIVLTF 154
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+ 
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           PE  +   ++   D ++ GVL+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 26/226 (11%)
Query: 512 LGEGGFGPVYKGVLIE----GQ----EIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           LG+G F  ++KGV  E    GQ    E+  K L K+     E F     +++KL H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
              G C   DE +L+ E++   SL+ ++        + W  + ++   +A  + +L +++
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLEENT 133
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISD--FGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
              +IH ++ A N+LL  E + K  +  F      GI  T    + +     ++PPE   
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIE 190
Query: 682 DGL-FSVKSDVFSFGVLVLEIVCG----------KRNRGFYHADHH 716
           +    ++ +D +SFG  + EI  G          +R   FY   H 
Sbjct: 191 NPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQ 236

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 39/220 (17%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN-EVLLIAKLQHRNL 562
           +++D   +G G FG VY+  L + G+ +A K++ +      + F+N E+ ++ KL H N+
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 80
Query: 563 VKL----IGCCTQRDERM--LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA--- 613
           V+L         ++DE    L+ +Y+P     + ++ V R     +S+  Q +  I    
Sbjct: 81  VRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVAR----HYSRAKQTLPVIYVKL 131
Query: 614 ------RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQTEANTN 666
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + E N +
Sbjct: 132 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVS 186
Query: 667 RVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
            +   Y Y  PE       ++   DV+S G ++ E++ G+
Sbjct: 187 YICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 39/220 (17%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN-EVLLIAKLQHRNL 562
           +++D   +G G FG VY+  L + G+ +A K++ +      + F+N E+ ++ KL H N+
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 87
Query: 563 VKL----IGCCTQRDERM--LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA--- 613
           V+L         ++DE    L+ +Y+P     + ++ V R     +S+  Q +  I    
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARH----YSRAKQTLPVIYVKL 138
Query: 614 ------RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQTEANTN 666
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + E N +
Sbjct: 139 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVS 193
Query: 667 RVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
            +   Y Y  PE       ++   DV+S G ++ E++ G+
Sbjct: 194 XICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 24/219 (10%)
Query: 496 WMAIANAT---ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFE 548
           W + A  T   + F     LG G FG V   +L++    G   A K L K     +++ E
Sbjct: 31  WESPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIE 87
Query: 549 ---NEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR 605
              NE  ++  +    LVKL           ++ EY+P   +   +  + R  F +   R
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHAR 145
Query: 606 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT 665
                 I     YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T
Sbjct: 146 F-YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 196
Query: 666 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
             + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 39/220 (17%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN-EVLLIAKLQHRNL 562
           +++D   +G G FG VY+  L + G+ +A K++ +      + F+N E+ ++ KL H N+
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 94
Query: 563 VKL----IGCCTQRDERM--LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA--- 613
           V+L         ++DE    L+ +Y+P     + ++ V R     +S+  Q +  I    
Sbjct: 95  VRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARH----YSRAKQTLPVIYVKL 145
Query: 614 ------RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQTEANTN 666
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + E N +
Sbjct: 146 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVS 200
Query: 667 RVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
            +   Y Y  PE       ++   DV+S G ++ E++ G+
Sbjct: 201 XICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 24/219 (10%)
Query: 496 WMAIANAT---ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFE 548
           W + A  T   + F     LG G FG V   +L++    G   A K L K     +++ E
Sbjct: 31  WESPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIE 87
Query: 549 ---NEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR 605
              NE  ++  +    LVKL           ++ EY+P   +   +  + R  F +   R
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHAR 145
Query: 606 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT 665
                 I     YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T
Sbjct: 146 F-YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 196
Query: 666 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
             + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 24/219 (10%)
Query: 496 WMAIANAT---ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFE 548
           W + A  T   + F     LG G FG V   +L++    G   A K L K     +++ E
Sbjct: 31  WESPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIE 87
Query: 549 ---NEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR 605
              NE  ++  +    LVKL           ++ EY+P   +   +  + R  F +   R
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHAR 145
Query: 606 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT 665
                 I     YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T
Sbjct: 146 F-YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 196
Query: 666 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
             + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 24/219 (10%)
Query: 496 WMAIANAT---ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFE 548
           W + A  T   + F     LG G FG V   +L++    G   A K L K     +++ E
Sbjct: 23  WESPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIE 79
Query: 549 ---NEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR 605
              NE  ++  +    LVKL           ++ EY+P   +   +  + R  F +   R
Sbjct: 80  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHAR 137
Query: 606 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT 665
                 I     YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T
Sbjct: 138 F-YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 188
Query: 666 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
             + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 189 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 39/220 (17%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN-EVLLIAKLQHRNL 562
           +++D   +G G FG VY+  L + G+ +A K++ +      + F+N E+ ++ KL H N+
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 83
Query: 563 VKL----IGCCTQRDERM--LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA--- 613
           V+L         ++DE    L+ +Y+P     + ++ V R     +S+  Q +  I    
Sbjct: 84  VRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARH----YSRAKQTLPVIYVKL 134
Query: 614 ------RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQTEANTN 666
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + E N +
Sbjct: 135 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVS 189
Query: 667 RVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
            +   Y Y  PE       ++   DV+S G ++ E++ G+
Sbjct: 190 XICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 24/219 (10%)
Query: 496 WMAIANAT---ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFE 548
           W + A  T   + F     LG G FG V   +L++    G   A K L K     +++ E
Sbjct: 51  WESPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIE 107
Query: 549 ---NEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR 605
              NE  ++  +    LVKL           ++ EY+P   +   +  + R  F +   R
Sbjct: 108 HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHAR 165
Query: 606 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT 665
                 I     YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T
Sbjct: 166 F-YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRT 216
Query: 666 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
             + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 217 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 94/218 (43%), Gaps = 31/218 (14%)
Query: 510 NKLGEGGFGPV--YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIG 567
            KLGEGGF  V   +G L +G   A KR+     Q  EE + E  +     H N+++L+ 
Sbjct: 35  QKLGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVA 93
Query: 568 CCTQ----RDERMLIYEYLPNKSL-NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
            C +    + E  L+  +    +L N+      +  FL   +   ++ GI RGL  +H  
Sbjct: 94  YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK 153
Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVG-------TYGYM 675
                 HRDLK +N+LL +E  P + D G      I    +     +        T  Y 
Sbjct: 154 G---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR 210
Query: 676 PPEYAIDGLFSVKS--------DVFSFGVLVLEIVCGK 705
            PE     LFSV+S        DV+S G ++  ++ G+
Sbjct: 211 APE-----LFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 37/219 (16%)
Query: 504 ENFSDKNKLGEGGFGPV---YKGVLIEGQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQ 558
           + + +   +G G  G V   Y  VL   + +A K+LS+   +    +    E++L+  + 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVN 81
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF--------IFDVTRSKF----LDWSKRC 606
           H+N++ L+   T            P K+L +F        + D    +     LD  +  
Sbjct: 82  HKNIISLLNVFT------------PQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS 129
Query: 607 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN 666
            ++  +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  G   T     
Sbjct: 130 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG---TSFMMT 183
Query: 667 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
             V T  Y  PE  +   +    D++S G ++ E+V  K
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 505 NFSDKNKLGEGGFGPVY------KGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ 558
           +FS    +G GGFG VY       G +   + +  KR+    G+ +   E  +L +    
Sbjct: 189 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 248
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
               +  +       +++     L N    D  + +++      +        I  GL +
Sbjct: 249 DCPFIVCMSYAFHTPDKLSFILDLMNG--GDLHYHLSQHGVFSEADMRFYAAEIILGLEH 306
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           +H  +R  +++RDLK +N+LLD   + +ISD G+A  F   +  A+    VGT+GYM PE
Sbjct: 307 MH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPE 359
Query: 679 YAIDGL-FSVKSDVFSFGVLVLEIVCG 704
               G+ +   +D FS G ++ +++ G
Sbjct: 360 VLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 505 NFSDKNKLGEGGFGPVY------KGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ 558
           +FS    +G GGFG VY       G +   + +  KR+    G+ +   E  +L +    
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
               +  +       +++     L N    D  + +++      +        I  GL +
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNG--GDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           +H  +R  +++RDLK +N+LLD   + +ISD G+A  F   +  A+    VGT+GYM PE
Sbjct: 308 MH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPE 360
Query: 679 YAIDGL-FSVKSDVFSFGVLVLEIVCG 704
               G+ +   +D FS G ++ +++ G
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 39/220 (17%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN-EVLLIAKLQHRNL 562
           +++D   +G G FG VY+  L + G+ +A K++ +      + F+N E+ ++ KL H N+
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 79
Query: 563 VKL----IGCCTQRDERM--LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA--- 613
           V+L         ++DE    L+ +Y+P     + ++ V R     +S+  Q +  I    
Sbjct: 80  VRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARH----YSRAKQTLPVIYVKL 130
Query: 614 ------RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQTEANTN 666
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + E N +
Sbjct: 131 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVS 185
Query: 667 RVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
            +   Y Y  PE       ++   DV+S G ++ E++ G+
Sbjct: 186 XICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 39/220 (17%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN-EVLLIAKLQHRNL 562
           +++D   +G G FG VY+  L + G+ +A K++ +      + F+N E+ ++ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 563 VKL----IGCCTQRDERM--LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA--- 613
           V+L         ++DE    L+ +Y+P     + ++ V R     +S+  Q +  I    
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARH----YSRAKQTLPVIYVKL 126
Query: 614 ------RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQTEANTN 666
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + E N +
Sbjct: 127 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVS 181
Query: 667 RVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
            +   Y Y  PE       ++   DV+S G ++ E++ G+
Sbjct: 182 XICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 505 NFSDKNKLGEGGFGPVY------KGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ 558
           +FS    +G GGFG VY       G +   + +  KR+    G+ +   E  +L +    
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
               +  +       +++     L N    D  + +++      +        I  GL +
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNG--GDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           +H  +R  +++RDLK +N+LLD   + +ISD G+A  F   +  A+    VGT+GYM PE
Sbjct: 308 MH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPE 360
Query: 679 YAIDGL-FSVKSDVFSFGVLVLEIVCG 704
               G+ +   +D FS G ++ +++ G
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 505 NFSDKNKLGEGGFGPVY------KGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ 558
           +FS    +G GGFG VY       G +   + +  KR+    G+ +   E  +L +    
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
               +  +       +++     L N    D  + +++      +        I  GL +
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNG--GDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           +H  +R  +++RDLK +N+LLD   + +ISD G+A  F   +  A+    VGT+GYM PE
Sbjct: 308 MH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPE 360
Query: 679 YAIDGL-FSVKSDVFSFGVLVLEIVCG 704
               G+ +   +D FS G ++ +++ G
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 39/220 (17%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN-EVLLIAKLQHRNL 562
           +++D   +G G FG VY+  L + G+ +A K++ +      + F+N E+ ++ KL H N+
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 76
Query: 563 VKL----IGCCTQRDERM--LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA--- 613
           V+L         ++DE    L+ +Y+P     + ++ V R     +S+  Q +  I    
Sbjct: 77  VRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARH----YSRAKQTLPVIYVKL 127
Query: 614 ------RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQTEANTN 666
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + E N +
Sbjct: 128 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVS 182
Query: 667 RVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
            +   Y Y  PE       ++   DV+S G ++ E++ G+
Sbjct: 183 XICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 39/220 (17%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN-EVLLIAKLQHRNL 562
           +++D   +G G FG VY+  L + G+ +A K++ +      + F+N E+ ++ KL H N+
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 88
Query: 563 VKL----IGCCTQRDERM--LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA--- 613
           V+L         ++DE    L+ +Y+P     + ++ V R     +S+  Q +  I    
Sbjct: 89  VRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARH----YSRAKQTLPVIYVKL 139
Query: 614 ------RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQTEANTN 666
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + E N +
Sbjct: 140 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVS 194
Query: 667 RVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
            +   Y Y  PE       ++   DV+S G ++ E++ G+
Sbjct: 195 YICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 496 WMAIANAT---ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFE 548
           W + A  T   + F     LG G FG V   +L++    G   A K L K     +++ E
Sbjct: 31  WESPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIE 87
Query: 549 ---NEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR 605
              NE  ++  +    LVKL           ++ EY P   +   +  + R  F +   R
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR--FSEPHAR 145
Query: 606 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT 665
                 I     YLH    L +I+RDLK  N+++D +   K++DFG A+     + +  T
Sbjct: 146 F-YAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRT 196
Query: 666 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
             + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 39/220 (17%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN-EVLLIAKLQHRNL 562
           +++D   +G G FG VY+  L + G+ +A K++ +      + F+N E+ ++ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 563 VKL----IGCCTQRDERM--LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA--- 613
           V+L         ++DE    L+ +Y+P     + ++ V R     +S+  Q +  I    
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARH----YSRAKQTLPVIYVKL 126
Query: 614 ------RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQTEANTN 666
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + E N +
Sbjct: 127 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVS 181
Query: 667 RVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
            +   Y Y  PE       ++   DV+S G ++ E++ G+
Sbjct: 182 XICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 88/205 (42%), Gaps = 15/205 (7%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFE---NEVLLIAKLQH 559
           + F     LG G FG V     +E G   A K L K     +++ E   NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
             L KL           ++ EY P   +   +  + R  F +   R      I     YL
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYL 158
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H    L +I+RDLK  N+++D +   K++DFG A+     + +  T  + GT  Y+ PE 
Sbjct: 159 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCG 704
            +   ++   D ++ GVL+ E+  G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 39/220 (17%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN-EVLLIAKLQHRNL 562
           +++D   +G G FG VY+  L + G+ +A K++ +      + F+N E+ ++ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 563 VKL----IGCCTQRDERM--LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA--- 613
           V+L         ++DE    L+ +Y+P     + ++ V R     +S+  Q +  I    
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARH----YSRAKQTLPVIYVKL 126
Query: 614 ------RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQTEANTN 666
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + E N +
Sbjct: 127 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVS 181
Query: 667 RVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
            +   Y Y  PE       ++   DV+S G ++ E++ G+
Sbjct: 182 YICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 88/207 (42%), Gaps = 16/207 (7%)
Query: 503 TENFSDKNKLGEGGFGPVYKGVL-IEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRN 561
           T+ +  K  +G G +    + +      E A K + KS     EE E   +L+   QH N
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE---ILLRYGQHPN 77
Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
           ++ L           ++ E +    L D I    R KF    +   ++  I + + YLH 
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLHA 134
Query: 622 DSRLRIIHRDLKASNVL-LDNEMNP---KISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
                ++HRDLK SN+L +D   NP   +I DFG A+    +     T     T  ++ P
Sbjct: 135 QG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP--CYTANFVAP 189
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           E      +    D++S GVL+  ++ G
Sbjct: 190 EVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 15/205 (7%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFE---NEVLLIAKLQH 559
           + F     LG G FG V     +E G   A K L K     +++ E   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
             LVKL           ++ EY P   +   +  + R  F +   R      I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR--FSEPHARF-YAAQIVLTFEYL 157
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H    L +I+RDLK  N+++D +   +++DFG A+     + +  T  + GT  Y+ PE 
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCG 704
            +   ++   D ++ GVL+ E+  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 88/205 (42%), Gaps = 15/205 (7%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFE---NEVLLIAKLQH 559
           + F     LG G FG V     +E G   A K L K     +++ E   NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
             L KL           ++ EY P   +   +  + R  F +   R      I     YL
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR--FSEPHARF-YAAQIVLTFEYL 158
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H    L +I+RDLK  N+++D +   K++DFG A+     + +  T  + GT  Y+ PE 
Sbjct: 159 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCG 704
            +   ++   D ++ GVL+ E+  G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 88/205 (42%), Gaps = 15/205 (7%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFE---NEVLLIAKLQH 559
           + F     LG G FG V     +E G   A K L K     +++ E   NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
             L KL           ++ EY P   +   +  + R  F +   R      I     YL
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR--FSEPHARF-YAAQIVLTFEYL 158
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H    L +I+RDLK  N+++D +   K++DFG A+     + +  T  + GT  Y+ PE 
Sbjct: 159 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCG 704
            +   ++   D ++ GVL+ E+  G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 512 LGEGGFGPVYKGVLIE----GQ----EIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           LG+G F  ++KGV  E    GQ    E+  K L K+     E F     +++KL H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
              G C   DE +L+ E++   SL+ ++        + W  + ++   +A  + +L +++
Sbjct: 76  LNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMHFLEENT 133
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISD--FGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
              +IH ++ A N+LL  E + K  +  F      GI  T    + +     ++PPE   
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIE 190
Query: 682 DGL-FSVKSDVFSFGVLVLEIVCG 704
           +    ++ +D +SFG  + EI  G
Sbjct: 191 NPKNLNLATDKWSFGTTLWEICSG 214

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 117/284 (41%), Gaps = 65/284 (22%)
Query: 512 LGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFEN------EVLLIAKLQ--HRNL 562
           LG GGFG VY G+ + +   +A K + K       E  N      EV+L+ K+      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 563 VKLIGCCTQRDERMLIYEYL-PNKSLNDFIF-------DVTRSKF---LDWSKRCQIIGG 611
           ++L+    + D  +LI E   P + L DFI        ++ RS F   L+  + C   G 
Sbjct: 91  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG- 149
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVG 670
                          ++HRD+K  N+L+D N    K+ DFG   A   D    + +   G
Sbjct: 150 ---------------VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---G 190
Query: 671 TYGYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 729
           T  Y PPE+     +  +S  V+S G+L+ ++VCG  +  F H +               
Sbjct: 191 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE--------------- 233
Query: 730 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
               E+I   +     +S    C  +   C+  RP DRP    +
Sbjct: 234 ----EIIRGQVFFRQRVSS--ECQHLIRWCLALRPSDRPTFEEI 271

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 117/284 (41%), Gaps = 65/284 (22%)
Query: 512 LGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFEN------EVLLIAKLQ--HRNL 562
           LG GGFG VY G+ + +   +A K + K       E  N      EV+L+ K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 563 VKLIGCCTQRDERMLIYEYL-PNKSLNDFIF-------DVTRSKF---LDWSKRCQIIGG 611
           ++L+    + D  +LI E   P + L DFI        ++ RS F   L+  + C   G 
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG- 162
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVG 670
                          ++HRD+K  N+L+D N    K+ DFG   A   D    + +   G
Sbjct: 163 ---------------VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---G 203
Query: 671 TYGYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 729
           T  Y PPE+     +  +S  V+S G+L+ ++VCG  +  F H +               
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE--------------- 246
Query: 730 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
               E+I   +     +S    C  +   C+  RP DRP    +
Sbjct: 247 ----EIIRGQVFFRQRVSS--ECQHLIRWCLALRPSDRPTFEEI 284

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 117/284 (41%), Gaps = 65/284 (22%)
Query: 512 LGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFEN------EVLLIAKLQ--HRNL 562
           LG GGFG VY G+ + +   +A K + K       E  N      EV+L+ K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 563 VKLIGCCTQRDERMLIYEYL-PNKSLNDFIF-------DVTRSKF---LDWSKRCQIIGG 611
           ++L+    + D  +LI E   P + L DFI        ++ RS F   L+  + C   G 
Sbjct: 77  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG- 135
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVG 670
                          ++HRD+K  N+L+D N    K+ DFG   A   D    + +   G
Sbjct: 136 ---------------VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---G 176
Query: 671 TYGYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 729
           T  Y PPE+     +  +S  V+S G+L+ ++VCG  +  F H +               
Sbjct: 177 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE--------------- 219
Query: 730 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
               E+I   +     +S    C  +   C+  RP DRP    +
Sbjct: 220 ----EIIRGQVFFRQRVSS--ECQHLIRWCLALRPSDRPTFEEI 257

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 105/220 (47%), Gaps = 39/220 (17%)
Query: 505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN-EVLLIAKLQHRNL 562
           +++D   +G G FG VY+  L + G+ +A K++ +      + F+N E+ ++ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 563 VKLIGCCTQRDERM------LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA--- 613
           V+L        E+       L+ +Y+P     + ++ V R     +S+  Q +  I    
Sbjct: 76  VRLRYFFYSSGEKKDVVYLNLVLDYVP-----ETVYRVARH----YSRAKQTLPVIYVKL 126
Query: 614 ------RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQTEANTN 666
                 R L Y+H      I HRD+K  N+LLD +    K+ DFG A+   + + E N +
Sbjct: 127 YMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVS 181
Query: 667 RVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
            +   Y Y  PE       ++   DV+S G ++ E++ G+
Sbjct: 182 XICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 117/284 (41%), Gaps = 65/284 (22%)
Query: 512 LGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFEN------EVLLIAKLQ--HRNL 562
           LG GGFG VY G+ + +   +A K + K       E  N      EV+L+ K+      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 563 VKLIGCCTQRDERMLIYEYL-PNKSLNDFIF-------DVTRSKF---LDWSKRCQIIGG 611
           ++L+    + D  +LI E   P + L DFI        ++ RS F   L+  + C   G 
Sbjct: 72  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNXG- 130
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVG 670
                          ++HRD+K  N+L+D N    K+ DFG   A   D    + +   G
Sbjct: 131 ---------------VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---G 171
Query: 671 TYGYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 729
           T  Y PPE+     +  +S  V+S G+L+ ++VCG  +  F H +               
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE--------------- 214
Query: 730 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
               E+I   +     +S    C  +   C+  RP DRP    +
Sbjct: 215 ----EIIRGQVFFRQRVSX--ECQHLIRWCLALRPSDRPTFEEI 252

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 117/284 (41%), Gaps = 65/284 (22%)
Query: 512 LGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFEN------EVLLIAKLQ--HRNL 562
           LG GGFG VY G+ + +   +A K + K       E  N      EV+L+ K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 563 VKLIGCCTQRDERMLIYEYL-PNKSLNDFIF-------DVTRSKF---LDWSKRCQIIGG 611
           ++L+    + D  +LI E   P + L DFI        ++ RS F   L+  + C   G 
Sbjct: 92  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG- 150
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVG 670
                          ++HRD+K  N+L+D N    K+ DFG   A   D    + +   G
Sbjct: 151 ---------------VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---G 191
Query: 671 TYGYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 729
           T  Y PPE+     +  +S  V+S G+L+ ++VCG  +  F H +               
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE--------------- 234
Query: 730 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
               E+I   +     +S    C  +   C+  RP DRP    +
Sbjct: 235 ----EIIRGQVFFRQRVSS--ECQHLIRWCLALRPSDRPTFEEI 272

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 117/284 (41%), Gaps = 65/284 (22%)
Query: 512 LGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFEN------EVLLIAKLQ--HRNL 562
           LG GGFG VY G+ + +   +A K + K       E  N      EV+L+ K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 563 VKLIGCCTQRDERMLIYEYL-PNKSLNDFIF-------DVTRSKF---LDWSKRCQIIGG 611
           ++L+    + D  +LI E   P + L DFI        ++ RS F   L+  + C   G 
Sbjct: 77  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG- 135
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVG 670
                          ++HRD+K  N+L+D N    K+ DFG   A   D    + +   G
Sbjct: 136 ---------------VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---G 176
Query: 671 TYGYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 729
           T  Y PPE+     +  +S  V+S G+L+ ++VCG  +  F H +               
Sbjct: 177 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE--------------- 219
Query: 730 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
               E+I   +     +S    C  +   C+  RP DRP    +
Sbjct: 220 ----EIIRGQVFFRQRVSS--ECQHLIRWCLALRPSDRPTFEEI 257

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 116/279 (41%), Gaps = 55/279 (19%)
Query: 512 LGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFEN------EVLLIAKLQ--HRNL 562
           LG GGFG VY G+ + +   +A K + K       E  N      EV+L+ K+      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 563 VKLIGCCTQRDERMLIYEYL-PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY--- 618
           ++L+    + D  +LI E   P + L DFI           ++R  +   +AR   +   
Sbjct: 72  IRLLDWFERPDSFVLILERPEPVQDLFDFI-----------TERGALQEELARSFFWQVL 120
Query: 619 --LHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYM 675
             +       ++HRD+K  N+L+D N    K+ DFG   A   D    + +   GT  Y 
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYS 176
Query: 676 PPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE 734
           PPE+     +  +S  V+S G+L+ ++VCG  +  F H +                   E
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE-------------------E 215
Query: 735 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
           +I   +     +S    C  +   C+  RP DRP    +
Sbjct: 216 IIRGQVFFRQRVSS--ECQHLIRWCLALRPSDRPTFEEI 252

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 117/284 (41%), Gaps = 65/284 (22%)
Query: 512 LGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFEN------EVLLIAKLQ--HRNL 562
           LG GGFG VY G+ + +   +A K + K       E  N      EV+L+ K+      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 563 VKLIGCCTQRDERMLIYEYL-PNKSLNDFIF-------DVTRSKF---LDWSKRCQIIGG 611
           ++L+    + D  +LI E   P + L DFI        ++ RS F   L+  + C   G 
Sbjct: 91  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG- 149
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVG 670
                          ++HRD+K  N+L+D N    K+ DFG   A   D    + +   G
Sbjct: 150 ---------------VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---G 190
Query: 671 TYGYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 729
           T  Y PPE+     +  +S  V+S G+L+ ++VCG  +  F H +               
Sbjct: 191 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE--------------- 233
Query: 730 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
               E+I   +     +S    C  +   C+  RP DRP    +
Sbjct: 234 ----EIIRGQVFFRQRVSX--ECQHLIRWCLALRPSDRPTFEEI 271

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 116/279 (41%), Gaps = 55/279 (19%)
Query: 512 LGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFEN------EVLLIAKLQ--HRNL 562
           LG GGFG VY G+ + +   +A K + K       E  N      EV+L+ K+      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 563 VKLIGCCTQRDERMLIYEYL-PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY--- 618
           ++L+    + D  +LI E   P + L DFI           ++R  +   +AR   +   
Sbjct: 76  IRLLDWFERPDSFVLILERPEPVQDLFDFI-----------TERGALQEELARSFFWQVL 124
Query: 619 --LHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYM 675
             +       ++HRD+K  N+L+D N    K+ DFG   A   D    + +   GT  Y 
Sbjct: 125 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYS 180
Query: 676 PPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE 734
           PPE+     +  +S  V+S G+L+ ++VCG  +  F H +                   E
Sbjct: 181 PPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE-------------------E 219
Query: 735 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
           +I   +     +S    C  +   C+  RP DRP    +
Sbjct: 220 IIRGQVFFRQRVSS--ECQHLIRWCLALRPSDRPTFEEI 256

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 512 LGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRNLVKLIGCC 569
           LGEG +  V   V ++ G+E A K + K +G        EV  + + Q ++N+++LI   
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFF 80
Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
                  L++E L   S+   +  + + K  +  +  +++  +A  L +LH      I H
Sbjct: 81  EDDTRFYLVFEKLQGGSI---LAHIQKQKHFNEREASRVVRDVAAALDFLHTKG---IAH 134
Query: 630 RDLKASNVLLDN--EMNP-KISDFGMARAFGIDQ-----TEANTNRVVGTYGYMPPEYA- 680
           RDLK  N+L ++  +++P KI DF +     ++      T        G+  YM PE   
Sbjct: 135 RDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVE 194
Query: 681 ----IDGLFSVKSDVFSFGVLVLEIVCG 704
                   +  + D++S GV++  ++ G
Sbjct: 195 VFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 117/284 (41%), Gaps = 65/284 (22%)
Query: 512 LGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFEN------EVLLIAKLQ--HRNL 562
           LG GGFG VY G+ + +   +A K + K       E  N      EV+L+ K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 563 VKLIGCCTQRDERMLIYEYL-PNKSLNDFIF-------DVTRSKF---LDWSKRCQIIGG 611
           ++L+    + D  +LI E   P + L DFI        ++ RS F   L+  + C   G 
Sbjct: 92  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG- 150
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVG 670
                          ++HRD+K  N+L+D N    K+ DFG   A   D    + +   G
Sbjct: 151 ---------------VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---G 191
Query: 671 TYGYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 729
           T  Y PPE+     +  +S  V+S G+L+ ++VCG  +  F H +               
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE--------------- 234
Query: 730 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
               E+I   +     +S    C  +   C+  RP DRP    +
Sbjct: 235 ----EIIRGQVFFRQRVSX--ECQHLIRWCLALRPSDRPTFEEI 272

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 24/219 (10%)
Query: 496 WMAIANAT---ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFE 548
           W + A  T   + F     LG G FG V   +L++    G   A K L K     +++ E
Sbjct: 31  WESPAQNTAHLDQFERIRTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIE 87
Query: 549 ---NEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR 605
              NE  +   +    LVKL           ++ EY P   +   +  + R  F +   R
Sbjct: 88  HTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGR--FSEPHAR 145
Query: 606 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT 665
                 I     YLH    L +I+RDLK  N+L+D +   K++DFG A+     + +  T
Sbjct: 146 F-YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRT 196
Query: 666 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
             + GT  Y+ PE  +   ++   D ++ GVL+ E+  G
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 116/279 (41%), Gaps = 55/279 (19%)
Query: 512 LGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFEN------EVLLIAKLQ--HRNL 562
           LG GGFG VY G+ + +   +A K + K       E  N      EV+L+ K+      +
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 563 VKLIGCCTQRDERMLIYEYL-PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY--- 618
           ++L+    + D  +LI E   P + L DFI           ++R  +   +AR   +   
Sbjct: 75  IRLLDWFERPDSFVLILERPEPVQDLFDFI-----------TERGALQEELARSFFWQVL 123
Query: 619 --LHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYM 675
             +       ++HRD+K  N+L+D N    K+ DFG   A   D    + +   GT  Y 
Sbjct: 124 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYS 179
Query: 676 PPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE 734
           PPE+     +  +S  V+S G+L+ ++VCG  +  F H +                   E
Sbjct: 180 PPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE-------------------E 218
Query: 735 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
           +I   +     +S    C  +   C+  RP DRP    +
Sbjct: 219 IIRGQVFFRQRVSS--ECQHLIRWCLALRPSDRPTFEEI 255

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 117/284 (41%), Gaps = 65/284 (22%)
Query: 512 LGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFEN------EVLLIAKLQ--HRNL 562
           LG GGFG VY G+ + +   +A K + K       E  N      EV+L+ K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 563 VKLIGCCTQRDERMLIYEYL-PNKSLNDFIF-------DVTRSKF---LDWSKRCQIIGG 611
           ++L+    + D  +LI E   P + L DFI        ++ RS F   L+  + C   G 
Sbjct: 77  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG- 135
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVG 670
                          ++HRD+K  N+L+D N    K+ DFG   A   D    + +   G
Sbjct: 136 ---------------VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---G 176
Query: 671 TYGYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 729
           T  Y PPE+     +  +S  V+S G+L+ ++VCG  +  F H +               
Sbjct: 177 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE--------------- 219
Query: 730 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
               E+I   +     +S    C  +   C+  RP DRP    +
Sbjct: 220 ----EIIRGQVFFRQRVSS--ECQHLIRWCLALRPSDRPTFEEI 257

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 93/201 (46%), Gaps = 19/201 (9%)
Query: 511 KLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
           +LG G FG V++ V    G+   AK ++          +NE+ ++ +L H  L+ L    
Sbjct: 58  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 570 TQRDERMLIYEYLPNKSLNDFI----FDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 625
             + E +LI E+L    L D I    + ++ ++ +++ ++         GL ++H+ S  
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQA------CEGLKHMHEHS-- 169
Query: 626 RIIHRDLKASNVLLDNEM--NPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
            I+H D+K  N++ + +   + KI DFG+A     D+    T     T  +  PE     
Sbjct: 170 -IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDRE 225
Query: 684 LFSVKSDVFSFGVLVLEIVCG 704
                +D+++ GVL   ++ G
Sbjct: 226 PVGFYTDMWAIGVLGYVLLSG 246

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 511 KLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL-----VK 564
           +LG G +G V K   +  GQ +A KR+  +      + +  +L+   +  R +     V 
Sbjct: 58  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN---SQEQKRLLMDLDISMRTVDCPFTVT 114
Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVT-RSKFLDWSKRCQIIGGIARGLLYLHQDS 623
             G   +  +  +  E + + SL+ F   V  + + +      +I   I + L +LH  S
Sbjct: 115 FYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH--S 171
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
           +L +IHRD+K SNVL++     K+ DFG++  + +D      +   G   YM PE     
Sbjct: 172 KLSVIHRDVKPSNVLINALGQVKMCDFGIS-GYLVDSVAKTID--AGCKPYMAPERINPE 228
Query: 684 L----FSVKSDVFSFGVLVLEI 701
           L    +SVKSD++S G+ ++E+
Sbjct: 229 LNQKGYSVKSDIWSLGITMIEL 250

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 117/284 (41%), Gaps = 65/284 (22%)
Query: 512 LGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFEN------EVLLIAKLQ--HRNL 562
           LG GGFG VY G+ + +   +A K + K       E  N      EV+L+ K+      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 563 VKLIGCCTQRDERMLIYEYL-PNKSLNDFIF-------DVTRSKF---LDWSKRCQIIGG 611
           ++L+    + D  +LI E   P + L DFI        ++ RS F   L+  + C   G 
Sbjct: 119 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG- 177
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVG 670
                          ++HRD+K  N+L+D N    K+ DFG   A   D    + +   G
Sbjct: 178 ---------------VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---G 218
Query: 671 TYGYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 729
           T  Y PPE+     +  +S  V+S G+L+ ++VCG  +  F H +               
Sbjct: 219 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE--------------- 261
Query: 730 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
               E+I   +     +S    C  +   C+  RP DRP    +
Sbjct: 262 ----EIIRGQVFFRQRVSX--ECQHLIRWCLALRPSDRPTFEEI 299

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 117/284 (41%), Gaps = 65/284 (22%)
Query: 512 LGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFEN------EVLLIAKLQ--HRNL 562
           LG GGFG VY G+ + +   +A K + K       E  N      EV+L+ K+      +
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 563 VKLIGCCTQRDERMLIYEYL-PNKSLNDFIF-------DVTRSKF---LDWSKRCQIIGG 611
           ++L+    + D  +LI E   P + L DFI        ++ RS F   L+  + C   G 
Sbjct: 124 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG- 182
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVG 670
                          ++HRD+K  N+L+D N    K+ DFG   A   D    + +   G
Sbjct: 183 ---------------VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---G 223
Query: 671 TYGYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 729
           T  Y PPE+     +  +S  V+S G+L+ ++VCG  +  F H +               
Sbjct: 224 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE--------------- 266
Query: 730 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
               E+I   +     +S    C  +   C+  RP DRP    +
Sbjct: 267 ----EIIRGQVFFRQRVSX--ECQHLIRWCLALRPSDRPTFEEI 304

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 117/284 (41%), Gaps = 65/284 (22%)
Query: 512 LGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFEN------EVLLIAKLQ--HRNL 562
           LG GGFG VY G+ + +   +A K + K       E  N      EV+L+ K+      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 563 VKLIGCCTQRDERMLIYEYL-PNKSLNDFIF-------DVTRSKF---LDWSKRCQIIGG 611
           ++L+    + D  +LI E   P + L DFI        ++ RS F   L+  + C   G 
Sbjct: 119 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG- 177
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVG 670
                          ++HRD+K  N+L+D N    K+ DFG   A   D    + +   G
Sbjct: 178 ---------------VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---G 218
Query: 671 TYGYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 729
           T  Y PPE+     +  +S  V+S G+L+ ++VCG  +  F H +               
Sbjct: 219 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE--------------- 261
Query: 730 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
               E+I   +     +S    C  +   C+  RP DRP    +
Sbjct: 262 ----EIIRGQVFFRQRVSS--ECQHLIRWCLALRPSDRPTFEEI 299

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 117/284 (41%), Gaps = 65/284 (22%)
Query: 512 LGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFEN------EVLLIAKLQ--HRNL 562
           LG GGFG VY G+ + +   +A K + K       E  N      EV+L+ K+      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 563 VKLIGCCTQRDERMLIYEYL-PNKSLNDFIF-------DVTRSKF---LDWSKRCQIIGG 611
           ++L+    + D  +LI E   P + L DFI        ++ RS F   L+  + C   G 
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG- 169
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVG 670
                          ++HRD+K  N+L+D N    K+ DFG   A   D    + +   G
Sbjct: 170 ---------------VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---G 210
Query: 671 TYGYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 729
           T  Y PPE+     +  +S  V+S G+L+ ++VCG  +  F H +               
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE--------------- 253
Query: 730 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
               E+I   +     +S    C  +   C+  RP DRP    +
Sbjct: 254 ----EIIRGQVFFRQRVSS--ECQHLIRWCLALRPSDRPTFEEI 291

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 98/202 (48%), Gaps = 20/202 (9%)
Query: 511 KLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL-----VK 564
           +LG G +G V K   +  GQ +A KR+  +      + +  +L+   +  R +     V 
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS---QEQKRLLMDLDISMRTVDCPFTVT 70
Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVT-RSKFLDWSKRCQIIGGIARGLLYLHQDS 623
             G   +  +  +  E + + SL+ F   V  + + +      +I   I + L +LH  S
Sbjct: 71  FYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH--S 127
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
           +L +IHRD+K SNVL++     K+ DFG++  + +D    + +   G   YM PE     
Sbjct: 128 KLSVIHRDVKPSNVLINALGQVKMCDFGIS-GYLVDDVAKDID--AGCKPYMAPERINPE 184
Query: 684 L----FSVKSDVFSFGVLVLEI 701
           L    +SVKSD++S G+ ++E+
Sbjct: 185 LNQKGYSVKSDIWSLGITMIEL 206

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 117/284 (41%), Gaps = 65/284 (22%)
Query: 512 LGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFEN------EVLLIAKLQ--HRNL 562
           LG GGFG VY G+ + +   +A K + K       E  N      EV+L+ K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 563 VKLIGCCTQRDERMLIYEYL-PNKSLNDFIF-------DVTRSKF---LDWSKRCQIIGG 611
           ++L+    + D  +LI E   P + L DFI        ++ RS F   L+  + C   G 
Sbjct: 92  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG- 150
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVG 670
                          ++HRD+K  N+L+D N    K+ DFG   A   D    + +   G
Sbjct: 151 ---------------VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---G 191
Query: 671 TYGYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 729
           T  Y PPE+     +  +S  V+S G+L+ ++VCG  +  F H +               
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE--------------- 234
Query: 730 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
               E+I   +     +S    C  +   C+  RP DRP    +
Sbjct: 235 ----EIIRGQVFFRQRVSX--ECQHLIRWCLALRPXDRPTFEEI 272

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 117/284 (41%), Gaps = 65/284 (22%)
Query: 512 LGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFEN------EVLLIAKLQ--HRNL 562
           LG GGFG VY G+ + +   +A K + K       E  N      EV+L+ K+      +
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 98
Query: 563 VKLIGCCTQRDERMLIYEYL-PNKSLNDFIF-------DVTRSKF---LDWSKRCQIIGG 611
           ++L+    + D  +LI E   P + L DFI        ++ RS F   L+  + C   G 
Sbjct: 99  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG- 157
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVG 670
                          ++HRD+K  N+L+D N    K+ DFG   A   D    + +   G
Sbjct: 158 ---------------VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---G 198
Query: 671 TYGYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 729
           T  Y PPE+     +  +S  V+S G+L+ ++VCG  +  F H +               
Sbjct: 199 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDE--------------- 241
Query: 730 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
               E+I   +     +S    C  +   C+  RP DRP    +
Sbjct: 242 ----EIIRGQVFFRQRVSX--ECQHLIRWCLALRPSDRPTFEEI 279

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 100/230 (43%), Gaps = 24/230 (10%)
Query: 481 DRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSS 540
           DR      M+LPI       + ++ +     +G G FG        +  E+ A +  +  
Sbjct: 2   DRPAVAGPMDLPIM------HDSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERG 55
Query: 541 GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFL 600
            +  E  + E++    L+H N+V+            ++ EY     L + I +  R  F 
Sbjct: 56  EKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FS 113
Query: 601 DWSKRC---QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP--KISDFGMARA 655
           +   R    Q+I G++    Y H    +++ HRDLK  N LLD    P  KI+DFG ++A
Sbjct: 114 EDEARFFFQQLISGVS----YAHA---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKA 166
Query: 656 FGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVK-SDVFSFGVLVLEIVCG 704
             +    +     VGT  Y+ PE  +   +  K +DV+S GV +  ++ G
Sbjct: 167 SVL---HSQPKSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEG-QEIAAKRLSKSSGQGMEEFENEVLLIAKLQ---- 558
           EN+  K  LG G    V + +     +E A K +  + G      E + L  A L+    
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 559 ------HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGI 612
                 H N+++L           L+++ +    L D++   T    L   +  +I+  +
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 133
Query: 613 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTY 672
              +  LH   +L I+HRDLK  N+LLD++MN K++DFG   +  +D  E     V GT 
Sbjct: 134 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF--SCQLDPGE-KLREVCGTP 187
Query: 673 GYMPPEYAIDGL------FSVKSDVFSFGVLVLEIVCG 704
            Y+ PE     +      +  + D++S GV++  ++ G
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEG-QEIAAKRLSKSSGQGMEEFENEVLLIAKLQ---- 558
           EN+  K  LG G    V + +     +E A K +  + G      E + L  A L+    
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 559 ------HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGI 612
                 H N+++L           L+++ +    L D++   T    L   +  +I+  +
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 120
Query: 613 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTY 672
              +  LH   +L I+HRDLK  N+LLD++MN K++DFG   +  +D  E     V GT 
Sbjct: 121 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF--SCQLDPGE-KLREVCGTP 174
Query: 673 GYMPPEYAIDGL------FSVKSDVFSFGVLVLEIVCG 704
            Y+ PE     +      +  + D++S GV++  ++ G
Sbjct: 175 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 509 KNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRNLVKLI 566
           ++ LGEG    V   + LI  QE A K + K  G        EV ++ + Q HRN+++LI
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 626
               + D   L++E +   S+   +  + + +  +  +   ++  +A  L +LH      
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSI---LSHIHKRRHFNELEASVVVQDVASALDFLHNKG--- 131
Query: 627 IIHRDLKASNVLLD--NEMNP-KISDFGMARAFGI--DQTEANTNRVV---GTYGYMPPE 678
           I HRDLK  N+L +  N+++P KI DF +     +  D +  +T  ++   G+  YM PE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 679 YA-----IDGLFSVKSDVFSFGVLVLEIVCG 704
                     ++  + D++S GV++  ++ G
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 86/207 (41%), Gaps = 16/207 (7%)
Query: 503 TENFSDKNKLGEGGFGPVYKGVL-IEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRN 561
           T+ +  K  +G G +    + +      E A K + KS     EE E   +L+   QH N
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIE---ILLRYGQHPN 77
Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
           ++ L           ++ E      L D I    R KF    +   ++  I + + YLH 
Sbjct: 78  IITLKDVYDDGKYVYVVTELXKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLHA 134
Query: 622 DSRLRIIHRDLKASNVL-LDNEMNP---KISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
                ++HRDLK SN+L +D   NP   +I DFG A+    +     T     T  ++ P
Sbjct: 135 QG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTP--CYTANFVAP 189
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           E      +    D++S GVL+   + G
Sbjct: 190 EVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 23/210 (10%)
Query: 502 ATENFSD-----KNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEE---FENEV 551
           + ENF++       +LG G F  V + +    GQE AAK L K   GQ        E  V
Sbjct: 22  SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAV 81
Query: 552 LLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG 611
           L +AK   R ++ L        E +LI EY     +         ++ +  +   ++I  
Sbjct: 82  LELAKSCPR-VINLHEVYENTSEIILILEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQ 139
Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGIDQTEANTNR 667
           I  G+ YLHQ++   I+H DLK  N+LL + + P    KI DFGM+R  G          
Sbjct: 140 ILEGVYYLHQNN---IVHLDLKPQNILLSS-IYPLGDIKIVDFGMSRKIG---HACELRE 192
Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVL 697
           ++GT  Y+ PE       +  +D+++ G++
Sbjct: 193 IMGTPEYLAPEILNYDPITTATDMWNIGII 222

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEG-QEIAAKRLSKSSGQGMEEFENEVLLIAKLQ---- 558
           EN+  K  LG G    V + +     +E A K +  + G      E + L  A L+    
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 559 ------HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGI 612
                 H N+++L           L+++ +    L D++   T    L   +  +I+  +
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 133
Query: 613 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTY 672
              +  LH   +L I+HRDLK  N+LLD++MN K++DFG   +  +D  E     V GT 
Sbjct: 134 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF--SCQLDPGE-KLRSVCGTP 187
Query: 673 GYMPPEYAIDGL------FSVKSDVFSFGVLVLEIVCG 704
            Y+ PE     +      +  + D++S GV++  ++ G
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 20/208 (9%)
Query: 506 FSD----KNKLGEGGFGPVYKGVL-IEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR 560
           FSD    K  +G G +    + V      E A K + KS     EE E   +L+   QH 
Sbjct: 25  FSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIE---ILLRYGQHP 81
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N++ L           L+ E +    L D I    R KF    +   ++  I + + YLH
Sbjct: 82  NIITLKDVYDDGKHVYLVTELMRGGELLDKIL---RQKFFSEREASFVLHTIGKTVEYLH 138
Query: 621 QDSRLRIIHRDLKASNVL-LDNEMNP---KISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
                 ++HRDLK SN+L +D   NP   +I DFG A+    +     T     T  ++ 
Sbjct: 139 SQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTP--CYTANFVA 193
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           PE      +    D++S G+L+  ++ G
Sbjct: 194 PEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 15/205 (7%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFE---NEVLLIAKLQH 559
           + F     LG G FG V     +E G   A K L K     +++ E   NE  ++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
             LVKL           ++ EY+    +   +  + R  F +   R      I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARF-YAAQIVLTFEYL 157
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+ PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCG 704
            +   ++   D ++ GVL+ E+  G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 20/208 (9%)
Query: 506 FSD----KNKLGEGGFGPVYKGVL-IEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR 560
           FSD    K  +G G +    + V      E A K + KS     EE E   +L+   QH 
Sbjct: 25  FSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIE---ILLRYGQHP 81
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N++ L           L+ E +    L D I    R KF    +   ++  I + + YLH
Sbjct: 82  NIITLKDVYDDGKHVYLVTELMRGGELLDKIL---RQKFFSEREASFVLHTIGKTVEYLH 138
Query: 621 QDSRLRIIHRDLKASNVL-LDNEMNP---KISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
                 ++HRDLK SN+L +D   NP   +I DFG A+    +     T     T  ++ 
Sbjct: 139 SQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTP--CYTANFVA 193
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           PE      +    D++S G+L+  ++ G
Sbjct: 194 PEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 18/214 (8%)
Query: 497 MAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAK 556
           M I + ++ +     +G G FG          +E+ A +  +      E  + E++    
Sbjct: 13  MPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRS 72
Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC---QIIGGIA 613
           L+H N+V+            +I EY     L + I +  R  F +   R    Q++ G++
Sbjct: 73  LRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGR--FSEDEARFFFQQLLSGVS 130
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGIDQTEANTNRVVGT 671
               Y H    ++I HRDLK  N LLD    P  KI DFG +++  +     +T   VGT
Sbjct: 131 ----YCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGT 180
Query: 672 YGYMPPEYAIDGLFSVK-SDVFSFGVLVLEIVCG 704
             Y+ PE  +   +  K +DV+S GV +  ++ G
Sbjct: 181 PAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFE---NEVLLIAK 556
           + F     LG G FG V   +L++    G   A K L K     +++ E   NE  ++  
Sbjct: 62  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 616
           +    LVKL           ++ EY+    +   +  + R  F +   R      I    
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTF 175
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+ 
Sbjct: 176 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 227
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           PE  +   ++   D ++ GVL+ E+  G
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFE---NEVLLIAK 556
           + F     LG G FG V   +L++    G   A K L K     +++ E   NE  ++  
Sbjct: 36  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 92
Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 616
           +    LVKL           ++ EY+    +   +  + R  F +   R      I    
Sbjct: 93  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTF 149
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+ 
Sbjct: 150 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 201
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           PE  +   ++   D ++ GVL+ E+  G
Sbjct: 202 PEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFE---NEVLLIAK 556
           + F     LG G FG V   +L++    G   A K L K     +++ E   NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 616
           +    LVKL           ++ EY+    +   +  + R  F +   R      I    
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTF 154
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+ 
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           PE  +   ++   D ++ GVL+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFE---NEVLLIAK 556
           + F     LG G FG V   +L++    G   A K L K     +++ E   NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 616
           +    LVKL           ++ EY+    +   +  + R  F +   R      I    
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTF 154
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+ 
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           PE  +   ++   D ++ GVL+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFE---NEVLLIAK 556
           + F     LG G FG V   +L++    G   A K L K     +++ E   NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 616
           +    LVKL           ++ EY+    +   +  + R  F +   R      I    
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTF 154
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+ 
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           PE  +   ++   D ++ GVL+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFE---NEVLLIAK 556
           + F     LG G FG V   +L++    G   A K L K     +++ E   NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 616
           +    LVKL           ++ EY+    +   +  + R  F +   R      I    
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARF-YAAQIVLTF 154
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+ 
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLAGTPEYLA 206
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           PE  +   ++   D ++ GVL+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFE---NEVLLIAK 556
           + F     LG G FG V   +L++    G   A K L K     +++ E   NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 616
           +    LVKL           ++ EY+    +   +  + R  F +   R      I    
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FAEPHARF-YAAQIVLTF 154
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+ 
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           PE  +   ++   D ++ GVL+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 94/206 (45%), Gaps = 14/206 (6%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEE--FENEVLLIAKLQHR 560
           E +    K+GEG +G V+K    + GQ +A K+  +S    + +     E+ ++ +L+H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDF-IFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
           NLV L+    ++    L++EY  +  L++   +     + L  S   Q +  +     + 
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVN----FC 118
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H+ +    IHRD+K  N+L+      K+ DFG AR         +    V T  Y  PE 
Sbjct: 119 HKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE--VATRWYRSPEL 173
Query: 680 AI-DGLFSVKSDVFSFGVLVLEIVCG 704
            + D  +    DV++ G +  E++ G
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFE---NEVLLIAK 556
           + F     LG G FG V   +L++    G   A K L K     +++ E   NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 616
           +    LVKL           ++ EY+    +   +  + R  F +   R      I    
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARF-YAAQIVLTF 154
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YLH    L +I+RDLK  N+++D +   +++DFG A+     + +  T  + GT  Y+ 
Sbjct: 155 EYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           PE  I   ++   D ++ GVL+ E+  G
Sbjct: 207 PEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFE---NEVLLIAK 556
           + F     LG G FG V   +L++    G   A K L K     +++ E   NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 616
           +    LVKL           ++ EY+    +   +  + R  F +   R      I    
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARF-YAAQIVLTF 154
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+ 
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           PE  +   ++   D ++ GVL+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 80/165 (48%), Gaps = 24/165 (14%)
Query: 506 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK 564
           + D   LG GG G V+  V  +  + +A K++  +  Q ++    E+ +I +L H N+VK
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 565 L--------------IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG 610
           +              +G  T+ +   ++ EY+      D    + +   L+   R   + 
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYME----TDLANVLEQGPLLEEHARL-FMY 127
Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMAR 654
            + RGL Y+H  +   ++HRDLK +N+ ++ E +  KI DFG+AR
Sbjct: 128 QLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLAR 169

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 102/228 (44%), Gaps = 25/228 (10%)
Query: 491 LPIFDWMAIANATENFSDK-------NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQG 543
           +P  + +    A ENF  K        +LG G +G V K   +   +I A +  +++   
Sbjct: 14  IPTTENLYFQGAXENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNS 73
Query: 544 MEEFENEVLLIAKLQHRNL-----VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVT-RS 597
            E+    +L    +  R +     V   G    R+  + I   L + SL+ F   V  + 
Sbjct: 74  QEQ--KRLLXDLDISXRTVDCPFTVTFYGALF-REGDVWICXELXDTSLDKFYKQVIDKG 130
Query: 598 KFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 657
           + +      +I   I + L +LH  S+L +IHRD+K SNVL++     K  DFG++  + 
Sbjct: 131 QTIPEDILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGIS-GYL 187
Query: 658 IDQTEANTNRVVGTYGYMPPEYAIDGL----FSVKSDVFSFGVLVLEI 701
           +D    + +   G   Y  PE     L    +SVKSD++S G+  +E+
Sbjct: 188 VDDVAKDID--AGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIEL 233

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFE---NEVLLIAK 556
           + F     LG G FG V   +L++    G   A K L K     +++ E   NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 616
           +    LVKL           ++ EY+    +   +  + R  F +   R      I    
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARF-YAAQIVLTF 154
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+ 
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           PE  +   ++   D ++ GVL+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFE---NEVLLIAK 556
           + F     LG G FG V   +L++    G   A K L K     +++ E   NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 616
           +    LVKL           ++ EY+    +   +  + R  F +   R      I    
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARF-YAAQIVLTF 154
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+ 
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLXGTPEYLA 206
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           PE  +   ++   D ++ GVL+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFE---NEVLLIAK 556
           + F     LG G FG V   +L++    G   A K L K     +++ E   NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 616
           +    LVKL           ++ EY+    +   +  + R  F +   R      I    
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARF-YAAQIVLTF 154
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+ 
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           PE  +   ++   D ++ GVL+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFE---NEVLLIAK 556
           + F     LG G FG V   +L++    G   A K L K     +++ E   NE  ++  
Sbjct: 42  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 616
           +    LVKL           ++ EY+    +   +  + R  F +   R      I    
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARF-YAAQIVLTF 155
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+ 
Sbjct: 156 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 207
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           PE  +   ++   D ++ GVL+ E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFE---NEVLLIAK 556
           + F     LG G FG V   +L++    G   A K L K     +++ E   NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 616
           +    LVKL           ++ EY+    +   +  + R  F +   R      I    
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARF-YAAQIVLTF 154
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+ 
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           PE  +   ++   D ++ GVL+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFE---NEVLLIAK 556
           + F     LG G FG V   +L++    G   A K L K     +++ E   NE  ++  
Sbjct: 28  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 84
Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 616
           +    LVKL           ++ EY+    +   +  + R  F +   R      I    
Sbjct: 85  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARF-YAAQIVLTF 141
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+ 
Sbjct: 142 EYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 193
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           PE  +   ++   D ++ GVL+ E+  G
Sbjct: 194 PEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFE---NEVLLIAK 556
           + F     LG G FG V   +L++    G   A K L K     +++ E   NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 616
           +    LVKL           ++ EY+    +   +  + R  F +   R      I    
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARF-YAAQIVLTF 154
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+ 
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           PE  +   ++   D ++ GVL+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 28/216 (12%)
Query: 503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL------SKSSGQGMEEFENEVLLIAK 556
            E++     +G G FG V        Q++ A +L       K S       E +++  A 
Sbjct: 74  AEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA- 132
Query: 557 LQHRNLVKLIGCCTQRDERM-LIYEYLPNKSLNDFI--FDVTRSKFLDWSKRCQIIGGIA 613
             +   V  + C  Q D+ + ++ EY+P   L + +  +DV       W+K        A
Sbjct: 133 --NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFY-----TA 181
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT-EANTNRVVGTY 672
             +L L     + +IHRD+K  N+LLD   + K++DFG      +D+T   + +  VGT 
Sbjct: 182 EVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGT--CMKMDETGMVHCDTAVGTP 239
Query: 673 GYMPPEY----AIDGLFSVKSDVFSFGVLVLEIVCG 704
            Y+ PE       DG +  + D +S GV + E++ G
Sbjct: 240 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 18/214 (8%)
Query: 497 MAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAK 556
           + I + ++ +     +G G FG        +  E+ A +  +   +  E  + E++    
Sbjct: 11  LPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRS 70
Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC---QIIGGIA 613
           L+H N+V+            ++ EY     L + I +  R  F +   R    Q+I G++
Sbjct: 71  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVS 128
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGIDQTEANTNRVVGT 671
               Y H    +++ HRDLK  N LLD    P  KI DFG +++  +     +T   VGT
Sbjct: 129 ----YCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGT 178
Query: 672 YGYMPPEYAIDGLFSVK-SDVFSFGVLVLEIVCG 704
             Y+ PE  +   +  K +DV+S GV +  ++ G
Sbjct: 179 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 511 KLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFE-NEVLLIAKLQHRNLVKLIGCC 569
           K+G G +G VYK    +G++     L +  G G+      E+ L+ +L+H N++ L    
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 570 TQRDERM--LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY-----LHQD 622
               +R   L+++Y  +   +  I    R+   +  K  Q+  G+ + LLY     +H  
Sbjct: 88  LSHADRKVWLLFDYAEHDLWH--IIKFHRASKAN-KKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 623 SRLRIIHRDLKASNVLLDNEMNP-----KISDFGMARAFGID-QTEANTNRVVGTYGYMP 676
               ++HRDLK +N+L+  E  P     KI+D G AR F    +  A+ + VV T+ Y  
Sbjct: 145 HANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 203
Query: 677 PEYAIDGLFSVKS-DVFSFGVLVLEIVCGK 705
           PE  +      K+ D+++ G +  E++  +
Sbjct: 204 PELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 99/230 (43%), Gaps = 24/230 (10%)
Query: 481 DRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSS 540
           DR      M+LPI       + ++ +     +G G FG        +  E+ A +  +  
Sbjct: 2   DRPAVSGPMDLPIM------HDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG 55
Query: 541 GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFL 600
            +     + E++    L+H N+V+            ++ EY     L + I +  R  F 
Sbjct: 56  EKIAANVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FS 113
Query: 601 DWSKRC---QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP--KISDFGMARA 655
           +   R    Q+I G++    Y H    +++ HRDLK  N LLD    P  KI DFG +++
Sbjct: 114 EDEARFFFQQLISGVS----YCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 166
Query: 656 FGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVK-SDVFSFGVLVLEIVCG 704
             +     +T   VGT  Y+ PE  +   +  K +DV+S GV +  ++ G
Sbjct: 167 SVLHSQPKST---VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFE---NEVLLIAK 556
           + F     LG G FG V   +L++    G   A K L K     +++ E   NE  ++  
Sbjct: 62  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 616
           +    LVKL           ++ EY+    +   +  + R  F +   R      I    
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARF-YAAQIVLTF 175
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+ 
Sbjct: 176 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGATWTLCGTPEYLA 227
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           PE  +   ++   D ++ GVL+ E+  G
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 103/218 (47%), Gaps = 38/218 (17%)
Query: 506 FSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVK 564
           +++   +G G FG V++  L+E  E+A K++ +      + F+N  L I ++ +H N+V 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVD 96
Query: 565 LIGCC----TQRDERM--LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG-------- 610
           L         ++DE    L+ EY+P     + ++  +R     ++K  Q +         
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVP-----ETVYRASRH----YAKLKQTMPMLLIKLYM 147
Query: 611 -GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQTEANTNRV 668
             + R L Y+H    + I HRD+K  N+LLD      K+ DFG A+   +   E N + +
Sbjct: 148 YQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI--LIAGEPNVSXI 202
Query: 669 VGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
              Y Y  PE       ++   D++S G ++ E++ G+
Sbjct: 203 CSRY-YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 93/232 (40%), Gaps = 47/232 (20%)
Query: 503 TENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFE--NEVLLIAKL-Q 558
           T  F +  K+G G FG V+K V  ++G   A KR  K     ++E     EV   A L Q
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 67
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTR-SKFLDWSKRCQIIGGIARGLL 617
           H ++V+      + D  ++  EY    SL D I +  R   +   ++   ++  + RGL 
Sbjct: 68  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 127
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNP-------------------KISDFGMARAFGI 658
           Y+H    + ++H D+K SN+ +     P                   KI D G       
Sbjct: 128 YIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 184
Query: 659 DQTEANTNRVVG------TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
            Q E   +R +        Y ++P           K+D+F+   L L +VC 
Sbjct: 185 PQVEEGDSRFLANEVLQENYTHLP-----------KADIFA---LALTVVCA 222

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 93/232 (40%), Gaps = 47/232 (20%)
Query: 503 TENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFE--NEVLLIAKL-Q 558
           T  F +  K+G G FG V+K V  ++G   A KR  K     ++E     EV   A L Q
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTR-SKFLDWSKRCQIIGGIARGLL 617
           H ++V+      + D  ++  EY    SL D I +  R   +   ++   ++  + RGL 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNP-------------------KISDFGMARAFGI 658
           Y+H    + ++H D+K SN+ +     P                   KI D G       
Sbjct: 130 YIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 659 DQTEANTNRVVG------TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
            Q E   +R +        Y ++P           K+D+F+   L L +VC 
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLP-----------KADIFA---LALTVVCA 224

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 93/232 (40%), Gaps = 47/232 (20%)
Query: 503 TENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFE--NEVLLIAKL-Q 558
           T  F +  K+G G FG V+K V  ++G   A KR  K     ++E     EV   A L Q
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 67
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTR-SKFLDWSKRCQIIGGIARGLL 617
           H ++V+      + D  ++  EY    SL D I +  R   +   ++   ++  + RGL 
Sbjct: 68  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 127
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNP-------------------KISDFGMARAFGI 658
           Y+H    + ++H D+K SN+ +     P                   KI D G       
Sbjct: 128 YIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 184
Query: 659 DQTEANTNRVVG------TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
            Q E   +R +        Y ++P           K+D+F+   L L +VC 
Sbjct: 185 PQVEEGDSRFLANEVLQENYTHLP-----------KADIFA---LALTVVCA 222

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 70/152 (46%), Gaps = 12/152 (7%)
Query: 512 LGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRNLVKLIGCC 569
           L EGGF  VY+   +  G+E A KRL  +  +       EV  + KL  H N+V+     
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 570 --------TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
                   T + E +L+ E L    L +F+  +     L      +I     R + ++H+
Sbjct: 96  SIGKEESDTGQAEFLLLTE-LCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 653
             +  IIHRDLK  N+LL N+   K+ DFG A
Sbjct: 155 Q-KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFE---NEVLLIAK 556
           + F     LG G FG V   +L++    G   A K L K     +++ E   NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 616
           +    LVKL           ++ EY+    +   +  + R  F +   R      I    
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARF-YAAQIVLTF 154
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+ 
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           PE  +   ++   D ++ GVL+ ++  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 93/225 (41%), Gaps = 23/225 (10%)
Query: 492 PIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEI----AAKRLSKSSGQGMEEF 547
           P+FD     N  ++F     +G+G FG V    +++  +     A K ++K       E 
Sbjct: 4   PVFDENEDVNF-DHFEILRAIGKGSFGKV---CIVQKNDTKKMYAMKYMNKQKCVERNEV 59
Query: 548 EN---EVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSK 604
            N   E+ ++  L+H  LV L       ++  ++ + L      D  + + ++       
Sbjct: 60  RNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLG---GDLRYHLQQNVHFKEET 116
Query: 605 RCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 664
               I  +   L YL      RIIHRD+K  N+LLD   +  I+DF +A        E  
Sbjct: 117 VKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP---RETQ 170
Query: 665 TNRVVGTYGYMPPEYAID---GLFSVKSDVFSFGVLVLEIVCGKR 706
              + GT  YM PE         +S   D +S GV   E++ G+R
Sbjct: 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 90/200 (45%), Gaps = 18/200 (9%)
Query: 511 KLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLL-IAKLQHRNLVKLIGC 568
           +LG G FG V++    + G + A K++       +E F  E L+  A L    +V L G 
Sbjct: 100 RLGRGSFGEVHRMEDKQTGFQCAVKKVR------LEVFRAEELMACAGLTSPRIVPLYGA 153
Query: 569 CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRII 628
             +     +  E L   SL      V     L   +    +G    GL YLH  SR RI+
Sbjct: 154 VREGPWVNIFMELLEGGSLGQL---VKEQGCLPEDRALYYLGQALEGLEYLH--SR-RIL 207
Query: 629 HRDLKASNVLLDNE-MNPKISDFGMARAF---GIDQTEANTNRVVGTYGYMPPEYAIDGL 684
           H D+KA NVLL ++  +  + DFG A      G+ ++    + + GT  +M PE  +   
Sbjct: 208 HGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS 267
Query: 685 FSVKSDVFSFGVLVLEIVCG 704
              K DV+S   ++L ++ G
Sbjct: 268 CDAKVDVWSSCCMMLHMLNG 287

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 38/124 (30%), Positives = 56/124 (45%), Gaps = 25/124 (20%)
Query: 601 DW-SKRC-----------QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKIS 648
           DW ++RC            I   IA  + +LH      ++HRDLK SN+    +   K+ 
Sbjct: 150 DWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG 206
Query: 649 DFGMARAFGIDQTE----------ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLV 698
           DFG+  A   D+ E          A     VGT  YM PE      +S K D+FS G+++
Sbjct: 207 DFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLIL 266
Query: 699 LEIV 702
            E++
Sbjct: 267 FELL 270

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 55/101 (54%), Gaps = 12/101 (11%)
Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVG 670
            I + L YL +  +  +IHRD+K SN+LLD     K+ DFG++     D+ +   +R  G
Sbjct: 132 AIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAG 186
Query: 671 TYGYMPPEYAIDGL------FSVKSDVFSFGVLVLEIVCGK 705
              YM PE  ID        + +++DV+S G+ ++E+  G+
Sbjct: 187 CAAYMAPE-RIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 99/230 (43%), Gaps = 24/230 (10%)
Query: 481 DRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSS 540
           DR      M+LPI       + ++ +     +G G FG        +  E+ A +  +  
Sbjct: 2   DRPAVSGPMDLPIM------HDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG 55
Query: 541 GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFL 600
            +  E  + E++    L+H N+V+            ++ EY     L + I +  R  F 
Sbjct: 56  EKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FS 113
Query: 601 DWSKRC---QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP--KISDFGMARA 655
           +   R    Q+I G++    Y H    +++ HRDLK  N LLD    P  KI  FG +++
Sbjct: 114 EDEARFFFQQLISGVS----YCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKS 166
Query: 656 FGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVK-SDVFSFGVLVLEIVCG 704
             +     +T   VGT  Y+ PE  +   +  K +DV+S GV +  ++ G
Sbjct: 167 SVLHSQPKDT---VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 18/205 (8%)
Query: 506 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFE-NEVLLIAKLQHRNLV 563
            + + +LG G FG V++    + G + A K++       +E F   E++  A L    +V
Sbjct: 74  MTHQPRLGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIV 127
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
            L G   +     +  E L   SL   I  +     L   +    +G    GL YLH   
Sbjct: 128 PLYGAVREGPWVNIFMELLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTR- 183
Query: 624 RLRIIHRDLKASNVLLDNEMN-PKISDFGMARAF---GIDQTEANTNRVVGTYGYMPPEY 679
             RI+H D+KA NVLL ++ +   + DFG A      G+ ++    + + GT  +M PE 
Sbjct: 184 --RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 241
Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCG 704
            +      K D++S   ++L ++ G
Sbjct: 242 VMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 15/203 (7%)
Query: 512 LGEGGFGPVYKGVLIE-GQEIAAK-----RLSKSSGQGMEEFENEVLLIAKLQHRNLVKL 565
           +G+G F  V + +  E GQ+ A K     + + S G   E+ + E  +   L+H ++V+L
Sbjct: 34  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 93
Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFL-DWSKRCQIIGGIARGLLYLHQDSR 624
           +   +      +++E++    L   I     + F+   +     +  I   L Y H ++ 
Sbjct: 94  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN- 152
Query: 625 LRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
             IIHRD+K   VLL ++ N    K+  FG+A   G     A     VGT  +M PE   
Sbjct: 153 --IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--VGTPHFMAPEVVK 208
Query: 682 DGLFSVKSDVFSFGVLVLEIVCG 704
              +    DV+  GV++  ++ G
Sbjct: 209 REPYGKPVDVWGCGVILFILLSG 231

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 89/200 (44%), Gaps = 18/200 (9%)
Query: 511 KLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLL-IAKLQHRNLVKLIGC 568
           +LG G FG V++    + G + A K++       +E F  E L+  A L    +V L G 
Sbjct: 81  RLGRGSFGEVHRMEDKQTGFQCAVKKVR------LEVFRAEELMACAGLTSPRIVPLYGA 134
Query: 569 CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRII 628
             +     +  E L   SL      V     L   +    +G    GL YLH  SR RI+
Sbjct: 135 VREGPWVNIFMELLEGGSLGQL---VKEQGCLPEDRALYYLGQALEGLEYLH--SR-RIL 188
Query: 629 HRDLKASNVLLDNE-MNPKISDFGMARAF---GIDQTEANTNRVVGTYGYMPPEYAIDGL 684
           H D+KA NVLL ++  +  + DFG A      G+ +     + + GT  +M PE  +   
Sbjct: 189 HGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS 248
Query: 685 FSVKSDVFSFGVLVLEIVCG 704
              K DV+S   ++L ++ G
Sbjct: 249 CDAKVDVWSSCCMMLHMLNG 268

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 99/230 (43%), Gaps = 24/230 (10%)
Query: 481 DRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSS 540
           DR      M+LPI       + ++ +     +G G FG        +  E+ A +  +  
Sbjct: 2   DRPAVSGPMDLPIM------HDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG 55
Query: 541 GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFL 600
            +  E  + E++    L+H N+V+            ++ EY     L + I +  R  F 
Sbjct: 56  EKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FS 113
Query: 601 DWSKRC---QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP--KISDFGMARA 655
           +   R    Q+I G++    Y H    +++ HRDLK  N LLD    P  KI  FG +++
Sbjct: 114 EDEARFFFQQLISGVS----YCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKS 166
Query: 656 FGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVK-SDVFSFGVLVLEIVCG 704
             +     +T   VGT  Y+ PE  +   +  K +DV+S GV +  ++ G
Sbjct: 167 SVLHSQPKST---VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 21/208 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFE---NEVLLIAK 556
           + F     LG G FG V   +L++    G   A K L K     +++ E   NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 616
           +    LVKL           ++ EY+    +   +  + R  F +   R      I    
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARF-YAAQIVLTF 154
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT  Y+ 
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLA 206
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           P   +   ++   D ++ GVL+ E+  G
Sbjct: 207 PAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 91/227 (40%), Gaps = 44/227 (19%)
Query: 503 TENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFE--NEVLLIAKL-Q 558
           T  F +  K+G G FG V+K V  ++G   A KR  K     ++E     EV   A L Q
Sbjct: 6   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 65
Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTR-SKFLDWSKRCQIIGGIARGLL 617
           H ++V+      + D  ++  EY    SL D I +  R   +   ++   ++  + RGL 
Sbjct: 66  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 125
Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNP-------------------KISDFGMARAFGI 658
           Y+H    + ++H D+K SN+ +     P                   KI D G       
Sbjct: 126 YIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 182
Query: 659 DQTEANTNRVVG------TYGYMPPEYAIDGLFSVKSDVFSFGVLVL 699
            Q E   +R +        Y ++P           K+D+F+  + V+
Sbjct: 183 PQVEEGDSRFLANEVLQENYTHLP-----------KADIFALALTVV 218

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 15/203 (7%)
Query: 512 LGEGGFGPVYKGVLIE-GQEIAAK-----RLSKSSGQGMEEFENEVLLIAKLQHRNLVKL 565
           +G+G F  V + +  E GQ+ A K     + + S G   E+ + E  +   L+H ++V+L
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFL-DWSKRCQIIGGIARGLLYLHQDSR 624
           +   +      +++E++    L   I     + F+   +     +  I   L Y H ++ 
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN- 150
Query: 625 LRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
             IIHRD+K   VLL ++ N    K+  FG+A   G     A     VGT  +M PE   
Sbjct: 151 --IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--VGTPHFMAPEVVK 206
Query: 682 DGLFSVKSDVFSFGVLVLEIVCG 704
              +    DV+  GV++  ++ G
Sbjct: 207 REPYGKPVDVWGCGVILFILLSG 229

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 94/229 (41%), Gaps = 19/229 (8%)
Query: 482 RGNREEEMELPIFDWMAIANA-TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSS 540
           RG   E ++ P +D     +   ++F   ++LG G +G V+K    E   + A + S S 
Sbjct: 34  RGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSP 93
Query: 541 GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDER------MLIYEYLPNKSLNDFIFDV 594
            +G ++   +   +A++     V    CC + ++       + +   L   SL       
Sbjct: 94  FRGPKDRARK---LAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAW 150
Query: 595 TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 654
             S         Q+ G +   LL L       ++H D+K +N+ L      K+ DFG+  
Sbjct: 151 GASL-----PEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLV 205
Query: 655 AFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC 703
             G   T        G   YM PE  + G +   +DVFS G+ +LE+ C
Sbjct: 206 ELG---TAGAGEVQEGDPRYMAPEL-LQGSYGTAADVFSLGLTILEVAC 250

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 18/205 (8%)
Query: 506 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFE-NEVLLIAKLQHRNLV 563
            + + ++G G FG V++    + G + A K++       +E F   E++  A L    +V
Sbjct: 60  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIV 113
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
            L G   +     +  E L   SL   I  +     L   +    +G    GL YLH   
Sbjct: 114 PLYGAVREGPWVNIFMELLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTR- 169
Query: 624 RLRIIHRDLKASNVLLDNEMN-PKISDFGMARAF---GIDQTEANTNRVVGTYGYMPPEY 679
             RI+H D+KA NVLL ++ +   + DFG A      G+ ++    + + GT  +M PE 
Sbjct: 170 --RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227
Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCG 704
            +      K D++S   ++L ++ G
Sbjct: 228 VMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 18/205 (8%)
Query: 506 FSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFE-NEVLLIAKLQHRNLV 563
            + + ++G G FG V++    + G + A K++       +E F   E++  A L    +V
Sbjct: 76  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIV 129
Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
            L G   +     +  E L   SL   I  +     L   +    +G    GL YLH   
Sbjct: 130 PLYGAVREGPWVNIFMELLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTR- 185
Query: 624 RLRIIHRDLKASNVLLDNEMN-PKISDFGMARAF---GIDQTEANTNRVVGTYGYMPPEY 679
             RI+H D+KA NVLL ++ +   + DFG A      G+ ++    + + GT  +M PE 
Sbjct: 186 --RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 243
Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCG 704
            +      K D++S   ++L ++ G
Sbjct: 244 VMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 21/208 (10%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQGMEEFE---NEVLLIAK 556
           + F     LG G FG V   +L++    G   A K L K     +++ E   NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 616
           +    LVKL           ++ EY+    +   +  + R  F +   R      I    
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARF-YAAQIVLTF 154
Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YLH    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT   + 
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEALA 206
Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           PE  +   ++   D ++ GVL+ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 19/201 (9%)
Query: 512 LGEGGFGPVYKGVLIEGQEI--AAKRLSKSSGQGMEEFENEVL-----LIAKLQHRNLVK 564
           +G+G FG V      + +E+  A K L K +    +E E  ++     L+  ++H  LV 
Sbjct: 46  IGKGSFGKVLLARH-KAEEVFYAVKVLQKKAILKKKE-EKHIMSERNVLLKNVKHPFLVG 103
Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSK-FLDWSKRCQIIGGIARGLLYLHQDS 623
           L       D+   + +Y+    L    + + R + FL+   R      IA  L YLH   
Sbjct: 104 LHFSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARF-YAAEIASALGYLHS-- 157
Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
            L I++RDLK  N+LLD++ +  ++DFG+ +   I+   + T+   GT  Y+ PE     
Sbjct: 158 -LNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHN-STTSTFCGTPEYLAPEVLHKQ 214
Query: 684 LFSVKSDVFSFGVLVLEIVCG 704
            +    D +  G ++ E++ G
Sbjct: 215 PYDRTVDWWCLGAVLYEMLYG 235

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/207 (21%), Positives = 88/207 (42%), Gaps = 18/207 (8%)
Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E +     LG G FG V++ V    ++    +  K  G      + E+ ++   +HRN++
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 564 KLIGCCTQRDERMLIYEYLPN----KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
            L       +E ++I+E++      + +N   F++   + + +      +  +   L +L
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY------VHQVCEALQFL 118
Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           H  +   I H D++  N++     +   KI +FG AR     +   N   +     Y  P
Sbjct: 119 HSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL---KPGDNFRLLFTAPEYYAP 172
Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           E     + S  +D++S G LV  ++ G
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSG 199

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 99/238 (41%), Gaps = 20/238 (8%)
Query: 490 ELPIFDWMAIANATEN-FSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGM---- 544
           E  + D +A  +A ++ ++ +  +  G +G V  GV  EG  +A KR+  +   G     
Sbjct: 7   EAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNI 66
Query: 545 -------EEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRS 597
                  +    E+ L+    H N++ L       +E  +   YL  + +   +  V   
Sbjct: 67  LSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHD 126
Query: 598 KFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 657
           + +  S +  I   +   LL LH      ++HRDL   N+LL +  +  I DF +AR   
Sbjct: 127 QRIVISPQ-HIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARE-- 183
Query: 658 IDQTEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK---RNRGFY 711
            D  +AN    V    Y  PE  +    F+   D++S G ++ E+   K   R   FY
Sbjct: 184 -DTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 99/238 (41%), Gaps = 20/238 (8%)
Query: 490 ELPIFDWMAIANATEN-FSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGM---- 544
           E  + D +A  +A ++ ++ +  +  G +G V  GV  EG  +A KR+  +   G     
Sbjct: 7   EAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNI 66
Query: 545 -------EEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRS 597
                  +    E+ L+    H N++ L       +E  +   YL  + +   +  V   
Sbjct: 67  LSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHD 126
Query: 598 KFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 657
           + +  S +  I   +   LL LH      ++HRDL   N+LL +  +  I DF +AR   
Sbjct: 127 QRIVISPQ-HIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARE-- 183
Query: 658 IDQTEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK---RNRGFY 711
            D  +AN    V    Y  PE  +    F+   D++S G ++ E+   K   R   FY
Sbjct: 184 -DTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 85/200 (42%), Gaps = 18/200 (9%)
Query: 512 LGEGGFGPVYKGVLIEG-QEIAAKRLSKSSGQGMEEFENEVLLIAKL--QHRNLVKLIGC 568
           LGEG F    K V  +  Q  A K +SK     ME    + +   KL   H N+VKL   
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 569 CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRII 628
              +    L+ E L    L + I    + K    ++   I+  +   + ++H    + ++
Sbjct: 75  FHDQLHTFLVMELLNGGELFERI---KKKKHFSETEASYIMRKLVSAVSHMHD---VGVV 128
Query: 629 HRDLKASNVLLDNE---MNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF 685
           HRDLK  N+L  +E   +  KI DFG AR    D     T     T  Y  PE      +
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP--CFTLHYAAPELLNQNGY 186
Query: 686 SVKSDVFSFGVLVLEIVCGK 705
               D++S GV++  ++ G+
Sbjct: 187 DESCDLWSLGVILYTMLSGQ 206

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 53/109 (48%), Gaps = 8/109 (7%)
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN--TNRVVGT 671
           RGL Y+H     ++IHRDLK SN+L++     KI DFGMAR       E        V T
Sbjct: 170 RGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 226
Query: 672 YGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL 719
             Y  PE  +    ++   D++S G +  E++   R + F   ++ H L
Sbjct: 227 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA--RRQLFPGKNYVHQL 273

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 505 NFSDKNKLGEGGFGP-VYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNL 562
           +F  K+ LG G  G  VY+G + + +++A KR+     +     + EV L+ +  +H N+
Sbjct: 25  SFCPKDVLGHGAEGTIVYRG-MFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNV 80
Query: 563 VKLIGCCTQRDERM-LIYEYLPNKSLNDFIFDVTRSKFLDWS-KRCQIIGGIARGLLYLH 620
           ++    CT++D +   I   L   +L ++   V +  F     +   ++     GL +LH
Sbjct: 81  IRYF--CTEKDRQFQYIAIELCAATLQEY---VEQKDFAHLGLEPITLLQQTTSGLAHLH 135
Query: 621 QDSRLRIIHRDLKASNVLLD-----NEMNPKISDFGMARAFGIDQTE-ANTNRVVGTYGY 674
               L I+HRDLK  N+L+       ++   ISDFG+ +   + +   +  + V GT G+
Sbjct: 136 S---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 675 MPPEYAIDGLF---SVKSDVFSFGVLVLEIV 702
           + PE   +      +   D+FS G +   ++
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVI 223

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 71/141 (50%), Gaps = 16/141 (11%)
Query: 544 MEEFENEVLLIAKLQHRNLVKLIGC--CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLD 601
           M EFE    ++ KL H+N+VKL      T    ++LI E+ P  SL   + + + +  L 
Sbjct: 55  MREFE----VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLP 110
Query: 602 WSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNEMNPKISDFGMARAFG 657
            S+   ++  +  G+ +L ++    I+HR++K  N++     D +   K++DFG AR   
Sbjct: 111 ESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167
Query: 658 IDQTEANTNRVVGTYGYMPPE 678
            D+   +   + GT  Y+ P+
Sbjct: 168 DDEQFVS---LYGTEEYLHPD 185

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 70/141 (49%), Gaps = 16/141 (11%)
Query: 544 MEEFENEVLLIAKLQHRNLVKLIGC--CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLD 601
           M EFE    ++ KL H+N+VKL      T    ++LI E+ P  SL   + + + +  L 
Sbjct: 55  MREFE----VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLP 110
Query: 602 WSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNEMNPKISDFGMARAFG 657
            S+   ++  +  G+ +L ++    I+HR++K  N++     D +   K++DFG AR   
Sbjct: 111 ESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167
Query: 658 IDQTEANTNRVVGTYGYMPPE 678
            D+       + GT  Y+ P+
Sbjct: 168 DDEQFVX---LYGTEEYLHPD 185

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 53/109 (48%), Gaps = 8/109 (7%)
Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN--TNRVVGT 671
           RGL Y+H     ++IHRDLK SN+L++     KI DFGMAR       E        V T
Sbjct: 169 RGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 225
Query: 672 YGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL 719
             Y  PE  +    ++   D++S G +  E++   R + F   ++ H L
Sbjct: 226 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA--RRQLFPGKNYVHQL 272

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 77/315 (24%), Positives = 122/315 (38%), Gaps = 55/315 (17%)
Query: 496 WMAIANATENFSDKNKLGEGGFGPVYKGV--LIEGQE--IAAKRLSKSSGQGMEEFENEV 551
           + A+   +  F  ++K+GEG F  VY     L  G E  IA K L  +S       E + 
Sbjct: 13  YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQC 72
Query: 552 LLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKS----LNDFIFDVTRSKFLDWSKRCQ 607
           L +A  Q  N++ +  C  + D  ++   YL ++S    LN   F   R   L+  K   
Sbjct: 73  LTVAGGQD-NVMGVKYCFRKNDHVVIAMPYLEHESFLDILNSLSFQEVREYMLNLFK--- 128
Query: 608 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARA--------FGI 658
                   L  +HQ     I+HRD+K SN L +  +    + DFG+A+            
Sbjct: 129 -------ALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKF 178
Query: 659 DQTEANTNRV------------------VGTYGYMPPEYAIDGLFSVKS-DVFSFGVLVL 699
            Q+EA   R                    GT G+  PE          + D++S GV+ L
Sbjct: 179 VQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFL 238
Query: 700 EIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLC 759
            ++ G+    FY A      L     +      ++   K+ G S   S+ +    +  LC
Sbjct: 239 SLLSGR--YPFYKASDDLTALAQIMTIRGSRETIQ-AAKTFGKSILCSKEVPAQDLRKLC 295
Query: 760 VQQRPEDR--PNMSS 772
            + R  D   P ++S
Sbjct: 296 ERLRGMDSSTPKLTS 310

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 20/165 (12%)
Query: 548 ENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQ 607
           E E+ ++ KL H  ++K+       D   ++ E +    L D +    R K       C+
Sbjct: 188 ETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLK----EATCK 242
Query: 608 I-IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGIDQTEA 663
           +    +   + YLH++    IIHRDLK  NVLL ++      KI+DFG ++  G    E 
Sbjct: 243 LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG----ET 295
Query: 664 NTNRVV-GTYGYMPPEYAID---GLFSVKSDVFSFGVLVLEIVCG 704
           +  R + GT  Y+ PE  +      ++   D +S GV++   + G
Sbjct: 296 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 20/165 (12%)
Query: 548 ENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQ 607
           E E+ ++ KL H  ++K+       D   ++ E +    L D +    R K       C+
Sbjct: 62  ETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLK----EATCK 116
Query: 608 I-IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGIDQTEA 663
           +    +   + YLH++    IIHRDLK  NVLL ++      KI+DFG ++  G    E 
Sbjct: 117 LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG----ET 169
Query: 664 NTNRVV-GTYGYMPPEYAID---GLFSVKSDVFSFGVLVLEIVCG 704
           +  R + GT  Y+ PE  +      ++   D +S GV++   + G
Sbjct: 170 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 20/165 (12%)
Query: 548 ENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQ 607
           E E+ ++ KL H  ++K+       D   ++ E +    L D +    R K       C+
Sbjct: 202 ETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLK----EATCK 256
Query: 608 I-IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGIDQTEA 663
           +    +   + YLH++    IIHRDLK  NVLL ++      KI+DFG ++  G    E 
Sbjct: 257 LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG----ET 309
Query: 664 NTNRVV-GTYGYMPPEYAID---GLFSVKSDVFSFGVLVLEIVCG 704
           +  R + GT  Y+ PE  +      ++   D +S GV++   + G
Sbjct: 310 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 106/269 (39%), Gaps = 51/269 (18%)
Query: 462 KRRHRKQGKTDGSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNK-LGEGGFGPV 520
           +++ RK+G   G        +G +     +P F+      + +N     K LG G  G V
Sbjct: 2   EKKKRKRGSRGGK-------KGRKSRIANIPNFE-----QSLKNLVVSEKILGYGSSGTV 49
Query: 521 YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKL-----QHRNLVKLIGCCTQRDER 575
                 +G+ +A KR+       + +F +  L+  KL      H N+++   C    D  
Sbjct: 50  VFQGSFQGRPVAVKRM-------LIDFCDIALMEIKLLTESDDHPNVIRYY-CSETTDRF 101
Query: 576 MLIYEYLPNKSLNDFIFDVTRS----KFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRD 631
           + I   L N +L D +     S    K         ++  IA G+ +LH    L+IIHRD
Sbjct: 102 LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRD 158
Query: 632 LKASNVLLDNE-------------MNPKISDFGMARAFGIDQT--EANTNRVVGTYGYMP 676
           LK  N+L+                +   ISDFG+ +     Q     N N   GT G+  
Sbjct: 159 LKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRA 218
Query: 677 PEY---AIDGLFSVKSDVFSFGVLVLEIV 702
           PE    +     +   D+FS G +   I+
Sbjct: 219 PELLEESTKRRLTRSIDIFSMGCVFYYIL 247

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 106/269 (39%), Gaps = 51/269 (18%)
Query: 462 KRRHRKQGKTDGSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNK-LGEGGFGPV 520
           +++ RK+G   G        +G +     +P F+      + +N     K LG G  G V
Sbjct: 2   EKKKRKRGSRGGK-------KGRKSRIANIPNFE-----QSLKNLVVSEKILGYGSSGTV 49
Query: 521 YKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKL-----QHRNLVKLIGCCTQRDER 575
                 +G+ +A KR+       + +F +  L+  KL      H N+++   C    D  
Sbjct: 50  VFQGSFQGRPVAVKRM-------LIDFCDIALMEIKLLTESDDHPNVIRYY-CSETTDRF 101
Query: 576 MLIYEYLPNKSLNDFIFDVTRS----KFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRD 631
           + I   L N +L D +     S    K         ++  IA G+ +LH    L+IIHRD
Sbjct: 102 LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRD 158
Query: 632 LKASNVLLDNE-------------MNPKISDFGMARAFGIDQT--EANTNRVVGTYGYMP 676
           LK  N+L+                +   ISDFG+ +     Q     N N   GT G+  
Sbjct: 159 LKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRA 218
Query: 677 PEY---AIDGLFSVKSDVFSFGVLVLEIV 702
           PE    +     +   D+FS G +   I+
Sbjct: 219 PELLEESTKRRLTRSIDIFSMGCVFYYIL 247

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 20/165 (12%)
Query: 548 ENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQ 607
           E E+ ++ KL H  ++K+       D   ++ E +    L D +    R K       C+
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLK----EATCK 117
Query: 608 I-IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGIDQTEA 663
           +    +   + YLH++    IIHRDLK  NVLL ++      KI+DFG ++  G    E 
Sbjct: 118 LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG----ET 170
Query: 664 NTNRVV-GTYGYMPPEYAID---GLFSVKSDVFSFGVLVLEIVCG 704
           +  R + GT  Y+ PE  +      ++   D +S GV++   + G
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 20/165 (12%)
Query: 548 ENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQ 607
           E E+ ++ KL H  ++K+       D   ++ E +    L D +    R K       C+
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLK----EATCK 117
Query: 608 I-IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGIDQTEA 663
           +    +   + YLH++    IIHRDLK  NVLL ++      KI+DFG ++  G    E 
Sbjct: 118 LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG----ET 170
Query: 664 NTNRVV-GTYGYMPPEYAID---GLFSVKSDVFSFGVLVLEIVCG 704
           +  R + GT  Y+ PE  +      ++   D +S GV++   + G
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	823
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-142
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-138
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-119
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-91
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	5e-73
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-59
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	9e-59
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-58
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-57
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	6e-57
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-56
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-55
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-54
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-53
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-51
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-51
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	6e-51
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-50
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	8e-47
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	8e-47
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-46
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-46
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-44
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-44
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-44
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-43
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-43
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-43
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-43
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-42
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-42
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-42
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-42
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	7e-42
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-41
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-41
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-41
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-41
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-41
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-41
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-41
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	6e-41
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-41
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	8e-41
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	9e-41
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-40
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-40
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-40
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-40
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-40
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-40
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-40
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-40
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-40
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-40
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-40
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-40
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-39
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-39
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-39
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-39
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-39
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-39
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	7e-39
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-38
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-38
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-38
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-38
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-38
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-38
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-38
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-37
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-37
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-37
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	6e-37
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-36
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-36
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-36
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-36
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	7e-36
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	8e-36
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-35
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	6e-34
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-34
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-33
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-33
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-33
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-33
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	7e-33
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	9e-33
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-32
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-32
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	8e-32
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	9e-32
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-31
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-31
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-31
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-30
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	7e-30
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-29
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-29
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-29
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-29
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	9e-29
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-28
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-28
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-28
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-28
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-28
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-28
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-28
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-28
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-28
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	8e-28
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-27
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-27
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-27
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-27
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-27
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-27
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-27
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-27
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	7e-27
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	9e-27
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-26
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-26
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-26
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-26
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-26
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-26
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-26
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-26
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-26
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-26
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-26
3an0_A	340	Dual specificity mitogen-activated protein kinase;	7e-26
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	7e-26
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-26
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-25
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-25
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-25
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-25
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-25
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-25
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-25
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-25
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	6e-25
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	6e-25
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-25
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	7e-25
3bhy_A	283	Death-associated protein kinase 3; death associate	8e-25
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	8e-25
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	9e-25
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-24
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-24
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-24
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-24
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-24
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	9e-24
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-23
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-23
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-23
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-23
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-23
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	8e-23
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-22
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-22
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-22
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-22
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-22
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	5e-22
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	9e-22
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	9e-22
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-21
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-21
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-21
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-21
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-21
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-20
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	7e-20
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-19
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-19
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-19
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-19
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-19
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-18
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-11
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-17
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	8e-17
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	8e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-16
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-16
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-16
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-16
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-15
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-15
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-15
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-15
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-15
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-15
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-15
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-15
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-15
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-15
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	6e-15
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-14
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-14
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-14
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-14
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-14
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-13
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-13
1kj1_A	109	Lectin I, lecgna 1; BULB lectin, mannose, plant pr	2e-12
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-12
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-11
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	5e-11
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-10
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	6e-10
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	8e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	9e-10
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-09
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-09
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	7e-09
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	8e-09
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	1e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-08
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-08
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	6e-08
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	1e-07
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-07
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-06
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	1e-07
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	3e-04
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	3e-07
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	4e-06
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-06
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-06
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	8e-04

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  420 bits (1083), Expect = e-142
 Identities = 103/313 (32%), Positives = 166/313 (53%), Gaps = 19/313 (6%)

Query: 481 DRGNREEEMELPIFDWMAIANATENFSDK------NKLGEGGFGPVYKGVLIEGQEIAAK 534
           ++     +     F +  + N T NF ++      NK+GEGGFG VYKG +     +A K
Sbjct: 2   NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60

Query: 535 RLSK----SSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF 590
           +L+     ++ +  ++F+ E+ ++AK QH NLV+L+G  +  D+  L+Y Y+PN SL D 
Sbjct: 61  KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120

Query: 591 IFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDF 650
           +  +  +  L W  RC+I  G A G+ +LH++     IHRD+K++N+LLD     KISDF
Sbjct: 121 LSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDF 177

Query: 651 GMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGF 710
           G+ARA         T+R+VGT  YM PE  + G  + KSD++SFGV++LEI+ G      
Sbjct: 178 GLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDE 236

Query: 711 YHADHHHNLLGHAWRLWIEERPVE-LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPN 769
           +       LL     +  EE+ +E  I+K +      + V     V   C+ ++   RP+
Sbjct: 237 HREP--QLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPD 293

Query: 770 MSSVVLMLSGERS 782
           +  V  +L    +
Sbjct: 294 IKKVQQLLQEMTA 306

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  410 bits (1057), Expect = e-138
 Identities = 124/292 (42%), Positives = 169/292 (57%), Gaps = 5/292 (1%)

Query: 493 IFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGME-EFENEV 551
            F    +  A++NFS+KN LG GGFG VYKG L +G  +A KRL +   QG E +F+ EV
Sbjct: 19  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEV 78

Query: 552 LLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSK-FLDWSKRCQIIG 610
            +I+   HRNL++L G C    ER+L+Y Y+ N S+   + +   S+  LDW KR +I  
Sbjct: 79  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138

Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVG 670
           G ARGL YLH     +IIHRD+KA+N+LLD E    + DFG+A+      T   T  V G
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRG 197

Query: 671 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRN--RGFYHADHHHNLLGHAWRLWI 728
           T G++ PEY   G  S K+DVF +GV++LE++ G+R         D    LL     L  
Sbjct: 198 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257

Query: 729 EERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 780
           E++   L++  L G+Y   EV + IQV LLC Q  P +RP MS VV ML G+
Sbjct: 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  362 bits (931), Expect = e-119
 Identities = 107/319 (33%), Positives = 168/319 (52%), Gaps = 6/319 (1%)

Query: 470 KTDGSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQ 529
            +  ++ ++     +     E      + +  AT NF  K  +G G FG VYKGVL +G 
Sbjct: 5   YSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGA 64

Query: 530 EIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLND 589
           ++A KR +  S QG+EEFE E+  ++  +H +LV LIG C +R+E +LIY+Y+ N +L  
Sbjct: 65  KVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKR 124

Query: 590 FIFDVTRSKF-LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKIS 648
            ++        + W +R +I  G ARGL YLH  +   IIHRD+K+ N+LLD    PKI+
Sbjct: 125 HLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKIT 181

Query: 649 DFGMARAF-GIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRN 707
           DFG+++    +DQT  +T  V GT GY+ PEY I G  + KSDV+SFGV++ E++C +  
Sbjct: 182 DFGISKKGTELDQTHLST-VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240

Query: 708 RGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDR 767
                     NL   A       +  ++++ +L        + +     + C+    EDR
Sbjct: 241 IVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDR 300

Query: 768 PNMSSVVLMLSGERSLPQP 786
           P+M  V+  L     L + 
Sbjct: 301 PSMGDVLWKLEYALRLQES 319

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  289 bits (742), Expect = 2e-91
 Identities = 66/302 (21%), Positives = 123/302 (40%), Gaps = 28/302 (9%)

Query: 499 IANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ 558
           +   +           G FG V+K   +  + +A K       Q  +  E EV  +  ++
Sbjct: 19  LYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSWQ-NEYEVYSLPGMK 76

Query: 559 HRNLVKLIGCCTQRD----ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIAR 614
           H N+++ IG   +      +  LI  +    SL+DF+    ++  + W++ C I   +AR
Sbjct: 77  HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMAR 132

Query: 615 GLLYLHQD-------SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 667
           GL YLH+D        +  I HRD+K+ NVLL N +   I+DFG+A  F   ++  +T+ 
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHG 192

Query: 668 VVGTYGYMPPEYAIDGL-----FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH 722
            VGT  YM PE     +       ++ D+++ G+++ E+            ++       
Sbjct: 193 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252

Query: 723 AWRLWIEERPVELINK-----SLGGSYSLSEVLRCI-QVGLLCVQQRPEDRPNMSSVVLM 776
             +    E   E++        L   +     +  + +    C     E R +   V   
Sbjct: 253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312

Query: 777 LS 778
           ++
Sbjct: 313 IT 314

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  241 bits (616), Expect = 5e-73
 Identities = 71/339 (20%), Positives = 128/339 (37%), Gaps = 51/339 (15%)

Query: 489 MELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFE 548
           ME    +        +N      +G G +G VYKG L + + +A K  S ++ Q     E
Sbjct: 1   MEAAASEPSL---DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFIN-E 55

Query: 549 NEVLLIAKLQHRNLVKLIGCCT-----QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWS 603
             +  +  ++H N+ + I          R E +L+ EY PN SL  ++         DW 
Sbjct: 56  KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWV 111

Query: 604 KRCQIIGGIARGLLYLHQD------SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF- 656
             C++   + RGL YLH +       +  I HRDL + NVL+ N+    ISDFG++    
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171

Query: 657 -----GIDQTEANTNRVVGTYGYMPPEYAIDGLFSV--------KSDVFSFGVLVLEIVC 703
                   + +      VGT  YM PE  ++G  ++        + D+++ G++  EI  
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFM 230

Query: 704 GKRNRGFYHADHHHNLLGHAWRLWIEERP-VELINK---------SLGGSYSLSEVLRCI 753
              +     +   + +   A++  +   P  E +               ++  + +    
Sbjct: 231 RCTDLFPGESVPEYQM---AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRS 287

Query: 754 QVGLL--CVQQRPEDRPNMSSVVLMLSG-ERSLPQPKQP 789
               +  C  Q  E R         ++       + K  
Sbjct: 288 LKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSV 326

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  204 bits (520), Expect = 1e-59
 Identities = 76/290 (26%), Positives = 140/290 (48%), Gaps = 28/290 (9%)

Query: 505 NFSD---KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQH 559
            + D   K K+G G FG V++     G ++A K L +     + + EF  EV ++ +L+H
Sbjct: 35  PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93

Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
            N+V  +G  TQ     ++ EYL   SL   +      + LD  +R  +   +A+G+ YL
Sbjct: 94  PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL 153

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H      I+HR+LK+ N+L+D +   K+ DFG++R      T  ++    GT  +M PE 
Sbjct: 154 HN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEV 210

Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE-ERPVELINK 738
             D   + KSDV+SFGV++ E+   ++    +    + N       +  + +R    I +
Sbjct: 211 LRDEPSNEKSDVYSFGVILWELATLQQ---PW---GNLNPAQVVAAVGFKCKRLE--IPR 262

Query: 739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG--ERSLPQP 786
           +L  +  ++ ++        C    P  RP+ ++++ +L    + ++P P
Sbjct: 263 NL--NPQVAAIIE------GCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  201 bits (514), Expect = 9e-59
 Identities = 70/298 (23%), Positives = 117/298 (39%), Gaps = 46/298 (15%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           +    +  +G G FG V K      +++A K++   S    + F  E+  ++++ H N+V
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIV 64

Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           KL G C       L+ EY    SL + +       +   +         ++G+ YLH   
Sbjct: 65  KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 624 RLRIIHRDLKASNVLLDNEMN-PKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID 682
              +IHRDLK  N+LL       KI DFG A     D     TN   G+  +M PE    
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNN-KGSAAWMAPEVFEG 177

Query: 683 GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP---------- 732
             +S K DVFS+G+++ E++  ++    +  +         W +    RP          
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK---PF-DEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 233

Query: 733 VELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML-SGERSLPQPKQP 789
             L+ +                    C  + P  RP+M  +V ++    R  P   +P
Sbjct: 234 ESLMTR--------------------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  199 bits (507), Expect = 3e-58
 Identities = 68/209 (32%), Positives = 102/209 (48%), Gaps = 21/209 (10%)

Query: 509 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKS----SGQGMEEFENEVLLIAKLQHRNLVK 564
           +  +G GGFG VY+     G E+A K           Q +E    E  L A L+H N++ 
Sbjct: 12  EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70

Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           L G C +     L+ E+     LN  +      K +           IARG+ YLH ++ 
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAI 126

Query: 625 LRIIHRDLKASNVLLDNEMNP--------KISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
           + IIHRDLK+SN+L+  ++          KI+DFG+AR     +T   +    G Y +M 
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE--WHRTTKMSA--AGAYAWMA 182

Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           PE     +FS  SDV+S+GVL+ E++ G+
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGE 211

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  196 bits (501), Expect = 6e-57
 Identities = 81/319 (25%), Positives = 119/319 (37%), Gaps = 50/319 (15%)

Query: 509 KNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIG 567
              LG+G FG   K    E G+ +  K L +   +    F  EV ++  L+H N++K IG
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74

Query: 568 CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI 627
              +      I EY+   +L   I          WS+R      IA G+ YLH    + I
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHS---MNI 129

Query: 628 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR------------VVGTYGYM 675
           IHRDL + N L+    N  ++DFG+AR    ++T+    R            VVG   +M
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189

Query: 676 PPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR---NRGFYHADHHHNLLGHAWRLWI-EER 731
            PE      +  K DVFSFG+++ EI+       +      D   N+ G     +     
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL-DRYCPPNC 248

Query: 732 PVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML-----SGERSLPQP 786
           P                      + + C    PE RP+   +   L          LP  
Sbjct: 249 PPSF-----------------FPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLG 291

Query: 787 KQ-----PGFFTERNPPES 800
            Q      GF+      ES
Sbjct: 292 PQLEQLDRGFWETYRRGES 310

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  194 bits (494), Expect = 3e-56
 Identities = 67/296 (22%), Positives = 131/296 (44%), Gaps = 52/296 (17%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQG-------MEEFENEVLLIA 555
                + ++G+GGFG V+KG L++    +A K L     +G        +EF+ EV +++
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 556 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARG 615
            L H N+VKL G         ++ E++P   L   + D  ++  + WS + +++  IA G
Sbjct: 79  NLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134

Query: 616 LLYLHQDSRLRIIHRDLKASNVLLDN-----EMNPKISDFGMARAFGIDQTEANTNRVVG 670
           + Y+       I+HRDL++ N+ L +      +  K++DFG+++     Q+  + + ++G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLG 188

Query: 671 TYGYMPPE--YAIDGLFSVKSDVFSFGVLVLEIVCGK---RNRGFYHADHHHNLLGHAWR 725
            + +M PE   A +  ++ K+D +SF +++  I+ G+       +      + +     R
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248

Query: 726 L----WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 777
                    R   +I                      C    P+ RP+ S +V  L
Sbjct: 249 PTIPEDCPPRLRNVIEL--------------------CWSGDPKKRPHFSYIVKEL 284

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  190 bits (484), Expect = 5e-55
 Identities = 50/212 (23%), Positives = 92/212 (43%), Gaps = 22/212 (10%)

Query: 505 NFSD---KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQH 559
           +F       KL E   G ++KG   +G +I  K L     S +   +F  E   +    H
Sbjct: 8   DFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66

Query: 560 RNLVKLIGCCTQRDER--MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
            N++ ++G C         LI  ++P  SL + + + T    +D S+  +    +ARG+ 
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDMARGMA 125

Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           +LH    L I    L + +V++D +M  +IS   +  +F        +   +    ++ P
Sbjct: 126 FLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAP 177

Query: 678 EYAIDG----LFSVKSDVFSFGVLVLEIVCGK 705
           E A+           +D++SF VL+ E+V  +
Sbjct: 178 E-ALQKKPEDTNRRSADMWSFAVLLWELVTRE 208

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  189 bits (482), Expect = 2e-54
 Identities = 64/279 (22%), Positives = 125/279 (44%), Gaps = 24/279 (8%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRN 561
              +   ++G G FG VYKG      ++A K L+ +  + Q ++ F+NEV ++ K +H N
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
           ++  +G  T   +  ++ ++    SL   +         +  K   I    ARG+ YLH 
Sbjct: 82  ILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHA 138

Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE--- 678
                IIHRDLK++N+ L  +   KI DFG+A             ++ G+  +M PE   
Sbjct: 139 ---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195

Query: 679 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 738
                 +S +SDV++FG+++ E++ G+     Y   + +N       +       +L   
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLP---Y--SNINNRDQIIEMVGRGSLSPDLSKV 250

Query: 739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 777
                  +  ++        C++++ ++RP+   ++  +
Sbjct: 251 RSNCPKRMKRLMA------ECLKKKRDERPSFPRILAEI 283

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  186 bits (473), Expect = 5e-53
 Identities = 72/303 (23%), Positives = 120/303 (39%), Gaps = 44/303 (14%)

Query: 509 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLI 566
              +G+G FG VY G      E+A + +     +   ++ F+ EV+   + +H N+V  +
Sbjct: 38  GELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95

Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 626
           G C       +I      ++L   + D      LD +K  QI   I +G+ YLH      
Sbjct: 96  GACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHA---KG 150

Query: 627 IIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR---VVGTYGYMPPE----- 678
           I+H+DLK+ NV  DN     I+DFG+    G+ Q     ++     G   ++ PE     
Sbjct: 151 ILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209

Query: 679 ----YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE 734
                     FS  SDVF+ G +  E+   +     +            W++    +P  
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWP---F---KTQPAEAIIWQMGTGMKP-N 262

Query: 735 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQ----PKQPG 790
           L    +     +S++L        C     E+RP  + ++ ML     LP+       PG
Sbjct: 263 LSQIGM--GKEISDILL------FCWAFEQEERPTFTKLMDML---EKLPKRNRRLSHPG 311

Query: 791 FFT 793
            F 
Sbjct: 312 HFW 314

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  182 bits (463), Expect = 2e-51
 Identities = 68/316 (21%), Positives = 121/316 (38%), Gaps = 43/316 (13%)

Query: 491 LPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENE 550
           LP+     IA   +      ++G+G +G V+ G    G+++A K    +        E E
Sbjct: 27  LPLLVQRTIA---KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEA-SWFRETE 81

Query: 551 VLLIAKLQHRNLVKLIGCCTQ----RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC 606
           +     ++H N++  I    +      +  LI +Y  N SL D++    +S  LD     
Sbjct: 82  IYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSML 137

Query: 607 QIIGGIARGLLYLHQDSRLR-----IIHRDLKASNVLLDNEMNPKISDFGMARAF--GID 659
           ++      GL +LH +         I HRDLK+ N+L+       I+D G+A  F    +
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN 197

Query: 660 QTEANTNRVVGTYGYMPPEYAIDGLFSV-------KSDVFSFGVLVLEIVCGKRNRG--- 709
           + +   N  VGT  YMPPE  +D   +         +D++SFG+++ E+     + G   
Sbjct: 198 EVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256

Query: 710 -----FYHADHHHNLLGHAWRLWIEE--RPVELINKSLGGSYSLSEVLRCIQVGLLCVQQ 762
                ++              +   +  RP             L ++ + +     C   
Sbjct: 257 EYQLPYHDLVPSDPSYEDMREIVCIKKLRPS--FPNRWSSDECLRQMGKLMTE---CWAH 311

Query: 763 RPEDRPNMSSVVLMLS 778
            P  R     V   L+
Sbjct: 312 NPASRLTALRVKKTLA 327

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  181 bits (460), Expect = 2e-51
 Identities = 67/296 (22%), Positives = 117/296 (39%), Gaps = 38/296 (12%)

Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
             +G+G +G V++G   +G+ +A K  S    +     E E+     L+H N++  I   
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEK-SWFRETELYNTVMLRHENILGFIASD 71

Query: 570 T----QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 625
                   +  LI  Y    SL D++    +   LD     +I+  IA GL +LH +   
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127

Query: 626 R-----IIHRDLKASNVLLDNEMNPKISDFGMAR--AFGIDQTEANTNRVVGTYGYMPPE 678
                 I HRDLK+ N+L+       I+D G+A   +   +Q +   N  VGT  YM PE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187

Query: 679 ------YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRG--------FYHADHHHNLLGHAW 724
                          + D+++FG+++ E+     + G        FY    +        
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247

Query: 725 RLWIEE--RPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 778
           ++   +  RP   I        +L+ + + ++    C  Q P  R     +   L+
Sbjct: 248 KVVCVDQQRPN--IPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTALRIKKTLT 298

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  179 bits (456), Expect = 2e-50
 Identities = 68/316 (21%), Positives = 122/316 (38%), Gaps = 43/316 (13%)

Query: 491 LPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENE 550
           LP+     IA        +  +G+G FG V++G    G+E+A K  S    +     E E
Sbjct: 32  LPLLVQRTIA---RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAE 86

Query: 551 VLLIAKLQHRNLVKLIGCCTQRD----ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC 606
           +     L+H N++  I    + +    +  L+ +Y  + SL D++        +      
Sbjct: 87  IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMI 142

Query: 607 QIIGGIARGLLYLHQD-----SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GID 659
           ++    A GL +LH +      +  I HRDLK+ N+L+       I+D G+A       D
Sbjct: 143 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 202

Query: 660 QTEANTNRVVGTYGYMPPEYAIDGLFSV-------KSDVFSFGVLVLEIVCGKRNRG--- 709
             +   N  VGT  YM PE  +D   ++       ++D+++ G++  EI       G   
Sbjct: 203 TIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261

Query: 710 -----FYHADHHHNLLGHAWRLWIEE--RPVELINKSLGGSYSLSEVLRCIQVGLLCVQQ 762
                +Y        +    ++  E+  RP   I        +L  + + ++    C   
Sbjct: 262 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPN--IPNRWQSCEALRVMAKIMR---ECWYA 316

Query: 763 RPEDRPNMSSVVLMLS 778
               R     +   LS
Sbjct: 317 NGAARLTALRIKKTLS 332

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  169 bits (429), Expect = 8e-47
 Identities = 81/332 (24%), Positives = 132/332 (39%), Gaps = 70/332 (21%)

Query: 509 KNKLGEGGFGPVYKGVLI-----EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
            ++LG+G FG V            G  +A K+L  S      +F+ E+ ++  L    +V
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87

Query: 564 KLIGCCTQRDER--MLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRCQIIGGIARGLL 617
           K  G       +   L+ EYLP+  L DF+      +  S+ L +S        I +G+ 
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS------QICKGME 141

Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP- 676
           YL      R +HRDL A N+L+++E + KI+DFG+A+   +D+       VV   G  P 
Sbjct: 142 YLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPI 194

Query: 677 ----PEYAIDGLFSVKSDVFSFGVLVLEIV-CGKRNRGFYHADHHHNLLGHAWRLWIEER 731
               PE   D +FS +SDV+SFGV++ E+     ++                        
Sbjct: 195 FWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS-------------------CSPSA 235

Query: 732 PVELINKSLGGSYSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVV 774
               +        +LS +L  ++ G                  LC    P+DRP+ S++ 
Sbjct: 236 EFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALG 295

Query: 775 L----MLSGERSLPQPKQPGFFTERNPPESGS 802
                + SG R             ++   S S
Sbjct: 296 PQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS 327

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  168 bits (428), Expect = 8e-47
 Identities = 75/311 (24%), Positives = 114/311 (36%), Gaps = 59/311 (18%)

Query: 509 KNKLGEGGFGPVYKGVLI-----EGQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNL 562
              LGEG FG V            G+ +A K L   +G Q    ++ E+ ++  L H ++
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 563 VKLIGCCTQRDER--MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           +K  GCC         L+ EY+P  SL D++        +  ++       I  G+ YLH
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 151

Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP---- 676
                  IHRDL A NVLLDN+   KI DFG+A+A             V   G  P    
Sbjct: 152 A---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RVREDGDSPVFWY 204

Query: 677 -PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 735
            PE   +  F   SDV+SFGV + E+          H D   +       L    +    
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYEL--------LTHCDSSQSPPTKFLELIGIAQG--- 253

Query: 736 INKSLGGSYSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVLMLS 778
                    ++  +   ++ G                   C +     RP   +++ +L 
Sbjct: 254 -------QMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK 306

Query: 779 GERSLPQPKQP 789
                 Q + P
Sbjct: 307 TVHEKYQGQAP 317

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  168 bits (427), Expect = 1e-46
 Identities = 75/303 (24%), Positives = 117/303 (38%), Gaps = 63/303 (20%)

Query: 509 KNKLGEGGFGPVYKGVLI-----EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
             +LG+G FG V            G+ +A K+L  S+ + + +FE E+ ++  LQH N+V
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 564 KLIGCCTQRDER--MLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRCQIIGGIARGLL 617
           K  G C     R   LI EYLP  SL D++      +   K L ++        I +G+ 
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS------QICKGME 159

Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG---- 673
           YL      R IHRDL   N+L++NE   KI DFG+ +    D+        V   G    
Sbjct: 160 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPI 212

Query: 674 -YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP 732
            +  PE   +  FSV SDV+SFGV++ E+           A+    +             
Sbjct: 213 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ-------- 264

Query: 733 VELINKSLGGSYSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVL 775
                    G   +  ++  ++                     C       RP+   + L
Sbjct: 265 ---------GQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315

Query: 776 MLS 778
            + 
Sbjct: 316 RVD 318

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  166 bits (422), Expect = 3e-46
 Identities = 77/303 (25%), Positives = 123/303 (40%), Gaps = 63/303 (20%)

Query: 509 KNKLGEGGFGPVYKGVLI-----EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
             +LG+G FG V            G+ +A K+L  S+ + + +FE E+ ++  LQH N+V
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74

Query: 564 KLIGCCTQRDER--MLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRCQIIGGIARGLL 617
           K  G C     R   LI EYLP  SL D++      +   K L ++        I +G+ 
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS------QICKGME 128

Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP- 676
           YL      R IHRDL   N+L++NE   KI DFG+ +    D+        V   G  P 
Sbjct: 129 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF----KVKEPGESPI 181

Query: 677 ----PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP 732
               PE   +  FSV SDV+SFGV++ E+        F + +   +      R+   ++ 
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYEL--------FTYIEKSKSPPAEFMRMIGNDKQ 233

Query: 733 VELINKSLGGSYSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVL 775
            ++I            ++  ++                     C       RP+   + L
Sbjct: 234 GQMIV---------FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284

Query: 776 MLS 778
            + 
Sbjct: 285 RVD 287

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  161 bits (409), Expect = 2e-44
 Identities = 80/314 (25%), Positives = 122/314 (38%), Gaps = 89/314 (28%)

Query: 509 KNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL 562
           K +LGEG FG V+           +   +A K L   +    ++F+ E  L+  LQH ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79

Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDF-------------IFDVTRSKFLDWSKRCQII 609
           VK  G C   D  ++++EY+ +  LN F                      L  S+   I 
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 610 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV 669
             IA G++YL   +    +HRDL   N L+   +  KI DFGM+R    D    +  R V
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYR-V 191

Query: 670 GTYG-----YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW 724
           G +      +MPPE  +   F+ +SDV+SFGV++ EI                       
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF---------------------- 229

Query: 725 RLWIEERPVELINKSLGGS----YSLSEVLRCIQVG-----------------LLCVQQR 763
                         + G       S +EV+ CI  G                 L C Q+ 
Sbjct: 230 --------------TYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYDVMLGCWQRE 275

Query: 764 PEDRPNMSSVVLML 777
           P+ R N+  +  +L
Sbjct: 276 PQQRLNIKEIYKIL 289

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  160 bits (408), Expect = 3e-44
 Identities = 70/308 (22%), Positives = 127/308 (41%), Gaps = 73/308 (23%)

Query: 509 KNKLGEGGFGPVYKGVLI-----EGQEIAAKRL-SKSSGQGMEEFENEVLLIAKLQHRNL 562
              LGEG FG V            G+++A K L  +S G  + + + E+ ++  L H N+
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 563 VKLIGCCTQRDER--MLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRCQIIGGIARGL 616
           VK  G CT+       LI E+LP+ SL +++      +   + L ++        I +G+
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV------QICKGM 139

Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG--- 673
            YL      + +HRDL A NVL+++E   KI DFG+ +A   D+        V       
Sbjct: 140 DYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY----TVKDDRDSP 192

Query: 674 --YMPPEYAIDGLFSVKSDVFSFGVLVLEIV-CGKRNRGFYHADHHHNLLGHAWRLWIEE 730
             +  PE  +   F + SDV+SFGV + E++     +                       
Sbjct: 193 VFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS--------------------- 231

Query: 731 RPVELINKSLGGSY---SLSEVLRCIQVG-----------------LLCVQQRPEDRPNM 770
            P+ L  K +G ++   +++ ++  ++ G                   C + +P +R + 
Sbjct: 232 -PMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSF 290

Query: 771 SSVVLMLS 778
            +++    
Sbjct: 291 QNLIEGFE 298

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  163 bits (414), Expect = 3e-44
 Identities = 73/305 (23%), Positives = 110/305 (36%), Gaps = 64/305 (20%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVL-IEGQEIAAKRL-SKSSGQGMEEFENEVLLIAKLQHRN 561
           E+     ++G G FG V+ G L  +   +A K            +F  E  ++ +  H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
           +V+LIG CTQ+    ++ E +       F+   T    L      Q++G  A G+ YL  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES 231

Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
                 IHRDL A N L+  +   KISDFGM+R        A+         +  PE   
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN 288

Query: 682 DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 741
            G +S +SDV+SFG+L+ E                                      SLG
Sbjct: 289 YGRYSSESDVWSFGILLWETF------------------------------------SLG 312

Query: 742 GS----YSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVLMLSGE 780
            S     S  +    ++ G                   C    P  RP+ S++   L   
Sbjct: 313 ASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372

Query: 781 RSLPQ 785
           R   +
Sbjct: 373 RKRHR 377

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  159 bits (403), Expect = 3e-43
 Identities = 76/313 (24%), Positives = 123/313 (39%), Gaps = 88/313 (28%)

Query: 509 KNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL 562
           K +LGEG FG V+           +   +A K L ++S    ++F+ E  L+  LQH+++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105

Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDF------------IFDVTRSKFLDWSKRCQIIG 610
           V+  G CT+    ++++EY+ +  LN F              +      L   +   +  
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165

Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVG 670
            +A G++YL   + L  +HRDL   N L+   +  KI DFGM+R    D    +  R VG
Sbjct: 166 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYR-VG 217

Query: 671 TYG-----YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 725
                   +MPPE  +   F+ +SDV+SFGV++ EI                        
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF----------------------- 254

Query: 726 LWIEERPVELINKSLGGS----YSLSEVLRCIQVG-----------------LLCVQQRP 764
                        + G       S +E + CI  G                   C Q+ P
Sbjct: 255 -------------TYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREP 301

Query: 765 EDRPNMSSVVLML 777
           + R ++  V   L
Sbjct: 302 QQRHSIKDVHARL 314

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  158 bits (403), Expect = 3e-43
 Identities = 79/330 (23%), Positives = 129/330 (39%), Gaps = 84/330 (25%)

Query: 509 KNKLGEGGFGPVYKGVLI------EGQEIAAKRLSK-SSGQGMEEFENEVLLIAKLQHRN 561
             +LG+G FG VY+GV            +A K +++ +S +   EF NE  ++ +    +
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDF-------IFDVTRSKFLDWSKRCQIIGGIAR 614
           +V+L+G  +Q    ++I E +    L  +       + +         SK  Q+ G IA 
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 615 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGY 674
           G+ YL   +  + +HRDL A N ++  +   KI DFGM R    D  E +  R  G  G 
Sbjct: 150 GMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYR-KGGKGL 201

Query: 675 -----MPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 729
                M PE   DG+F+  SDV+SFGV++ EI                            
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA--------------------------- 234

Query: 730 ERPVELINKSLGGS----YSLSEVLRCIQVG-----------------LLCVQQRPEDRP 768
                    +L        S  +VLR +  G                  +C Q  P+ RP
Sbjct: 235 ---------TLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRP 285

Query: 769 NMSSVVLMLSGERSLPQPKQPGFFTERNPP 798
           +   ++  +  E      +   +++E N  
Sbjct: 286 SFLEIISSIKEEMEPGFREVSFYYSEENKL 315

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  157 bits (400), Expect = 3e-43
 Identities = 78/315 (24%), Positives = 123/315 (39%), Gaps = 90/315 (28%)

Query: 509 KNKLGEGGFGPVYKGVLI------EGQEIAAKRLSK-SSGQGMEEFENEVLLIAKLQHRN 561
             +LGE  FG VYKG L       + Q +A K L   + G   EEF +E +L A+LQH N
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDF-------------IFDVTRSKFLDWSKRCQI 608
           +V L+G  T+     +I+ Y  +  L++F               D T    L+      +
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
           +  IA G+ YL   S   ++H+DL   NVL+ +++N KISD G+ R   +   +      
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR--EVYAADYYK--- 185

Query: 669 VGTYG-----YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 723
           +         +M PE  + G FS+ SD++S+GV++ E+                      
Sbjct: 186 LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF--------------------- 224

Query: 724 WRLWIEERPVELINKSLGGS----YSLSEVLRCIQVG-----------------LLCVQQ 762
                          S G      YS  +V+  I+                   + C  +
Sbjct: 225 ---------------SYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNE 269

Query: 763 RPEDRPNMSSVVLML 777
            P  RP    +   L
Sbjct: 270 FPSRRPRFKDIHSRL 284

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  158 bits (401), Expect = 6e-43
 Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 30/208 (14%)

Query: 510 NKLGEGGFGPVYKGVLIEGQE-----IAAKRLSK-SSGQGMEEFENEVLLIAKLQHRNLV 563
             LG G FG VYKG+ I   E     +A K L + +S +  +E  +E  ++A + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRCQIIGGIARGLLYL 619
           +L+G C       LI + +P   L D++ +    +     L+W         IA+G+ YL
Sbjct: 81  RLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYL 133

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP--- 676
                 R++HRDL A NVL+    + KI+DFG+A+  G ++ E +        G +P   
Sbjct: 134 ---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKW 185

Query: 677 --PEYAIDGLFSVKSDVFSFGVLVLEIV 702
              E  +  +++ +SDV+S+GV V E++
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELM 213

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  157 bits (398), Expect = 1e-42
 Identities = 88/332 (26%), Positives = 121/332 (36%), Gaps = 84/332 (25%)

Query: 509 KNKLGEGGFGPVYKGVLI------EGQEIAAKRLSK-SSGQGMEEFENEVLLIAKLQHRN 561
              LG G FG VY+G +          ++A K L +  S Q   +F  E L+I+K  H+N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFI----FDVTRSKFLDWSKRCQIIGGIARGLL 617
           +V+ IG   Q   R ++ E +    L  F+       ++   L       +   IA G  
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 618 YLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGIDQTEANTNRVVGTYGY 674
           YL        IHRD+ A N LL         KI DFGMAR    D   A+  R  G    
Sbjct: 155 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYR-KGGCAM 206

Query: 675 -----MPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 729
                MPPE  ++G+F+ K+D +SFGVL+ EI                            
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF--------------------------- 239

Query: 730 ERPVELINKSLGGS----YSLSEVLRCIQVG-----------------LLCVQQRPEDRP 768
                    SLG       S  EVL  +  G                   C Q +PEDRP
Sbjct: 240 ---------SLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 290

Query: 769 NMSSVVLMLSGERSLPQPKQPGFFTERNPPES 800
           N + ++  +      P         E  P   
Sbjct: 291 NFAIILERIEYCTQDPDVINTALPIEYGPLVE 322

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  157 bits (398), Expect = 3e-42
 Identities = 88/332 (26%), Positives = 120/332 (36%), Gaps = 84/332 (25%)

Query: 509 KNKLGEGGFGPVYKGVLI------EGQEIAAKRLSK-SSGQGMEEFENEVLLIAKLQHRN 561
              LG G FG VY+G +          ++A K L +  S Q   +F  E L+I+K  H+N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFI----FDVTRSKFLDWSKRCQIIGGIARGLL 617
           +V+ IG   Q   R ++ E +    L  F+       ++   L       +   IA G  
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 618 YLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGIDQTEANTNRVVGTYGY 674
           YL        IHRD+ A N LL         KI DFGMAR    D   A   R  G    
Sbjct: 196 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYR-KGGCAM 247

Query: 675 -----MPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 729
                MPPE  ++G+F+ K+D +SFGVL+ EI                            
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF--------------------------- 280

Query: 730 ERPVELINKSLGGS----YSLSEVLRCIQVG-----------------LLCVQQRPEDRP 768
                    SLG       S  EVL  +  G                   C Q +PEDRP
Sbjct: 281 ---------SLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 331

Query: 769 NMSSVVLMLSGERSLPQPKQPGFFTERNPPES 800
           N + ++  +      P         E  P   
Sbjct: 332 NFAIILERIEYCTQDPDVINTALPIEYGPLVE 363

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  155 bits (395), Expect = 4e-42
 Identities = 79/346 (22%), Positives = 132/346 (38%), Gaps = 97/346 (28%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLI--------EGQEIAAKRL-SKSSGQGMEEFENEVLLI 554
           +  +    LGEG FG V     +        E   +A K L   ++ + + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 555 AKL-QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG-- 611
             + +H+N++ L+G CTQ     +I EY    +L +++    R   +++S     +    
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA-RRPPGMEYSYDINRVPEEQ 153

Query: 612 ------------IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 659
                       +ARG+ YL   +  + IHRDL A NVL+      KI+DFG+AR    D
Sbjct: 154 MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----D 206

Query: 660 QTEANTNRVVGTYG-----YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHAD 714
               +  +   T G     +M PE   D +++ +SDV+SFGVL+ EI             
Sbjct: 207 INNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF------------ 253

Query: 715 HHHNLLGHAWRLWIEERPVELINKSLGGS----YSLSEVLRCIQVG-------------- 756
                                   +LGGS      + E+ + ++ G              
Sbjct: 254 ------------------------TLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELY 289

Query: 757 ---LLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNPPE 799
                C    P  RP    +V  L  +R L       +     P E
Sbjct: 290 MMMRDCWHAVPSQRPTFKQLVEDL--DRILTLTTNEEYLDLSQPLE 333

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  153 bits (389), Expect = 5e-42
 Identities = 77/298 (25%), Positives = 116/298 (38%), Gaps = 78/298 (26%)

Query: 509 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGC 568
             ++G G FG V+ G  +   ++A K + +      E+F  E  ++ KL H  LV+L G 
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 569 CTQRDERMLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           C ++    L+ E++ +  L+D++            L           +  G+ YL     
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCL------DVCEGMAYL---EE 122

Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT---YGYMPPEYAI 681
             +IHRDL A N L+      K+SDFGM R    DQ  ++T    GT     +  PE   
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFS 178

Query: 682 DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 741
              +S KSDV+SFGVL+ E+                                     S G
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVF------------------------------------SEG 202

Query: 742 GS----YSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVLMLS 778
                  S SEV+  I  G                   C ++RPEDRP  S ++  L+
Sbjct: 203 KIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 260

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  154 bits (392), Expect = 7e-42
 Identities = 79/344 (22%), Positives = 133/344 (38%), Gaps = 96/344 (27%)

Query: 509 KNKLGEGGFGPVYKGVLIEGQE---IAAKRL-SKSSGQGMEEFENEVLLIAKL-QHRNLV 563
           ++ +GEG FG V K  + +       A KR+   +S     +F  E+ ++ KL  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDF-------------IFDVTRSKFLDWSKRCQIIG 610
            L+G C  R    L  EY P+ +L DF                 + +  L   +      
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN---- 666
            +ARG+ YL   S+ + IHRDL A N+L+      KI+DFG++R  G +     T     
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLP 204

Query: 667 -RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR 725
            R      +M  E     +++  SDV+S+GVL+ EIV                       
Sbjct: 205 VR------WMAIESLNYSVYTTNSDVWSYGVLLWEIV----------------------- 235

Query: 726 LWIEERPVELINKSLGGS----YSLSEVLRCIQVG-----------------LLCVQQRP 764
                        SLGG+     + +E+   +  G                   C +++P
Sbjct: 236 -------------SLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKP 282

Query: 765 EDRPNMSSVVLMLSGERSLPQPKQ---PGFFTERNPPESGSSSS 805
            +RP+ + +++ L   R L + K       + +        S+ 
Sbjct: 283 YERPSFAQILVSL--NRMLEERKTYVNTTLYEKFTYAGIDCSAE 324

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  153 bits (389), Expect = 1e-41
 Identities = 66/302 (21%), Positives = 117/302 (38%), Gaps = 78/302 (25%)

Query: 510 NKLGEGGFGPVYKGVLIEG----QEIAAKRLSK-SSGQGMEEFENEVLLIAKLQHRNLVK 564
             +G G FG VY G L++        A K L++ +    + +F  E +++    H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 565 LIGCCTQRDE-RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           L+G C + +   +++  Y+ +  L +FI +   +              +A+G+ YL   +
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYL---A 145

Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG------YMPP 677
             + +HRDL A N +LD +   K++DFG+AR    D  +     V    G      +M  
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMAL 201

Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 737
           E      F+ KSDV+SFGVL+ E++                                   
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELM----------------------------------- 226

Query: 738 KSLGGS----YSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVLM 776
            + G       +  ++   +  G                 L C   + E RP+ S +V  
Sbjct: 227 -TRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285

Query: 777 LS 778
           +S
Sbjct: 286 IS 287

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  154 bits (392), Expect = 1e-41
 Identities = 71/323 (21%), Positives = 118/323 (36%), Gaps = 98/323 (30%)

Query: 509 KNKLGEGGFGPVYKGVLI------EGQEIAAKRL-SKSSGQGMEEFENEVLLIAKLQHRN 561
              +GEG FG V++              +A K L  ++S     +F+ E  L+A+  + N
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDF---------------------IFDVTRSKFL 600
           +VKL+G C       L++EY+    LN+F                              L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 601 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 660
             +++  I   +A G+ YL   S  + +HRDL   N L+   M  KI+DFG++R    + 
Sbjct: 172 SCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR----NI 224

Query: 661 TEANTNRVVGTYGY-----MPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 715
             A+  +            MPPE      ++ +SDV+++GV++ EI              
Sbjct: 225 YSADYYK-ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF------------- 270

Query: 716 HHNLLGHAWRLWIEERPVELINKSLGGS----YSLSEVLRCIQVG--------------- 756
                                  S G       +  EV+  ++ G               
Sbjct: 271 -----------------------SYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYN 307

Query: 757 --LLCVQQRPEDRPNMSSVVLML 777
              LC  + P DRP+  S+  +L
Sbjct: 308 LMRLCWSKLPADRPSFCSIHRIL 330

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  151 bits (385), Expect = 2e-41
 Identities = 75/299 (25%), Positives = 119/299 (39%), Gaps = 70/299 (23%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E  +   +LG G FG V  G      ++A K + K      +EF  E   + KL H  LV
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66

Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           K  G C++     ++ EY+ N  L +++   +  K L+ S+  ++   +  G+ +L    
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---E 121

Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT---YGYMPPEYA 680
             + IHRDL A N L+D ++  K+SDFGM R    DQ  ++     GT     +  PE  
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV----GTKFPVKWSAPEVF 177

Query: 681 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 740
               +S KSDV++FG+L+ E+                                     SL
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVF------------------------------------SL 201

Query: 741 GGS----YSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVLMLS 778
           G      Y+ SEV+  +  G                   C  + PE RP    ++  + 
Sbjct: 202 GKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIE 260

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  152 bits (387), Expect = 3e-41
 Identities = 76/328 (23%), Positives = 126/328 (38%), Gaps = 98/328 (29%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVL--IEGQE----IAAKRL-SKSSGQGMEEFENEVLLIAK 556
           +N      LGEG FG V K     ++G+     +A K L   +S   + +  +E  ++ +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82

Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF---------------------IFDVT 595
           + H +++KL G C+Q    +LI EY    SL  F                       D  
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 596 RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 655
             + L           I++G+ YL   + ++++HRDL A N+L+      KISDFG++R 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR- 198

Query: 656 FGIDQTEANTNRVVGTYG-----YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGF 710
              D  E ++     + G     +M  E   D +++ +SDV+SFGVL+ EIV        
Sbjct: 199 ---DVYEEDSYV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV-------- 246

Query: 711 YHADHHHNLLGHAWRLWIEERPVELINKSLGGS----YSLSEVLRCIQVG---------- 756
                                       +LGG+         +   ++ G          
Sbjct: 247 ----------------------------TLGGNPYPGIPPERLFNLLKTGHRMERPDNCS 278

Query: 757 -------LLCVQQRPEDRPNMSSVVLML 777
                  L C +Q P+ RP  + +   L
Sbjct: 279 EEMYRLMLQCWKQEPDKRPVFADISKDL 306

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  152 bits (385), Expect = 4e-41
 Identities = 69/324 (21%), Positives = 116/324 (35%), Gaps = 84/324 (25%)

Query: 487 EEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQE----IAAKRLSK-SSG 541
           +++ +P  + +              +G+G FG VY G  I+  +     A K LS+ +  
Sbjct: 12  KDVLIP-HERVVT-------HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM 63

Query: 542 QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDER-MLIYEYLPNKSLNDFIFDVTRSKFL 600
           Q +E F  E LL+  L H N++ LIG     +    ++  Y+ +  L  FI      +  
Sbjct: 64  QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS--PQRNP 121

Query: 601 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 660
                      +ARG+ YL   +  + +HRDL A N +LD     K++DFG+AR   I  
Sbjct: 122 TVKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLAR--DILD 176

Query: 661 TEANTNRVVGTYG-----YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 715
            E  + +    +      +   E      F+ KSDV+SFGVL+ E++             
Sbjct: 177 REYYSVQ-QHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELL------------- 222

Query: 716 HHNLLGHAWRLWIEERPVELINKSLGGS----YSLSEVLRCIQVG--------------- 756
                                  + G          ++   +  G               
Sbjct: 223 -----------------------TRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQ 259

Query: 757 --LLCVQQRPEDRPNMSSVVLMLS 778
               C +  P  RP    +V  + 
Sbjct: 260 VMQQCWEADPAVRPTFRVLVGEVE 283

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  152 bits (386), Expect = 5e-41
 Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 30/209 (14%)

Query: 509 KNKLGEGGFGPVYKGVLI---EGQEI--AAKRLSKSSG-QGMEEFENEVLLIAKLQHRNL 562
              LG G FG V+KGV I   E  +I    K +   SG Q  +   + +L I  L H ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRCQIIGGIARGLLY 618
           V+L+G C       L+ +YLP  SL D +      +     L+W         IA+G+ Y
Sbjct: 78  VRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV------QIAKGMYY 130

Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-- 676
           L       ++HR+L A NVLL +    +++DFG+A     D  +   +         P  
Sbjct: 131 L---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPIK 182

Query: 677 ---PEYAIDGLFSVKSDVFSFGVLVLEIV 702
               E    G ++ +SDV+S+GV V E++
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTVWELM 211

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  151 bits (383), Expect = 5e-41
 Identities = 67/298 (22%), Positives = 118/298 (39%), Gaps = 70/298 (23%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           ++ +   +LG G FG V  G      ++A K + K      +EF  E  ++  L H  LV
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82

Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           +L G CT++    +I EY+ N  L +++            +  ++   +   + YL    
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---E 137

Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT---YGYMPPEYA 680
             + +HRDL A N L++++   K+SDFG++R    D+  ++     G+     + PPE  
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV----GSKFPVRWSPPEVL 193

Query: 681 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 740
           +   FS KSD+++FGVL+ EI                                     SL
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIY------------------------------------SL 217

Query: 741 GGS----YSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVLML 777
           G      ++ SE    I  G                   C  ++ ++RP    ++  +
Sbjct: 218 GKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 275

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  153 bits (389), Expect = 6e-41
 Identities = 80/335 (23%), Positives = 133/335 (39%), Gaps = 97/335 (28%)

Query: 509 KNKLGEGGFGPVYKGVLI--------EGQEIAAKRL-SKSSGQGMEEFENEVLLIAKL-Q 558
              LGEG FG V     I           ++A K L S ++ + + +  +E+ ++  + +
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG------- 611
           H+N++ L+G CTQ     +I EY    +L +++    R   L++S               
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQA-RRPPGLEYSYNPSHNPEEQLSSKD 192

Query: 612 -------IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGIDQTEA 663
                  +ARG+ YL   +  + IHRDL A NVL+  +   KI+DFG+AR    ID  + 
Sbjct: 193 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249

Query: 664 NTN-----RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHN 718
            TN     +      +M PE   D +++ +SDV+SFGVL+ EI                 
Sbjct: 250 TTNGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIF---------------- 287

Query: 719 LLGHAWRLWIEERPVELINKSLGGS----YSLSEVLRCIQVG-----------------L 757
                               +LGGS      + E+ + ++ G                  
Sbjct: 288 --------------------TLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMR 327

Query: 758 LCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFF 792
            C    P  RP    +V  L    +L   ++ G++
Sbjct: 328 DCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYY 362

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  150 bits (382), Expect = 7e-41
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 17/200 (8%)

Query: 509 KNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIG 567
           K+KLG G +G VY+GV       +A K L K     +EEF  E  ++ +++H NLV+L+G
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76

Query: 568 CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI 627
            CT+     +I E++   +L D++ +    + +       +   I+  + YL    +   
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYL---EKKNF 132

Query: 628 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN-----RVVGTYGYMPPEYAID 682
           IHRDL A N L+      K++DFG++R    D   A+       +      +  PE    
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAPESLAY 186

Query: 683 GLFSVKSDVFSFGVLVLEIV 702
             FS+KSDV++FGVL+ EI 
Sbjct: 187 NKFSIKSDVWAFGVLLWEIA 206

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  151 bits (384), Expect = 8e-41
 Identities = 67/311 (21%), Positives = 116/311 (37%), Gaps = 86/311 (27%)

Query: 509 KNKLGEGGFGPVYKGVLI----EGQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQHRNL 562
              LGEG FG V +G L        ++A K +    SS + +EEF +E   +    H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 563 VKLIGCCTQRD-----ERMLIYEYLPNKSLNDFI---FDVTRSKFLDWSKRCQIIGGIAR 614
           ++L+G C +       + M+I  ++    L+ ++      T  K +      + +  IA 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 615 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA-FGIDQTEANTN-----RV 668
           G+ YL   S    +HRDL A N +L ++M   ++DFG+++  +  D            + 
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK- 214

Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWI 728
                ++  E   D +++ KSDV++FGV + EI                           
Sbjct: 215 -----WIAIESLADRVYTSKSDVWAFGVTMWEIA-------------------------- 243

Query: 729 EERPVELINKSLGGS----YSLSEVLRCIQVG-----------------LLCVQQRPEDR 767
                     + G +        E+   +  G                   C +  P DR
Sbjct: 244 ----------TRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDR 293

Query: 768 PNMSSVVLMLS 778
           P  S + L L 
Sbjct: 294 PTFSVLRLQLE 304

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  152 bits (387), Expect = 9e-41
 Identities = 73/323 (22%), Positives = 123/323 (38%), Gaps = 93/323 (28%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLI--------EGQEIAAKRL-SKSSGQGMEEFENEVLLI 554
           +  +    LGEG FG V     +        E   +A K L   ++ + + +  +E+ ++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140

Query: 555 AKL-QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF-------------IFDVTRSKFL 600
             + +H+N++ L+G CTQ     +I EY    +L ++               +    + +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 601 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 660
            +         +ARG+ YL   +  + IHRDL A NVL+      KI+DFG+AR    D 
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DI 253

Query: 661 TEANTNRVVGTYG-----YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 715
              +  +   T G     +M PE   D +++ +SDV+SFGVL+ EI              
Sbjct: 254 NNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF------------- 299

Query: 716 HHNLLGHAWRLWIEERPVELINKSLGGS----YSLSEVLRCIQVG--------------- 756
                                  +LGGS      + E+ + ++ G               
Sbjct: 300 -----------------------TLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYM 336

Query: 757 --LLCVQQRPEDRPNMSSVVLML 777
               C    P  RP    +V  L
Sbjct: 337 MMRDCWHAVPSQRPTFKQLVEDL 359

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  151 bits (383), Expect = 2e-40
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 30/208 (14%)

Query: 510 NKLGEGGFGPVYKGVLIEGQE-----IAAKRL-SKSSGQGMEEFENEVLLIAKLQHRNLV 563
             LG G FG VYKG+ I   E     +A K L   +S +  +E  +E  ++A + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRCQIIGGIARGLLYL 619
           +L+G C       LI + +P   L D++ +    +     L+W         IA+G+ YL
Sbjct: 81  RLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYL 133

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP--- 676
                 R++HRDL A NVL+    + KI+DFG+A+  G ++ E +        G +P   
Sbjct: 134 ---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKW 185

Query: 677 --PEYAIDGLFSVKSDVFSFGVLVLEIV 702
              E  +  +++ +SDV+S+GV V E++
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELM 213

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  149 bits (379), Expect = 2e-40
 Identities = 60/321 (18%), Positives = 110/321 (34%), Gaps = 103/321 (32%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVL--------IEGQEIAAKRLSKSSGQGMEEFENEVLLIA 555
           E+      LG+G F  ++KGV         +   E+  K L K+     E F     +++
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67

Query: 556 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRCQIIGG 611
           KL H++LV   G C   DE +L+ E++   SL+ ++      +     L+ +K       
Sbjct: 68  KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK------Q 121

Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP--------KISDFGMARAFGIDQTEA 663
           +A  + +L       +IH ++ A N+LL  E +         K+SD G++          
Sbjct: 122 LAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-------- 170

Query: 664 NTNRVVGTYGY------MPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH 716
               V+           +PPE   +    ++ +D +SFG  + EI               
Sbjct: 171 ----VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEIC-------------- 212

Query: 717 HNLLGHAWRLWIEERPVELINKSLGGS----YSLSEVLRCIQVG---------------L 757
                                 S G            L+  +                  
Sbjct: 213 ----------------------SGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLIN 250

Query: 758 LCVQQRPEDRPNMSSVVLMLS 778
            C+   P+ RP+  +++  L+
Sbjct: 251 NCMDYEPDHRPSFRAIIRDLN 271

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  150 bits (382), Expect = 2e-40
 Identities = 72/302 (23%), Positives = 120/302 (39%), Gaps = 78/302 (25%)

Query: 509 KNKLGEGGFGPVYKGVLI----EGQEIAAKRL-SKSSGQGMEEFENEVLLIAKLQHRNLV 563
           +  +G G  G V  G L         +A K L +  + +   +F +E  ++ +  H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           +L G  T+    M++ EY+ N SL+ F+   T        +   ++ G+  G+ YL   S
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---S 168

Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG------YMPP 677
            L  +HRDL A NVL+D+ +  K+SDFG++R    D   A T     T G      +  P
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT-----TTGGKIPIRWTAP 223

Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 737
           E      FS  SDV+SFGV++ E++                                   
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVL----------------------------------- 248

Query: 738 KSLG----GSYSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVLM 776
            + G     + +  +V+  ++ G                 L C  +    RP  S +V +
Sbjct: 249 -AYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV 307

Query: 777 LS 778
           L 
Sbjct: 308 LD 309

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  150 bits (382), Expect = 2e-40
 Identities = 82/373 (21%), Positives = 131/373 (35%), Gaps = 103/373 (27%)

Query: 456 GFVYLWKRRHRKQGKTDGSSKLDYNDRGNREEEMELPIFD-WMAIANATE----NFSDKN 510
           G  Y +K++ + Q +       + N      +  +LP  + W       E    N     
Sbjct: 1   GVDYKYKQKPKYQVRWKIIESYEGNSYTF-IDPTQLPYNEKW-------EFPRNNLQFGK 52

Query: 511 KLGEGGFGPVYKGVL--IEGQE----IAAKRL-SKSSGQGMEEFENEVLLIAKL-QHRNL 562
            LG G FG V +     +  ++    +A K L S +     E   +E+ +++ L QH N+
Sbjct: 53  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112

Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDF-----------IFDVTRSKFLDWSKRCQIIGG 611
           V L+G CT     ++I EY     L +F                 +              
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172

Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 671
           +A+G+ +L   +    IHRD+ A NVLL N    KI DFG+AR    D    +    V  
Sbjct: 173 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR----DIMNDSNYI-VKG 224

Query: 672 YG-----YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL 726
                  +M PE   D +++V+SDV+S+G+L+ EI                         
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF------------------------ 260

Query: 727 WIEERPVELINKSLGGS-Y----SLSEVLRCIQVG-----------------LLCVQQRP 764
                       SLG + Y      S+  + ++ G                   C    P
Sbjct: 261 ------------SLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEP 308

Query: 765 EDRPNMSSVVLML 777
             RP    +   L
Sbjct: 309 THRPTFQQICSFL 321

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  150 bits (380), Expect = 3e-40
 Identities = 64/311 (20%), Positives = 111/311 (35%), Gaps = 85/311 (27%)

Query: 509 KNKLGEGGFGPVYKGVLI----EGQEIAAKRLSK--SSGQGMEEFENEVLLIAKLQHRNL 562
              LG+G FG V +  L        ++A K L     +   +EEF  E   + +  H ++
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 563 VKLIGCCTQRDER------MLIYEYLPNKSLNDFIFD---VTRSKFLDWSKRCQIIGGIA 613
            KL+G   +   +      M+I  ++ +  L+ F+           L      + +  IA
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
            G+ YL   S    IHRDL A N +L  +M   ++DFG++R         +  R  G   
Sbjct: 148 CGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR----KIYSGDYYR-QGCAS 199

Query: 674 -----YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWI 728
                ++  E   D L++V SDV++FGV + EI+                          
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIM-------------------------- 233

Query: 729 EERPVELINKSLGGS----YSLSEVLRCIQVG-----------------LLCVQQRPEDR 767
                     + G +       +E+   +  G                   C    P+ R
Sbjct: 234 ----------TRGQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQR 283

Query: 768 PNMSSVVLMLS 778
           P+ + + + L 
Sbjct: 284 PSFTCLRMELE 294

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  150 bits (381), Expect = 3e-40
 Identities = 80/322 (24%), Positives = 130/322 (40%), Gaps = 64/322 (19%)

Query: 509 KNKLGEGGFGPVYKGVLIEGQE-----IAAKRLSK-SSGQGMEEFENEVLLIAKLQHRNL 562
           +  +G G FG VYKG+L          +A K L    + +   +F  E  ++ +  H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
           ++L G  ++    M+I EY+ N +L+ F+    +       +   ++ GIA G+ YL   
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYL--- 163

Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGY--MPPEYA 680
           + +  +HRDL A N+L+++ +  K+SDFG++R    D  EA      G        PE  
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEATYTTSGGKIPIRWTAPEAI 222

Query: 681 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 740
               F+  SDV+SFG+++ E++                  G        ERP        
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMT----------------YG--------ERPYW------ 252

Query: 741 GGSYSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVLMLSGERSL 783
               S  EV++ I  G                 + C QQ    RP  + +V +L      
Sbjct: 253 --ELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310

Query: 784 PQP-KQPGFFTERNPPESGSSS 804
           P   K    F  R      S+S
Sbjct: 311 PDSLKTLADFDPRVSIRLPSTS 332

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  148 bits (377), Expect = 3e-40
 Identities = 53/201 (26%), Positives = 88/201 (43%), Gaps = 25/201 (12%)

Query: 509 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGC 568
              +G+G FG V  G    G ++A K +   +    + F  E  ++ +L+H NLV+L+G 
Sbjct: 26  LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 82

Query: 569 CTQRDER-MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI 627
             +      ++ EY+   SL D++        L      +    +   + YL        
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYL---EGNNF 138

Query: 628 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG------YMPPEYAI 681
           +HRDL A NVL+  +   K+SDFG+ +    + +                  +  PE   
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK----EASST-------QDTGKLPVKWTAPEALR 187

Query: 682 DGLFSVKSDVFSFGVLVLEIV 702
           +  FS KSDV+SFG+L+ EI 
Sbjct: 188 EKKFSTKSDVWSFGILLWEIY 208

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  149 bits (378), Expect = 3e-40
 Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 21/202 (10%)

Query: 511 KLGEGGFGPVYKGVL-IEGQEI--AAKRLSK--SSGQGMEEFENEVLLIAKLQHRNLVKL 565
           +LG G FG V KG   ++      A K L    +     +E   E  ++ +L +  +V++
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 625
           IG C   +  ML+ E      LN +   + +++ +      +++  ++ G+ YL      
Sbjct: 84  IGICEA-ESWMLVMEMAELGPLNKY---LQQNRHVKDKNIIELVHQVSMGMKYL---EES 136

Query: 626 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----PEYA 680
             +HRDL A NVLL  +   KISDFG+++A   D+          T+G  P     PE  
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAPECI 192

Query: 681 IDGLFSVKSDVFSFGVLVLEIV 702
               FS KSDV+SFGVL+ E  
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAF 214

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  153 bits (388), Expect = 4e-40
 Identities = 77/293 (26%), Positives = 120/293 (40%), Gaps = 70/293 (23%)

Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
            KLG G FG V+     +  ++A K + K     +E F  E  ++  LQH  LVKL    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
           T+ +   +I E++   SL DF+            K       IA G+ ++    +   IH
Sbjct: 253 TK-EPIYIITEFMAKGSLLDFLKS-DEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIH 307

Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT---YGYMPPEYAIDGLFS 686
           RDL+A+N+L+   +  KI+DFG+AR    ++  A      G      +  PE    G F+
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTARE----GAKFPIKWTAPEAINFGSFT 363

Query: 687 VKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS-Y- 744
           +KSDV+SFG+L++EIV                                    + G   Y 
Sbjct: 364 IKSDVWSFGILLMEIV------------------------------------TYGRIPYP 387

Query: 745 --SLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVLMLS 778
             S  EV+R ++ G                 + C + RPE+RP    +  +L 
Sbjct: 388 GMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 440

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  151 bits (382), Expect = 5e-40
 Identities = 65/302 (21%), Positives = 118/302 (39%), Gaps = 78/302 (25%)

Query: 510 NKLGEGGFGPVYKGVLIEG----QEIAAKRLSK-SSGQGMEEFENEVLLIAKLQHRNLVK 564
             +G G FG VY G L++        A K L++ +    + +F  E +++    H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 565 LIGCCTQRDE-RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           L+G C + +   +++  Y+ +  L +FI +   +              +A+G+ +L   +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFL---A 209

Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG------YMPP 677
             + +HRDL A N +LD +   K++DFG+AR    D  +   + V    G      +M  
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEFDSVHNKTGAKLPVKWMAL 265

Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 737
           E      F+ KSDV+SFGVL+ E++                                   
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELM----------------------------------- 290

Query: 738 KSLGGS----YSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVLM 776
            + G       +  ++   +  G                 L C   + E RP+ S +V  
Sbjct: 291 -TRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349

Query: 777 LS 778
           +S
Sbjct: 350 IS 351

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  148 bits (376), Expect = 5e-40
 Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 19/203 (9%)

Query: 509 KNKLGEGGFGPVYKGVLIEGQE---IAAKRLSK-SSGQGMEEFENEVLLIAKLQHRNLVK 564
             +LG G FG V +GV    ++   +A K L + +     EE   E  ++ +L +  +V+
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           LIG C   +  ML+ E      L+ F+  V + + +  S   +++  ++ G+ YL     
Sbjct: 75  LIGVCQA-EALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EE 128

Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----PEY 679
              +HRDL A NVLL N    KISDFG+++A G D +         + G  P     PE 
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR----SAGKWPLKWYAPEC 184

Query: 680 AIDGLFSVKSDVFSFGVLVLEIV 702
                FS +SDV+S+GV + E +
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEAL 207

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  153 bits (389), Expect = 6e-40
 Identities = 72/291 (24%), Positives = 117/291 (40%), Gaps = 64/291 (21%)

Query: 510 NKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGC 568
           +KLG G +G VY+GV       +A K L K     +EEF  E  ++ +++H NLV+L+G 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 569 CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRII 628
           CT+     +I E++   +L D++ +  R + +       +   I+  + YL    +   I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYL---EKKNFI 340

Query: 629 HRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVK 688
           HR+L A N L+      K++DFG++R    D   A+         +  PE      FS+K
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIK 399

Query: 689 SDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS----Y 744
           SDV++FGVL+ EI                                     + G S     
Sbjct: 400 SDVWAFGVLLWEIA------------------------------------TYGMSPYPGI 423

Query: 745 SLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVLMLS 778
            LS+V   ++                     C Q  P DRP+ + +     
Sbjct: 424 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 474

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  148 bits (375), Expect = 1e-39
 Identities = 73/318 (22%), Positives = 113/318 (35%), Gaps = 93/318 (29%)

Query: 509 KNKLGEGGFGPVYKGVLI------EGQEIAAKRL-SKSSGQGMEEFENEVLLIAKL-QHR 560
              LG G FG V +            + +A K L   ++        +E+ ++  +  H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91

Query: 561 NLVKLIGCCTQRDE-RMLIYEYLPNKSLNDF-------------IFDVTRSKFLDWSKRC 606
           N+V L+G CT+     M+I E+    +L+ +               +     FL      
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 607 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN 666
                +A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+AR    D  +    
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDY 204

Query: 667 RVVGTYG-----YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLG 721
                       +M PE   D +++++SDV+SFGVL+ EI                    
Sbjct: 205 V-RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF------------------- 244

Query: 722 HAWRLWIEERPVELINKSLGGS-Y----SLSEVLRCIQVG-----------------LLC 759
                            SLG S Y       E  R ++ G                 L C
Sbjct: 245 -----------------SLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 287

Query: 760 VQQRPEDRPNMSSVVLML 777
               P  RP  S +V  L
Sbjct: 288 WHGEPSQRPTFSELVEHL 305

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  149 bits (379), Expect = 1e-39
 Identities = 72/295 (24%), Positives = 120/295 (40%), Gaps = 64/295 (21%)

Query: 509 KNKLGEGGFGPVYKGVLIEGQE----IAAKRLSK-SSGQGMEEFENEVLLIAKLQHRNLV 563
              +G G FG V  G L    +    +A K L    + +   +F  E  ++ +  H N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           +L G  T+    M++ EY+ N SL+ F+            +   ++ GIA G+ YL   S
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL---S 164

Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT---YGYMPPEYA 680
            +  +HRDL A N+L+++ +  K+SDFG+ R    D   A T R  G      +  PE  
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWTSPEAI 222

Query: 681 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 740
               F+  SDV+S+G+++ E++                  G        ERP        
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMS----------------YG--------ERPYW------ 252

Query: 741 GGSYSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVLMLS 778
               S  +V++ +  G                 L C Q+   +RP    +V +L 
Sbjct: 253 --EMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  146 bits (372), Expect = 1e-39
 Identities = 67/197 (34%), Positives = 102/197 (51%), Gaps = 13/197 (6%)

Query: 509 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGC 568
             +LG G FG V+ G      ++A K L K      + F  E  L+ +LQH+ LV+L   
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 569 CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRII 628
            TQ +   +I EY+ N SL DF+        L  +K   +   IA G+ ++        I
Sbjct: 77  VTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFI---EERNYI 131

Query: 629 HRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT---YGYMPPEYAIDGLF 685
           HRDL+A+N+L+ + ++ KI+DFG+AR    ++  A      G      +  PE    G F
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE----GAKFPIKWTAPEAINYGTF 187

Query: 686 SVKSDVFSFGVLVLEIV 702
           ++KSDV+SFG+L+ EIV
Sbjct: 188 TIKSDVWSFGILLTEIV 204

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  147 bits (372), Expect = 2e-39
 Identities = 60/206 (29%), Positives = 85/206 (41%), Gaps = 26/206 (12%)

Query: 511 KLGEGGFGPVYKGVL--IEGQEI--AAKRL---SKSSGQGMEEFENEVLLIAKLQHRNLV 563
           KLG+G FG V +G      G+ +  A K L     S  + M++F  EV  +  L HRNL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFI----FDVTRSKFLDWSKRCQIIGGIARGLLYL 619
           +L G         ++ E  P  SL D +              ++        +A G+ YL
Sbjct: 85  RLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV------QVAEGMGYL 137

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT---YGYMP 676
                 R IHRDL A N+LL      KI DFG+ RA   +               + +  
Sbjct: 138 ---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCA 192

Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIV 702
           PE      FS  SD + FGV + E+ 
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMF 218

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  150 bits (382), Expect = 2e-39
 Identities = 66/294 (22%), Positives = 106/294 (36%), Gaps = 74/294 (25%)

Query: 509 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGC 568
              +G+G FG V  G    G ++A K +   +    + F  E  ++ +L+H NLV+L+G 
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 254

Query: 569 CTQRDER-MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI 627
             +      ++ EY+   SL D++    R   L      +    +   + YL        
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYL---EGNNF 310

Query: 628 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGY--MPPEYAIDGLF 685
           +HRDL A NVL+  +   K+SDFG+ +       EA++ +  G        PE   +  F
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKF 363

Query: 686 SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS-- 743
           S KSDV+SFG+L+ EI                                     S G    
Sbjct: 364 STKSDVWSFGILLWEIY------------------------------------SFGRVPY 387

Query: 744 --YSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVLMLS 778
               L +V+  ++ G                   C       RP    +   L 
Sbjct: 388 PRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLE 441

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  150 bits (381), Expect = 3e-39
 Identities = 73/290 (25%), Positives = 119/290 (41%), Gaps = 64/290 (22%)

Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
            KLG+G FG V+ G       +A K L K      E F  E  ++ KL+H  LV+L    
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
           ++ +   ++ EY+   SL DF+      K+L   +   +   IA G+ Y+    R+  +H
Sbjct: 249 SE-EPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 303

Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 689
           RDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G F++KS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 362

Query: 690 DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS----YS 745
           DV+SFG+L+ E+                                     + G        
Sbjct: 363 DVWSFGILLTELT------------------------------------TKGRVPYPGMV 386

Query: 746 LSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVLMLS 778
             EVL  ++ G                   C ++ PE+RP    +   L 
Sbjct: 387 NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  151 bits (382), Expect = 7e-39
 Identities = 73/290 (25%), Positives = 119/290 (41%), Gaps = 64/290 (22%)

Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
            KLG+G FG V+ G       +A K L K      E F  E  ++ KL+H  LV+L    
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
           ++ +   ++ EY+   SL DF+      K+L   +   +   IA G+ Y+    R+  +H
Sbjct: 332 SE-EPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 386

Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKS 689
           RDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G F++KS
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 445

Query: 690 DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS----YS 745
           DV+SFG+L+ E+                                     + G        
Sbjct: 446 DVWSFGILLTELT------------------------------------TKGRVPYPGMV 469

Query: 746 LSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVLMLS 778
             EVL  ++ G                   C ++ PE+RP    +   L 
Sbjct: 470 NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 519

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  144 bits (365), Expect = 1e-38
 Identities = 66/306 (21%), Positives = 110/306 (35%), Gaps = 89/306 (29%)

Query: 509 KNKLGEGGFGPVYKGVLI--EGQEI--AAKRLSK-SSGQGMEEFENEVLLIAKLQHRNLV 563
              LGEG FG VY+GV    +G++I  A K   K  +    E+F +E +++  L H ++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFI----FDVTRSKFLDWSKRCQIIGGIARGLLYL 619
           KLIG   + +   +I E  P   L  ++      +     + +S        I + + YL
Sbjct: 77  KLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL------QICKAMAYL 129

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG------ 673
                +  +HRD+   N+L+ +    K+ DFG++R    +     +              
Sbjct: 130 ---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS-------VTRLPIK 179

Query: 674 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV 733
           +M PE      F+  SDV+ F V + EI+                               
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEIL------------------------------- 208

Query: 734 ELINKSLGGS----YSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSS 772
                S G          +V+  ++ G                   C    P DRP  + 
Sbjct: 209 -----SFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTE 263

Query: 773 VVLMLS 778
           +V  LS
Sbjct: 264 LVCSLS 269

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  146 bits (370), Expect = 1e-38
 Identities = 74/375 (19%), Positives = 123/375 (32%), Gaps = 104/375 (27%)

Query: 459 YLWKRRHRKQGKTDGSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFG 518
           Y  + R+  Q +         ++     +  E             EN      LG G FG
Sbjct: 3   YKKQFRYESQLQM-VQVTGSSDNEYFYVDFREYEYDLKWEFPR--ENLEFGKVLGSGAFG 59

Query: 519 PVYKGVLI------EGQEIAAKRLSKS-SGQGMEEFENEVLLIAKL-QHRNLVKLIGCCT 570
            V               ++A K L +       E   +E+ ++ +L  H N+V L+G CT
Sbjct: 60  KVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119

Query: 571 QRDERMLIYEYLPNKSLNDF------IFDVTRSKFLDWSKRCQIIGG------------- 611
                 LI+EY     L ++       F     ++ +  +  +                 
Sbjct: 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAY 179

Query: 612 -IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGIDQTEANTN--- 666
            +A+G+ +L        +HRDL A NVL+ +    KI DFG+AR            N   
Sbjct: 180 QVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARL 236

Query: 667 --RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW 724
             +      +M PE   +G++++KSDV+S+G+L+ EI                       
Sbjct: 237 PVK------WMAPESLFEGIYTIKSDVWSYGILLWEIF---------------------- 268

Query: 725 RLWIEERPVELINKSLGGS-Y----SLSEVLRCIQVG-----------------LLCVQQ 762
                         SLG + Y      +   + IQ G                   C   
Sbjct: 269 --------------SLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAF 314

Query: 763 RPEDRPNMSSVVLML 777
               RP+  ++   L
Sbjct: 315 DSRKRPSFPNLTSFL 329

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  145 bits (367), Expect = 1e-38
 Identities = 69/325 (21%), Positives = 110/325 (33%), Gaps = 96/325 (29%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKS-SGQGMEEFENEVLLIAK 556
              S    LG G FG V +              +A K L  S      E   +E+ +++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 557 L-QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG---- 611
           L  H N+V L+G CT     ++I EY     L +F+     S     +    +       
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 612 -----------IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR-AFGID 659
                      +A+G+ +L   +    IHRDL A N+LL +    KI DFG+AR      
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 660 QTEANTN-----RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHAD 714
                 N     +      +M PE   + +++ +SDV+S+G+ + E+             
Sbjct: 200 NYVVKGNARLPVK------WMAPESIFNCVYTFESDVWSYGIFLWELF------------ 241

Query: 715 HHHNLLGHAWRLWIEERPVELINKSLGGS-Y----SLSEVLRCIQVG------------- 756
                                   SLG S Y      S+  + I+ G             
Sbjct: 242 ------------------------SLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEM 277

Query: 757 ----LLCVQQRPEDRPNMSSVVLML 777
                 C    P  RP    +V ++
Sbjct: 278 YDIMKTCWDADPLKRPTFKQIVQLI 302

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  143 bits (363), Expect = 2e-38
 Identities = 64/312 (20%), Positives = 110/312 (35%), Gaps = 87/312 (27%)

Query: 511 KLGEGGFGPVYKGVLI--EGQEI--AAKRLSK-SSGQGMEEFENEVLLIAKLQHRNLVKL 565
            +GEG FG V++G+ +  E   +  A K     +S    E+F  E L + +  H ++VKL
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFI----FDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
           IG  T+ +   +I E      L  F+    + +  +  + ++        ++  L YL  
Sbjct: 82  IGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY------QLSTALAYL-- 132

Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN-----RVVGTYGYMP 676
               R +HRD+ A NVL+ +    K+ DFG++R          +      +      +M 
Sbjct: 133 -ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK------WMA 185

Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 736
           PE      F+  SDV+ FGV + EI+                                  
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEIL---------------------------------- 211

Query: 737 NKSLGGS----YSLSEVLRCIQVG-----------------LLCVQQRPEDRPNMSSVVL 775
               G         ++V+  I+ G                   C    P  RP  + +  
Sbjct: 212 --MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269

Query: 776 MLSGERSLPQPK 787
            LS      + +
Sbjct: 270 QLSTILEEEKAQ 281

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  143 bits (363), Expect = 2e-38
 Identities = 68/289 (23%), Positives = 120/289 (41%), Gaps = 53/289 (18%)

Query: 504 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL 562
            +F +   +G GGFG V+K    I+G+    KR+  ++    E+ E EV  +AKL H N+
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66

Query: 563 VKLIGCCTQRDERM----------------LIYEYLPNKSLNDFIFDVTRSKFLDWSKRC 606
           V   GC    D                   +  E+    +L  +I +  R + LD     
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125

Query: 607 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN 666
           ++   I +G+ Y+H     ++I+RDLK SN+ L +    KI DFG+  +    + +    
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRT 179

Query: 667 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL 726
           R  GT  YM PE      +  + D+++ G+++ E++          A             
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD-----TAFETSKFF------ 228

Query: 727 WIEERPVELINKSLGGSYS--LSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
                  +L +  +   +      +L+        + ++PEDRPN S +
Sbjct: 229 ------TDLRDGIISDIFDKKEKTLLQ------KLLSKKPEDRPNTSEI 265

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  150 bits (380), Expect = 4e-38
 Identities = 61/203 (30%), Positives = 98/203 (48%), Gaps = 19/203 (9%)

Query: 509 KNKLGEGGFGPVYKGVLIEGQE---IAAKRL-SKSSGQGMEEFENEVLLIAKLQHRNLVK 564
             +LG G FG V +GV    ++   +A K L   +     EE   E  ++ +L +  +V+
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 565 LIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSR 624
           LIG C   +  ML+ E      L+ F+  V + + +  S   +++  ++ G+ YL     
Sbjct: 401 LIGVCQ-AEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EE 454

Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP-----PEY 679
              +HR+L A NVLL N    KISDFG+++A G D +         + G  P     PE 
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR----SAGKWPLKWYAPEC 510

Query: 680 AIDGLFSVKSDVFSFGVLVLEIV 702
                FS +SDV+S+GV + E +
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEAL 533

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  144 bits (366), Expect = 4e-38
 Identities = 61/273 (22%), Positives = 115/273 (42%), Gaps = 25/273 (9%)

Query: 504 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAK--RLSKSSGQGMEEFENEVLLIAKLQHR 560
           E +    K+GEG FG         +G++   K   +S+ S +  EE   EV ++A ++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+V+      +     ++ +Y     L   I    +       +       I   L ++H
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVH 142

Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
                +I+HRD+K+ N+ L  +   ++ DFG+AR        A     +GT  Y+ PE  
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197

Query: 681 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 740
            +  ++ KSD+++ G ++ E+   K     + A    NL+       I       ++   
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHA---FEAGSMKNLVLK-----IISGSFPPVSLHY 249

Query: 741 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
             SY L  ++          ++ P DRP+++S+
Sbjct: 250 --SYDLRSLVS------QLFKRNPRDRPSVNSI 274

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  149 bits (378), Expect = 1e-37
 Identities = 74/352 (21%), Positives = 124/352 (35%), Gaps = 71/352 (20%)

Query: 462 KRRHRKQGKTDGSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVY 521
           +++  +      S   DY +  + E+   +P      I    E       +GEG FG V+
Sbjct: 350 EKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQR--ERIELGRCIGEGQFGDVH 407

Query: 522 KGVLI--EGQEI--AAKRL-SKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM 576
           +G+ +  E   +  A K   + +S    E+F  E L + +  H ++VKLIG  T+ +   
Sbjct: 408 QGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW 466

Query: 577 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASN 636
           +I E      L  F+    R   LD +        ++  L YL      R +HRD+ A N
Sbjct: 467 IIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARN 521

Query: 637 VLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGV 696
           VL+ +    K+ DFG++R          +   +    +M PE      F+  SDV+ FGV
Sbjct: 522 VLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGV 580

Query: 697 LVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS----YSLSEVLRC 752
            + EI+                                      G         ++V+  
Sbjct: 581 CMWEIL------------------------------------MHGVKPFQGVKNNDVIGR 604

Query: 753 IQVG-----------------LLCVQQRPEDRPNMSSVVLMLSGERSLPQPK 787
           I+ G                   C    P  RP  + +   LS      + +
Sbjct: 605 IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKLQ 656

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  141 bits (357), Expect = 3e-37
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 23/217 (10%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRN 561
             +S   ++G GG   V++ +  + Q  A K ++      Q ++ + NE+  + KLQ  +
Sbjct: 28  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87

Query: 562 L--VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
              ++L           ++ E   N  LN ++    + K +D  +R      +   +  +
Sbjct: 88  DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 143

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE- 678
           HQ     I+H DLK +N L+ +    K+ DFG+A     D T    +  VGT  YMPPE 
Sbjct: 144 HQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199

Query: 679 ----------YAIDGLFSVKSDVFSFGVLVLEIVCGK 705
                            S KSDV+S G ++  +  GK
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  140 bits (355), Expect = 4e-37
 Identities = 58/245 (23%), Positives = 103/245 (42%), Gaps = 38/245 (15%)

Query: 503 TENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRN 561
             +F +   LG+G FG V K    ++ +  A K++  +  + +    +EV+L+A L H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63

Query: 562 LVKLIGC----------CTQRDERMLIY---EYLPNKSLNDFIFDVTRSKFLDWSKRCQI 608
           +V+               T   ++  ++   EY  N +L D I   + +      +  ++
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYWRL 121

Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF------------ 656
              I   L Y+H      IIHRDLK  N+ +D   N KI DFG+A+              
Sbjct: 122 FRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 657 GIDQTEANTNRVVGTYGYMPPE-YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 715
            +  +  N    +GT  Y+  E     G ++ K D++S G++  E++       F     
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-----PFSTGME 233

Query: 716 HHNLL 720
             N+L
Sbjct: 234 RVNIL 238

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  140 bits (354), Expect = 6e-37
 Identities = 63/327 (19%), Positives = 114/327 (34%), Gaps = 58/327 (17%)

Query: 504 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRN 561
            +F     LG GGFG V++    ++    A KR+         E+   EV  +AKL+H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 562 LVKLIGC---------CTQRDERMLIY---EYLPNKSLNDFIFDVTRSKFLDWSKRCQII 609
           +V+                   ++ +Y   +    ++L D++      +  + S    I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 610 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV- 668
             IA  + +LH      ++HRDLK SN+    +   K+ DFG+  A   D+ E       
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 669 ---------VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL 719
                    VGT  YM PE      +S K D+FS G+++ E++       F         
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-----PFSTQMERVRT 236

Query: 720 LGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG 779
           L       +       +            +++        +   P +RP   +++     
Sbjct: 237 LTD-----VRNLKFPPLFTQK--YPCEYVMVQ------DMLSPSPMERPEAINII----- 278

Query: 780 ERSLPQPKQPGFFTERNPPESGSSSSK 806
                  +    F + + P       +
Sbjct: 279 -------ENA-VFEDLDFPGKTVLRQR 297

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  139 bits (353), Expect = 2e-36
 Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 23/211 (10%)

Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNL--VKL 565
            ++G GG   V++ +  + Q  A K ++      Q ++ + NE+  + KLQ  +   ++L
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 625
                      ++ E   N  LN ++    + K +D  +R      +   +  +HQ    
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ---H 127

Query: 626 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE------- 678
            I+H DLK +N L+ +    K+ DFG+A     D T    +  VGT  YMPPE       
Sbjct: 128 GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186

Query: 679 ----YAIDGLFSVKSDVFSFGVLVLEIVCGK 705
                      S KSDV+S G ++  +  GK
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  138 bits (349), Expect = 2e-36
 Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 17/203 (8%)

Query: 511 KLGEGGFGPVYKGV-LIEGQEIAAK--RLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIG 567
           ++G G F  VYKG+      E+A    +  K +    + F+ E  ++  LQH N+V+   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 568 CC--TQRDERML--IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
               T + ++ +  + E + + +L  ++    R K +           I +GL +LH  +
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRT 149

Query: 624 RLRIIHRDLKASNVLLDNEM-NPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID 682
              IIHRDLK  N+ +     + KI D G+A      +  +    V+GT  +M PE   +
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEM-YE 203

Query: 683 GLFSVKSDVFSFGVLVLEIVCGK 705
             +    DV++FG+ +LE+   +
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSE 226

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  137 bits (348), Expect = 2e-36
 Identities = 71/283 (25%), Positives = 116/283 (40%), Gaps = 36/283 (12%)

Query: 504 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHR 560
           E++     +G G +G   K     +G+ +  K L     +    +   +EV L+ +L+H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 561 NLVKLIGCCTQRDERML--IYEYLPNKSLNDFIFDVTRSK-FLDWSKRCQIIGGIARGLL 617
           N+V+       R    L  + EY     L   I   T+ + +LD     +++  +   L 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 618 YLHQ--DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYM 675
             H+  D    ++HRDLK +NV LD + N K+ DFG+AR    D + A T   VGT  YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183

Query: 676 PPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 735
            PE      ++ KSD++S G L+ E+        F                       EL
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALM--PPFTAFSQK-----------------EL 224

Query: 736 INKSLGGSYS-----LSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
             K   G +       S+ L  I   +L ++     RP++  +
Sbjct: 225 AGKIREGKFRRIPYRYSDELNEIITRMLNLK--DYHRPSVEEI 265

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  137 bits (347), Expect = 5e-36
 Identities = 67/281 (23%), Positives = 121/281 (43%), Gaps = 35/281 (12%)

Query: 504 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRL---SKSSGQGMEEFENEVLLIAKLQH 559
            NF  + K+G G F  VY+   L++G  +A K++        +   +   E+ L+ +L H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRS-KFLDWSKRCQIIGGIARGLLY 618
            N++K      + +E  ++ E      L+  I    +  + +      +    +   L +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           +H     R++HRD+K +NV +      K+ D G+ R F    T A++  +VGT  YM PE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206

Query: 679 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 738
              +  ++ KSD++S G L+ E+   +     ++ D  +                 L  K
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMN--------------LYSLCKK 249

Query: 739 SLGGSYS------LSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
                Y        SE LR  Q+  +C+   PE RP+++ V
Sbjct: 250 IEQCDYPPLPSDHYSEELR--QLVNMCINPDPEKRPDVTYV 288

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  137 bits (347), Expect = 7e-36
 Identities = 66/309 (21%), Positives = 115/309 (37%), Gaps = 48/309 (15%)

Query: 504 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL 562
           +++    KLGEGGF  V     L +G   A KR+     Q  EE + E  +     H N+
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88

Query: 563 VKLIGCCTQRDERM----LIYEYLPNKSLNDFIFDVTRSK-FLDWSKRCQIIGGIARGLL 617
           ++L+  C +         L+  +    +L + I  +     FL   +   ++ GI RGL 
Sbjct: 89  LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148

Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV-------G 670
            +H        HRDLK +N+LL +E  P + D G      I    +     +        
Sbjct: 149 AIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205

Query: 671 TYGYMPPEYAIDG----LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL 726
           T  Y  PE         +   ++DV+S G ++  ++ G+               G     
Sbjct: 206 TISYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGE------GPYDMVFQKG----- 253

Query: 727 WIEERPVELINKSLGGSYSL------SEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 780
                  + +  ++    S+      S  L  +   ++ V   P  RP++  ++  L   
Sbjct: 254 -------DSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVD--PHQRPHIPLLLSQLEAL 304

Query: 781 RSLPQPKQP 789
           +  P P Q 
Sbjct: 305 QP-PAPGQH 312

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  139 bits (351), Expect = 8e-36
 Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 23/211 (10%)

Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNL--VKL 565
            ++G GG   V++ +  + Q  A K ++      Q ++ + NE+  + KLQ  +   ++L
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 625
                      ++ E   N  LN ++    + K +D  +R      +   +  +HQ    
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ---H 174

Query: 626 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE------- 678
            I+H DLK +N L+ +    K+ DFG+A     D T    +  VG   YMPPE       
Sbjct: 175 GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233

Query: 679 ----YAIDGLFSVKSDVFSFGVLVLEIVCGK 705
                      S KSDV+S G ++  +  GK
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  136 bits (344), Expect = 1e-35
 Identities = 64/235 (27%), Positives = 105/235 (44%), Gaps = 29/235 (12%)

Query: 481 DRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS 539
           D  +   E +    +            D+  LG+G +G VY G  +     IA K + + 
Sbjct: 9   DCESDLLEYDYEYDENG----------DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER 58

Query: 540 SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKF 599
             +  +    E+ L   L+H+N+V+ +G  ++     +  E +P  SL+  +    RSK+
Sbjct: 59  DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALL----RSKW 114

Query: 600 LDWSKRCQIIGGIAR----GLLYLHQDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMAR 654
                  Q IG   +    GL YLH +   +I+HRD+K  NVL++      KISDFG ++
Sbjct: 115 GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSK 171

Query: 655 AFGIDQTEANTNRVVGTYGYMPPEYAIDGL---FSVKSDVFSFGVLVLEIVCGKR 706
              +      T    GT  YM PE  ID     +   +D++S G  ++E+  GK 
Sbjct: 172 R--LAGINPCTETFTGTLQYMAPE-IIDKGPRGYGKAADIWSLGCTIIEMATGKP 223

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  132 bits (334), Expect = 6e-34
 Identities = 55/201 (27%), Positives = 87/201 (43%), Gaps = 18/201 (8%)

Query: 512 LGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEE-FENEVLLIAKLQHRNLVKLIG 567
           LG+GGF   ++    +  +  A K + KS        E    E+ +   L H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 568 CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC---QIIGGIARGLLYLHQDSR 624
                D   ++ E    +SL +      R    +   R    QI+ G      YLH+   
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQIVLG----CQYLHR--- 159

Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 684
            R+IHRDLK  N+ L+ ++  KI DFG+A     D        + GT  Y+ PE      
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKG 217

Query: 685 FSVKSDVFSFGVLVLEIVCGK 705
            S + DV+S G ++  ++ GK
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGK 238

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  130 bits (330), Expect = 8e-34
 Identities = 56/201 (27%), Positives = 87/201 (43%), Gaps = 18/201 (8%)

Query: 512 LGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEE-FENEVLLIAKLQHRNLVKLIG 567
           LG+GGF   ++    +  +  A K + KS        E    E+ +   L H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 568 CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC---QIIGGIARGLLYLHQDSR 624
                D   ++ E    +SL +      R    +   R    QI+ G      YLH   R
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQIVLG----CQYLH---R 133

Query: 625 LRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL 684
            R+IHRDLK  N+ L+ ++  KI DFG+A     D        + GT  Y+ PE      
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKG 191

Query: 685 FSVKSDVFSFGVLVLEIVCGK 705
            S + DV+S G ++  ++ GK
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGK 212

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  130 bits (329), Expect = 2e-33
 Identities = 61/272 (22%), Positives = 101/272 (37%), Gaps = 38/272 (13%)

Query: 504 ENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFE--NEVLLIAKL-QH 559
           ++F   ++LG G +G V+K     +G+  A KR         +      EV    K+ QH
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116

Query: 560 RNLVKLIGCCTQRDERMLIY-EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
              V+L     +    + +  E     SL            L  ++    +      L +
Sbjct: 117 PCCVRLEQA-WEEGGILYLQTELC-GPSLQQHCEA--WGASLPEAQVWGYLRDTLLALAH 172

Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           LH      ++H D+K +N+ L      K+ DFG+    G            G   YM PE
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA-GEV--QEGDPRYMAPE 226

Query: 679 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 738
             + G +   +DVFS G+ +LE+ C             H   G  W+        +L   
Sbjct: 227 -LLQGSYGTAADVFSLGLTILEVACNME--------LPHG--GEGWQ--------QLRQG 267

Query: 739 SLGGSYS--LSEVLRCIQVGLLCVQQRPEDRP 768
            L   ++  LS  LR   V ++ ++  P+ R 
Sbjct: 268 YLPPEFTAGLSSELR--SVLVMMLEPDPKLRA 297

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  131 bits (330), Expect = 2e-33
 Identities = 55/251 (21%), Positives = 101/251 (40%), Gaps = 27/251 (10%)

Query: 462 KRRHRKQGKTDGSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVY 521
            +  R   +T+ +  +   ++    +        W          + + ++G G FG V+
Sbjct: 25  AKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHW---------MTHQPRVGRGSFGEVH 75

Query: 522 KGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE 580
           +    + G + A K++     +       E++  A L    +V L G   +     +  E
Sbjct: 76  RMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130

Query: 581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD 640
            L   SL   I    +   L   +    +G    GL YLH     RI+H D+KA NVLL 
Sbjct: 131 LLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLS 184

Query: 641 NEMNP-KISDFGMAR---AFGIDQTEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFG 695
           ++ +   + DFG A      G+ ++    + + GT  +M PE  + G     K D++S  
Sbjct: 185 SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE-VVMGKPCDAKVDIWSSC 243

Query: 696 VLVLEIVCGKR 706
            ++L ++ G  
Sbjct: 244 CMMLHMLNGCH 254

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  129 bits (326), Expect = 4e-33
 Identities = 60/244 (24%), Positives = 109/244 (44%), Gaps = 11/244 (4%)

Query: 464 RHRKQGKTDGSSKLDYNDRGN-REEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYK 522
            H      D  ++  Y   G    E+ +  +   +   +         K+GEG  G V  
Sbjct: 4   HHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCL 63

Query: 523 GVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY 581
                 G+++A K +     Q  E   NEV+++   QH N+V++       +E  ++ E+
Sbjct: 64  AREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123

Query: 582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN 641
           L   +L D    +     L+  +   +   + + L YLH      +IHRD+K+ ++LL  
Sbjct: 124 LQGGALTD----IVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTL 176

Query: 642 EMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
           +   K+SDFG      I +       +VGT  +M PE     L++ + D++S G++V+E+
Sbjct: 177 DGRVKLSDFGFCAQ--ISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEM 234

Query: 702 VCGK 705
           V G+
Sbjct: 235 VDGE 238

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  128 bits (323), Expect = 7e-33
 Identities = 54/204 (26%), Positives = 105/204 (51%), Gaps = 10/204 (4%)

Query: 503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRN 561
            + ++   K+G+G  G VY  + +  GQE+A ++++       E   NE+L++ + ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
           +V  +      DE  ++ EYL   SL D    V     +D  +   +     + L +LH 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALEFLHS 134

Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
           +   ++IHRD+K+ N+LL  + + K++DFG      I   ++  + +VGT  +M PE   
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGTPYWMAPEVVT 189

Query: 682 DGLFSVKSDVFSFGVLVLEIVCGK 705
              +  K D++S G++ +E++ G+
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGE 213

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  129 bits (325), Expect = 7e-33
 Identities = 71/331 (21%), Positives = 116/331 (35%), Gaps = 64/331 (19%)

Query: 511 KLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRNLVKLIGC 568
            L EGGF  VY+   +  G+E A KRL  +  +       EV  + KL  H N+V+    
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 569 CTQRDERM-------LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
            +   E         L+   L    L +F+  +     L      +I     R + ++H+
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154

Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR----------VVGT 671
             +  IIHRDLK  N+LL N+   K+ DFG A         + + +             T
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 672 YGYMPPEYAIDGLFSV--------KSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA 723
             Y  PE     +  +        K D+++ G ++  +   +      H       L   
Sbjct: 214 PMYRTPE-----IIDLYSNFPIGEKQDIWALGCILYLLCFRQ------HPFEDGAKL--- 259

Query: 724 WRLWIEERPVELINKSLGGSYSL------SEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 777
                         + + G YS+        V   +   +L V   PE+R +++ VV  L
Sbjct: 260 --------------RIVNGKYSIPPHDTQYTVFHSLIRAMLQVN--PEERLSIAEVVHQL 303

Query: 778 SGERSLPQPKQPGFFTERNPPESGSSSSKRS 808
               +          TE      G  S+  S
Sbjct: 304 QEIAAARNVNPKSPITELLEQNGGYGSATLS 334

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  128 bits (323), Expect = 9e-33
 Identities = 50/221 (22%), Positives = 92/221 (41%), Gaps = 22/221 (9%)

Query: 501 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEE-FENEVLLIAKLQ 558
            +   +   + LG+G    V++G   + G   A K  +  S     +    E  ++ KL 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65

Query: 559 HRNLVKLIGCCTQRDERM--LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 616
           H+N+VKL     +   R   LI E+ P  SL   + + + +  L  S+   ++  +  G+
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125

Query: 617 LYLHQDSRLRIIHRDLKASNVLL----DNEMNPKISDFGMARAFGIDQTEANTNRVVGTY 672
            +L +     I+HR++K  N++     D +   K++DFG AR    D  +  +  + GT 
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGTE 179

Query: 673 GYMPPE--------YAIDGLFSVKSDVFSFGVLVLEIVCGK 705
            Y+ P+              +    D++S GV       G 
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  126 bits (319), Expect = 2e-32
 Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 17/201 (8%)

Query: 512 LGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEE-FENEVLLIAKLQHRNLVKLIG 567
           LG+G F  VY+   I  G E+A K + K +    GM +  +NEV +  +L+H ++++L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 568 CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI 627
                +   L+ E   N  +N ++    R K    ++    +  I  G+LYLH      I
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFMHQIITGMLYLH---SHGI 133

Query: 628 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR---VVGTYGYMPPEYAIDGL 684
           +HRDL  SN+LL   MN KI+DFG+A      Q +    +   + GT  Y+ PE A    
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLA-----TQLKMPHEKHYTLCGTPNYISPEIATRSA 188

Query: 685 FSVKSDVFSFGVLVLEIVCGK 705
             ++SDV+S G +   ++ G+
Sbjct: 189 HGLESDVWSLGCMFYTLLIGR 209

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  129 bits (326), Expect = 3e-32
 Identities = 46/210 (21%), Positives = 89/210 (42%), Gaps = 19/210 (9%)

Query: 505 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEV-LLIAKLQHRNLV 563
           +F  K+ LG G  G +    + + +++A KR+           + EV LL    +H N++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81

Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           +       R  + +  E     +L +++    +       +   ++     GL +LH   
Sbjct: 82  RYFCTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHS-- 136

Query: 624 RLRIIHRDLKASNVLLDN-----EMNPKISDFGMARAFGIDQTE-ANTNRVVGTYGYMPP 677
            L I+HRDLK  N+L+       ++   ISDFG+ +   + +   +  + V GT G++ P
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

Query: 678 EY---AIDGLFSVKSDVFSFGVLVLEIVCG 704
           E          +   D+FS G +   ++  
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  127 bits (321), Expect = 8e-32
 Identities = 50/221 (22%), Positives = 92/221 (41%), Gaps = 22/221 (9%)

Query: 501 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEE-FENEVLLIAKLQ 558
            +   +   + LG+G    V++G   + G   A K  +  S     +    E  ++ KL 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65

Query: 559 HRNLVKLIGCCTQRDERM--LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 616
           H+N+VKL     +   R   LI E+ P  SL   + + + +  L  S+   ++  +  G+
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125

Query: 617 LYLHQDSRLRIIHRDLKASNVLL----DNEMNPKISDFGMARAFGIDQTEANTNRVVGTY 672
            +L +     I+HR++K  N++     D +   K++DFG AR    D  +  +  + GT 
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGTE 179

Query: 673 GYMPPE--------YAIDGLFSVKSDVFSFGVLVLEIVCGK 705
            Y+ P+              +    D++S GV       G 
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  125 bits (315), Expect = 9e-32
 Identities = 57/209 (27%), Positives = 104/209 (49%), Gaps = 13/209 (6%)

Query: 503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRN 561
            E +    +LG+G FG VYK    E G   AAK +   S + +E++  E+ ++A   H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
           +VKL+G      +  ++ E+ P  +++  +  +   + L   +   +   +   L +LH 
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQMLEALNFLHS 135

Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE--- 678
               RIIHRDLKA NVL+  E + +++DFG++      +T    +  +GT  +M PE   
Sbjct: 136 K---RIIHRDLKAGNVLMTLEGDIRLADFGVSAK--NLKTLQKRDSFIGTPYWMAPEVVM 190

Query: 679 --YAIDGLFSVKSDVFSFGVLVLEIVCGK 705
                D  +  K+D++S G+ ++E+   +
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIE 219

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  124 bits (314), Expect = 1e-31
 Identities = 65/294 (22%), Positives = 108/294 (36%), Gaps = 57/294 (19%)

Query: 503 TENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKR--LSKSSGQGMEEFENEVLLIAKL-Q 558
           T  F +  K+G G FG V+K V  ++G   A KR     +     +    EV   A L Q
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 559 HRNLVKLIGCCTQRDERMLIY-EYLPNKSLNDFIFDVTRS-KFLDWSKRCQIIGGIARGL 616
           H ++V+      + D  MLI  EY    SL D I +  R   +   ++   ++  + RGL
Sbjct: 70  HSHVVRYFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128

Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNP-------------------KISDFGMARAFG 657
            Y+H      ++H D+K SN+ +     P                   KI D G      
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185

Query: 658 IDQTEANTNRVVGTYGYMPPEYAIDGLFS--VKSDVFSFGVLVLEIVCGKRNRGFYHADH 715
             Q E       G   ++  E  +   ++   K+D+F+  + V+     +          
Sbjct: 186 SPQVE------EGDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAE---------- 228

Query: 716 HHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPN 769
                G  W    + R   +       S   +E+L+      + +   PE RP+
Sbjct: 229 PLPRNGDQWHEIRQGRLPRIPQVL---SQEFTELLK------VMIHPDPERRPS 273

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  124 bits (314), Expect = 2e-31
 Identities = 66/204 (32%), Positives = 108/204 (52%), Gaps = 10/204 (4%)

Query: 503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRN 561
            E F    KLGEG +G VYK +  E GQ +A K++       ++E   E+ ++ +    +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
           +VK  G   +  +  ++ EY    S++D I    R+K L   +   I+    +GL YLH 
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLHF 143

Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
               R IHRD+KA N+LL+ E + K++DFG+A    +  T A  N V+GT  +M PE   
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVAGQ--LTDTMAKRNTVIGTPFWMAPEVIQ 198

Query: 682 DGLFSVKSDVFSFGVLVLEIVCGK 705
           +  ++  +D++S G+  +E+  GK
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGK 222

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  123 bits (311), Expect = 3e-31
 Identities = 61/208 (29%), Positives = 107/208 (51%), Gaps = 11/208 (5%)

Query: 500 ANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLS-KSSGQGMEEFENEVLLIAKL 557
           A+  E F+   K+G+G FG V+KG+     + +A K +  + +   +E+ + E+ ++++ 
Sbjct: 18  ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 77

Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
               + K  G   +  +  +I EYL   S  D    +     LD ++   I+  I +GL 
Sbjct: 78  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD----LLEPGPLDETQIATILREILKGLD 133

Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           YLH +   + IHRD+KA+NVLL      K++DFG+A    +  T+   N  VGT  +M P
Sbjct: 134 YLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAP 188

Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E      +  K+D++S G+  +E+  G+
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGE 216

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  127 bits (321), Expect = 1e-30
 Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 17/213 (7%)

Query: 505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEE-FENEVLLIAKLQHRNL 562
            +  K +LG GGFG V + +  + G+++A K+  +       E +  E+ ++ KL H N+
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 563 VKLI------GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 616
           V               D  +L  EY     L  ++        L       ++  I+  L
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134

Query: 617 LYLHQDSRLRIIHRDLKASNVLLD---NEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
            YLH+    RIIHRDLK  N++L      +  KI D G A+              VGT  
Sbjct: 135 RYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTE--FVGTLQ 188

Query: 674 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR 706
           Y+ PE      ++V  D +SFG L  E + G R
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  119 bits (300), Expect = 7e-30
 Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 13/201 (6%)

Query: 511 KLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEE----FENEVLLIAKLQHRNLVKL 565
           KLG GG   VY     I   ++A K +     +  EE    FE EV   ++L H+N+V +
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76

Query: 566 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 625
           I    + D   L+ EY+   +L+++I        L           I  G+ + H    +
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---DM 130

Query: 626 RIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF 685
           RI+HRD+K  N+L+D+    KI DFG+A+A   + +   TN V+GT  Y  PE A     
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEAT 189

Query: 686 SVKSDVFSFGVLVLEIVCGKR 706
              +D++S G+++ E++ G+ 
Sbjct: 190 DECTDIYSIGIVLYEMLVGEP 210

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  119 bits (300), Expect = 1e-29
 Identities = 66/234 (28%), Positives = 106/234 (45%), Gaps = 18/234 (7%)

Query: 484 NREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQG 543
           +      L   D  A+ +    F     +G G +G VYKG  ++  ++AA ++   +G  
Sbjct: 4   SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE 63

Query: 544 MEEFENEVLLIAKL-QHRNLVKLIGC------CTQRDERMLIYEYLPNKSLNDFIFDVTR 596
            EE + E+ ++ K   HRN+    G           D+  L+ E+    S+ D +   T+
Sbjct: 64  EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTK 122

Query: 597 SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 656
              L       I   I RGL +LHQ    ++IHRD+K  NVLL      K+ DFG++   
Sbjct: 123 GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA-- 177

Query: 657 GIDQTEANTNRVVGTYGYMPPE-----YAIDGLFSVKSDVFSFGVLVLEIVCGK 705
            +D+T    N  +GT  +M PE        D  +  KSD++S G+  +E+  G 
Sbjct: 178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  120 bits (302), Expect = 1e-29
 Identities = 34/222 (15%), Positives = 67/222 (30%), Gaps = 22/222 (9%)

Query: 503 TENFSDKNKLGEGGFGPVYKGV------LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAK 556
           ++     + LGEG F  VY+            Q+   K    ++          +  +  
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123

Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFI--FDVTRSKFLDWSKRCQIIGGIAR 614
                 +K       ++  +L+ E     +L + I  +  T  K +           +  
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183

Query: 615 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-----------KISDFGMARAFGIDQTEA 663
            +  +H      IIH D+K  N +L N                + D G +    +     
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240

Query: 664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
                  T G+   E   +  ++ + D F     V  ++ G 
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  121 bits (306), Expect = 1e-29
 Identities = 55/237 (23%), Positives = 86/237 (36%), Gaps = 38/237 (16%)

Query: 499 IANATENFSD----KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEV-LL 553
           I N  ++  +    +  LG G  G V      +G+ +A KR+        +    E+ LL
Sbjct: 6   IPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLL 62

Query: 554 IAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFI----FDVTRSKFLDWSKRCQII 609
                H N+++     T      +  E   N +L D +          K         ++
Sbjct: 63  TESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLL 121

Query: 610 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-------------KISDFGMARAF 656
             IA G+ +LH    L+IIHRDLK  N+L+                    ISDFG+ +  
Sbjct: 122 RQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178

Query: 657 GIDQT--EANTNRVVGTYGYMPPEYAIDGLFSV-------KSDVFSFGVLVLEIVCG 704
              Q+    N N   GT G+  PE   +              D+FS G +   I+  
Sbjct: 179 DSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  120 bits (304), Expect = 4e-29
 Identities = 62/222 (27%), Positives = 98/222 (44%), Gaps = 24/222 (10%)

Query: 497 MAIANATENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFEN 549
           M I +   + S+      KLG G +G V          E A K + K+  S     +   
Sbjct: 26  MFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE 85

Query: 550 EVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQ 607
           EV ++  L H N++KL      +    L+ E      L D I  + R KF   ++     
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI--IHRMKF---NEVDAAV 140

Query: 608 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFGIDQTEAN 664
           II  +  G+ YLH+     I+HRDLK  N+LL++   +   KI DFG++  F   +    
Sbjct: 141 IIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK--- 194

Query: 665 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR 706
               +GT  Y+ PE  +   +  K DV+S GV++  ++ G  
Sbjct: 195 MKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYP 235

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  121 bits (306), Expect = 9e-29
 Identities = 57/291 (19%), Positives = 101/291 (34%), Gaps = 51/291 (17%)

Query: 511 KLGEGGFGPVYKGV--LIEGQEIAAKRLSKSSGQGMEE-FENEVLLIAKLQHRNLVKL-- 565
            +  GG G +Y  +   + G+ +  K L  S     +     E   +A++ H ++V++  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 566 IGCCTQRDERMLIY---EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
               T R    + Y   EY+  +SL            L  ++    +  I   L YLH  
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLH-- 199

Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID 682
             + +++ DLK  N++L  E   K+ D G      I+        + GT G+  PE    
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR--INSF----GYLYGTPGFQAPEIV-R 250

Query: 683 GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 742
              +V +D+++ G  +  +          +  +   L         E+ PV     S   
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDLP---TRNGRYVDGL--------PEDDPVLKTYDSY-- 297

Query: 743 SYSLSEVLRCIQVGLLCVQQRPEDRPN----MSSVVLMLSGERSLPQPKQP 789
              L  + R I          P  R      MS+ +  +  E        P
Sbjct: 298 -GRL--LRRAI-------DPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVP 338

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  117 bits (294), Expect = 1e-28
 Identities = 61/323 (18%), Positives = 128/323 (39%), Gaps = 39/323 (12%)

Query: 476 KLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKR 535
           +L+ +++  +  E  L     +      ++F   ++LG G  G V+K        + A++
Sbjct: 6   ELELDEQQRKRLEAFLTQKQKVGELKD-DDFEKISELGAGNGGVVFKVSHKPSGLVMARK 64

Query: 536 L--SKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD 593
           L   +       +   E+ ++ +     +V   G      E  +  E++   SL+  +  
Sbjct: 65  LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-- 122

Query: 594 VTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 653
             ++  +      ++   + +GL YL    + +I+HRD+K SN+L+++    K+ DFG++
Sbjct: 123 -KKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 179

Query: 654 RAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK-------- 705
               +  + AN+   VGT  YM PE      +SV+SD++S G+ ++E+  G+        
Sbjct: 180 G--QLIDSMANSF--VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235

Query: 706 -RNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGL------- 757
                 +      +      R     RP+           ++ E+L  I           
Sbjct: 236 KELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSG 295

Query: 758 -----------LCVQQRPEDRPN 769
                       C+ + P +R +
Sbjct: 296 VFSLEFQDFVNKCLIKNPAERAD 318

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  115 bits (289), Expect = 1e-28
 Identities = 66/209 (31%), Positives = 97/209 (46%), Gaps = 20/209 (9%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEE-FENEVLLIAKLQH 559
           E+F     LG+G FG VY     +    +A K L K+     G+E     EV + + L+H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
            N+++L G         LI EY P  ++   +     SKF +       I  +A  L Y 
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTA-TYITELANALSYC 125

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR---VVGTYGYMP 676
           H     R+IHRD+K  N+LL +    KI+DFG +         A ++R   + GT  Y+P
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDYLP 175

Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           PE     +   K D++S GVL  E + GK
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  115 bits (291), Expect = 2e-28
 Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 19/207 (9%)

Query: 511 KLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEE----FENEVLLIAKLQHRNLVKL 565
            LG GG   V+    L + +++A K L ++           F  E    A L H  +V +
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAV 77

Query: 566 --IGCCTQRDERMLIY---EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
              G   +     L Y   EY+   +L D +        +   +  ++I    + L + H
Sbjct: 78  YDTGE-AETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH 133

Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID-QTEANTNRVVGTYGYMPPEY 679
              +  IIHRD+K +N+++      K+ DFG+ARA      +   T  V+GT  Y+ PE 
Sbjct: 134 ---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190

Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCGKR 706
           A       +SDV+S G ++ E++ G+ 
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEP 217

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  115 bits (291), Expect = 2e-28
 Identities = 57/186 (30%), Positives = 95/186 (51%), Gaps = 28/186 (15%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFEN--------EVLLIA 555
           E +    K+GEG +G VYK    +G+ +A KR+       ++  +         E+ L+ 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74

Query: 556 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC---QIIGGI 612
           +L H N+V LI          L++E++  K L   + D  ++   D   +    Q++   
Sbjct: 75  ELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVL-DENKTGLQDSQIKIYLYQLL--- 129

Query: 613 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTY 672
            RG+ + HQ    RI+HRDLK  N+L++++   K++DFG+ARAFGI    + T+ VV T 
Sbjct: 130 -RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV-TL 183

Query: 673 GYMPPE 678
            Y  P+
Sbjct: 184 WYRAPD 189

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  119 bits (299), Expect = 2e-28
 Identities = 68/221 (30%), Positives = 108/221 (48%), Gaps = 25/221 (11%)

Query: 497 MAIANATENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFE 548
           M + ++T  FSD+      LG+G FG V        GQE A K +SK         E   
Sbjct: 15  MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 74

Query: 549 NEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--C 606
            EV L+ +L H N++KL      +    L+ E      L D I  ++R +F   S+    
Sbjct: 75  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRF---SEVDAA 129

Query: 607 QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFGIDQTEA 663
           +II  +  G+ Y+H+    +I+HRDLK  N+LL++   + N +I DFG++  F   +   
Sbjct: 130 RIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-- 184

Query: 664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
                +GT  Y+ PE  + G +  K DV+S GV++  ++ G
Sbjct: 185 -MKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  115 bits (290), Expect = 2e-28
 Identities = 52/188 (27%), Positives = 91/188 (48%), Gaps = 21/188 (11%)

Query: 501 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN-------EVL 552
           +++  F    KLG G +  VYKG+    G  +A K +       ++  E        E+ 
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK------LDSEEGTPSTAIREIS 55

Query: 553 LIAKLQHRNLVKLIGCCTQRDERMLIYEYLPN--KSLNDFIFDVTRSKFLDWSKRCQIIG 610
           L+ +L+H N+V+L       ++  L++E++ N  K   D        + L+ +       
Sbjct: 56  LMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW 115

Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVG 670
            + +GL + H++   +I+HRDLK  N+L++     K+ DFG+ARAFGI      ++ VV 
Sbjct: 116 QLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGI-PVNTFSSEVV- 170

Query: 671 TYGYMPPE 678
           T  Y  P+
Sbjct: 171 TLWYRAPD 178

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score =  114 bits (288), Expect = 3e-28
 Identities = 56/184 (30%), Positives = 92/184 (50%), Gaps = 22/184 (11%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN--------EVLLI 554
           ENF    K+GEG +G VYK      G+ +A K++       ++            E+ L+
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLL 56

Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIAR 614
            +L H N+VKL+      ++  L++E+L  + L  F+ D +    +        +  + +
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQ 114

Query: 615 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGY 674
           GL + H     R++HRDLK  N+L++ E   K++DFG+ARAFG+      T+ VV T  Y
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVV-TLWY 169

Query: 675 MPPE 678
             PE
Sbjct: 170 RAPE 173

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  116 bits (293), Expect = 3e-28
 Identities = 54/243 (22%), Positives = 100/243 (41%), Gaps = 11/243 (4%)

Query: 465 HRKQGKTDGSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGV 524
            + +GK DG    DY+       +  +P    +   +  + +    +LG G FG V++ V
Sbjct: 12  SKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCV 71

Query: 525 LIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP 583
               G+   AK ++          +NE+ ++ +L H  L+ L      + E +LI E+L 
Sbjct: 72  EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131

Query: 584 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM 643
              L D I        +  ++    +     GL ++H+     I+H D+K  N++ + + 
Sbjct: 132 GGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKK 186

Query: 644 NP--KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
               KI DFG+A     D+          T  +  PE          +D+++ GVL   +
Sbjct: 187 ASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVL 243

Query: 702 VCG 704
           + G
Sbjct: 244 LSG 246

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  115 bits (290), Expect = 4e-28
 Identities = 68/232 (29%), Positives = 107/232 (46%), Gaps = 20/232 (8%)

Query: 482 RGNREEEMELP-IFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLS-- 537
            G R   ++ P + +     +  + FSD  ++G G FG VY    +   + +A K++S  
Sbjct: 31  AGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS 90

Query: 538 -KSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTR 596
            K S +  ++   EV  + KL+H N ++  GC  +     L+ EY    S +D +     
Sbjct: 91  GKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLL--EVH 147

Query: 597 SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 656
            K L   +   +  G  +GL YLH      +IHRD+KA N+LL      K+ DFG A   
Sbjct: 148 KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM 204

Query: 657 GIDQTEANTNRVVGTYGYMPPE---YAIDGLFSVKSDVFSFGVLVLEIVCGK 705
                 AN+   VGT  +M PE      +G +  K DV+S G+  +E+   K
Sbjct: 205 ----APANS--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  112 bits (283), Expect = 8e-28
 Identities = 51/212 (24%), Positives = 94/212 (44%), Gaps = 22/212 (10%)

Query: 503 TENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKL 557
             + +      N +G G +G V   V        AAK++ K   + ++ F+ E+ ++  L
Sbjct: 4   KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL 63

Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQIIGGIARG 615
            H N+++L        +  L+ E      L + +  V +  F    +    +I+  +   
Sbjct: 64  DHPNIIRLYETFEDNTDIYLVMELCTGGELFERV--VHKRVF---RESDAARIMKDVLSA 118

Query: 616 LLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFGIDQTEANTNRVVGTY 672
           + Y H+   L + HRDLK  N L      +   K+ DFG+A  F   +        VGT 
Sbjct: 119 VAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVGTP 172

Query: 673 GYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
            Y+ P+  ++GL+  + D +S GV++  ++CG
Sbjct: 173 YYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  115 bits (288), Expect = 1e-27
 Identities = 26/230 (11%), Positives = 53/230 (23%), Gaps = 45/230 (19%)

Query: 512 LGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIG 567
           L  G    V+    +E  ++ A K  +     S   +E         A+L   +  +   
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 568 CC--------------------------TQRDERMLIYEYLPNKSLNDFI----FDVTRS 597
                                             +L+     +  L        F     
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP-AASVDLELLFSTLDFVYVFR 188

Query: 598 KFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 657
                     +   + R    L       ++H      N+ +  +    + D       G
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245

Query: 658 IDQTEANTNRVVGTYGYMPPEY--AIDGLFSVKSDVFSFGVLVLEIVCGK 705
                           Y P E+  A    F+   + +  G+ +  + C  
Sbjct: 246 -----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  112 bits (283), Expect = 1e-27
 Identities = 51/189 (26%), Positives = 88/189 (46%), Gaps = 33/189 (17%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAA-KRLSKSSGQGMEEFEN--------EVLLI 554
           + +    K+GEG +G V+K    E  EI A KR+       +++ +         E+ L+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55

Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPN--KSLNDFIFDVTRSKFLDWSKRC---QII 609
            +L+H+N+V+L        +  L++E+     K      FD           +    Q++
Sbjct: 56  KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKY----FDSCNGDLDPEIVKSFLFQLL 111

Query: 610 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV 669
               +GL + H      ++HRDLK  N+L++     K+++FG+ARAFGI      +  VV
Sbjct: 112 ----KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVV 163

Query: 670 GTYGYMPPE 678
            T  Y PP+
Sbjct: 164 -TLWYRPPD 171

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  112 bits (283), Expect = 1e-27
 Identities = 55/186 (29%), Positives = 92/186 (49%), Gaps = 28/186 (15%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFEN--------EVLLIA 555
           E +    K+GEG +G VYK     G+  A K++       +E+ +         E+ ++ 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55

Query: 556 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC---QIIGGI 612
           +L+H N+VKL      +   +L++E+L  + L   + DV        + +    Q++   
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLL-DVCEGGLESVTAKSFLLQLL--- 110

Query: 613 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTY 672
             G+ Y H     R++HRDLK  N+L++ E   KI+DFG+ARAFGI      T+ +V T 
Sbjct: 111 -NGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIV-TL 164

Query: 673 GYMPPE 678
            Y  P+
Sbjct: 165 WYRAPD 170

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  114 bits (287), Expect = 2e-27
 Identities = 45/333 (13%), Positives = 89/333 (26%), Gaps = 68/333 (20%)

Query: 512 LGEGGFGPVYKGV-LIEGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQH-------- 559
           LG+       +      G+         +       +++ + EVL +  L+         
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 560 --------RNLVKLIGCCT-----QRDERMLIYEY-----LPNKSLNDFIF----DVTRS 597
                    +LVK             +  M +            +L  F        +  
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 598 KFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 657
           K L    R Q+   + R L  LH      ++H  L+  +++LD      ++ F      G
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262

Query: 658 IDQTEANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYH 712
                +   R                     L +   D ++ G+ +  I C         
Sbjct: 263 -ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA-------- 313

Query: 713 ADHHHNLLGHAWRL-WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMS 771
                        L   ++  +           ++ + +R +  G L  +   EDR    
Sbjct: 314 ------------DLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFL--RYPKEDRLLPL 359

Query: 772 SVVL--MLSGERSLPQPKQPGFFTERNPPESGS 802
             +        R+      P + T+  P   G 
Sbjct: 360 QAMETPEYEQLRTELSAALPLYQTDGEPTREGG 392

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  115 bits (290), Expect = 3e-27
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 24/214 (11%)

Query: 503 TENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIA 555
              F+++      LG+G FG V K       QE A K ++K+    +       EV L+ 
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76

Query: 556 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQIIGGIA 613
           KL H N++KL           ++ E      L D I  + R +F   S+    +II  + 
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI--IKRKRF---SEHDAARIIKQVF 131

Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFGIDQTEANTNRVVG 670
            G+ Y+H+     I+HRDLK  N+LL++   + + KI DFG++  F  +         +G
Sbjct: 132 SGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIG 185

Query: 671 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           T  Y+ PE  + G +  K DV+S GV++  ++ G
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  112 bits (283), Expect = 3e-27
 Identities = 54/221 (24%), Positives = 91/221 (41%), Gaps = 35/221 (15%)

Query: 511 KLGEGGFGPVY---------------KGVLIEGQEIAAKRLSKSSGQGMEE-FENEVLLI 554
            L +G F  +                K +L + ++       K S +   + F+NE+ +I
Sbjct: 38  TLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFI-----FDVTRSKFLDWSKRCQII 609
             +++   +   G  T  DE  +IYEY+ N S+  F       D   + F+       II
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 610 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV 669
             +     Y+H  +   I HRD+K SN+L+D     K+SDFG +        +       
Sbjct: 158 KSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM----VDKKIKGSR 211

Query: 670 GTYGYMPPE-----YAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           GTY +MPPE      + +G    K D++S G+ +  +    
Sbjct: 212 GTYEFMPPEFFSNESSYNGA---KVDIWSLGICLYVMFYNV 249

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  111 bits (280), Expect = 5e-27
 Identities = 44/203 (21%), Positives = 82/203 (40%), Gaps = 17/203 (8%)

Query: 511 KLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQG---MEEFENEVLLIAKLQHRNLVKL- 565
            +G GG G VY+    +  + +A K +S++           + E     +LQ  ++V + 
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100

Query: 566 -IGCCTQRDERM-LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
             G   + D ++ +    +    L   +    R   L   +   I+  I   L   H   
Sbjct: 101 DFG---EIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAHAA- 153

Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
                HRD+K  N+L+  +    + DFG+A A   D+        VGT  YM PE   + 
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFSES 210

Query: 684 LFSVKSDVFSFGVLVLEIVCGKR 706
             + ++D+++   ++ E + G  
Sbjct: 211 HATYRADIYALTCVLYECLTGSP 233

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  111 bits (280), Expect = 6e-27
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 25/216 (11%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVL-----LIAKL 557
           E+  D  ++G G +G V K V    GQ +A KR+  +     E+ + ++L     ++   
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD---EKEQKQLLMDLDVVMRSS 78

Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIAR--- 614
               +V+  G   +  +  +  E + + S + F   V     LD     +I+G I     
Sbjct: 79  DCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSV--LDDVIPEEILGKITLATV 135

Query: 615 -GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
             L +L     L+IIHRD+K SN+LLD   N K+ DFG++    +  + A T    G   
Sbjct: 136 KALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISG--QLVDSIAKTR-DAGCRP 190

Query: 674 YMPPE----YAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           YM PE     A    + V+SDV+S G+ + E+  G+
Sbjct: 191 YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  111 bits (279), Expect = 7e-27
 Identities = 56/185 (30%), Positives = 83/185 (44%), Gaps = 26/185 (14%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN-------EVLLIA 555
           E +   +KLGEG +  VYKG        +A K +       +E  E        EV L+ 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR------LEHEEGAPCTAIREVSLLK 55

Query: 556 KLQHRNLVKLIGCCTQRDERMLIYEYLPN--KSLNDFIFDVTRSKFLDWSKRCQIIGGIA 613
            L+H N+V L           L++EYL    K   D          ++       +  + 
Sbjct: 56  DLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLD-----DCGNIINMHNVKLFLFQLL 110

Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
           RGL Y H+    +++HRDLK  N+L++     K++DFG+ARA  I  T+   N VV T  
Sbjct: 111 RGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYDNEVV-TLW 165

Query: 674 YMPPE 678
           Y PP+
Sbjct: 166 YRPPD 170

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  110 bits (276), Expect = 9e-27
 Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 24/214 (11%)

Query: 503 TENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIA 555
              F+++      LG+G FG V K       QE A K ++K+    +       EV L+ 
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76

Query: 556 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQIIGGIA 613
           KL H N++KL           ++ E      L D I  + R +F   S+    +II  + 
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI--IKRKRF---SEHDAARIIKQVF 131

Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFGIDQTEANTNRVVG 670
            G+ Y+H+     I+HRDLK  N+LL   + + + KI DFG++  F  +         +G
Sbjct: 132 SGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIG 185

Query: 671 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           T  Y+ PE  + G +  K DV+S GV++  ++ G
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  114 bits (287), Expect = 1e-26
 Identities = 50/244 (20%), Positives = 99/244 (40%), Gaps = 11/244 (4%)

Query: 464 RHRKQGKTDGSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKG 523
              K  +  G+   +Y++      +   P    +   +  +++    +LG G FG V++ 
Sbjct: 117 EQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRV 176

Query: 524 VLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL 582
                G   AAK +        E    E+  ++ L+H  LV L       +E ++IYE++
Sbjct: 177 TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236

Query: 583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE 642
               L + +        +   +  + +  + +GL ++H+      +H DLK  N++   +
Sbjct: 237 SGGELFEKV--ADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTK 291

Query: 643 MNP--KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLE 700
            +   K+ DFG+       Q   +     GT  +  PE A        +D++S GVL   
Sbjct: 292 RSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYI 348

Query: 701 IVCG 704
           ++ G
Sbjct: 349 LLSG 352

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  109 bits (275), Expect = 1e-26
 Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 30/218 (13%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVL-----LIAKL 557
           ++     +LG G +G V K   +  GQ +A KR+  +      + +  +L      +  +
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN---SQEQKRLLMDLDISMRTV 63

Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC--QIIGGIAR- 614
                V   G   +  +  +  E + + SL+ F   V         +     I+G IA  
Sbjct: 64  DCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKG-----QTIPEDILGKIAVS 117

Query: 615 ---GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 671
               L +LH  S+L +IHRD+K SNVL++     K+ DFG++    +D    + +   G 
Sbjct: 118 IVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID--AGC 172

Query: 672 YGYMPPE----YAIDGLFSVKSDVFSFGVLVLEIVCGK 705
             YM PE          +SVKSD++S G+ ++E+   +
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  109 bits (275), Expect = 1e-26
 Identities = 55/212 (25%), Positives = 86/212 (40%), Gaps = 17/212 (8%)

Query: 503 TENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEE-FENEVLLIAK 556
                D      KLG G FG V+       G E   K ++K   Q   E  E E+ ++  
Sbjct: 17  QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKS 76

Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD-VTRSKFLDWSKRCQIIGGIARG 615
           L H N++K+           ++ E      L + I     R K L      +++  +   
Sbjct: 77  LDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA 136

Query: 616 LLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFGIDQTEANTNRVVGTY 672
           L Y H      ++H+DLK  N+L  +       KI DFG+A  F  D+    +    GT 
Sbjct: 137 LAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTA 190

Query: 673 GYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
            YM PE       + K D++S GV++  ++ G
Sbjct: 191 LYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  110 bits (278), Expect = 2e-26
 Identities = 50/196 (25%), Positives = 88/196 (44%), Gaps = 30/196 (15%)

Query: 497 MAIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN------ 549
           + + +  + +   + LGEG F  VYK       Q +A K++         E ++      
Sbjct: 3   LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH---RSEAKDGINRTA 59

Query: 550 --EVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPN--KSLNDFIFDVTRSKFLDWSKR 605
             E+ L+ +L H N++ L+     +    L+++++    + +                 +
Sbjct: 60  LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVI----IKDNSLVLTPSHIK 115

Query: 606 C---QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE 662
                 +    +GL YLHQ     I+HRDLK +N+LLD     K++DFG+A++FG     
Sbjct: 116 AYMLMTL----QGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-PNR 167

Query: 663 ANTNRVVGTYGYMPPE 678
           A T++VV T  Y  PE
Sbjct: 168 AYTHQVV-TRWYRAPE 182

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  110 bits (278), Expect = 2e-26
 Identities = 54/200 (27%), Positives = 91/200 (45%), Gaps = 43/200 (21%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAA-KRLSKSSGQGMEEFEN--------EVLLI 554
             +    K+G+G FG V+K    +  +  A K++       ME  +         E+ ++
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKIL 70

Query: 555 AKLQHRNLVKLIGCCTQRDERM--------LIYEYLPN--KSLNDFIFDVTRSKFLDWSK 604
             L+H N+V LI  C  +            L++++  +    L          KF     
Sbjct: 71  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL----LSNVLVKFTLSEI 126

Query: 605 RC---QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
           +     ++     GL Y+H++   +I+HRD+KA+NVL+  +   K++DFG+ARAF + + 
Sbjct: 127 KRVMQMLL----NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179

Query: 662 EAN---TNRVVGTYGYMPPE 678
                 TNRVV T  Y PPE
Sbjct: 180 SQPNRYTNRVV-TLWYRPPE 198

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  109 bits (274), Expect = 2e-26
 Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 26/222 (11%)

Query: 501 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLS-KSSGQGMEEFENEVLLIAKLQ 558
              +++  +  +G G    V         +++A KR++ +     M+E   E+  +++  
Sbjct: 12  INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71

Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSK-RCQIIGGIAR--- 614
           H N+V        +DE  L+ + L   S+ D I  +               I  I R   
Sbjct: 72  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131

Query: 615 -GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA---RAFGIDQTEANTNRVVG 670
            GL YLH++     IHRD+KA N+LL  + + +I+DFG++      G           VG
Sbjct: 132 EGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188

Query: 671 TYGYMPPE-------YAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           T  +M PE       Y        K+D++SFG+  +E+  G 
Sbjct: 189 TPCWMAPEVMEQVRGY------DFKADIWSFGITAIELATGA 224

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  110 bits (276), Expect = 3e-26
 Identities = 43/311 (13%), Positives = 90/311 (28%), Gaps = 81/311 (26%)

Query: 512 LGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQ--------- 558
           LG+       +    E G+         +       +++ + EVL +  L+         
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 559 ----------------HRNLVKLIGCCTQRDERMLIY---EYLPNKSLNDF---IFDVTR 596
                            + ++++     +RD  +L           +L  F   +   + 
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRL--DERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 597 -SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 655
             K L    R Q+   + R L  LH      ++H  L+  +++LD      ++ F     
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255

Query: 656 FGIDQTEANTNRVVGTYGYMPPEYAID-----------GLFSVKSDVFSFGVLVLEIVCG 704
            G             + G+ PPE                L +   D ++ G+++  I C 
Sbjct: 256 DGARVV------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309

Query: 705 KRNRGFYHADHHHNLLGHAWRL-WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQR 763
                                L   ++  +           ++ + +R +  G L     
Sbjct: 310 --------------------DLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRY--P 347

Query: 764 PEDRPNMSSVV 774
            EDR      +
Sbjct: 348 KEDRLLPLQAM 358

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  110 bits (276), Expect = 4e-26
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 17/215 (7%)

Query: 492 PIFDWMAIANATENFSD------KNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGM 544
             FD   +       +          LG G FG V+K      G ++AAK +     +  
Sbjct: 71  APFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK 130

Query: 545 EEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSK 604
           EE +NE+ ++ +L H NL++L      +++ +L+ EY+    L D I  +  S  L    
Sbjct: 131 EEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRI--IDESYNLTELD 188

Query: 605 RCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGIDQTE 662
               +  I  G+ ++HQ   + I+H DLK  N+L  N      KI DFG+AR +   +  
Sbjct: 189 TILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-- 243

Query: 663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVL 697
                  GT  ++ PE       S  +D++S GV+
Sbjct: 244 -KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVI 277

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  112 bits (281), Expect = 4e-26
 Identities = 65/233 (27%), Positives = 100/233 (42%), Gaps = 35/233 (15%)

Query: 497 MAIANATENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS------------ 539
           M +        +      KLG G +G V          E A K + KS            
Sbjct: 25  MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNK 84

Query: 540 -SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSK 598
              +  EE  NE+ L+  L H N++KL      +    L+ E+     L + I  + R K
Sbjct: 85  NIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI--INRHK 142

Query: 599 FLDWSKR--CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMA 653
           F    +     I+  I  G+ YLH+     I+HRD+K  N+LL+N    +N KI DFG++
Sbjct: 143 F---DECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLS 196

Query: 654 RAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR 706
             F  D         +GT  Y+ PE  +   ++ K DV+S GV++  ++CG  
Sbjct: 197 SFFSKDYK---LRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYP 245

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  108 bits (271), Expect = 4e-26
 Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 23/206 (11%)

Query: 503 TENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIA 555
           +  FSD      +LG+G F  V + V    G E AAK ++    S +  ++ E E  +  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 556 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQIIGGIA 613
           KLQH N+V+L     +     L+++ +    L + I  V R  +   S+      I  I 
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFY---SEADASHCIQQIL 115

Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGIDQTEANTNRVVG 670
             + Y H      I+HR+LK  N+LL ++      K++DFG+A      +     +   G
Sbjct: 116 ESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAG 169

Query: 671 TYGYMPPEYAIDGLFSVKSDVFSFGV 696
           T GY+ PE      +S   D+++ GV
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGV 195

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  109 bits (275), Expect = 6e-26
 Identities = 36/215 (16%), Positives = 73/215 (33%), Gaps = 16/215 (7%)

Query: 503 TENFSDKNKLGEG--GFGPVYKGVLIEGQEIAA-KR--LSKSSGQGMEEFENEVLLIAKL 557
              +     +G+G      V         E    +R  L   S + +   + E+ +    
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
            H N+V         +E  ++  ++   S  D +        ++      I+ G+ + L 
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMNELAIAYILQGVLKALD 142

Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT-----NRVVGTY 672
           Y+H       +HR +KAS++L+  +    +S      +                  V   
Sbjct: 143 YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199

Query: 673 GYMPPE--YAIDGLFSVKSDVFSFGVLVLEIVCGK 705
            ++ PE        +  KSD++S G+   E+  G 
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  108 bits (271), Expect = 7e-26
 Identities = 43/185 (23%), Positives = 80/185 (43%), Gaps = 25/185 (13%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN---------EVLL 553
           E +    K+GEG +G V+K    + GQ +A K+        +E  ++         E+ +
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-------LESEDDPVIKKIALREIRM 55

Query: 554 IAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA 613
           + +L+H NLV L+    ++    L++EY  + ++   +      + +       I     
Sbjct: 56  LKQLKHPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDR--YQRGVPEHLVKSITWQTL 112

Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
           + + + H+      IHRD+K  N+L+      K+ DFG AR      ++   + V  T  
Sbjct: 113 QAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVA-TRW 167

Query: 674 YMPPE 678
           Y  PE
Sbjct: 168 YRSPE 172

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  107 bits (270), Expect = 7e-26
 Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 22/212 (10%)

Query: 503 TENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKL 557
           T N          LG G F  V+       G+  A K + KS        ENE+ ++ K+
Sbjct: 4   TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI 63

Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQIIGGIARG 615
           +H N+V L           L+ + +    L D I  + R  +   +++    +I  +   
Sbjct: 64  KHENIVTLEDIYESTTHYYLVMQLVSGGELFDRI--LERGVY---TEKDASLVIQQVLSA 118

Query: 616 LLYLHQDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFGIDQTEANTNRVVGTY 672
           + YLH+     I+HRDLK  N+L    +      I+DFG+++           +   GT 
Sbjct: 119 VKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTACGTP 171

Query: 673 GYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
           GY+ PE      +S   D +S GV+   ++CG
Sbjct: 172 GYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  108 bits (271), Expect = 1e-25
 Identities = 48/188 (25%), Positives = 85/188 (45%), Gaps = 31/188 (16%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN---------EVLL 553
           E + +   +GEG +G V K    + G+ +A K+        +E  ++         E+ L
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-------LESDDDKMVKKIAMREIKL 77

Query: 554 IAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC---QIIG 610
           + +L+H NLV L+  C ++    L++E++ + ++ D + ++  +       +    QII 
Sbjct: 78  LKQLRHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDL-ELFPNGLDYQVVQKYLFQII- 134

Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVG 670
               G+ + H      IIHRD+K  N+L+      K+ DFG AR       E   + V  
Sbjct: 135 ---NGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA- 186

Query: 671 TYGYMPPE 678
           T  Y  PE
Sbjct: 187 TRWYRAPE 194

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  106 bits (267), Expect = 1e-25
 Identities = 55/201 (27%), Positives = 89/201 (44%), Gaps = 20/201 (9%)

Query: 512 LGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEE-FENEVLLIAKLQHRNLVKLIG 567
           LG+G FG VY     +    +A K L KS    +G+E     E+ + + L+H N++++  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 568 CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI 627
               R    L+ E+ P   L   +      +F +       +  +A  L Y H     ++
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSA-TFMEELADALHYCH---ERKV 135

Query: 628 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR---VVGTYGYMPPEYAIDGL 684
           IHRD+K  N+L+  +   KI+DFG +         A + R   + GT  Y+PPE      
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRTMCGTLDYLPPEMIEGKT 188

Query: 685 FSVKSDVFSFGVLVLEIVCGK 705
              K D++  GVL  E + G 
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGM 209

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  107 bits (270), Expect = 2e-25
 Identities = 57/212 (26%), Positives = 89/212 (41%), Gaps = 28/212 (13%)

Query: 503 TENFSD----KNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS------GQGMEEFENEV 551
            +   D      +LG G F  V K      G E AAK + K        G   EE E EV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66

Query: 552 LLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQII 609
            ++ ++ H N++ L      R + +LI E +    L DF+    +      S+      I
Sbjct: 67  SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL--AQKESL---SEEEATSFI 121

Query: 610 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGIDQTEANT 665
             I  G+ YLH     +I H DLK  N++L ++  P    K+ DFG+A            
Sbjct: 122 KQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---F 175

Query: 666 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVL 697
             + GT  ++ PE        +++D++S GV+
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  107 bits (269), Expect = 2e-25
 Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 23/218 (10%)

Query: 496 WMAIANATENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAK-----RLSKSSGQGME 545
            + +A+    F D       +G+G F  V + +  E GQ+ A K     + + S G   E
Sbjct: 12  ILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTE 71

Query: 546 EFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDW--- 602
           + + E  +   L+H ++V+L+   +      +++E++    L   I  V R+        
Sbjct: 72  DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEI--VKRADAGFVYSE 129

Query: 603 SKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGID 659
           +     +  I   L Y H      IIHRD+K   VLL ++ N    K+  FG+A   G  
Sbjct: 130 AVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES 186

Query: 660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVL 697
              A     VGT  +M PE      +    DV+  GV+
Sbjct: 187 GLVAGG--RVGTPHFMAPEVVKREPYGKPVDVWGCGVI 222

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  106 bits (267), Expect = 3e-25
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 24/210 (11%)

Query: 503 TENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS------SGQGMEEFENEV 551
            +   D      +LG G F  V K      G E AAK + K        G   EE E EV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66

Query: 552 LLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG 611
            ++ ++ H N++ L      R + +LI E +    L DF+    + + L   +    I  
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQ 123

Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGIDQTEANTNR 667
           I  G+ YLH     +I H DLK  N++L ++  P    K+ DFG+A              
Sbjct: 124 ILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKN 177

Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVL 697
           + GT  ++ PE        +++D++S GV+
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  106 bits (267), Expect = 3e-25
 Identities = 40/178 (22%), Positives = 72/178 (40%), Gaps = 13/178 (7%)

Query: 537 SKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTR 596
             SS   M+    ++  +     +N V  +   + +    +  +    ++L D++     
Sbjct: 98  PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157

Query: 597 SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 656
            +  +      I   IA  + +LH      ++HRDLK SN+    +   K+ DFG+  A 
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214

Query: 657 GIDQTEANTN----------RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
             D+ E                VGT  YM PE      +S K D+FS G+++ E++  
Sbjct: 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  106 bits (267), Expect = 3e-25
 Identities = 58/191 (30%), Positives = 85/191 (44%), Gaps = 33/191 (17%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN--------EVLLI 554
           + +    KLGEG +G VYK +     + +A KR+       +E  E         EV L+
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87

Query: 555 AKLQHRNLVKLIGCCTQRDERMLIYEYLPN--KSLNDFIFDVTRSKFLDWSKRCQIIGGI 612
            +LQHRN+++L           LI+EY  N  K   D      ++  +        +  +
Sbjct: 88  KELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMD------KNPDVSMRVIKSFLYQL 141

Query: 613 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-----KISDFGMARAFGIDQTEANTNR 667
             G+ + H     R +HRDLK  N+LL           KI DFG+ARAFGI      T+ 
Sbjct: 142 INGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-PIRQFTHE 197

Query: 668 VVGTYGYMPPE 678
           ++ T  Y PPE
Sbjct: 198 II-TLWYRPPE 207

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  105 bits (265), Expect = 4e-25
 Identities = 43/201 (21%), Positives = 81/201 (40%), Gaps = 16/201 (7%)

Query: 504 ENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ 558
           +   +K      LG G FG V++ V     +   AK +    G      + E+ ++   +
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIAR 59

Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           HRN++ L       +E ++I+E++    + + I   T +  L+  +    +  +   L +
Sbjct: 60  HRNILHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQF 117

Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
           LH      I H D++  N++     +   KI +FG AR             +     Y  
Sbjct: 118 LHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYA 171

Query: 677 PEYAIDGLFSVKSDVFSFGVL 697
           PE     + S  +D++S G L
Sbjct: 172 PEVHQHDVVSTATDMWSLGTL 192

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  106 bits (267), Expect = 6e-25
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 23/210 (10%)

Query: 499 IANATENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEV 551
           + NA+  FSD      +LG+G F  V + V    G E AAK ++    S +  ++ E E 
Sbjct: 20  MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79

Query: 552 LLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQII 609
            +  KLQH N+V+L     +     L+++ +    L + I  V R  +   S+      I
Sbjct: 80  RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFY---SEADASHCI 134

Query: 610 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGIDQTEANTN 666
             I   + Y H      I+HR+LK  N+LL ++      K++DFG+A      +     +
Sbjct: 135 QQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WH 188

Query: 667 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGV 696
              GT GY+ PE      +S   D+++ GV
Sbjct: 189 GFAGTPGYLSPEVLKKDPYSKPVDIWACGV 218

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  105 bits (263), Expect = 6e-25
 Identities = 52/233 (22%), Positives = 99/233 (42%), Gaps = 34/233 (14%)

Query: 495 DWMAIANATENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGM----- 544
             +  +++T  F +       LG G    V + +     +E A K +  + G        
Sbjct: 4   AALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEV 63

Query: 545 ----EEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKF 599
               E    EV ++ K+  H N+++L           L+++ +    L D++    +   
Sbjct: 64  QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTL 121

Query: 600 LDWSKR--CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 657
              S++   +I+  +   +  LH+   L I+HRDLK  N+LLD++MN K++DFG +    
Sbjct: 122 ---SEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175

Query: 658 IDQTEANTNRVVGTYGYMPPE------YAIDGLFSVKSDVFSFGVLVLEIVCG 704
             +       V GT  Y+ PE            +  + D++S GV++  ++ G
Sbjct: 176 PGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  106 bits (265), Expect = 6e-25
 Identities = 51/275 (18%), Positives = 90/275 (32%), Gaps = 52/275 (18%)

Query: 480 NDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAK---- 534
           +   +     E   F   ++    + +  K  +G+G +G V   +  +     A K    
Sbjct: 2   HHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNK 61

Query: 535 -RLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD 593
            ++ + + + +E  + EV L+ KL H N+ +L           L+ E      L D +  
Sbjct: 62  NKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNV 121

Query: 594 VTRSKFLDWSKRC-------------------------------------QIIGGIARGL 616
                    +                                         I+  I   L
Sbjct: 122 FIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181

Query: 617 LYLHQDSRLRIIHRDLKASNVLL--DNEMNPKISDFGMARAFGIDQTEANT--NRVVGTY 672
            YLH      I HRD+K  N L   +     K+ DFG+++ F               GT 
Sbjct: 182 HYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTP 238

Query: 673 GYMPPE--YAIDGLFSVKSDVFSFGVLVLEIVCGK 705
            ++ PE     +  +  K D +S GVL+  ++ G 
Sbjct: 239 YFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  105 bits (264), Expect = 7e-25
 Identities = 50/193 (25%), Positives = 90/193 (46%), Gaps = 32/193 (16%)

Query: 504 ENFSDKNKLGEGGFGPVYKG--VLIEGQEIAAKRLSKSSGQGMEEFEN--------EVLL 553
           + +    ++GEG +G V+K   +   G+ +A KR+       ++  E         EV +
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAV 64

Query: 554 IAKLQ---HRNLVKLIGCCTQRDER-----MLIYEYLPNKSLNDFIFDVTRSKFLDWSKR 605
           +  L+   H N+V+L   CT           L++E++ ++ L  ++ D      +     
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETI 122

Query: 606 CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT 665
             ++  + RGL +LH     R++HRDLK  N+L+ +    K++DFG+AR +        T
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--T 177

Query: 666 NRVVGTYGYMPPE 678
           + VV T  Y  PE
Sbjct: 178 SVVV-TLWYRAPE 189

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  104 bits (261), Expect = 8e-25
 Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 24/211 (11%)

Query: 500 ANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS------SGQGMEEFENEVL 552
           +   +++    +LG G F  V K      G+E AAK + K        G   EE E EV 
Sbjct: 1   SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60

Query: 553 LIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQIIG 610
           ++ +++H N++ L      + + +LI E +    L DF+    +      ++    Q + 
Sbjct: 61  ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL--AEKESL---TEDEATQFLK 115

Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGIDQTEANTN 666
            I  G+ YLH     RI H DLK  N++L ++  P    K+ DFG+A             
Sbjct: 116 QILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FK 169

Query: 667 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVL 697
            + GT  ++ PE        +++D++S GV+
Sbjct: 170 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 200

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  105 bits (264), Expect = 8e-25
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 28/212 (13%)

Query: 503 TENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS------SGQGMEEFENEV 551
            EN  D      +LG G F  V K      G + AAK + K        G   E+ E EV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65

Query: 552 LLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQII 609
            ++ ++QH N++ L      + + +LI E +    L DF+    +      ++    + +
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESL---TEEEATEFL 120

Query: 610 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGIDQTEANT 665
             I  G+ YLH    L+I H DLK  N++L +   P    KI DFG+A            
Sbjct: 121 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---F 174

Query: 666 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVL 697
             + GT  ++ PE        +++D++S GV+
Sbjct: 175 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  103 bits (260), Expect = 9e-25
 Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 25/204 (12%)

Query: 512 LGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEE-FENEVLLIAKLQHRNLVKLIGCC 569
           LGEG +G V   V  +  + +A K +         E  + E+ +   L H N+VK  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR---CQIIGGIARGLLYLHQDSRLR 626
            + + + L  EY     L D I         +   +    Q++ G+     YLH    + 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV----YLH---GIG 125

Query: 627 IIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE------YA 680
           I HRD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE      + 
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF- 184

Query: 681 IDGLFSVKSDVFSFGVLVLEIVCG 704
                    DV+S G+++  ++ G
Sbjct: 185 -HAE---PVDVWSCGIVLTAMLAG 204

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  103 bits (260), Expect = 2e-24
 Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 25/204 (12%)

Query: 512 LGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEE-FENEVLLIAKLQHRNLVKLIGCC 569
           LGEG +G V   V  +  + +A K +         E  + E+ +   L H N+VK  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC---QIIGGIARGLLYLHQDSRLR 626
            + + + L  EY     L D I         +   +    Q++ G+     YLH    + 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV----YLH---GIG 125

Query: 627 IIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE------YA 680
           I HRD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE      + 
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF- 184

Query: 681 IDGLFSVKSDVFSFGVLVLEIVCG 704
                    DV+S G+++  ++ G
Sbjct: 185 -HAE---PVDVWSCGIVLTAMLAG 204

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  103 bits (259), Expect = 2e-24
 Identities = 53/191 (27%), Positives = 86/191 (45%), Gaps = 22/191 (11%)

Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLS-KSSGQGMEEFEN----EVLLIA 555
           AT  +    ++G G +G VYK      G  +A K +   + G G          EV L+ 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 556 KLQ---HRNLVKLIGCCTQRDER-----MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQ 607
           +L+   H N+V+L+  C            L++E++ ++ L  ++ D      L       
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124

Query: 608 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 667
           ++    RGL +LH +    I+HRDLK  N+L+ +    K++DFG+AR +        T  
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LTPV 179

Query: 668 VVGTYGYMPPE 678
           VV T  Y  PE
Sbjct: 180 VV-TLWYRAPE 189

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  103 bits (260), Expect = 3e-24
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 37/210 (17%)

Query: 512 LGEGGFGPVYKGV-LIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGC 568
           +G+G F  V     ++ G+E+A K + K+  +   +++   EV ++  L H N+VKL   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 569 CTQRDERMLIYEYLPNKSLNDFIF-------DVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
                   LI EY     + D++           RSKF       QI+  +     Y H 
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF------RQIVSAVQ----YCH- 131

Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE--- 678
             + RI+HRDLKA N+LLD +MN KI+DFG +  F +       +   G   Y  PE   
Sbjct: 132 --QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL---DAFCGAPPYAAPELFQ 186

Query: 679 ---YAIDGLFSVKSDVFSFGVLVLEIVCGK 705
              Y  DG    + DV+S GV++  +V G 
Sbjct: 187 GKKY--DGP---EVDVWSLGVILYTLVSGS 211

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  103 bits (258), Expect = 3e-24
 Identities = 43/213 (20%), Positives = 85/213 (39%), Gaps = 22/213 (10%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAA-KRLSKSSGQGMEEFENEVL-----LIAKL 557
            +  +  ++G G  G V+K    +   + A K++ +S     +E    +L     ++   
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN---KEENKRILMDLDVVLKSH 81

Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
               +V+  G      +  +  E +                 +      ++   I + L 
Sbjct: 82  DCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLK--KRMQGPIPERILGKMTVAIVKALY 138

Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           YL    +  +IHRD+K SN+LLD     K+ DFG++    +   +A      G   YM P
Sbjct: 139 YLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGISG--RLVDDKAKDR-SAGCAAYMAP 193

Query: 678 E-----YAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E           + +++DV+S G+ ++E+  G+
Sbjct: 194 ERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  103 bits (259), Expect = 5e-24
 Identities = 50/253 (19%), Positives = 99/253 (39%), Gaps = 29/253 (11%)

Query: 462 KRRHRKQGKTDGSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVY 521
                +  K + +      +   +    E  + DW A     + +  K+ +G G    V 
Sbjct: 52  ANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVR 111

Query: 522 KGVLIE-GQEIAAKRLSKSSGQG--------MEEFENEVLLIAKL-QHRNLVKLIGCCTQ 571
           + V    G E A K +  ++ +          E    E  ++ ++  H +++ LI     
Sbjct: 112 RCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES 171

Query: 572 RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQIIGGIARGLLYLHQDSRLRIIH 629
                L+++ +    L D++    +      S++    I+  +   + +LH      I+H
Sbjct: 172 SSFMFLVFDLMRKGELFDYL--TEKVAL---SEKETRSIMRSLLEAVSFLHA---NNIVH 223

Query: 630 RDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE------YAIDG 683
           RDLK  N+LLD+ M  ++SDFG +      +       + GT GY+ PE           
Sbjct: 224 RDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHP 280

Query: 684 LFSVKSDVFSFGV 696
            +  + D+++ GV
Sbjct: 281 GYGKEVDLWACGV 293

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  101 bits (255), Expect = 9e-24
 Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 30/217 (13%)

Query: 503 TENFSD-----KNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAK 556
           +  F D     ++ LGEG    V   + +   QE A K + K  G        EV ++ +
Sbjct: 7   SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66

Query: 557 LQ-HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQIIGGIA 613
            Q HRN+++LI    + D   L++E +   S+   I    R  F   ++     ++  +A
Sbjct: 67  CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHI--HKRRHF---NELEASVVVQDVA 121

Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAF--GIDQTEANTNR- 667
             L +LH      I HRDLK  N+L ++       KI DF +        D +  +T   
Sbjct: 122 SALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178

Query: 668 --VVGTYGYMPPE-----YAIDGLFSVKSDVFSFGVL 697
               G+  YM PE          ++  + D++S GV+
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  101 bits (254), Expect = 1e-23
 Identities = 55/216 (25%), Positives = 87/216 (40%), Gaps = 40/216 (18%)

Query: 512 LGEGGFGPVYKGV-LIEGQEIAAKRLSKSS----GQGMEEFENEVLLIAKLQHRNLVKL- 565
           LGEG +G V + +        A K L K        G    + E+ L+ +L+H+N+++L 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 566 --IGCCTQRDERMLIY---EYLPNKSLNDFIFD-VTRSKFLDWSKR---CQIIGGIARGL 616
             +    ++     +Y   EY         + D V   +F         CQ+I G+    
Sbjct: 73  DVLYNEEKQK----MYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE--- 123

Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            YLH      I+H+D+K  N+LL      KIS  G+A A      +       G+  + P
Sbjct: 124 -YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179

Query: 677 PE-------YAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           PE       +   G    K D++S GV +  I  G 
Sbjct: 180 PEIANGLDTF--SGF---KVDIWSAGVTLYNITTGL 210

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  103 bits (259), Expect = 1e-23
 Identities = 53/225 (23%), Positives = 99/225 (44%), Gaps = 46/225 (20%)

Query: 503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFEN-EVLLIAKLQHRN 561
              +++   +G G FG V++  L+E  E+A K++ +      + F+N E+ ++  ++H N
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPN 93

Query: 562 LVKLIGCCTQRDERM------LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGG---- 611
           +V L        ++       L+ EY+P +++        + K        Q +      
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHYAKLK--------QTMPMLLIK 144

Query: 612 -----IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQTEANT 665
                + R L Y+H    + I HRD+K  N+LLD      K+ DFG A+       E N 
Sbjct: 145 LYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNV 199

Query: 666 NRVVGTYGYMPPEYAIDGLF-----SVKSDVFSFGVLVLEIVCGK 705
           + +   Y Y  PE     +F     +   D++S G ++ E++ G+
Sbjct: 200 SYICSRY-YRAPEL----IFGATNYTTNIDIWSTGCVMAELMQGQ 239

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  102 bits (257), Expect = 2e-23
 Identities = 48/194 (24%), Positives = 82/194 (42%), Gaps = 42/194 (21%)

Query: 511 KLGEGGFGPVYKGVLIE---GQEIAAKRLSKSSGQGMEEFEN-------EVLLIAKLQHR 560
           K+G G +G VYK    +    ++ A K++         E          E+ L+ +L+H 
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQI---------EGTGISMSACREIALLRELKHP 78

Query: 561 NLVKLIGCCTQRDER--MLIYEYLPN------KSLNDFIFDVTRSKFLDWSKRC---QII 609
           N++ L        +R   L+++Y  +      K       +    +      +    QI+
Sbjct: 79  NVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138

Query: 610 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGI-DQTEAN 664
                G+ YLH +    ++HRDLK +N+L+  E       KI+D G AR F    +  A+
Sbjct: 139 ----DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 191

Query: 665 TNRVVGTYGYMPPE 678
            + VV T+ Y  PE
Sbjct: 192 LDPVVVTFWYRAPE 205

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  102 bits (256), Expect = 4e-23
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 22/206 (10%)

Query: 503 TENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEE--FENEVLLIA 555
              F+++     +LG+G F  V + V +  GQE AA  ++       +    E E  +  
Sbjct: 6   CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65

Query: 556 KLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQIIGGIA 613
            L+H N+V+L    ++     LI++ +    L + I  V R  +   S+      I  I 
Sbjct: 66  LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI--VAREYY---SEADASHCIQQIL 120

Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGIDQTEANTNRVVG 670
             +L+ HQ   + ++HR+LK  N+LL +++     K++DFG+A     +Q         G
Sbjct: 121 EAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAG 175

Query: 671 TYGYMPPEYAIDGLFSVKSDVFSFGV 696
           T GY+ PE      +    D+++ GV
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGV 201

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  100 bits (251), Expect = 4e-23
 Identities = 54/219 (24%), Positives = 89/219 (40%), Gaps = 36/219 (16%)

Query: 503 TENFSD----KNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKL 557
           +  F+D    K  +G G +    + +      E A K + KS     EE E   +L+   
Sbjct: 17  SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE---ILLRYG 73

Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQIIGGIARG 615
           QH N++ L           ++ E +    L D I  + +  F   S+R    ++  I + 
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKI--LRQKFF---SEREASAVLFTITKT 128

Query: 616 LLYLHQDSRLRIIHRDLKASNVLL----DNEMNPKISDFGMARAFGIDQTEANTNRVVGT 671
           + YLH      ++HRDLK SN+L      N  + +I DFG A+    +     T     T
Sbjct: 129 VEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYT 183

Query: 672 YGYMPPE------YAIDGLFSVKSDVFSFGVLVLEIVCG 704
             ++ PE      Y          D++S GVL+  ++ G
Sbjct: 184 ANFVAPEVLERQGY------DAACDIWSLGVLLYTMLTG 216

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  100 bits (252), Expect = 8e-23
 Identities = 52/221 (23%), Positives = 90/221 (40%), Gaps = 29/221 (13%)

Query: 503 TENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEE--------FEN 549
            +   D+      LG G  G V      +  +++A + +SK                 E 
Sbjct: 130 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVET 189

Query: 550 EVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQII 609
           E+ ++ KL H  ++K+       D   ++ E +    L D +     +K L  +      
Sbjct: 190 EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKV---VGNKRLKEATCKLYF 245

Query: 610 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGIDQTEANTN 666
             +   + YLH+     IIHRDLK  NVLL ++      KI+DFG ++  G + +   T 
Sbjct: 246 YQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRT- 300

Query: 667 RVVGTYGYMPPE---YAIDGLFSVKSDVFSFGVLVLEIVCG 704
            + GT  Y+ PE         ++   D +S GV++   + G
Sbjct: 301 -LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 99.0 bits (247), Expect = 1e-22
 Identities = 60/218 (27%), Positives = 94/218 (43%), Gaps = 46/218 (21%)

Query: 512 LGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFEN------EVLLIAKLQHR--NL 562
           LG GGFG VY G+ + +   +A K + K       E  N      EV+L+ K+      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 563 VKLIGCCTQRDERMLIYEY-LPNKSLNDFIF-------DVTRSKFLDWSKRCQIIGGIAR 614
           ++L+    + D  +LI E   P + L DFI        ++ RS F       Q++  +  
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF------WQVLEAVR- 163

Query: 615 GLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
              + H      ++HRD+K  N+L+D N    K+ DFG          +       GT  
Sbjct: 164 ---HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRV 213

Query: 674 YMPPE------YAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           Y PPE      Y   G     + V+S G+L+ ++VCG 
Sbjct: 214 YSPPEWIRYHRY--HGR---SAAVWSLGILLYDMVCGD 246

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 98.6 bits (246), Expect = 2e-22
 Identities = 55/245 (22%), Positives = 96/245 (39%), Gaps = 23/245 (9%)

Query: 462 KRRHRKQGKTDGSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDK----NKLGEGGF 517
                  G  +   +   +   +        + D+    +  +  SD     ++LG G  
Sbjct: 7   HSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGAT 66

Query: 518 GPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM 576
             VY+       +  A K L K+  +  +    E+ ++ +L H N++KL        E  
Sbjct: 67  SIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124

Query: 577 LIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQIIGGIARGLLYLHQDSRLRIIHRDLKA 634
           L+ E +    L D I  V +  +   S+R     +  I   + YLH+     I+HRDLK 
Sbjct: 125 LVLELVTGGELFDRI--VEKGYY---SERDAADAVKQILEAVAYLHE---NGIVHRDLKP 176

Query: 635 SNVLL---DNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDV 691
            N+L      +   KI+DFG+++             V GT GY  PE      +  + D+
Sbjct: 177 ENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDM 233

Query: 692 FSFGV 696
           +S G+
Sbjct: 234 WSVGI 238

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 98.1 bits (245), Expect = 2e-22
 Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 23/209 (11%)

Query: 503 TENFSDK-----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLI 554
            ENF++       +LG G F  V + +    GQE AAK L K         E  +E+ ++
Sbjct: 23  MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVL 82

Query: 555 AKLQHR-NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQIIGG 611
              +    ++ L        E +LI EY     +               S+    ++I  
Sbjct: 83  ELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMV---SENDVIRLIKQ 139

Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAFGIDQTEANTNRV 668
           I  G+ YLHQ     I+H DLK  N+LL +     + KI DFGM+R  G          +
Sbjct: 140 ILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREI 193

Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVL 697
           +GT  Y+ PE       +  +D+++ G++
Sbjct: 194 MGTPEYLAPEILNYDPITTATDMWNIGII 222

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 97.8 bits (244), Expect = 2e-22
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 38/214 (17%)

Query: 512 LGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFEN------EV----LLIAKLQHR 560
           LG+GGFG V+ G  L +  ++A K + ++   G     +      EV     + A   H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 561 NLVKLIGCCTQRDERMLIYEY-LPNKSLNDFIF-------DVTRSKFLDWSKRCQIIGGI 612
            +++L+     ++  ML+ E  LP + L D+I          +R  F       Q++  I
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF------GQVVAAI 152

Query: 613 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQTEANTNRVVGT 671
                + H      ++HRD+K  N+L+D      K+ DFG   A  +           GT
Sbjct: 153 Q----HCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSG-AL-LHDEPYTD--FDGT 201

Query: 672 YGYMPPEYAIDGLFS-VKSDVFSFGVLVLEIVCG 704
             Y PPE+     +  + + V+S G+L+ ++VCG
Sbjct: 202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 99.4 bits (248), Expect = 3e-22
 Identities = 58/220 (26%), Positives = 103/220 (46%), Gaps = 35/220 (15%)

Query: 503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN-EVLLIAKLQHR 560
             +++D   +G G FG VY+  L + G+ +A K++ +      + F+N E+ ++ KL H 
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107

Query: 561 NLVKLIGCCTQRDERM------LIYEYLPNKSLNDFIFDVTRSK-FLDWSKRCQIIGGIA 613
           N+V+L        E+       L+ +Y+P +++       +R+K  L        +  + 
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166

Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQTEANTNRVVGTY 672
           R L Y+H      I HRD+K  N+LLD +    K+ DFG A+     + E N + +   Y
Sbjct: 167 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY 221

Query: 673 GYMPPE-------YAIDGLFSVKSDVFSFGVLVLEIVCGK 705
            Y  PE       Y      +   DV+S G ++ E++ G+
Sbjct: 222 -YRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 97.0 bits (242), Expect = 5e-22
 Identities = 53/230 (23%), Positives = 89/230 (38%), Gaps = 39/230 (16%)

Query: 499 IANATENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEE------- 546
           ++   +   D+      LG G  G V      +  +++A K +SK               
Sbjct: 1   MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL 60

Query: 547 -FENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY---EYLPNKSLNDFIFDVTRSKFLDW 602
             E E+ ++ KL H  ++K+       D     Y   E +    L D +  V   +    
Sbjct: 61  NVETEIEILKKLNHPCIIKIKNFFDAED----YYIVLELMEGGELFDKV--VGNKRL--- 111

Query: 603 SKR--CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFG 657
            +         +   + YLH      IIHRDLK  NVLL   + +   KI+DFG ++  G
Sbjct: 112 KEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168

Query: 658 IDQTEANTNRVVGTYGYMPPE---YAIDGLFSVKSDVFSFGVLVLEIVCG 704
            + +   T  + GT  Y+ PE         ++   D +S GV++   + G
Sbjct: 169 -ETSLMRT--LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 99.1 bits (247), Expect = 9e-22
 Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 32/218 (14%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEI-AAKRLSKS-----SGQGMEEFENEVLLIAKL 557
           + F D   LG GGFG V+   +    ++ A K+L+K       G      E ++L  AK+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL--AKV 242

Query: 558 QHRNLVKLIGCCTQRDERM-LIYEY---------LPNKSLNDFIFDVTRSKFLDWSKRCQ 607
             R +V L     +    + L+            + N   ++  F   R+ F        
Sbjct: 243 HSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY------- 294

Query: 608 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 667
               I  GL +LHQ     II+RDLK  NVLLD++ N +ISD G+A      QT+     
Sbjct: 295 -TAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-- 348

Query: 668 VVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
             GT G+M PE  +   +    D F+ GV + E++  +
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 96.3 bits (240), Expect = 9e-22
 Identities = 48/232 (20%), Positives = 85/232 (36%), Gaps = 52/232 (22%)

Query: 512 LGEGGFGPVYKGV-LIEGQEIAAKRLSKS--SGQGMEEFEN------EVLLIAKLQHRNL 562
           LG G FG V+  V   + +E+  K + K         E         E+ ++++++H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 563 VKLIGCCTQRDERMLIYE-YLPNKSLNDFIF-------DVTRSKFLDWSKRCQIIGGIAR 614
           +K++     +    L+ E +     L  FI         +    F       Q++  +  
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIF------RQLVSAVG- 144

Query: 615 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGY 674
              YL       IIHRD+K  N+++  +   K+ DFG A      +         GT  Y
Sbjct: 145 ---YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEY 195

Query: 675 MPPE------YAIDGLFSVKSDVFSFGVLVLEIVCG--------KRNRGFYH 712
             PE      Y   G    + +++S GV +  +V          +      H
Sbjct: 196 CAPEVLMGNPY--RGP---ELEMWSLGVTLYTLVFEENPFCELEETVEAAIH 242

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 95.4 bits (238), Expect = 1e-21
 Identities = 56/232 (24%), Positives = 92/232 (39%), Gaps = 53/232 (22%)

Query: 512 LGEGGFGPVYKGV-LIEGQEIAAKRLSKS-------------------------SGQGME 545
           +G+G +G V       +    A K LSK                            +G  
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 546 EF-ENEVLLIAKLQHRNLVKL---IGCCTQRDERMLIYEYLPNKSLNDFIFD-VTRSKFL 600
           E    E+ ++ KL H N+VKL   +      D   +++E +    +     +  T     
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPN-EDHLYMVFELVNQGPV----MEVPTLKPLS 135

Query: 601 DWSKRC---QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 657
           +   R     +I GI     YLH     +IIHRD+K SN+L+  + + KI+DFG++  F 
Sbjct: 136 EDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188

Query: 658 IDQTEANTNRVVGTYGYMPPEYAIDGLFSV----KSDVFSFGVLVLEIVCGK 705
                 +    VGT  +M PE ++     +      DV++ GV +   V G+
Sbjct: 189 GSDALLSN--TVGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 95.8 bits (239), Expect = 1e-21
 Identities = 54/216 (25%), Positives = 84/216 (38%), Gaps = 27/216 (12%)

Query: 503 TENFSD-------KNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLI 554
              F            LGEG F    K V  +  Q  A K +SK         + E+  +
Sbjct: 3   DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITAL 59

Query: 555 AKLQ-HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR--CQIIGG 611
              + H N+VKL      +    L+ E L    L + I    +  F   S+     I+  
Sbjct: 60  KLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERI--KKKKHF---SETEASYIMRK 114

Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP---KISDFGMARAFGIDQTEANTNRV 668
           +   + ++H    + ++HRDLK  N+L  +E +    KI DFG AR    D     T   
Sbjct: 115 LVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--P 169

Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
             T  Y  PE      +    D++S GV++  ++ G
Sbjct: 170 CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSG 205

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 95.4 bits (238), Expect = 1e-21
 Identities = 61/206 (29%), Positives = 89/206 (43%), Gaps = 26/206 (12%)

Query: 512 LGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEEF-----ENEVLLIAKLQHRNLVKL 565
           LGEG F  V     +      A K L K       +      E +V+  ++L H   VKL
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM--SRLDHPFFVKL 95

Query: 566 IGCCTQRDERM-LIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
                Q DE++     Y  N  L         FD T ++F            I   L YL
Sbjct: 96  YFTF-QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--------TAEIVSALEYL 146

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  Y+ PE 
Sbjct: 147 HG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 203

Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCGK 705
             +      SD+++ G ++ ++V G 
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGL 229

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 98.8 bits (246), Expect = 2e-21
 Identities = 55/218 (25%), Positives = 94/218 (43%), Gaps = 34/218 (15%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEI-AAKRLSKSS-----GQGMEEFENEVL-LIAK 556
            +FS    +G GGFG VY     +  ++ A K L K       G+ +   E  +L L++ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 557 LQHRNLVKLIGCCTQRDERM-LIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIG 610
                +V +        +++  I + +    L        +F     +F           
Sbjct: 249 GDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY--------AA 299

Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVG 670
            I  GL ++H      +++RDLK +N+LLD   + +ISD G+A  F    ++   +  VG
Sbjct: 300 EIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVG 352

Query: 671 TYGYMPPEYAIDGL---FSVKSDVFSFGVLVLEIVCGK 705
           T+GYM PE    G+    S   D FS G ++ +++ G 
Sbjct: 353 THGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGH 388

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 97.9 bits (244), Expect = 2e-21
 Identities = 63/219 (28%), Positives = 93/219 (42%), Gaps = 37/219 (16%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEI-AAKRLSKS-----SGQGMEEFENEVLLIAKL 557
             F     LG+GGFG V    +    ++ A K+L K       G+ M   E ++L   K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL--EKV 241

Query: 558 QHRNLVKLIGCCTQRDERM-LIYEYLPNKSL-------NDFIFDVTRSKFLDWSKRCQII 609
             R +V L     +  + + L+   +    L           F   R+ F          
Sbjct: 242 NSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY--------A 292

Query: 610 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV 669
             I  GL  LH   R RI++RDLK  N+LLD+  + +ISD G+A      QT       V
Sbjct: 293 AEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRV 346

Query: 670 GTYGYMPPEYAIDGL---FSVKSDVFSFGVLVLEIVCGK 705
           GT GYM PE  +      FS   D ++ G L+ E++ G+
Sbjct: 347 GTVGYMAPE-VVKNERYTFSP--DWWALGCLLYEMIAGQ 382

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 91.9 bits (229), Expect = 1e-20
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 38/211 (18%)

Query: 512 LGEGGFGPVYKGV-LIEGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIG 567
           LG G FG V  G   + G ++A K L++    S   + + + E+  +   +H +++KL  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 568 CCTQRDERMLIYEYLPNKSLNDFIF-------DVTRSKFLDWSKRCQIIGGIARGLLYLH 620
             +   +  ++ EY+    L D+I           R  F       QI+  +     Y H
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF------QQILSAVD----YCH 128

Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE-- 678
              R  ++HRDLK  NVLLD  MN KI+DFG++     D     T    G+  Y  PE  
Sbjct: 129 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRT--SCGSPNYAAPEVI 182

Query: 679 ----YAIDGLFSVKSDVFSFGVLVLEIVCGK 705
               Y   G    + D++S GV++  ++CG 
Sbjct: 183 SGRLY--AGP---EVDIWSCGVILYALLCGT 208

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 92.5 bits (230), Expect = 7e-20
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 38/211 (18%)

Query: 512 LGEGGFGPVYKGV-LIEGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIG 567
           LG G FG V  G   + G ++A K L++    S   + +   E+  +   +H +++KL  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 568 CCTQRDERMLIYEYLPNKSLNDFIF-------DVTRSKFLDWSKRCQIIGGIARGLLYLH 620
             +   +  ++ EY+    L D+I          +R  F       QI+ G+     Y H
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLF------QQILSGVD----YCH 133

Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE-- 678
              R  ++HRDLK  NVLLD  MN KI+DFG++      +    T+   G+  Y  PE  
Sbjct: 134 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTS--CGSPNYAAPEVI 187

Query: 679 ----YAIDGLFSVKSDVFSFGVLVLEIVCGK 705
               Y   G    + D++S GV++  ++CG 
Sbjct: 188 SGRLY--AGP---EVDIWSSGVILYALLCGT 213

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 90.1 bits (224), Expect = 1e-19
 Identities = 49/218 (22%), Positives = 82/218 (37%), Gaps = 31/218 (14%)

Query: 503 TENFSD-----KNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEV-LLIA 555
               +D     K  LG G  G V +      GQ+ A K L  S      +   EV     
Sbjct: 23  KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQ 77

Query: 556 KLQHRNLVKLIGCC-TQRDERMLIY---EYLPNKSLNDFIFDVTRSKFLDWSKR--CQII 609
                ++V ++         +  +    E +    L   I +     F   ++R   +I+
Sbjct: 78  ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAF---TEREAAEIM 134

Query: 610 GGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFGIDQTEANTN 666
             I   + +LH      I HRD+K  N+L    + +   K++DFG A+     Q    T 
Sbjct: 135 RDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQT- 188

Query: 667 RVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
               T  Y+ PE      +    D++S GV++  ++CG
Sbjct: 189 -PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 90.0 bits (224), Expect = 2e-19
 Identities = 51/231 (22%), Positives = 89/231 (38%), Gaps = 47/231 (20%)

Query: 501 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN---------E 550
              + F  +   G+G FG V  G     G  +A K++           ++          
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV----------IQDPRFRNRELQI 69

Query: 551 VLLIAKLQHRNLVKLIGCCTQRDER-------MLIYEYLPNKSLNDFIFDVTRSK-FLDW 602
           +  +A L H N+V+L        ER        ++ EY+P  +L+    +  R +     
Sbjct: 70  MQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPP 128

Query: 603 SKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP-KISDFGMARAFGIDQT 661
                 +  + R +  LH  S + + HRD+K  NVL++      K+ DFG A+      +
Sbjct: 129 ILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL--SPS 185

Query: 662 EANTNRVVGTYGYMPPE-------YAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           E N   +   Y Y  PE       Y      +   D++S G +  E++ G+
Sbjct: 186 EPNVAYICSRY-YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 88.5 bits (220), Expect = 4e-19
 Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 39/211 (18%)

Query: 512 LGEGGFGPVYKGV-LIEGQEIAAKRLSKS--SGQGMEE-FENEVLLIAKLQHRNLVKLIG 567
           LGEG FG V         Q++A K +S+       M    E E+  +  L+H +++KL  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 568 CCTQRDERMLIYEYLPNKSLNDFIF-------DVTRSKFLDWSKRCQIIGGIARGLLYLH 620
             T   + +++ EY     L D+I        D  R  F       QII  I     Y H
Sbjct: 77  VITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFF------QQIICAIE----YCH 125

Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE-- 678
              R +I+HRDLK  N+LLD+ +N KI+DFG++           T+   G+  Y  PE  
Sbjct: 126 ---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-LKTS--CGSPNYAAPEVI 179

Query: 679 ----YAIDGLFSVKSDVFSFGVLVLEIVCGK 705
               Y   G    + DV+S G+++  ++ G+
Sbjct: 180 NGKLY--AGP---EVDVWSCGIVLYVMLVGR 205

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 89.0 bits (221), Expect = 5e-19
 Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 40/210 (19%)

Query: 512 LGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEE-FENEVLLIAKLQHRNLVKLIGCC 569
           +G G FG        +  + +A K + +  G  ++E  + E++    L+H N+V+     
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVI 85

Query: 570 TQRDERMLIYEYLPNKSLNDFIF-------DVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
                  +I EY     L + I        D  R  F       Q++ G++    Y H  
Sbjct: 86  LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ------QLLSGVS----YCH-- 133

Query: 623 SRLRIIHRDLKASNVLLD--NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE-- 678
             ++I HRDLK  N LLD       KI DFG +++  +      +   VGT  Y+ PE  
Sbjct: 134 -SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS--TVGTPAYIAPEVL 189

Query: 679 ----YAIDGLFSVKSDVFSFGVLVLEIVCG 704
               Y  DG     +DV+S GV +  ++ G
Sbjct: 190 LRQEY--DGK---IADVWSCGVTLYVMLVG 214

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 86.6 bits (215), Expect = 3e-18
 Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 32/210 (15%)

Query: 512 LGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEEFEN---EVLLIAKLQHRNLVKLIG 567
           +G+G FG V      + +++ A K ++K       E  N   E+ ++  L+H  LV L  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW- 81

Query: 568 CCTQRDERM-LIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
              Q +E M ++ + L    L      +  F     K          I  +   L YL  
Sbjct: 82  YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF--------ICELVMALDYLQN 133

Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE--Y 679
               RIIHRD+K  N+LLD   +  I+DF +A      +T+  T  + GT  YM PE   
Sbjct: 134 ---QRIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITT--MAGTKPYMAPEMFS 187

Query: 680 AIDGL---FSVKSDVFSFGVLVLEIVCGKR 706
           +  G    F+V  D +S GV   E++ G+R
Sbjct: 188 SRKGAGYSFAV--DWWSLGVTAYELLRGRR 215

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 86.3 bits (214), Expect = 4e-18
 Identities = 49/209 (23%), Positives = 81/209 (38%), Gaps = 27/209 (12%)

Query: 508 DKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEV-LLIAKLQHRNLVKL 565
               LG G  G V +       ++ A K L         +   EV L     Q  ++V++
Sbjct: 66  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 120

Query: 566 IGCC-TQRDERMLIY---EYLPNKSLNDFIFDVTRSKFLDWSKR--CQIIGGIARGLLYL 619
           +         R  +    E L    L   I D     F   ++R   +I+  I   + YL
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF---TEREASEIMKSIGEAIQYL 177

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGIDQTEANTNRVVGTYGYM 675
           H    + I HRD+K  N+L  ++  P    K++DFG A+      +         T  Y+
Sbjct: 178 HS---INIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYV 230

Query: 676 PPEYAIDGLFSVKSDVFSFGVLVLEIVCG 704
            PE      +    D++S GV++  ++CG
Sbjct: 231 APEVLGPEKYDKSCDMWSLGVIMYILLCG 259

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 84.6 bits (209), Expect = 1e-17
 Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 11/95 (11%)

Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 671
           +A+G+ +L   +  + IHRDL A N+LL  +   KI DFG+AR    D  +       G 
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYVRKGD 254

Query: 672 ----YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 702
                 +M PE   D +++++SDV+SFGVL+ EI 
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 66.5 bits (162), Expect = 1e-11
 Identities = 31/160 (19%), Positives = 60/160 (37%), Gaps = 19/160 (11%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSSGQG-MEEFENEVLLIAK 556
           +       LG G FG V +            + +A K L + +         +E+ ++  
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81

Query: 557 L-QHRNLVKLIGCCTQRDER-MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIAR 614
           +  H N+V L+G CT+     M+I E+    +L+ ++           SKR + +    +
Sbjct: 82  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131

Query: 615 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 654
           G  +      +  I  DLK     + +  +   S F   +
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 83.7 bits (207), Expect = 4e-17
 Identities = 60/285 (21%), Positives = 108/285 (37%), Gaps = 52/285 (18%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEEF-----ENEVLLIAKL 557
           E+F     +G G FG V    L    ++ A K L+K       E      E +VL     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVL--VNG 131

Query: 558 QHRNLVKLIGCCTQRDERM-LIYEYLPNKSL------NDFIFDVTRSKFLDWSKRCQIIG 610
             + +  L     Q D  + L+ +Y     L       +       ++F         + 
Sbjct: 132 DSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY--------LA 182

Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVG 670
            +   +  +HQ   L  +HRD+K  N+L+D   + +++DFG      ++     ++  VG
Sbjct: 183 EMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLK-LMEDGTVQSSVAVG 238

Query: 671 TYGYMPPE-----YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH---HNLLGH 722
           T  Y+ PE         G +  + D +S GV + E++ G+    FY          ++ H
Sbjct: 239 TPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP--FYAESLVETYGKIMNH 296

Query: 723 AWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDR 767
             R    + P ++ +        +SE  + +   L+C     E R
Sbjct: 297 KERF---QFPTQVTD--------VSENAKDLIRRLIC---SREHR 327

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 82.5 bits (204), Expect = 8e-17
 Identities = 48/221 (21%), Positives = 83/221 (37%), Gaps = 35/221 (15%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEEF-----ENEVLLIAKL 557
           ++F     +G G F  V    + +  ++ A K ++K       E      E +VL     
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVL--VNG 118

Query: 558 QHRNLVKLIGCCTQRDERM-LIYEYLPNKSL------NDFIFDVTRSKFLDWSKRCQIIG 610
             R + +L     Q +  + L+ EY     L               ++F         + 
Sbjct: 119 DRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFY--------LA 169

Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVG 670
            I   +  +H+   L  +HRD+K  N+LLD   + +++DFG       D T   +   VG
Sbjct: 170 EIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVG 225

Query: 671 TYGYMPPE-------YAIDGLFSVKSDVFSFGVLVLEIVCG 704
           T  Y+ PE           G +  + D ++ GV   E+  G
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 82.9 bits (205), Expect = 8e-17
 Identities = 63/216 (29%), Positives = 92/216 (42%), Gaps = 29/216 (13%)

Query: 512 LGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEEF-----ENEVLLIAKLQHRNLVKL 565
           LG+G FG V            A K L K      +E      EN VL     +H  L  L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVL--QNSRHPFLTAL 213

Query: 566 IGCCTQRDERM-LIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
                Q  +R+  + EY     L      + +F   R++F            I   L YL
Sbjct: 214 K-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY--------GAEIVSALDYL 264

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H  S   +++RDLK  N++LD + + KI+DFG+ +  GI    A      GT  Y+ PE 
Sbjct: 265 H--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKD-GATMKTFCGTPEYLAPEV 320

Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 715
             D  +    D +  GV++ E++CG+    FY+ DH
Sbjct: 321 LEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 354

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 80.4 bits (199), Expect = 2e-16
 Identities = 51/229 (22%), Positives = 99/229 (43%), Gaps = 29/229 (12%)

Query: 501 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ- 558
              +++    KLG G +  V++ + I   +++  K L        ++ + E+ ++  L+ 
Sbjct: 33  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRG 89

Query: 559 HRNLVKLIGCCTQRDERM--LIYEYLPNKSLNDFIFDVTRSKFLDWSKRC---QIIGGIA 613
             N++ L         R   L++E++ N                D+  R    +I+    
Sbjct: 90  GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEIL---- 140

Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMARAFGIDQTEANTNRVVGTY 672
           + L Y H  S   I+HRD+K  NV++D+E    ++ D+G+A  F     E    RV   Y
Sbjct: 141 KALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQE-YNVRVASRY 195

Query: 673 GYMPPEYAIDGLFSVKS-DVFSFGVLVLEIVCGKRNRGFYHADHHHNLL 720
            +  PE  +D      S D++S G ++  ++  K    F+H   +++ L
Sbjct: 196 -FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK--EPFFHGHDNYDQL 241

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 80.9 bits (200), Expect = 2e-16
 Identities = 50/253 (19%), Positives = 99/253 (39%), Gaps = 65/253 (25%)

Query: 501 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN-EVLLIAKLQ 558
            +++ +S    LG G FG V +   IE G+  A K++ +        ++N E+ ++  L 
Sbjct: 4   TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLD 58

Query: 559 HRNLVKLIGC--------------------CTQRDERMLIYEYLPNKSLNDFIF------ 592
           H N++KL+                         ++  +  +      + +   +      
Sbjct: 59  HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118

Query: 593 --DVTRSKFLD-WSKRCQIIGG---------IARGLLYLHQDSRLRIIHRDLKASNVLLD 640
               T  K L  + +  + I           + R + ++H    L I HRD+K  N+L++
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVN 175

Query: 641 NEMNP-KISDFGMARAFGIDQTEANTNRVVGTYGYMPPE-------YAIDGLFSVKSDVF 692
           ++ N  K+ DFG A+      +E +   +   + Y  PE       Y      +   D++
Sbjct: 176 SKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEY------TPSIDLW 226

Query: 693 SFGVLVLEIVCGK 705
           S G +  E++ GK
Sbjct: 227 SIGCVFGELILGK 239

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 79.9 bits (198), Expect = 3e-16
 Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 36/211 (17%)

Query: 512 LGEGGFGPVY---KGVLIEGQEI-AAKRLSKSSGQGMEEF----ENEVLLIAKLQHRNLV 563
           LG+G FG V+   K    + +++ A K L K++ +  +      E ++L+     H  +V
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN--HPFIV 89

Query: 564 KLIGCCTQRDERM-LIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           KL     Q + ++ LI ++L    L      + +F     KF         +  +A  L 
Sbjct: 90  KLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY--------LAELALALD 140

Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           +LH    L II+RDLK  N+LLD E + K++DFG+++     + +A +    GT  YM P
Sbjct: 141 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAP 195

Query: 678 EYAIDGL---FSVKSDVFSFGVLVLEIVCGK 705
           E  ++      S   D +SFGVL+ E++ G 
Sbjct: 196 E-VVNRRGHTQSA--DWWSFGVLMFEMLTGT 223

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 79.2 bits (196), Expect = 5e-16
 Identities = 55/206 (26%), Positives = 85/206 (41%), Gaps = 28/206 (13%)

Query: 512 LGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEEF-----ENEVLLIAKLQHRNLVKL 565
           LG+G FG V            A K L K      +E      E+ VL     +H  L  L
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL--QNTRHPFLTAL 70

Query: 566 IGCCTQRDERM-LIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
                Q  +R+  + EY     L      + +F   R++F            I   L YL
Sbjct: 71  K-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY--------GAEIVSALEYL 121

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H      +++RD+K  N++LD + + KI+DFG+ +    D     T    GT  Y+ PE 
Sbjct: 122 HS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEV 176

Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCGK 705
             D  +    D +  GV++ E++CG+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 79.1 bits (195), Expect = 1e-15
 Identities = 36/207 (17%), Positives = 79/207 (38%), Gaps = 57/207 (27%)

Query: 503 TENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFEN---------EVL 552
            + +  ++ +G G +G V +    +E + +A K++ +        FE+         E+ 
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIA 104

Query: 553 LIAKLQHRNLVKLIGCCTQRDERM-----LIYEYLP---------NKSLND-----FIFD 593
           ++ +L H ++VK++     +D        ++ E               L +      ++ 
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY- 163

Query: 594 VTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA 653
                         ++     G+ Y+H  S   I+HRDLK +N L++ + + K+ DFG+A
Sbjct: 164 -------------NLL----VGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLA 203

Query: 654 RAFGIDQTEANTNRVVGTYGYMPPEYA 680
           R     +   +   +      M     
Sbjct: 204 RTVDYPENGNSQLPISPREDDMNLVTF 230

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 78.6 bits (194), Expect = 2e-15
 Identities = 51/214 (23%), Positives = 89/214 (41%), Gaps = 26/214 (12%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEE---FENEVLLIAKLQH 559
           E++     +G G FG V        +++ A K LSK       +   F  E  ++A    
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128

Query: 560 RNLVKLIGCCTQRDERM-LIYEYLPN----KSLNDFIFDVTRSKFLDWSKRCQIIGGIAR 614
             +V+L     Q D  + ++ EY+P       ++++      ++F            +  
Sbjct: 129 PWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY--------TAEVVL 179

Query: 615 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGY 674
            L  +H    +  IHRD+K  N+LLD   + K++DFG       +      +  VGT  Y
Sbjct: 180 ALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDY 235

Query: 675 MPPE----YAIDGLFSVKSDVFSFGVLVLEIVCG 704
           + PE       DG +  + D +S GV + E++ G
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 77.7 bits (192), Expect = 2e-15
 Identities = 57/254 (22%), Positives = 101/254 (39%), Gaps = 30/254 (11%)

Query: 473 GSSKLDYNDRGNREEEMELPIFDWMAIANAT-ENFSDKNKLGEGGFGPVYKGVLIEGQEI 531
           GS +    +   + +E  L  ++  +   A  + F     LG G FG V      E    
Sbjct: 9   GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNH 68

Query: 532 -AAKRLSKSSGQGMEEFE---NEVLLIAKLQHRNLVKLIGCCTQRDERM-LIYEYLPNKS 586
            A K L K     +++ E   NE  ++  +    LVKL     + +  + ++ EY+    
Sbjct: 69  YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-KDNSNLYMVMEYVAGGE 127

Query: 587 L-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN 641
           +         F    ++F            I     YLH    L +I+RDLK  N+L+D 
Sbjct: 128 MFSHLRRIGRFSEPHARF--------YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQ 176

Query: 642 EMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEI 701
           +   +++DFG A+     + +  T  + GT   + PE  +   ++   D ++ GVL+ E+
Sbjct: 177 QGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEM 231

Query: 702 VCGKRNRGFYHADH 715
             G     F+    
Sbjct: 232 AAGYPP--FFADQP 243

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 77.3 bits (191), Expect = 2e-15
 Identities = 60/209 (28%), Positives = 89/209 (42%), Gaps = 33/209 (15%)

Query: 512 LGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEEF-----ENEVLLIAKLQHRNLVKL 565
           +G G +  V    L +   I A K + K      E+      E  V   A   H  LV L
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA-SNHPFLVGL 75

Query: 566 IGCCTQRDERM-LIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
              C Q + R+  + EY+    L              ++F            I+  L YL
Sbjct: 76  H-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY--------SAEISLALNYL 126

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H+     II+RDLK  NVLLD+E + K++D+GM +         +T    GT  Y+ PE 
Sbjct: 127 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAPE- 180

Query: 680 AIDGL---FSVKSDVFSFGVLVLEIVCGK 705
            + G    FSV  D ++ GVL+ E++ G+
Sbjct: 181 ILRGEDYGFSV--DWWALGVLMFEMMAGR 207

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 77.8 bits (192), Expect = 2e-15
 Identities = 54/227 (23%), Positives = 98/227 (43%), Gaps = 51/227 (22%)

Query: 503 TENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFEN---------EVL 552
            + + +   +G G  G V      I  + +A K+LS+        F+N         E++
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRELV 76

Query: 553 LIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF-----IFD--------VTRSKF 599
           L+  + H+N++ L+              + P KSL +F     + +        V + + 
Sbjct: 77  LMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMEL 124

Query: 600 LDWSKRCQ-IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI 658
               +R   ++  +  G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR    
Sbjct: 125 DH--ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TA 177

Query: 659 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
             +   T  VV T  Y  PE  +   +    D++S G ++ E++ G 
Sbjct: 178 GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 77.3 bits (191), Expect = 3e-15
 Identities = 60/206 (29%), Positives = 87/206 (42%), Gaps = 27/206 (13%)

Query: 512 LGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEEF-----ENEVLLIAKLQHRNLVKL 565
           LG+G FG V         E+ A K L K      ++      E  VL +   +   L +L
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-KPPFLTQL 86

Query: 566 IGCCTQRDERM-LIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
              C Q  +R+  + EY+    L         F    + F            IA GL +L
Sbjct: 87  H-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF--------YAAEIAIGLFFL 137

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
                  II+RDLK  NV+LD+E + KI+DFGM +    D     T    GT  Y+ PE 
Sbjct: 138 QS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYIAPEI 192

Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCGK 705
                +    D ++FGVL+ E++ G+
Sbjct: 193 IAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 77.8 bits (192), Expect = 3e-15
 Identities = 55/206 (26%), Positives = 85/206 (41%), Gaps = 27/206 (13%)

Query: 512 LGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEEF-----ENEVLLIAKLQHRNLVKL 565
           +G G +  V    L +   I A + + K      E+      E  V   A   H  LV L
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA-SNHPFLVGL 118

Query: 566 IGCCTQRDERM-LIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
              C Q + R+  + EY+    L              ++F            I+  L YL
Sbjct: 119 H-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY--------SAEISLALNYL 169

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H+     II+RDLK  NVLLD+E + K++D+GM +         +T    GT  Y+ PE 
Sbjct: 170 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAPEI 224

Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCGK 705
                +    D ++ GVL+ E++ G+
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGR 250

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 77.3 bits (191), Expect = 3e-15
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 27/206 (13%)

Query: 512 LGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEEF-----ENEVLLIAKLQHRNLVKL 565
           LG+G FG V    + E  ++ A K L K      ++      E  +L +A+  H  L +L
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 89

Query: 566 IGCCTQRDERM-LIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
             CC Q  +R+  + E++    L         FD  R++F            I   L++L
Sbjct: 90  F-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF--------YAAEIISALMFL 140

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H      II+RDLK  NVLLD+E + K++DFGM +    +     T    GT  Y+ PE 
Sbjct: 141 HD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTPDYIAPEI 195

Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCGK 705
             + L+    D ++ GVL+ E++CG 
Sbjct: 196 LQEMLYGPAVDWWAMGVLLYEMLCGH 221

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 77.3 bits (191), Expect = 3e-15
 Identities = 51/226 (22%), Positives = 84/226 (37%), Gaps = 38/226 (16%)

Query: 503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEE--FEN---------EV 551
              ++ +  +  G +G V  GV  EG  +A KR+  +   G       +         E+
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 552 LLIAKLQHRNLVKLIGCCTQRDERM-----LIYEYLPNKSLNDFIFDVTRSKFLDWSK-R 605
            L+    H N++ L       +E       L+ E +    L   I      + +  S   
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI----HDQRIVISPQH 135

Query: 606 CQ-IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN 664
            Q  +  I  GL  LH+     ++HRDL   N+LL +  +  I DF +AR          
Sbjct: 136 IQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR--EDTADANK 190

Query: 665 TNRVVGTYGYMPPEYAIDGLFSVKS-----DVFSFGVLVLEIVCGK 705
           T+ V     Y  PE     +   K      D++S G ++ E+   K
Sbjct: 191 THYVT-HRWYRAPEL----VMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 76.9 bits (190), Expect = 3e-15
 Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 27/205 (13%)

Query: 512 LGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEEF-----ENEVLLIAKLQHRNLVKL 565
           LG+G FG V+     +  +  A K L K      ++      E  VL +A  +H  L  +
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTHM 83

Query: 566 IGCCTQRDERM-LIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
             C  Q  E +  + EYL    L     +   FD++R+ F            I  GL +L
Sbjct: 84  F-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF--------YAAEIILGLQFL 134

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H      I++RDLK  N+LLD + + KI+DFGM +   +   +A TN   GT  Y+ PE 
Sbjct: 135 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE-NMLG-DAKTNTFCGTPDYIAPEI 189

Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCG 704
            +   ++   D +SFGVL+ E++ G
Sbjct: 190 LLGQKYNHSVDWWSFGVLLYEMLIG 214

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 76.4 bits (189), Expect = 3e-15
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 32/210 (15%)

Query: 512 LGEGGFGPVY---KGVLIEGQEI-AAKRLSKSS-GQGMEEF-----ENEVLLIAKLQHRN 561
           LG+GG+G V+   K       +I A K L K+   +  ++      E  +L   +++H  
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL--EEVKHPF 82

Query: 562 LVKLIGCCTQRDERM-LIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARG 615
           +V LI    Q   ++ LI EYL    L      + IF    + F         +  I+  
Sbjct: 83  IVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY--------LAEISMA 133

Query: 616 LLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYM 675
           L +LHQ     II+RDLK  N++L+++ + K++DFG+ +    D T  +T    GT  YM
Sbjct: 134 LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYM 188

Query: 676 PPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
            PE  +    +   D +S G L+ +++ G 
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 76.6 bits (189), Expect = 5e-15
 Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 40/221 (18%)

Query: 503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN---------EVL 552
            + +     +G G +G V   +    G+++A K+LS+        F++         E+L
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAKRAYRELL 75

Query: 553 LIAKLQHRNLVKL--IGCCTQRDERM----LIYEYLPNKSLNDFIFDVTRSKFLDWSKRC 606
           L+  +QH N++ L  +              L+  ++    L   +      KF +  ++ 
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM----GLKFSE--EKI 128

Query: 607 Q-IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT 665
           Q ++  + +GL Y+H      ++HRDLK  N+ ++ +   KI DFG+AR    + T    
Sbjct: 129 QYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG--- 182

Query: 666 NRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGK 705
              V T  Y  PE  +    ++   D++S G ++ E++ GK
Sbjct: 183 --YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 76.6 bits (189), Expect = 5e-15
 Identities = 65/272 (23%), Positives = 110/272 (40%), Gaps = 45/272 (16%)

Query: 462 KRRHRKQGKTDGSSKLDYNDRGNREEEMELPIFDWMAIANAT-------ENFSDKNKLGE 514
              H ++G + G +     D G+  E++     +               ENF     LG 
Sbjct: 5   HHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGT 64

Query: 515 GGFGPVY---KGVLIEGQEI-AAKRLSKSS-GQGMEEF-----ENEVLLIAKLQHRNLVK 564
           G +G V+   K    +  ++ A K L K++  Q  +       E +VL   + Q   LV 
Sbjct: 65  GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-QSPFLVT 123

Query: 565 LIGCCTQRDERM-LIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           L     Q + ++ LI +Y+    L         F     +          +G I   L +
Sbjct: 124 LH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI--------YVGEIVLALEH 174

Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           LH+   L II+RD+K  N+LLD+  +  ++DFG+++   +           GT  YM P+
Sbjct: 175 LHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGTIEYMAPD 230

Query: 679 YAIDGL-----FSVKSDVFSFGVLVLEIVCGK 705
             + G       +V  D +S GVL+ E++ G 
Sbjct: 231 -IVRGGDSGHDKAV--DWWSLGVLMYELLTGA 259

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 76.5 bits (189), Expect = 6e-15
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 33/209 (15%)

Query: 512 LGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEEF-----ENEVLLIAKLQHRNLVKL 565
           +G+G FG V        +   A K L K +    +E      E  VLL   ++H  LV L
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKN-VKHPFLVGL 104

Query: 566 IGCCTQRDERM-LIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
                Q  +++  + +Y+    L      +  F   R++F            IA  L YL
Sbjct: 105 H-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFY--------AAEIASALGYL 155

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H    L I++RDLK  N+LLD++ +  ++DFG+ +   I+   + T+   GT  Y+ PE 
Sbjct: 156 HS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEH-NSTTSTFCGTPEYLAPE- 209

Query: 680 AIDGL---FSVKSDVFSFGVLVLEIVCGK 705
            +       +V  D +  G ++ E++ G 
Sbjct: 210 VLHKQPYDRTV--DWWCLGAVLYEMLYGL 236

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 76.6 bits (188), Expect = 1e-14
 Identities = 60/206 (29%), Positives = 87/206 (42%), Gaps = 27/206 (13%)

Query: 512 LGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEEF-----ENEVLLIAKLQHRNLVKL 565
           LG+G FG V         E+ A K L K      ++      E  VL +   +   L +L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP-GKPPFLTQL 407

Query: 566 IGCCTQRDERM-LIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
              C Q  +R+  + EY+    L         F    + F            IA GL +L
Sbjct: 408 H-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY--------AAEIAIGLFFL 458

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
                  II+RDLK  NV+LD+E + KI+DFGM +   I      T    GT  Y+ PE 
Sbjct: 459 QS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NI-WDGVTTKTFCGTPDYIAPEI 513

Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCGK 705
                +    D ++FGVL+ E++ G+
Sbjct: 514 IAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 75.0 bits (185), Expect = 1e-14
 Identities = 46/193 (23%), Positives = 81/193 (41%), Gaps = 34/193 (17%)

Query: 503 TENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFEN---------EVL 552
              +++ + +GEG +G V      +    +A K++S         FE+         E+ 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77

Query: 553 LIAKLQHRNLVKLIGCCTQRDERM-----LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQ 607
           ++ + +H N++ +                ++ + +    L   +    +++ L     C 
Sbjct: 78  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICY 132

Query: 608 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN--T 665
            +  I RGL Y+H  S   ++HRDLK SN+LL+   + KI DFG+AR    D       T
Sbjct: 133 FLYQILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189

Query: 666 NRVVGTYGYMPPE 678
             V  T  Y  PE
Sbjct: 190 EYVA-TRWYRAPE 201

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 32/294 (10%), Positives = 85/294 (28%), Gaps = 52/294 (17%)

Query: 511 KLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQHRNLVKLI 566
             G       ++ +     +++A   +          ++E  +  L ++++    + +++
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 567 GCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLR 626
                R   +++ E++   SL +                 + +  +A      H   R  
Sbjct: 98  DVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH---RAG 149

Query: 627 IIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFS 686
           +       S V         +S  G                V+     MP         +
Sbjct: 150 VALSIDHPSRVR--------VSIDGDV--------------VLAYPATMPDA-------N 180

Query: 687 VKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSL 746
            + D+   G  +  ++  +            + L  A R     +P+E  +      + +
Sbjct: 181 PQDDIRGIGASLYALLVNRWP---LPEAGVRSGLAPAERD-TAGQPIEPADIDRDIPFQI 236

Query: 747 SEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTERNPPES 800
           S V          VQ     R   S+++ ++    ++    +     +  P  +
Sbjct: 237 SAVA------ARSVQGDGGIRSA-STLLNLMQQATAVADRTEVLGPIDEAPVSA 283

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 75.1 bits (185), Expect = 2e-14
 Identities = 52/231 (22%), Positives = 97/231 (41%), Gaps = 59/231 (25%)

Query: 503 TENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFEN---------EVL 552
              + D   +G G +G V   V    G ++A K+L +        F++         E+ 
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAKRAYRELR 76

Query: 553 LIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF-----IFD--------VTRSKF 599
           L+  ++H N++ L+              + P+++L+DF     +          + + + 
Sbjct: 77  LLKHMRHENVIGLLDV------------FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK 124

Query: 600 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 659
           L   +   ++  + +GL Y+H      IIHRDLK  N+ ++ +   KI DFG+AR    +
Sbjct: 125 LGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181

Query: 660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKS-----DVFSFGVLVLEIVCGK 705
            T       V T  Y  PE     + +        D++S G ++ E++ GK
Sbjct: 182 MTGY-----VVTRWYRAPEV----ILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 75.7 bits (186), Expect = 2e-14
 Identities = 53/229 (23%), Positives = 96/229 (41%), Gaps = 55/229 (24%)

Query: 503 TENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFEN---------EVL 552
            + + +   +G G  G V      +  + +A K+LS+        F+N         E++
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELV 113

Query: 553 LIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF-----IFD--------VTRSKF 599
           L+  + H+N++ L+              + P K+L +F     + +        V + + 
Sbjct: 114 LMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMEL 161

Query: 600 LDWSKR---CQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF 656
                     Q++     G+ +LH      IIHRDLK SN+++ ++   KI DFG+AR  
Sbjct: 162 DHERMSYLLYQML----CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-- 212

Query: 657 GIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
               +   T  VV T  Y  PE  +   +    D++S G ++ E+V  K
Sbjct: 213 TAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 38/156 (24%), Positives = 60/156 (38%), Gaps = 22/156 (14%)

Query: 509 KNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEV-LLIAKLQHRNLVKLI 566
              LG G  G V +       ++ A K L         +   EV L     Q  ++V+++
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIV 77

Query: 567 GCC-TQRDERMLIY---EYLPNKSLNDFIFDVTRSKFLDWSKR--CQIIGGIARGLLYLH 620
                    R  +    E L    L   I D     F   ++R   +I+  I   + YLH
Sbjct: 78  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF---TEREASEIMKSIGEAIQYLH 134

Query: 621 QDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMA 653
               + I HRD+K  N+L  ++      K++DFG A
Sbjct: 135 S---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 73.0 bits (180), Expect = 4e-14
 Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 33/206 (16%)

Query: 512 LGEGGFGPVYKGVLIEGQEI-AAKRLSKSSGQGMEEFE---NEVLLIAKLQHRNLVKLIG 567
           LG G FG V+           A K L K     +++ E   +E L+++ + H  ++++ G
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73

Query: 568 CCTQRDERM-LIYEYLPNKSL-----NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
              Q  +++ +I +Y+    L         F    +KF            +   L YLH 
Sbjct: 74  TF-QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY--------AAEVCLALEYLHS 124

Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
                II+RDLK  N+LLD   + KI+DFG A+          T  + GT  Y+ PE  +
Sbjct: 125 ---KDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPE-VV 175

Query: 682 DGL---FSVKSDVFSFGVLVLEIVCG 704
                  S+  D +SFG+L+ E++ G
Sbjct: 176 STKPYNKSI--DWWSFGILIYEMLAG 199

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 73.1 bits (180), Expect = 5e-14
 Identities = 52/231 (22%), Positives = 89/231 (38%), Gaps = 46/231 (19%)

Query: 503 TENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFEN---------EVL 552
              + D   LG GG G V+  V     + +A K++            +         E+ 
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60

Query: 553 LIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLND--FIFD--------VTRSKFLDW 602
           +I +L H N+VK+           L  +      LN    + +        V     L  
Sbjct: 61  IIRRLDHDNIVKVFEILGP-SGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLE 119

Query: 603 SKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMARAFGIDQT 661
                 +  + RGL Y+H  +   ++HRDLK +N+ ++ E +  KI DFG+AR      +
Sbjct: 120 EHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176

Query: 662 EAN--TNRVVGTYGYMPPEYAIDGLFSVKS-----DVFSFGVLVLEIVCGK 705
                +  +V T  Y  P      L S  +     D+++ G +  E++ GK
Sbjct: 177 HKGHLSEGLV-TKWYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 72.9 bits (179), Expect = 1e-13
 Identities = 41/230 (17%), Positives = 84/230 (36%), Gaps = 51/230 (22%)

Query: 478 DYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRL 536
            ++    RE      I +     +  +N+  K+ +G G +G VY        + +A K++
Sbjct: 4   HHHHSSGRENLYFQGIKNV----HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV 59

Query: 537 SKSSGQGMEEFEN---------EVLLIAKLQHRNLVKLIGCCTQRDERM-----LIYEYL 582
           ++        FE+         E+ ++ +L+   +++L       D        ++ E  
Sbjct: 60  NRM-------FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA 112

Query: 583 P---------NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLK 633
                        L +        K + +     ++     G  ++H      IIHRDLK
Sbjct: 113 DSDLKKLFKTPIFLTEE-----HIKTILY----NLL----LGENFIH--ES-GIIHRDLK 156

Query: 634 ASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
            +N LL+ + + K+ DFG+AR    ++     N +       P    +  
Sbjct: 157 PANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 72.0 bits (177), Expect = 2e-13
 Identities = 55/227 (24%), Positives = 99/227 (43%), Gaps = 51/227 (22%)

Query: 503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN---------EVL 552
            E + + + +G G +G V      + G  +A K+LS+        F++         E+ 
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELR 80

Query: 553 LIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDF-----IFD--------VTRSKF 599
           L+  ++H N++ L+              + P +SL +F     +          + + + 
Sbjct: 81  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 128

Query: 600 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 659
           L       +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR    +
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185

Query: 660 QTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGK 705
            T       V T  Y  PE  ++   ++   D++S G ++ E++ G+
Sbjct: 186 MTGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 70.7 bits (172), Expect = 3e-13
 Identities = 38/200 (19%), Positives = 63/200 (31%), Gaps = 46/200 (23%)

Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRL--------SKSSGQGMEEFENEVLL 553
            TE      K+GEG FG V++ +  +   +A K +        + S  +  EE   E+++
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 554 IAKLQ---------HRNLVKLIG--CCTQRDERMLIYEYL----PNKSLNDFI------- 591
             +L              + L    C       +L+  +        S ND         
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 592 -------------FDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVL 638
                         +  R+K    +    I+  +   L        LR  HRDL   NVL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194

Query: 639 LDNEMNPKISDFGMARAFGI 658
           L      K+      ++  I
Sbjct: 195 LKKTSLKKLHYTLNGKSSTI 214

>1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109

 Score = 63.3 bits (154), Expect = 2e-12
 Identities = 26/129 (20%), Positives = 48/129 (37%), Gaps = 21/129 (16%)

Query: 18  RDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPL 77
           R+ L  G+ +  G++L      +                + Y    + T +W +N     
Sbjct: 1   RNLLTNGEGLYAGQSLDVEP--YHFIMQEDCNL------VLYD---HSTSVWASNTGILG 49

Query: 78  SDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPD 137
                   + S GN   V+ ++    +W+S++ R   N V VL E GN+V+         
Sbjct: 50  KKGC-KAVLQSDGN--FVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD----- 101

Query: 138 NFLWQSFDY 146
             +W +  Y
Sbjct: 102 --IWSTGTY 108

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 67.3 bits (165), Expect = 5e-12
 Identities = 45/192 (23%), Positives = 81/192 (42%), Gaps = 34/192 (17%)

Query: 503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN---------EVL 552
           + +F  K+ LGEG +G V        G+ +A K++          F+          E+ 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61

Query: 553 LIAKLQHRNLVKLIGCCTQRDERM-----LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQ 607
           ++   +H N++ +                +I E +    L+  I     ++ L       
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVI----STQMLSDDHIQY 116

Query: 608 IIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR 667
            I    R +  LH  +   +IHRDLK SN+L+++  + K+ DFG+AR   ID++ A+ + 
Sbjct: 117 FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR--IIDESAADNSE 171

Query: 668 VVGTYGYMPPEY 679
             G    M  E+
Sbjct: 172 PTGQQSGM-VEF 182

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 66.2 bits (162), Expect = 1e-11
 Identities = 46/196 (23%), Positives = 91/196 (46%), Gaps = 30/196 (15%)

Query: 503 TENFSDKNKLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFEN---------EVL 552
              +    KLG+G +G V+K +    G+ +A K++  +       F+N         E++
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIM 60

Query: 553 LIAKLQ-HRNLVKLIGCCT--QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQ-I 608
           ++ +L  H N+V L+         +  L+++Y+    L+  I    R+  L+     Q +
Sbjct: 61  ILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVI----RANILE-PVHKQYV 114

Query: 609 IGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRV 668
           +  + + + YLH  S   ++HRD+K SN+LL+ E + K++DFG++R+F   +   N   +
Sbjct: 115 VYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171

Query: 669 VGTYGYMPPEYAIDGL 684
                    +     L
Sbjct: 172 SINENTENFDDDQPIL 187

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110

 Score = 59.4 bits (144), Expect = 5e-11
 Identities = 23/125 (18%), Positives = 46/125 (36%), Gaps = 21/125 (16%)

Query: 19  DTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLS 78
           ++L+   S+  G +L     S+ L              + Y    +G  +W +N     S
Sbjct: 2   NSLSSPNSLFTGHSL-EVGPSYRLIMQGDCNF------VLYD---SGKPVWASNTGGLGS 51

Query: 79  DRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDN 138
                L      N  LV+ + +N ++W +  +    + V VL +  N+V+          
Sbjct: 52  GCRLTL----HNNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIY-------GP 100

Query: 139 FLWQS 143
            +W +
Sbjct: 101 VVWAT 105

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 60.8 bits (148), Expect = 4e-10
 Identities = 42/157 (26%), Positives = 69/157 (43%), Gaps = 25/157 (15%)

Query: 511 KLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH-RNLVKLIGC 568
           K+G G FG +Y G  I  G+E+A K     +       E+++  +  +Q    +  +  C
Sbjct: 16  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKM--MQGGVGIPTIRWC 73

Query: 569 CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC------QIIGGIARGLLYLHQD 622
             + D  +++ E L   SL D +F+    KF   S +       Q+I  I     Y+H  
Sbjct: 74  GAEGDYNVMVMELL-GPSLED-LFNFCSRKF---SLKTVLLLADQMISRIE----YIHSK 124

Query: 623 SRLRIIHRDLKASNVLLDNEMNPK---ISDFGMARAF 656
           +    IHRD+K  N L+          I DFG+A+ +
Sbjct: 125 N---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112

 Score = 56.5 bits (136), Expect = 6e-10
 Identities = 26/125 (20%), Positives = 49/125 (39%), Gaps = 20/125 (16%)

Query: 19  DTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLS 78
           D LN G  +  G +L      +     +        L ++     N   +W +  +   S
Sbjct: 2   DRLNSGHQLDTGGSLA--EGGYLFIIQNDCN-----LVLYD----NNRAVWASGTNGKAS 50

Query: 79  DRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDN 138
                L + + GN  LV+ +  +  +W+SN +R   N   +L    N+V+ D      +N
Sbjct: 51  GCV--LKMQNDGN--LVIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVIYDNS----NN 101

Query: 139 FLWQS 143
            +W +
Sbjct: 102 AIWAT 106

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115

 Score = 56.1 bits (135), Expect = 8e-10
 Identities = 28/125 (22%), Positives = 43/125 (34%), Gaps = 22/125 (17%)

Query: 19  DTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLS 78
           + L  GQ++    +L +    + L   +          + Y+   NG  IW +N D    
Sbjct: 3   NVLLSGQTLHADHSLQAGA--YTLTIQNKCNL------VKYQ---NGRQIWASNTDR--R 49

Query: 79  DRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDN 138
                L + S GN  LV+ +  N  VW S           VL + G  V+          
Sbjct: 50  GSGCRLTLLSDGN--LVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIY-------GP 100

Query: 139 FLWQS 143
            LW  
Sbjct: 101 VLWSL 105

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 60.1 bits (146), Expect = 9e-10
 Identities = 35/158 (22%), Positives = 58/158 (36%), Gaps = 25/158 (15%)

Query: 511 KLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
           K+G G FG +  G  L   + +A K     S       E             + ++    
Sbjct: 16  KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-SGDGIPQVYYFG 74

Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC------QIIGGIARGLLYLHQDS 623
                  ++ E L   SL D +FD+    F   S +       Q+I  +     Y+H  +
Sbjct: 75  PCGKYNAMVLELL-GPSLED-LFDLCDRTF---SLKTVLMIAIQLISRME----YVHSKN 125

Query: 624 RLRIIHRDLKASNVLLDNEMNPK-----ISDFGMARAF 656
              +I+RD+K  N L+    N       I DF +A+ +
Sbjct: 126 ---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 42/186 (22%), Positives = 77/186 (41%), Gaps = 38/186 (20%)

Query: 511 KLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV-KLIGC 568
           K+G G FG +Y G  +   +E+A K  +  +      +E+++  I  LQ    +  +   
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRI--LQGGTGIPNVRWF 71

Query: 569 CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC------QIIGGIARGLLYLHQD 622
             + D  +L+ + L   SL D +F+    K    S +       Q+I  +     ++H  
Sbjct: 72  GVEGDYNVLVMDLL-GPSLED-LFNFCSRKL---SLKTVLMLADQMINRVE----FVHSK 122

Query: 623 SRLRIIHRDLKASNVLLDNEMNPK---ISDFGMARAFGIDQTEANTNR---------VVG 670
           S    +HRD+K  N L+          I DFG+A+ +     + +T++         + G
Sbjct: 123 S---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY----RDTSTHQHIPYRENKNLTG 175

Query: 671 TYGYMP 676
           T  Y  
Sbjct: 176 TARYAS 181

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 33/158 (20%), Positives = 66/158 (41%), Gaps = 25/158 (15%)

Query: 511 KLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
           ++GEG FG +++G  L+  Q++A K   + S       E     +       +  +    
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLA-GCTGIPNVYYFG 75

Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC------QIIGGIARGLLYLHQDS 623
            +    +L+ + L   SL D + D+   KF   S +       Q++  +      +H+ S
Sbjct: 76  QEGLHNVLVIDLLG-PSLED-LLDLCGRKF---SVKTVAMAAKQMLARVQ----SIHEKS 126

Query: 624 RLRIIHRDLKASNVLLDNEMNPK-----ISDFGMARAF 656
              +++RD+K  N L+    +       + DFGM + +
Sbjct: 127 ---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109

 Score = 53.3 bits (128), Expect = 7e-09
 Identities = 29/125 (23%), Positives = 45/125 (36%), Gaps = 22/125 (17%)

Query: 19  DTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLS 78
           + L  G+++  GE L   N  +                + Y        IW  N      
Sbjct: 2   NILYSGETLSPGEFL--NNGRYVFIMQEDCNL------VLYD---VDKPIWATNTGGL-- 48

Query: 79  DRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDN 138
           DR   L++ S GN  LV+ +  N  +W+SN      N V VL +  N+V+          
Sbjct: 49  DRRCHLSMQSDGN--LVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIY-------GT 99

Query: 139 FLWQS 143
             W +
Sbjct: 100 ARWAT 104

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 57.4 bits (139), Expect = 8e-09
 Identities = 53/239 (22%), Positives = 96/239 (40%), Gaps = 47/239 (19%)

Query: 511 KLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ----------- 558
           KLG G F  V+    ++    +A K + +      E  E+E+ L+ ++            
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 559 HRNLVKLIGCCTQRDERM----LIYEYLPNKSLNDFIFDVTRSKF----LDWSKRCQIIG 610
             +++KL+     +        +++E L  ++L   I    + +     L + K+  I  
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALI---KKYEHRGIPLIYVKQ--ISK 138

Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP------KISDFGMARAFGIDQTEAN 664
            +  GL Y+H   R  IIH D+K  NVL++   +P      KI+D G A        + +
Sbjct: 139 QLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC-----WYDEH 191

Query: 665 TNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK-----RNRGFYHADHHH 717
               + T  Y  PE  + G  +   +D++S   L+ E++ G           Y  D  H
Sbjct: 192 YTNSIQTREYRSPE-VLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119

 Score = 53.0 bits (127), Expect = 1e-08
 Identities = 23/137 (16%), Positives = 43/137 (31%), Gaps = 24/137 (17%)

Query: 7   FLFYTIRTATARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGT 66
            +F           L+  +S+     ++     +     +          + Y    N  
Sbjct: 3   IIFSKQPDDNHPQILHATESL----EILFGTHVYRFIMQTDCNL------VLYD---NNN 49

Query: 67  VIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNL 126
            IW  N     +       +   G   LV++ + N  VW S  +  A + V VL    N+
Sbjct: 50  PIWATNTGGLGNG--CRAVLQPDGV--LVVITNENVTVWQSPVAGKAGHYVLVLQPDRNV 105

Query: 127 VVKDGKDIDPDNFLWQS 143
           V+         + LW +
Sbjct: 106 VIY-------GDALWAT 115

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 56.7 bits (137), Expect = 1e-08
 Identities = 31/200 (15%), Positives = 70/200 (35%), Gaps = 46/200 (23%)

Query: 510 NKLGEGGFGPVYKGV---------LIEGQEIAAKRLSKSSGQGMEEF--------ENEVL 552
           +       G +Y+             + Q+ + K L    G+   E           +V 
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVN 106

Query: 553 LIAKLQHRNLV---KLIGCCTQRDE-RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC-- 606
              KL    L+     +G    +D+ R L+   L  +SL   +    +      S+R   
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVL---SERSVL 162

Query: 607 ----QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI--SDFGMARAF---- 656
               +++  +     +LH++     +H ++ A N+ +D E   ++  + +G A  +    
Sbjct: 163 QVACRLLDALE----FLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215

Query: 657 -GIDQTEANTNRVVGTYGYM 675
             +   E + +   G   ++
Sbjct: 216 KHVAYVEGSRSPHEGDLEFI 235

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 33/175 (18%), Positives = 67/175 (38%), Gaps = 41/175 (23%)

Query: 511 KLGEGGFGPVYKGVLIEGQEI------AAKRLSKSSGQGMEEFE-----NEVLLIAKLQH 559
            +G+GGFG +Y   +   + +        K     +G    E +      +   I K   
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 560 RNLVKLIG----------CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC--- 606
              +K +G              +  R +I +      L   I++    +F   S++    
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQK-IYEANAKRF---SRKTVLQ 156

Query: 607 ---QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI--SDFGMARAF 656
              +I+  +     Y+H+      +H D+KASN+LL+ +   ++   D+G+A  +
Sbjct: 157 LSLRILDILE----YIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109

 Score = 50.6 bits (121), Expect = 6e-08
 Identities = 28/127 (22%), Positives = 40/127 (31%), Gaps = 25/127 (19%)

Query: 17  ARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAP 76
             + L  GQ++     L   N  F+L           Y G W     N            
Sbjct: 2   GTNYLLSGQTLDTEGHLK--NGDFDLVMQDDCNL-VLYNGNWQSNTAN------------ 46

Query: 77  LSDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDP 136
            + R   L ++  G   LV+ N     VW S A     N  AV+   G LVV        
Sbjct: 47  -NGRDCKLTLTDYGE--LVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVF------- 96

Query: 137 DNFLWQS 143
              +++ 
Sbjct: 97  GPSVFKI 103

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113

 Score = 50.2 bits (120), Expect = 1e-07
 Identities = 18/112 (16%), Positives = 35/112 (31%), Gaps = 13/112 (11%)

Query: 17  ARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAP 76
            R+ L   Q + D   L + +  + L              +  K      ++W +     
Sbjct: 5   VRNVLFSSQVMYDNAQLATRD--YSLVMRDDCNL------VLTKG-SKTNIVWESGTS-- 53

Query: 77  LSDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVV 128
              R     +    +  L + +     V+ SN      + V +L  +G  VV
Sbjct: 54  --GRGQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVV 103

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 33/173 (19%), Positives = 62/173 (35%), Gaps = 40/173 (23%)

Query: 511 KLGEGGFGPVYKGVLIEGQEIAAKRLSK--SSGQGMEEFENEVLLIA------------- 555
           K+G GGFG +Y        E  A+ + K      G    E +                  
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 556 KLQHRNLVKLIGC----CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRC----- 606
           +L +  +    G        R  R ++ E L    L   I       F    K       
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQK-ISGQNG-TF---KKSTVLQLG 157

Query: 607 -QIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI--SDFGMARAF 656
            +++  +     Y+H++     +H D+KA+N+LL  +   ++  +D+G++  +
Sbjct: 158 IRMLDVLE----YIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 53.9 bits (130), Expect = 1e-07
 Identities = 53/215 (24%), Positives = 84/215 (39%), Gaps = 38/215 (17%)

Query: 510 NKLGEGGFGPVYKGVLIEGQEIAA----KRLSKSSGQGMEEFENEVLLIAKLQHR----- 560
           + +G+G FG V K      QE  A    K       Q       EV L+  +        
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ----IEVRLLELMNKHDTEMK 115

Query: 561 -NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWS-KRCQIIGG-IARGLL 617
             +V L      R+   L++E L + +L D +     + F   S    +     +   LL
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEML-SYNLYDLL---RNTNFRGVSLNLTRKFAQQMCTALL 171

Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGIDQTEANTNRVVGTY--- 672
           +L     L IIH DLK  N+LL N      KI DFG +             + +  Y   
Sbjct: 172 FLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS---------CQLGQRIYQYIQS 221

Query: 673 -GYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGK 705
             Y  PE  + G+ + +  D++S G +++E+  G+
Sbjct: 222 RFYRSPE-VLLGMPYDLAIDMWSLGCILVEMHTGE 255

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 54.5 bits (130), Expect = 1e-07
 Identities = 56/477 (11%), Positives = 132/477 (27%), Gaps = 133/477 (27%)

Query: 399 FHDLIDMKELSESGQDLFVRMAASELDDIERKKPKKKKKVAIVITSVLLVTGVILLGGFV 458
           F D  D K++ +  + +    +  E+D I             +    LL     ++  FV
Sbjct: 29  FVDNFDCKDVQDMPKSIL---SKEEIDHI-IMSKDAVSGTLRLFW-TLLSKQEEMVQKFV 83

Query: 459 ---------YLWKRRHRKQGKTDGSSKL--DYNDRG------------NREEEMELPIFD 495
                    +L      +Q +    +++  +  DR             +R +        
Sbjct: 84  EEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYL----- 138

Query: 496 WMAIANATENFSDKNKL---GEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVL 552
              +  A         +   G  G G   K  +      A         Q   + + ++ 
Sbjct: 139 --KLRQALLELRPAKNVLIDGVLGSG---KTWV------ALDVCLSYKVQ--CKMDFKIF 185

Query: 553 LIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGI 612
            +           +  C   +  + +        L   ++ +      +W+ R      I
Sbjct: 186 WLN----------LKNCNSPETVLEM--------LQKLLYQIDP----NWTSRSDHSSNI 223

Query: 613 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID-QT------EANT 665
              +  +  + R  +  +  +   ++L N  N K        AF +  +       +  T
Sbjct: 224 KLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKA-----WNAFNLSCKILLTTRFKQVT 278

Query: 666 NRVVG-TYGYMPPEYAIDGLFSVKS-DVFS--FGV--------------LVLEIVCGKRN 707
           + +   T  ++  ++    L   +   +                       L I+  +  
Sbjct: 279 DFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSII-AESI 337

Query: 708 RGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLS--EVLRC-IQVGLLCVQQRP 764
           R         N     W+    ++   +I  SL     L   E  +   ++ +      P
Sbjct: 338 RD--GLATWDN-----WKHVNCDKLTTIIESSLN---VLEPAEYRKMFDRLSVF-----P 382

Query: 765 EDRPNMSSVVLMLSGERSLPQPKQPGFFTERNPPESGSSSSKRSLL--STNEITISL 819
                 + ++ ++  +             + +     +   K SL+     E TIS+
Sbjct: 383 PSAHIPTILLSLIWFDV-----------IKSDVMVVVNKLHKYSLVEKQPKESTISI 428

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.1 bits (116), Expect = 6e-06
 Identities = 63/395 (15%), Positives = 125/395 (31%), Gaps = 103/395 (26%)

Query: 465 HRKQGKTD-GSSKLDYNDRGNREEEMELPIFDWMAIANATEN-FSDKNKLGEGGFGPVYK 522
           H      + G  +  Y D  +  E+  +  FD   + +  ++  S +             
Sbjct: 3   HHHHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKE----------EID 52

Query: 523 GVLIEGQEIAAKR-----LSKSSGQGMEEFENEVL------LIAKLQHRNLVKLIGCCTQ 571
            +++    ++        L     + +++F  EVL      L++ ++            Q
Sbjct: 53  HIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTE--------QRQ 104

Query: 572 RDERMLIYEYLPNKSLND---FI-FDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI 627
                 +Y    ++  ND   F  ++V+R +             + + LL L     + +
Sbjct: 105 PSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYL---------KLRQALLELRPAKNV-L 154

Query: 628 IHRDL---K---ASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE--- 678
           I   L   K   A +V L  ++  K+ DF +   F ++    N+   V     +      
Sbjct: 155 IDGVLGSGKTWVALDVCLSYKVQCKM-DFKI---FWLNLKNCNSPETV-----LEMLQKL 205

Query: 679 -YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL--LGHAWRLWIEERPVEL 735
            Y ID  ++ +SD  S   L +  +  +  R      + + L  L +             
Sbjct: 206 LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKA----WNA 261

Query: 736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTER 795
            N            L C ++ L  +  R   +     +    +   SL            
Sbjct: 262 FN------------LSC-KI-L--LTTR--FKQVTDFLSAATTTHISL-DHHSMTL---- 298

Query: 796 NPPESGSSSSK----------RSLLSTNEITISLI 820
            P E  S   K          R +L+TN   +S+I
Sbjct: 299 TPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSII 333

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.1 bits (116), Expect = 6e-06
 Identities = 86/658 (13%), Positives = 177/658 (26%), Gaps = 201/658 (30%)

Query: 103 IVWSSNASRTARNPVAVLLESGNLVVKD--GKDIDPD-NFLWQSFDY----PSHILIAGM 155
           I+ S +A          LL     +V+    + +  +  FL          PS +     
Sbjct: 54  IIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTR--- 110

Query: 156 KLGVNLVTGLNRFISSWKSADDPAQDDYVYGIDPSGVPQAVFR--KGSTIR-----YRAG 208
                       +I          Q D +Y  +       V R      +R      R  
Sbjct: 111 -----------MYIE---------QRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPA 150

Query: 209 SWNGLHWTGMP------------------QLQPNPVY--TFEYVSNENEVFYRFNLIKSS 248
               +   G+                         ++    +  ++   V      +   
Sbjct: 151 KNVLID--GVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQ 208

Query: 249 VPSMMVMNPLGD---PQRLTWMEQ----TQKWAPFVPFSGLILDQCDNYALCGAYAVCNM 301
           +                R+  ++       K  P+     L+L   +         V N 
Sbjct: 209 IDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY-ENCLLVLL--N---------VQNA 256

Query: 302 NSNSA---KCECLEGFVPKSPSEWDLLDKSDGCVRRTQLDCEH-GDGFLKRESVKLPDTR 357
            + +A    C+ L     +     D L  +      T +  +H        E   L    
Sbjct: 257 KAWNAFNLSCKIL--LTTRFKQVTDFLSAA----TTTHISLDHHSMTLTPDEVKSL---- 306

Query: 358 FSL-VDNKISLLECKELCSKN---CSCTAYANADVRGGGSGCLLW-FHDLIDMKELSESG 412
               +D +   L  +E+ + N    S  A     +R G +    W     ++  +L+   
Sbjct: 307 LLKYLDCRPQDLP-REVLTTNPRRLSIIA---ESIRDGLA---TWDNWKHVNCDKLTTI- 358

Query: 413 QDLFVRMAASELDDIERKKPKKKKKVAIVITSVLLVTGVILLGGFVYLWKRRHRKQGKTD 472
               +  + + L+  E +  K   ++++   S  + T ++ L     +W           
Sbjct: 359 ----IESSLNVLEPAEYR--KMFDRLSVFPPSAHIPTILLSL-----IW----------- 396

Query: 473 GSSKLDYNDRGNREEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIA 532
                      +  +       D M + N    +S                 L+E Q   
Sbjct: 397 ----------FDVIKS------DVMVVVNKLHKYS-----------------LVEKQ--- 420

Query: 533 AKRLSKSSGQGMEEFENEVLLIAKLQHRNLV---KLIGCCTQRD-----ERMLIYEYLP- 583
            K  + S      E + ++     L HR++V    +       D          Y ++  
Sbjct: 421 PKESTISIPSIYLELKVKLENEYAL-HRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH 479

Query: 584 --NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDL--KASNVLL 639
                 +     + R  FLD+               +L Q    +I H      AS  +L
Sbjct: 480 HLKNIEHPERMTLFRMVFLDFR--------------FLEQ----KIRHDSTAWNASGSIL 521

Query: 640 DNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVL 697
           +      +      + + I   +    R+V       P+   + + S  +D+    ++
Sbjct: 522 NT-----LQQLKFYKPY-ICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALM 573

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110

 Score = 49.5 bits (118), Expect = 1e-07
 Identities = 21/115 (18%), Positives = 40/115 (34%), Gaps = 16/115 (13%)

Query: 14  TATARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANR 73
                + L  GQ +     L + N   +L            L ++  K       W +N 
Sbjct: 2   IPFTNNLLFSGQVLYGDGRLTAKN--HQLVMQGDCN-----LVLYGGKY-----GWQSNT 49

Query: 74  DAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVV 128
               +     L ++ +G   L++ +     +WSS +S      V +L + G  V+
Sbjct: 50  HG--NGEHCFLRLNHKGE--LIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVI 100

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110

 Score = 39.8 bits (93), Expect = 3e-04
 Identities = 17/72 (23%), Positives = 25/72 (34%), Gaps = 8/72 (11%)

Query: 72  NRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDG 131
             D  L+ ++  L +    N  LVL        W SN      +    L   G L++KD 
Sbjct: 16  YGDGRLTAKNHQLVMQGDCN--LVLYGGK--YGWQSNTHGNGEHCFLRLNHKGELIIKDD 71

Query: 132 KDIDPDNFLWQS 143
                   +W S
Sbjct: 72  D----FKTIWSS 79

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276

 Score = 51.6 bits (122), Expect = 3e-07
 Identities = 35/171 (20%), Positives = 60/171 (35%), Gaps = 22/171 (12%)

Query: 14  TATARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANR 73
                  L   Q++  G+ L+S N+ F+L     G      L I      NG  +WVAN 
Sbjct: 10  NGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGN-----LVIQD----NGATVWVANE 60

Query: 74  DAP----LSDRSGALNISSQGNATLVLLNSTNGIVWSS-----NASRTARNPVAVLLESG 124
             P    +  R+    ++        L + +   VW +      ++        VL + G
Sbjct: 61  QQPFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDG 120

Query: 125 NLVVKDGKDI--DPDNFLWQSFDYPSHILIAGMKL--GVNLVTGLNRFISS 171
           N+V+ D   +               S +L  G +L  GV    G ++ +  
Sbjct: 121 NIVLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQ 171

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276

 Score = 48.1 bits (113), Expect = 4e-06
 Identities = 21/86 (24%), Positives = 36/86 (41%), Gaps = 12/86 (13%)

Query: 63  GNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLE 122
            NG   W A      +   GA+    QG+  LV+  + N ++W S+    A + V  L  
Sbjct: 181 PNGAATWNAG-----TQGKGAVRAVFQGDGNLVVYGAGNAVLWHSHTGGHA-SAVLRLQA 234

Query: 123 SGNLVVKDGKDIDPDNFLWQSFDYPS 148
           +G++ + D K +      W  F +  
Sbjct: 235 NGSIAILDEKPV------WARFGFQP 254

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 50.7 bits (121), Expect = 1e-06
 Identities = 48/271 (17%), Positives = 77/271 (28%), Gaps = 100/271 (36%)

Query: 590 FIFDVTRSKFLDWSKRC-----------QIIGGIARGLLYLHQDSRLRIIHRDLKASNVL 638
            +F+V     L W  +            +II  + +GL YLH  ++ RIIH D+K  N+L
Sbjct: 122 MVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENIL 179

Query: 639 LDNE-------------------------------------------------MNPKISD 649
           L                                                    +  KI+D
Sbjct: 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIAD 239

Query: 650 FGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR--- 706
            G A       TE      + T  Y   E  I   ++  +D++S   +  E+  G     
Sbjct: 240 LGNACWVHKHFTE-----DIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFE 294

Query: 707 ---NRGFYHADHH----HNLLG----HAWRLWIEERPV------ELINKSLGGSYSLSEV 749
                 +   + H      LLG           +          +L + +    + L EV
Sbjct: 295 PHSGEEYTRDEDHIALIIELLGKVPRKLIVAG-KYSKEFFTKKGDLKHITKLKPWGLFEV 353

Query: 750 LR------------CIQVGLLCVQQRPEDRP 768
           L                  L  ++  PE R 
Sbjct: 354 LVEKYEWSQEEAAGFTDFLLPMLELIPEKRA 384

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 38/212 (17%)

Query: 512 LGEGGFGPVYKGV-LIEGQEIAAKRL---SKSSGQGMEEFENEVLLIAKLQHR------N 561
           +G+G FG V K       Q +A K +    +   Q  EE    + ++  L+ +      N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE----IRILEHLRKQDKDNTMN 160

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWS-KRCQIIGG-IARGLLYL 619
           ++ ++   T R+   + +E L + +L + I    ++KF  +S    +     I + L  L
Sbjct: 161 VIHMLENFTFRNHICMTFELL-SMNLYELI---KKNKFQGFSLPLVRKFAHSILQCLDAL 216

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGIDQTEANTNRVVGTY----G 673
           H   + RIIH DLK  N+LL  +     K+ DFG +            ++ V TY     
Sbjct: 217 H---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---------CYEHQRVYTYIQSRF 264

Query: 674 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
           Y  PE  +   + +  D++S G ++ E++ G 
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236

 Score = 41.1 bits (95), Expect = 8e-04
 Identities = 18/65 (27%), Positives = 26/65 (40%), Gaps = 4/65 (6%)

Query: 64  NGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLES 123
               +W  N     +     L    Q N  + +L + N  VW+S  SR+A   V VL   
Sbjct: 167 RDDRVWSTNTAGKGTGCRAVL----QPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPD 222

Query: 124 GNLVV 128
            NL +
Sbjct: 223 RNLAI 227

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	823
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.98
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.9
4h3o_A	105	Lectin; cadmium, plant protein; 2.17A {Allium sati	99.85
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.84
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	99.83
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	99.83
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	99.81
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	99.79
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	99.75
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.71
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	99.7
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	99.68
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	99.64
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	99.61
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	99.59
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.56
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	99.52
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	99.5
3mez_A	111	Mannose-specific lectin 3 chain 1; heterotetramer,	99.49
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	99.23
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.19
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	99.18
3mez_A	111	Mannose-specific lectin 3 chain 1; heterotetramer,	99.17
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	99.03
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	98.98
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	98.98
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.98
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.86
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.71
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	98.63
4h3o_A	105	Lectin; cadmium, plant protein; 2.17A {Allium sati	98.62
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.37
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.32
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.15
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.13
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.11
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.08
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.73
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.71
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.55
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.54
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.28
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.97
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.96
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.88
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.84
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.83
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.77
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.63
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.27
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.99
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.76
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	95.39
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.34
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	91.35
3no2_A	276	Uncharacterized protein; six-bladed beta-propeller	90.89
3no2_A	276	Uncharacterized protein; six-bladed beta-propeller	82.98
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	80.79

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.4e-51  Score=445.57  Aligned_cols=261  Identities=26%  Similarity=0.399  Sum_probs=207.6

Q ss_pred             cCCCcCCeeeccCccceEEEEee------cCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~------~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      ++|...++||+|+||.||+|++.      +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45667789999999999999864      377899999988777777889999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCC------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCc
Q 003391          578 IYEYLPNKSLNDFIFDVTR------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP  645 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  645 (823)
                      |||||++|+|.++|+....            ..+++|.+++.|+.||++||+|||+.+   ||||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            9999999999999965322            246999999999999999999999987   9999999999999999999


Q ss_pred             eeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHH
Q 003391          646 KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAW  724 (823)
Q Consensus       646 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~  724 (823)
                      ||+|||+|+.+.............||+.|||||++.+..++.++|||||||+||||+| |+.||......   .+    .
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~---~~----~  270 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT---EA----I  270 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH---HH----H
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH---HH----H
Confidence            9999999997654444444455789999999999999999999999999999999999 89997533211   11    1


Q ss_pred             HHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCCC
Q 003391          725 RLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL  783 (823)
Q Consensus       725 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~  783 (823)
                      .....+.         ....+.....++.+|+.+||+.||++||||+||+++|+.+...
T Consensus       271 ~~i~~g~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          271 DCITQGR---------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHHHHTC---------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHcCC---------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            1111111         1112223345788999999999999999999999999987543

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.1e-51  Score=440.27  Aligned_cols=259  Identities=28%  Similarity=0.433  Sum_probs=213.6

Q ss_pred             cCCCcCCeeeccCccceEEEEee------cCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~------~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      ++|...++||+|+||.||+|++.      ++..||||+++.......++|.+|++++++++|||||+++|+|.+++..+|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            46777889999999999999874      367899999987777777889999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccC----------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCcee
Q 003391          578 IYEYLPNKSLNDFIFDVT----------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI  647 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl  647 (823)
                      |||||++|+|.++|....          ....++|.+++.|+.||++||+|||+.+   ||||||||+||||++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            999999999999996532          2356999999999999999999999987   999999999999999999999


Q ss_pred             eccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHH
Q 003391          648 SDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRL  726 (823)
Q Consensus       648 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~  726 (823)
                      +|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||......   .+    ...
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~---~~----~~~  242 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EV----IEC  242 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HH----HHH
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HH----HHH
Confidence            99999987654443334444679999999999999999999999999999999999 89997543211   11    111


Q ss_pred             hhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          727 WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       727 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      ...+..         ...+.....++.+|+.+||+.||++||||+||++.|+.+.
T Consensus       243 i~~~~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~  288 (299)
T 4asz_A          243 ITQGRV---------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA  288 (299)
T ss_dssp             HHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            111111         1122233457889999999999999999999999998753

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3.3e-51  Score=438.56  Aligned_cols=259  Identities=27%  Similarity=0.422  Sum_probs=211.5

Q ss_pred             CCCcCCeeeccCccceEEEEee------cCcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      .++..++||+|+||.||+|++.      +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+.+..+|
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            3455679999999999999973      36789999997653 3456789999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCC-------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCC
Q 003391          578 IYEYLPNKSLNDFIFDVTR-------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN  644 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~  644 (823)
                      |||||++|+|.++|.....             ...++|..+++|+.|||+||+|||+.+   ||||||||+||||++++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence            9999999999999964321             235899999999999999999999987   999999999999999999


Q ss_pred             ceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHH
Q 003391          645 PKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHA  723 (823)
Q Consensus       645 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~  723 (823)
                      +||+|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |+.||......   .+.   
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~---~~~---  257 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVV---  257 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH---HHH---
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH---HHH---
Confidence            99999999997654444444455789999999999999999999999999999999998 89997533211   111   


Q ss_pred             HHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCC
Q 003391          724 WRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  782 (823)
Q Consensus       724 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  782 (823)
                       .....+         .....+...+..+.+|+.+||+.||++||||+||++.|+....
T Consensus       258 -~~i~~~---------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n  306 (308)
T 4gt4_A          258 -EMIRNR---------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN  306 (308)
T ss_dssp             -HHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred             -HHHHcC---------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence             111111         1112233345678899999999999999999999999986543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-50  Score=429.92  Aligned_cols=259  Identities=24%  Similarity=0.381  Sum_probs=201.0

Q ss_pred             cCCCcCCeeeccCccceEEEEeecCcEEEEEEecCC--ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      +++...++||+|+||+||+|++.  ..||||+++..  ..+..++|.+|+.++++++|||||+++|++.+ +..+|||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy  112 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW  112 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence            56777889999999999999874  36999998654  33456789999999999999999999999865 568999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      |++|+|.++|..  ....++|..+..|+.||++||+|||+.+   ||||||||+||||++++.+||+|||+|+.......
T Consensus       113 ~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          113 CEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             CSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             CCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            999999999964  3346999999999999999999999987   99999999999999999999999999987654333


Q ss_pred             ccccccccccCCccCcccccc---CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          662 EANTNRVVGTYGYMPPEYAID---GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~---~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                      .......+||+.|||||++.+   .+|+.++|||||||+||||+||+.||.......      ...........    .+
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~~~----~p  257 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRGYA----SP  257 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTTCC----CC
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCC----CC
Confidence            344455789999999999964   468999999999999999999999985332110      11111111100    00


Q ss_pred             hcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       739 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      .+ ..........+.+|+.+||+.||++||||+||++.|+.+.
T Consensus       258 ~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~  299 (307)
T 3omv_A          258 DL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ  299 (307)
T ss_dssp             CS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred             Cc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            00 0112223457889999999999999999999999998764

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=5.5e-49  Score=428.68  Aligned_cols=270  Identities=26%  Similarity=0.365  Sum_probs=217.3

Q ss_pred             cCHHHHHHHhcCCCcCCeeeccCccceEEEEeec------CcEEEEEEecCCcc-ccHHHHHHHHHHHhccCC-CCceeE
Q 003391          494 FDWMAIANATENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQH-RNLVKL  565 (823)
Q Consensus       494 ~~~~~l~~~~~~~~~~~~LG~G~fg~Vyk~~~~~------~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H-~niv~l  565 (823)
                      ++..+.+...++|+..++||+|+||.||+|++..      ++.||||++..... ...++|.+|+.+|.+++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            3444455566889999999999999999999754      35799999976543 345679999999999965 999999


Q ss_pred             EEEeecC-CceEEEEeecCCCCcchhhhccCC-------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecc
Q 003391          566 IGCCTQR-DERMLIYEYLPNKSLNDFIFDVTR-------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRD  631 (823)
Q Consensus       566 ~g~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~D  631 (823)
                      +|+|.+. +..+||||||++|+|.++|+....             ...++|..++.++.|||+||+|||+.+   |||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence            9999764 568999999999999999965321             345899999999999999999999998   99999


Q ss_pred             cCCCcEEEcCCCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCC
Q 003391          632 LKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGF  710 (823)
Q Consensus       632 lk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~  710 (823)
                      |||+|||+++++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||+||||+| |+.||..
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999998755544444555789999999999999999999999999999999998 8999854


Q ss_pred             cCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          711 YHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       711 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      .....      ........+.         ....+.....++.+++.+||+.||++|||++||++.|+.+.
T Consensus       291 ~~~~~------~~~~~i~~g~---------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll  346 (353)
T 4ase_A          291 VKIDE------EFCRRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  346 (353)
T ss_dssp             CCCSH------HHHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCHHH------HHHHHHHcCC---------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            32211      1111111111         11122223356789999999999999999999999998653

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.1e-48  Score=422.91  Aligned_cols=250  Identities=23%  Similarity=0.343  Sum_probs=200.5

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      ++|++.++||+|+||.||+|++.. ++.||||++.+..  ....+.+.+|+.++++++|||||++++++.+.+..+||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            689999999999999999999864 8999999997653  3345679999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |+++|+|.++|.. .+...+++..++.|+.||+.||+|||+.+   ||||||||+||||++++.+||+|||+|+.+... 
T Consensus       104 y~~gg~L~~~i~~-~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-  178 (350)
T 4b9d_A          104 YCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-  178 (350)
T ss_dssp             CCTTCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred             CCCCCcHHHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence            9999999999954 23445789999999999999999999998   999999999999999999999999999875322 


Q ss_pred             cccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhc
Q 003391          661 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL  740 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l  740 (823)
                       .......+||+.|||||++.+..|+.++|||||||+||||++|+.||.....   ..+...    ......        
T Consensus       179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~~~----i~~~~~--------  242 (350)
T 4b9d_A          179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM---KNLVLK----IISGSF--------  242 (350)
T ss_dssp             -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHH----HHHTCC--------
T ss_pred             -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHH----HHcCCC--------
Confidence             1223346899999999999999999999999999999999999999853211   111111    111111        


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          741 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                       ...+.....++.+|+.+||+.||++|||+.|+++
T Consensus       243 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          243 -PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0111122346788999999999999999999986

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.2e-48  Score=420.06  Aligned_cols=249  Identities=22%  Similarity=0.332  Sum_probs=207.2

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      +.|+..++||+|+||.||+|++.. |+.||||++........+.+.+|+.+|++++|||||++++++.+.+..+|||||+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            568888999999999999999865 8999999998776666778899999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  662 (823)
                      ++|+|.+++..    ..+++..+..++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+.+....  
T Consensus       154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--  224 (346)
T 4fih_A          154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--  224 (346)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--
T ss_pred             CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC--
Confidence            99999998853    35899999999999999999999998   9999999999999999999999999999764332  


Q ss_pred             cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCC
Q 003391          663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG  742 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~  742 (823)
                      ......+||+.|||||++.+..|+.++|||||||+||||++|+.||.....   ....    ..........     +  
T Consensus       225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~----~~i~~~~~~~-----~--  290 (346)
T 4fih_A          225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAM----KMIRDNLPPR-----L--  290 (346)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHH----HHHHHSSCCC-----C--
T ss_pred             CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHH----HHHHcCCCCC-----C--
Confidence            233457899999999999999999999999999999999999999853211   1111    1111111000     0  


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          743 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ........++.+|+.+||+.||++|||++|+++
T Consensus       291 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          291 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            011112246788999999999999999999975

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.3e-48  Score=419.14  Aligned_cols=263  Identities=22%  Similarity=0.287  Sum_probs=200.0

Q ss_pred             cCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCC----ceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD----ERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lV~  579 (823)
                      ++|...++||+|+||.||+|++ .|+.||||+++.... ....++.|+..+.+++|||||+++|+|.+.+    ..+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            3567778999999999999998 689999999965432 2223455677778899999999999998654    579999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcC-----CCceEecccCCCcEEEcCCCCceeeccccce
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS-----RLRIIHRDLKASNVLLDNEMNPKISDFGMAR  654 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  654 (823)
                      |||++|+|.++|..    ..++|..+.+++.|+++||+|||+++     .++||||||||+||||++++++||+|||+|+
T Consensus        81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            99999999999953    35899999999999999999999872     3359999999999999999999999999998


Q ss_pred             ecCCCccc--cccccccccCCccCccccccC------CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccc--------
Q 003391          655 AFGIDQTE--ANTNRVVGTYGYMPPEYAIDG------LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHN--------  718 (823)
Q Consensus       655 ~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~------~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~--------  718 (823)
                      ........  ......+||+.|||||++.+.      .++.++|||||||+||||+||+.|+..........        
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            76443222  223346899999999999764      46789999999999999999998865432211110        


Q ss_pred             hhHHHHHHhhhcCchhhhhhhcCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          719 LLGHAWRLWIEERPVELINKSLGGSY-----SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       719 l~~~~~~~~~~~~~~~~~~~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      ........        +....++...     +.+.+..+.+|+.+||+.||++||||.||+++|+.+
T Consensus       237 ~~~~~~~~--------~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l  295 (303)
T 3hmm_A          237 SVEEMRKV--------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             CHHHHHHH--------HTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             hHHHHHHH--------HhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            00111111        1111122221     234556788999999999999999999999999865

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.1e-48  Score=416.08  Aligned_cols=248  Identities=24%  Similarity=0.320  Sum_probs=208.3

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC---ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ++|++.++||+|+||+||+|++.. ++.||||++.+.   .....+.+.+|++++++++|||||++++++.+.+..+|||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            579999999999999999999865 889999999754   3445678999999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+++|+|.++|..   .+.+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+.+...
T Consensus       112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            99999999999953   345899999999999999999999998   999999999999999999999999999987655


Q ss_pred             ccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                      .........+||+.|||||++.+..|+.++||||+||+||||++|+.||...+   ...+...    .....        
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~----i~~~~--------  250 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EGLIFAK----IIKLE--------  250 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHH----HHHTC--------
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHH----HHcCC--------
Confidence            44455566899999999999999999999999999999999999999985321   1111111    11111        


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 003391          740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV  774 (823)
Q Consensus       740 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl  774 (823)
                      .  .++.....++.+|+.+||+.||++|||++|++
T Consensus       251 ~--~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          251 Y--DFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             C--CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             C--CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence            0  11111123677899999999999999999864

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.5e-48  Score=417.21  Aligned_cols=263  Identities=23%  Similarity=0.274  Sum_probs=207.3

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      +.|...++||+|+||.||+|++.. ++.||||+++....     ..+|+.++++++|||||++++++.+.+..+|||||+
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            457778899999999999999865 89999999975432     247999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCC-CceeeccccceecCCCcc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAFGIDQT  661 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DFGla~~~~~~~~  661 (823)
                      ++|+|.++|..   ...+++..+..++.||+.||+|||+++   ||||||||+||||+.++ .+||+|||+|+.+.....
T Consensus       133 ~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          133 EGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             TTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            99999999954   345999999999999999999999998   99999999999999987 699999999998754322


Q ss_pred             c---cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          662 E---ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       662 ~---~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                      .   ......+||+.|||||++.+..|+.++|||||||+||||++|+.||.......   +.....    ..... .  .
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~i~----~~~~~-~--~  276 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---LCLKIA----SEPPP-I--R  276 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---CHHHHH----HSCCG-G--G
T ss_pred             ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHHH----cCCCC-c--h
Confidence            1   12334689999999999999999999999999999999999999986433222   221111    11110 0  0


Q ss_pred             hcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc----CCCCCCCCCCCC
Q 003391          739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG----ERSLPQPKQPGF  791 (823)
Q Consensus       739 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~----~~~~~~p~~p~~  791 (823)
                      .+    +......+.+++.+||+.||++|||+.|+++.|..    ...+.-|....+
T Consensus       277 ~~----~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~  329 (336)
T 4g3f_A          277 EI----PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY  329 (336)
T ss_dssp             GS----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred             hc----CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence            11    11223467789999999999999999999987754    344555554443

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-47  Score=406.07  Aligned_cols=246  Identities=23%  Similarity=0.360  Sum_probs=194.8

Q ss_pred             CcCCeeeccCccceEEEEeec-CcEEEEEEecCC--ccccHHHHHHHHHHHhccCCCCceeEEEEeec----CCceEEEE
Q 003391          507 SDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ----RDERMLIY  579 (823)
Q Consensus       507 ~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~  579 (823)
                      ...++||+|+||.||+|++.. ++.||+|++...  .....+.|.+|+.++++++|||||++++++.+    .+..+|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            455689999999999999865 889999999654  23345679999999999999999999999865    34579999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcC-CCCceeeccccceecCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-EMNPKISDFGMARAFGI  658 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DFGla~~~~~  658 (823)
                      |||++|+|.++|..   ...+++..+..++.||+.||+|||+++ ++||||||||+||||+. ++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            99999999999954   346899999999999999999999975 35999999999999984 78999999999985422


Q ss_pred             CccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                          ......+||+.|||||++.+ .|+.++|||||||+||||+||+.||.....  .    ...............+. 
T Consensus       185 ----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~--~----~~~~~~i~~~~~~~~~~-  252 (290)
T 3fpq_A          185 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--A----AQIYRRVTSGVKPASFD-  252 (290)
T ss_dssp             ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--H----HHHHHHHTTTCCCGGGG-
T ss_pred             ----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc--H----HHHHHHHHcCCCCCCCC-
Confidence                22345789999999998864 699999999999999999999999853211  1    11111111111111111 


Q ss_pred             hcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       739 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                             .....++.+|+.+||+.||++|||++|+++
T Consensus       253 -------~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          253 -------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   111235778999999999999999999985

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.2e-47  Score=420.96  Aligned_cols=250  Identities=22%  Similarity=0.332  Sum_probs=207.7

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      .+.|+..++||+|+||.||+|++.. |+.||||++........+.+.+|+.+|++++|||||++++++.+.+..+|||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            3568889999999999999999865 899999999877666677899999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      |++|+|.+++..    ..+++..+..++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+.+.... 
T Consensus       230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-  301 (423)
T 4fie_A          230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-  301 (423)
T ss_dssp             CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred             CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence            999999998843    34899999999999999999999998   9999999999999999999999999999764332 


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                       ......+||+.|||||++.+..|+.++|||||||+||||++|+.||.....   ....    ........     ..+.
T Consensus       302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~----~~i~~~~~-----~~~~  368 (423)
T 4fie_A          302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAM----KMIRDNLP-----PRLK  368 (423)
T ss_dssp             -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHH----HHHHHSCC-----CCCS
T ss_pred             -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHH----HHHHcCCC-----CCCc
Confidence             233457899999999999999999999999999999999999999853211   1111    11111110     0011


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          742 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      .  ......++.+|+.+||+.||++|||+.|+++
T Consensus       369 ~--~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          369 N--LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             C--TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             c--cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0  1111246778999999999999999999975

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=8.5e-47  Score=396.19  Aligned_cols=245  Identities=24%  Similarity=0.357  Sum_probs=189.1

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ++|++.+.||+|+||+||+|++.. ++.||+|++.+..   ....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            689999999999999999999754 8999999997642   334567999999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+ +|+|.+++.+   ...+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+|+.....
T Consensus        93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 6799998853   346999999999999999999999998   999999999999999999999999999865322


Q ss_pred             ccccccccccccCCccCccccccCCC-CccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                         ......+||+.|||||++.+..+ +.++||||+||+||||++|+.||....   ...+...    ......      
T Consensus       166 ---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~---~~~~~~~----i~~~~~------  229 (275)
T 3hyh_A          166 ---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES---IPVLFKN----ISNGVY------  229 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHH----HHHTCC------
T ss_pred             ---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC---HHHHHHH----HHcCCC------
Confidence               22334689999999999998876 579999999999999999999985321   1111111    111110      


Q ss_pred             hcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       739 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                          .++.....++.+++.+||+.||++|||++|+++
T Consensus       230 ----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          230 ----TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             ----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                111111246778999999999999999999987

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.4e-47  Score=403.14  Aligned_cols=247  Identities=23%  Similarity=0.274  Sum_probs=194.5

Q ss_pred             cCCCcCCeeeccCccceEEEEee----cCcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLI----EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~----~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      ++|++.+.||+|+||+||+|+..    .++.||+|++++..  .....++.+|+.++++++|||||++++++.+.+..+|
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            56889999999999999999863    26789999997642  2234468899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      ||||+++|+|.++|..   ...+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+|+...
T Consensus       104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            9999999999999954   346899999999999999999999998   9999999999999999999999999998653


Q ss_pred             CCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhh
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN  737 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  737 (823)
                      ...  ......+||+.|||||++.+..|+.++||||+||+||||+||+.||.....   ..+...    .....      
T Consensus       178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~~~----i~~~~------  242 (304)
T 3ubd_A          178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR---KETMTM----ILKAK------  242 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH----HHHCC------
T ss_pred             CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH---HHHHHH----HHcCC------
Confidence            222  233447899999999999999999999999999999999999999853221   111111    11111      


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 003391          738 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNM-----SSVVL  775 (823)
Q Consensus       738 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~  775 (823)
                        .  .++.....++.+|+.+||+.||++|||+     +|+++
T Consensus       243 --~--~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          243 --L--GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             --C--CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             --C--CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence              0  1111122467889999999999999984     56654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.3e-45  Score=394.15  Aligned_cols=248  Identities=24%  Similarity=0.344  Sum_probs=188.2

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc-ccHHHHHHHHHHHhccCCCCceeEEEEeecCC--------
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD--------  573 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--------  573 (823)
                      ++|+..+.||+|+||.||+|++.. ++.||||+++.... ...+.+.+|+.++++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            458888999999999999999764 89999999975543 34567899999999999999999999987544        


Q ss_pred             ----ceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeec
Q 003391          574 ----ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISD  649 (823)
Q Consensus       574 ----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D  649 (823)
                          ..++||||+++|+|.+++.........++..++.++.||++||+|||+++   |+||||||+||||+.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence                36899999999999999965444445677788999999999999999998   99999999999999999999999


Q ss_pred             cccceecCCCccc----------cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccch
Q 003391          650 FGMARAFGIDQTE----------ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL  719 (823)
Q Consensus       650 FGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l  719 (823)
                      ||+|+.+......          ......+||+.|||||++.+..|+.++|||||||+||||++   ||...     ...
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-----~~~  233 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-----MER  233 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-----HHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-----cHH
Confidence            9999876443221          11234579999999999999999999999999999999996   54310     000


Q ss_pred             hHHHHHHhhhcCchhhhhhhcCCCCCH---HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          720 LGHAWRLWIEERPVELINKSLGGSYSL---SEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       720 ~~~~~~~~~~~~~~~~~~~~l~~~~~~---~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ..             .+.......++.   .....+.+++.+||+.||++|||+.|+++
T Consensus       234 ~~-------------~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          234 VR-------------TLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HH-------------HHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HH-------------HHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            00             011111111211   12235678999999999999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.5e-43  Score=384.32  Aligned_cols=284  Identities=36%  Similarity=0.598  Sum_probs=241.3

Q ss_pred             HHHHHhcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          498 AIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       498 ~l~~~~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      ++...+++|...+.||+|+||.||+|++.+++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  112 (321)
T 2qkw_B           33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL  112 (321)
T ss_dssp             CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred             HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            34456789999999999999999999987899999999987777778889999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceec
Q 003391          578 IYEYLPNKSLNDFIFDVTR-SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  656 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  656 (823)
                      ||||+++++|.+++..... ...+++..++.++.||++||+|||+.+   |+||||||+||+++.++.+||+|||+++..
T Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  189 (321)
T 2qkw_B          113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG  189 (321)
T ss_dssp             EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred             EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccccc
Confidence            9999999999999864322 235899999999999999999999988   999999999999999999999999999875


Q ss_pred             CCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          657 GIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       657 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      .............||+.|+|||++.+..++.++||||||+++|||++|+.||....+........+.............+
T Consensus       190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (321)
T 2qkw_B          190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV  269 (321)
T ss_dssp             SSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSS
T ss_pred             ccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhc
Confidence            43333333344578999999999999999999999999999999999999987665555555555444444444445555


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCCCC
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLP  784 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~  784 (823)
                      ++.+......+....+.+++.+|++.||++|||+.|+++.|+.+..+.
T Consensus       270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~  317 (321)
T 2qkw_B          270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ  317 (321)
T ss_dssp             SSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             ChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence            555666667788889999999999999999999999999999775443

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.2e-43  Score=387.04  Aligned_cols=262  Identities=20%  Similarity=0.283  Sum_probs=199.8

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeec------CCc
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ------RDE  574 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~~  574 (823)
                      ++|.+.++||+|+||+||+|++.. |+.||||++....  ....+.+.+|+.+|++++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            578999999999999999999864 8999999997543  2345678899999999999999999998754      357


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccce
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  654 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  654 (823)
                      .+||||||+ |+|.+++.   +...+++..+..++.||+.||.|||+.+   ||||||||+|||++.++.+||+|||+|+
T Consensus       134 ~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             EEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence            899999996 67999884   3456999999999999999999999998   9999999999999999999999999998


Q ss_pred             ecCCCc--cccccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcC
Q 003391          655 AFGIDQ--TEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER  731 (823)
Q Consensus       655 ~~~~~~--~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  731 (823)
                      .+....  ........+||+.|||||++.+. .++.++||||+||++|||++|+.||......+   .+........ ..
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~---~l~~I~~~~g-~p  282 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH---QLQLIMMVLG-TP  282 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH---HHHHHHHHHC-CC
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhcC-CC
Confidence            764322  22234457899999999998875 56999999999999999999999986432211   1111111100 00


Q ss_pred             chhhh-----------hhhcC--CCCCHHH-----HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          732 PVELI-----------NKSLG--GSYSLSE-----VLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       732 ~~~~~-----------~~~l~--~~~~~~~-----~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      .....           ...+.  ...+.+.     ..++.+|+.+||+.||++|||+.|+++.
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            00000           00000  0111111     1367889999999999999999999763

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.7e-42  Score=375.31  Aligned_cols=291  Identities=42%  Similarity=0.678  Sum_probs=239.7

Q ss_pred             ccCccCHHHHHHHhcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCcc-ccHHHHHHHHHHHhccCCCCceeEEEE
Q 003391          490 ELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGC  568 (823)
Q Consensus       490 ~~~~~~~~~l~~~~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~  568 (823)
                      ....++..++....++|...+.||+|+||.||+|++.+++.||+|++..... .....+.+|+.++++++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            3456788999999999999999999999999999987899999999976532 233478999999999999999999999


Q ss_pred             eecCCceEEEEeecCCCCcchhhhccC-CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCcee
Q 003391          569 CTQRDERMLIYEYLPNKSLNDFIFDVT-RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI  647 (823)
Q Consensus       569 ~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl  647 (823)
                      +.+.+..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+...++|+||||||+|||++.++.+||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            999999999999999999999997543 3445999999999999999999999993233999999999999999999999


Q ss_pred             eccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcC--CCCccchhHHHHH
Q 003391          648 SDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYH--ADHHHNLLGHAWR  725 (823)
Q Consensus       648 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~--~~~~~~l~~~~~~  725 (823)
                      +|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||+...  ......+..+...
T Consensus       176 ~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  254 (326)
T 3uim_A          176 GDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG  254 (326)
T ss_dssp             CCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred             ccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence            99999987643322 22333568999999999999999999999999999999999999986322  1122222333323


Q ss_pred             HhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          726 LWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       726 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      ...........+..+......+....+.+++.+|++.||++|||++||+++|++..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence            33334445556666667778888899999999999999999999999999999754

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.1e-42  Score=376.93  Aligned_cols=198  Identities=25%  Similarity=0.364  Sum_probs=170.5

Q ss_pred             HHhcCCCcCCeeeccCccceEEEEee----cCcEEEEEEecCCccccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCce
Q 003391          501 NATENFSDKNKLGEGGFGPVYKGVLI----EGQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDER  575 (823)
Q Consensus       501 ~~~~~~~~~~~LG~G~fg~Vyk~~~~----~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~  575 (823)
                      ...++|++.++||+|+||+||+|+..    .++.||+|++....  ...++.+|++++..+ +|||||++++++.+.++.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            45678999999999999999999864    26789999986543  346788999999998 699999999999999999


Q ss_pred             EEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCC-CCceeeccccce
Q 003391          576 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMAR  654 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DFGla~  654 (823)
                      ++||||+++|+|.+++.      .+++.++..++.||+.||+|||+.+   |+||||||+|||++.+ +.+||+|||+|+
T Consensus        96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~  166 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ  166 (361)
T ss_dssp             EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence            99999999999999882      3889999999999999999999998   9999999999999877 799999999998


Q ss_pred             ecCCCccc--------------------------cccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCC
Q 003391          655 AFGIDQTE--------------------------ANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRN  707 (823)
Q Consensus       655 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p  707 (823)
                      ........                          ......+||+.|||||++.+. .++.++||||+||++|||++|+.|
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P  246 (361)
T 4f9c_A          167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP  246 (361)
T ss_dssp             ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred             ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence            65432110                          112335799999999999876 489999999999999999999999


Q ss_pred             CC
Q 003391          708 RG  709 (823)
Q Consensus       708 ~~  709 (823)
                      |.
T Consensus       247 f~  248 (361)
T 4f9c_A          247 FY  248 (361)
T ss_dssp             SS
T ss_pred             CC
Confidence            84

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A*

Probab=100.00  E-value=1.9e-42  Score=361.87  Aligned_cols=230  Identities=18%  Similarity=0.239  Sum_probs=181.1

Q ss_pred             cccccccccCCCcccCCCeEeeCCCeEEEeeecCCCCCCeEEEEEEeecCCCcEEEeecCCCCCCCC----CCceEEEec
Q 003391           14 TATARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLSDR----SGALNISSQ   89 (823)
Q Consensus        14 ~~~~~~~~~~g~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~giw~~~~~~~~~vW~an~~~p~~~~----~~~l~~~~~   89 (823)
                      ++++.|+|++||+|++|++|+|++|.|+||||.++   ++|+   |+  +.+ +||+|||++|+.++    +++|+|+.|
T Consensus        10 ~~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~   80 (276)
T 3m7h_A           10 NGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPLAFY   80 (276)
T ss_dssp             CCTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCSEEE
T ss_pred             ccccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC--CCC-eEEECCCCCCcCCcccccceEEEEeCC
Confidence            56788999999999999999999999999999543   5677   77  777 99999999999885    789999999


Q ss_pred             CCceEEE--ecCCCCeEEeecCCCC-----CCcceEEEecCCCEEEecCCCCCCCcceeeecCCCcccccccCcccceec
Q 003391           90 GNATLVL--LNSTNGIVWSSNASRT-----ARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVNLV  162 (823)
Q Consensus        90 g~~~l~l--~~~~~~~~w~~~~~~~-----~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqSFd~PTDtlLpgq~l~~~~~  162 (823)
                      |+  |||  .|++|.+||+|+++..     ..+.+|+|+|+|||||++      +.+||||  |||||||||||||.+++
T Consensus        81 G~--Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~------~~~lWqS--~ptdtlLpg~~~~~~l~  150 (276)
T 3m7h_A           81 VQ--YGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD------SLALWNG--TPAIPLVPGAIDSLLLA  150 (276)
T ss_dssp             ES--SSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE------EEEEEES--CTTSCCCCSCTTCEEEC
T ss_pred             Cc--EEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC------CceeeCc--ccccccccccccccccc
Confidence            99  888  7888999999997642     345789999999999997      5689999  99999999999999999


Q ss_pred             cCcceeEEEcccCCCCCCCccEEeeCCCCCCeEEEEcCceeeeecCCCCCceeeccCCCCCCCceEEEEeecCc-eEEEE
Q 003391          163 TGLNRFISSWKSADDPAQDDYVYGIDPSGVPQAVFRKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEYVSNEN-EVFYR  241 (823)
Q Consensus       163 tg~~~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~sg~w~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  241 (823)
                      +|..  |   ++.+||++|.|++.++++|...+ .+++..+||++|+|++...  .-.++...  .+.+.++.. .+.++
T Consensus       151 ~g~~--L---~S~~dps~G~fsl~l~~dGnlvL-y~~~~~~yW~Sgt~~~~~~--~l~l~~dG--nLvl~d~~~~~vWsS  220 (276)
T 3m7h_A          151 PGSE--L---VQGVVYGAGASKLVFQGDGNLVA-YGPNGAATWNAGTQGKGAV--RAVFQGDG--NLVVYGAGNAVLWHS  220 (276)
T ss_dssp             SSEE--E---CTTCEEEETTEEEEECTTSCEEE-ECTTSSEEEECCCTTTTCC--EEEECTTS--CEEEECTTSCEEEEC
T ss_pred             cCcc--c---ccCCCCCCceEEEeecCCceEEE-EeCCCeEEEECCCCCCccE--EEEEcCCC--eEEEEeCCCcEEEEe
Confidence            8865  5   67899999999999999996432 2345689999999975321  11122222  223333332 33333


Q ss_pred             EeecCCCcceeEEEccCCCeeEEEEecccccceeee
Q 003391          242 FNLIKSSVPSMMVMNPLGDPQRLTWMEQTQKWAPFV  277 (823)
Q Consensus       242 ~~~~~~s~~~~~~l~~~G~l~~~~w~~~~~~w~~~~  277 (823)
                      +  .......|++|+.||++++|.|   ...|..++
T Consensus       221 ~--t~~~~~~rl~Ld~dGnLvly~~---~~~Wqsf~  251 (276)
T 3m7h_A          221 H--TGGHASAVLRLQANGSIAILDE---KPVWARFG  251 (276)
T ss_dssp             S--CTTCTTCEEEECTTSCEEEEEE---EEEEESSS
T ss_pred             c--CCCCCCEEEEEcCCccEEEEcC---CCeEEccC
Confidence            2  2233458999999999999999   45787766

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=6.5e-42  Score=397.82  Aligned_cols=253  Identities=21%  Similarity=0.305  Sum_probs=206.7

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      .++|.+.+.||+|+||.||+|++.. |+.||+|++........+.+.+|+.+|++++|||||++++++.+.+..+|||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            3679999999999999999999865 899999999877666677899999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCC--CCceeeccccceecCCC
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE--MNPKISDFGMARAFGID  659 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~--~~~kl~DFGla~~~~~~  659 (823)
                      |++|+|.++|..  +...+++..+..++.||++||.|||+++   |+||||||+|||++.+  +.+||+|||+|+.+...
T Consensus       236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            999999999843  3346899999999999999999999998   9999999999999854  89999999999986433


Q ss_pred             ccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                      .   .....+||+.|||||++.+..|+.++||||+||+||||++|+.||......   .....    ...... .. ...
T Consensus       311 ~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~---~~~~~----i~~~~~-~~-~~~  378 (573)
T 3uto_A          311 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLRN----VKSCDW-NM-DDS  378 (573)
T ss_dssp             S---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHH----HHTTCC-CC-CSG
T ss_pred             C---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHH----HHhCCC-CC-Ccc
Confidence            2   233468999999999999999999999999999999999999998532211   11111    110000 00 000


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       740 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      .....    ..++.+|+.+||+.||++|||+.|+++.
T Consensus       379 ~~~~~----s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          379 AFSGI----SEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             GGTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             cccCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00111    2367789999999999999999999873

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.3e-40  Score=356.80  Aligned_cols=284  Identities=35%  Similarity=0.575  Sum_probs=230.6

Q ss_pred             cccCccCHHHHHHHhcCCCcC------CeeeccCccceEEEEeecCcEEEEEEecCCc----cccHHHHHHHHHHHhccC
Q 003391          489 MELPIFDWMAIANATENFSDK------NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSS----GQGMEEFENEVLLIAKLQ  558 (823)
Q Consensus       489 ~~~~~~~~~~l~~~~~~~~~~------~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~  558 (823)
                      ...+.|++.++..++++|...      ++||+|+||.||+|.. +++.||+|++....    ....+.+.+|+.++++++
T Consensus        10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~   88 (307)
T 2nru_A           10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ   88 (307)
T ss_dssp             -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred             CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence            345678999999999999877      8999999999999987 68899999986532    334677999999999999


Q ss_pred             CCCceeEEEEeecCCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEE
Q 003391          559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVL  638 (823)
Q Consensus       559 H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIl  638 (823)
                      ||||+++++++.+.+..++||||+++++|.+++........+++..++.++.||++||.|||+.+   |+||||||+||+
T Consensus        89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil  165 (307)
T 2nru_A           89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL  165 (307)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred             CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence            99999999999999999999999999999999976555667999999999999999999999998   999999999999


Q ss_pred             EcCCCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccc
Q 003391          639 LDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHN  718 (823)
Q Consensus       639 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~  718 (823)
                      +++++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|+.||........  
T Consensus       166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--  242 (307)
T 2nru_A          166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--  242 (307)
T ss_dssp             ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--
T ss_pred             EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--
Confidence            99999999999999987654333333344678999999998765 589999999999999999999999865433221  


Q ss_pred             hhHHHHHHhhh--cCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          719 LLGHAWRLWIE--ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       719 l~~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                       ..........  ......++..+ ..........+.+++.+|++.+|.+||++++++++|+.+.
T Consensus       243 -~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          243 -LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             -TTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             -HHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence             1111111111  11122222222 2345566778999999999999999999999999998764

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.4e-41  Score=392.05  Aligned_cols=249  Identities=23%  Similarity=0.263  Sum_probs=198.3

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHH---HHHHHHhccCCCCceeEEEEeecCCce
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFE---NEVLLIAKLQHRNLVKLIGCCTQRDER  575 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~---~Ei~~l~~l~H~niv~l~g~~~~~~~~  575 (823)
                      .++|.+.++||+|+||.||+|++.. ++.||+|++.+..   ......+.   .++.+++.++|||||++++++.+.+..
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            4679999999999999999999875 8999999996531   22233333   446677788999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccccee
Q 003391          576 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                      +|||||++||+|.++|..   ...+++..+..++.||+.||+|||+.+   ||||||||+||||+.++.+||+|||+|+.
T Consensus       268 ylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence            999999999999999954   345899999999999999999999998   99999999999999999999999999997


Q ss_pred             cCCCccccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchh
Q 003391          656 FGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE  734 (823)
Q Consensus       656 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  734 (823)
                      +...    .....+||+.|||||++.+ ..|+.++||||+||+||||++|+.||..........+...    ....    
T Consensus       342 ~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~----i~~~----  409 (689)
T 3v5w_A          342 FSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM----TLTM----  409 (689)
T ss_dssp             CSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHH----HHHC----
T ss_pred             cCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh----hcCC----
Confidence            6432    2344789999999999974 5799999999999999999999999864332221111111    0000    


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 003391          735 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPN-----MSSVVL  775 (823)
Q Consensus       735 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  775 (823)
                          .  ..++.....++.+|+.+||+.||++|++     +.||++
T Consensus       410 ----~--~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          410 ----A--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             ----C--CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             ----C--CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence                0  0111112246788999999999999998     577664

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.8e-40  Score=367.31  Aligned_cols=260  Identities=27%  Similarity=0.389  Sum_probs=211.4

Q ss_pred             hcCCCcCCeeeccCccceEEEEee--------cCcEEEEEEecCCc-cccHHHHHHHHHHHhcc-CCCCceeEEEEeecC
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI--------EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQR  572 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~--------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~  572 (823)
                      .++|...+.||+|+||.||+|++.        .+..||+|++.... ....+++.+|+.+++++ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            467888999999999999999864        24579999997653 33456789999999999 899999999999999


Q ss_pred             CceEEEEeecCCCCcchhhhccCC-------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEE
Q 003391          573 DERMLIYEYLPNKSLNDFIFDVTR-------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL  639 (823)
Q Consensus       573 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll  639 (823)
                      +..++||||+++|+|.+++.....             ...+++..++.++.||++||+|||+.+   |+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            999999999999999999965331             235899999999999999999999998   9999999999999


Q ss_pred             cCCCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccc
Q 003391          640 DNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHN  718 (823)
Q Consensus       640 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~  718 (823)
                      +.++.+||+|||+++.+.............+|+.|+|||++.+..++.++||||||+++|||++ |+.||......   .
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---~  313 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---E  313 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---G
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---H
Confidence            9999999999999997654433333444567889999999999999999999999999999999 99987543211   1


Q ss_pred             hhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          719 LLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       719 l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      +..    .....         .....+......+.+++.+||+.+|++||++.|+++.|+.+.
T Consensus       314 ~~~----~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          314 LFK----LLKEG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             HHH----HHHTT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHH----HHhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            111    11111         111122233457889999999999999999999999998753

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=359.17  Aligned_cols=260  Identities=28%  Similarity=0.419  Sum_probs=212.1

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      .++|...++||+|+||.||+|++.. ++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            3578888999999999999999865 889999999777777778899999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++++|.+++...  ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            9999999999642  345899999999999999999999998   99999999999999999999999999987643322


Q ss_pred             cc------------ccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhh
Q 003391          662 EA------------NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE  729 (823)
Q Consensus       662 ~~------------~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  729 (823)
                      ..            ......||+.|+|||++.+..++.++||||||+++|||++|..|+.............        
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~--------  235 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN--------  235 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC--------
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh--------
Confidence            11            1114579999999999999999999999999999999999999876443322211110        


Q ss_pred             cCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          730 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       730 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                        ............    ....+.+++.+|++.||++|||+.|+++.|+.+.
T Consensus       236 --~~~~~~~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~  281 (310)
T 3s95_A          236 --VRGFLDRYCPPN----CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR  281 (310)
T ss_dssp             --HHHHHHHTCCTT----CCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --hhccccccCCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence              011111111111    1235778999999999999999999999998764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=7.5e-41  Score=361.05  Aligned_cols=267  Identities=27%  Similarity=0.401  Sum_probs=203.7

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ..++|.+.++||+|+||.||+|+. .++.||+|++....  ....+++.+|+.++++++||||+++++++.+.+..++||
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            457888999999999999999987 68899999987653  334567899999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+++++|.+++........+++..++.++.||++||+|||+.+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~  192 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST  192 (309)
T ss_dssp             ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred             ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence            99999999999965433345899999999999999999999975 34999999999999999999999999999854322


Q ss_pred             ccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                      .  .......||+.|+|||++.+..++.++||||||+++|||++|+.||.......   ..    ....        ...
T Consensus       193 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---~~----~~~~--------~~~  255 (309)
T 3p86_A          193 F--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ---VV----AAVG--------FKC  255 (309)
T ss_dssp             -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH---HH----HHHH--------HSC
T ss_pred             c--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH----HHHH--------hcC
Confidence            1  22334678999999999999999999999999999999999999975332110   00    0000        000


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCCCCCCC
Q 003391          740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPK  787 (823)
Q Consensus       740 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~p~  787 (823)
                      .....+......+.+++.+||+.+|++|||++|+++.|+.+..-..|+
T Consensus       256 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~  303 (309)
T 3p86_A          256 KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP  303 (309)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred             CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence            011112222346789999999999999999999999999875444433

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=7.3e-41  Score=363.46  Aligned_cols=267  Identities=24%  Similarity=0.338  Sum_probs=208.5

Q ss_pred             hcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCc----eEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE----RMLI  578 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----~~lV  578 (823)
                      .++|...++||+|+||.||+|++ .++.||||++.... .....+..|+.++.+++||||+++++++.+...    .++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            46788899999999999999987 48999999996543 334456779999999999999999999987543    6999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhc----------CCCceEecccCCCcEEEcCCCCceee
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD----------SRLRIIHRDLKASNVLLDNEMNPKIS  648 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------~~~~ivH~Dlk~~NIll~~~~~~kl~  648 (823)
                      |||+++|+|.+++..    ..+++..+..++.||++||+|||+.          +   |+||||||+|||++.++.+||+
T Consensus       101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A          101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred             EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence            999999999999953    3489999999999999999999998          6   9999999999999999999999


Q ss_pred             ccccceecCCCccccccccccccCCccCcccccc-----CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHH
Q 003391          649 DFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID-----GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA  723 (823)
Q Consensus       649 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~  723 (823)
                      |||+++.+.............||+.|+|||++.+     ..++.++||||||+++|||++|+.||...............
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            9999987755444444445679999999999986     35677899999999999999999998654332222111110


Q ss_pred             HHHhhhcCchhhh----hhhcCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          724 WRLWIEERPVELI----NKSLGGSY-----SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       724 ~~~~~~~~~~~~~----~~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                         ........+.    ........     .......+.+++.+||+.||++|||+.||++.|+.+.
T Consensus       254 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~  317 (322)
T 3soc_A          254 ---GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ  317 (322)
T ss_dssp             ---CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence               0000111111    11111111     1234567899999999999999999999999998753

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=5.1e-40  Score=352.54  Aligned_cols=250  Identities=23%  Similarity=0.376  Sum_probs=206.9

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      .++|...++||+|+||.||+|+.. .++.||+|++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            468999999999999999999964 4889999999877666778899999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++++|.+++..    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus        99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            999999999853    34899999999999999999999998   99999999999999999999999999987643322


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                        ......||+.|+|||++.+..++.++||||||+++|||++|+.||......      ............        .
T Consensus       172 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~~--------~  235 (297)
T 3fxz_A          172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTP--------E  235 (297)
T ss_dssp             --CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSC--------C
T ss_pred             --ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC--------C
Confidence              233467999999999999999999999999999999999999997532211      111110000000        0


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          742 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ...+......+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          236 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            0111222346789999999999999999999986

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.3e-39  Score=353.56  Aligned_cols=254  Identities=25%  Similarity=0.328  Sum_probs=203.4

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      .++|+..+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            367899999999999999999986 48899999986543 2334678899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |+++++|.+++.   ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+....
T Consensus        86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            999999999984   3446899999999999999999999998   9999999999999999999999999998765443


Q ss_pred             cccccccccccCCccCccccccCCC-CccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          661 TEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                      .........||+.|+|||++.+..+ +.++||||||+++|||++|+.||........  .    ...+.....       
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~----~~~~~~~~~-------  226 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--E----YSDWKEKKT-------  226 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH--H----HHHHHTTCT-------
T ss_pred             cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH--H----HHHHhcccc-------
Confidence            3344445789999999999988775 7899999999999999999999864332211  0    011111100       


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       740 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                       ...........+.+++.+||+.||++|||+.|+++.
T Consensus       227 -~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          227 -YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             -TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence             000011123466789999999999999999999864

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.7e-40  Score=357.51  Aligned_cols=260  Identities=25%  Similarity=0.376  Sum_probs=207.5

Q ss_pred             hcCCCcCCeeeccCccceEEEEee----cCcEEEEEEecCC-ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI----EGQEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~----~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      .++|.+.+.||+|+||.||+|++.    .+..||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            356788899999999999999985    3456999999765 33445679999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      ||||+++++|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       128 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          128 VTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            9999999999999853  3345899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCccc-cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhh
Q 003391          658 IDQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVEL  735 (823)
Q Consensus       658 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  735 (823)
                      ..... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......   ..    ...         
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~----~~~---------  266 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DV----ISS---------  266 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HH----HHH---------
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HH----HHH---------
Confidence            43221 12223456778999999999999999999999999999999 99997432111   00    011         


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCCC
Q 003391          736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL  783 (823)
Q Consensus       736 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~  783 (823)
                      +........+......+.+++..||+.||++||++.|++++|+.+...
T Consensus       267 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~  314 (325)
T 3kul_A          267 VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS  314 (325)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence            111111112223345788999999999999999999999999987543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.1e-39  Score=350.40  Aligned_cols=262  Identities=24%  Similarity=0.332  Sum_probs=213.0

Q ss_pred             CccCHHHHHHHhcC----------CCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccccHHHHHHHHHHHhccCCC
Q 003391          492 PIFDWMAIANATEN----------FSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR  560 (823)
Q Consensus       492 ~~~~~~~l~~~~~~----------~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~  560 (823)
                      +.++..++..+++.          |...++||+|+||.||+|++. +++.||||++........+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            45677777777654          566679999999999999987 5899999999877777778899999999999999


Q ss_pred             CceeEEEEeecCCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEc
Q 003391          561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD  640 (823)
Q Consensus       561 niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~  640 (823)
                      ||+++++++...+..++||||+++++|.+++.    ...+++..+..++.||++||.|||+.+   |+||||||+|||++
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~  175 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT  175 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence            99999999999999999999999999999884    345899999999999999999999998   99999999999999


Q ss_pred             CCCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchh
Q 003391          641 NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL  720 (823)
Q Consensus       641 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~  720 (823)
                      .++.+||+|||++........  ......||+.|+|||++.+..++.++||||||+++|||++|+.||......      
T Consensus       176 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~------  247 (321)
T 2c30_A          176 LDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV------  247 (321)
T ss_dssp             TTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------
T ss_pred             CCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------
Confidence            999999999999987643322  223467999999999999999999999999999999999999997532110      


Q ss_pred             HHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          721 GHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       721 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                       .............     +  .........+.+++.+||+.||++|||+.|+++.
T Consensus       248 -~~~~~~~~~~~~~-----~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          248 -QAMKRLRDSPPPK-----L--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             -HHHHHHHHSSCCC-----C--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             -HHHHHHhcCCCCC-----c--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0111111111100     0  0011122467889999999999999999999863

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.6e-40  Score=365.20  Aligned_cols=274  Identities=26%  Similarity=0.383  Sum_probs=216.2

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec--------CcEEEEEEecCCc-cccHHHHHHHHHHHhcc-CCCCceeEEEEeecC
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE--------GQEIAAKRLSKSS-GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQR  572 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~--------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~  572 (823)
                      .++|...++||+|+||.||+|++..        +..||+|++.... ....+++.+|+++++++ +||||+++++++.+.
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            4678889999999999999999642        3579999997653 33456789999999999 999999999999999


Q ss_pred             CceEEEEeecCCCCcchhhhccCC-------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEE
Q 003391          573 DERMLIYEYLPNKSLNDFIFDVTR-------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL  639 (823)
Q Consensus       573 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll  639 (823)
                      +..++||||+++|+|.+++.....             ...+++..++.++.||+.||+|||+.+   |+||||||+|||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence            999999999999999999965331             245899999999999999999999998   9999999999999


Q ss_pred             cCCCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccc
Q 003391          640 DNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHN  718 (823)
Q Consensus       640 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~  718 (823)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+......    
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~----  300 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----  300 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----
Confidence            9999999999999987654433334444567889999999999999999999999999999999 99987532211    


Q ss_pred             hhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCCCCCCCCCCCcccC
Q 003391          719 LLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTER  795 (823)
Q Consensus       719 l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~p~~p~~~~~~  795 (823)
                         .........         .....+.....++.+++.+||+.+|++||+++||++.|+.+..........++...
T Consensus       301 ---~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~  365 (382)
T 3tt0_A          301 ---ELFKLLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYYHHH  365 (382)
T ss_dssp             ---HHHHHHHTT---------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC-------
T ss_pred             ---HHHHHHHcC---------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCCCCcc
Confidence               111111111         11112222335688999999999999999999999999988766555555554433

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.4e-40  Score=367.39  Aligned_cols=257  Identities=26%  Similarity=0.369  Sum_probs=207.7

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCcc-ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      .++|...+.||+|+||.||+|++. +++.||||++..... ...++|.+|+.++++++||||+++++++.+.+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            467888899999999999999986 588999999875532 234568899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |+++|+|.+++..  ....+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       193 ~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          193 LVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV  267 (377)
T ss_dssp             CCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred             cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence            9999999999954  2345899999999999999999999998   9999999999999999999999999998654332


Q ss_pred             cccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          661 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                      .........++..|+|||.+.+..++.++||||||+++|||++ |+.|+.......       ...         .+...
T Consensus       268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-------~~~---------~~~~~  331 (377)
T 3cbl_A          268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-------TRE---------FVEKG  331 (377)
T ss_dssp             EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-------HHH---------HHHTT
T ss_pred             eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHH---------HHHcC
Confidence            2222222345778999999999999999999999999999998 888875332110       011         11111


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       740 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      .....+......+.+++.+||+.||++|||++++++.|+.+
T Consensus       332 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  372 (377)
T 3cbl_A          332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI  372 (377)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            11112222335678999999999999999999999999865

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=4.3e-40  Score=362.83  Aligned_cols=269  Identities=26%  Similarity=0.372  Sum_probs=213.9

Q ss_pred             cCHHHHHHHhcCCCcCCeeeccCccceEEEEee------cCcEEEEEEecCCcc-ccHHHHHHHHHHHhcc-CCCCceeE
Q 003391          494 FDWMAIANATENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSSG-QGMEEFENEVLLIAKL-QHRNLVKL  565 (823)
Q Consensus       494 ~~~~~l~~~~~~~~~~~~LG~G~fg~Vyk~~~~------~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l  565 (823)
                      +.........++|...+.||+|+||.||+|++.      .++.||||++..... ...+.+.+|++++.++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            445556667789999999999999999999843      257899999976533 3456799999999999 79999999


Q ss_pred             EEEeecCC-ceEEEEeecCCCCcchhhhccCC------------------------------------------------
Q 003391          566 IGCCTQRD-ERMLIYEYLPNKSLNDFIFDVTR------------------------------------------------  596 (823)
Q Consensus       566 ~g~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------  596 (823)
                      ++++.+.+ ..++||||+++|+|.+++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            99998765 48999999999999999965332                                                


Q ss_pred             ---------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          597 ---------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       597 ---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                                     ...+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.....
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                           122899999999999999999999998   99999999999999999999999999987644433


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhc
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL  740 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l  740 (823)
                      ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||.......      .........         .
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~~---------~  313 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEG---------T  313 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHHT---------C
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHHHHcC---------C
Confidence            334445678899999999999999999999999999999998 999975432211      111111111         1


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          741 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      ....+.....++.+++..|++.||++|||+.|+++.|+.+
T Consensus       314 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  353 (359)
T 3vhe_A          314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  353 (359)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            1111122234678899999999999999999999999865

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=9.6e-40  Score=344.98  Aligned_cols=255  Identities=27%  Similarity=0.394  Sum_probs=208.5

Q ss_pred             cCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecC
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP  583 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (823)
                      ++|...+.||+|+||.||+|++.+++.||+|++.... ...+++.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            5688889999999999999999889999999997543 345789999999999999999999999999999999999999


Q ss_pred             CCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccc
Q 003391          584 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA  663 (823)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  663 (823)
                      +++|.+++..  ....+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++...... ..
T Consensus        89 ~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  162 (269)
T 4hcu_A           89 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT  162 (269)
T ss_dssp             TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred             CCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc-cc
Confidence            9999999853  3346899999999999999999999998   9999999999999999999999999998654322 12


Q ss_pred             ccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCC
Q 003391          664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG  742 (823)
Q Consensus       664 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~  742 (823)
                      ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......   ..    .......         ...
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~---~~----~~~~~~~---------~~~  226 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EV----VEDISTG---------FRL  226 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HH----HHHHHTT---------CCC
T ss_pred             cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH---HH----HHHHhcC---------ccC
Confidence            2233556788999999999999999999999999999999 89887532211   01    1111110         111


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          743 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      ..+......+.+++..|++.+|++||+++|+++.|+.+.
T Consensus       227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~  265 (269)
T 4hcu_A          227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  265 (269)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence            111122346789999999999999999999999998653

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=5.1e-40  Score=357.61  Aligned_cols=256  Identities=25%  Similarity=0.435  Sum_probs=201.4

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-Cc----EEEEEEecCC-ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQ----EIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~----~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      ++|+..++||+|+||.||+|++.. ++    .||+|++... .....+++.+|+.++++++||||+++++++.+.. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            568888999999999999999754 33    3688887544 3456678999999999999999999999998754 789


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      |+||+++|+|.+++...  ...+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        94 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             EEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            99999999999999642  345899999999999999999999998   9999999999999999999999999998775


Q ss_pred             CCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      ............+|+.|+|||++.+..++.++||||||+++|||++ |+.||.......   +             ...+
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~-------------~~~~  232 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---I-------------SSIL  232 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---H-------------HHHH
T ss_pred             CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---H-------------HHHH
Confidence            4444333444567889999999999999999999999999999999 999975432211   1             1111


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      ........+.....++.+++.+||+.+|++||+++|+++.|+.+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~  277 (327)
T 3poz_A          233 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  277 (327)
T ss_dssp             HTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred             HcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            111111222233457889999999999999999999999997653

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2e-39  Score=342.19  Aligned_cols=257  Identities=27%  Similarity=0.372  Sum_probs=209.7

Q ss_pred             hcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      .++|+..+.||+|+||.||+|...++..||+|++.... ...+++.+|+.++.+++||||+++++++.+....++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            46788889999999999999998888899999996543 34577999999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  662 (823)
                      ++++|.+++...  ...+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++.........
T Consensus        86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred             CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence            999999998542  345899999999999999999999998   999999999999999999999999999876433222


Q ss_pred             cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                       ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......       .........         .
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~---------~  223 (268)
T 3sxs_A          161 -SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE-------VVLKVSQGH---------R  223 (268)
T ss_dssp             -ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHHHHTTC---------C
T ss_pred             -cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH-------HHHHHHcCC---------C
Confidence             2223456778999999999899999999999999999999 999975322110       000001000         0


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCC
Q 003391          742 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  782 (823)
Q Consensus       742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  782 (823)
                      ...+......+.+++..|++.+|++|||+.|+++.|+.+..
T Consensus       224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          224 LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence            01111122467899999999999999999999999998764

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.6e-40  Score=355.92  Aligned_cols=274  Identities=27%  Similarity=0.377  Sum_probs=205.6

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-----cCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecC--Cce
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-----EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR--DER  575 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-----~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~  575 (823)
                      .++|+..++||+|+||.||+|++.     .++.||+|++........+.+.+|+.++++++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            367888999999999999999842     4889999999877766778899999999999999999999998654  558


Q ss_pred             EEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccccee
Q 003391          576 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                      ++||||+++++|.+++...  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            9999999999999999543  235899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCccc-cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchh
Q 003391          656 FGIDQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE  734 (823)
Q Consensus       656 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  734 (823)
                      ....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+.........................+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  243 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence            6433221 122234567789999999999999999999999999999999988643211000000000000000000011


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          735 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       735 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      .+........+.....++.+++.+||+.||++|||++|+++.|+.+.
T Consensus       244 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~  290 (295)
T 3ugc_A          244 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  290 (295)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            11111112222333457889999999999999999999999998753

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=8.8e-40  Score=362.07  Aligned_cols=258  Identities=26%  Similarity=0.413  Sum_probs=197.4

Q ss_pred             hcCCCcCCeeeccCccceEEEEee----cCcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI----EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~----~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      .++|...+.||+|+||.||+|++.    .+..||||++.... ....++|.+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            357889999999999999999975    46789999997653 3445679999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      ||||+++++|.+++..  ....+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       124 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          124 VTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            9999999999999953  3346899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCcccc-ccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhh
Q 003391          658 IDQTEA-NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVEL  735 (823)
Q Consensus       658 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  735 (823)
                      ...... ......++..|+|||++.+..++.++||||||+++|||++ |+.||......   ..    .         ..
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~---~~----~---------~~  262 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---DV----I---------KA  262 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---HH----H---------HH
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HH----H---------HH
Confidence            332211 1222345778999999999999999999999999999998 99997432211   00    0         11


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       736 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      +........+......+.+++.+|++.+|++||++.||+++|+.+.
T Consensus       263 i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~  308 (373)
T 2qol_A          263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI  308 (373)
T ss_dssp             HHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence            1111111222233457889999999999999999999999998763

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.9e-39  Score=350.54  Aligned_cols=259  Identities=27%  Similarity=0.399  Sum_probs=211.0

Q ss_pred             hcCCCcCCeeeccCccceEEEEee------cCcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCce
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDER  575 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~  575 (823)
                      .++|...+.||+|+||.||+|+..      +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            467888999999999999999873      24789999997643 34456789999999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhccCC---------------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCC
Q 003391          576 MLIYEYLPNKSLNDFIFDVTR---------------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKA  634 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~  634 (823)
                      ++||||+++++|.+++.....                     ...+++..++.++.||++||.|||+.+   |+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence            999999999999999975432                     234899999999999999999999998   99999999


Q ss_pred             CcEEEcCCCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCC
Q 003391          635 SNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHA  713 (823)
Q Consensus       635 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~  713 (823)
                      +||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987654433333344567889999999999999999999999999999999 9999754322


Q ss_pred             CCccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          714 DHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       714 ~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      ..   +.    ......         .....+......+.+++.+|++.||++||++.|+++.|+.+
T Consensus       259 ~~---~~----~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~  309 (314)
T 2ivs_A          259 ER---LF----NLLKTG---------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM  309 (314)
T ss_dssp             GG---HH----HHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HH---HH----HHhhcC---------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            11   11    111111         11112222335688999999999999999999999999865

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-39  Score=354.47  Aligned_cols=263  Identities=25%  Similarity=0.398  Sum_probs=211.9

Q ss_pred             HHhcCCCcCCeeeccCccceEEEEeec------CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCC
Q 003391          501 NATENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD  573 (823)
Q Consensus       501 ~~~~~~~~~~~LG~G~fg~Vyk~~~~~------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~  573 (823)
                      ...++|...+.||+|+||.||+|++..      ++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            346789999999999999999999853      3789999997653 334567899999999999999999999999999


Q ss_pred             ceEEEEeecCCCCcchhhhccCC---------------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEeccc
Q 003391          574 ERMLIYEYLPNKSLNDFIFDVTR---------------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDL  632 (823)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dl  632 (823)
                      ..++||||+++++|.+++.....                     ...+++..++.++.||++||.|||+.+   |+||||
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl  200 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL  200 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence            99999999999999999965321                     156899999999999999999999998   999999


Q ss_pred             CCCcEEEcCCCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCc
Q 003391          633 KASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFY  711 (823)
Q Consensus       633 k~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~  711 (823)
                      ||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            99999999999999999999987643333233344567889999999999999999999999999999999 99887532


Q ss_pred             CCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCC
Q 003391          712 HADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  782 (823)
Q Consensus       712 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  782 (823)
                      ...       ...........         ...+......+.+++.+||+.+|++||++.++++.|+.+..
T Consensus       281 ~~~-------~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          281 AHE-------EVIYYVRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             CHH-------HHHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ChH-------HHHHHHhCCCc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            110       11111111110         11122223468899999999999999999999999998753

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.8e-39  Score=369.28  Aligned_cols=258  Identities=28%  Similarity=0.416  Sum_probs=209.5

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      ..++|...++||+|+||.||+|++.++..||||++.... ...++|.+|+.++++++||||+++++++. .+..++||||
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~  263 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF  263 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred             chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence            456788889999999999999999888999999997644 45788999999999999999999999987 5678999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++|+|.+++... ....+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus       264 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~  339 (454)
T 1qcf_A          264 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  339 (454)
T ss_dssp             CTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred             cCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence            9999999999532 1235788999999999999999999998   99999999999999999999999999987543211


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhc
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL  740 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l  740 (823)
                       .......+|..|+|||++....++.++||||||++||||++ |+.||......   ...    .....         ..
T Consensus       340 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~----~~i~~---------~~  402 (454)
T 1qcf_A          340 -TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVI----RALER---------GY  402 (454)
T ss_dssp             -HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHH----HHHHH---------TC
T ss_pred             -eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHc---------CC
Confidence             11223456788999999999999999999999999999999 99997532211   111    11111         11


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCC
Q 003391          741 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  782 (823)
Q Consensus       741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  782 (823)
                      ....+......+.+++.+||+.||++|||+.+|+++|+.+..
T Consensus       403 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          403 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence            111122234578899999999999999999999999998754

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=4e-39  Score=370.18  Aligned_cols=257  Identities=27%  Similarity=0.421  Sum_probs=211.5

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      .++|...++||+|+||.||+|++.. +..||||++.... ...++|.+|+.++++++||||+++++++.+.+..++||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            4567888999999999999999876 8899999996543 3568899999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++|+|.+++... ....+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus       298 ~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  373 (495)
T 1opk_A          298 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY  373 (495)
T ss_dssp             CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred             cCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence            9999999999653 2345899999999999999999999998   99999999999999999999999999987643221


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhc
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL  740 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l  740 (823)
                       .......++..|+|||++.+..++.++||||||++||||++ |+.|+.......   .    .         +.+....
T Consensus       374 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~----~---------~~~~~~~  436 (495)
T 1opk_A          374 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---V----Y---------ELLEKDY  436 (495)
T ss_dssp             -ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---H----H---------HHHHTTC
T ss_pred             -eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---H----H---------HHHHcCC
Confidence             22223456788999999999999999999999999999999 888875432211   1    1         1111111


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          741 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      ....+......+.+|+.+||+.+|++|||+.+++++|+.+.
T Consensus       437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            11222233457889999999999999999999999999864

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.3e-39  Score=352.19  Aligned_cols=248  Identities=25%  Similarity=0.382  Sum_probs=203.5

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCC--ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      .++|...+.||+|+||.||+|++. .++.||+|++...  .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            467899999999999999999984 5899999999654  2344567889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+++++|.+++...   ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        94 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           94 EYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             CCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             ECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            999999999998543   35899999999999999999999998   999999999999999999999999999865432


Q ss_pred             ccccccccccccCCccCccccccCCCC-ccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFS-VKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s-~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                         .......||+.|+|||++.+..+. .++||||||+++|||++|+.||......   .+    ........       
T Consensus       168 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~----~~~i~~~~-------  230 (328)
T 3fe3_A          168 ---GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK---EL----RERVLRGK-------  230 (328)
T ss_dssp             ---CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHCC-------
T ss_pred             ---CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH---HH----HHHHHhCC-------
Confidence               223446799999999999888765 8999999999999999999998532210   01    11111110       


Q ss_pred             hcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       739 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                       .  ..+.....++.+++.+||+.||.+|||+.|+++.
T Consensus       231 -~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          231 -Y--RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             -C--CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             -C--CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence             0  1111123467789999999999999999999864

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=360.15  Aligned_cols=260  Identities=29%  Similarity=0.410  Sum_probs=207.8

Q ss_pred             hcCCCcCCeeeccCccceEEEEee------cCcEEEEEEecCC-ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCce
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDER  575 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~------~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~  575 (823)
                      .++|...++||+|+||.||+|++.      .++.||||++... ......++.+|+.++++++||||+++++++.+....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            357888899999999999999953      3668999999654 334556789999999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhccC----CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCC---Cceee
Q 003391          576 MLIYEYLPNKSLNDFIFDVT----RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM---NPKIS  648 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~  648 (823)
                      ++||||+++|+|.+++....    ....+++..++.++.||++||+|||+.+   |+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999996532    2245899999999999999999999998   99999999999999554   59999


Q ss_pred             ccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHh
Q 003391          649 DFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLW  727 (823)
Q Consensus       649 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~  727 (823)
                      |||+++.+.............+|+.|+|||++.+..++.++||||||+++|||++ |+.||......   .+    ....
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~---~~----~~~i  299 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EV----LEFV  299 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HH----HHHH
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHHH
Confidence            9999986533333333344567899999999999999999999999999999998 98987532211   01    1111


Q ss_pred             hhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          728 IEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       728 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      ...         .....+......+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus       300 ~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          300 TSG---------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             HTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HcC---------CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            111         111112223346789999999999999999999999997653

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.6e-38  Score=349.68  Aligned_cols=246  Identities=23%  Similarity=0.305  Sum_probs=203.5

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc------ccHHHHHHHHHHHhccCCCCceeEEEEeecCCc
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG------QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE  574 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~  574 (823)
                      ..+.|...+.||+|+||.||+++... ++.||+|++.+...      ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            34678899999999999999999865 88999999976532      235789999999999999999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCC----Cceeecc
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM----NPKISDF  650 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~DF  650 (823)
                      .++||||+++|+|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    .+||+||
T Consensus        90 ~~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           90 VVLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            999999999999999984   3456899999999999999999999998   99999999999998877    7999999


Q ss_pred             ccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhc
Q 003391          651 GMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE  730 (823)
Q Consensus       651 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  730 (823)
                      |+++.+...   .......||+.|+|||++.+..++.++||||||+++|||++|+.||.....   ..            
T Consensus       164 G~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~---~~------------  225 (361)
T 2yab_A          164 GLAHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QE------------  225 (361)
T ss_dssp             SSCEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HH------------
T ss_pred             CCceEcCCC---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HH------------
Confidence            999876432   223346799999999999999999999999999999999999999753211   11            


Q ss_pred             CchhhhhhhcCC--CCCHH----HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          731 RPVELINKSLGG--SYSLS----EVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       731 ~~~~~~~~~l~~--~~~~~----~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                          .+......  .++.+    ....+.+++.+||+.||++|||+.|+++
T Consensus       226 ----~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          226 ----TLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             ----HHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ----HHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                11111111  11111    1236788999999999999999999985

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.9e-39  Score=345.43  Aligned_cols=254  Identities=24%  Similarity=0.376  Sum_probs=197.5

Q ss_pred             cCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecC
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP  583 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (823)
                      ++|...+.||+|+||.||+|++ .++.||+|++...  ...+.+.+|+.++++++||||+++++++.+  ..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence            5678889999999999999987 5789999998643  345789999999999999999999999874  5899999999


Q ss_pred             CCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCC-ceeeccccceecCCCccc
Q 003391          584 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN-PKISDFGMARAFGIDQTE  662 (823)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~-~kl~DFGla~~~~~~~~~  662 (823)
                      +++|.+++........+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||++......   
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence            9999999976544445789999999999999999999943234999999999999998887 799999999765322   


Q ss_pred             cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCC
Q 003391          663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG  742 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~  742 (823)
                        .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......    ....+.. ....         ..
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~-~~~~---------~~  223 (307)
T 2eva_A          160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMWAV-HNGT---------RP  223 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHHHH-HTTC---------CC
T ss_pred             --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHHHH-hcCC---------CC
Confidence              223468999999999999999999999999999999999999985332211    1111110 1110         01


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          743 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      .........+.+++.+|++.||++|||++|++++|+.+.
T Consensus       224 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  262 (307)
T 2eva_A          224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM  262 (307)
T ss_dssp             CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred             CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            111122346788999999999999999999999998763

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.7e-39  Score=353.20  Aligned_cols=256  Identities=25%  Similarity=0.363  Sum_probs=202.5

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-Cc----EEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQ----EIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~----~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      ++|...++||+|+||.||+|++.. ++    .||+|.+.... ......+.+|+.++++++||||+++++++. .+..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            568888999999999999999754 43    37888875442 344556789999999999999999999986 467899


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      ||||+++|+|.+++..  ....+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        92 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEECCTTCBSHHHHHS--SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEeCCCCCHHHHHHH--ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence            9999999999999854  2346899999999999999999999998   9999999999999999999999999999875


Q ss_pred             CCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      ............+|..|+|||++.+..++.++||||||+++|||++ |+.||.......   ..    .......     
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~----~~~~~~~-----  234 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VP----DLLEKGE-----  234 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HH----HHHHTTC-----
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HH----HHHHcCC-----
Confidence            5444444445678889999999999999999999999999999999 999986432211   11    1111110     


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                          ....+......+.+++.+||+.||++||++.|+++.|+.+.
T Consensus       235 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~  275 (325)
T 3kex_A          235 ----RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA  275 (325)
T ss_dssp             ----BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred             ----CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                01111112235678999999999999999999999998764

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-39  Score=353.26  Aligned_cols=262  Identities=26%  Similarity=0.410  Sum_probs=209.3

Q ss_pred             HhcCCCcCCeeeccCccceEEEEee------cCcEEEEEEecCC-ccccHHHHHHHHHHHhcc-CCCCceeEEEEeecCC
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKS-SGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRD  573 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~------~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~  573 (823)
                      ..++|...+.||+|+||.||+|++.      .+..||+|++... .....+.+.+|+.++.++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            4578889999999999999999973      3568999999754 334567899999999999 8999999999999999


Q ss_pred             ceEEEEeecCCCCcchhhhccCCC--------------------CccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccC
Q 003391          574 ERMLIYEYLPNKSLNDFIFDVTRS--------------------KFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLK  633 (823)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk  633 (823)
                      ..++||||+++|+|.+++......                    ..+++..++.++.||++||+|||+.+   |+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence            999999999999999999653221                    34799999999999999999999998   9999999


Q ss_pred             CCcEEEcCCCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcC
Q 003391          634 ASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYH  712 (823)
Q Consensus       634 ~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~  712 (823)
                      |+|||++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999999999987654433333344567889999999999999999999999999999998 999975432


Q ss_pred             CCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          713 ADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       713 ~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      ...      .....         +........+......+.+++.+||+.||.+||++.|+++.|+.+.
T Consensus       280 ~~~------~~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~  333 (344)
T 1rjb_A          280 VDA------NFYKL---------IQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL  333 (344)
T ss_dssp             CSH------HHHHH---------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             cHH------HHHHH---------HhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            211      01111         1111111122223457888999999999999999999999998754

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-38  Score=343.94  Aligned_cols=270  Identities=21%  Similarity=0.265  Sum_probs=213.8

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCC--ceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD--ERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~  579 (823)
                      ++|...++||+|+||.||+|++.. ++.||+|++.... ....+.+.+|++++++++||||+++++++....  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            568889999999999999999875 8899999997543 345677889999999999999999999997765  679999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEE----cCCCCceeecccccee
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNEMNPKISDFGMARA  655 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~DFGla~~  655 (823)
                      ||+++++|.+++........+++..+..++.||++||+|||+.+   |+||||||+|||+    +.++.+||+|||+++.
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            99999999999976555555999999999999999999999998   9999999999999    7788899999999987


Q ss_pred             cCCCccccccccccccCCccCccccc--------cCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHh
Q 003391          656 FGIDQTEANTNRVVGTYGYMPPEYAI--------DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW  727 (823)
Q Consensus       656 ~~~~~~~~~~~~~~gt~~y~aPE~l~--------~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  727 (823)
                      .....   ......||+.|+|||++.        +..++.++||||||+++|||++|+.||.........  .. .....
T Consensus       166 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~-~~~~~  239 (319)
T 4euu_A          166 LEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KE-VMYKI  239 (319)
T ss_dssp             CCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HH-HHHHH
T ss_pred             cCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HH-HHHHH
Confidence            64332   223356899999999986        577899999999999999999999998543322111  11 11111


Q ss_pred             hhcCchhhhh---------------hhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCC
Q 003391          728 IEERPVELIN---------------KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  782 (823)
Q Consensus       728 ~~~~~~~~~~---------------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  782 (823)
                      ....+.....               ..............+.+++.+||+.||++|||++|+++..++...
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~  309 (319)
T 4euu_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (319)
T ss_dssp             HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred             hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence            1111111000               001113344556688899999999999999999999999887643

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=5.3e-39  Score=339.51  Aligned_cols=254  Identities=29%  Similarity=0.441  Sum_probs=196.0

Q ss_pred             hcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCc----cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSS----GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      .++|+..+.||+|+||.||+|++ .++.+|+|++....    ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            35788889999999999999997 48899999986543    23457789999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcC--------CCCceeecc
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN--------EMNPKISDF  650 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~--------~~~~kl~DF  650 (823)
                      |||+++++|.+++.    ...+++..+..++.|+++||+|||+.+..+|+||||||+||+++.        ++.+||+||
T Consensus        85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999999883    346899999999999999999999987555899999999999986        678999999


Q ss_pred             ccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhc
Q 003391          651 GMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE  730 (823)
Q Consensus       651 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  730 (823)
                      |+++......    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......      .....     
T Consensus       161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~-----  225 (271)
T 3dtc_A          161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL------AVAYG-----  225 (271)
T ss_dssp             CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHH-----
T ss_pred             Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHh-----
Confidence            9998653322    22357899999999999999999999999999999999999997532211      00000     


Q ss_pred             CchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          731 RPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       731 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                          ..........+......+.+++.+|++.+|++|||+.|+++.|+.+
T Consensus       226 ----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          226 ----VAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             ----HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             ----hhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                0111111112222335688999999999999999999999999863

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5.2e-39  Score=341.94  Aligned_cols=255  Identities=24%  Similarity=0.387  Sum_probs=205.4

Q ss_pred             hcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      .++|...+.||+|+||.||++.+.++..||+|++.... ...+++.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            46788889999999999999999888899999997543 34578999999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  662 (823)
                      ++++|.+++...  ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++....... 
T Consensus       102 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-  175 (283)
T 3gen_A          102 ANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-  175 (283)
T ss_dssp             TTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-
T ss_pred             CCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc-
Confidence            999999999542  345899999999999999999999998   99999999999999999999999999986543221 


Q ss_pred             cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                      .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.......   .    ....         .....
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~---~----~~~~---------~~~~~  239 (283)
T 3gen_A          176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---T----AEHI---------AQGLR  239 (283)
T ss_dssp             HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---H----HHHH---------HTTCC
T ss_pred             ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH---H----HHHH---------hcccC
Confidence            22223456788999999999999999999999999999998 999975322110   0    0001         11111


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          742 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      ...+......+.+++.+||+.+|++|||++|+++.|+.+
T Consensus       240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~  278 (283)
T 3gen_A          240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  278 (283)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            111112234678999999999999999999999999764

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.1e-38  Score=347.28  Aligned_cols=250  Identities=24%  Similarity=0.352  Sum_probs=199.7

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCC-------
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD-------  573 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-------  573 (823)
                      .++|+..+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            457888999999999999999987 58999999997543 345678999999999999999999999986543       


Q ss_pred             --------------------------------------------------ceEEEEeecCCCCcchhhhccCCCCccCHH
Q 003391          574 --------------------------------------------------ERMLIYEYLPNKSLNDFIFDVTRSKFLDWS  603 (823)
Q Consensus       574 --------------------------------------------------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~  603 (823)
                                                                        ..++||||+++++|.+++.........++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              279999999999999999765555567788


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc----------cccccccccCC
Q 003391          604 KRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE----------ANTNRVVGTYG  673 (823)
Q Consensus       604 ~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~  673 (823)
                      .++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++........          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            89999999999999999998   999999999999999999999999999977543211          12234579999


Q ss_pred             ccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCC---HHHHH
Q 003391          674 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYS---LSEVL  750 (823)
Q Consensus       674 y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~---~~~~~  750 (823)
                      |+|||++.+..++.++||||||+++|||++|..|+..        .             ............+   .....
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--------~-------------~~~~~~~~~~~~~~~~~~~~~  300 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--------R-------------VRIITDVRNLKFPLLFTQKYP  300 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--------H-------------HHHHHHHHTTCCCHHHHHHCH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--------H-------------HHHHHHhhccCCCcccccCCh
Confidence            9999999999999999999999999999998766210        0             0011111111122   12234


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          751 RCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       751 ~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      .+.+++.+||+.||++||++.|+++.
T Consensus       301 ~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          301 QEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             hHHHHHHHHccCCCCcCCCHHHHhhc
Confidence            66889999999999999999999863

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4e-39  Score=366.14  Aligned_cols=262  Identities=26%  Similarity=0.410  Sum_probs=206.1

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      ..++|...++||+|+||.||+|++.++..||||++.... ...++|.+|+.++++++||||+++++++.+ +..++||||
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            346788889999999999999999888889999997644 346789999999999999999999999976 678999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++|+|.+++... ....+++..+..++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++.......
T Consensus       260 ~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          260 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             CTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             hcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence            9999999999532 2245899999999999999999999998   99999999999999999999999999987643221


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhc
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL  740 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l  740 (823)
                       .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+......       ........         ..
T Consensus       336 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-------~~~~~i~~---------~~  398 (452)
T 1fmk_A          336 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLDQVER---------GY  398 (452)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHT---------TC
T ss_pred             -ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHc---------CC
Confidence             12223456789999999999999999999999999999999 89887532211       01111111         11


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCCCCCC
Q 003391          741 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQP  786 (823)
Q Consensus       741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~p  786 (823)
                      ....+......+.+++.+||+.+|++|||+++++++|+.+..-..|
T Consensus       399 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~  444 (452)
T 1fmk_A          399 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP  444 (452)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence            1112223345788999999999999999999999999987544333

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.6e-38  Score=340.36  Aligned_cols=263  Identities=25%  Similarity=0.336  Sum_probs=205.6

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      .++|+..+.||+|+||.||+|++.. ++.||+|++....   ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            3678899999999999999999754 8899999985543   23456789999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      |||+++++|.+++..   ...+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++.+..
T Consensus        90 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            999999999999854   235899999999999999999999998   99999999999999999999999999986532


Q ss_pred             CccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                      .. ........||+.|+|||.+.+..++.++||||||+++|||++|+.||.....      .......... ..... ..
T Consensus       164 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~-~~~~~-~~  234 (294)
T 4eqm_A          164 TS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQD-SVPNV-TT  234 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------HHHHHHHHSS-CCCCH-HH
T ss_pred             cc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhhc-cCCCc-ch
Confidence            21 1223346799999999999999999999999999999999999999753221      1111111111 11000 01


Q ss_pred             hcCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhccCCCCC
Q 003391          739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRP-NMSSVVLMLSGERSLP  784 (823)
Q Consensus       739 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~~~~~~  784 (823)
                      ....    .....+.+++.+|++.||++|| ++.++.+.|+....-.
T Consensus       235 ~~~~----~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~  277 (294)
T 4eqm_A          235 DVRK----DIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN  277 (294)
T ss_dssp             HSCT----TSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred             hccc----CCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence            1111    1234678899999999999999 9999999999865433

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.9e-39  Score=349.86  Aligned_cols=261  Identities=23%  Similarity=0.381  Sum_probs=193.6

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeecCc----EEEEEEecCC--ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCce
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIEGQ----EIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDER  575 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~~~----~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~  575 (823)
                      ..++|...+.||+|+||.||+|++....    .||+|++...  .....+++.+|+.++++++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            3467999999999999999999976533    7999998765  344567899999999999999999999999877655


Q ss_pred             ------EEEEeecCCCCcchhhhccC---CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCce
Q 003391          576 ------MLIYEYLPNKSLNDFIFDVT---RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPK  646 (823)
Q Consensus       576 ------~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k  646 (823)
                            ++||||+++++|.+++....   ....+++..+..++.||++||+|||+.+   |+||||||+|||+++++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence                  99999999999999986432   2225899999999999999999999998   99999999999999999999


Q ss_pred             eeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHH
Q 003391          647 ISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWR  725 (823)
Q Consensus       647 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~  725 (823)
                      |+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......   ..    .
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~----~  250 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IY----N  250 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH----H
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HH----H
Confidence            999999987644433333334556789999999999999999999999999999999 888875432211   11    1


Q ss_pred             HhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          726 LWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       726 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      ......         ...........+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       251 ~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l  297 (323)
T 3qup_A          251 YLIGGN---------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL  297 (323)
T ss_dssp             HHHTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhcCC---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            111110         11112223357889999999999999999999999999764

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=6.7e-39  Score=346.07  Aligned_cols=260  Identities=25%  Similarity=0.391  Sum_probs=210.6

Q ss_pred             hcCCCcCCeeeccCccceEEEEee------cCcEEEEEEecCCcc-ccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCc
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSSG-QGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDE  574 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~------~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~  574 (823)
                      .++|...+.||+|+||.||+|++.      .++.||+|++..... ...+.+.+|+.++.++ +||||+++++++.+.+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            467888999999999999999852      367899999976543 3456789999999999 99999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCC---------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEE
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTR---------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL  639 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll  639 (823)
                      .++||||+++|+|.+++.....               ...+++..++.++.||++||.|||+.+   |+||||||+||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence            9999999999999999965332               224899999999999999999999998   9999999999999


Q ss_pred             cCCCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccc
Q 003391          640 DNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHN  718 (823)
Q Consensus       640 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~  718 (823)
                      +.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......   
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---  255 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS---  255 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH---
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh---
Confidence            9999999999999987654433333344567889999999999999999999999999999999 999875432211   


Q ss_pred             hhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          719 LLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       719 l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      .   ....         +........+......+.+++.+|++.||.+|||+.|++++|+.+
T Consensus       256 ~---~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  305 (313)
T 1t46_A          256 K---FYKM---------IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (313)
T ss_dssp             H---HHHH---------HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H---HHHH---------hccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            0   1111         111111111122235678999999999999999999999999865

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.1e-38  Score=347.74  Aligned_cols=249  Identities=22%  Similarity=0.298  Sum_probs=204.2

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC---ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      .++|...+.||+|+||.||+++... ++.||+|++.+.   .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            3578889999999999999999864 889999999764   334567789999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      |||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            999999999998853   345899999999999999999999998   99999999999999999999999999986432


Q ss_pred             CccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                      .  ........||+.|+|||++.+..++.++||||||+++|||++|+.||.....   ..+.    ......        
T Consensus       158 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~----~~i~~~--------  220 (337)
T 1o6l_A          158 D--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLF----ELILME--------  220 (337)
T ss_dssp             T--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH----HHHHHC--------
T ss_pred             C--CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH---HHHH----HHHHcC--------
Confidence            2  1223446899999999999999999999999999999999999999753211   1111    111111        


Q ss_pred             hcCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003391          739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVLM  776 (823)
Q Consensus       739 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~  776 (823)
                      ..  .++.....++.+++.+||+.||++||     +++|+++.
T Consensus       221 ~~--~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          221 EI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             CC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CC--CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            00  11112234678899999999999999     89999764

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.8e-38  Score=344.32  Aligned_cols=260  Identities=18%  Similarity=0.198  Sum_probs=207.8

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceEEEEe
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      .++|...+.||+|+||.||+|+.. +++.||||++.....  .+++.+|+.+++++ +||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            367888999999999999999974 488999999865432  34688999999999 99999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCC-----ceeecccccee
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN-----PKISDFGMARA  655 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~-----~kl~DFGla~~  655 (823)
                      |+ +++|.+++...  ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.     +||+|||+++.
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            99 99999998643  346899999999999999999999998   999999999999998887     99999999997


Q ss_pred             cCCCcccc-----ccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhc
Q 003391          656 FGIDQTEA-----NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE  730 (823)
Q Consensus       656 ~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  730 (823)
                      +.......     ......||+.|+|||++.+..++.++||||||+++|||++|+.||..................-...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~  239 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT  239 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence            64332211     1245689999999999999999999999999999999999999987554333222222111110000


Q ss_pred             CchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          731 RPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       731 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                       ..    ..+....    + ++.+++..|++.+|.+||++.+|++.|+.+
T Consensus       240 -~~----~~~~~~~----p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~  279 (330)
T 2izr_A          240 -PI----EVLCENF----P-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL  279 (330)
T ss_dssp             -CH----HHHTTTC----H-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             -CH----HHHhccC----h-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence             00    0111111    2 788999999999999999999999999754

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.6e-38  Score=341.21  Aligned_cols=261  Identities=23%  Similarity=0.318  Sum_probs=198.4

Q ss_pred             hcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhc--cCCCCceeEEEEeecC----CceE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAK--LQHRNLVKLIGCCTQR----DERM  576 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~----~~~~  576 (823)
                      .++|...+.||+|+||.||+|++ +++.||||++...   ....+..|.+++..  ++||||+++++++...    ...+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46788999999999999999987 7899999998653   33455666666665  7999999999987543    4589


Q ss_pred             EEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHH--------hcCCCceEecccCCCcEEEcCCCCceee
Q 003391          577 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH--------QDSRLRIIHRDLKASNVLLDNEMNPKIS  648 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~Dlk~~NIll~~~~~~kl~  648 (823)
                      +||||+++|+|.+++.    ...+++..+..++.||++||+|||        +.+   |+||||||+|||++.++.+||+
T Consensus        83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred             EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence            9999999999999993    346899999999999999999999        665   9999999999999999999999


Q ss_pred             ccccceecCCCccc--cccccccccCCccCccccccC------CCCccchhHhHHHHHHHHHhc----------CCCCCC
Q 003391          649 DFGMARAFGIDQTE--ANTNRVVGTYGYMPPEYAIDG------LFSVKSDVFSFGVLVLEIVCG----------KRNRGF  710 (823)
Q Consensus       649 DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~------~~s~ksDVwS~Gvvl~elltG----------~~p~~~  710 (823)
                      |||+++........  .......||+.|+|||++.+.      .++.++||||||+++|||++|          +.||..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            99999876433221  122335799999999999876      556799999999999999999          566533


Q ss_pred             cCCCCccchhHHHHHHhhhcCchhhhhhhcC-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          711 YHADHHHNLLGHAWRLWIEERPVELINKSLG-GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       711 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      .......  .............    .+.+. ..........+.+++.+||+.||++|||+.||++.|+.+
T Consensus       236 ~~~~~~~--~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          236 VVPNDPS--FEDMRKVVCVDQQ----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TSCSSCC--HHHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCcc--hhhhhHHHhccCC----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            2221111  1111111100000    00000 001224566899999999999999999999999999753

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4e-39  Score=349.55  Aligned_cols=263  Identities=26%  Similarity=0.412  Sum_probs=211.2

Q ss_pred             HHhcCCCcCCeeeccCccceEEEEee------cCcEEEEEEecCCcc-ccHHHHHHHHHHHhccCCCCceeEEEEeecCC
Q 003391          501 NATENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD  573 (823)
Q Consensus       501 ~~~~~~~~~~~LG~G~fg~Vyk~~~~------~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~  573 (823)
                      ...++|...+.||+|+||.||+|++.      .++.||+|++..... ....++.+|+.++++++||||+++++++.+.+
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~  101 (322)
T 1p4o_A           22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ  101 (322)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence            35578999999999999999999875      267899999975532 34457899999999999999999999999999


Q ss_pred             ceEEEEeecCCCCcchhhhccC-------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCce
Q 003391          574 ERMLIYEYLPNKSLNDFIFDVT-------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPK  646 (823)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k  646 (823)
                      ..++||||+++++|.+++....       ....+++..++.++.||++||.|||+.+   |+||||||+||+++.++.+|
T Consensus       102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~k  178 (322)
T 1p4o_A          102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK  178 (322)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred             ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEE
Confidence            9999999999999999986422       1245789999999999999999999998   99999999999999999999


Q ss_pred             eeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHH
Q 003391          647 ISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWR  725 (823)
Q Consensus       647 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~  725 (823)
                      |+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+......       ....
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~~  251 (322)
T 1p4o_A          179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-------QVLR  251 (322)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-------HHHH
T ss_pred             ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH-------HHHH
Confidence            999999986643333233334567889999999999999999999999999999999 78886432110       0111


Q ss_pred             HhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCC
Q 003391          726 LWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  782 (823)
Q Consensus       726 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  782 (823)
                      .......         ..........+.+++.+|++.+|++||++.|+++.|+....
T Consensus       252 ~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          252 FVMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            1111110         11112223467899999999999999999999999998755

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.4e-38  Score=361.38  Aligned_cols=251  Identities=24%  Similarity=0.340  Sum_probs=204.8

Q ss_pred             hcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCC-ceEEEEee
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD-ERMLIYEY  581 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV~e~  581 (823)
                      .++|...++||+|+||.||+|.+ .++.||||+++...  ..+.|.+|+.++++++||||+++++++.+.+ ..++||||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            46788889999999999999987 47899999997653  4578999999999999999999999987665 78999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++|+|.+++... ....+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  
T Consensus       269 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  342 (450)
T 1k9a_A          269 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  342 (450)
T ss_dssp             CTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence            9999999999653 2334789999999999999999999998   999999999999999999999999999864321  


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhc
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL  740 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l  740 (823)
                         .....++..|+|||++.+..++.++||||||+++|||++ |+.||......+   ...    ....+         .
T Consensus       343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~----~i~~~---------~  403 (450)
T 1k9a_A          343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP----RVEKG---------Y  403 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHH----HHHTT---------C
T ss_pred             ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHcC---------C
Confidence               112356889999999999999999999999999999998 999976433221   111    11111         1


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          741 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      ....+......+.+++..||+.||++|||+.++++.|+.+.
T Consensus       404 ~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~  444 (450)
T 1k9a_A          404 KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR  444 (450)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            11122233457889999999999999999999999998753

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.4e-38  Score=349.81  Aligned_cols=250  Identities=21%  Similarity=0.288  Sum_probs=202.4

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC-----ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS-----SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM  576 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  576 (823)
                      .++|...+.||+|+||.||+|+... ++.||+|++...     .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            3568889999999999999999864 899999998543     1234678999999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhccC-CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCC---ceeecccc
Q 003391          577 LIYEYLPNKSLNDFIFDVT-RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN---PKISDFGM  652 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~DFGl  652 (823)
                      +||||+++++|.+++.... ....+++..+..++.||++||+|||+.+   |+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999998885432 3345899999999999999999999998   999999999999987654   99999999


Q ss_pred             ceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCc
Q 003391          653 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP  732 (823)
Q Consensus       653 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  732 (823)
                      ++......  .......||+.|+|||++.+..++.++||||||+++|||++|+.||....    ..+    .........
T Consensus       180 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~----~~~i~~~~~  249 (351)
T 3c0i_A          180 AIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERL----FEGIIKGKY  249 (351)
T ss_dssp             CEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHH----HHHHHHTCC
T ss_pred             eeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHH----HHHHHcCCC
Confidence            98764322  22334679999999999999999999999999999999999999975321    011    111111100


Q ss_pred             hhhhhhhcCCCCCHH----HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          733 VELINKSLGGSYSLS----EVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       733 ~~~~~~~l~~~~~~~----~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                                .....    ...++.+++.+||+.||++|||+.|+++
T Consensus       250 ----------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          250 ----------KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             ----------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----------CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                      01111    1246789999999999999999999986

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2e-38  Score=340.19  Aligned_cols=249  Identities=24%  Similarity=0.306  Sum_probs=194.6

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc--------------------------ccHHHHHHHHHHHh
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG--------------------------QGMEEFENEVLLIA  555 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~--------------------------~~~~~~~~Ei~~l~  555 (823)
                      .++|...+.||+|+||.||+|++.. ++.||+|++.....                          ...+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            3678899999999999999999754 88999999865431                          12356889999999


Q ss_pred             ccCCCCceeEEEEeec--CCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccC
Q 003391          556 KLQHRNLVKLIGCCTQ--RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLK  633 (823)
Q Consensus       556 ~l~H~niv~l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk  633 (823)
                      +++||||+++++++.+  .+..++||||+++++|.+++    ....+++..+..++.||++||+|||+.+   |+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence            9999999999999986  56789999999999998865    3456899999999999999999999998   9999999


Q ss_pred             CCcEEEcCCCCceeeccccceecCCCccccccccccccCCccCccccccCC---CCccchhHhHHHHHHHHHhcCCCCCC
Q 003391          634 ASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL---FSVKSDVFSFGVLVLEIVCGKRNRGF  710 (823)
Q Consensus       634 ~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~s~ksDVwS~Gvvl~elltG~~p~~~  710 (823)
                      |+|||++.++.+||+|||+++.+.....  ......||+.|+|||++.+..   ++.++||||||+++|||++|+.||..
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            9999999999999999999987643321  223457899999999998765   47889999999999999999999753


Q ss_pred             cCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          711 YHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       711 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ...   ..+    .......        .............+.+++.+||+.||++||++.|+++
T Consensus       243 ~~~---~~~----~~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          243 ERI---MCL----HSKIKSQ--------ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SSH---HHH----HHHHHHC--------CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccH---HHH----HHHHhcc--------cCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            211   000    0111110        0000111112346789999999999999999999874

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-38  Score=344.63  Aligned_cols=248  Identities=19%  Similarity=0.276  Sum_probs=203.0

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      .++|...+.||+|+||.||+|+... ++.+|+|.+... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            4678899999999999999999865 788999998644 33456788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcC--CCCceeeccccceecCCC
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN--EMNPKISDFGMARAFGID  659 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~--~~~~kl~DFGla~~~~~~  659 (823)
                      +++++|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.  ++.+||+|||+++.+...
T Consensus        83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            999999999843  2345899999999999999999999998   999999999999987  789999999999876432


Q ss_pred             ccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                      .   ......||+.|+|||++.+..++.++||||||+++|||++|+.||......   ...    .......        
T Consensus       158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~----~~i~~~~--------  219 (321)
T 1tki_A          158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QII----ENIMNAE--------  219 (321)
T ss_dssp             C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHH----HHHHHTC--------
T ss_pred             C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH---HHH----HHHHcCC--------
Confidence            2   223457899999999999988999999999999999999999997532211   111    1111110        


Q ss_pred             cCCCCCHH----HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          740 LGGSYSLS----EVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       740 l~~~~~~~----~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                        ..++.+    ...++.+++.+|++.||++|||+.|+++.
T Consensus       220 --~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          220 --YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             --CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             --CCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence              001111    12467899999999999999999999973

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.7e-38  Score=343.13  Aligned_cols=262  Identities=26%  Similarity=0.352  Sum_probs=201.1

Q ss_pred             hcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCcc--ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSG--QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      .++|+..++||+|+||.||+|++.+++.||+|++.....  ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            467899999999999999999998899999999965432  234678899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |+++ +|.+++..  ....+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       100 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A          100 FMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             CCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             CCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            9985 78887753  3345899999999999999999999998   9999999999999999999999999998764322


Q ss_pred             cccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhh----
Q 003391          661 TEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL----  735 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~----  735 (823)
                        .......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+.   ................    
T Consensus       174 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~  248 (311)
T 3niz_A          174 --RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPKIFSILGTPNPREWPQVQ  248 (311)
T ss_dssp             --C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHHHHHHHCCCCTTTSGGGT
T ss_pred             --ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHHCCCChHHhhhhh
Confidence              22233578999999999876 5689999999999999999999999865433322   1111111111000000    


Q ss_pred             ----hhh-h--cCCCCCHH-----HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          736 ----INK-S--LGGSYSLS-----EVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       736 ----~~~-~--l~~~~~~~-----~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                          ... .  ........     ...++.+++.+||+.||++|||++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                000 0  00001111     1236789999999999999999999986

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.2e-38  Score=347.83  Aligned_cols=260  Identities=27%  Similarity=0.399  Sum_probs=209.5

Q ss_pred             hcCCCcCCeeeccCccceEEEEee--------cCcEEEEEEecCCc-cccHHHHHHHHHHHhcc-CCCCceeEEEEeecC
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI--------EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQR  572 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~--------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~  572 (823)
                      .++|...+.||+|+||.||+|++.        ++..||+|++.... ....+++.+|+.+++++ +||||+++++++.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            478889999999999999999873        36789999997653 33456789999999999 899999999999999


Q ss_pred             CceEEEEeecCCCCcchhhhccCC-------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEE
Q 003391          573 DERMLIYEYLPNKSLNDFIFDVTR-------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL  639 (823)
Q Consensus       573 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll  639 (823)
                      +..++||||+++++|.+++.....             ...+++..++.++.||++||+|||+.+   |+||||||+||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence            999999999999999999965332             234899999999999999999999998   9999999999999


Q ss_pred             cCCCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccc
Q 003391          640 DNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHN  718 (823)
Q Consensus       640 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~  718 (823)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+......   .
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~  267 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---E  267 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH---H
Confidence            9999999999999987654433333344567889999999999999999999999999999999 99987532211   1


Q ss_pred             hhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          719 LLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       719 l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      +    .......         .....+......+.+++.+|++.+|.+||++.|+++.|+.+.
T Consensus       268 ~----~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~  317 (334)
T 2pvf_A          268 L----FKLLKEG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  317 (334)
T ss_dssp             H----HHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H----HHHHhcC---------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            1    1111111         111112223346789999999999999999999999998764

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.7e-38  Score=342.75  Aligned_cols=248  Identities=23%  Similarity=0.321  Sum_probs=203.1

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc------ccHHHHHHHHHHHhccCCCCceeEEEEeecCCce
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG------QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDER  575 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~  575 (823)
                      .++|...+.||+|+||.||+++... ++.||+|++.....      ...+.+.+|+.++++++||||+++++++.+....
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            3568889999999999999999865 88999999865432      2467899999999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCC----Cceeeccc
Q 003391          576 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM----NPKISDFG  651 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~DFG  651 (823)
                      ++||||+++++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        90 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           90 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            99999999999999984   3456899999999999999999999998   99999999999999887    89999999


Q ss_pred             cceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcC
Q 003391          652 MARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER  731 (823)
Q Consensus       652 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  731 (823)
                      +++......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....   ......    .... 
T Consensus       164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~----~~~~-  232 (326)
T 2y0a_A          164 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLAN----VSAV-  232 (326)
T ss_dssp             TCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHH----HHHT-
T ss_pred             CCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH---HHHHHH----HHhc-
Confidence            998764322   22345799999999999999999999999999999999999999753211   111110    0000 


Q ss_pred             chhhhhhhcCCCCCHH----HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          732 PVELINKSLGGSYSLS----EVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       732 ~~~~~~~~l~~~~~~~----~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                               ......+    ....+.+++.+||+.||++|||+.|+++.
T Consensus       233 ---------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          233 ---------NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             ---------CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ---------CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                     0011111    12367789999999999999999999874

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=5.6e-39  Score=350.20  Aligned_cols=261  Identities=26%  Similarity=0.395  Sum_probs=209.0

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec------CcEEEEEEecCCcc-ccHHHHHHHHHHHhcc-CCCCceeEEEEeecCC
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSSG-QGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRD  573 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~------~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~  573 (823)
                      ..++|...+.||+|+||.||+|....      ...||+|++..... ...+.+.+|+.++.++ +||||+++++++.+.+
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            45788999999999999999999753      24799999976532 3456789999999999 8999999999999999


Q ss_pred             ceEEEEeecCCCCcchhhhccC-----------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCC
Q 003391          574 ERMLIYEYLPNKSLNDFIFDVT-----------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE  642 (823)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~  642 (823)
                      ..++||||+++|+|.+++....           ....+++..++.++.||+.||+|||+.+   |+||||||+|||++.+
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence            9999999999999999986422           1345799999999999999999999998   9999999999999999


Q ss_pred             CCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhH
Q 003391          643 MNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLG  721 (823)
Q Consensus       643 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~  721 (823)
                      +.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |..||.......   .  
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~--  275 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS---K--  275 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH---H--
T ss_pred             CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH---H--
Confidence            9999999999987644333333334567889999999999999999999999999999999 888875332211   0  


Q ss_pred             HHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          722 HAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       722 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                       ...         .+........+......+.+++.+|++.||.+|||+.|+++.|+..
T Consensus       276 -~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          276 -FYK---------LVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             -HHH---------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHH---------HHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence             011         1111111111112234678899999999999999999999999764

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1e-38  Score=350.39  Aligned_cols=249  Identities=26%  Similarity=0.374  Sum_probs=198.5

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC---ccccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERM  576 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~  576 (823)
                      ..++|...++||+|+||.||+|++.. ++.||+|++.+.   .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            34789999999999999999999865 889999999754   234556788999999988 7999999999999999999


Q ss_pred             EEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceec
Q 003391          577 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  656 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  656 (823)
                      +||||+++|+|.+++...   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       101 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence            999999999999998542   45899999999999999999999998   999999999999999999999999999854


Q ss_pred             CCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          657 GIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       657 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      ...  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+..    .....      
T Consensus       175 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~----~i~~~------  239 (353)
T 3txo_A          175 ICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED---DLFE----AILND------  239 (353)
T ss_dssp             CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHC------
T ss_pred             ccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH---HHHH----HHHcC------
Confidence            222  22334468999999999999999999999999999999999999998532211   1111    11111      


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNM------SSVVL  775 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~  775 (823)
                        ..  .++......+.+++.+||+.||++||++      .|+++
T Consensus       240 --~~--~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          240 --EV--VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             --CC--CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             --CC--CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence              11  1111123467889999999999999998      66665

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=8.3e-38  Score=335.04  Aligned_cols=262  Identities=16%  Similarity=0.189  Sum_probs=209.4

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceEEEEe
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      .++|...+.||+|+||.||+|+.. +++.||+|++....  ..+.+.+|+.++.++ +|+|++++++++.+....++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            467889999999999999999974 58899999986543  234678899999999 79999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCC-----ceeecccccee
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN-----PKISDFGMARA  655 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~-----~kl~DFGla~~  655 (823)
                      |+ +++|.+++...  ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.     +||+|||+++.
T Consensus        87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            99 99999999542  345899999999999999999999988   999999999999987776     99999999997


Q ss_pred             cCCCccc-----cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhc
Q 003391          656 FGIDQTE-----ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE  730 (823)
Q Consensus       656 ~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  730 (823)
                      .......     .......||+.|+|||++.+..++.++||||||+++|||++|+.||......................
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  240 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence            6543221     12344679999999999999999999999999999999999999987544333222222211111111


Q ss_pred             CchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          731 RPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       731 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      ...     .+....    ...+.+++.+|++.+|++||++++|++.|+.+.
T Consensus       241 ~~~-----~~~~~~----~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~  282 (298)
T 1csn_A          241 PLR-----ELCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  282 (298)
T ss_dssp             CHH-----HHTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             cHH-----HHHhhC----cHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence            111     111111    246789999999999999999999999998763

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.7e-38  Score=335.23  Aligned_cols=255  Identities=27%  Similarity=0.491  Sum_probs=202.2

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCcccc-------HHHHHHHHHHHhccCCCCceeEEEEeecCCc
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQG-------MEEFENEVLLIAKLQHRNLVKLIGCCTQRDE  574 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~-------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~  574 (823)
                      .++|...+.||+|+||.||+|++. +++.||+|++.......       .+.+.+|+.++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            367888999999999999999985 48899999986543221       267899999999999999999999987654 


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCC-----ceeec
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN-----PKISD  649 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~-----~kl~D  649 (823)
                       ++||||+++++|.+++..  +...+++..+..++.|++.||+|||+.+ .+|+||||||+|||++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             799999999999998854  3456899999999999999999999975 24999999999999988776     99999


Q ss_pred             cccceecCCCccccccccccccCCccCcccc--ccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHh
Q 003391          650 FGMARAFGIDQTEANTNRVVGTYGYMPPEYA--IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW  727 (823)
Q Consensus       650 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l--~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  727 (823)
                      ||+++....     ......||+.|+|||++  ....++.++||||||+++|||++|+.||.........    . ....
T Consensus       173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~-~~~~  242 (287)
T 4f0f_A          173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK----F-INMI  242 (287)
T ss_dssp             CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH----H-HHHH
T ss_pred             CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH----H-HHHH
Confidence            999975322     23346789999999998  4556789999999999999999999998643322110    0 0000


Q ss_pred             hhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          728 IEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       728 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                              .........+......+.+++.+||+.||++|||++|+++.|+.+
T Consensus       243 --------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          243 --------REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             --------HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             --------hccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                    111111122223345788999999999999999999999999864

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.2e-38  Score=337.93  Aligned_cols=257  Identities=27%  Similarity=0.419  Sum_probs=210.6

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      ..++|...+.||+|+||.||+|++.. +..||+|++... ....+++.+|+.++++++||||+++++++.+.+..++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            34678888999999999999999876 788999999654 3456789999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |+++++|.+++... ....+++..+..++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||++.......
T Consensus        90 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           90 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             CCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             cCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            99999999999643 3355899999999999999999999998   9999999999999999999999999998664332


Q ss_pred             cccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          661 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                      . .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+.......   ..             +.+...
T Consensus       166 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~-------------~~~~~~  228 (288)
T 3kfa_A          166 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VY-------------ELLEKD  228 (288)
T ss_dssp             S-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HH-------------HHHHTT
T ss_pred             c-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH-------------HHHhcc
Confidence            2 22233567889999999999999999999999999999999 888875432211   10             111111


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       740 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      .....+......+.+++.+|++.||++||++.|+++.|+..
T Consensus       229 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence            11122222335788999999999999999999999999764

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.3e-38  Score=351.83  Aligned_cols=250  Identities=23%  Similarity=0.320  Sum_probs=198.3

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l  577 (823)
                      .++|...++||+|+||.||++++.. ++.+|+|++.+..   ....+.+..|..++.++ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            4678899999999999999999875 7889999997652   23345678899999887 89999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      ||||+++|+|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       131 V~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            9999999999999854   345899999999999999999999998   9999999999999999999999999998532


Q ss_pred             CCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCcc--chhHHHHHHhhhcCchhh
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHH--NLLGHAWRLWIEERPVEL  735 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~--~l~~~~~~~~~~~~~~~~  735 (823)
                      ..  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.........  ............      
T Consensus       205 ~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~------  276 (396)
T 4dc2_A          205 RP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE------  276 (396)
T ss_dssp             CT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH------
T ss_pred             cC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc------
Confidence            22  22334578999999999999999999999999999999999999998643222111  111111111111      


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 003391          736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNM  770 (823)
Q Consensus       736 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  770 (823)
                        ..+  .++.....++.+++.+||+.||++||++
T Consensus       277 --~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          277 --KQI--RIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             --CCC--CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             --ccc--CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence              111  1111223467899999999999999996

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.3e-38  Score=344.24  Aligned_cols=269  Identities=26%  Similarity=0.373  Sum_probs=213.1

Q ss_pred             cCHHHHHHHhcCCCcCCeeeccCccceEEEEee------cCcEEEEEEecCCcc-ccHHHHHHHHHHHhcc-CCCCceeE
Q 003391          494 FDWMAIANATENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSSG-QGMEEFENEVLLIAKL-QHRNLVKL  565 (823)
Q Consensus       494 ~~~~~l~~~~~~~~~~~~LG~G~fg~Vyk~~~~------~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l  565 (823)
                      +.........++|...+.||+|+||.||+|++.      .++.||+|++..... ...+.+.+|+.++.++ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            344455556788999999999999999999853      357899999976533 3456789999999999 79999999


Q ss_pred             EEEeecCC-ceEEEEeecCCCCcchhhhccCC-------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecc
Q 003391          566 IGCCTQRD-ERMLIYEYLPNKSLNDFIFDVTR-------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRD  631 (823)
Q Consensus       566 ~g~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~D  631 (823)
                      ++++...+ ..++||||+++++|.+++.....             ...+++..+..++.||++||.|||+.+   |+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence            99987654 58999999999999999965332             223889999999999999999999998   99999


Q ss_pred             cCCCcEEEcCCCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCC
Q 003391          632 LKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGF  710 (823)
Q Consensus       632 lk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~  710 (823)
                      |||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            999999999999999999999987654433333444677889999999999999999999999999999998 9999754


Q ss_pred             cCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          711 YHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       711 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      .....      ..........         ....+......+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus       254 ~~~~~------~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  308 (316)
T 2xir_A          254 VKIDE------EFCRRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  308 (316)
T ss_dssp             CCCSH------HHHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cchhH------HHHHHhccCc---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            32211      1111111111         1111112234678899999999999999999999999865

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.7e-38  Score=334.74  Aligned_cols=255  Identities=27%  Similarity=0.378  Sum_probs=207.8

Q ss_pred             cCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecC
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP  583 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (823)
                      ++|...+.||+|+||.||+|+..+++.||+|++..... ..+++.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            56888899999999999999998888999999976543 45789999999999999999999999999999999999999


Q ss_pred             CCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccc
Q 003391          584 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA  663 (823)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  663 (823)
                      +++|.+++..  ....+++..+..++.|+++||.|||+.+   |+|+||||+||+++.++.+||+|||++....... ..
T Consensus        87 ~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~  160 (267)
T 3t9t_A           87 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT  160 (267)
T ss_dssp             TCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred             CCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc-cc
Confidence            9999999854  2345899999999999999999999998   9999999999999999999999999998653221 11


Q ss_pred             ccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCC
Q 003391          664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG  742 (823)
Q Consensus       664 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~  742 (823)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......       .........         ...
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~i~~~---------~~~  224 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-------EVVEDISTG---------FRL  224 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTT---------CCC
T ss_pred             ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH-------HHHHHHhcC---------CcC
Confidence            2223456788999999999999999999999999999999 88887532110       011111111         011


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          743 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      ..+......+.+++.+|++.+|++||+++++++.|+.+.
T Consensus       225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (267)
T 3t9t_A          225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  263 (267)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            111122346788999999999999999999999998753

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.8e-38  Score=348.54  Aligned_cols=253  Identities=23%  Similarity=0.329  Sum_probs=202.7

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      ..++|...+.||+|+||.||+|++.. ++.||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            35679999999999999999999864 8899999996543  23456788999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCC---Cceeecccccee
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM---NPKISDFGMARA  655 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~DFGla~~  655 (823)
                      |||+++|+|.+++.   ....+++..+..++.||++||.|||+.+   |+||||||+|||++.++   .+||+|||++..
T Consensus       107 ~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          107 FDLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             ECCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             EecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            99999999999884   3456899999999999999999999998   99999999999998654   599999999987


Q ss_pred             cCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhh
Q 003391          656 FGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL  735 (823)
Q Consensus       656 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  735 (823)
                      .....   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ..+.    ......... .
T Consensus       181 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---~~~~----~~i~~~~~~-~  249 (362)
T 2bdw_A          181 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLY----AQIKAGAYD-Y  249 (362)
T ss_dssp             CTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH----HHHHHTCCC-C
T ss_pred             ecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHH----HHHHhCCCC-C
Confidence            64222   22346799999999999999999999999999999999999999753211   1111    111111000 0


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       736 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                           ..........++.+++.+||+.||++||++.|+++.
T Consensus       250 -----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          250 -----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             -----CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             -----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                 000001123467899999999999999999998764

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=6.6e-38  Score=346.96  Aligned_cols=249  Identities=22%  Similarity=0.316  Sum_probs=203.1

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC---ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ++|...+.||+|+||.||+++... ++.||+|++.+.   .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            678889999999999999999865 788999998654   2345678899999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        95 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             CCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            99999999999853   445899999999999999999999998   999999999999999999999999999876432


Q ss_pred             ccccccccccccCCccCcccccc---CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAID---GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~---~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                         .......||+.|+|||++.+   ..++.++|||||||++|||++|+.||..........+...    ....      
T Consensus       169 ---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~----~~~~------  235 (384)
T 4fr4_A          169 ---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT----FETT------  235 (384)
T ss_dssp             ---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH----HHHC------
T ss_pred             ---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH----Hhhc------
Confidence               22344689999999999964   4589999999999999999999999864433222111111    0000      


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPN-MSSVVL  775 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~  775 (823)
                          ...++......+.+++.+||+.||++||+ +.++.+
T Consensus       236 ----~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          236 ----VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ----ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                01111222346789999999999999998 666664

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.4e-38  Score=357.53  Aligned_cols=254  Identities=22%  Similarity=0.296  Sum_probs=202.0

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      ..++|...++||+|+||.||+|+... ++.+|+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            45778999999999999999999754 8899999986543  23456789999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEc---CCCCceeecccccee
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NEMNPKISDFGMARA  655 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~DFGla~~  655 (823)
                      |||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++   .++.+||+|||+++.
T Consensus        89 ~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           89 FDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             ECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            999999999998854   345899999999999999999999998   99999999999998   467899999999987


Q ss_pred             cCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhh
Q 003391          656 FGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL  735 (823)
Q Consensus       656 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  735 (823)
                      .....  .......||+.|+|||++.+..++.++||||+|+++|||++|+.||.....   ..+.    ........ ..
T Consensus       163 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~---~~~~----~~i~~~~~-~~  232 (444)
T 3soa_A          163 VEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ---HRLY----QQIKAGAY-DF  232 (444)
T ss_dssp             CCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHH----HHHHHTCC-CC
T ss_pred             ecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH---HHHH----HHHHhCCC-CC
Confidence            64332  222346799999999999999999999999999999999999999743211   1111    11111100 00


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       736 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                           ..........++.+++.+||+.||++|||+.|+++.
T Consensus       233 -----~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          233 -----PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             -----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -----CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                 000001112467889999999999999999999874

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.7e-38  Score=335.62  Aligned_cols=255  Identities=30%  Similarity=0.429  Sum_probs=205.7

Q ss_pred             hcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      .++|...+.||+|+||.||+|...+++.||+|++.... ...+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~   89 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence            36788899999999999999998878899999996543 346789999999999999999999999874 5689999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  662 (823)
                      ++++|.+++... ....+++..+..++.|+++||+|||+.+   |+|+||||+||++++++.+||+|||++........ 
T Consensus        90 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  164 (279)
T 1qpc_A           90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-  164 (279)
T ss_dssp             TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred             CCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc-
Confidence            999999998431 1225899999999999999999999998   99999999999999999999999999987643322 


Q ss_pred             cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......   ..    .......         ..
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~----~~~~~~~---------~~  228 (279)
T 1qpc_A          165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EV----IQNLERG---------YR  228 (279)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HH----HHHHHTT---------CC
T ss_pred             ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HH----HHHHhcc---------cC
Confidence            12223456789999999998899999999999999999999 88887532111   11    1111111         11


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          742 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      ...+......+.+++.+|++.+|++|||+.++++.|+..
T Consensus       229 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  267 (279)
T 1qpc_A          229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (279)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence            111122235778999999999999999999999999875

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=6.1e-38  Score=334.73  Aligned_cols=261  Identities=24%  Similarity=0.340  Sum_probs=198.1

Q ss_pred             cCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      ++|...+.||+|+||.||+|+...++.+|+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            5688889999999999999999779999999986543  23457788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++ +|.+++..  ....+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  154 (288)
T 1ob3_A           82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-  154 (288)
T ss_dssp             CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence            986 89888853  2345899999999999999999999998   9999999999999999999999999998654321 


Q ss_pred             ccccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCch------h
Q 003391          662 EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV------E  734 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~------~  734 (823)
                       .......+|+.|+|||++.+. .++.++||||||+++|||++|+.||......   ................      +
T Consensus       155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T 1ob3_A          155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMRIFRILGTPNSKNWPNVTE  230 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHHCCCChhhchhhhc
Confidence             122335689999999999764 5899999999999999999999998543211   1111111111000000      0


Q ss_pred             --hhhhhcCC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          735 --LINKSLGG-------SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       735 --~~~~~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                        ..++....       ........++.+++.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence              00000000       000112346789999999999999999999985

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-38  Score=348.06  Aligned_cols=252  Identities=24%  Similarity=0.337  Sum_probs=196.1

Q ss_pred             hcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCC--ccccHHHHHHHHHHHhccCC--CCceeEEEEeecCCceEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQH--RNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lV  578 (823)
                      .++|.+.+.||+|+||.||++...+++.||+|++...  .....+.+.+|+.++.+++|  |||+++++++.+.+..++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            3568889999999999999999988999999998654  33445778999999999976  9999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      || +.+++|.+++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||++ ++.+||+|||+++.+..
T Consensus        88 ~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             Ee-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            99 568899999954   346899999999999999999999998   99999999999997 57899999999987654


Q ss_pred             CccccccccccccCCccCcccccc-----------CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAID-----------GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW  727 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  727 (823)
                      ...........||+.|+|||++.+           ..++.++||||||+++|||++|+.||.....     .....    
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~----  230 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKL----  230 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHH----
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHH----
Confidence            433333445679999999999865           6789999999999999999999999753211     11111    


Q ss_pred             hhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          728 IEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       728 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                           ...++.......+.....++.+++.+||+.||.+|||+.|+++.
T Consensus       231 -----~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          231 -----HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             -----HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -----HHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence                 11111111112222223467899999999999999999999865

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2e-38  Score=337.12  Aligned_cols=255  Identities=24%  Similarity=0.319  Sum_probs=193.9

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec----CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~----~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      .++|...+.||+|+||.||+|++..    +..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            4678889999999999999999754    4569999987643 334567899999999999999999999985 467899


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      ||||+++++|.+++...  ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence            99999999999998542  345899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      .... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......   ....    ......     
T Consensus       168 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~----~i~~~~-----  234 (281)
T 1mp8_A          168 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIG----RIENGE-----  234 (281)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHH----HHHTTC-----
T ss_pred             cccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHH----HHHcCC-----
Confidence            3221 12223456788999999999999999999999999999997 88897543221   1111    111110     


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                          ....+......+.+++.+|++.||++||++.|+++.|+.+
T Consensus       235 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          235 ----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                1111222335678999999999999999999999999864

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.6e-38  Score=337.81  Aligned_cols=260  Identities=24%  Similarity=0.403  Sum_probs=193.8

Q ss_pred             hcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      .++|+..++||+|+||.||+|++.  ..+|+|++....  ....+.+.+|+.++++++||||+++++++ .....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            467889999999999999999863  469999986553  33456789999999999999999999965 4567899999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |+++++|.+++..  ....+++..++.++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+++......
T Consensus       100 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A          100 WCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             CCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             ecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence            9999999999843  3456899999999999999999999998   9999999999999999999999999998654333


Q ss_pred             cccccccccccCCccCccccc---cCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhh
Q 003391          661 TEANTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN  737 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  737 (823)
                      .........||+.|+|||++.   +..++.++||||||+++|||++|+.||.......      ............... 
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~-  247 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIEMVGRGSLSPDL-  247 (289)
T ss_dssp             ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH------HHHHHHHHTSCCCCT-
T ss_pred             ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH------HHHHHhcccccCcch-
Confidence            333344467899999999986   6678999999999999999999999975332211      111111111110000 


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          738 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       738 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                          ..........+.+++.+|++.+|++||++.|++++|+.+.
T Consensus       248 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          248 ----SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             ----TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ----hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence                0111122357889999999999999999999999998764

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.5e-38  Score=343.46  Aligned_cols=272  Identities=23%  Similarity=0.319  Sum_probs=199.8

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCcc---ccHHHHHHHHHHHhccCCCCceeEEEEeecCCce---
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDER---  575 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~---  575 (823)
                      .++|...+.||+|+||.||+|++. +++.||+|++.....   .....+.+|+.++.+++||||+++++++......   
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            467899999999999999999974 488999999976532   3345788999999999999999999998766544   


Q ss_pred             -EEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccce
Q 003391          576 -MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  654 (823)
Q Consensus       576 -~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  654 (823)
                       ++||||+++++|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence             999999999999999854   235899999999999999999999998   9999999999999999999999999998


Q ss_pred             ecCCCccc-cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCch
Q 003391          655 AFGIDQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV  733 (823)
Q Consensus       655 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  733 (823)
                      .+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......      .............
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~  238 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIP  238 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCC
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCCCC
Confidence            76433221 2233457899999999999999999999999999999999999997532211      1111111111000


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHH-HHHHhccCCCCCCCCCCCCcc
Q 003391          734 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSS-VVLMLSGERSLPQPKQPGFFT  793 (823)
Q Consensus       734 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e-vl~~L~~~~~~~~p~~p~~~~  793 (823)
                      .   ......    ...++.+++.+||+.||++||++.+ +...|........|..|....
T Consensus       239 ~---~~~~~~----~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~~~~~~  292 (311)
T 3ork_A          239 P---SARHEG----LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLT  292 (311)
T ss_dssp             H---HHHSTT----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSSCCCCC
T ss_pred             c---ccccCC----CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCCCcccc
Confidence            0   000011    1246788999999999999996555 445555544444444444443

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.4e-38  Score=369.01  Aligned_cols=262  Identities=26%  Similarity=0.408  Sum_probs=210.4

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      ..++|...++||+|+||.||+|++.++..||||++.... ...++|.+|+.++++++||||+++++++.+ +..++||||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            346788889999999999999999888899999997654 346789999999999999999999999976 678999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++|+|.++|... ....+++..++.++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++...... 
T Consensus       343 ~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  417 (535)
T 2h8h_A          343 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-  417 (535)
T ss_dssp             CTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-
T ss_pred             hcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-
Confidence            9999999999532 2245899999999999999999999998   9999999999999999999999999998654221 


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhc
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL  740 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l  740 (823)
                      ........++..|+|||++.+..++.++||||||++||||++ |+.||......       .........         .
T Consensus       418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~-------~~~~~i~~~---------~  481 (535)
T 2h8h_A          418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLDQVERG---------Y  481 (535)
T ss_dssp             HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH-------HHHHHHHTT---------C
T ss_pred             eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcC---------C
Confidence            111223456788999999999999999999999999999999 89887532211       111111111         1


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCCCCCC
Q 003391          741 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQP  786 (823)
Q Consensus       741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~p  786 (823)
                      ....+......+.+|+.+||+.||++|||+.+|+++|+.+..-..|
T Consensus       482 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~  527 (535)
T 2h8h_A          482 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP  527 (535)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence            1112223345788999999999999999999999999987544333

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.6e-38  Score=344.05  Aligned_cols=258  Identities=25%  Similarity=0.425  Sum_probs=200.1

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-Cc----EEEEEEecCC-ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQ----EIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM  576 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~----~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  576 (823)
                      .++|+..++||+|+||.||+|++.. ++    .||+|.+... .....+++.+|+.++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            3678889999999999999999754 44    3578877544 3456778999999999999999999999998754 88


Q ss_pred             EEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceec
Q 003391          577 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  656 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  656 (823)
                      +|+||+++|+|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            999999999999998642  345899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhh
Q 003391          657 GIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVEL  735 (823)
Q Consensus       657 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  735 (823)
                      .............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......   +.             ..
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~-------------~~  231 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS-------------SI  231 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH-------------HH
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HH-------------HH
Confidence            54433333344567889999999999999999999999999999999 999975432211   11             11


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCC
Q 003391          736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  782 (823)
Q Consensus       736 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  782 (823)
                      +........+.....++.+++.+||+.||.+||++.|+++.|+.+..
T Consensus       232 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          232 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             HHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             HHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            11111111222233468899999999999999999999999997653

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=9.4e-38  Score=333.93  Aligned_cols=262  Identities=23%  Similarity=0.304  Sum_probs=199.2

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      ++|+..++||+|+||.||+|++.. ++.||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            578889999999999999999865 8899999997543  2334678899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |+++ +|.+++..  ....+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            9986 55555532  2356899999999999999999999998   9999999999999999999999999998764322


Q ss_pred             cccccccccccCCccCccccccCC-CCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhh--hh
Q 003391          661 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL--IN  737 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~~~-~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~--~~  737 (823)
                        .......+|+.|+|||++.+.. ++.++||||||+++|||++|..|+-..  ......................  ..
T Consensus       156 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~--~~~~~~~~~i~~~~~~~~~~~~~~~~  231 (292)
T 3o0g_A          156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG--NDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC--SSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             --ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCC--CCHHHHHHHHHHHhCCCChhhhhhhc
Confidence              2223457899999999998766 899999999999999999999885211  1111112211111110000000  00


Q ss_pred             h----h---------cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          738 K----S---------LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       738 ~----~---------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      .    .         ............+.+++.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            0    0         000011112346779999999999999999999986

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.7e-38  Score=357.58  Aligned_cols=263  Identities=18%  Similarity=0.214  Sum_probs=206.0

Q ss_pred             HHHHHHHhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeec
Q 003391          496 WMAIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ  571 (823)
Q Consensus       496 ~~~l~~~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~  571 (823)
                      ..++....++|...++||+|+||.||+|++.. ++.||+|++.+..   ....+.+.+|+.++..++||||+++++++.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            33444557899999999999999999999876 7889999986532   2233458899999999999999999999999


Q ss_pred             CCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccc
Q 003391          572 RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG  651 (823)
Q Consensus       572 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFG  651 (823)
                      .+..++||||+++|+|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG  220 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG  220 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence            9999999999999999999954  2346899999999999999999999998   9999999999999999999999999


Q ss_pred             cceecCCCccccccccccccCCccCccccc-----cCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHH
Q 003391          652 MARAFGIDQTEANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL  726 (823)
Q Consensus       652 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  726 (823)
                      +++....... ......+||+.|+|||++.     ...++.++|||||||++|||++|+.||......   ......   
T Consensus       221 la~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~---~~~~~i---  293 (437)
T 4aw2_A          221 SCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKI---  293 (437)
T ss_dssp             TCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHH---
T ss_pred             hhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh---HHHHhh---
Confidence            9987643322 2223468999999999997     567899999999999999999999998532211   111111   


Q ss_pred             hhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 003391          727 WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPED--RPNMSSVVLM  776 (823)
Q Consensus       727 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~  776 (823)
                       .... ...   .. .........++.+++.+|++.+|++  ||+++|+++.
T Consensus       294 -~~~~-~~~---~~-p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          294 -MNHK-ERF---QF-PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             -HTHH-HHC---CC-CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             -hhcc-ccc---cC-CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence             0000 000   00 0000112246778999999888888  9999999874

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-38  Score=339.77  Aligned_cols=245  Identities=23%  Similarity=0.299  Sum_probs=202.3

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      .++|...+.||+|+||.||+++... ++.||+|++.+..   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            3678889999999999999999864 8899999997542   34566788999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      |||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            999999999999954   345899999999999999999999998   99999999999999999999999999987532


Q ss_pred             CccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                           ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....   ...    .......        
T Consensus       159 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~----~~~i~~~--------  218 (318)
T 1fot_A          159 -----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT---MKT----YEKILNA--------  218 (318)
T ss_dssp             -----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHH----HHHHHHC--------
T ss_pred             -----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHH----HHHHHhC--------
Confidence                 22346799999999999999999999999999999999999999753211   001    1111111        


Q ss_pred             hcCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003391          739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVL  775 (823)
Q Consensus       739 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  775 (823)
                      .+  .++.....++.+++.+|++.||++||     ++.|+++
T Consensus       219 ~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          219 EL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             CC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CC--CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            11  11111224678899999999999999     8888884

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.9e-38  Score=341.21  Aligned_cols=259  Identities=24%  Similarity=0.362  Sum_probs=189.1

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      .++|+..++||+|+||.||+|+... ++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            4678899999999999999999764 8899999986553 3345778999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccC---CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          581 YLPNKSLNDFIFDVT---RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      |++ ++|.+++....   ....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 59999886422   2245899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCccccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCch---
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV---  733 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~---  733 (823)
                      ....  ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+   ......... .....   
T Consensus       160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~-~~~~~~~~  233 (317)
T 2pmi_A          160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE---QLKLIFDIM-GTPNESLW  233 (317)
T ss_dssp             SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHH-CSCCTTTC
T ss_pred             CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHh-CCCChhHh
Confidence            3221  2233578999999999976 468999999999999999999999986432211   111111110 00000   


Q ss_pred             ----------------------hhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          734 ----------------------ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       734 ----------------------~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                                            +.+.+....    ....++.+++.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKE----PLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSS----CCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhhhcccccccccchhHHHhhcccccc----cCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                                  000000111    11236789999999999999999999975

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=5.5e-38  Score=346.84  Aligned_cols=267  Identities=18%  Similarity=0.181  Sum_probs=204.5

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec------CcEEEEEEecCCcccc-----------HHHHHHHHHHHhccCCCCcee
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSSGQG-----------MEEFENEVLLIAKLQHRNLVK  564 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~------~~~vavK~l~~~~~~~-----------~~~~~~Ei~~l~~l~H~niv~  564 (823)
                      ..++|.+.++||+|+||.||+|.+..      ++.||+|++.......           ...+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            34689999999999999999999865      3689999986653211           112344566677788999999


Q ss_pred             EEEEeecC----CceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEc
Q 003391          565 LIGCCTQR----DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD  640 (823)
Q Consensus       565 l~g~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~  640 (823)
                      +++++...    ...++||||+ +++|.+++..  ....+++..++.++.||+.||+|||+.+   |+||||||+|||++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~  186 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence            99998765    4589999999 9999999854  3356999999999999999999999998   99999999999999


Q ss_pred             --CCCCceeeccccceecCCCccc-----cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCC
Q 003391          641 --NEMNPKISDFGMARAFGIDQTE-----ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHA  713 (823)
Q Consensus       641 --~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~  713 (823)
                        .++.+||+|||+++.+......     .......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              8899999999999876433221     111335699999999999999999999999999999999999999864322


Q ss_pred             CCccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          714 DHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       714 ~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      +.  ....... ........++++..+...   ....++.+++..|++.+|++||++.+++++|+.+
T Consensus       267 ~~--~~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~  327 (364)
T 3op5_A          267 DP--KYVRDSK-IRYRENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG  327 (364)
T ss_dssp             CH--HHHHHHH-HHHHHCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             CH--HHHHHHH-HHhhhhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence            21  1111111 111223334444433211   1124677899999999999999999999999865

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.2e-38  Score=346.61  Aligned_cols=273  Identities=27%  Similarity=0.363  Sum_probs=210.7

Q ss_pred             cCCCcCCeeeccCccceEEEEe-----ecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEee--cCCceE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVL-----IEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT--QRDERM  576 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~-----~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~--~~~~~~  576 (823)
                      ++|+..+.||+|+||.||++++     ..++.||+|++........+.+.+|++++++++||||+++++++.  +....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            6788899999999999999984     347899999998776666778999999999999999999999886  455689


Q ss_pred             EEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceec
Q 003391          577 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  656 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  656 (823)
                      +||||+++++|.+++...  ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             EEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence            999999999999998542  235899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCccc-cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhh
Q 003391          657 GIDQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL  735 (823)
Q Consensus       657 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  735 (823)
                      ...... .......+|..|+|||++.+..++.++||||||+++|||++|+.|+............ ............+.
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~  256 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG-CERDVPALSRLLEL  256 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-----CCHHHHHHHH
T ss_pred             ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc-cccccccHHHHHHH
Confidence            433222 2223356788899999999999999999999999999999999986432110000000 00000000001111


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCC
Q 003391          736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  782 (823)
Q Consensus       736 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  782 (823)
                      +........+......+.+++.+|++.||++|||++|+++.|+.+..
T Consensus       257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  303 (327)
T 3lxl_A          257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS  303 (327)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred             hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            12222222233334578899999999999999999999999998753

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2e-38  Score=354.27  Aligned_cols=258  Identities=20%  Similarity=0.213  Sum_probs=204.7

Q ss_pred             HHHHHhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC---ccccHHHHHHHHHHHhccCCCCceeEEEEeecCC
Q 003391          498 AIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD  573 (823)
Q Consensus       498 ~l~~~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~  573 (823)
                      .+....++|...++||+|+||.||+|++.. ++.||+|++.+.   .....+.+.+|+.++..++||||+++++++.+.+
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~  142 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  142 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            344456889999999999999999999875 889999998653   2233456889999999999999999999999999


Q ss_pred             ceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccc
Q 003391          574 ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  653 (823)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  653 (823)
                      ..++||||+++|+|.+++..    ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a  215 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC  215 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecccee
Confidence            99999999999999999853    24889999999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCccccccccccccCCccCccccccCC----CCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhh
Q 003391          654 RAFGIDQTEANTNRVVGTYGYMPPEYAIDGL----FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE  729 (823)
Q Consensus       654 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  729 (823)
                      +....... ......+||+.|+|||++.+..    ++.++|||||||++|||++|+.||.....   .......    ..
T Consensus       216 ~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i----~~  287 (410)
T 3v8s_A          216 MKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---VGTYSKI----MN  287 (410)
T ss_dssp             EECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHH----HT
T ss_pred             EeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh---hhHHHHH----Hh
Confidence            87643321 2233468999999999998765    88999999999999999999999853221   1111110    00


Q ss_pred             cCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 003391          730 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPED--RPNMSSVVLM  776 (823)
Q Consensus       730 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~  776 (823)
                      ..      ..+..........++.+++.+||+.+|.+  ||++.||++.
T Consensus       288 ~~------~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          288 HK------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             HH------HHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             cc------ccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            00      00000000111246778999999999998  9999999975

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.2e-38  Score=338.05  Aligned_cols=252  Identities=23%  Similarity=0.371  Sum_probs=203.2

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-C-------cEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCc
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-G-------QEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE  574 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~-------~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~  574 (823)
                      .++|...+.||+|+||.||+|+... +       ..||+|++........+.+.+|+.++++++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            3568888999999999999999765 3       4799999987777777889999999999999999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCC--------ce
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN--------PK  646 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~--------~k  646 (823)
                      .++||||+++++|.+++..  ....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.        +|
T Consensus        87 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CEEEEECCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence            9999999999999999954  2334899999999999999999999998   999999999999998887        99


Q ss_pred             eeccccceecCCCccccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHH
Q 003391          647 ISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR  725 (823)
Q Consensus       647 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~  725 (823)
                      |+|||++.....      .....+|+.|+|||++.+ ..++.++||||||+++|||++|..|+.....     ... ...
T Consensus       162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~-----~~~-~~~  229 (289)
T 4fvq_A          162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-----SQR-KLQ  229 (289)
T ss_dssp             ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----HHH-HHH
T ss_pred             eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc-----hHH-HHH
Confidence            999999865421      123467889999999987 7799999999999999999997655321110     000 000


Q ss_pred             HhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCC
Q 003391          726 LWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  782 (823)
Q Consensus       726 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  782 (823)
                      ....           ....+.....++.+++.+||+.||++|||+.|+++.|+.+..
T Consensus       230 ~~~~-----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          230 FYED-----------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             HHHT-----------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             Hhhc-----------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            0000           001111112357789999999999999999999999998754

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.6e-38  Score=332.71  Aligned_cols=254  Identities=20%  Similarity=0.322  Sum_probs=203.4

Q ss_pred             hcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecC--CceEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR--DERMLI  578 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV  578 (823)
                      .++|...+.||+|+||.||+|++ .++.+|+|++....  ....+++.+|+.++++++||||+++++++.+.  ...++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            35788889999999999999998 58899999997653  33456799999999999999999999999877  778999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      |||+++|+|.+++... ....+++..+..++.||++||+|||+.+ ..|+||||||+||+++.++.++|+|||++.... 
T Consensus        88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-  164 (271)
T ss_dssp             EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred             ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence            9999999999999642 2335899999999999999999999874 359999999999999999999999999876432 


Q ss_pred             CccccccccccccCCccCccccccCCCCc---cchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGLFSV---KSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL  735 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~---ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  735 (823)
                            .....+|+.|+|||.+.+..++.   ++||||||+++|||++|+.||......      .....         .
T Consensus       165 ------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~---------~  223 (271)
T 3kmu_A          165 ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------EIGMK---------V  223 (271)
T ss_dssp             ------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH------HHHHH---------H
T ss_pred             ------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH------HHHHH---------H
Confidence                  12356789999999998765544   899999999999999999997532211      00000         1


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       736 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      .........+......+.+++..|++.||++|||++|+++.|+.+.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          224 ALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             HHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            1111111222223346789999999999999999999999998754

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=5.2e-38  Score=339.98  Aligned_cols=263  Identities=23%  Similarity=0.318  Sum_probs=206.0

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEee----cCCceEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT----QRDERML  577 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~----~~~~~~l  577 (823)
                      .++|...+.||+|+||.||+++.. +++.||+|++........+.+.+|+.++++++||||+++++++.    .....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            467999999999999999999974 58999999997766667778999999999999999999999986    3457899


Q ss_pred             EEeecCCCCcchhhhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceec
Q 003391          578 IYEYLPNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  656 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  656 (823)
                      ||||+++++|.+++... .....+++..++.++.||++||+|||+.+   |+||||||+||+++.++.+||+|||++...
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            99999999999998652 23456899999999999999999999998   999999999999999999999999998765


Q ss_pred             CCCcccc-------ccccccccCCccCccccccCC---CCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHH
Q 003391          657 GIDQTEA-------NTNRVVGTYGYMPPEYAIDGL---FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL  726 (823)
Q Consensus       657 ~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~---~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  726 (823)
                      .......       ......||+.|+|||++.+..   ++.++||||||+++|||++|+.||......... .       
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~-------  256 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-V-------  256 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-H-------
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-h-------
Confidence            3211110       112345799999999987654   689999999999999999999997432111100 0       


Q ss_pred             hhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCC
Q 003391          727 WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  782 (823)
Q Consensus       727 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  782 (823)
                            ...+...............+.+++.+||+.||.+||++.|+++.|+.+..
T Consensus       257 ------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          257 ------ALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             ------HHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             ------hHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence                  00011111111111223468899999999999999999999999998753

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.4e-37  Score=339.17  Aligned_cols=266  Identities=19%  Similarity=0.232  Sum_probs=200.1

Q ss_pred             hcCCCcCCeeeccCccceEEEEee----cCcEEEEEEecCCccc-----------cHHHHHHHHHHHhccCCCCceeEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI----EGQEIAAKRLSKSSGQ-----------GMEEFENEVLLIAKLQHRNLVKLIG  567 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~----~~~~vavK~l~~~~~~-----------~~~~~~~Ei~~l~~l~H~niv~l~g  567 (823)
                      .++|...+.||+|+||.||+|+..    .+..+|+|++......           ....+.+|+..+..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            357888999999999999999986    4678999998765322           2234667888999999999999999


Q ss_pred             Eeec----CCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCC
Q 003391          568 CCTQ----RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM  643 (823)
Q Consensus       568 ~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~  643 (823)
                      ++..    ....++||||+ +++|.+++..   ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence            9987    67899999999 9999999853   236899999999999999999999998   99999999999999887


Q ss_pred             --CceeeccccceecCCCccc-----cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCc
Q 003391          644 --NPKISDFGMARAFGIDQTE-----ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH  716 (823)
Q Consensus       644 --~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~  716 (823)
                        .+||+|||+++.+......     .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... 
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-  267 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP-  267 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH-
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc-
Confidence              9999999999876432211     11234579999999999999999999999999999999999999985322111 


Q ss_pred             cchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          717 HNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       717 ~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                       .................+. .....   .....++.+++..|++.||++||++.+|++.|+...
T Consensus       268 -~~~~~~~~~~~~~~~~~~~-~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          268 -VAVQTAKTNLLDELPQSVL-KWAPS---GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             -HHHHHHHHHHHHTTTHHHH-HHSCT---TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             -HHHHHHHHhhcccccHHHH-hhccc---cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence             1111111111111111111 11110   012246788999999999999999999999999865

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.7e-38  Score=351.20  Aligned_cols=251  Identities=24%  Similarity=0.335  Sum_probs=196.5

Q ss_pred             cCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCc--cccHHHHHHHHHHHhccC--CCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQ--HRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ++|.+.+.||+|+||.||++....++.||||++....  ....+.+.+|+.++.+++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            4688999999999999999998889999999986543  345578899999999996  599999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      | +.+++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||+++.+...
T Consensus       136 E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          136 E-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             E-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             e-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            9 678899999854   336889999999999999999999998   99999999999995 589999999999876544


Q ss_pred             ccccccccccccCCccCcccccc-----------CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAID-----------GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWI  728 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~-----------~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~  728 (823)
                      ..........||+.|+|||++.+           ..++.++|||||||+||||++|+.||.....     .....     
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~-----  277 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKL-----  277 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHH-----
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHH-----
Confidence            33333345679999999999865           4689999999999999999999999853211     11110     


Q ss_pred             hcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          729 EERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       729 ~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                          ..+++.......+.....++.+++.+||+.||++||++.|+++.
T Consensus       278 ----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          278 ----HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             ----HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ----HHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence                11111111111111123467889999999999999999999864

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.4e-37  Score=329.38  Aligned_cols=253  Identities=25%  Similarity=0.337  Sum_probs=204.4

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      .++|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            467888999999999999999986 48899999986543 3445778999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |+++++|.+++.   ....+++..+..++.|+++||.|||+.+   |+|+||||+||+++.++.+||+|||++..+....
T Consensus        86 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            999999999884   3456899999999999999999999998   9999999999999999999999999998764333


Q ss_pred             cccccccccccCCccCccccccCCC-CccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          661 TEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                      .........|++.|+|||++.+..+ +.++||||||+++|||++|+.||........  .    ...+......      
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~----~~~~~~~~~~------  227 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--E----YSDWKEKKTY------  227 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--H----HHHHHTTCTT------
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--H----HHHhhhcccc------
Confidence            3333345678999999999987765 7899999999999999999999864332111  0    1111111100      


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       740 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                        ..........+.+++.+|++.||++|||++|+++
T Consensus       228 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          228 --LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             --STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence              0000112246778999999999999999999975

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.8e-38  Score=340.85  Aligned_cols=263  Identities=21%  Similarity=0.293  Sum_probs=197.8

Q ss_pred             cCCCcC-CeeeccCccceEEEEee-cCcEEEEEEecCCccccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceEEEEe
Q 003391          504 ENFSDK-NKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       504 ~~~~~~-~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      +.|.+. +.||+|+||.||+|+.. +++.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            456663 68999999999999975 4889999999877666778899999999985 79999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCC---ceeeccccceecC
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN---PKISDFGMARAFG  657 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~DFGla~~~~  657 (823)
                      |+++++|.+++...   ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.   +||+|||++....
T Consensus        92 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           92 KMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             cCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            99999999999542   45899999999999999999999998   999999999999998776   9999999998653


Q ss_pred             CCcc-----ccccccccccCCccCcccccc-----CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHh
Q 003391          658 IDQT-----EANTNRVVGTYGYMPPEYAID-----GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW  727 (823)
Q Consensus       658 ~~~~-----~~~~~~~~gt~~y~aPE~l~~-----~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  727 (823)
                      ....     ........||+.|+|||++.+     ..++.++||||||+++|||++|+.||......+..........  
T Consensus       166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--  243 (316)
T 2ac3_A          166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP--  243 (316)
T ss_dssp             ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH--
T ss_pred             cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch--
Confidence            2211     111223568999999999875     5688999999999999999999999865433221111000000  


Q ss_pred             hhcCchhhhhhhcCC--CCCHH----HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          728 IEERPVELINKSLGG--SYSLS----EVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       728 ~~~~~~~~~~~~l~~--~~~~~----~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                        .....+.......  ..+..    ....+.+++.+||+.||++|||+.|+++.
T Consensus       244 --~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          244 --ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             --HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             --hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence              0000001111111  11111    12467899999999999999999999873

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=7.6e-38  Score=347.52  Aligned_cols=253  Identities=21%  Similarity=0.253  Sum_probs=204.8

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      .++|...+.||+|+||.||+|+... ++.+|+|++..........+.+|+.++.+++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            4678999999999999999999864 889999999776655667899999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcC--CCCceeeccccceecCCC
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN--EMNPKISDFGMARAFGID  659 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~--~~~~kl~DFGla~~~~~~  659 (823)
                      +++++|.+++..  ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.  ++.+||+|||+++.....
T Consensus       130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            999999998843  2345899999999999999999999998   999999999999974  477999999999876432


Q ss_pred             ccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                      .   ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....   ......    ......      .
T Consensus       205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~----i~~~~~------~  268 (387)
T 1kob_A          205 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQN----VKRCDW------E  268 (387)
T ss_dssp             S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHH----HHHCCC------C
T ss_pred             c---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH---HHHHHH----HHhCCC------C
Confidence            2   22335789999999999999999999999999999999999999753221   111111    000000      0


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       740 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ...........++.+++.+||+.||++|||+.|+++.
T Consensus       269 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          269 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            0001111123467899999999999999999999874

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5e-38  Score=342.78  Aligned_cols=257  Identities=26%  Similarity=0.411  Sum_probs=199.2

Q ss_pred             cCCCcCCeeeccCccceEEEEeecC-----cEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIEG-----QEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~~-----~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      ++|...+.||+|+||.||+|++...     ..||+|++.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            4667778999999999999997642     359999997653 3345578999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      ||||+++++|.+++..  ....+++..++.++.||++||+|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus       124 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          124 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            9999999999999854  2346899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCccc-cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhh
Q 003391          658 IDQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVEL  735 (823)
Q Consensus       658 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  735 (823)
                      ..... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......   .    ........     
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~----~~~~~~~~-----  266 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---E----VMKAINDG-----  266 (333)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---H----HHHHHHTT-----
T ss_pred             cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---H----HHHHHHCC-----
Confidence            33221 11222346778999999999999999999999999999999 99997432110   0    11111111     


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       736 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                          .....+......+.+++.+||+.+|++||++.+++++|+.+.
T Consensus       267 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  308 (333)
T 1mqb_A          267 ----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  308 (333)
T ss_dssp             ----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ----CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                111112223456789999999999999999999999998754

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=9.6e-39  Score=346.12  Aligned_cols=268  Identities=26%  Similarity=0.361  Sum_probs=205.9

Q ss_pred             CCcCCeeeccCccceEEEEee-----cCcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecC--CceEE
Q 003391          506 FSDKNKLGEGGFGPVYKGVLI-----EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR--DERML  577 (823)
Q Consensus       506 ~~~~~~LG~G~fg~Vyk~~~~-----~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l  577 (823)
                      |+..++||+|+||.||++.+.     .++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            488899999999999988753     47889999997653 34456789999999999999999999999874  56899


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      ||||+++++|.+++..    ..+++..++.++.||+.||+|||+.+   |+|+||||+||+++.++.+||+|||++....
T Consensus       113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            9999999999999843    34899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCccc-cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          658 IDQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       658 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      ..... .......+|..|+|||++.+..++.++||||||+++|||++|+.|+........ ................+.+
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  264 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTVLRLTELL  264 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHHHHHHHHH
T ss_pred             ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhHHHHHHHH
Confidence            43221 223335678889999999999999999999999999999999998643211000 0000000000001111222


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      ........+......+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus       265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  309 (318)
T 3lxp_A          265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH  309 (318)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            222222233334457889999999999999999999999998764

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=9.8e-38  Score=341.76  Aligned_cols=249  Identities=23%  Similarity=0.321  Sum_probs=198.3

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV  578 (823)
                      ++|...+.||+|+||.||++++.. ++.||+|++.+..   ....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            568889999999999999999865 8899999997653   23345678999999987 899999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      |||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        89 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            999999999999854   235899999999999999999999998   99999999999999999999999999986422


Q ss_pred             CccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCcc--chhHHHHHHhhhcCchhhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHH--NLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~--~l~~~~~~~~~~~~~~~~~  736 (823)
                      .  ........||+.|+|||++.+..++.++|||||||++|||++|+.||.........  .............      
T Consensus       163 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~------  234 (345)
T 3a8x_A          163 P--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK------  234 (345)
T ss_dssp             T--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC------
T ss_pred             C--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC------
Confidence            2  12234468999999999999999999999999999999999999998643221110  0011111111111      


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNM  770 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  770 (823)
                        ..  .++......+.+++.+||+.||++||++
T Consensus       235 --~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          235 --QI--RIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             --CC--CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             --CC--CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence              11  1111223467889999999999999996

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.9e-38  Score=341.38  Aligned_cols=260  Identities=23%  Similarity=0.379  Sum_probs=196.2

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec----CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCc-
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE-  574 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~----~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-  574 (823)
                      ..++|...+.||+|+||.||+|++..    ++.||+|++....  ....+.+.+|+.++++++||||+++++++.+.+. 
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            45778889999999999999998753    3479999986543  3345678999999999999999999999977653 


Q ss_pred             ----eEEEEeecCCCCcchhhhcc---CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCcee
Q 003391          575 ----RMLIYEYLPNKSLNDFIFDV---TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI  647 (823)
Q Consensus       575 ----~~lV~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl  647 (823)
                          .++||||+++++|.+++...   .....+++..++.++.||++||.|||+.+   |+||||||+||+++.++.+||
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence                49999999999999998542   23456999999999999999999999998   999999999999999999999


Q ss_pred             eccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHH
Q 003391          648 SDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRL  726 (823)
Q Consensus       648 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~  726 (823)
                      +|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......   ....    .
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~----~  261 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EMYD----Y  261 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHH----H
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHH----H
Confidence            99999987644333233334567889999999999999999999999999999999 88887533221   1111    1


Q ss_pred             hhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          727 WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       727 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      .....         ....+......+.+++.+|++.+|++||++.++++.|+.+
T Consensus       262 ~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l  306 (313)
T 3brb_A          262 LLHGH---------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL  306 (313)
T ss_dssp             HHTTC---------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHcCC---------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11110         1111222234688999999999999999999999999865

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=9.6e-38  Score=348.15  Aligned_cols=204  Identities=17%  Similarity=0.238  Sum_probs=176.5

Q ss_pred             hcCCCcCCeeecc--CccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          503 TENFSDKNKLGEG--GFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       503 ~~~~~~~~~LG~G--~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      .++|++.++||+|  +||.||+|+... ++.||||++....  ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4678899999999  999999999874 8999999997553  3345678889999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      ||||+++++|.+++... ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            99999999999998643 2345899999999999999999999998   9999999999999999999999999987542


Q ss_pred             CCcc-----ccccccccccCCccCcccccc--CCCCccchhHhHHHHHHHHHhcCCCCCC
Q 003391          658 IDQT-----EANTNRVVGTYGYMPPEYAID--GLFSVKSDVFSFGVLVLEIVCGKRNRGF  710 (823)
Q Consensus       658 ~~~~-----~~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwS~Gvvl~elltG~~p~~~  710 (823)
                      ....     ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||..
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  239 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  239 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            2111     112233478899999999987  6799999999999999999999999864

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=4.8e-38  Score=339.53  Aligned_cols=244  Identities=22%  Similarity=0.267  Sum_probs=191.6

Q ss_pred             cCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCcc--ccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG--QGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ++|+..++||+|+||+||+|++. +++.||||++.....  ....++..|+..+.++ +||||+++++++.+++..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            57899999999999999999987 589999999865432  2333455666666555 8999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+ +++|.+++...  ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus       137 e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             ECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred             ecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence            999 67999888543  346899999999999999999999998   999999999999999999999999999876432


Q ss_pred             ccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                      .   ......||+.|+|||++.+ .++.++||||||+++|||++|..++...          ..+...........    
T Consensus       211 ~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----------~~~~~~~~~~~~~~----  272 (311)
T 3p1a_A          211 G---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----------EGWQQLRQGYLPPE----  272 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----------HHHHHHTTTCCCHH----
T ss_pred             C---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----------cHHHHHhccCCCcc----
Confidence            2   2233568999999998876 7999999999999999999997664211          01111111111000    


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       740 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ...    ....++.+++.+||+.||++|||++|+++
T Consensus       273 ~~~----~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          273 FTA----GLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccc----CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            000    11246789999999999999999999986

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.4e-38  Score=341.20  Aligned_cols=266  Identities=24%  Similarity=0.330  Sum_probs=199.5

Q ss_pred             HHHHhcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhc--cCCCCceeEEEEeecC----
Q 003391          499 IANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAK--LQHRNLVKLIGCCTQR----  572 (823)
Q Consensus       499 l~~~~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~----  572 (823)
                      .....++|...++||+|+||.||+|++ .++.||+|++....   ...+..|.+++..  ++||||+++++++...    
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~  107 (337)
T 3mdy_A           32 QRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW  107 (337)
T ss_dssp             HTTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred             ccccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence            334557899999999999999999987 48999999985432   2344555555555  4999999999999877    


Q ss_pred             CceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcC-----CCceEecccCCCcEEEcCCCCcee
Q 003391          573 DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS-----RLRIIHRDLKASNVLLDNEMNPKI  647 (823)
Q Consensus       573 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~Dlk~~NIll~~~~~~kl  647 (823)
                      ...++||||+++|+|.+++..    ..+++..++.++.|++.||+|||+..     +.+|+||||||+|||++.++.+||
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl  183 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI  183 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred             CceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence            678999999999999999943    35899999999999999999999881     113999999999999999999999


Q ss_pred             eccccceecCCCcccc--ccccccccCCccCccccccCCCCcc------chhHhHHHHHHHHHhcCCC----------CC
Q 003391          648 SDFGMARAFGIDQTEA--NTNRVVGTYGYMPPEYAIDGLFSVK------SDVFSFGVLVLEIVCGKRN----------RG  709 (823)
Q Consensus       648 ~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~k------sDVwS~Gvvl~elltG~~p----------~~  709 (823)
                      +|||+++.+.......  ......||+.|+|||++.+.....+      +||||||+++|||++|..|          +.
T Consensus       184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~  263 (337)
T 3mdy_A          184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH  263 (337)
T ss_dssp             CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence            9999998764332221  1234579999999999987776655      9999999999999999544          33


Q ss_pred             CcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCC
Q 003391          710 FYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYS-----LSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  782 (823)
Q Consensus       710 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  782 (823)
                      ........  .......        ..........+     .....++.+++.+||+.||++|||+.||++.|+.+..
T Consensus       264 ~~~~~~~~--~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  331 (337)
T 3mdy_A          264 DLVPSDPS--YEDMREI--------VCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE  331 (337)
T ss_dssp             TTSCSSCC--HHHHHHH--------HTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhcCCCCc--hhhhHHH--------HhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence            22111111  1111010        01111112222     2456688999999999999999999999999987643

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=7.2e-38  Score=346.57  Aligned_cols=247  Identities=25%  Similarity=0.310  Sum_probs=194.9

Q ss_pred             cCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCCCC
Q 003391          508 DKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKS  586 (823)
Q Consensus       508 ~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  586 (823)
                      ..+.||+|+||.||+|+... ++.||+|++........+++.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            35689999999999999754 88999999987665667789999999999999999999999999999999999999999


Q ss_pred             cchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEE--cCCCCceeeccccceecCCCccccc
Q 003391          587 LNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL--DNEMNPKISDFGMARAFGIDQTEAN  664 (823)
Q Consensus       587 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll--~~~~~~kl~DFGla~~~~~~~~~~~  664 (823)
                      |.+++..  ....+++..+..++.||++||+|||+.+   |+||||||+|||+  +.++.+||+|||+++.+....   .
T Consensus       173 L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~  244 (373)
T 2x4f_A          173 LFDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---K  244 (373)
T ss_dssp             EHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---B
T ss_pred             HHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---c
Confidence            9998854  2345899999999999999999999998   9999999999999  567789999999998764332   2


Q ss_pred             cccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCC
Q 003391          665 TNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY  744 (823)
Q Consensus       665 ~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~  744 (823)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||......   .....    ...... ...... ..  
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~----i~~~~~-~~~~~~-~~--  313 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA---ETLNN----ILACRW-DLEDEE-FQ--  313 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHH----HHHTCC-CSCSGG-GT--
T ss_pred             cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH----HHhccC-CCChhh-hc--
Confidence            23356999999999999999999999999999999999999997532211   11111    111000 000000 00  


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          745 SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       745 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                        ....++.+++.+||+.||.+||++.|+++
T Consensus       314 --~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          314 --DISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             --TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --cCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              11246789999999999999999999987

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.2e-38  Score=346.38  Aligned_cols=248  Identities=26%  Similarity=0.360  Sum_probs=202.1

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERM  576 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~  576 (823)
                      ..++|...+.||+|+||.||+|++.. ++.||+|++++..   ....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~   94 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   94 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence            45789999999999999999999865 8899999997642   34566788899999887 9999999999999999999


Q ss_pred             EEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceec
Q 003391          577 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  656 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  656 (823)
                      +||||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        95 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A           95 FVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             EEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence            99999999999999854   235899999999999999999999998   999999999999999999999999999864


Q ss_pred             CCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          657 GIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       657 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      ....  ......+||+.|+|||++.+..++.++||||||+++|||++|+.||.....   ..+.    .......     
T Consensus       169 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~----~~i~~~~-----  234 (345)
T 1xjd_A          169 MLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EELF----HSIRMDN-----  234 (345)
T ss_dssp             CCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH----HHHHHCC-----
T ss_pred             ccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH---HHHH----HHHHhCC-----
Confidence            3221  223456899999999999999999999999999999999999999753221   1111    1111110     


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMS-SVV  774 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl  774 (823)
                           ..++.....++.+++.+||+.||++||++. |++
T Consensus       235 -----~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          235 -----PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             -----CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                 011111224678899999999999999998 665

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.4e-38  Score=343.62  Aligned_cols=245  Identities=23%  Similarity=0.320  Sum_probs=200.7

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCC---ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      .++|.+.+.||+|+||.||+|++. .++.||+|++...   .......+.+|+.+++.++||||+++++++...+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            367889999999999999999975 4889999998653   223456789999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      |||+ +|+|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||++.....
T Consensus        88 ~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             ECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             EECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            9999 78999888542   45899999999999999999999998   99999999999999999999999999986543


Q ss_pred             CccccccccccccCCccCccccccCCC-CccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN  737 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  737 (823)
                      .   .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||........                   ..
T Consensus       161 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-------------------~~  218 (336)
T 3h4j_B          161 G---NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-------------------FK  218 (336)
T ss_dssp             S---BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-------------------BC
T ss_pred             C---cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-------------------HH
Confidence            2   22334679999999999988876 7899999999999999999999854322111                   00


Q ss_pred             hhcCC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          738 KSLGG--SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       738 ~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      .....  ..+......+.+++.+|++.||.+|||++|+++.
T Consensus       219 ~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          219 KVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             CCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             HHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            00000  1111122467789999999999999999999864

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=8.2e-38  Score=343.21  Aligned_cols=252  Identities=22%  Similarity=0.314  Sum_probs=188.0

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      ..++|...+.||+|+||.||+|++.. ++.||+|++....  ..+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            35678899999999999999999875 7889999997543  34678899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcC---CCCceeeccccceecC
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMARAFG  657 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~DFGla~~~~  657 (823)
                      |+++++|.+++.   ....+++..+..++.||++||.|||+.+   |+||||||+|||++.   ++.+||+|||+++...
T Consensus       129 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          129 LVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             eCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            999999999984   3445899999999999999999999998   999999999999975   8899999999998653


Q ss_pred             CCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhh
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN  737 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  737 (823)
                      ..   .......||+.|+|||++.+..++.++||||||+++|||++|+.||.......  .+    ......... .   
T Consensus       203 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~----~~~i~~~~~-~---  269 (349)
T 2w4o_A          203 HQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FM----FRRILNCEY-Y---  269 (349)
T ss_dssp             -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HH----HHHHHTTCC-C---
T ss_pred             cc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HH----HHHHHhCCC-c---
Confidence            22   12234678999999999999999999999999999999999999974322110  01    111111100 0   


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          738 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       738 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                        ............+.+++.+||+.||++|||+.|+++.
T Consensus       270 --~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          270 --FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             --CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             --cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              0000111223467899999999999999999999873

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.2e-37  Score=330.33  Aligned_cols=247  Identities=20%  Similarity=0.301  Sum_probs=203.4

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      ..++|...++||+|+||.||+|+... +..+|+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            34678889999999999999999866 67899999987766778899999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEE---cCCCCceeeccccceecC
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFG  657 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DFGla~~~~  657 (823)
                      |+++++|.+++..   ...+++..+..++.|++.||+|||+.+   |+|+||||+||++   +.++.+||+|||++....
T Consensus        87 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           87 LCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             ccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            9999999998854   345899999999999999999999998   9999999999999   788999999999998764


Q ss_pred             CCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhh
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN  737 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  737 (823)
                      ...   ......+|+.|+|||++.+. ++.++||||||+++|||++|+.||......   .    .........      
T Consensus       161 ~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~----~~~~~~~~~------  223 (277)
T 3f3z_A          161 PGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS---E----VMLKIREGT------  223 (277)
T ss_dssp             TTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---H----HHHHHHHCC------
T ss_pred             Ccc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH---H----HHHHHHhCC------
Confidence            322   22345789999999988654 899999999999999999999997532211   0    011111110      


Q ss_pred             hhcCCCCCHH----HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          738 KSLGGSYSLS----EVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       738 ~~l~~~~~~~----~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                          ...+..    ....+.+++.+|++.||++||++.|+++
T Consensus       224 ----~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          224 ----FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             ----CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ----CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                011111    1246789999999999999999999975

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=8.1e-38  Score=344.82  Aligned_cols=253  Identities=20%  Similarity=0.270  Sum_probs=193.1

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      .++|...+.||+|+||.||+++.. .++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            467999999999999999999987 488999999965433 346788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCC--ceeeccccceecCCC
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN--PKISDFGMARAFGID  659 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~--~kl~DFGla~~~~~~  659 (823)
                      +++|+|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.  +||+|||+++.....
T Consensus        98 ~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           98 ASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            999999999854   235899999999999999999999998   999999999999987765  999999999753221


Q ss_pred             ccccccccccccCCccCccccccCCCCcc-chhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFSVK-SDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~k-sDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                         .......||+.|+|||++.+..+..+ +||||||+++|||++|+.||.......  ..... ....        ...
T Consensus       172 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~-~~~~--------~~~  237 (361)
T 3uc3_A          172 ---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKT-IQRI--------LSV  237 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHH-HHHH--------HTT
T ss_pred             ---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHH-HHHH--------hcC
Confidence               22234579999999999988887665 899999999999999999986432211  11111 1110        110


Q ss_pred             hcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       739 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      .............+.+++.+||+.||++|||+.|+++.
T Consensus       238 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          238 KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            01101111122467899999999999999999999874

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-37  Score=332.70  Aligned_cols=255  Identities=27%  Similarity=0.403  Sum_probs=204.5

Q ss_pred             cCCCcCC-eeeccCccceEEEEee---cCcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          504 ENFSDKN-KLGEGGFGPVYKGVLI---EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       504 ~~~~~~~-~LG~G~fg~Vyk~~~~---~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      ++|...+ .||+|+||.||+|++.   .+..||+|++.... ....+++.+|+.++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4455555 8999999999999864   47789999997653 34567789999999999999999999999 45678999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      |||+++++|.+++..  ....+++..+..++.||++||.|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            999999999999853  3456899999999999999999999998   99999999999999999999999999987643


Q ss_pred             Cccc-cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          659 DQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       659 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      .... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.......   ..    ......      
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~----~~i~~~------  229 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VM----AFIEQG------  229 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HH----HHHHTT------
T ss_pred             CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HH----HHHhcC------
Confidence            3221 22233456889999999998899999999999999999998 999975432211   11    111111      


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                         .....+......+.+++..|++.+|++||++.++++.|+.+
T Consensus       230 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  270 (287)
T 1u59_A          230 ---KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  270 (287)
T ss_dssp             ---CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               11112223345788999999999999999999999999865

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.3e-38  Score=337.82  Aligned_cols=265  Identities=20%  Similarity=0.280  Sum_probs=197.5

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc--ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG--QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      ++|...++||+|+||.||+|++.. ++.||+|++.....  ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            578889999999999999999865 88999999865533  235668899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |+++++|.+++..   ...+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            9999999988742   345899999999999999999999998   9999999999999999999999999998764322


Q ss_pred             cccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHH--------HHhhhcC
Q 003391          661 TEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW--------RLWIEER  731 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~--------~~~~~~~  731 (823)
                      .  ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+.........        ..+....
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (311)
T 4agu_A          157 D--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ  234 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred             c--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence            1  2233578999999999976 678999999999999999999999986433221111111000        0000000


Q ss_pred             chhhhh-hhcCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          732 PVELIN-KSLGGSYS-----LSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       732 ~~~~~~-~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ...... +.......     ......+.+++.+||+.||++|||++|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            000000 00000000     0112357899999999999999999999864

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.8e-38  Score=340.94  Aligned_cols=263  Identities=25%  Similarity=0.385  Sum_probs=204.7

Q ss_pred             cCCCcCCeeeccCccceEEEEe-----ecCcEEEEEEecCC-ccccHHHHHHHHHHHhccCCCCceeEEEEeecC--Cce
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVL-----IEGQEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR--DER  575 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~-----~~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~  575 (823)
                      +.|+..++||+|+||.||+|++     ..++.||+|++... .....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4578889999999999999984     34889999999754 334567899999999999999999999999876  668


Q ss_pred             EEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccccee
Q 003391          576 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                      ++||||+++++|.+++...  ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus       101 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence            9999999999999998542  345899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCccc-cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcC--------CCCccchhHHHHHH
Q 003391          656 FGIDQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYH--------ADHHHNLLGHAWRL  726 (823)
Q Consensus       656 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~--------~~~~~~l~~~~~~~  726 (823)
                      ....... .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+....        ..........    
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----  251 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR----  251 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH----
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH----
Confidence            6543321 22334567888999999999999999999999999999999998743110        0000000000    


Q ss_pred             hhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          727 WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       727 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                           ....+........+......+.+++.+||+.||++|||+.|+++.|+.+
T Consensus       252 -----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          252 -----LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             -----HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence                 0011111111122223345788999999999999999999999999864

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.1e-38  Score=349.67  Aligned_cols=210  Identities=28%  Similarity=0.328  Sum_probs=180.5

Q ss_pred             ccCccCHHHHHHHhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccC-----CCCce
Q 003391          490 ELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-----HRNLV  563 (823)
Q Consensus       490 ~~~~~~~~~l~~~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----H~niv  563 (823)
                      +...+.+.+.....++|.+.++||+|+||.||+|++.. ++.||||++... ....+.+..|+.++.+++     ||||+
T Consensus        21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv   99 (360)
T 3llt_A           21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIV   99 (360)
T ss_dssp             GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred             cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence            34445555555667899999999999999999999854 889999999643 334566788999999986     99999


Q ss_pred             eEEEEeecCCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcC--
Q 003391          564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN--  641 (823)
Q Consensus       564 ~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~--  641 (823)
                      ++++++...+..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.  
T Consensus       100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~  174 (360)
T 3llt_A          100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPY  174 (360)
T ss_dssp             CEEEEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTT
T ss_pred             cccceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccc
Confidence            9999999999999999999 99999998643 2335899999999999999999999998   999999999999975  


Q ss_pred             -----------------------CCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHH
Q 003391          642 -----------------------EMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLV  698 (823)
Q Consensus       642 -----------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl  698 (823)
                                             ++.+||+|||+++.....     .....||+.|+|||++.+..++.++||||||+++
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  249 (360)
T 3llt_A          175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL  249 (360)
T ss_dssp             CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred             ccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence                                   789999999999864321     2346789999999999999999999999999999


Q ss_pred             HHHHhcCCCCCC
Q 003391          699 LEIVCGKRNRGF  710 (823)
Q Consensus       699 ~elltG~~p~~~  710 (823)
                      |||++|+.||..
T Consensus       250 ~ell~g~~pf~~  261 (360)
T 3llt_A          250 AELYTGSLLFRT  261 (360)
T ss_dssp             HHHHHSSCSCCC
T ss_pred             HHHHHCCCCCCC
Confidence            999999999864

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=8.1e-38  Score=342.97  Aligned_cols=244  Identities=21%  Similarity=0.250  Sum_probs=202.5

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC---ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ++|...+.||+|+||.||+++... ++.||+|++.+.   .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            578889999999999999999864 889999998654   2345677899999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+++|+|.+++...   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       121 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence            999999999999542   35899999999999999999999998   999999999999999999999999999875422


Q ss_pred             ccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                           .....||+.|+|||++.+..++.++||||||+++|||++|+.||.....   ...    ........        
T Consensus       195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~----~~~i~~~~--------  254 (350)
T 1rdq_E          195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQI----YEKIVSGK--------  254 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH----HHHHHHCC--------
T ss_pred             -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH---HHH----HHHHHcCC--------
Confidence                 2346799999999999999999999999999999999999999753211   111    11111111        


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 003391          740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPN-----MSSVVL  775 (823)
Q Consensus       740 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  775 (823)
                      .  .++.....++.+++.+||+.||++||+     +.|+++
T Consensus       255 ~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          255 V--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             C--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             C--CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            0  111122346789999999999999998     888875

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.9e-38  Score=345.97  Aligned_cols=258  Identities=23%  Similarity=0.272  Sum_probs=190.7

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccccHHHHHHHHHHHhccC-CCCceeEEEEee--------cC
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRNLVKLIGCCT--------QR  572 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~--------~~  572 (823)
                      ..+|...++||+|+||.||+|++. .++.||+|++........+.+.+|+.++.++. ||||+++++++.        ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            457888999999999999999975 48899999997766666778999999999996 999999999984        33


Q ss_pred             CceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccc
Q 003391          573 DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM  652 (823)
Q Consensus       573 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl  652 (823)
                      ...++|+||++ |+|.+++........+++..++.++.||+.||.|||+.+ ++|+||||||+|||++.++.+||+|||+
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  184 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS  184 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence            45799999996 799998866555567999999999999999999999875 3499999999999999999999999999


Q ss_pred             ceecCCCcccc----------ccccccccCCccCcccc---ccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccch
Q 003391          653 ARAFGIDQTEA----------NTNRVVGTYGYMPPEYA---IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL  719 (823)
Q Consensus       653 a~~~~~~~~~~----------~~~~~~gt~~y~aPE~l---~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l  719 (823)
                      ++.........          ......+|+.|+|||++   .+..++.++||||||+++|||++|+.||......     
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----  259 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-----  259 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-----
Confidence            98764322111          11134689999999998   5677899999999999999999999997532111     


Q ss_pred             hHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          720 LGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       720 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                                    ..+...............+.+++.+||+.||++||++.|+++.|+.+.
T Consensus       260 --------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~  307 (337)
T 3ll6_A          260 --------------RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA  307 (337)
T ss_dssp             --------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --------------HhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                          011111111111111234678999999999999999999999998763

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1e-37  Score=341.82  Aligned_cols=262  Identities=20%  Similarity=0.225  Sum_probs=200.4

Q ss_pred             HHHHhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC-----ccccHHHHHHHHHHHhccCCCCceeEEEEeecC
Q 003391          499 IANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS-----SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR  572 (823)
Q Consensus       499 l~~~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~  572 (823)
                      +....++|...+.||+|+||.||+|+... ++.||+|++...     .....+.+.+|+.++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            34566789999999999999999999854 788999998654     345567899999999999999999999999999


Q ss_pred             CceEEEEeecCCCCcchhhhccC-------------------------------------CCCccCHHHHHHHHHHHHHH
Q 003391          573 DERMLIYEYLPNKSLNDFIFDVT-------------------------------------RSKFLDWSKRCQIIGGIARG  615 (823)
Q Consensus       573 ~~~~lV~e~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~g  615 (823)
                      +..++||||+++|+|.+++....                                     ....+++..+..++.||++|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            99999999999999999884210                                     02234677788999999999


Q ss_pred             HHHHHhcCCCceEecccCCCcEEEcCCC--CceeeccccceecCCCccc--cccccccccCCccCcccccc--CCCCccc
Q 003391          616 LLYLHQDSRLRIIHRDLKASNVLLDNEM--NPKISDFGMARAFGIDQTE--ANTNRVVGTYGYMPPEYAID--GLFSVKS  689 (823)
Q Consensus       616 L~yLH~~~~~~ivH~Dlk~~NIll~~~~--~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~--~~~s~ks  689 (823)
                      |+|||+.+   |+||||||+|||++.++  .+||+|||+++.+......  .......||+.|+|||++.+  ..++.++
T Consensus       181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            99999998   99999999999998776  8999999999876432211  12334678999999999975  6789999


Q ss_pred             hhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 003391          690 DVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPN  769 (823)
Q Consensus       690 DVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs  769 (823)
                      ||||||+++|||++|+.||......      ... ......... ...+     ........+.+++.+|++.+|.+||+
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~------~~~-~~~~~~~~~-~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps  324 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDA------DTI-SQVLNKKLC-FENP-----NYNVLSPLARDLLSNLLNRNVDERFD  324 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHH------HHH-HHHHHCCCC-TTSG-----GGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChH------HHH-HHHHhcccc-cCCc-----ccccCCHHHHHHHHHHcCCChhHCCC
Confidence            9999999999999999997532211      011 111111000 0000     00011246789999999999999999


Q ss_pred             HHHHHHH
Q 003391          770 MSSVVLM  776 (823)
Q Consensus       770 ~~evl~~  776 (823)
                      +.|+++.
T Consensus       325 ~~~~l~h  331 (345)
T 3hko_A          325 AMRALQH  331 (345)
T ss_dssp             HHHHHHS
T ss_pred             HHHHhcC
Confidence            9999873

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.5e-37  Score=329.68  Aligned_cols=253  Identities=24%  Similarity=0.362  Sum_probs=200.1

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      ++|.....||+|+||.||+|+... ++.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            445566799999999999999754 7899999998776666788999999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcC-CCCceeeccccceecCCCcc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-EMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DFGla~~~~~~~~  661 (823)
                      ++++|.+++........+++..+..++.||++||.|||+.+   |+|+||||+||+++. ++.+||+|||++....... 
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-  177 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-  177 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence            99999999976544456788999999999999999999998   999999999999987 8999999999998764321 


Q ss_pred             ccccccccccCCccCccccccCC--CCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGL--FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~--~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                       .......|++.|+|||++.+..  ++.++||||||+++|||++|+.||.......     ......         ....
T Consensus       178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~---------~~~~  242 (295)
T 2clq_A          178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ-----AAMFKV---------GMFK  242 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH-----HHHHHH---------HHHC
T ss_pred             -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh-----HHHHhh---------cccc
Confidence             1223457899999999997654  8899999999999999999999975321110     000000         0001


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       740 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      .....+.....++.+++.+||+.||++||++.|+++
T Consensus       243 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          243 VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111122222346788999999999999999999985

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-38  Score=345.04  Aligned_cols=265  Identities=28%  Similarity=0.401  Sum_probs=207.7

Q ss_pred             hcCCCcCCeeeccCccceEEEEe-----ecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCC--ce
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVL-----IEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD--ER  575 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~-----~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~  575 (823)
                      .++|...+.||+|+||.||++++     ..++.||+|++........+.+.+|+.++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            35688889999999999999984     248899999998777667788999999999999999999999987654  78


Q ss_pred             EEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccccee
Q 003391          576 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                      ++||||+++++|.+++...  ...+++..++.++.||++||+|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus       120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            9999999999999999642  345899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCccc-cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhc----
Q 003391          656 FGIDQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE----  730 (823)
Q Consensus       656 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~----  730 (823)
                      ....... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+.....        .........    
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~--------~~~~~~~~~~~~~  266 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA--------EFMRMIGNDKQGQ  266 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH--------HHHHHHCTTCCTH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH--------HHHHhhccccchh
Confidence            6543221 112234567789999999998999999999999999999999988542100        000000000    


Q ss_pred             ----CchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          731 ----RPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       731 ----~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                          ...+.+........+.....++.+++.+||+.||++||++.|+++.|+.+
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          267 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                00111111111112223345788999999999999999999999999865

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.4e-37  Score=350.49  Aligned_cols=247  Identities=24%  Similarity=0.385  Sum_probs=202.9

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      .++|...+.||+|+||.||+|++. .++.||||++....   ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            357888999999999999999986 48999999996542   23456789999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      |||+++|+|.+++.   +...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        95 ~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           95 MEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             EECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            99999999999984   3456899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CccccccccccccCCccCccccccCCC-CccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN  737 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  737 (823)
                      ..   ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....   ..+.    .......      
T Consensus       169 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~~----~~i~~~~------  232 (476)
T 2y94_A          169 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---PTLF----KKICDGI------  232 (476)
T ss_dssp             TC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS---HHHH----HHHHTTC------
T ss_pred             cc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH---HHHH----HHHhcCC------
Confidence            22   2234579999999999988775 7899999999999999999999853221   1111    1111110      


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          738 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       738 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                        .  ..+.....++.+++.+||+.||++|||+.|+++
T Consensus       233 --~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          233 --F--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             --C--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --c--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence              0  011111236788999999999999999999997

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.1e-37  Score=331.47  Aligned_cols=256  Identities=25%  Similarity=0.341  Sum_probs=201.8

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec----CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM  576 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~----~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  576 (823)
                      ..++|...+.||+|+||.||+|++..    +..||+|++.... ....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence            34678889999999999999999754    2359999987653 3456778999999999999999999999875 4578


Q ss_pred             EEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceec
Q 003391          577 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  656 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  656 (823)
                      +||||+++++|.+++..  ....+++..+..++.|+++||.|||+.+   |+|+||||+||+++.++.+||+|||++...
T Consensus        89 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           89 IIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             EEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             EEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence            99999999999999954  2345899999999999999999999998   999999999999999999999999999865


Q ss_pred             CCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhh
Q 003391          657 GIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVEL  735 (823)
Q Consensus       657 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  735 (823)
                      ..... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......   ....    ....     
T Consensus       164 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~----~~~~-----  230 (281)
T 3cc6_A          164 EDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGV----LEKG-----  230 (281)
T ss_dssp             ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHH----HHHT-----
T ss_pred             ccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHH----HhcC-----
Confidence            43221 12223456789999999999999999999999999999998 999975332211   1111    1111     


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       736 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                          .....+......+.+++.+|++.+|++||++.|+++.|+.+
T Consensus       231 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          231 ----DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence                01111112234678999999999999999999999999865

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-37  Score=365.52  Aligned_cols=248  Identities=26%  Similarity=0.397  Sum_probs=197.5

Q ss_pred             eeeccCccceEEEEee---cCcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCCCC
Q 003391          511 KLGEGGFGPVYKGVLI---EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKS  586 (823)
Q Consensus       511 ~LG~G~fg~Vyk~~~~---~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  586 (823)
                      +||+|+||.||+|.+.   ++..||||+++... ....++|.+|+.++++++|||||++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999875   35679999997653 3457889999999999999999999999976 56899999999999


Q ss_pred             cchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc-ccc
Q 003391          587 LNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE-ANT  665 (823)
Q Consensus       587 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~  665 (823)
                      |.+++..  +...+++..+..++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++.+...... ...
T Consensus       422 L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  496 (613)
T 2ozo_A          422 LHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR  496 (613)
T ss_dssp             HHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred             HHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence            9999853  3456899999999999999999999998   999999999999999999999999999876433221 112


Q ss_pred             ccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCC
Q 003391          666 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY  744 (823)
Q Consensus       666 ~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~  744 (823)
                      ....+|+.|+|||++.+..++.++||||||++||||++ |+.||......+   .    .......         .....
T Consensus       497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~----~~~i~~~---------~~~~~  560 (613)
T 2ozo_A          497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---V----MAFIEQG---------KRMEC  560 (613)
T ss_dssp             -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---H----HHHHHTT---------CCCCC
T ss_pred             cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---H----HHHHHcC---------CCCCC
Confidence            22345689999999999999999999999999999998 999976432211   1    1111111         11122


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          745 SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       745 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      +.....++.+|+..||+.+|++||++.+|++.|+..
T Consensus       561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            223345788999999999999999999999999864

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.6e-37  Score=337.53  Aligned_cols=244  Identities=24%  Similarity=0.287  Sum_probs=178.5

Q ss_pred             CCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccC-CCCceeEEEEeecCCceEEEEeecCCCC
Q 003391          509 KNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLIYEYLPNKS  586 (823)
Q Consensus       509 ~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gs  586 (823)
                      .+.||+|+||.||+|++.. ++.||+|++...   ....+.+|+.++..+. ||||+++++++.+....++||||+++++
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            4789999999999999864 889999999643   3467789999999997 9999999999999999999999999999


Q ss_pred             cchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCC---CceeeccccceecCCCcccc
Q 003391          587 LNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM---NPKISDFGMARAFGIDQTEA  663 (823)
Q Consensus       587 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~DFGla~~~~~~~~~~  663 (823)
                      |.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++   .+||+|||+++......  .
T Consensus        93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~  164 (325)
T 3kn6_A           93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--Q  164 (325)
T ss_dssp             HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--C
Confidence            9999954   356899999999999999999999998   99999999999998765   79999999998654322  2


Q ss_pred             ccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCC
Q 003391          664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS  743 (823)
Q Consensus       664 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~  743 (823)
                      ......+|+.|+|||++.+..++.++||||||+++|||++|+.||.............            +++.....+.
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~------------~~~~~i~~~~  232 (325)
T 3kn6_A          165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAV------------EIMKKIKKGD  232 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHH------------HHHHHHTTTC
T ss_pred             cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHH------------HHHHHHHcCC
Confidence            2234578999999999999999999999999999999999999986433221111111            1111111111


Q ss_pred             C--CHH----HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          744 Y--SLS----EVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       744 ~--~~~----~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      .  ..+    ...++.+++.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          233 FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             CCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             CCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            1  111    1347789999999999999999999874

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-37  Score=347.35  Aligned_cols=270  Identities=21%  Similarity=0.265  Sum_probs=212.4

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCC--ceEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD--ERMLI  578 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV  578 (823)
                      .++|...++||+|+||.||+|++.. ++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            3578889999999999999999875 8899999997543 345677889999999999999999999998765  67999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEE----cCCCCceeeccccce
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNEMNPKISDFGMAR  654 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~DFGla~  654 (823)
                      |||+++|+|.+++........+++..++.++.||+.||+|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999965544445999999999999999999999998   9999999999999    777889999999998


Q ss_pred             ecCCCccccccccccccCCccCcccccc--------CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHH
Q 003391          655 AFGIDQTEANTNRVVGTYGYMPPEYAID--------GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL  726 (823)
Q Consensus       655 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  726 (823)
                      ......   ......||+.|+|||++.+        ..++.++||||||+++|||++|+.||.........  .. ....
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~-~~~~  238 (396)
T 4eut_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KE-VMYK  238 (396)
T ss_dssp             ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HH-HHHH
T ss_pred             EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HH-HHHH
Confidence            764322   2233578999999999865        56788999999999999999999998543322211  11 1111


Q ss_pred             hhhcCchhhhh---------------hhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          727 WIEERPVELIN---------------KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       727 ~~~~~~~~~~~---------------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      .....+...+.               ..............+.+++..||+.||++||++.|+++.|+.+.
T Consensus       239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il  308 (396)
T 4eut_A          239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (396)
T ss_dssp             HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred             HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence            12222111110               00111233556678889999999999999999999999887653

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=6.6e-37  Score=327.59  Aligned_cols=262  Identities=21%  Similarity=0.279  Sum_probs=203.9

Q ss_pred             HhcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEe-ecCCceEEEE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC-TQRDERMLIY  579 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~-~~~~~~~lV~  579 (823)
                      ..++|...+.||+|+||.||+|++. .++.||+|++......  .++.+|+.++..++|++++..++.+ .+.+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            4578999999999999999999974 4889999987554322  3578899999999988877777666 5667789999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEE---cCCCCceeeccccceec
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAF  656 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DFGla~~~  656 (823)
                      ||+ +++|.+++...  ...+++..+..++.||+.||.|||+.+   |+||||||+|||+   ++++.+||+|||+++..
T Consensus        85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            999 99999998532  345899999999999999999999998   9999999999999   78999999999999876


Q ss_pred             CCCccc-----cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcC
Q 003391          657 GIDQTE-----ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER  731 (823)
Q Consensus       657 ~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  731 (823)
                      ......     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......................
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence            543221     122346789999999999999999999999999999999999999876554443333332221111111


Q ss_pred             chhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          732 PVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       732 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      .     ..+....    ...+.+++..|++.+|++||+++++++.|+.+
T Consensus       239 ~-----~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~  278 (296)
T 4hgt_A          239 I-----EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             H-----HHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             h-----hhhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence            0     0111111    24678999999999999999999999999865

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=9.6e-38  Score=331.98  Aligned_cols=251  Identities=27%  Similarity=0.432  Sum_probs=203.0

Q ss_pred             HhcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeec---------
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ---------  571 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~---------  571 (823)
                      ..++|...+.||+|+||.||+|++. +++.||+|++....    +.+.+|++++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            3467888999999999999999986 58999999996543    356789999999999999999998854         


Q ss_pred             -------CCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCC
Q 003391          572 -------RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN  644 (823)
Q Consensus       572 -------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~  644 (823)
                             ....++||||+++++|.+++... ....+++..+..++.||+.||.|||+.+   |+|+||||+||++++++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence                   44579999999999999999643 2346899999999999999999999998   999999999999999999


Q ss_pred             ceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHH
Q 003391          645 PKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW  724 (823)
Q Consensus       645 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~  724 (823)
                      +||+|||++.......   ......+|+.|+|||++.+..++.++||||||+++|||++|..|+...         ....
T Consensus       161 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------~~~~  228 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------SKFF  228 (284)
T ss_dssp             EEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------HHHH
T ss_pred             EEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------HHHH
Confidence            9999999998764332   223356899999999999999999999999999999999999874210         0001


Q ss_pred             HHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCCCC
Q 003391          725 RLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLP  784 (823)
Q Consensus       725 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~  784 (823)
                      .        .+....+....    ...+.+++.+|++.||++||++.|+++.|+....-+
T Consensus       229 ~--------~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~  276 (284)
T 2a19_B          229 T--------DLRDGIISDIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP  276 (284)
T ss_dssp             H--------HHHTTCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred             H--------HhhcccccccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence            1        11111111112    235678999999999999999999999998765433

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.2e-37  Score=341.75  Aligned_cols=249  Identities=26%  Similarity=0.322  Sum_probs=202.0

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC---ccccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERM  576 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~  576 (823)
                      ..++|...+.||+|+||.||+|+... ++.||+|++.+.   .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            34688999999999999999999865 788999999764   234567788999999988 8999999999999999999


Q ss_pred             EEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceec
Q 003391          577 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  656 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  656 (823)
                      +||||+++|+|.+++...   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        98 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            999999999999998542   35899999999999999999999998   999999999999999999999999999864


Q ss_pred             CCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          657 GIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       657 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      ...  .......+||+.|+|||++.+..++.++||||||+++|||++|+.||.....   ..+..    .....      
T Consensus       172 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~----~i~~~------  236 (353)
T 2i0e_A          172 IWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQ----SIMEH------  236 (353)
T ss_dssp             CCT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH----HHHHC------
T ss_pred             ccC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH---HHHHH----HHHhC------
Confidence            222  2233446899999999999999999999999999999999999999753211   11111    11111      


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPN-----MSSVVL  775 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  775 (823)
                        ..  .++.....++.+++.+||+.||++||+     +.|+++
T Consensus       237 --~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          237 --NV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             --CC--CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             --CC--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence              11  111122346788999999999999995     466664

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=4.1e-37  Score=333.71  Aligned_cols=252  Identities=23%  Similarity=0.292  Sum_probs=203.1

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc------ccHHHHHHHHHHHhccCCCCceeEEEEeecCCce
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG------QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDER  575 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~  575 (823)
                      .++|...+.||+|+||.||+|+... ++.||+|++.....      ...+++.+|+.++.+++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            4568889999999999999999864 88999999866432      1467899999999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCC----Cceeeccc
Q 003391          576 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM----NPKISDFG  651 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~DFG  651 (823)
                      ++||||+++++|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+||+++.++    .+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            999999999999999853   346899999999999999999999998   99999999999999888    79999999


Q ss_pred             cceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcC
Q 003391          652 MARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER  731 (823)
Q Consensus       652 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  731 (823)
                      ++.......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||......   ...    .......
T Consensus       165 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~----~~i~~~~  234 (321)
T 2a2a_A          165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETL----ANITSVS  234 (321)
T ss_dssp             TCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHH----HHHHTTC
T ss_pred             cceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH---HHH----HHHHhcc
Confidence            998764322   223456899999999999999999999999999999999999997532111   010    0000000


Q ss_pred             chhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          732 PVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       732 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      . . .......    .....+.+++.+|++.||++|||+.|+++.
T Consensus       235 ~-~-~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          235 Y-D-FDEEFFS----HTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             C-C-CCHHHHT----TCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             c-c-cChhhhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0 0 0000000    112367889999999999999999999873

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=9.4e-38  Score=339.66  Aligned_cols=248  Identities=23%  Similarity=0.308  Sum_probs=192.3

Q ss_pred             hcCCCcCCeeeccCccceEEEEee----cCcEEEEEEecCCc----cccHHHHHHHHHHHhccCCCCceeEEEEeecCCc
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI----EGQEIAAKRLSKSS----GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE  574 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~----~~~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~  574 (823)
                      .++|...+.||+|+||.||+++..    .++.||+|++.+..    ......+.+|+.++++++||||+++++++.+.+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            467889999999999999999973    58899999997652    2344567899999999999999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccce
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  654 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  654 (823)
                      .++||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            9999999999999999853   345889999999999999999999998   9999999999999999999999999997


Q ss_pred             ecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchh
Q 003391          655 AFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE  734 (823)
Q Consensus       655 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  734 (823)
                      ......  .......||+.|+|||++.+..++.++||||||+++|||++|+.||.....   .....    ...      
T Consensus       170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~----~i~------  234 (327)
T 3a62_A          170 ESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR---KKTID----KIL------  234 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHH----HHH------
T ss_pred             ccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH---HHHHH----HHH------
Confidence            543221  223346799999999999999999999999999999999999999853221   11111    111      


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003391          735 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVL  775 (823)
Q Consensus       735 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  775 (823)
                        ....  ..+......+.+++.+||+.||++||     ++.|+++
T Consensus       235 --~~~~--~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          235 --KCKL--NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             --HTCC--CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             --hCCC--CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence              1111  11112234678899999999999999     6778775

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=9e-38  Score=339.83  Aligned_cols=260  Identities=29%  Similarity=0.407  Sum_probs=203.1

Q ss_pred             hcCCCcCCeeeccCccceEEEEee------cCcEEEEEEecCC-ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCce
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDER  575 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~------~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~  575 (823)
                      .++|...+.||+|+||.||+|++.      .++.||+|++... ......++.+|+.++++++||||+++++++.+....
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            467889999999999999999842      3678999999654 334556789999999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhccCC----CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcC---CCCceee
Q 003391          576 MLIYEYLPNKSLNDFIFDVTR----SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKIS  648 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~  648 (823)
                      ++||||+++++|.+++.....    ...+++..++.++.||++||.|||+.+   |+||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999975332    245899999999999999999999998   999999999999984   4569999


Q ss_pred             ccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHh
Q 003391          649 DFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLW  727 (823)
Q Consensus       649 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~  727 (823)
                      |||++................+|+.|+|||++.+..++.++||||||+++|||++ |+.||......       ......
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~~~~  258 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFV  258 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------HHHHHH
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH-------HHHHHH
Confidence            9999986543333333344567889999999999999999999999999999998 88887532111       011111


Q ss_pred             hhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          728 IEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       728 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      ...         ............+.+++.+||+.||.+||++.++++.|+...
T Consensus       259 ~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          259 TSG---------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             HTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hcC---------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            111         011111222346789999999999999999999999998653

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=7e-38  Score=334.76  Aligned_cols=255  Identities=26%  Similarity=0.371  Sum_probs=201.2

Q ss_pred             hcCCCcCC-eeeccCccceEEEEee---cCcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceE
Q 003391          503 TENFSDKN-KLGEGGFGPVYKGVLI---EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM  576 (823)
Q Consensus       503 ~~~~~~~~-~LG~G~fg~Vyk~~~~---~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  576 (823)
                      .++|...+ .||+|+||.||+|.+.   .++.||+|++....  ....+++.+|+.++++++||||+++++++ +.+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            35677777 9999999999999653   26789999997653  23356799999999999999999999999 567789


Q ss_pred             EEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceec
Q 003391          577 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  656 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  656 (823)
                      +||||+++++|.+++..   ...+++..+..++.||++||+|||+.+   |+|+||||+||+++.++.+||+|||++...
T Consensus        94 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            99999999999999954   345899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCcccc-ccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchh
Q 003391          657 GIDQTEA-NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVE  734 (823)
Q Consensus       657 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  734 (823)
                      ....... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......       .........    
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~----  236 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKG----  236 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTT----
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcC----
Confidence            4432221 1222346788999999998899999999999999999999 99997532211       011111111    


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          735 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       735 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                           .....+......+.+++..|++.||++||++.++++.|+.+
T Consensus       237 -----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          237 -----ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                 11112222345788999999999999999999999999864

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.1e-36  Score=326.09  Aligned_cols=261  Identities=21%  Similarity=0.274  Sum_probs=207.1

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEe-ecCCceEEEEe
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC-TQRDERMLIYE  580 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~-~~~~~~~lV~e  580 (823)
                      .++|...+.||+|+||.||+|++. +++.||+|++.....  .+++.+|+.++..++|++++..+..+ .+.+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            468899999999999999999974 588999999865443  34688999999999998877766665 55677899999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEE---cCCCCceeeccccceecC
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFG  657 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DFGla~~~~  657 (823)
                      |+ +++|.+++..  ....+++..+..++.||+.||+|||+.+   |+||||||+|||+   +.++.+||+|||+++...
T Consensus        86 ~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           86 LL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             ec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            99 9999999853  2345899999999999999999999998   9999999999999   588999999999998765


Q ss_pred             CCccc-----cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCc
Q 003391          658 IDQTE-----ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP  732 (823)
Q Consensus       658 ~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  732 (823)
                      .....     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........................
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence            43221     1123467999999999999999999999999999999999999998765444333333222221111111


Q ss_pred             hhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          733 VELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       733 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                           ..+....    ..++.+++.+|++.||++||++.++++.|+.+
T Consensus       240 -----~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  278 (296)
T 3uzp_A          240 -----EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             -----HHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             -----HHHHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence                 0111111    24678899999999999999999999999875

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.2e-38  Score=345.99  Aligned_cols=256  Identities=25%  Similarity=0.366  Sum_probs=192.0

Q ss_pred             CCCcCCeeeccCccceEEEEeec----CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeec-CCceEEE
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ-RDERMLI  578 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~----~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV  578 (823)
                      .|...+.||+|+||.||+|++.+    ...+|+|.+.... ....++|.+|+.++++++||||+++++++.+ .+..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            45667899999999999999754    2368999886543 3456789999999999999999999998754 4678999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      |||+++|+|.+++..  ....+++..+..++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++.+..
T Consensus       170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence            999999999999953  3345789999999999999999999998   99999999999999999999999999986543


Q ss_pred             Cccc--cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhh
Q 003391          659 DQTE--ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVEL  735 (823)
Q Consensus       659 ~~~~--~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  735 (823)
                      ....  .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+   ....    .....    
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~----~~~~~----  313 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY----LLQGR----  313 (373)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHH----HHTTC----
T ss_pred             cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHH----HHcCC----
Confidence            2211  12233457789999999999999999999999999999999 566654322211   1111    11111    


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       736 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                           ....+......+.+++.+||+.+|++||+++|+++.|+.+.
T Consensus       314 -----~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~  354 (373)
T 3c1x_A          314 -----RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  354 (373)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                 00111122346789999999999999999999999998764

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.6e-37  Score=338.88  Aligned_cols=243  Identities=22%  Similarity=0.325  Sum_probs=200.9

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc--------ccHHHHHHHHHHHhccCCCCceeEEEEeecC
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG--------QGMEEFENEVLLIAKLQHRNLVKLIGCCTQR  572 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~--------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~  572 (823)
                      ..++|...+.||+|+||.||+|++.. ++.||+|++.....        ...+.+.+|+.++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            45789999999999999999999754 88999999876531        1334677899999999999999999999999


Q ss_pred             CceEEEEeecCCC-CcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccc
Q 003391          573 DERMLIYEYLPNK-SLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG  651 (823)
Q Consensus       573 ~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFG  651 (823)
                      +..++||||+.+| +|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999999777 99998843   345899999999999999999999998   9999999999999999999999999


Q ss_pred             cceecCCCccccccccccccCCccCccccccCCC-CccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhc
Q 003391          652 MARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE  730 (823)
Q Consensus       652 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  730 (823)
                      +++......   ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....                 
T Consensus       176 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------------  235 (335)
T 3dls_A          176 SAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-----------------  235 (335)
T ss_dssp             TCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----------------
T ss_pred             cceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----------------
Confidence            998764332   2234678999999999988877 8899999999999999999999753111                 


Q ss_pred             CchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          731 RPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       731 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                          ..........  ....++.+++.+||+.||++|||+.|+++.
T Consensus       236 ----~~~~~~~~~~--~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          236 ----TVEAAIHPPY--LVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ----GTTTCCCCSS--CCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ----HHhhccCCCc--ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                1111111111  112367889999999999999999999975

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.2e-37  Score=353.67  Aligned_cols=248  Identities=23%  Similarity=0.293  Sum_probs=192.7

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC---ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      .++|...++||+|+||.||+|+... ++.||+|++...   .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            4678889999999999999999764 889999999754   334456678899999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      |||+++|+|.+++..   ...+++..+..++.||++||+|||+ .+   |+||||||+|||++.++.+||+|||+++...
T Consensus       227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            999999999999854   3458999999999999999999998 76   9999999999999999999999999998543


Q ss_pred             CCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhh
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN  737 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  737 (823)
                      ..  ........||+.|+|||++.+..++.++||||||+++|||++|+.||.....   ..+..    .....       
T Consensus       301 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~----~i~~~-------  364 (446)
T 4ejn_A          301 KD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFE----LILME-------  364 (446)
T ss_dssp             C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH----HHHHC-------
T ss_pred             CC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HHHHH----HHHhC-------
Confidence            22  2223446899999999999999999999999999999999999999743211   11111    11100       


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003391          738 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVL  775 (823)
Q Consensus       738 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  775 (823)
                       ..  .++.....++.+++.+||+.||.+||     +++|+++
T Consensus       365 -~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          365 -EI--RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             -CC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -CC--CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence             00  11112234678999999999999999     9999986

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2e-37  Score=332.28  Aligned_cols=258  Identities=25%  Similarity=0.349  Sum_probs=200.2

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec----CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEee-cCCceE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCT-QRDERM  576 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~----~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~-~~~~~~  576 (823)
                      ..+|...++||+|+||.||+|++.+    ...+|+|++.... ....+++.+|+.++++++||||+++++++. ..+..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3567888999999999999999754    2358999987643 334567899999999999999999999864 456789


Q ss_pred             EEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceec
Q 003391          577 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  656 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  656 (823)
                      +||||+++++|.+++..  ....+++..+..++.|+++||+|||+.+   |+||||||+||++++++.+||+|||+++..
T Consensus       104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence            99999999999999954  3455899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCccc--cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCC-CCCCcCCCCccchhHHHHHHhhhcCch
Q 003391          657 GIDQTE--ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR-NRGFYHADHHHNLLGHAWRLWIEERPV  733 (823)
Q Consensus       657 ~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~-p~~~~~~~~~~~l~~~~~~~~~~~~~~  733 (823)
                      ......  .......+|+.|+|||.+.+..++.++||||||+++|||++|.. |+......   .....    .....  
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~~~~----~~~~~--  249 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVY----LLQGR--  249 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT---THHHH----HHTTC--
T ss_pred             cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH---HHHHH----HhcCC--
Confidence            433221  22233567889999999999999999999999999999999554 44322111   11110    01110  


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          734 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       734 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                             ....+......+.+++.+|++.+|++||+++|+++.|+.+.
T Consensus       250 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  290 (298)
T 3f66_A          250 -------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  290 (298)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                   00111112346789999999999999999999999998764

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.3e-37  Score=330.45  Aligned_cols=248  Identities=26%  Similarity=0.362  Sum_probs=200.0

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      +.++|...+.||+|+||.||+|++.. ++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            34678889999999999999999865 6789999986532   2345678999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      ||||+++++|.+++...   ..+++..+..++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||++....
T Consensus        87 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            99999999999998543   34899999999999999999999987   9999999999999999999999999986543


Q ss_pred             CCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhh
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN  737 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  737 (823)
                      ..    ......+++.|+|||.+.+..++.++||||||+++|||++|+.||......   ..    ......        
T Consensus       161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~----~~~~~~--------  221 (279)
T 3fdn_A          161 SS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---ET----YKRISR--------  221 (279)
T ss_dssp             -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HH----HHHHHH--------
T ss_pred             cc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH---HH----HHHHHh--------
Confidence            22    223357899999999999999999999999999999999999997532111   00    000000        


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          738 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       738 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                        .....+......+.+++.+||+.+|++||++.|+++.
T Consensus       222 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          222 --VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             --TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             --CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence              0111111223467789999999999999999999974

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.3e-37  Score=335.77  Aligned_cols=263  Identities=22%  Similarity=0.327  Sum_probs=198.5

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      .++|.+.+.||+|+||.||+|... +++.||+|++....   ....+++.+|+.++++++||||+++++++.+.+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            457889999999999999999975 58999999997532   33456788999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          579 YEYLPNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      |||+++++|.+++... .....+++..++.++.||++||.|||+.+   |+|+||||+||+++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            9999999999998642 23456899999999999999999999998   9999999999999999999999999998654


Q ss_pred             CCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhh
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN  737 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  737 (823)
                      ...  .......+++.|+|||.+.+..++.++||||||+++|||++|+.||......    .... ........      
T Consensus       188 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~-~~~~~~~~------  254 (310)
T 2wqm_A          188 SKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSL-CKKIEQCD------  254 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHH-HHHHHTTC------
T ss_pred             CCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHH-HHHhhccc------
Confidence            322  1223356899999999999999999999999999999999999997532111    1111 01111100      


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCCC
Q 003391          738 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL  783 (823)
Q Consensus       738 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~  783 (823)
                        ...........++.+++.+||+.||++||++.+++++|+.+...
T Consensus       255 --~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~  298 (310)
T 2wqm_A          255 --YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC  298 (310)
T ss_dssp             --SCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --CCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence              00001111234678999999999999999999999999987533

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.1e-37  Score=342.30  Aligned_cols=252  Identities=15%  Similarity=0.124  Sum_probs=203.0

Q ss_pred             HhcCCCcCCeeeccCccceEEEE------eecCcEEEEEEecCCccccHHHHHHHHHHHhccC---CCCceeEEEEeecC
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGV------LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ---HRNLVKLIGCCTQR  572 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~------~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~  572 (823)
                      ..++|...++||+|+||.||+|+      ...++.||+|++...   ...++..|+.++..++   |+||+++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            34678889999999999999994      335889999999654   3456778888888776   99999999999999


Q ss_pred             CceEEEEeecCCCCcchhhhccC--CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcC---------
Q 003391          573 DERMLIYEYLPNKSLNDFIFDVT--RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---------  641 (823)
Q Consensus       573 ~~~~lV~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~---------  641 (823)
                      +..++||||+++|+|.+++....  ....+++..++.++.||++||+|||+.+   |+||||||+|||++.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence            99999999999999999996422  3456999999999999999999999988   999999999999998         


Q ss_pred             --CCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccch
Q 003391          642 --EMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL  719 (823)
Q Consensus       642 --~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l  719 (823)
                        ++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||........   
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---  293 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC---  293 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce---
Confidence              899999999999876433333344557899999999999999999999999999999999999999743221110   


Q ss_pred             hHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHhccC
Q 003391          720 LGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDR-PNMSSVVLMLSGE  780 (823)
Q Consensus       720 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Ps~~evl~~L~~~  780 (823)
                                     .+...+....   ....+.+++..|++.+|.+| |+++++.+.|+..
T Consensus       294 ---------------~~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          294 ---------------KPEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             ---------------EECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             ---------------eechhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence                           0011111111   12355678889999999998 5788888888754

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-37  Score=331.46  Aligned_cols=256  Identities=26%  Similarity=0.323  Sum_probs=201.5

Q ss_pred             CCCcCCeeeccCccceEEEEeec-C---cEEEEEEecCCcc-ccHHHHHHHHHHHhccCCCCceeEEEEeecCCce-EEE
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-G---QEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDER-MLI  578 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~---~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~-~lV  578 (823)
                      .|...++||+|+||.||+|++.+ +   ..+|+|++..... ...+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            45556899999999999999754 2   2699999876433 4457789999999999999999999999876655 999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      +||+.+++|.+++..  ....+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++....
T Consensus       102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            999999999999954  3456899999999999999999999998   99999999999999999999999999986543


Q ss_pred             Cc--cccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          659 DQ--TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       659 ~~--~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      ..  .........+|+.|+|||.+.+..++.++||||||+++|||++|..|+....  .......             .+
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~--~~~~~~~-------------~~  241 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI--DPFDLTH-------------FL  241 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--CGGGHHH-------------HH
T ss_pred             CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC--CHHHHHH-------------Hh
Confidence            22  1122334567889999999999999999999999999999999776632111  1111110             01


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      ........+......+.+++.+|++.+|.+|||++++++.|+.+
T Consensus       242 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  285 (298)
T 3pls_A          242 AQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI  285 (298)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            11111111122234678999999999999999999999999875

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.8e-37  Score=330.19  Aligned_cols=249  Identities=27%  Similarity=0.403  Sum_probs=204.4

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      .+.|...+.||+|+||.||+|+... ++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            4668889999999999999999754 8899999986553 4456789999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |+++++|.+++.    ...+++..+..++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||++.......
T Consensus       101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A          101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            999999999983    346899999999999999999999998   9999999999999999999999999998764332


Q ss_pred             cccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhc
Q 003391          661 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL  740 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l  740 (823)
                        .......|++.|+|||++.+..++.++||||||+++|||++|+.|+......      . .........         
T Consensus       174 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~-~~~~~~~~~---------  235 (303)
T 3a7i_A          174 --IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM------K-VLFLIPKNN---------  235 (303)
T ss_dssp             --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------H-HHHHHHHSC---------
T ss_pred             --cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH------H-HHHHhhcCC---------
Confidence              1223457899999999999999999999999999999999999997532211      0 000001111         


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          741 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ...........+.+++..|++.+|++|||+.|+++.
T Consensus       236 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          236 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            111111223467899999999999999999999864

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-37  Score=348.22  Aligned_cols=261  Identities=19%  Similarity=0.223  Sum_probs=203.7

Q ss_pred             HHHHHHhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecC
Q 003391          497 MAIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR  572 (823)
Q Consensus       497 ~~l~~~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~  572 (823)
                      .+.....++|...++||+|+||.||+++... ++.||+|++.+..   ....+.+.+|..++.+++||||+++++++.+.
T Consensus        54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  133 (412)
T 2vd5_A           54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE  133 (412)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            3444456889999999999999999999864 8999999996532   22344588999999999999999999999999


Q ss_pred             CceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccc
Q 003391          573 DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM  652 (823)
Q Consensus       573 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl  652 (823)
                      +..++||||+++|+|.+++...  ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       134 ~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGl  208 (412)
T 2vd5_A          134 NYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGS  208 (412)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechh
Confidence            9999999999999999999642  235899999999999999999999998   99999999999999999999999999


Q ss_pred             ceecCCCccccccccccccCCccCccccc-------cCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHH
Q 003391          653 ARAFGIDQTEANTNRVVGTYGYMPPEYAI-------DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR  725 (823)
Q Consensus       653 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~-------~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~  725 (823)
                      ++....... ......+||+.|+|||++.       ...++.++|||||||++|||++|+.||......   ......  
T Consensus       209 a~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~i--  282 (412)
T 2vd5_A          209 CLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA---ETYGKI--  282 (412)
T ss_dssp             CEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHH--
T ss_pred             heeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH---HHHHHH--
Confidence            987643322 1223468999999999997       457899999999999999999999998532211   111110  


Q ss_pred             HhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCC---CCHHHHHHH
Q 003391          726 LWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDR---PNMSSVVLM  776 (823)
Q Consensus       726 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~evl~~  776 (823)
                        .... .....+.    .......++.+++.+||+ +|.+|   |+++|+++.
T Consensus       283 --~~~~-~~~~~p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          283 --VHYK-EHLSLPL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             --HTHH-HHCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             --Hhcc-cCcCCCc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence              0000 0000000    011122467889999999 99998   589998764

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.2e-37  Score=328.51  Aligned_cols=249  Identities=27%  Similarity=0.440  Sum_probs=182.6

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      .++|...+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            467888999999999999999975 58899999986542   23457789999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      |||+++++|.+++..  ....+++..+..++.|+++||.|||+.+   |+|+||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           90 LEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            999999999999853  3356899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                      ...  ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||.........   .            .....
T Consensus       165 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~------------~~~~~  227 (278)
T 3cok_A          165 PHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL---N------------KVVLA  227 (278)
T ss_dssp             -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSS
T ss_pred             CCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH---H------------HHhhc
Confidence            222  222357899999999999999999999999999999999999998643221110   0            00000


Q ss_pred             hcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       739 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ..  ..+.....++.+++.+|++.||++||+++++++
T Consensus       228 ~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          228 DY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cc--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            00  111112246778999999999999999999975

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.6e-37  Score=336.21  Aligned_cols=256  Identities=27%  Similarity=0.432  Sum_probs=201.8

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcE--EEEEEecCC-ccccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQE--IAAKRLSKS-SGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~--vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV  578 (823)
                      ++|...+.||+|+||.||+|++.. +..  +|+|++... .....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            678889999999999999999865 554  489988653 334456789999999999 899999999999999999999


Q ss_pred             EeecCCCCcchhhhccC-------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCc
Q 003391          579 YEYLPNKSLNDFIFDVT-------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP  645 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  645 (823)
                      |||+++++|.+++....             ....+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            99999999999996432             2346899999999999999999999998   9999999999999999999


Q ss_pred             eeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHH
Q 003391          646 KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAW  724 (823)
Q Consensus       646 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~  724 (823)
                      ||+|||+++....   ........+++.|+|||++.+..++.++||||||+++|||++ |+.||......       ...
T Consensus       182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-------~~~  251 (327)
T 1fvr_A          182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------ELY  251 (327)
T ss_dssp             EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHH
T ss_pred             EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-------HHH
Confidence            9999999974321   112223456889999999998899999999999999999998 99997532211       011


Q ss_pred             HHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          725 RLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       725 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      .....         ......+......+.+++.+|++.+|++||++.|+++.|+.+.
T Consensus       252 ~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  299 (327)
T 1fvr_A          252 EKLPQ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  299 (327)
T ss_dssp             HHGGG---------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhhc---------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            11111         1111112222346789999999999999999999999998754

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.2e-37  Score=340.11  Aligned_cols=265  Identities=25%  Similarity=0.354  Sum_probs=194.6

Q ss_pred             hcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHH--HHHHhccCCCCceeEEEEeec-----CCce
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENE--VLLIAKLQHRNLVKLIGCCTQ-----RDER  575 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~E--i~~l~~l~H~niv~l~g~~~~-----~~~~  575 (823)
                      .++|...++||+|+||.||+|+. +++.||||++....   ...+..|  +..+..++||||+++++.+..     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            46788899999999999999976 78999999986443   2334444  444556899999999985532     2357


Q ss_pred             EEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhc---------CCCceEecccCCCcEEEcCCCCce
Q 003391          576 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD---------SRLRIIHRDLKASNVLLDNEMNPK  646 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------~~~~ivH~Dlk~~NIll~~~~~~k  646 (823)
                      ++||||+++|+|.+++..    ...++..+..++.||++||+|||+.         +   |+||||||+|||++.++.+|
T Consensus        88 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred             EEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence            899999999999999943    2358899999999999999999998         6   99999999999999999999


Q ss_pred             eeccccceecCCCcc------ccccccccccCCccCcccccc-------CCCCccchhHhHHHHHHHHHhcCCCCCCcCC
Q 003391          647 ISDFGMARAFGIDQT------EANTNRVVGTYGYMPPEYAID-------GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHA  713 (823)
Q Consensus       647 l~DFGla~~~~~~~~------~~~~~~~~gt~~y~aPE~l~~-------~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~  713 (823)
                      |+|||+++.+.....      ........||+.|+|||++.+       ..++.++||||||+++|||++|+.|+-....
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            999999987643221      112234579999999999987       4567899999999999999999877532221


Q ss_pred             C-CccchhHHHHHHhhhcCchh-----hhhhhcCCC------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          714 D-HHHNLLGHAWRLWIEERPVE-----LINKSLGGS------YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       714 ~-~~~~l~~~~~~~~~~~~~~~-----~~~~~l~~~------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      . ........   ........+     .........      ........+.+++.+||+.||++|||++|+++.|+.+.
T Consensus       241 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll  317 (336)
T 3g2f_A          241 VPEYQMAFQT---EVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM  317 (336)
T ss_dssp             CCCCCCTTHH---HHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hhHHHHhhhc---ccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence            1 11111100   000000000     000111111      12234557899999999999999999999999998865

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.3e-37  Score=338.38  Aligned_cols=252  Identities=23%  Similarity=0.317  Sum_probs=198.7

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceEEEE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ..++|...+.||+|+||.||++++.. ++.||+|++.+....    ..+|++++.++ +||||+++++++.+.+..++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            35678999999999999999999865 889999999765433    35688888887 7999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCC----CCceeecccccee
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE----MNPKISDFGMARA  655 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~----~~~kl~DFGla~~  655 (823)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||+.++    +.+||+|||+++.
T Consensus        96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            99999999999853   346899999999999999999999998   9999999999998543    3499999999987


Q ss_pred             cCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhh
Q 003391          656 FGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL  735 (823)
Q Consensus       656 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  735 (823)
                      .....  .......||+.|+|||++.+..++.++||||||+++|||++|+.||..........+..    .......   
T Consensus       170 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~----~i~~~~~---  240 (342)
T 2qr7_A          170 LRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA----RIGSGKF---  240 (342)
T ss_dssp             CBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHH----HHHHCCC---
T ss_pred             CcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHH----HHccCCc---
Confidence            64332  22334678999999999998889999999999999999999999986432222111111    1111110   


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       736 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                         .............+.+++.+||+.||++||++.|+++
T Consensus       241 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          241 ---SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             ---CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ---ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence               0001111112346778999999999999999999986

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=5.3e-37  Score=335.64  Aligned_cols=264  Identities=22%  Similarity=0.286  Sum_probs=205.8

Q ss_pred             HHHHHHHhcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhc--cCCCCceeEEEEeecCC
Q 003391          496 WMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAK--LQHRNLVKLIGCCTQRD  573 (823)
Q Consensus       496 ~~~l~~~~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~~  573 (823)
                      ........++|...+.||+|+||.||+|++ .++.||+|++...   ....+.+|++++..  ++||||+++++++....
T Consensus        34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~  109 (342)
T 1b6c_B           34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN  109 (342)
T ss_dssp             HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred             eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence            333445567899999999999999999997 6899999998643   34667888888887  78999999999998776


Q ss_pred             ----ceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHH--------hcCCCceEecccCCCcEEEcC
Q 003391          574 ----ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH--------QDSRLRIIHRDLKASNVLLDN  641 (823)
Q Consensus       574 ----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~Dlk~~NIll~~  641 (823)
                          ..++||||+++|+|.+++..    ..+++..++.++.|++.||+|||        +.+   |+||||||+|||++.
T Consensus       110 ~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~  182 (342)
T 1b6c_B          110 GTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKK  182 (342)
T ss_dssp             SSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECT
T ss_pred             CccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECC
Confidence                78999999999999999953    35899999999999999999999        665   999999999999999


Q ss_pred             CCCceeeccccceecCCCcccc--ccccccccCCccCccccccC------CCCccchhHhHHHHHHHHHhc---------
Q 003391          642 EMNPKISDFGMARAFGIDQTEA--NTNRVVGTYGYMPPEYAIDG------LFSVKSDVFSFGVLVLEIVCG---------  704 (823)
Q Consensus       642 ~~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~------~~s~ksDVwS~Gvvl~elltG---------  704 (823)
                      ++.+||+|||++..........  ......||+.|+|||++.+.      .++.++||||||+++|||++|         
T Consensus       183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~  262 (342)
T 1b6c_B          183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED  262 (342)
T ss_dssp             TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence            9999999999998764332211  23345789999999999776      344789999999999999999         


Q ss_pred             -CCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003391          705 -KRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSY-----SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS  778 (823)
Q Consensus       705 -~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  778 (823)
                       +.||........  ..........        ...+....     +.+....+.+++.+||+.||++|||+.||++.|+
T Consensus       263 ~~~p~~~~~~~~~--~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~  332 (342)
T 1b6c_B          263 YQLPYYDLVPSDP--SVEEMRKVVC--------EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS  332 (342)
T ss_dssp             CCCTTTTTSCSSC--CHHHHHHHHT--------TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred             cccCccccCcCcc--cHHHHHHHHH--------HHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence             555432221111  1111111111        11111111     2355668899999999999999999999999998


Q ss_pred             cC
Q 003391          779 GE  780 (823)
Q Consensus       779 ~~  780 (823)
                      .+
T Consensus       333 ~i  334 (342)
T 1b6c_B          333 QL  334 (342)
T ss_dssp             HH
T ss_pred             HH
Confidence            75

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.8e-37  Score=333.23  Aligned_cols=264  Identities=17%  Similarity=0.184  Sum_probs=198.1

Q ss_pred             HhcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccc---cHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQ---GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      ..++|...+.||+|+||.||+|+.. +++.||+|++......   ..+.+.+|+.++++++||||+++++++...+..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            3478999999999999999999986 4889999998765322   34678999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      ||||+++++|.+++...   ..+++..+..++.|+++||.|||+.+   |+|+||||+||+++.++.+||+|||++....
T Consensus       112 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            99999999999998542   35899999999999999999999998   9999999999999999999999999998654


Q ss_pred             CCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhh
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN  737 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  737 (823)
                      .... .......+++.|+|||++.+..++.++||||||+++|||++|+.||......       .......... ...  
T Consensus       186 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~-~~~--  254 (309)
T 2h34_A          186 DEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAI-PRP--  254 (309)
T ss_dssp             ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCC-CCG--
T ss_pred             cccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCC-CCc--
Confidence            3221 2223456899999999999999999999999999999999999997532111       0001111110 000  


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhccCCCCCCC
Q 003391          738 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRP-NMSSVVLMLSGERSLPQP  786 (823)
Q Consensus       738 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~~~~~~~p  786 (823)
                      ...    .......+.+++.+||+.||++|| ++.++++.|+.......+
T Consensus       255 ~~~----~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~  300 (309)
T 2h34_A          255 STV----RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ  300 (309)
T ss_dssp             GGT----STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred             ccc----CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence            001    111123677899999999999999 999999999987554433

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.8e-37  Score=329.11  Aligned_cols=252  Identities=25%  Similarity=0.343  Sum_probs=196.9

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      .++|...++||+|+||.||+++... +..+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            3678889999999999999999754 8899999987653 3456789999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEE---cCCCCceeeccccceec
Q 003391          581 YLPNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAF  656 (823)
Q Consensus       581 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DFGla~~~  656 (823)
                      |+++++|.+++... .....+++..+..++.||++||+|||+.+   |+||||||+||++   +.++.+||+|||++..+
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999998643 23456899999999999999999999998   9999999999999   45678999999999865


Q ss_pred             CCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          657 GIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       657 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      ....   ......+|+.|+|||++. ..++.++||||||+++|||++|+.||.......   .    .........    
T Consensus       178 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~---~----~~~~~~~~~----  242 (285)
T 3is5_A          178 KSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE---V----QQKATYKEP----  242 (285)
T ss_dssp             ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H----HHHHHHCCC----
T ss_pred             CCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH---H----HhhhccCCc----
Confidence            4322   223457899999999875 568999999999999999999999975322110   0    000000000    


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                        .... ........+.+++.+||+.||++|||+.|+++
T Consensus       243 --~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          243 --NYAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             --CCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             --cccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              0000 00011246778999999999999999999985

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.8e-37  Score=327.56  Aligned_cols=252  Identities=23%  Similarity=0.342  Sum_probs=201.9

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      .++|...+.||+|+||.||+|.+.. ++.||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            4678999999999999999999865 8899999986543  334567889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCC---ceeeccccceec
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN---PKISDFGMARAF  656 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~DFGla~~~  656 (823)
                      ||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.   +||+|||++...
T Consensus        85 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           85 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            99999999988854   345899999999999999999999998   999999999999987665   999999999876


Q ss_pred             CCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          657 GIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       657 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      ....   ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....   ....    ........ .. 
T Consensus       159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~----~~~~~~~~-~~-  226 (284)
T 3kk8_A          159 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLY----AQIKAGAY-DY-  226 (284)
T ss_dssp             CSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH----HHHHHTCC-CC-
T ss_pred             ccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch---hHHH----HHHHhccc-cC-
Confidence            4322   22335789999999999999999999999999999999999999743211   1111    11111100 00 


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                          ...........+.+++.+|++.||++|||+.|+++.
T Consensus       227 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          227 ----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             ----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             ----CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                000001122467899999999999999999999863

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.6e-37  Score=343.07  Aligned_cols=246  Identities=20%  Similarity=0.234  Sum_probs=190.4

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHH-HhccCCCCceeEEEEeecCCceEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLL-IAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      .++|...+.||+|+||.||+++... ++.||+|++.+..   ....+.+..|..+ ++.++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            4678899999999999999999865 7889999997653   2234456667776 567899999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      ||||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            9999999999999854   345889999999999999999999998   9999999999999999999999999998532


Q ss_pred             CCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhh
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN  737 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  737 (823)
                      ..  .......+||+.|+|||++.+..++.++||||||+++|||++|+.||.....   ..+.    .....        
T Consensus       191 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~----~~i~~--------  253 (373)
T 2r5t_A          191 EH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---AEMY----DNILN--------  253 (373)
T ss_dssp             CC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH---HHHH----HHHHH--------
T ss_pred             cC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---HHHH----HHHHh--------
Confidence            22  2233457899999999999999999999999999999999999999753211   1111    11111        


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 003391          738 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV  773 (823)
Q Consensus       738 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev  773 (823)
                      ..+.  ++......+.+++.+||+.||.+||++.+.
T Consensus       254 ~~~~--~~~~~~~~~~~li~~lL~~dp~~R~~~~~~  287 (373)
T 2r5t_A          254 KPLQ--LKPNITNSARHLLEGLLQKDRTKRLGAKDD  287 (373)
T ss_dssp             SCCC--CCSSSCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred             cccC--CCCCCCHHHHHHHHHHcccCHHhCCCCCCC
Confidence            1111  111122467889999999999999998543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=5.1e-37  Score=353.76  Aligned_cols=254  Identities=26%  Similarity=0.341  Sum_probs=205.6

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC---ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      .++|...+.||+|+||.||+|++.. ++.||+|++.+.   .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            4678888999999999999999864 899999999654   234556788999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      |||+++|+|.+++.... ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            99999999999986432 334899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                      ..   ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........   .......         
T Consensus       339 ~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~---i~~~i~~---------  403 (576)
T 2acx_A          339 GQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---VERLVKE---------  403 (576)
T ss_dssp             TC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHH---HHHHHHH---------
T ss_pred             Cc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHH---HHHHhhc---------
Confidence            22   22335799999999999999999999999999999999999999864332211111   1111110         


Q ss_pred             hcCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003391          739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVLM  776 (823)
Q Consensus       739 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~  776 (823)
                       ....++.....++.+++.+||+.||++||     +++|+++.
T Consensus       404 -~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          404 -VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             -CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             -ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence             01111112234678899999999999999     77888753

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.5e-37  Score=329.82  Aligned_cols=251  Identities=24%  Similarity=0.339  Sum_probs=196.5

Q ss_pred             hcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecC-CceEEEEee
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR-DERMLIYEY  581 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~e~  581 (823)
                      .++|+..+.||+|+||.||+++. .++.||+|++....  ..+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            46788899999999999999987 58899999986543  457889999999999999999999997554 578999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++++|.+++... ....+++..+..++.|+++||+|||+.+   |+|+||||+||+++.++.+||+|||++......  
T Consensus        97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--  170 (278)
T 1byg_A           97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  170 (278)
T ss_dssp             CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence            9999999998542 1234789999999999999999999998   999999999999999999999999999754322  


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhc
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL  740 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l  740 (823)
                         .....+++.|+|||.+.+..++.++||||||+++|||++ |+.|+......   ...    .....         ..
T Consensus       171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~----~~~~~---------~~  231 (278)
T 1byg_A          171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVV----PRVEK---------GY  231 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHH----HHHTT---------TC
T ss_pred             ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHhc---------CC
Confidence               122356889999999999999999999999999999998 99987533211   111    11111         11


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          741 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      ...........+.+++.+|++.||++||++.|+++.|+.+.
T Consensus       232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~  272 (278)
T 1byg_A          232 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  272 (278)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence            11122223356789999999999999999999999998753

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.6e-37  Score=346.29  Aligned_cols=202  Identities=26%  Similarity=0.480  Sum_probs=162.7

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC--ccccHHHHHHHHHHHhccC-CCCceeEEEEeecCC--ce
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRD--ER  575 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~--~~  575 (823)
                      ..++|...+.||+|+||.||+|.+.. ++.||+|++...  .....+.+.+|+.++.++. ||||+++++++...+  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            45789999999999999999999754 889999999654  2334566789999999997 999999999997544  68


Q ss_pred             EEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccccee
Q 003391          576 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                      ++||||++ ++|.+++..    ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        87 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS  158 (388)
T ss_dssp             EEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence            99999997 589888843    35899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCc-------------------cccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCc
Q 003391          656 FGIDQ-------------------TEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFY  711 (823)
Q Consensus       656 ~~~~~-------------------~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~  711 (823)
                      +....                   ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  234 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS  234 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence            53211                   1112234679999999999986 67899999999999999999999998643

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.4e-37  Score=332.31  Aligned_cols=263  Identities=24%  Similarity=0.349  Sum_probs=196.6

Q ss_pred             HhcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCc-----cccHHHHHHHHHHHhccC---CCCceeEEEEeecC
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS-----GQGMEEFENEVLLIAKLQ---HRNLVKLIGCCTQR  572 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~  572 (823)
                      ..++|+..++||+|+||.||+|++. .++.||+|++....     ......+.+|+.++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4578999999999999999999974 48899999986432     222356677888777764   99999999999775


Q ss_pred             C-----ceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCcee
Q 003391          573 D-----ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI  647 (823)
Q Consensus       573 ~-----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl  647 (823)
                      .     ..++||||+. ++|.+++.... ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence            5     4799999997 59999985432 334899999999999999999999998   999999999999999999999


Q ss_pred             eccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHh
Q 003391          648 SDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW  727 (823)
Q Consensus       648 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  727 (823)
                      +|||+++.....   .......||+.|+|||++.+..++.++||||||+++|||++|+.||......   ..........
T Consensus       162 ~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~  235 (308)
T 3g33_A          162 ADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA---DQLGKIFDLI  235 (308)
T ss_dssp             CSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH---HHHHHHHHHH
T ss_pred             eeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHh
Confidence            999999865322   2233467899999999999999999999999999999999999998543221   1111111111


Q ss_pred             hhcCchh------hhhhhcC--CCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          728 IEERPVE------LINKSLG--GSYSL-----SEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       728 ~~~~~~~------~~~~~l~--~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      .......      .......  .....     +....+.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            0000000      0000000  00011     11246789999999999999999999985

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.8e-37  Score=365.77  Aligned_cols=248  Identities=27%  Similarity=0.395  Sum_probs=196.4

Q ss_pred             CeeeccCccceEEEEeec---CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCC
Q 003391          510 NKLGEGGFGPVYKGVLIE---GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPN  584 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~---~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (823)
                      ++||+|+||.||+|.+..   ++.||||+++...  ....+++.+|+.++++++|||||++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            479999999999997642   5789999997643  3346789999999999999999999999964 568899999999


Q ss_pred             CCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc-c
Q 003391          585 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE-A  663 (823)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~-~  663 (823)
                      |+|.+++..   ...+++..+..|+.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus       454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            999999953   345899999999999999999999998   999999999999999999999999999876433221 2


Q ss_pred             ccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCC
Q 003391          664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG  742 (823)
Q Consensus       664 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~  742 (823)
                      ......+|+.|+|||++.+..++.++||||||++||||++ |+.||......+       ...         .+......
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~---------~i~~~~~~  591 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTA---------MLEKGERM  591 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHH---------HHHTTCCC
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHH---------HHHcCCCC
Confidence            2223456788999999999999999999999999999998 999975332211       111         11111111


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          743 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      ..+.....++.+++..||+.||++||++.+|+++|+..
T Consensus       592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            22223345788999999999999999999999999753

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.4e-37  Score=330.04  Aligned_cols=259  Identities=24%  Similarity=0.292  Sum_probs=202.2

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEee--cCCceEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCT--QRDERML  577 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~--~~~~~~l  577 (823)
                      .++|+..+.||+|+||.||+++... ++.||+|++....  ....+.+.+|+.++++++||||+++++++.  .....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            4678889999999999999999864 8899999997543  334567899999999999999999999874  3567899


Q ss_pred             EEeecCCCCcchhhhccC-CCCccCHHHHHHHHHHHHHHHHHHHhcC--CCceEecccCCCcEEEcCCCCceeeccccce
Q 003391          578 IYEYLPNKSLNDFIFDVT-RSKFLDWSKRCQIIGGIARGLLYLHQDS--RLRIIHRDLKASNVLLDNEMNPKISDFGMAR  654 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  654 (823)
                      ||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+  ..+|+|+||||+||+++.++.+||+|||+++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999999996532 2345899999999999999999999976  2349999999999999999999999999998


Q ss_pred             ecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchh
Q 003391          655 AFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE  734 (823)
Q Consensus       655 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  734 (823)
                      .......  ......+++.|+|||.+.+..++.++||||||+++|||++|+.||.....   ..+    .........  
T Consensus       165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~----~~~i~~~~~--  233 (279)
T 2w5a_A          165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KEL----AGKIREGKF--  233 (279)
T ss_dssp             HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH----HHHHHHTCC--
T ss_pred             eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHH----HHHHhhccc--
Confidence            6543211  12235689999999999999999999999999999999999999754321   111    111111111  


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          735 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       735 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                             ...+.....++.+++.+||+.+|++||++.|+++.+..
T Consensus       234 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          234 -------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             -------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence                   11111223467899999999999999999999987643

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=5.9e-37  Score=334.60  Aligned_cols=248  Identities=23%  Similarity=0.333  Sum_probs=203.1

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      .++|...+.||+|+||.||++++.+ ++.+|+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            4678889999999999999999865 7889999986542   23456788999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      |||+++++|.+++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       120 ~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          120 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             ECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            999999999998853   245899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                      ..  .......||+.|+|||++.+..++.++||||||+++|||++|+.||......       ..........       
T Consensus       194 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~-------  257 (335)
T 2owb_A          194 DG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-------ETYLRIKKNE-------  257 (335)
T ss_dssp             TT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHTC-------
T ss_pred             Cc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH-------HHHHHHhcCC-------
Confidence            22  2223467899999999999999999999999999999999999997532211       0011111110       


Q ss_pred             hcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       739 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                       .  ..+......+.+++.+||+.||++||++.|+++
T Consensus       258 -~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          258 -Y--SIPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             -C--CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             -C--CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0  111112236778999999999999999999987

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.2e-36  Score=349.81  Aligned_cols=255  Identities=26%  Similarity=0.371  Sum_probs=205.2

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      .++|...+.||+|+||.||+|++.. ++.||+|++.+..   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            3678888999999999999999864 8999999996542   34557789999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCC-CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          579 YEYLPNKSLNDFIFDVTR-SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      |||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            999999999999865432 446899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhh
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN  737 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  737 (823)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........   ..........       
T Consensus       341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~---~~~~~~i~~~-------  408 (543)
T 3c4z_A          341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN---KELKQRVLEQ-------  408 (543)
T ss_dssp             TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH---HHHHHHHHHC-------
T ss_pred             CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH---HHHHHHHhhc-------
Confidence            3322  233458999999999999999999999999999999999999998643221111   1111111111       


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 003391          738 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNM-----SSVVL  775 (823)
Q Consensus       738 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~  775 (823)
                       ..  .++......+.+++.+||+.||++||++     .++++
T Consensus       409 -~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          409 -AV--TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             -CC--CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             -cc--CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence             01  1112223467789999999999999975     55553

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.5e-37  Score=328.05  Aligned_cols=247  Identities=23%  Similarity=0.319  Sum_probs=198.0

Q ss_pred             HhcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCc--cccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceEE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l  577 (823)
                      ..++|...+.||+|+||.||+|+.. +++.||+|++....  .....++.+|+..+.++ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3467888999999999999999986 48999999987642  33456788999999999 99999999999999999999


Q ss_pred             EEeecCCCCcchhhhccC-CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcC---------------
Q 003391          578 IYEYLPNKSLNDFIFDVT-RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---------------  641 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~---------------  641 (823)
                      ||||+++++|.+++.... ....+++..+..++.||++||+|||+.+   |+||||||+|||++.               
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence            999999999999996432 2255899999999999999999999998   999999999999984               


Q ss_pred             ----CCCceeeccccceecCCCccccccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCc
Q 003391          642 ----EMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH  716 (823)
Q Consensus       642 ----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~  716 (823)
                          ...+||+|||++.......      ...||+.|+|||++.+. .++.++||||||+++|||++|..++...     
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----  234 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG-----  234 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-----
T ss_pred             ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-----
Confidence                4479999999998764322      24589999999999876 6678999999999999999998764211     


Q ss_pred             cchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          717 HNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       717 ~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                       .    .+........         ...+......+.+++.+||+.||++|||+.|+++.
T Consensus       235 -~----~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          235 -D----QWHEIRQGRL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             -H----HHHHHHTTCC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             -h----HHHHHHcCCC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence             0    0111111111         11111223467889999999999999999999853

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=338.78  Aligned_cols=260  Identities=24%  Similarity=0.336  Sum_probs=192.5

Q ss_pred             cCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccc-cHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQ-GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      ++|...++||+|+||.||+|+.. +++.||+|++...... ....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57888999999999999999986 4889999998654322 122455799999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      ++ ++|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-  154 (324)
T 3mtl_A           82 LD-KDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-  154 (324)
T ss_dssp             CS-EEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence            97 589888854  2346899999999999999999999998   9999999999999999999999999998653221 


Q ss_pred             ccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh-
Q 003391          662 EANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS-  739 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~-  739 (823)
                       .......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+   ......... .....+..... 
T Consensus       155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~-~~~~~~~~~~~~  229 (324)
T 3mtl_A          155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRIL-GTPTEETWPGIL  229 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHH-CCCCTTTSTTGG
T ss_pred             -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHh-CCCChHhchhhh
Confidence             22233578999999999876 568999999999999999999999986433211   111111111 00000000000 


Q ss_pred             ---------cCC--CCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          740 ---------LGG--SYS-----LSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       740 ---------l~~--~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                               ...  ...     .....++.+++.+||+.||++|||++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                     000  000     011236789999999999999999999987

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.1e-37  Score=339.59  Aligned_cols=246  Identities=29%  Similarity=0.436  Sum_probs=197.0

Q ss_pred             cCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCcc---ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      +.|...+.||+|+||.||+|+.. +++.||||++.....   ...+++.+|+.++++++||||+++++++.+.+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            45888899999999999999974 588999999975432   23457889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||++ |+|.+++..  ....+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||++..... 
T Consensus       134 e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  206 (348)
T ss_dssp             ECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             ecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence            9997 688887743  2346899999999999999999999998   99999999999999999999999999976532 


Q ss_pred             ccccccccccccCCccCccccc---cCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                           .....||+.|+|||++.   +..++.++||||||+++|||++|+.||.....      ....... ......   
T Consensus       207 -----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~-~~~~~~---  271 (348)
T 1u5q_A          207 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHI-AQNESP---  271 (348)
T ss_dssp             -----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHH-HHSCCC---
T ss_pred             -----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHH-HhcCCC---
Confidence                 22357899999999985   56789999999999999999999999743211      1111111 111100   


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                        ..   ........+.+++.+||+.+|++|||+.++++.
T Consensus       272 --~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          272 --AL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             --CC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             --CC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence              00   011122457789999999999999999999864

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.7e-36  Score=326.10  Aligned_cols=252  Identities=21%  Similarity=0.258  Sum_probs=198.4

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc----cccHHHHHHHHHHHhccCCCCceeEEEEe--ecCCce
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS----GQGMEEFENEVLLIAKLQHRNLVKLIGCC--TQRDER  575 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~--~~~~~~  575 (823)
                      .++|...+.||+|+||.||++.... ++.+|+|++....    ....+.+.+|+.++++++||||+++++++  .+....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            4689999999999999999999854 7899999996542    34467899999999999999999999998  445678


Q ss_pred             EEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccccee
Q 003391          576 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                      ++||||++++ |.+++... ....+++..+..++.||++||.|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999887 77766443 3456899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCccccccccccccCCccCccccccCC--CCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCch
Q 003391          656 FGIDQTEANTNRVVGTYGYMPPEYAIDGL--FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV  733 (823)
Q Consensus       656 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  733 (823)
                      ..............||+.|+|||++.+..  ++.++||||||+++|||++|+.||.....       ...........  
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~i~~~~--  229 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-------YKLFENIGKGS--  229 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHCC--
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-------HHHHHHHhcCC--
Confidence            65433333334467899999999997654  47899999999999999999999753211       01111111110  


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          734 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       734 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                              ...+......+.+++.+|++.||++||++.|+++.
T Consensus       230 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          230 --------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             --------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             --------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                    01111223467789999999999999999999964

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.8e-37  Score=342.22  Aligned_cols=263  Identities=22%  Similarity=0.303  Sum_probs=202.1

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      .++|...+.||+|+||.||++++.. ++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            3678889999999999999999864 8899999987653 3345678999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhc-CCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      |+++++|.+++...   ..+++..+..++.+++.||.|||+. +   |+||||||+|||++.++.+||+|||++..... 
T Consensus       112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-  184 (360)
T 3eqc_A          112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-  184 (360)
T ss_dssp             CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred             CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc-
Confidence            99999999999542   3589999999999999999999986 6   99999999999999999999999999975421 


Q ss_pred             ccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHH----------------
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA----------------  723 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~----------------  723 (823)
                         .......||+.|+|||++.+..++.++||||||+++|||++|+.||...............                
T Consensus       185 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          185 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             ---HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred             ---ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence               1223457899999999999999999999999999999999999998643221110000000                


Q ss_pred             -------HHHhhhcCchhhhhhhcCC---C-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          724 -------WRLWIEERPVELINKSLGG---S-YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       724 -------~~~~~~~~~~~~~~~~l~~---~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                             ..........+.++.....   . .......++.+++.+||+.||++|||++|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                   0000000001111111111   0 11112346889999999999999999999986

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-37  Score=337.95  Aligned_cols=255  Identities=24%  Similarity=0.308  Sum_probs=201.9

Q ss_pred             hcCCCcCCeeeccCccceEEEEee----cCcEEEEEEecCCc----cccHHHHHHHHHHHhcc-CCCCceeEEEEeecCC
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI----EGQEIAAKRLSKSS----GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRD  573 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~----~~~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~  573 (823)
                      .++|...+.||+|+||.||+++..    .++.||||++....    ....+.+.+|+.++.++ +||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            367888999999999999999973    58899999986542    23445678899999999 6999999999999999


Q ss_pred             ceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccc
Q 003391          574 ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  653 (823)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  653 (823)
                      ..++||||+++++|.+++...   ..+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            999999999999999999542   35899999999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCccccccccccccCCccCcccccc--CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcC
Q 003391          654 RAFGIDQTEANTNRVVGTYGYMPPEYAID--GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER  731 (823)
Q Consensus       654 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  731 (823)
                      +.+..... .......||+.|+|||++.+  ..++.++||||||+++|||++|+.||.........   .......... 
T Consensus       207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~---~~~~~~~~~~-  281 (355)
T 1vzo_A          207 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ---AEISRRILKS-  281 (355)
T ss_dssp             EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH---HHHHHHHHHC-
T ss_pred             eecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH---HHHHHHHhcc-
Confidence            87643222 22334679999999999986  34789999999999999999999998643322111   1111111110 


Q ss_pred             chhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHh
Q 003391          732 PVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVLML  777 (823)
Q Consensus       732 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L  777 (823)
                               ....+......+.+++.+||+.||++||     ++.|+++..
T Consensus       282 ---------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          282 ---------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             ---------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             ---------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence                     1111222234677899999999999999     999998764

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.2e-36  Score=323.56  Aligned_cols=246  Identities=23%  Similarity=0.313  Sum_probs=198.9

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc------ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG------QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM  576 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  576 (823)
                      ++|...+.||+|+||.||+++... ++.+|+|++.....      ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            568888999999999999999874 88999999865422      24678999999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCC----Cceeecccc
Q 003391          577 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM----NPKISDFGM  652 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~DFGl  652 (823)
                      +||||+++++|.+++..   ...+++..+..++.||++||.|||+.+   |+|+||||+||+++.++    .+||+|||+
T Consensus        85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence            99999999999999854   345899999999999999999999998   99999999999998877    899999999


Q ss_pred             ceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCc
Q 003391          653 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP  732 (823)
Q Consensus       653 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  732 (823)
                      +.......   ......+++.|+|||++.+..++.++||||||+++|||++|+.||......   ..    .......  
T Consensus       159 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~----~~~~~~~--  226 (283)
T 3bhy_A          159 AHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ---ET----LTNISAV--  226 (283)
T ss_dssp             CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HH----HHHHHTT--
T ss_pred             ceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH---HH----HHHhHhc--
Confidence            98764322   223356899999999999999999999999999999999999997532211   00    0111000  


Q ss_pred             hhhhhhhcCCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          733 VELINKSLGGSYSL----SEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       733 ~~~~~~~l~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                              ......    .....+.+++.+|++.||++||++.|+++
T Consensus       227 --------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          227 --------NYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             --------CCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --------ccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence                    001111    11236788999999999999999999987

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.1e-36  Score=338.05  Aligned_cols=252  Identities=20%  Similarity=0.214  Sum_probs=189.6

Q ss_pred             cCCCcC-CeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhc-cCCCCceeEEEEeec----CCceE
Q 003391          504 ENFSDK-NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAK-LQHRNLVKLIGCCTQ----RDERM  576 (823)
Q Consensus       504 ~~~~~~-~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~----~~~~~  576 (823)
                      ++|... +.||+|+||.||++++.. ++.||||++..     ...+.+|+.++.+ .+||||+++++++..    ....+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            456555 689999999999999865 88999999853     2467788888754 589999999999865    56789


Q ss_pred             EEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcC---CCCceeeccccc
Q 003391          577 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGMA  653 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~DFGla  653 (823)
                      +||||+++|+|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||++
T Consensus       136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence            999999999999999642 2345899999999999999999999988   999999999999997   789999999999


Q ss_pred             eecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCch
Q 003391          654 RAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV  733 (823)
Q Consensus       654 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  733 (823)
                      +.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.............   ........ 
T Consensus       212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~---~~i~~~~~-  284 (400)
T 1nxk_A          212 KETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---TRIRMGQY-  284 (400)
T ss_dssp             EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHH---HHHHHTCC-
T ss_pred             cccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHH---HHHHcCcc-
Confidence            865422   12234678999999999999999999999999999999999999986443322111110   00010000 


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          734 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       734 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      .     ...........++.+++.+||+.||++|||+.|+++.
T Consensus       285 ~-----~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          285 E-----FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             C-----CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             c-----CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            0     0000001122467899999999999999999999975

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=6.3e-37  Score=333.21  Aligned_cols=257  Identities=22%  Similarity=0.285  Sum_probs=200.5

Q ss_pred             HHHhcCCCcC-CeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCc
Q 003391          500 ANATENFSDK-NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDE  574 (823)
Q Consensus       500 ~~~~~~~~~~-~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~  574 (823)
                      ....++|... +.||+|+||.||+|+... ++.||+|++....  .....++.+|+.++.++ +||||+++++++.+.+.
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~  103 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE  103 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence            3445566666 789999999999999865 8999999987643  34467889999999999 56999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcC---CCCceeeccc
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFG  651 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~DFG  651 (823)
                      .++||||+++++|.+++.. .....+++..++.++.||+.||+|||+.+   |+||||||+|||++.   ++.+||+|||
T Consensus       104 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg  179 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFG  179 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSS-CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred             EEEEEEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCc
Confidence            9999999999999999843 23356899999999999999999999998   999999999999988   7899999999


Q ss_pred             cceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcC
Q 003391          652 MARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER  731 (823)
Q Consensus       652 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  731 (823)
                      +++......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......   ...    ......
T Consensus       180 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~----~i~~~~  249 (327)
T 3lm5_A          180 MSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE---TYL----NISQVN  249 (327)
T ss_dssp             GCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHTC
T ss_pred             cccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH---HHH----HHHhcc
Confidence            998764322   2233578999999999999999999999999999999999999975322110   000    000000


Q ss_pred             chhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          732 PVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       732 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                            ..............+.+++.+||+.||++|||++|+++.
T Consensus       250 ------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          250 ------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             ------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             ------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence                  000011111223467889999999999999999999864

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.1e-36  Score=342.63  Aligned_cols=253  Identities=21%  Similarity=0.305  Sum_probs=190.2

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--------cccHHHHHHHHHHHhccCCCCceeEEEEeecC
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--------GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR  572 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~  572 (823)
                      ..++|...+.||+|+||.||+|.... ++.||+|++....        ......+.+|+.++++++||||+++++++.. 
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            46789999999999999999999865 7899999986532        1122357899999999999999999999854 


Q ss_pred             CceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCC---CCceeec
Q 003391          573 DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISD  649 (823)
Q Consensus       573 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~D  649 (823)
                      +..++||||+++++|.+++.   ....+++..+..++.||++||+|||+.+   |+||||||+|||++.+   ..+||+|
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~D  285 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD  285 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred             CceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEee
Confidence            55899999999999999884   3456899999999999999999999998   9999999999999754   4599999


Q ss_pred             cccceecCCCccccccccccccCCccCcccccc---CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHH
Q 003391          650 FGMARAFGIDQTEANTNRVVGTYGYMPPEYAID---GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL  726 (823)
Q Consensus       650 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  726 (823)
                      ||+++.....   .......||+.|+|||++.+   ..++.++||||||+++|||++|+.||.......  .+...    
T Consensus       286 FG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~----  356 (419)
T 3i6u_A          286 FGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQ----  356 (419)
T ss_dssp             SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHH----
T ss_pred             cccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHH----
Confidence            9999875422   22334679999999999863   678899999999999999999999985432211  11111    


Q ss_pred             hhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          727 WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       727 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ...... ..... ...    .....+.+++.+||+.||++||+++|+++.
T Consensus       357 i~~~~~-~~~~~-~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          357 ITSGKY-NFIPE-VWA----EVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             HHTTCC-CCCHH-HHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HhcCCC-CCCch-hhc----ccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            000000 00000 000    112467899999999999999999999863

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=7.4e-37  Score=348.00  Aligned_cols=259  Identities=23%  Similarity=0.283  Sum_probs=193.7

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC--ccccHHHHHHHHHHHhccCCCCceeEEEEeecC------C
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR------D  573 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~  573 (823)
                      .++|...++||+|+||.||+|++.. ++.||||++...  .....+++.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            4689999999999999999999765 889999999764  334456788999999999999999999999654      3


Q ss_pred             ceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccc
Q 003391          574 ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  653 (823)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  653 (823)
                      ..++||||++++ |.+.+.     ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence            569999999764 555552     23889999999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhh-----
Q 003391          654 RAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWI-----  728 (823)
Q Consensus       654 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~-----  728 (823)
                      +.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+   ..........     
T Consensus       212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~---~~~~i~~~lg~p~~~  285 (464)
T 3ttj_A          212 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID---QWNKVIEQLGTPCPE  285 (464)
T ss_dssp             -----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCSCCHH
T ss_pred             eecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHH
Confidence            865422   22344689999999999999999999999999999999999999986432211   1111111000     


Q ss_pred             -------------hcCc-------hhhhhhhcCCCCC---HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          729 -------------EERP-------VELINKSLGGSYS---LSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       729 -------------~~~~-------~~~~~~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                                   ....       ...+...+.....   .....++.+|+.+||+.||++|||++|+++.
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                         0000       0000000000000   0113468899999999999999999999874

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=7e-37  Score=327.43  Aligned_cols=249  Identities=23%  Similarity=0.328  Sum_probs=203.4

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      .++|...+.||+|+||.||++++.. ++.+|+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            4678889999999999999999875 7889999986542   23456788999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      |||+++++|.+++..   ...+++..+..++.|+++||+|||+.+   |+|+||||+||+++.++.+||+|||++.....
T Consensus        94 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           94 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            999999999998843   245899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                      ..  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......       ..........       
T Consensus       168 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~-------  231 (294)
T 2rku_A          168 DG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-------ETYLRIKKNE-------  231 (294)
T ss_dssp             TT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTTC-------
T ss_pred             Cc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhhcc-------
Confidence            22  2223357899999999999999999999999999999999999997532211       0011111110       


Q ss_pred             hcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       739 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                       .  ..+......+.+++.+|++.||++||++.|+++.
T Consensus       232 -~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          232 -Y--SIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             -C--CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             -C--CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence             0  1111122467789999999999999999999874

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5.6e-37  Score=329.90  Aligned_cols=257  Identities=23%  Similarity=0.325  Sum_probs=202.9

Q ss_pred             HhcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      ..++|...+.||+|+||.||+++.. +++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            3467888999999999999999986 488999999987655556678999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEE---cCCCCceeeccccceecC
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFG  657 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DFGla~~~~  657 (823)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+|+||||+||++   ++++.+||+|||++....
T Consensus        87 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           87 LVSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             CCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             cCCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            9999999998854   235899999999999999999999998   9999999999999   788999999999997543


Q ss_pred             CCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhh
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN  737 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  737 (823)
                      ..    ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....   ..+    ......... .   
T Consensus       161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~----~~~i~~~~~-~---  225 (304)
T 2jam_A          161 NG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE---SKL----FEKIKEGYY-E---  225 (304)
T ss_dssp             CB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH---HHH----HHHHHHCCC-C---
T ss_pred             CC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHH----HHHHHcCCC-C---
Confidence            21    22335689999999999999999999999999999999999999753211   111    111111100 0   


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhccCC
Q 003391          738 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL--MLSGER  781 (823)
Q Consensus       738 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~  781 (823)
                        ............+.+++.+|++.||++||++.|+++  .+++..
T Consensus       226 --~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          226 --FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             --CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             --CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence              000111122346789999999999999999999986  344433

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.6e-36  Score=335.06  Aligned_cols=254  Identities=22%  Similarity=0.375  Sum_probs=203.9

Q ss_pred             HHHHHHHhcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccc--------cHHHHHHHHHHHhcc-CCCCceeE
Q 003391          496 WMAIANATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQ--------GMEEFENEVLLIAKL-QHRNLVKL  565 (823)
Q Consensus       496 ~~~l~~~~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~--------~~~~~~~Ei~~l~~l-~H~niv~l  565 (823)
                      +.......++|...+.||+|+||.||+|++. +|+.||||++......        ..+.+.+|+.++.++ +||||+++
T Consensus        86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~  165 (365)
T 2y7j_A           86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL  165 (365)
T ss_dssp             HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            3344555678999999999999999999986 5899999998765321        245678999999999 79999999


Q ss_pred             EEEeecCCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCc
Q 003391          566 IGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP  645 (823)
Q Consensus       566 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  645 (823)
                      ++++......++||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+|+||||+|||++.++.+
T Consensus       166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~i  239 (365)
T 2y7j_A          166 IDSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQI  239 (365)
T ss_dssp             EEEEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred             EEEEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence            9999999999999999999999999854   245899999999999999999999998   9999999999999999999


Q ss_pred             eeeccccceecCCCccccccccccccCCccCcccccc------CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccch
Q 003391          646 KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID------GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL  719 (823)
Q Consensus       646 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l  719 (823)
                      ||+|||++..+....   ......||+.|+|||++.+      ..++.++||||||+++|||++|+.||.....   ...
T Consensus       240 kl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---~~~  313 (365)
T 2y7j_A          240 RLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ---ILM  313 (365)
T ss_dssp             EECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHH
T ss_pred             EEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH---HHH
Confidence            999999998764322   2234678999999999863      3588999999999999999999999753211   001


Q ss_pred             hHHHHHHhhhcCchhhhhhhcCCCCCHH----HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          720 LGHAWRLWIEERPVELINKSLGGSYSLS----EVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       720 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~----~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      .    .......          .....+    ....+.+++.+||+.||++||++.|+++
T Consensus       314 ~----~~i~~~~----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          314 L----RMIMEGQ----------YQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             H----HHHHHTC----------CCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             H----HHHHhCC----------CCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1    1011100          001111    1236788999999999999999999986

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.1e-37  Score=337.25  Aligned_cols=263  Identities=24%  Similarity=0.321  Sum_probs=191.4

Q ss_pred             HHhcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCcc--ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          501 NATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG--QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       501 ~~~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      ...++|...++||+|+||.||+|+.. +++.||+|++.....  ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            34578999999999999999999975 488999999965532  234567899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEc-----CCCCceeecccc
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD-----NEMNPKISDFGM  652 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~-----~~~~~kl~DFGl  652 (823)
                      ||||+++ +|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++     +++.+||+|||+
T Consensus       111 v~e~~~~-~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          111 IFEYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             EEECCSE-EHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             EEecCCC-CHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            9999985 99998853   335899999999999999999999998   99999999999994     445599999999


Q ss_pred             ceecCCCccccccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcC
Q 003391          653 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER  731 (823)
Q Consensus       653 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  731 (823)
                      ++.+....  .......+|+.|+|||++.+. .++.++||||||+++|||++|+.||......   ..............
T Consensus       184 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~  258 (329)
T 3gbz_A          184 ARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI---DQLFKIFEVLGLPD  258 (329)
T ss_dssp             HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCC
T ss_pred             ccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH---HHHHHHHHHhCCCc
Confidence            98764322  222335679999999999875 4899999999999999999999998543211   11111111100000


Q ss_pred             chhh--h------hhhcC--CCCCHH------HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          732 PVEL--I------NKSLG--GSYSLS------EVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       732 ~~~~--~------~~~l~--~~~~~~------~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ....  .      .....  ......      ...++.+++.+||+.||++|||++|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            0000  0      00000  000111      1246789999999999999999999986

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=9.2e-37  Score=335.26  Aligned_cols=264  Identities=22%  Similarity=0.342  Sum_probs=199.6

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecC-------
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR-------  572 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-------  572 (823)
                      .++|...++||+|+||.||+|+.. +++.||+|++....  ......+.+|+.++++++||||+++++++...       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            367889999999999999999985 48899999986543  23356788999999999999999999999773       


Q ss_pred             -CceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccc
Q 003391          573 -DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG  651 (823)
Q Consensus       573 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFG  651 (823)
                       +..++||||+++ +|.+.+..  ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence             468999999985 77777643  2345899999999999999999999998   9999999999999999999999999


Q ss_pred             cceecCCCcc--ccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhh
Q 003391          652 MARAFGIDQT--EANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWI  728 (823)
Q Consensus       652 la~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~  728 (823)
                      +++.+.....  ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......   ....... ..
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~-~~  245 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH---QLALISQ-LC  245 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHH-HH
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHH-Hh
Confidence            9987643221  222334678999999999876 458999999999999999999999986432211   1111111 11


Q ss_pred             hcCchhhh---------hh---hcCCCCCHHH-------HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          729 EERPVELI---------NK---SLGGSYSLSE-------VLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       729 ~~~~~~~~---------~~---~l~~~~~~~~-------~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      .....+..         +.   ..........       ...+.+++.+||+.||++|||++|+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            11110000         00   0000111111       1357899999999999999999999863

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-36  Score=346.17  Aligned_cols=197  Identities=21%  Similarity=0.384  Sum_probs=155.9

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecC-----Cc
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR-----DE  574 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~  574 (823)
                      .++|.+.++||+|+||.||+|++.. ++.||||++....  ....+++.+|+.++++++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            3679999999999999999999764 8899999996643  33456788999999999999999999999443     56


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccce
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  654 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  654 (823)
                      .++||||+ +++|.+++.   ....+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus       132 ~~lv~e~~-~~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEEECCC-SEEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEecc-ccchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence            89999998 568988884   3456899999999999999999999998   9999999999999999999999999998


Q ss_pred             ecCCCccc-------------------------cccccccccCCccCcccc-ccCCCCccchhHhHHHHHHHHHhcCC
Q 003391          655 AFGIDQTE-------------------------ANTNRVVGTYGYMPPEYA-IDGLFSVKSDVFSFGVLVLEIVCGKR  706 (823)
Q Consensus       655 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~l-~~~~~s~ksDVwS~Gvvl~elltG~~  706 (823)
                      ........                         ......+||+.|+|||++ ....++.++|||||||+||||++|..
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~  282 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK  282 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence            76432211                         122346789999999976 46679999999999999999999543

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=4.3e-36  Score=342.02  Aligned_cols=261  Identities=20%  Similarity=0.265  Sum_probs=205.3

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccccHHHHHHHHHHHhccCC-CCceeEEEEeecCCceEEEEe
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH-RNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~e  580 (823)
                      .++|.+.++||+|+||.||+|++. +++.||||++......  .++..|++++..++| +++..+..++.+.+..+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            467999999999999999999974 4889999987654332  357899999999977 556666666677888899999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEE---cCCCCceeeccccceecC
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARAFG  657 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DFGla~~~~  657 (823)
                      |+ +++|.+++...  ...+++..++.|+.||+.||+|||+.+   |+||||||+||||   +.++.+||+|||+++.+.
T Consensus        84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99 99999998532  345899999999999999999999998   9999999999999   688999999999999765


Q ss_pred             CCccc-----cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCc
Q 003391          658 IDQTE-----ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP  732 (823)
Q Consensus       658 ~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  732 (823)
                      .....     .......||+.|+|||++.+..++.++||||||++||||++|+.||...........+............
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI  237 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence            43221     1223567999999999999999999999999999999999999998754443322222221111111111


Q ss_pred             hhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          733 VELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       733 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      ..+.     ..+    ..++.+++..|++.+|++||++.+|+++|+.+
T Consensus       238 ~~l~-----~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          238 EALC-----RGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             HHHH-----TTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             HHHh-----cCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            1110     111    24678999999999999999999999999764

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.5e-37  Score=336.98  Aligned_cols=265  Identities=23%  Similarity=0.355  Sum_probs=197.9

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc--ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG--QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      .++|+..+.||+|+||.||+|+... ++.||+|++.....  ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            4678889999999999999999865 88999999865433  23456789999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+++++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       104 e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          104 EFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             ECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            9999999988763   2345899999999999999999999998   999999999999999999999999999865432


Q ss_pred             ccccccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhH--------HHHHHhhhc
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLG--------HAWRLWIEE  730 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~--------~~~~~~~~~  730 (823)
                      .  .......+|+.|+|||++.+. .++.++||||||+++|||++|+.||......+......        .....+...
T Consensus       178 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          178 G--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             c--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence            2  222335789999999999875 78999999999999999999999986432211100000        000000000


Q ss_pred             Cch-hhhhhhcCCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          731 RPV-ELINKSLGGSYSL-----SEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       731 ~~~-~~~~~~l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ... ....+.+......     .....+.+++.+||+.||++|||++|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            000 0000011111111     11347889999999999999999999875

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.5e-37  Score=330.85  Aligned_cols=264  Identities=25%  Similarity=0.393  Sum_probs=185.9

Q ss_pred             HhcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ..++|...+.||+|+||.||+|+.. +++.||+|++.... ....+++.+|+.++.+++||||+++++++...+..++||
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            4578999999999999999999975 48899999986543 344567889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhcc-----CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccce
Q 003391          580 EYLPNKSLNDFIFDV-----TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  654 (823)
Q Consensus       580 e~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  654 (823)
                      ||+++++|.+++...     .....+++..+..++.||++||.|||+.+   |+|+||||+||+++.++.+||+|||++.
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            999999999998641     12456899999999999999999999998   9999999999999999999999999997


Q ss_pred             ecCCCcc---ccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhc
Q 003391          655 AFGIDQT---EANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE  730 (823)
Q Consensus       655 ~~~~~~~---~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  730 (823)
                      .......   ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......   ..   .. ....
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~---~~-~~~~  242 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---VL---ML-TLQN  242 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HH---HH-HHTS
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---HH---HH-Hhcc
Confidence            6543211   112234578999999999876 568999999999999999999999986432211   10   00 1111


Q ss_pred             CchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          731 RPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       731 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      .....................+.+++.+||+.||.+||++.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            111110000000111111246788999999999999999999985

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.2e-37  Score=345.75  Aligned_cols=242  Identities=17%  Similarity=0.179  Sum_probs=188.1

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCC---ccccHHHHHHHH---HHHhccCCCCceeEE-------EE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS---SGQGMEEFENEV---LLIAKLQHRNLVKLI-------GC  568 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei---~~l~~l~H~niv~l~-------g~  568 (823)
                      .++|...+.||+|+||.||+|++. +++.||||++...   .....+.+.+|+   +++++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            467888899999999999999974 4899999999743   334567889999   455556899999998       66


Q ss_pred             eecCC-----------------ceEEEEeecCCCCcchhhhccC----CCCccCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 003391          569 CTQRD-----------------ERMLIYEYLPNKSLNDFIFDVT----RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRI  627 (823)
Q Consensus       569 ~~~~~-----------------~~~lV~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i  627 (823)
                      +.+.+                 ..++||||+ +|+|.+++....    ....+++..++.|+.||++||+|||+.+   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            55443                 278999999 689999996421    1233556888999999999999999998   9


Q ss_pred             EecccCCCcEEEcCCCCceeeccccceecCCCccccccccccccCCccCccccccC-----------CCCccchhHhHHH
Q 003391          628 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG-----------LFSVKSDVFSFGV  696 (823)
Q Consensus       628 vH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~s~ksDVwS~Gv  696 (823)
                      +||||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999986322     2233567 999999999887           8999999999999


Q ss_pred             HHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          697 LVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       697 vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ++|||++|+.||..........               .+.. . ....    ..++.+++.+||+.||++||++.|+++
T Consensus       302 il~elltg~~Pf~~~~~~~~~~---------------~~~~-~-~~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGGSE---------------WIFR-S-CKNI----PQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHHSSCCC------CCSG---------------GGGS-S-CCCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHHCCCCCcccccccchh---------------hhhh-h-ccCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            9999999999975332211110               0000 0 0111    246778999999999999999999985

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=4e-37  Score=338.32  Aligned_cols=261  Identities=15%  Similarity=0.161  Sum_probs=202.2

Q ss_pred             cCCCcCCeeeccCccceEEEEeec---------CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCcee----------
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE---------GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVK----------  564 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~---------~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~----------  564 (823)
                      ++|...+.||+|+||.||+|+...         ++.||+|++...     +.+.+|+.++.+++||||++          
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            678899999999999999999864         788999998654     46789999999999999988          


Q ss_pred             -----EEEEeec-CCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEE
Q 003391          565 -----LIGCCTQ-RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVL  638 (823)
Q Consensus       565 -----l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIl  638 (823)
                           +++++.. ....++||||+ +++|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+|||
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl  191 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIF  191 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEE
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEE
Confidence                 5677765 67889999999 99999999643 2356999999999999999999999998   999999999999


Q ss_pred             EcCCC--CceeeccccceecCCCccc-----cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCc
Q 003391          639 LDNEM--NPKISDFGMARAFGIDQTE-----ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFY  711 (823)
Q Consensus       639 l~~~~--~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~  711 (823)
                      ++.++  .+||+|||+++.+......     .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  9999999999876433211     1123357999999999999999999999999999999999999998644


Q ss_pred             CCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          712 HADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       712 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      .....  ........+. .....+......   .......+.+++.+|++.||++||++++++++|+.+
T Consensus       272 ~~~~~--~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  334 (352)
T 2jii_A          272 LPNTE--DIMKQKQKFV-DKPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL  334 (352)
T ss_dssp             TTCHH--HHHHHHHHHH-HSCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             CcCHH--HHHHHHHhcc-CChhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence            32211  1111111111 111111111000   001124678899999999999999999999999875

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.6e-37  Score=328.89  Aligned_cols=258  Identities=26%  Similarity=0.356  Sum_probs=196.1

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec--Cc--EEEEEEecCC---ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCce
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE--GQ--EIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDER  575 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~--~~--~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~  575 (823)
                      .++|+..+.||+|+||.||+|++..  ++  .||+|++...   .....+.+.+|+.++++++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            3578889999999999999998643  33  6899988654   2345678899999999999999999999998755 8


Q ss_pred             EEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccccee
Q 003391          576 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                      ++|+||+++++|.+++...  ...+++..+..++.||++||.|||+.+   |+|+||||+||+++.++.+||+|||++..
T Consensus        96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence            8999999999999998642  345899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCccc-cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCch
Q 003391          656 FGIDQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPV  733 (823)
Q Consensus       656 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  733 (823)
                      ....... .......+|..|+|||++.+..++.++||||||+++|||++ |+.||......   ..    .......   
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~----~~~~~~~---  240 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QI----LHKIDKE---  240 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HH----HHHHHTS---
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH---HH----HHHHHcc---
Confidence            6433221 12233567788999999999899999999999999999999 99997532211   01    0111100   


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          734 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       734 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                           .............+.+++.+|++.+|++||++.++++.|+.+.
T Consensus       241 -----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          241 -----GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             -----CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             -----CCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence                 0011111223357889999999999999999999999998765

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.2e-36  Score=324.89  Aligned_cols=249  Identities=22%  Similarity=0.351  Sum_probs=195.3

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC--ccccHHHHHHHHHHHhccCCCCceeEEEEeec----CCceE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ----RDERM  576 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~  576 (823)
                      +.|...+.||+|+||.||+|.+.. +..||+|++...  .....+.+.+|+.++++++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            346777899999999999999865 778999998654  23445678999999999999999999998865    35589


Q ss_pred             EEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEc-CCCCceeecccccee
Q 003391          577 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARA  655 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~DFGla~~  655 (823)
                      +||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+ .+|+|+||||+|||++ +++.+||+|||++..
T Consensus       106 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            99999999999999954   245899999999999999999999875 3499999999999998 789999999999975


Q ss_pred             cCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhh
Q 003391          656 FGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL  735 (823)
Q Consensus       656 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  735 (823)
                      ....    ......||+.|+|||++. ..++.++||||||+++|||++|+.||......      ...............
T Consensus       182 ~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~  250 (290)
T 1t4h_A          182 KRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPAS  250 (290)
T ss_dssp             CCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGG
T ss_pred             cccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH------HHHHHHHhccCCccc
Confidence            4322    223356899999999876 45899999999999999999999997532211      111111111111111


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       736 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                              .+.....++.+++..||+.||++|||+.|+++
T Consensus       251 --------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          251 --------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             --------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                    01111246789999999999999999999985

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.5e-36  Score=323.22  Aligned_cols=246  Identities=23%  Similarity=0.308  Sum_probs=202.0

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC---ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      .++|...+.||+|+||.||+|+... ++.||+|++...   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            3678889999999999999999865 778999998653   233456789999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      |||+++++|.+++...   ..+++..+..++.||++||.|||+.+   |+|+||||+||+++.++.+||+|||++.....
T Consensus        93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           93 LEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            9999999999998543   35899999999999999999999988   99999999999999999999999999976532


Q ss_pred             CccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                      .    ......|++.|+|||++.+..++.++||||||+++|||++|+.||.......       .......        .
T Consensus       167 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~--------~  227 (284)
T 2vgo_A          167 L----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-------THRRIVN--------V  227 (284)
T ss_dssp             S----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHT--------T
T ss_pred             c----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH-------HHHHHhc--------c
Confidence            2    1233578999999999999999999999999999999999999975322110       0011111        0


Q ss_pred             hcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       739 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      .  ...+......+.+++.+|++.||.+||++.|+++
T Consensus       228 ~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          228 D--LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             c--cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            0  0111112346788999999999999999999986

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.3e-36  Score=340.17  Aligned_cols=199  Identities=23%  Similarity=0.389  Sum_probs=167.1

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecC-----Cc
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR-----DE  574 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~  574 (823)
                      .++|...+.||+|+||.||+|++.. ++.||||++....  ....+.+.+|+.++++++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            4789999999999999999999865 7889999997643  23456789999999999999999999999766     56


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccce
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  654 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  654 (823)
                      .++||||++ ++|.+++.   ....+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       105 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            899999986 59999884   3356899999999999999999999998   9999999999999999999999999999


Q ss_pred             ecCCCccc--------------------cccccccccCCccCcccc-ccCCCCccchhHhHHHHHHHHHhcCCCC
Q 003391          655 AFGIDQTE--------------------ANTNRVVGTYGYMPPEYA-IDGLFSVKSDVFSFGVLVLEIVCGKRNR  708 (823)
Q Consensus       655 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~l-~~~~~s~ksDVwS~Gvvl~elltG~~p~  708 (823)
                      ........                    ......+||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            76433211                    123456899999999986 5667999999999999999999876654

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=9.4e-37  Score=325.49  Aligned_cols=252  Identities=22%  Similarity=0.308  Sum_probs=185.1

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccc--cHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQ--GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      .++|+..+.||+|+||.||+|+.. +++.||+|++......  ..+.+.++...++.++||||+++++++.+.+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            467888999999999999999985 4889999999765322  2233445555678889999999999999999999999


Q ss_pred             eecCCCCcchhhhc-cCCCCccCHHHHHHHHHHHHHHHHHHHhc-CCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          580 EYLPNKSLNDFIFD-VTRSKFLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       580 e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      ||+++ +|.+++.. ......+++..+..++.||+.||+|||+. +   |+||||||+||+++.++.+||+|||+++...
T Consensus        86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99974 88887754 23345699999999999999999999998 7   9999999999999999999999999998654


Q ss_pred             CCccccccccccccCCccCcccc----ccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCch
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYA----IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV  733 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l----~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  733 (823)
                      ...   ......||+.|+|||++    .+..++.++||||||+++|||++|+.||......     ...... .....  
T Consensus       162 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~-~~~~~--  230 (290)
T 3fme_A          162 DDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-----FQQLKQ-VVEEP--  230 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-----HHHHHH-HHHSC--
T ss_pred             ccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-----HHHHHH-HhccC--
Confidence            321   22234689999999996    5667899999999999999999999997532111     111111 11111  


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          734 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       734 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                            ...........++.+++.+|++.||++|||+.|+++
T Consensus       231 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          231 ------SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             ------CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ------CCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                  001111112346789999999999999999999976

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-36  Score=330.95  Aligned_cols=265  Identities=23%  Similarity=0.293  Sum_probs=196.1

Q ss_pred             HHhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccc-----cHHHHHHHHHHHhccCCCCceeEEEEeecCCc
Q 003391          501 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQ-----GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE  574 (823)
Q Consensus       501 ~~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~  574 (823)
                      ...++|...+.||+|+||.||+|++.. ++.||+|++......     ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            345789999999999999999999865 889999998654221     23467899999999999999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccce
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  654 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  654 (823)
                      .++||||+++ +|.+++..  ....+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence            9999999986 88888743  3346889999999999999999999998   9999999999999999999999999998


Q ss_pred             ecCCCccccccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCch
Q 003391          655 AFGIDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV  733 (823)
Q Consensus       655 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  733 (823)
                      .+....  .......+|+.|+|||++.+. .++.++||||||+++|||++|..||.....   .................
T Consensus       161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~---~~~~~~i~~~~~~~~~~  235 (346)
T 1ua2_A          161 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPTEE  235 (346)
T ss_dssp             TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCTT
T ss_pred             eccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHcCCCChh
Confidence            764322  223346789999999999764 589999999999999999999988753221   11111111111000000


Q ss_pred             h------hhhhhc---CCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          734 E------LINKSL---GGSYSL-----SEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       734 ~------~~~~~l---~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      .      ..+...   ....+.     ....++.+++.+|++.||++|||+.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            0      000000   001111     112478899999999999999999999975

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.1e-36  Score=331.92  Aligned_cols=258  Identities=22%  Similarity=0.309  Sum_probs=202.5

Q ss_pred             hcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCcccc-----------------HHHHHHHHHHHhccCCCCceeE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQG-----------------MEEFENEVLLIAKLQHRNLVKL  565 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~-----------------~~~~~~Ei~~l~~l~H~niv~l  565 (823)
                      .++|...+.||+|+||.||+|+. +++.||+|++.......                 .+.+.+|+.++.+++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46889999999999999999999 89999999986542211                 1789999999999999999999


Q ss_pred             EEEeecCCceEEEEeecCCCCcchh------hhccCCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCceEecccCCCcEE
Q 003391          566 IGCCTQRDERMLIYEYLPNKSLNDF------IFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ-DSRLRIIHRDLKASNVL  638 (823)
Q Consensus       566 ~g~~~~~~~~~lV~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NIl  638 (823)
                      ++++.+.+..++||||+++++|.++      +.. .....+++..+..++.||+.||.|||+ .+   |+|+||||+||+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence            9999999999999999999999998      422 225679999999999999999999999 77   999999999999


Q ss_pred             EcCCCCceeeccccceecCCCccccccccccccCCccCccccccC-CCCc-cchhHhHHHHHHHHHhcCCCCCCcCCCCc
Q 003391          639 LDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG-LFSV-KSDVFSFGVLVLEIVCGKRNRGFYHADHH  716 (823)
Q Consensus       639 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~-ksDVwS~Gvvl~elltG~~p~~~~~~~~~  716 (823)
                      ++.++.+||+|||++......    ......++..|+|||.+.+. .++. ++||||||+++|||++|+.||......  
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--  258 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--  258 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--
T ss_pred             EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--
Confidence            999999999999999876432    23346789999999999887 6666 999999999999999999998643321  


Q ss_pred             cchhHHHHHHhhhcCchhh------hhhhcCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          717 HNLLGHAWRLWIEERPVEL------INKSLGG---SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       717 ~~l~~~~~~~~~~~~~~~~------~~~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ..+    ............      .......   .........+.+++.+||+.||.+||++.|+++
T Consensus       259 ~~~----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          259 VEL----FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHH----HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHH----HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111    111111110000      0000000   000112347789999999999999999999986

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=6.1e-36  Score=325.59  Aligned_cols=256  Identities=18%  Similarity=0.280  Sum_probs=197.8

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccccHHHHHHHHHHHhccC-CCCceeEEEEeec--CCceEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQ--RDERMLI  578 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~--~~~~~lV  578 (823)
                      .++|+..++||+|+||.||+|+.. +++.||+|++...   ..+.+.+|+.++++++ ||||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            367889999999999999999875 4889999998643   3567899999999997 9999999999987  5678999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCC-CceeeccccceecC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAFG  657 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DFGla~~~~  657 (823)
                      |||+++++|.+++.      .+++..+..++.||++||+|||+.+   |+||||||+|||++.++ .+||+|||+++...
T Consensus       112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            99999999999873      3789999999999999999999998   99999999999999776 89999999998764


Q ss_pred             CCccccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      ...   ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......  .................+.+
T Consensus       183 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~--~~~l~~~~~~~~~~~~~~~~  257 (330)
T 3nsz_A          183 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YDQLVRIAKVLGTEDLYDYI  257 (330)
T ss_dssp             TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH--HHHHHHHHHHHCHHHHHHHH
T ss_pred             CCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch--HHHHHHHHHhcCCchhhhHH
Confidence            332   2233578999999999987 67899999999999999999999997432211  11111111100000000000


Q ss_pred             -----------------------hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          737 -----------------------NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       737 -----------------------~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                                             ..............++.+++.+||+.||++|||++|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                                   000111111112357889999999999999999999986

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=4.4e-36  Score=335.24  Aligned_cols=262  Identities=22%  Similarity=0.252  Sum_probs=202.2

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccC--------CCCceeEEEEee---
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ--------HRNLVKLIGCCT---  570 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~--------H~niv~l~g~~~---  570 (823)
                      .++|.+.++||+|+||.||+|+... ++.||+|++... ....+.+.+|+.+++.++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            3679999999999999999999754 789999999644 334567889999999985        788999999987   


Q ss_pred             -cCCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhc-CCCceEecccCCCcEEEcCCC-----
Q 003391          571 -QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEM-----  643 (823)
Q Consensus       571 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NIll~~~~-----  643 (823)
                       +....++||||+ +++|.+++... ....+++..+..++.||++||+|||+. +   |+||||||+|||++.++     
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence             566899999999 56676666432 234589999999999999999999998 7   99999999999998775     


Q ss_pred             --------------------------------------------CceeeccccceecCCCccccccccccccCCccCccc
Q 003391          644 --------------------------------------------NPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY  679 (823)
Q Consensus       644 --------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~  679 (823)
                                                                  .+||+|||+++.....     .....||+.|+|||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence                                                        8999999999875422     233578999999999


Q ss_pred             cccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHH--HHhhhcCchhhh----------hh---------
Q 003391          680 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW--RLWIEERPVELI----------NK---------  738 (823)
Q Consensus       680 l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~--~~~~~~~~~~~~----------~~---------  738 (823)
                      +.+..++.++|||||||+||||++|+.||................  .......+...+          ..         
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  344 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK  344 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence            999999999999999999999999999987544433221111110  011111111110          00         


Q ss_pred             --------h--cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          739 --------S--LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       739 --------~--l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                              .  -....+......+.+|+.+||+.||++|||++|+++
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                    0  011234555678899999999999999999999985

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.1e-36  Score=326.98  Aligned_cols=253  Identities=24%  Similarity=0.380  Sum_probs=198.0

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      ..++|++.+.||+|+||.||+|++.. ++.+|+|++........+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            34678899999999999999999865 88999999987777778899999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |+++++|.+++...  ...+++..+..++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||++...... 
T Consensus        97 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  170 (302)
T 2j7t_A           97 FCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-  170 (302)
T ss_dssp             CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred             eCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence            99999999988542  345899999999999999999999998   999999999999999999999999997643111 


Q ss_pred             cccccccccccCCccCcccc-----ccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhh
Q 003391          661 TEANTNRVVGTYGYMPPEYA-----IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL  735 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l-----~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  735 (823)
                       ........||+.|+|||++     .+..++.++||||||+++|||++|+.|+......      ..... .........
T Consensus       171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~-~~~~~~~~~  242 (302)
T 2j7t_A          171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLK-IAKSDPPTL  242 (302)
T ss_dssp             -HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHH-HHHSCCCCC
T ss_pred             -ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHHHH-HhccCCccc
Confidence             1112235689999999998     3667899999999999999999999997533211      11111 111110000


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       736 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                             ..+......+.+++.+|++.||++|||+.++++
T Consensus       243 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          243 -------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             -------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             -------CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                   011112346789999999999999999999975

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.1e-36  Score=359.10  Aligned_cols=249  Identities=26%  Similarity=0.320  Sum_probs=203.3

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC---ccccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERM  576 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~  576 (823)
                      ..++|...++||+|+||.||+|++.. ++.||||++.+.   .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            34678999999999999999999865 788999999754   234566788999999987 7999999999999999999


Q ss_pred             EEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceec
Q 003391          577 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  656 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  656 (823)
                      |||||+++|+|.+++...   ..+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++..
T Consensus       419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            999999999999999643   35899999999999999999999998   999999999999999999999999999864


Q ss_pred             CCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          657 GIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       657 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      ....  .......||+.|+|||++.+..++.++||||||++||||++|+.||...+.   ..+..    ...        
T Consensus       493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~---~~~~~----~i~--------  555 (674)
T 3pfq_A          493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQ----SIM--------  555 (674)
T ss_dssp             CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH----HHH--------
T ss_pred             ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH---HHHHH----HHH--------
Confidence            3222  233457899999999999999999999999999999999999999853221   11111    111        


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNM-----SSVVL  775 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~  775 (823)
                      ...+  .++.....++.+|+..||+.||++||++     +||++
T Consensus       556 ~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          556 EHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             SSCC--CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             hCCC--CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence            1111  1122223467899999999999999998     66664

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1

Probab=100.00  E-value=5.2e-36  Score=308.47  Aligned_cols=217  Identities=17%  Similarity=0.167  Sum_probs=170.8

Q ss_pred             cccccccCCCcccCCCeEeeCCCeEEEeeecCCCCCCeEEEEEEeecCCCcEEEeecCCCCCCCCCCceEEEecCCceEE
Q 003391           16 TARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLSDRSGALNISSQGNATLV   95 (823)
Q Consensus        16 ~~~~~~~~g~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~giw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~~~l~   95 (823)
                      ++.|+|.+||+|.+|++|  ++|.|+|||+.+++.     . +|..   +|+||+|||+.|   ..+.|+|+.|||  ||
T Consensus         6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gnl-----~-ly~~---~~~vW~an~~~~---~~~~l~l~~dGn--Lv   69 (236)
T 1dlp_A            6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCNL-----V-LFDS---DVRVWASNTAGA---TGCRAVLQSDGL--LV   69 (236)
T ss_dssp             CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSCE-----E-EEES---SSEEECCCCCSC---SCCBCCBCSSSC--BC
T ss_pred             eccceeCCCCEECCCCEE--EcCCEEEEECCCCcE-----E-EEEC---CEEEEECCCCCC---CCeEEEEcCCCc--EE
Confidence            567999999999999999  599999999877651     2 3442   799999999988   478999999999  99


Q ss_pred             EecCCCCeEEeecCCCCCCcceEEEecCCCEEEecCCCCCCCcceeeecCCCcccc-cccCccccee-ccCc-----cee
Q 003391           96 LLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFDYPSHIL-IAGMKLGVNL-VTGL-----NRF  168 (823)
Q Consensus        96 l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqSFd~PTDtl-Lpgq~l~~~~-~tg~-----~~~  168 (823)
                      |+|++|.+||+|++........|+|+|+|||||++.       ++||||||||||+ ||||  +.|. .+|.     ++.
T Consensus        70 l~d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~-------~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~  140 (236)
T 1dlp_A           70 ILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP-------GLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQT  140 (236)
T ss_dssp             CBCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEECS-------EEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCE
T ss_pred             EEcCCCcEEEeCCccccCCcEEEEEeCCCCEEEecC-------CEEECCCCCCcccccCCc--cceEEecCCcCCCccce
Confidence            999999999999976544556899999999999952       6999999999877 6665  5554 5555     567


Q ss_pred             EEEcccCCCCCCCccEEeeCCCCCCeEEEEcCceeeeecCCCCCceeeccCCCCCCCceEEEEeecCceEEEEEeecCCC
Q 003391          169 ISSWKSADDPAQDDYVYGIDPSGVPQAVFRKGSTIRYRAGSWNGLHWTGMPQLQPNPVYTFEYVSNENEVFYRFNLIKSS  248 (823)
Q Consensus       169 l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~sg~w~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  248 (823)
                      |+   +.+||++|.|++.++++|  +++++++..+||++++|++. +.+.+.+..+..+ +.|..+..+++..|+.... 
T Consensus       141 L~---s~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gnl-~ly~~~~~~vw~s~~~~~~-  212 (236)
T 1dlp_A          141 LH---ATQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGRM-DVLTNQNIAVWTSGNSRSA-  212 (236)
T ss_dssp             EC---SSCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTEE-EEEETTTEEEEECCCCCSS-
T ss_pred             EE---cCcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCCcE-EEEeCCCcEEEEeCCCCCC-
Confidence            76   478999999999999999  57778888899999999754 5556666555432 2333444555555554433 


Q ss_pred             cceeEEEccCCCeeEEE
Q 003391          249 VPSMMVMNPLGDPQRLT  265 (823)
Q Consensus       249 ~~~~~~l~~~G~l~~~~  265 (823)
                      ...|++|++||++++|.
T Consensus       213 ~~~rl~Ld~dG~l~ly~  229 (236)
T 1dlp_A          213 GRYVFVLQPDRNLAIYG  229 (236)
T ss_dssp             SCCEEEECSSSCEEEEC
T ss_pred             CCEEEEEcCCCcEEEeC
Confidence            46899999999999984

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.9e-36  Score=320.78  Aligned_cols=248  Identities=23%  Similarity=0.343  Sum_probs=194.5

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCC---ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      .++|.+.+.||+|+||.||+|++. +++.||+|++...   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            367888999999999999999986 4899999998654   234566889999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      |||+++++|.+++...   ..+++..+..++.||++||.|||+.+   |+|+||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           90 MEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             EeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            9999999999998543   34899999999999999999999998   99999999999999999999999999986543


Q ss_pred             CccccccccccccCCccCccccccCCC-CccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN  737 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  737 (823)
                      ..   ......+++.|+|||.+.+..+ +.++||||||+++|||++|+.||.....   .    ..........      
T Consensus       164 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~----~~~~~~~~~~------  227 (276)
T 2h6d_A          164 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV---P----TLFKKIRGGV------  227 (276)
T ss_dssp             ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH---H----HHHHHHHHCC------
T ss_pred             Cc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH---H----HHHHHhhcCc------
Confidence            21   1233568999999999988765 6899999999999999999999753211   0    1111111110      


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          738 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       738 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                          ...+......+.+++.+|++.||++|||+.|+++.
T Consensus       228 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          228 ----FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ----ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                00111122467789999999999999999999974

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=5.8e-36  Score=345.16  Aligned_cols=248  Identities=27%  Similarity=0.381  Sum_probs=198.9

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc-------------ccHHHHHHHHHHHhccCCCCceeEEE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG-------------QGMEEFENEVLLIAKLQHRNLVKLIG  567 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~-------------~~~~~~~~Ei~~l~~l~H~niv~l~g  567 (823)
                      ..++|...++||+|+||.||+|+... ++.+|+|++.....             ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            45789999999999999999999865 78999999865421             34567899999999999999999999


Q ss_pred             EeecCCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCC---C
Q 003391          568 CCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM---N  644 (823)
Q Consensus       568 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~---~  644 (823)
                      ++.+....++||||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++   .
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence            99999999999999999999998854   245899999999999999999999998   99999999999998776   6


Q ss_pred             ceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHH
Q 003391          645 PKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW  724 (823)
Q Consensus       645 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~  724 (823)
                      +||+|||+++.+....   ......||+.|+|||++. ..++.++||||+|+++|||++|+.||......   .+.    
T Consensus       188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~----  256 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ---DII----  256 (504)
T ss_dssp             EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----
T ss_pred             EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHH----
Confidence            9999999998764332   223457999999999886 56899999999999999999999998532211   111    


Q ss_pred             HHhhhcCchhhhhhhcCCCCCHH----HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          725 RLWIEERPVELINKSLGGSYSLS----EVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       725 ~~~~~~~~~~~~~~~l~~~~~~~----~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ........          .++.+    ...++.+++.+||+.||.+|||+.|+++.
T Consensus       257 ~~i~~~~~----------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          257 KKVEKGKY----------YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             HHHHHCCC----------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHcCCC----------CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            11111110          01111    12467899999999999999999999863

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.1e-36  Score=337.29  Aligned_cols=253  Identities=10%  Similarity=0.055  Sum_probs=179.4

Q ss_pred             cCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCcc---ccHHHHHHHHHHHhcc--CCCCceeEE-------EEee
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG---QGMEEFENEVLLIAKL--QHRNLVKLI-------GCCT  570 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l--~H~niv~l~-------g~~~  570 (823)
                      ..|...+.||+|+||.||+|++. +++.||+|++.....   ...+.+.+|+.++..+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            45788899999999999999976 488999999977543   3455677885544444  699988855       3433


Q ss_pred             cC-----------------CceEEEEeecCCCCcchhhhccCCCCccCHHHH------HHHHHHHHHHHHHHHhcCCCce
Q 003391          571 QR-----------------DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKR------CQIIGGIARGLLYLHQDSRLRI  627 (823)
Q Consensus       571 ~~-----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~i  627 (823)
                      ..                 ...++||||++ |+|.+++...  ...+.+..+      ..++.||++||+|||+.+   |
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i  215 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG---L  215 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence            22                 33799999999 8999999643  223455556      788899999999999998   9


Q ss_pred             EecccCCCcEEEcCCCCceeeccccceecCCCccccccccccccCCccCcccccc--CCCCccchhHhHHHHHHHHHhcC
Q 003391          628 IHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID--GLFSVKSDVFSFGVLVLEIVCGK  705 (823)
Q Consensus       628 vH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwS~Gvvl~elltG~  705 (823)
                      +||||||+|||++.++.+||+|||+++.....     .....+|+.|+|||++.+  ..++.++||||||++||||++|+
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~  290 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF  290 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence            99999999999999999999999999865321     113456799999999987  77999999999999999999999


Q ss_pred             CCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          706 RNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       706 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      .||.............        ......................+.+++.+||+.||++|||+.|+++
T Consensus       291 ~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          291 LPFGLVTPGIKGSWKR--------PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             CSTTBCCTTCTTCCCB--------CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCcCcccccchhh--------hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            9986543322111000        0000000000000111122346788999999999999999999974

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3e-36  Score=346.66  Aligned_cols=250  Identities=25%  Similarity=0.323  Sum_probs=195.6

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      .++|...++||+|+||.||+|+... +..+|+|++....  ......+.+|+.+++.++||||+++++++.+....++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            4568889999999999999999864 8899999987653  344678899999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCC---CCceeeccccceec
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARAF  656 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DFGla~~~  656 (823)
                      ||+++|+|.+++...   ..+++..+..++.||++||.|||+.+   |+||||||+|||++..   +.+||+|||+++.+
T Consensus       116 e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          116 ECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            999999999988543   45899999999999999999999998   9999999999999764   45999999999876


Q ss_pred             CCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          657 GIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       657 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      ....   ......||+.|+|||++. ..++.++||||+||++|||++|+.||......   .+.    ........ ...
T Consensus       190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~----~~i~~~~~-~~~  257 (494)
T 3lij_A          190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ---EIL----RKVEKGKY-TFD  257 (494)
T ss_dssp             BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHTCC-CCC
T ss_pred             CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhCCC-CCC
Confidence            4322   233467999999999876 56999999999999999999999998532211   111    11111100 000


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      .+.. .    .....+.+++.+||+.+|.+|||+.|+++
T Consensus       258 ~~~~-~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          258 SPEW-K----NVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             SGGG-T----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             chhc-c----cCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            0000 0    11246778999999999999999999985

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-36  Score=336.76  Aligned_cols=257  Identities=22%  Similarity=0.332  Sum_probs=193.5

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCC------
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD------  573 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------  573 (823)
                      .++|...+.||+|+||.||+|++.. ++.||||++....  ....+++.+|+.++++++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            4678899999999999999999854 8999999996542  234567889999999999999999999997653      


Q ss_pred             ceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccc
Q 003391          574 ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  653 (823)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  653 (823)
                      ..++||||+ +++|.+++..    ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            469999999 8899998853    35899999999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCccccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCc
Q 003391          654 RAFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP  732 (823)
Q Consensus       654 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  732 (823)
                      +.....     .....+|+.|+|||++.+ ..++.++||||+||+++||++|+.||...+..   ......... .....
T Consensus       176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~-~g~~~  246 (367)
T 1cm8_A          176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL---DQLKEIMKV-TGTPP  246 (367)
T ss_dssp             EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHH-HCCCC
T ss_pred             cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHh-cCCCC
Confidence            875322     234578999999999987 67999999999999999999999998643221   111111110 01111


Q ss_pred             hhhhhh-----------hcC----C---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          733 VELINK-----------SLG----G---SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       733 ~~~~~~-----------~l~----~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      .+.+..           .+.    .   .........+.+++.+||+.||++|||+.|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            111000           000    0   0001112467889999999999999999999983

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.7e-36  Score=324.09  Aligned_cols=251  Identities=28%  Similarity=0.417  Sum_probs=198.5

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      ..++|...+.||+|+||.||+|+... ++.||+|++....  ..+++.+|+.++.+++||||+++++++.+.+..++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            45778999999999999999999865 8899999986543  45788999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |+++++|.+++..  ....+++..+..++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||++.......
T Consensus       105 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (314)
T 3com_A          105 YCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM  179 (314)
T ss_dssp             CCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred             cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence            9999999999853  2346899999999999999999999998   9999999999999999999999999998764322


Q ss_pred             cccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhc
Q 003391          661 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL  740 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l  740 (823)
                        .......+++.|+|||++.+..++.++||||||+++|||++|+.||......      .... ..........     
T Consensus       180 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~-~~~~~~~~~~-----  245 (314)
T 3com_A          180 --AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------RAIF-MIPTNPPPTF-----  245 (314)
T ss_dssp             --SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHH-HHHHSCCCCC-----
T ss_pred             --cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------HHHH-HHhcCCCccc-----
Confidence              2223457899999999999999999999999999999999999997532211      0000 0001100000     


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          741 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                        .........+.+++.+|++.||.+||++.++++
T Consensus       246 --~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          246 --RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             --SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             --CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence              011111346789999999999999999999976

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.8e-36  Score=327.30  Aligned_cols=253  Identities=24%  Similarity=0.335  Sum_probs=195.3

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCc--cccHHHHHHHHHHHhccC--CCCceeEEEEeecCCceEE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQ--HRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~l  577 (823)
                      ..++|...+.||+|+||.||+++..+++.||+|++....  ....+.+.+|+.++.+++  ||||+++++++.+.+..++
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            456789999999999999999998889999999986543  345677899999999997  5999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      ||| +.+++|.+++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||+++ +.+||+|||+++...
T Consensus       106 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~  177 (313)
T 3cek_A          106 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQ  177 (313)
T ss_dssp             EEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred             EEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccccccc
Confidence            999 668899999854   346899999999999999999999998   999999999999964 899999999998764


Q ss_pred             CCccccccccccccCCccCcccccc-----------CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHH
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAID-----------GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL  726 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  726 (823)
                      ............||+.|+|||++.+           ..++.++||||||+++|||++|+.||......     ....   
T Consensus       178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~~---  249 (313)
T 3cek_A          178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKL---  249 (313)
T ss_dssp             ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHH---
T ss_pred             CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----HHHH---
Confidence            4333333344678999999999875           46889999999999999999999997532111     1110   


Q ss_pred             hhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          727 WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       727 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                            ...++.......+......+.+++.+||+.||++||++.|+++.
T Consensus       250 ------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          250 ------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             ------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ------HHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence                  11111111111111123467889999999999999999999863

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.5e-36  Score=324.02  Aligned_cols=262  Identities=21%  Similarity=0.295  Sum_probs=193.7

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEee-----------
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT-----------  570 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~-----------  570 (823)
                      .++|...+.||+|+||.||+|+... ++.||+|++........+++.+|+.++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            4678889999999999999999876 8899999998776667788999999999999999999999873           


Q ss_pred             ---cCCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEc-CCCCce
Q 003391          571 ---QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPK  646 (823)
Q Consensus       571 ---~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~-~~~~~k  646 (823)
                         +....++||||++ |+|.+++.    ...+++..+..++.||++||+|||+.+   |+||||||+||+++ +++.+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence               3467899999998 69999883    345899999999999999999999998   99999999999997 567999


Q ss_pred             eeccccceecCCCcc-ccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHH
Q 003391          647 ISDFGMARAFGIDQT-EANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW  724 (823)
Q Consensus       647 l~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~  724 (823)
                      |+|||+++....... ........+|..|+|||.+.+ ..++.++||||||+++|||++|+.||.......   ......
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~  238 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE---QMQLIL  238 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHH
Confidence            999999987643211 122233567899999998865 678999999999999999999999986432211   111110


Q ss_pred             HHhh----------hcCchhhhhhhcC-CCCCHH-----HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          725 RLWI----------EERPVELINKSLG-GSYSLS-----EVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       725 ~~~~----------~~~~~~~~~~~l~-~~~~~~-----~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ....          .......+..... ......     ...++.+++.+|++.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            0000          0000000111111 111111     1246889999999999999999999986

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.3e-36  Score=345.66  Aligned_cols=252  Identities=25%  Similarity=0.307  Sum_probs=199.7

Q ss_pred             HhcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCC--ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      ..++|.+.++||+|+||.||+|+.. .++.||+|++...  .......+.+|+.++++++||||+++++++.+....++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            3467899999999999999999986 4889999998653  234567889999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEc---CCCCceeecccccee
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NEMNPKISDFGMARA  655 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~DFGla~~  655 (823)
                      |||+++++|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++   .++.+||+|||+++.
T Consensus       100 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            9999999999988543   45899999999999999999999998   99999999999995   456799999999986


Q ss_pred             cCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhh
Q 003391          656 FGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL  735 (823)
Q Consensus       656 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  735 (823)
                      +...   .......||+.|+|||++.+ .++.++||||+||++|||++|+.||.....   ....    .......... 
T Consensus       174 ~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~----~~i~~~~~~~-  241 (486)
T 3mwu_A          174 FQQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDIL----KRVETGKYAF-  241 (486)
T ss_dssp             BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH----HHHHHTCCCS-
T ss_pred             CCCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHH----HHHHhCCCCC-
Confidence            5332   22234579999999999875 599999999999999999999999753211   1111    1111110000 


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       736 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                           ..........++.+++.+||+.+|++|||+.|+++.
T Consensus       242 -----~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          242 -----DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             -----CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             -----CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                 000001112467899999999999999999999974

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2e-36  Score=347.47  Aligned_cols=251  Identities=25%  Similarity=0.323  Sum_probs=201.7

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCc---cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      .++|...++||+|+||.||+|+.. .++.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            467888999999999999999986 48999999986542   34567899999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEE---cCCCCceeecccccee
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNEMNPKISDFGMARA  655 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DFGla~~  655 (823)
                      |||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|||+++.
T Consensus       105 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          105 GEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             ECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            999999999998853   345899999999999999999999998   9999999999999   5678999999999986


Q ss_pred             cCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhh
Q 003391          656 FGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL  735 (823)
Q Consensus       656 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  735 (823)
                      +....   ......||+.|+|||++.+ .++.++||||+|+++|||++|+.||......   ...    .......... 
T Consensus       179 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~----~~i~~~~~~~-  246 (484)
T 3nyv_A          179 FEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---DIL----KKVEKGKYTF-  246 (484)
T ss_dssp             BCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHCCCCC-
T ss_pred             ccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---HHH----HHHHcCCCCC-
Confidence            54322   2234579999999999876 6999999999999999999999998532211   111    1111111000 


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       736 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                           ...........+.+++.+||+.+|++|||+.|+++.
T Consensus       247 -----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          247 -----ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             -----CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -----CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence                 000001122467899999999999999999999863

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=5.1e-36  Score=325.24  Aligned_cols=252  Identities=22%  Similarity=0.311  Sum_probs=194.3

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--------cccHHHHHHHHHHHhccCCCCceeEEEEeecC
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--------GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR  572 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~  572 (823)
                      ..++|...+.||+|+||.||+|++.. ++.||||++....        ......+.+|+.++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            34678899999999999999999865 7899999986542        12234588999999999999999999998765


Q ss_pred             CceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCC---ceeec
Q 003391          573 DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN---PKISD  649 (823)
Q Consensus       573 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~D  649 (823)
                      . .++||||+++++|.+++.   ....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.   +||+|
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             c-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence            4 899999999999999884   3456899999999999999999999998   999999999999987664   99999


Q ss_pred             cccceecCCCccccccccccccCCccCccccc---cCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHH
Q 003391          650 FGMARAFGIDQTEANTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL  726 (823)
Q Consensus       650 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  726 (823)
                      ||+++......   ......||+.|+|||++.   ...++.++||||||+++|||++|+.||.......  .+....   
T Consensus       161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~---  232 (322)
T 2ycf_A          161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI---  232 (322)
T ss_dssp             CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHH---
T ss_pred             Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHH---
Confidence            99998764321   122356899999999974   5678999999999999999999999985432211  111111   


Q ss_pred             hhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          727 WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       727 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                       ..... ... +....    .....+.+++.+||+.||++||++.|+++
T Consensus       233 -~~~~~-~~~-~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          233 -TSGKY-NFI-PEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             -HHTCC-CCC-HHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -HhCcc-ccC-chhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence             11100 000 00000    11246789999999999999999999985

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=6.4e-36  Score=337.28  Aligned_cols=198  Identities=22%  Similarity=0.293  Sum_probs=171.2

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhcc------CCCCceeEEEEeecCCce
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKL------QHRNLVKLIGCCTQRDER  575 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l------~H~niv~l~g~~~~~~~~  575 (823)
                      ..+|.+.++||+|+||.||+|+... ++.||||++... ....+++.+|+.++..+      +|+||+++++++......
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            4678999999999999999998765 789999999653 23345677888888877      577999999999999999


Q ss_pred             EEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCC--ceeeccccc
Q 003391          576 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN--PKISDFGMA  653 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~--~kl~DFGla  653 (823)
                      ++||||+. ++|.+++... ....+++..+..++.||++||+|||+.+   |+||||||+|||++.++.  +||+|||++
T Consensus       175 ~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence            99999996 6899988543 2334899999999999999999999998   999999999999999887  999999999


Q ss_pred             eecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCc
Q 003391          654 RAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFY  711 (823)
Q Consensus       654 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~  711 (823)
                      +....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       250 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          250 CYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             EETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            76432     223357899999999999999999999999999999999999998643

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.6e-36  Score=332.55  Aligned_cols=262  Identities=20%  Similarity=0.280  Sum_probs=194.0

Q ss_pred             HHHhcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecC------
Q 003391          500 ANATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR------  572 (823)
Q Consensus       500 ~~~~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------  572 (823)
                      ....++|...+.||+|+||.||+|++. +++.||+|++......    ..+|+.+++.++||||+++++++...      
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            345678999999999999999999975 4899999998654332    24799999999999999999998443      


Q ss_pred             --------------------------------CceEEEEeecCCCCcchhhhc-cCCCCccCHHHHHHHHHHHHHHHHHH
Q 003391          573 --------------------------------DERMLIYEYLPNKSLNDFIFD-VTRSKFLDWSKRCQIIGGIARGLLYL  619 (823)
Q Consensus       573 --------------------------------~~~~lV~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yL  619 (823)
                                                      ...++||||++ ++|.+.+.. ......+++..+..++.||++||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                            33789999998 588877754 23445689999999999999999999


Q ss_pred             HhcCCCceEecccCCCcEEEc-CCCCceeeccccceecCCCccccccccccccCCccCccccccC-CCCccchhHhHHHH
Q 003391          620 HQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVL  697 (823)
Q Consensus       620 H~~~~~~ivH~Dlk~~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvv  697 (823)
                      |+.+   |+||||||+|||++ .++.+||+|||+++.+....   ......+|+.|+|||++.+. .++.++||||+|++
T Consensus       158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9988   99999999999998 68899999999998764332   22335789999999998875 48999999999999


Q ss_pred             HHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhh----------hhcCCC-----CCHHHHHHHHHHHHHcccc
Q 003391          698 VLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN----------KSLGGS-----YSLSEVLRCIQVGLLCVQQ  762 (823)
Q Consensus       698 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~----------~~l~~~-----~~~~~~~~l~~l~~~Cl~~  762 (823)
                      +|||++|+.||......+   ................+..          +.+...     .+......+.+++.+||+.
T Consensus       232 l~ell~g~~pf~~~~~~~---~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  308 (383)
T 3eb0_A          232 FGELILGKPLFSGETSID---QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY  308 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred             HHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence            999999999986432211   1111111110000000000          000000     1111234678999999999


Q ss_pred             CCCCCCCHHHHHH
Q 003391          763 RPEDRPNMSSVVL  775 (823)
Q Consensus       763 dP~~RPs~~evl~  775 (823)
                      ||++|||+.|+++
T Consensus       309 dP~~R~t~~e~l~  321 (383)
T 3eb0_A          309 EPDLRINPYEAMA  321 (383)
T ss_dssp             SGGGSCCHHHHHT
T ss_pred             ChhhCCCHHHHhc
Confidence            9999999999985

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.7e-36  Score=338.24  Aligned_cols=259  Identities=20%  Similarity=0.267  Sum_probs=193.8

Q ss_pred             cCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCc------eEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE------RML  577 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~------~~l  577 (823)
                      .+|...++||+|+||.||+|++..+..+|+|++......    ..+|+.+++.++||||+++++++.....      .++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            568889999999999999999988888999998654332    2469999999999999999999965433      789


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEc-CCCCceeeccccceec
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAF  656 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~DFGla~~~  656 (823)
                      ||||++++.+............+++..+..++.||++||+|||+.+   |+||||||+|||++ .++.+||+|||+++.+
T Consensus       116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~  192 (394)
T 4e7w_A          116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL  192 (394)
T ss_dssp             EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence            9999987544443322333556899999999999999999999998   99999999999999 7999999999999876


Q ss_pred             CCCccccccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhh
Q 003391          657 GIDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL  735 (823)
Q Consensus       657 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  735 (823)
                      ....   ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+   ......... .....+.
T Consensus       193 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~l~~i~~~~-g~p~~~~  265 (394)
T 4e7w_A          193 IAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID---QLVEIIKVL-GTPSREQ  265 (394)
T ss_dssp             CTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHH-CCCCHHH
T ss_pred             cCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHh-CCCCHHH
Confidence            4322   22335789999999998765 58999999999999999999999986432211   111111110 0000000


Q ss_pred             h--------hhhcCC--C------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          736 I--------NKSLGG--S------YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       736 ~--------~~~l~~--~------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      +        ......  .      +......++.+++.+||+.||++|||+.|+++.
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            0        000000  0      011122478899999999999999999999974

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.9e-36  Score=330.88  Aligned_cols=269  Identities=21%  Similarity=0.257  Sum_probs=198.1

Q ss_pred             HHHHHHHhcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccc-----------cHHHHHHHHHHHhccCCCCcee
Q 003391          496 WMAIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQ-----------GMEEFENEVLLIAKLQHRNLVK  564 (823)
Q Consensus       496 ~~~l~~~~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~-----------~~~~~~~Ei~~l~~l~H~niv~  564 (823)
                      ..++....++|...+.||+|+||.||+|+..+++.||||++......           ..+.+.+|+.++++++||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            45677788999999999999999999999888999999998654221           1377899999999999999999


Q ss_pred             EEEEeec-----CCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEE
Q 003391          565 LIGCCTQ-----RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL  639 (823)
Q Consensus       565 l~g~~~~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll  639 (823)
                      +++++..     ....++||||++ |+|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||+
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL  167 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence            9999843     335799999998 588888753  3446899999999999999999999998   9999999999999


Q ss_pred             cCCCCceeeccccceecCCCccccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccc
Q 003391          640 DNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHN  718 (823)
Q Consensus       640 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~  718 (823)
                      +.++.+||+|||+++.....   .......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......   .
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~  241 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY---N  241 (362)
T ss_dssp             CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---H
T ss_pred             cCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH---H
Confidence            99999999999999754322   22234578999999999887 67899999999999999999999998543211   1


Q ss_pred             hhHHHHHHhhhcCc-----------hhhhhhhcCCCC--C-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          719 LLGHAWRLWIEERP-----------VELINKSLGGSY--S-----LSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       719 l~~~~~~~~~~~~~-----------~~~~~~~l~~~~--~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ..............           ...+........  .     ......+.+++.+||+.||++|||+.|+++.
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            11111111000000           001111110000  0     0112367899999999999999999999864

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=5.7e-36  Score=320.87  Aligned_cols=252  Identities=22%  Similarity=0.299  Sum_probs=200.9

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---------cccHHHHHHHHHHHhccC-CCCceeEEEEee
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---------GQGMEEFENEVLLIAKLQ-HRNLVKLIGCCT  570 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---------~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~  570 (823)
                      ..++|...+.||+|+||.||+|++.. ++.||+|++....         ....+.+.+|+.+++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            35788999999999999999999864 7899999986543         122456789999999995 999999999999


Q ss_pred             cCCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecc
Q 003391          571 QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDF  650 (823)
Q Consensus       571 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF  650 (823)
                      ..+..++||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+|+||||+||+++.++.+||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence            99999999999999999999854   245899999999999999999999998   999999999999999999999999


Q ss_pred             ccceecCCCccccccccccccCCccCccccc------cCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHH
Q 003391          651 GMARAFGIDQTEANTNRVVGTYGYMPPEYAI------DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAW  724 (823)
Q Consensus       651 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~  724 (823)
                      |++.......   ......+++.|+|||++.      ...++.++||||||+++|||++|+.||......   ..    .
T Consensus       169 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~----~  238 (298)
T 1phk_A          169 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---LM----L  238 (298)
T ss_dssp             TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----H
T ss_pred             cchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH---HH----H
Confidence            9998764322   223357899999999985      456889999999999999999999997432110   00    1


Q ss_pred             HHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          725 RLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       725 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      .........      ............+.+++.+|++.||++||++.|+++
T Consensus       239 ~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          239 RMIMSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHHHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHhcCCcc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            111111000      000001122346889999999999999999999975

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.2e-36  Score=329.60  Aligned_cols=259  Identities=25%  Similarity=0.358  Sum_probs=198.2

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ..++|...+.||+|+||.||+|+...  .+|+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  108 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT  108 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence            35778899999999999999998743  59999986542  334456788999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+++++|.+++..  ....+++..+..++.||++||+|||+.+   |+||||||+||+++ ++.+||+|||+++.....
T Consensus       109 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          109 SLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             BCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred             ecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence            99999999999853  2346899999999999999999999998   99999999999998 679999999998765322


Q ss_pred             c---cccccccccccCCccCcccccc---------CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHh
Q 003391          660 Q---TEANTNRVVGTYGYMPPEYAID---------GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW  727 (823)
Q Consensus       660 ~---~~~~~~~~~gt~~y~aPE~l~~---------~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  727 (823)
                      .   .........|++.|+|||++.+         ..++.++||||||+++|||++|+.||......   ..    ....
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~----~~~~  255 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---AI----IWQM  255 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH---HH----HHHH
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HH----HHHh
Confidence            1   1122233568999999999874         45789999999999999999999997532211   01    0111


Q ss_pred             hhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCCC
Q 003391          728 IEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL  783 (823)
Q Consensus       728 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~  783 (823)
                      .......     .   ........+.+++.+|++.+|++|||+.+++++|+.+...
T Consensus       256 ~~~~~~~-----~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          256 GTGMKPN-----L---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             HTTCCCC-----C---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             ccCCCCC-----C---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence            1111000     0   0011123577899999999999999999999999987543

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.2e-35  Score=327.39  Aligned_cols=268  Identities=21%  Similarity=0.248  Sum_probs=190.5

Q ss_pred             HHHHHHhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCc-
Q 003391          497 MAIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE-  574 (823)
Q Consensus       497 ~~l~~~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-  574 (823)
                      .......++|...+.||+|+||.||+|++.. ++.||||++.... .....+.+|++.+..++||||+++++++..... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            3455677899999999999999999999864 8899999986543 233456788888999999999999999965443 


Q ss_pred             ------eEEEEeecCCCCcchhhhc-cCCCCccCHHHHHHHHHHHHHHHHHHH--hcCCCceEecccCCCcEEEcC-CCC
Q 003391          575 ------RMLIYEYLPNKSLNDFIFD-VTRSKFLDWSKRCQIIGGIARGLLYLH--QDSRLRIIHRDLKASNVLLDN-EMN  644 (823)
Q Consensus       575 ------~~lV~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivH~Dlk~~NIll~~-~~~  644 (823)
                            .++||||+++ +|.+.+.. ......+++..+..++.|++.||.|||  +.+   |+||||||+|||++. ++.
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~  170 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT  170 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence                  7899999987 44444432 344566899999999999999999999  777   999999999999997 899


Q ss_pred             ceeeccccceecCCCccccccccccccCCccCccccccCC-CCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHH
Q 003391          645 PKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA  723 (823)
Q Consensus       645 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~  723 (823)
                      +||+|||+++.+....   ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||......   ......
T Consensus       171 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~~~~  244 (360)
T 3e3p_A          171 LKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA---GQLHEI  244 (360)
T ss_dssp             EEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH
T ss_pred             EEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH---HHHHHH
Confidence            9999999998764322   223356899999999987654 899999999999999999999998543221   111111


Q ss_pred             HHHhhhcCchhhhhhh-------------------cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          724 WRLWIEERPVELINKS-------------------LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       724 ~~~~~~~~~~~~~~~~-------------------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ... ......+.+...                   ............+.+++.+||+.||.+|||+.|+++.
T Consensus       245 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          245 VRV-LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HHH-HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHH-cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            111 111111111000                   0111112234578899999999999999999999853

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.5e-36  Score=332.34  Aligned_cols=257  Identities=24%  Similarity=0.352  Sum_probs=183.2

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecC------C
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR------D  573 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~  573 (823)
                      .++|...+.||+|+||.||+|+... ++.||||++....  ....+.+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            4789999999999999999999754 8899999996542  23456788999999999999999999998654      5


Q ss_pred             ceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccc
Q 003391          574 ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  653 (823)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  653 (823)
                      ..++|+|++ +++|.+++.    ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence            679999999 789999883    245899999999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCccccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCc
Q 003391          654 RAFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP  732 (823)
Q Consensus       654 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  732 (823)
                      +.....     .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..   ......... .....
T Consensus       180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~-~g~p~  250 (367)
T 2fst_X          180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRL-VGTPG  250 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHH-HCSCC
T ss_pred             cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHH-hCCCC
Confidence            864321     234678999999999987 67899999999999999999999998643221   111111111 11111


Q ss_pred             hhhhhh-----------hcC--CCCCHHH-----HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          733 VELINK-----------SLG--GSYSLSE-----VLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       733 ~~~~~~-----------~l~--~~~~~~~-----~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      .+.+..           .+.  .......     ...+.+|+.+||+.||++|||+.|+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            111000           000  0111111     2367899999999999999999999874

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-36  Score=329.70  Aligned_cols=255  Identities=27%  Similarity=0.401  Sum_probs=195.5

Q ss_pred             HHHHhcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccccHHHHHHHHHHHhcc-CCCCceeEEEEeec-----
Q 003391          499 IANATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQ-----  571 (823)
Q Consensus       499 l~~~~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~-----  571 (823)
                      +....++|...+.||+|+||.||+|++. +++.||+|++.... ...+.+.+|+.++.++ +||||+++++++..     
T Consensus        19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   97 (326)
T 2x7f_A           19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   97 (326)
T ss_dssp             CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred             ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence            3345678999999999999999999985 48899999986543 3457889999999999 89999999999976     


Q ss_pred             -CCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecc
Q 003391          572 -RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDF  650 (823)
Q Consensus       572 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF  650 (823)
                       .+..++||||+++++|.+++... ....+++..+..++.||+.||.|||+.+   |+|+||||+||+++.++.+||+||
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Df  173 (326)
T 2x7f_A           98 MDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDF  173 (326)
T ss_dssp             CCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCC
T ss_pred             ccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeC
Confidence             45789999999999999998643 2346899999999999999999999998   999999999999999999999999


Q ss_pred             ccceecCCCccccccccccccCCccCccccc-----cCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHH
Q 003391          651 GMARAFGIDQTEANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR  725 (823)
Q Consensus       651 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~  725 (823)
                      |++.......  .......||+.|+|||++.     +..++.++||||||+++|||++|+.||......      .... 
T Consensus       174 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~-  244 (326)
T 2x7f_A          174 GVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------RALF-  244 (326)
T ss_dssp             TTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHH-
T ss_pred             cCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HHHH-
Confidence            9998653221  1223357899999999987     567899999999999999999999997432211      1100 


Q ss_pred             HhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          726 LWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       726 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      .........     .   ........+.+++.+||+.||++||++.++++
T Consensus       245 ~~~~~~~~~-----~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          245 LIPRNPAPR-----L---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHHHSCCCC-----C---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HhhcCcccc-----C---CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            011111000     0   01111246788999999999999999999987

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=8.2e-36  Score=329.44  Aligned_cols=262  Identities=20%  Similarity=0.310  Sum_probs=200.0

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecC-----Cce
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR-----DER  575 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~  575 (823)
                      .++|...+.||+|+||.||+|+... ++.||+|++.... ....+.+.+|+.++.+++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            4679999999999999999999764 7889999997543 23346788999999999999999999999655     368


Q ss_pred             EEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccccee
Q 003391          576 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                      ++|+||++ ++|.+++..    ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            99999997 489888843    35899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCcccc-ccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCch
Q 003391          656 FGIDQTEA-NTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV  733 (823)
Q Consensus       656 ~~~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  733 (823)
                      ........ ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+   ......... .....
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~-~~~~~  253 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILGIL-GSPSQ  253 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG---HHHHHHHHH-CSCCH
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH---HHHHHHHHh-CCCCH
Confidence            64332221 2344689999999998765 458999999999999999999999986433222   111111110 01111


Q ss_pred             hhhh------------hhc-CCCCCHH-----HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          734 ELIN------------KSL-GGSYSLS-----EVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       734 ~~~~------------~~l-~~~~~~~-----~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      +.+.            ... .......     ...++.+++.+||+.||++|||+.|+++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000            000 0011111     12467899999999999999999999863

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.1e-35  Score=329.34  Aligned_cols=259  Identities=22%  Similarity=0.280  Sum_probs=190.9

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCC------
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD------  573 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------  573 (823)
                      .++|...+.||+|+||.||+|+... ++.||||++....  ....+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            4678999999999999999999764 8899999997542  334567889999999999999999999997654      


Q ss_pred             ceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccc
Q 003391          574 ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  653 (823)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  653 (823)
                      ..++||||+++ +|.+++.     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence            67999999975 7887773     23889999999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHH--------
Q 003391          654 RAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR--------  725 (823)
Q Consensus       654 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~--------  725 (823)
                      +.....   .......||+.|+|||++.+..++.++||||||+++|||++|+.||...+...   .......        
T Consensus       175 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~  248 (371)
T 2xrw_A          175 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID---QWNKVIEQLGTPCPE  248 (371)
T ss_dssp             ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHC-CCCCCHH
T ss_pred             cccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHH
Confidence            865322   12234678999999999999999999999999999999999999986432211   0000000        


Q ss_pred             ----------HhhhcCc-------hhhhhhhcCCCCC---HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          726 ----------LWIEERP-------VELINKSLGGSYS---LSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       726 ----------~~~~~~~-------~~~~~~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                                .+.....       ...+.........   ......+.+++.+||+.||++|||++|+++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence                      0000000       0000000101111   1124578899999999999999999999874

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.5e-35  Score=323.31  Aligned_cols=258  Identities=21%  Similarity=0.279  Sum_probs=201.0

Q ss_pred             hcCCCcCCeeeccCccceEEEEee--cCcEEEEEEecCCccccHHHHHHHHHHHhccCCCC------ceeEEEEeecCCc
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI--EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRN------LVKLIGCCTQRDE  574 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~--~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n------iv~l~g~~~~~~~  574 (823)
                      .++|.+.+.||+|+||.||+|...  +++.||+|++... ....+.+.+|+.+++.++|++      ++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            367899999999999999999873  4789999999654 334567889999999887654      9999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcC-------------
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-------------  641 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~-------------  641 (823)
                      .++||||+ +++|.+++... ....+++..+..++.||++||+|||+.+   |+||||||+|||++.             
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence            99999999 88999998543 2345889999999999999999999998   999999999999987             


Q ss_pred             ------CCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCC
Q 003391          642 ------EMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH  715 (823)
Q Consensus       642 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~  715 (823)
                            ++.+||+|||+++.....     .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  241 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE  241 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred             ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence                  678999999999864321     233578999999999999999999999999999999999999986433221


Q ss_pred             ccchhHHHHHHhhhcCchhhhhh--------------------------hc-----CCCCCHHHHHHHHHHHHHccccCC
Q 003391          716 HHNLLGHAWRLWIEERPVELINK--------------------------SL-----GGSYSLSEVLRCIQVGLLCVQQRP  764 (823)
Q Consensus       716 ~~~l~~~~~~~~~~~~~~~~~~~--------------------------~l-----~~~~~~~~~~~l~~l~~~Cl~~dP  764 (823)
                      .....    .......+......                          ..     ...........+.+++.+||+.||
T Consensus       242 ~~~~~----~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  317 (339)
T 1z57_A          242 HLAMM----ERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP  317 (339)
T ss_dssp             HHHHH----HHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             HHHHH----HHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence            11111    00111111110000                          00     001123345678999999999999


Q ss_pred             CCCCCHHHHHH
Q 003391          765 EDRPNMSSVVL  775 (823)
Q Consensus       765 ~~RPs~~evl~  775 (823)
                      .+|||+.|+++
T Consensus       318 ~~Rpt~~ell~  328 (339)
T 1z57_A          318 AKRITLREALK  328 (339)
T ss_dssp             TTSCCHHHHTT
T ss_pred             ccccCHHHHhc
Confidence            99999999975

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.2e-35  Score=326.84  Aligned_cols=268  Identities=22%  Similarity=0.283  Sum_probs=201.0

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccccHHHHHHHHHHHhccC-----------CCCceeEEEEee
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-----------HRNLVKLIGCCT  570 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~g~~~  570 (823)
                      .++|...+.||+|+||.||+|+.. +++.||+|++... ....+.+.+|+.++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            357889999999999999999975 4889999999643 234567889999999886           899999999987


Q ss_pred             cCC----ceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhc-CCCceEecccCCCcEEEc-----
Q 003391          571 QRD----ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLD-----  640 (823)
Q Consensus       571 ~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NIll~-----  640 (823)
                      ..+    ..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+. +   |+||||||+|||++     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence            654    789999999 899999986532 34589999999999999999999998 7   99999999999995     


Q ss_pred             -CCCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccch
Q 003391          641 -NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL  719 (823)
Q Consensus       641 -~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l  719 (823)
                       ..+.+||+|||+++.....     .....+|+.|+|||++.+..++.++||||||+++|||++|+.||...........
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence             3447999999999875422     2235789999999999999999999999999999999999999865432221111


Q ss_pred             hHHHHH--HhhhcCchhhh---------------------------hh--hcCCCCCHHHHHHHHHHHHHccccCCCCCC
Q 003391          720 LGHAWR--LWIEERPVELI---------------------------NK--SLGGSYSLSEVLRCIQVGLLCVQQRPEDRP  768 (823)
Q Consensus       720 ~~~~~~--~~~~~~~~~~~---------------------------~~--~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP  768 (823)
                      ......  ......+....                           ..  .-....+......+.+++.+||+.||++||
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence            111000  00111111000                           00  001123455667889999999999999999


Q ss_pred             CHHHHHH--HhccCC
Q 003391          769 NMSSVVL--MLSGER  781 (823)
Q Consensus       769 s~~evl~--~L~~~~  781 (823)
                      |++|+++  .+.+..
T Consensus       327 t~~ell~hp~f~~~~  341 (373)
T 1q8y_A          327 DAGGLVNHPWLKDTL  341 (373)
T ss_dssp             CHHHHHTCGGGTTCT
T ss_pred             CHHHHhhChhhhccc
Confidence            9999987  344443

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.1e-35  Score=318.78  Aligned_cols=253  Identities=23%  Similarity=0.377  Sum_probs=191.5

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeec----------
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ----------  571 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----------  571 (823)
                      .++|+..+.||+|+||.||+|+.. +++.||+|++... ....+.+.+|+.++++++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            467888999999999999999975 5889999998543 3445778999999999999999999998865          


Q ss_pred             ---CCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceee
Q 003391          572 ---RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKIS  648 (823)
Q Consensus       572 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~  648 (823)
                         ....++||||+++++|.+++..  ....+++..++.++.||++||+|||+.+   |+|+||||+||+++.++.+||+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence               3567999999999999999964  3345788999999999999999999998   9999999999999999999999


Q ss_pred             ccccceecCCCcc------------ccccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCC
Q 003391          649 DFGMARAFGIDQT------------EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH  715 (823)
Q Consensus       649 DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~  715 (823)
                      |||++........            ........||+.|+|||++.+. .++.++||||||+++|||++   |+...  ..
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~--~~  233 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG--ME  233 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH--HH
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc--hh
Confidence            9999986542210            1122345689999999999865 68999999999999999998   33210  00


Q ss_pred             ccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          716 HHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       716 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      .    .........      ................+.+++.+|++.||++|||+.|+++.
T Consensus       234 ~----~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          234 R----VNILKKLRS------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             H----HHHHHHHHS------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             H----HHHHHhccc------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            0    000011100      01111122333334567899999999999999999999863

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=7.2e-36  Score=353.45  Aligned_cols=256  Identities=24%  Similarity=0.313  Sum_probs=201.1

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec----CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM  576 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~----~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  576 (823)
                      ..++|...+.||+|+||.||+|++..    +..||+|++.... ....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~  466 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW  466 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceE
Confidence            34678888999999999999999753    4579999986543 3345678999999999999999999999854 5689


Q ss_pred             EEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceec
Q 003391          577 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  656 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  656 (823)
                      +||||+++|+|.+++..  +...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       467 lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~  541 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  541 (656)
T ss_dssp             EEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred             EEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence            99999999999999954  2335899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhh
Q 003391          657 GIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVEL  735 (823)
Q Consensus       657 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  735 (823)
                      ..... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||......   ...    ......     
T Consensus       542 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~----~~i~~~-----  608 (656)
T 2j0j_A          542 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVI----GRIENG-----  608 (656)
T ss_dssp             CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH----HHHHHT-----
T ss_pred             CCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHH----HHHHcC-----
Confidence            43221 12223456789999999999999999999999999999997 88887532211   111    111111     


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       736 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                          .....+......+.+++.+||+.||++||++.|+++.|+.+
T Consensus       609 ----~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          609 ----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                01111222335778999999999999999999999999864

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=4.6e-36  Score=337.64  Aligned_cols=257  Identities=21%  Similarity=0.288  Sum_probs=191.2

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecC------CceE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR------DERM  576 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~~  576 (823)
                      .+|...+.||+|+||.||+|++.. ++.||||++.....    .+.+|++++++++||||+++++++...      ...+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            457888999999999999999865 89999999865432    234799999999999999999998542      2367


Q ss_pred             EEEeecCCCCcchhhhc-cCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCC-CCceeeccccce
Q 003391          577 LIYEYLPNKSLNDFIFD-VTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMAR  654 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DFGla~  654 (823)
                      +||||+++ +|.+.+.. ......+++..+..++.||++||+|||+.+   |+||||||+|||++.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            89999986 56665543 223456899999999999999999999988   9999999999999965 568999999998


Q ss_pred             ecCCCccccccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCch
Q 003391          655 AFGIDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV  733 (823)
Q Consensus       655 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  733 (823)
                      .+....   ......+|+.|+|||++.+. .++.++|||||||+||||++|+.||......   ..+....... .....
T Consensus       206 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~---~~l~~i~~~l-g~p~~  278 (420)
T 1j1b_A          206 QLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV---DQLVEIIKVL-GTPTR  278 (420)
T ss_dssp             ECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHH-CSCCH
T ss_pred             hcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHh-CCCCH
Confidence            764322   12335789999999999765 7999999999999999999999998643211   1111111111 01111


Q ss_pred             hhhhh-----------hcCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          734 ELINK-----------SLGGS-----YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       734 ~~~~~-----------~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      +.+..           .+...     +......++.+|+.+||+.||++||++.|+++
T Consensus       279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            11100           00000     01112347889999999999999999999986

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=5e-36  Score=336.08  Aligned_cols=202  Identities=25%  Similarity=0.379  Sum_probs=154.5

Q ss_pred             CCCc-CCeeeccCccceEEEEee---cCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEee--cCCceEEE
Q 003391          505 NFSD-KNKLGEGGFGPVYKGVLI---EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCT--QRDERMLI  578 (823)
Q Consensus       505 ~~~~-~~~LG~G~fg~Vyk~~~~---~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~--~~~~~~lV  578 (823)
                      .|.. .++||+|+||.||+|++.   .++.||+|++....  ....+.+|+.++++++||||+++++++.  .....++|
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence            3544 568999999999999976   37889999996543  2357889999999999999999999994  46788999


Q ss_pred             EeecCCCCcchhhhcc------CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEE----cCCCCceee
Q 003391          579 YEYLPNKSLNDFIFDV------TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNEMNPKIS  648 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~  648 (823)
                      |||+++ +|.+++...      .....+++..++.++.||+.||+|||+.+   |+||||||+|||+    +.++.+||+
T Consensus        99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            999975 787777421      12234899999999999999999999998   9999999999999    778899999


Q ss_pred             ccccceecCCCcc-ccccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcC
Q 003391          649 DFGMARAFGIDQT-EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYH  712 (823)
Q Consensus       649 DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~  712 (823)
                      |||+++.+..... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            9999987643221 1233446789999999999874 58999999999999999999999986443

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.9e-35  Score=324.91  Aligned_cols=262  Identities=22%  Similarity=0.275  Sum_probs=196.8

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecC-----Cce
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR-----DER  575 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~~  575 (823)
                      .++|...+.||+|+||.||+|++.. ++.||||++.... ......+.+|+.++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            4678899999999999999999864 8899999996543 23455788999999999999999999998654     678


Q ss_pred             EEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccccee
Q 003391          576 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                      ++||||++ ++|.+++..    ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            99999997 589888843    35899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCcccc--------ccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHH
Q 003391          656 FGIDQTEA--------NTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL  726 (823)
Q Consensus       656 ~~~~~~~~--------~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  726 (823)
                      ........        ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......   ........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~  238 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH---QLLLIFGI  238 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHH
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHH
Confidence            64322111        1223578999999998764 678999999999999999999999986432111   01000000


Q ss_pred             hhhcC------------chhhhhhhcC-CCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          727 WIEER------------PVELINKSLG-GSYSL-----SEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       727 ~~~~~------------~~~~~~~~l~-~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      .....            ..+.+..... .....     ....++.+++.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            00000            0000000000 00011     11246789999999999999999999987

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=6.4e-35  Score=324.43  Aligned_cols=200  Identities=24%  Similarity=0.332  Sum_probs=169.3

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccC-CC-----CceeEEEEeecCCc
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HR-----NLVKLIGCCTQRDE  574 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~-----niv~l~g~~~~~~~  574 (823)
                      ..++|...+.||+|+||.||+|+... ++.||||++... .....++..|+.++..++ |+     +++++++++...+.
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            45789999999999999999999764 788999999643 234567788999888874 55     49999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEc--CCCCceeecccc
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD--NEMNPKISDFGM  652 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~--~~~~~kl~DFGl  652 (823)
                      .++||||++ ++|.+++.... ...+++..+..++.||+.||.|||++. .+|+||||||+|||++  .++.+||+|||+
T Consensus       131 ~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~  207 (382)
T 2vx3_A          131 LCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGS  207 (382)
T ss_dssp             EEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             eEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence            999999996 59999986532 245899999999999999999999531 2499999999999995  477899999999


Q ss_pred             ceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCC
Q 003391          653 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGF  710 (823)
Q Consensus       653 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~  710 (823)
                      ++.....     .....+|+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       208 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~  260 (382)
T 2vx3_A          208 SCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG  260 (382)
T ss_dssp             CEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9876322     2346789999999999999999999999999999999999999864

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=4.1e-35  Score=324.62  Aligned_cols=256  Identities=20%  Similarity=0.306  Sum_probs=194.5

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCce----
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDER----  575 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~----  575 (823)
                      .++|...+.||+|+||.||+|++.. ++.||+|++....  ....+.+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            4678889999999999999999764 8899999997643  23356788999999999999999999999877654    


Q ss_pred             --EEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccc
Q 003391          576 --MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  653 (823)
Q Consensus       576 --~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  653 (823)
                        ++||||++ ++|.+++.     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence              99999997 58877762     23899999999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCccccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCc
Q 003391          654 RAFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP  732 (823)
Q Consensus       654 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  732 (823)
                      +.....     .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......   ......... .....
T Consensus       192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~-~~~~~  262 (371)
T 4exu_A          192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKV-TGVPG  262 (371)
T ss_dssp             -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHH-HCCCC
T ss_pred             cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHH-hCCCc
Confidence            864322     233578999999999987 67999999999999999999999998543211   111111110 00000


Q ss_pred             hh------------hhhhhcCC-CCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          733 VE------------LINKSLGG-SYSL-----SEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       733 ~~------------~~~~~l~~-~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      .+            ........ ....     .....+.+++.+||+.||++|||++|+++.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            00            00000000 0011     113477899999999999999999999864

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.9e-35  Score=318.59  Aligned_cols=263  Identities=23%  Similarity=0.337  Sum_probs=198.0

Q ss_pred             HhcCCCcCCeeeccCccceEEEEee--cCcEEEEEEecCCc--cccHHHHHHHHHHHhcc---CCCCceeEEEEee----
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLI--EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKL---QHRNLVKLIGCCT----  570 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~--~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~----  570 (823)
                      ..++|...+.||+|+||.||+|++.  +++.||+|++....  ......+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4578999999999999999999984  47889999986432  22234566777777766   8999999999987    


Q ss_pred             -cCCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeec
Q 003391          571 -QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISD  649 (823)
Q Consensus       571 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D  649 (823)
                       .....++||||++ |+|.+++.... ...+++..+..++.||++||.|||+.+   |+|+||||+||+++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence             5567899999998 69999986432 334899999999999999999999998   99999999999999999999999


Q ss_pred             cccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhh
Q 003391          650 FGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE  729 (823)
Q Consensus       650 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  729 (823)
                      ||+++.....   .......+|+.|+|||++.+..++.++||||||+++|||++|+.||......   ............
T Consensus       164 fg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~  237 (326)
T 1blx_A          164 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGL  237 (326)
T ss_dssp             CCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCC
T ss_pred             CcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHcCC
Confidence            9999865322   1233467899999999999999999999999999999999999997543211   111111111000


Q ss_pred             cCchh----------hhhhhcC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          730 ERPVE----------LINKSLG---GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       730 ~~~~~----------~~~~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      .....          .+.....   ..........+.+++.+||+.||++||++.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00000          0000000   0001112246778999999999999999999985

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.5e-35  Score=314.24  Aligned_cols=251  Identities=25%  Similarity=0.303  Sum_probs=199.5

Q ss_pred             HhcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      ..++|.+.+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            4578999999999999999999986 48899999986542  34567899999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCC---CCceeecccccee
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE---MNPKISDFGMARA  655 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DFGla~~  655 (823)
                      +||+++++|.+++...   ..+++..+..++.||+.||.|||+.+   |+|+||||+||+++.+   ..+||+|||++..
T Consensus       100 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A          100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             EEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            9999999999988542   35899999999999999999999998   9999999999999764   4699999999986


Q ss_pred             cCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhh
Q 003391          656 FGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL  735 (823)
Q Consensus       656 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  735 (823)
                      .....   ......+++.|+|||.+.+ .++.++||||||+++|||++|+.||......   .    .............
T Consensus       174 ~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~----~~~~~~~~~~~~~  242 (287)
T 2wei_A          174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---D----ILKRVETGKYAFD  242 (287)
T ss_dssp             BCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H----HHHHHHHCCCCCC
T ss_pred             ecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH---H----HHHHHHcCCCCCC
Confidence            53221   2223468899999998875 4899999999999999999999997532111   1    1111111110000


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       736 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      . +. .    .....++.+++.+|++.+|++|||+.|+++
T Consensus       243 ~-~~-~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          243 L-PQ-W----RTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             S-GG-G----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             c-hh-h----hhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            0 00 0    011246789999999999999999999987

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.5e-35  Score=320.54  Aligned_cols=255  Identities=24%  Similarity=0.350  Sum_probs=177.6

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCcc-ccHHHHHHHHH-HHhccCCCCceeEEEEeecCCceEEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG-QGMEEFENEVL-LIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~-~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      .++|...+.||+|+||.||+|... +++.||+|++..... ....++..|+. +++.++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            367888999999999999999986 488999999976532 33445566666 677789999999999999999999999


Q ss_pred             eecCCCCcchhhhc--cCCCCccCHHHHHHHHHHHHHHHHHHHhc-CCCceEecccCCCcEEEcCCCCceeeccccceec
Q 003391          580 EYLPNKSLNDFIFD--VTRSKFLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  656 (823)
Q Consensus       580 e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  656 (823)
                      ||+++ +|.+++..  ......+++..+..++.|+++||.|||+. +   |+||||||+|||++.++.+||+|||+++..
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99985 78777743  12245689999999999999999999998 7   999999999999999999999999999865


Q ss_pred             CCCccccccccccccCCccCcccc----ccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCc
Q 003391          657 GIDQTEANTNRVVGTYGYMPPEYA----IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP  732 (823)
Q Consensus       657 ~~~~~~~~~~~~~gt~~y~aPE~l----~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  732 (823)
                      ....   ......||+.|+|||++    .+..++.++||||||+++|||++|+.||........  ..    ........
T Consensus       177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~----~~~~~~~~  247 (327)
T 3aln_A          177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--QL----TQVVKGDP  247 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSCC
T ss_pred             cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--HH----HHHhcCCC
Confidence            3221   12234689999999998    466789999999999999999999999854221100  00    00000000


Q ss_pred             hhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          733 VELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       733 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                           ..+...........+.+++.+||+.||++||++.|+++
T Consensus       248 -----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          248 -----PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             -----CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -----CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence                 00111111112346789999999999999999999975

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.2e-35  Score=319.98  Aligned_cols=253  Identities=19%  Similarity=0.214  Sum_probs=171.8

Q ss_pred             HhcCCCcCC-eeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeec----CCce
Q 003391          502 ATENFSDKN-KLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ----RDER  575 (823)
Q Consensus       502 ~~~~~~~~~-~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~  575 (823)
                      ..++|.+.+ .||+|+||.||+|++.. ++.||+|++....    ....+....+..++||||+++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            356788744 69999999999999874 8999999986532    222233334566799999999999876    4458


Q ss_pred             EEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcC---CCCceeecccc
Q 003391          576 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGM  652 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~DFGl  652 (823)
                      ++||||+++|+|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||+
T Consensus       102 ~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence            9999999999999999643 2346899999999999999999999998   999999999999976   45599999999


Q ss_pred             ceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCc
Q 003391          653 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP  732 (823)
Q Consensus       653 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  732 (823)
                      ++.....    ......+|+.|+|||++.+..++.++||||||+++|||++|+.||.............   .....   
T Consensus       178 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~~---  247 (336)
T 3fhr_A          178 AKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK---RRIRL---  247 (336)
T ss_dssp             CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred             ceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH---Hhhhc---
Confidence            9865322    2233568999999999998899999999999999999999999985432221100000   00000   


Q ss_pred             hhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          733 VELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       733 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                       .  ...............+.+++.+||+.||++|||+.|+++
T Consensus       248 -~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          248 -G--QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -c--ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             0  000000001122346789999999999999999999997

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-35  Score=318.42  Aligned_cols=244  Identities=24%  Similarity=0.441  Sum_probs=190.0

Q ss_pred             HHHhcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccc------cHHHHHHHHHHHhcc----CCCCceeEEEE
Q 003391          500 ANATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQ------GMEEFENEVLLIAKL----QHRNLVKLIGC  568 (823)
Q Consensus       500 ~~~~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~------~~~~~~~Ei~~l~~l----~H~niv~l~g~  568 (823)
                      ....++|...+.||+|+||.||+|++. +++.||+|++......      ....+.+|+.++.++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            345678999999999999999999875 4889999999665321      223456799999988    89999999999


Q ss_pred             eecCCceEEEEee-cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEc-CCCCce
Q 003391          569 CTQRDERMLIYEY-LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPK  646 (823)
Q Consensus       569 ~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~-~~~~~k  646 (823)
                      +...+..++|+|+ +.+++|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+||+++ .++.+|
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence            9999999999999 789999999954   235899999999999999999999998   99999999999999 889999


Q ss_pred             eeccccceecCCCccccccccccccCCccCccccccCCC-CccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHH
Q 003391          647 ISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWR  725 (823)
Q Consensus       647 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~  725 (823)
                      |+|||++.......    .....|+..|+|||++.+..+ +.++||||||+++|||++|+.||....             
T Consensus       181 l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------------  243 (312)
T 2iwi_A          181 LIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------------  243 (312)
T ss_dssp             ECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------
T ss_pred             EEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------------
Confidence            99999998764322    233568999999999987766 458999999999999999999974210             


Q ss_pred             HhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          726 LWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       726 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                              +......  .........+.+++.+|++.+|++||++.|+++.
T Consensus       244 --------~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          244 --------EILEAEL--HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             --------HHHHTCC--CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             --------HHhhhcc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                    0011111  1111223467889999999999999999999874

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.3e-34  Score=318.13  Aligned_cols=258  Identities=21%  Similarity=0.289  Sum_probs=198.6

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-C-cEEEEEEecCCccccHHHHHHHHHHHhccCCCC------ceeEEEEeecCCc
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-G-QEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRN------LVKLIGCCTQRDE  574 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~-~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n------iv~l~g~~~~~~~  574 (823)
                      .++|...+.||+|+||.||+|+... + +.||+|++... ....+.+.+|+.++++++|++      ++.+.+++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            4689999999999999999999754 4 68999998643 334567888999999987665      9999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEE---------------
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL---------------  639 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll---------------  639 (823)
                      .++||||+ +++|.+++... ....+++..+..++.||++||+|||+.+   |+||||||+|||+               
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence            99999999 66777777542 2345899999999999999999999998   9999999999999               


Q ss_pred             ----cCCCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCC
Q 003391          640 ----DNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH  715 (823)
Q Consensus       640 ----~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~  715 (823)
                          +.++.+||+|||+++.....     .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE  246 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                67889999999999864322     233578999999999999999999999999999999999999986432211


Q ss_pred             ccchhHHHHHHhhhcCchhhhhhh--------------------------c-----CCCCCHHHHHHHHHHHHHccccCC
Q 003391          716 HHNLLGHAWRLWIEERPVELINKS--------------------------L-----GGSYSLSEVLRCIQVGLLCVQQRP  764 (823)
Q Consensus       716 ~~~l~~~~~~~~~~~~~~~~~~~~--------------------------l-----~~~~~~~~~~~l~~l~~~Cl~~dP  764 (823)
                      .   ...... .....+.......                          .     .......+...+.+++.+||+.||
T Consensus       247 ~---~~~~~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  322 (355)
T 2eu9_A          247 H---LVMMEK-ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP  322 (355)
T ss_dssp             H---HHHHHH-HHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             H---HHHHHH-HcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence            1   111100 1111111110000                          0     001122334578899999999999


Q ss_pred             CCCCCHHHHHH
Q 003391          765 EDRPNMSSVVL  775 (823)
Q Consensus       765 ~~RPs~~evl~  775 (823)
                      ++|||+.|+++
T Consensus       323 ~~Rpt~~e~l~  333 (355)
T 2eu9_A          323 AQRITLAEALL  333 (355)
T ss_dssp             TTSCCHHHHTT
T ss_pred             hhCcCHHHHhc
Confidence            99999999974

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3e-35  Score=323.48  Aligned_cols=256  Identities=20%  Similarity=0.298  Sum_probs=194.4

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCc-----
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE-----  574 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-----  574 (823)
                      .++|...+.||+|+||.||+|++.. ++.||||++....  ....+.+.+|+.++++++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            3678889999999999999999864 8899999997643  2335678899999999999999999999987654     


Q ss_pred             -eEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccc
Q 003391          575 -RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  653 (823)
Q Consensus       575 -~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  653 (823)
                       .++||||++ ++|.+++.     ..+++..+..++.||++||.|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999997 58888762     24899999999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCccccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCc
Q 003391          654 RAFGIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP  732 (823)
Q Consensus       654 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  732 (823)
                      +.....     .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......   ......... .....
T Consensus       174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~i~~~-~~~~~  244 (353)
T 3coi_A          174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKV-TGVPG  244 (353)
T ss_dssp             TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH---HHHHHHHHH-HCBCC
T ss_pred             cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHH-hCCCC
Confidence            764322     233578999999999887 67899999999999999999999998643211   111111110 00000


Q ss_pred             hh------------hhhhh---cCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          733 VE------------LINKS---LGG---SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       733 ~~------------~~~~~---l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      .+            .+...   ...   .........+.+++.+|++.||++|||++|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             HHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            00            00000   000   0111223577899999999999999999999863

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.7e-35  Score=320.85  Aligned_cols=242  Identities=25%  Similarity=0.408  Sum_probs=197.0

Q ss_pred             HhcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccc------cHHHHHHHHHHHhccC--CCCceeEEEEeecC
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQ------GMEEFENEVLLIAKLQ--HRNLVKLIGCCTQR  572 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~------~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~  572 (823)
                      ..++|...+.||+|+||.||+|+.. +++.||+|++......      ..+.+.+|+.++++++  ||||+++++++.+.
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            4578999999999999999999975 4889999998654321      2345678999999996  59999999999999


Q ss_pred             CceEEEEeecCC-CCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEc-CCCCceeecc
Q 003391          573 DERMLIYEYLPN-KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDF  650 (823)
Q Consensus       573 ~~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~DF  650 (823)
                      +..++|+|++.+ ++|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++ +++.+||+||
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Df  194 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF  194 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCC
T ss_pred             CcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeC
Confidence            999999999986 899999854   345899999999999999999999998   99999999999999 7889999999


Q ss_pred             ccceecCCCccccccccccccCCccCccccccCCC-CccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhh
Q 003391          651 GMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE  729 (823)
Q Consensus       651 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  729 (823)
                      |+++.....    ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||....                 
T Consensus       195 g~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----------------  253 (320)
T 3a99_A          195 GSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----------------  253 (320)
T ss_dssp             TTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------------
T ss_pred             ccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----------------
Confidence            999876432    2223568999999999987765 788999999999999999999974311                 


Q ss_pred             cCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          730 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       730 ~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                          +.......  .......++.+++.+||+.||++||++.|+++.
T Consensus       254 ----~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          254 ----EIIRGQVF--FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             ----HHHHCCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ----hhhccccc--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                00000000  111122467889999999999999999999863

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=5.9e-35  Score=330.03  Aligned_cols=252  Identities=23%  Similarity=0.281  Sum_probs=184.8

Q ss_pred             CCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceEEEEeecC
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEYLP  583 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~  583 (823)
                      .|...+.||+|+||+||.+...+++.||||++...   ..+.+.+|+.++.++ +||||+++++++.+.+..++||||++
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            34556789999999998766667999999998643   345678999999886 89999999999999999999999996


Q ss_pred             CCCcchhhhccCCCC----ccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCC-------------CCce
Q 003391          584 NKSLNDFIFDVTRSK----FLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-------------MNPK  646 (823)
Q Consensus       584 ~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~-------------~~~k  646 (823)
                       |+|.+++.......    ..++..++.++.||+.||+|||+.+   |+||||||+|||++.+             ..+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence             69999996432211    1234456789999999999999998   9999999999999754             4799


Q ss_pred             eeccccceecCCCccc--cccccccccCCccCcccccc-------CCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCc
Q 003391          647 ISDFGMARAFGIDQTE--ANTNRVVGTYGYMPPEYAID-------GLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHH  716 (823)
Q Consensus       647 l~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-------~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~  716 (823)
                      |+|||+++........  .......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||....... 
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-  247 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-  247 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence            9999999987543222  12234679999999999976       678999999999999999999 899975321110 


Q ss_pred             cchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          717 HNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       717 ~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                          ..    .......   ..............++.+++.+||+.||++|||+.|+++
T Consensus       248 ----~~----i~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 ----SN----IIRGIFS---LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             ----HH----HHHTCCC---CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----HH----HhcCCCC---cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence                00    0000000   000111123344567889999999999999999999985

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-34  Score=325.45  Aligned_cols=250  Identities=20%  Similarity=0.304  Sum_probs=184.8

Q ss_pred             hcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceEEEEee
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      ..+|...+.||+|+||+|+.....+++.||||++......   .+.+|+.+++++ +||||+++++++.+....++||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            4568888999999999966555567999999999654322   356899999999 799999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcC-----CCCceeeccccceec
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-----EMNPKISDFGMARAF  656 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~-----~~~~kl~DFGla~~~  656 (823)
                      ++ |+|.+++....  ....+..+..++.||++||.|||+.+   |+||||||+|||++.     ...+||+|||+++.+
T Consensus       100 ~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A          100 CA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             CS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             CC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            96 59999985432  23445566789999999999999998   999999999999953     335789999999876


Q ss_pred             CCCcc-ccccccccccCCccCccccc---cCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcC
Q 003391          657 GIDQT-EANTNRVVGTYGYMPPEYAI---DGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEER  731 (823)
Q Consensus       657 ~~~~~-~~~~~~~~gt~~y~aPE~l~---~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~  731 (823)
                      ..... ........||+.|+|||++.   ...++.++|||||||++|||++ |..||+.....       . ........
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-------~-~~~~~~~~  245 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-------Q-ANILLGAC  245 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-------H-HHHHTTCC
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-------H-HHHHhccC
Confidence            43321 12234467999999999997   4567889999999999999999 88887422111       0 00011110


Q ss_pred             chhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          732 PVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       732 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ....      ..........+.+++.+||+.||++|||+.||++
T Consensus       246 ~~~~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          246 SLDC------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CCTT------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             Cccc------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            0000      0111223345778999999999999999999984

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.5e-34  Score=312.81  Aligned_cols=251  Identities=21%  Similarity=0.346  Sum_probs=176.5

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccc--cHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQ--GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      .++|...+.||+|+||.||+|++. +++.||+|++......  ..+.+.++..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            467888899999999999999986 4889999999765322  2233445556788889999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhc-CCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      ||+ ++.+..+. .. ....+++..+..++.||++||.|||+. +   |+|+||||+||+++.++.+||+|||++.....
T Consensus       104 e~~-~~~~~~l~-~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          104 ELM-GTCAEKLK-KR-MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             CCC-SEEHHHHH-HH-HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecc-CCcHHHHH-HH-hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            999 44444443 21 234589999999999999999999995 7   99999999999999999999999999976533


Q ss_pred             CccccccccccccCCccCccccc-----cCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCch
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV  733 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  733 (823)
                      ..   ......+|+.|+|||++.     ...++.++||||||+++|||++|+.||......     . ............
T Consensus       178 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~-~~~~~~~~~~~~  248 (318)
T 2dyl_A          178 DK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----F-EVLTKVLQEEPP  248 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----H-HHHHHHHHSCCC
T ss_pred             Cc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----H-HHHHHHhccCCC
Confidence            22   222356899999999994     556889999999999999999999997532111     0 011111111110


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          734 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       734 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      .     +..  ......++.+++.+||+.||.+||++.|+++
T Consensus       249 ~-----~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          249 L-----LPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             C-----CCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             C-----CCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            0     000  0112246788999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=6.9e-35  Score=339.14  Aligned_cols=264  Identities=23%  Similarity=0.301  Sum_probs=196.9

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC-ccccHHHHHHHHHHHhccCCCCceeEEEEeec------CCc
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ------RDE  574 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~~  574 (823)
                      .++|...++||+|+||.||+|.+.. ++.||+|++... .....+.+.+|+.++++++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            4789999999999999999999754 889999998764 33445678999999999999999999999765      677


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCC---ceeeccc
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMN---PKISDFG  651 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~DFG  651 (823)
                      .++||||+++++|.+++........+++..+..++.+|+.||+|||+.+   |+||||||+||+++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence            8999999999999999976555557899999999999999999999998   999999999999997765   8999999


Q ss_pred             cceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCc--cchhHHHHHH-hh
Q 003391          652 MARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH--HNLLGHAWRL-WI  728 (823)
Q Consensus       652 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~--~~l~~~~~~~-~~  728 (823)
                      ++.......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||........  .......... ..
T Consensus       170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~  246 (676)
T 3qa8_A          170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV  246 (676)
T ss_dssp             CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred             ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence            998764322   22346789999999999999999999999999999999999999853210000  0000000000 00


Q ss_pred             hcCchhh--hhhhc--CCCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 003391          729 EERPVEL--INKSL--GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSS  772 (823)
Q Consensus       729 ~~~~~~~--~~~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e  772 (823)
                      .......  ....+  ...........+.+++..|++.||++|||++|
T Consensus       247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence            0000000  00000  11123344568899999999999999999976

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.9e-34  Score=340.11  Aligned_cols=237  Identities=21%  Similarity=0.289  Sum_probs=190.5

Q ss_pred             cCCCcCCeeeccCccceEEEEee--cCcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCc-----e
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLI--EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE-----R  575 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~--~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-----~  575 (823)
                      ++|.+.+.||+|+||.||+|++.  +++.||||++.... ....+.+.+|+.++.+++||||+++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            67899999999999999999986  47899999986543 3445678899999999999999999999987665     6


Q ss_pred             EEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccccee
Q 003391          576 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                      +|||||+++++|.+++..     .+++..++.++.||++||.|||+.+   |+||||||+|||++.+ .+||+|||+++.
T Consensus       160 ~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             EEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence            999999999999987632     5899999999999999999999998   9999999999999986 899999999987


Q ss_pred             cCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhh
Q 003391          656 FGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL  735 (823)
Q Consensus       656 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  735 (823)
                      ....      ....||+.|+|||++.+.. +.++||||||++||||++|..|+.........                  
T Consensus       231 ~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~------------------  285 (681)
T 2pzi_A          231 INSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP------------------  285 (681)
T ss_dssp             TTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC------------------
T ss_pred             cccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc------------------
Confidence            5432      3467999999999987654 89999999999999999998875421111000                  


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHhcc
Q 003391          736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPN-MSSVVLMLSG  779 (823)
Q Consensus       736 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~L~~  779 (823)
                           ...........+.+++.+|++.||++||+ +.++...|.+
T Consensus       286 -----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          286 -----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             -----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             -----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence                 00000112246788999999999999994 6666666654

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=5.3e-33  Score=296.05  Aligned_cols=232  Identities=10%  Similarity=0.079  Sum_probs=181.9

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc---ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ++|.+.+.||+|+||.||+|++.. ++.||+|++.....   ...+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            679999999999999999999865 89999999976533   23467899999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+++++|.+++..    . ....++.+++.||++||+|||+.+   |+||||||+|||++.++.+||++++        
T Consensus       111 e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~--------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA--------  174 (286)
T ss_dssp             ECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred             EecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc--------
Confidence            99999999999832    2 355578899999999999999998   9999999999999999999997543        


Q ss_pred             ccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                                    |++|       ++.++||||||+++|||++|+.||..............   . .......  ...
T Consensus       175 --------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~---~-~~~~~~~--~~~  227 (286)
T 3uqc_A          175 --------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER---D-TAGQPIE--PAD  227 (286)
T ss_dssp             --------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB---C-TTSCBCC--HHH
T ss_pred             --------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH---H-hccCCCC--hhh
Confidence                          3333       68899999999999999999999865433221100000   0 0000000  000


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCCC
Q 003391          740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSL  783 (823)
Q Consensus       740 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~  783 (823)
                      ....    ....+.+++.+||+.||++| |+.|+++.|+.....
T Consensus       228 ~~~~----~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          228 IDRD----IPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             HCTT----SCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             cccC----CCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence            1111    12367899999999999999 999999999876443

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2e-33  Score=315.45  Aligned_cols=240  Identities=17%  Similarity=0.171  Sum_probs=177.9

Q ss_pred             cCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCc---cccHHHHHHHHHHHhccCC-CCce---------e-----
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQH-RNLV---------K-----  564 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H-~niv---------~-----  564 (823)
                      ..|...+.||+|+||.||+|++. +++.||||++....   ....+.+.+|+.++..++| +|..         .     
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            45667789999999999999965 48999999987433   2346789999999999987 2211         1     


Q ss_pred             -------EEEEeec-----CCceEEEEeecCCCCcchhhhc----cCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceE
Q 003391          565 -------LIGCCTQ-----RDERMLIYEYLPNKSLNDFIFD----VTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRII  628 (823)
Q Consensus       565 -------l~g~~~~-----~~~~~lV~e~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv  628 (823)
                             ++.+...     ....+++|+++ +++|.+++..    ......+++..++.++.||++||+|||+.+   |+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence                   1111111     12356666654 6899988842    223456889999999999999999999998   99


Q ss_pred             ecccCCCcEEEcCCCCceeeccccceecCCCccccccccccccCCccCcccc----------ccCCCCccchhHhHHHHH
Q 003391          629 HRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA----------IDGLFSVKSDVFSFGVLV  698 (823)
Q Consensus       629 H~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l----------~~~~~s~ksDVwS~Gvvl  698 (823)
                      ||||||+|||++.++.+||+|||+++.....     .....| +.|+|||++          .+..++.++|||||||++
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            9999999999999999999999999865322     333567 999999999          556688999999999999


Q ss_pred             HHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 003391          699 LEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV  774 (823)
Q Consensus       699 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl  774 (823)
                      |||++|+.||........                   ....+......  ...+.+++.+||+.||++||++.+++
T Consensus       308 ~elltg~~Pf~~~~~~~~-------------------~~~~~~~~~~~--~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          308 YWIWCADLPNTDDAALGG-------------------SEWIFRSCKNI--PQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHSSCCCCTTGGGSC-------------------SGGGGSSCCCC--CHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHCCCCCCCcchhhh-------------------HHHHHhhcccC--CHHHHHHHHHHccCChhhCcCHHHHH
Confidence            999999999854322111                   11111111111  24678899999999999999976664

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.5e-32  Score=292.97  Aligned_cols=227  Identities=20%  Similarity=0.250  Sum_probs=176.3

Q ss_pred             hcCCCcC-CeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHH-hccCCCCceeEEEEeec----CCce
Q 003391          503 TENFSDK-NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLI-AKLQHRNLVKLIGCCTQ----RDER  575 (823)
Q Consensus       503 ~~~~~~~-~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l-~~l~H~niv~l~g~~~~----~~~~  575 (823)
                      .++|... +.||+|+||.||++.... ++.||+|++..     ...+.+|+.++ +.++||||+++++++..    ....
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            3556665 679999999999999854 88999999853     24677888888 55699999999999876    6778


Q ss_pred             EEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcC---CCCceeecccc
Q 003391          576 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGM  652 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~DFGl  652 (823)
                      ++||||+++++|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||+
T Consensus        91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            9999999999999999653 2346899999999999999999999998   999999999999998   78899999999


Q ss_pred             ceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCc
Q 003391          653 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP  732 (823)
Q Consensus       653 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  732 (823)
                      +....                        +..++.++||||||+++|||++|+.||..........           ...
T Consensus       167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-----------~~~  211 (299)
T 3m2w_A          167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-----------GMK  211 (299)
T ss_dssp             CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-----------CSC
T ss_pred             ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-----------HHH
Confidence            87532                        2346789999999999999999999985432211000           000


Q ss_pred             hhhhhhhcCCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          733 VELINKSLGGSYSL----SEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       733 ~~~~~~~l~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ......  ....+.    ....++.+++.+||+.||++|||+.|+++
T Consensus       212 ~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          212 TRIRMG--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             CSSCTT--CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhhc--cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            000000  001111    11246789999999999999999999997

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.98  E-value=1e-32  Score=301.19  Aligned_cols=237  Identities=16%  Similarity=0.160  Sum_probs=182.6

Q ss_pred             hcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCc--------cccHHHHHHHHHHHhccC---------CCCceeE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSS--------GQGMEEFENEVLLIAKLQ---------HRNLVKL  565 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l~---------H~niv~l  565 (823)
                      .++|...++||+|+||.||+|+. +++.||||++....        ....+.+.+|+.++++++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46788899999999999999998 78999999997653        234478899999998885         7777777


Q ss_pred             EEEee------------------------------cCCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHH
Q 003391          566 IGCCT------------------------------QRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARG  615 (823)
Q Consensus       566 ~g~~~------------------------------~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g  615 (823)
                      .+.+.                              +.+..++||||+++|++.+.+.    ...+++..+..++.||+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHH
Confidence            76642                              2678999999999998777763    2458999999999999999


Q ss_pred             HHHHH-hcCCCceEecccCCCcEEEcCCC--------------------CceeeccccceecCCCccccccccccccCCc
Q 003391          616 LLYLH-QDSRLRIIHRDLKASNVLLDNEM--------------------NPKISDFGMARAFGIDQTEANTNRVVGTYGY  674 (823)
Q Consensus       616 L~yLH-~~~~~~ivH~Dlk~~NIll~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y  674 (823)
                      |+||| +.+   |+||||||+|||++.++                    .+||+|||+|+.....       ...||+.|
T Consensus       174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y  243 (336)
T 2vuw_A          174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS  243 (336)
T ss_dssp             HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred             HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence            99999 887   99999999999999887                    8999999999875421       35799999


Q ss_pred             cCccccccCCCCccchhHhHHHH-HHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhc-CCCC----CHHH
Q 003391          675 MPPEYAIDGLFSVKSDVFSFGVL-VLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL-GGSY----SLSE  748 (823)
Q Consensus       675 ~aPE~l~~~~~s~ksDVwS~Gvv-l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l-~~~~----~~~~  748 (823)
                      +|||++.+.. +.++||||++++ .+++++|..||..           ..|   .......++.... ....    ....
T Consensus       244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~-----------~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (336)
T 2vuw_A          244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN-----------VLW---LHYLTDKMLKQMTFKTKCNTPAMKQI  308 (336)
T ss_dssp             TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH-----------HHH---HHHHHHHHHHTCCCSSCCCSHHHHHH
T ss_pred             cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc-----------hhh---hhHHHHhhhhhhccCcccchhhhhhc
Confidence            9999998776 899999998777 7888989888521           000   0000011111100 0111    1123


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHH
Q 003391          749 VLRCIQVGLLCVQQRPEDRPNMSSVV  774 (823)
Q Consensus       749 ~~~l~~l~~~Cl~~dP~~RPs~~evl  774 (823)
                      ..++.+|+.+||+.|     |++|++
T Consensus       309 s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          309 KRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             CHHHHHHHHHHhccC-----CHHHHH
Confidence            457899999999976     999988

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=4.1e-28  Score=281.82  Aligned_cols=185  Identities=18%  Similarity=0.179  Sum_probs=131.1

Q ss_pred             eeeccCccceEEEEee-cCcEEEEEEecCCc----------cccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceEEE
Q 003391          511 KLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS----------GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       511 ~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~----------~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV  578 (823)
                      .++.|++|.+..++.. -|+.+++|.+.+..          +...++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            4566777766665543 38899999986542          22346799999999999 799999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      |||++|++|.++|.+   ..+++..   +|+.||+.||+|||+++   ||||||||+||||++++.+||+|||+|+....
T Consensus       321 MEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          321 MEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             EECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             EecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            999999999999953   3445543   58899999999999998   99999999999999999999999999987643


Q ss_pred             CccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCC
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRN  707 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p  707 (823)
                      ..  ......+||+.|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus       392 ~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          392 DC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            32  23344789999999999875 467789999999999998776544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.90  E-value=1.3e-24  Score=251.10  Aligned_cols=184  Identities=18%  Similarity=0.191  Sum_probs=144.6

Q ss_pred             CcCCeeeccCccceEEEEeecCcEEEEEEecCCcc--------ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          507 SDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSG--------QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       507 ~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~--------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      ...++||+|+||.||+|.. .++.+++|+......        ...+++.+|++++++++||||+++..++...+..+||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4457899999999999954 578899998654321        1134589999999999999999666666677788999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      |||+++++|.+++..           +..++.|+++||+|||+.+   |+||||||+|||+++  .+||+|||+++....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999999843           5589999999999999998   999999999999999  999999999998754


Q ss_pred             Ccccc-----ccccccccCCccCcccccc--CCCCccchhHhHHHHHHHHHhcCCC
Q 003391          659 DQTEA-----NTNRVVGTYGYMPPEYAID--GLFSVKSDVFSFGVLVLEIVCGKRN  707 (823)
Q Consensus       659 ~~~~~-----~~~~~~gt~~y~aPE~l~~--~~~s~ksDVwS~Gvvl~elltG~~p  707 (823)
                      .....     ......||+.|||||++..  ..|+..+|+|+..+-.++.+.++.+
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~r  537 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRAR  537 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccc
Confidence            32211     1235689999999999987  5688889999999888888877655

>4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D*

Probab=99.85  E-value=5.7e-21  Score=168.91  Aligned_cols=105  Identities=21%  Similarity=0.453  Sum_probs=91.2

Q ss_pred             cccccCCCcccCCCeEeeCCCeEEEeeecCCCCCCeEEEEEEeecCCCcEEEeecCCCCCCCCCCceEEEecCCceEEEe
Q 003391           18 RDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLL   97 (823)
Q Consensus        18 ~~~~~~g~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~giw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~~~l~l~   97 (823)
                      +|+|.+||.|.+|++|.|  |.|.|.|+.+++     |.++.    ..++||+|||++|... .+.|+|+.|||  |||+
T Consensus         1 kn~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~----~~~~vW~ant~~~~~~-~~~L~l~~dGn--LvL~   66 (105)
T 4h3o_A            1 RNILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYD----HSTSTWASNTEIGGKS-GCSAVLQSDGN--FVVY   66 (105)
T ss_dssp             CCEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE----TTEEEEECCCCCTTCC-SCEEEECTTSC--EEEE
T ss_pred             CCCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEE----CCEEEEEecCCCCCCc-cEEEEEeCCcc--EEEE
Confidence            589999999999999998  789999988777     44433    5789999999999765 57899999999  9999


Q ss_pred             cCCCCeEEeecCCCCCCcceEEEecCCCEEEecCCCCCCCcceeee
Q 003391           98 NSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQS  143 (823)
Q Consensus        98 ~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqS  143 (823)
                      |+++.+||+|++.......+++|+|+|||||++.       .||||
T Consensus        67 d~~~~~vWss~t~~~~~~~~l~L~ddGNlVly~~-------~~W~S  105 (105)
T 4h3o_A           67 DSSGRSLWASHSTRGSGNYILILQDDGNVIIYGS-------DIWST  105 (105)
T ss_dssp             CTTCCEEEECCCCCCSSCEEEEECTTSCEEEEES-------EEEEC
T ss_pred             CCCcEEEEEecCCCCCCCEEEEEeCCCeEEEECC-------cEecC
Confidence            9999999999987666667899999999999963       49998

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.84  E-value=1.4e-21  Score=206.86  Aligned_cols=151  Identities=18%  Similarity=0.120  Sum_probs=120.3

Q ss_pred             HHHHhcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCcc------------------ccHHHHHHHHHHHhccCCC
Q 003391          499 IANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSG------------------QGMEEFENEVLLIAKLQHR  560 (823)
Q Consensus       499 l~~~~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~------------------~~~~~~~~Ei~~l~~l~H~  560 (823)
                      +......|...+.||+|+||.||+|+..+++.||+|.++....                  .....+.+|+.++++++| 
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~-  163 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG-  163 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT-
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC-
Confidence            3344556777799999999999999996699999999964321                  134568999999999984 


Q ss_pred             CceeEEEEeecCCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEc
Q 003391          561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD  640 (823)
Q Consensus       561 niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~  640 (823)
                        +++.+++. .+..++||||+++++|.+ +..         .....++.|+++||.|||+.+   |+||||||+|||++
T Consensus       164 --~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~  227 (282)
T 1zar_A          164 --LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS  227 (282)
T ss_dssp             --SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred             --CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE
Confidence              55555443 356799999999999998 411         224479999999999999998   99999999999999


Q ss_pred             CCCCceeeccccceecCCCccccccccccccCCccCcccccc
Q 003391          641 NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID  682 (823)
Q Consensus       641 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~  682 (823)
                       ++.+||+|||+|+.               +..++|||++..
T Consensus       228 -~~~vkl~DFG~a~~---------------~~~~~a~e~l~r  253 (282)
T 1zar_A          228 -EEGIWIIDFPQSVE---------------VGEEGWREILER  253 (282)
T ss_dssp             -TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred             -CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence             99999999999864               345789998743

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1

Probab=99.83  E-value=2.7e-20  Score=168.57  Aligned_cols=108  Identities=21%  Similarity=0.324  Sum_probs=94.1

Q ss_pred             cccccccCCCcccCCCeEe--eCCCeEEEeeecCCCCCCeEEEEEEeecCCCcEEEeecCCCCCCCCCCceEEEecCCce
Q 003391           16 TARDTLNLGQSIRDGETLV--SANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLSDRSGALNISSQGNAT   93 (823)
Q Consensus        16 ~~~~~~~~g~~l~~~~~l~--s~~g~f~~gf~~~~~~~~~~~giw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~~~   93 (823)
                      ++.|+|.+|++|.+|++|+  |++|.|+|+|+.+|+      -+||++   +++||+||++.|  +.++.|+|+.|||  
T Consensus         6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn------lvly~~---~~~vW~sn~~~~--~~~~~l~l~~dGN--   72 (119)
T 1b2p_A            6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN------LVLYDN---NNPIWATNTGGL--GNGCRAVLQPDGV--   72 (119)
T ss_dssp             CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC------EEEEET---TEEEEECCCTTS--CSSCEEEECTTSC--
T ss_pred             ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC------EEEEEC---CEEEEeCCCccC--CCceEEEEccCCE--
Confidence            5679999999999999999  999999999999876      257875   799999999876  3357899999999  


Q ss_pred             EEEecCCCCeEEeecCCCCCCcceEEEecCCCEEEecCCCCCCCcceeee
Q 003391           94 LVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQS  143 (823)
Q Consensus        94 l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqS  143 (823)
                      |||+|.++.++|+|++........++|+|+|||||++.       ++|||
T Consensus        73 LVl~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~~-------~~W~S  115 (119)
T 1b2p_A           73 LVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGD-------ALWAT  115 (119)
T ss_dssp             EEEECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEES-------EEEEC
T ss_pred             EEEEeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEECc-------cEeCC
Confidence            99999999999999976555566789999999999962       59998

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A*

Probab=99.83  E-value=3.8e-20  Score=165.48  Aligned_cols=110  Identities=22%  Similarity=0.419  Sum_probs=95.0

Q ss_pred             cccccCCCcccCCCeEeeCCCeEEEeeecCCCCCCeEEEEEEeecCCCcEEEeecCCCCCCCCCCceEEEecCCceEEEe
Q 003391           18 RDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLL   97 (823)
Q Consensus        18 ~~~~~~g~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~giw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~~~l~l~   97 (823)
                      .|+|.+||+|.+|++|+ ++|.|+|+|+.+|+      -+||+   .+++||.||++.|.  .++.|.|..|||  |||+
T Consensus         1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn------lvl~~---~~~~vW~sn~~~~~--~~~~l~l~~dGN--LVl~   66 (110)
T 3a0c_A            1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN------FVLYD---SGKPVWASNTGGLG--SGCRLTLHNNGN--LVIY   66 (110)
T ss_dssp             CCEEETTCEECTTCEEE-ETTTEEEEECTTSC------EEEEE---TTEEEEECCCTTSC--SSCEEEECTTSC--EEEE
T ss_pred             CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc------EEEEE---CCEEEEECCCCCCC--CcEEEEEeCCCC--EEEE
Confidence            38999999999999999 99999999998877      26776   47999999998763  357899999999  9999


Q ss_pred             cCCCCeEEeecCCCCCCcceEEEecCCCEEEecCCCCCCCcceeeecCCCc
Q 003391           98 NSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFDYPS  148 (823)
Q Consensus        98 ~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqSFd~PT  148 (823)
                      |.++.++|+|++........++|+|+|||||++.       .+||||+||.
T Consensus        67 ~~~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~-------~~W~S~~~~~  110 (110)
T 3a0c_A           67 DQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP-------VVWATGSGPA  110 (110)
T ss_dssp             CTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS-------EEEECSCCC-
T ss_pred             CCCCcEEEecCCCCCCCCEEEEEeCCccEEEECC-------CEecCCCcCC
Confidence            9989999999987555556899999999999963       5999999984

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A*

Probab=99.81  E-value=1.3e-19  Score=163.70  Aligned_cols=110  Identities=25%  Similarity=0.398  Sum_probs=93.6

Q ss_pred             cccccCCCcccCCCeEeeCCCeEEEeeecCCCCCCeEEEEEEeecCCCcEEEeecCCCCCCCCCCceEEEecCCceEEEe
Q 003391           18 RDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLL   97 (823)
Q Consensus        18 ~~~~~~g~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~giw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~~~l~l~   97 (823)
                      .|||.+||+|.+|++|+  +|.|+|+|+.+|+   .   ++|+   .+++||+||++.|.  .++.|.|+.|||  |||+
T Consensus         2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgn---l---vly~---~~~~vW~sn~~~~~--~~~~l~l~~~Gn--Lvl~   66 (115)
T 2dpf_A            2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCN---L---VKYQ---NGRQIWASNTDRRG--SGCRLTLLSDGN--LVIY   66 (115)
T ss_dssp             CCEEETTCEEETTEEEE--ETTEEEEECTTSC---E---EEEE---TTEEEEECSCTTSC--SSCEEEECTTSC--EEEE
T ss_pred             CCEeCCCCEECCCCEEE--CCCEEEEEcCCCc---E---EEEe---CCEEEEeCCCCCCC--CceEEEECCCCc--EEEE
Confidence            58999999999999998  7999999988765   2   2465   48999999999883  357899999999  9999


Q ss_pred             cCCCCeEEeecCCCCCCcceEEEecCCCEEEecCCCCCCCcceeeecCCCcc
Q 003391           98 NSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFDYPSH  149 (823)
Q Consensus        98 ~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqSFd~PTD  149 (823)
                      |.++.++|+|++..+.....++|+|+|||||++      . ++||||.+++.
T Consensus        67 d~~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~------~-~~W~S~~~~~~  111 (115)
T 2dpf_A           67 DHNNNDVWGSACWGDNGKYALVLQKDGRFVIYG------P-VLWSLGPNGCR  111 (115)
T ss_dssp             CTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC------S-EEECSSTTCBC
T ss_pred             CCCceEEEEcCCCCCCCCEEEEEeCCCeEEEEC------C-CEEECCCCCCc
Confidence            988899999997654455689999999999995      2 69999998764

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A

Probab=99.79  E-value=2.4e-19  Score=161.17  Aligned_cols=110  Identities=23%  Similarity=0.467  Sum_probs=93.1

Q ss_pred             cccccCCCcccCCCeEeeCCCeEEEeeecCCCCCCeEEEEEEeecCCCcEEEeecCCCCCCCCCCceEEEecCCceEEEe
Q 003391           18 RDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLL   97 (823)
Q Consensus        18 ~~~~~~g~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~giw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~~~l~l~   97 (823)
                      .|||.+||+|.+|++|  ++|.|+|+|+.+|+      -+||++   +++||+||++.+  ..++.|+|..|||  |||+
T Consensus         1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgn------lvl~~~---~~~vW~sn~~~~--~~~~~l~l~~~GN--Lvl~   65 (112)
T 1xd5_A            1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCN------LVLYDN---NRAVWASGTNGK--ASGCVLKMQNDGN--LVIY   65 (112)
T ss_dssp             CCEEETTEEECTTCEE--EETTEEEEECTTSC------EEEEET---TEEEEECCCTTS--CSSEEEEECTTSC--EEEE
T ss_pred             CCCCCCCCEECCCCEE--eCCCEEEEEcCCCc------EEEEEC---CEEEEeCCCcCC--CCCEEEEEeCCCC--EEEE
Confidence            4899999999999999  58999999999877      246764   789999999753  3357899999999  9999


Q ss_pred             cCCCCeEEeecCCCCCCcceEEEecCCCEEEecCCCCCCCcceeeecCCC
Q 003391           98 NSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFDYP  147 (823)
Q Consensus        98 ~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqSFd~P  147 (823)
                      | ++.++|+|.+........++|+++|||||++..    +.++||||+|.
T Consensus        66 d-~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~----~~~~W~S~~~~  110 (112)
T 1xd5_A           66 S-GSRAIWASNTNRQNGNYYLILQRDRNVVIYDNS----NNAIWATHTNV  110 (112)
T ss_dssp             E-TTEEEEECCCCCSCCCCEEEECTTSCEEEECTT----SCEEEECCCCC
T ss_pred             c-CCEEEEECCccCCCCCEEEEEeCCCcEEEECCC----CceEEECCCcc
Confidence            9 788999999765555568999999999999854    67899999985

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A*

Probab=99.75  E-value=2.9e-18  Score=153.11  Aligned_cols=105  Identities=28%  Similarity=0.427  Sum_probs=88.0

Q ss_pred             cccccCCCcccCCCeEeeCCCeEEEeeecCCCCCCeEEEEEEeecCCCcEEEeecCCCCCCCCCCceEEEecCCceEEEe
Q 003391           18 RDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLL   97 (823)
Q Consensus        18 ~~~~~~g~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~giw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~~~l~l~   97 (823)
                      ++||.|||+|.+|+.|+  +|.|.|.|+.+|+   .+   .|..   .++||++|++.+  +.++.|.|+.|||  |||+
T Consensus         1 ~ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn---Lv---ly~~---~~~vW~snt~~~--~~~~~l~l~~dGN--Lvl~   65 (109)
T 3dzw_A            1 DNILYSGETLSPGEFLN--NGRYVFIMQEDCN---LV---LYDV---DKPIWATNTGGL--DRRCHLSMQSDGN--LVVY   65 (109)
T ss_dssp             CCEEETTEEECTTCEEE--ETTEEEEECTTSC---EE---EEET---TEEEEECCCTTS--SSSCEEEECTTSC--EEEE
T ss_pred             CCCcCCCCEeCCCCEEE--CCCEEEEEcCCCc---EE---EEeC---CEEEEECCcccC--CCCEEEEEeCCCC--EEEE
Confidence            47999999999999997  7999999988876   22   2553   689999999876  3357899999999  9999


Q ss_pred             cCCCCeEEeecCCCCCCcceEEEecCCCEEEecCCCCCCCcceeeec
Q 003391           98 NSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQSF  144 (823)
Q Consensus        98 ~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqSF  144 (823)
                      |.++.++|+|++.......+|+|+|+|||||++.       .+|||=
T Consensus        66 ~~~~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~-------~~W~s~  105 (109)
T 3dzw_A           66 SPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGT-------ARWATG  105 (109)
T ss_dssp             CTTSCEEEECCCCCSSSCEEEEECTTSCEEEEES-------CCCCCC
T ss_pred             CCCCCEEEECCCCCCCCCEEEEEeCCCEEEEECC-------CEEeCC
Confidence            9988999999986554456799999999999973       499983

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.71  E-value=1.1e-17  Score=174.65  Aligned_cols=136  Identities=15%  Similarity=0.182  Sum_probs=105.5

Q ss_pred             CCcCCeeeccCccceEEEEe-ecCcE--EEEEEecCCccc------------------------cHHHHHHHHHHHhccC
Q 003391          506 FSDKNKLGEGGFGPVYKGVL-IEGQE--IAAKRLSKSSGQ------------------------GMEEFENEVLLIAKLQ  558 (823)
Q Consensus       506 ~~~~~~LG~G~fg~Vyk~~~-~~~~~--vavK~l~~~~~~------------------------~~~~~~~Ei~~l~~l~  558 (823)
                      |...+.||+|+||.||+|.+ .+|+.  ||||+++.....                        ....+.+|+.++.+++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56678999999999999998 67888  999987543211                        1135789999999998


Q ss_pred             CCCc--eeEEEEeecCCceEEEEeecCC-C----CcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHH-hcCCCceEec
Q 003391          559 HRNL--VKLIGCCTQRDERMLIYEYLPN-K----SLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH-QDSRLRIIHR  630 (823)
Q Consensus       559 H~ni--v~l~g~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~  630 (823)
                      |+++  ..+++.    ...+|||||+.+ |    +|.++...      .++..+..++.|++.+|.||| +.+   |+||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr  195 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA  195 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence            8753  444443    367899999942 4    45544321      234567889999999999999 887   9999


Q ss_pred             ccCCCcEEEcCCCCceeeccccceec
Q 003391          631 DLKASNVLLDNEMNPKISDFGMARAF  656 (823)
Q Consensus       631 Dlk~~NIll~~~~~~kl~DFGla~~~  656 (823)
                      ||||+|||+++  .++|+|||+|...
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999998  9999999999764

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=99.70  E-value=3.6e-17  Score=145.95  Aligned_cols=106  Identities=19%  Similarity=0.298  Sum_probs=85.8

Q ss_pred             ccccccccCCCcccCCCeEeeCCCeEEEeeecCCCCCCeEEEEEEeecCCCcEEEeecCCCCCCCCCCceEEEecCCceE
Q 003391           15 ATARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLSDRSGALNISSQGNATL   94 (823)
Q Consensus        15 ~~~~~~~~~g~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~giw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~~~l   94 (823)
                      ..|.|||.+||+|.+|+.|+|.  .|.|-|...|+     |.+ |..    .+||.+|++..  +..+.|.|+.|||  |
T Consensus         3 ~~~~dtL~~gq~L~~g~~L~sg--~~~L~~q~dGn-----Lvl-~~~----~~vW~snt~~~--~~~~~l~l~~dGN--L   66 (110)
T 3r0e_B            3 PFTNNLLFSGQVLYGDGRLTAK--NHQLVMQGDCN-----LVL-YGG----KYGWQSNTHGN--GEHCFLRLNHKGE--L   66 (110)
T ss_dssp             CCBTTEEETTCEEETTEEEECS--SCEEEECTTSC-----EEE-ECS----SSCEECCCTTS--SSSCEEEECTTSC--E
T ss_pred             ccccCEECCCCEecCCCEEEeC--CEEEEEcCCCe-----EEE-ECC----eEEEECCCcCC--CcCEEEEEeCCCc--E
Confidence            3578999999999999999984  58887766554     333 543    58999999862  3357899999999  9


Q ss_pred             EEecCCCCeEEeecCCCCCCcceEEEecCCCEEEecCCCCCCCcceeee
Q 003391           95 VLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQS  143 (823)
Q Consensus        95 ~l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqS  143 (823)
                      ||+|.++.++|+|++.......+|+|+|+|||||++.       .+|+|
T Consensus        67 vl~d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~~-------~~W~t  108 (110)
T 3r0e_B           67 IIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYGP-------AIFET  108 (110)
T ss_dssp             EEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS-------EEEES
T ss_pred             EEEeCCCCEEEEcCCcCCCCCEEEEEcCCccEEEecC-------CEecC
Confidence            9999999999999986444457899999999999973       49987

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.68  E-value=2e-16  Score=141.94  Aligned_cols=108  Identities=19%  Similarity=0.310  Sum_probs=88.5

Q ss_pred             cccccccCCCcccCCCeEeeCCCeEEEeeecCCCCCCeEEEEEEeecCCCcEEEeecCCCCCCCCCCceEEEecCCceEE
Q 003391           16 TARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLSDRSGALNISSQGNATLV   95 (823)
Q Consensus        16 ~~~~~~~~g~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~giw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~~~l~   95 (823)
                      .+.|+|.+||.|.+|+.|.+  |.|.|-|...|+     |.+ |.. ...++||.+|+..+  ...+.|.|+.|||  ||
T Consensus         4 ~~~~tL~~gq~L~~g~~L~~--g~~~L~~q~dGN-----LvL-~~~-~~~~~vWssnt~~~--~~~~~l~l~~dGN--LV   70 (113)
T 3mez_B            4 RVRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCN-----LVL-TKG-SKTNIVWESGTSGR--GQHCFMRLGHSGE--LD   70 (113)
T ss_dssp             CCSSEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEE-EET-TTTEEEEECCCTTS--CSSCEEEECTTSC--EE
T ss_pred             ccCCEeCCCCEECCCCEeEc--CCEEEEEcCCCE-----EEE-EEC-CCCEEEEECCcccC--CcCEEEEEeCCCc--EE
Confidence            46899999999999999975  889998887766     444 322 14789999999865  2357899999999  99


Q ss_pred             EecCCCCeEEeecCCCCCCcceEEEecCCCEEEecCCCCCCCcceeee
Q 003391           96 LLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQS  143 (823)
Q Consensus        96 l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqS  143 (823)
                      |+|.++.++|+|++.......+|+|+|+|||||++       ..+|+|
T Consensus        71 l~d~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~-------~~~W~s  111 (113)
T 3mez_B           71 ITDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYG-------PAVWST  111 (113)
T ss_dssp             EECTTSCEEEECSCCCSSSCCEEEECTTSCEEEEC-------SEEEES
T ss_pred             EECCCCCEEEECCCcCCCCCEEEEEcCCceEEEec-------CCEecC
Confidence            99998999999998654445789999999999996       249997

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=99.64  E-value=4.9e-16  Score=138.29  Aligned_cols=103  Identities=26%  Similarity=0.382  Sum_probs=84.4

Q ss_pred             cccccccCCCcccCCCeEeeCCCeEEEeeecCCCCCCeEEEEEEeecCCCcEEEeecCCCCCCCCCCceEEEecCCceEE
Q 003391           16 TARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLSDRSGALNISSQGNATLV   95 (823)
Q Consensus        16 ~~~~~~~~g~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~giw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~~~l~   95 (823)
                      .|.|||.|||.|.+|+.|  .+|.|.|.|+.+|+      -+.|..      +|.+|+..+  ...+.|+|+.|||  ||
T Consensus         1 ~~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGN------Lvl~~~------~Wssnt~~~--~~~~~l~l~~dGn--Lv   62 (109)
T 3r0e_A            1 LGTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCN------LVLYNG------NWQSNTANN--GRDCKLTLTDYGE--LV   62 (109)
T ss_dssp             CCCSEEETTCEECTTCEE--EETTEEEEECTTSC------EEEETT------TEECCCTTS--CSSCEEEECTTSC--EE
T ss_pred             CccCCcCCCCCcCCCCEe--ECCCEEEEEecCCe------EEEEeC------eEEcCCCCC--CCcEEEEEcCCCe--EE
Confidence            378999999999999999  47999999987766      122331      699998764  3367899999999  99


Q ss_pred             EecCCCCeEEeecCCCCCCcceEEEecCCCEEEecCCCCCCCcceeee
Q 003391           96 LLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQS  143 (823)
Q Consensus        96 l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqS  143 (823)
                      |+|.++.++|+|++.......+|+|+|+|||||++       ..+|+|
T Consensus        63 l~d~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~-------~~~W~s  103 (109)
T 3r0e_A           63 IKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG-------PSVFKI  103 (109)
T ss_dssp             EECTTSCEEEECCCCCSSSCCEEEEETTTEEEEEC-------SEEEEE
T ss_pred             EEeCCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe-------cCEECC
Confidence            99998899999998654445689999999999996       249998

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A

Probab=99.61  E-value=1.9e-15  Score=135.64  Aligned_cols=96  Identities=22%  Similarity=0.329  Sum_probs=78.3

Q ss_pred             CCCCCCCceEEEecCCceEEEecCCCCeEEeecCCCCCCcceEEEecCCCEEEecCCCCCCCcceeeecCCCcccccccC
Q 003391           76 PLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGM  155 (823)
Q Consensus        76 p~~~~~~~l~~~~~g~~~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqSFd~PTDtlLpgq  155 (823)
                      |+.+...+|.|+.|||  |||++. +.+||++++........++|+|+|||||++ +    +.++||||+          
T Consensus        15 ~L~~~~~~L~~~~dgn--lvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~----~~~~W~S~~----------   76 (112)
T 1xd5_A           15 SLAEGGYLFIIQNDCN--LVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-G----SRAIWASNT----------   76 (112)
T ss_dssp             EEEETTEEEEECTTSC--EEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-T----TEEEEECCC----------
T ss_pred             EEeCCCEEEEEcCCCc--EEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-C----CEEEEECCc----------
Confidence            3444467899999999  999987 789999997654455789999999999998 5    678999994          


Q ss_pred             cccceeccCcceeEEEcccCCCCCCCccEEeeCCCCCCeEEEEc-CceeeeecCCCCC
Q 003391          156 KLGVNLVTGLNRFISSWKSADDPAQDDYVYGIDPSGVPQAVFRK-GSTIRYRAGSWNG  212 (823)
Q Consensus       156 ~l~~~~~tg~~~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~-~~~~~~~sg~w~g  212 (823)
                                           +|+.|.|++.++++|..  +++. ...+||++++|+|
T Consensus        77 ---------------------~~~~g~~~l~l~~dGnl--vl~~~~~~~~W~S~~~~g  111 (112)
T 1xd5_A           77 ---------------------NRQNGNYYLILQRDRNV--VIYDNSNNAIWATHTNVG  111 (112)
T ss_dssp             ---------------------CCSCCCCEEEECTTSCE--EEECTTSCEEEECCCCCC
T ss_pred             ---------------------cCCCCCEEEEEeCCCcE--EEECCCCceEEECCCccC
Confidence                                 44568899999999984  3444 5689999999986

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A*

Probab=99.59  E-value=3.8e-15  Score=132.94  Aligned_cols=89  Identities=26%  Similarity=0.384  Sum_probs=73.5

Q ss_pred             CCCceEEEecCCceEEEecCCCCeEEeecCCCCCCcceEEEecCCCEEEecCCCCCCCcceeeecCCCcccccccCcccc
Q 003391           80 RSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGV  159 (823)
Q Consensus        80 ~~~~l~~~~~g~~~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqSFd~PTDtlLpgq~l~~  159 (823)
                      ...+|.|+.|||  |||++ .+.+||++++........++|+|+|||||++.+    +.+|||||.              
T Consensus        20 ~~~~l~~~~dGn--lvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~----~~~~W~S~t--------------   78 (110)
T 3a0c_A           20 PSYRLIMQGDCN--FVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQS----NRVIWQTKT--------------   78 (110)
T ss_dssp             TTEEEEECTTSC--EEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTT----CCEEEECCC--------------
T ss_pred             CCEEEEEcCCCc--EEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCC----CcEEEecCC--------------
Confidence            367899999999  99998 478999999865545578999999999999876    779999993              


Q ss_pred             eeccCcceeEEEcccCCCCCCCccEEeeCCCCCCeEEEEcCceeeeecCCC
Q 003391          160 NLVTGLNRFISSWKSADDPAQDDYVYGIDPSGVPQAVFRKGSTIRYRAGSW  210 (823)
Q Consensus       160 ~~~tg~~~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~sg~w  210 (823)
                                       ++++|.|++.++++|..  +++++  +||+++++
T Consensus        79 -----------------~~~~g~~~l~l~~dGnl--vl~~~--~~W~S~~~  108 (110)
T 3a0c_A           79 -----------------NGKEDHYVLVLQQDRNV--VIYGP--VVWATGSG  108 (110)
T ss_dssp             -----------------CCSSSCCEEEECTTSCE--EEECS--EEEECSCC
T ss_pred             -----------------CCCCCCEEEEEeCCccE--EEECC--CEecCCCc
Confidence                             45678999999999984  44554  79999875

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.56  E-value=1.7e-15  Score=164.43  Aligned_cols=137  Identities=14%  Similarity=0.187  Sum_probs=100.1

Q ss_pred             cCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCcc--------------ccHHH--------HHHHHHHHhccCCCC
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSG--------------QGMEE--------FENEVLLIAKLQHRN  561 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~--------------~~~~~--------~~~Ei~~l~~l~H~n  561 (823)
                      .-|.+.++||+|+||.||+|...+|+.||||+++....              .....        ...|+..|.++.+.+
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            34888999999999999999998899999998754210              00111        234566666664433


Q ss_pred             c--eeEEEEeecCCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEE
Q 003391          562 L--VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL  639 (823)
Q Consensus       562 i--v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll  639 (823)
                      +  ...++.    ...+|||||+++++|.++..         ......++.||+.+|.+||+.+   ||||||||.|||+
T Consensus       175 v~vp~p~~~----~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl  238 (397)
T 4gyi_A          175 FPVPEPIAQ----SRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHG---LIHGDFNEFNILI  238 (397)
T ss_dssp             CSCCCEEEE----ETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred             CCCCeeeec----cCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEE
Confidence            2  222222    23479999999988876541         1234568899999999999988   9999999999999


Q ss_pred             cCCCC----------ceeeccccceec
Q 003391          640 DNEMN----------PKISDFGMARAF  656 (823)
Q Consensus       640 ~~~~~----------~kl~DFGla~~~  656 (823)
                      ++++.          +.|+||+-+...
T Consensus       239 ~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          239 REEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             eCCCCcccccccccceEEEEeCCcccC
Confidence            88773          889999977643

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1

Probab=99.52  E-value=4.8e-14  Score=127.43  Aligned_cols=87  Identities=24%  Similarity=0.330  Sum_probs=71.7

Q ss_pred             CCceEEEecCCceEEEecCCCCeEEeecCCCCCCcceEEEecCCCEEEecCCCCCCCcceeeecCCCcccccccCcccce
Q 003391           81 SGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVN  160 (823)
Q Consensus        81 ~~~l~~~~~g~~~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqSFd~PTDtlLpgq~l~~~  160 (823)
                      ..+|.|+.|||  |||++. +.+||++++........++|+|+|||||++.+    ++++||||                
T Consensus        31 ~~~L~~~~dgn--lvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~----~~~lW~S~----------------   87 (119)
T 1b2p_A           31 VYRFIMQTDCN--LVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNE----NVTVWQSP----------------   87 (119)
T ss_dssp             EEEEEECTTSC--EEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTT----CCEEEECS----------------
T ss_pred             CEEEEEecCCC--EEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCC----CcEEEcCC----------------
Confidence            35688899999  999987 78999999865545578999999999999876    77999999                


Q ss_pred             eccCcceeEEEcccCCCCCCCccEEeeCCCCCCeEEEEcCceeeeecCC
Q 003391          161 LVTGLNRFISSWKSADDPAQDDYVYGIDPSGVPQAVFRKGSTIRYRAGS  209 (823)
Q Consensus       161 ~~tg~~~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~sg~  209 (823)
                                     ++|++|.|++.++++|..  +++.  .+||++|+
T Consensus        88 ---------------~~~~~g~~~l~l~~~Gnl--vl~~--~~~W~Sg~  117 (119)
T 1b2p_A           88 ---------------VAGKAGHYVLVLQPDRNV--VIYG--DALWATQT  117 (119)
T ss_dssp             ---------------CCCCSSCEEEEECTTSCE--EEEE--SEEEECCC
T ss_pred             ---------------CCCCCCCEEEEEECCCcE--EEEC--ccEeCCCC
Confidence                           355678999999999984  4444  38999986

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A*

Probab=99.50  E-value=8.6e-14  Score=125.36  Aligned_cols=90  Identities=26%  Similarity=0.378  Sum_probs=74.1

Q ss_pred             CCceEEEecCCceEEEecCCCCeEEeecCCCCCCcceEEEecCCCEEEecCCCCCCCcceeeecCCCcccccccCcccce
Q 003391           81 SGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVN  160 (823)
Q Consensus        81 ~~~l~~~~~g~~~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqSFd~PTDtlLpgq~l~~~  160 (823)
                      ...|.|+.|||  |||++ .+.++|++++.....+..++|+++|||||++.+    +.++||||++              
T Consensus        21 ~~~L~~~~dgn--lvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~----~~~vW~S~~~--------------   79 (115)
T 2dpf_A           21 AYTLTIQNKCN--LVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHN----NNDVWGSACW--------------   79 (115)
T ss_dssp             TEEEEECTTSC--EEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTT----CCEEEECCCC--------------
T ss_pred             CEEEEEcCCCc--EEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCC----ceEEEEcCCC--------------
Confidence            56788999999  99998 478999999765444578999999999999865    6789999997              


Q ss_pred             eccCcceeEEEcccCCCCCCCccEEeeCCCCCCeEEEEcCceeeeecCCCCC
Q 003391          161 LVTGLNRFISSWKSADDPAQDDYVYGIDPSGVPQAVFRKGSTIRYRAGSWNG  212 (823)
Q Consensus       161 ~~tg~~~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~sg~w~g  212 (823)
                                       ++.|.|++.++++|..  ++++.  .+|++++|..
T Consensus        80 -----------------~~~g~~~l~l~~dGnl--vl~~~--~~W~S~~~~~  110 (115)
T 2dpf_A           80 -----------------GDNGKYALVLQKDGRF--VIYGP--VLWSLGPNGC  110 (115)
T ss_dssp             -----------------CSSSCCEEEECTTSCE--EEECS--EEECSSTTCB
T ss_pred             -----------------CCCCCEEEEEeCCCeE--EEECC--CEEECCCCCC
Confidence                             3467899999999984  44554  8999999964

>3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.49  E-value=6.9e-14  Score=124.81  Aligned_cols=103  Identities=18%  Similarity=0.270  Sum_probs=81.6

Q ss_pred             cccccCCCcccCCCeEeeCCCeEEEeeecCCCCCCeEEEEEEeecCCCcEEEeecCCCCCCCCCCceEEEecCCceEEEe
Q 003391           18 RDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLL   97 (823)
Q Consensus        18 ~~~~~~g~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~giw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~~~l~l~   97 (823)
                      .|+|.+||.|.+|+.|.  +|.|.|.|...|+     |-+ |..   .. ||.+|+..+  ...+.|.|+.|||  |||+
T Consensus         2 ~~~l~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-~~~---~~-vW~snt~~~--~~~~~l~l~~dGN--LVl~   65 (111)
T 3mez_A            2 NNVLLTGDVIHTDNQLS--YESAAFVMQGDCN-----LVL-YNE---AG-GFQSNTHGR--GVDCTLRLNNRGQ--LEIH   65 (111)
T ss_dssp             TTEEETTCEECTTCEEE--ETTEEEEECTTSC-----EEE-ECS---SC-CEECCCTTS--CSSCEEEECTTSC--EEEE
T ss_pred             cCEeCCCCEeCCCCEEe--cCCEEEEEccCCe-----EEE-ECC---CC-EEECCcccC--CcCEEEEEcCCCc--EEEE
Confidence            58999999999999994  6899999987766     222 432   33 999999876  2357899999999  9999


Q ss_pred             cCCCC-eEEeecCCC--CCCcceEEEecCCCEEEecCCCCCCCcceeee
Q 003391           98 NSTNG-IVWSSNASR--TARNPVAVLLESGNLVVKDGKDIDPDNFLWQS  143 (823)
Q Consensus        98 ~~~~~-~~w~~~~~~--~~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqS  143 (823)
                      |.++. ++|+|++..  .....+++|+++|||||++       ..+|+|
T Consensus        66 ~~~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~-------~~~W~s  107 (111)
T 3mez_A           66 SANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG-------PAIWST  107 (111)
T ss_dssp             CSSCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC-------SEEEEC
T ss_pred             eCCCCEEEEEeccccCCCCcCEEEEECCCCeEEEec-------cCEEcc
Confidence            98776 599999642  2345678999999999996       349987

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.23  E-value=2.9e-11  Score=108.15  Aligned_cols=95  Identities=25%  Similarity=0.333  Sum_probs=73.4

Q ss_pred             CCCCCCCCCceEEEecCCceEEEecC-CCCeEEeecCCCCCCcceEEEecCCCEEEecCCCCCCCcceeeecCCCccccc
Q 003391           74 DAPLSDRSGALNISSQGNATLVLLNS-TNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFDYPSHILI  152 (823)
Q Consensus        74 ~~p~~~~~~~l~~~~~g~~~l~l~~~-~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqSFd~PTDtlL  152 (823)
                      +.|+.+...+|.|+.|||  |||++. .+.++|++++........++|+++|||||++.+    +.++|||=.+-     
T Consensus        18 g~~L~~g~~~L~~q~dGN--LvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~----~~~iW~S~t~~-----   86 (113)
T 3mez_B           18 NAQLATRDYSLVMRDDCN--LVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDR----LNTVFVSNTVG-----   86 (113)
T ss_dssp             TCEEEETTEEEEECTTSC--EEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTT----SCEEEECSCCC-----
T ss_pred             CCEeEcCCEEEEEcCCCE--EEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCC----CCEEEECCCcC-----
Confidence            445555577899999999  999988 488999999865444568999999999999876    67899973310     


Q ss_pred             ccCcccceeccCcceeEEEcccCCCCCCCccEEeeCCCCCCeEEEEcCceeeeecCC
Q 003391          153 AGMKLGVNLVTGLNRFISSWKSADDPAQDDYVYGIDPSGVPQAVFRKGSTIRYRAGS  209 (823)
Q Consensus       153 pgq~l~~~~~tg~~~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~sg~  209 (823)
                                                ..|.|.+.++.+|...++  .  .+.|.+|+
T Consensus        87 --------------------------~~~~~~~~L~~dGnlvly--~--~~~W~s~~  113 (113)
T 3mez_B           87 --------------------------QEGDYVLILQINGQAVVY--G--PAVWSTAA  113 (113)
T ss_dssp             --------------------------SSSCCEEEECTTSCEEEE--C--SEEEESCC
T ss_pred             --------------------------CCCCEEEEEcCCceEEEe--c--CCEecCCC
Confidence                                      124588999999987766  2  57888774

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.19  E-value=4e-11  Score=124.99  Aligned_cols=146  Identities=17%  Similarity=0.095  Sum_probs=114.2

Q ss_pred             HHHhcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccC-CCCceeEEEEeecCCceEEE
Q 003391          500 ANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       500 ~~~~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV  578 (823)
                      ......|.....++.|+.+.||+... .++.+++|+...........+.+|+.+++.+. |..+.++++++.+.+..++|
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            34456787777888888899999975 47899999986533233346889999999884 77888999999888889999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhc------------------------------------
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD------------------------------------  622 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------  622 (823)
                      |||++|.+|.+.+.        +......++.+++++|..||+.                                    
T Consensus        89 ~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T 3tm0_A           89 MSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred             EEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence            99999999877531        1122347888999999999981                                    


Q ss_pred             --------------------CCCceEecccCCCcEEEcCCCCceeeccccce
Q 003391          623 --------------------SRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  654 (823)
Q Consensus       623 --------------------~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  654 (823)
                                          .+..++|+|+++.||+++++..+.|+||+.+.
T Consensus       161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                11348999999999999876566799999775

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A*

Probab=99.18  E-value=3.9e-11  Score=124.95  Aligned_cols=113  Identities=22%  Similarity=0.382  Sum_probs=85.5

Q ss_pred             cccccccCCCc----ccCCCeEeeCCCeEEEeeecCC--CCCCeEEEEEEeecCCCcEEEeecCCCCCCCCCCceEEEec
Q 003391           16 TARDTLNLGQS----IRDGETLVSANESFELGFFSPG--KSKSRYLGIWYKKIGNGTVIWVANRDAPLSDRSGALNISSQ   89 (823)
Q Consensus        16 ~~~~~~~~g~~----l~~~~~l~s~~g~f~~gf~~~~--~~~~~~~giw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~   89 (823)
                      .-.|||.||+.    |..|+.|.|+ ..++.|+|...  .....+  + |.+  ..+++|.+++.++  + ...|.++.+
T Consensus       134 ~ptdtlLpg~~~~~~l~~g~~L~S~-~dps~G~fsl~l~~dGnlv--L-y~~--~~~~yW~Sgt~~~--~-~~~l~l~~d  204 (276)
T 3m7h_A          134 TPAIPLVPGAIDSLLLAPGSELVQG-VVYGAGASKLVFQGDGNLV--A-YGP--NGAATWNAGTQGK--G-AVRAVFQGD  204 (276)
T ss_dssp             CTTSCCCCSCTTCEEECSSEEECTT-CEEEETTEEEEECTTSCEE--E-ECT--TSSEEEECCCTTT--T-CCEEEECTT
T ss_pred             ccccccccccccccccccCcccccC-CCCCCceEEEeecCCceEE--E-EeC--CCeEEEECCCCCC--c-cEEEEEcCC
Confidence            34699999999    8899998664 45555555321  122333  3 332  3689999999876  2 268999999


Q ss_pred             CCceEEEecCCCCeEEeecCCCCCCcceEEEecCCCEEEecCCCCCCCcceeeecCC
Q 003391           90 GNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFDY  146 (823)
Q Consensus        90 g~~~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqSFd~  146 (823)
                      |+  |+++|.++.++|++++... ...+++|+++|||||++.      +.+||||||
T Consensus       205 Gn--Lvl~d~~~~~vWsS~t~~~-~~~rl~Ld~dGnLvly~~------~~~Wqsf~~  252 (276)
T 3m7h_A          205 GN--LVVYGAGNAVLWHSHTGGH-ASAVLRLQANGSIAILDE------KPVWARFGF  252 (276)
T ss_dssp             SC--EEEECTTSCEEEECSCTTC-TTCEEEECTTSCEEEEEE------EEEEESSSC
T ss_pred             Ce--EEEEeCCCcEEEEecCCCC-CCEEEEEcCCccEEEEcC------CCeEEccCc
Confidence            99  9999998889999997643 457899999999999973      469999997

>3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.17  E-value=8.2e-11  Score=104.81  Aligned_cols=93  Identities=19%  Similarity=0.225  Sum_probs=71.0

Q ss_pred             CCCCCCCceEEEecCCceEEEecCCCCeEEeecCCCCCCcceEEEecCCCEEEecCCCCCCCc-ceeeecCCCccccccc
Q 003391           76 PLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDN-FLWQSFDYPSHILIAG  154 (823)
Q Consensus        76 p~~~~~~~l~~~~~g~~~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~-~~wqSFd~PTDtlLpg  154 (823)
                      ++......|.|+.|||  |||++.++  +|++++........++|+++|||||++.+    ++ ++|||.-+        
T Consensus        16 ~L~~g~~~L~~q~dGn--Lvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~----~~~~vW~S~t~--------   79 (111)
T 3mez_A           16 QLSYESAAFVMQGDCN--LVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSAN----SNTPVWVYPRS--------   79 (111)
T ss_dssp             EEEETTEEEEECTTSC--EEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSS----CSSCSEEESSS--------
T ss_pred             EEecCCEEEEEccCCe--EEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCC----CCEEEEEeccc--------
Confidence            3444467899999999  99999876  99999865444578999999999999876    44 59999731        


Q ss_pred             CcccceeccCcceeEEEcccCCCCCCCccEEeeCCCCCCeEEEEcCceeeeecCC
Q 003391          155 MKLGVNLVTGLNRFISSWKSADDPAQDDYVYGIDPSGVPQAVFRKGSTIRYRAGS  209 (823)
Q Consensus       155 q~l~~~~~tg~~~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~sg~  209 (823)
                                           .....|.|.+.++.+|...++-    .++|.+++
T Consensus        80 ---------------------~~~~~~~~~l~Lq~dGNlvly~----~~~W~s~t  109 (111)
T 3mez_A           80 ---------------------VNTVRGNYAATLGPDQHVTIYG----PAIWSTPA  109 (111)
T ss_dssp             ---------------------CCCCSSCCEEEECTTSCEEEEC----SEEEECCC
T ss_pred             ---------------------cCCCCcCEEEEECCCCeEEEec----cCEEccCC
Confidence                                 0112468899999999877662    67888764

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=99.03  E-value=7.9e-10  Score=98.24  Aligned_cols=86  Identities=23%  Similarity=0.329  Sum_probs=66.7

Q ss_pred             CCceEEEecCCceEEEecCCCCeEEeecCCCCCCcceEEEecCCCEEEecCCCCCCCcceeeecCCCcccccccCcccce
Q 003391           81 SGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVN  160 (823)
Q Consensus        81 ~~~l~~~~~g~~~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqSFd~PTDtlLpgq~l~~~  160 (823)
                      ...|.|+.|||  |||++.  .++|++++........++|+++|||||++.+    +.++|||-.+-             
T Consensus        25 ~~~L~~q~dGn--Lvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~----~~~iW~S~t~~-------------   83 (110)
T 3r0e_B           25 NHQLVMQGDCN--LVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDD----FKTIWSSRSSS-------------   83 (110)
T ss_dssp             SCEEEECTTSC--EEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTT----CCEEEECCCCC-------------
T ss_pred             CEEEEEcCCCe--EEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCC----CCEEEEcCCcC-------------
Confidence            46789999999  999987  5899999875444568999999999999876    67899986421             


Q ss_pred             eccCcceeEEEcccCCCCCCCccEEeeCCCCCCeEEEEcCceeeeecCC
Q 003391          161 LVTGLNRFISSWKSADDPAQDDYVYGIDPSGVPQAVFRKGSTIRYRAGS  209 (823)
Q Consensus       161 ~~tg~~~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~sg~  209 (823)
                                        ..|.|.+.++.+|...++-    .+.|.+|+
T Consensus        84 ------------------~~~~~~~~L~~dGNlvly~----~~~W~t~~  110 (110)
T 3r0e_B           84 ------------------KQGEYVLILQDDGFGVIYG----PAIFETSS  110 (110)
T ss_dssp             ------------------SSSCCEEEECTTSCEEEEC----SEEEESCC
T ss_pred             ------------------CCCCEEEEEcCCccEEEec----CCEecCCC
Confidence                              1245888999999877652    46787763

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A*

Probab=98.98  E-value=1.8e-09  Score=95.93  Aligned_cols=87  Identities=23%  Similarity=0.330  Sum_probs=67.5

Q ss_pred             CCceEEEecCCceEEEecCCCCeEEeecCCCCCCcceEEEecCCCEEEecCCCCCCCcceeeecCCCcccccccCcccce
Q 003391           81 SGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVN  160 (823)
Q Consensus        81 ~~~l~~~~~g~~~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqSFd~PTDtlLpgq~l~~~  160 (823)
                      ...|.|+.|||  |||++. +.++|++++........++|+++|||||++.+    +.++|||....             
T Consensus        20 ~~~L~~q~dGn--Lvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~----~~~~W~S~t~~-------------   79 (109)
T 3dzw_A           20 RYVFIMQEDCN--LVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPR----NNPIWASNTGG-------------   79 (109)
T ss_dssp             TEEEEECTTSC--EEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTT----SCEEEECCCCC-------------
T ss_pred             CEEEEEcCCCc--EEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCC----CCEEEECCCCC-------------
Confidence            56799999999  999987 68999999865444568899999999999876    67899986421             


Q ss_pred             eccCcceeEEEcccCCCCCCCccEEeeCCCCCCeEEEEcCceeeeecCC
Q 003391          161 LVTGLNRFISSWKSADDPAQDDYVYGIDPSGVPQAVFRKGSTIRYRAGS  209 (823)
Q Consensus       161 ~~tg~~~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~sg~  209 (823)
                                        ..+.|.+.++.+|...++-    .+.|.++.
T Consensus        80 ------------------~~~~~~~~L~ddGNlvly~----~~~W~s~t  106 (109)
T 3dzw_A           80 ------------------ENGNYVCVLQKDRNVVIYG----TARWATGT  106 (109)
T ss_dssp             ------------------SSSCEEEEECTTSCEEEEE----SCCCCCCC
T ss_pred             ------------------CCCCEEEEEeCCCEEEEEC----CCEEeCCC
Confidence                              1245788999999877652    26677764

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=98.98  E-value=1.1e-09  Score=97.14  Aligned_cols=91  Identities=25%  Similarity=0.465  Sum_probs=69.4

Q ss_pred             CCCCCCCCceEEEecCCceEEEecCCCCeEEeecCCCCCCcceEEEecCCCEEEecCCCCCCCcceeeecCCCccccccc
Q 003391           75 APLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAG  154 (823)
Q Consensus        75 ~p~~~~~~~l~~~~~g~~~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqSFd~PTDtlLpg  154 (823)
                      .|+.+....|.|+.|||  |||+++    +|+|++........++|+++|||||++.+    +.++|+|-.+        
T Consensus        16 ~~L~~g~~~L~~q~dGN--Lvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~----~~~vWss~t~--------   77 (109)
T 3r0e_A           16 GHLKNGDFDLVMQDDCN--LVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGD----GSTVWKSGAQ--------   77 (109)
T ss_dssp             CEEEETTEEEEECTTSC--EEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTT----SCEEEECCCC--------
T ss_pred             CEeECCCEEEEEecCCe--EEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCC----CCEEEcCCCc--------
Confidence            34444567899999999  999984    79999875545678899999999999876    6789975210        


Q ss_pred             CcccceeccCcceeEEEcccCCCCCCCccEEeeCCCCCCeEEEEcCceeeeecCCC
Q 003391          155 MKLGVNLVTGLNRFISSWKSADDPAQDDYVYGIDPSGVPQAVFRKGSTIRYRAGSW  210 (823)
Q Consensus       155 q~l~~~~~tg~~~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~sg~w  210 (823)
                                             ...+.|.+.++.+|...++  .  .+.|.+++|
T Consensus        78 -----------------------~~~~~~~~~L~~dGNlvly--~--~~~W~s~t~  106 (109)
T 3r0e_A           78 -----------------------SVKGNYAAVVHPDGRLVVF--G--PSVFKIDPW  106 (109)
T ss_dssp             -----------------------CSSSCCEEEEETTTEEEEE--C--SEEEEECTT
T ss_pred             -----------------------CCCcCEEEEEcCCCeEEEE--e--cCEECCCCc
Confidence                                   1135678999999987665  2  678999987

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.98  E-value=4.3e-10  Score=116.75  Aligned_cols=131  Identities=15%  Similarity=0.165  Sum_probs=97.8

Q ss_pred             eee-ccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCC--ceeEEEEeecCCceEEEEeecCCCCc
Q 003391          511 KLG-EGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRN--LVKLIGCCTQRDERMLIYEYLPNKSL  587 (823)
Q Consensus       511 ~LG-~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~~~~~~~~lV~e~~~~gsL  587 (823)
                      .++ .|..+.||+....+|+.+++|.....   ....+..|+.+++.+.+.+  +.+++++....+..++||||++|.+|
T Consensus        26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l  102 (264)
T 1nd4_A           26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL  102 (264)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             ecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence            444 55568999998766788999987554   2345788999998885444  56688888887889999999999888


Q ss_pred             chhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 003391          588 NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS--------------------------------------------  623 (823)
Q Consensus       588 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------------  623 (823)
                      .  ...      .+   ...++.++++.|..||+..                                            
T Consensus       103 ~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (264)
T 1nd4_A          103 L--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  171 (264)
T ss_dssp             T--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             C--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence            4  211      11   2256777788888888643                                            


Q ss_pred             -----------CCceEecccCCCcEEEcCCCCceeecccccee
Q 003391          624 -----------RLRIIHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       624 -----------~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                                 +..++|+|++|.||+++++..+.|+||+.+..
T Consensus       172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          172 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                       12399999999999998776677999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.86  E-value=8.2e-09  Score=112.74  Aligned_cols=142  Identities=18%  Similarity=0.264  Sum_probs=107.6

Q ss_pred             cCCeeeccCccceEEEEeecCcEEEEEEec--CCc-cccHHHHHHHHHHHhccC--CCCceeEEEEeecC---CceEEEE
Q 003391          508 DKNKLGEGGFGPVYKGVLIEGQEIAAKRLS--KSS-GQGMEEFENEVLLIAKLQ--HRNLVKLIGCCTQR---DERMLIY  579 (823)
Q Consensus       508 ~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~--~~~-~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~---~~~~lV~  579 (823)
                      ..+.|+.|.++.||+.... +..+++|+..  ... ......+.+|+.+++.+.  +..+.++++++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            3467899999999998874 5678888775  322 123456788999999986  56688999998776   4589999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS------------------------------------  623 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------  623 (823)
                      ||++|..+.+..     ...++...+..++.++++.|+.||+..                                    
T Consensus       121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            999998886522     123677888899999999999999731                                    


Q ss_pred             -------------------CCceEecccCCCcEEEcCCCC--ceeecccccee
Q 003391          624 -------------------RLRIIHRDLKASNVLLDNEMN--PKISDFGMARA  655 (823)
Q Consensus       624 -------------------~~~ivH~Dlk~~NIll~~~~~--~kl~DFGla~~  655 (823)
                                         ...++|+|+++.||+++.++.  +.|+||+++..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               246999999999999997753  68999998875

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.71  E-value=1.2e-08  Score=108.68  Aligned_cols=186  Identities=19%  Similarity=0.216  Sum_probs=121.0

Q ss_pred             CCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccC-CC--CceeEEEEeecCC---ceEEEEeec
Q 003391          509 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HR--NLVKLIGCCTQRD---ERMLIYEYL  582 (823)
Q Consensus       509 ~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~--niv~l~g~~~~~~---~~~lV~e~~  582 (823)
                      .+.++.|....||+..    +.+++|+....  .....+.+|+.+++.+. +.  .+.+++......+   ..++|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4578999999999853    56888876432  34567889999998873 32  2445555544333   358899999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD----------------------------------------  622 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------  622 (823)
                      +|.+|.+...     ..++..++..++.++++.|+.||+.                                        
T Consensus        99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9998875432     2356677778888888888888861                                        


Q ss_pred             ---------------CCCceEecccCCCcEEEcC--CCCceeeccccceecCCCccccccc------------cccccCC
Q 003391          623 ---------------SRLRIIHRDLKASNVLLDN--EMNPKISDFGMARAFGIDQTEANTN------------RVVGTYG  673 (823)
Q Consensus       623 ---------------~~~~ivH~Dlk~~NIll~~--~~~~kl~DFGla~~~~~~~~~~~~~------------~~~gt~~  673 (823)
                                     ..+.++|+|+++.||++++  ...+.|+||+.+........-....            ......+
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence                           1235899999999999998  4567899999887532111000000            0000011


Q ss_pred             ccC-ccccccCCCCccchhHhHHHHHHHHHhcCCC
Q 003391          674 YMP-PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRN  707 (823)
Q Consensus       674 y~a-PE~l~~~~~s~ksDVwS~Gvvl~elltG~~p  707 (823)
                      ... |+....  .....+.|+++.++|++.+|..+
T Consensus       254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~  286 (304)
T 3sg8_A          254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMD  286 (304)
T ss_dssp             CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHH
T ss_pred             CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHH
Confidence            111 222111  11236899999999999999865

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1

Probab=98.63  E-value=1.3e-07  Score=96.49  Aligned_cols=87  Identities=26%  Similarity=0.356  Sum_probs=64.9

Q ss_pred             CCceEEEecCCceEEEecCCCCeEEeecCCCCCCcceEEEecCCCEEEecCCCCCCCcceeeecCCCcccccccCcccce
Q 003391           81 SGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVN  160 (823)
Q Consensus        81 ~~~l~~~~~g~~~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqSFd~PTDtlLpgq~l~~~  160 (823)
                      .-.|.|..||+  |+++++ +.+||.+++... ....++|+++|||||++.+    +++||+|+++.             
T Consensus        27 ~f~l~f~~~gn--l~ly~~-~~~vW~an~~~~-~~~~l~l~~dGnLvl~d~~----~~~vW~s~~~~-------------   85 (236)
T 1dlp_A           27 SFRFTMQSDCN--LVLFDS-DVRVWASNTAGA-TGCRAVLQSDGLLVILTAQ----NTIRWSSGTKG-------------   85 (236)
T ss_dssp             TEEEEECTTSC--EEEEES-SSEEECCCCCSC-SCCBCCBCSSSCBCCBCTT----TCCSCCCCCCC-------------
T ss_pred             CEEEEECCCCc--EEEEEC-CEEEEECCCCCC-CCeEEEEcCCCcEEEEcCC----CcEEEeCCccc-------------
Confidence            34577778888  999986 689999997644 5567889999999999976    77899999751             


Q ss_pred             eccCcceeEEEcccCCCCCCCccEEeeCCCCCCeEEEEcCceeeeecCCC
Q 003391          161 LVTGLNRFISSWKSADDPAQDDYVYGIDPSGVPQAVFRKGSTIRYRAGSW  210 (823)
Q Consensus       161 ~~tg~~~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~sg~w  210 (823)
                                        +.|.|.+.++.+|...++  .  ..+|.+..+
T Consensus        86 ------------------~~~~~~~~l~d~Gnlvl~--~--~~~W~S~~~  113 (236)
T 1dlp_A           86 ------------------SIGNYVLVLQPDRTVTIY--G--PGLWDSGTS  113 (236)
T ss_dssp             ------------------CSSCCEEEECSSSCEEEE--C--SEEEECSCC
T ss_pred             ------------------cCCcEEEEEeCCCCEEEe--c--CCEEECCCC
Confidence                              134567777777776554  2  167777655

>4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D*

Probab=98.62  E-value=1.7e-07  Score=82.31  Aligned_cols=77  Identities=26%  Similarity=0.374  Sum_probs=59.4

Q ss_pred             CceEEEecCCceEEEecCCCCeEEeecCCCC-CCcceEEEecCCCEEEecCCCCCCCcceeeecCCCcccccccCcccce
Q 003391           82 GALNISSQGNATLVLLNSTNGIVWSSNASRT-ARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVN  160 (823)
Q Consensus        82 ~~l~~~~~g~~~l~l~~~~~~~~w~~~~~~~-~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqSFd~PTDtlLpgq~l~~~  160 (823)
                      -+|.|+.|||  |||++. +.+||++++... .....+.|.++|||||+|.+    ++++|+|=.               
T Consensus        21 y~l~~q~DgN--Lvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~----~~~vWss~t---------------   78 (105)
T 4h3o_A           21 YHFIMQDDCN--LVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDSS----GRSLWASHS---------------   78 (105)
T ss_dssp             EEEEECTTSC--EEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECTT----CCEEEECCC---------------
T ss_pred             EEEEECCCCe--EEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECCC----cEEEEEecC---------------
Confidence            4688999999  999985 579999997643 23457899999999999977    678998621               


Q ss_pred             eccCcceeEEEcccCCCCCCCccEEeeCCCCCCeEE
Q 003391          161 LVTGLNRFISSWKSADDPAQDDYVYGIDPSGVPQAV  196 (823)
Q Consensus       161 ~~tg~~~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~  196 (823)
                                      ....+.+.+.++.+|...++
T Consensus        79 ----------------~~~~~~~~l~L~ddGNlVly   98 (105)
T 4h3o_A           79 ----------------TRGSGNYILILQDDGNVIIY   98 (105)
T ss_dssp             ----------------CCCSSCEEEEECTTSCEEEE
T ss_pred             ----------------CCCCCCEEEEEeCCCeEEEE
Confidence                            11245678899999987665

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.15  E-value=1.1e-05  Score=85.75  Aligned_cols=136  Identities=20%  Similarity=0.164  Sum_probs=92.5

Q ss_pred             CCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCC---CceeEEEEee-cCCceEEEEeecCC
Q 003391          509 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR---NLVKLIGCCT-QRDERMLIYEYLPN  584 (823)
Q Consensus       509 ~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~---niv~l~g~~~-~~~~~~lV~e~~~~  584 (823)
                      .+.++.|....||+.    ++.+++|+...  ......+..|+.+|..+.+.   .+.+.+.+.. ..+..++|||+++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            356788888899987    57788887532  23456789999999998642   3566676664 44567899999999


Q ss_pred             CCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 003391          585 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD------------------------------------------  622 (823)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------  622 (823)
                      .+|.+....     .++......++.++++.|+.||+.                                          
T Consensus        98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            888763211     123334444444444444444432                                          


Q ss_pred             ---------------CCCceEecccCCCcEEEcC---CCCc-eeecccccee
Q 003391          623 ---------------SRLRIIHRDLKASNVLLDN---EMNP-KISDFGMARA  655 (823)
Q Consensus       623 ---------------~~~~ivH~Dlk~~NIll~~---~~~~-kl~DFGla~~  655 (823)
                                     .+..++|+|+++.||+++.   ++.+ .|+||+.+..
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                           2335799999999999987   4554 8999998864

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.13  E-value=9.7e-06  Score=84.27  Aligned_cols=135  Identities=18%  Similarity=0.157  Sum_probs=94.7

Q ss_pred             eeeccCcc-ceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccC-CCCceeEEEEeecCCceEEEEeecCCCCc
Q 003391          511 KLGEGGFG-PVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLIYEYLPNKSL  587 (823)
Q Consensus       511 ~LG~G~fg-~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL  587 (823)
                      .+..|..+ .||+..... +..+++|+-...   ...++.+|...|+.+. +--+.++++++.+.+..++|||++++.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            55566666 589877654 567888876432   3456788999988874 44577889999988999999999999887


Q ss_pred             chhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhc---------------------------------------------
Q 003391          588 NDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD---------------------------------------------  622 (823)
Q Consensus       588 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------------------  622 (823)
                      .+....       .......+..++++.|.-||+.                                             
T Consensus       108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            665421       1122234445555555555532                                             


Q ss_pred             ----------CCCceEecccCCCcEEEcCCCCceeecccccee
Q 003391          623 ----------SRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       623 ----------~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                                ..+.++|+|+.+.||++++++.+-|+||+.+..
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                      112379999999999999887778999998753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.11  E-value=1.2e-05  Score=87.36  Aligned_cols=80  Identities=9%  Similarity=0.015  Sum_probs=57.0

Q ss_pred             Cee-eccCccceEEEEee-------cCcEEEEEEecCCc---cccHHHHHHHHHHHhccC-C--CCceeEEEEeecC---
Q 003391          510 NKL-GEGGFGPVYKGVLI-------EGQEIAAKRLSKSS---GQGMEEFENEVLLIAKLQ-H--RNLVKLIGCCTQR---  572 (823)
Q Consensus       510 ~~L-G~G~fg~Vyk~~~~-------~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~-H--~niv~l~g~~~~~---  572 (823)
                      +.| +.|....+|+....       +++.+++|+.....   ......+..|+.+++.+. +  ..+.++++++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            467 78888999998765       26678888765432   112245778888888874 2  4577888887665   


Q ss_pred             CceEEEEeecCCCCcch
Q 003391          573 DERMLIYEYLPNKSLND  589 (823)
Q Consensus       573 ~~~~lV~e~~~~gsL~~  589 (823)
                      +..++||||++|..+.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            35689999999988764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.73  E-value=9.9e-05  Score=79.27  Aligned_cols=140  Identities=14%  Similarity=0.166  Sum_probs=79.9

Q ss_pred             CeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccC--CCCceeEEE------EeecCCceEEEEee
Q 003391          510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ--HRNLVKLIG------CCTQRDERMLIYEY  581 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~--H~niv~l~g------~~~~~~~~~lV~e~  581 (823)
                      +.|+.|..+.||+....+ ..+++|+....    ..++..|+.++..+.  ...+.+++.      +....+..++||||
T Consensus        38 ~~l~gG~~n~~~~v~~~~-~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDS-GAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETT-EEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCC-CCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            346566788999988744 45889988652    234445555555542  113334433      11235667899999


Q ss_pred             cCCCCcch--------------hhhccCC----C-------CccCHHHHH------------------------------
Q 003391          582 LPNKSLND--------------FIFDVTR----S-------KFLDWSKRC------------------------------  606 (823)
Q Consensus       582 ~~~gsL~~--------------~l~~~~~----~-------~~l~~~~~~------------------------------  606 (823)
                      ++|..+..              .++....    .       ....|....                              
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            99976531              1111100    0       012332211                              


Q ss_pred             -HHHHHHHHHHHHHHh----------cCCCceEecccCCCcEEEcCCCCceeeccccce
Q 003391          607 -QIIGGIARGLLYLHQ----------DSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  654 (823)
Q Consensus       607 -~i~~~ia~gL~yLH~----------~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  654 (823)
                       .+...+.+++.+|++          ..+..++|+|+++.||+++.++.+.|+||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence             011123345666663          123469999999999999888899999999775

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.71  E-value=0.00013  Score=80.45  Aligned_cols=75  Identities=9%  Similarity=0.129  Sum_probs=50.2

Q ss_pred             CCeeeccCccceEEEEee-cCcEEEEEEecCCcc-------ccHHHHHHHHHHHhccCC--CC-ceeEEEEeecCCceEE
Q 003391          509 KNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG-------QGMEEFENEVLLIAKLQH--RN-LVKLIGCCTQRDERML  577 (823)
Q Consensus       509 ~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~-------~~~~~~~~Ei~~l~~l~H--~n-iv~l~g~~~~~~~~~l  577 (823)
                      .+.||.|.++.||++... +++.+++|.......       ...+.+..|.++++.+.+  +. +.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            357899999999999764 467899997653221       234566788888887742  33 4455544  3455789


Q ss_pred             EEeecCCC
Q 003391          578 IYEYLPNK  585 (823)
Q Consensus       578 V~e~~~~g  585 (823)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999874

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.55  E-value=0.0002  Score=75.12  Aligned_cols=80  Identities=18%  Similarity=0.211  Sum_probs=60.0

Q ss_pred             CCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCC---CCceeEEEEeecCCceEEEEee
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH---RNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H---~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      .....+.+|.|..+.||+.++.+|+.+++|+...........|..|+..|+.+..   ..+.++++..    ..++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence            4455678999999999999999999999998765554455678899998888742   2345555542    34789999


Q ss_pred             cCCCCcc
Q 003391          582 LPNKSLN  588 (823)
Q Consensus       582 ~~~gsL~  588 (823)
                      ++.+...
T Consensus        92 l~~~~~~   98 (288)
T 3f7w_A           92 VDERPPT   98 (288)
T ss_dssp             CCCCCCC
T ss_pred             ecccCCC
Confidence            9887643

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.54  E-value=0.00048  Score=72.93  Aligned_cols=139  Identities=19%  Similarity=0.165  Sum_probs=93.7

Q ss_pred             cCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccC---CCCceeEEEEeecCCceEEEEeecCC
Q 003391          508 DKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ---HRNLVKLIGCCTQRDERMLIYEYLPN  584 (823)
Q Consensus       508 ~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~e~~~~  584 (823)
                      ..+.|+.|....+|+... +++.+++|+....   ....+..|...|+.+.   ...+.+++++....+..++||||+++
T Consensus        40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            346789999999999876 5778888876532   3567889999888873   36788899988888889999999999


Q ss_pred             CCcch-----------hhhccCC-CC------------------ccCHHHHH---HHHH----------------HHHHH
Q 003391          585 KSLND-----------FIFDVTR-SK------------------FLDWSKRC---QIIG----------------GIARG  615 (823)
Q Consensus       585 gsL~~-----------~l~~~~~-~~------------------~l~~~~~~---~i~~----------------~ia~g  615 (823)
                      ..+..           .|+.... ..                  .-+|....   ++..                .+++-
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            87632           1222111 00                  12454322   1111                11111


Q ss_pred             -HHHHHh-cCCCceEecccCCCcEEEcCCCCceeeccc
Q 003391          616 -LLYLHQ-DSRLRIIHRDLKASNVLLDNEMNPKISDFG  651 (823)
Q Consensus       616 -L~yLH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DFG  651 (823)
                       ...|.. ..++.++|+|+.+.||+++.++ +.|.|+.
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             223432 2356799999999999999887 8899973

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.28  E-value=0.00086  Score=74.36  Aligned_cols=78  Identities=9%  Similarity=0.051  Sum_probs=48.6

Q ss_pred             CCceEecccCCCcEEEcCCCCceeeccccceecCCCcccccccccc--ccCCccCccccccC---CCCccchhHhHHHHH
Q 003391          624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV--GTYGYMPPEYAIDG---LFSVKSDVFSFGVLV  698 (823)
Q Consensus       624 ~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~--gt~~y~aPE~l~~~---~~s~ksDVwS~Gvvl  698 (823)
                      ...++|+|+++.|||++.++ ++|+||+.+..-.....   .....  -...|++|+.....   ......++......+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D---la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD---IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT  306 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH---HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH---HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence            34699999999999998876 99999998875321100   00000  01345666554311   112235566888888


Q ss_pred             HHHHhcC
Q 003391          699 LEIVCGK  705 (823)
Q Consensus       699 ~elltG~  705 (823)
                      |+.++++
T Consensus       307 ~~~y~~~  313 (420)
T 2pyw_A          307 WNLFNKR  313 (420)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            8888764

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.97  E-value=0.0034  Score=68.23  Aligned_cols=141  Identities=18%  Similarity=0.231  Sum_probs=84.4

Q ss_pred             CeeeccCccceEEEEeec--------CcEEEEEEecCCccccHHHHHHHHHHHhccC-CCCceeEEEEeecCCceEEEEe
Q 003391          510 NKLGEGGFGPVYKGVLIE--------GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~--------~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      +.|..|-...+|+....+        ++.+++|+... .......+.+|..+++.+. +.-..++++++.++    +|+|
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEE
Confidence            467778888899988742        47888888633 2234566778999988874 33346677776542    9999


Q ss_pred             ecCCCCcchh-----------------hhcc--CCCCccC--HHHHHHHHHHHH-------------------HHHHHH-
Q 003391          581 YLPNKSLNDF-----------------IFDV--TRSKFLD--WSKRCQIIGGIA-------------------RGLLYL-  619 (823)
Q Consensus       581 ~~~~gsL~~~-----------------l~~~--~~~~~l~--~~~~~~i~~~ia-------------------~gL~yL-  619 (823)
                      |++|..|..-                 |+..  .-.+...  |.++.++..++.                   +.+..| 
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998766421                 0111  0011122  344444443332                   122333 


Q ss_pred             ---Hhc-CCCceEecccCCCcEEEcCC----CCceeecccccee
Q 003391          620 ---HQD-SRLRIIHRDLKASNVLLDNE----MNPKISDFGMARA  655 (823)
Q Consensus       620 ---H~~-~~~~ivH~Dlk~~NIll~~~----~~~kl~DFGla~~  655 (823)
                         ... .+..++|+|+.+.||+++.+    +.+.|+||..+..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence               222 23468999999999999876    7899999998864

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.96  E-value=0.0023  Score=71.02  Aligned_cols=73  Identities=18%  Similarity=0.259  Sum_probs=50.5

Q ss_pred             CeeeccCccceEEEEeec--------CcEEEEEEecCCccccHHHHHHHHHHHhccCCCC-ceeEEEEeecCCceEEEEe
Q 003391          510 NKLGEGGFGPVYKGVLIE--------GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRN-LVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~--------~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e  580 (823)
                      +.|+.|....+|+....+        ++.+++|+....  ...+.+..|..++..+...+ ..++++.+.+    .+|+|
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e  152 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  152 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence            467888889999998753        478888887432  12255667988888874323 3567776643    38999


Q ss_pred             ecCCCCcc
Q 003391          581 YLPNKSLN  588 (823)
Q Consensus       581 ~~~~gsL~  588 (823)
                      |+++.+|.
T Consensus       153 ~l~G~~l~  160 (429)
T 1nw1_A          153 YIPSRPLS  160 (429)
T ss_dssp             CCCEEECC
T ss_pred             EeCCcccC
Confidence            99875553

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.88  E-value=0.0023  Score=67.99  Aligned_cols=157  Identities=13%  Similarity=0.092  Sum_probs=85.9

Q ss_pred             CHHHHHHHhcCCCc-----CCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCC--CceeEEE
Q 003391          495 DWMAIANATENFSD-----KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR--NLVKLIG  567 (823)
Q Consensus       495 ~~~~l~~~~~~~~~-----~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g  567 (823)
                      +..++......|..     .+.|+.|....+|+....++ .+++|......  ..+++..|+.++..+...  .+.+++.
T Consensus         8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~   84 (322)
T 2ppq_A            8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP   84 (322)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred             CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence            34444444455544     23456687789999887555 68888886521  223456677777766321  1333332


Q ss_pred             E------eecCCceEEEEeecCCCCcchh--------------hhccCC----C-----CccCHHHHHH-----------
Q 003391          568 C------CTQRDERMLIYEYLPNKSLNDF--------------IFDVTR----S-----KFLDWSKRCQ-----------  607 (823)
Q Consensus       568 ~------~~~~~~~~lV~e~~~~gsL~~~--------------l~~~~~----~-----~~l~~~~~~~-----------  607 (823)
                      .      ....+..+++++|++|..+...              ++....    .     ....|.....           
T Consensus        85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~  164 (322)
T 2ppq_A           85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK  164 (322)
T ss_dssp             BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred             CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence            1      1123457899999998765320              111100    0     0112322111           


Q ss_pred             -HHHHHHHHHHHHHhc----CCCceEecccCCCcEEEcCCCCceeeccccce
Q 003391          608 -IIGGIARGLLYLHQD----SRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  654 (823)
Q Consensus       608 -i~~~ia~gL~yLH~~----~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  654 (823)
                       +...+.+.++.+++.    .+..++|+|+++.||+++++..+.|+||+.+.
T Consensus       165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence             011234455555532    23469999999999999987666899998775

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.84  E-value=0.0036  Score=65.83  Aligned_cols=138  Identities=12%  Similarity=0.074  Sum_probs=76.0

Q ss_pred             CCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCc-eeEEEEeecCCceEEEEeec-CCCC
Q 003391          509 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL-VKLIGCCTQRDERMLIYEYL-PNKS  586 (823)
Q Consensus       509 ~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~-~~gs  586 (823)
                      .+.|+.|....+|+.     +.+++|+........ ....+|+.+++.+....+ .+++++.  .+.-++|+||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence            568989999999998     568888775432221 123567777777642222 4566543  33457899999 6655


Q ss_pred             cchh--------h----------hccCC--CCccCH-HHHHHHHH--------------HHHHHHH----HHHh-cCCCc
Q 003391          587 LNDF--------I----------FDVTR--SKFLDW-SKRCQIIG--------------GIARGLL----YLHQ-DSRLR  626 (823)
Q Consensus       587 L~~~--------l----------~~~~~--~~~l~~-~~~~~i~~--------------~ia~gL~----yLH~-~~~~~  626 (823)
                      |...        +          +....  ....+. .....+..              .+.+.+.    .|.. ..+..
T Consensus        95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~  174 (301)
T 3dxq_A           95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA  174 (301)
T ss_dssp             CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred             CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence            5421        0          11000  000111 11111111              0111111    1111 22345


Q ss_pred             eEecccCCCcEEEcCCCCceeecccccee
Q 003391          627 IIHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       627 ivH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                      ++|+|+.+.||+ ..++.+.|+||..+..
T Consensus       175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          175 ACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            899999999999 6667789999998864

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.83  E-value=0.0038  Score=69.67  Aligned_cols=74  Identities=15%  Similarity=0.101  Sum_probs=48.4

Q ss_pred             CeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCc-eeEEEEeecCCceEEEEeecCCCCc
Q 003391          510 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL-VKLIGCCTQRDERMLIYEYLPNKSL  587 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~gsL  587 (823)
                      +.|+.|-...+|+....+ ++.+++|+......... ....|..++..+...++ .++++.+..    .+|+||+++.+|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence            478888889999998755 47888887754322211 22578888888864444 567777632    359999998665


Q ss_pred             c
Q 003391          588 N  588 (823)
Q Consensus       588 ~  588 (823)
                      .
T Consensus       189 ~  189 (458)
T 2qg7_A          189 S  189 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.77  E-value=0.0063  Score=64.93  Aligned_cols=141  Identities=17%  Similarity=0.124  Sum_probs=72.0

Q ss_pred             CeeeccCccc-eEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccC--CCCceeEEEEeecCCceEEEEeecCCCC
Q 003391          510 NKLGEGGFGP-VYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ--HRNLVKLIGCCTQRDERMLIYEYLPNKS  586 (823)
Q Consensus       510 ~~LG~G~fg~-Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV~e~~~~gs  586 (823)
                      +.|+.|.... +|+....+++.+++|.......   +++..|+.++..+.  .-.+.+++.+..+.  -+++||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence            3565555444 6777654467777776543321   23345666666553  23455677664333  378999998766


Q ss_pred             cchhhhcc---------------------CC--CCccCHHHHH-------H-------------HHHHHHHHHHHHH---
Q 003391          587 LNDFIFDV---------------------TR--SKFLDWSKRC-------Q-------------IIGGIARGLLYLH---  620 (823)
Q Consensus       587 L~~~l~~~---------------------~~--~~~l~~~~~~-------~-------------i~~~ia~gL~yLH---  620 (823)
                      +.+++...                     ..  ...++.....       .             ....+.+.+..|.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            65433210                     00  0111111000       0             0001112222221   


Q ss_pred             hcCCCceEecccCCCcEEEcCC----CCceeecccccee
Q 003391          621 QDSRLRIIHRDLKASNVLLDNE----MNPKISDFGMARA  655 (823)
Q Consensus       621 ~~~~~~ivH~Dlk~~NIll~~~----~~~kl~DFGla~~  655 (823)
                      ......++|+|+.+.||+++.+    ..+.|+||+.+..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            1123469999999999999875    6789999998865

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.63  E-value=0.01  Score=62.98  Aligned_cols=142  Identities=11%  Similarity=0.115  Sum_probs=82.0

Q ss_pred             CeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCC--CCceeEEEE-----eecCCceEEEEeec
Q 003391          510 NKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH--RNLVKLIGC-----CTQRDERMLIYEYL  582 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~-----~~~~~~~~lV~e~~  582 (823)
                      ..|+ |....||+....+|+.+++|...... ....++..|..++..+..  -.+.+++..     ....+..++|++++
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            3566 77788999877667789999986332 234567778888877742  224444443     11234567899999


Q ss_pred             CCCCcch----h----------hhccC------CCCccCHHHH----HHHH---------------HHHHHHHHHHHhc-
Q 003391          583 PNKSLND----F----------IFDVT------RSKFLDWSKR----CQII---------------GGIARGLLYLHQD-  622 (823)
Q Consensus       583 ~~gsL~~----~----------l~~~~------~~~~l~~~~~----~~i~---------------~~ia~gL~yLH~~-  622 (823)
                      +|..+..    .          ++...      .....++...    ..+.               ..+.+.++.+.+. 
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            9865431    0          11100      0111222211    0010               0111222333221 


Q ss_pred             ---CCCceEecccCCCcEEEcCCCCceeecccccee
Q 003391          623 ---SRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       623 ---~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                         .+..++|+|+++.||+++ + .+.|+||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence               234589999999999999 4 899999987754

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.27  E-value=0.0099  Score=64.41  Aligned_cols=73  Identities=14%  Similarity=0.123  Sum_probs=44.2

Q ss_pred             CeeeccCccceEEEEeecC---------cEEEEEEecCCccccHHHHHHHHHHHhccCCCC-ceeEEEEeecCCceEEEE
Q 003391          510 NKLGEGGFGPVYKGVLIEG---------QEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRN-LVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~~---------~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~  579 (823)
                      +.|+.|....+|+....++         +.+++|+....... ......|..+++.+...+ ..++++...    -++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence            4677788889999887542         67888876543221 122467888887774223 446665542    36899


Q ss_pred             eecCCCCc
Q 003391          580 EYLPNKSL  587 (823)
Q Consensus       580 e~~~~gsL  587 (823)
                      ||++|..+
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99998654

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.99  E-value=0.026  Score=60.36  Aligned_cols=32  Identities=31%  Similarity=0.416  Sum_probs=28.2

Q ss_pred             CCceEecccCCCcEEEcCCCCceeecccccee
Q 003391          624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       624 ~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                      +..++|+|+.+.||++++++.+.|+||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            34699999999999999888899999987764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=95.39  E-value=0.043  Score=53.77  Aligned_cols=101  Identities=9%  Similarity=0.033  Sum_probs=65.0

Q ss_pred             CcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccccc
Q 003391          586 SLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT  665 (823)
Q Consensus       586 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  665 (823)
                      ||.+.|.  ....++++++++.++.|.++.|.-+-.... + ..+=+.|..|++..+|.+.+.+ ..+.           
T Consensus        34 SL~eIL~--~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           34 SLEEILR--LYNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             cHHHHHH--HcCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc-----------
Confidence            6888774  345689999999999999999877622111 1 1333457899999999988764 1110           


Q ss_pred             ccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCC
Q 003391          666 NRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR  706 (823)
Q Consensus       666 ~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~  706 (823)
                         .....+.|||... ...+.+.-|||+|+++|.-+-=..
T Consensus        98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL  134 (229)
T 2yle_A           98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL  134 (229)
T ss_dssp             ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred             ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence               1123566888653 455788999999999999885333

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.34  E-value=0.24  Score=54.31  Aligned_cols=74  Identities=14%  Similarity=0.143  Sum_probs=48.4

Q ss_pred             CeeeccCccceEEEEeec--------CcEEEEEEecCCccccHHHHHHHHHHHhccC-CCCceeEEEEeecCCceEEEEe
Q 003391          510 NKLGEGGFGPVYKGVLIE--------GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~--------~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      +.|..|-...+|+....+        ++.+++|+....... .-...+|..+++.+. +.-..++++.+.    -++|+|
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence            467777788899998753        578888886443322 223367888887774 333455665432    378999


Q ss_pred             ecCCCCcc
Q 003391          581 YLPNKSLN  588 (823)
Q Consensus       581 ~~~~gsL~  588 (823)
                      |++|..|.
T Consensus       151 fI~G~~l~  158 (424)
T 3mes_A          151 FIDGEPLT  158 (424)
T ss_dssp             CCCSEECC
T ss_pred             EeCCccCC
Confidence            99997653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=91.35  E-value=0.61  Score=50.81  Aligned_cols=30  Identities=23%  Similarity=0.371  Sum_probs=25.3

Q ss_pred             ceEecccCCCcEEE------cCCCCceeecccccee
Q 003391          626 RIIHRDLKASNVLL------DNEMNPKISDFGMARA  655 (823)
Q Consensus       626 ~ivH~Dlk~~NIll------~~~~~~kl~DFGla~~  655 (823)
                      .++|+|+.+.||++      +++..++++||.+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4567799999998864

>3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae}

Probab=90.89  E-value=4.8  Score=40.97  Aligned_cols=74  Identities=15%  Similarity=0.245  Sum_probs=45.1

Q ss_pred             EEEEEEeecCCCcEEEeecCCCC--CC----CCCCceEEEecCCceEEEecCCCCeEEeecCCCCCCcceEEEecCCCEE
Q 003391           54 YLGIWYKKIGNGTVIWVANRDAP--LS----DRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLV  127 (823)
Q Consensus        54 ~~giw~~~~~~~~~vW~an~~~p--~~----~~~~~l~~~~~g~~~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlv  127 (823)
                      .+.||  +...++++|...+..+  +.    .+.+.+-++.++.  +..+|.+|..+|.-..........+..+.+||++
T Consensus        16 ~v~~~--d~~tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~--V~~~d~~G~~~W~~~~~~~~~~~~~~~~~dG~~l   91 (276)
T 3no2_A           16 KIAII--NKDTKEIVWEYPLEKGWECNSVAATKAGEILFSYSKG--AKMITRDGRELWNIAAPAGCEMQTARILPDGNAL   91 (276)
T ss_dssp             EEEEE--ETTTTEEEEEEECCTTCCCCEEEECTTSCEEEECBSE--EEEECTTSCEEEEEECCTTCEEEEEEECTTSCEE
T ss_pred             EEEEE--ECCCCeEEEEeCCCccCCCcCeEECCCCCEEEeCCCC--EEEECCCCCEEEEEcCCCCccccccEECCCCCEE
Confidence            34455  2336888999877542  11    1244555544433  7777888999999886422222345677888888


Q ss_pred             EecC
Q 003391          128 VKDG  131 (823)
Q Consensus       128 l~~~  131 (823)
                      +.+.
T Consensus        92 v~~~   95 (276)
T 3no2_A           92 VAWC   95 (276)
T ss_dssp             EEEE
T ss_pred             EEec
Confidence            8653

>3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae}

Probab=82.98  E-value=7  Score=39.68  Aligned_cols=68  Identities=24%  Similarity=0.248  Sum_probs=43.5

Q ss_pred             CCCcEEEeecCCC-CCC---CCCCceEEEecCCceEEEecCC-CCeEEeecCCCC-----CCcceEEEecCCCEEEec
Q 003391           63 GNGTVIWVANRDA-PLS---DRSGALNISSQGNATLVLLNST-NGIVWSSNASRT-----ARNPVAVLLESGNLVVKD  130 (823)
Q Consensus        63 ~~~~~vW~an~~~-p~~---~~~~~l~~~~~g~~~l~l~~~~-~~~~w~~~~~~~-----~~~~~~~l~d~gnlvl~~  130 (823)
                      +.+.++|...+.. |..   .+++.+-+...+++.++..|.+ |.++|.-.....     .....+.++.+||+++.+
T Consensus       153 ~~G~~~w~~~~~~~~~~~~~~~~g~~~v~~~~~~~v~~~d~~tG~~~w~~~~~~~~~~~l~~~~~~~~~~~G~i~v~~  230 (276)
T 3no2_A          153 PNGQLLNSVKLSGTPFSSAFLDNGDCLVACGDAHCFVQLNLESNRIVRRVNANDIEGVQLFFVAQLFPLQNGGLYICN  230 (276)
T ss_dssp             TTSCEEEEEECSSCCCEEEECTTSCEEEECBTTSEEEEECTTTCCEEEEEEGGGSBSCCCSEEEEEEECTTSCEEEEE
T ss_pred             CCCCEEEEEECCCCccceeEcCCCCEEEEeCCCCeEEEEeCcCCcEEEEecCCCCCCccccccccceEcCCCCEEEEe
Confidence            4588999988753 321   1234444544444458888887 999999864211     112345788999999976

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=80.79  E-value=0.5  Score=33.27  Aligned_cols=7  Identities=43%  Similarity=0.909  Sum_probs=2.8

Q ss_pred             heeeecc
Q 003391          459 YLWKRRH  465 (823)
Q Consensus       459 ~~~~rr~  465 (823)
                      ++++||+
T Consensus        33 ~~~RRr~   39 (44)
T 2ks1_B           33 LFMRRRH   39 (44)
T ss_dssp             HHHHTTT
T ss_pred             HHhhhhH
Confidence            3344433

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	823
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-72
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-66
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-63
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-63
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-63
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-61
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-61
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-61
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-61
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-59
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-59
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-59
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-59
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-58
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-58
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-58
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-58
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	5e-58
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-58
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-57
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-57
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-57
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-57
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-56
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-55
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-55
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-55
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-54
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-52
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-51
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-50
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-49
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-49
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-47
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-45
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-45
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-45
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-45
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-44
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	8e-44
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-43
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-43
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	8e-43
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-42
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-41
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-41
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-40
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-40
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-40
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-39
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-38
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-37
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-37
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-37
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	7e-37
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-35
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	8e-34
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-32
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-31
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-30
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-27
d1kj1a_	109	b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium	1e-22
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	6e-22
d1jpca_	108	b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan	5e-16
d1dlpa2	120	b.78.1.1 (A:116-235) Fetuin-binding protein Scafet	7e-16
d1xd5a_	112	b.78.1.1 (A:) Gastrodianin (antifungal protein) {G	3e-15
d1b2pa_	119	b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill	3e-12
d1dlpa1	115	b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p	6e-10

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  235 bits (600), Expect = 6e-72
 Identities = 63/286 (22%), Positives = 135/286 (47%), Gaps = 21/286 (7%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
              +   ++G G FG VYKG       +    ++  + Q ++ F+NEV ++ K +H N++
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
             +G  T   +  ++ ++    SL   +         +  K   I    A+G+ YLH  S
Sbjct: 68  LFMGYSTA-PQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS 124

Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA--- 680
              IIHRDLK++N+ L  ++  KI DFG+A             ++ G+  +M PE     
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 681 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 740
               +S +SDV++FG+++ E++ G+    + + ++   ++    R ++     ++ +   
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFMVGRGYLSPDLSKVRS--- 236

Query: 741 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG-ERSLPQ 785
               +  + ++  ++   C++++ ++RP    ++  +    RSLP+
Sbjct: 237 ----NCPKAMK--RLMAECLKKKRDERPLFPQILASIELLARSLPK 276

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (560), Expect = 3e-66
 Identities = 83/274 (30%), Positives = 132/274 (48%), Gaps = 22/274 (8%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E      +LG G FG V+ G      ++A K L + S    + F  E  L+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71

Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           +L    TQ +   +I EY+ N SL DF+   +  K L  +K   +   IA G+ ++ + +
Sbjct: 72  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN 129

Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
               IHRDL+A+N+L+ + ++ KI+DFG+AR    ++  A          +  PE    G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185

Query: 684 LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 743
            F++KSDV+SFG+L+ EIV   R    Y    +  ++ +  R +   RP           
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRI--PYPGMTNPEVIQNLERGYRMVRPDNCPE------ 237

Query: 744 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 777
                     Q+  LC ++RPEDRP    +  +L
Sbjct: 238 -------ELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 1e-63
 Identities = 70/276 (25%), Positives = 118/276 (42%), Gaps = 24/276 (8%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
              +   ++G G FG V+ G  +   ++A K + + +    E+F  E  ++ KL H  LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63

Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           +L G C ++    L++E++ +  L+D++    +           +   +  G+ YL +  
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEE-- 119

Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
              +IHRDL A N L+      K+SDFGM R    DQ   ++        +  PE     
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177

Query: 684 LFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 742
            +S KSDV+SFGVL+ E+   GK              +   +RL+               
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST-------- 229

Query: 743 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 778
                      Q+   C ++RPEDRP  S ++  L+
Sbjct: 230 --------HVYQIMNHCWKERPEDRPAFSRLLRQLA 257

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 1e-63
 Identities = 77/288 (26%), Positives = 131/288 (45%), Gaps = 23/288 (7%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E+   + KLG+G FG V+ G       +A K L   +    E F  E  ++ KL+H  LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75

Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           +L    ++ +   ++ EY+   SL DF+      K+L   +   +   IA G+ Y+ +  
Sbjct: 76  QLYAVVSE-EPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVER-- 131

Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
            +  +HRDL+A+N+L+   +  K++DFG+AR    ++  A          +  PE A+ G
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYG 189

Query: 684 LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS 743
            F++KSDV+SFG+L+ E+    R    Y    +  +L    R +    P E         
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRV--PYPGMVNREVLDQVERGYRMPCPPECPE------ 241

Query: 744 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPK-QPG 790
                      +   C ++ PE+RP    +   L    +  +P+ QPG
Sbjct: 242 -------SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (540), Expect = 4e-63
 Identities = 61/292 (20%), Positives = 113/292 (38%), Gaps = 28/292 (9%)

Query: 509 KNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGC 568
           +  +G+G FG V++G    G+E+A K  S    +     E E+     L+H N++  I  
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAA 65

Query: 569 CTQRD----ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD-- 622
             + +    +  L+ +Y  + SL D++        +      ++    A GL +LH +  
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIV 121

Query: 623 ---SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF--GIDQTEANTNRVVGTYGYMPP 677
               +  I HRDLK+ N+L+       I+D G+A       D  +   N  VGT  YM P
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 678 EYAIDGL------FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHH----NLLGHAWRLW 727
           E   D +         ++D+++ G++  EI       G +               +    
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

Query: 728 IEERPVELINKSLGGSYSLSEVLRCI-QVGLLCVQQRPEDRPNMSSVVLMLS 778
            +    + +  ++   +   E LR + ++   C       R     +   LS
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  207 bits (527), Expect = 2e-61
 Identities = 72/321 (22%), Positives = 125/321 (38%), Gaps = 56/321 (17%)

Query: 485 REEEMELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSK 538
           +   +E P            N      +GEG FG V++              +A K L +
Sbjct: 4   KLLSLEYP----------RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE 53

Query: 539 SSGQGME-EFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRS 597
            +   M+ +F+ E  L+A+  + N+VKL+G C       L++EY+    LN+F+  ++  
Sbjct: 54  EASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPH 113

Query: 598 KF---------------------LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASN 636
                                  L  +++  I   +A G+ YL +    + +HRDL   N
Sbjct: 114 TVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRN 170

Query: 637 VLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGV 696
            L+   M  KI+DFG++R                   +MPPE      ++ +SDV+++GV
Sbjct: 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGV 230

Query: 697 LVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVG 756
           ++ EI         Y+   H  ++ +     I   P                 L    + 
Sbjct: 231 VLWEIFSYGLQ--PYYGMAHEEVIYYVRDGNILACPENC-------------PLELYNLM 275

Query: 757 LLCVQQRPEDRPNMSSVVLML 777
            LC  + P DRP+  S+  +L
Sbjct: 276 RLCWSKLPADRPSFCSIHRIL 296

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 3e-61
 Identities = 64/275 (23%), Positives = 120/275 (43%), Gaps = 24/275 (8%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           ++ +   +LG G FG V  G      ++A K + + S    +EF  E  ++  L H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62

Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
           +L G CT++    +I EY+ N  L +++ +          +  ++   +   + YL    
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK- 119

Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDG 683
             + +HRDL A N L++++   K+SDFG++R + +D    ++        + PPE  +  
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYS 176

Query: 684 LFSVKSDVFSFGVLVLEIV-CGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 742
            FS KSD+++FGVL+ EI   GK     +        +    RL+      E        
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE-------- 228

Query: 743 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 777
                   +   +   C  ++ ++RP    ++  +
Sbjct: 229 --------KVYTIMYSCWHEKADERPTFKILLSNI 255

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  206 bits (525), Expect = 4e-61
 Identities = 71/275 (25%), Positives = 123/275 (44%), Gaps = 22/275 (8%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL 562
            + + K+KLG G +G VY+GV  +    +A K L + + + +EEF  E  ++ +++H NL
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75

Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
           V+L+G CT+     +I E++   +L D++ +    + +       +   I+  + YL   
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLE-- 132

Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID 682
            +   IHRDL A N L+      K++DFG++R    D   A+         +  PE    
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAY 190

Query: 683 GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 742
             FS+KSDV++FGVL+ EI     +   Y       +              EL+ K    
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMS--PYPGIDLSQVY-------------ELLEKDYRM 235

Query: 743 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 777
                   +  ++   C Q  P DRP+ + +    
Sbjct: 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 5e-61
 Identities = 49/207 (23%), Positives = 97/207 (46%), Gaps = 11/207 (5%)

Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGM-EEFENEVLLIAKLQH 559
             ++F   ++LG G  G V+K      G  +A K +       +  +   E+ ++ +   
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
             +V   G      E  +  E++   SL+  +    ++  +      ++   + +GL YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
               + +I+HRD+K SN+L+++    K+ DFG++        ++  N  VGT  YM PE 
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174

Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCGKR 706
                +SV+SD++S G+ ++E+  G+ 
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRY 201

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 2e-59
 Identities = 71/282 (25%), Positives = 122/282 (43%), Gaps = 27/282 (9%)

Query: 502 ATENFS-DKNKLGEGGFGPVYKGVLI---EGQEIAAKRLSKSSGQG-MEEFENEVLLIAK 556
             +N      +LG G FG V +GV     +  ++A K L + + +   EE   E  ++ +
Sbjct: 6   KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65

Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 616
           L +  +V+LIG C Q +  ML+ E      L+ F+    + + +  S   +++  ++ G+
Sbjct: 66  LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGM 122

Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEAN-TNRVVGTYGYM 675
            YL +      +HRDL A NVLL N    KISDFG+++A G D +     +       + 
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179

Query: 676 PPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 735
            PE      FS +SDV+S+GV + E +   +    Y       ++    +    E P E 
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQK--PYKKMKGPEVMAFIEQGKRMECPPEC 237

Query: 736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 777
             +                +   C   + EDRP+  +V   +
Sbjct: 238 PPE-------------LYALMSDCWIYKWEDRPDFLTVEQRM 266

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 3e-59
 Identities = 69/288 (23%), Positives = 124/288 (43%), Gaps = 27/288 (9%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQE-----IAAKRLSKSSGQGM-EEFENEVLLIAKL 557
              + +  +G G FG VYKG+L          +A K L     +    +F  E  ++ + 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
            H N+++L G  ++    M+I EY+ N +L+ F+ +  +       +   ++ GIA G+ 
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124

Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT-NRVVGTYGYMP 676
           YL     +  +HRDL A N+L+++ +  K+SDFG++R    D     T +       +  
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 736
           PE      F+  SDV+SFG+++ E++        Y    +H ++             + I
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGER--PYWELSNHEVM-------------KAI 226

Query: 737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLP 784
           N        +       Q+ + C QQ    RP  + +V +L      P
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 3e-59
 Identities = 62/275 (22%), Positives = 106/275 (38%), Gaps = 28/275 (10%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           +       +G+G FG V  G    G ++A K +   +    + F  E  ++ +L+H NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63

Query: 564 KLIGCCTQRDERM-LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
           +L+G   +    + ++ EY+   SL D++        L      +    +   + YL   
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLE-- 120

Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID 682
                +HRDL A NVL+  +   K+SDFG+ +     Q             +  PE   +
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALRE 174

Query: 683 GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 742
             FS KSDV+SFG+L+ EI    R    Y      +++    + +  + P          
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRV--PYPRIPLKDVVPRVEKGYKMDAPDGCPPA---- 228

Query: 743 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 777
                      +V   C       RP+   +   L
Sbjct: 229 ---------VYEVMKNCWHLDAAMRPSFLQLREQL 254

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  200 bits (510), Expect = 6e-59
 Identities = 66/301 (21%), Positives = 120/301 (39%), Gaps = 37/301 (12%)

Query: 494 FDWMAIANATENFSDK---------NKLGEGGFGPVYKGVLI----EGQEIAAKRLSKS- 539
           F +     A   F+ +           +G G FG V  G L         +A K L    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 540 SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKF 599
           + +   +F +E  ++ +  H N++ L G  T+    M+I E++ N SL+ F+        
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQ 124

Query: 600 LDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID 659
               +   ++ GIA G+ YL     +  +HRDL A N+L+++ +  K+SDFG++R    D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 660 QTEANTNRVVG---TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHH 716
            ++      +G      +  PE      F+  SDV+S+G+++ E++              
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---------- 231

Query: 717 HNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM 776
                  +     +  +  I +       +       Q+ L C Q+    RP    +V  
Sbjct: 232 -----RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

Query: 777 L 777
           L
Sbjct: 287 L 287

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  200 bits (509), Expect = 1e-58
 Identities = 80/320 (25%), Positives = 126/320 (39%), Gaps = 47/320 (14%)

Query: 503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQG---MEEFENEVLLIAKLQ 558
            + FSD  ++G G FG VY    +   + +A K++S S  Q     ++   EV  + KL+
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           H N ++  GC  +     L+ EY    + +         K L   +   +  G  +GL Y
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAY 130

Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           LH      +IHRD+KA N+LL      K+ DFG A         A  N  VGT  +M PE
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPE 181

Query: 679 YAI---DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 735
             +   +G +  K DV+S G+  +E+   K         +  + L        +     L
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKP---PLFNMNAMSAL----YHIAQNESPAL 234

Query: 736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPGFFTER 795
            +         SE  R       C+Q+ P+DRP    ++            K   F    
Sbjct: 235 QSG------HWSEYFR--NFVDSCLQKIPQDRPTSEVLL------------KHR-FVLRE 273

Query: 796 NPPESGSSSSKRSLLSTNEI 815
            PP       +R+  +  E+
Sbjct: 274 RPPTVIMDLIQRTKDAVREL 293

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 2e-58
 Identities = 76/316 (24%), Positives = 133/316 (42%), Gaps = 48/316 (15%)

Query: 490 ELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIEG---QEIAAKRLSK-SSGQGME 545
             P+ DW        +   ++ +GEG FG V K  + +     + A KR+ + +S     
Sbjct: 3   IYPVLDW-------NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR 55

Query: 546 EFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFI------------- 591
           +F  E+ ++ KL  H N++ L+G C  R    L  EY P+ +L DF+             
Sbjct: 56  DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 115

Query: 592 FDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG 651
              + +  L   +       +ARG+ YL Q    + IHRDL A N+L+      KI+DFG
Sbjct: 116 IANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 172

Query: 652 MARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFY 711
           ++R     +             +M  E     +++  SDV+S+GVL+ EIV        Y
Sbjct: 173 LSRGQ---EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PY 227

Query: 712 HADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMS 771
                  L     + +  E+P+   ++                +   C +++P +RP+ +
Sbjct: 228 CGMTCAELYEKLPQGYRLEKPLNCDDE-------------VYDLMRQCWREKPYERPSFA 274

Query: 772 SVVLMLSGERSLPQPK 787
            +++ L   R L + K
Sbjct: 275 QILVSL--NRMLEERK 288

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 4e-58
 Identities = 67/276 (24%), Positives = 113/276 (40%), Gaps = 28/276 (10%)

Query: 508 DKNKLGEGGFGPVYKGVLIE---GQEIAAKRLSKSSGQG--MEEFENEVLLIAKLQHRNL 562
           +  +LG G FG V KG        + +A K L   +      +E   E  ++ +L +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
           V++IG C + +  ML+ E      LN ++    +++ +      +++  ++ G+ YL + 
Sbjct: 71  VRMIGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES 126

Query: 623 SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTN-RVVGTYGYMPPEYAI 681
                +HRDL A NVLL  +   KISDFG+++A   D+              +  PE   
Sbjct: 127 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183

Query: 682 DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 741
              FS KSDV+SFGVL+ E     +    Y       +               ++ K   
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQK--PYRGMKGSEVT-------------AMLEKGER 228

Query: 742 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 777
                        +  LC     E+RP  ++V L L
Sbjct: 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 5e-58
 Identities = 65/273 (23%), Positives = 110/273 (40%), Gaps = 23/273 (8%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGM-EEFENEVLLIAKLQHRN 561
           E++     LGEG +G V   V     + +A K +         E  + E+ +   L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
           +VK  G   + + + L  EY     L D I        +      +    +  G++YLH 
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
              + I HRD+K  N+LLD   N KISDFG+A  F  +  E   N++ GT  Y+ PE   
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 682 DGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 740
              F +   DV+S G+++  ++ G+            +     +  W E++      K +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLNPWKKI 232

Query: 741 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
               +   +L         + + P  R  +  +
Sbjct: 233 --DSAPLALLHK------ILVENPSARITIPDI 257

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 5e-58
 Identities = 69/279 (24%), Positives = 114/279 (40%), Gaps = 26/279 (9%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHR 560
           E++     +G G +G   K      G+ +  K L   S      +   +EV L+ +L+H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 561 NLVKLIGCCTQRDERML--IYEYLPNKSLNDFIFDVTRSK-FLDWSKRCQIIGGIARGLL 617
           N+V+       R    L  + EY     L   I   T+ + +LD     +++  +   L 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 618 YLHQ--DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYM 675
             H+  D    ++HRDLK +NV LD + N K+ DFG+AR    D + A     VGT  YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYM 181

Query: 676 PPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 735
            PE      ++ KSD++S G L+ E+         + A     L G          P   
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMP---PFTAFSQKELAGKIREGKFRRIPYRY 238

Query: 736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 774
                  S  L+E++         +  +   RP++  ++
Sbjct: 239 -------SDELNEIITR------MLNLKDYHRPSVEEIL 264

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 6e-58
 Identities = 64/279 (22%), Positives = 124/279 (44%), Gaps = 27/279 (9%)

Query: 501 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH 559
           N  + +    +LG+G FG VYK    E     AAK +   S + +E++  E+ ++A   H
Sbjct: 9   NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 68

Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
            N+VKL+      +   ++ E+    +++  + +    + L  S+   +       L YL
Sbjct: 69  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYL 126

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H     +IIHRDLKA N+L   + + K++DFG++          ++   +GT  +M PE 
Sbjct: 127 HD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEV 181

Query: 680 AI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVE 734
            +     D  +  K+DV+S G+ ++E+   +     +H  +   +L    ++   E P  
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIEP---PHHELNPMRVL---LKIAKSEPPTL 235

Query: 735 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
                   S +  + L+       C+++  + R   S +
Sbjct: 236 AQPSRW--SSNFKDFLKK------CLEKNVDARWTTSQL 266

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 2e-57
 Identities = 65/282 (23%), Positives = 123/282 (43%), Gaps = 30/282 (10%)

Query: 505 NFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSGQG-MEEFENEVLLIAKLQH 559
           +F     +G G FG VY G L++        A K L++ +  G + +F  E +++    H
Sbjct: 30  HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87

Query: 560 RNLVKLIGCCTQRDER-MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
            N++ L+G C + +   +++  Y+ +  L +FI +   +              +A+G+  
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGM-- 143

Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNR--VVGTYGYMP 676
               +  + +HRDL A N +LD +   K++DFG+AR     + ++  N+        +M 
Sbjct: 144 -KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202

Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI 736
            E      F+ KSDV+SFGVL+ E++        Y   +  ++  +  +     +P    
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQGRRLLQPEYCP 260

Query: 737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 778
           +                +V L C   + E RP+ S +V  +S
Sbjct: 261 DP-------------LYEVMLKCWHPKAEMRPSFSELVSRIS 289

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 2e-57
 Identities = 76/326 (23%), Positives = 136/326 (41%), Gaps = 29/326 (8%)

Query: 497 MAIANATENFSDKNKLGEGGFGPVYKGVLIEGQE-----IAAKRLSKS-SGQGMEEFENE 550
           + I   TE F     LG G FG VYKG+ I   E     +A K L ++ S +  +E  +E
Sbjct: 3   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61

Query: 551 VLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIG 610
             ++A + + ++ +L+G C       LI + +P   L D++ +      +          
Sbjct: 62  AYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCV 118

Query: 611 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVG 670
            IA+G+ YL      R++HRDL A NVL+    + KI+DFG+A+  G ++ E +      
Sbjct: 119 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 175

Query: 671 TYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE 730
              +M  E  +  +++ +SDV+S+GV V E++        Y       +           
Sbjct: 176 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK--PYDGIPASEIS---------- 223

Query: 731 RPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQPG 790
               ++ K           +    + + C     + RP    +++  S     PQ     
Sbjct: 224 ---SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 280

Query: 791 FFTER-NPPESGSSSSKRSLLSTNEI 815
              ER + P    S+  R+L+   ++
Sbjct: 281 QGDERMHLPSPTDSNFYRALMDEEDM 306

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 2e-57
 Identities = 64/302 (21%), Positives = 109/302 (36%), Gaps = 40/302 (13%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSSGQG-MEEFENEVLLIAK 556
              S    LG G FG V +              +A K L  S+     E   +E+ +++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 557 L-QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD---------------VTRSKFL 600
           L  H N+V L+G CT     ++I EY     L +F+                       L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 601 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 660
           D          +A+G+ +L        IHRDL A N+LL +    KI DFG+AR    D 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 661 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL 720
                        +M PE   + +++ +SDV+S+G+ + E+     +             
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------------- 246

Query: 721 GHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE 780
                + ++ +  ++I +                +   C    P  RP    +V ++  +
Sbjct: 247 -PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

Query: 781 RS 782
            S
Sbjct: 306 IS 307

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 5e-57
 Identities = 74/308 (24%), Positives = 133/308 (43%), Gaps = 34/308 (11%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVL------IEGQEIAAKRLSKS-SGQGMEEFENEVLLIAK 556
           E  +   +LG+G FG VY+GV            +A K ++++ S +   EF NE  ++ +
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIF-------DVTRSKFLDWSKRCQII 609
               ++V+L+G  +Q    ++I E +    L  ++        +         SK  Q+ 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 610 GGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVV 669
           G IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R            + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 670 GTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIE 729
               +M PE   DG+F+  SDV+SFGV++ EI         Y    +  +L       + 
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--PYQGLSNEQVLRFVMEGGLL 254

Query: 730 ERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPKQP 789
           ++P    +                ++  +C Q  P+ RP+   ++  +  E   P  ++ 
Sbjct: 255 DKPDNCPD-------------MLFELMRMCWQYNPKMRPSFLEIISSIKEEME-PGFREV 300

Query: 790 GFF-TERN 796
            F+ +E N
Sbjct: 301 SFYYSEEN 308

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 4e-56
 Identities = 65/305 (21%), Positives = 109/305 (35%), Gaps = 45/305 (14%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSSGQG-MEEFENEVLLIAK 556
           EN      LG G FG V               ++A K L + +     E   +E+ ++ +
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 557 L-QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFD--------------------VT 595
           L  H N+V L+G CT      LI+EY     L +++                        
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 596 RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARA 655
               L +         +A+G+ +L        +HRDL A NVL+ +    KI DFG+AR 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 656 FGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADH 715
              D              +M PE   +G++++KSDV+S+G+L+ EI        +     
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV-NPYPGIPV 272

Query: 716 HHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 775
             N        +  ++P     +                +   C       RP+  ++  
Sbjct: 273 DANFYKLIQNGFKMDQPFYATEE-------------IYIIMQSCWAFDSRKRPSFPNLTS 319

Query: 776 MLSGE 780
            L  +
Sbjct: 320 FLGCQ 324

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 1e-55
 Identities = 73/286 (25%), Positives = 108/286 (37%), Gaps = 36/286 (12%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLI----EGQEIAAKRLSK---SSGQGMEEFENEVLLIAK 556
           ++     KLG+G FG V +G       +   +A K L     S  + M++F  EV  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 557 LQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 616
           L HRNL++L G       +M + E  P  SL D +               +    +A G+
Sbjct: 68  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGM 124

Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE-ANTNRVVGTYGYM 675
            YL      R IHRDL A N+LL      KI DFG+ RA   +             + + 
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 676 PPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 735
            PE      FS  SD + FGV + E+    +                    WI     ++
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQ------------------EPWIGLNGSQI 223

Query: 736 INKSLGGSYSLSEVLRC----IQVGLLCVQQRPEDRPNMSSVVLML 777
           ++K       L     C      V + C   +PEDRP   ++   L
Sbjct: 224 LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 1e-55
 Identities = 56/274 (20%), Positives = 109/274 (39%), Gaps = 31/274 (11%)

Query: 509 KNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKL 565
             ++G G F  VYKG+  E   E+A   L     +    + F+ E  ++  LQH N+V+ 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 566 IGCC----TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
                     +   +L+ E + + +L  ++    R K +           I +GL +LH 
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 622 DSRLRIIHRDLKASNVLLDNE-MNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
            +   IIHRDLK  N+ +     + KI D G+A              V+GT  +M PE  
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEM- 184

Query: 681 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 740
            +  +    DV++FG+ +LE+   +    +    +   +              ++    +
Sbjct: 185 YEEKYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQIYRRVTSGVKPASFDKVAIPEV 242

Query: 741 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVV 774
                        ++   C++Q  ++R ++  ++
Sbjct: 243 ------------KEIIEGCIRQNKDERYSIKDLL 264

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 3e-55
 Identities = 63/276 (22%), Positives = 127/276 (46%), Gaps = 24/276 (8%)

Query: 499 IANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKL 557
           + +  + ++   K+G+G  G VY  + +  GQE+A ++++       E   NE+L++ + 
Sbjct: 15  VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN 74

Query: 558 QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           ++ N+V  +      DE  ++ EYL   SL D + +      +D  +   +     + L 
Sbjct: 75  KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALE 130

Query: 618 YLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPP 677
           +LH     ++IHRD+K+ N+LL  + + K++DFG       +Q++ +T  +VGT  +M P
Sbjct: 131 FLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAP 185

Query: 678 EYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 737
           E      +  K D++S G++ +E++ G+     Y  ++    L   + +     P     
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEP---PYLNENPLRAL---YLIATNGTPELQNP 239

Query: 738 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
           + L  S    + L        C+    E R +   +
Sbjct: 240 EKL--SAIFRDFLNR------CLDMDVEKRGSAKEL 267

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 1e-54
 Identities = 65/277 (23%), Positives = 109/277 (39%), Gaps = 35/277 (12%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQH 559
           E+F     LG+G FG VY     +    +A K L K+         +   EV + + L+H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
            N+++L G         LI EY P  ++   +  +++    D  +    I  +A  L Y 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H     R+IHRD+K  N+LL +    KI+DFG +      +       + GT  Y+PPE 
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175

Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 739
               +   K D++S GVL  E + GK                     +      E   + 
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGK-------------------PPFEANTYQETYKRI 216

Query: 740 LGGSYSLSEVL--RCIQVGLLCVQQRPEDRPNMSSVV 774
               ++  + +      +    ++  P  RP +  V+
Sbjct: 217 SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 6e-52
 Identities = 67/280 (23%), Positives = 112/280 (40%), Gaps = 27/280 (9%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLI----EGQEIAAKRLSKSSGQGM-EEFENEVLLIAKLQ 558
           E       +GEG FG V++G+ +        +A K     +   + E+F  E L + +  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           H ++VKLIG  T+ +   +I E      L  F+     S  LD +        ++  L Y
Sbjct: 67  HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123

Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           L      R +HRD+ A NVL+ +    K+ DFG++R    D T    ++      +M PE
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPE 179

Query: 679 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 738
                 F+  SDV+ FGV + EI+        +    +++++G          P      
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVK--PFQGVKNNDVIGRIENGERLPMPPNC--- 234

Query: 739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 778
                 +L  ++        C    P  RP  + +   LS
Sbjct: 235 ----PPTLYSLMTK------CWAYDPSRRPRFTELKAQLS 264

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 4e-51
 Identities = 69/297 (23%), Positives = 107/297 (36%), Gaps = 39/297 (13%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSSGQG--MEEFENEVLLIA 555
           +       LG G FG V +            + +A K L + +             +LI 
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 556 KLQHRNLVKLIGCCTQRDER-MLIYEYLPNKSLNDFIF-------------DVTRSKFLD 601
              H N+V L+G CT+     M+I E+    +L+ ++              +     FL 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 602 WSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT 661
                     +A+G+ +L      + IHRDL A N+LL  +   KI DFG+AR    D  
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLG 721
                       +M PE   D +++++SDV+SFGVL+ EI                 +  
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----LGASPYPGVKIDE 244

Query: 722 HAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 778
              R   E   +   + +              Q  L C    P  RP  S +V  L 
Sbjct: 245 EFCRRLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVEHLG 292

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 6e-50
 Identities = 70/298 (23%), Positives = 114/298 (38%), Gaps = 41/298 (13%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE--------GQEIAAKRLSK-SSGQGMEEFENEVLLI 554
           +       LGEG FG V     I           ++A K L   ++ + + +  +E+ ++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 555 AKL-QHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIF-------------DVTRSKFL 600
             + +H+N++ L+G CTQ     +I EY    +L +++                   + L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 601 DWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ 660
                      +ARG+ YL      + IHRDL A NVL+  +   KI+DFG+AR      
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 661 TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLL 720
               T        +M PE   D +++ +SDV+SFGVL+ EI     +   Y       L 
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--PYPGVPVEELF 247

Query: 721 GHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 778
                    ++P    N+                +   C    P  RP    +V  L 
Sbjct: 248 KLLKEGHRMDKPSNCTNE-------------LYMMMRDCWHAVPSQRPTFKQLVEDLD 292

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 1e-49
 Identities = 62/274 (22%), Positives = 99/274 (36%), Gaps = 31/274 (11%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQH 559
           E+F     LGEG F  V     +   +E A K L K        +     E  ++++L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
              VKL       ++      Y  N  L  +I    +    D +        I   L YL
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYL 124

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H      IIHRDLK  N+LL+ +M+ +I+DFG A+    +  +A  N  VGT  Y+ PE 
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181

Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 739
             +      SD+++ G ++ ++V G                      +       +  K 
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGL-------------------PPFRAGNEYLIFQKI 222

Query: 740 LGGSYSLSEVL--RCIQVGLLCVQQRPEDRPNMS 771
           +   Y   E    +   +    +      R    
Sbjct: 223 IKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCE 256

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  174 bits (442), Expect = 6e-49
 Identities = 52/274 (18%), Positives = 106/274 (38%), Gaps = 26/274 (9%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL 562
           +++    +LG G FG V++      G   AAK +        E    E+  ++ L+H  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
           V L       +E ++IYE++    L + + D      +   +  + +  + +GL ++H  
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH-- 141

Query: 623 SRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
                +H DLK  N++   + +   K+ DFG+         + +     GT  +  PE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVA 197

Query: 681 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 740
                   +D++S GVL   ++ G      +  ++    L +     ++     + + + 
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLS---PFGGENDDETLRN-----VKSCDWNMDDSAF 249

Query: 741 GG-SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
            G S    + +R        +   P  R  +   
Sbjct: 250 SGISEDGKDFIRK------LLLADPNTRMTIHQA 277

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  171 bits (433), Expect = 1e-47
 Identities = 55/273 (20%), Positives = 104/273 (38%), Gaps = 24/273 (8%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL 562
           + +    +LG G FG V++ V    G+   AK ++          +NE+ ++ +L H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
           + L      + E +LI E+L    L D I        +  ++    +     GL ++H  
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMH-- 144

Query: 623 SRLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
               I+H D+K  N++ + +     KI DFG+A     D+          T  +  PE  
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200

Query: 681 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 740
                   +D+++ GVL   ++ G      +  +     L +  R   +    E    S+
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLS---PFAGEDDLETLQNVKR--CDWEFDEDAFSSV 255

Query: 741 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
             S    + ++        +Q+ P  R  +   
Sbjct: 256 --SPEAKDFIKN------LLQKEPRKRLTVHDA 280

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (417), Expect = 1e-45
 Identities = 60/291 (20%), Positives = 116/291 (39%), Gaps = 21/291 (7%)

Query: 501 NATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGM-EEFENEVLLIAKLQ 558
           +    +++ + +GEG +G V           +A K++S    Q   +    E+ ++ + +
Sbjct: 5   DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64

Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           H N++ +           +   YL    +   ++ + +++ L     C  +  I RGL Y
Sbjct: 65  HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKY 124

Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANT-NRVVGTYGYMPP 677
           +H      ++HRDLK SN+LL+   + KI DFG+AR    D          V T  Y  P
Sbjct: 125 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181

Query: 678 EYAIDGLFSVKS-DVFSFGVLVLEIVCGKR-NRGFYHADHHHNLLGHAWRLWIEERPVEL 735
           E  ++     KS D++S G ++ E++  +    G ++ D  +++LG       E+    +
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241

Query: 736 INKSLGGSYS--------LSEVLRCIQVGLL-----CVQQRPEDRPNMSSV 773
             K+     S         + +        L      +   P  R  +   
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  162 bits (412), Expect = 1e-45
 Identities = 60/282 (21%), Positives = 112/282 (39%), Gaps = 28/282 (9%)

Query: 503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQG---MEEFENEVLLIAKLQ 558
           ++ +     LG GG   V+    +   +++A K L     +       F  E    A L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 559 HRNLVKLIGCCTQRDER----MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIAR 614
           H  +V +               ++ EY+   +L D +        +   +  ++I    +
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122

Query: 615 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE-ANTNRVVGTYG 673
            L + H   +  IIHRD+K +N+++      K+ DFG+ARA          T  V+GT  
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 674 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV 733
           Y+ PE A       +SDV+S G ++ E++ G+     +  D   ++        + E P+
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP---PFTGDSPVSVA----YQHVREDPI 232

Query: 734 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 775
               +  G S  L  V+         + + PE+R   ++ + 
Sbjct: 233 PPSARHEGLSADLDAVVLK------ALAKNPENRYQTAAEMR 268

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  163 bits (414), Expect = 1e-45
 Identities = 62/327 (18%), Positives = 116/327 (35%), Gaps = 36/327 (11%)

Query: 496 WMAIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEE-FENEVLL 553
           W    +  + +  ++ LG G F  V         + +A K ++K + +G E   ENE+ +
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 554 IAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIA 613
           + K++H N+V L           LI + +    L D I       F       ++I  + 
Sbjct: 61  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVL 117

Query: 614 RGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYG 673
             + YLH    +    +        LD +    ISDFG+++           +   GT G
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPG 174

Query: 674 YMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV 733
           Y+ PE      +S   D +S GV+   ++CG                      + +E   
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY-------------------PPFYDENDA 215

Query: 734 ELINKSLGGSYSLSEVLR------CIQVGLLCVQQRPEDRPNMSSVVLM--LSGERSLPQ 785
           +L  + L   Y                     +++ PE R      +    ++G+ +L +
Sbjct: 216 KLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDK 275

Query: 786 PKQPGFFTERNPPESGSSSSKRSLLST 812
                  +E+       S  K++  +T
Sbjct: 276 NIHQ-SVSEQIKKNFAKSKWKQAFNAT 301

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (412), Expect = 4e-45
 Identities = 51/278 (18%), Positives = 101/278 (36%), Gaps = 35/278 (12%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           E +     LG G FG V++ V    ++    +  K  G      + E+ ++   +HRN++
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64

Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
            L       +E ++I+E++    + + I   T +  L+  +    +  +   L +LH   
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS-- 120

Query: 624 RLRIIHRDLKASNVLLDNEMNP--KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
              I H D++  N++     +   KI +FG AR         N   +     Y  PE   
Sbjct: 121 -HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQ 176

Query: 682 DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 741
             + S  +D++S G LV  ++ G                      ++ E   ++I   + 
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGI-------------------NPFLAETNQQIIENIMN 217

Query: 742 GSYSLSEVLR------CIQVGLLCVQQRPEDRPNMSSV 773
             Y+  E          +      + +  + R   S  
Sbjct: 218 AEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 5e-44
 Identities = 69/277 (24%), Positives = 110/277 (39%), Gaps = 30/277 (10%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFEN----EVLLIAKLQ 558
           E+F     LG+G FG V+     +  Q  A K L K      ++ E     + +L    +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 559 HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
           H  L  +      ++    + EYL    L   I         D S+       I  GL +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118

Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           LH      I++RDLK  N+LLD + + KI+DFGM +   +   + NT    GT  Y+ PE
Sbjct: 119 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173

Query: 679 YAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK 738
             +   ++   D +SFGVL+ E++ G+     +H      L  H+ R+     P  L   
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQS---PFHGQDEEELF-HSIRMDNPFYPRWL--- 226

Query: 739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL 775
                    ++L           + PE R  +   + 
Sbjct: 227 ----EKEAKDLLVK------LFVREPEKRLGVRGDIR 253

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  160 bits (406), Expect = 8e-44
 Identities = 64/275 (23%), Positives = 108/275 (39%), Gaps = 32/275 (11%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQ- 558
            +FS    +G GGFG VY     + G+  A K L K      QG     NE ++++ +  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 559 --HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGL 616
                +V +       D+   I + +    L+  +    +      +        I  GL
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120

Query: 617 LYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
            ++H      +++RDLK +N+LLD   + +ISD G+A  F   +     +  VGT+GYM 
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173

Query: 677 PEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL 735
           PE    G+ +   +D FS G ++ +++ G      +     H +      + +E      
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD--- 230

Query: 736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNM 770
                    S S  LR +  GLL        R   
Sbjct: 231 ---------SFSPELRSLLEGLLQRD--VNRRLGC 254

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  157 bits (397), Expect = 1e-43
 Identities = 60/287 (20%), Positives = 110/287 (38%), Gaps = 39/287 (13%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGM---------EEFENEVLL 553
           EN+  K  LG G    V + +     +E A K +  + G            E    EV +
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 554 IAKLQ-HRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGI 612
           + K+  H N+++L           L+++ +    L D++   T    L   +  +I+  +
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119

Query: 613 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTY 672
              +  LH   +L I+HRDLK  N+LLD++MN K++DFG +      +       V GT 
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTP 173

Query: 673 GYMPPEYAIDGL------FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL 726
            Y+ PE     +      +  + D++S GV++  ++ G      +       +L      
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP---PFWHRKQMLMLRMIMSG 230

Query: 727 WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
             +    E  + S         V   +      +  +P+ R      
Sbjct: 231 NYQFGSPEWDDYS-------DTVKDLVS---RFLVVQPQKRYTAEEA 267

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  157 bits (398), Expect = 1e-43
 Identities = 54/276 (19%), Positives = 93/276 (33%), Gaps = 25/276 (9%)

Query: 511 KLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
           K+G G FG +Y G  I  G+E+A K     +     +   E  +   +Q    +  I  C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 570 TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIH 629
               +  ++   L   SL D       S+         +   +   + Y+H       IH
Sbjct: 72  GAEGDYNVMVMELLGPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIH---SKNFIH 126

Query: 630 RDLKASNVL---LDNEMNPKISDFGMARAFGIDQTEAN-----TNRVVGTYGYMPPEYAI 681
           RD+K  N L           I DFG+A+ +   +T  +        + GT  Y      +
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186

Query: 682 DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG 741
               S + D+ S G +++    G        A                  P+E++ K   
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY-ERISEKKMSTPIEVLCKGY- 244

Query: 742 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLML 777
                +  L        C   R +D+P+ S +  + 
Sbjct: 245 -PSEFATYLNF------CRSLRFDDKPDYSYLRQLF 273

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  156 bits (394), Expect = 8e-43
 Identities = 54/271 (19%), Positives = 96/271 (35%), Gaps = 36/271 (13%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQH 559
           ++F     LG G FG V+       G+  A K L K      + +E   +E L+++ + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
             ++++ G      +  +I +Y+    L   +    R            +       L L
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
                  II+RDLK  N+LLD   + KI+DFG A+             + GT  Y+ PE 
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYIAPEV 172

Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 739
                ++   D +SFG+L+ E++ G                      + +   ++   K 
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGY-------------------TPFYDSNTMKTYEKI 213

Query: 740 LGGSYSLSEVL--RCIQVGLLCVQQRPEDRP 768
           L                +    + +    R 
Sbjct: 214 LNAELRFPPFFNEDVKDLLSRLITRDLSQRL 244

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  153 bits (388), Expect = 3e-42
 Identities = 66/287 (22%), Positives = 112/287 (39%), Gaps = 27/287 (9%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAK--RLSKSSGQGMEEFENEVLLIAKLQHRN 561
           E +    K+GEG +G VYK     G+  A K  RL K           E+ ++ +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
           +VKL      +   +L++E+L                 L+       +  +  G+ Y H 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 622 DSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAI 681
               R++HRDLK  N+L++ E   KI+DFG+ARAFGI   +     +V  +   P     
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH-EIVTLWYRAPDVLMG 174

Query: 682 DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLW----------IEER 731
              +S   D++S G +  E+V G      +      + L   +R+           + E 
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTP---LFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231

Query: 732 PVELINKSLGGSYSLSEVLRCIQVGLL-----CVQQRPEDRPNMSSV 773
           P    N ++         L+ +    +      ++  P  R      
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 4e-41
 Identities = 65/315 (20%), Positives = 113/315 (35%), Gaps = 45/315 (14%)

Query: 510 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEE-----FENEVLLIAKLQHRNLV 563
           + LGEG F  VYK       Q +A K++        ++        E+ L+ +L H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 564 KLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS 623
            L+     +    L+++++              S  L  S     +    +GL YLHQ  
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119

Query: 624 RLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID- 682
              I+HRDLK +N+LLD     K++DFG+A++FG           V T  Y  PE     
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGA 175

Query: 683 GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 742
            ++ V  D+++ G ++ E++       F   D   + L   +         +  +     
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVP---FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232

Query: 743 SYSLSEVLRCIQVGLL--------------CVQQRPEDRPNMSSVVLMLSGERSLPQPKQ 788
            Y   +    I +  +                   P  R   +  +            K 
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL------------KM 280

Query: 789 PGFFTERNPPESGSS 803
             +F+ R  P  G  
Sbjct: 281 K-YFSNRPGPTPGCQ 294

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 4e-41
 Identities = 61/295 (20%), Positives = 114/295 (38%), Gaps = 32/295 (10%)

Query: 502 ATENFSDKNKLGEGGFGPVYKGVLIE--GQEIAAKRLSKSSGQGM--EEFENEVLLIAKL 557
           A + +    ++GEG +G V+K   ++  G+ +A KR+   +G+         EV ++  L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 558 ---QHRNLVKLIGCCTQRDERMLIYEYLPNKSLN---DFIFDVTRSKFLDWSKRCQIIGG 611
              +H N+V+L   CT           L  + ++       D      +       ++  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 612 IARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGT 671
           + RGL +LH     R++HRDLK  N+L+ +    K++DFG+AR +           VV T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVT 178

Query: 672 YGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL----- 726
             Y  PE  +   ++   D++S G +  E+   K     +      + LG    +     
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP---LFRGSSDVDQLGKILDVIGLPG 235

Query: 727 ---WIEERPVELINKSLGGSYSLSEVLRCIQVGLL-----CVQQRPEDRPNMSSV 773
              W  +  +         +  + + +  I          C+   P  R +  S 
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  149 bits (376), Expect = 1e-40
 Identities = 43/286 (15%), Positives = 95/286 (33%), Gaps = 27/286 (9%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNL 562
            ++    ++GEG FG +++G  +   Q++A K   + S     +  +E      L     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62

Query: 563 VKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD 622
           +  +    Q     ++   L   SL D +      +             +   +  +H+ 
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHE- 119

Query: 623 SRLRIIHRDLKASNVLLDNEMNP-----KISDFGMARAFGIDQTEAN-----TNRVVGTY 672
               +++RD+K  N L+    +       + DFGM + +    T+ +        + GT 
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

Query: 673 GYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP 732
            YM     +    S + D+ + G + +  + G        A  +           I E+ 
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY-----ERIGEKK 232

Query: 733 VELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS 778
                + L   +   E  + +           +  P+   +  + S
Sbjct: 233 QSTPLRELCAGFP-EEFYKYMH---YARNLAFDATPDYDYLQGLFS 274

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 2e-40
 Identities = 66/288 (22%), Positives = 115/288 (39%), Gaps = 27/288 (9%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHR 560
           ENF    K+GEG +G VYK      G+ +A K++     +         E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+VKL+      ++  L++E+L          D +    +        +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
                R++HRDLK  N+L++ E   K++DFG+ARAFG       T+ VV  +   P    
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTLWYRAPEILL 175

Query: 681 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 740
               +S   D++S G +  E+V  +     +  D   + L   +R       V     + 
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRA---LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232

Query: 741 GGSY----------SLSEVLRCIQVGLL-----CVQQRPEDRPNMSSV 773
              Y            S+V+  +           +   P  R +  + 
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 5e-40
 Identities = 62/289 (21%), Positives = 111/289 (38%), Gaps = 29/289 (10%)

Query: 505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLV 563
           +++D   +G G FG VY+  L + G+ +A K++ +           E+ ++ KL H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76

Query: 564 KLIGCCTQRDERM------LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLL 617
           +L        E+       L+ +Y+P              + L        +  + R L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136

Query: 618 YLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMARAFGIDQTEANTNRVVGTYGYMP 676
           Y+H      I HRD+K  N+LLD +    K+ DFG A+     + E N + +   Y   P
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAP 191

Query: 677 PEYAIDGLFSVKSDVFSFGVLVLEIVCGKR----NRGFYHADHHHNLLGHAWRLWIEERP 732
                   ++   DV+S G ++ E++ G+     + G         +LG   R  I E  
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251

Query: 733 VELINKSLG--GSYSLSEVLR------CIQVGLLCVQQRPEDRPNMSSV 773
                       ++  ++V R       I +    ++  P  R      
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 1e-39
 Identities = 67/285 (23%), Positives = 112/285 (39%), Gaps = 37/285 (12%)

Query: 504 ENFSDK----NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS------GQGMEEFENEVL 552
           EN  D      +LG G F  V K      G + AAK + K        G   E+ E EV 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65

Query: 553 LIAKLQHRNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGI 612
           ++ ++QH N++ L      + + +LI E +    L DF+      + L   +  + +  I
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQI 122

Query: 613 ARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP----KISDFGMARAFGIDQTEANTNRV 668
             G+ YLH    L+I H DLK  N++L +   P    KI DFG+A              +
Sbjct: 123 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNI 176

Query: 669 VGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWI 728
            GT  ++ PE        +++D++S GV+   ++ G      +  D     L +   +  
Sbjct: 177 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS---PFLGDTKQETLANVSAVNY 233

Query: 729 EERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
           E       N S        + +R        + + P+ R  +   
Sbjct: 234 EFEDEYFSNTSA----LAKDFIRR------LLVKDPKKRMTIQDS 268

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 3e-38
 Identities = 54/272 (19%), Positives = 99/272 (36%), Gaps = 32/272 (11%)

Query: 512 LGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCC 569
           LG G  G V +       ++ A K L         +   EV L  +  Q  ++V+++   
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 74

Query: 570 ----TQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRL 625
                 R   +++ E L    L   I D    +     +  +I+  I   + YLH    +
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHS---I 130

Query: 626 RIIHRDLKASNVLLDNEMNP---KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAID 682
            I HRD+K  N+L  ++      K++DFG A+      +         T  Y+ PE    
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGP 187

Query: 683 GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG 742
             +    D++S GV++  ++CG          +H   +    +  I     E  N     
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYP----PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243

Query: 743 -SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
            S  +  ++R        ++  P  R  ++  
Sbjct: 244 VSEEVKMLIRN------LLKTEPTQRMTITEF 269

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 1e-37
 Identities = 62/313 (19%), Positives = 119/313 (38%), Gaps = 40/313 (12%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG--QGMEEFENEVLLIAKLQHR 560
           + +    K+GEG +G V+K    E  + +A KR+               E+ L+ +L+H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N+V+L        +  L++E+        F      +  LD       +  + +GL + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
                 ++HRDLK  N+L++     K+++FG+ARAFGI      +  VV  +   P    
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPDVLF 174

Query: 681 IDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL 740
              L+S   D++S G +  E+    R    +  +   + L   +RL       +  + + 
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRP--LFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232

Query: 741 GGSYSLSEVLRCIQVGLL---------------CVQQRPEDRPNMSSVVLMLSGERSLPQ 785
              Y    +       +                 ++  P  R +    +           
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL----------- 281

Query: 786 PKQPGFFTERNPP 798
            + P +F++  PP
Sbjct: 282 -QHP-YFSDFCPP 292

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 2e-37
 Identities = 60/274 (21%), Positives = 96/274 (35%), Gaps = 43/274 (15%)

Query: 511 KLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEE------FENEVLLIAKLQ--HRN 561
            LG GGFG VY G+ +     +A K + K       E         EV+L+ K+      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 562 LVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ 621
           +++L+    + D  +LI E             +T    L           +   + + H 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDF--ITERGALQEELARSFFWQVLEAVRHCHN 128

Query: 622 DSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY- 679
                ++HRD+K  N+L+D N    K+ DFG          +       GT  Y PPE+ 
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 181

Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 739
                    + V+S G+L+ ++VCG      +  D         +R  +      LI   
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDI---PFEHDEEIIRGQVFFRQRVSSECQHLIRW- 237

Query: 740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSV 773
                              C+  RP DRP    +
Sbjct: 238 -------------------CLALRPSDRPTFEEI 252

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 2e-37
 Identities = 62/314 (19%), Positives = 119/314 (37%), Gaps = 41/314 (13%)

Query: 489 MELPIFDWMAIANATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQG--ME 545
           +E P  D +        +    K+G+G FG V+K    + GQ++A K++   + +     
Sbjct: 1   VECPFCDEV------SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI 54

Query: 546 EFENEVLLIAKLQHRNLVKLIGCCTQRDERM--------LIYEYLPNKSLNDFIFDVTRS 597
               E+ ++  L+H N+V LI  C  +            L++++  +         + + 
Sbjct: 55  TALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF 114

Query: 598 KFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG 657
              +  +  Q++      L  L+   R +I+HRD+KA+NVL+  +   K++DFG+ARAF 
Sbjct: 115 TLSEIKRVMQML------LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168

Query: 658 IDQTEANTNR--VVGTYGYMPPEYAI-DGLFSVKSDVFSFGVLVLEIVCGKR----NRGF 710
           + +          V T  Y PPE  + +  +    D++  G ++ E+         N   
Sbjct: 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ 228

Query: 711 YHADHHHNLLG----HAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLL-------C 759
           +       L G      W         E +    G    + + L+               
Sbjct: 229 HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKL 288

Query: 760 VQQRPEDRPNMSSV 773
           +   P  R +    
Sbjct: 289 LVLDPAQRIDSDDA 302

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 7e-37
 Identities = 55/273 (20%), Positives = 94/273 (34%), Gaps = 33/273 (12%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQH 559
            +F     LG+G FG V        G+  A K L K    +   +     E  ++   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
             L  L       D    + EY     L   +   +R +     +       I   L YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYL 121

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H      +++RD+K  N++LD + + KI+DFG+ +    D          GT  Y+ PE 
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEV 176

Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 739
             D  +    D +  GV++ E++CG+                     +  +    L    
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR-------------------LPFYNQDHERLFELI 217

Query: 740 LGGSYSLSEVL--RCIQVGLLCVQQRPEDRPNM 770
           L         L      +    +++ P+ R   
Sbjct: 218 LMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGG 250

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  134 bits (339), Expect = 4e-35
 Identities = 59/270 (21%), Positives = 95/270 (35%), Gaps = 32/270 (11%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQH 559
           + F     LG G FG V      E G   A K L K      + +E   NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
             LVKL           ++ EY+    +   +    R               I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H    L +I+RDLK  N+L+D +   +++DFG A+     + +  T  + GT   + PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEI 209

Query: 680 AIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS 739
            +   ++   D ++ GVL+ E+  G      + AD    +        +           
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYP---PFFADQPIQIYEKIVSGKVRFPS------- 259

Query: 740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPN 769
                  S  L+ +   LL V      R  
Sbjct: 260 -----HFSSDLKDLLRNLLQVD--LTKRFG 282

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 8e-34
 Identities = 51/207 (24%), Positives = 97/207 (46%), Gaps = 13/207 (6%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHR 560
             + D   +G G +G V   V    G ++A K+L +   S    +    E+ L+  ++H 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 561 NLVKLIGCCTQRDERMLIYE-YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
           N++ L+   T  +      + YL    +   +  + + + L   +   ++  + +GL Y+
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEY 679
           H      IIHRDLK  N+ ++ +   KI DFG+AR     Q ++     V T  Y  PE 
Sbjct: 138 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEV 189

Query: 680 AIDGL-FSVKSDVFSFGVLVLEIVCGK 705
            ++ + ++   D++S G ++ E++ GK
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGK 216

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  126 bits (316), Expect = 3e-32
 Identities = 49/241 (20%), Positives = 105/241 (43%), Gaps = 23/241 (9%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRN 561
           +++    KLG G +  V++ + I   +++  K L        ++ + E+ ++  L+   N
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91

Query: 562 LVKLIGCCTQRDERM--LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
           ++ L         R   L++E++ N             + L        +  I + L Y 
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYC 145

Query: 620 HQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           H    + I+HRD+K  NV++D+E    ++ D+G+A  +   Q     N  V +  +  PE
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPE 199

Query: 679 YAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN 737
             +D  ++    D++S G ++  ++  K    F+H   +++ L    ++   E   + I+
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEP--FFHGHDNYDQLVRIAKVLGTEDLYDYID 257

Query: 738 K 738
           K
Sbjct: 258 K 258

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 1e-31
 Identities = 66/276 (23%), Positives = 112/276 (40%), Gaps = 31/276 (11%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSS----GQGMEEFENEVLLIA 555
           ENF     LG G +G V+    I     G+  A K L K++     +  E    E  ++ 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 556 KLQHR-NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIAR 614
            ++    LV L        +  LI +Y+    L   +    R       +    +G I  
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVL 140

Query: 615 GLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGY 674
            L +LH   +L II+RD+K  N+LLD+  +  ++DFG+++ F  D+TE       GT  Y
Sbjct: 141 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 196

Query: 675 MPPEYAIDGL--FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP 732
           M P+    G        D +S GVL+ E++ G      +  D   N      R  ++  P
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS---PFTVDGEKNSQAEISRRILKSEP 253

Query: 733 VELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRP 768
                + +  S    ++++        + + P+ R 
Sbjct: 254 P--YPQEM--SALAKDLIQR------LLMKDPKKRL 279

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 2e-30
 Identities = 49/205 (23%), Positives = 88/205 (42%), Gaps = 9/205 (4%)

Query: 504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHR 560
           + + +   +G G  G V         + +A K+LS+   +    +    E++L+  + H+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 561 NLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLH 620
           N++ L+   T +       +      L D          LD  +   ++  +  G+ +LH
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136

Query: 621 QDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYA 680
                 IIHRDLK SN+++ ++   KI DFG+AR  G           V T  Y  PE  
Sbjct: 137 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVI 190

Query: 681 IDGLFSVKSDVFSFGVLVLEIVCGK 705
           +   +    D++S G ++ E+V  K
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHK 215

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 3e-30
 Identities = 51/207 (24%), Positives = 92/207 (44%), Gaps = 11/207 (5%)

Query: 503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQH 559
            E + + + +G G +G V      + G  +A K+LS+   S    +    E+ L+  ++H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 560 RNLVKLIGCCTQRDERMLI-YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLY 618
            N++ L+   T           YL    +   + ++ + + L       +I  I RGL Y
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 619 LHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPE 678
           +H      IIHRDLK SN+ ++ +   KI DFG+AR    + T     R    +   P  
Sbjct: 137 IHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEI 189

Query: 679 YAIDGLFSVKSDVFSFGVLVLEIVCGK 705
                 ++   D++S G ++ E++ G+
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGR 216

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  111 bits (277), Expect = 6e-27
 Identities = 39/210 (18%), Positives = 77/210 (36%), Gaps = 18/210 (8%)

Query: 511 KLGEGGFGPVYKGV-LIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCC 569
           KLG G F  V+    ++    +A K +        E  E+E+ L+ ++   +  K     
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 570 TQRDERMLIYEYLPNKSL-------------NDFIFDVTRSKFLDWSKRCQIIGGIARGL 616
                ++L +      +                 +      + +      QI   +  GL
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 617 LYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYM 675
            Y+H+  R  IIH D+K  NVL++  +    +    +A        + +    + T  Y 
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 676 PPEYAIDGLFSVKSDVFSFGVLVLEIVCGK 705
            PE  +   +   +D++S   L+ E++ G 
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

 Score = 91.6 bits (227), Expect = 1e-22
 Identities = 26/129 (20%), Positives = 50/129 (38%), Gaps = 21/129 (16%)

Query: 18  RDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPL 77
           R+ L  G+ +  G++L      +              L ++     + T +W +N     
Sbjct: 1   RNLLTNGEGLYAGQSLDVEP--YHFIMQEDC-----NLVLYD----HSTSVWASNTGILG 49

Query: 78  SDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPD 137
                   + S GN   V+ ++    +W+S++ R   N V VL E GN+V+         
Sbjct: 50  KKGCK-AVLQSDGN--FVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIY-------G 99

Query: 138 NFLWQSFDY 146
           + +W +  Y
Sbjct: 100 SDIWSTGTY 108

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 92.2 bits (228), Expect = 6e-22
 Identities = 31/155 (20%), Positives = 54/155 (34%), Gaps = 20/155 (12%)

Query: 510 NKLGEGGFGPVYKGVLIEGQEIAAK--RLSKSSGQ--------GMEEFENEVLLIAKLQH 559
             +GEG    V+     +  E   K  ++  +S +        G   F    +  A+ + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 560 RNLVKLIGCCTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYL 619
           R L KL G    +      Y +  N  L + I      +    +   +++  I   +   
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119

Query: 620 HQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR 654
           +      I+H DL   NVL+  E    I DF  + 
Sbjct: 120 YHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

 Score = 72.4 bits (177), Expect = 5e-16
 Identities = 29/128 (22%), Positives = 48/128 (37%), Gaps = 22/128 (17%)

Query: 19  DTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLS 78
           + L  G+++  GE L     SF              L ++         IW  N      
Sbjct: 2   NILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYD----VDKPIWATNTGGL-- 48

Query: 79  DRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDN 138
            RS  L++ + GN  LV+ N +N  +W+SN      N V +L +  N+V+          
Sbjct: 49  SRSCFLSMQTDGN--LVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIY-------GT 99

Query: 139 FLWQSFDY 146
             W +  +
Sbjct: 100 DRWATGTH 107

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 72.3 bits (177), Expect = 7e-16
 Identities = 22/92 (23%), Positives = 36/92 (39%), Gaps = 7/92 (7%)

Query: 57  IWYKKIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNP 116
           I Y   GN       +    L      L++ +  N  LVL +  +  VWS+N +      
Sbjct: 12  ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCN--LVLFDR-DDRVWSTNTAGKGTGC 68

Query: 117 VAVLLESGNLVVKDGKDIDPDNFLWQSFDYPS 148
            AVL  +G + V   +    +  +W S +  S
Sbjct: 69  RAVLQPNGRMDVLTNQ----NIAVWTSGNSRS 96

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

 Score = 70.2 bits (171), Expect = 3e-15
 Identities = 25/129 (19%), Positives = 48/129 (37%), Gaps = 20/129 (15%)

Query: 19  DTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLS 78
           D LN G  +  G +L      +     +          + Y    N   +W +  +   S
Sbjct: 2   DRLNSGHQLDTGGSLAEGG--YLFIIQNDCNL------VLYD---NNRAVWASGTNGKAS 50

Query: 79  DRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDN 138
                L + + GN   +++ S +  +W+SN +R   N   +L    N+V+ D      +N
Sbjct: 51  GC--VLKMQNDGN---LVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDN----SNN 101

Query: 139 FLWQSFDYP 147
            +W +    
Sbjct: 102 AIWATHTNV 110

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 62.0 bits (150), Expect = 3e-12
 Identities = 22/139 (15%), Positives = 42/139 (30%), Gaps = 24/139 (17%)

Query: 8   LFYTIRTATARDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTV 67
           +F           L+  +S+     ++     +     +        L ++     N   
Sbjct: 4   IFSKQPDDNHPQILHATESL----EILFGTHVYRFIMQTDCN-----LVLY----DNNNP 50

Query: 68  IWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLV 127
           IW  N             +   G    V++ + N  VW S  +  A + V VL    N+V
Sbjct: 51  IWATNTGGL--GNGCRAVLQPDGVL--VVITNENVTVWQSPVAGKAGHYVLVLQPDRNVV 106

Query: 128 VKDGKDIDPDNFLWQSFDY 146
           +         + LW +   
Sbjct: 107 IY-------GDALWATQTV 118

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 55.3 bits (133), Expect = 6e-10
 Identities = 22/88 (25%), Positives = 33/88 (37%), Gaps = 8/88 (9%)

Query: 57  IWYKKIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNP 116
           I +     G+     +    L   S    + S  N  LVL +S +  VW+SN +      
Sbjct: 3   ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCN--LVLFDS-DVRVWASNTAGA-TGC 58

Query: 117 VAVLLESGNLVVKDGKDIDPDNFLWQSF 144
            AVL   G LV+   +    +   W S 
Sbjct: 59  RAVLQSDGLLVILTAQ----NTIRWSSG 82

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	823
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.84
d1xd5a_	112	Gastrodianin (antifungal protein) {Gastrodia elata	99.83
d1jpca_	108	Lectin (agglutinin) {Snowdrop (Galanthus nivalis)	99.82
d1kj1a_	109	Lectin (agglutinin) {Garlic (Allium sativum) [TaxI	99.82
d1dlpa2	120	Fetuin-binding protein Scafet precursor {Bluebell	99.67
d1b2pa_	119	Lectin (agglutinin) {Bluebell (Scilla campanulata)	99.55
d1dlpa1	115	Fetuin-binding protein Scafet precursor {Bluebell	99.52
d1dlpa1	115	Fetuin-binding protein Scafet precursor {Bluebell	99.39
d1dlpa2	120	Fetuin-binding protein Scafet precursor {Bluebell	99.08
d1b2pa_	119	Lectin (agglutinin) {Bluebell (Scilla campanulata)	98.88
d1jpca_	108	Lectin (agglutinin) {Snowdrop (Galanthus nivalis)	98.82
d1kj1a_	109	Lectin (agglutinin) {Garlic (Allium sativum) [TaxI	98.69
d1xd5a_	112	Gastrodianin (antifungal protein) {Gastrodia elata	98.5
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.35
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.66
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.22
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.43
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.29
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.99
d1emoa2	39	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	93.06
d2vj3a1	42	Neurogenic locus notch homolog protein 1, Notch1 {	90.67
d1xkba1	39	Factor X, N-terminal module {Human (Homo sapiens)	88.43
d1emoa1	43	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	86.39
d1i0ua2	41	Low density lipoprotein (LDL) receptor, different	86.31
d1lmja2	42	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	86.04
d2vj3a2	39	Neurogenic locus notch homolog protein 1, Notch1 {	84.2
d1uzka1	43	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	84.18
d1edmb_	39	Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606	84.04
d1lmja1	44	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	82.68

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-48  Score=406.40  Aligned_cols=255  Identities=26%  Similarity=0.392  Sum_probs=198.8

Q ss_pred             cCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecC
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP  583 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (823)
                      ++|+..++||+|+||.||+|++.+++.||||+++.. ....++|.+|++++++++|||||+++|+|.+.+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            467888999999999999999988889999999754 3456789999999999999999999999999999999999999


Q ss_pred             CCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccc
Q 003391          584 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA  663 (823)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  663 (823)
                      +|+|.+++..  ....+++..+..++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++....... .
T Consensus        84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~  157 (263)
T d1sm2a_          84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T  157 (263)
T ss_dssp             TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc-e
Confidence            9999999854  3456899999999999999999999988   99999999999999999999999999987643322 2


Q ss_pred             ccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCC
Q 003391          664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS  743 (823)
Q Consensus       664 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~  743 (823)
                      ......||+.|+|||++.+..++.++|||||||++|||+|+..|+....  ....+...    ....         ....
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~--~~~~~~~~----i~~~---------~~~~  222 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVED----ISTG---------FRLY  222 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC--CHHHHHHH----HHHT---------CCCC
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC--CHHHHHHH----HHhc---------CCCC
Confidence            2233578999999999999999999999999999999999655432111  11111111    1111         1111


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          744 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       744 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      .+.....++.+++.+||+.||++||||+||++.|+++
T Consensus       223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            1222235678999999999999999999999999865

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-48  Score=407.10  Aligned_cols=260  Identities=23%  Similarity=0.374  Sum_probs=201.6

Q ss_pred             hcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCC--ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      .++|...++||+|+||+||+|++.  ..||||+++..  .....++|.+|+.++++++|||||++++++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            367888999999999999999864  46999998654  34566789999999999999999999999865 56899999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |+++|+|.+++..  ....+++..+..++.||++||+|||+.+   ||||||||+||||+.++.+||+|||+|+......
T Consensus        84 y~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          84 WCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             CCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             cCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            9999999999954  3345899999999999999999999987   9999999999999999999999999998765444


Q ss_pred             cccccccccccCCccCcccccc---CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhh
Q 003391          661 TEANTNRVVGTYGYMPPEYAID---GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN  737 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~---~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  737 (823)
                      .........||+.|||||++.+   ..++.++|||||||+||||+||+.||.......   ..   ............. 
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~---~~---~~~~~~~~~~p~~-  231 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QI---IFMVGRGYLSPDL-  231 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HH---HHHHHHTSCCCCG-
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH---HH---HHHHhcCCCCCcc-
Confidence            4444455789999999999864   358999999999999999999999985332111   11   1111111110000 


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          738 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       738 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      ..    .......++.+++.+||+.||++||||+||++.|+.+.
T Consensus       232 ~~----~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~  271 (276)
T d1uwha_         232 SK----VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA  271 (276)
T ss_dssp             GG----SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hh----ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            01    11122346789999999999999999999999998763

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-48  Score=404.05  Aligned_cols=253  Identities=25%  Similarity=0.329  Sum_probs=203.4

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      .++|+..++||+|+||+||+|++.. ++.||||++.... ....+++.+|+.++++++|||||++++++.+.+..++|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            3578889999999999999999864 8999999987653 3345678999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |+++|+|.++|.   +...+++..+..++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+|+.+....
T Consensus        84 y~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          84 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ccCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            999999999984   3456999999999999999999999998   9999999999999999999999999999875444


Q ss_pred             cccccccccccCCccCccccccCCC-CccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          661 TEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                      ........+||+.|||||++.+..+ +.++|||||||+||||++|+.||........  ..    .........      
T Consensus       158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~~----~~~~~~~~~------  225 (271)
T d1nvra_         158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EY----SDWKEKKTY------  225 (271)
T ss_dssp             EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH--HH----HHHHTTCTT------
T ss_pred             ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH--HH----HHHhcCCCC------
Confidence            4444455789999999999988876 6789999999999999999999864322111  10    001111100      


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       740 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                        .........++.+++.+||+.||++|||++|+++
T Consensus       226 --~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         226 --LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             --STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              0001111246678999999999999999999864

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=402.77  Aligned_cols=255  Identities=30%  Similarity=0.421  Sum_probs=205.4

Q ss_pred             hcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      .++|+..++||+|+||.||+|++.+++.||||+++... ...++|.+|+.++++++|||||+++|++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            35688889999999999999999888899999996543 456789999999999999999999998865 5679999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  662 (823)
                      ++|+|.+++... ....+++..+++|+.||++||.|||+.+   |+||||||+||||++++.+||+|||+|+.+..... 
T Consensus        90 ~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-  164 (272)
T d1qpca_          90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-  164 (272)
T ss_dssp             TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred             CCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc-
Confidence            999999987432 2235899999999999999999999987   99999999999999999999999999998754322 


Q ss_pred             cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCC
Q 003391          663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG  742 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~  742 (823)
                      .......||+.|||||++.+..++.++|||||||+||||+||..|+.....  ....    .......         ...
T Consensus       165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~----~~~i~~~---------~~~  229 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEV----IQNLERG---------YRM  229 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHH----HHHHHTT---------CCC
T ss_pred             ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHHH----HHHHHhc---------CCC
Confidence            223346789999999999999999999999999999999997766421111  1111    1111111         111


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          743 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                      ..+.....++.+|+.+||+.||++||||+||+++|+.
T Consensus       230 ~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence            1122233467899999999999999999999999975

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.9e-48  Score=407.70  Aligned_cols=258  Identities=26%  Similarity=0.394  Sum_probs=211.1

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      .++|+..++||+|+||+||+|++.. ++.||||+++... ...++|.+|+.++++++|||||++++++.+++..++||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            4578888999999999999999875 8899999996543 4567899999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +++|+|.+++... ....+++..++.++.||++||+|||+.+   |+||||||+||||++++.+||+|||+|+.......
T Consensus        95 ~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          95 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred             ccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence            9999999998643 3456899999999999999999999998   99999999999999999999999999987643322


Q ss_pred             ccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          662 EANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                       .......|++.|+|||++.+..++.++|||||||++|||++|..|+....  ...    ....         .+.....
T Consensus       171 -~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~--~~~----~~~~---------~i~~~~~  234 (287)
T d1opja_         171 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLS----QVYE---------LLEKDYR  234 (287)
T ss_dssp             -EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC--CHH----HHHH---------HHHTTCC
T ss_pred             -eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc--hHH----HHHH---------HHhcCCC
Confidence             22233568899999999999999999999999999999999877742111  111    1111         1111112


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          742 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      ...+.....++.+|+.+||+.||++||||+||++.|+.+.
T Consensus       235 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            2222233457889999999999999999999999998753

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-47  Score=394.10  Aligned_cols=254  Identities=24%  Similarity=0.385  Sum_probs=210.8

Q ss_pred             cCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecC
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP  583 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (823)
                      ++|+..++||+|+||+||+|++++++.||||++++.. ...++|.+|+.++++++||||++++|+|.+.+..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            5788899999999999999999888899999997654 356789999999999999999999999999999999999999


Q ss_pred             CCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccc
Q 003391          584 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA  663 (823)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  663 (823)
                      +|+|.+++..  ....+++..+.+++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++.+...... 
T Consensus        83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-  156 (258)
T d1k2pa_          83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-  156 (258)
T ss_dssp             TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred             CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence            9999998753  3345889999999999999999999988   999999999999999999999999999876543222 


Q ss_pred             ccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCC
Q 003391          664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG  742 (823)
Q Consensus       664 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~  742 (823)
                      ......+|+.|+|||++.+..++.++||||||+++|||+| |+.||......   .+.    ......         ...
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~~----~~i~~~---------~~~  220 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETA----EHIAQG---------LRL  220 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHH----HHHHTT---------CCC
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HHH----HHHHhC---------CCC
Confidence            2333578999999999999999999999999999999998 78887543221   111    111111         111


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          743 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      ..+......+.+++.+||+.||++|||++|+++.|.++
T Consensus       221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            12222335778999999999999999999999998653

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2e-47  Score=406.54  Aligned_cols=257  Identities=25%  Similarity=0.390  Sum_probs=197.2

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-C---cEEEEEEecCC-ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-G---QEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~---~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      ++|+..++||+|+||+||+|++.. +   ..||||++... .....++|.+|++++++++|||||+++|++.+.+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            456667899999999999999754 2   25889988654 334556799999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      |||+++|+|.+++..  ....++|.++..++.||++||+|||+.+   |+||||||+||||+.++.+||+|||+|+.+..
T Consensus       106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence            999999999998853  3446899999999999999999999987   99999999999999999999999999987654


Q ss_pred             Ccccc---ccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchh
Q 003391          659 DQTEA---NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVE  734 (823)
Q Consensus       659 ~~~~~---~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  734 (823)
                      .....   ......+|+.|||||.+.+..++.++|||||||+||||+| |+.||......   .+.    ..        
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~----~~--------  245 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVI----NA--------  245 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH----HH--------
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHH----HH--------
Confidence            32221   1222457899999999999999999999999999999998 89997532211   111    11        


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          735 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       735 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                       +........+......+.+|+.+||+.||++||||+||++.|+.+.
T Consensus       246 -i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l  291 (299)
T d1jpaa_         246 -IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI  291 (299)
T ss_dssp             -HHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             -HHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence             1111112223334457889999999999999999999999998753

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-47  Score=399.06  Aligned_cols=249  Identities=23%  Similarity=0.376  Sum_probs=206.5

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      ++|+..++||+|+||+||+|++.. ++.||||++........+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            579999999999999999999754 8999999998776667788999999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  662 (823)
                      ++|+|.+++.+    ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+|+.+....  
T Consensus       100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--  170 (293)
T d1yhwa1         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--  170 (293)
T ss_dssp             TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred             CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc--
Confidence            99999998743    35899999999999999999999998   9999999999999999999999999999764332  


Q ss_pred             cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCC
Q 003391          663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG  742 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~  742 (823)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||......      ............        ..
T Consensus       171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~~~~--------~~  236 (293)
T d1yhwa1         171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTP--------EL  236 (293)
T ss_dssp             CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSC--------CC
T ss_pred             ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHhCCCC--------CC
Confidence            2234467999999999999999999999999999999999999998532211      111111111110        00


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          743 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ..+.....++.+++.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111112346789999999999999999999974

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-47  Score=407.33  Aligned_cols=258  Identities=26%  Similarity=0.411  Sum_probs=206.7

Q ss_pred             hcCCCcCCeeeccCccceEEEEeecC------cEEEEEEecCC-ccccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCc
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIEG------QEIAAKRLSKS-SGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDE  574 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~~------~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~  574 (823)
                      .++|+..++||+|+||+||+|++...      ..||+|++... .......+.+|+.++.++ +|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            36788899999999999999997642      26899998654 344556789999999998 89999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCC--------------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCC
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTR--------------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKA  634 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~  634 (823)
                      .++||||+++|+|.++|.....                    ...+++..++.++.||++||+|||+.+   |+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence            9999999999999999965321                    235899999999999999999999987   99999999


Q ss_pred             CcEEEcCCCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCC
Q 003391          635 SNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHA  713 (823)
Q Consensus       635 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~  713 (823)
                      +|||++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||+||||+| |+.||.....
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987654444333445678999999999999999999999999999999998 8999754322


Q ss_pred             CCccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 003391          714 DHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLS  778 (823)
Q Consensus       714 ~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  778 (823)
                      ..   .+   ..         ++........+.....++.+|+.+||+.||++||||+||+++|.
T Consensus       273 ~~---~~---~~---------~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 DA---NF---YK---------LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SH---HH---HH---------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HH---HH---HH---------HHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            11   11   11         11111111222223357889999999999999999999999985

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-47  Score=395.14  Aligned_cols=245  Identities=26%  Similarity=0.353  Sum_probs=203.9

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC---ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ++|++.+.||+|+||.||+|++.. ++.||+|++.+.   .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            568889999999999999999865 889999998653   2345678899999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+++|+|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+|+.....
T Consensus        86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            99999999999853   345899999999999999999999998   999999999999999999999999999865322


Q ss_pred             ccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                          ......||+.|||||++.+..++.++|||||||+||||++|+.||.....   ..+.    .......        
T Consensus       160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~----~~i~~~~--------  220 (263)
T d2j4za1         160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY---QETY----KRISRVE--------  220 (263)
T ss_dssp             ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHH----HHHHTTC--------
T ss_pred             ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH---HHHH----HHHHcCC--------
Confidence                23346799999999999999999999999999999999999999853221   1111    1111110        


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       740 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                        ...+.....++.+++.+||+.||++|||++|+++
T Consensus       221 --~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         221 --FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence              0111112346778999999999999999999985

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-47  Score=397.89  Aligned_cols=254  Identities=24%  Similarity=0.310  Sum_probs=193.2

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeec--CCceEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ--RDERMLI  578 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV  578 (823)
                      ++|++.+.||+|+||.||+|+... ++.||+|++....  +...+.+.+|++++++++|||||++++++.+  .+..++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            678899999999999999999764 8899999997653  3345678999999999999999999999865  4568999


Q ss_pred             EeecCCCCcchhhhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhcC--CCceEecccCCCcEEEcCCCCceeecccccee
Q 003391          579 YEYLPNKSLNDFIFDV-TRSKFLDWSKRCQIIGGIARGLLYLHQDS--RLRIIHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                      |||+++|+|.+++... .....+++..++.++.||++||.|||+.+  ..+|+||||||+||||+.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998643 23457999999999999999999999865  23599999999999999999999999999987


Q ss_pred             cCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhh
Q 003391          656 FGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL  735 (823)
Q Consensus       656 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  735 (823)
                      +....  .......||+.|||||++.+..++.++|||||||++|||++|+.||.....   ..+.    .........  
T Consensus       164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~---~~~~----~~i~~~~~~--  232 (269)
T d2java1         164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELA----GKIREGKFR--  232 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHH----HHHHHTCCC--
T ss_pred             cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH---HHHH----HHHHcCCCC--
Confidence            64322  223346899999999999999999999999999999999999999853221   1111    111111111  


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          736 INKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       736 ~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                             ..+.....++.+|+.+||+.||++|||++|+++
T Consensus       233 -------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         233 -------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                   111122246788999999999999999999975

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=398.34  Aligned_cols=259  Identities=26%  Similarity=0.419  Sum_probs=201.2

Q ss_pred             cCCCcCCeeeccCccceEEEEeecC-----cEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIEG-----QEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~~-----~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      +.|+..++||+|+||.||+|.+...     ..||||++.... ....++|.+|+.++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4577788999999999999998652     369999997653 3345578999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      ||||+.+++|.+++..  ....+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.+.
T Consensus        87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence            9999999999988754  3356899999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCccc-cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          658 IDQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       658 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      ..... .......||+.|||||++.+..++.++|||||||++|||++|..|+......  ..    ....         +
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~----~~~~---------i  226 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HE----VMKA---------I  226 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HH----HHHH---------H
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HH----HHHH---------H
Confidence            43222 2233456899999999999999999999999999999999977664321111  11    1111         1


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCC
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  782 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  782 (823)
                      ........+.....++.+|+.+||+.||++||||+||+++|+.+..
T Consensus       227 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             hccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence            1112222333344578899999999999999999999999987654

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-46  Score=396.49  Aligned_cols=247  Identities=27%  Similarity=0.389  Sum_probs=197.3

Q ss_pred             CeeeccCccceEEEEeec---CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecCC
Q 003391          510 NKLGEGGFGPVYKGVLIE---GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLPN  584 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~---~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  584 (823)
                      ++||+|+||.||+|.+.+   ++.||||+++...  ....++|.+|+.++++++|||||+++|+|.. +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            479999999999998754   4679999996543  3345679999999999999999999999965 567899999999


Q ss_pred             CCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc-c
Q 003391          585 KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE-A  663 (823)
Q Consensus       585 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~-~  663 (823)
                      |+|.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus        92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            999999853   345899999999999999999999987   999999999999999999999999999976544322 2


Q ss_pred             ccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCC
Q 003391          664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGG  742 (823)
Q Consensus       664 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~  742 (823)
                      ......||+.|||||.+.+..++.++|||||||++|||+| |+.||......   .+    ......+         ...
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~----~~~i~~~---------~~~  229 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EV----TAMLEKG---------ERM  229 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HH----HHHHHTT---------CCC
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HH----HHHHHcC---------CCC
Confidence            2334578999999999999999999999999999999998 89997532211   11    1111111         111


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          743 SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                      ..+.....++.+|+.+||+.||++|||+++|+++|+.
T Consensus       230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            1222234577899999999999999999999998864

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-46  Score=396.34  Aligned_cols=262  Identities=26%  Similarity=0.409  Sum_probs=205.4

Q ss_pred             cCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeecC
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYLP  583 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  583 (823)
                      ++|++.+.||+|+||.||+|++.+++.||||++... ....+.|.+|+.++++++|||||+++|++.+ +..++||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            578889999999999999999988889999999654 4456789999999999999999999999865 56889999999


Q ss_pred             CCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcccc
Q 003391          584 NKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTEA  663 (823)
Q Consensus       584 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~~  663 (823)
                      +|+|.+++... ....++|.+++.++.||++||+|||+.+   |+||||||+||||++++++||+|||+|+.+..... .
T Consensus        95 ~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~  169 (285)
T d1fmka3          95 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T  169 (285)
T ss_dssp             TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-e
Confidence            99999988543 2335899999999999999999999998   99999999999999999999999999987643322 2


Q ss_pred             ccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcCCC
Q 003391          664 NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLGGS  743 (823)
Q Consensus       664 ~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~  743 (823)
                      ......||+.|+|||++.++.++.++||||||+++|||++|..|+.....  .....    .....         .....
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~----~~i~~---------~~~~~  234 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVL----DQVER---------GYRMP  234 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHH----HHHHT---------TCCCC
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--HHHHH----HHHHh---------cCCCC
Confidence            22335789999999999999999999999999999999998776432111  11111    11111         11112


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCCCCCCC
Q 003391          744 YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERSLPQPK  787 (823)
Q Consensus       744 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~p~  787 (823)
                      .+.....++.+++.+||+.||++||+|++|+++|+....-..|+
T Consensus       235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~  278 (285)
T d1fmka3         235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ  278 (285)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred             CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCC
Confidence            22233357889999999999999999999999999865444443

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-46  Score=395.54  Aligned_cols=254  Identities=26%  Similarity=0.408  Sum_probs=204.0

Q ss_pred             cCCCcCC-eeeccCccceEEEEeec---CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          504 ENFSDKN-KLGEGGFGPVYKGVLIE---GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       504 ~~~~~~~-~LG~G~fg~Vyk~~~~~---~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      ++|...+ +||+|+||.||+|++..   +..||||+++... ....++|.+|++++++++|||||+++|++.+ +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            3455555 49999999999998643   4579999997654 3446789999999999999999999999865 568999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      |||+++|+|.+++..  ....+++..+..++.||++||+|||+.+   |+||||||+||||+.++.+||+|||+++.+..
T Consensus        87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence            999999999998743  3346899999999999999999999987   99999999999999999999999999998754


Q ss_pred             Cccc-cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          659 DQTE-ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       659 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      .... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||......   .+.    .....+.     
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~----~~i~~~~-----  229 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVM----AFIEQGK-----  229 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHH----HHHHTTC-----
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCC-----
Confidence            3322 23334578999999999999999999999999999999998 89998643221   111    1111111     


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcc
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSG  779 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  779 (823)
                          ....+.....++.+|+.+||+.+|++||||.+|++.|+.
T Consensus       230 ----~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         230 ----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                112222334578899999999999999999999999875

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-47  Score=398.65  Aligned_cols=249  Identities=24%  Similarity=0.304  Sum_probs=201.9

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC---ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ++|++.+.||+|+||+||+|++.. ++.||||++.+.   .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            568899999999999999999854 889999998653   2445678999999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+++|+|.+++..   .+.+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+|+.+...
T Consensus        88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence            99999999998853   345899999999999999999999998   999999999999999999999999999987554


Q ss_pred             ccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                      ..........||+.|||||++.+..++.++|||||||+||||++|+.||.....   ..+.    .......        
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~----~~i~~~~--------  226 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YLIF----QKIIKLE--------  226 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH----HHHHTTC--------
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH---HHHH----HHHHcCC--------
Confidence            444444557899999999999999999999999999999999999999853211   1111    1111110        


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       740 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                        ..++.....++.+|+.+||+.||++|||++|++.
T Consensus       227 --~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         227 --YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             --CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             --CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence              0111122346789999999999999999998743

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-46  Score=396.01  Aligned_cols=251  Identities=24%  Similarity=0.351  Sum_probs=205.4

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      +.|++.++||+|+||.||+|++.. ++.||||++........+.+.+|++++++++|||||++++++.+.+..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            468888999999999999999864 8899999998777777788999999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  662 (823)
                      ++|+|.+++.+  ....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+|+.....  .
T Consensus        92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~  164 (288)
T d2jfla1          92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--I  164 (288)
T ss_dssp             TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH--H
T ss_pred             CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC--c
Confidence            99999998754  2346899999999999999999999998   999999999999999999999999999865322  1


Q ss_pred             cccccccccCCccCccccc-----cCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhh
Q 003391          663 ANTNRVVGTYGYMPPEYAI-----DGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELIN  737 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~-----~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  737 (823)
                      .......||+.|||||++.     +..|+.++|||||||+||||++|+.||......+   ....    ........+  
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~~~~----i~~~~~~~~--  235 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---VLLK----IAKSEPPTL--  235 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHHH----HHHSCCCCC--
T ss_pred             ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---HHHH----HHcCCCCCC--
Confidence            2233468999999999984     4568999999999999999999999985432211   1111    111111000  


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          738 KSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       738 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                           ..+.....++.+++.+||+.||++|||++|+++
T Consensus       236 -----~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         236 -----AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             -----SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 111122346789999999999999999999975

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.5e-46  Score=397.28  Aligned_cols=261  Identities=25%  Similarity=0.389  Sum_probs=210.3

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec------CcEEEEEEecCCccc-cHHHHHHHHHHHhccCCCCceeEEEEeecCCc
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSSGQ-GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDE  574 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~------~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~  574 (823)
                      ..++|+..++||+|+||+||+|++..      ++.||||+++..... ..++|.+|++++++++||||+++++++.+.+.
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   90 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP   90 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence            45789999999999999999999752      468999999765433 45679999999999999999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccC---------------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccC
Q 003391          575 RMLIYEYLPNKSLNDFIFDVT---------------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLK  633 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk  633 (823)
                      .++||||+++|+|.++|....                     ....+++..++.|+.||+.||+|||+.+   |||||||
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK  167 (301)
T d1lufa_          91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA  167 (301)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred             eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence            999999999999999996422                     1234899999999999999999999988   9999999


Q ss_pred             CCcEEEcCCCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCC-CCCCcC
Q 003391          634 ASNVLLDNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR-NRGFYH  712 (823)
Q Consensus       634 ~~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~-p~~~~~  712 (823)
                      |+||||+.++.+||+|||+|+...............+|+.|+|||.+.+..++.++|||||||++|||++|.. |+....
T Consensus       168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~  247 (301)
T d1lufa_         168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  247 (301)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence            9999999999999999999987654444444445678899999999999999999999999999999999975 543221


Q ss_pred             CCCccchhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          713 ADHHHNLLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       713 ~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      .   ..+.    ..+..+..         ...+...+.++.+|+.+||+.+|++||||.||+++|+.+.
T Consensus       248 ~---~e~~----~~v~~~~~---------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         248 H---EEVI----YYVRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             H---HHHH----HHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             H---HHHH----HHHHcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            1   1111    11111111         1122223357889999999999999999999999999864

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-46  Score=401.16  Aligned_cols=263  Identities=22%  Similarity=0.310  Sum_probs=203.3

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      .++|+..++||+|+||+||+|++.. ++.||+|+++... ....+++.+|+.++++++|||||++++++.+.++.++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            4678999999999999999999864 8899999997653 3345678999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhc-CCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      |+++|+|.+++.+   ...+++..+..++.||++||.|||+. +   |+||||||+|||+++++.+||+|||+|+.+.. 
T Consensus        85 y~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-  157 (322)
T d1s9ja_          85 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-  157 (322)
T ss_dssp             CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred             cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC-
Confidence            9999999999954   34589999999999999999999974 6   99999999999999999999999999986532 


Q ss_pred             ccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhH-HHHHH------------
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLG-HAWRL------------  726 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~-~~~~~------------  726 (823)
                         ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||............. .....            
T Consensus       158 ---~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         158 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             ---HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred             ---CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence               22334689999999999999999999999999999999999999986433221100000 00000            


Q ss_pred             ------hhh----cCchhhhhhhcCCC---CC-HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          727 ------WIE----ERPVELINKSLGGS---YS-LSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       727 ------~~~----~~~~~~~~~~l~~~---~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                            ...    ....+..+......   .+ .....++.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                  000    00001111111110   00 011236788999999999999999999986

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-45  Score=386.32  Aligned_cols=246  Identities=23%  Similarity=0.356  Sum_probs=193.7

Q ss_pred             CcCCeeeccCccceEEEEeec-CcEEEEEEecCC--ccccHHHHHHHHHHHhccCCCCceeEEEEeec----CCceEEEE
Q 003391          507 SDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ----RDERMLIY  579 (823)
Q Consensus       507 ~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~  579 (823)
                      +..++||+|+||+||+|++.. ++.||+|++...  .....+.|.+|++++++++|||||++++++.+    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            455689999999999999865 789999998654  33345678999999999999999999999865    34579999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEc-CCCCceeeccccceecCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NEMNPKISDFGMARAFGI  658 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~DFGla~~~~~  658 (823)
                      ||+++|+|.+++..   ...+++..+..++.||++||+|||+++ ++|+||||||+|||++ +++.+||+|||+|+....
T Consensus        92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            99999999999954   345899999999999999999999875 3599999999999996 578999999999975432


Q ss_pred             CccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                          .......||+.|||||++.+ .++.++|||||||+||||++|+.||......      ...............+  
T Consensus       168 ----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~------~~~~~~i~~~~~~~~~--  234 (270)
T d1t4ha_         168 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPASF--  234 (270)
T ss_dssp             ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCGGG--
T ss_pred             ----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH------HHHHHHHHcCCCCccc--
Confidence                22334689999999998865 6999999999999999999999998532111      1111111111111111  


Q ss_pred             hcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       739 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                            +.....++.+++.+||+.||++|||++|+++
T Consensus       235 ------~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         235 ------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             ------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ------CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                  1111235778999999999999999999985

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-45  Score=395.73  Aligned_cols=255  Identities=25%  Similarity=0.440  Sum_probs=202.0

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-Cc----EEEEEEecCC-ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQ----EIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~----~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      ++|+..++||+|+||+||+|++.. ++    .||+|+++.. ..+..++|.+|+.++++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            458889999999999999999754 33    5899998654 445678899999999999999999999999864 5678


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      ++||+.+|+|.+++..  +...+++..+++++.||++||+|||+.+   |+||||||+||||+.++.+||+|||+|+.+.
T Consensus        88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            8999999999998854  3456899999999999999999999987   9999999999999999999999999999876


Q ss_pred             CCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      ............||+.|+|||++.++.++.++|||||||+||||+| |+.||+.....+   +..             .+
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~-------------~i  226 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS-------------IL  226 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHH-------------HH
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHH-------------HH
Confidence            5544444445678999999999999999999999999999999998 778865432211   111             11


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      ........+.....++.+|+.+||+.||++|||+.|+++.|+.+
T Consensus       227 ~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         227 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             HHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence            11111122223345788999999999999999999999998765

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-45  Score=393.85  Aligned_cols=253  Identities=23%  Similarity=0.302  Sum_probs=189.0

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ..+.|+..+.||+|+||+||+|++.. ++.||||++.+.. ....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            34678899999999999999999864 8899999997653 233456889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEc---CCCCceeeccccceec
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NEMNPKISDFGMARAF  656 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~DFGla~~~  656 (823)
                      ||+++|+|.++|..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||+.   +++.+||+|||+|+..
T Consensus        87 E~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          87 QLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             CCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             eccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            99999999999953   456999999999999999999999998   99999999999994   5789999999999865


Q ss_pred             CCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          657 GIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       657 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      ...   ......+||+.|||||++.+..++.++|||||||+||||++|+.||.....   ..+.    ........    
T Consensus       161 ~~~---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~----~~i~~~~~----  226 (307)
T d1a06a_         161 DPG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND---AKLF----EQILKAEY----  226 (307)
T ss_dssp             ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHH----HHHHTTCC----
T ss_pred             cCC---CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH---HHHH----HHHhccCC----
Confidence            322   223346799999999999999999999999999999999999999853211   1111    11111100    


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                        ............++.+++.+||+.||++|||++|+++.
T Consensus       227 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         227 --EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             --CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             --CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence              00001111122467899999999999999999999874

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-45  Score=383.27  Aligned_cols=249  Identities=24%  Similarity=0.347  Sum_probs=195.6

Q ss_pred             cCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeec-CCceEEEEeec
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ-RDERMLIYEYL  582 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~e~~  582 (823)
                      ++|+..++||+|+||.||+|++ .|+.||||+++..  ...++|.+|++++++++||||++++|+|.+ .+..++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            5677788999999999999998 5889999999654  345789999999999999999999999865 45689999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  662 (823)
                      ++|+|.++|... ....++|..+++++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++....    
T Consensus        84 ~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~----  155 (262)
T d1byga_          84 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----  155 (262)
T ss_dssp             TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC----
Confidence            999999999642 2235899999999999999999999987   99999999999999999999999999986432    


Q ss_pred             cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhcC
Q 003391          663 ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSLG  741 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~  741 (823)
                       ......+|..|+|||++.+..++.++||||||+++|||+| |+.|+......   .+...    ..         ....
T Consensus       156 -~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~----i~---------~~~~  218 (262)
T d1byga_         156 -TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPR----VE---------KGYK  218 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHH----HT---------TTCC
T ss_pred             -CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHH----HH---------cCCC
Confidence             2233567899999999999999999999999999999998 56665432211   11111    11         1111


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          742 GSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      ...+.....++.+|+.+||+.||++||||.|++++|+.+
T Consensus       219 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            222223335778999999999999999999999999865

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=7.5e-45  Score=394.38  Aligned_cols=253  Identities=21%  Similarity=0.294  Sum_probs=206.7

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      .++|++.++||+|+||.||+|++.. |+.||||++........+.+.+|+.++++++|||||++++++.+.+..++||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            3579999999999999999999854 899999999877666677899999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEc--CCCCceeeccccceecCCC
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD--NEMNPKISDFGMARAFGID  659 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~--~~~~~kl~DFGla~~~~~~  659 (823)
                      +++|+|.+++..  ....+++..+..++.||+.||+|||+.+   |+||||||+|||++  .++.+||+|||+|+.+...
T Consensus       105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            999999998843  3346999999999999999999999998   99999999999996  4678999999999876433


Q ss_pred             ccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                      .   ......||+.|||||++.+..++.++|||||||++|||++|+.||.....   .......    .....      .
T Consensus       180 ~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i----~~~~~------~  243 (350)
T d1koaa2         180 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DETLRNV----KSCDW------N  243 (350)
T ss_dssp             S---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH----HHTCC------C
T ss_pred             c---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH---HHHHHHH----HhCCC------C
Confidence            2   22346799999999999999999999999999999999999999853211   1111111    10000      0


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       740 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ...........++.+++.+||+.||++|||++|+++.
T Consensus       244 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         244 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000001112467889999999999999999999984

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-45  Score=392.06  Aligned_cols=245  Identities=29%  Similarity=0.419  Sum_probs=198.4

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc---ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      +.|+..++||+|+||.||+|++.. ++.||||++.....   ...+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            458888999999999999999754 88899999976543   33456889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+++|+|..++.   ..+.+++..++.++.||+.||.|||+.+   |+||||||+||||++++.+||+|||+|+.... 
T Consensus        95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             EecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence            9999999977663   3356899999999999999999999998   99999999999999999999999999986432 


Q ss_pred             ccccccccccccCCccCcccccc---CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAID---GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~---~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                           .....||+.|||||++.+   ..|+.++|||||||++|||++|+.||.....      ...... ......... 
T Consensus       168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~------~~~~~~-i~~~~~~~~-  234 (309)
T d1u5ra_         168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYH-IAQNESPAL-  234 (309)
T ss_dssp             -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHH-HHHSCCCCC-
T ss_pred             -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH------HHHHHH-HHhCCCCCC-
Confidence                 234679999999999864   4589999999999999999999999753211      111111 111111000 


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                             .+......+.+++.+||+.||++|||++|+++
T Consensus       235 -------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         235 -------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             -------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence                   11111246788999999999999999999976

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-44  Score=386.72  Aligned_cols=261  Identities=26%  Similarity=0.366  Sum_probs=198.9

Q ss_pred             HhcCCCcCCeeeccCccceEEEEeec------CcEEEEEEecCCc-cccHHHHHHHHHHHhcc-CCCCceeEEEEeecC-
Q 003391          502 ATENFSDKNKLGEGGFGPVYKGVLIE------GQEIAAKRLSKSS-GQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQR-  572 (823)
Q Consensus       502 ~~~~~~~~~~LG~G~fg~Vyk~~~~~------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-  572 (823)
                      ..++|...++||+|+||.||+|++..      ++.||||+++... ....+++.+|+.++.++ +|+||+++++++.+. 
T Consensus        11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~   90 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   90 (299)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence            34678999999999999999999753      3689999997543 33456678888888877 689999999998664 


Q ss_pred             CceEEEEeecCCCCcchhhhccC-------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEE
Q 003391          573 DERMLIYEYLPNKSLNDFIFDVT-------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL  639 (823)
Q Consensus       573 ~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll  639 (823)
                      ...++||||+++|+|.++|....             ....+++..+..++.||++||+|||+.+   |+||||||+||||
T Consensus        91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl  167 (299)
T d1ywna1          91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL  167 (299)
T ss_dssp             SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred             CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeE
Confidence            46899999999999999996432             1345899999999999999999999998   9999999999999


Q ss_pred             cCCCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCC-CCCCcCCCCccc
Q 003391          640 DNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR-NRGFYHADHHHN  718 (823)
Q Consensus       640 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~-p~~~~~~~~~~~  718 (823)
                      ++++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|.. ||.......   
T Consensus       168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~---  244 (299)
T d1ywna1         168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---  244 (299)
T ss_dssp             CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH---
T ss_pred             CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH---
Confidence            9999999999999987655544445556789999999999999999999999999999999999764 554322111   


Q ss_pred             hhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          719 LLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       719 l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                         ........+.         ....+.....++.+++.+||+.||++||||+|++++|+.+
T Consensus       245 ---~~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         245 ---EFCRRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             ---HHHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHHHHHhcCC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence               1111111111         1112222234678999999999999999999999999865

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-44  Score=380.89  Aligned_cols=247  Identities=23%  Similarity=0.331  Sum_probs=202.7

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCc------cccHHHHHHHHHHHhccCCCCceeEEEEeecCCce
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS------GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDER  575 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~  575 (823)
                      .++|+..+.||+|+||+||+|++. +|+.||||++.+..      ....+.+.+|+.++++++|||||++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            367899999999999999999985 48999999986542      22467899999999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCC----Cceeeccc
Q 003391          576 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM----NPKISDFG  651 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~DFG  651 (823)
                      ++||||+++|+|.+++..   .+.+++..++.++.||+.||+|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence            999999999999999854   345999999999999999999999998   99999999999998776    59999999


Q ss_pred             cceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcC
Q 003391          652 MARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER  731 (823)
Q Consensus       652 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  731 (823)
                      +|+......   ......||+.|+|||++.+..++.++|||||||+||||++|+.||......   ....    ......
T Consensus       163 ~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~----~i~~~~  232 (293)
T d1jksa_         163 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLA----NVSAVN  232 (293)
T ss_dssp             TCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHTTC
T ss_pred             hhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH---HHHH----HHHhcC
Confidence            998764332   223457899999999999999999999999999999999999998532211   1110    000000


Q ss_pred             chhhhhhhcCCCCCHH----HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          732 PVELINKSLGGSYSLS----EVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       732 ~~~~~~~~l~~~~~~~----~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                                .....+    ....+.+++.+||+.||++|||++|+++
T Consensus       233 ----------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         233 ----------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             ----------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----------CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                      011111    1236778999999999999999999986

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.6e-44  Score=390.42  Aligned_cols=253  Identities=21%  Similarity=0.250  Sum_probs=206.3

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      .++|++.++||+|+||.||+|+.. +++.||||+++.......+.+.+|+.++++++|||||++++++.+.+..++||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            357999999999999999999975 4899999999876655667889999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEc--CCCCceeeccccceecCCC
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD--NEMNPKISDFGMARAFGID  659 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~--~~~~~kl~DFGla~~~~~~  659 (823)
                      +++|+|.+++..  ....+++..++.++.||+.||+|||+.+   |+||||||+||||+  .++.+||+|||+|+.+...
T Consensus       108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence            999999887732  3446999999999999999999999998   99999999999998  6789999999999986533


Q ss_pred             ccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                      .   ......||+.|+|||++.+..++.++||||+||+||||++|+.||......   .....    ......      .
T Consensus       183 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~----i~~~~~------~  246 (352)
T d1koba_         183 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQN----VKRCDW------E  246 (352)
T ss_dssp             S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHH----HHHCCC------C
T ss_pred             C---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHH----HHhCCC------C
Confidence            2   233467899999999999999999999999999999999999998532211   11111    111000      0


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       740 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      ...........++.+|+.+||+.||++|||+.|+++.
T Consensus       247 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0011111122467889999999999999999999874

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-44  Score=385.95  Aligned_cols=261  Identities=26%  Similarity=0.397  Sum_probs=211.0

Q ss_pred             hcCCCcCCeeeccCccceEEEEee------cCcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCCce
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDER  575 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~  575 (823)
                      .++|...++||+|+||.||+|.+.      .++.||||+++... ......|.+|+.++++++|||||++++++...+..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            367888899999999999999874      25789999997643 33445689999999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhcc-------CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceee
Q 003391          576 MLIYEYLPNKSLNDFIFDV-------TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKIS  648 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~  648 (823)
                      ++||||+++|+|.+++...       .....+++..+.+++.|+++||.|||+.+   |+||||||+|||+++++++||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence            9999999999999998632       22345799999999999999999999987   9999999999999999999999


Q ss_pred             ccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcC-CCCCCcCCCCccchhHHHHHHh
Q 003391          649 DFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGK-RNRGFYHADHHHNLLGHAWRLW  727 (823)
Q Consensus       649 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~  727 (823)
                      |||+|+.+.............+|+.|+|||.+.+..++.++||||||+++|||+||. .|+.....   ...    ....
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~---~~~----~~~i  248 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQV----LRFV  248 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HHH----HHHH
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH---HHH----HHHH
Confidence            999998775544444445567899999999999999999999999999999999996 45432111   111    1111


Q ss_pred             hhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCC
Q 003391          728 IEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  782 (823)
Q Consensus       728 ~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  782 (823)
                      ..+.         ....+......+.+++.+||+.+|++||||.+|+++|+...+
T Consensus       249 ~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         249 MEGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HhCC---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            1111         111112223578899999999999999999999999988654

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-44  Score=384.18  Aligned_cols=260  Identities=27%  Similarity=0.369  Sum_probs=207.6

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec--------CcEEEEEEecCCcc-ccHHHHHHHHHHHhcc-CCCCceeEEEEeecC
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE--------GQEIAAKRLSKSSG-QGMEEFENEVLLIAKL-QHRNLVKLIGCCTQR  572 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~--------~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~  572 (823)
                      .++|.+.++||+|+||.||+|+...        +..||||+++.... ....++.+|+..+.++ +|||||+++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            3678888999999999999998643        24799999976543 3457788999999888 899999999999999


Q ss_pred             CceEEEEeecCCCCcchhhhccCC-------------CCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEE
Q 003391          573 DERMLIYEYLPNKSLNDFIFDVTR-------------SKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL  639 (823)
Q Consensus       573 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll  639 (823)
                      +..++||||+++|+|.++|.....             ...+++..+++++.||+.||+|||+.+   ||||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence            999999999999999999965331             245899999999999999999999998   9999999999999


Q ss_pred             cCCCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccc
Q 003391          640 DNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHN  718 (823)
Q Consensus       640 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~  718 (823)
                      +.++.+||+|||+++...............+|+.|+|||.+.++.|+.++||||||+++|||++ |+.||.....     
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~-----  243 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----  243 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH-----
Confidence            9999999999999998765555555556789999999999999999999999999999999998 6777643221     


Q ss_pred             hhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          719 LLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       719 l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                        ......+..+         .....+.....++.+|+.+||+.||++||||.||+++|+.+.
T Consensus       244 --~~~~~~i~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         244 --EELFKLLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             --HHHHHHHHTT---------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHHHHHHHcC---------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence              1111111111         111122222346889999999999999999999999998764

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-44  Score=378.74  Aligned_cols=255  Identities=25%  Similarity=0.333  Sum_probs=194.8

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec----CcEEEEEEecCCcc-ccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE----GQEIAAKRLSKSSG-QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERML  577 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~----~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l  577 (823)
                      .++|...+.||+|+||.||+|++..    +..||||+++.... ...+.|.+|+.++++++|||||++++++.+ +..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence            3578888999999999999999754    34689999865433 345679999999999999999999999964 67899


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecC
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFG  657 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~  657 (823)
                      ||||+++|+|.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+||++++++.+||+|||+|+.+.
T Consensus        85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence            9999999999998753  3446899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchhhh
Q 003391          658 IDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVELI  736 (823)
Q Consensus       658 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  736 (823)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++ |..|+......   .+...    ......    
T Consensus       160 ~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~~----i~~~~~----  227 (273)
T d1mp8a_         160 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGR----IENGER----  227 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHH----HHTTCC----
T ss_pred             CCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHHHH----HHcCCC----
Confidence            3322 22334678999999999999999999999999999999998 78887543221   11111    111111    


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          737 NKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       737 ~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                           ...+......+.+|+.+||+.||++|||+.||++.|+.+
T Consensus       228 -----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i  266 (273)
T d1mp8a_         228 -----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  266 (273)
T ss_dssp             -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                 112222335688999999999999999999999998754

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-44  Score=385.08  Aligned_cols=260  Identities=25%  Similarity=0.379  Sum_probs=210.4

Q ss_pred             hcCCCcCCeeeccCccceEEEEee------cCcEEEEEEecCCcc-ccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCc
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI------EGQEIAAKRLSKSSG-QGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDE  574 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~------~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~  574 (823)
                      .++|+..++||+|+||.||+|++.      .++.||||+++.... ....+|.+|+.++.++ +|||||++++++.+.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            467888899999999999999863      256899999976543 3455789999999999 79999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccC---------------CCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEE
Q 003391          575 RMLIYEYLPNKSLNDFIFDVT---------------RSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLL  639 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll  639 (823)
                      .++||||+++|+|.++++...               ....+++..+..++.||++||+|||+++   |+||||||+|||+
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence            999999999999999996532               1235899999999999999999999998   9999999999999


Q ss_pred             cCCCCceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCC-CCCcCCCCccc
Q 003391          640 DNEMNPKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRN-RGFYHADHHHN  718 (823)
Q Consensus       640 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p-~~~~~~~~~~~  718 (823)
                      +.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||+|+..| +......   .
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~---~  255 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD---S  255 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS---H
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH---H
Confidence            99999999999999987554444445557899999999999999999999999999999999995554 3322111   1


Q ss_pred             hhHHHHHHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          719 LLGHAWRLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       719 l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      .   ...         ++........+.....++.+|+.+||+.||++||||+||+++|+..
T Consensus       256 ~---~~~---------~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         256 K---FYK---------MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             H---HHH---------HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H---HHH---------HHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            1   111         1111122222222345788999999999999999999999999864

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-45  Score=381.02  Aligned_cols=256  Identities=27%  Similarity=0.361  Sum_probs=195.5

Q ss_pred             cCCCcCCeeeccCccceEEEEeec--C--cEEEEEEecCC---ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE--G--QEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERM  576 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~--~--~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~  576 (823)
                      ++|+..+.||+|+||.||+|++..  +  ..||||++.+.   ..+..++|.+|+.++++++|||||+++|++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            568888999999999999999753  2  37899998654   33446789999999999999999999999976 4678


Q ss_pred             EEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceec
Q 003391          577 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  656 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  656 (823)
                      +||||+++|+|.+++..  +...+++..++.++.||++||.|||+++   |+||||||+||||+.++.+||+|||+++.+
T Consensus        87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence            99999999999998754  3446999999999999999999999987   999999999999999999999999999987


Q ss_pred             CCCcccc-ccccccccCCccCccccccCCCCccchhHhHHHHHHHHHh-cCCCCCCcCCCCccchhHHHHHHhhhcCchh
Q 003391          657 GIDQTEA-NTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVC-GKRNRGFYHADHHHNLLGHAWRLWIEERPVE  734 (823)
Q Consensus       657 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  734 (823)
                      ....... ......++..|+|||.+.+..++.++||||||+++|||+| |+.||......   ....   . ...     
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~---~~~~---~-i~~-----  229 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILH---K-IDK-----  229 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH---H-HHT-----
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH---HHHH---H-HHh-----
Confidence            5443322 3334567889999999999999999999999999999998 89997532211   1111   1 111     


Q ss_pred             hhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          735 LINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       735 ~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                         .......+......+.+++.+||+.||++||||+||+++|++.
T Consensus       230 ---~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         230 ---EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ---SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence               1111111122234678999999999999999999999999753

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-44  Score=383.45  Aligned_cols=248  Identities=23%  Similarity=0.297  Sum_probs=204.5

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC---ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      .++|.+.+.||+|+||.||+|+... ++.||+|++++.   .....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            3578899999999999999999854 899999999754   344567889999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      |||+++|+|.+++..   ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+|+....
T Consensus        84 ~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eeccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            999999999999854   345889999999999999999999998   99999999999999999999999999986543


Q ss_pred             CccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                      ..  ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.....   ..+..    ......       
T Consensus       158 ~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~---~~~~~----~i~~~~-------  221 (337)
T d1o6la_         158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFE----LILMEE-------  221 (337)
T ss_dssp             TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH----HHHHCC-------
T ss_pred             CC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH---HHHHH----HHhcCC-------
Confidence            22  233457899999999999999999999999999999999999999754321   11111    111111       


Q ss_pred             hcCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 003391          739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPN-----MSSVVL  775 (823)
Q Consensus       739 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  775 (823)
                       .  .++.....++.+|+.+||+.||++||+     +.|+++
T Consensus       222 -~--~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         222 -I--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             -C--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -C--CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence             0  111112245778999999999999995     778876

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-44  Score=384.40  Aligned_cols=263  Identities=22%  Similarity=0.292  Sum_probs=198.2

Q ss_pred             cCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCC----ceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD----ERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lV~  579 (823)
                      +.|...++||+|+||.||+|++ +|+.||||+++.... ....++.|+..+.+++|||||++++++.+.+    ..++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            4566778999999999999997 789999999964422 1222344566667789999999999997654    578999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcC-----CCceEecccCCCcEEEcCCCCceeeccccce
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS-----RLRIIHRDLKASNVLLDNEMNPKISDFGMAR  654 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  654 (823)
                      ||+++|+|.++|..    ..++|..+++++.|++.||+|||+..     ..+|+||||||+||||++++.+||+|||+++
T Consensus        81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            99999999999953    35899999999999999999999741     2359999999999999999999999999999


Q ss_pred             ecCCCccc--cccccccccCCccCccccccCC------CCccchhHhHHHHHHHHHhcCCCCCCcCCCCccch-------
Q 003391          655 AFGIDQTE--ANTNRVVGTYGYMPPEYAIDGL------FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNL-------  719 (823)
Q Consensus       655 ~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~------~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l-------  719 (823)
                      ........  .......||+.|+|||++.+..      ++.++|||||||+||||+||..|+...........       
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence            77443222  2334568999999999987643      67799999999999999999988654222211100       


Q ss_pred             -hHHHHHHhhhcCchhhhhhhcCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          720 -LGHAWRLWIEERPVELINKSLGGSY-----SLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       720 -~~~~~~~~~~~~~~~~~~~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                       ......        ...+..++...     +.+.+..+.+++.+||+.||++||||.||++.|+.+
T Consensus       237 ~~~~~~~--------~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i  295 (303)
T d1vjya_         237 SVEEMRK--------VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             CHHHHHH--------HHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             hHHHHHH--------HHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence             011111        11111121111     223456788999999999999999999999999765

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-44  Score=381.70  Aligned_cols=257  Identities=26%  Similarity=0.418  Sum_probs=203.0

Q ss_pred             cCCCcCCeeeccCccceEEEEeecC-c--EEEEEEecCC-ccccHHHHHHHHHHHhcc-CCCCceeEEEEeecCCceEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIEG-Q--EIAAKRLSKS-SGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~~-~--~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV  578 (823)
                      ++|+..++||+|+||.||+|++.++ .  .||||++... .....++|.+|++++.++ +|||||+++|++.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            6788889999999999999998763 3  4788887654 334566899999999998 799999999999999999999


Q ss_pred             EeecCCCCcchhhhcc-------------CCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCc
Q 003391          579 YEYLPNKSLNDFIFDV-------------TRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNP  645 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  645 (823)
                      |||+++|+|.++|+..             .....+++..+.+++.||++||.|||+.+   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            9999999999999643             23456999999999999999999999997   9999999999999999999


Q ss_pred             eeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCC-CCCCcCCCCccchhHHHH
Q 003391          646 KISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKR-NRGFYHADHHHNLLGHAW  724 (823)
Q Consensus       646 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~-p~~~~~~~~~~~l~~~~~  724 (823)
                      ||+|||+++.....   .......||..|+|||.+.+..++.++|||||||++|||++|.. |+.....   ..+    .
T Consensus       167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~---~~~----~  236 (309)
T d1fvra_         167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AEL----Y  236 (309)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHH----H
T ss_pred             EEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH---HHH----H
Confidence            99999999864322   22234568999999999999999999999999999999999875 4432111   111    1


Q ss_pred             HHhhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCCC
Q 003391          725 RLWIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGERS  782 (823)
Q Consensus       725 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  782 (823)
                      .....         ......+.....++.+|+.+||+.||++||||+||++.|+.+..
T Consensus       237 ~~i~~---------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         237 EKLPQ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             HHGGG---------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHh---------cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            11111         11112222334578899999999999999999999999988643

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.3e-43  Score=379.72  Aligned_cols=245  Identities=23%  Similarity=0.283  Sum_probs=202.8

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC---ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ++|++.++||+|+||+||+|++.. |+.||||++++.   .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            568889999999999999999854 899999999653   2345678999999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+++|+|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+|+.....
T Consensus        84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            99999999998843   445788899999999999999999998   999999999999999999999999999876422


Q ss_pred             ccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                           ....+||+.|||||++.+..++.++|||||||+||||++|+.||.....   ..+.    .......        
T Consensus       158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~----~~i~~~~--------  217 (316)
T d1fota_         158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT---MKTY----EKILNAE--------  217 (316)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHH----HHHHHCC--------
T ss_pred             -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH---HHHH----HHHHcCC--------
Confidence                 2346899999999999999999999999999999999999999853211   1111    1111110        


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 003391          740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVLM  776 (823)
Q Consensus       740 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~  776 (823)
                        ...+.....++.+++.+||+.||.+||     |++|+++.
T Consensus       218 --~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         218 --LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence              011111224678899999999999996     89999863

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.3e-43  Score=381.73  Aligned_cols=244  Identities=21%  Similarity=0.240  Sum_probs=202.9

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC---ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~  579 (823)
                      ++|++.++||+|+||.||+|++.. |+.||||++.+.   .....+.+.+|+.+++.++|||||++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            578899999999999999999864 899999998653   2345677899999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGID  659 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~  659 (823)
                      ||+.+|+|.+++..   .+.+++..+..++.||+.||.|||+.+   ||||||||+|||++.++.+||+|||+|+.+...
T Consensus       121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            99999999999854   235899999999999999999999998   999999999999999999999999999976422


Q ss_pred             ccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                           .....||+.|||||++.+..++.++|||||||+||||++|+.||.....   ..+...    .....        
T Consensus       195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~----i~~~~--------  254 (350)
T d1rdqe_         195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEK----IVSGK--------  254 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH----HHHCC--------
T ss_pred             -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH---HHHHHH----HhcCC--------
Confidence                 2346899999999999999999999999999999999999999853211   111111    11111        


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 003391          740 LGGSYSLSEVLRCIQVGLLCVQQRPEDRP-----NMSSVVL  775 (823)
Q Consensus       740 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  775 (823)
                      .  ..+.....++.+++.+||+.||.+|+     |++|+++
T Consensus       255 ~--~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         255 V--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             C--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             C--CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            0  11111224678899999999999994     8999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-43  Score=378.30  Aligned_cols=253  Identities=25%  Similarity=0.370  Sum_probs=200.9

Q ss_pred             CCeeeccCccceEEEEeecC----cEEEEEEecCC-ccccHHHHHHHHHHHhccCCCCceeEEEEeec-CCceEEEEeec
Q 003391          509 KNKLGEGGFGPVYKGVLIEG----QEIAAKRLSKS-SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ-RDERMLIYEYL  582 (823)
Q Consensus       509 ~~~LG~G~fg~Vyk~~~~~~----~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~e~~  582 (823)
                      .++||+|+||+||+|++.++    ..||||+++.. .....++|.+|++++++++||||++++|++.+ +...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46899999999999998652    25899999754 44456789999999999999999999999875 45789999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  662 (823)
                      ++|+|.+++..  ....+++..+++++.|+++||.|||+.+   |+||||||+||||++++.+||+|||+++........
T Consensus       112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            99999998854  3445788899999999999999999998   999999999999999999999999999976543222


Q ss_pred             --cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhhc
Q 003391          663 --ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKSL  740 (823)
Q Consensus       663 --~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l  740 (823)
                        .......||+.|+|||.+.+..++.++||||||+++|||+||+.|+......  ......    ...+.         
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~----i~~g~---------  251 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVY----LLQGR---------  251 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH----HHTTC---------
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHH----HHcCC---------
Confidence              2223357899999999999999999999999999999999988886432211  111111    11111         


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccCC
Q 003391          741 GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGER  781 (823)
Q Consensus       741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  781 (823)
                      ....+.....++.+|+.+||+.||++||+|.||++.|+.+.
T Consensus       252 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~  292 (311)
T d1r0pa_         252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  292 (311)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            01111122346789999999999999999999999999874

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.1e-43  Score=372.13  Aligned_cols=259  Identities=23%  Similarity=0.307  Sum_probs=198.4

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCcc---ccHHHHHHHHHHHhccCCCCceeEEEEeecCC----c
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG---QGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD----E  574 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~  574 (823)
                      .++|.+.+.||+|+||.||+|++. .++.||||+++....   ...+.|.+|++++++++|||||++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            367999999999999999999975 488999999976533   33457899999999999999999999987654    3


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccce
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  654 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  654 (823)
                      .++||||+++++|.+++..   .+.+++.+++.++.||++||+|||+.+   |+||||||+|||++.++..+|+|||.++
T Consensus        86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence            7899999999999998853   345899999999999999999999998   9999999999999999999999999998


Q ss_pred             ecCCCc-cccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCch
Q 003391          655 AFGIDQ-TEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV  733 (823)
Q Consensus       655 ~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  733 (823)
                      ...... .........||+.|+|||++.+..++.++|||||||++|||+||+.||.....      ..............
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~~~~~~~  233 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIP  233 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCC
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HHHHHHHHhcCCCC
Confidence            654332 22234456899999999999999999999999999999999999999853221      11111111111110


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhccC
Q 003391          734 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRP-NMSSVVLMLSGE  780 (823)
Q Consensus       734 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~~  780 (823)
                      .   ......    ...++.+++.+||+.||++|| |++++++.|..+
T Consensus       234 ~---~~~~~~----~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         234 P---SARHEG----LSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             G---GGTSSS----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             C---chhccC----CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence            0   001111    124678899999999999999 899998887643

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=5e-43  Score=367.84  Aligned_cols=250  Identities=22%  Similarity=0.311  Sum_probs=201.0

Q ss_pred             cCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccc---------cHHHHHHHHHHHhccC-CCCceeEEEEeecC
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQ---------GMEEFENEVLLIAKLQ-HRNLVKLIGCCTQR  572 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~---------~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~  572 (823)
                      ++|+..+.||+|+||+||+|+.. +++.||||++.+....         ..+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            67889999999999999999975 4889999999765321         2345889999999997 99999999999999


Q ss_pred             CceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecccc
Q 003391          573 DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGM  652 (823)
Q Consensus       573 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGl  652 (823)
                      +..+|||||+++|+|.++|..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence            999999999999999999954   346899999999999999999999998   99999999999999999999999999


Q ss_pred             ceecCCCccccccccccccCCccCcccccc------CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHH
Q 003391          653 ARAFGIDQTEANTNRVVGTYGYMPPEYAID------GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL  726 (823)
Q Consensus       653 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  726 (823)
                      ++.+....   ......||+.|+|||++.+      ..++.++||||+||+||||++|+.||.....   ...    ...
T Consensus       157 a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~---~~~----~~~  226 (277)
T d1phka_         157 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---MLM----LRM  226 (277)
T ss_dssp             CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH----HHH
T ss_pred             eeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH---HHH----HHH
Confidence            99764322   2234679999999999853      3478899999999999999999999853221   111    111


Q ss_pred             hhhcCchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          727 WIEERPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       727 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      .......      ...........++.+++.+||+.||++|||++||++
T Consensus       227 i~~~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         227 IMSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHhCCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            1111110      001111122246789999999999999999999965

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-42  Score=372.91  Aligned_cols=245  Identities=19%  Similarity=0.284  Sum_probs=201.9

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      .++|.+.+.||+|+||+||+|++.. ++.||||+++.... ....+.+|+++|++++|||||++++++.+.+..++||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            4678999999999999999999865 88999999976532 345688999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCC--CCceeeccccceecCCC
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE--MNPKISDFGMARAFGID  659 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~--~~~kl~DFGla~~~~~~  659 (823)
                      +++|+|.+++..  +...+++.++..++.||++||+|||+.+   |+||||||+|||++.+  ..+||+|||+++.....
T Consensus        83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            999999999843  2335899999999999999999999998   9999999999999854  58999999999876432


Q ss_pred             ccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhhh
Q 003391          660 QTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINKS  739 (823)
Q Consensus       660 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  739 (823)
                      .   ......+|+.|+|||.+.+..++.++||||+||++|||++|+.||......                   +++...
T Consensus       158 ~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-------------------~~~~~i  215 (321)
T d1tkia_         158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-------------------QIIENI  215 (321)
T ss_dssp             C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------------------HHHHHH
T ss_pred             C---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-------------------HHHHHH
Confidence            2   233467899999999999999999999999999999999999998532211                   111111


Q ss_pred             cCCC--CCHH----HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          740 LGGS--YSLS----EVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       740 l~~~--~~~~----~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      +...  ++.+    ...++.+++.+||+.||++|||+.|+++
T Consensus       216 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         216 MNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1111  1111    1236789999999999999999999997

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=9.8e-43  Score=380.00  Aligned_cols=246  Identities=24%  Similarity=0.286  Sum_probs=196.9

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc---cccHHHHHH---HHHHHhccCCCCceeEEEEeecCCceE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS---GQGMEEFEN---EVLLIAKLQHRNLVKLIGCCTQRDERM  576 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~---~~~~~~~~~---Ei~~l~~l~H~niv~l~g~~~~~~~~~  576 (823)
                      ++|++.++||+|+||.||+|++.. |+.||||++.+..   ......+.+   |+.+++.++|||||++++++.+.+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            678899999999999999999865 8999999986431   222333444   467777788999999999999999999


Q ss_pred             EEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceec
Q 003391          577 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  656 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  656 (823)
                      +||||+++|+|.++|..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+
T Consensus        84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            99999999999999854   345789999999999999999999998   999999999999999999999999999976


Q ss_pred             CCCccccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhh
Q 003391          657 GIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL  735 (823)
Q Consensus       657 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  735 (823)
                      ...    ......||+.|+|||++.. ..++.++|||||||+||||+||+.||..........+                
T Consensus       158 ~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~----------------  217 (364)
T d1omwa3         158 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----------------  217 (364)
T ss_dssp             SSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH----------------
T ss_pred             CCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH----------------
Confidence            433    2334679999999999975 5689999999999999999999999865433221110                


Q ss_pred             hhhhcCC--CCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 003391          736 INKSLGG--SYSLSEVLRCIQVGLLCVQQRPEDRPN-----MSSVVL  775 (823)
Q Consensus       736 ~~~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  775 (823)
                      .......  ..+.....++.+++.+||+.||++|||     ++|+++
T Consensus       218 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         218 DRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             HHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             HHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            0000100  111112246788999999999999999     688875

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-43  Score=371.24  Aligned_cols=256  Identities=22%  Similarity=0.252  Sum_probs=193.3

Q ss_pred             CCeeeccCccceEEEEeec-CcEEEEEEecCCccc-----cHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEeec
Q 003391          509 KNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQ-----GMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEYL  582 (823)
Q Consensus       509 ~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  582 (823)
                      .++||+|+||+||+|++.. ++.||||+++.....     ..+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            4689999999999999865 899999998654322     2346889999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCccc
Q 003391          583 PNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQTE  662 (823)
Q Consensus       583 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~~  662 (823)
                      +++++..++   .....+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+|+......  
T Consensus        83 ~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--  154 (299)
T d1ua2a_          83 ETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--  154 (299)
T ss_dssp             SEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--
T ss_pred             cchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc--
Confidence            988776655   34556899999999999999999999998   9999999999999999999999999998754332  


Q ss_pred             cccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhh------
Q 003391          663 ANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL------  735 (823)
Q Consensus       663 ~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~------  735 (823)
                      .......||+.|+|||++... .++.++|||||||++|||++|+.||......+   .................      
T Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~l~~i~~~~~~~~~~~~~~~~~~  231 (299)
T d1ua2a_         155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWPDMCSL  231 (299)
T ss_dssp             CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSSSTTSS
T ss_pred             ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH---HHHHHHHhcCCCChhhccchhcc
Confidence            222346799999999998754 57999999999999999999999985432211   11111111100000000      


Q ss_pred             hhhh-c--CCCCCHH-----HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          736 INKS-L--GGSYSLS-----EVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       736 ~~~~-l--~~~~~~~-----~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      .... .  ....+..     ...++.+|+.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            0000 0  0011111     1246889999999999999999999986

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-43  Score=375.60  Aligned_cols=247  Identities=26%  Similarity=0.363  Sum_probs=200.4

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCC---ccccHHHHHHHHHHHh-ccCCCCceeEEEEeecCCceEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS---SGQGMEEFENEVLLIA-KLQHRNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~-~l~H~niv~l~g~~~~~~~~~lV  578 (823)
                      ++|.+.+.||+|+||+||+|++.. ++.||||++++.   .....+.+..|..++. .++|||||++++++.+++..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            578889999999999999999865 889999999753   2344566777777765 68999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCC
Q 003391          579 YEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGI  658 (823)
Q Consensus       579 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~  658 (823)
                      |||+++|+|.+++..   ...+++.++..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            999999999999954   335889999999999999999999998   99999999999999999999999999986543


Q ss_pred             CccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhhhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELINK  738 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  738 (823)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ..+.    .......       
T Consensus       156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~----~~i~~~~-------  219 (320)
T d1xjda_         156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EELF----HSIRMDN-------  219 (320)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH----HHHHHCC-------
T ss_pred             cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH---HHHH----HHHHcCC-------
Confidence            32  233346899999999999999999999999999999999999999853221   1111    1111111       


Q ss_pred             hcCCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 003391          739 SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMS-SVVL  775 (823)
Q Consensus       739 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~  775 (823)
                         ...+.....++.+|+.+||+.||++||++. |+++
T Consensus       220 ---~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         220 ---PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ---CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence               011111224678999999999999999996 6753

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-42  Score=371.74  Aligned_cols=247  Identities=20%  Similarity=0.245  Sum_probs=195.7

Q ss_pred             hcCCCcCC-eeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhcc-CCCCceeEEEEeec----CCce
Q 003391          503 TENFSDKN-KLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKL-QHRNLVKLIGCCTQ----RDER  575 (823)
Q Consensus       503 ~~~~~~~~-~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~----~~~~  575 (823)
                      .++|.+.. .||+|+||.||+|++.. ++.||||+++.     ...+.+|+.++.++ +|||||++++++.+    ....
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            46787764 59999999999999754 89999999854     35678899987655 89999999999865    4568


Q ss_pred             EEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcC---CCCceeecccc
Q 003391          576 MLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---EMNPKISDFGM  652 (823)
Q Consensus       576 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~DFGl  652 (823)
                      ++||||+++|+|.++|... ....+++.++..++.||+.||+|||+.+   |+||||||+|||+++   ++.+||+|||+
T Consensus        85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence            9999999999999999642 2346999999999999999999999998   999999999999985   56799999999


Q ss_pred             ceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCc
Q 003391          653 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP  732 (823)
Q Consensus       653 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  732 (823)
                      |+......   ......||+.|||||++.+..|+.++|||||||+||||+||+.||...........             
T Consensus       161 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~-------------  224 (335)
T d2ozaa1         161 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-------------  224 (335)
T ss_dssp             CEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------------
T ss_pred             eeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH-------------
Confidence            98764332   23346799999999999999999999999999999999999999854322111000             


Q ss_pred             hhhhhhhcCCC--CCH----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          733 VELINKSLGGS--YSL----SEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       733 ~~~~~~~l~~~--~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                        +........  ++.    ....++.+|+.+||+.||++|||+.|+++.
T Consensus       225 --~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         225 --MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             -----CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             --HHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence              000000111  111    112468899999999999999999999883

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-42  Score=366.36  Aligned_cols=261  Identities=25%  Similarity=0.355  Sum_probs=198.3

Q ss_pred             cCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      ++|++.++||+|+||+||+|++. +++.||||+++...  ....+++.+|++++++++|||||++++++.+++..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            57889999999999999999985 48999999996543  3346789999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      |+.++ +.+++.. .....+++..+..++.||+.||+|||+.+   ||||||||+|||++.++.+||+|||+|+....+.
T Consensus        82 ~~~~~-~~~~~~~-~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQD-LKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEE-HHHHHHH-TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCCc-hhhhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence            99764 4444432 34456999999999999999999999998   9999999999999999999999999998764322


Q ss_pred             cccccccccccCCccCccccccCC-CCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhhh---
Q 003391          661 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVELI---  736 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~~~-~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~---  736 (823)
                        .......||+.|+|||.+.... ++.++||||+||++|||++|+.||......   ...........  ...+..   
T Consensus       157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~---~~~~~i~~~~~--~~~~~~~~~  229 (298)
T d1gz8a_         157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---DQLFRIFRTLG--TPDEVVWPG  229 (298)
T ss_dssp             --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHC--CCCTTTSTT
T ss_pred             --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH---HHHHHHHHhcC--CCchhhccc
Confidence              2333467999999999887665 588999999999999999999998643211   11111111100  000000   


Q ss_pred             -h------hhc--CCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          737 -N------KSL--GGSYSL-----SEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       737 -~------~~l--~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                       .      ...  ......     ....++.+++.+||+.||++|||+.|+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             GGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence             0      000  000011     111367889999999999999999999874

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=7.3e-42  Score=362.13  Aligned_cols=261  Identities=24%  Similarity=0.331  Sum_probs=199.1

Q ss_pred             cCCCcCCeeeccCccceEEEEeecCcEEEEEEecCC--ccccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEee
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYEY  581 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  581 (823)
                      ++|...++||+|+||+||+|++.+++.||||++...  .....+++.+|+.++++++|||||++++++...+..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            578889999999999999999988999999999664  334467899999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCcc
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQT  661 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~~  661 (823)
                      +.++.+..+.   ...+.+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++.....+..
T Consensus        82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            9887766665   34466999999999999999999999987   99999999999999999999999999987643322


Q ss_pred             ccccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCc------hh
Q 003391          662 EANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP------VE  734 (823)
Q Consensus       662 ~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~------~~  734 (823)
                        ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||......   ...............      ..
T Consensus       156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~  230 (286)
T d1ob3a_         156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMRIFRILGTPNSKNWPNVTE  230 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH---HHHHHHHHhhCCCChhhccchhh
Confidence              23335689999999998764 5699999999999999999999998533211   111111111100000      00


Q ss_pred             hh--hhhcC--CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          735 LI--NKSLG--GSYS-----LSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       735 ~~--~~~l~--~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ..  .....  ...+     .....++.+++.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00  00000  0000     011236789999999999999999999974

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-42  Score=361.43  Aligned_cols=239  Identities=25%  Similarity=0.390  Sum_probs=193.3

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCcc------ccHHHHHHHHHHHhccC--CCCceeEEEEeecCCc
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSG------QGMEEFENEVLLIAKLQ--HRNLVKLIGCCTQRDE  574 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~  574 (823)
                      ++|++.++||+|+||.||+|+... ++.||||++.+...      ....++.+|+.++++++  |||||++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            578899999999999999999864 89999999865421      12234678999999986  8999999999999999


Q ss_pred             eEEEEeecCC-CCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCC-CCceeecccc
Q 003391          575 RMLIYEYLPN-KSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNE-MNPKISDFGM  652 (823)
Q Consensus       575 ~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DFGl  652 (823)
                      .++||||+.+ +++.+++..   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.+ +.+||+|||+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence            9999999976 567777643   345899999999999999999999998   9999999999999854 7899999999


Q ss_pred             ceecCCCccccccccccccCCccCccccccCCC-CccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcC
Q 003391          653 ARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLF-SVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEER  731 (823)
Q Consensus       653 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  731 (823)
                      |+.....    ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.....             .....
T Consensus       158 a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------------i~~~~  220 (273)
T d1xwsa_         158 GALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------IIRGQ  220 (273)
T ss_dssp             CEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------HHHCC
T ss_pred             ceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-------------Hhhcc
Confidence            9875322    2234679999999999987765 6779999999999999999999753110             00000


Q ss_pred             chhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          732 PVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       732 ~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                            .......    ..++.+++.+||+.||++|||++|+++
T Consensus       221 ------~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         221 ------VFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             ------CCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------cCCCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                  0111122    246788999999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-41  Score=360.62  Aligned_cols=262  Identities=22%  Similarity=0.310  Sum_probs=194.6

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-c-CcEEEEEEecCCc--cccHHHHHHHHHHHhcc---CCCCceeEEEEeec----
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-E-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKL---QHRNLVKLIGCCTQ----  571 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~----  571 (823)
                      .++|++.++||+|+||+||+|++. . ++.||||+++...  ......+.+|+.+++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            468999999999999999999974 3 5679999986542  22233566777777665   79999999999853    


Q ss_pred             -CCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeecc
Q 003391          572 -RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDF  650 (823)
Q Consensus       572 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DF  650 (823)
                       ....++++||++++.+.....  .....+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence             346799999999887654432  34556899999999999999999999998   999999999999999999999999


Q ss_pred             ccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhc
Q 003391          651 GMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE  730 (823)
Q Consensus       651 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  730 (823)
                      |+++.....   .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+   ............
T Consensus       161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~  234 (305)
T d1blxa_         161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLP  234 (305)
T ss_dssp             CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCC
T ss_pred             hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhhCCC
Confidence            999864322   23345789999999999999999999999999999999999999986432211   111111110000


Q ss_pred             Cchh------hhhhhcC--CC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          731 RPVE------LINKSLG--GS-----YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       731 ~~~~------~~~~~l~--~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ....      .......  ..     ........+.+|+.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0000      0000000  00     00111235678999999999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-40  Score=356.48  Aligned_cols=264  Identities=22%  Similarity=0.325  Sum_probs=196.5

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCC--ccccHHHHHHHHHHHhccCCCCceeEEEEeec--------
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKS--SGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ--------  571 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--------  571 (823)
                      .++|++.++||+|+||+||+|++. +++.||||++...  .....+++.+|+.+|++++|||++++++.+..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            478999999999999999999985 5899999998654  33456788999999999999999999999855        


Q ss_pred             CCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccc
Q 003391          572 RDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFG  651 (823)
Q Consensus       572 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFG  651 (823)
                      ....++||||+.++.+..+.   .....++...+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence            34579999999887766544   33456888999999999999999999998   9999999999999999999999999


Q ss_pred             cceecCCCccc--cccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhh
Q 003391          652 MARAFGIDQTE--ANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWI  728 (823)
Q Consensus       652 la~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~  728 (823)
                      +++.+......  .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.........   ...... .
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~---~~i~~~-~  238 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL---ALISQL-C  238 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHH-H
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHH---HHHHHh-c
Confidence            99876533222  223345799999999998765 6899999999999999999999998533221111   111111 1


Q ss_pred             hcCchhh------------hhhhcCCCCCHHH-------HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          729 EERPVEL------------INKSLGGSYSLSE-------VLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       729 ~~~~~~~------------~~~~l~~~~~~~~-------~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                      .....+.            +...........+       ...+++|+.+||+.||++|||++|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            1100000            0000011111111       1256789999999999999999999864

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-40  Score=360.19  Aligned_cols=257  Identities=21%  Similarity=0.278  Sum_probs=191.7

Q ss_pred             CCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeEEEEeecC------CceEE
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKLIGCCTQR------DERML  577 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~~l  577 (823)
                      +|+..++||+|+||+||+|++.. ++.||||++......    +.+|++++++++||||+++++++...      ...+|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            57778899999999999999865 899999999765432    34799999999999999999998543      34689


Q ss_pred             EEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCC-Cceeeccccceec
Q 003391          578 IYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAF  656 (823)
Q Consensus       578 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DFGla~~~  656 (823)
                      ||||++++.+............+++..+..++.||++||+|||+.+   |+||||||+|||++.++ .+||+|||+++.+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999987654443332344557999999999999999999999988   99999999999999775 8999999999876


Q ss_pred             CCCccccccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCchhh
Q 003391          657 GIDQTEANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPVEL  735 (823)
Q Consensus       657 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  735 (823)
                      ....   ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+   ........ ......+.
T Consensus       174 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~---~l~~i~~~-~g~~~~~~  246 (350)
T d1q5ka_         174 VRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD---QLVEIIKV-LGTPTREQ  246 (350)
T ss_dssp             CTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH---HHHHHHHH-HCCCCHHH
T ss_pred             cCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH---HHHHHHHH-hCCChHHh
Confidence            4332   2233679999999998875 568999999999999999999999985432211   11111110 00000000


Q ss_pred             hhh--------hc---CC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          736 INK--------SL---GG-----SYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       736 ~~~--------~l---~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ...        ..   ..     ........++.+|+.+||+.||++|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000        00   00     001112236788999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.1e-39  Score=343.19  Aligned_cols=260  Identities=20%  Similarity=0.262  Sum_probs=196.6

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCCCCceeE-EEEeecCCceEEEEee
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRNLVKL-IGCCTQRDERMLIYEY  581 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l-~g~~~~~~~~~lV~e~  581 (823)
                      ++|++.++||+|+||.||+|++.. ++.||||++.....  .+++..|++++++++|+|++.. .++..+.+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            578999999999999999999754 88999998865433  2457889999999987765555 5555777888999999


Q ss_pred             cCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEc---CCCCceeeccccceecCC
Q 003391          582 LPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NEMNPKISDFGMARAFGI  658 (823)
Q Consensus       582 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~DFGla~~~~~  658 (823)
                      + +++|.+.+..  ....+++..+..++.|+++||+|||+++   |+||||||+|||++   .+..+||+|||+|+.+..
T Consensus        85 ~-~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          85 L-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             C-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             c-CCchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            9 4566665533  3446899999999999999999999998   99999999999985   456799999999998754


Q ss_pred             Cccc-----cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCch
Q 003391          659 DQTE-----ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV  733 (823)
Q Consensus       659 ~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  733 (823)
                      ....     .......||+.|||||.+.+..++.++|||||||++|||++|+.||.......................  
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~--  236 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--  236 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC--
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC--
Confidence            3221     223446799999999999999999999999999999999999999865544333222221111111111  


Q ss_pred             hhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          734 ELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       734 ~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                         .+.+....    +.++.+++..|++.+|++||+++++.+.|+..
T Consensus       237 ---~~~~~~~~----p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         237 ---IEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             ---HHHHTTTS----CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             ---hhHhccCC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence               11111112    24678899999999999999999999888754

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.1e-39  Score=342.50  Aligned_cols=261  Identities=16%  Similarity=0.192  Sum_probs=205.0

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccCC-CCceeEEEEeecCCceEEEEe
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQH-RNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~e  580 (823)
                      .++|.+.++||+|+||.||+|++.. ++.||||++.....  ..++.+|++.++.++| +|++.+++++.++...++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            3678999999999999999999764 88999998865432  2457788999999865 899999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcC-----CCCceeecccccee
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-----EMNPKISDFGMARA  655 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~-----~~~~kl~DFGla~~  655 (823)
                      |+ +++|.+++..  ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.     ++.+||+|||+|+.
T Consensus        82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            98 6899998854  3346899999999999999999999998   999999999999974     57899999999998


Q ss_pred             cCCCccc-----cccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhc
Q 003391          656 FGIDQTE-----ANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEE  730 (823)
Q Consensus       656 ~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  730 (823)
                      +......     .......||+.|||||++.+..++.++||||||+++|||++|+.||..................-...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  235 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence            6433221     22334679999999999999999999999999999999999999986544433222221111111111


Q ss_pred             CchhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhccC
Q 003391          731 RPVELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLMLSGE  780 (823)
Q Consensus       731 ~~~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  780 (823)
                      ..     ..+....+    .++.+++..|++.+|++||+++.+.+.|+.+
T Consensus       236 ~~-----~~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         236 PL-----RELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             CH-----HHHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             Ch-----HHhcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            11     11112222    4678899999999999999999998888754

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-39  Score=353.42  Aligned_cols=264  Identities=20%  Similarity=0.296  Sum_probs=196.2

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCc-cccHHHHHHHHHHHhccCCCCceeEEEEeecCC----ceE
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSS-GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD----ERM  576 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~  576 (823)
                      .++|...++||+|+||+||+|+.. +++.||||++.+.. ....+++.+|+.+|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            457889999999999999999975 58999999997643 334567899999999999999999999996653    345


Q ss_pred             EEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceec
Q 003391          577 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAF  656 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~  656 (823)
                      ++++|+.+|+|.+++..    ..+++..+..++.||++||+|||+++   ||||||||+|||+++++.+||+|||+++..
T Consensus        87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            66677889999999843    35899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCccc-cccccccccCCccCcccccc-CCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCch-
Q 003391          657 GIDQTE-ANTNRVVGTYGYMPPEYAID-GLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV-  733 (823)
Q Consensus       657 ~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-  733 (823)
                      ...... .......||+.|+|||++.. ..++.++||||+||++|||++|+.||......+.   .............. 
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~  236 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQED  236 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHHH
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH---HHHHhhhccCCChhh
Confidence            443222 23345679999999999854 5678999999999999999999999854322111   11110000000000 


Q ss_pred             ----------hhhhhh-cCCCCCHHH-----HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          734 ----------ELINKS-LGGSYSLSE-----VLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       734 ----------~~~~~~-l~~~~~~~~-----~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                                ...... .....+...     ..++.+++.+||+.||++|||+.|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                      000000 001111111     1267899999999999999999999974

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-39  Score=352.67  Aligned_cols=262  Identities=21%  Similarity=0.318  Sum_probs=193.0

Q ss_pred             hcCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCC------
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRD------  573 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------  573 (823)
                      .++|+..++||+|+||+||+|++.. ++.||||+++...  ....+.+.+|+.+|++++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            4678899999999999999999754 8999999997542  234567889999999999999999999997654      


Q ss_pred             ceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccc
Q 003391          574 ERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMA  653 (823)
Q Consensus       574 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla  653 (823)
                      ..++||||+ +.+|..++.    ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+|
T Consensus        97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence            469999999 556766653    345899999999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCccccccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCc
Q 003391          654 RAFGIDQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP  732 (823)
Q Consensus       654 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  732 (823)
                      +.....     .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.......   ........ .....
T Consensus       169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~---~~~~~~~~-~~~~~  239 (346)
T d1cm8a_         169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD---QLKEIMKV-TGTPP  239 (346)
T ss_dssp             EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHH-HCCCC
T ss_pred             eccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH---HHHHHHhc-cCCCc
Confidence            875432     2346789999999998764 57899999999999999999999985432111   11110000 00000


Q ss_pred             hhhh-----------hhhc---CCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hccCC
Q 003391          733 VELI-----------NKSL---GGS----YSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM--LSGER  781 (823)
Q Consensus       733 ~~~~-----------~~~l---~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~  781 (823)
                      .+..           ...+   ...    ........+.+|+.+||+.||++|||++|+++.  |+.+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            0000           0000   000    000112356789999999999999999999985  55543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-39  Score=342.13  Aligned_cols=262  Identities=23%  Similarity=0.285  Sum_probs=201.1

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeecCCceEEEEe
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      ++|++.++||+|+||+||+|++.. ++.||||+++...  ....+++.+|+.+++.++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            578899999999999999999754 8899999986543  3446789999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccceecCCCc
Q 003391          581 YLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMARAFGIDQ  660 (823)
Q Consensus       581 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~~~~~~  660 (823)
                      ++.+++|..++.   ..+.+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||.++......
T Consensus        82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            999999888774   3456889999999999999999999998   9999999999999999999999999999765432


Q ss_pred             cccccccccccCCccCccccccCC-CCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCc------h
Q 003391          661 TEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP------V  733 (823)
Q Consensus       661 ~~~~~~~~~gt~~y~aPE~l~~~~-~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~------~  733 (823)
                      .  ......++..|+|||.+.... ++.++||||+||++|||++|+.|+-..  ...................      .
T Consensus       156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (292)
T d1unla_         156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG--NDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC--SSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCC--CCHHHHHHHHHhhcCCCChhhhhhhh
Confidence            2  222345778999999987665 699999999999999999999996321  1111111111111110000      0


Q ss_pred             hhhhhh--------c-CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          734 ELINKS--------L-GGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       734 ~~~~~~--------l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                      ...+..        . ...........+.+|+.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000000        0 00001111236778999999999999999999976

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=6.2e-39  Score=346.43  Aligned_cols=255  Identities=18%  Similarity=0.281  Sum_probs=194.5

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCccccHHHHHHHHHHHhccC-CCCceeEEEEeecC--CceEEEE
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQR--DERMLIY  579 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~lV~  579 (823)
                      ++|++.++||+|+||+||+|++.. ++.||||+++..   ..+++.+|+.+|++++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            579999999999999999999854 889999999653   3467899999999995 99999999998743  5689999


Q ss_pred             eecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCC-CceeeccccceecCC
Q 003391          580 EYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEM-NPKISDFGMARAFGI  658 (823)
Q Consensus       580 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DFGla~~~~~  658 (823)
                      ||+++++|..+.      +.+++..+..++.||++||+|||+.+   |+||||||+|||++.++ .+||+|||+|+....
T Consensus       112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence            999999998764      34899999999999999999999998   99999999999998765 589999999987643


Q ss_pred             CccccccccccccCCccCccccccC-CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHH--------hhh
Q 003391          659 DQTEANTNRVVGTYGYMPPEYAIDG-LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRL--------WIE  729 (823)
Q Consensus       659 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~--------~~~  729 (823)
                      ..   ......+|+.|+|||.+.+. .++.++||||+|++++||++|+.||........  ........        +..
T Consensus       183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~--~~~~i~~~~g~~~~~~~~~  257 (328)
T d3bqca1         183 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVRIAKVLGTEDLYDYID  257 (328)
T ss_dssp             TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH--HHHHHHHHHCHHHHHHHHH
T ss_pred             CC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHH--HHHHHHHHHCCchhhhhhh
Confidence            32   23346789999999998765 479999999999999999999999854332111  10000000        000


Q ss_pred             ---cCchhhhhhh------------cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 003391          730 ---ERPVELINKS------------LGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSSVVL  775 (823)
Q Consensus       730 ---~~~~~~~~~~------------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  775 (823)
                         ..........            ...........++.+|+.+||+.||++|||++|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               0000000000            000001111246789999999999999999999985

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-39  Score=345.77  Aligned_cols=252  Identities=24%  Similarity=0.316  Sum_probs=199.5

Q ss_pred             cCCCcCCeeeccCccceEEEEee----cCcEEEEEEecCCc----cccHHHHHHHHHHHhccCC-CCceeEEEEeecCCc
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLI----EGQEIAAKRLSKSS----GQGMEEFENEVLLIAKLQH-RNLVKLIGCCTQRDE  574 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~----~~~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~  574 (823)
                      ++|+..++||+|+||+||+|+..    .|+.||||++.+..    ....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            66899999999999999999863    27899999986542    2345678899999999966 899999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccce
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  654 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  654 (823)
                      .++||||+.+|+|.+++...   ..++...+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence            99999999999999998543   34678889999999999999999998   9999999999999999999999999998


Q ss_pred             ecCCCccccccccccccCCccCccccccC--CCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCc
Q 003391          655 AFGIDQTEANTNRVVGTYGYMPPEYAIDG--LFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERP  732 (823)
Q Consensus       655 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  732 (823)
                      .+..... .......|++.|+|||.+.+.  .++.++|||||||+||||++|+.||.........   ........... 
T Consensus       178 ~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~---~~i~~~~~~~~-  252 (322)
T d1vzoa_         178 EFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ---AEISRRILKSE-  252 (322)
T ss_dssp             ECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH---HHHHHHHHHCC-
T ss_pred             hhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcccCC-
Confidence            7643322 223346799999999999764  4788999999999999999999998654332221   11111111111 


Q ss_pred             hhhhhhhcCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 003391          733 VELINKSLGGSYSLSEVLRCIQVGLLCVQQRPEDRPN-----MSSVVL  775 (823)
Q Consensus       733 ~~~~~~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  775 (823)
                               ...+.....++.+++.+||+.||++|||     ++|+++
T Consensus       253 ---------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         253 ---------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ---------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                     1111223357788999999999999994     788876

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-38  Score=341.61  Aligned_cols=262  Identities=23%  Similarity=0.315  Sum_probs=195.3

Q ss_pred             hcCCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCcc--ccHHHHHHHHHHHhccCCCCceeEEEEeecC-----Cc
Q 003391          503 TENFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSG--QGMEEFENEVLLIAKLQHRNLVKLIGCCTQR-----DE  574 (823)
Q Consensus       503 ~~~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~  574 (823)
                      .++|++.++||+|+||+||+|++. +++.||||++++...  ...+++.+|+.++++++|||+|++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            568999999999999999999975 489999999976532  3455788999999999999999999998643     34


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccce
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  654 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  654 (823)
                      .+++++|+.+|+|.+++.    .+.+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+|++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence            577788889999999883    345999999999999999999999998   9999999999999999999999999997


Q ss_pred             ecCCCccccccccccccCCccCccccccCC-CCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHHHHHhhhcCch
Q 003391          655 AFGIDQTEANTNRVVGTYGYMPPEYAIDGL-FSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHAWRLWIEERPV  733 (823)
Q Consensus       655 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  733 (823)
                      ....     ......||+.|+|||.+.+.. ++.++||||+||++|||++|+.||...+....   ........ .....
T Consensus       170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~---~~~i~~~~-~~~~~  240 (348)
T d2gfsa1         170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ---LKLILRLV-GTPGA  240 (348)
T ss_dssp             CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHH-CCCCH
T ss_pred             ccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH---HHHHHHhc-CCCCh
Confidence            5432     233467899999999877654 68999999999999999999999854322111   11111100 00000


Q ss_pred             hh-----------hhhhc--CCCCCHH-----HHHHHHHHHHHccccCCCCCCCHHHHHH--HhccC
Q 003391          734 EL-----------INKSL--GGSYSLS-----EVLRCIQVGLLCVQQRPEDRPNMSSVVL--MLSGE  780 (823)
Q Consensus       734 ~~-----------~~~~l--~~~~~~~-----~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~  780 (823)
                      +.           ....+  .......     ...++.+|+.+||+.||++|||++|+++  .|++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence            00           00000  0011111     1235778999999999999999999997  34443

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-38  Score=343.07  Aligned_cols=261  Identities=23%  Similarity=0.283  Sum_probs=188.1

Q ss_pred             cCCCcCCeeeccCccceEEEEeec-CcEEEEEEecCCc--cccHHHHHHHHHHHhccCCCCceeEEEEeec------CCc
Q 003391          504 ENFSDKNKLGEGGFGPVYKGVLIE-GQEIAAKRLSKSS--GQGMEEFENEVLLIAKLQHRNLVKLIGCCTQ------RDE  574 (823)
Q Consensus       504 ~~~~~~~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~~  574 (823)
                      ++|++.++||+|+||+||+|++.. ++.||||++....  .....++.+|+.++++++||||+++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            679999999999999999999864 8999999997543  3345578899999999999999999999853      367


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceeeccccce
Q 003391          575 RMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGMAR  654 (823)
Q Consensus       575 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  654 (823)
                      .++||||+.++.+. .+.     ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~iv~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEeccchHHHH-hhh-----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence            89999999765544 331     34789999999999999999999998   9999999999999999999999999988


Q ss_pred             ecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHH--------HH--
Q 003391          655 AFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGH--------AW--  724 (823)
Q Consensus       655 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~--------~~--  724 (823)
                      .....   .......+|+.|+|||++.+..++.++||||+||+++||++|+.||...+.......+..        .+  
T Consensus       168 ~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (355)
T d2b1pa1         168 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             ccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence            65432   233446789999999999999999999999999999999999999854321111000000        00  


Q ss_pred             -----HHhhhcCc-------hhhhhhhcCCCCC---HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 003391          725 -----RLWIEERP-------VELINKSLGGSYS---LSEVLRCIQVGLLCVQQRPEDRPNMSSVVLM  776 (823)
Q Consensus       725 -----~~~~~~~~-------~~~~~~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  776 (823)
                           ........       .............   .....++.+|+.+||+.||++|||++|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                 00000000       0011111111111   1223478899999999999999999999854

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.2e-34  Score=315.13  Aligned_cols=279  Identities=19%  Similarity=0.227  Sum_probs=199.8

Q ss_pred             CCCcCCeeeccCccceEEEEee-cCcEEEEEEecCCccccHHHHHHHHHHHhccC-----------CCCceeEEEEeecC
Q 003391          505 NFSDKNKLGEGGFGPVYKGVLI-EGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-----------HRNLVKLIGCCTQR  572 (823)
Q Consensus       505 ~~~~~~~LG~G~fg~Vyk~~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~g~~~~~  572 (823)
                      +|++.++||+|+||+||+|+.. +|+.||||++++.. ...+.+.+|+.++++++           |+||+++++++...
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            5889999999999999999975 48999999997543 23467788999888875           57899999888653


Q ss_pred             --CceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHh-cCCCceEecccCCCcEEEcCCCC-----
Q 003391          573 --DERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNEMN-----  644 (823)
Q Consensus       573 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NIll~~~~~-----  644 (823)
                        ...+++++++..+..............+++..+..++.||++||+|||+ .+   |+||||||+||||+.++.     
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccc
Confidence              4567777777666555444445566678999999999999999999998 55   999999999999986654     


Q ss_pred             -ceeeccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHHHHHHhcCCCCCCcCCCCccchhHHH
Q 003391          645 -PKISDFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIVCGKRNRGFYHADHHHNLLGHA  723 (823)
Q Consensus       645 -~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl~elltG~~p~~~~~~~~~~~l~~~~  723 (823)
                       ++++|||.+.....     ......||+.|+|||++.+..++.++||||+||+++||++|+.||...............
T Consensus       170 ~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~  244 (362)
T d1q8ya_         170 QIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  244 (362)
T ss_dssp             EEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             eeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence             89999999986532     223467999999999999999999999999999999999999998643322211111111


Q ss_pred             HHH--hhhcCchhhhhh-----------------------------hcCCCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 003391          724 WRL--WIEERPVELINK-----------------------------SLGGSYSLSEVLRCIQVGLLCVQQRPEDRPNMSS  772 (823)
Q Consensus       724 ~~~--~~~~~~~~~~~~-----------------------------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e  772 (823)
                      ...  .......+....                             ............++.+|+.+||+.||.+|||++|
T Consensus       245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e  324 (362)
T d1q8ya_         245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  324 (362)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence            000  000000000000                             0011233455668899999999999999999999


Q ss_pred             HHHH--hcc---CCCCCCCCCCCCc
Q 003391          773 VVLM--LSG---ERSLPQPKQPGFF  792 (823)
Q Consensus       773 vl~~--L~~---~~~~~~p~~p~~~  792 (823)
                      +++.  |++   ..++..|..+-+.
T Consensus       325 ~L~Hp~f~~~~~~~~~~~p~~~~~~  349 (362)
T d1q8ya_         325 LVNHPWLKDTLGMEEIRVPDRELYG  349 (362)
T ss_dssp             HHTCGGGTTCTTCTTCCCTTSCTTC
T ss_pred             HhcCcccCCCCCcccCCCCCcccCC
Confidence            9874  432   2344455554443

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.84  E-value=1.5e-21  Score=191.99  Aligned_cols=169  Identities=19%  Similarity=0.141  Sum_probs=121.0

Q ss_pred             CcCCeeeccCccceEEEEeecCcEEEEEEecCCcc------------------ccHHHHHHHHHHHhccCCCCceeEEEE
Q 003391          507 SDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSG------------------QGMEEFENEVLLIAKLQHRNLVKLIGC  568 (823)
Q Consensus       507 ~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~------------------~~~~~~~~Ei~~l~~l~H~niv~l~g~  568 (823)
                      .+.++||+|+||.||+|++.+|+.||||+++....                  .....+..|+..+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            45689999999999999988899999998753211                  012234568889999999999998866


Q ss_pred             eecCCceEEEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEEcCCCCceee
Q 003391          569 CTQRDERMLIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKIS  648 (823)
Q Consensus       569 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIll~~~~~~kl~  648 (823)
                      .    ..+++|||+++..+.+          ++......++.|++++|+|||+.+   |+||||||+|||+++++ ++|+
T Consensus        83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~li  144 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWII  144 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEEC
T ss_pred             c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEE
Confidence            3    2479999998865543          334456689999999999999998   99999999999999654 8999


Q ss_pred             ccccceecCCCccccccccccccCCccCccccccCCCCccchhHhHHHHH
Q 003391          649 DFGMARAFGIDQTEANTNRVVGTYGYMPPEYAIDGLFSVKSDVFSFGVLV  698 (823)
Q Consensus       649 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~ksDVwS~Gvvl  698 (823)
                      |||+|.....+.........+.   . -.| +....|+.++|+||..--+
T Consensus       145 DFG~a~~~~~~~~~~~l~rd~~---~-~~~-~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         145 DFPQSVEVGEEGWREILERDVR---N-IIT-YFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCTTCEETTSTTHHHHHHHHHH---H-HHH-HHHHHHCCCCCHHHHHHHH
T ss_pred             ECCCcccCCCCCcHHHHHHHHH---H-HHH-HHcCCCCCcccHHHHHHHH
Confidence            9999986532211100000000   0 011 1245678899999975443

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

Probab=99.83  E-value=1.1e-20  Score=167.51  Aligned_cols=112  Identities=23%  Similarity=0.468  Sum_probs=94.8

Q ss_pred             cccccCCCcccCCCeEeeCCCeEEEeeecCCCCCCeEEEEEEeecCCCcEEEeecCCCCCCCCCCceEEEecCCceEEEe
Q 003391           18 RDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLL   97 (823)
Q Consensus        18 ~~~~~~g~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~giw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~~~l~l~   97 (823)
                      .|+|.|||.|.+|++|+|  |.|.|.|+.+|+     |.++.    ..++||.||++.|..  .+.|.|+.||+  |||+
T Consensus         1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~----~~~~vW~s~~~~~~~--~~~l~l~~dGn--Lvl~   65 (112)
T d1xd5a_           1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD----NNRAVWASGTNGKAS--GCVLKMQNDGN--LVIY   65 (112)
T ss_dssp             CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE----TTEEEEECCCTTSCS--SEEEEECTTSC--EEEE
T ss_pred             CCEecCCCEecCCCEEEE--CCEEEEEcCCCC-----EEEEc----CCcEEEEccCccCCC--CcEEEEecccc--EEEE
Confidence            489999999999999985  999999998887     44443    578999999998743  46899999999  9999


Q ss_pred             cCCCCeEEeecCCCCCCcceEEEecCCCEEEecCCCCCCCcceeeecCCCcc
Q 003391           98 NSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFDYPSH  149 (823)
Q Consensus        98 ~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqSFd~PTD  149 (823)
                      +. +..+|++++.......+++|+|+|||||++.+    ++++|||+.+|+|
T Consensus        66 ~~-~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~----~~~~W~S~t~~~n  112 (112)
T d1xd5a_          66 SG-SRAIWASNTNRQNGNYYLILQRDRNVVIYDNS----NNAIWATHTNVGN  112 (112)
T ss_dssp             ET-TEEEEECCCCCSCCCCEEEECTTSCEEEECTT----SCEEEECCCCCCC
T ss_pred             ec-CCeEEEEeeccCCCceEEEEcCCCCEEEECCC----CcEEecCCCccCC
Confidence            86 56788888765556678999999999999876    7789999999985

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

Probab=99.82  E-value=2.2e-20  Score=163.97  Aligned_cols=107  Identities=27%  Similarity=0.409  Sum_probs=92.2

Q ss_pred             cccccCCCcccCCCeEeeCCCeEEEeeecCCCCCCeEEEEEEeecCCCcEEEeecCCCCCCCCCCceEEEecCCceEEEe
Q 003391           18 RDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLL   97 (823)
Q Consensus        18 ~~~~~~g~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~giw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~~~l~l~   97 (823)
                      .|+|.+||.|.+|+.|.  +|.|.|.|+.+|+     |.|+.    ..++||.||++.|-  ..+.|.|+.||+  |+|+
T Consensus         1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~----~~~~vW~s~~~~~~--~~~~l~l~~~Gn--lvl~   65 (108)
T d1jpca_           1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYD----VDKPIWATNTGGLS--RSCFLSMQTDGN--LVVY   65 (108)
T ss_dssp             CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEE----TTEEEEECCCTTSC--SSCEEEECTTSC--EEEE
T ss_pred             CCCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEe----CCceeeEeCCCCCC--CccEEEEeccce--EEEE
Confidence            48999999999999995  6999999999888     55654    46889999999873  356899999999  9999


Q ss_pred             cCCCCeEEeecCCCCCCcceEEEecCCCEEEecCCCCCCCcceeeecCC
Q 003391           98 NSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFDY  146 (823)
Q Consensus        98 ~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqSFd~  146 (823)
                      +++|.+||+|++.......+|+|+|+|||||++..       +||||+|
T Consensus        66 ~~~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~~-------~W~S~t~  107 (108)
T d1jpca_          66 NPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGTD-------RWATGTH  107 (108)
T ss_dssp             CTTCCEEEECCCCCSCSCEEEEECTTSCEEEEECC-------CCCCCCC
T ss_pred             CCCccceEEccccCCCCcEEEEEcCCCCEEEeCCC-------cccCCCC
Confidence            99999999999876666668899999999999643       8999987

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

Probab=99.82  E-value=3.2e-20  Score=162.89  Aligned_cols=108  Identities=26%  Similarity=0.463  Sum_probs=92.0

Q ss_pred             cccccCCCcccCCCeEeeCCCeEEEeeecCCCCCCeEEEEEEeecCCCcEEEeecCCCCCCCCCCceEEEecCCceEEEe
Q 003391           18 RDTLNLGQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLL   97 (823)
Q Consensus        18 ~~~~~~g~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~giw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~~~l~l~   97 (823)
                      +|+|.+||.|.+|++|.+  |.|.|+|+.+|+     |.+ |.   ..++||+||++.|... .+.|.|+.||+  |||+
T Consensus         1 ~~~L~~g~~L~~g~~l~~--g~~~l~~q~dgn-----Lvl-~~---~~~~vW~ant~~~~~~-~~~l~l~~dGn--Lvl~   66 (109)
T d1kj1a_           1 RNLLTNGEGLYAGQSLDV--EPYHFIMQEDCN-----LVL-YD---HSTSVWASNTGILGKK-GCKAVLQSDGN--FVVY   66 (109)
T ss_dssp             CCEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEE-EE---TTEEEEECCCCCTTCC-CCEEEECTTSC--EEEE
T ss_pred             CCCccCCCEEeCCCEEEe--CCEEEEecCCCe-----EEE-Ee---CCEEEEEeCCCCCCce-eEEEEEcCCce--EEEE
Confidence            489999999999999975  889999988777     334 32   5689999999998765 67899999999  9999


Q ss_pred             cCCCCeEEeecCCCCCCcceEEEecCCCEEEecCCCCCCCcceeeecCC
Q 003391           98 NSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFDY  146 (823)
Q Consensus        98 ~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqSFd~  146 (823)
                      |++|.+||+|+++......+|+|+|+|||||++.       .+|||+-|
T Consensus        67 ~~~g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~-------~~W~S~t~  108 (109)
T d1kj1a_          67 DAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGS-------DIWSTGTY  108 (109)
T ss_dssp             CSSSCEEEECCCCCCSSCCEEEECTTSCEEEECC-------EEEECCCC
T ss_pred             eCCCcEEEEEeeECCCCCEEEEEeCCCcEEEECC-------CEecCCCc
Confidence            9999999999987655667899999999999963       39999865

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.67  E-value=4.9e-17  Score=144.72  Aligned_cols=103  Identities=23%  Similarity=0.344  Sum_probs=88.3

Q ss_pred             EEEEeecCCCcEEEeecCCCCCCCCCCceEEEecCCceEEEecCCCCeEEeecCCCCCCcceEEEecCCCEEEecCCCCC
Q 003391           56 GIWYKKIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDID  135 (823)
Q Consensus        56 giw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~~~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~  135 (823)
                      -|||.++++++.+|++|++.|+....-+|.|+.|||  |||++. +.++|++++.+......+.|+++|||||++.+   
T Consensus        11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGN--LvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~---   84 (120)
T d1dlpa2          11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCN--LVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQ---   84 (120)
T ss_dssp             EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTE--EEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETT---
T ss_pred             eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCc--EEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCC---
Confidence            589999999999999999999998778999999999  999986 67899999876666778999999999999977   


Q ss_pred             CCcceeeecCCCcccccccCcccceeccCcceeEEEcccCCCCCCCccEEeeCCCCCCeEE
Q 003391          136 PDNFLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSADDPAQDDYVYGIDPSGVPQAV  196 (823)
Q Consensus       136 ~~~~~wqSFd~PTDtlLpgq~l~~~~~tg~~~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~  196 (823)
                       +++|||||.                               +.+.|.|.+.++++|...++
T Consensus        85 -~~~lW~S~t-------------------------------~~~~~~~~l~Lq~DGnlvlY  113 (120)
T d1dlpa2          85 -NIAVWTSGN-------------------------------SRSAGRYVFVLQPDRNLAIY  113 (120)
T ss_dssp             -TEEEEECCC-------------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred             -CCEEEEeCC-------------------------------CCCCCcEEEEECCCCcEEEe
Confidence             789999984                               23467889999999987665

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.55  E-value=9.8e-15  Score=129.15  Aligned_cols=101  Identities=23%  Similarity=0.367  Sum_probs=80.5

Q ss_pred             CcccCCCe--EeeCCCeEEEeeecCCCCCCeEEEEEEeecCCCcEEEeecCCCCCCCCCCceEEEecCCceEEEecCCCC
Q 003391           25 QSIRDGET--LVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNG  102 (823)
Q Consensus        25 ~~l~~~~~--l~s~~g~f~~gf~~~~~~~~~~~giw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~~~l~l~~~~~~  102 (823)
                      |.|.++|.  +.+..|.|.|.|+.+||     |.+ |.   ..++||.||+..|..  .+.|.|+.||+  |+|.|++|.
T Consensus        15 ~~l~~~q~l~~~~~~~~y~l~mQ~DGN-----LVL-y~---~~~~vWssnt~~~~~--~~~l~l~~dGn--LvL~d~~g~   81 (119)
T d1b2pa_          15 QILHATESLEILFGTHVYRFIMQTDCN-----LVL-YD---NNNPIWATNTGGLGN--GCRAVLQPDGV--LVVITNENV   81 (119)
T ss_dssp             CEEETTCEEEEEETTEEEEEEECTTSC-----EEE-EE---TTEEEEECCCTTSCS--SCEEEECTTSC--EEEECTTCC
T ss_pred             CEEeCCCeEEEecCCceEEEEECCCCc-----EEE-EE---CCeEEEEecCCCCCc--ceEEEEEeCCC--EEEECCCCc
Confidence            44445554  46679999999999888     333 43   478999999987633  47899999999  999999999


Q ss_pred             eEEeecCCCCCCcceEEEecCCCEEEecCCCCCCCcceeeecC
Q 003391          103 IVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFD  145 (823)
Q Consensus       103 ~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqSFd  145 (823)
                      +||++++.......+++|+|+|||||++.       .+|||-.
T Consensus        82 ~vWsS~t~~~~~~~~l~Lq~DGNlvlYg~-------~~W~S~T  117 (119)
T d1b2pa_          82 TVWQSPVAGKAGHYVLVLQPDRNVVIYGD-------ALWATQT  117 (119)
T ss_dssp             EEEECSCCCCSSCEEEEECTTSCEEEEES-------EEEECCC
T ss_pred             EEEECCCcCCCCceEEEEcCCCCEEEECC-------CEeccCC
Confidence            99999987655666789999999999953       4999964

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.52  E-value=2.8e-15  Score=131.73  Aligned_cols=110  Identities=25%  Similarity=0.319  Sum_probs=92.5

Q ss_pred             EEEeecCCCcEEEeecCCCCCCCCCCceEEEecCCceEEEecCCCCeEEeecCCCCCCcceEEEecCCCEEEecCCCCCC
Q 003391           57 IWYKKIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDP  136 (823)
Q Consensus        57 iw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~~~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~  136 (823)
                      |||...+..+..|..+.+.++.....+|.|+.|||  |||+++ +.++|++++.+ .....+.|+|+|||||++.+    
T Consensus         3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGN--LvL~~~-~~~vW~s~t~~-~~~~~l~l~~dGNLvl~d~~----   74 (115)
T d1dlpa1           3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCN--LVLFDS-DVRVWASNTAG-ATGCRAVLQSDGLLVILTAQ----   74 (115)
T ss_dssp             CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSC--EEEEES-SSEEECCCCCS-CSCCBCCBCSSSCBCCBCTT----
T ss_pred             EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCe--EEEEcC-CeeEEEcccCC-CCceEEEEeccCCEEEEccC----
Confidence            78877788888999999999988788999999999  999985 67899999864 45678899999999999977    


Q ss_pred             CcceeeecCCCcccccccCcccceeccCcceeEEEcccCCCCCCCccEEeeCCCCCCeEEEEcCceeeeecCC
Q 003391          137 DNFLWQSFDYPSHILIAGMKLGVNLVTGLNRFISSWKSADDPAQDDYVYGIDPSGVPQAVFRKGSTIRYRAGS  209 (823)
Q Consensus       137 ~~~~wqSFd~PTDtlLpgq~l~~~~~tg~~~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~sg~  209 (823)
                      +.+||||+-                               +.+.|.|.+.++++|...++    ..++|.+|.
T Consensus        75 ~~~vWsS~t-------------------------------~~~~g~y~l~Lq~DGNlvlY----~~~~Wssgt  112 (115)
T d1dlpa1          75 NTIRWSSGT-------------------------------KGSIGNYVLVLQPDRTVTIY----GPGLWDSGT  112 (115)
T ss_dssp             TCCSCCCCC-------------------------------CCCSSCCEEEECSSSCEEEE----CSEEEECSC
T ss_pred             CCEEEEcCC-------------------------------CCCCCCEEEEECCCCcEEEe----CCCeecCCC
Confidence            778999873                               34578999999999997655    347888775

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.39  E-value=1.4e-13  Score=120.77  Aligned_cols=99  Identities=25%  Similarity=0.368  Sum_probs=78.0

Q ss_pred             CCcccCCCeEeeCCCeEEEeeecCCCCCCeEEEEEEeecCCCcEEEeecCCCCCCCCCCceEEEecCCceEEEecCCCCe
Q 003391           24 GQSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGI  103 (823)
Q Consensus        24 g~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~giw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~~~l~l~~~~~~~  103 (823)
                      .|+|.+++.|  .+|.|.|.|..+|+     |.++.    ...+||.+|...   ...+.+.|..|||  |||+|.++.+
T Consensus        14 ~~tl~~~~~l--~~g~~~l~~q~DGN-----LvL~~----~~~~vW~s~t~~---~~~~~l~l~~dGN--Lvl~d~~~~~   77 (115)
T d1dlpa1          14 PQTLHAAQSL--ELSSFRFTMQSDCN-----LVLFD----SDVRVWASNTAG---ATGCRAVLQSDGL--LVILTAQNTI   77 (115)
T ss_dssp             CSCCCTTCEE--CSTTEEEEECTTSC-----EEEEE----SSSEEECCCCCS---CSCCBCCBCSSSC--BCCBCTTTCC
T ss_pred             cceecCCCcE--EcCCEEEEECCCCe-----EEEEc----CCeeEEEcccCC---CCceEEEEeccCC--EEEEccCCCE
Confidence            3555556666  36779999998888     45543    467899999754   2357899999999  9999999999


Q ss_pred             EEeecCCCCCCcceEEEecCCCEEEecCCCCCCCcceeeecC
Q 003391          104 VWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFD  145 (823)
Q Consensus       104 ~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqSFd  145 (823)
                      ||++++.......+++|+++|||||++.       .+|+|-.
T Consensus        78 vWsS~t~~~~g~y~l~Lq~DGNlvlY~~-------~~Wssgt  112 (115)
T d1dlpa1          78 RWSSGTKGSIGNYVLVLQPDRTVTIYGP-------GLWDSGT  112 (115)
T ss_dssp             SCCCCCCCCSSCCEEEECSSSCEEEECS-------EEEECSC
T ss_pred             EEEcCCCCCCCCEEEEECCCCcEEEeCC-------CeecCCC
Confidence            9999987666667899999999999953       4999854

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.08  E-value=1.1e-10  Score=102.91  Aligned_cols=97  Identities=24%  Similarity=0.408  Sum_probs=70.4

Q ss_pred             CcccCCCeEeeCCCeEEEeeecCCCCCCeEEEEEEeecCCCcEEEeecCCCCCCCCCCceEEEecCCceEEEecCCCCeE
Q 003391           25 QSIRDGETLVSANESFELGFFSPGKSKSRYLGIWYKKIGNGTVIWVANRDAPLSDRSGALNISSQGNATLVLLNSTNGIV  104 (823)
Q Consensus        25 ~~l~~~~~l~s~~g~f~~gf~~~~~~~~~~~giw~~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~~~l~l~~~~~~~~  104 (823)
                      +.|.+++.|.  .|.|.|.|...|+     |.|+.    ...+||.++...  ......+.|..+||  |||+|.++.++
T Consensus        24 ~~l~~~q~l~--~g~y~L~~q~DGN-----LvL~~----~~~~vW~s~t~~--~~~~~~~~l~~~Gn--Lvl~d~~~~~l   88 (120)
T d1dlpa2          24 QTLHATQSLQ--LSPYRLSMETDCN-----LVLFD----RDDRVWSTNTAG--KGTGCRAVLQPNGR--MDVLTNQNIAV   88 (120)
T ss_dssp             CEECSSCCCB--CSSCEEEEETTTE-----EEEEB----TTBCCSCCCCCS--SCSSCEEEEETTTE--EEEEETTTEEE
T ss_pred             cEEcCCCeeE--cCCEEEEEcCCCc-----EEEec----CCcEEEEEcccc--CCCcEEEEEeCCee--EEEEcCCCCEE
Confidence            4444444442  3557777766655     33432    457789997543  34456899999999  99999999999


Q ss_pred             EeecCCCCCCcceEEEecCCCEEEecCCCCCCCcceeee
Q 003391          105 WSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQS  143 (823)
Q Consensus       105 w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqS  143 (823)
                      |+|++.......+++|+++|||||++.       .+|.|
T Consensus        89 W~S~t~~~~~~~~l~Lq~DGnlvlY~~-------~~W~t  120 (120)
T d1dlpa2          89 WTSGNSRSAGRYVFVLQPDRNLAIYGG-------ALWTT  120 (120)
T ss_dssp             EECCCCCSSSCCEEEECSSSCEEEECC-------CCCBC
T ss_pred             EEeCCCCCCCcEEEEECCCCcEEEeCC-------CcccC
Confidence            999987666667889999999999953       28876

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=98.88  E-value=4e-09  Score=92.49  Aligned_cols=85  Identities=24%  Similarity=0.340  Sum_probs=67.2

Q ss_pred             ceEEEecCCceEEEecCCCCeEEeecCCCCCCcceEEEecCCCEEEecCCCCCCCcceeeecCCCcccccccCcccceec
Q 003391           83 ALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVNLV  162 (823)
Q Consensus        83 ~l~~~~~g~~~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqSFd~PTDtlLpgq~l~~~~~  162 (823)
                      +|.|+.|||  |||+++ +.++|++++.+......+.|.++|||||++.+    +.+||+|.-                 
T Consensus        33 ~l~mQ~DGN--LVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~----g~~vWsS~t-----------------   88 (119)
T d1b2pa_          33 RFIMQTDCN--LVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNE----NVTVWQSPV-----------------   88 (119)
T ss_dssp             EEEECTTSC--EEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTT----CCEEEECSC-----------------
T ss_pred             EEEECCCCc--EEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECCC----CcEEEECCC-----------------
Confidence            578899999  999976 46899999876656678999999999999977    778897632                 


Q ss_pred             cCcceeEEEcccCCCCCCCccEEeeCCCCCCeEEEEcCceeeeecCC
Q 003391          163 TGLNRFISSWKSADDPAQDDYVYGIDPSGVPQAVFRKGSTIRYRAGS  209 (823)
Q Consensus       163 tg~~~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~sg~  209 (823)
                                    .-+.|.|.+.++++|...++    ..+.|.++.
T Consensus        89 --------------~~~~~~~~l~Lq~DGNlvlY----g~~~W~S~T  117 (119)
T d1b2pa_          89 --------------AGKAGHYVLVLQPDRNVVIY----GDALWATQT  117 (119)
T ss_dssp             --------------CCCSSCEEEEECTTSCEEEE----ESEEEECCC
T ss_pred             --------------cCCCCceEEEEcCCCCEEEE----CCCEeccCC
Confidence                          12346788999999988765    246787764

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

Probab=98.82  E-value=6.7e-09  Score=89.68  Aligned_cols=85  Identities=22%  Similarity=0.359  Sum_probs=65.6

Q ss_pred             CceEEEecCCceEEEecCCCCeEEeecCCCCCCcceEEEecCCCEEEecCCCCCCCcceeeecCCCcccccccCccccee
Q 003391           82 GALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVNL  161 (823)
Q Consensus        82 ~~l~~~~~g~~~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqSFd~PTDtlLpgq~l~~~~  161 (823)
                      -+|.|+.|||  |||++. +.+||++++.+......+.|.++|||||++.+    +.+||+|                  
T Consensus        21 ~~l~~q~DGN--Lvly~~-~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~----g~~vWsS------------------   75 (108)
T d1jpca_          21 FVFIMQEDCN--LVLYDV-DKPIWATNTGGLSRSCFLSMQTDGNLVVYNPS----NKPIWAS------------------   75 (108)
T ss_dssp             EEEEECTTSC--EEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTT----CCEEEEC------------------
T ss_pred             EEEEECCCCe--EEEEeC-CceeeEeCCCCCCCccEEEEeccceEEEECCC----ccceEEc------------------
Confidence            4688999999  999985 57899999876656678999999999999987    7789986                  


Q ss_pred             ccCcceeEEEcccCCCCCCCccEEeeCCCCCCeEEEEcCceeeeecC
Q 003391          162 VTGLNRFISSWKSADDPAQDDYVYGIDPSGVPQAVFRKGSTIRYRAG  208 (823)
Q Consensus       162 ~tg~~~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~sg  208 (823)
                                   ......+.|.+.++.+|...++    ..+.|.++
T Consensus        76 -------------~t~~~~~~~~l~L~ddGNlVly----~~~~W~S~  105 (108)
T d1jpca_          76 -------------NTGGQNGNYVCILQKDRNVVIY----GTDRWATG  105 (108)
T ss_dssp             -------------CCCCSCSCEEEEECTTSCEEEE----ECCCCCCC
T ss_pred             -------------cccCCCCcEEEEEcCCCCEEEe----CCCcccCC
Confidence                         1112356788899999987765    23456555

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

Probab=98.69  E-value=4.4e-08  Score=84.45  Aligned_cols=87  Identities=26%  Similarity=0.397  Sum_probs=64.9

Q ss_pred             CceEEEecCCceEEEecCCCCeEEeecCCCC-CCcceEEEecCCCEEEecCCCCCCCcceeeecCCCcccccccCcccce
Q 003391           82 GALNISSQGNATLVLLNSTNGIVWSSNASRT-ARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVN  160 (823)
Q Consensus        82 ~~l~~~~~g~~~l~l~~~~~~~~w~~~~~~~-~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqSFd~PTDtlLpgq~l~~~  160 (823)
                      -.|.|+.|||  |||++. +.+||++++... .....+.|.++|||||++++    +.++|+|=                
T Consensus        21 ~~l~~q~dgn--Lvl~~~-~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~----g~~vW~s~----------------   77 (109)
T d1kj1a_          21 YHFIMQEDCN--LVLYDH-STSVWASNTGILGKKGCKAVLQSDGNFVVYDAE----GRSLWASH----------------   77 (109)
T ss_dssp             EEEEECTTSC--EEEEET-TEEEEECCCCCTTCCCCEEEECTTSCEEEECSS----SCEEEECC----------------
T ss_pred             EEEEecCCCe--EEEEeC-CEEEEEeCCCCCCceeEEEEEcCCceEEEEeCC----CcEEEEEe----------------
Confidence            4678889999  999874 578999997643 23466889999999999977    77889871                


Q ss_pred             eccCcceeEEEcccCCCCCCCccEEeeCCCCCCeEEEEcCceeeeecCCC
Q 003391          161 LVTGLNRFISSWKSADDPAQDDYVYGIDPSGVPQAVFRKGSTIRYRAGSW  210 (823)
Q Consensus       161 ~~tg~~~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~sg~w  210 (823)
                                     +..+.|.|.+.++++|...++  .  .+.|.++.+
T Consensus        78 ---------------t~~~~~~~~l~L~ddGNlvly--~--~~~W~S~t~  108 (109)
T d1kj1a_          78 ---------------SVRGNGNYVLVLQEDGNVVIY--G--SDIWSTGTY  108 (109)
T ss_dssp             ---------------CCCCSSCCEEEECTTSCEEEE--C--CEEEECCCC
T ss_pred             ---------------eECCCCCEEEEEeCCCcEEEE--C--CCEecCCCc
Confidence                           112246788999999987665  2  357877653

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

Probab=98.50  E-value=2.9e-07  Score=79.87  Aligned_cols=89  Identities=21%  Similarity=0.324  Sum_probs=66.2

Q ss_pred             CCceEEEecCCceEEEecCCCCeEEeecCCCCCCcceEEEecCCCEEEecCCCCCCCcceeeecCCCcccccccCcccce
Q 003391           81 SGALNISSQGNATLVLLNSTNGIVWSSNASRTARNPVAVLLESGNLVVKDGKDIDPDNFLWQSFDYPSHILIAGMKLGVN  160 (823)
Q Consensus        81 ~~~l~~~~~g~~~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~wqSFd~PTDtlLpgq~l~~~  160 (823)
                      .-.|.|+.|||  |||++. +.+||++++........+.|..+|||||++..     +.+|.|                 
T Consensus        20 ~~~l~~q~DGN--Lvly~~-~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~~-----~~~w~s-----------------   74 (112)
T d1xd5a_          20 GYLFIIQNDCN--LVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYSGS-----RAIWAS-----------------   74 (112)
T ss_dssp             TEEEEECTTSC--EEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEETT-----EEEEEC-----------------
T ss_pred             CEEEEEcCCCC--EEEEcC-CcEEEEccCccCCCCcEEEEeccccEEEEecC-----CeEEEE-----------------
Confidence            45788999999  999974 57999999776556678999999999999843     345543                 


Q ss_pred             eccCcceeEEEcccCCCCCCCccEEeeCCCCCCeEEEEcCceeeeecCC
Q 003391          161 LVTGLNRFISSWKSADDPAQDDYVYGIDPSGVPQAVFRKGSTIRYRAGS  209 (823)
Q Consensus       161 ~~tg~~~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~sg~  209 (823)
                                    .+.-..|.+.+.++.+|...++- ....+.|.++.
T Consensus        75 --------------~t~~~~~~~~l~L~ddGNlvly~-~~~~~~W~S~t  108 (112)
T d1xd5a_          75 --------------NTNRQNGNYYLILQRDRNVVIYD-NSNNAIWATHT  108 (112)
T ss_dssp             --------------CCCCSCCCCEEEECTTSCEEEEC-TTSCEEEECCC
T ss_pred             --------------eeccCCCceEEEEcCCCCEEEEC-CCCcEEecCCC
Confidence                          22233567899999999876653 33467888875

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.35  E-value=7.4e-07  Score=89.85  Aligned_cols=149  Identities=17%  Similarity=0.104  Sum_probs=99.7

Q ss_pred             HHHHHhcCCCcCCeeeccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccC-CCCceeEEEEeecCCceE
Q 003391          498 AIANATENFSDKNKLGEGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERM  576 (823)
Q Consensus       498 ~l~~~~~~~~~~~~LG~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~  576 (823)
                      ++....+.|+..+..+.+....||+... +++.+++|+...........+.+|...+..+. +--+.+++.+..+++..+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            4455556666554444344467998764 56778889887665555556788888887763 545678888888888899


Q ss_pred             EEEeecCCCCcchhhhccCCCCccCHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 003391          577 LIYEYLPNKSLNDFIFDVTRSKFLDWSKRCQIIGGIARGLLYLHQDS---------------------------------  623 (823)
Q Consensus       577 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------  623 (823)
                      +||+++++.++.+.....        .....++.++++.++.||+..                                 
T Consensus        87 lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred             EEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence            999999998776543111        111223344444444444321                                 


Q ss_pred             -----------------------CCceEecccCCCcEEEcCCCCceeecccccee
Q 003391          624 -----------------------RLRIIHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       624 -----------------------~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                                             ...++|+|+.+.||++++++..-|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                   11379999999999999877677999998753

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.66  E-value=8e-05  Score=73.91  Aligned_cols=141  Identities=14%  Similarity=0.109  Sum_probs=84.9

Q ss_pred             eeeccCc-cceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccC--CCCceeEEEEeecCCceEEEEeecCCCCc
Q 003391          511 KLGEGGF-GPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQ--HRNLVKLIGCCTQRDERMLIYEYLPNKSL  587 (823)
Q Consensus       511 ~LG~G~f-g~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV~e~~~~gsL  587 (823)
                      .+..|.. ..||+....++..+++|.......   ..+..|...++.+.  ...+.+++++..+.+..++||+++++.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4445554 578999887777888887654432   24566777776663  34467788888888889999999998766


Q ss_pred             chhhh--------------cc---C-CCCcc--CHHHHHHHHH--------------------HHHHHHHHHHhc----C
Q 003391          588 NDFIF--------------DV---T-RSKFL--DWSKRCQIIG--------------------GIARGLLYLHQD----S  623 (823)
Q Consensus       588 ~~~l~--------------~~---~-~~~~l--~~~~~~~i~~--------------------~ia~gL~yLH~~----~  623 (823)
                      .+...              ..   . ....+  .+.....-..                    .....+..+...    .
T Consensus        94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  173 (255)
T d1nd4a_          94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE  173 (255)
T ss_dssp             TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred             ccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence            44210              00   0 00000  0000000000                    011223333322    1


Q ss_pred             CCceEecccCCCcEEEcCCCCceeeccccce
Q 003391          624 RLRIIHRDLKASNVLLDNEMNPKISDFGMAR  654 (823)
Q Consensus       624 ~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~  654 (823)
                      +..++|+|+.|.||+++++..+-|+||+.+.
T Consensus       174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             CEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence            2248999999999999987777899998775

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.22  E-value=0.0004  Score=73.65  Aligned_cols=76  Identities=12%  Similarity=0.157  Sum_probs=49.3

Q ss_pred             CeeeccCccceEEEEeec-CcEEEEEEecCC-------ccccHHHHHHHHHHHhccC-C--CCceeEEEEeecCCceEEE
Q 003391          510 NKLGEGGFGPVYKGVLIE-GQEIAAKRLSKS-------SGQGMEEFENEVLLIAKLQ-H--RNLVKLIGCCTQRDERMLI  578 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~-~~~vavK~l~~~-------~~~~~~~~~~Ei~~l~~l~-H--~niv~l~g~~~~~~~~~lV  578 (823)
                      +.||.|....||+....+ ++.+++|.-...       .....++...|.+.|+.+. +  ..+.+++.+  +.+..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            478999999999998765 678899865331       1123445566887777662 2  345556554  44567899


Q ss_pred             EeecCCCCc
Q 003391          579 YEYLPNKSL  587 (823)
Q Consensus       579 ~e~~~~gsL  587 (823)
                      ||++++..+
T Consensus       110 mE~L~~~~~  118 (392)
T d2pula1         110 MEDLSHLKI  118 (392)
T ss_dssp             ECCCTTSEE
T ss_pred             EeccCCccc
Confidence            999987554

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.43  E-value=0.004  Score=63.78  Aligned_cols=135  Identities=11%  Similarity=0.150  Sum_probs=77.9

Q ss_pred             cceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCCC--ceeEEE-----EeecCCceEEEEeecCCCCcchh
Q 003391          518 GPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHRN--LVKLIG-----CCTQRDERMLIYEYLPNKSLNDF  590 (823)
Q Consensus       518 g~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g-----~~~~~~~~~lV~e~~~~gsL~~~  590 (823)
                      -.||+.+..+|+.+++|..+.. ....+++..|+..+..|....  ++..+.     .....+..+.++++++|..+...
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            5799999988999999987654 335677888988888774221  222211     12234557889999987544310


Q ss_pred             --------------hhc------cCCCCccCHHH-------------------HHHHHHHHHHHHHHHHh----cCCCce
Q 003391          591 --------------IFD------VTRSKFLDWSK-------------------RCQIIGGIARGLLYLHQ----DSRLRI  627 (823)
Q Consensus       591 --------------l~~------~~~~~~l~~~~-------------------~~~i~~~ia~gL~yLH~----~~~~~i  627 (823)
                                    ++.      ......+++..                   ...+...+.+.++.+..    ..+..+
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence                          010      00111122111                   11111112223333322    234468


Q ss_pred             EecccCCCcEEEcCCCCceeecccccee
Q 003391          628 IHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       628 vH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                      ||+|+.+.|||++++  ..++||+-+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999754  45889998764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.29  E-value=0.0065  Score=63.98  Aligned_cols=73  Identities=16%  Similarity=0.215  Sum_probs=49.7

Q ss_pred             CeeeccCccceEEEEeecC--------cEEEEEEecCCccccHHHHHHHHHHHhccC-CCCceeEEEEeecCCceEEEEe
Q 003391          510 NKLGEGGFGPVYKGVLIEG--------QEIAAKRLSKSSGQGMEEFENEVLLIAKLQ-HRNLVKLIGCCTQRDERMLIYE  580 (823)
Q Consensus       510 ~~LG~G~fg~Vyk~~~~~~--------~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e  580 (823)
                      +.|+.|-.-.+|+....++        +.|++++.. .. .......+|..+++.+. +.-..++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            4788788889999987542        456666554 32 23345678888888874 4334577887754    68999


Q ss_pred             ecCCCCcc
Q 003391          581 YLPNKSLN  588 (823)
Q Consensus       581 ~~~~gsL~  588 (823)
                      |+++..|.
T Consensus       122 fi~g~~l~  129 (395)
T d1nw1a_         122 YIPSRPLS  129 (395)
T ss_dssp             CCCEEECC
T ss_pred             EeccccCC
Confidence            99886554

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.99  E-value=0.066  Score=53.76  Aligned_cols=158  Identities=12%  Similarity=-0.014  Sum_probs=81.2

Q ss_pred             CHHHHHHHhcCCCcCCeee-----ccCccceEEEEeecCcEEEEEEecCCccccHHHHHHHHHHHhccCCC--CceeEEE
Q 003391          495 DWMAIANATENFSDKNKLG-----EGGFGPVYKGVLIEGQEIAAKRLSKSSGQGMEEFENEVLLIAKLQHR--NLVKLIG  567 (823)
Q Consensus       495 ~~~~l~~~~~~~~~~~~LG-----~G~fg~Vyk~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g  567 (823)
                      +..++.....+|..++...     .|---+.|+.+..++ .+++|+.....  ..+++..|+.++..+.+.  .+...+.
T Consensus         4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~   80 (316)
T d2ppqa1           4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP   80 (316)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred             CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence            4556777777787655443     455567899887555 58899886532  223455566666666322  1222211


Q ss_pred             E------eecCCceEEEEeecCCCCcchhh--------------hccCC--------CCcc----------------CHH
Q 003391          568 C------CTQRDERMLIYEYLPNKSLNDFI--------------FDVTR--------SKFL----------------DWS  603 (823)
Q Consensus       568 ~------~~~~~~~~lV~e~~~~gsL~~~l--------------~~~~~--------~~~l----------------~~~  603 (823)
                      .      .........++.++.+......-              +....        ....                ...
T Consensus        81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (316)
T d2ppqa1          81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK  160 (316)
T ss_dssp             BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred             ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence            1      11234456677777664432110              00000        0000                000


Q ss_pred             HHHHHHHHHHHHHHHHHhc-CCCceEecccCCCcEEEcCCCCceeecccccee
Q 003391          604 KRCQIIGGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNEMNPKISDFGMARA  655 (823)
Q Consensus       604 ~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~kl~DFGla~~  655 (823)
                      .....+..+...+.-.+.. -+..+||+|+.+.||+++.+...-|.||+.+..
T Consensus       161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            1111122222222222221 233599999999999999988778999998863

>d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=93.06  E-value=0.021  Score=35.78  Aligned_cols=33  Identities=33%  Similarity=0.757  Sum_probs=26.1

Q ss_pred             ccCCccCCCCCCccccCCCCCCcccccCCCccCC
Q 003391          285 DQCDNYALCGAYAVCNMNSNSAKCECLEGFVPKS  318 (823)
Q Consensus       285 d~Cd~~g~CG~~g~C~~~~~~~~C~C~~Gf~~~~  318 (823)
                      |+|.+-..|| ||.|+.--..-.|.|-.||+|..
T Consensus         2 dECsignpCG-nGTCtNviGgFec~C~~GFepgp   34 (39)
T d1emoa2           2 DECSVGNPCG-NGTCKNVIGGFECTCEEGFEPGP   34 (39)
T ss_dssp             CGGGTTCSSS-SSCEEECSSSEEECCSSSSCCCS
T ss_pred             CccccCCccC-CceeeecccceEEeecCCcCCCc
Confidence            7899999998 68896432345799999999874

>d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Neurogenic locus notch homolog protein 1, Notch1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=90.67  E-value=0.041  Score=37.00  Aligned_cols=32  Identities=28%  Similarity=0.702  Sum_probs=25.7

Q ss_pred             cccCCc-cCCCCCCccccCCCCCCcccccCCCc
Q 003391          284 LDQCDN-YALCGAYAVCNMNSNSAKCECLEGFV  315 (823)
Q Consensus       284 ~d~Cd~-~g~CG~~g~C~~~~~~~~C~C~~Gf~  315 (823)
                      .|+|.. ...|..+|.|.....+..|.|++||.
T Consensus         3 ideC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~   35 (42)
T d2vj3a1           3 VDECSLGANPCEHAGKCINTLGSFECQCLQGYT   35 (42)
T ss_dssp             CCTTTSSSCSSSTTCEEEECSSSEEEECCTTEE
T ss_pred             CccccCCCCCCCCCcEeECCCCCEEeECCCCCc
Confidence            367875 57899999997554667999999995

>d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Factor X, N-terminal module
species: Human (Homo sapiens) [TaxId: 9606]

Probab=88.43  E-value=0.11  Score=34.10  Aligned_cols=30  Identities=37%  Similarity=0.823  Sum_probs=23.1

Q ss_pred             ccCCccCCCCCCccccCCCCCCcccccCCCc
Q 003391          285 DQCDNYALCGAYAVCNMNSNSAKCECLEGFV  315 (823)
Q Consensus       285 d~Cd~~g~CG~~g~C~~~~~~~~C~C~~Gf~  315 (823)
                      |+|. ...|...|.|........|.|++||.
T Consensus         1 D~C~-~~PC~ngg~C~~~~~~y~C~C~~G~~   30 (39)
T d1xkba1           1 DQCE-TSPCQNQGKCKDGLGEYTCTCLEGFE   30 (39)
T ss_dssp             CTTT-TCCCCSSCEECCCSSSCCEECCTTEE
T ss_pred             CcCC-CCCCCCCcEEECCCCCEEEECCCCCC
Confidence            4565 47789999997554667899999985

>d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=86.39  E-value=0.2  Score=33.59  Aligned_cols=32  Identities=25%  Similarity=0.552  Sum_probs=25.3

Q ss_pred             cccCCccCCCCCCccccCCCCCCcccccCCCcc
Q 003391          284 LDQCDNYALCGAYAVCNMNSNSAKCECLEGFVP  316 (823)
Q Consensus       284 ~d~Cd~~g~CG~~g~C~~~~~~~~C~C~~Gf~~  316 (823)
                      .|+|... .|+.++.|.....+-.|.|++||..
T Consensus         5 idEC~~~-~~~~~~~C~Nt~Gsy~C~C~~Gy~~   36 (43)
T d1emoa1           5 MDECKEP-DVCKHGQCINTDGSYRCECPFGYIL   36 (43)
T ss_dssp             CCSSSST-TSCSSSCCCCCSSCCCCCCCTTEEE
T ss_pred             eeccCCc-CCCCCCEeECCCCCeEeECCCCccc
Confidence            4889765 4567899976657789999999976

>d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Low density lipoprotein (LDL) receptor, different EGF domains
species: Human (Homo sapiens) [TaxId: 9606]

Probab=86.31  E-value=0.16  Score=33.68  Aligned_cols=31  Identities=32%  Similarity=0.746  Sum_probs=24.4

Q ss_pred             ccCCccCCCCCCccccCCCCCCcccccCCCccC
Q 003391          285 DQCDNYALCGAYAVCNMNSNSAKCECLEGFVPK  317 (823)
Q Consensus       285 d~Cd~~g~CG~~g~C~~~~~~~~C~C~~Gf~~~  317 (823)
                      |+|...+.|  ..+|.....+-.|+|++||...
T Consensus         2 dEC~~~~~C--~~~C~n~~Gsy~C~C~~Gy~L~   32 (41)
T d1i0ua2           2 DECQDPDTC--SQLCVNLEGGYKCQCEEGFQLD   32 (41)
T ss_dssp             CTTTTTTSC--SSCEECSSSCCEECCCTTEEEC
T ss_pred             ccCCCCCCC--CCEeECCCCCEEeECCCCCeEC
Confidence            678877777  4689765567799999999875

>d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=86.04  E-value=0.052  Score=36.45  Aligned_cols=33  Identities=33%  Similarity=0.712  Sum_probs=24.4

Q ss_pred             ccCCc-cCCCCCCccccCCCCCCcccccCCCccCC
Q 003391          285 DQCDN-YALCGAYAVCNMNSNSAKCECLEGFVPKS  318 (823)
Q Consensus       285 d~Cd~-~g~CG~~g~C~~~~~~~~C~C~~Gf~~~~  318 (823)
                      |+|.. ++.|. +++|.....+-.|.|++||....
T Consensus         3 dEC~~~~~~C~-~~~C~Nt~Gsy~C~C~~Gy~l~~   36 (42)
T d1lmja2           3 DECQRDPLLCR-GGVCHNTEGSYRCECPPGHQLSP   36 (42)
T ss_dssp             CHHHHCSSTTT-TSEEEEETTEEEEESCTTSCCCS
T ss_pred             cccCCCCCCCC-CCEeECCCCCeEEeCCCCCeECc
Confidence            45644 56774 78997655677999999998753

>d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Neurogenic locus notch homolog protein 1, Notch1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=84.20  E-value=0.16  Score=33.24  Aligned_cols=30  Identities=23%  Similarity=0.605  Sum_probs=23.0

Q ss_pred             ccCCccCCCCCCccccCCCCCCcccccCCCc
Q 003391          285 DQCDNYALCGAYAVCNMNSNSAKCECLEGFV  315 (823)
Q Consensus       285 d~Cd~~g~CG~~g~C~~~~~~~~C~C~~Gf~  315 (823)
                      |+|. ..-|...|.|.....+..|.|++||.
T Consensus         2 d~C~-~~PC~n~g~C~~~~~~y~C~C~~G~~   31 (39)
T d2vj3a2           2 NECV-SNPCQNDATCLDQIGEFQCICMPGYE   31 (39)
T ss_dssp             CTTT-TCCCCSSCEEEECSSCEEEECCTTEE
T ss_pred             cCCc-CCCCCCCCEEECCCCCEEEeCCCCCc
Confidence            4564 46799999997554677999999984

>d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=84.18  E-value=0.11  Score=34.89  Aligned_cols=33  Identities=21%  Similarity=0.522  Sum_probs=25.8

Q ss_pred             cccCCccCCCCCCccccCCCCCCcccccCCCccC
Q 003391          284 LDQCDNYALCGAYAVCNMNSNSAKCECLEGFVPK  317 (823)
Q Consensus       284 ~d~Cd~~g~CG~~g~C~~~~~~~~C~C~~Gf~~~  317 (823)
                      .|+|.....| -+++|.....+-.|+|++||+..
T Consensus         3 idEC~~~~~~-c~~~C~Nt~G~y~C~C~~Gy~l~   35 (43)
T d1uzka1           3 VNECLDPTTC-ISGNCVNTPGSYICDCPPDFELN   35 (43)
T ss_dssp             CCGGGSTTSS-BTSEEEEETTEEEEECCTTCEEC
T ss_pred             ccccCCCCcC-cCCEeECCCCCEEEecCCCCEEC
Confidence            3789887666 57999755567799999999875

>d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Factor IX (IXa)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=84.04  E-value=0.14  Score=33.61  Aligned_cols=31  Identities=35%  Similarity=0.580  Sum_probs=24.6

Q ss_pred             cccCCccCCCCCCccccCCCCCCcccccCCCc
Q 003391          284 LDQCDNYALCGAYAVCNMNSNSAKCECLEGFV  315 (823)
Q Consensus       284 ~d~Cd~~g~CG~~g~C~~~~~~~~C~C~~Gf~  315 (823)
                      .|+|. ...|-..|.|.......+|.|++||+
T Consensus         3 ~d~C~-~~PC~ngg~C~~~~~~y~C~C~~g~~   33 (39)
T d1edmb_           3 GDQCE-SNPCLNGGSCKDDINSYECWCPFGFE   33 (39)
T ss_dssp             CCTTT-TCCCCTTCEEEEETTEEEEECCTTCC
T ss_pred             cccCC-CCCCCCCcEEEcCCCCEEEECCCCCC
Confidence            36786 57899999997554677999999985

>d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=82.68  E-value=0.16  Score=34.24  Aligned_cols=34  Identities=26%  Similarity=0.641  Sum_probs=25.2

Q ss_pred             cccCCc-cCCCCCCccccCCCCCCcccccCCCccCC
Q 003391          284 LDQCDN-YALCGAYAVCNMNSNSAKCECLEGFVPKS  318 (823)
Q Consensus       284 ~d~Cd~-~g~CG~~g~C~~~~~~~~C~C~~Gf~~~~  318 (823)
                      .|+|.. ...| .++.|.....+-.|.|++||+...
T Consensus         3 idEC~~~~~~C-~~~~C~Nt~Gsy~C~C~~Gy~~~~   37 (44)
T d1lmja1           3 IDECRISPDLC-GRGQCVNTPGDFECKCDEGYESGF   37 (44)
T ss_dssp             CCTTTTCSSTT-TTSCEEEETTEEEECCCSSEEECT
T ss_pred             ccccCCCCCCC-CCCEeEcCCCCeEEeCCCCCccCC
Confidence            377876 4455 479997555678999999997653